Prevalence	O
of	O
Local	O
Immune	O
Response	O
against	O
Oral	O
Infection	O
in	O
a	O
Drosophila	B-Organism
/	O
Pseudomonas	B-Organism
Infection	O
Model	O

Pathogens	O
have	O
developed	O
multiple	O
strategies	O
that	O
allow	O
them	O
to	O
exploit	O
host	O
resources	O
and	O
resist	O
the	O
immune	O
response	O
.	O
<EOS>	B-X
Pathogens	B-X
have	B-X
developed	B-X
multiple	B-X
strategies	B-X
that	B-X
allow	B-X
them	B-X
to	B-X
exploit	B-X
host	B-X
resources	B-X
and	B-X
resist	B-X
the	B-X
immune	B-X
response	B-X
.	B-X
Flies	B-X
orally	B-X
infected	B-X
with	B-X
P.	B-X
entomophila	B-X
rapidly	B-X
succumb	B-X
despite	B-X
the	B-X
induction	B-X
of	B-X
both	B-X
local	B-X
and	B-X
systemic	B-X
immune	B-X
responses	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
bacterium	B-X
has	B-X
developed	B-X
specific	B-X
strategies	B-X
to	B-X
escape	B-X
the	B-X
fly	B-X
immune	B-X
response	B-X
.	B-X
Using	B-X
a	B-X
combined	B-X
genetic	B-X
approach	B-X
on	B-X
both	B-X
host	B-X
and	B-X
pathogen	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
P.	B-X
entomophila	B-X
virulence	B-X
is	B-X
multi-factorial	B-X
with	B-X
a	B-X
clear	B-X
differentiation	B-X
between	B-X
factors	B-X
that	B-X
trigger	B-X
the	B-X
immune	B-X
response	B-X
and	B-X
those	B-X
that	B-X
promote	B-X
pathogenicity	B-X
.	B-X
Inactivation	B-X
of	B-X
aprA	B-X
attenuated	B-X
both	B-X
the	B-X
capacity	B-X
to	B-X
persist	B-X
in	B-X
the	B-X
host	B-X
and	B-X
pathogenicity	B-X
.	B-X
Interestingly	B-X
,	B-X
aprA	B-X
mutants	B-X
were	B-X
able	B-X
to	B-X
survive	B-X
to	B-X
wild-type	B-X
levels	B-X
in	B-X
immune-deficient	B-X
Relish	B-X
flies	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
protease	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
protection	B-X
against	B-X
the	B-X
Drosophila	B-X
immune	B-X
response	B-X
.	B-X
Our	B-X
study	B-X
also	B-X
reveals	B-X
that	B-X
the	B-X
major	B-X
contribution	B-X
to	B-X
the	B-X
fly	B-X
defense	B-X
against	B-X
P.	B-X
entomophila	B-X
is	B-X
provided	B-X
by	B-X
the	B-X
local	B-X
,	B-X
rather	B-X
than	B-X
the	B-X
systemic	B-X
immune	B-X
response	B-X
.	B-X

To	O
study	O
how	O
Drosophila	B-Organism
flies	O
deal	O
with	O
infectious	O
diseases	O
in	O
a	O
natural	O
context	O
,	O
we	O
investigated	O
the	O
interactions	O
between	O
Drosophila	B-Organism
and	O
a	O
newly	O
identified	O
entomopathogen	O
,	O
Pseudomonas	B-Organism
entomophila	I-Organism
.	O

Flies	O
orally	O
infected	O
with	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
rapidly	O
succumb	O
despite	O
the	O
induction	O
of	O
both	O
local	O
and	O
systemic	O
immune	O
responses	O
,	O
indicating	O
that	O
this	O
bacterium	O
has	O
developed	O
specific	O
strategies	O
to	O
escape	O
the	O
fly	O
immune	O
response	O
.	O

Using	O
a	O
combined	O
genetic	O
approach	O
on	O
both	O
host	O
and	O
pathogen	O
,	O
we	O
showed	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
is	O
multi	O
-	O
factorial	O
with	O
a	O
clear	O
differentiation	O
between	O
factors	O
that	O
trigger	O
the	O
immune	O
response	O
and	O
those	O
that	O
promote	O
pathogenicity	O
.	O

We	O
demonstrate	O
that	O
AprA	O
,	O
an	O
abundant	O
secreted	O
metalloprotease	O
produced	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
is	O
an	O
important	O
virulence	O
factor	O
.	O
<EOS>	B-X
Pathogens	B-X
have	B-X
developed	B-X
multiple	B-X
strategies	B-X
that	B-X
allow	B-X
them	B-X
to	B-X
exploit	B-X
host	B-X
resources	B-X
and	B-X
resist	B-X
the	B-X
immune	B-X
response	B-X
.	B-X
To	B-X
study	B-X
how	B-X
Drosophila	B-X
flies	B-X
deal	B-X
with	B-X
infectious	B-X
diseases	B-X
in	B-X
a	B-X
natural	B-X
context	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
interactions	B-X
between	B-X
Drosophila	B-X
and	B-X
a	B-X
newly	B-X
identified	B-X
entomopathogen	B-X
,	B-X
Pseudomonas	B-X
entomophila	B-X
.	B-X
Flies	B-X
orally	B-X
infected	B-X
with	B-X
P.	B-X
entomophila	B-X
rapidly	B-X
succumb	B-X
despite	B-X
the	B-X
induction	B-X
of	B-X
both	B-X
local	B-X
and	B-X
systemic	B-X
immune	B-X
responses	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
bacterium	B-X
has	B-X
developed	B-X
specific	B-X
strategies	B-X
to	B-X
escape	B-X
the	B-X
fly	B-X
immune	B-X
response	B-X
.	B-X
Using	B-X
a	B-X
combined	B-X
genetic	B-X
approach	B-X
on	B-X
both	B-X
host	B-X
and	B-X
pathogen	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
P.	B-X
entomophila	B-X
virulence	B-X
is	B-X
multi-factorial	B-X
with	B-X
a	B-X
clear	B-X
differentiation	B-X
between	B-X
factors	B-X
that	B-X
trigger	B-X
the	B-X
immune	B-X
response	B-X
and	B-X
those	B-X
that	B-X
promote	B-X
pathogenicity	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
AprA	B-X
,	B-X
an	B-X
abundant	B-X
secreted	B-X
metalloprotease	B-X
produced	B-X
by	B-X
P.	B-X
entomophila	B-X
,	B-X
is	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X
Interestingly	B-X
,	B-X
aprA	B-X
mutants	B-X
were	B-X
able	B-X
to	B-X
survive	B-X
to	B-X
wild-type	B-X
levels	B-X
in	B-X
immune-deficient	B-X
Relish	B-X
flies	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
protease	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
protection	B-X
against	B-X
the	B-X
Drosophila	B-X
immune	B-X
response	B-X
.	B-X
Our	B-X
study	B-X
also	B-X
reveals	B-X
that	B-X
the	B-X
major	B-X
contribution	B-X
to	B-X
the	B-X
fly	B-X
defense	B-X
against	B-X
P.	B-X
entomophila	B-X
is	B-X
provided	B-X
by	B-X
the	B-X
local	B-X
,	B-X
rather	B-X
than	B-X
the	B-X
systemic	B-X
immune	B-X
response	B-X
.	B-X
More	B-X
precisely	B-X
,	B-X
our	B-X
data	B-X
points	B-X
to	B-X
an	B-X
important	B-X
role	B-X
for	B-X
the	B-X
antimicrobial	B-X
peptide	B-X
Diptericin	B-X
against	B-X
orally	B-X
infectious	B-X
Gram-negative	B-X
bacteria	B-X
,	B-X
emphasizing	B-X
the	B-X
critical	B-X
role	B-X
of	B-X
local	B-X
antimicrobial	B-X
peptide	B-X
expression	B-X
against	B-X
food-borne	B-X
pathogens	B-X
.	B-X

Inactivation	O
of	O
aprA	O
attenuated	O
both	O
the	O
capacity	O
to	O
persist	O
in	O
the	O
host	O
and	O
pathogenicity	O
.	O
<EOS>	B-X
Pathogens	B-X
have	B-X
developed	B-X
multiple	B-X
strategies	B-X
that	B-X
allow	B-X
them	B-X
to	B-X
exploit	B-X
host	B-X
resources	B-X
and	B-X
resist	B-X
the	B-X
immune	B-X
response	B-X
.	B-X
Using	B-X
a	B-X
combined	B-X
genetic	B-X
approach	B-X
on	B-X
both	B-X
host	B-X
and	B-X
pathogen	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
P.	B-X
entomophila	B-X
virulence	B-X
is	B-X
multi-factorial	B-X
with	B-X
a	B-X
clear	B-X
differentiation	B-X
between	B-X
factors	B-X
that	B-X
trigger	B-X
the	B-X
immune	B-X
response	B-X
and	B-X
those	B-X
that	B-X
promote	B-X
pathogenicity	B-X
.	B-X
Inactivation	B-X
of	B-X
aprA	B-X
attenuated	B-X
both	B-X
the	B-X
capacity	B-X
to	B-X
persist	B-X
in	B-X
the	B-X
host	B-X
and	B-X
pathogenicity	B-X
.	B-X
Interestingly	B-X
,	B-X
aprA	B-X
mutants	B-X
were	B-X
able	B-X
to	B-X
survive	B-X
to	B-X
wild-type	B-X
levels	B-X
in	B-X
immune-deficient	B-X
Relish	B-X
flies	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
protease	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
protection	B-X
against	B-X
the	B-X
Drosophila	B-X
immune	B-X
response	B-X
.	B-X

Interestingly	O
,	O
aprA	O
mutants	O
were	O
able	O
to	O
survive	O
to	O
wild	O
-	O
type	O
levels	O
in	O
immune	O
-	O
deficient	O
Relish	B-Organism
flies	I-Organism
,	O
indicating	O
that	O
the	O
protease	O
plays	O
an	O
important	O
role	O
in	O
protection	O
against	O
the	O
Drosophila	B-Organism
immune	O
response	O
.	O
<EOS>	B-X
Pathogens	B-X
have	B-X
developed	B-X
multiple	B-X
strategies	B-X
that	B-X
allow	B-X
them	B-X
to	B-X
exploit	B-X
host	B-X
resources	B-X
and	B-X
resist	B-X
the	B-X
immune	B-X
response	B-X
.	B-X
To	B-X
study	B-X
how	B-X
Drosophila	B-X
flies	B-X
deal	B-X
with	B-X
infectious	B-X
diseases	B-X
in	B-X
a	B-X
natural	B-X
context	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
interactions	B-X
between	B-X
Drosophila	B-X
and	B-X
a	B-X
newly	B-X
identified	B-X
entomopathogen	B-X
,	B-X
Pseudomonas	B-X
entomophila	B-X
.	B-X
Flies	B-X
orally	B-X
infected	B-X
with	B-X
P.	B-X
entomophila	B-X
rapidly	B-X
succumb	B-X
despite	B-X
the	B-X
induction	B-X
of	B-X
both	B-X
local	B-X
and	B-X
systemic	B-X
immune	B-X
responses	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
bacterium	B-X
has	B-X
developed	B-X
specific	B-X
strategies	B-X
to	B-X
escape	B-X
the	B-X
fly	B-X
immune	B-X
response	B-X
.	B-X
Using	B-X
a	B-X
combined	B-X
genetic	B-X
approach	B-X
on	B-X
both	B-X
host	B-X
and	B-X
pathogen	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
P.	B-X
entomophila	B-X
virulence	B-X
is	B-X
multi-factorial	B-X
with	B-X
a	B-X
clear	B-X
differentiation	B-X
between	B-X
factors	B-X
that	B-X
trigger	B-X
the	B-X
immune	B-X
response	B-X
and	B-X
those	B-X
that	B-X
promote	B-X
pathogenicity	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
AprA	B-X
,	B-X
an	B-X
abundant	B-X
secreted	B-X
metalloprotease	B-X
produced	B-X
by	B-X
P.	B-X
entomophila	B-X
,	B-X
is	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X
Inactivation	B-X
of	B-X
aprA	B-X
attenuated	B-X
both	B-X
the	B-X
capacity	B-X
to	B-X
persist	B-X
in	B-X
the	B-X
host	B-X
and	B-X
pathogenicity	B-X
.	B-X
Interestingly	B-X
,	B-X
aprA	B-X
mutants	B-X
were	B-X
able	B-X
to	B-X
survive	B-X
to	B-X
wild-type	B-X
levels	B-X
in	B-X
immune-deficient	B-X
Relish	B-X
flies	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
protease	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
protection	B-X
against	B-X
the	B-X
Drosophila	B-X
immune	B-X
response	B-X
.	B-X
Our	B-X
study	B-X
also	B-X
reveals	B-X
that	B-X
the	B-X
major	B-X
contribution	B-X
to	B-X
the	B-X
fly	B-X
defense	B-X
against	B-X
P.	B-X
entomophila	B-X
is	B-X
provided	B-X
by	B-X
the	B-X
local	B-X
,	B-X
rather	B-X
than	B-X
the	B-X
systemic	B-X
immune	B-X
response	B-X
.	B-X
More	B-X
precisely	B-X
,	B-X
our	B-X
data	B-X
points	B-X
to	B-X
an	B-X
important	B-X
role	B-X
for	B-X
the	B-X
antimicrobial	B-X
peptide	B-X
Diptericin	B-X
against	B-X
orally	B-X
infectious	B-X
Gram-negative	B-X
bacteria	B-X
,	B-X
emphasizing	B-X
the	B-X
critical	B-X
role	B-X
of	B-X
local	B-X
antimicrobial	B-X
peptide	B-X
expression	B-X
against	B-X
food-borne	B-X
pathogens	B-X
.	B-X

Our	O
study	O
also	O
reveals	O
that	O
the	O
major	O
contribution	O
to	O
the	O
fly	O
defense	O
against	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
is	O
provided	O
by	O
the	O
local	O
,	O
rather	O
than	O
the	O
systemic	O
immune	O
response	O
.	O

More	O
precisely	O
,	O
our	O
data	O
points	O
to	O
an	O
important	O
role	O
for	O
the	O
antimicrobial	O
peptide	O
Diptericin	O
against	O
orally	O
infectious	O
Gram	O
-	O
negative	O
bacteria	O
,	O
emphasizing	O
the	O
critical	O
role	O
of	O
local	O
antimicrobial	O
peptide	O
expression	O
against	O
food	O
-	O
borne	O
pathogens	O
.	O

Introduction	O

Host	O
-	O
pathogen	O
interactions	O
are	O
complex	O
relationships	O
in	O
which	O
the	O
success	O
of	O
each	O
organism	O
depends	O
on	O
its	O
ability	O
to	O
overcome	O
the	O
other	O
.	O

Consequently	O
,	O
hosts	O
have	O
evolved	O
surveillance	O
and	O
defense	O
mechanisms	O
to	O
detect	O
and	O
eliminate	O
invading	O
microorganisms	O
,	O
whereas	O
pathogens	O
use	O
sophisticated	O
strategies	O
to	O
counteract	O
such	O
responses	O
.	O

In	O
recent	O
years	O
,	O
Drosophila	B-Organism
has	O
emerged	O
as	O
a	O
powerful	O
model	O
for	O
the	O
study	O
of	O
host	O
-	O
pathogen	O
interactions	O
[	O
1	O
,	O
2	O
]	O
.	O

An	O
attractive	O
feature	O
of	O
the	O
Drosophila	B-Organism
system	O
is	O
the	O
existence	O
of	O
multiple	O
defense	O
reactions	O
that	O
are	O
shared	O
with	O
higher	O
organisms	O
[	O
3	O
-	O
5	O
]	O
.	O

These	O
strategies	O
include	O
physical	O
barriers	O
,	O
together	O
with	O
the	O
local	O
and	O
systemic	O
immune	O
responses	O
.	O
<EOS>	B-X
These	B-X
reactions	B-X
include	B-X
the	B-X
use	B-X
of	B-X
physical	B-X
barriers	B-X
together	B-X
with	B-X
local	B-X
and	B-X
systemic	B-X
immune	B-X
responses	B-X
.	B-X
First	B-X
,	B-X
epithelia	B-X
,	B-X
such	B-X
as	B-X
those	B-X
beneath	B-X
the	B-X
cuticle	B-X
,	B-X
in	B-X
the	B-X
alimentary	B-X
tract	B-X
,	B-X
and	B-X
in	B-X
tracheae	B-X
,	B-X
act	B-X
both	B-X
as	B-X
a	B-X
physical	B-X
barrier	B-X
and	B-X
local	B-X
defense	B-X
against	B-X
pathogens	B-X
by	B-X
producing	B-X
antimicrobial	B-X
peptides	B-X
and	B-X
reactive	B-X
oxygen	B-X
species	B-X
.	B-X
Here	B-X
we	B-X
review	B-X
our	B-X
current	B-X
knowledge	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
Drosophila	B-X
defense	B-X
reactions	B-X
together	B-X
with	B-X
strategies	B-X
evolved	B-X
by	B-X
pathogens	B-X
to	B-X
evade	B-X
them	B-X
.	B-X

Several	O
tissues	O
participate	O
in	O
a	O
coordinated	O
defense	O
against	O
microbial	O
infection	O
.	O

Firstly	O
,	O
epithelia	O
,	O
such	O
as	O
alimentary	O
tract	O
and	O
tracheae	O
,	O
are	O
the	O
first	O
line	O
of	O
defense	O
against	O
pathogens	O
and	O
produce	O
both	O
antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
and	O
reactive	O
oxygen	O
species	O
.	O

Secondly	O
,	O
specialized	O
hemocytes	O
participate	O
in	O
phagocytosis	O
and	O
encapsulation	O
of	O
foreign	O
intruders	O
.	O

Finally	O
,	O
the	O
fat	O
body	O
,	O
a	O
functional	O
equivalent	O
of	O
the	O
mammalian	O
liver	O
,	O
is	O
the	O
site	O
of	O
the	O
humoral	O
response	O
.	O

Several	O
genetic	O
studies	O
have	O
demonstrated	O
the	O
regulation	O
of	O
AMP	O
synthesis	O
by	O
the	O
Toll	O
and	O
immune	O
-	O
deficient	O
(	O
Imd	O
)	O
pathways	O
.	O
<EOS>	B-X
An	B-X
important	B-X
innate	B-X
immune	B-X
response	B-X
in	B-X
Drosophila	B-X
melanogaster	B-X
is	B-X
the	B-X
production	B-X
of	B-X
antimicrobial	B-X
peptides	B-X
(	B-X
AMPs	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
AMP	B-X
genes	B-X
is	B-X
mediated	B-X
by	B-X
the	B-X
Toll	B-X
and	B-X
immune	B-X
deficiency	B-X
(	B-X
IMD	B-X
)	B-X
pathways	B-X
via	B-X
NF-κB	B-X
transcription	B-X
factors	B-X
Dorsal	B-X
,	B-X
DIF	B-X
and	B-X
Relish	B-X
.	B-X
Dorsal	B-X
and	B-X
DIF	B-X
act	B-X
downstream	B-X
of	B-X
the	B-X
Toll	B-X
pathway	B-X
,	B-X
whereas	B-X
Relish	B-X
acts	B-X
in	B-X
the	B-X
IMD	B-X
pathway	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
activity	B-X
of	B-X
Rel	B-X
homology	B-X
domains	B-X
(	B-X
RHDs	B-X
)	B-X
of	B-X
Dorsal	B-X
,	B-X
DIF	B-X
and	B-X
Relish	B-X
in	B-X
activation	B-X
of	B-X
Drosophila	B-X
AMP	B-X
gene	B-X
promoters	B-X
,	B-X
demonstrated	B-X
that	B-X
Relish-RHD	B-X
(	B-X
Rel-RHD	B-X
)	B-X
interacted	B-X
with	B-X
both	B-X
Dorsal-RHD	B-X
and	B-X
DIF-RHD	B-X
,	B-X
Relish-N	B-X
interacted	B-X
with	B-X
DIF	B-X
and	B-X
Dorsal	B-X
,	B-X
and	B-X
overexpression	B-X
of	B-X
individual	B-X
RHD	B-X
and	B-X
co-expression	B-X
of	B-X
any	B-X
two	B-X
RHDs	B-X
activated	B-X
the	B-X
activity	B-X
of	B-X
AMP	B-X
gene	B-X
promoters	B-X
to	B-X
various	B-X
levels	B-X
,	B-X
suggesting	B-X
formation	B-X
of	B-X
homodimers	B-X
and	B-X
heterodimers	B-X
among	B-X
Dorsal	B-X
,	B-X
DIF	B-X
and	B-X
Relish	B-X
.	B-X
Rel-RHD	B-X
homodimers	B-X
were	B-X
stronger	B-X
activators	B-X
than	B-X
heterodimers	B-X
of	B-X
Rel-RHD	B-X
with	B-X
either	B-X
DIF-RHD	B-X
or	B-X
Dorsal-RHD	B-X
,	B-X
while	B-X
DIF-RHD-Dorsal-RHD	B-X
heterodimers	B-X
were	B-X
stronger	B-X
activators	B-X
than	B-X
either	B-X
DIF-RHD	B-X
or	B-X
Dorsal-RHD	B-X
homodimers	B-X
in	B-X
activation	B-X
of	B-X
AMP	B-X
gene	B-X
promoters	B-X
.	B-X

The	O
Toll	O
pathway	O
is	O
mainly	O
activated	O
by	O
Gram	O
-	O
positive	O
bacteria	O
and	O
fungi	O
,	O
and	O
controls	O
,	O
to	O
a	O
large	O
extent	O
,	O
the	O
expression	O
of	O
AMPs	O
(	O
e	O
.	O
g	O
.	O
,	O
Drosomycin	O
)	O
through	O
the	O
nuclear	O
factor	O
-	O
kappaB	O
transactivators	O
Dif	O
and	O
Dorsal	O
.	O

In	O
contrast	O
,	O
the	O
Imd	O
pathway	O
mainly	O
responds	O
to	O
Gram	O
-	O
negative	O
bacterial	O
infections	O
and	O
controls	O
different	O
AMP	O
genes	O
(	O
e	O
.	O
g	O
.	O
,	O
Diptericin	O
)	O
via	O
the	O
activation	O
of	O
the	O
nuclear	O
factor	O
-	O
kappaB	O
transactivator	O
Relish	O
(	O
Rel	O
)	O
[	O
3	O
,	O
4	O
,	O
6	O
]	O
.	O

In	O
addition	O
,	O
the	O
Imd	O
pathway	O
plays	O
a	O
predominant	O
role	O
in	O
the	O
regulation	O
of	O
AMPs	O
in	O
the	O
alimentary	O
tract	O
and	O
tracheal	O
epithelia	O
[	O
7	O
]	O
.	O

Our	O
knowledge	O
of	O
the	O
Drosophila	B-Organism
immune	O
response	O
is	O
mainly	O
based	O
on	O
the	O
analysis	O
of	O
host	O
reactions	O
following	O
direct	O
injection	O
of	O
non	O
-	O
pathogenic	O
bacteria	O
into	O
the	O
insect	O
hemocoel	O
.	O

One	O
limitation	O
associated	O
with	O
this	O
approach	O
is	O
that	O
it	O
bypasses	O
the	O
initial	O
steps	O
of	O
naturally	O
occurring	O
infections	O
,	O
including	O
bacterial	O
colonization	O
and	O
persistence	O
and	O
host	O
local	O
immune	O
responses	O
.	O

Septic	O
injury	O
is	O
probably	O
of	O
little	O
consequence	O
in	O
nature	O
,	O
unlike	O
oral	O
infection	O
upon	O
ingestion	O
.	O

In	O
addition	O
,	O
the	O
response	O
to	O
non	O
-	O
pathogenic	O
microorganisms	O
does	O
not	O
necessarily	O
reflect	O
a	O
natural	O
host	O
reaction	O
to	O
a	O
real	O
pathogen	O
.	O
<EOS>	B-X
A	B-X
large	B-X
variety	B-X
of	B-X
microorganisms	B-X
can	B-X
cause	B-X
pneumonia	B-X
,	B-X
including	B-X
bacteria	B-X
,	B-X
respiratory	B-X
viruses	B-X
and	B-X
fungi	B-X
,	B-X
and	B-X
there	B-X
are	B-X
great	B-X
geographical	B-X
variations	B-X
in	B-X
their	B-X
prevalence	B-X
.	B-X
Development	B-X
of	B-X
the	B-X
disease	B-X
largely	B-X
depends	B-X
on	B-X
the	B-X
host	B-X
immune	B-X
response	B-X
,	B-X
with	B-X
pathogen	B-X
characteristics	B-X
having	B-X
a	B-X
less	B-X
prominent	B-X
role	B-X
.	B-X
It	B-X
is	B-X
crucial	B-X
to	B-X
identify	B-X
the	B-X
causative	B-X
pathogens	B-X
,	B-X
as	B-X
delayed	B-X
and	B-X
inadequate	B-X
antimicrobial	B-X
therapy	B-X
can	B-X
lead	B-X
to	B-X
poor	B-X
outcomes	B-X
.	B-X
New	B-X
antibiotic	B-X
and	B-X
non-antibiotic	B-X
therapies	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
rapid	B-X
and	B-X
accurate	B-X
diagnostic	B-X
tests	B-X
that	B-X
can	B-X
detect	B-X
pathogens	B-X
and	B-X
antibiotic	B-X
resistance	B-X
will	B-X
improve	B-X
the	B-X
management	B-X
of	B-X
pneumonia	B-X
.	B-X

Recently	O
we	O
have	O
developed	O
the	O
use	O
of	O
natural	O
oral	O
infection	O
to	O
dissect	O
host	O
responses	O
of	O
Drosophila	B-Organism
after	O
challenge	O
with	O
bacteria	O
demonstrated	O
to	O
be	O
infectious	O
for	O
this	O
insect	O
.	O

We	O
have	O
isolated	O
several	O
Erwinia	B-Organism
carotovora	I-Organism
strains	O
,	O
such	O
as	O
Ecc15	B-Organism
,	O
for	O
their	O
capacity	O
to	O
persist	O
in	O
the	O
Drosophila	B-Organism
larval	O
gut	O
and	O
to	O
trigger	O
a	O
strong	O
systemic	O
immune	O
response	O
following	O
oral	O
infection	O
[	O
8	O
]	O
.	O

Although	O
not	O
a	O
pathogen	O
to	O
Drosophila	B-Organism
,	O
use	O
of	O
Ecc15	B-Organism
has	O
been	O
pivotal	O
in	O
revealing	O
the	O
ability	O
of	O
Drosophila	B-Organism
to	O
activate	O
an	O
adapted	O
response	O
to	O
persistent	O
microorganisms	O
in	O
the	O
gut	O
,	O
including	O
the	O
induction	O
of	O
local	O
immune	O
responses	O
.	O

More	O
recently	O
,	O
we	O
isolated	O
Pseudomonas	B-Organism
entomophila	I-Organism
,	O
a	O
Gram	O
-	O
negative	O
natural	O
bacterial	O
pathogen	O
of	O
Drosophila	B-Organism
,	O
from	O
flies	O
in	O
Guadeloupe	O
[	O
9	O
]	O
.	O

We	O
demonstrated	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
induces	O
both	O
systemic	O
and	O
local	O
immune	O
responses	O
in	O
Drosophila	B-Organism
and	O
causes	O
a	O
food	O
-	O
uptake	O
cessation	O
following	O
oral	O
infection	O
in	O
larvae	O
.	O

Importantly	O
,	O
in	O
contrast	O
to	O
Ecc15	B-Organism
,	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
is	O
highly	O
pathogenic	O
for	O
Drosophila	B-Organism
as	O
well	O
as	O
for	O
species	O
from	O
a	O
different	O
insect	O
order	O
(	O
Lepidoptera	O
)	O
.	O

The	O
genome	O
sequence	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
has	O
been	O
completed	O
and	O
reveals	O
the	O
existence	O
of	O
a	O
large	O
set	O
of	O
genes	O
encoding	O
putative	O
virulence	O
factors	O
such	O
as	O
proteases	O
,	O
lipases	O
,	O
toxins	O
,	O
alginate	O
synthesis	O
,	O
and	O
adhesion	O
factors	O
[	O
10	O
]	O
.	O

Transposon	O
mutagenesis	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
allowed	O
us	O
to	O
identify	O
several	O
regulatory	O
genes	O
required	O
to	O
infect	O
or	O
to	O
kill	O
Drosophila	B-Organism
.	O
<EOS>	B-X
Ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
is	B-X
used	B-X
to	B-X
treat	B-X
more	B-X
than	B-X
half	B-X
of	B-X
human	B-X
cancer	B-X
patients	B-X
.	B-X
Drosophila	B-X
melanogaster	B-X
is	B-X
a	B-X
premier	B-X
genetic	B-X
model	B-X
and	B-X
,	B-X
relevant	B-X
to	B-X
radiation	B-X
biology	B-X
of	B-X
cancer	B-X
,	B-X
Drosophila	B-X
larvae	B-X
display	B-X
an	B-X
amazing	B-X
capacity	B-X
to	B-X
regenerate	B-X
.	B-X
IR	B-X
doses	B-X
that	B-X
kill	B-X
more	B-X
than	B-X
half	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
larval	B-X
tissues	B-X
still	B-X
allow	B-X
complete	B-X
regeneration	B-X
to	B-X
produce	B-X
an	B-X
adult	B-X
fly	B-X
of	B-X
normal	B-X
size	B-X
and	B-X
pattern	B-X
.	B-X
In	B-X
this	B-X
regard	B-X
,	B-X
Drosophila	B-X
offers	B-X
an	B-X
unparalleled	B-X
model	B-X
to	B-X
study	B-X
both	B-X
types	B-X
of	B-X
responses	B-X
.	B-X

Among	O
them	O
we	O
identified	O
the	O
GacS	O
/	O
GacA	O
two	O
-	O
component	O
regulatory	O
system	O
which	O
,	O
in	O
Pseudomonas	B-Organism
fluorescens	I-Organism
,	O
has	O
been	O
well	O
characterized	O
and	O
demonstrated	O
to	O
be	O
an	O
essential	O
regulator	O
of	O
virulence	O
[	O
11	O
]	O
.	O

P	O
.	O
entomophila	O
gacA	O
mutants	O
are	O
non	O
-	O
pathogenic	O
and	O
fail	O
to	O
trigger	O
a	O
systemic	O
immune	O
response	O
after	O
ingestion	O
,	O
indicating	O
that	O
the	O
GacS	O
/	O
GacA	O
two	O
-	O
component	O
system	O
regulates	O
important	O
bacterial	O
virulence	O
effectors	O
required	O
to	O
infect	O
and	O
kill	O
flies	O
[	O
9	O
]	O
.	O

Despite	O
these	O
studies	O
,	O
little	O
is	O
known	O
about	O
the	O
mechanisms	O
used	O
by	O
bacterial	O
pathogens	O
to	O
interfere	O
with	O
the	O
corresponding	O
insect	O
host	O
defenses	O
.	O

Here	O
we	O
report	O
an	O
in	O
vivo	O
analysis	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
to	O
both	O
Drosophila	B-Organism
larvae	O
and	O
adult	O
flies	O
following	O
natural	O
oral	O
infection	O
.	O

We	O
present	O
in	O
vivo	O
evidence	O
for	O
a	O
direct	O
role	O
in	O
pathogenesis	O
of	O
the	O
secreted	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
zinc	O
metalloprotease	O
,	O
AprA	O
,	O
which	O
counteracts	O
AMPs	O
synthesized	O
by	O
the	O
host	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
the	O
Drosophila	B-Organism
Imd	O
-	O
regulated	O
local	O
gut	O
response	O
is	O
necessary	O
to	O
combat	O
infection	O
and	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
AprA	O
-	O
regulation	O
via	O
GacS	O
/	O
GacA	O
and	O
PrtR	O
regulators	O
is	O
used	O
as	O
a	O
strategy	O
to	O
escape	O
AMP	O
activity	O
.	O

This	O
study	O
also	O
highlights	O
the	O
importance	O
of	O
the	O
gut	O
immune	O
response	O
in	O
the	O
control	O
of	O
food	O
-	O
borne	O
pathogens	O
.	O

Results	O

P	B-Organism
.	I-Organism
entomophila	I-Organism
Secretes	O
an	O
Abundant	O
Protease	O
A	O
common	O
strategy	O
used	O
by	O
bacterial	O
pathogens	O
is	O
to	O
secrete	O
toxins	O
and	O
other	O
virulence	O
factors	O
that	O
damage	O
host	O
tissues	O
.	O

To	O
test	O
whether	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
could	O
secrete	O
such	O
toxic	O
factors	O
,	O
a	O
supernatant	O
filtrate	O
from	O
a	O
bacterial	O
culture	O
was	O
tested	O
for	O
its	O
ability	O
to	O
kill	O
Drosophila	B-Organism
.	O

Figure	O
1A	O
shows	O
that	O
a	O
concentrated	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
culture	O
filtrate	O
had	O
a	O
moderate	O
but	O
significant	O
effect	O
on	O
Drosophila	B-Organism
larvae	O
survival	O
following	O
ingestion	O
.	O

Although	O
the	O
filtrate	O
did	O
not	O
kill	O
adult	O
flies	O
after	O
feeding	O
(	O
unpublished	O
data	O
)	O
,	O
it	O
was	O
highly	O
toxic	O
by	O
direct	O
injection	O
into	O
the	O
hemocoel	O
(	O
Figure	O
1B	O
)	O
.	O

No	O
killing	O
of	O
either	O
larvae	O
or	O
adults	O
was	O
observed	O
with	O
a	O
culture	O
filtrate	O
derived	O
from	O
the	O
avirulent	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
strain	O
carrying	O
a	O
Tn5	O
transposon	O
in	O
the	O
gacA	O
gene	O
[	O
9	O
]	O
.	O
<EOS>	B-X
Therefore	B-X
,	B-X
to	B-X
investigate	B-X
the	B-X
decoction	B-X
effect	B-X
of	B-X
the	B-X
plant	B-X
C.	B-X
abrotanoides	B-X
L.	B-X
on	B-X
mosquito	B-X
larvae	B-X
killing	B-X
,	B-X
we	B-X
detected	B-X
the	B-X
mortality	B-X
of	B-X
larvae	B-X
after	B-X
treatment	B-X
with	B-X
different	B-X
concentrations	B-X
(	B-X
60	B-X
mg/mL	B-X
,	B-X
120	B-X
mg/mL	B-X
,	B-X
and	B-X
180	B-X
mg/mL	B-X
)	B-X
of	B-X
decoction	B-X
within	B-X
a	B-X
series	B-X
of	B-X
time	B-X
points	B-X
(	B-X
12	B-X
h	B-X
,	B-X
24	B-X
h	B-X
,	B-X
36	B-X
h	B-X
,	B-X
and	B-X
48	B-X
h	B-X
)	B-X
.	B-X
We	B-X
found	B-X
that	B-X
24	B-X
h	B-X
with	B-X
180	B-X
mg/mL	B-X
C.	B-X
abrotanoides	B-X
L.	B-X
decoction	B-X
treatment	B-X
killed	B-X
92.35	B-X
%	B-X
of	B-X
mosquitoes	B-X
relative	B-X
to	B-X
the	B-X
control	B-X
treatment	B-X
.	B-X
Meanwhile	B-X
,	B-X
36	B-X
h	B-X
with	B-X
120	B-X
mg/mL	B-X
could	B-X
also	B-X
kill	B-X
more	B-X
than	B-X
90	B-X
%	B-X
of	B-X
mosquitoes	B-X
.	B-X
This	B-X
study	B-X
provides	B-X
a	B-X
possible	B-X
plant	B-X
candidate	B-X
that	B-X
could	B-X
be	B-X
used	B-X
for	B-X
designing	B-X
plant-derived	B-X
insecticides	B-X
.	B-X

These	O
data	O
suggested	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
secreted	O
one	O
or	O
more	O
factors	O
with	O
toxic	O
activity	O
under	O
the	O
control	O
of	O
the	O
GacS	O
/	O
GacA	O
two	O
-	O
component	O
system	O
.	O

In	O
an	O
attempt	O
to	O
identify	O
the	O
factor	O
(	O
s	O
)	O
responsible	O
for	O
toxicity	O
,	O
we	O
analyzed	O
the	O
proteins	O
present	O
in	O
the	O
supernatant	O
.	O

The	O
protein	O
profile	O
for	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
supernantant	O
(	O
Figure	O
1C	O
,	O
lane	O
2	O
)	O
shows	O
a	O
major	O
protein	O
band	O
at	O
51	O
kDa	O
and	O
several	O
minor	O
bands	O
.	O

MALDI	O
-	O
TOF	O
analysis	O
of	O
tryptic	O
fragments	O
of	O
the	O
51	O
-	O
kDa	O
band	O
identified	O
this	O
protein	O
as	O
a	O
homolog	O
of	O
the	O
previously	O
characterized	O
Apr	O
proteases	O
from	O
Pseudomonas	B-Organism
spp	O
.	O
,	O
Prt	O
proteases	O
from	O
Erwinia	B-Organism
spp	O
.	O
and	O
Photorhabdus	B-Organism
spp	O
.	O
,	O
and	O
serralysins	O
from	O
Serratia	B-Organism
spp	O
.	O

[	O
12	O
-	O
14	O
]	O
.	O
<EOS>	B-X
Malathion	B-X
A	B-X
and	B-X
B	B-X
esterases	B-X
of	B-X
mouse	B-X
liver-I	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
adrenaline	B-X
and	B-X
of	B-X
alpha-	B-X
and	B-X
beta-adrenergic	B-X
blocking	B-X
agents	B-X
on	B-X
ATP	B-X
concentration	B-X
and	B-X
on	B-X
incorporation	B-X
of	B-X
32Pi	B-X
into	B-X
ATP	B-X
in	B-X
rat	B-X
fat	B-X
cells	B-X
.	B-X

All	O
of	O
these	O
proteases	O
are	O
members	O
of	O
the	O
zinc	O
metzincin	O
family	O
of	O
Type	O
I	O
-	O
secreted	O
RTX	O
proteins	O
[	O
15	O
]	O
.	O

We	O
subsequently	O
purified	O
this	O
protease	O
,	O
termed	O
AprA	O
,	O
to	O
homogeneity	O
from	O
the	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
supernatant	O
by	O
anion	O
exchange	O
chromatography	O
followed	O
by	O
size	O
exclusion	O
chromatography	O
(	O
Figure	O
1D	O
)	O
.	O

Injection	O
of	O
pure	O
AprA	O
into	O
the	O
hemocoel	O
rapidly	O
killed	O
adult	O
flies	O
,	O
identifying	O
this	O
protein	O
as	O
a	O
bacterial	O
toxin	O
(	O
Figure	O
1E	O
)	O
.	O

Feeding	O
of	O
larvae	O
with	O
high	O
concentrations	O
(	O
1	O
.	O
5	O
mg	O
/	O
ml	O
)	O
of	O
AprA	O
led	O
to	O
modest	O
lethality	O
(	O
unpublished	O
data	O
)	O
,	O
recapitulating	O
the	O
properties	O
of	O
the	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
supernatant	O
.	O

Interestingly	O
,	O
in	O
a	O
gacA	O
mutant	O
the	O
number	O
of	O
proteins	O
in	O
the	O
supernatant	O
was	O
greatly	O
reduced	O
,	O
including	O
the	O
complete	O
absence	O
of	O
the	O
51	O
-	O
kDa	O
band	O
corresponding	O
to	O
AprA	O
(	O
Figure	O
1C	O
,	O
lane	O
3	O
)	O
.	O

In	O
P	B-Organism
.	I-Organism
fluorescens	I-Organism
,	O
membrane	O
-	O
localized	O
anti	O
-	O
sigma	O
factor	O
PrtR	O
cleaves	O
the	O
extracytoplasmic	O
sigma	O
factor	O
PrtI	O
,	O
resulting	O
in	O
increased	O
expression	O
of	O
multiple	O
genes	O
,	O
including	O
one	O
encoding	O
for	O
a	O
metalloprotease	O
,	O
aprX	O
[	O
16	O
]	O
.	O

Two	O
independent	O
Tn5	O
insertions	O
in	O
the	O
prtR	O
gene	O
affecting	O
virulence	O
have	O
recently	O
been	O
identified	O
in	O
a	O
random	O
insertional	O
mutagenesis	O
screen	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
[	O
10	O
]	O
.	O

To	O
test	O
a	O
possible	O
role	O
of	O
prtR	O
in	O
the	O
regulation	O
of	O
aprA	O
expression	O
,	O
we	O
analyzed	O
the	O
proteins	O
present	O
in	O
the	O
supernatant	O
of	O
prtR	O
mutants	O
.	O

Interestingly	O
,	O
both	O
prtR	O
mutants	O
(	O
CL25	B-Organism
and	O
CU1	B-Organism
)	O
displayed	O
a	O
secreted	O
protein	O
profile	O
identical	O
to	O
the	O
wild	O
-	O
type	O
strain	O
except	O
for	O
a	O
marked	O
decrease	O
of	O
AprA	O
(	O
Figure	O
1C	O
,	O
lanes	O
4	O
and	O
5	O
)	O
.	O

Measurement	O
of	O
in	O
vitro	O
protease	O
activity	O
with	O
azocasein	O
revealed	O
that	O
the	O
gacA	O
mutant	O
secretes	O
no	O
detectable	O
protease	O
activity	O
and	O
that	O
prtR	O
mutants	O
retain	O
only	O
30	O
%	O
of	O
wild	O
-	O
type	O
supernatant	O
activity	O
,	O
thus	O
indicating	O
a	O
role	O
for	O
PrtR	O
in	O
the	O
regulation	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
protease	O
secretion	O
(	O
Figure	O
1F	O
)	O
.	O

Furthermore	O
,	O
the	O
prtR	O
supernatant	O
showed	O
no	O
toxicity	O
toward	O
flies	O
after	O
injection	O
,	O
suggesting	O
a	O
correlation	O
between	O
AprA	O
levels	O
and	O
virulence	O
(	O
unpublished	O
data	O
)	O
.	O

Altogether	O
,	O
this	O
analysis	O
indicates	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
gacA	O
and	O
prtR	O
genes	O
regulate	O
the	O
secretion	O
of	O
a	O
protease	O
with	O
toxic	O
activity	O
when	O
injected	O
into	O
flies	O
or	O
fed	O
to	O
larvae	O
.	O
<EOS>	B-X
Biodegradation	B-X
by	B-X
insect	B-X
larvae	B-X
is	B-X
potentially	B-X
an	B-X
eco-friendly	B-X
method	B-X
to	B-X
treat	B-X
WEEE	B-X
plastics	B-X
,	B-X
but	B-X
information	B-X
about	B-X
the	B-X
feeding	B-X
preference	B-X
of	B-X
insect	B-X
larvae	B-X
to	B-X
WEEE	B-X
plastics	B-X
is	B-X
lacking	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
a	B-X
total	B-X
of	B-X
nine	B-X
WEEE	B-X
and	B-X
pristine	B-X
plastics	B-X
were	B-X
chosen	B-X
to	B-X
feed	B-X
larvae	B-X
of	B-X
the	B-X
following	B-X
two	B-X
insect	B-X
species	B-X
,	B-X
i.e	B-X
.	B-X
G.	B-X
mellonella	B-X
larvae	B-X
significantly	B-X
favor	B-X
corresponding	B-X
pristine	B-X
plastics	B-X
compared	B-X
to	B-X
two	B-X
types	B-X
of	B-X
WEEE	B-X
plastics	B-X
,	B-X
waste	B-X
rigid	B-X
polyurethane	B-X
(	B-X
RPU	B-X
)	B-X
and	B-X
waste	B-X
polystyrene	B-X
(	B-X
PS	B-X
)	B-X
.	B-X
One	B-X
possible	B-X
explanation	B-X
is	B-X
the	B-X
increased	B-X
chlorine	B-X
or	B-X
metals	B-X
in	B-X
the	B-X
WEEE	B-X
plastics	B-X
measured	B-X
using	B-X
X-ray	B-X
fluorescence	B-X
spectrometer	B-X
analysis	B-X
.	B-X
Scanning	B-X
electron	B-X
microscopy	B-X
and	B-X
Fourier	B-X
transform	B-X
infrared	B-X
spectroscopy	B-X
show	B-X
that	B-X
the	B-X
destruction	B-X
of	B-X
physical	B-X
structures	B-X
and	B-X
changes	B-X
in	B-X
surface	B-X
functional	B-X
groups	B-X
were	B-X
found	B-X
in	B-X
the	B-X
two	B-X
types	B-X
of	B-X
WEEE	B-X
plastics	B-X
in	B-X
the	B-X
larval	B-X
frass	B-X
,	B-X
implying	B-X
that	B-X
the	B-X
larvae	B-X
partly	B-X
biodegraded	B-X
the	B-X
plastics	B-X
.	B-X
Meanwhile	B-X
,	B-X
the	B-X
powdered	B-X
waste	B-X
high	B-X
impact	B-X
polystyrene	B-X
plastics	B-X
(	B-X
WHIPS	B-X
)	B-X
were	B-X
ingested	B-X
,	B-X
but	B-X
not	B-X
the	B-X
lumpy	B-X
ones	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
consumption	B-X
by	B-X
G.	B-X
mellonella	B-X
larvae	B-X
is	B-X
improved	B-X
by	B-X
the	B-X
WHIPS	B-X
physical	B-X
modification	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
G.	B-X
mellonella	B-X
larvae	B-X
presented	B-X
the	B-X
following	B-X
decreasing	B-X
preference	B-X
for	B-X
pristine	B-X
plastics	B-X
under	B-X
individual-plastic-fed	B-X
mode	B-X
:	B-X
RPU	B-X
>	B-X
phenol-formaldehyde	B-X
resin	B-X
>	B-X
polyethylene	B-X
(	B-X
PE	B-X
)	B-X
>	B-X
polypropylene	B-X
>	B-X
PS	B-X
≈	B-X
polyvinyl	B-X
chloride	B-X
;	B-X
this	B-X
is	B-X
possibly	B-X
due	B-X
to	B-X
differences	B-X
in	B-X
physical	B-X
properties	B-X
and	B-X
chemical	B-X
structures	B-X
of	B-X
the	B-X
plastics	B-X
;	B-X
feeding	B-X
preference	B-X
of	B-X
the	B-X
larvae	B-X
under	B-X
multiple-plastics-fed	B-X
mode	B-X
is	B-X
relatively	B-X
consistent	B-X
to	B-X
that	B-X
under	B-X
individual-plastic-fed	B-X
mode	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
consumption	B-X
by	B-X
G.	B-X
mellonella	B-X
larvae	B-X
of	B-X
PE	B-X
is	B-X
higher	B-X
than	B-X
that	B-X
of	B-X
PS	B-X
,	B-X
while	B-X
T.	B-X
molitor	B-X
larvae	B-X
showed	B-X
the	B-X
opposite	B-X
trend	B-X
,	B-X
implying	B-X
that	B-X
insect	B-X
larvae	B-X
have	B-X
different	B-X
plastics	B-X
preference	B-X
.	B-X
The	B-X
findings	B-X
provide	B-X
insights	B-X
into	B-X
biodegradation	B-X
of	B-X
WEEE	B-X
plastics	B-X
by	B-X
insect	B-X
larvae	B-X
.	B-X

The	O
P	O
.	O
entomophila	O
aprA	O
Mutant	O
Displays	O
Attenuated	O
Pathogenicity	O

The	O
experiments	O
described	O
above	O
suggested	O
that	O
AprA	O
plays	O
an	O
important	O
in	O
vivo	O
role	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
.	O

To	O
further	O
test	O
this	O
hypothesis	O
,	O
we	O
used	O
a	O
genetic	O
approach	O
by	O
inactivating	O
the	O
aprA	O
gene	O
.	O

Sequence	O
analysis	O
of	O
the	O
locus	O
corresponding	O
to	O
aprA	O
revealed	O
a	O
genetic	O
organization	O
characteristic	O
of	O
this	O
class	O
of	O
Type	O
I	O
-	O
secreted	O
proteases	O
[	O
14	O
]	O
.	O

The	O
structural	O
gene	O
for	O
the	O
metalloprotease	O
,	O
aprA	O
,	O
is	O
followed	O
by	O
a	O
gene	O
encoding	O
its	O
periplasmic	O
inhibitor	O
,	O
aprI	O
,	O
and	O
three	O
genes	O
encoding	O
the	O
Type	O
I	O
transporter	O
,	O
aprD	O
,	O
E	O
,	O
and	O
F	O
(	O
Figure	O
2A	O
)	O
.	O

Studies	O
in	O
other	O
bacteria	O
have	O
shown	O
that	O
AprD	O
,	O
E	O
,	O
and	O
F	O
participate	O
in	O
the	O
elaboration	O
of	O
a	O
Type	O
I	O
transporter	O
required	O
for	O
AprA	O
secretion	O
to	O
the	O
external	O
medium	O
[	O
17	O
]	O
.	O

We	O
inactivated	O
the	O
aprA	O
gene	O
by	O
inserting	O
a	O
tetracycline	O
resistance	O
cassette	O
by	O
a	O
double	O
homologous	O
recombination	O
event	O
.	O

SDS	O
-	O
PAGE	O
protein	O
profiles	O
of	O
culture	O
supernatants	O
clearly	O
demonstrated	O
the	O
absence	O
of	O
the	O
51	O
-	O
kDa	O
band	O
,	O
and	O
in	O
vitro	O
protease	O
activity	O
of	O
the	O
aprA	O
mutant	O
confirmed	O
the	O
concomitant	O
absence	O
of	O
secreted	O
protease	O
activity	O
(	O
Figure	O
1C	O
,	O
lane	O
6	O
,	O
and	O
1F	O
)	O
.	O

To	O
analyze	O
the	O
in	O
vivo	O
contribution	O
of	O
AprA	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
,	O
we	O
performed	O
a	O
survival	O
analysis	O
of	O
Drosophila	B-Organism
larvae	O
and	O
adults	O
after	O
oral	O
infection	O
with	O
various	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
derivatives	O
.	O

Only	O
40	O
%	O
of	O
the	O
aprA	O
-	O
infected	O
larvae	O
succumbed	O
within	O
3	O
days	O
,	O
while	O
70	O
%	O
of	O
the	O
larvae	O
died	O
after	O
infection	O
with	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
demonstrating	O
that	O
the	O
aprA	O
mutant	O
was	O
attenuated	O
for	O
virulence	O
(	O
Figure	O
2B	O
)	O
.	O

Similarly	O
,	O
the	O
aprA	O
mutant	O
showed	O
reduced	O
pathogenicity	O
after	O
oral	O
infection	O
of	O
adult	O
flies	O
(	O
Figure	O
S1	O
)	O
.	O

Using	O
the	O
same	O
assay	O
,	O
both	O
prtR	O
and	O
gacA	O
mutants	O
were	O
almost	O
avirulent	O
toward	O
Drosophila	B-Organism
indicating	O
that	O
both	O
genes	O
regulate	O
other	O
virulence	O
factors	O
in	O
addition	O
to	O
AprA	O
(	O
Figure	O
2B	O
)	O
.	O

We	O
next	O
compared	O
persistence	O
of	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
the	O
aprA	O
mutant	O
by	O
quantifying	O
the	O
number	O
of	O
bacteria	O
in	O
larvae	O
and	O
adults	O
at	O
different	O
time	O
points	O
after	O
infection	O
.	O

Whereas	O
the	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
titer	O
remained	O
high	O
,	O
aprA	O
bacterial	O
levels	O
decreased	O
significantly	O
with	O
time	O
(	O
Figure	O
3A	O
,	O
not	O
shown	O
for	O
larvae	O
)	O
.	O

However	O
,	O
aprA	O
gut	O
persistence	O
remained	O
higher	O
than	O
that	O
of	O
gacA	O
mutants	O
.	O

We	O
could	O
not	O
exclude	O
that	O
the	O
aprA	O
mutant	O
phenotype	O
was	O
due	O
to	O
polar	O
effects	O
of	O
the	O
insertion	O
in	O
the	O
operon	O
upon	O
expression	O
of	O
apr	O
I	O
,	O
D	O
,	O
E	O
,	O
and	O
F	O
.	O

In	O
support	O
of	O
this	O
hypothesis	O
,	O
previous	O
studies	O
have	O
demonstrated	O
for	O
both	O
Serratia	B-Organism
marcescens	I-Organism
and	O
P	B-Organism
.	I-Organism
fluorescens	I-Organism
that	O
Type	O
I	O
transporters	O
can	O
be	O
polyvalent	O
and	O
secrete	O
different	O
types	O
of	O
proteins	O
such	O
as	O
proteases	O
and	O
lipases	O
[	O
18	O
,	O
19	O
]	O
.	O

Complementation	O
of	O
the	O
aprA	O
mutant	O
with	O
the	O
wild	O
-	O
type	O
apr	O
operon	O
restored	O
protease	O
secretion	O
and	O
activity	O
(	O
Figure	O
1C	O
,	O
lane	O
7	O
,	O
and	O
1F	O
)	O
and	O
resulted	O
in	O
a	O
complete	O
regain	O
of	O
function	O
with	O
respect	O
to	O
all	O
virulence	O
phenotypes	O
(	O
Figures	O
2B	O
and	O
S1	O
)	O
.	O

In	O
contrast	O
,	O
no	O
rescue	O
was	O
observed	O
with	O
a	O
plasmid	O
containing	O
the	O
full	O
apr	O
operon	O
but	O
carrying	O
a	O
non	O
-	O
polar	O
mutation	O
in	O
aprA	O
(	O
Figures	O
2B	O
and	O
S1	O
)	O
.	O

These	O
data	O
confirmed	O
that	O
the	O
protease	O
AprA	O
itself	O
contributes	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
.	O

The	O
aprA	O
Mutant	O
Retains	O
the	O
Capacity	O
to	O
Trigger	O
an	O
Immune	O
Response	O
and	O
to	O
Induce	O
Food	O
-	O
Uptake	O
Cessation	O

In	O
addition	O
to	O
its	O
pathogenicity	O
,	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
provokes	O
a	O
food	O
-	O
uptake	O
cessation	O
in	O
larvae	O
and	O
triggers	O
an	O
immune	O
response	O
in	O
both	O
larvae	O
and	O
adults	O
[	O
9	O
]	O
.	O

Feeding	O
of	O
larvae	O
with	O
medium	O
containing	O
bromophenol	O
blue	O
,	O
leads	O
to	O
a	O
clearly	O
visible	O
food	O
uptake	O
,	O
discernable	O
by	O
blue	O
coloration	O
throughout	O
the	O
gut	O
.	O

In	O
contrast	O
,	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
-	O
infected	O
larvae	O
show	O
only	O
a	O
pale	O
blue	O
coloration	O
indicating	O
that	O
infected	O
larvae	O
cease	O
to	O
ingest	O
food	O
.	O

Whereas	O
this	O
food	O
-	O
uptake	O
cessation	O
was	O
still	O
observed	O
in	O
aprA	O
and	O
prtR	O
mutants	O
,	O
it	O
was	O
not	O
evident	O
in	O
gacA	O
mutant	O
-	O
infected	O
larvae	O
(	O
Figure	O
2D	O
and	O
data	O
not	O
shown	O
for	O
prtR	O
)	O
.	O

The	O
kinetics	O
of	O
the	O
expression	O
of	O
the	O
AMP	O
,	O
Diptericin	O
,	O
in	O
larvae	O
and	O
adults	O
after	O
natural	O
infection	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
its	O
derivative	O
mutants	O
,	O
was	O
analyzed	O
by	O
real	O
time	O
quantitative	O
PCR	O
(	O
RT	O
-	O
qPCR	O
)	O
.	O

Diptericin	O
was	O
expressed	O
at	O
a	O
wild	O
-	O
type	O
level	O
following	O
oral	O
infection	O
with	O
the	O
aprA	O
and	O
prtR	O
mutants	O
,	O
but	O
no	O
expression	O
was	O
detected	O
in	O
the	O
case	O
of	O
the	O
gacA	O
mutant	O
(	O
Figures	O
2C	O
and	O
5A	O
)	O
.	O

Observation	O
of	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
fluorescence	O
in	O
infected	O
larvae	O
carrying	O
a	O
Diptericin	O
-	O
GFP	O
reporter	O
gene	O
confirmed	O
that	O
prtR	O
and	O
aprA	O
mutants	O
elicited	O
an	O
immune	O
response	O
,	O
whereas	O
gacA	O
mutants	O
failed	O
to	O
do	O
so	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
data	O
presented	O
above	O
clearly	O
indicate	O
that	O
AprA	O
is	O
a	O
major	O
virulence	O
factor	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
that	O
promotes	O
bacterial	O
persistence	O
and	O
killing	O
of	O
the	O
host	O
,	O
but	O
that	O
other	O
virulence	O
factors	O
controlled	O
by	O
gacA	O
and	O
prtR	O
exist	O
.	O

It	O
also	O
reveals	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
is	O
multi	O
-	O
factorial	O
with	O
a	O
clear	O
distinction	O
between	O
factors	O
that	O
promote	O
pathogenicity	O
and	O
those	O
that	O
trigger	O
the	O
immune	O
response	O
.	O

The	O
observation	O
that	O
both	O
factors	O
are	O
under	O
the	O
control	O
of	O
the	O
GacS	O
/	O
GacA	O
,	O
confirmed	O
that	O
this	O
two	O
-	O
component	O
system	O
is	O
the	O
master	O
regulator	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
.	O

AprA	O
Confers	O
Protection	O
against	O
the	O
Imd	O
-	O
Dependent	O
Immune	O
Response	O

Virulence	O
factors	O
allow	O
pathogens	O
to	O
survive	O
in	O
the	O
hostile	O
environment	O
of	O
the	O
host	O
,	O
to	O
escape	O
the	O
immune	O
system	O
,	O
or	O
to	O
establish	O
a	O
biotope	O
where	O
they	O
can	O
proliferate	O
by	O
altering	O
host	O
functions	O
.	O

The	O
observation	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
persistence	O
in	O
flies	O
and	O
larvae	O
is	O
lower	O
in	O
aprA	O
mutants	O
clearly	O
indicates	O
that	O
the	O
AprA	O
protease	O
promotes	O
bacterial	O
persistence	O
in	O
the	O
Drosophila	B-Organism
gut	O
.	O

Our	O
previous	O
study	O
had	O
already	O
revealed	O
that	O
the	O
humoral	O
arm	O
of	O
the	O
Drosophila	B-Organism
immune	O
response	O
mediated	O
by	O
the	O
Imd	O
pathway	O
contributes	O
to	O
resistance	O
against	O
orally	O
transmitted	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
since	O
flies	O
mutated	O
in	O
the	O
Relish	O
(	O
Rel	O
)	O
gene	O
showed	O
a	O
consistently	O
increased	O
mortality	O
rate	O
[	O
9	O
]	O
.	O

To	O
determine	O
whether	O
AprA	O
plays	O
a	O
role	O
in	O
counteracting	O
the	O
Imd	O
-	O
dependent	O
immune	O
response	O
,	O
we	O
compared	O
persistence	O
of	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
gacA	O
,	O
and	O
aprA	O
derivatives	O
by	O
quantifying	O
the	O
number	O
of	O
bacteria	O
in	O
Rel	O
flies	O
and	O
larvae	O
.	O

Whereas	O
the	O
titer	O
of	O
gacA	O
mutants	O
decreased	O
with	O
time	O
,	O
we	O
observed	O
that	O
the	O
aprA	O
derivative	O
persisted	O
at	O
a	O
level	O
similar	O
to	O
wild	O
-	O
type	O
bacteria	O
in	O
Rel	O
-	O
deficient	O
mutant	O
flies	O
and	O
larvae	O
(	O
Figure	O
3A	O
and	O
3B	O
,	O
and	O
unpublished	O
data	O
)	O
.	O

The	O
observation	O
that	O
AprA	O
was	O
required	O
to	O
promote	O
persistence	O
in	O
wild	O
-	O
type	O
flies	O
and	O
larvae	O
but	O
was	O
dispensable	O
in	O
a	O
Rel	O
background	O
,	O
indicates	O
that	O
AprA	O
plays	O
an	O
important	O
role	O
in	O
the	O
protection	O
against	O
the	O
Imd	O
-	O
dependent	O
immune	O
response	O
.	O

To	O
investigate	O
the	O
connection	O
between	O
activation	O
of	O
the	O
Imd	O
pathway	O
and	O
the	O
outcome	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
in	O
more	O
detail	O
,	O
we	O
focused	O
our	O
analysis	O
on	O
the	O
adult	O
stage	O
when	O
it	O
is	O
easier	O
to	O
monitor	O
survival	O
.	O

P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
triggers	O
Imd	O
pathway	O
activation	O
within	O
hours	O
.	O

To	O
determine	O
at	O
which	O
time	O
Imd	O
was	O
required	O
to	O
impede	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
,	O
we	O
monitored	O
survival	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
in	O
flies	O
in	O
which	O
the	O
Imd	O
pathway	O
was	O
artificially	O
activated	O
in	O
a	O
time	O
-	O
dependent	O
manner	O
.	O

We	O
utilized	O
an	O
engineered	O
fly	O
line	O
(	O
UAS	O
-	O
imd	O
,	O
hs	O
-	O
Gal4	O
)	O
over	O
-	O
expressing	O
imd	O
under	O
the	O
control	O
of	O
a	O
heat	O
-	O
shock	O
promoter	O
via	O
the	O
UAS	O
-	O
Gal4	O
system	O
,	O
which	O
consequently	O
leads	O
to	O
strong	O
expression	O
of	O
Imd	O
-	O
dependent	O
AMP	O
genes	O
.	O

Figure	O
4A	O
shows	O
that	O
over	O
-	O
expressing	O
imd	O
12	O
h	O
prior	O
to	O
infection	O
protected	O
flies	O
from	O
a	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
,	O
whereas	O
over	O
-	O
expressing	O
imd	O
6	O
h	O
before	O
contributed	O
only	O
modestly	O
to	O
survival	O
of	O
the	O
flies	O
.	O

This	O
experiment	O
indicates	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
can	O
be	O
eliminated	O
when	O
the	O
Imd	O
pathway	O
is	O
activated	O
at	O
a	O
high	O
level	O
prior	O
to	O
infection	O
.	O

It	O
further	O
suggests	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
is	O
sensitive	O
to	O
immune	O
defenses	O
during	O
a	O
short	O
time	O
frame	O
and	O
subsequently	O
becomes	O
insensitive	O
.	O

Since	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
is	O
pathogenic	O
under	O
normal	O
wild	O
-	O
type	O
conditions	O
,	O
it	O
may	O
overcome	O
the	O
immune	O
response	O
by	O
establishing	O
a	O
niche	O
in	O
the	O
gut	O
before	O
the	O
Imd	O
pathway	O
is	O
activated	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
in	O
agreement	O
with	O
the	O
results	O
described	O
above	O
,	O
persistence	O
of	O
both	O
the	O
aprA	O
mutant	O
and	O
wild	O
-	O
type	O
bacteria	O
was	O
significantly	O
altered	O
in	O
fly	O
lines	O
over	O
-	O
expressing	O
the	O
Imd	O
pathway	O
,	O
and	O
that	O
aprA	O
mutants	O
survived	O
less	O
than	O
wild	O
-	O
type	O
bacteria	O
(	O
Figure	O
4B	O
)	O
.	O

Altogether	O
,	O
these	O
data	O
reveal	O
that	O
the	O
Imd	O
pathway	O
is	O
crucial	O
for	O
host	O
survival	O
after	O
oral	O
infection	O
with	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
that	O
AprA	O
plays	O
a	O
key	O
role	O
in	O
counteracting	O
this	O
effect	O
.	O

Local	O
,	O
but	O
Not	O
Systemic	O
Immunity	O
,	O
Contributes	O
to	O
Resistance	O
against	O
Oral	O
Infection	O
with	O
P	B-Organism
.	I-Organism
entomophila	I-Organism

P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
but	O
not	O
the	O
gacA	O
derivative	O
,	O
rapidly	O
activates	O
both	O
the	O
local	O
and	O
systemic	O
Imd	O
-	O
dependent	O
immune	O
responses	O
in	O
Drosophila	B-Organism
adults	O
,	O
which	O
can	O
be	O
demonstrated	O
using	O
RT	O
-	O
qPCR	O
with	O
fat	O
body	O
and	O
gut	O
extracts	O
(	O
Figure	O
5A	O
)	O
.	O
<EOS>	B-X
Pseudomonas	B-X
species	B-X
can	B-X
grow	B-X
in	B-X
media	B-X
containing	B-X
different	B-X
BAs	B-X
as	B-X
carbon	B-X
and	B-X
energy	B-X
sources	B-X
,	B-X
a	B-X
reason	B-X
why	B-X
these	B-X
bacteria	B-X
are	B-X
excellent	B-X
models	B-X
for	B-X
studying	B-X
such	B-X
catabolic	B-X
pathways	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
analyse	B-X
most	B-X
of	B-X
the	B-X
routes	B-X
used	B-X
by	B-X
different	B-X
species	B-X
of	B-X
Pseudomonas	B-X
(	B-X
P.	B-X
putida	B-X
,	B-X
P.	B-X
aeruginosa	B-X
,	B-X
P.	B-X
entomophila	B-X
and	B-X
P.	B-X
fluorescens	B-X
)	B-X
to	B-X
degrade	B-X
BAs	B-X
.	B-X
The	B-X
insect	B-X
gut	B-X
is	B-X
frequently	B-X
exposed	B-X
to	B-X
pathogenic	B-X
threats	B-X
and	B-X
must	B-X
not	B-X
only	B-X
clear	B-X
these	B-X
potential	B-X
infections	B-X
,	B-X
but	B-X
also	B-X
tolerate	B-X
relatively	B-X
high	B-X
microbe	B-X
loads	B-X
.	B-X
Pathogens	B-X
are	B-X
a	B-X
major	B-X
driver	B-X
of	B-X
host	B-X
evolution	B-X
and	B-X
,	B-X
unlike	B-X
abiotic	B-X
selection	B-X
pressures	B-X
,	B-X
undergo	B-X
epidemiological	B-X
and	B-X
co-evolutionary	B-X
cycles	B-X
with	B-X
the	B-X
host	B-X
involving	B-X
adaptation	B-X
and	B-X
counteradaptation	B-X
.	B-X
Because	B-X
of	B-X
this	B-X
,	B-X
populations	B-X
harbor	B-X
ample	B-X
genetic	B-X
variation	B-X
underlying	B-X
immunity	B-X
and	B-X
the	B-X
opportunity	B-X
for	B-X
sexual	B-X
selection	B-X
based	B-X
on	B-X
condition-dependent	B-X
``	B-X
good	B-X
genes	B-X
''	B-X
is	B-X
expected	B-X
to	B-X
be	B-X
large	B-X
.	B-X

Use	O
of	O
Diptericin	O
-	O
GFP	O
or	O
lacZ	O
reporter	O
genes	O
reveals	O
strong	O
Diptericin	O
expression	O
in	O
the	O
proventriculus	O
,	O
an	O
organ	O
that	O
acts	O
as	O
a	O
valve	O
between	O
the	O
oesophagus	O
and	O
the	O
anterior	O
midgut	O
(	O
Figure	O
5B	O
)	O
.	O
<EOS>	B-X
We	B-X
assessed	B-X
the	B-X
temporospatial	B-X
fate	B-X
of	B-X
green	B-X
fluorescent	B-X
protein	B-X
(	B-X
GFP	B-X
)	B-X
-expressing	B-X
E.	B-X
coli	B-X
O157	B-X
:	B-X
H7	B-X
(	B-X
GFP-ECO157	B-X
)	B-X
in	B-X
house	B-X
flies	B-X
along	B-X
with	B-X
fly	B-X
antimicrobial	B-X
responses	B-X
up	B-X
to	B-X
12	B-X
h	B-X
post-ingestion	B-X
.	B-X
In	B-X
flies	B-X
fed	B-X
GFP-ECO157	B-X
,	B-X
culture	B-X
and	B-X
microscopy	B-X
revealed	B-X
a	B-X
steady	B-X
decrease	B-X
in	B-X
bacterial	B-X
load	B-X
over	B-X
12	B-X
h	B-X
,	B-X
which	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
attributable	B-X
to	B-X
the	B-X
combined	B-X
effects	B-X
of	B-X
immobilization	B-X
within	B-X
the	B-X
peritrophic	B-X
matrix	B-X
,	B-X
lysis	B-X
and	B-X
peristaltic	B-X
excretion	B-X
.	B-X
Quantitative	B-X
reverse-transcriptase	B-X
polymerase	B-X
chain	B-X
reaction	B-X
analysis	B-X
of	B-X
antimicrobial	B-X
peptides	B-X
(	B-X
AMPs	B-X
)	B-X
and	B-X
lysozyme	B-X
gene	B-X
expression	B-X
showed	B-X
minimal	B-X
upregulation	B-X
in	B-X
both	B-X
the	B-X
gut	B-X
and	B-X
carcass	B-X
of	B-X
house	B-X
flies	B-X
fed	B-X
GFP-ECO157	B-X
.	B-X
However	B-X
,	B-X
these	B-X
genes	B-X
were	B-X
upregulated	B-X
in	B-X
fly	B-X
heads	B-X
and	B-X
salivary	B-X
glands	B-X
,	B-X
and	B-X
effector	B-X
proteins	B-X
were	B-X
detected	B-X
in	B-X
the	B-X
gut	B-X
in	B-X
some	B-X
flies	B-X
.	B-X

This	O
suggests	O
a	O
critical	O
role	O
of	O
this	O
organ	O
in	O
the	O
elimination	O
of	O
bacteria	O
.	O
<EOS>	B-X
Severe	B-X
complications	B-X
arising	B-X
from	B-X
pandemic	B-X
influenza	B-X
or	B-X
the	B-X
highly	B-X
pathogenic	B-X
avian	B-X
H5N1	B-X
viruses	B-X
are	B-X
often	B-X
associated	B-X
with	B-X
rapid	B-X
,	B-X
massive	B-X
inflammatory	B-X
cell	B-X
infiltration	B-X
,	B-X
acute	B-X
respiratory	B-X
distress	B-X
,	B-X
reactive	B-X
hemophagocytosis	B-X
and	B-X
multiple	B-X
organ	B-X
involvement	B-X
.	B-X
Histological	B-X
and	B-X
pathological	B-X
indicators	B-X
strongly	B-X
suggest	B-X
a	B-X
key	B-X
role	B-X
for	B-X
an	B-X
excessive	B-X
host	B-X
response	B-X
in	B-X
mediating	B-X
at	B-X
least	B-X
some	B-X
of	B-X
this	B-X
pathology	B-X
.	B-X
Generally	B-X
,	B-X
the	B-X
same	B-X
immunological	B-X
factors	B-X
mediating	B-X
tissue	B-X
damage	B-X
during	B-X
the	B-X
anti-influenza	B-X
immune	B-X
response	B-X
are	B-X
also	B-X
critical	B-X
for	B-X
efficient	B-X
elimination	B-X
of	B-X
virus	B-X
,	B-X
thereby	B-X
posing	B-X
a	B-X
significant	B-X
challenge	B-X
in	B-X
the	B-X
design	B-X
of	B-X
harmless	B-X
yet	B-X
effective	B-X
therapeutic	B-X
strategies	B-X
for	B-X
tackling	B-X
influenza	B-X
virus	B-X
.	B-X
The	B-X
bursa	B-X
of	B-X
Fabricius	B-X
is	B-X
critical	B-X
to	B-X
normal	B-X
B-lymphocyte	B-X
development	B-X
in	B-X
birds	B-X
.	B-X
The	B-X
bursa	B-X
is	B-X
a	B-X
gut-associated	B-X
organ	B-X
and	B-X
antigen	B-X
is	B-X
focused	B-X
to	B-X
bursal	B-X
lymphoid	B-X
follicles	B-X
after	B-X
hatch	B-X
.	B-X

We	O
next	O
examined	O
the	O
respective	O
contribution	O
of	O
the	O
local	O
gut	O
and	O
the	O
systemic	O
immune	O
responses	O
to	O
controlling	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
.	O

We	O
thus	O
compared	O
resistance	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
of	O
flies	O
that	O
were	O
previously	O
either	O
orally	O
infected	O
with	O
Ecc15	B-Organism
(	O
to	O
activate	O
a	O
local	O
immune	O
response	O
)	O
or	O
pricked	O
with	O
Ecc15	B-Organism
(	O
to	O
activate	O
a	O
systemic	O
immune	O
response	O
)	O
.	O

The	O
rationale	O
behind	O
this	O
experiment	O
is	O
based	O
on	O
previous	O
observations	O
that	O
an	O
oral	O
infection	O
with	O
Ecc15	B-Organism
triggers	O
a	O
local	O
,	O
but	O
not	O
a	O
systemic	O
immune	O
response	O
at	O
the	O
adult	O
stage	O
(	O
our	O
unpublished	O
data	O
)	O
[	O
8	O
]	O
.	O

Figure	O
5C	O
shows	O
that	O
a	O
prior	O
infection	O
with	O
Ecc15	B-Organism
protected	O
flies	O
against	O
a	O
subsequent	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
only	O
when	O
Ecc15	B-Organism
was	O
administrated	O
orally	O
,	O
indicating	O
that	O
the	O
local	O
,	O
but	O
not	O
the	O
systemic	O
immune	O
response	O
,	O
plays	O
an	O
important	O
role	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
clearance	O
.	O

To	O
ascertain	O
that	O
the	O
protection	O
was	O
due	O
to	O
Imd	O
pathway	O
activation	O
and	O
not	O
to	O
a	O
competition	O
between	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
Ecc15	B-Organism
,	O
we	O
next	O
monitored	O
resistance	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
of	O
wild	O
-	O
type	O
and	O
Rel	O
flies	O
orally	O
infected	O
by	O
Ecc15	O
evf	O
-	O
.	O

We	O
used	O
the	O
evf	O
-	O
deficient	O
derivative	O
because	O
this	O
bacterium	O
triggers	O
a	O
local	O
immune	O
response	O
without	O
persisting	O
in	O
the	O
gut	O
.	O

This	O
experiment	O
shows	O
that	O
wild	O
-	O
type	O
,	O
but	O
not	O
Rel	O
flies	O
previously	O
infected	O
with	O
Ecc15	O
evf	O
-	O
,	O
resisted	O
a	O
second	O
challenge	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
(	O
Figure	O
5D	O
)	O
.	O
<EOS>	B-X
By	B-X
expressing	B-X
the	B-X
light-responsive	B-X
ChR	B-X
in	B-X
neurons	B-X
using	B-X
cell-type	B-X
selective	B-X
promoters	B-X
or	B-X
other	B-X
methods	B-X
,	B-X
specific	B-X
neurons	B-X
can	B-X
be	B-X
depolarized	B-X
by	B-X
light	B-X
in	B-X
a	B-X
temporally	B-X
precise	B-X
manner	B-X
with	B-X
millisecond	B-X
resolution	B-X
even	B-X
if	B-X
their	B-X
membrane	B-X
biophysical	B-X
properties	B-X
are	B-X
less	B-X
favorable	B-X
for	B-X
electrical	B-X
stimulation	B-X
.	B-X
To	B-X
conduct	B-X
an	B-X
experiment	B-X
with	B-X
ChR	B-X
,	B-X
experimenters	B-X
need	B-X
to	B-X
make	B-X
the	B-X
correct	B-X
choices	B-X
on	B-X
the	B-X
three	B-X
main	B-X
components	B-X
to	B-X
such	B-X
an	B-X
experiment	B-X
:	B-X
the	B-X
expression	B-X
system	B-X
,	B-X
the	B-X
illumination	B-X
source	B-X
,	B-X
and	B-X
the	B-X
ChR	B-X
variant	B-X
used	B-X
.	B-X
This	B-X
chapter	B-X
aims	B-X
to	B-X
provide	B-X
some	B-X
discussions	B-X
on	B-X
the	B-X
current	B-X
developments	B-X
of	B-X
these	B-X
aspects	B-X
of	B-X
the	B-X
experiments	B-X
.	B-X
In	B-X
terms	B-X
of	B-X
the	B-X
instrumentation	B-X
,	B-X
an	B-X
illumination	B-X
source	B-X
that	B-X
is	B-X
capable	B-X
of	B-X
providing	B-X
the	B-X
desired	B-X
wavelength	B-X
with	B-X
high	B-X
intensity	B-X
is	B-X
crucial	B-X
for	B-X
the	B-X
success	B-X
of	B-X
the	B-X
experiment	B-X
.	B-X
The	B-X
important	B-X
factors	B-X
regarding	B-X
the	B-X
light	B-X
source	B-X
used	B-X
include	B-X
the	B-X
cost	B-X
,	B-X
light	B-X
density	B-X
output	B-X
,	B-X
efficiency	B-X
for	B-X
fiber	B-X
coupling	B-X
for	B-X
in	B-X
vivo	B-X
rodent	B-X
experiments	B-X
,	B-X
and	B-X
the	B-X
available	B-X
methods	B-X
to	B-X
control	B-X
light	B-X
intensity	B-X
and	B-X
onset/termination	B-X
.	B-X
The	B-X
third	B-X
component	B-X
of	B-X
the	B-X
experiment	B-X
is	B-X
the	B-X
choice	B-X
of	B-X
the	B-X
appropriate	B-X
variants	B-X
of	B-X
ChR	B-X
.	B-X
Many	B-X
novel	B-X
ChR	B-X
variants	B-X
with	B-X
unique	B-X
properties	B-X
have	B-X
been	B-X
engineered	B-X
,	B-X
and	B-X
it	B-X
can	B-X
be	B-X
difficult	B-X
for	B-X
the	B-X
experimenters	B-X
to	B-X
choose	B-X
the	B-X
right	B-X
variant	B-X
with	B-X
the	B-X
desired	B-X
properties	B-X
for	B-X
their	B-X
experiments	B-X
,	B-X
as	B-X
some	B-X
information	B-X
necessary	B-X
for	B-X
the	B-X
experimenter	B-X
to	B-X
make	B-X
the	B-X
right	B-X
selection	B-X
is	B-X
often	B-X
incomplete	B-X
or	B-X
unavailable	B-X
.	B-X
Currently	B-X
,	B-X
the	B-X
available	B-X
variants	B-X
for	B-X
neuroscientific	B-X
research	B-X
are	B-X
wild-type	B-X
ChR2	B-X
,	B-X
ChR2+H134R	B-X
,	B-X
ChETA	B-X
,	B-X
VChR1	B-X
,	B-X
SFO	B-X
,	B-X
ChD	B-X
,	B-X
ChEF	B-X
,	B-X
ChIEF	B-X
,	B-X
ChRGR	B-X
,	B-X
CatCh	B-X
,	B-X
and	B-X
TC	B-X
.	B-X

This	O
demonstrates	O
that	O
the	O
protection	O
was	O
indeed	O
due	O
to	O
Imd	O
pathway	O
activation	O
in	O
the	O
gut	O
.	O

The	O
results	O
described	O
above	O
were	O
corroborated	O
by	O
the	O
over	O
-	O
expression	O
of	O
Imd	O
in	O
the	O
gut	O
or	O
in	O
the	O
fat	O
body	O
using	O
specific	O
Gal4	O
drivers	O
.	O
<EOS>	B-X
The	B-X
ability	B-X
to	B-X
drive	B-X
expression	B-X
of	B-X
exogenous	B-X
genes	B-X
in	B-X
different	B-X
tissues	B-X
and	B-X
cell	B-X
types	B-X
,	B-X
under	B-X
the	B-X
control	B-X
of	B-X
specific	B-X
enhancers	B-X
,	B-X
has	B-X
been	B-X
crucial	B-X
for	B-X
discovery	B-X
in	B-X
biology	B-X
.	B-X
While	B-X
many	B-X
enhancers	B-X
drive	B-X
expression	B-X
broadly	B-X
,	B-X
several	B-X
genetic	B-X
tools	B-X
were	B-X
developed	B-X
to	B-X
obtain	B-X
access	B-X
to	B-X
isolated	B-X
cell	B-X
types	B-X
.	B-X
To	B-X
access	B-X
the	B-X
same	B-X
cells	B-X
within	B-X
a	B-X
given	B-X
expression	B-X
pattern	B-X
consistently	B-X
across	B-X
fruit	B-X
flies	B-X
,	B-X
we	B-X
developed	B-X
the	B-X
light-gated	B-X
expression	B-X
system	B-X
LOV-LexA	B-X
.	B-X
LOV-LexA	B-X
enables	B-X
spatial	B-X
and	B-X
temporal	B-X
control	B-X
of	B-X
expression	B-X
of	B-X
transgenes	B-X
under	B-X
LexAop	B-X
sequences	B-X
in	B-X
larval	B-X
fat	B-X
body	B-X
and	B-X
pupal	B-X
and	B-X
adult	B-X
neurons	B-X
with	B-X
blue	B-X
light	B-X
.	B-X
The	B-X
LOV-LexA	B-X
tool	B-X
is	B-X
ready	B-X
to	B-X
use	B-X
with	B-X
GAL4	B-X
and	B-X
Split-GAL4	B-X
drivers	B-X
in	B-X
its	B-X
current	B-X
form	B-X
and	B-X
constitutes	B-X
another	B-X
layer	B-X
of	B-X
intersectional	B-X
genetics	B-X
that	B-X
provides	B-X
light-controlled	B-X
genetic	B-X
access	B-X
to	B-X
specific	B-X
cells	B-X
across	B-X
flies	B-X
.	B-X

Over	O
-	O
expression	O
of	O
Imd	O
in	O
the	O
gut	O
protected	O
against	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
whereas	O
its	O
activation	O
in	O
the	O
fat	O
body	O
did	O
not	O
(	O
Figure	O
S2	O
)	O
.	O

However	O
,	O
the	O
previous	O
results	O
did	O
not	O
address	O
whether	O
the	O
Imd	O
pathway	O
induced	O
during	O
the	O
course	O
of	O
a	O
natural	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
contributes	O
to	O
fly	O
resistance	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
.	O
<EOS>	B-X
Metal	B-X
ligands	B-X
such	B-X
as	B-X
clioquinol	B-X
(	B-X
CQ	B-X
)	B-X
,	B-X
DP-109	B-X
or	B-X
pyrrolidine	B-X
dithiocarbamate	B-X
(	B-X
PDTC	B-X
)	B-X
have	B-X
shown	B-X
promising	B-X
results	B-X
in	B-X
animal	B-X
models	B-X
of	B-X
AD	B-X
,	B-X
however	B-X
,	B-X
the	B-X
actual	B-X
mode	B-X
of	B-X
action	B-X
in	B-X
vivo	B-X
has	B-X
not	B-X
been	B-X
fully	B-X
determined	B-X
.	B-X
We	B-X
previously	B-X
reported	B-X
that	B-X
CQ-metal	B-X
complexes	B-X
were	B-X
able	B-X
to	B-X
increase	B-X
intracellular	B-X
copper	B-X
levels	B-X
in	B-X
vitro	B-X
.	B-X
This	B-X
resulted	B-X
in	B-X
stimulation	B-X
of	B-X
phosphoinositol-3-kinase	B-X
activity	B-X
and	B-X
mitogen	B-X
activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPK	B-X
)	B-X
.	B-X
Increased	B-X
kinase	B-X
activity	B-X
resulted	B-X
in	B-X
up-regulated	B-X
matrix	B-X
metalloprotease	B-X
(	B-X
MMP2	B-X
and	B-X
MMP3	B-X
)	B-X
activity	B-X
resulting	B-X
in	B-X
enhanced	B-X
degradation	B-X
of	B-X
secreted	B-X
A	B-X
beta	B-X
.	B-X
These	B-X
findings	B-X
are	B-X
consistent	B-X
with	B-X
previous	B-X
studies	B-X
reporting	B-X
metal-mediated	B-X
activation	B-X
of	B-X
MAPKs	B-X
and	B-X
MMPs	B-X
.	B-X
How	B-X
this	B-X
activation	B-X
occurs	B-X
is	B-X
unknown	B-X
but	B-X
evidence	B-X
suggests	B-X
that	B-X
copper	B-X
may	B-X
be	B-X
able	B-X
to	B-X
activate	B-X
membrane	B-X
receptors	B-X
such	B-X
as	B-X
the	B-X
epidermal	B-X
growth	B-X
factor	B-X
receptor	B-X
(	B-X
EGFR	B-X
)	B-X
and	B-X
result	B-X
in	B-X
downstream	B-X
activation	B-X
of	B-X
MAPK	B-X
pathways	B-X
.	B-X
However	B-X
,	B-X
further	B-X
studies	B-X
are	B-X
necessary	B-X
to	B-X
determine	B-X
if	B-X
metal	B-X
complexes	B-X
such	B-X
as	B-X
CQ-copper	B-X
induce	B-X
up-regulation	B-X
of	B-X
A	B-X
beta-degrading	B-X
MMP	B-X
activity	B-X
through	B-X
this	B-X
mechanism	B-X
.	B-X
Elucidation	B-X
of	B-X
this	B-X
pathway	B-X
may	B-X
have	B-X
important	B-X
implications	B-X
for	B-X
the	B-X
development	B-X
of	B-X
metal	B-X
ligand	B-X
based	B-X
therapeutics	B-X
for	B-X
treatment	B-X
of	B-X
AD	B-X
and	B-X
other	B-X
neurodegenerative	B-X
disorders	B-X
.	B-X

Thus	O
,	O
we	O
next	O
compared	O
survival	O
of	O
Rel	O
flies	O
specifically	O
expressing	O
a	O
wild	O
-	O
type	O
copy	O
of	O
Rel	O
in	O
the	O
intestine	O
using	O
caudal	O
(	O
cad	O
)	O
-	O
Gal4	O
.	O

These	O
flies	O
lack	O
a	O
functional	O
Imd	O
pathway	O
except	O
in	O
the	O
gut	O
where	O
cad	O
-	O
Gal4	O
is	O
expressed	O
.	O

In	O
these	O
flies	O
,	O
the	O
Imd	O
pathway	O
was	O
not	O
constitutively	O
active	O
in	O
the	O
gut	O
but	O
could	O
be	O
induced	O
upon	O
oral	O
bacterial	O
infection	O
similarly	O
to	O
the	O
wild	O
-	O
type	O
situation	O
(	O
Figure	O
S3A	O
)	O
.	O
<EOS>	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
studies	B-X
from	B-X
the	B-X
fruit	B-X
fly	B-X
Drosophila	B-X
melanogaster	B-X
and	B-X
the	B-X
nematode	B-X
Caenorhabditis	B-X
elegans	B-X
that	B-X
highlight	B-X
the	B-X
roles	B-X
of	B-X
autophagy	B-X
in	B-X
innate	B-X
immune	B-X
responses	B-X
to	B-X
viral	B-X
,	B-X
bacterial	B-X
,	B-X
and	B-X
fungal	B-X
pathogens	B-X
.	B-X
Studies	B-X
of	B-X
simple	B-X
,	B-X
short-lived	B-X
invertebrates	B-X
such	B-X
as	B-X
flies	B-X
and	B-X
worms	B-X
will	B-X
continue	B-X
to	B-X
provide	B-X
valuable	B-X
insights	B-X
into	B-X
the	B-X
molecular	B-X
mechanisms	B-X
by	B-X
which	B-X
autophagy	B-X
and	B-X
immunity	B-X
pathways	B-X
intersect	B-X
and	B-X
their	B-X
contribution	B-X
to	B-X
organismal	B-X
survival	B-X
.	B-X
Abbreviations	B-X
Atg	B-X
autophagy	B-X
related	B-X
BECN1	B-X
Beclin	B-X
1	B-X
CALCOCO2	B-X
calcium	B-X
binding	B-X
and	B-X
coiled-coil	B-X
domain	B-X
2	B-X
Cry5B	B-X
crystal	B-X
toxin	B-X
5B	B-X
Daf	B-X
abnormal	B-X
dauer	B-X
formation	B-X
DKF-1	B-X
D	B-X
kinase	B-X
family-1	B-X
EPG-7	B-X
Ectopic	B-X
P	B-X
Granules-7	B-X
FuDR	B-X
fluorodeoxyuridine	B-X
GFP	B-X
green	B-X
fluorescent	B-X
protein	B-X
HLH-30	B-X
Helix	B-X
Loop	B-X
Helix-30	B-X
Imd	B-X
immune	B-X
deficiency	B-X
ins-18	B-X
INSulin	B-X
related-18	B-X
;	B-X
LET-363	B-X
,	B-X
LEThal-363	B-X
lgg-1	B-X
LC3	B-X
,	B-X
GABARAP	B-X
and	B-X
GATE-16	B-X
family-1	B-X
MAPK	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
MATH	B-X
the	B-X
meprin	B-X
and	B-X
TRAF	B-X
homology	B-X
MTOR	B-X
mechanistic	B-X
target	B-X
of	B-X
rapamycin	B-X
NBR1	B-X
neighbor	B-X
of	B-X
BRCA1	B-X
gene	B-X
1	B-X
NFKB	B-X
nuclear	B-X
factor	B-X
of	B-X
kappa	B-X
light	B-X
polypeptide	B-X
gene	B-X
enhancer	B-X
in	B-X
B	B-X
cells	B-X
NOD	B-X
nucleotide-binding	B-X
oligomerization	B-X
domain	B-X
containing	B-X
OPTN	B-X
optineurin	B-X
PAMPs	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
Park2	B-X
Parkinson	B-X
disease	B-X
(	B-X
autosomal	B-X
recessive	B-X
,	B-X
juvenile	B-X
)	B-X
2	B-X
,	B-X
parkin	B-X
pdr-1	B-X
Parkinson	B-X
disease	B-X
related	B-X
PFTs	B-X
pore-forming	B-X
toxins	B-X
PGRP	B-X
peptidoglycan-recognition	B-X
proteins	B-X
PIK3C3	B-X
phosphatidylinositol	B-X
3-	B-X
kinase	B-X
catalytic	B-X
subunit	B-X
type	B-X
3	B-X
pink-1	B-X
PINK	B-X
(	B-X
PTEN-I	B-X
induced	B-X
kinase	B-X
)	B-X
homolog	B-X
PRKD	B-X
protein	B-X
kinase	B-X
D	B-X
;	B-X
PLC	B-X
,	B-X
phospholipase	B-X
C	B-X
PRKN	B-X
parkin	B-X
RBR	B-X
E3	B-X
ubiquitin	B-X
protein	B-X
ligase	B-X
PRRs	B-X
pattern-recognition	B-X
receptors	B-X
PtdIns3P	B-X
phosphatidylinositol-3-phosphate	B-X
rab-5	B-X
RAB	B-X
family-5	B-X
RB1CC1	B-X
RB1-inducible	B-X
coiled-coil	B-X
1	B-X
RNAi	B-X
RNA	B-X
interference	B-X
sqst	B-X
SeQueSTosome	B-X
related	B-X
SQSTM1	B-X
sequestosome	B-X
1	B-X
TBK1	B-X
TANK-binding	B-X
kinase	B-X
1	B-X
TFEB	B-X
transcription	B-X
factor	B-X
EB	B-X
TGFB/TGF-β	B-X
transforming	B-X
growth	B-X
factor	B-X
beta	B-X
TLRs	B-X
toll-like	B-X
receptors	B-X
unc-51	B-X
UNCoordinated-51	B-X
VPS	B-X
vacuolar	B-X
protein	B-X
sorting	B-X
;	B-X
VSV	B-X
,	B-X
vesicular	B-X
stomatitis	B-X
virus	B-X
VSV-G	B-X
VSV	B-X
surface	B-X
glycoprotein	B-X
G	B-X
Wipi2	B-X
WD	B-X
repeat	B-X
domain	B-X
,	B-X
phosphoinositide	B-X
interacting	B-X
2	B-X
.	B-X
The	B-X
gut	B-X
microbiota	B-X
affects	B-X
the	B-X
physiology	B-X
and	B-X
metabolism	B-X
of	B-X
animals	B-X
and	B-X
its	B-X
alteration	B-X
can	B-X
lead	B-X
to	B-X
diseases	B-X
such	B-X
as	B-X
gut	B-X
dysplasia	B-X
or	B-X
metabolic	B-X
disorders	B-X
.	B-X
Several	B-X
reports	B-X
have	B-X
shown	B-X
that	B-X
the	B-X
immune	B-X
system	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
shaping	B-X
both	B-X
bacterial	B-X
community	B-X
composition	B-X
and	B-X
abundance	B-X
in	B-X

Figure	O
5E	O
shows	O
that	O
Rel	O
flies	O
expressing	O
Rel	O
in	O
the	O
gut	O
survive	O
better	O
than	O
Rel	O
mutant	O
flies	O
.	O

These	O
data	O
demonstrate	O
that	O
the	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
-	O
induced	O
local	O
immune	O
response	O
in	O
the	O
intestine	O
plays	O
an	O
important	O
role	O
in	O
the	O
defense	O
against	O
this	O
Gram	O
-	O
negative	O
bacterium	O
.	O

AprA	O
Confers	O
Protection	O
against	O
Diptericin	O

We	O
have	O
shown	O
that	O
AprA	O
protects	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
against	O
the	O
Imd	O
-	O
regulated	O
immune	O
response	O
.	O

This	O
immune	O
pathway	O
regulates	O
the	O
expression	O
of	O
several	O
AMP	O
genes	O
,	O
as	O
well	O
as	O
many	O
other	O
immune	O
genes	O
.	O
<EOS>	B-X
Many	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
PAMPs	B-X
)	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
and	B-X
lipoteichoic	B-X
acid	B-X
,	B-X
are	B-X
potent	B-X
immunostimulatory	B-X
molecules	B-X
and	B-X
promote	B-X
the	B-X
expression	B-X
of	B-X
cyclooxygenase	B-X
2	B-X
(	B-X
COX-2	B-X
)	B-X
.	B-X
Parathyroid	B-X
hormone-related	B-X
protein	B-X
(	B-X
PTHrP	B-X
)	B-X
expression	B-X
in	B-X
breast	B-X
cancer	B-X
is	B-X
enriched	B-X
in	B-X
bone	B-X
metastases	B-X
compared	B-X
to	B-X
primary	B-X
tumors	B-X
.	B-X
Human	B-X
MCF7	B-X
breast	B-X
cancer	B-X
cells	B-X
``	B-X
home	B-X
''	B-X
to	B-X
the	B-X
bones	B-X
of	B-X
immune	B-X
deficient	B-X
mice	B-X
following	B-X
intracardiac	B-X
inoculation	B-X
,	B-X
but	B-X
do	B-X
not	B-X
grow	B-X
well	B-X
and	B-X
stain	B-X
negatively	B-X
for	B-X
Ki67	B-X
,	B-X
thus	B-X
serving	B-X
as	B-X
a	B-X
model	B-X
of	B-X
breast	B-X
cancer	B-X
dormancy	B-X
Dendritic	B-X
cells	B-X
(	B-X
DCs	B-X
)	B-X
have	B-X
been	B-X
proposed	B-X
as	B-X
mediators	B-X
of	B-X
immunity	B-X
against	B-X
malaria	B-X
parasites	B-X
,	B-X
as	B-X
well	B-X
as	B-X
a	B-X
target	B-X
for	B-X
inhibition	B-X
of	B-X
cellular	B-X
responses	B-X
.	B-X
Many	B-X
cellular	B-X
functions	B-X
suffer	B-X
extensive	B-X
genomic	B-X
regulation	B-X
including	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
the	B-X
glycolysis	B-X
and	B-X
purine	B-X
metabolism	B-X
pathways	B-X
and	B-X
also	B-X
defence	B-X
responses	B-X
.	B-X
Only	B-X
a	B-X
small	B-X
fraction	B-X
of	B-X
the	B-X
regulated	B-X
genes	B-X
are	B-X
coincident	B-X
with	B-X
the	B-X
response	B-X
induced	B-X
by	B-X
other	B-X
pathogens	B-X
,	B-X
suggesting	B-X
that	B-X
Plasmodium	B-X
induces	B-X
a	B-X
unique	B-X
genetic	B-X
re-programming	B-X
of	B-X
DCs	B-X
.	B-X
We	B-X
further	B-X
dissected	B-X
a	B-X
signalling	B-X
pathway	B-X
regulating	B-X
Plasmodium-induced	B-X
expression	B-X
of	B-X
IL-6	B-X
by	B-X
DCs	B-X
,	B-X
which	B-X
is	B-X
mediated	B-X
by	B-X
release	B-X
of	B-X
PGE2	B-X
,	B-X
increases	B-X
in	B-X
intracellular	B-X
cAMP	B-X
and	B-X
activation	B-X
of	B-X
PKA	B-X
and	B-X
p38-MAPK	B-X
.	B-X

Previous	O
studies	O
indicated	O
that	O
Attacin	O
A	O
and	O
Diptericin	O
are	O
the	O
AMP	O
genes	O
most	O
strongly	O
induced	O
in	O
the	O
gut	O
following	O
ingestion	O
of	O
infectious	O
bacteria	O
[	O
7	O
]	O
.	O

It	O
has	O
also	O
been	O
suggested	O
that	O
proteases	O
homologous	O
to	O
AprA	O
in	O
other	O
bacterial	O
species	O
degrade	O
AMPs	O
in	O
vitro	O
,	O
thereby	O
enabling	O
pathogens	O
to	O
withstand	O
the	O
attack	O
of	O
the	O
host	O
immune	O
system	O
[	O
20	O
,	O
21	O
]	O
.	O

We	O
confirmed	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
AprA	O
rapidly	O
degrades	O
Cecropin	O
A	O
in	O
vitro	O
(	O
unpublished	O
data	O
)	O
.	O

To	O
investigate	O
a	O
possible	O
in	O
vivo	O
role	O
of	O
AprA	O
in	O
the	O
protection	O
against	O
AMPs	O
synthesized	O
in	O
the	O
gut	O
,	O
we	O
compared	O
survival	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
in	O
imd	O
-	O
deficient	O
flies	O
over	O
-	O
expressing	O
Attacin	O
A	O
or	O
Diptericin	O
ubiquitously	O
under	O
the	O
control	O
of	O
the	O
daughterless	O
Gal4	O
driver	O
(	O
daGal4	O
)	O
using	O
the	O
UAS	O
-	O
Gal4	O
system	O
(	O
referred	O
to	O
as	O
imd	O
;	O
da	O
>	O
AMP	O
,	O
Figure	O
S3B	O
)	O
.	O

This	O
strategy	O
allowed	O
us	O
to	O
study	O
the	O
contribution	O
of	O
each	O
antibacterial	O
peptide	O
to	O
the	O
defense	O
against	O
a	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
.	O

In	O
a	O
first	O
set	O
of	O
experiments	O
,	O
we	O
compared	O
the	O
survival	O
rate	O
of	O
wild	O
-	O
type	O
,	O
imd	O
,	O
and	O
imd	O
;	O
da	O
>	O
Dpt	O
or	O
AttA	O
flies	O
to	O
natural	O
infection	O
with	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
.	O

Ubiquitous	O
expression	O
of	O
Attacin	O
A	O
and	O
Diptericin	O
with	O
the	O
da	O
-	O
Gal4	O
driver	O
greatly	O
increased	O
the	O
resistance	O
of	O
imd	O
mutant	O
flies	O
(	O
Figure	O
6A	O
)	O
.	O

This	O
experiment	O
demonstrates	O
that	O
these	O
AMPs	O
can	O
confer	O
protection	O
against	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
is	O
in	O
good	O
agreement	O
with	O
a	O
previous	O
study	O
showing	O
that	O
Attacin	O
is	O
the	O
most	O
potent	O
AMP	O
against	O
Gram	O
-	O
negative	O
bacteria	O
[	O
22	O
]	O
.	O

Importantly	O
,	O
it	O
also	O
reveals	O
for	O
the	O
first	O
time	O
a	O
major	O
contribution	O
of	O
Diptericin	O
to	O
host	O
defense	O
,	O
which	O
was	O
not	O
previously	O
detected	O
using	O
systemic	O
injection	O
of	O
microbes	O
[	O
22	O
]	O
.	O

To	O
investigate	O
the	O
in	O
vivo	O
relationship	O
between	O
AMP	O
activity	O
and	O
microbial	O
persistence	O
we	O
next	O
compared	O
the	O
numbers	O
of	O
bacteria	O
of	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
aprA	O
mutants	O
in	O
imd	O
fly	O
lines	O
over	O
-	O
expressing	O
Diptericin	O
.	O

Figure	O
6B	O
shows	O
that	O
the	O
aprA	O
mutant	O
persisted	O
less	O
well	O
than	O
wild	O
-	O
type	O
bacteria	O
in	O
imd	O
flies	O
over	O
-	O
expressing	O
Diptericin	O
.	O

This	O
result	O
clearly	O
indicates	O
an	O
in	O
vivo	O
action	O
of	O
AprA	O
against	O
Diptericin	O
.	O

No	O
effect	O
could	O
be	O
detected	O
when	O
Attacin	O
A	O
was	O
over	O
-	O
expressed	O
in	O
agreement	O
with	O
the	O
bacteriostatic	O
mode	O
of	O
action	O
of	O
this	O
AMP	O
(	O
unpublished	O
data	O
)	O
.	O

Altogether	O
,	O
our	O
results	O
provide	O
an	O
in	O
vivo	O
demonstration	O
that	O
AprA	O
functions	O
in	O
the	O
protection	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
against	O
Drosophila	B-Organism
AMPs	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Pathogens	O
have	O
developed	O
a	O
plethora	O
of	O
strategies	O
that	O
allow	O
them	O
to	O
exploit	O
host	O
resources	O
and	O
resist	O
the	O
attacks	O
of	O
the	O
host	O
immune	O
response	O
.	O

To	O
study	O
how	O
flies	O
deal	O
with	O
infections	O
in	O
a	O
natural	O
context	O
,	O
we	O
investigated	O
the	O
interactions	O
between	O
Drosophila	B-Organism
and	O
a	O
newly	O
identified	O
entomopathogen	O
,	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
.	O

Using	O
a	O
combined	O
genetic	O
approach	O
for	O
both	O
the	O
host	O
and	O
pathogen	O
we	O
reveal	O
the	O
importance	O
of	O
the	O
local	O
immune	O
response	O
in	O
host	O
defense	O
against	O
gastrointestinal	O
infections	O
and	O
provide	O
an	O
in	O
vivo	O
demonstration	O
for	O
the	O
role	O
of	O
a	O
bacterial	O
metalloprotease	O
in	O
protection	O
against	O
AMPs	O
.	O

Our	O
analysis	O
reveals	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
is	O
multi	O
-	O
factorial	O
,	O
as	O
one	O
might	O
expect	O
,	O
but	O
can	O
be	O
decrypted	O
through	O
genetic	O
analysis	O
of	O
the	O
two	O
interacting	O
partners	O
.	O

Local	O
Expression	O
of	O
AMP	O
Genes	O
Plays	O
a	O
Major	O
Role	O
against	O
Food	O
-	O
Borne	O
Infections	O
The	O
use	O
of	O
GFP	O
reporter	O
transgenes	O
in	O
Drosophila	B-Organism
has	O
revealed	O
that	O
,	O
in	O
addition	O
to	O
the	O
fat	O
body	O
,	O
AMP	O
genes	O
can	O
be	O
expressed	O
in	O
several	O
barrier	O
epithelia	O
that	O
are	O
in	O
direct	O
contact	O
with	O
microorganisms	O
from	O
the	O
environment	O
[	O
7	O
,	O
23	O
]	O
.	O

The	O
precise	O
relevance	O
of	O
this	O
local	O
immune	O
response	O
in	O
Drosophila	B-Organism
has	O
not	O
been	O
established	O
to	O
date	O
.	O

The	O
present	O
study	O
demonstrates	O
a	O
key	O
role	O
for	O
the	O
local	O
Imd	O
immune	O
response	O
in	O
the	O
gut	O
against	O
oral	O
infection	O
by	O
bacterial	O
pathogens	O
.	O

The	O
Imd	O
pathway	O
regulates	O
a	O
large	O
number	O
of	O
immune	O
genes	O
including	O
those	O
encoding	O
AMPs	O
;	O
and	O
two	O
peptides	O
,	O
Diptericin	O
and	O
Attacin	O
,	O
are	O
preferentially	O
synthesized	O
following	O
bacterial	O
infection	O
in	O
the	O
digestive	O
tract	O
of	O
Drosophila	B-Organism
[	O
7	O
]	O
.	O

To	O
explore	O
the	O
potential	O
implication	O
of	O
AMPs	O
in	O
the	O
Imd	O
immune	O
defense	O
against	O
oral	O
infection	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
we	O
compared	O
survival	O
of	O
flies	O
expressing	O
only	O
a	O
single	O
AMP	O
.	O

Our	O
study	O
reveals	O
that	O
over	O
-	O
expression	O
of	O
either	O
Diptericin	O
or	O
Attacin	O
confers	O
protection	O
against	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
,	B-X
through	B-X
a	B-X
long-term	B-X
laboratory	B-X
selection	B-X
over	B-X
many	B-X
generations	B-X
,	B-X
we	B-X
generated	B-X
a	B-X
Drosophila	B-X
melanogaster	B-X
strain	B-X
that	B-X
can	B-X
live	B-X
and	B-X
reproduce	B-X
in	B-X
very	B-X
high	B-X
O	B-X
(	B-X
2	B-X
)	B-X
environments	B-X
(	B-X
90	B-X
%	B-X
O	B-X
(	B-X
2	B-X
)	B-X
)	B-X
,	B-X
a	B-X
lethal	B-X
condition	B-X
to	B-X
naïve	B-X
flies	B-X
.	B-X
Gene	B-X
expression	B-X
profiling	B-X
revealed	B-X
that	B-X
227	B-X
genes	B-X
were	B-X
significantly	B-X
altered	B-X
in	B-X
expression	B-X
and	B-X
two	B-X
third	B-X
of	B-X
these	B-X
genes	B-X
were	B-X
down-regulated	B-X
.	B-X
Using	B-X
a	B-X
mutant	B-X
screen	B-X
strategy	B-X
,	B-X
we	B-X
studied	B-X
the	B-X
role	B-X
of	B-X
some	B-X
altered	B-X
genes	B-X
(	B-X
up-	B-X
or	B-X
down-regulated	B-X
in	B-X
the	B-X
microarrays	B-X
)	B-X
by	B-X
testing	B-X
the	B-X
survival	B-X
of	B-X
available	B-X
corresponding	B-X
P-element	B-X
or	B-X
UAS	B-X
construct	B-X
lines	B-X
under	B-X
hyperoxic	B-X
conditions	B-X
.	B-X
We	B-X
report	B-X
that	B-X
down-regulation	B-X
of	B-X
several	B-X
candidate	B-X
genes	B-X
including	B-X
Tropomyosin	B-X
1	B-X
,	B-X
Glycerol	B-X
3	B-X
phosphate	B-X
dehydrogenase	B-X
,	B-X
CG33129	B-X
,	B-X
and	B-X
UGP	B-X
as	B-X
well	B-X
as	B-X
up-regulation	B-X
of	B-X
Diptericin	B-X
and	B-X
Attacin	B-X
conferred	B-X
tolerance	B-X
to	B-X
severe	B-X
hyperoxia	B-X
.	B-X
Thus	B-X
our	B-X
study	B-X
provides	B-X
a	B-X
molecular	B-X
basis	B-X
for	B-X
understanding	B-X
the	B-X
mechanisms	B-X
of	B-X
hyperoxia	B-X
tolerance	B-X
.	B-X

This	O
observation	O
,	O
combined	O
with	O
our	O
data	O
demonstrating	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
expresses	O
specific	O
virulence	O
factors	O
in	O
order	O
to	O
resist	O
AMPs	O
,	O
underlines	O
the	O
critical	O
role	O
of	O
local	O
AMP	O
expression	O
against	O
food	O
-	O
borne	O
pathogens	O
.	O

Previous	O
studies	O
revealed	O
only	O
a	O
modest	O
contribution	O
of	O
Diptericin	O
to	O
resistance	O
against	O
Gram	O
-	O
negative	O
bacteria	O
during	O
systemic	O
infection	O
[	O
22	O
]	O
.	O

In	O
contrast	O
,	O
our	O
data	O
reveal	O
that	O
Diptericin	O
plays	O
an	O
essential	O
role	O
in	O
the	O
defense	O
against	O
Gram	O
-	O
negative	O
bacteria	O
when	O
they	O
are	O
ingested	O
.	O

The	O
antibacterial	O
activity	O
of	O
Diptericin	O
may	O
be	O
enhanced	O
in	O
the	O
gut	O
by	O
pH	O
and	O
other	O
factors	O
such	O
as	O
lysozymes	O
[	O
24	O
]	O
.	O

It	O
is	O
also	O
possible	O
that	O
Diptericin	O
could	O
reach	O
high	O
concentration	O
levels	O
in	O
restricted	O
areas	O
of	O
the	O
Drosophila	B-Organism
gut	O
such	O
as	O
the	O
proventriculus	O
and	O
thus	O
be	O
more	O
effective	O
against	O
pathogens	O
than	O
in	O
other	O
body	O
compartments	O
.	O

Our	O
study	O
suggests	O
that	O
Diptericin	O
expression	O
in	O
the	O
anterior	O
gut	O
provides	O
an	O
efficient	O
early	O
barrier	O
allowing	O
Drosophila	B-Organism
to	O
rapidly	O
eliminate	O
most	O
ingested	O
bacteria	O
.	O

Finally	O
,	O
it	O
remains	O
surprising	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
triggers	O
a	O
systemic	O
immune	O
response	O
that	O
has	O
no	O
overt	O
function	O
against	O
the	O
bacteria	O
that	O
remain	O
in	O
the	O
gut	O
lumen	O
.	O

This	O
response	O
could	O
be	O
interpreted	O
as	O
anticipation	O
of	O
possible	O
breaching	O
of	O
the	O
gut	O
barrier	O
.	O

Alternatively	O
,	O
our	O
results	O
suggest	O
the	O
possibility	O
that	O
bacteria	O
such	O
as	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
may	O
subvert	O
insect	O
host	O
defenses	O
by	O
triggering	O
this	O
systemic	O
response	O
.	O

This	O
can	O
be	O
compared	O
with	O
many	O
human	B-Organism
pathogens	O
for	O
which	O
activation	O
of	O
an	O
inflammatory	O
response	O
represents	O
a	O
part	O
of	O
their	O
invasive	O
strategy	O
[	O
25	O
]	O
.	O

AprA	O
Protects	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
from	O
Antibacterial	O
Peptides	O

In	O
bacteria	O
,	O
nitrogen	O
and	O
carbon	O
sources	O
are	O
frequently	O
provided	O
by	O
enzymatic	O
degradation	O
of	O
extracellular	O
biopolymers	O
by	O
proteases	O
and	O
glycosidases	O
.	O

Proteases	O
,	O
especially	O
metalloproteases	O
,	O
are	O
also	O
known	O
to	O
contribute	O
to	O
virulence	O
in	O
some	O
pathogenic	O
bacteria	O
including	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
,	O
S	B-Organism
.	I-Organism
marcescens	I-Organism
,	O
and	O
Bacillus	B-Organism
thuringiensis	I-Organism
[	O
20	O
,	O
21	O
,	O
26	O
]	O
.	O

Molecular	O
mechanisms	O
for	O
pathogenesis	O
attributed	O
to	O
these	O
proteases	O
include	O
degradation	O
of	O
structural	O
matrices	O
and	O
destruction	O
of	O
proteins	O
involved	O
in	O
host	O
protective	O
functions	O
such	O
as	O
AMPs	O
or	O
complement	O
factors	O
.	O
<EOS>	B-X
Complement	B-X
.	B-X
First	B-X
of	B-X
two	B-X
parts	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
the	B-X
complement	B-X
system	B-X
to	B-X
rapidly	B-X
and	B-X
broadly	B-X
react	B-X
to	B-X
microbial	B-X
intruders	B-X
,	B-X
apoptotic	B-X
cells	B-X
and	B-X
other	B-X
threats	B-X
by	B-X
inducing	B-X
forceful	B-X
elimination	B-X
responses	B-X
is	B-X
indispensable	B-X
for	B-X
its	B-X
role	B-X
as	B-X
host	B-X
defense	B-X
and	B-X
surveillance	B-X
system	B-X
.	B-X
However	B-X
,	B-X
the	B-X
danger	B-X
sensing	B-X
versatility	B-X
of	B-X
complement	B-X
may	B-X
come	B-X
at	B-X
a	B-X
steep	B-X
price	B-X
for	B-X
patients	B-X
suffering	B-X
from	B-X
various	B-X
immune	B-X
,	B-X
inflammatory	B-X
,	B-X
age-related	B-X
,	B-X
or	B-X
biomaterial-induced	B-X
conditions	B-X
.	B-X
Misguided	B-X
recognition	B-X
of	B-X
cell	B-X
debris	B-X
or	B-X
transplants	B-X
,	B-X
excessive	B-X
activation	B-X
by	B-X
microbial	B-X
or	B-X
damaged	B-X
host	B-X
cells	B-X
,	B-X
autoimmune	B-X
events	B-X
,	B-X
and	B-X
dysregulation	B-X
of	B-X
the	B-X
complement	B-X
response	B-X
may	B-X
all	B-X
induce	B-X
effector	B-X
functions	B-X
that	B-X
damage	B-X
rather	B-X
than	B-X
protect	B-X
host	B-X
tissue	B-X
.	B-X
Although	B-X
complement	B-X
has	B-X
long	B-X
been	B-X
associated	B-X
with	B-X
disease	B-X
,	B-X
the	B-X
prevalence	B-X
,	B-X
impact	B-X
and	B-X
complexity	B-X
of	B-X
complement	B-X
's	B-X
involvement	B-X
in	B-X
pathological	B-X
processes	B-X
is	B-X
only	B-X
now	B-X
becoming	B-X
fully	B-X
recognized	B-X
.	B-X
While	B-X
complement	B-X
rarely	B-X
constitutes	B-X
the	B-X
sole	B-X
driver	B-X
of	B-X
disease	B-X
,	B-X
it	B-X
acts	B-X
as	B-X
initiator	B-X
,	B-X
contributor	B-X
,	B-X
and/or	B-X
exacerbator	B-X
in	B-X
numerous	B-X
disorders	B-X
.	B-X
Identifying	B-X
the	B-X
factors	B-X
that	B-X
tip	B-X
complement	B-X
's	B-X
balance	B-X
from	B-X
protective	B-X
to	B-X
damaging	B-X
effects	B-X
in	B-X
a	B-X
particular	B-X
disease	B-X
continues	B-X
to	B-X
prove	B-X
challenging	B-X
.	B-X
Fortunately	B-X
,	B-X
however	B-X
,	B-X
molecular	B-X
insight	B-X
into	B-X
complement	B-X
functions	B-X
,	B-X
improved	B-X
disease	B-X
models	B-X
,	B-X
and	B-X
growing	B-X
clinical	B-X
experience	B-X
has	B-X
led	B-X
to	B-X
a	B-X
greatly	B-X
improved	B-X
understanding	B-X
of	B-X
complement	B-X
's	B-X
pathological	B-X
side	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
novel	B-X
complement-mediated	B-X
indications	B-X
and	B-X
the	B-X
clinical	B-X
availability	B-X
of	B-X
the	B-X
first	B-X
therapeutic	B-X
complement	B-X
inhibitors	B-X
has	B-X
also	B-X
sparked	B-X
a	B-X
renewed	B-X
interest	B-X
in	B-X
developing	B-X
complement-targeted	B-X
drugs	B-X
,	B-X
which	B-X
meanwhile	B-X
led	B-X
to	B-X
new	B-X
approvals	B-X
and	B-X
promising	B-X
candidates	B-X
in	B-X
late-stage	B-X
evaluation	B-X
.	B-X
More	B-X
than	B-X
a	B-X
century	B-X
after	B-X
its	B-X
description	B-X
,	B-X
complement	B-X
now	B-X
has	B-X
truly	B-X
reached	B-X
the	B-X
clinic	B-X
and	B-X
the	B-X
recent	B-X
developments	B-X
hold	B-X
great	B-X
promise	B-X
for	B-X
diagnosis	B-X
and	B-X
therapy	B-X
alike	B-X
.	B-X

However	O
,	O
in	O
most	O
cases	O
,	O
attempts	O
to	O
evaluate	O
the	O
role	O
of	O
metalloproteases	O
in	O
virulence	O
have	O
failed	O
to	O
obtain	O
conclusive	O
results	O
with	O
respect	O
to	O
a	O
specific	O
function	O
[	O
20	O
,	O
21	O
]	O
.	O

Thus	O
,	O
our	O
approach	O
focusing	O
on	O
both	O
host	O
and	O
pathogen	O
is	O
the	O
first	O
to	O
clearly	O
demonstrate	O
a	O
key	O
role	O
of	O
the	O
AprA	O
metalloprotease	O
in	O
the	O
protection	O
against	O
AMPs	O
in	O
vivo	O
.	O

This	O
conclusion	O
is	O
based	O
on	O
our	O
observations	O
that	O
(	O
i	O
)	O
aprA	O
mutants	O
show	O
attenuated	O
virulence	O
,	O
(	O
ii	O
)	O
aprA	O
mutants	O
survive	O
less	O
well	O
than	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
in	O
Drosophila	B-Organism
and	O
are	O
more	O
sensitive	O
to	O
Imd	O
-	O
mediated	O
defense	O
,	O
and	O
(	O
iii	O
)	O
AprA	O
provides	O
specific	O
protection	O
in	O
vivo	O
against	O
Diptericin	O
.	O

Altogether	O
,	O
our	O
study	O
reveals	O
that	O
local	O
AMP	O
expression	O
plays	O
an	O
important	O
role	O
in	O
defense	O
against	O
oral	O
pathogens	O
and	O
that	O
entomopathogens	O
such	O
as	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
can	O
counteract	O
this	O
effect	O
by	O
expressing	O
aprA	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
S	B-Organism
.	I-Organism
marcescens	I-Organism
,	O
another	O
potent	O
oral	O
pathogen	O
of	O
Drosophila	B-Organism
,	O
also	O
expresses	O
a	O
protease	O
that	O
can	O
degrade	O
AMPs	O
in	O
vitro	O
[	O
12	O
]	O
.	O

However	O
,	O
in	O
the	O
absence	O
of	O
a	O
Serratia	B-Organism
protease	I-Organism
mutant	I-Organism
,	O
the	O
in	O
vivo	O
relevance	O
of	O
the	O
protease	O
is	O
not	O
yet	O
established	O
.	O

Taken	O
together	O
,	O
this	O
observation	O
and	O
our	O
findings	O
suggest	O
that	O
proteases	O
may	O
represent	O
a	O
common	O
strategy	O
used	O
by	O
Drosophila	B-Organism
pathogens	O
to	O
circumvent	O
the	O
potent	O
antimicrobial	O
host	O
defense	O
.	O

We	O
cannot	O
exclude	O
that	O
AprA	O
degrades	O
other	O
immune	O
effectors	O
or	O
participates	O
directly	O
as	O
a	O
toxic	O
factor	O
by	O
degrading	O
the	O
gut	O
epithelium	O
or	O
the	O
peritrophic	O
matrix	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
found	B-X
that	B-X
the	B-X
gut	B-X
microbiota	B-X
of	B-X
Anopheles	B-X
stephensi	B-X
,	B-X
a	B-X
competent	B-X
malaria	B-X
vector	B-X
,	B-X
is	B-X
involved	B-X
in	B-X
tryptophan	B-X
metabolism	B-X
and	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
catabolism	B-X
of	B-X
the	B-X
peritrophic	B-X
matrix	B-X
impairing	B-X
tryptophan	B-X
metabolites	B-X
.	B-X
Of	B-X
these	B-X
metabolites	B-X
,	B-X
3-HK	B-X
impaired	B-X
the	B-X
structure	B-X
of	B-X
the	B-X
peritrophic	B-X
matrix	B-X
and	B-X
promoted	B-X
Plasmodium	B-X
berghei	B-X
infection	B-X
.	B-X
Among	B-X
the	B-X
major	B-X
gut	B-X
microbiota	B-X
members	B-X
in	B-X
A.	B-X
stephensi	B-X
,	B-X
Pseudomonas	B-X
alcaligenes	B-X
catabolized	B-X
3-HK	B-X
as	B-X
revealed	B-X
by	B-X
whole-genome	B-X
sequencing	B-X
and	B-X
LC-MS	B-X
metabolic	B-X
analysis	B-X
.	B-X
Mutation	B-X
of	B-X
KynU	B-X
resulted	B-X
in	B-X
a	B-X
P.	B-X
alcaligenes	B-X
strain	B-X
that	B-X
was	B-X
unable	B-X
to	B-X
metabolize	B-X
3-HK	B-X
and	B-X
unable	B-X
to	B-X
protect	B-X
the	B-X
peritrophic	B-X
matrix	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
this	B-X
study	B-X
identifies	B-X
an	B-X
unexpected	B-X
function	B-X
of	B-X
mosquito	B-X
gut	B-X
microbiota	B-X
in	B-X
controlling	B-X
mosquito	B-X
tryptophan	B-X
metabolism	B-X
,	B-X
with	B-X
important	B-X
implications	B-X
for	B-X
vector	B-X
competence	B-X
.	B-X

In	O
B	B-Organism
.	I-Organism
thuringiensis	I-Organism
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
protease	O
InhA2	O
participates	O
in	O
the	O
degradation	O
of	O
the	O
gut	O
,	O
thus	O
facilitating	O
the	O
action	O
of	O
the	O
Cry	O
toxins	O
[	O
27	O
,	O
28	O
]	O
.	O

Alternatively	O
,	O
in	O
Photorhabdus	B-Organism
luminescens	I-Organism
,	O
an	O
AprA	O
homologue	O
,	O
PrtA	O
,	O
has	O
been	O
proposed	O
not	O
to	O
be	O
a	O
virulence	O
factor	O
,	O
but	O
rather	O
to	O
be	O
involved	O
in	O
degrading	O
host	O
tissues	O
following	O
host	O
death	O
in	O
order	O
to	O
promote	O
efficient	O
nutrition	O
and	O
development	O
of	O
its	O
symbiotic	O
nematode	O
host	O
[	O
14	O
,	O
29	O
]	O
.	O

The	O
observation	O
that	O
injection	O
of	O
AprA	O
into	O
the	O
hemocoel	O
is	O
lethal	O
to	O
adult	O
flies	O
supports	O
the	O
hypothesis	O
of	O
additional	O
roles	O
for	O
the	O
protease	O
in	O
bacterial	O
pathogenesis	O
.	O

However	O
,	O
oral	O
ingestion	O
of	O
purified	O
AprA	O
induces	O
only	O
low	O
levels	O
of	O
lethality	O
,	O
indicating	O
that	O
AprA	O
alone	O
is	O
not	O
sufficient	O
to	O
kill	O
the	O
host	O
via	O
this	O
route	O
of	O
entry	O
,	O
and	O
other	O
factors	O
participate	O
in	O
oral	O
toxicity	O
.	O

P	B-Organism
.	I-Organism
entomophila	I-Organism
Virulence	O
Is	O
Multi	O
-	O
Factorial	O
<EOS>	B-X
Pathogens	B-X
have	B-X
developed	B-X
multiple	B-X
strategies	B-X
that	B-X
allow	B-X
them	B-X
to	B-X
exploit	B-X
host	B-X
resources	B-X
and	B-X
resist	B-X
the	B-X
immune	B-X
response	B-X
.	B-X
To	B-X
study	B-X
how	B-X
Drosophila	B-X
flies	B-X
deal	B-X
with	B-X
infectious	B-X
diseases	B-X
in	B-X
a	B-X
natural	B-X
context	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
interactions	B-X
between	B-X
Drosophila	B-X
and	B-X
a	B-X
newly	B-X
identified	B-X
entomopathogen	B-X
,	B-X
Pseudomonas	B-X
entomophila	B-X
.	B-X
Flies	B-X
orally	B-X
infected	B-X
with	B-X
P.	B-X
entomophila	B-X
rapidly	B-X
succumb	B-X
despite	B-X
the	B-X
induction	B-X
of	B-X
both	B-X
local	B-X
and	B-X
systemic	B-X
immune	B-X
responses	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
bacterium	B-X
has	B-X
developed	B-X
specific	B-X
strategies	B-X
to	B-X
escape	B-X
the	B-X
fly	B-X
immune	B-X
response	B-X
.	B-X
Using	B-X
a	B-X
combined	B-X
genetic	B-X
approach	B-X
on	B-X
both	B-X
host	B-X
and	B-X
pathogen	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
P.	B-X
entomophila	B-X
virulence	B-X
is	B-X
multi-factorial	B-X
with	B-X
a	B-X
clear	B-X
differentiation	B-X
between	B-X
factors	B-X
that	B-X
trigger	B-X
the	B-X
immune	B-X
response	B-X
and	B-X
those	B-X
that	B-X
promote	B-X
pathogenicity	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
AprA	B-X
,	B-X
an	B-X
abundant	B-X
secreted	B-X
metalloprotease	B-X
produced	B-X
by	B-X
P.	B-X
entomophila	B-X
,	B-X
is	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X
Our	B-X
study	B-X
also	B-X
reveals	B-X
that	B-X
the	B-X
major	B-X
contribution	B-X
to	B-X
the	B-X
fly	B-X
defense	B-X
against	B-X
P.	B-X
entomophila	B-X
is	B-X
provided	B-X
by	B-X
the	B-X
local	B-X
,	B-X
rather	B-X
than	B-X
the	B-X
systemic	B-X
immune	B-X
response	B-X
.	B-X

In	O
agreement	O
with	O
previous	O
studies	O
,	O
we	O
show	O
that	O
aprA	O
expression	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
depends	O
on	O
both	O
PrtR	O
and	O
the	O
GacS	O
/	O
GacA	O
system	O
.	O

The	O
GacS	O
/	O
GacA	O
two	O
-	O
component	O
regulatory	O
system	O
is	O
conserved	O
in	O
numerous	O
Gram	O
-	O
negative	O
bacteria	O
and	O
has	O
been	O
shown	O
to	O
regulate	O
a	O
wide	O
variety	O
of	O
cellular	O
functions	O
and	O
virulence	O
factors	O
[	O
30	O
,	O
31	O
]	O
.	O

Our	O
study	O
indicates	O
that	O
it	O
is	O
the	O
master	O
regulator	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
.	O

In	O
a	O
gacA	O
mutant	O
background	O
,	O
AprA	O
synthesis	O
is	O
not	O
restored	O
when	O
a	O
plasmid	O
with	O
the	O
aprA	O
locus	O
is	O
expressed	O
in	O
trans	O
(	O
unpublished	O
data	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
post	O
-	O
transcriptional	O
regulation	O
of	O
aprA	O
by	O
gacA	O
via	O
the	O
two	O
small	O
non	O
-	O
coding	O
RNAs	O
RsmY	O
and	O
RsmZ	O
[	O
11	O
]	O
.	O

As	O
opposed	O
to	O
the	O
pleiotropic	O
effects	O
of	O
GacS	O
/	O
GacA	O
,	O
PrtR	O
appears	O
to	O
be	O
a	O
more	O
specific	O
regulator	O
of	O
aprA	O
expression	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
reminiscent	O
of	O
aprX	O
regulation	O
in	O
P	B-Organism
.	I-Organism
fluorescens	I-Organism
[	O
32	O
]	O
.	O

Many	O
pseudomonads	B-Organism
and	O
other	O
bacteria	O
express	O
proteases	O
similar	O
to	O
AprA	O
but	O
are	O
not	O
able	O
to	O
infect	O
Drosophila	B-Organism
by	O
oral	O
ingestion	O
.	O

This	O
indicates	O
that	O
AprA	O
is	O
not	O
the	O
sole	O
virulence	O
factor	O
required	O
for	O
persistence	O
in	O
the	O
Drosophila	B-Organism
gastrointestinal	O
tract	O
.	O
<EOS>	B-X
Risk	B-X
factors	B-X
are	B-X
radiotherapy	B-X
and	B-X
hormone	B-X
intake	B-X
.	B-X
Autocrine	B-X
proliferation	B-X
repressor	B-X
protein	B-X
A	B-X
(	B-X
AprA	B-X
)	B-X
is	B-X
a	B-X
protein	B-X
secreted	B-X
by	B-X
Dictyostelium	B-X
discoideum	B-X
cells	B-X
.	B-X
Although	B-X
there	B-X
is	B-X
very	B-X
little	B-X
sequence	B-X
similarity	B-X
between	B-X
AprA	B-X
and	B-X
any	B-X
human	B-X
protein	B-X
,	B-X
AprA	B-X
has	B-X
a	B-X
predicted	B-X
structural	B-X
similarity	B-X
to	B-X
the	B-X
human	B-X
protein	B-X
dipeptidyl	B-X
peptidase	B-X
IV	B-X
(	B-X
DPPIV	B-X
)	B-X
.	B-X
AprA	B-X
is	B-X
a	B-X
chemorepellent	B-X
for	B-X
Dictyostelium	B-X
cells	B-X
,	B-X
and	B-X
DPPIV	B-X
is	B-X
a	B-X
chemorepellent	B-X
for	B-X
neutrophils	B-X
.	B-X
This	B-X
led	B-X
us	B-X
to	B-X
investigate	B-X
if	B-X
AprA	B-X
and	B-X
DPPIV	B-X
have	B-X
additional	B-X
functional	B-X
similarities	B-X
.	B-X
We	B-X
find	B-X
that	B-X
like	B-X
AprA	B-X
,	B-X
DPPIV	B-X
is	B-X
a	B-X
chemorepellent	B-X
for	B-X
,	B-X
and	B-X
inhibits	B-X
the	B-X
proliferation	B-X
of	B-X
,	B-X
D.	B-X
discoideum	B-X
cells	B-X
,	B-X
and	B-X
that	B-X
AprA	B-X
binds	B-X
some	B-X
DPPIV	B-X
binding	B-X
partners	B-X
such	B-X
as	B-X
fibronectin	B-X
.	B-X
Conversely	B-X
,	B-X
rAprA	B-X
has	B-X
DPPIV-like	B-X
protease	B-X
activity	B-X
.	B-X

The	O
difference	O
in	O
pathogenicity	O
exhibited	O
by	O
gacA	O
,	O
prtR	O
,	O
and	O
aprA	O
mutants	O
underlines	O
the	O
complexity	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
factors	O
.	O

The	O
observation	O
that	O
both	O
aprA	O
and	O
prtR	O
,	O
but	O
not	O
gacA	O
,	O
mutants	O
retained	O
the	O
capacity	O
to	O
trigger	O
a	O
systemic	O
immune	O
response	O
indicates	O
a	O
clear	O
distinction	O
between	O
pathogenicity	O
and	O
immune	O
activation	O
.	O

Our	O
current	O
hypothesis	O
is	O
that	O
systemic	O
immune	O
activation	O
is	O
linked	O
to	O
bacterial	O
persistence	O
in	O
the	O
gut	O
and	O
release	O
of	O
peptidoglycan	O
fragments	O
small	O
enough	O
to	O
cross	O
the	O
gut	O
barrier	O
[	O
33	O
]	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
GacS	O
/	O
GacA	O
two	O
-	O
component	O
system	O
regulates	O
one	O
or	O
several	O
genes	O
that	O
promote	O
bacterial	O
survival	O
in	O
the	O
gut	O
.	O
<EOS>	B-X
The	B-X
gastrointestinal	B-X
tract	B-X
(	B-X
GIT	B-X
)	B-X
is	B-X
the	B-X
largest	B-X
immune	B-X
organ	B-X
and	B-X
maintains	B-X
systemic	B-X
immune	B-X
homeostasis	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
bacterial	B-X
challenge	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
host	B-X
immunity	B-X
regulates	B-X
the	B-X
microbiome	B-X
by	B-X
altering	B-X
bacteria-associated	B-X
signaling	B-X
to	B-X
influence	B-X
tumor	B-X
surveillance	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
the	B-X
intricate	B-X
crosstalk	B-X
among	B-X
the	B-X
gut	B-X
microbiome	B-X
,	B-X
cancer	B-X
immune	B-X
response	B-X
,	B-X
and	B-X
immunotherapy	B-X
.	B-X
Interactive	B-X
modulation	B-X
of	B-X
the	B-X
host	B-X
microbiota	B-X
provides	B-X
new	B-X
therapeutic	B-X
strategies	B-X
to	B-X
promote	B-X
anticancer	B-X
therapy	B-X
efficacy	B-X
and/or	B-X
reduce	B-X
toxicity	B-X
.	B-X

This	O
hypothesized	O
persistence	O
-	O
promoting	O
factor	O
may	O
have	O
a	O
function	O
similar	O
to	O
the	O
Erwinia	O
virulence	O
factor	O
(	O
evf	O
)	O
gene	O
of	O
E	B-Organism
.	I-Organism
carotovora	I-Organism
Ecc15	I-Organism
that	O
promotes	O
persistence	O
of	O
Gram	O
-	O
negative	O
bacteria	O
in	O
the	O
larval	O
gut	O
[	O
34	O
]	O
.	O

Since	O
gacA	O
mutants	O
did	O
not	O
persist	O
in	O
imd	O
-	O
deficient	O
mutant	O
hosts	O
,	O
we	O
speculate	O
that	O
this	O
persistence	O
-	O
promoting	O
factor	O
provides	O
general	O
protection	O
against	O
gut	O
intestinal	O
conditions	O
rather	O
than	O
a	O
specific	O
protection	O
against	O
the	O
fly	O
immune	O
response	O
.	O
<EOS>	B-X
This	B-X
current	B-X
study	B-X
assessed	B-X
the	B-X
toxicological	B-X
responses	B-X
to	B-X
aerosols	B-X
from	B-X
this	B-X
NVP	B-X
.	B-X
A	B-X
gacA	B-X
mutant	B-X
deficient	B-X
in	B-X
the	B-X
production	B-X
of	B-X
N-acylhomoserine	B-X
lactones	B-X
(	B-X
AHLs	B-X
)	B-X
and	B-X
phenazine	B-X
was	B-X
isolated	B-X
through	B-X
transposon	B-X
mutagenesis	B-X
.	B-X
Further	B-X
phenotypic	B-X
characterization	B-X
revealed	B-X
that	B-X
in	B-X
strain	B-X
G5	B-X
,	B-X
similar	B-X
to	B-X
other	B-X
P.	B-X
chlororaphis	B-X
strains	B-X
,	B-X
a	B-X
gacA	B-X
mutation	B-X
caused	B-X
inability	B-X
to	B-X
produce	B-X
biocontrol	B-X
factors	B-X
such	B-X
as	B-X
phenazine	B-X
,	B-X
HCN	B-X
and	B-X
proteases	B-X
responsible	B-X
for	B-X
antifungal	B-X
activity	B-X
,	B-X
but	B-X
overproduced	B-X
siderophores	B-X
.	B-X
LC-MS/MS	B-X
analysis	B-X
revealed	B-X
that	B-X
AHL	B-X
production	B-X
was	B-X
also	B-X
practically	B-X
abolished	B-X
in	B-X
this	B-X
mutant	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
other	B-X
isolates	B-X
of	B-X
this	B-X
organism	B-X
,	B-X
GacA	B-X
in	B-X
strain	B-X
G5	B-X
was	B-X
shown	B-X
to	B-X
negatively	B-X
regulate	B-X
biofilm	B-X
formation	B-X
and	B-X
oxidative	B-X
stress	B-X
response	B-X
whilst	B-X
positively	B-X
regulating	B-X
cell	B-X
motility	B-X
and	B-X
biosynthesis	B-X
of	B-X
indole-3-acetic	B-X
acid	B-X
(	B-X
IAA	B-X
)	B-X
.	B-X

Another	O
interesting	O
feature	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
is	O
the	O
food	O
-	O
uptake	O
cessation	O
which	O
is	O
observed	O
in	O
prtR	O
and	O
aprA	O
but	O
not	O
in	O
gacA	O
mutants	O
.	O

Food	O
-	O
uptake	O
cessation	O
or	O
blockage	O
in	O
insects	O
is	O
induced	O
by	O
several	O
other	O
entomopathogenic	O
bacteria	O
including	O
S	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
Yersinia	B-Organism
pestis	I-Organism
,	O
enabling	O
persistence	O
in	O
the	O
digestive	O
tract	O
of	O
their	O
insect	O
hosts	O
[	O
35	O
,	O
36	O
]	O
.	O
<EOS>	B-X
It	B-X
is	B-X
widely	B-X
assumed	B-X
that	B-X
this	B-X
weight	B-X
gain	B-X
reflects	B-X
a	B-X
metabolic	B-X
or	B-X
behavioural	B-X
compensatory	B-X
response	B-X
to	B-X
the	B-X
cessation	B-X
of	B-X
cocaine	B-X
use	B-X
.	B-X
We	B-X
hypothesize	B-X
that	B-X
the	B-X
cocaine-induced	B-X
alteration	B-X
in	B-X
fat	B-X
regulation	B-X
results	B-X
in	B-X
cocaine	B-X
users	B-X
developing	B-X
a	B-X
pronounced	B-X
appetite	B-X
for	B-X
fatty	B-X
food	B-X
but	B-X
keeps	B-X
their	B-X
fat	B-X
mass	B-X
low	B-X
.	B-X
In	B-X
the	B-X
face	B-X
of	B-X
increasing	B-X
tobacco	B-X
consumption	B-X
in	B-X
Sub-Saharan	B-X
Africa	B-X
,	B-X
it	B-X
is	B-X
crucial	B-X
to	B-X
not	B-X
only	B-X
curb	B-X
the	B-X
uptake	B-X
of	B-X
tobacco	B-X
,	B-X
but	B-X
to	B-X
ensure	B-X
that	B-X
tobacco	B-X
users	B-X
quit	B-X
.	B-X
Considering	B-X
the	B-X
minimal	B-X
attention	B-X
that	B-X
tobacco	B-X
cessation	B-X
interventions	B-X
receive	B-X
in	B-X
Sub-Saharan	B-X
Africa	B-X
,	B-X
this	B-X
review	B-X
aims	B-X
to	B-X
describe	B-X
studies	B-X
that	B-X
evaluated	B-X
tobacco	B-X
cessation	B-X
interventions	B-X
in	B-X
the	B-X
region	B-X
.	B-X

This	O
observation	O
suggests	O
that	O
peristaltic	O
movements	O
of	O
the	O
gut	O
may	O
also	O
play	O
an	O
important	O
role	O
in	O
the	O
elimination	O
of	O
bacteria	O
,	O
and	O
that	O
entomopathogens	O
have	O
developed	O
strategies	O
to	O
abrogate	O
these	O
movements	O
.	O

In	O
S	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
it	O
has	O
been	O
shown	O
that	O
genes	O
encoded	O
by	O
a	O
prophage	O
were	O
responsible	O
for	O
the	O
anti	O
-	O
feeding	O
reaction	O
in	O
its	O
natural	O
insect	O
host	O
,	O
the	O
grass	O
grub	O
Costelytra	B-Organism
zealandica	I-Organism
larvae	O
[	O
35	O
]	O
.	O

Y	B-Organism
.	I-Organism
pestis	I-Organism
is	O
able	O
to	O
multiply	O
in	O
the	O
flea	O
midgut	O
and	O
forms	O
cohesive	O
aggregates	O
.	O

The	O
absence	O
of	O
homologous	O
genes	O
to	O
these	O
factors	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
indicates	O
that	O
other	O
factors	O
are	O
probably	O
implicated	O
in	O
this	O
bacterium	O
[	O
10	O
]	O
.	O

Determining	O
the	O
cause	O
of	O
this	O
food	O
-	O
uptake	O
cessation	O
and	O
its	O
possible	O
link	O
to	O
the	O
persistence	O
-	O
promoting	O
factor	O
will	O
be	O
essential	O
for	O
the	O
elucidation	O
of	O
the	O
initial	O
events	O
involved	O
in	O
gut	O
colonization	O
.	O

Finally	O
,	O
our	O
study	O
shows	O
that	O
aprA	O
,	O
but	O
not	O
gacA	O
,	O
mutants	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
retain	O
a	O
moderate	O
capacity	O
to	O
kill	O
both	O
adult	O
flies	O
and	O
larvae	O
.	O
<EOS>	B-X
Geochemical	B-X
researches	B-X
at	B-X
Lake	B-X
Pavin	B-X
,	B-X
a	B-X
low-sulfate-containing	B-X
freshwater	B-X
lake	B-X
,	B-X
suggest	B-X
that	B-X
the	B-X
dominant	B-X
biogeochemical	B-X
processes	B-X
are	B-X
iron	B-X
and	B-X
sulfate	B-X
reduction	B-X
,	B-X
and	B-X
methanogenesis	B-X
.	B-X
The	B-X
aim	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
assess	B-X
the	B-X
vertical	B-X
distribution	B-X
of	B-X
these	B-X
microbes	B-X
and	B-X
their	B-X
diversities	B-X
and	B-X
to	B-X
test	B-X
the	B-X
hypothesis	B-X
suggesting	B-X
that	B-X
only	B-X
few	B-X
SRP	B-X
populations	B-X
are	B-X
involved	B-X
in	B-X
dissimilatory	B-X
sulfate	B-X
reduction	B-X
and	B-X
that	B-X
Epsilonproteobacteria	B-X
are	B-X
the	B-X
likely	B-X
key	B-X
players	B-X
in	B-X
the	B-X
oxidative	B-X
phase	B-X
of	B-X
sulfur	B-X
cycle	B-X
by	B-X
using	B-X
a	B-X
PCR	B-X
aprA	B-X
gene-based	B-X
approach	B-X
in	B-X
comparison	B-X
with	B-X
a	B-X
16S	B-X
rRNA	B-X
gene-based	B-X
analysis	B-X
.	B-X
Finally	B-X
,	B-X
this	B-X
preliminary	B-X
work	B-X
points	B-X
strongly	B-X
the	B-X
likelihood	B-X
of	B-X
novel	B-X
metabolic	B-X
processes	B-X
upon	B-X
the	B-X
availability	B-X
of	B-X
sulfate	B-X
and	B-X
other	B-X
electron	B-X
acceptors	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
report	B-X
the	B-X
localization	B-X
,	B-X
molecular	B-X
function	B-X
,	B-X
and	B-X
interactome	B-X
of	B-X
Cln5	B-X
,	B-X
the	B-X
CLN5	B-X
homolog	B-X
in	B-X
the	B-X
social	B-X
amoeba	B-X
Dictyostelium	B-X
discoideum	B-X
.	B-X
Finally	B-X
,	B-X
immunoprecipitation	B-X
coupled	B-X
with	B-X
mass	B-X
spectrometry	B-X
identified	B-X
61	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
Cln5	B-X
in	B-X
Dictyostelium	B-X
.	B-X
In	B-X
total	B-X
,	B-X
this	B-X
work	B-X
reveals	B-X
a	B-X
CLN5	B-X
homolog	B-X
in	B-X
Dictyostelium	B-X
and	B-X
further	B-X
establishes	B-X
this	B-X
organism	B-X
as	B-X
a	B-X
complementary	B-X
model	B-X
system	B-X
for	B-X
studying	B-X
the	B-X
functions	B-X
of	B-X
proteins	B-X
linked	B-X
to	B-X
NCL	B-X
in	B-X
humans	B-X
.	B-X

This	O
confirms	O
the	O
existence	O
of	O
other	O
bacterial	O
virulence	O
factors	O
.	O
<EOS>	B-X
The	B-X
ubiquitous	B-X
``	B-X
jack-of-all-trades	B-X
,	B-X
''	B-X
Aeromonas	B-X
hydrophila	B-X
,	B-X
is	B-X
a	B-X
freshwater	B-X
,	B-X
Gram-negative	B-X
bacterial	B-X
pathogen	B-X
under	B-X
revision	B-X
in	B-X
regard	B-X
to	B-X
its	B-X
phylogenetic	B-X
and	B-X
functional	B-X
affiliation	B-X
with	B-X
other	B-X
aeromonads	B-X
.	B-X
While	B-X
virulence	B-X
factors	B-X
are	B-X
expectedly	B-X
diverse	B-X
across	B-X
A.	B-X
hydrophila	B-X
strains	B-X
and	B-X
closely	B-X
related	B-X
species	B-X
,	B-X
our	B-X
mechanistic	B-X
knowledge	B-X
of	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
these	B-X
factors	B-X
is	B-X
based	B-X
on	B-X
the	B-X
molecular	B-X
characterization	B-X
of	B-X
the	B-X
strains	B-X
A.	B-X
hydrophila	B-X
AH-3	B-X
and	B-X
SSU	B-X
,	B-X
which	B-X
were	B-X
reclassified	B-X
as	B-X
A.	B-X
piscicola	B-X
AH-3	B-X
in	B-X
2009	B-X
and	B-X
A.	B-X
dhakensis	B-X
SSU	B-X
in	B-X
2013	B-X
.	B-X
Individually	B-X
,	B-X
these	B-X
reclassifications	B-X
raise	B-X
important	B-X
questions	B-X
involving	B-X
the	B-X
applicability	B-X
of	B-X
previous	B-X
research	B-X
on	B-X
A.	B-X
hydrophila	B-X
virulence	B-X
mechanisms	B-X
;	B-X
however	B-X
,	B-X
this	B-X
issue	B-X
is	B-X
exacerbated	B-X
by	B-X
a	B-X
lack	B-X
of	B-X
genomic	B-X
data	B-X
on	B-X
other	B-X
research	B-X
strains	B-X
.	B-X
This	B-X
review	B-X
revisits	B-X
what	B-X
is	B-X
known	B-X
about	B-X
virulence	B-X
in	B-X
A.	B-X
hydrophila	B-X
and	B-X
the	B-X
feasibility	B-X
of	B-X
using	B-X
comparative	B-X
genomics	B-X
in	B-X
light	B-X
of	B-X
this	B-X
phylogenetic	B-X
revision	B-X
.	B-X
Conflicting	B-X
data	B-X
between	B-X
virulence	B-X
factors	B-X
,	B-X
secretion	B-X
systems	B-X
,	B-X
quorum	B-X
sensing	B-X
,	B-X
and	B-X
their	B-X
effect	B-X
on	B-X
A.	B-X
hydrophila	B-X
pathogenicity	B-X
appears	B-X
to	B-X
be	B-X
an	B-X
artifact	B-X
of	B-X
inappropriate	B-X
taxonomic	B-X
comparisons	B-X
and/or	B-X
be	B-X
due	B-X
to	B-X
the	B-X
fact	B-X
that	B-X
these	B-X
properties	B-X
are	B-X
strain-specific	B-X
.	B-X
This	B-X
review	B-X
audits	B-X
emerging	B-X
data	B-X
on	B-X
dominant	B-X
virulence	B-X
factors	B-X
that	B-X
are	B-X
present	B-X
in	B-X
both	B-X
A.	B-X
dhakensis	B-X
and	B-X
A.	B-X
hydrophila	B-X
in	B-X
order	B-X
to	B-X
synthesize	B-X
existing	B-X
data	B-X
with	B-X
the	B-X
aim	B-X
of	B-X
locating	B-X
where	B-X
future	B-X
research	B-X
is	B-X
needed	B-X
.	B-X

The	O
genome	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
contains	O
several	O
genes	O
encoding	O
putative	O
insecticidal	O
toxins	O
(	O
e	O
.	O
g	O
.	O
,	O
Tc	O
toxins	O
,	O
hemolysins	O
,	O
and	O
lipopeptides	O
)	O
.	O

Therefore	O
,	O
it	O
remains	O
to	O
be	O
determined	O
whether	O
the	O
strategies	O
developed	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
to	O
persist	O
in	O
the	O
larval	O
gut	O
and	O
to	O
kill	O
its	O
host	O
involves	O
genes	O
related	O
to	O
those	O
identified	O
in	O
other	O
entomopathogenic	O
bacteria	O
and	O
how	O
the	O
different	O
factors	O
contribute	O
to	O
pathogenesis	O
.	O

A	O
Comprehensive	O
Genetic	O
Characterization	O
of	O
Bacterial	O
Motility	O
<EOS>	B-X
Motility	B-X
of	B-X
bacterial	B-X
cells	B-X
promotes	B-X
a	B-X
range	B-X
of	B-X
important	B-X
physiological	B-X
phenomena	B-X
such	B-X
as	B-X
nutrient	B-X
detection	B-X
,	B-X
harm	B-X
avoidance	B-X
,	B-X
biofilm	B-X
formation	B-X
,	B-X
and	B-X
pathogenesis	B-X
.	B-X
Genome	B-X
characterization	B-X
of	B-X
a	B-X
uropathogenic	B-X
Motility	B-X
is	B-X
one	B-X
such	B-X
behavior	B-X
that	B-X
has	B-X
been	B-X
the	B-X
focus	B-X
many	B-X
modeling	B-X
efforts	B-X
in	B-X
the	B-X
past	B-X
.	B-X
Molecular	B-X
Signatures	B-X
Related	B-X
to	B-X
the	B-X
Virulence	B-X
of	B-X
Bacillus	B-X
cereus	B-X
Sensu	B-X
Lato	B-X
,	B-X
a	B-X
Leading	B-X
Cause	B-X
of	B-X
Devastating	B-X
Endophthalmitis	B-X
.	B-X

We	O
have	O
developed	O
a	O
powerful	O
experimental	O
framework	O
that	O
combines	O
competitive	O
selection	O
and	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
to	O
comprehensively	O
reveal	O
the	O
genetic	O
basis	O
of	O
bacterial	O
behaviors	O
.	O
<EOS>	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
powerful	B-X
experimental	B-X
framework	B-X
that	B-X
combines	B-X
competitive	B-X
selection	B-X
and	B-X
microarray-based	B-X
genetic	B-X
footprinting	B-X
to	B-X
comprehensively	B-X
reveal	B-X
the	B-X
genetic	B-X
basis	B-X
of	B-X
bacterial	B-X
behaviors	B-X
.	B-X
Application	B-X
of	B-X
this	B-X
method	B-X
to	B-X
Escherichia	B-X
coli	B-X
motility	B-X
identifies	B-X
95	B-X
%	B-X
of	B-X
the	B-X
known	B-X
flagellar	B-X
and	B-X
chemotaxis	B-X
genes	B-X
,	B-X
and	B-X
reveals	B-X
three	B-X
dozen	B-X
novel	B-X
loci	B-X
that	B-X
,	B-X
to	B-X
varying	B-X
degrees	B-X
and	B-X
through	B-X
diverse	B-X
mechanisms	B-X
,	B-X
affect	B-X
motility	B-X
.	B-X
To	B-X
probe	B-X
the	B-X
network	B-X
context	B-X
in	B-X
which	B-X
these	B-X
genes	B-X
function	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
method	B-X
that	B-X
uncovers	B-X
genome-wide	B-X
epistatic	B-X
interactions	B-X
through	B-X
comprehensive	B-X
analyses	B-X
of	B-X
double-mutant	B-X
phenotypes	B-X
.	B-X
This	B-X
unifying	B-X
framework	B-X
enables	B-X
sensitive	B-X
and	B-X
comprehensive	B-X
genetic	B-X
characterization	B-X
of	B-X
complex	B-X
behaviors	B-X
across	B-X
the	B-X
microbial	B-X
biosphere	B-X
.	B-X

Application	O
of	O
this	O
method	O
to	O
Escherichia	B-Organism
coli	I-Organism
motility	O
identifies	O
95	O
%	O
of	O
the	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
,	O
and	O
reveals	O
three	O
dozen	O
novel	O
loci	O
that	O
,	O
to	O
varying	O
degrees	O
and	O
through	O
diverse	O
mechanisms	O
,	O
affect	O
motility	O
.	O
<EOS>	B-X
Application	B-X
of	B-X
this	B-X
method	B-X
to	B-X
Escherichia	B-X
coli	B-X
motility	B-X
identifies	B-X
95	B-X
%	B-X
of	B-X
the	B-X
known	B-X
flagellar	B-X
and	B-X
chemotaxis	B-X
genes	B-X
,	B-X
and	B-X
reveals	B-X
three	B-X
dozen	B-X
novel	B-X
loci	B-X
that	B-X
,	B-X
to	B-X
varying	B-X
degrees	B-X
and	B-X
through	B-X
diverse	B-X
mechanisms	B-X
,	B-X
affect	B-X
motility	B-X
.	B-X
To	B-X
probe	B-X
the	B-X
network	B-X
context	B-X
in	B-X
which	B-X
these	B-X
genes	B-X
function	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
method	B-X
that	B-X
uncovers	B-X
genome-wide	B-X
epistatic	B-X
interactions	B-X
through	B-X
comprehensive	B-X
analyses	B-X
of	B-X
double-mutant	B-X
phenotypes	B-X
.	B-X
This	B-X
allows	B-X
us	B-X
to	B-X
place	B-X
the	B-X
novel	B-X
genes	B-X
within	B-X
the	B-X
context	B-X
of	B-X
signaling	B-X
and	B-X
regulatory	B-X
networks	B-X
,	B-X
including	B-X
the	B-X
Rcs	B-X
phosphorelay	B-X
pathway	B-X
and	B-X
the	B-X
cyclic	B-X
di-GMP	B-X
second-messenger	B-X
system	B-X
.	B-X

To	O
probe	O
the	O
network	O
context	O
in	O
which	O
these	O
genes	O
function	O
,	O
we	O
developed	O
a	O
method	O
that	O
uncovers	O
genome	O
-	O
wide	O
epistatic	O
interactions	O
through	O
comprehensive	O
analyses	O
of	O
double	O
-	O
mutant	O
phenotypes	O
.	O

This	O
allows	O
us	O
to	O
place	O
the	O
novel	O
genes	O
within	O
the	O
context	O
of	O
signaling	O
and	O
regulatory	O
networks	O
,	O
including	O
the	O
Rcs	O
phosphorelay	O
pathway	O
and	O
the	O
cyclic	O
di	O
-	O
GMP	O
second	O
-	O
messenger	O
system	O
.	O
<EOS>	B-X
Application	B-X
of	B-X
this	B-X
method	B-X
to	B-X
Escherichia	B-X
coli	B-X
motility	B-X
identifies	B-X
95	B-X
%	B-X
of	B-X
the	B-X
known	B-X
flagellar	B-X
and	B-X
chemotaxis	B-X
genes	B-X
,	B-X
and	B-X
reveals	B-X
three	B-X
dozen	B-X
novel	B-X
loci	B-X
that	B-X
,	B-X
to	B-X
varying	B-X
degrees	B-X
and	B-X
through	B-X
diverse	B-X
mechanisms	B-X
,	B-X
affect	B-X
motility	B-X
.	B-X
To	B-X
probe	B-X
the	B-X
network	B-X
context	B-X
in	B-X
which	B-X
these	B-X
genes	B-X
function	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
method	B-X
that	B-X
uncovers	B-X
genome-wide	B-X
epistatic	B-X
interactions	B-X
through	B-X
comprehensive	B-X
analyses	B-X
of	B-X
double-mutant	B-X
phenotypes	B-X
.	B-X
This	B-X
allows	B-X
us	B-X
to	B-X
place	B-X
the	B-X
novel	B-X
genes	B-X
within	B-X
the	B-X
context	B-X
of	B-X
signaling	B-X
and	B-X
regulatory	B-X
networks	B-X
,	B-X
including	B-X
the	B-X
Rcs	B-X
phosphorelay	B-X
pathway	B-X
and	B-X
the	B-X
cyclic	B-X
di-GMP	B-X
second-messenger	B-X
system	B-X
.	B-X

This	O
unifying	O
framework	O
enables	O
sensitive	O
and	O
comprehensive	O
genetic	O
characterization	O
of	O
complex	O
behaviors	O
across	O
the	O
microbial	O
biosphere	O
.	O
<EOS>	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
powerful	B-X
experimental	B-X
framework	B-X
that	B-X
combines	B-X
competitive	B-X
selection	B-X
and	B-X
microarray-based	B-X
genetic	B-X
footprinting	B-X
to	B-X
comprehensively	B-X
reveal	B-X
the	B-X
genetic	B-X
basis	B-X
of	B-X
bacterial	B-X
behaviors	B-X
.	B-X
To	B-X
probe	B-X
the	B-X
network	B-X
context	B-X
in	B-X
which	B-X
these	B-X
genes	B-X
function	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
method	B-X
that	B-X
uncovers	B-X
genome-wide	B-X
epistatic	B-X
interactions	B-X
through	B-X
comprehensive	B-X
analyses	B-X
of	B-X
double-mutant	B-X
phenotypes	B-X
.	B-X
This	B-X
unifying	B-X
framework	B-X
enables	B-X
sensitive	B-X
and	B-X
comprehensive	B-X
genetic	B-X
characterization	B-X
of	B-X
complex	B-X
behaviors	B-X
across	B-X
the	B-X
microbial	B-X
biosphere	B-X
.	B-X

Introduction	O

Structured	O
microbial	O
habitats	O
have	O
selected	O
for	O
a	O
dazzling	O
diversity	O
of	O
bacterial	O
behaviors	O
.	O

These	O
behaviors	O
are	O
contingent	O
on	O
sophisticated	O
sensory	O
systems	O
that	O
maximize	O
fitness	O
in	O
the	O
complex	O
and	O
highly	O
dynamic	O
environments	O
where	O
physical	O
,	O
chemical	O
,	O
and	O
biological	O
parameters	O
change	O
on	O
many	O
different	O
time	O
scales	O
.	O

Modern	O
genetic	O
and	O
molecular	O
studies	O
have	O
largely	O
focused	O
on	O
a	O
limited	O
repertoire	O
of	O
behaviors	O
of	O
a	O
few	O
model	O
organisms	O
in	O
the	O
non	O
-	O
native	O
context	O
of	O
the	O
laboratory	O
.	O

However	O
,	O
even	O
at	O
the	O
level	O
of	O
basic	O
phenomenology	O
,	O
the	O
vast	O
majority	O
of	O
phenotypes	O
in	O
the	O
microbial	O
biosphere	O
remain	O
uncharacterized	O
.	O

A	O
major	O
challenge	O
of	O
the	O
post	O
-	O
genome	O
era	O
is	O
the	O
development	O
of	O
efficient	O
and	O
comprehensive	O
methods	O
for	O
revealing	O
the	O
genetic	O
basis	O
of	O
these	O
behaviors	O
across	O
diverse	O
clades	O
,	O
especially	O
as	O
the	O
emerging	O
field	O
of	O
metagenomics	O
begins	O
to	O
reveal	O
the	O
wide	O
assortment	O
of	O
microbial	O
life	O
on	O
the	O
planet	O
[	O
1	O
]	O
.	O

Chemotaxis	O
,	O
the	O
capacity	O
to	O
move	O
up	O
and	O
down	O
chemical	O
gradients	O
,	O
is	O
widespread	O
in	O
the	O
bacterial	O
world	O
.	O

An	O
impressive	O
achievement	O
of	O
20th	O
-	O
century	O
biology	O
was	O
a	O
systems	O
-	O
level	O
understanding	O
of	O
bacterial	O
chemotaxis	O
in	O
terms	O
of	O
the	O
structures	O
,	O
interactions	O
,	O
and	O
organization	O
of	O
the	O
roughly	O
50	O
constituent	O
molecular	O
components	O
[	O
2	O
-	O
4	O
]	O
.	O

The	O
best	O
-	O
characterized	O
chemotaxis	O
machineries	O
are	O
those	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
and	O
its	O
close	O
relative	O
Salmonella	B-Organism
enterica	I-Organism
[	O
5	O
,	O
6	O
]	O
.	O

These	O
species	O
propel	O
themselves	O
by	O
rotating	O
multiple	O
extracellular	O
helical	O
filaments	O
called	O
flagella	O
.	O

When	O
the	O
filament	O
rotates	O
in	O
the	O
counterclockwise	O
(	O
CCW	O
)	O
direction	O
,	O
as	O
viewed	O
from	O
outside	O
the	O
cell	O
,	O
a	O
helical	O
wave	O
travels	O
down	O
the	O
filament	O
away	O
from	O
the	O
cell	O
body	O
.	O

In	O
this	O
CCW	O
mode	O
,	O
multiple	O
rotating	O
flagella	O
come	O
together	O
to	O
form	O
a	O
bundle	O
,	O
propelling	O
the	O
cell	O
forward	O
in	O
a	O
motion	O
called	O
"	O
smooth	O
swimming	O
.	O
"	O
When	O
one	O
or	O
more	O
motors	O
reverse	O
to	O
the	O
clockwise	O
(	O
CW	O
)	O
direction	O
,	O
the	O
bundle	O
comes	O
apart	O
and	O
the	O
cell	O
"	O
tumbles	O
"	O
briefly	O
,	O
reorienting	O
the	O
cell	O
in	O
a	O
new	O
direction	O
;	O
subsequent	O
motor	O
switching	O
to	O
the	O
CCW	O
direction	O
causes	O
the	O
cell	O
to	O
swim	O
forward	O
again	O
.	O

The	O
direction	O
of	O
rotation	O
is	O
influenced	O
by	O
the	O
output	O
of	O
the	O
chemotaxis	O
network	O
,	O
which	O
consists	O
of	O
a	O
signal	O
transduction	O
cascade	O
that	O
allows	O
robust	O
adaptation	O
to	O
local	O
concentrations	O
of	O
ligands	O
over	O
many	O
orders	O
of	O
magnitude	O
[	O
7	O
,	O
8	O
]	O
.	O

When	O
cells	O
detect	O
an	O
increase	O
in	O
the	O
concentration	O
of	O
an	O
attractant	O
,	O
tumbling	O
is	O
suppressed	O
so	O
as	O
to	O
allow	O
cells	O
to	O
migrate	O
towards	O
the	O
source	O
through	O
the	O
statistical	O
strategy	O
of	O
a	O
biased	O
random	O
walk	O
[	O
9	O
]	O
.	O

The	O
signaling	O
circuit	O
that	O
mediates	O
this	O
behavior	O
terminates	O
at	O
the	O
flagellar	O
machinery	O
,	O
which	O
is	O
synthesized	O
through	O
a	O
sequential	O
hierarchy	O
of	O
gene	O
activation	O
events	O
[	O
10	O
]	O
initiated	O
by	O
the	O
expression	O
of	O
the	O
master	O
transcriptional	O
regulator	O
FlhDC	O
.	O

These	O
events	O
yield	O
an	O
orderly	O
"	O
just	O
-	O
in	O
-	O
time	O
"	O
expression	O
and	O
assembly	O
of	O
the	O
flagellar	O
components	O
[	O
11	O
]	O
,	O
which	O
consist	O
of	O
a	O
basal	O
body	O
complex	O
and	O
a	O
filament	O
.	O

The	O
basal	O
body	O
complex	O
contains	O
a	O
central	O
rod	O
that	O
connects	O
the	O
motor	O
to	O
the	O
filament	O
through	O
a	O
short	O
hook	O
.	O

The	O
identification	O
of	O
the	O
molecular	O
components	O
and	O
their	O
organization	O
into	O
the	O
two	O
dominant	O
modules	O
-	O
the	O
chemotaxis	O
network	O
and	O
the	O
flagellum	O
/	O
basal	O
body	O
/	O
motor	O
system	O
-	O
took	O
the	O
better	O
part	O
of	O
40	O
years	O
and	O
the	O
work	O
of	O
dozens	O
of	O
laboratories	O
.	O

These	O
efforts	O
have	O
culminated	O
in	O
a	O
level	O
of	O
understanding	O
nearly	O
unmatched	O
in	O
any	O
other	O
domain	O
of	O
molecular	O
biology	O
.	O

For	O
these	O
reasons	O
,	O
flagellar	O
-	O
mediated	O
motility	O
is	O
an	O
ideal	O
test	O
case	O
for	O
any	O
modern	O
post	O
-	O
genomic	O
approach	O
that	O
attempts	O
to	O
efficiently	O
and	O
comprehensively	O
reveal	O
the	O
genetic	O
basis	O
of	O
a	O
complex	O
bacterial	O
phenotype	O
.	O

In	O
this	O
study	O
,	O
we	O
make	O
improvements	O
on	O
a	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
strategy	O
[	O
12	O
]	O
,	O
increasing	O
its	O
sensitivity	O
and	O
specificity	O
in	O
revealing	O
the	O
contribution	O
of	O
each	O
and	O
every	O
gene	O
in	O
the	O
genome	O
to	O
a	O
phenotype	O
of	O
interest	O
.	O

We	O
demonstrate	O
the	O
manner	O
in	O
which	O
this	O
strategy	O
can	O
be	O
used	O
to	O
explore	O
the	O
genetic	O
basis	O
of	O
complex	O
bacterial	O
behavior	O
by	O
following	O
the	O
population	O
dynamics	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
insertional	O
mutants	O
in	O
environments	O
where	O
reproductive	O
fitness	O
is	O
coupled	O
to	O
motility	O
.	O

To	O
fully	O
identify	O
the	O
genetic	O
determinants	O
for	O
this	O
phenotype	O
,	O
a	O
library	O
of	O
transposon	O
-	O
mutagenized	O
cells	O
was	O
functionally	O
enriched	O
en	O
masse	O
for	O
impaired	O
swimming	O
and	O
surface	O
-	O
mediated	O
swarming	O
motility	O
.	O

We	O
also	O
selected	O
for	O
resistance	O
to	O
bacteriophage	O
chi	B-Organism
,	O
which	O
is	O
known	O
to	O
infect	O
and	O
lyse	O
cells	O
only	O
when	O
they	O
are	O
motile	O
.	O

Additionally	O
,	O
we	O
identified	O
the	O
genetic	O
basis	O
of	O
motility	O
suppression	O
by	O
environmental	O
factors	O
.	O

Using	O
DNA	O
microarray	O
hybridization	O
,	O
we	O
monitored	O
the	O
relative	O
abundance	O
of	O
each	O
mutant	O
throughout	O
the	O
selections	O
.	O

The	O
comprehensive	O
nature	O
of	O
our	O
methodology	O
is	O
reflected	O
by	O
the	O
identification	O
of	O
nearly	O
all	O
of	O
the	O
known	O
structural	O
and	O
regulatory	O
components	O
of	O
flagellar	O
-	O
mediated	O
chemotaxis	O
.	O

Strikingly	O
,	O
we	O
also	O
identify	O
dozens	O
of	O
additional	O
loci	O
that	O
contribute	O
to	O
this	O
phenotype	O
.	O

Further	O
characterization	O
of	O
these	O
novel	O
genes	O
revealed	O
that	O
they	O
impair	O
motility	O
through	O
diverse	O
mechanisms	O
such	O
as	O
disrupting	O
signaling	O
through	O
phosphorelay	O
cascades	O
,	O
altering	O
concentrations	O
of	O
the	O
recently	O
appreciated	O
cyclic	O
di	O
-	O
GMP	O
(	O
c	O
-	O
di	O
-	O
GMP	O
)	O
second	O
messenger	O
,	O
and	O
by	O
mechanisms	O
that	O
have	O
yet	O
to	O
be	O
revealed	O
.	O

Subsequent	O
genome	O
-	O
wide	O
epistasis	O
analyses	O
allow	O
us	O
to	O
organize	O
the	O
discovered	O
loci	O
into	O
signaling	O
and	O
regulatory	O
pathways	O
.	O

This	O
systematic	O
framework	O
for	O
genetic	O
characterization	O
can	O
be	O
applied	O
to	O
any	O
microorganism	O
that	O
is	O
amenable	O
to	O
transposon	O
mutagenesis	O
,	O
making	O
it	O
accessible	O
to	O
the	O
vast	O
majority	O
of	O
bacterial	O
systems	O
of	O
importance	O
to	O
basic	O
,	O
industrial	O
,	O
environmental	O
,	O
and	O
clinical	O
research	O
.	O

Results	O
/	O
Discussion	O
<EOS>	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X
Results	B-X
suggest	B-X
that	B-X
discussing	B-X
a	B-X
negative	B-X
societal	B-X
stereotype	B-X
(	B-X
relative	B-X
to	B-X
individual	B-X
rumination	B-X
in	B-X
Studies	B-X
1	B-X
and	B-X
3	B-X
and	B-X
alternative	B-X
discussions	B-X
in	B-X
Studies	B-X
2	B-X
and	B-X
3	B-X
)	B-X
increases	B-X
intentions	B-X
to	B-X
engage	B-X
in	B-X
discrimination	B-X
against	B-X
the	B-X
out-group	B-X
target	B-X
of	B-X
the	B-X
stereotype	B-X
.	B-X
Discussion	B-X
of	B-X
religion	B-X
and/or	B-X
spirituality	B-X
in	B-X
the	B-X
medical	B-X
consultation	B-X
is	B-X
desired	B-X
by	B-X
patients	B-X
and	B-X
known	B-X
to	B-X
be	B-X
beneficial	B-X
.	B-X

Mapping	O
Phenotype	O
to	O
Genotype	O
Using	O
Microarray	O
-	O
Based	O
Genetic	O
Footprinting	O
Traditional	O
methods	O
of	O
genetic	O
investigation	O
have	O
been	O
extremely	O
successful	O
in	O
providing	O
a	O
deep	O
molecular	O
understanding	O
of	O
many	O
phenotypes	O
in	O
model	O
microorganisms	O
.	O

However	O
,	O
faced	O
with	O
literally	O
thousands	O
of	O
important	O
and	O
mostly	O
uncharacterized	O
bacterial	O
species	O
,	O
we	O
need	O
entirely	O
novel	O
methods	O
of	O
genetic	O
functional	O
analysis	O
and	O
pathway	O
elucidation	O
that	O
scale	O
to	O
the	O
task	O
at	O
hand	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
applied	O
a	O
systematic	O
genome	O
-	O
wide	O
strategy	O
to	O
determine	O
the	O
contribution	O
of	O
nearly	O
all	O
genetic	O
loci	O
in	O
the	O
genome	O
to	O
a	O
phenotype	O
of	O
interest	O
.	O

Our	O
approach	O
combines	O
genetic	O
footprinting	O
[	O
13	O
]	O
with	O
microarray	O
hybridization	O
[	O
14	O
]	O
in	O
order	O
to	O
monitor	O
,	O
in	O
parallel	O
,	O
the	O
relative	O
abundances	O
of	O
transposon	O
-	O
mutagenized	O
cells	O
throughout	O
a	O
competitive	O
selection	O
experiment	O
[	O
12	O
]	O
.	O

Saturation	O
transposon	O
mutagenesis	O
is	O
a	O
powerful	O
,	O
versatile	O
,	O
and	O
efficient	O
strategy	O
for	O
creating	O
comprehensive	O
mutant	O
libraries	O
for	O
genomic	O
functional	O
characterization	O
[	O
15	O
]	O
.	O

We	O
have	O
used	O
a	O
hyperactive	O
Tn5	O
transposition	O
system	O
with	O
reduced	O
target	O
specificity	O
[	O
16	O
]	O
to	O
create	O
a	O
library	O
of	O
approximately	O
5	O
x	O
105	O
independent	O
transposon	O
insertional	O
mutants	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
MG1655	I-Organism
.	O

Given	O
the	O
reduced	O
target	O
specificity	O
and	O
a	O
genome	O
of	O
approximately	O
4	O
,	O
300	O
genes	O
,	O
the	O
mutagenesis	O
of	O
our	O
library	O
is	O
saturating	O
with	O
an	O
average	O
of	O
approximately100	O
independent	O
insertions	O
within	O
each	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
.	O

In	O
each	O
of	O
our	O
experiments	O
,	O
a	O
population	O
of	O
mutants	O
is	O
challenged	O
for	O
competitive	O
growth	O
under	O
a	O
selection	O
of	O
interest	O
.	O

Each	O
mutant	O
within	O
the	O
population	O
is	O
uniquely	O
defined	O
by	O
the	O
local	O
sequence	O
flanking	O
the	O
transposon	O
insertion	O
site	O
.	O

The	O
series	O
of	O
molecular	O
manipulations	O
detailed	O
in	O
Figure	O
S1	O
allow	O
the	O
amplification	O
of	O
roughly	O
200	O
base	O
pairs	O
flanking	O
each	O
transposon	O
insertion	O
site	O
in	O
a	O
population	O
in	O
parallel	O
.	O

Fluorescent	O
labeling	O
and	O
hybridization	O
of	O
the	O
amplicons	O
to	O
a	O
spotted	O
DNA	O
microarray	O
(	O
created	O
as	O
described	O
in	O
Protocol	O
S1	O
)	O
reveal	O
the	O
relative	O
abundance	O
of	O
each	O
mutant	O
as	O
reflected	O
by	O
the	O
signal	O
intensity	O
of	O
the	O
corresponding	O
ORF	O
on	O
the	O
array	O
.	O

As	O
a	O
consequence	O
of	O
selection	O
,	O
individual	O
insertional	O
mutants	O
can	O
increase	O
or	O
decrease	O
in	O
abundance	O
during	O
the	O
course	O
of	O
an	O
experiment	O
,	O
and	O
these	O
relative	O
changes	O
can	O
be	O
monitored	O
by	O
comparing	O
genome	O
-	O
wide	O
hybridization	O
values	O
before	O
and	O
after	O
selection	O
.	O
<EOS>	B-X
Transposable	B-X
elements	B-X
(	B-X
TEs	B-X
)	B-X
are	B-X
mobile	B-X
DNA	B-X
sequences	B-X
that	B-X
make	B-X
up	B-X
a	B-X
large	B-X
fraction	B-X
of	B-X
eukaryotic	B-X
genomes	B-X
.	B-X
By	B-X
quantifying	B-X
expression	B-X
levels	B-X
of	B-X
32	B-X
TE	B-X
families	B-X
in	B-X
piRNA	B-X
pathway	B-X
mutants	B-X
relative	B-X
to	B-X
wild-type	B-X
fruit	B-X
flies	B-X
,	B-X
we	B-X
provide	B-X
evidence	B-X
that	B-X
piRNAs	B-X
can	B-X
severely	B-X
silence	B-X
the	B-X
activities	B-X
of	B-X
retrotransposons	B-X
.	B-X
Our	B-X
theoretical	B-X
and	B-X
empirical	B-X
analysis	B-X
suggests	B-X
that	B-X
piRNAs	B-X
can	B-X
significantly	B-X
increase	B-X
the	B-X
fitness	B-X
of	B-X
individuals	B-X
that	B-X
bear	B-X
them	B-X
;	B-X
however	B-X
,	B-X
piRNAs	B-X
may	B-X
provide	B-X
a	B-X
shelter	B-X
or	B-X
Trojan	B-X
horse	B-X
for	B-X
retrotransposons	B-X
,	B-X
allowing	B-X
them	B-X
to	B-X
increase	B-X
in	B-X
frequency	B-X
in	B-X
a	B-X
population	B-X
by	B-X
shielding	B-X
the	B-X
host	B-X
from	B-X
the	B-X
deleterious	B-X
consequences	B-X
of	B-X
retrotransposition	B-X
.	B-X
Food	B-X
preservation	B-X
by	B-X
the	B-X
use	B-X
of	B-X
essential	B-X
oils	B-X
(	B-X
EOs	B-X
)	B-X
is	B-X
being	B-X
extensively	B-X
studied	B-X
because	B-X
of	B-X
the	B-X
antimicrobial	B-X
properties	B-X
of	B-X
their	B-X
individual	B-X
constituents	B-X
(	B-X
ICs	B-X
)	B-X
.	B-X
Three	B-X
resistant	B-X
mutants	B-X
(	B-X
termed	B-X
CAR	B-X
,	B-X
CIT	B-X
,	B-X
and	B-X
LIM	B-X
)	B-X
of	B-X

In	O
a	O
proof	O
-	O
of	O
-	O
principle	O
analysis	O
of	O
the	O
unselected	O
transposon	O
library	O
,	O
we	O
show	O
that	O
the	O
hybridization	O
intensities	O
corresponding	O
to	O
known	O
essential	O
genes	O
are	O
strongly	O
biased	O
towards	O
the	O
lowest	O
values	O
,	O
consistent	O
with	O
their	O
inability	O
to	O
harbor	O
transposon	O
insertions	O
(	O
Figure	O
S2	O
)	O
.	O

Quantitative	O
Analysis	O
of	O
Selection	O
within	O
the	O
Pool	O
of	O
Mutants	O
<EOS>	B-X
This	B-X
crop	B-X
has	B-X
a	B-X
narrow	B-X
genetic	B-X
base	B-X
due	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
gene	B-X
pool	B-X
barriers	B-X
during	B-X
interspecific	B-X
hybridization	B-X
within	B-X
and	B-X
across	B-X
species	B-X
.	B-X
Mutants	B-X
in	B-X
genes	B-X
important	B-X
in	B-X
virulence	B-X
are	B-X
identified	B-X
by	B-X
negative	B-X
selection	B-X
in	B-X
which	B-X
the	B-X
mutants	B-X
fail	B-X
to	B-X
colonize	B-X
or	B-X
disseminate	B-X
in	B-X
the	B-X
animal	B-X
host	B-X
and	B-X
tick	B-X
vector	B-X
.	B-X
Quantitative	B-X
lipid	B-X
analysis	B-X
revealed	B-X
that	B-X
PE	B-X
levels	B-X
are	B-X
substantially	B-X
reduced	B-X
in	B-X
the	B-X
mcd4-174	B-X
mutant	B-X
but	B-X
can	B-X
be	B-X
restored	B-X
by	B-X
deletion	B-X
of	B-X
ATG7	B-X
or	B-X
CHO2	B-X
.	B-X
Quantitative	B-X
criteria	B-X
are	B-X
developed	B-X
to	B-X
analyze	B-X
the	B-X
EOM	B-X
selected	B-X
models	B-X
and	B-X
to	B-X
determine	B-X
the	B-X
optimum	B-X
number	B-X
of	B-X
conformers	B-X
in	B-X
the	B-X
ensemble	B-X
.	B-X

To	O
determine	O
the	O
degree	O
to	O
which	O
each	O
gene	O
contributes	O
to	O
fitness	O
under	O
a	O
particular	O
selection	O
,	O
we	O
quantify	O
the	O
extent	O
of	O
enrichment	O
or	O
depletion	O
of	O
all	O
transposon	O
insertions	O
within	O
a	O
gene	O
after	O
a	O
selection	O
is	O
imposed	O
.	O

We	O
assign	O
the	O
total	O
hybridization	O
signal	O
for	O
each	O
ORF	O
on	O
the	O
array	O
as	O
the	O
sum	O
of	O
contributions	O
from	O
all	O
the	O
mutants	O
that	O
harbor	O
an	O
insertion	O
somewhere	O
within	O
or	O
in	O
close	O
proximity	O
to	O
the	O
ORF	O
.	O

The	O
ORF	O
intensities	O
from	O
five	O
hybridizations	O
of	O
the	O
maximally	O
diverse	O
unselected	O
library	O
(	O
Dataset	O
S1	O
)	O
are	O
used	O
as	O
a	O
statistical	O
reference	O
to	O
quantify	O
the	O
degree	O
of	O
enrichment	O
or	O
depletion	O
after	O
the	O
library	O
is	O
exposed	O
to	O
a	O
selection	O
of	O
interest	O
.	O

In	O
this	O
way	O
,	O
the	O
five	O
unselected	O
hybridizations	O
define	O
the	O
null	O
variation	O
with	O
respect	O
to	O
which	O
significant	O
differences	O
are	O
quantified	O
.	O

The	O
normalized	O
hybridization	O
intensity	O
value	O
(	O
x	O
)	O
of	O
an	O
ORF	O
from	O
a	O
selection	O
experiment	O
is	O
compared	O
to	O
the	O
null	O
distribution	O
for	O
that	O
ORF	O
(	O
mean	O
:	O
<	O
xn	O
>	O
,	O
standard	O
deviation	O
:	O
sigma	O
)	O
,	O
by	O
calculating	O
a	O
z	O
-	O
score	O
:	O
z	O
=	O
(	O
x	O
-	O
<	O
xn	O
>	O
)	O
/	O
sigma	O
.	O

ORFs	O
that	O
harbor	O
deleterious	O
mutations	O
during	O
the	O
selection	O
will	O
have	O
negative	O
z	O
-	O
scores	O
(	O
corresponding	O
to	O
depletion	O
)	O
,	O
whereas	O
ORFs	O
that	O
harbor	O
relatively	O
favorable	O
mutations	O
during	O
the	O
selection	O
will	O
have	O
positive	O
z	O
-	O
scores	O
(	O
corresponding	O
to	O
enrichment	O
)	O
.	O

In	O
other	O
words	O
,	O
the	O
z	O
-	O
score	O
reflects	O
the	O
number	O
of	O
standard	O
deviations	O
above	O
or	O
below	O
the	O
mean	O
of	O
the	O
unselected	O
replicates	O
.	O
<EOS>	B-X
Two	B-X
replicates	B-X
of	B-X
a	B-X
randomly	B-X
selected	B-X
herd	B-X
of	B-X
Hereford	B-X
cattle	B-X
have	B-X
been	B-X
developed	B-X
at	B-X
the	B-X
Livestock	B-X
and	B-X
Range	B-X
Research	B-X
Station	B-X
in	B-X
Miles	B-X
City	B-X
,	B-X
Montana	B-X
.	B-X
Subsets	B-X
were	B-X
determined	B-X
by	B-X
parental	B-X
birth	B-X
weights	B-X
,	B-X
either	B-X
above	B-X
(	B-X
H	B-X
)	B-X
or	B-X
below	B-X
(	B-X
L	B-X
)	B-X
the	B-X
overall	B-X
mean	B-X
for	B-X
parents	B-X
of	B-X
that	B-X
sex	B-X
.	B-X
Genetic	B-X
variance	B-X
components	B-X
including	B-X
additive	B-X
direct	B-X
effects	B-X
(	B-X
sigma	B-X
2A	B-X
)	B-X
,	B-X
additive	B-X
maternal	B-X
effects	B-X
(	B-X
sigma	B-X
2M	B-X
)	B-X
and	B-X
a	B-X
covariance	B-X
between	B-X
transmitted	B-X
and	B-X
maternal	B-X
effects	B-X
(	B-X
sigma	B-X
AM	B-X
)	B-X
were	B-X
estimated	B-X
by	B-X
solving	B-X
simultaneous	B-X
equations	B-X
after	B-X
estimating	B-X
coefficients	B-X
for	B-X
offspring-sire	B-X
,	B-X
offspring-dam	B-X
and	B-X
offspring-midparent	B-X
mean	B-X
regressions	B-X
and	B-X
a	B-X
paternal	B-X
half-sib	B-X
covariance	B-X
.	B-X

Genetic	O
Basis	O
of	O
Swimming	O
Motility	O
and	O
Chemotaxis	O
<EOS>	B-X
Motility	B-X
of	B-X
the	B-X
up-motile	B-X
strain	B-X
was	B-X
greatly	B-X
increased	B-X
relative	B-X
to	B-X
wild-type	B-X
on	B-X
soft	B-X
agar	B-X
at	B-X
alkaline	B-X
pH	B-X
but	B-X
not	B-X
in	B-X
liquid	B-X
except	B-X
when	B-X
polyvinylpyrrolidone	B-X
was	B-X
added	B-X
to	B-X
increase	B-X
viscosity	B-X
.	B-X
Chemotaxis	B-X
assays	B-X
revealed	B-X
that	B-X
V.	B-X
anguillarum	B-X
swims	B-X
towards	B-X
both	B-X
types	B-X
of	B-X
mucus	B-X
,	B-X
with	B-X
a	B-X
higher	B-X
chemotactic	B-X
response	B-X
being	B-X
observed	B-X
for	B-X
intestinal	B-X
mucus	B-X
.	B-X

Semi	O
-	O
solid	O
tryptone	O
agar	O
provides	O
a	O
robust	O
setting	O
for	O
studying	O
E	B-Organism
.	I-Organism
coli	I-Organism
chemotaxis	O
.	O

Once	O
inoculated	O
into	O
a	O
region	O
of	O
the	O
soft	O
agar	O
,	O
bacteria	O
deplete	O
local	O
nutrients	O
and	O
chemotax	O
radially	O
outward	O
following	O
the	O
concentration	O
gradient	O
of	O
preferred	O
substrates	O
[	O
17	O
]	O
.	O

To	O
systematically	O
and	O
completely	O
identify	O
the	O
genetic	O
determinants	O
for	O
swimming	O
motility	O
,	O
approximately107	O
cells	O
of	O
the	O
mutant	O
library	O
were	O
functionally	O
enriched	O
en	O
masse	O
for	O
an	O
impaired	O
ability	O
to	O
swim	O
through	O
soft	O
agar	O
.	O

After	O
an	O
8	O
-	O
h	O
incubation	O
to	O
allow	O
motile	O
cells	O
to	O
swim	O
away	O
from	O
the	O
site	O
of	O
inoculation	O
,	O
the	O
population	O
enriched	O
for	O
nonmotile	O
mutants	O
was	O
transferred	O
to	O
a	O
fresh	O
plate	O
for	O
further	O
enrichment	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
percentage	O
of	O
nonmotile	O
mutants	O
was	O
determined	O
after	O
each	O
stage	O
of	O
enrichment	O
by	O
a	O
clonal	O
plating	O
assay	O
and	O
,	O
after	O
five	O
stages	O
,	O
96	O
%	O
of	O
the	O
mutants	O
showed	O
an	O
impaired	O
ability	O
to	O
swim	O
(	O
Figure	O
S3	O
)	O
.	O

The	O
amplification	O
of	O
transposon	O
insertion	O
sites	O
from	O
a	O
small	O
sample	O
of	O
these	O
mutants	O
showed	O
that	O
the	O
nonmotile	O
phenotype	O
is	O
the	O
result	O
of	O
a	O
single	O
gene	O
disruption	O
in	O
each	O
mutant	O
.	O

As	O
expected	O
,	O
the	O
vast	O
majority	O
of	O
these	O
disruptions	O
occurred	O
in	O
previously	O
known	O
flagellar	O
or	O
chemotaxis	O
genes	O
(	O
Table	O
S3	O
)	O
.	O

However	O
,	O
even	O
in	O
this	O
small	O
sample	O
,	O
we	O
found	O
transposon	O
insertions	O
in	O
genes	O
without	O
a	O
previously	O
known	O
role	O
in	O
motility	O
.	O

To	O
obtain	O
a	O
genome	O
-	O
wide	O
catalog	O
of	O
loci	O
involved	O
in	O
swimming	O
motility	O
,	O
we	O
applied	O
our	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
assay	O
to	O
the	O
population	O
of	O
mutants	O
at	O
the	O
end	O
of	O
the	O
enrichments	O
.	O

The	O
z	O
-	O
scores	O
reveal	O
that	O
the	O
vast	O
majority	O
of	O
ORFs	O
lie	O
within	O
a	O
tight	O
Gaussian	O
-	O
shaped	O
distribution	O
centered	O
around	O
zero	O
(	O
Figure	O
1B	O
)	O
.	O

However	O
,	O
of	O
the	O
115	O
ORFs	O
with	O
z	O
-	O
scores	O
greater	O
than	O
12	O
,	O
49	O
are	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
.	O

Since	O
the	O
microarray	O
contained	O
52	O
out	O
of	O
the	O
total	O
of	O
54	O
known	O
motility	O
genes	O
[	O
18	O
]	O
,	O
the	O
chance	O
likelihood	O
of	O
observing	O
this	O
level	O
of	O
enrichment	O
was	O
extremely	O
low	O
(	O
p	O
<	O
10	O
-	O
76	O
)	O
.	O

The	O
three	O
remaining	O
motility	O
genes	O
that	O
were	O
not	O
significantly	O
enriched	O
are	O
two	O
chemoreceptor	O
genes	O
,	O
trg	O
and	O
aer	O
,	O
and	O
the	O
filament	O
cap	O
chaperone	O
,	O
fliT	O
.	O
<EOS>	B-X
The	B-X
resulting	B-X
decrease	B-X
in	B-X
muscle	B-X
strength	B-X
and	B-X
motility	B-X
irreversibly	B-X
impacts	B-X
quality	B-X
of	B-X
life	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
directly	B-X
affecting	B-X
skeletal	B-X
muscle	B-X
,	B-X
pathogenesis	B-X
can	B-X
also	B-X
arise	B-X
from	B-X
dysfunctional	B-X
crosstalk	B-X
between	B-X
nerves	B-X
and	B-X
muscles	B-X
,	B-X
and	B-X
may	B-X
include	B-X
cardiac	B-X
impairment	B-X
.	B-X
We	B-X
explore	B-X
the	B-X
expression	B-X
dynamics	B-X
of	B-X
myopathogenes	B-X
,	B-X
genes	B-X
whose	B-X
mutation	B-X
leads	B-X
to	B-X
skeletal	B-X
muscle	B-X
pathogenesis	B-X
,	B-X
using	B-X
transcriptomic	B-X
analysis	B-X
.	B-X
This	B-X
revealed	B-X
that	B-X
45	B-X
%	B-X
of	B-X
myopathogenes	B-X
are	B-X
differentially	B-X
expressed	B-X
during	B-X
early	B-X
satellite	B-X
cell	B-X
activation	B-X
(	B-X
0	B-X
-	B-X
5	B-X
hours	B-X
)	B-X
.	B-X
Of	B-X
these	B-X
271	B-X
myopathogenes	B-X
,	B-X
83	B-X
respond	B-X
to	B-X
Pax7	B-X
,	B-X
a	B-X
master	B-X
regulator	B-X
of	B-X
satellite	B-X
cells	B-X
.	B-X

Based	O
on	O
the	O
hybridization	O
results	O
,	O
insertional	O
mutations	O
in	O
these	O
genes	O
should	O
not	O
measurably	O
impair	O
motility	O
.	O
<EOS>	B-X
Next-generation	B-X
sequencing	B-X
assays	B-X
allow	B-X
the	B-X
efficient	B-X
and	B-X
unbiased	B-X
detection	B-X
of	B-X
clinically	B-X
actionable	B-X
mutations	B-X
.	B-X
To	B-X
enable	B-X
precision	B-X
oncology	B-X
in	B-X
patients	B-X
with	B-X
solid	B-X
tumors	B-X
,	B-X
we	B-X
developed	B-X
Memorial	B-X
Sloan	B-X
Kettering-Integrated	B-X
Mutation	B-X
Profiling	B-X
of	B-X
Actionable	B-X
Cancer	B-X
Targets	B-X
(	B-X
MSK-IMPACT	B-X
)	B-X
,	B-X
a	B-X
hybridization	B-X
capture-based	B-X
next-generation	B-X
sequencing	B-X
assay	B-X
for	B-X
targeted	B-X
deep	B-X
sequencing	B-X
of	B-X
all	B-X
exons	B-X
and	B-X
selected	B-X
introns	B-X
of	B-X
341	B-X
key	B-X
cancer	B-X
genes	B-X
in	B-X
formalin-fixed	B-X
,	B-X
paraffin-embedded	B-X
tumors	B-X
.	B-X
Barcoded	B-X
libraries	B-X
from	B-X
patient-matched	B-X
tumor	B-X
and	B-X
normal	B-X
samples	B-X
were	B-X
captured	B-X
,	B-X
sequenced	B-X
,	B-X
and	B-X
subjected	B-X
to	B-X
a	B-X
custom	B-X
analysis	B-X
pipeline	B-X
to	B-X
identify	B-X
somatic	B-X
mutations	B-X
.	B-X
We	B-X
tested	B-X
284	B-X
tumor	B-X
samples	B-X
with	B-X
previously	B-X
known	B-X
point	B-X
mutations	B-X
and	B-X
insertions/deletions	B-X
in	B-X
47	B-X
exons	B-X
of	B-X
19	B-X
cancer	B-X
genes	B-X
.	B-X
The	B-X
detection	B-X
limit	B-X
for	B-X
low-frequency	B-X
variants	B-X
was	B-X
approximately	B-X
2	B-X
%	B-X
for	B-X
hotspot	B-X
mutations	B-X
and	B-X
5	B-X
%	B-X
for	B-X
nonhotspot	B-X
mutations	B-X
.	B-X
Paired	B-X
analysis	B-X
of	B-X
tumors	B-X
and	B-X
patient-matched	B-X
normal	B-X
samples	B-X
enables	B-X
unambiguous	B-X
detection	B-X
of	B-X
somatic	B-X
mutations	B-X
to	B-X
guide	B-X
treatment	B-X
decisions	B-X
.	B-X

We	O
confirmed	O
this	O
expectation	O
by	O
showing	O
that	O
deletions	O
of	O
fliT	O
and	O
aer	O
did	O
not	O
affect	O
motility	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
neutral	O
behavior	O
of	O
the	O
fliT	O
mutation	O
is	O
not	O
surprising	O
since	O
fliT	O
null	O
strains	O
were	O
found	O
to	O
make	O
functional	O
flagella	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
[	O
19	O
]	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
reported	O
that	O
fliT	O
mutations	O
enhance	O
expression	O
of	O
class	O
2	O
flagellar	O
operons	O
[	O
20	O
]	O
because	O
FliT	O
acts	O
as	O
a	O
negative	O
regulator	O
of	O
these	O
operons	O
by	O
binding	O
to	O
and	O
inhibiting	O
the	O
activity	O
of	O
FlhDC	O
[	O
21	O
]	O
.	O

The	O
protein	O
encoded	O
by	O
aer	O
mediates	O
oxygen	O
and	O
redox	O
sensing	O
,	O
and	O
as	O
such	O
shares	O
overlapping	O
function	O
with	O
the	O
Tsr	O
receptor	O
[	O
22	O
]	O
.	O

Because	O
of	O
this	O
redundancy	O
,	O
only	O
aer	O
tsr	O
double	O
mutants	O
are	O
expected	O
to	O
show	O
a	O
motility	O
phenotype	O
in	O
tryptone	O
plates	O
.	O

Finally	O
,	O
the	O
product	O
of	O
trg	O
is	O
a	O
transmembrane	O
methyl	O
-	O
accepting	O
chemotaxis	O
protein	O
that	O
senses	O
ribose	O
and	O
galactose	O
[	O
23	O
]	O
.	O

Although	O
these	O
sugars	O
are	O
absent	O
from	O
tryptone	O
plates	O
,	O
deletion	O
of	O
trg	O
did	O
result	O
in	O
a	O
measurable	O
motility	O
defect	O
(	O
unpublished	O
data	O
)	O
.	O

Therefore	O
,	O
of	O
the	O
more	O
than	O
50	O
known	O
genes	O
involved	O
,	O
trg	O
is	O
the	O
only	O
false	O
negative	O
under	O
the	O
motility	O
conditions	O
we	O
used	O
.	O

Remarkably	O
,	O
the	O
selection	O
results	O
revealed	O
many	O
genes	O
with	O
high	O
z	O
-	O
scores	O
without	O
a	O
previously	O
known	O
role	O
in	O
motility	O
.	O

We	O
were	O
concerned	O
that	O
some	O
marginally	O
high	O
z	O
-	O
scores	O
may	O
be	O
due	O
to	O
"	O
hitchhiking	O
"	O
of	O
spontaneously	O
arising	O
mutations	O
in	O
motility	O
genes	O
on	O
the	O
background	O
of	O
transposon	O
insertions	O
in	O
nonessential	O
genes	O
.	O

To	O
minimize	O
such	O
false	O
positives	O
,	O
we	O
demanded	O
that	O
a	O
candidate	O
motility	O
gene	O
obtain	O
a	O
z	O
-	O
score	O
above	O
12	O
in	O
at	O
least	O
two	O
of	O
the	O
three	O
replicate	O
selections	O
(	O
Datasets	O
S2	O
,	O
S3	O
,	O
and	O
S4	O
)	O
.	O

The	O
40	O
candidate	O
genes	O
that	O
fit	O
these	O
criteria	O
were	O
targeted	O
for	O
deletion	O
,	O
and	O
20	O
of	O
them	O
were	O
found	O
to	O
show	O
a	O
significant	O
defect	O
in	O
swimming	O
motility	O
(	O
Figure	O
1C	O
;	O
Table	O
S1	O
)	O
.	O

We	O
observed	O
that	O
some	O
false	O
positives	O
were	O
indeed	O
due	O
to	O
hitchhiking	O
,	O
but	O
others	O
were	O
due	O
to	O
polar	O
effects	O
of	O
transposon	O
insertions	O
on	O
downstream	O
genes	O
within	O
operons	O
.	O

Additionally	O
,	O
some	O
genes	O
may	O
be	O
deemed	O
false	O
positive	O
because	O
the	O
nature	O
of	O
the	O
mutation	O
caused	O
by	O
transposon	O
insertion	O
cannot	O
be	O
replicated	O
by	O
a	O
clean	O
deletion	O
of	O
the	O
gene	O
.	O

The	O
criteria	O
we	O
used	O
for	O
identifying	O
candidate	O
motility	O
genes	O
favored	O
sensitivity	O
(	O
essentially	O
100	O
%	O
)	O
over	O
specificity	O
.	O

However	O
,	O
the	O
number	O
of	O
false	O
positives	O
can	O
be	O
driven	O
lower	O
by	O
decreasing	O
the	O
cycles	O
of	O
selection	O
,	O
increasing	O
the	O
number	O
of	O
replicates	O
,	O
or	O
by	O
focusing	O
on	O
genes	O
with	O
relatively	O
high	O
z	O
-	O
scores	O
.	O
<EOS>	B-X
There	B-X
is	B-X
an	B-X
increasing	B-X
number	B-X
of	B-X
cancer	B-X
patients	B-X
undertaking	B-X
treatment-focused	B-X
genetic	B-X
testing	B-X
despite	B-X
not	B-X
having	B-X
a	B-X
strong	B-X
family	B-X
history	B-X
or	B-X
high	B-X
a	B-X
priori	B-X
risk	B-X
of	B-X
being	B-X
carriers	B-X
because	B-X
of	B-X
the	B-X
decreasing	B-X
cost	B-X
of	B-X
genetic	B-X
testing	B-X
and	B-X
development	B-X
of	B-X
new	B-X
therapies	B-X
.	B-X
Breast	B-X
cancer	B-X
patients	B-X
enrolled	B-X
under	B-X
the	B-X
Malaysian	B-X
Breast	B-X
Cancer	B-X
Genetic	B-X
Study	B-X
between	B-X
October	B-X
2002	B-X
and	B-X
February	B-X
2018	B-X
were	B-X
tested	B-X
for	B-X
BRCA1	B-X
,	B-X
BRCA2	B-X
and	B-X
PALB2	B-X
genes	B-X
.	B-X
Of	B-X
the	B-X
104	B-X
carriers	B-X
,	B-X
64	B-X
%	B-X
(	B-X
N	B-X
=	B-X
66	B-X
)	B-X
had	B-X
low	B-X
a	B-X
priori	B-X
risk	B-X
as	B-X
determined	B-X
by	B-X
PENN	B-X
II	B-X
scores	B-X
.	B-X
At	B-X
baseline	B-X
,	B-X
younger	B-X
carriers	B-X
with	B-X
high	B-X
a	B-X
priori	B-X
risk	B-X
had	B-X
higher	B-X
Cancer	B-X
Worry	B-X
Scale	B-X
scores	B-X
than	B-X
those	B-X
with	B-X
low	B-X
a	B-X
priori	B-X
risk	B-X
but	B-X
all	B-X
scores	B-X
were	B-X
within	B-X
acceptable	B-X
range	B-X
.	B-X
Around	B-X
75	B-X
%	B-X
and	B-X
55	B-X
%	B-X
of	B-X
high	B-X
a	B-X
priori	B-X
risk	B-X
carriers	B-X
as	B-X
well	B-X
as	B-X
80	B-X
%	B-X
and	B-X
67	B-X
%	B-X
of	B-X
low	B-X
a	B-X
priori	B-X
risk	B-X
carriers	B-X
had	B-X
problems	B-X
in	B-X
the	B-X
``	B-X
living	B-X
with	B-X
cancer	B-X
''	B-X
and	B-X
``	B-X
children	B-X
''	B-X
psychosocial	B-X
domains	B-X
respectively	B-X
.	B-X

In	O
the	O
sections	O
that	O
follow	O
,	O
we	O
explore	O
the	O
manner	O
in	O
which	O
the	O
validated	O
newly	O
identified	O
genes	O
affect	O
motility	O
.	O

Identifying	O
Flagellar	O
Components	O
through	O
Bacteriophage	O
chi	O
Selection	O

As	O
a	O
complementary	O
approach	O
to	O
determining	O
the	O
components	O
necessary	O
for	O
a	O
functioning	O
flagellum	O
,	O
we	O
designed	O
a	O
simple	O
selection	O
to	O
identify	O
mutants	O
resistant	O
to	O
chi	B-Organism
-	O
phage	O
infection	O
.	O

Bacteriophage	O
chi	B-Organism
infects	O
E	B-Organism
.	I-Organism
coli	I-Organism
by	O
attaching	O
to	O
and	O
traveling	O
along	O
flagellar	O
filaments	O
[	O
24	O
]	O
.	O

CCW	O
flagellar	O
rotation	O
and	O
the	O
correct	O
pattern	O
of	O
grooves	O
on	O
the	O
surface	O
of	O
the	O
flagellum	O
are	O
thought	O
to	O
drive	O
chi	B-Organism
-	O
phage	O
down	O
the	O
filament	O
to	O
the	O
surface	O
of	O
the	O
membrane	O
,	O
very	O
similar	O
to	O
how	O
a	O
nut	O
follows	O
the	O
grooves	O
of	O
a	O
rotating	O
bolt	O
[	O
25	O
]	O
.	O

The	O
library	O
of	O
transposon	O
insertional	O
mutants	O
was	O
exposed	O
to	O
chi	B-Organism
-	O
phage	O
in	O
an	O
environment	O
conducive	O
to	O
motility	O
(	O
Figure	O
2A	O
)	O
.	O

Survival	O
of	O
a	O
mutant	O
meant	O
either	O
the	O
loss	O
of	O
its	O
flagella	O
,	O
the	O
loss	O
of	O
flagellar	O
CCW	O
rotation	O
,	O
or	O
the	O
loss	O
of	O
other	O
components	O
necessary	O
for	O
infection	O
.	O
<EOS>	B-X
Although	B-X
longer	B-X
follow-up	B-X
is	B-X
necessary	B-X
for	B-X
total	B-X
ankle	B-X
arthroplasty	B-X
(	B-X
TAA	B-X
)	B-X
to	B-X
displace	B-X
arthrodesis	B-X
as	B-X
the	B-X
surgical	B-X
``	B-X
gold	B-X
standard	B-X
,	B-X
''	B-X
intermediate-term	B-X
results	B-X
are	B-X
encouraging	B-X
.	B-X
Contraindications	B-X
to	B-X
TAA	B-X
include	B-X
unresectable	B-X
osteonecrotic	B-X
bone	B-X
,	B-X
peripheral	B-X
vascular	B-X
disease	B-X
,	B-X
neuropathy	B-X
,	B-X
active	B-X
and/or	B-X
recent	B-X
ankle	B-X
infection	B-X
,	B-X
nonreconstructible	B-X
ankle	B-X
ligaments	B-X
,	B-X
loss	B-X
of	B-X
lower	B-X
leg	B-X
muscular	B-X
control	B-X
,	B-X
and	B-X
severe	B-X
osteopenia	B-X
or	B-X
osteoporosis	B-X
.	B-X
Some	B-X
TAA	B-X
designs	B-X
feature	B-X
a	B-X
nonconstrained	B-X
polyethylene	B-X
meniscus	B-X
(	B-X
mobile	B-X
bearing	B-X
)	B-X
that	B-X
articulates	B-X
between	B-X
the	B-X
porous-coated	B-X
tibial	B-X
and	B-X
talar	B-X
components	B-X
.	B-X
In	B-X
this	B-X
condition	B-X
,	B-X
the	B-X
treatment	B-X
was	B-X
ineffective	B-X
and	B-X
more	B-X
chances	B-X
of	B-X
spreading	B-X
of	B-X
infection	B-X
into	B-X
other	B-X
organisms	B-X
.	B-X
Hence	B-X
,	B-X
it	B-X
is	B-X
necessary	B-X
to	B-X
initiate	B-X
infection	B-X
control	B-X
efforts	B-X
and	B-X
prevention	B-X
activities	B-X
against	B-X
multidrug	B-X
resistant	B-X
microbes	B-X
,	B-X
to	B-X
reduce	B-X
the	B-X
death	B-X
rate	B-X
of	B-X
people	B-X
.	B-X
Further	B-X
,	B-X
many	B-X
research	B-X
works	B-X
have	B-X
shown	B-X
nanocomposites	B-X
developed	B-X
from	B-X
nanoparticles	B-X
coupled	B-X
with	B-X
other	B-X
nanoparticles	B-X
,	B-X
polymers	B-X
,	B-X
carbon	B-X
material	B-X
acted	B-X
as	B-X
an	B-X
exotic	B-X
substance	B-X
against	B-X
microbes	B-X
causing	B-X
severe	B-X
loss	B-X
.	B-X
The	B-X
bactericidal	B-X
mechanism	B-X
of	B-X
metal	B-X
and	B-X
metal	B-X
oxide	B-X
nanocomposites	B-X
involve	B-X
in	B-X
the	B-X
production	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
which	B-X
includes	B-X
superoxide	B-X
radical	B-X
anions	B-X
,	B-X
hydrogen	B-X
peroxide	B-X
anions	B-X
and	B-X
hydrogen	B-X
peroxide	B-X
which	B-X
interact	B-X
with	B-X
the	B-X
cell	B-X
wall	B-X
of	B-X
bacteria	B-X
causing	B-X
damage	B-X
to	B-X
the	B-X
cell	B-X
membrane	B-X
in	B-X
turn	B-X
inhibiting	B-X
the	B-X
further	B-X
growth	B-X
of	B-X
cell	B-X
with	B-X
leakage	B-X
of	B-X
internal	B-X
cellular	B-X
components	B-X
,	B-X
leading	B-X
to	B-X
death	B-X
of	B-X
bacteria	B-X
.	B-X

In	O
a	O
sample	O
of	O
mutants	O
taken	O
after	O
selection	O
,	O
98	O
%	O
were	O
completely	O
nonmotile	O
(	O
Figure	O
S4	O
)	O
.	O

Figure	O
2B	O
shows	O
the	O
distribution	O
of	O
z	O
-	O
scores	O
after	O
library	O
selection	O
upon	O
exposure	O
to	O
bacteriophage	O
chi	B-Organism
,	O
and	O
the	O
complete	O
microarray	O
results	O
for	O
duplicate	O
selections	O
can	O
be	O
found	O
in	O
Datasets	O
S5	O
and	O
S6	O
.	O

As	O
expected	O
,	O
insertional	O
mutations	O
in	O
flagellar	O
genes	O
conferred	O
resistance	O
to	O
chi	B-Organism
-	O
phage	O
infection	O
.	O

In	O
contrast	O
,	O
while	O
mutants	O
of	O
the	O
chemotaxis	O
sensory	O
network	O
were	O
in	O
high	O
abundance	O
after	O
the	O
chemotaxis	O
selection	O
,	O
insertional	O
mutants	O
of	O
cheA	O
,	O
cheB	O
,	O
cheR	O
,	O
cheW	O
,	O
tap	O
,	O
tar	O
,	O
trg	O
,	O
and	O
tsr	O
were	O
in	O
low	O
abundance	O
after	O
exposure	O
to	O
chi	B-Organism
-	O
phage	O
.	O

This	O
is	O
to	O
be	O
expected	O
,	O
since	O
null	O
mutations	O
in	O
these	O
genes	O
do	O
not	O
entirely	O
abolish	O
CCW	O
flagellar	O
rotation	O
.	O
<EOS>	B-X
In	B-X
addition	B-X
to	B-X
directly	B-X
affecting	B-X
skeletal	B-X
muscle	B-X
,	B-X
pathogenesis	B-X
can	B-X
also	B-X
arise	B-X
from	B-X
dysfunctional	B-X
crosstalk	B-X
between	B-X
nerves	B-X
and	B-X
muscles	B-X
,	B-X
and	B-X
may	B-X
include	B-X
cardiac	B-X
impairment	B-X
.	B-X
We	B-X
explore	B-X
the	B-X
expression	B-X
dynamics	B-X
of	B-X
myopathogenes	B-X
,	B-X
genes	B-X
whose	B-X
mutation	B-X
leads	B-X
to	B-X
skeletal	B-X
muscle	B-X
pathogenesis	B-X
,	B-X
using	B-X
transcriptomic	B-X
analysis	B-X
.	B-X
This	B-X
revealed	B-X
that	B-X
45	B-X
%	B-X
of	B-X
myopathogenes	B-X
are	B-X
differentially	B-X
expressed	B-X
during	B-X
early	B-X
satellite	B-X
cell	B-X
activation	B-X
(	B-X
0	B-X
-	B-X
5	B-X
hours	B-X
)	B-X
.	B-X
Of	B-X
these	B-X
271	B-X
myopathogenes	B-X
,	B-X
83	B-X
respond	B-X
to	B-X
Pax7	B-X
,	B-X
a	B-X
master	B-X
regulator	B-X
of	B-X
satellite	B-X
cells	B-X
.	B-X

The	O
only	O
exception	O
among	O
the	O
che	O
genes	O
is	O
cheZ	O
,	O
whose	O
z	O
-	O
score	O
of	O
+	O
8	O
.	O
7	O
indicates	O
a	O
CW	O
flagellar	O
rotation	O
bias	O
and	O
reduced	O
susceptibility	O
to	O
chi	B-Organism
-	O
phage	O
infection	O
.	O

CheZ	O
is	O
a	O
phosphatase	O
of	O
CheY	O
,	O
the	O
protein	O
whose	O
phosphorylated	O
state	O
biases	O
the	O
flagella	O
toward	O
the	O
CW	O
direction	O
[	O
26	O
,	O
27	O
]	O
.	O

Therefore	O
,	O
in	O
the	O
absence	O
of	O
CheZ	O
,	O
CheY	O
is	O
maintained	O
in	O
the	O
phosphorylated	O
state	O
,	O
"	O
locking	O
"	O
flagellar	O
rotation	O
in	O
the	O
CW	O
direction	O
,	O
and	O
hence	O
minimizing	O
infection	O
by	O
chi	B-Organism
-	O
phage	O
.	O

In	O
addition	O
to	O
these	O
findings	O
,	O
the	O
selection	O
results	O
revealed	O
that	O
cellular	O
structures	O
other	O
than	O
the	O
flagella	O
may	O
be	O
required	O
for	O
infection	O
(	O
Table	O
S1	O
)	O
.	O

The	O
role	O
these	O
structures	O
play	O
in	O
chi	B-Organism
-	O
phage	O
infection	O
and	O
the	O
impact	O
they	O
have	O
on	O
motility	O
are	O
discussed	O
in	O
a	O
separate	O
section	O
below	O
.	O

Genetic	O
Basis	O
of	O
Swarming	O
Motility	O
<EOS>	B-X
Swarming	B-X
and	B-X
twitching	B-X
motility	B-X
are	B-X
processes	B-X
taking	B-X
place	B-X
at	B-X
the	B-X
interface	B-X
between	B-X
a	B-X
solid	B-X
phase	B-X
and	B-X
a	B-X
liquid	B-X
or	B-X
gas	B-X
phase	B-X
.	B-X
Swarming	B-X
is	B-X
a	B-X
social	B-X
phenomenon	B-X
that	B-X
enables	B-X
motile	B-X
bacteria	B-X
to	B-X
move	B-X
co-ordinately	B-X
over	B-X
solid	B-X
surfaces	B-X
.	B-X

Whereas	O
flagellar	O
-	O
mediated	O
swimming	O
is	O
among	O
the	O
best	O
-	O
understood	O
bacterial	O
behaviors	O
,	O
very	O
little	O
is	O
known	O
about	O
the	O
genetic	O
program	O
that	O
leads	O
to	O
the	O
development	O
of	O
swarming	O
.	O

Swarming	O
is	O
exhibited	O
by	O
many	O
flagellated	O
bacteria	O
,	O
and	O
is	O
defined	O
as	O
a	O
coordinated	O
multicellular	O
migration	O
across	O
a	O
solid	O
surface	O
by	O
morphologically	O
differentiated	O
cells	O
[	O
28	O
]	O
.	O

Confocal	O
fluorescence	O
microscopy	O
shows	O
swarming	O
cells	O
aligning	O
themselves	O
lengthwise	O
and	O
moving	O
coordinately	O
in	O
groups	O
,	O
forming	O
"	O
rafts	O
"	O
(	O
Movie	O
S1	O
)	O
.	O

In	O
this	O
context	O
,	O
the	O
cells	O
appear	O
to	O
execute	O
smooth	O
swimming	O
behavior	O
almost	O
exclusively	O
,	O
in	O
contrast	O
to	O
the	O
extensive	O
switching	O
back	O
and	O
forth	O
seen	O
during	O
chemotaxis	O
.	O

Aside	O
from	O
the	O
requirement	O
for	O
flagella	O
,	O
other	O
aspects	O
of	O
the	O
behavior	O
are	O
poorly	O
understood	O
.	O

Because	O
the	O
genetic	O
basis	O
of	O
swarming	O
is	O
not	O
well	O
characterized	O
,	O
this	O
behavior	O
is	O
well	O
suited	O
for	O
comprehensive	O
analysis	O
using	O
our	O
approach	O
.	O
<EOS>	B-X
In	B-X
virology	B-X
,	B-X
quasispecies	B-X
are	B-X
defined	B-X
as	B-X
complex	B-X
distributions	B-X
of	B-X
closely	B-X
related	B-X
variant	B-X
genomes	B-X
subjected	B-X
to	B-X
genetic	B-X
variation	B-X
,	B-X
competition	B-X
and	B-X
selection	B-X
,	B-X
and	B-X
that	B-X
may	B-X
act	B-X
as	B-X
a	B-X
unit	B-X
of	B-X
selection	B-X
.	B-X
Crossing	B-X
such	B-X
a	B-X
limit	B-X
leads	B-X
to	B-X
RNA	B-X
virus	B-X
extinction	B-X
,	B-X
a	B-X
transition	B-X
that	B-X
is	B-X
the	B-X
basis	B-X
of	B-X
an	B-X
antiviral	B-X
design	B-X
termed	B-X
lethal	B-X
mutagenesis	B-X
.	B-X
This	B-X
process	B-X
can	B-X
be	B-X
described	B-X
as	B-X
a	B-X
behavioral	B-X
migration-response	B-X
of	B-X
an	B-X
organism	B-X
toward	B-X
a	B-X
change	B-X
in	B-X
illumination	B-X
regime	B-X
.	B-X
In	B-X
this	B-X
chapter	B-X
we	B-X
discuss	B-X
three	B-X
of	B-X
these	B-X
migration	B-X
responses	B-X
,	B-X
based	B-X
on	B-X
swimming	B-X
,	B-X
swarming	B-X
,	B-X
and	B-X
twitching	B-X
motility	B-X
,	B-X
respectively	B-X
.	B-X
Swimming	B-X
motility	B-X
has	B-X
been	B-X
studied	B-X
using	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
techniques	B-X
,	B-X
usually	B-X
microscopy	B-X
based	B-X
.	B-X
We	B-X
present	B-X
a	B-X
detailed	B-X
description	B-X
of	B-X
the	B-X
assays	B-X
used	B-X
to	B-X
study	B-X
phototaxis	B-X
in	B-X
liquid	B-X
cultures	B-X
of	B-X
the	B-X
phototrophic	B-X
organisms	B-X
Halobacterium	B-X
salinarum	B-X
,	B-X
Halorhodospira	B-X
halophila	B-X
,	B-X
and	B-X
Rhodobacter	B-X
sphaeroides	B-X
and	B-X
briefly	B-X
describe	B-X
the	B-X
molecular	B-X
basis	B-X
of	B-X
these	B-X
responses	B-X
.	B-X

In	O
order	O
to	O
explore	O
the	O
genetic	O
basis	O
of	O
swarming	O
,	O
we	O
expressed	O
this	O
phenotype	O
in	O
terms	O
of	O
a	O
quantitative	O
selection	O
,	O
much	O
as	O
was	O
done	O
for	O
swimming	O
motility	O
.	O

A	O
single	O
round	O
of	O
enrichment	O
consisted	O
of	O
inoculating	O
our	O
library	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
mutants	O
onto	O
the	O
center	O
of	O
agar	O
plates	O
,	O
incubating	O
the	O
plates	O
to	O
allow	O
the	O
cells	O
to	O
migrate	O
outward	O
from	O
the	O
site	O
of	O
inoculation	O
,	O
and	O
transferring	O
bacteria	O
from	O
the	O
original	O
area	O
of	O
inoculation	O
to	O
a	O
fresh	O
plate	O
.	O

After	O
twenty	O
rounds	O
of	O
daily	O
successive	O
transfers	O
(	O
Figure	O
3A	O
)	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
population	O
exhibited	O
a	O
defect	O
in	O
swarming	O
(	O
Figure	O
S5	O
)	O
.	O

The	O
enriched	O
mutants	O
were	O
then	O
subjected	O
to	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
.	O

As	O
expected	O
,	O
the	O
selection	O
results	O
were	O
dominated	O
by	O
flagellar	O
and	O
chemotaxis	O
genes	O
(	O
Figure	O
3B	O
)	O
.	O

While	O
mutants	O
with	O
a	O
defect	O
in	O
the	O
flagellar	O
apparatus	O
did	O
not	O
swarm	O
,	O
chemotaxis	O
mutants	O
formed	O
swarming	O
patterns	O
as	O
finger	O
-	O
like	O
projections	O
,	O
in	O
contrast	O
to	O
the	O
more	O
uniform	O
swarming	O
patterns	O
generated	O
by	O
the	O
wild	O
-	O
type	O
parent	O
strain	O
(	O
Figure	O
3C	O
)	O
.	O
<EOS>	B-X
This	B-X
regulation	B-X
not	B-X
only	B-X
depends	B-X
on	B-X
the	B-X
presence	B-X
of	B-X
multiple	B-X
dynein	B-X
isoforms	B-X
,	B-X
but	B-X
also	B-X
clearly	B-X
involves	B-X
other	B-X
structures	B-X
in	B-X
the	B-X
axoneme	B-X
such	B-X
as	B-X
the	B-X
radial	B-X
spokes	B-X
and	B-X
central	B-X
apparatus	B-X
;	B-X
mutants	B-X
lacking	B-X
these	B-X
structures	B-X
have	B-X
paralyzed	B-X
flagella	B-X
.	B-X
In	B-X
this	B-X
article	B-X
,	B-X
we	B-X
review	B-X
recent	B-X
progress	B-X
in	B-X
identifying	B-X
protein	B-X
components	B-X
of	B-X
the	B-X
central	B-X
apparatus	B-X
and	B-X
discuss	B-X
the	B-X
role	B-X
of	B-X
these	B-X
components	B-X
in	B-X
regulation	B-X
of	B-X
flagellar	B-X
motility	B-X
and	B-X
central	B-X
apparatus	B-X
assembly	B-X
.	B-X
The	B-X
central	B-X
apparatus	B-X
is	B-X
composed	B-X
of	B-X
two	B-X
single	B-X
microtubules	B-X
and	B-X
their	B-X
associated	B-X
structures	B-X
which	B-X
include	B-X
the	B-X
central	B-X
pair	B-X
projections	B-X
,	B-X
the	B-X
central	B-X
pair	B-X
bridges	B-X
linking	B-X
the	B-X
two	B-X
tubules	B-X
,	B-X
and	B-X
the	B-X
central	B-X
pair	B-X
caps	B-X
which	B-X
are	B-X
attached	B-X
to	B-X
the	B-X
distal	B-X
or	B-X
plus	B-X
ends	B-X
of	B-X
the	B-X
microtubules	B-X
.	B-X
To	B-X
date	B-X
,	B-X
the	B-X
genes	B-X
encoding	B-X
four	B-X
components	B-X
of	B-X
the	B-X
central	B-X
apparatus	B-X
have	B-X
been	B-X
cloned	B-X
,	B-X
PF15	B-X
,	B-X
PF16	B-X
,	B-X
PF20	B-X
and	B-X
KLP1	B-X
.	B-X
Two	B-X
additional	B-X
components	B-X
have	B-X
been	B-X
identified	B-X
immunologically	B-X
,	B-X
a	B-X
110	B-X
kD	B-X
polypeptide	B-X
recognized	B-X
by	B-X
an	B-X
antibody	B-X
generated	B-X
against	B-X
highly	B-X
conserved	B-X
kinesin	B-X
peptide	B-X
sequence	B-X
,	B-X
and	B-X
a	B-X
97	B-X
kD	B-X
polypeptide	B-X
recognized	B-X
by	B-X
CREST	B-X
antisera	B-X
.	B-X
Based	B-X
on	B-X
a	B-X
variety	B-X
of	B-X
data	B-X
,	B-X
one	B-X
model	B-X
that	B-X
has	B-X
emerged	B-X
to	B-X
explain	B-X
the	B-X
role	B-X
of	B-X
the	B-X
central	B-X
apparatus	B-X
in	B-X
flagellar	B-X
motility	B-X
is	B-X
that	B-X
the	B-X
central	B-X
apparatus	B-X
ultimately	B-X
regulates	B-X
dynein	B-X
through	B-X
interactions	B-X
with	B-X
the	B-X
radial	B-X
spokes	B-X
.	B-X
The	B-X
challenge	B-X
now	B-X
is	B-X
to	B-X
determine	B-X
the	B-X
precise	B-X
mechanism	B-X
by	B-X
which	B-X
the	B-X
polypeptides	B-X
comprising	B-X
the	B-X
central	B-X
apparatus	B-X
and	B-X
the	B-X
radial	B-X
spokes	B-X
interact	B-X
to	B-X
transduce	B-X
a	B-X
regulatory	B-X
signal	B-X
to	B-X
the	B-X
dynein	B-X
arms	B-X
.	B-X
In	B-X
terms	B-X
of	B-X
assembly	B-X
,	B-X
the	B-X
central	B-X
apparatus	B-X
microtubules	B-X
assemble	B-X
with	B-X
their	B-X
plus	B-X
ends	B-X
distal	B-X
to	B-X
the	B-X
cell	B-X
body	B-X
but	B-X
,	B-X
unlike	B-X
the	B-X
nine	B-X
doublet	B-X
microtubules	B-X
,	B-X
they	B-X
are	B-X
not	B-X
nucleated	B-X
from	B-X
the	B-X
basal	B-X
bodies	B-X
.	B-X
Since	B-X
some	B-X
central	B-X
apparatus	B-X
defective	B-X
mutants	B-X
fail	B-X
to	B-X
assemble	B-X
the	B-X
entire	B-X
central	B-X
apparatus	B-X
,	B-X
their	B-X
gene	B-X
products	B-X
may	B-X
eventually	B-X
prove	B-X
to	B-X
have	B-X
microtubule	B-X
nucleating	B-X
or	B-X
stabilizing	B-X
properties	B-X
.	B-X
By	B-X
continuing	B-X
to	B-X
identify	B-X
the	B-X
genes	B-X
that	B-X
encode	B-X
central	B-X
apparatus	B-X
components	B-X
,	B-X
we	B-X
will	B-X
begin	B-X
to	B-X
understand	B-X
the	B-X
contribution	B-X
of	B-X
these	B-X
microtubules	B-X
to	B-X
flagellar	B-X
motility	B-X
and	B-X
gain	B-X
insight	B-X
into	B-X
their	B-X
nucleation	B-X
,	B-X
assembly	B-X
,	B-X
and	B-X
stability	B-X
.	B-X

These	O
observations	O
indicate	O
that	O
the	O
chemotaxis	O
sensory	O
system	O
and	O
flagellar	O
switching	O
have	O
an	O
effect	O
on	O
,	O
but	O
are	O
not	O
critical	O
for	O
,	O
surface	O
motility	O
.	O

Although	O
this	O
observation	O
contradicts	O
earlier	O
studies	O
on	O
swarming	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
and	O
S	B-Organism
.	I-Organism
enterica	I-Organism
[	O
29	O
]	O
,	O
more	O
recent	O
work	O
has	O
shown	O
that	O
chemotaxis	O
mutants	O
are	O
capable	O
of	O
surface	O
motility	O
when	O
the	O
surface	O
of	O
the	O
agar	O
is	O
sprayed	O
with	O
a	O
fine	O
mist	O
of	O
water	O
[	O
30	O
]	O
,	O
or	O
when	O
the	O
agar	O
concentration	O
of	O
the	O
swarming	O
media	O
is	O
reduced	O
from	O
0	O
.	O
6	O
%	O
to	O
0	O
.	O
45	O
%	O
[	O
31	O
]	O
.	O

The	O
microarray	O
results	O
(	O
Datasets	O
S7	O
-	O
S10	O
)	O
guided	O
the	O
interrogation	O
of	O
additional	O
genes	O
that	O
may	O
have	O
a	O
role	O
in	O
swarming	O
.	O

In	O
addition	O
to	O
flagellar	O
genes	O
,	O
we	O
found	O
other	O
loci	O
that	O
also	O
contribute	O
to	O
swarming	O
motility	O
(	O
Table	O
S1	O
)	O
,	O
which	O
are	O
discussed	O
in	O
more	O
detail	O
below	O
.	O

Novel	O
Genes	O
Implicated	O
in	O
Swimming	O
,	O
Swarming	O
,	O
and	O
chi	O
-	O
Phage	O
Infection	O

Application	O
of	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
to	O
swimming	O
,	O
swarming	O
,	O
and	O
chi	B-Organism
-	O
phage	O
selection	O
was	O
effective	O
in	O
identifying	O
nearly	O
all	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
.	O

Remarkably	O
,	O
the	O
selection	O
results	O
guided	O
the	O
identification	O
of	O
three	O
dozen	O
additional	O
genes	O
that	O
affect	O
motility	O
,	O
most	O
of	O
which	O
have	O
no	O
previous	O
evidence	O
of	O
involvement	O
in	O
motility	O
(	O
Table	O
S1	O
)	O
.	O

Most	O
of	O
these	O
non	O
-	O
flagellar	O
genes	O
encode	O
components	O
of	O
the	O
cell	O
envelope	O
.	O

For	O
example	O
,	O
of	O
the	O
20	O
non	O
-	O
flagellar	O
genes	O
revealed	O
to	O
affect	O
swimming	O
motility	O
,	O
twelve	O
encode	O
constituents	O
of	O
the	O
inner	O
membrane	O
and	O
periplasmic	O
space	O
.	O

These	O
gene	O
products	O
include	O
transport	O
proteins	O
(	O
SdaC	O
,	O
TatA	O
,	O
TatB	O
,	O
TatC	O
,	O
and	O
WzxE	O
)	O
,	O
enzymes	O
(	O
DsbA	O
and	O
Prc	O
)	O
,	O
periplasmic	O
glucan	O
synthesis	O
proteins	O
(	O
MdoG	O
and	O
MdoH	O
)	O
,	O
members	O
of	O
a	O
signaling	O
pathway	O
(	O
RcsC	O
and	O
RcsD	O
)	O
,	O
and	O
a	O
predicted	O
inner	O
membrane	O
protein	O
of	O
unknown	O
function	O
(	O
YrfF	O
)	O
.	O

Of	O
these	O
,	O
only	O
the	O
genes	O
encoding	O
RcsD	O
and	O
glucan	O
synthesis	O
proteins	O
had	O
been	O
previously	O
implicated	O
in	O
swimming	O
motility	O
[	O
32	O
,	O
33	O
]	O
.	O

In	O
addition	O
,	O
we	O
identified	O
several	O
genes	O
that	O
encode	O
cytoplasmic	O
components	O
and	O
other	O
genes	O
of	O
unknown	O
function	O
,	O
including	O
fimE	O
,	O
hycG	O
,	O
intG	O
,	O
rep	O
,	O
ulaE	O
,	O
and	O
yhjH	O
.	O

We	O
systematically	O
tested	O
all	O
newly	O
identified	O
swimming	O
mutants	O
for	O
surface	O
motility	O
,	O
and	O
found	O
that	O
deletions	O
of	O
dsbA	O
,	O
intG	O
,	O
prc	O
,	O
rcsC	O
,	O
rep	O
,	O
tatB	O
,	O
tatC	O
,	O
wzxE	O
,	O
and	O
yrfF	O
strongly	O
impair	O
swarming	O
.	O

Surprisingly	O
,	O
while	O
mutants	O
with	O
deletions	O
of	O
rcsD	O
,	O
sdaC	O
,	O
tatA	O
,	O
and	O
yhjH	O
were	O
impaired	O
in	O
swimming	O
,	O
these	O
mutants	O
swarmed	O
normally	O
(	O
unpublished	O
data	O
)	O
.	O

Interrogation	O
of	O
genes	O
with	O
high	O
z	O
-	O
scores	O
in	O
the	O
enrichment	O
for	O
mutants	O
incapable	O
of	O
swarming	O
identified	O
two	O
additional	O
genes	O
that	O
impact	O
surface	O
motility	O
:	O
hns	O
,	O
encoding	O
a	O
global	O
transcriptional	O
regulator	O
,	O
and	O
yfiR	O
,	O
encoding	O
a	O
predicted	O
periplasmic	O
protein	O
of	O
unknown	O
function	O
.	O

In	O
-	O
frame	O
deletions	O
of	O
these	O
genes	O
abolished	O
swarming	O
;	O
however	O
,	O
while	O
the	O
Deltahns	O
mutant	O
showed	O
a	O
severe	O
swimming	O
defect	O
,	O
the	O
swimming	O
motility	O
of	O
the	O
DeltayfiR	O
mutant	O
was	O
only	O
mildly	O
impaired	O
(	O
Figures	O
3D	O
and	O
4	O
)	O
.	O
<EOS>	B-X
The	B-X
aims	B-X
of	B-X
this	B-X
study	B-X
were	B-X
to	B-X
create	B-X
and	B-X
evaluate	B-X
the	B-X
Gateway-compatible	B-X
plasmids	B-X
for	B-X
investigating	B-X
the	B-X
function	B-X
of	B-X
genes	B-X
in	B-X
Vibrio	B-X
alginolyticus	B-X
and	B-X
other	B-X
Gram-negative	B-X
bacteria	B-X
.	B-X
A	B-X
10	B-X
kb	B-X
fragment	B-X
containing	B-X
fliF	B-X
,	B-X
fliH	B-X
,	B-X
fliN	B-X
,	B-X
motA	B-X
,	B-X
flbD	B-X
,	B-X
flhA	B-X
,	B-X
flhF	B-X
and	B-X
fleN	B-X
genes	B-X
was	B-X
cloned	B-X
from	B-X
the	B-X
genomic	B-X
DNA	B-X
of	B-X
Azospirillum	B-X
brasilense	B-X
Yu62	B-X
.	B-X
These	B-X
eight	B-X
genes	B-X
appear	B-X
to	B-X
be	B-X
structurally	B-X
organized	B-X
as	B-X
an	B-X
operon	B-X
.	B-X
FlbD	B-X
,	B-X
encoded	B-X
by	B-X
flbD	B-X
,	B-X
has	B-X
a	B-X
HTH	B-X
DNA	B-X
binding	B-X
domain	B-X
and	B-X
shows	B-X
homology	B-X
to	B-X
sigma	B-X
(	B-X
54	B-X
)	B-X
-dependent	B-X
transcriptional	B-X
activators	B-X
such	B-X
as	B-X
NtrC	B-X
,	B-X
NifA	B-X
and	B-X
DctD	B-X
.	B-X
An	B-X
in-frame	B-X
deletion	B-X
of	B-X
flbD	B-X
in	B-X
A.	B-X
brasilense	B-X
abolishes	B-X
biosynthesis	B-X
of	B-X
lateral	B-X
flagella	B-X
and	B-X
swarming	B-X
ability	B-X
when	B-X
grown	B-X
on	B-X
semi-solid	B-X
surfaces	B-X
.	B-X
An	B-X
intact	B-X
copy	B-X
of	B-X
flbD	B-X
on	B-X
a	B-X
plasmid	B-X
complemented	B-X
the	B-X
DeltaflbD	B-X
mutant	B-X
by	B-X
restoring	B-X
lateral	B-X
flagellation	B-X
and	B-X
swarming	B-X
ability	B-X
.	B-X
DNA	B-X
binding	B-X
assays	B-X
indicated	B-X
direct	B-X
interaction	B-X
between	B-X
FlbD	B-X
and	B-X
the	B-X
promoter	B-X
regions	B-X
of	B-X
laf1	B-X
,	B-X
fliF	B-X
and	B-X
flgB	B-X
genes	B-X
.	B-X

Among	O
the	O
loci	O
exhibiting	O
high	O
z	O
-	O
scores	O
after	O
chi	O
-	O
phage	O
selection	O
were	O
the	O
rfa	O
and	O
mdo	O
gene	O
clusters	O
responsible	O
for	O
the	O
structural	O
assembly	O
of	O
lipopolysaccharides	O
(	O
LPS	O
)	O
and	O
osmoregulated	O
periplasmic	O
glucans	O
(	O
OPG	O
)	O
.	O

Genes	O
involved	O
with	O
the	O
synthesis	O
of	O
LPS	O
and	O
OPG	O
precursors	O
(	O
hldD	O
,	O
hldE	O
,	O
galU	O
,	O
gmhA	O
,	O
gmhB	O
,	O
and	O
pgm	O
)	O
were	O
also	O
highly	O
abundant	O
after	O
chi	B-Organism
-	O
phage	O
selection	O
.	O

These	O
findings	O
suggested	O
that	O
mutations	O
in	O
LPS	O
and	O
OPG	O
biosynthetic	O
genes	O
may	O
compromise	O
motility	O
.	O

We	O
confirmed	O
this	O
expectation	O
by	O
creating	O
in	O
-	O
frame	O
deletions	O
of	O
nearly	O
all	O
genes	O
involved	O
in	O
LPS	O
and	O
OPG	O
biosynthesis	O
and	O
assaying	O
the	O
mutants	O
for	O
motility	O
.	O

OPG	O
mutants	O
were	O
defective	O
in	O
both	O
swimming	O
and	O
swarming	O
;	O
surprisingly	O
,	O
however	O
,	O
only	O
mutants	O
with	O
large	O
LPS	O
truncations	O
showed	O
significant	O
defects	O
in	O
these	O
behaviors	O
(	O
Figures	O
3E	O
and	O
4	O
)	O
.	O

The	O
wide	O
functional	O
repertoire	O
of	O
gene	O
products	O
found	O
to	O
affect	O
motility	O
prompted	O
us	O
to	O
examine	O
whether	O
genetic	O
perturbations	O
in	O
these	O
loci	O
affect	O
motility	O
by	O
signaling	O
upstream	O
of	O
the	O
regulatory	O
circuit	O
that	O
controls	O
flagellar	O
biogenesis	O
,	O
resulting	O
in	O
repression	O
of	O
the	O
flhDC	O
flagellar	O
master	O
operon	O
.	O

To	O
investigate	O
this	O
possibility	O
,	O
we	O
introduced	O
flhDC	O
-	O
lacZ	O
translational	O
fusions	O
in	O
the	O
deletion	O
strains	O
and	O
performed	O
beta	O
-	O
galactosidase	O
assays	O
.	O

Surprisingly	O
,	O
a	O
large	O
fraction	O
of	O
the	O
mutants	O
tested	O
showed	O
significant	O
reduction	O
in	O
flhDC	O
-	O
lacZ	O
expression	O
values	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
,	O
demonstrating	O
that	O
the	O
motility	O
defects	O
can	O
be	O
partly	O
attributed	O
to	O
reduced	O
expression	O
of	O
the	O
flhDC	O
operon	O
.	O

In	O
addition	O
,	O
we	O
noticed	O
that	O
LPS	O
mutants	O
varied	O
widely	O
in	O
flhDC	O
expression	O
and	O
that	O
the	O
repression	O
of	O
this	O
operon	O
,	O
and	O
the	O
corresponding	O
motility	O
defect	O
,	O
were	O
related	O
to	O
the	O
degree	O
of	O
LPS	O
truncation	O
(	O
Figure	O
4	O
)	O
.	O

LPS	O
and	O
OPG	O
Mutations	O
Impair	O
Motility	O
by	O
Repressing	O
Flagellar	O
Gene	O
Expression	O
through	O
the	O
Rcs	O
Signaling	O
Pathway	O

The	O
widespread	O
influence	O
of	O
LPS	O
and	O
OPG	O
mutations	O
on	O
swimming	O
,	O
swarming	O
,	O
and	O
chi	B-Organism
-	O
phage	O
infection	O
prompted	O
us	O
to	O
explore	O
the	O
genetic	O
mechanism	O
of	O
these	O
mutations	O
in	O
more	O
detail	O
.	O

Previous	O
evidence	O
links	O
LPS	O
and	O
OPG	O
mutations	O
to	O
the	O
activation	O
of	O
the	O
Rcs	O
phosphorelay	O
system	O
[	O
34	O
,	O
35	O
]	O
,	O
and	O
the	O
Rcs	O
system	O
is	O
known	O
to	O
negatively	O
regulate	O
the	O
flhDC	O
operon	O
[	O
36	O
]	O
.	O

The	O
Rcs	O
pathway	O
consists	O
of	O
a	O
phosphotransfer	O
protein	O
(	O
RcsD	O
)	O
that	O
mediates	O
phosphate	O
transfer	O
from	O
a	O
sensor	O
kinase	O
(	O
RcsC	O
)	O
to	O
a	O
response	O
regulator	O
(	O
RcsB	O
)	O
that	O
binds	O
DNA	O
with	O
an	O
accessory	O
protein	O
(	O
RcsA	O
)	O
.	O

Phosphorylated	O
RcsB	O
is	O
known	O
to	O
bind	O
upstream	O
of	O
the	O
flhDC	O
operon	O
and	O
to	O
repress	O
its	O
expression	O
.	O

The	O
pathway	O
also	O
includes	O
a	O
recently	O
identified	O
outer	O
membrane	O
lipoprotein	O
(	O
RcsF	O
)	O
that	O
is	O
known	O
to	O
activate	O
the	O
Rcs	O
system	O
[	O
37	O
]	O
.	O

To	O
determine	O
the	O
role	O
of	O
the	O
Rcs	O
signaling	O
pathway	O
in	O
LPS	O
/	O
OPG	O
mediated	O
repression	O
of	O
motility	O
,	O
we	O
disrupted	O
each	O
of	O
the	O
components	O
of	O
the	O
Rcs	O
system	O
in	O
most	O
of	O
our	O
LPS	O
and	O
OPG	O
mutants	O
.	O

We	O
found	O
that	O
deletion	O
of	O
rcsB	O
,	O
rcsD	O
,	O
or	O
rcsF	O
was	O
sufficient	O
to	O
rescue	O
motility	O
in	O
both	O
LPS	O
and	O
OPG	O
mutants	O
(	O
Figure	O
S6	O
)	O
,	O
providing	O
strong	O
evidence	O
that	O
perturbations	O
in	O
these	O
structures	O
repress	O
motility	O
by	O
signaling	O
through	O
the	O
Rcs	O
pathway	O
.	O
<EOS>	B-X
We	B-X
screened	B-X
His-Asp	B-X
phosphorelay	B-X
systems	B-X
for	B-X
their	B-X
effect	B-X
on	B-X
virulence	B-X
expression	B-X
in	B-X
enterohaemorrhagic	B-X
Escherichia	B-X
coli	B-X
(	B-X
EHEC	B-X
)	B-X
,	B-X
and	B-X
found	B-X
rcsD	B-X
or	B-X
rcsB	B-X
overexpression	B-X
enhanced	B-X
locus	B-X
for	B-X
enterocyte	B-X
effacement	B-X
(	B-X
LEE	B-X
)	B-X
gene	B-X
transcription	B-X
and	B-X
adherence	B-X
to	B-X
Caco-2	B-X
cells	B-X
through	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
ler	B-X
regulatory	B-X
gene	B-X
.	B-X
An	B-X
EHEC-specific	B-X
regulator	B-X
GrvA	B-X
,	B-X
encoded	B-X
by	B-X
ECs1274	B-X
,	B-X
was	B-X
required	B-X
for	B-X
ler	B-X
transcription	B-X
activation	B-X
by	B-X
RcsB	B-X
.	B-X
Stimulation	B-X
of	B-X
the	B-X
RcsDCB	B-X
regulatory	B-X
system	B-X
by	B-X
RcsF	B-X
overexpression	B-X
slightly	B-X
increased	B-X
EspB	B-X
expression	B-X
in	B-X
the	B-X
wild	B-X
type	B-X
but	B-X
not	B-X
the	B-X
ECs1274	B-X
mutant	B-X
.	B-X
However	B-X
,	B-X
EspB	B-X
expression	B-X
in	B-X
an	B-X
rcsB	B-X
deletion	B-X
mutant	B-X
increased	B-X
compared	B-X
with	B-X
wild	B-X
type	B-X
,	B-X
suggesting	B-X
that	B-X
RcsB	B-X
negatively	B-X
regulates	B-X
LEE	B-X
gene	B-X
expression	B-X
and	B-X
that	B-X
active	B-X
RcsB	B-X
protein	B-X
is	B-X
present	B-X
under	B-X
normal	B-X
growth	B-X
conditions	B-X
.	B-X
Deletion	B-X
of	B-X
pchA	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
positive	B-X
regulator	B-X
for	B-X
ler	B-X
,	B-X
abolished	B-X
the	B-X
effect	B-X
of	B-X
the	B-X
rcsB	B-X
deletion	B-X
,	B-X
suggesting	B-X
that	B-X
pchA	B-X
mediated	B-X
the	B-X
negative	B-X
RcsB	B-X
effect	B-X
.	B-X
pchA	B-X
transcript	B-X
levels	B-X
decreased	B-X
when	B-X
RcsB	B-X
expression	B-X
increased	B-X
.	B-X
Thus	B-X
,	B-X
LEE	B-X
gene	B-X
transcription	B-X
may	B-X
be	B-X
regulated	B-X
by	B-X
RcsB	B-X
through	B-X
two	B-X
oppositely	B-X
regulated	B-X
O157-specific	B-X
regulators	B-X
,	B-X
PchA	B-X
and	B-X
GrvA	B-X
.	B-X

Deletion	O
of	O
rcsC	O
rescued	O
motility	O
to	O
a	O
lesser	O
extent	O
.	O

This	O
observation	O
is	O
consistent	O
with	O
the	O
dual	O
functional	O
role	O
of	O
RcsC	O
as	O
both	O
kinase	O
and	O
phosphatase	O
,	O
moving	O
phosphates	O
both	O
to	O
and	O
away	O
from	O
RcsB	O
via	O
RcsD	O
,	O
and	O
that	O
RcsB	O
remains	O
phosphorylated	O
in	O
rcsC	O
null	O
mutants	O
[	O
38	O
,	O
39	O
]	O
.	O

Therefore	O
,	O
while	O
rcsC	O
mutations	O
disrupt	O
the	O
RcsF	O
-	O
-	O
>	O
RcsC	O
-	O
-	O
>	O
RcsD	O
-	O
-	O
>	O
RcsB	O
phosphorelay	O
cascade	O
,	O
the	O
phosphorylation	O
of	O
RcsB	O
cannot	O
be	O
fully	O
reversed	O
in	O
the	O
absence	O
of	O
RcsC	O
phosphatase	O
activity	O
,	O
as	O
observed	O
by	O
the	O
reduced	O
flhDC	O
-	O
lacZ	O
expression	O
and	O
motility	O
exhibited	O
by	O
rcsC	O
and	O
rcsD	O
mutants	O
(	O
Figure	O
4	O
)	O
.	O

This	O
conclusion	O
is	O
further	O
supported	O
by	O
the	O
dramatic	O
reduction	O
in	O
swimming	O
motility	O
by	O
rcsC137	O
mutants	O
(	O
Figure	O
S7	O
)	O
,	O
in	O
which	O
the	O
rcsC137	O
gene	O
product	O
has	O
lost	O
its	O
phosphatase	O
activity	O
[	O
40	O
]	O
.	O

The	O
chi	O
-	O
phage	O
selection	O
results	O
suggest	O
that	O
LPS	O
and	O
OPG	O
are	O
necessary	O
for	O
infection	O
.	O

However	O
,	O
since	O
functional	O
flagella	O
are	O
a	O
prerequisite	O
for	O
chi	B-Organism
-	O
phage	O
infection	O
,	O
we	O
sought	O
to	O
determine	O
whether	O
defects	O
in	O
LPS	O
and	O
OPG	O
affect	O
chi	B-Organism
-	O
phage	O
infection	O
directly	O
or	O
whether	O
the	O
observed	O
selection	O
results	O
are	O
primarily	O
due	O
to	O
reduced	O
flagellar	O
expression	O
.	O

To	O
evaluate	O
the	O
necessity	O
of	O
LPS	O
and	O
OPG	O
for	O
phage	O
infection	O
,	O
we	O
needed	O
mutants	O
that	O
were	O
defective	O
in	O
these	O
structures	O
but	O
still	O
synthesized	O
functional	O
flagella	O
and	O
were	O
motile	O
.	O

Therefore	O
,	O
we	O
created	O
double	O
mutants	O
combining	O
an	O
LPS	O
or	O
OPG	O
mutation	O
and	O
a	O
secondary	O
mutation	O
in	O
one	O
of	O
the	O
components	O
of	O
the	O
Rcs	O
signaling	O
pathway	O
.	O

These	O
mutants	O
were	O
used	O
in	O
an	O
infectivity	O
assay	O
in	O
which	O
plaque	O
-	O
forming	O
units	O
(	O
PFUs	O
)	O
are	O
monitored	O
over	O
time	O
to	O
assess	O
sensitivity	O
to	O
phage	O
infection	O
[	O
25	O
]	O
.	O

An	O
flhD	O
mutant	O
was	O
used	O
as	O
a	O
chi	B-Organism
-	O
phage	O
-	O
resistant	O
control	O
and	O
,	O
as	O
expected	O
,	O
showed	O
no	O
sensitivity	O
,	O
whereas	O
chi	B-Organism
-	O
phage	O
multiplied	O
rapidly	O
in	O
the	O
presence	O
of	O
the	O
wild	O
-	O
type	O
strain	O
(	O
Figure	O
5A	O
)	O
.	O

Both	O
OPG	O
and	O
LPS	O
mutants	O
showed	O
decreased	O
sensitivity	O
to	O
chi	B-Organism
-	O
phage	O
,	O
and	O
the	O
decrease	O
in	O
sensitivity	O
was	O
eliminated	O
by	O
introducing	O
DeltarcsF	O
deletions	O
,	O
indicating	O
that	O
OPG	O
and	O
LPS	O
are	O
not	O
directly	O
required	O
for	O
chi	B-Organism
-	O
phage	O
infection	O
(	O
Figures	O
5B	O
-	O
D	O
)	O
.	O

We	O
also	O
observed	O
that	O
sensitivity	O
to	O
chi	B-Organism
-	O
phage	O
was	O
higher	O
in	O
rfaI	O
mutants	O
than	O
rfaC	O
mutants	O
,	O
indicating	O
that	O
chi	B-Organism
-	O
phage	O
infectivity	O
is	O
directly	O
related	O
to	O
the	O
degree	O
of	O
flhDC	O
expression	O
(	O
Figures	O
4	O
,	O
5B	O
,	O
and	O
5C	O
)	O
.	O

In	O
a	O
previous	O
study	O
,	O
the	O
swarming	O
deficiency	O
of	O
LPS	O
mutants	O
had	O
suggested	O
an	O
essential	O
role	O
for	O
LPS	O
in	O
swarming	O
behavior	O
[	O
41	O
]	O
.	O

To	O
test	O
whether	O
such	O
a	O
direct	O
role	O
exists	O
,	O
we	O
interrogated	O
our	O
collection	O
of	O
LPS	O
and	O
OPG	O
mutants	O
for	O
swarming	O
proficiency	O
.	O

We	O
found	O
that	O
mutants	O
with	O
OPG	O
defects	O
and	O
severe	O
LPS	O
truncations	O
were	O
incapable	O
of	O
swarming	O
and	O
that	O
introducing	O
DeltarcsF	O
deletions	O
into	O
these	O
mutants	O
was	O
sufficient	O
to	O
rescue	O
the	O
phenotype	O
(	O
Figures	O
3F	O
and	O
S6	O
)	O
.	O

These	O
data	O
indicate	O
that	O
LPS	O
and	O
OPG	O
are	O
not	O
directly	O
necessary	O
for	O
swarming	O
,	O
and	O
that	O
the	O
behavior	O
exhibited	O
by	O
such	O
mutants	O
results	O
from	O
Rcs	O
-	O
mediated	O
repression	O
of	O
the	O
flhDC	O
operon	O
.	O
<EOS>	B-X
To	B-X
investigate	B-X
the	B-X
influence	B-X
of	B-X
Pg-LPS	B-X
stimulated	B-X
monocyte	B-X
(	B-X
RAW264.7	B-X
)	B-X
culture	B-X
supernatant	B-X
on	B-X
the	B-X
OPG/RANKL	B-X
expression	B-X
of	B-X
osteoblastic	B-X
cells	B-X
(	B-X
MC3T3-E1	B-X
)	B-X
.	B-X
The	B-X
aim	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
evaluate	B-X
the	B-X
effects	B-X
of	B-X
ZA	B-X
on	B-X
the	B-X
serum	B-X
levels	B-X
of	B-X
soluble	B-X
receptor	B-X
activator	B-X
of	B-X
NF-kB	B-X
ligand	B-X
(	B-X
sRANKL	B-X
)	B-X
and	B-X
osteoprotegerin	B-X
(	B-X
OPG	B-X
)	B-X
.	B-X
At	B-X
the	B-X
3-week	B-X
time	B-X
point	B-X
,	B-X
all	B-X
mice	B-X
were	B-X
subjected	B-X
to	B-X
oral	B-X
inflammatory	B-X
stimulation	B-X
with	B-X
bacterial	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
The	B-X
sera	B-X
of	B-X
these	B-X
mice	B-X
were	B-X
obtained	B-X
every	B-X
week	B-X
and	B-X
the	B-X
levels	B-X
of	B-X
sRANKL	B-X
and	B-X
OPG	B-X
were	B-X
measured	B-X
using	B-X
enzyme-linked	B-X
immunosorbent	B-X
assay	B-X
.	B-X
Our	B-X
data	B-X
indicated	B-X
that	B-X
ZA	B-X
administration	B-X
remarkably	B-X
reduced	B-X
bone	B-X
turnover	B-X
and	B-X
significantly	B-X
increased	B-X
the	B-X
basal	B-X
level	B-X
of	B-X
sRANKL	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
PSL+ZA	B-X
group	B-X
showed	B-X
a	B-X
dramatically	B-X
elevated	B-X
sRANKL	B-X
level	B-X
after	B-X
LPS	B-X
stimulation	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
that	B-X
,	B-X
particularly	B-X
with	B-X
combination	B-X
treatment	B-X
of	B-X
ZA	B-X
and	B-X
glucocorticoids	B-X
,	B-X
surviving	B-X
lymphocytes	B-X
might	B-X
be	B-X
the	B-X
source	B-X
of	B-X
inflammation-induced	B-X
sRANKL	B-X
.	B-X

A	O
model	O
summarizing	O
the	O
involvement	O
of	O
Rcs	O
signaling	O
on	O
swimming	O
,	O
swarming	O
,	O
and	O
chi	B-Organism
-	O
phage	O
infection	O
is	O
shown	O
in	O
Figure	O
3G	O
.	O

yhjH	O
Affects	O
Flagellar	O
Motor	O
Bias	O
<EOS>	B-X
yhjH	B-X
mutants	B-X
have	B-X
elevated	B-X
c-di-GMP	B-X
levels	B-X
and	B-X
require	B-X
YcgR	B-X
,	B-X
a	B-X
c-di-GMP-binding	B-X
protein	B-X
,	B-X
for	B-X
motility	B-X
inhibition	B-X
.	B-X

Mutations	O
in	O
yhjH	O
were	O
recently	O
found	O
to	O
impair	O
swimming	O
motility	O
[	O
42	O
]	O
.	O

Consistent	O
with	O
this	O
,	O
we	O
found	O
that	O
insertions	O
in	O
yhjH	O
exhibit	O
a	O
high	O
average	O
z	O
-	O
score	O
of	O
+	O
277	O
in	O
our	O
enrichment	O
for	O
nonmotile	O
mutants	O
.	O

Surprisingly	O
,	O
this	O
gene	O
showed	O
a	O
negative	O
z	O
-	O
score	O
of	O
-	O
8	O
after	O
bacteriophage	O
chi	O
selection	O
,	O
indicating	O
that	O
this	O
mutant	O
is	O
impaired	O
in	O
swimming	O
motility	O
but	O
may	O
show	O
increased	O
susceptibility	O
to	O
chi	B-Organism
-	O
phage	O
infection	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Based	O
on	O
these	O
observations	O
,	O
we	O
hypothesized	O
that	O
this	O
mutant	O
has	O
flagella	O
with	O
an	O
extreme	O
CCW	O
rotation	O
bias	O
,	O
a	O
phenotype	O
also	O
exhibited	O
,	O
to	O
varying	O
degrees	O
,	O
by	O
cheA	O
,	O
cheR	O
,	O
and	O
cheW	O
mutants	O
[	O
43	O
]	O
.	O

To	O
further	O
characterize	O
the	O
effect	O
of	O
this	O
mutation	O
on	O
motility	O
,	O
an	O
in	O
-	O
frame	O
deletion	O
of	O
yhjH	O
was	O
constructed	O
.	O

Electron	O
microscopy	O
of	O
DeltayhjH	O
mutants	O
showed	O
the	O
appearance	O
of	O
flagella	O
,	O
and	O
light	O
microscopy	O
showed	O
vigorous	O
cellular	O
movement	O
(	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
the	O
flagella	O
are	O
capable	O
of	O
rotating	O
;	O
still	O
,	O
this	O
mutant	O
exhibited	O
severe	O
impairment	O
in	O
swimming	O
(	O
Figure	O
1C	O
)	O
.	O

To	O
determine	O
whether	O
the	O
absence	O
of	O
yhjH	O
alters	O
the	O
direction	O
of	O
flagellar	O
rotation	O
,	O
several	O
functional	O
studies	O
were	O
performed	O
.	O

First	O
,	O
chi	B-Organism
-	O
phage	O
infectivity	O
assays	O
with	O
DeltayhjH	O
mutants	O
showed	O
comparable	O
levels	O
of	O
infection	O
to	O
cheR	O
mutants	O
(	O
which	O
exhibit	O
CCW	O
flagellar	O
rotation	O
bias	O
)	O
in	O
contrast	O
to	O
the	O
reduced	O
sensitivity	O
displayed	O
by	O
cheZ	O
mutants	O
(	O
which	O
have	O
CW	O
flagellar	O
rotation	O
bias	O
)	O
,	O
consistent	O
with	O
the	O
z	O
-	O
scores	O
of	O
our	O
chi	O
-	O
phage	O
selection	O
(	O
Figure	O
5E	O
)	O
.	O

Second	O
,	O
while	O
DeltayhjH	O
mutants	O
are	O
impaired	O
in	O
swimming	O
motility	O
,	O
they	O
did	O
not	O
show	O
a	O
measurable	O
defect	O
in	O
swarming	O
(	O
Figure	O
6A	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
our	O
finding	O
that	O
flagellar	O
motor	O
switching	O
is	O
not	O
critical	O
for	O
swarming	O
.	O

In	O
a	O
final	O
functional	O
test	O
,	O
individual	O
cells	O
of	O
four	O
different	O
strains	O
-	O
wild	O
-	O
type	O
cells	O
and	O
mutants	O
with	O
yhjH	O
,	O
cheR	O
,	O
and	O
cheZ	O
deletions	O
-	O
were	O
tethered	O
to	O
a	O
microscope	O
slide	O
and	O
the	O
frequency	O
of	O
flagellar	O
rotation	O
switching	O
was	O
measured	O
using	O
computer	O
tracking	O
software	O
in	O
a	O
fashion	O
similar	O
to	O
Block	O
et	O
al	O
.	O

[	O
44	O
]	O
.	O

These	O
measurements	O
revealed	O
that	O
indeed	O
the	O
flagella	O
of	O
DeltayhjH	O
mutants	O
,	O
while	O
not	O
strictly	O
locked	O
in	O
one	O
direction	O
of	O
rotation	O
,	O
exhibit	O
a	O
strong	O
CCW	O
bias	O
with	O
a	O
rotational	O
switching	O
frequency	O
intermediate	O
between	O
that	O
found	O
in	O
wild	O
-	O
type	O
cells	O
and	O
in	O
DeltacheR	O
mutants	O
(	O
Figure	O
6B	O
)	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
chi	B-Organism
-	O
phage	O
selection	O
results	O
.	O
<EOS>	B-X
J.	B-X
Solé-Violán	B-X
,	B-X
M.	B-X
López-Rodríguez	B-X
,	B-X
E.	B-X
Herrera-Ramos	B-X
,	B-X
J.	B-X
Ruíz-Hernández	B-X
,	B-X
L.	B-X
Borderías	B-X
,	B-X
J.	B-X
Horcajada	B-X
,	B-X
N.	B-X
González-Quevedo	B-X
,	B-X
O.	B-X
Rajas	B-X
,	B-X
M.	B-X
Briones	B-X
,	B-X
F.	B-X
Rodríguez	B-X
de	B-X
Castro	B-X
,	B-X
C.	B-X
Rodríguez	B-X
Gallego	B-X
P003	B-X
-	B-X
Brain	B-X
protective	B-X
effects	B-X
of	B-X
intravenous	B-X
immunoglobulin	B-X
through	B-X
inhibition	B-X
of	B-X
complement	B-X
activation	B-X
and	B-X
apoptosis	B-X
in	B-X
a	B-X
rat	B-X
model	B-X
of	B-X
sepsis	B-X
F.	B-X
Esen	B-X
,	B-X
G.	B-X
Orhun	B-X
,	B-X
P.	B-X
Ergin	B-X
Ozcan	B-X
,	B-X
E.	B-X
Senturk	B-X
,	B-X
C.	B-X
Ugur	B-X
Yilmaz	B-X
,	B-X
N.	B-X
Orhan	B-X
,	B-X
N.	B-X
Arican	B-X
,	B-X
M.	B-X
Kaya	B-X
,	B-X
M.	B-X
Kucukerden	B-X
,	B-X
M.	B-X
Giris	B-X
,	B-X
U.	B-X
Akcan	B-X
,	B-X
S.	B-X
Bilgic	B-X
Gazioglu	B-X
,	B-X
E.	B-X
Tuzun	B-X
P004	B-X
-	B-X
Adenosine	B-X
a1	B-X
receptor	B-X
dysfunction	B-X
is	B-X
associated	B-X
with	B-X
leukopenia	B-X
:	B-X
A	B-X
possible	B-X
mechanism	B-X
for	B-X
sepsis-induced	B-X
leukopenia	B-X
R.	B-X
Riff	B-X
,	B-X
O.	B-X
Naamani	B-X
,	B-X
A.	B-X
Douvdevani	B-X
P005	B-X
-	B-X
Analysis	B-X
of	B-X
neutrophil	B-X
by	B-X
hyper	B-X
spectral	B-X
imaging	B-X
-	B-X
A	B-X
preliminary	B-X
report	B-X
R.	B-X
Takegawa	B-X
,	B-X
H.	B-X
Yoshida	B-X
,	B-X
T.	B-X
Hirose	B-X
,	B-X
N.	B-X
Yamamoto	B-X
,	B-X
H.	B-X
Hagiya	B-X
,	B-X
M.	B-X
Ojima	B-X
,	B-X
Y.	B-X
Akeda	B-X
,	B-X
O.	B-X
Tasaki	B-X
,	B-X
K.	B-X
Tomono	B-X
,	B-X
T.	B-X
Shimazu	B-X
P006	B-X
-	B-X
Chemiluminescent	B-X
intensity	B-X
assessed	B-X
by	B-X
eaa	B-X
predicts	B-X
the	B-X
incidence	B-X
of	B-X
postoperative	B-X
infectious	B-X
complications	B-X
following	B-X
gastrointestinal	B-X
surgery	B-X
S.	B-X
Ono	B-X
,	B-X
T.	B-X
Kubo	B-X
,	B-X
S.	B-X
Suda	B-X
,	B-X
T.	B-X
Ueno	B-X
,	B-X
T.	B-X
Ikeda	B-X
P007	B-X
-	B-X
Serial	B-X
change	B-X
of	B-X
c1	B-X
inhibitor	B-X
in	B-X
patients	B-X
with	B-X
sepsis	B-X
–	B-X
A	B-X
prospective	B-X
observational	B-X
study	B-X
T.	B-X
Hirose	B-X
,	B-X
H.	B-X
Ogura	B-X
,	B-X
H.	B-X
Takahashi	B-X
,	B-X
M.	B-X
Ojima	B-X
,	B-X
J.	B-X
Kang	B-X
,	B-X
Y.	B-X
Nakamura	B-X
,	B-X
T.	B-X
Kojima	B-X
,	B-X
T.	B-X
Shimazu	B-X
P008	B-X
-	B-X
Comparison	B-X
of	B-X
bacteremia	B-X
and	B-X
sepsis	B-X
on	B-X
sepsis	B-X
related	B-X
biomarkers	B-X
T.	B-X
Ikeda	B-X
,	B-X
S.	B-X
Suda	B-X
,	B-X
Y.	B-X
Izutani	B-X
,	B-X
T.	B-X
Ueno	B-X
,	B-X
S.	B-X
Ono	B-X
P009	B-X
-	B-X
The	B-X
changes	B-X
of	B-X
procalcitonin	B-X
levels	B-X
in	B-X
critical	B-X
patients	B-X
with	B-X
abdominal	B-X
septic	B-X
shock	B-X
during	B-X
blood	B-X
purification	B-X
T.	B-X
Taniguchi	B-X
,	B-X
M.	B-X
O	B-X
P010	B-X
-	B-X
Validation	B-X
of	B-X
a	B-X
new	B-X
sensitive	B-X
point	B-X
of	B-X
care	B-X
device	B-X
for	B-X
rapid	B-X
measurement	B-X
of	B-X
procalcitonin	B-X
C.	B-X
Dinter	B-X
,	B-X
J.	B-X
Lotz	B-X
,	B-X
B.	B-X
Eilers	B-X
,	B-X
C.	B-X
Wissmann	B-X
,	B-X
R.	B-X
Lott	B-X
P011	B-X
-	B-X
Infection	B-X
biomarkers	B-X
in	B-X
primary	B-X
care	B-X
patients	B-X
with	B-X
acute	B-X
respiratory	B-X
tract	B-X
infections	B-X
–	B-X
Comparison	B-X
of	B-X
procalcitonin	B-X
and	B-X
C-reactive	B-X
protein	B-X
M.	B-X
M.	B-X
Meili	B-X
,	B-X
P.	B-X
S.	B-X
Schuetz	B-X
P012	B-X
-	B-X
Do	B-X
we	B-X
need	B-X
a	B-X
lower	B-X
procalcitonin	B-X
cut	B-X
off	B-X
?	B-X
C.	B-X
Mcgrath	B-X
,	B-X
E.	B-X
Nsutebu	B-X
P038	B-X
-	B-X
Prehospital	B-X
transport	B-X
of	B-X
acute	B-X
septic	B-X
patients	B-X
P.	B-X
Bank	B-X
Pedersen	B-X
,	B-X
D.	B-X
Pilsgaard	B-X
Henriksen	B-X
,	B-X
S.	B-X
Mikkelsen	B-X
,	B-X
A.	B-X
Touborg	B-X
Lassen	B-X
P039	B-X
-	B-X
Vasodilatory	B-X
plant	B-X
extracts	B-X
gel	B-X
as	B-X
an	B-X
alternative	B-X
treatment	B-X
for	B-X
fever	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
R.	B-X
Tincu	B-X
,	B-X
C.	B-X
Cobilinschi	B-X
,	B-X
D.	B-X
Tomescu	B-X
,	B-X
Z.	B-X
Ghiorghiu	B-X
,	B-X
R.	B-X
Macovei	B-X
P040	B-X
-	B-X
Host	B-X
response	B-X
and	B-X
outcome	B-X
of	B-X
hypothermic	B-X
sepsis	B-X
M.	B-X
A.	B-X
Wiewel	B-X
,	B-X
M.	B-X
B.	B-X
Harmon	B-X
,	B-X
L.	B-X
A	B-X
.	B-X
Van	B-X
Vught	B-X
,	B-X
B.	B-X
P.	B-X
Scicluna	B-X
,	B-X
A.	B-X
J.	B-X
Hoogendijk	B-X
,	B-X
J.	B-X
Horn	B-X
,	B-X
A.	B-X
H.	B-X
Zwinderman	B-X
,	B-X
O.	B-X
L.	B-X
Cremer	B-X
,	B-X
M.	B-X
J.	B-X
Bonten	B-X
,	B-X
M.	B-X
J.	B-X
Schultz	B-X
,	B-X
T.	B-X
Van	B-X
der	B-X
Poll	B-X
,	B-X
N.	B-X
P.	B-X
Juffermans	B-X
,	B-X
W.	B-X
J.	B-X
Wiersinga	B-X
P041	B-X
-	B-X
Septic	B-X
shock	B-X
alert	B-X
over	B-X
SIRS	B-X
criteria	B-X
has	B-X
an	B-X
impact	B-X
on	B-X
outcome	B-X
but	B-X
needs	B-X
to	B-X
be	B-X
revised	B-X
G.	B-X
Eren	B-X
,	B-X
Y	B-X
Tekdos	B-X
,	B-X
M.	B-X
Dogan	B-X
,	B-X
O.	B-X
Acicbe	B-X
,	B-X
E.	B-X
Kaya	B-X
,	B-X
O.	B-X
Hergunsel	B-X
P042	B-X
-	B-X
Association	B-X
between	B-X
previous	B-X
prescription	B-X
of	B-X
βblockers	B-X
and	B-X
mortality	B-X
rate	B-X
among	B-X
septic	B-X
patients	B-X
:	B-X
A	B-X
retrospective	B-X
observational	B-X
study	B-X
S.	B-X
Alsolamy	B-X
,	B-X
G.	B-X
Ghamdi	B-X
,	B-X
L.	B-X
Alswaidan	B-X
,	B-X
S.	B-X
Alharbi	B-X
,	B-X
F.	B-X
Alenezi	B-X
,	B-X
Y.	B-X
Arabi	B-X
P043	B-X
-	B-X
Recognition	B-X
and	B-X
treatment	B-X
of	B-X
sepsis	B-X
on	B-X
labour	B-X
ward–	B-X
teaching	B-X
&	B-X
information	B-X
resources	B-X
can	B-X
improve	B-X
knowledge	B-X
J.	B-X
Heaton	B-X
,	B-X
A.	B-X
Boyce	B-X
,	B-X
L.	B-X
Nolan	B-X
,	B-X
J.	B-X
Johnston	B-X
,	B-X
A.	B-X
Dukoff-Gordon	B-X
,	B-X
A	B-X
.	B-X
A	B-X
retrospective	B-X
series	B-X
of	B-X
39	B-X
patients	B-X
L.	B-X
Caneva	B-X
,	B-X
A.	B-X
Casazza	B-X
,	B-X
E.	B-X
Bellazzi	B-X
,	B-X
S.	B-X
Marra	B-X
,	B-X
L.	B-X
Pagani	B-X
,	B-X
M.	B-X
Vetere	B-X
,	B-X
R.	B-X
Vanzino	B-X
,	B-X
D.	B-X
Ciprandi	B-X
,	B-X
R.	B-X
Preda	B-X
,	B-X
R.	B-X
Boschi	B-X
,	B-X
L.	B-X
Carnevale	B-X
P050	B-X
-	B-X
Methylene	B-X
blue	B-X
effectiveness	B-X
as	B-X
contributory	B-X
treatment	B-X
in	B-X
patients	B-X
with	B-X
septic	B-X
shock	B-X
V.	B-X
Lopez	B-X
,	B-X
M.	B-X
Aguilar	B-X
Arzapalo	B-X
,	B-X
L.	B-X
Barradas	B-X
,	B-X
A.	B-X
Escalante	B-X
,	B-X
J.	B-X
Gongora	B-X
,	B-X
M.	B-X
Cetina	B-X
P051	B-X
-	B-X
Coagulation	B-X
disorders	B-X
in	B-X
patients	B-X
with	B-X
severe	B-X
sepsis	B-X
and	B-X
DIC	B-X
evaluated	B-X
with	B-X
thromboelastometry	B-X
.	B-X
A	B-X
case-control	B-X
pilot	B-X
study	B-X
E.	B-X
Scarlatescu	B-X
,	B-X
D.	B-X
Tomescu	B-X
,	B-X
G.	B-X
Droc	B-X
,	B-X
S.	B-X
Arama	B-X
P054	B-X
-	B-X
Thromboelastometry	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
with	B-X
disseminated	B-X
intravascular	B-X
coagulation	B-X
M.	B-X
Müller	B-X
,	B-X
M.	B-X
Straat	B-X
,	B-X
S.	B-X
S.	B-X
Zeerleder	B-X
,	B-X
N.	B-X
P.	B-X
Juffermans	B-X
P055	B-X
-	B-X
Cessation	B-X
of	B-X
a	B-X
preexisting	B-X
chronic	B-X
antiplatelet	B-X
therapy	B-X
is	B-X
associated	B-X
with	B-X
increased	B-X
mortality	B-X
rates	B-X
in	B-X
severe	B-X
sepsis	B-X
and	B-X
septic	B-X
shock	B-X
C.	B-X
F.	B-X
Fuchs	B-X
,	B-X
C.	B-X
S.	B-X
Scheer	B-X
,	B-X
S.	B-X
W.	B-X
Wauschkuhn	B-X
,	B-X
M.	B-X
V.	B-X
Vollmer	B-X
,	B-X
K.	B-X
M.	B-X
Meissner	B-X
,	B-X
S.	B-X
K.	B-X
Kuhn	B-X
,	B-X
K.	B-X
H.	B-X
Hahnenkamp	B-X
,	B-X
S.	B-X
R.	B-X
Rehberg	B-X
,	B-X
M.	B-X
G.	B-X
Gründling	B-X
P056	B-X
-	B-X
Neutrophil	B-X
Extracellular	B-X
Traps	B-X
(	B-X
NETs	B-X
)	B-X
production	B-X
under	B-X
hypoxic	B-X
condition	B-X
N.	B-X
Yamamoto	B-X
,	B-X
M.	B-X
Ojima	B-X
,	B-X
S.	B-X
Hamaguchi	B-X
,	B-X
T.	B-X
Hirose	B-X
,	B-X
Y.	B-X
Akeda	B-X
,	B-X
R.	B-X
Takegawa	B-X
,	B-X
O.	B-X
Tasaki	B-X
,	B-X
T.	B-X
Shimazu	B-X
,	B-X
K.	B-X
Tomono	B-X
P057	B-X
-	B-X
Impact	B-X
of	B-X
ultraviolet	B-X
air	B-X
sterilizer	B-X
in	B-X
intensive	B-X
care	B-X
unit	B-X
room	B-X
,	B-X
and	B-X
clinical	B-X
outcomes	B-X
of	B-X
patients	B-X
E.	B-X
Gómez-Sánchez	B-X
,	B-X
M.	B-X
Heredia-Rodríguez	B-X
,	B-X
E.	B-X
Álvarez-Fuente	B-X
,	B-X
M.	B-X
Lorenzo-López	B-X
,	B-X
E.	B-X
Gómez-Pesquera	B-X
,	B-X
M.	B-X
Aragón-Camino	B-X
,	B-X
P.	B-X
Liu-Zhu	B-X
,	B-X
A.	B-X
Sánchez-López	B-X
,	B-X
A.	B-X
Hernández-Lozano	B-X
,	B-X
M.	B-X
T.	B-X
Peláez-Jareño	B-X
,	B-X
E.	B-X
Tamayo	B-X
P058	B-X
-	B-X
Focus	B-X
of	B-X
infection	B-X
in	B-X
severe	B-X
sepsis	B-X
-	B-X
comparison	B-X
of	B-X
administrative	B-X
data	B-X
and	B-X
prospective	B-X
cohorts	B-X
from	B-X
Germany	B-X
D.	B-X
O.	B-X
Thomas-Rüddel	B-X
,	B-X
C.	B-X
Fleischmann	B-X
,	B-X
C.	B-X
Haas	B-X
,	B-X
U.	B-X
Dennler	B-X
,	B-X
K.	B-X
Reinhart	B-X
P059	B-X
-	B-X
“	B-X
Zero	B-X
CLABSI	B-X
”	B-X
–	B-X
can	B-X
we	B-X
get	B-X
there	B-X
?	B-X
Obstacles	B-X
on	B-X
the	B-X
4	B-X
year	B-X
journey	B-X
and	B-X
our	B-X
strategies	B-X
to	B-X
overcome	B-X
them	B-X
–	B-X
experience	B-X
from	B-X
an	B-X
Indian	B-X
ICU	B-X
R.	B-X
Rao	B-X
,	B-X
A.	B-X
Kar	B-X
,	B-X
A.	B-X
Chakraborty	B-X
P062	B-X
-	B-X
Prevention	B-X
of	B-X
central	B-X
line-associated	B-X
bloodstream	B-X
infections	B-X
in	B-X
intensive	B-X
care	B-X
units	B-X
:	B-X
An	B-X
international	B-X
online	B-X
survey	B-X
C.	B-X
Valencia	B-X
,	B-X
N.	B-X
Hammami	B-X
,	B-X
S.	B-X
Blot	B-X
,	B-X
J.	B-X
L.	B-X
Vincent	B-X
,	B-X
M.	B-X
L.	B-X
Lambert	B-X
P063	B-X
-	B-X
30	B-X
days	B-X
antimicrobial	B-X
efficacy	B-X
of	B-X
non-leaching	B-X
central	B-X
venous	B-X
catheters	B-X
J.	B-X
Brunke	B-X
,	B-X
T.	B-X
Riemann	B-X
,	B-X
I.	B-X
Roschke	B-X
P064	B-X
-	B-X
Efficacy	B-X
of	B-X
noble	B-X
metal	B-X
alloy-coated	B-X
catheter	B-X
in	B-X
prevention	B-X
of	B-X
bacteriuria	B-X
R.	B-X
Tincu	B-X
,	B-X
C.	B-X
Cobilinschi	B-X
,	B-X
D.	B-X
Tomescu	B-X
,	B-X
Z.	B-X
Ghiorghiu	B-X
,	B-X
R.	B-X
Macovei	B-X
P065	B-X
-	B-X
Predicting	B-X
bacteremic	B-X
urinary	B-X
tract	B-X
infection	B-X
in	B-X
community	B-X
setting	B-X
:	B-X
A	B-X
prospective	B-X
observational	B-X
study	B-X
S.	B-X
Nimitvilai	B-X
,	B-X
K.	B-X
Jintanapramote	B-X
,	B-X
S.	B-X
Jarupongprapa	B-X
P066	B-X
-	B-X
Eight-year	B-X
analysis	B-X
of	B-X
acinetobacter	B-X
spp	B-X
.	B-X
A.	B-X
R.	B-X
Robles	B-X
Caballero	B-X
,	B-X
B.	B-X
Civantos	B-X
,	B-X
J.	B-X
C.	B-X
Figueira	B-X
,	B-X
J.	B-X
López	B-X
P080	B-X
-	B-X
Mediterranean	B-X
spotted	B-X
fever	B-X
in	B-X
an	B-X
infectious	B-X
diseases	B-X
intensive	B-X
care	B-X
unit	B-X
A.	B-X
Silva-Pinto	B-X
,	B-X
F.	B-X
Ceia	B-X
,	B-X
A.	B-X
Sarmento	B-X
,	B-X
L.	B-X
Santos	B-X
P081	B-X
-	B-X
Clinical	B-X
features	B-X
and	B-X
outcomes	B-X
of	B-X
patients	B-X
with	B-X
Middle	B-X
East	B-X
respiratory	B-X
syndrome	B-X
requiring	B-X
admission	B-X
to	B-X
a	B-X
saudi	B-X
intensive	B-X
care	B-X
unit	B-X
:	B-X
A	B-X
retrospective	B-X
analysis	B-X
of	B-X
31	B-X
cases	B-X
G.	B-X
Almekhlafi	B-X
,	B-X
Y.	B-X
Sakr	B-X
P082	B-X
-	B-X
The	B-X
ICU	B-X
response	B-X
to	B-X
a	B-X
hospital	B-X
outbreak	B-X
of	B-X
Middle	B-X
East	B-X
respiratory	B-X
syndrome	B-X
coronavirus	B-X
infection	B-X
H.	B-X
Al-Dorzi	B-X
,	B-X
R.	B-X
Khan	B-X
,	B-X
S.	B-X
Baharoon	B-X
,	B-X
A.	B-X
Aldawood	B-X
,	B-X
A.	B-X
Matroud	B-X
,	B-X
J.	B-X
Alchin	B-X
,	B-X
S.	B-X
Al	B-X
Johani	B-X
,	B-X
H.	B-X
Balkhy	B-X
,	B-X
Y.	B-X
Arabi	B-X
P083	B-X
-	B-X
Middle	B-X
East	B-X
respiratory	B-X
syndrome	B-X
:	B-X
Surveillance	B-X
data	B-X
analysis	B-X
S.	B-X
Alsolamy	B-X
,	B-X
S.	B-X
Y.	B-X
Yousif	B-X
,	B-X
B.	B-X
O.	B-X
Alotabi	B-X
,	B-X
A.	B-X
S.	B-X
Alsaawi	B-X
P085	B-X
-	B-X
Use	B-X
of	B-X
Taqman	B-X
array	B-X
card	B-X
molecular	B-X
diagnostics	B-X
in	B-X
severe	B-X
pneumonia	B-X
:	B-X
A	B-X
case	B-X
series	B-X
J.	B-X
Ang	B-X
,	B-X
MD	B-X
Curran	B-X
,	B-X
D.	B-X
Enoch	B-X
,	B-X
V.	B-X
Navapurkar	B-X
,	B-X
A.	B-X
Conway	B-X
Morris	B-X
P086	B-X
-	B-X
‘	B-X
BUNS	B-X
’	B-X
:	B-X
An	B-X
investigation	B-X
protocol	B-X
improves	B-X
the	B-X
ICU	B-X
management	B-X
of	B-X
pneumonia	B-X
R.	B-X
Sharvill	B-X
,	B-X
J.	B-X
Astin	B-X
P087	B-X
-	B-X
Pneumonia	B-X
in	B-X
patients	B-X
following	B-X
secondary	B-X
peritonitis	B-X
:	B-X
epidemiological	B-X
features	B-X
and	B-X
impact	B-X
on	B-X
mortality	B-X
M.	B-X
Heredia-Rodríguez	B-X
,	B-X
E.	B-X
Gómez-Sánchez	B-X
,	B-X
M.	B-X
T.	B-X
Peláez-Jareño	B-X
,	B-X
E.	B-X
Gómez-Pesquera	B-X
,	B-X
M.	B-X
Lorenzo-López	B-X
,	B-X
P.	B-X
Liu-Zhu	B-X
,	B-X
M.	B-X
Aragón-Camino	B-X
,	B-X
A.	B-X
Hernández-Lozano	B-X
,	B-X
A.	B-X
Sánchez-López	B-X
,	B-X
E.	B-X
Álvarez-Fuente	B-X
,	B-X
E.	B-X
Tamayo	B-X
P088	B-X
-	B-X
The	B-X
use	B-X
of	B-X
the	B-X
“	B-X
CURB-65	B-X
score	B-X
”	B-X
by	B-X
emergency	B-X
room	B-X
clinicians	B-X
in	B-X
a	B-X
large	B-X
teaching	B-X
hospital	B-X
J.	B-X
Patel	B-X
,	B-X
C.	B-X
Kruger	B-X
P089	B-X
-	B-X
Incidence	B-X
of	B-X
community	B-X
acquired	B-X
pneumonia	B-X
with	B-X
viral	B-X
infection	B-X
in	B-X
mechanically	B-X
ventilated	B-X
patients	B-X
in	B-X
the	B-X
medical	B-X
intensive	B-X
care	B-X
unit	B-X
J.	B-X
O	B-X
’	B-X
Neal	B-X
,	B-X
H.	B-X
Rhodes	B-X
,	B-X
J.	B-X
Jancik	B-X
P090	B-X
-	B-X
The	B-X
SAATELLITE	B-X
Study	B-X
:	B-X
Prevention	B-X
of	B-X
S	B-X
aureus	B-X
Nosocomial	B-X
Pneumonia	B-X
(	B-X
NP	B-X
)	B-X
with	B-X
MEDI4893	B-X
,	B-X
a	B-X
Human	B-X
Monoclonal	B-X
Antibody	B-X
(	B-X
mAb	B-X
)	B-X
Against	B-X
S	B-X
aureus	B-X
B.	B-X
François	B-X
,	B-X
P.	B-X
F.	B-X
Laterre	B-X
,	B-X
P.	B-X
Eggimann	B-X
,	B-X
A.	B-X
Torres	B-X
,	B-X
M.	B-X
Sánchez	B-X
,	B-X
P.	B-X
F.	B-X
Dequin	B-X
,	B-X
G.	B-X
L.	B-X
Bassi	B-X
,	B-X
J.	B-X
Chastre	B-X
,	B-X
H.	B-X
S.	B-X
Jafri	B-X
P091	B-X
-	B-X
Risk	B-X
factors	B-X
and	B-X
microbiological	B-X
profile	B-X
for	B-X
nosocomial	B-X
infections	B-X
in	B-X
trauma	B-X
patients	B-X
M.	B-X
Ben	B-X
Romdhane	B-X
,	B-X
Z.	B-X
Douira	B-X
,	B-X
S.	B-X
Kamoun	B-X
,	B-X
M.	B-X
Bousselmi	B-X
,	B-X
A.	B-X
Ben	B-X
Souissi	B-X
,	B-X
Y.	B-X
Boussarsar	B-X
,	B-X
A.	B-X
Riahi	B-X
,	B-X
M.S	B-X
.	B-X
A.	B-X
Vakalos	B-X
,	B-X
V.	B-X
Avramidis	B-X
P093	B-X
-	B-X
A	B-X
comparison	B-X
of	B-X
two	B-X
ventilator	B-X
associated	B-X
pneumonia	B-X
surveillance	B-X
techniques	B-X
T.	B-X
H.	B-X
Craven	B-X
,	B-X
G.	B-X
Wojcik	B-X
,	B-X
K.	B-X
Kefala	B-X
,	B-X
J.	B-X
McCoubrey	B-X
,	B-X
J.	B-X
Reilly	B-X
,	B-X
R.	B-X
Paterson	B-X
,	B-X
D.	B-X
Inverarity	B-X
,	B-X
I.	B-X
Laurenson	B-X
,	B-X
T.	B-X
S.	B-X
Walsh	B-X
P094	B-X
-	B-X
Lung	B-X
ultrasound	B-X
before	B-X
and	B-X
after	B-X
fiberbronchoscopy	B-X
-	B-X
modifications	B-X
may	B-X
improve	B-X
ventilator-associated	B-X
pneumonia	B-X
diagnosis	B-X
S.	B-X
Mongodi	B-X
,	B-X
B.	B-X
Bouhemad	B-X
,	B-X
A.	B-X
Orlando	B-X
,	B-X
A.	B-X
Stella	B-X
,	B-X
G.	B-X
Via	B-X
,	B-X
G.	B-X
Iotti	B-X
,	B-X
A.	B-X
Braschi	B-X
,	B-X
F.	B-X
Mojoli	B-X
P095	B-X
-	B-X
Comparing	B-X
the	B-X
accuracy	B-X
of	B-X
predictors	B-X
of	B-X
mortality	B-X
in	B-X
ventilator-associated	B-X
pneumonia	B-X
M.	B-X
Haliloglu	B-X
,	B-X
B.	B-X
Bilgili	B-X
,	B-X
U.	B-X
Kasapoglu	B-X
,	B-X
I.	B-X
Sayan	B-X
,	B-X
M.	B-X
Süzer	B-X
Aslan	B-X
,	B-X
A.	B-X
Yalcın	B-X
,	B-X
I.	B-X
Cinel	B-X
P096	B-X
-	B-X
Impact	B-X
of	B-X
pRBCs	B-X
transfusion	B-X
on	B-X
percentage	B-X
of	B-X
ventilated	B-X
patients	B-X
developed	B-X
VAP	B-X
in	B-X
ICU	B-X
patients	B-X
A.	B-X
Vakalos	B-X
,	B-X
V.	B-X
Avramidis	B-X
P097	B-X
-	B-X
The	B-X
impact	B-X
of	B-X
a	B-X
series	B-X
of	B-X
interventions	B-X
on	B-X
the	B-X
rate	B-X
of	B-X
ventilator	B-X
associated	B-X
pneumonia	B-X
in	B-X
a	B-X
large	B-X
teaching	B-X
hospital	B-X
H.	B-X
E.	B-X
Ellis	B-X
,	B-X
K.	B-X
Bauchmuller	B-X
,	B-X
D.	B-X
Miller	B-X
,	B-X
A	B-X
Temple	B-X
P098	B-X
-	B-X
The	B-X
EVADE	B-X
study	B-X
:	B-X
Prevention	B-X
of	B-X
Nosocomial	B-X
Pneumonia	B-X
(	B-X
NP	B-X
)	B-X
caused	B-X
by	B-X
P	B-X
aeruginosa	B-X
with	B-X
MEDI3902	B-X
,	B-X
a	B-X
Novel	B-X
Bispecific	B-X
Monoclonal	B-X
Antibody	B-X
,	B-X
against	B-X
P	B-X
aeruginosa	B-X
virulence	B-X
factors	B-X
J.	B-X
Chastre	B-X
,	B-X
B.	B-X
François	B-X
,	B-X
A.	B-X
Torres	B-X
,	B-X
C.	B-X
E.	B-X
Luyt	B-X
,	B-X
M.	B-X
Sánchez	B-X
,	B-X
M.	B-X
Singer	B-X
,	B-X
H.	B-X
S.	B-X
Jafri	B-X
P099	B-X
-	B-X
Short-term	B-X
inhaled	B-X
colistin	B-X
adjunctive	B-X
therapy	B-X
for	B-X
ventilator-associated	B-X
pneumonia	B-X
Y.	B-X
Nassar	B-X
,	B-X
M.	B-X
S.	B-X
Ayad	B-X
P100	B-X
-	B-X
Effect	B-X
of	B-X
aerosolised	B-X
colistin	B-X
on	B-X
weaning	B-X
from	B-X
mechanical	B-X
ventilation	B-X
A.	B-X
Trifi	B-X
,	B-X
S.	B-X
Abdellatif	B-X
,	B-X
F.	B-X
Daly	B-X
,	B-X
R.	B-X
Nasri	B-X
,	B-X
S.	B-X
Ben	B-X
Lakhal	B-X
P101	B-X
-	B-X
Septic	B-X
shock	B-X
is	B-X
an	B-X
independent	B-X
risk	B-X
factor	B-X
for	B-X
colistin-induced	B-X
severe	B-X
acute	B-X
kidney	B-X
injury	B-X
:	B-X
a	B-X
retrospective	B-X
cohort	B-X
study	B-X
B.	B-X
Bilgili	B-X
,	B-X
M.	B-X
Haliloglu	B-X
,	B-X
F.	B-X
Gul	B-X
,	B-X
I.	B-X
Cinel	B-X
P102	B-X
-	B-X
Nosocomial	B-X
pneumonia	B-X
-	B-X
emphasis	B-X
on	B-X
inhaled	B-X
tobramycin	B-X
A.	B-X
Kuzovlev	B-X
,	B-X
A.	B-X
Shabanov	B-X
,	B-X
S.	B-X
Polovnikov	B-X
,	B-X
V.	B-X
Moroz	B-X
P103	B-X
-	B-X
In	B-X
vitro	B-X
evaluation	B-X
of	B-X
amikacin	B-X
inhale	B-X
and	B-X
commercial	B-X
nebulizers	B-X
in	B-X
a	B-X
mechanical	B-X
ventilator	B-X
N.	B-X
Kadrichu	B-X
,	B-X
T.	B-X
Dang	B-X
,	B-X
K.	B-X
Corkery	B-X
,	B-X
P.	B-X
Challoner	B-X
P104	B-X
-	B-X
The	B-X
effects	B-X
of	B-X
nebulized	B-X
amikacin/fosfomycin	B-X
and	B-X
systemic	B-X
meropenem	B-X
on	B-X
severe	B-X
amikacin-resistant	B-X
meropenem-susceptible	B-X
P.aeruginosa	B-X
pneumonia	B-X
G.	B-X
Li	B-X
Bassi	B-X
,	B-X
E.	B-X
Aguilera	B-X
,	B-X
C.	B-X
Chiurazzi	B-X
,	B-X
C.	B-X
Travierso	B-X
,	B-X
A.	B-X
Motos	B-X
,	B-X
L.	B-X
Fernandez	B-X
,	B-X
R.	B-X
Amaro	B-X
,	B-X
T.	B-X
Senussi	B-X
,	B-X
F.	B-X
Idone	B-X
,	B-X
J.	B-X
Bobi	B-X
,	B-X
M.	B-X
Rigol	B-X
,	B-X
A.	B-X
Torres	B-X
P105	B-X
-	B-X
Optimization	B-X
of	B-X
gentamicin	B-X
peak	B-X
concentrations	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
C.	B-X
J.	B-X
Hodiamont	B-X
,	B-X
N.	B-X
P.	B-X
Juffermans	B-X
,	B-X
J.	B-X
M.	B-X
Janssen	B-X
,	B-X
C.	B-X
S.	B-X
Bouman	B-X
,	B-X
R.	B-X
A.	B-X
Mathôt	B-X
,	B-X
M.	B-X
D.	B-X
De	B-X
Jong	B-X
,	B-X
R.	B-X
M.	B-X
Van	B-X
Hest	B-X
P106	B-X
-	B-X
Systematic	B-X
review	B-X
of	B-X
cefepime	B-X
induced	B-X
neurotoxicity	B-X
L.	B-X
Payne	B-X
,	B-X
G.	B-X
L.	B-X
Fraser	B-X
P107	B-X
-	B-X
Unasyn®	B-X
causes	B-X
QT	B-X
prolongation	B-X
during	B-X
treatment	B-X
of	B-X
intensive	B-X
care	B-X
patients	B-X
B.	B-X
Tudor	B-X
,	B-X
M.	B-X
Lahner	B-X
,	B-X
G.	B-X
Roth	B-X
,	B-X
C.	B-X
Krenn	B-X
P108	B-X
-	B-X
Comparative	B-X
study	B-X
between	B-X
teicoplanin	B-X
and	B-X
vancomycin	B-X
in	B-X
methicillin-resistant	B-X
staphylococcus	B-X
aureus	B-X
(	B-X
mrsa	B-X
)	B-X
infectious	B-X
of	B-X
toxicological	B-X
intensive	B-X
care	B-X
unit	B-X
(	B-X
ticu	B-X
)	B-X
patients	B-X
–	B-X
Tehran	B-X
,	B-X
Iran	B-X
H.	B-X
Talaie	B-X
P109	B-X
-	B-X
Phage	B-X
therapy	B-X
against	B-X
antimicrobial	B-X
resistance	B-X
,	B-X
design	B-X
of	B-X
the	B-X
first	B-X
clinical	B-X
study	B-X
phagoburn	B-X
P.	B-X
Jault	B-X
,	B-X
J.	B-X
Gabard	B-X
,	B-X
T.	B-X
Leclerc	B-X
,	B-X
S.	B-X
Jennes	B-X
,	B-X
Y.	B-X
Que	B-X
,	B-X
A.	B-X
Rousseau	B-X
,	B-X
F.	B-X
Ravat	B-X
P110	B-X
-	B-X
Antibiotic	B-X
dosing	B-X
errors	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
with	B-X
severe	B-X
sepsis	B-X
or	B-X
septic	B-X
shock	B-X
H.	B-X
Al-Dorzi	B-X
,	B-X
A.	B-X
Eissa	B-X
,	B-X
S.	B-X
Al-Harbi	B-X
,	B-X
T.	B-X
Aldabbagh	B-X
,	B-X
R.	B-X
Khan	B-X
,	B-X
Y.	B-X
Arabi	B-X
P111	B-X
-	B-X
Does	B-X
empiric	B-X
antifungal	B-X
therapy	B-X
improve	B-X
survival	B-X
in	B-X
septic	B-X
critically	B-X
ill	B-X
patients	B-X
?	B-X
A.	B-X
Murdoch	B-X
,	B-X
S.	B-X
M.	B-X
Tibby	B-X
P130	B-X
-	B-X
Nadir	B-X
hemoglobulin	B-X
during	B-X
cardiopulmonary	B-X
bypass	B-X
:	B-X
impact	B-X
on	B-X
postoperative	B-X
morbidity	B-X
and	B-X
mortality	B-X
F.	B-X
Ampatzidou	B-X
,	B-X
D.	B-X
Moisidou	B-X
,	B-X
E.	B-X
Dalampini	B-X
,	B-X
M.	B-X
Nastou	B-X
,	B-X
E.	B-X
Vasilarou	B-X
,	B-X
V.	B-X
Kalaizi	B-X
,	B-X
H.	B-X
Chatzikostenoglou	B-X
,	B-X
G.	B-X
Drossos	B-X
P131	B-X
-	B-X
Red	B-X
blood	B-X
cell	B-X
transfusion	B-X
do	B-X
not	B-X
influence	B-X
the	B-X
prognostic	B-X
value	B-X
of	B-X
RDW	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
S.	B-X
Spadaro	B-X
,	B-X
A.	B-X
Fogagnolo	B-X
,	B-X
T.	B-X
Fiore	B-X
,	B-X
A.	B-X
Schiavi	B-X
,	B-X
V.	B-X
Fontana	B-X
,	B-X
F.	B-X
Taccone	B-X
,	B-X
C.	B-X
Volta	B-X
P132	B-X
-	B-X
Reasons	B-X
for	B-X
admission	B-X
in	B-X
the	B-X
paediatric	B-X
intensive	B-X
care	B-X
unit	B-X
and	B-X
the	B-X
need	B-X
for	B-X
blood	B-X
and	B-X
blood	B-X
products	B-X
transfusions	B-X
E.	B-X
Chochliourou	B-X
,	B-X
E.	B-X
Volakli	B-X
,	B-X
A.	B-X
Violaki	B-X
,	B-X
E.	B-X
Samkinidou	B-X
,	B-X
G.	B-X
Evlavis	B-X
,	B-X
V.	B-X
Panagiotidou	B-X
,	B-X
M.	B-X
Sdougka	B-X
P133	B-X
-	B-X
The	B-X
implementation	B-X
of	B-X
a	B-X
massive	B-X
haemorrhage	B-X
protocol	B-X
(	B-X
mhp	B-X
)	B-X
for	B-X
the	B-X
management	B-X
of	B-X
major	B-X
trauma	B-X
:	B-X
a	B-X
ten	B-X
year	B-X
,	B-X
single-centre	B-X
study	B-X
R.	B-X
Mothukuri	B-X
,	B-X
C.	B-X
Battle	B-X
,	B-X
K.	B-X
Guy	B-X
,	B-X
G.	B-X
Mills	B-X
,	B-X
P.	B-X
Evans	B-X
P134	B-X
-	B-X
An	B-X
integrated	B-X
major	B-X
haemorrhage	B-X
protocol	B-X
for	B-X
pre-hospital	B-X
and	B-X
retrieval	B-X
medical	B-X
teams	B-X
J.	B-X
Wijesuriya	B-X
,	B-X
S.	B-X
Keogh	B-X
P135	B-X
-	B-X
The	B-X
impact	B-X
of	B-X
transfusion	B-X
thresholds	B-X
on	B-X
mortality	B-X
and	B-X
cardiovascular	B-X
events	B-X
in	B-X
patients	B-X
with	B-X
cardiovascular	B-X
disease	B-X
(	B-X
non-cardiac	B-X
surgery	B-X
)	B-X
:	B-X
a	B-X
systematic	B-X
review	B-X
and	B-X
meta-analysis	B-X
A.	B-X
Docherty	B-X
,	B-X
R.	B-X
O	B-X
’	B-X
Donnell	B-X
,	B-X
S.	B-X
Brunskill	B-X
,	B-X
M.	B-X
Trivella	B-X
,	B-X
C.	B-X
Doree	B-X
,	B-X
L.	B-X
Holst	B-X
,	B-X
M.	B-X
Parker	B-X
,	B-X
M.	B-X
Gregersen	B-X
,	B-X
J.	B-X
Almeida	B-X
,	B-X
T.	B-X
Walsh	B-X
,	B-X
S.	B-X
Stanworth	B-X
P136	B-X
-	B-X
The	B-X
relationship	B-X
between	B-X
poor	B-X
pre-operative	B-X
immune	B-X
status	B-X
and	B-X
outcome	B-X
from	B-X
cardiac	B-X
surgery	B-X
is	B-X
specific	B-X
to	B-X
the	B-X
peri-operative	B-X
antigenic	B-X
threat	B-X
S.	B-X
Moravcova	B-X
,	B-X
J.	B-X
Mansell	B-X
,	B-X
A.	B-X
Rogers	B-X
,	B-X
R.	B-X
A.	B-X
Smith	B-X
,	B-X
C.	B-X
Hamilton-Davies	B-X
P137	B-X
-	B-X
Impact	B-X
of	B-X
simple	B-X
clinical	B-X
practice	B-X
guidelines	B-X
for	B-X
reducing	B-X
post-operative	B-X
atrial	B-X
fibrillation	B-X
after	B-X
cardiac	B-X
surgery	B-X
.	B-X
A.	B-X
Omar	B-X
,	B-X
M.	B-X
Allam	B-X
,	B-X
O.	B-X
Bilala	B-X
,	B-X
A.	B-X
Kindawi	B-X
,	B-X
H.	B-X
Ewila	B-X
P138	B-X
-	B-X
Dexamethasone	B-X
administration	B-X
during	B-X
cardiopulmonary	B-X
bypass	B-X
has	B-X
no	B-X
beneficial	B-X
effects	B-X
on	B-X
elective	B-X
postoperative	B-X
cardiac	B-X
surgery	B-X
patients	B-X
F.	B-X
Ampatzidou	B-X
,	B-X
D.	B-X
Moisidou	B-X
,	B-X
M.	B-X
Nastou	B-X
,	B-X
E.	B-X
Dalampini	B-X
,	B-X
A.	B-X
Malamas	B-X
,	B-X
E.	B-X
Vasilarou	B-X
,	B-X
G.	B-X
Drossos	B-X
P139	B-X
-	B-X
Intra-aortic	B-X
balloon	B-X
counterpulsation	B-X
in	B-X
patients	B-X
undergoing	B-X
cardiac	B-X
surgery	B-X
(	B-X
IABCS	B-X
)	B-X
:	B-X
preliminary	B-X
results	B-X
G.	B-X
Ferreira	B-X
,	B-X
J.	B-X
Caldas	B-X
,	B-X
J.	B-X
Fukushima	B-X
,	B-X
E.	B-X
A.	B-X
Osawa	B-X
,	B-X
E.	B-X
Arita	B-X
,	B-X
L.	B-X
Camara	B-X
,	B-X
S.	B-X
Zeferino	B-X
,	B-X
J.	B-X
Jardim	B-X
,	B-X
F.	B-X
Gaioto	B-X
,	B-X
L.	B-X
Dallan	B-X
,	B-X
F.	B-X
B.	B-X
Jatene	B-X
,	B-X
R.	B-X
Kalil	B-X
Filho	B-X
,	B-X
.F	B-X
Galas	B-X
,	B-X
L.	B-X
A.	B-X
Hajjar	B-X
P140	B-X
-	B-X
Effects	B-X
of	B-X
low-dose	B-X
atrial	B-X
natriuretic	B-X
peptide	B-X
infusion	B-X
on	B-X
cardiac	B-X
surgery-associated	B-X
acute	B-X
kidney	B-X
injury	B-X
C.	B-X
Mitaka	B-X
,	B-X
T.	B-X
Ohnuma	B-X
,	B-X
T.	B-X
Murayama	B-X
,	B-X
F.	B-X
Kunimoto	B-X
,	B-X
M.	B-X
Nagashima	B-X
,	B-X
T.	B-X
Takei	B-X
,	B-X
M.	B-X
Tomita	B-X
P141	B-X
-	B-X
Acute	B-X
kidney	B-X
injury	B-X
influence	B-X
on	B-X
high	B-X
sensitive	B-X
troponin	B-X
measurements	B-X
after	B-X
cardiac	B-X
surgery	B-X
A.	B-X
Omar	B-X
,	B-X
K.	B-X
Mahmoud	B-X
,	B-X
S.	B-X
Hanoura	B-X
,	B-X
S.	B-X
Sudarsanan	B-X
,	B-X
P.	B-X
Sivadasan	B-X
,	B-X
H.	B-X
Othamn	B-X
,	B-X
Y.	B-X
Shouman	B-X
,	B-X
R.	B-X
Singh	B-X
,	B-X
A.	B-X
Al	B-X
Khulaifi	B-X
P142	B-X
-	B-X
Complex	B-X
evaluation	B-X
of	B-X
endothelial	B-X
dysfunction	B-X
markers	B-X
for	B-X
prognosis	B-X
of	B-X
outcomes	B-X
in	B-X
patients	B-X
undergoing	B-X
cardiac	B-X
surgery	B-X
I.	B-X
Mandel	B-X
,	B-X
S.	B-X
Mikheev	B-X
,	B-X
I.	B-X
Suhodolo	B-X
,	B-X
V.	B-X
Kiselev	B-X
,	B-X
Y.	B-X
Svirko	B-X
,	B-X
Y.	B-X
Podoksenov	B-X
P143	B-X
-	B-X
New-onset	B-X
atrial	B-X
fibrillation	B-X
in	B-X
intensive	B-X
care	B-X
:	B-X
incidence	B-X
,	B-X
management	B-X
and	B-X
outcome	B-X
S.	B-X
A.	B-X
Jenkins	B-X
,	B-X
R.	B-X
Griffin	B-X
P144	B-X
-	B-X
One	B-X
single	B-X
spot	B-X
measurement	B-X
of	B-X
the	B-X
sublingual	B-X
microcirculation	B-X
during	B-X
acute	B-X
pulmonary	B-X
hypertension	B-X
in	B-X
a	B-X
pig	B-X
model	B-X
of	B-X
shock	B-X
M.	B-X
S.	B-X
Tovar	B-X
Doncel	B-X
,	B-X
A.	B-X
Lima	B-X
,	B-X
C.	B-X
Aldecoa	B-X
,	B-X
C.	B-X
Ince	B-X
P145	B-X
-	B-X
Assessment	B-X
of	B-X
levosimendan	B-X
as	B-X
a	B-X
therapeutic	B-X
option	B-X
to	B-X
recruit	B-X
the	B-X
microcirculation	B-X
in	B-X
cardiogenic	B-X
shock	B-X
–	B-X
initial	B-X
experience	B-X
in	B-X
cardiac	B-X
ICU	B-X
A.	B-X
Taha	B-X
,	B-X
A.	B-X
Shafie	B-X
,	B-X
M.	B-X
Mostafa	B-X
,	B-X
N.	B-X
Syed	B-X
,	B-X
H.	B-X
Hon	B-X
P146	B-X
-	B-X
Terlipressin	B-X
vs.	B-X
norepinephrine	B-X
in	B-X
the	B-X
Potential	B-X
Multiorgan	B-X
Donor	B-X
(	B-X
PMD	B-X
)	B-X
F.	B-X
Righetti	B-X
,	B-X
E.	B-X
Colombaroli	B-X
,	B-X
G.	B-X
Castellano	B-X
P147	B-X
-	B-X
Echocardiography	B-X
in	B-X
the	B-X
potential	B-X
heart	B-X
donor	B-X
exposed	B-X
to	B-X
substitution	B-X
hormonotherapy	B-X
F.	B-X
Righetti	B-X
,	B-X
E.	B-X
Colombaroli	B-X
P148	B-X
-	B-X
Machine	B-X
learning	B-X
can	B-X
reduce	B-X
rate	B-X
of	B-X
monitor	B-X
alarms	B-X
M.	B-X
Hravnak	B-X
,	B-X
L.	B-X
C.	B-X
Chen	B-X
,	B-X
A.	B-X
D.	B-X
Dubrawski	B-X
,	B-X
G.	B-X
C.	B-X
Clermont	B-X
,	B-X
M.	B-X
R.	B-X
Pinsky	B-X
P149	B-X
-	B-X
Peripherally	B-X
inserted	B-X
central	B-X
catheters	B-X
placed	B-X
in	B-X
the	B-X
ICU	B-X
S.	B-X
Gonzalez	B-X
,	B-X
D.	B-X
Macias	B-X
,	B-X
J.	B-X
Acosta	B-X
,	B-X
P.	B-X
Jimenez	B-X
,	B-X
A.	B-X
Loza	B-X
,	B-X
A.	B-X
Lesmes	B-X
,	B-X
F.	B-X
Lucena	B-X
,	B-X
C.	B-X
Leon	B-X
P150	B-X
-	B-X
Recordings	B-X
of	B-X
abnormal	B-X
central	B-X
venous	B-X
pressure	B-X
waveform	B-X
morphology	B-X
during	B-X
an	B-X
episode	B-X
of	B-X
pulmonary	B-X
hypertension	B-X
in	B-X
a	B-X
porcine	B-X
shock	B-X
model	B-X
M.	B-X
S.	B-X
Tovar	B-X
Doncel	B-X
,	B-X
C.	B-X
Ince	B-X
,	B-X
C.	B-X
Aldecoa	B-X
,	B-X
A.	B-X
Lima	B-X
P151	B-X
-	B-X
Ultrasound	B-X
guided	B-X
central	B-X
venous	B-X
access	B-X
technique	B-X
among	B-X
French	B-X
intensivists	B-X
M.	B-X
Bastide	B-X
,	B-X
J.	B-X
Richecoeur	B-X
,	B-X
E.	B-X
Frenoy	B-X
,	B-X
C.	B-X
Lemaire	B-X
,	B-X
B.	B-X
Sauneuf	B-X
,	B-X
F.	B-X
Tamion	B-X
,	B-X
S.	B-X
Nseir	B-X
,	B-X
D.	B-X
Du	B-X
Cheyron	B-X
,	B-X
H.	B-X
Dupont	B-X
,	B-X
J.	B-X
Maizel	B-X
P152	B-X
-	B-X
Predictive	B-X
ability	B-X
of	B-X
the	B-X
Pv-aCO2	B-X
gap	B-X
in	B-X
patients	B-X
with	B-X
shock	B-X
M.	B-X
Shaban	B-X
,	B-X
R.	B-X
Kolko	B-X
,	B-X
N.	B-X
Salahuddin	B-X
,	B-X
M.	B-X
Sharshir	B-X
,	B-X
M.	B-X
AbuRageila	B-X
,	B-X
A.	B-X
AlHussain	B-X
P153	B-X
-	B-X
Comparison	B-X
of	B-X
echocardiography	B-X
and	B-X
pulmonary	B-X
artery	B-X
catheter	B-X
measurements	B-X
of	B-X
hemodynamic	B-X
parameters	B-X
in	B-X
critical	B-X
ill	B-X
patients	B-X
P.	B-X
Mercado	B-X
,	B-X
J.	B-X
Maizel	B-X
,	B-X
L.	B-X
Kontar	B-X
,	B-X
D.	B-X
Titeca	B-X
,	B-X
F.	B-X
Brazier	B-X
,	B-X
A.	B-X
Riviere	B-X
,	B-X
M.	B-X
Joris	B-X
,	B-X
T.	B-X
Soupison	B-X
,	B-X
B	B-X
.	B-X
De	B-X
Cagny	B-X
,	B-X
M.	B-X
Slama	B-X
P154	B-X
-	B-X
The	B-X
volume	B-X
clamp	B-X
method	B-X
for	B-X
noninvasive	B-X
cardiac	B-X
output	B-X
measurement	B-X
in	B-X
postoperative	B-X
cardiothoracic	B-X
surgery	B-X
patients	B-X
:	B-X
a	B-X
comparison	B-X
with	B-X
intermittent	B-X
pulmonary	B-X
artery	B-X
thermodilution	B-X
J.	B-X
Wagner	B-X
,	B-X
A.	B-X
Körner	B-X
,	B-X
M.	B-X
Kubik	B-X
,	B-X
S.	B-X
Kluge	B-X
,	B-X
D.	B-X
Reuter	B-X
,	B-X
B.	B-X
Saugel	B-X
P155	B-X
-	B-X
Hemodynamic	B-X
monitoring	B-X
in	B-X
patients	B-X
with	B-X
septic	B-X
shock	B-X
(	B-X
SS	B-X
)	B-X
–	B-X
CPCCO	B-X
(	B-X
continuous	B-X
pulse	B-X
contour	B-X
cardiac	B-X
output	B-X
)	B-X
vs.	B-X
TEE	B-X
(	B-X
transesophageal	B-X
echocardiography	B-X
)	B-X
E.	B-X
Colombaroli	B-X
,	B-X
F.	B-X
Righetti	B-X
,	B-X
G.	B-X
Castellano	B-X
P156	B-X
-	B-X
Cardiac	B-X
output	B-X
measurement	B-X
with	B-X
transthoracic	B-X
echocardiography	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
:	B-X
a	B-X
pragmatic	B-X
clinical	B-X
study	B-X
T.	B-X
Tran	B-X
,	B-X
D.	B-X
De	B-X
Bels	B-X
,	B-X
A.	B-X
Cudia	B-X
,	B-X
M.	B-X
Strachinaru	B-X
,	B-X
P.	B-X
Ghottignies	B-X
,	B-X
J.	B-X
Devriendt	B-X
,	B-X
C.	B-X
Pierrakos	B-X
P157	B-X
-	B-X
Left	B-X
ventricular	B-X
outflow	B-X
tract	B-X
velocity	B-X
time	B-X
integral	B-X
correlates	B-X
with	B-X
stroke	B-X
volume	B-X
index	B-X
in	B-X
mechanically	B-X
ventilated	B-X
patients	B-X
Ó.	B-X
Martínez	B-X
González	B-X
,	B-X
R.	B-X
Blancas	B-X
,	B-X
J.	B-X
Luján	B-X
,	B-X
D.	B-X
Ballesteros	B-X
,	B-X
C.	B-X
Martínez	B-X
Díaz	B-X
,	B-X
A.	B-X
Núñez	B-X
,	B-X
C.	B-X
Martín	B-X
Parra	B-X
,	B-X
B.	B-X
López	B-X
Matamala	B-X
,	B-X
M.	B-X
Alonso	B-X
Fernández	B-X
,	B-X
M.	B-X
Chana	B-X
P158	B-X
-	B-X
Transpulmonary	B-X
thermodilution	B-X
(	B-X
TPTD	B-X
)	B-X
derived	B-X
from	B-X
femoral	B-X
vs.	B-X
jugular	B-X
central	B-X
venous	B-X
catheter	B-X
:	B-X
validation	B-X
of	B-X
a	B-X
previously	B-X
published	B-X
correction	B-X
formula	B-X
and	B-X
a	B-X
proprietary	B-X
correction	B-X
formula	B-X
for	B-X
global	B-X
end-diastolic	B-X
volume	B-X
index	B-X
(	B-X
GEDVI	B-X
)	B-X
W.	B-X
Huber	B-X
,	B-X
M.	B-X
Eckmann	B-X
,	B-X
F.	B-X
Elkmann	B-X
,	B-X
A.	B-X
Gruber	B-X
,	B-X
I.	B-X
Klein	B-X
,	B-X
R.	B-X
M.	B-X
Schmid	B-X
,	B-X
T.	B-X
Lahmer	B-X
P160	B-X
-	B-X
Dynamic	B-X
arterial	B-X
elastance	B-X
calculated	B-X
with	B-X
lidcoplus	B-X
monitor	B-X
does	B-X
not	B-X
predict	B-X
changes	B-X
in	B-X
arterial	B-X
pressure	B-X
after	B-X
a	B-X
fluid	B-X
challenge	B-X
in	B-X
postsurgical	B-X
patients	B-X
D.	B-X
Bastoni	B-X
,	B-X
H.	B-X
Aya	B-X
,	B-X
L.	B-X
Toscani	B-X
,	B-X
L.	B-X
Pigozzi	B-X
,	B-X
A.	B-X
Rhodes	B-X
,	B-X
M.	B-X
Cecconi	B-X
P159	B-X
-	B-X
Venous	B-X
return	B-X
driving	B-X
pressure	B-X
and	B-X
resistance	B-X
in	B-X
acute	B-X
blood	B-X
volume	B-X
changes	B-X
P.	B-X
W.	B-X
Moller	B-X
,	B-X
S.	B-X
Sondergaard	B-X
,	B-X
S.	B-X
M.	B-X
Jakob	B-X
,	B-X
J.	B-X
Takala	B-X
,	B-X
D.	B-X
Berger	B-X
P160	B-X
-	B-X
Dynamic	B-X
arterial	B-X
elastance	B-X
calculated	B-X
with	B-X
lidcoplus	B-X
monitor	B-X
does	B-X
not	B-X
predict	B-X
changes	B-X
in	B-X
arterial	B-X
pressure	B-X
after	B-X
a	B-X
fluid	B-X
challenge	B-X
in	B-X
postsurgical	B-X
patients	B-X
D.	B-X
Bastoni	B-X
,	B-X
H.	B-X
Aya	B-X
,	B-X
L.	B-X
Toscani	B-X
,	B-X
L.	B-X
Pigozzi	B-X
,	B-X
A.	B-X
Rhodes	B-X
,	B-X
M.	B-X
Cecconi	B-X
P161	B-X
-	B-X
Analysis	B-X
of	B-X
duration	B-X
of	B-X
post-operative	B-X
goal-directed	B-X
therapy	B-X
protocol	B-X
C.	B-X
Ostrowska	B-X
,	B-X
H.	B-X
Aya	B-X
,	B-X
A.	B-X
Abbas	B-X
,	B-X
J.	B-X
Mellinghoff	B-X
,	B-X
C.	B-X
Ryan	B-X
,	B-X
D.	B-X
Dawson	B-X
,	B-X
A.	B-X
Rhodes	B-X
,	B-X
M.	B-X
Cecconi	B-X
P162	B-X
-	B-X
Hemodynamic	B-X
optimization	B-X
–	B-X
back	B-X
to	B-X
square	B-X
one	B-X
?	B-X
Wall	B-X
,	B-X
E.	B-X
Nyberg	B-X
,	B-X
R.	B-X
Zeng	B-X
,	B-X
C.	B-X
Svensen	B-X
,	B-X
J.	B-X
Mårtensson	B-X
,	B-X
E.	B-X
Joelsson-Alm	B-X
P163	B-X
-	B-X
Effectiveness	B-X
of	B-X
fluid	B-X
thoracic	B-X
content	B-X
measurement	B-X
by	B-X
bioimpedance	B-X
guiding	B-X
intravascular	B-X
volume	B-X
optimization	B-X
in	B-X
patients	B-X
with	B-X
septic	B-X
shock	B-X
M.	B-X
Aguilar	B-X
Arzapalo	B-X
,	B-X
L.	B-X
Barradas	B-X
,	B-X
V.	B-X
Lopez	B-X
,	B-X
M.	B-X
Cetina	B-X
P164	B-X
-	B-X
A	B-X
systematic	B-X
review	B-X
on	B-X
the	B-X
role	B-X
of	B-X
internal	B-X
jugular	B-X
vein	B-X
ultrasound	B-X
measurements	B-X
in	B-X
assessment	B-X
of	B-X
volume	B-X
status	B-X
in	B-X
critical	B-X
shock	B-X
patients	B-X
N.	B-X
Parenti	B-X
,	B-X
C.	B-X
Palazzi	B-X
,	B-X
L.	B-X
A.	B-X
Amidei	B-X
,	B-X
F.	B-X
B.	B-X
Borrelli	B-X
,	B-X
S.	B-X
C.	B-X
Campanale	B-X
,	B-X
F.	B-X
T.	B-X
Tagliazucchi	B-X
,	B-X
G.	B-X
S.	B-X
Sedoni	B-X
,	B-X
D.	B-X
L.	B-X
Lucchesi	B-X
,	B-X
E.	B-X
C.	B-X
Carella	B-X
,	B-X
A.	B-X
L	B-X
Luciani	B-X
P165	B-X
-	B-X
Importance	B-X
of	B-X
recognizing	B-X
dehydration	B-X
in	B-X
medical	B-X
Intensive	B-X
Care	B-X
Unit	B-X
M.	B-X
Mackovic	B-X
,	B-X
N.	B-X
Maric	B-X
,	B-X
M.	B-X
Bakula	B-X
P166	B-X
-	B-X
Effect	B-X
of	B-X
volume	B-X
for	B-X
a	B-X
fluid	B-X
challenge	B-X
in	B-X
septic	B-X
patients	B-X
H.	B-X
Aya	B-X
,	B-X
A.	B-X
Rhodes	B-X
,	B-X
R.	B-X
M.	B-X
Grounds	B-X
,	B-X
N.	B-X
Fletcher	B-X
,	B-X
M.	B-X
Cecconi	B-X
P167	B-X
-	B-X
Fluid	B-X
bolus	B-X
practices	B-X
in	B-X
a	B-X
large	B-X
Australian	B-X
intensive	B-X
care	B-X
unit	B-X
B.	B-X
Avard	B-X
,	B-X
P.	B-X
Zhang	B-X
P168	B-X
-	B-X
Liberal	B-X
late	B-X
fluid	B-X
management	B-X
is	B-X
associated	B-X
with	B-X
longer	B-X
ventilation	B-X
duration	B-X
and	B-X
worst	B-X
outcome	B-X
in	B-X
severe	B-X
trauma	B-X
patients	B-X
:	B-X
a	B-X
retrospective	B-X
cohort	B-X
of	B-X
294	B-X
patients	B-X
M.	B-X
Mezidi	B-X
,	B-X
J.	B-X
Charbit	B-X
,	B-X
M.	B-X
Ould-Chikh	B-X
,	B-X
P.	B-X
Deras	B-X
,	B-X
C.	B-X
Maury	B-X
,	B-X
O.	B-X
Martinez	B-X
,	B-X
X.	B-X
Capdevila	B-X
P169	B-X
-	B-X
Association	B-X
of	B-X
fluids	B-X
and	B-X
outcomes	B-X
in	B-X
emergency	B-X
department	B-X
patients	B-X
hospitalized	B-X
with	B-X
community-acquired	B-X
pneumonia	B-X
P.	B-X
Hou	B-X
,	B-X
W.	B-X
Z.	B-X
Linde-Zwirble	B-X
,	B-X
I.	B-X
D.	B-X
Douglas	B-X
,	B-X
N.	B-X
S.	B-X
Shapiro	B-X
P170	B-X
-	B-X
Association	B-X
of	B-X
positive	B-X
fluid	B-X
balance	B-X
with	B-X
poor	B-X
outcome	B-X
in	B-X
medicosurgical	B-X
ICU	B-X
patients	B-X
A.	B-X
Ben	B-X
Souissi	B-X
,	B-X
I.	B-X
Mezghani	B-X
,	B-X
Y.	B-X
Ben	B-X
Aicha	B-X
,	B-X
S.	B-X
Kamoun	B-X
,	B-X
B.	B-X
Laribi	B-X
,	B-X
B.	B-X
Jeribi	B-X
,	B-X
A.	B-X
Riahi	B-X
,	B-X
M.	B-X
S.	B-X
Mebazaa	B-X
P171	B-X
-	B-X
Impact	B-X
of	B-X
fluid	B-X
balance	B-X
to	B-X
organ	B-X
dysfunction	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
C.	B-X
Pereira	B-X
,	B-X
R.	B-X
Marinho	B-X
,	B-X
R.	B-X
Antunes	B-X
,	B-X
A.	B-X
Marinho	B-X
P172	B-X
-	B-X
Volume	B-X
bolus	B-X
in	B-X
ICU	B-X
patients	B-X
:	B-X
do	B-X
we	B-X
need	B-X
to	B-X
balance	B-X
our	B-X
crystalloids	B-X
?	B-X
First	B-X
findings	B-X
of	B-X
farius	B-X
,	B-X
an	B-X
education-programme	B-X
in	B-X
structural	B-X
ultrasonography	B-X
S.	B-X
K.	B-X
Kloesel	B-X
,	B-X
C.	B-X
Goldfuss	B-X
,	B-X
A.	B-X
Stieglitz	B-X
,	B-X
A.	B-X
S.	B-X
Stieglitz	B-X
,	B-X
L.	B-X
Krstevska	B-X
,	B-X
G.	B-X
Albuszies	B-X
P200	B-X
-	B-X
Effectiveness	B-X
of	B-X
renal	B-X
angina	B-X
index	B-X
score	B-X
predicting	B-X
acute	B-X
kidney	B-X
injury	B-X
on	B-X
critically	B-X
ill	B-X
patients	B-X
M.	B-X
Aguilar	B-X
Arzapalo	B-X
,	B-X
L.	B-X
Barradas	B-X
,	B-X
V.	B-X
Lopez	B-X
,	B-X
A.	B-X
Escalante	B-X
,	B-X
G.	B-X
Jimmy	B-X
,	B-X
M.	B-X
Cetina	B-X
P201	B-X
-	B-X
Time	B-X
length	B-X
below	B-X
blood	B-X
pressure	B-X
thresholds	B-X
and	B-X
progression	B-X
of	B-X
acute	B-X
kidney	B-X
injury	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
with	B-X
or	B-X
without	B-X
sepsis	B-X
:	B-X
a	B-X
retrospective	B-X
,	B-X
exploratory	B-X
cohort	B-X
study	B-X
J.	B-X
Izawa	B-X
,	B-X
T.	B-X
Iwami	B-X
,	B-X
S.	B-X
Uchino	B-X
,	B-X
M.	B-X
Takinami	B-X
,	B-X
T.	B-X
Kitamura	B-X
,	B-X
T.	B-X
Kawamura	B-X
P202	B-X
-	B-X
Anaemia	B-X
does	B-X
not	B-X
affect	B-X
renal	B-X
recovery	B-X
in	B-X
acute	B-X
kidney	B-X
injury	B-X
J.	B-X
G.	B-X
Powell-Tuck	B-X
,	B-X
S.	B-X
Crichton	B-X
,	B-X
M.	B-X
Raimundo	B-X
,	B-X
L.	B-X
Camporota	B-X
,	B-X
D.	B-X
Wyncoll	B-X
,	B-X
M.	B-X
Ostermann	B-X
P203	B-X
-	B-X
Estimated	B-X
glomerular	B-X
filtration	B-X
rate	B-X
based	B-X
on	B-X
serum	B-X
creatinine	B-X
:	B-X
actual	B-X
practice	B-X
in	B-X
Dutch	B-X
ICU	B-X
’	B-X
s	B-X
A.	B-X
Hana	B-X
,	B-X
H.	B-X
R.	B-X
De	B-X
Geus	B-X
P204	B-X
-	B-X
Comparison	B-X
of	B-X
estimated	B-X
glomerular	B-X
filtration	B-X
rate	B-X
calculated	B-X
by	B-X
mdrd	B-X
,	B-X
ckd-epi-serum-creatinine	B-X
and	B-X
ckd-epi-cystatin-c	B-X
in	B-X
adult	B-X
critically	B-X
ill	B-X
patients	B-X
H.	B-X
R.	B-X
De	B-X
Geus	B-X
,	B-X
A.	B-X
Hana	B-X
P205	B-X
-	B-X
Early	B-X
diagnosis	B-X
of	B-X
septic	B-X
acute	B-X
kidney	B-X
injury	B-X
in	B-X
medical	B-X
critical	B-X
care	B-X
patients	B-X
with	B-X
a	B-X
urine	B-X
cell	B-X
cycle	B-X
arrest	B-X
marker	B-X
:	B-X
insulin	B-X
like	B-X
growth	B-X
factor	B-X
binding	B-X
protein-7	B-X
(	B-X
IGFBP-7	B-X
)	B-X
M.	B-X
Aydogdu	B-X
,	B-X
N.	B-X
Boyaci	B-X
,	B-X
S.	B-X
Yuksel	B-X
,	B-X
G.	B-X
Gursel	B-X
,	B-X
A	B-X
.	B-X
A	B-X
single	B-X
center	B-X
retrospective	B-X
study	B-X
S.	B-X
Hanoura	B-X
,	B-X
A.	B-X
Omar	B-X
,	B-X
H.	B-X
Othamn	B-X
,	B-X
S.	B-X
Sudarsanan	B-X
,	B-X
M.	B-X
Allam	B-X
,	B-X
M.	B-X
Maksoud	B-X
,	B-X
R.	B-X
Singh	B-X
,	B-X
A.	B-X
Al	B-X
Khulaifi	B-X
P216	B-X
-	B-X
Post-operative	B-X
acute	B-X
kidney	B-X
injury	B-X
after	B-X
major	B-X
non-cardiac	B-X
surgery	B-X
and	B-X
its	B-X
association	B-X
with	B-X
death	B-X
in	B-X
the	B-X
following	B-X
year	B-X
M.	B-X
E.	B-X
O	B-X
’	B-X
Connor	B-X
,	B-X
R.	B-X
W.	B-X
Hewson	B-X
,	B-X
C.	B-X
J.	B-X
Kirwan	B-X
,	B-X
R.	B-X
M.	B-X
Pearse	B-X
,	B-X
J.	B-X
Prowle	B-X
P217	B-X
-	B-X
Factors	B-X
affecting	B-X
acute	B-X
renal	B-X
failure	B-X
in	B-X
intensive	B-X
care	B-X
unit	B-X
and	B-X
effect	B-X
of	B-X
these	B-X
factors	B-X
on	B-X
mortality	B-X
O.	B-X
Uzundere	B-X
,	B-X
D.	B-X
Memis	B-X
,	B-X
M.	B-X
Ýnal	B-X
,	B-X
A.	B-X
,	B-X
N.	B-X
Turan	B-X
P218	B-X
-	B-X
Results	B-X
of	B-X
the	B-X
live	B-X
kidney	B-X
transplantations	B-X
according	B-X
to	B-X
national	B-X
data	B-X
of	B-X
turkish	B-X
organ	B-X
and	B-X
tissue	B-X
information	B-X
system	B-X
M.	B-X
A.	B-X
Aydin	B-X
,	B-X
H.	B-X
Basar	B-X
,	B-X
I.	B-X
Sencan	B-X
,	B-X
A.	B-X
Kapuagasi	B-X
,	B-X
M.	B-X
Ozturk	B-X
,	B-X
Z.	B-X
Uzundurukan	B-X
,	B-X
D.	B-X
Gokmen	B-X
,	B-X
A.	B-X
Ozcan	B-X
,	B-X
C.	B-X
Kaymak	B-X
P219	B-X
-	B-X
Anaesthesia	B-X
procedure	B-X
and	B-X
intensive	B-X
therapy	B-X
in	B-X
patients	B-X
with	B-X
neck	B-X
phlegmon	B-X
V.	B-X
A.	B-X
Artemenko	B-X
,	B-X
A.	B-X
Budnyuk	B-X
P220	B-X
-	B-X
Nasal	B-X
high	B-X
flow	B-X
oygen	B-X
for	B-X
acute	B-X
respiratory	B-X
failure	B-X
:	B-X
a	B-X
systematic	B-X
review	B-X
R.	B-X
Pugh	B-X
,	B-X
S.	B-X
Bhandari	B-X
P221	B-X
-	B-X
Setting	B-X
optimal	B-X
flow	B-X
rate	B-X
during	B-X
high	B-X
flow	B-X
nasal	B-X
cannula	B-X
support	B-X
:	B-X
preliminary	B-X
results	B-X
T.	B-X
Mauri	B-X
,	B-X
C.	B-X
Turrini	B-X
,	B-X
T.	B-X
Langer	B-X
,	B-X
P.	B-X
Taccone	B-X
,	B-X
C.	B-X
A.	B-X
Volta	B-X
,	B-X
C.	B-X
Marenghi	B-X
,	B-X
L.	B-X
Gattinoni	B-X
,	B-X
A.	B-X
Pesenti	B-X
P222	B-X
-	B-X
Dose	B-X
to	B-X
dose	B-X
consistency	B-X
across	B-X
two	B-X
different	B-X
gas	B-X
flow	B-X
rates	B-X
using	B-X
cystic	B-X
fibrosis	B-X
and	B-X
normal	B-X
adult	B-X
breathing	B-X
profiles	B-X
during	B-X
nasal	B-X
high	B-X
flow	B-X
oxygen	B-X
therapy	B-X
L.	B-X
Sweeney	B-X
,	B-X
A	B-X
.	B-X
O	B-X
’	B-X
Sullivan	B-X
,	B-X
P.	B-X
Kelly	B-X
,	B-X
E.	B-X
Mukeria	B-X
,	B-X
R.	B-X
MacLoughlin	B-X
P223	B-X
-	B-X
Final	B-X
results	B-X
of	B-X
an	B-X
evaluation	B-X
of	B-X
airway	B-X
medix	B-X
closed	B-X
suction	B-X
system	B-X
compared	B-X
to	B-X
a	B-X
standard	B-X
closed	B-X
suction	B-X
system	B-X
M.	B-X
Pfeffer	B-X
,	B-X
J.	B-X
T.	B-X
Thomas	B-X
,	B-X
G.	B-X
B.	B-X
Bregman	B-X
,	B-X
G.	B-X
K.	B-X
Karp	B-X
,	B-X
E.	B-X
K.	B-X
Kishinevsky	B-X
,	B-X
D.	B-X
S.	B-X
Stavi	B-X
,	B-X
N.	B-X
A.	B-X
Adi	B-X
P224	B-X
-	B-X
Different	B-X
cuff	B-X
materials	B-X
and	B-X
different	B-X
leak	B-X
tests	B-X
-	B-X
one	B-X
size	B-X
does	B-X
not	B-X
fit	B-X
all	B-X
T.	B-X
Poropat	B-X
,	B-X
R.	B-X
Knafelj	B-X
P225	B-X
-	B-X
Observational	B-X
study	B-X
on	B-X
the	B-X
value	B-X
of	B-X
the	B-X
cuff-leak	B-X
test	B-X
and	B-X
the	B-X
onset	B-X
of	B-X
upper	B-X
airway	B-X
obstruction	B-X
after	B-X
extubation	B-X
E.	B-X
Llopart	B-X
,	B-X
M.	B-X
Batlle	B-X
,	B-X
C.	B-X
De	B-X
Haro	B-X
,	B-X
J.	B-X
Mesquida	B-X
,	B-X
A.	B-X
Artigas	B-X
P226	B-X
-	B-X
A	B-X
device	B-X
for	B-X
emergency	B-X
transtracheal	B-X
lung	B-X
ventilation	B-X
D.	B-X
Pavlovic	B-X
,	B-X
L.	B-X
Lewerentz	B-X
,	B-X
A.	B-X
Spassov	B-X
,	B-X
R.	B-X
Schneider	B-X
P227	B-X
-	B-X
Long-term	B-X
outcome	B-X
and	B-X
health-related	B-X
quality	B-X
of	B-X
life	B-X
in	B-X
patients	B-X
discharged	B-X
from	B-X
the	B-X
intensive	B-X
care	B-X
unit	B-X
with	B-X
a	B-X
tracheostomy	B-X
and	B-X
with	B-X
or	B-X
without	B-X
prolonged	B-X
mechanical	B-X
ventilation	B-X
S.	B-X
De	B-X
Smet	B-X
,	B-X
S.	B-X
De	B-X
Raedt	B-X
,	B-X
E.	B-X
Derom	B-X
,	B-X
P	B-X
Depuydt	B-X
,	B-X
S.	B-X
Oeyen	B-X
,	B-X
D.	B-X
Benoit	B-X
,	B-X
J.	B-X
Decruyenaere	B-X
P228	B-X
-	B-X
Ultrasound-guided	B-X
percutaneous	B-X
dilational	B-X
tracheostomy	B-X
versus	B-X
bronchoscopy-guided	B-X
percutaneous	B-X
dilational	B-X
tracheostomy	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
(	B-X
trachus	B-X
)	B-X
:	B-X
a	B-X
randomized	B-X
clinical	B-X
trial	B-X
A.	B-X
Gobatto	B-X
,	B-X
B.	B-X
Bese	B-X
,	B-X
P.	B-X
Tierno	B-X
,	B-X
L.	B-X
Melro	B-X
,	B-X
P.	B-X
Mendes	B-X
,	B-X
F.	B-X
Cadamuro	B-X
,	B-X
M.	B-X
Park	B-X
,	B-X
L.	B-X
M.	B-X
Malbouisson	B-X
P229	B-X
-	B-X
Is	B-X
it	B-X
safe	B-X
to	B-X
discharge	B-X
patients	B-X
with	B-X
tracheostomy	B-X
from	B-X
the	B-X
ICU	B-X
to	B-X
the	B-X
ward	B-X
?	B-X
B.	B-X
C.	B-X
Civanto	B-X
,	B-X
J.	B-X
L.	B-X
Lopez	B-X
,	B-X
A.	B-X
Robles	B-X
,	B-X
J.	B-X
Figueira	B-X
,	B-X
S.	B-X
Yus	B-X
,	B-X
A.	B-X
Garcia	B-X
P230	B-X
-	B-X
The	B-X
application	B-X
of	B-X
tracheostomy	B-X
in	B-X
children	B-X
in	B-X
ICU	B-X
A.	B-X
Oglinda	B-X
,	B-X
G.	B-X
Ciobanu	B-X
,	B-X
C.	B-X
Oglinda	B-X
,	B-X
L.	B-X
Schirca	B-X
,	B-X
T.	B-X
Sertinean	B-X
,	B-X
V.	B-X
Lupu	B-X
P231	B-X
-	B-X
The	B-X
impact	B-X
of	B-X
passive	B-X
humidifiers	B-X
on	B-X
aerosol	B-X
drug	B-X
delivery	B-X
during	B-X
mechanical	B-X
ventilation	B-X
P.	B-X
Kelly	B-X
,	B-X
A.	B-X
O	B-X
’	B-X
Sullivan	B-X
,	B-X
L.	B-X
Sweeney	B-X
,	B-X
R.	B-X
MacLoughlin	B-X
P232	B-X
-	B-X
Evaluation	B-X
of	B-X
vibrating	B-X
mesh	B-X
and	B-X
jet	B-X
nebuliser	B-X
performance	B-X
at	B-X
two	B-X
different	B-X
attachment	B-X
setups	B-X
in	B-X
line	B-X
with	B-X
a	B-X
humidifier	B-X
nebuliser	B-X
system	B-X
A.	B-X
O	B-X
’	B-X
Sullivan	B-X
,	B-X
P.	B-X
Kelly	B-X
,	B-X
L.	B-X
Sweeney	B-X
,	B-X
E.	B-X
Mukeria	B-X
,	B-X
M.	B-X
Wolny	B-X
,	B-X
R.	B-X
MacLoughlin	B-X
P233	B-X
-	B-X
Psv-niv	B-X
versus	B-X
cpap	B-X
in	B-X
the	B-X
treatment	B-X
of	B-X
acute	B-X
cardiogenic	B-X
pulmonary	B-X
edema	B-X
A.	B-X
Pagano	B-X
,	B-X
F.	B-X
Numis	B-X
,	B-X
G.	B-X
Vison	B-X
,	B-X
L.	B-X
Saldamarco	B-X
,	B-X
T.	B-X
Russo	B-X
,	B-X
G.	B-X
Porta	B-X
,	B-X
F.	B-X
Paladino	B-X
P234	B-X
-	B-X
Noninvasive	B-X
ventilation	B-X
in	B-X
patients	B-X
with	B-X
haematologic	B-X
malignancy	B-X
:	B-X
a	B-X
retrospective	B-X
review	B-X
C.	B-X
Bell	B-X
,	B-X
J.	B-X
Liu	B-X
,	B-X
J.	B-X
Debacker	B-X
,	B-X
C.	B-X
Lee	B-X
,	B-X
E.	B-X
Tamberg	B-X
,	B-X
V.	B-X
Campbell	B-X
,	B-X
S.	B-X
Mehta	B-X
P235	B-X
-	B-X
Use	B-X
of	B-X
non-invasive	B-X
ventilation	B-X
in	B-X
infectious	B-X
diseases	B-X
besides	B-X
classical	B-X
indications	B-X
A.	B-X
Silva-Pinto	B-X
,	B-X
A.	B-X
Sarmento	B-X
,	B-X
L.	B-X
Santos	B-X
P236	B-X
-	B-X
The	B-X
impact	B-X
of	B-X
fragility	B-X
on	B-X
noninvasive	B-X
mechanical	B-X
ventilation	B-X
application	B-X
and	B-X
results	B-X
in	B-X
the	B-X
ICU	B-X
Ý.	B-X
Kara	B-X
,	B-X
F.	B-X
Yýldýrým	B-X
,	B-X
A.	B-X
Zerman	B-X
,	B-X
Z.	B-X
Güllü	B-X
,	B-X
N.	B-X
Boyacý	B-X
,	B-X
B.	B-X
Basarýk	B-X
Aydogan	B-X
,	B-X
Ü.	B-X
Gaygýsýz	B-X
,	B-X
K.	B-X
Gönderen	B-X
,	B-X
G.	B-X
Arýk	B-X
,	B-X
M.	B-X
Turkoglu	B-X
,	B-X
M.	B-X
Aydogdu	B-X
,	B-X
G.	B-X
Aygencel	B-X
,	B-X
Z.	B-X
Ülger	B-X
,	B-X
G.	B-X
Gursel	B-X
P237	B-X
-	B-X
Effects	B-X
of	B-X
metabolic	B-X
alkalosis	B-X
on	B-X
noninvasive	B-X
ventilation	B-X
success	B-X
and	B-X
ICU	B-X
outcome	B-X
in	B-X
patients	B-X
with	B-X
hypercapnic	B-X
respiratory	B-X
failure	B-X
N.	B-X
Boyacý	B-X
,	B-X
Z.	B-X
Isýkdogan	B-X
,	B-X
Ö.	B-X
Özdedeoglu	B-X
,	B-X
Z.	B-X
Güllü	B-X
,	B-X
M.	B-X
Badoglu	B-X
,	B-X
U.	B-X
Gaygýsýz	B-X
,	B-X
M.	B-X
Aydogdu	B-X
,	B-X
G.	B-X
Gursel	B-X
P238	B-X
-	B-X
Asynchrony	B-X
index	B-X
and	B-X
breathing	B-X
patterns	B-X
of	B-X
acute	B-X
exacerbation	B-X
copd	B-X
patients	B-X
assisted	B-X
with	B-X
noninvasive	B-X
pressure	B-X
support	B-X
ventilation	B-X
and	B-X
neurally	B-X
adjusted	B-X
ventilatory	B-X
assist	B-X
N.	B-X
Kongpolprom	B-X
,	B-X
C.	B-X
Sittipunt	B-X
P239	B-X
-	B-X
High	B-X
frequency	B-X
jet	B-X
ventilation	B-X
for	B-X
severe	B-X
acute	B-X
hypoxemia	B-X
A.	B-X
Eden	B-X
,	B-X
Y.	B-X
Kokhanovsky	B-X
,	B-X
S.	B-X
Bursztein	B-X
–	B-X
De	B-X
Myttenaere	B-X
,	B-X
R.	B-X
Pizov	B-X
P240	B-X
-	B-X
HFOV	B-X
revisited	B-X
:	B-X
a	B-X
7	B-X
year	B-X
retrospective	B-X
analysis	B-X
of	B-X
patients	B-X
receiving	B-X
HFOV	B-X
who	B-X
met	B-X
oscillate	B-X
trial	B-X
entry	B-X
criteria	B-X
L.	B-X
Neilans	B-X
,	B-X
N.	B-X
MacIntyre	B-X
P241	B-X
-	B-X
Implementation	B-X
of	B-X
a	B-X
goal-directed	B-X
mechanical	B-X
ventilation	B-X
order	B-X
set	B-X
driven	B-X
by	B-X
respiratory	B-X
therapists	B-X
can	B-X
improve	B-X
compliance	B-X
with	B-X
best	B-X
practices	B-X
for	B-X
mechanical	B-X
ventilation	B-X
M.	B-X
Radosevich	B-X
,	B-X
B.	B-X
Wanta	B-X
,	B-X
V.	B-X
Weber	B-X
,	B-X
T.	B-X
Meyer	B-X
,	B-X
N.	B-X
Smischney	B-X
,	B-X
D.	B-X
Brown	B-X
,	B-X
D.	B-X
Diedrich	B-X
P242	B-X
-	B-X
A	B-X
reduction	B-X
in	B-X
tidal	B-X
volumes	B-X
for	B-X
ventilated	B-X
patients	B-X
on	B-X
ICU	B-X
calculated	B-X
from	B-X
IBW	B-X
.	B-X
A.	B-X
Kellum	B-X
P266	B-X
-	B-X
Procalcitonin	B-X
as	B-X
predictor	B-X
of	B-X
primary	B-X
graft	B-X
dysfunction	B-X
and	B-X
mortality	B-X
in	B-X
post-lung	B-X
transplantation	B-X
C.	B-X
Mazo	B-X
Torre	B-X
,	B-X
J.	B-X
Riera	B-X
,	B-X
S.	B-X
Ramirez	B-X
,	B-X
B.	B-X
Borgatta	B-X
,	B-X
L.	B-X
Lagunes	B-X
,	B-X
J.	B-X
Rello	B-X
P267	B-X
-	B-X
New	B-X
molecular	B-X
biomarkers	B-X
of	B-X
acute	B-X
respiratory	B-X
distress	B-X
syndrome	B-X
in	B-X
abdominal	B-X
sepsis	B-X
A.	B-X
K.	B-X
Kuzovlev	B-X
,	B-X
V.	B-X
Moroz	B-X
,	B-X
A.	B-X
Goloubev	B-X
,	B-X
S.	B-X
Polovnikov	B-X
,	B-X
S.	B-X
Nenchuk	B-X
P268	B-X
-	B-X
Tight	B-X
junction	B-X
’	B-X
s	B-X
proteins	B-X
claudin	B-X
-5	B-X
and	B-X
regulation	B-X
by	B-X
tnf	B-X
in	B-X
experimental	B-X
murine	B-X
lung	B-X
injury	B-X
model	B-X
of	B-X
ali/ards	B-X
V.	B-X
Karavana	B-X
,	B-X
C.	B-X
Glynos	B-X
,	B-X
A.	B-X
Asimakos	B-X
,	B-X
K.	B-X
Pappas	B-X
,	B-X
C.	B-X
Vrettou	B-X
,	B-X
M.	B-X
Magkou	B-X
,	B-X
E.	B-X
Ischaki	B-X
,	B-X
G.	B-X
Stathopoulos	B-X
,	B-X
S.	B-X
Zakynthinos	B-X
P269	B-X
-	B-X
Cell	B-X
counts	B-X
in	B-X
endobronchial	B-X
aspirate	B-X
to	B-X
assess	B-X
airway	B-X
inflammation	B-X
in	B-X
ARDS	B-X
patients	B-X
:	B-X
a	B-X
pilot	B-X
study	B-X
S.	B-X
Spadaro	B-X
,	B-X
I.	B-X
Kozhevnikova	B-X
,	B-X
F.	B-X
Dalla	B-X
Corte	B-X
,	B-X
S.	B-X
Grasso	B-X
,	B-X
P.	B-X
Casolari	B-X
,	B-X
G.	B-X
Caramori	B-X
,	B-X
C.	B-X
Volta	B-X
P270	B-X
-	B-X
Epidemiological	B-X
and	B-X
clinical	B-X
profile	B-X
of	B-X
patients	B-X
with	B-X
acute	B-X
respiratory	B-X
distress	B-X
syndrome	B-X
in	B-X
the	B-X
surgical	B-X
intensive	B-X
care	B-X
unit	B-X
surgical	B-X
,	B-X
hospital	B-X
JRA	B-X
,	B-X
Antananarivo	B-X
T.	B-X
Andrianjafiarinoa	B-X
,	B-X
T.	B-X
Randriamandrato	B-X
,	B-X
T.	B-X
Rajaonera	B-X
P271	B-X
-	B-X
Effect	B-X
of	B-X
high	B-X
PEEP	B-X
after	B-X
recruitment	B-X
maneuver	B-X
on	B-X
right	B-X
ventricular	B-X
function	B-X
in	B-X
ARDS	B-X
.	B-X
De	B-X
Cagny	B-X
,	B-X
S.	B-X
El	B-X
Dash	B-X
,	B-X
M.	B-X
Slama	B-X
P273	B-X
-	B-X
Inhaled	B-X
nitric	B-X
oxide	B-X
–	B-X
is	B-X
switching	B-X
supplier	B-X
cost	B-X
effective	B-X
?	B-X
T.	B-X
Oshima	B-X
,	B-X
S.	B-X
Graf	B-X
,	B-X
C.	B-X
Heidegger	B-X
,	B-X
L.	B-X
Genton	B-X
,	B-X
V.	B-X
Karsegard	B-X
,	B-X
Y.	B-X
Dupertuis	B-X
,	B-X
C.	B-X
Pichard	B-X
P285	B-X
-	B-X
Revisiting	B-X
the	B-X
refeeding	B-X
syndrome	B-X
:	B-X
results	B-X
of	B-X
a	B-X
systematic	B-X
review	B-X
N.	B-X
Friedli	B-X
,	B-X
Z.	B-X
Stanga	B-X
,	B-X
B.	B-X
Mueller	B-X
,	B-X
P.	B-X
Schuetz	B-X
P286	B-X
-	B-X
Compliance	B-X
with	B-X
the	B-X
new	B-X
protocol	B-X
for	B-X
parenteral	B-X
nutrition	B-X
in	B-X
our	B-X
ICU	B-X
L.	B-X
Vandersteen	B-X
,	B-X
B.	B-X
Stessel	B-X
,	B-X
S.	B-X
Evers	B-X
,	B-X
A.	B-X
R.	B-X
Marinho	B-X
,	B-X
M.	B-X
Santos	B-X
,	B-X
E.	B-X
Lafuente	B-X
,	B-X
H.	B-X
Castro	B-X
,	B-X
S.	B-X
Cabral	B-X
,	B-X
J.	B-X
Moura	B-X
,	B-X
P.	B-X
Martins	B-X
,	B-X
B.	B-X
Oliveira	B-X
,	B-X
A.	B-X
Salgueiro	B-X
,	B-X
S.	B-X
Duarte	B-X
,	B-X
S.	B-X
Castro	B-X
,	B-X
M.	B-X
Melo	B-X
,	B-X
P.	B-X
Casteloes	B-X
,	B-X
A.	B-X
Marinho	B-X
P289	B-X
Protein	B-X
provision	B-X
in	B-X
an	B-X
adult	B-X
intensive	B-X
care	B-X
unit	B-X
S.	B-X
Gray	B-X
P290	B-X
-	B-X
Prevalence	B-X
and	B-X
clinical	B-X
outcomes	B-X
of	B-X
vitamin	B-X
d	B-X
deficiency	B-X
in	B-X
the	B-X
medical	B-X
critically	B-X
ill	B-X
patients	B-X
in	B-X
Songklanagarind	B-X
hospital	B-X
K.	B-X
Maipang	B-X
,	B-X
R.	B-X
Bhurayanontachai	B-X
P291	B-X
-	B-X
Vitamin	B-X
d	B-X
deficiency	B-X
strongly	B-X
predicts	B-X
adverse	B-X
medical	B-X
outcome	B-X
across	B-X
different	B-X
medical	B-X
inpatient	B-X
populations	B-X
:	B-X
results	B-X
from	B-X
a	B-X
prospective	B-X
study	B-X
L.	B-X
G.	B-X
Grädel	B-X
,	B-X
P.	B-X
Schütz	B-X
P292	B-X
-	B-X
Omega-3	B-X
fatty	B-X
acids	B-X
in	B-X
patients	B-X
undergoing	B-X
cardiac	B-X
surgery	B-X
:	B-X
a	B-X
systematic	B-X
review	B-X
and	B-X
meta-analysis	B-X
P.	B-X
Langlois	B-X
,	B-X
W.	B-X
Manzanares	B-X
P293	B-X
-	B-X
Can	B-X
5-hydroxytriptophan	B-X
prevent	B-X
post-traumatic	B-X
stress	B-X
disorder	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
?	B-X
R.	B-X
Tincu	B-X
,	B-X
C.	B-X
Cobilinschi	B-X
,	B-X
D.	B-X
Tomescu	B-X
,	B-X
Z.	B-X
Ghiorghiu	B-X
,	B-X
R.	B-X
Macovei	B-X
P294	B-X
-	B-X
Parenteral	B-X
selenium	B-X
in	B-X
the	B-X
critically	B-X
ill	B-X
:	B-X
an	B-X
updated	B-X
systematic	B-X
review	B-X
and	B-X
meta-analysis	B-X
W.	B-X
Manzanares	B-X
,	B-X
P.	B-X
Langlois	B-X
,	B-X
M.	B-X
Lemieux	B-X
,	B-X
G.	B-X
Elke	B-X
,	B-X
F.	B-X
Bloos	B-X
,	B-X
K.	B-X
Reinhart	B-X
,	B-X
D.	B-X
Heyland	B-X
P295	B-X
-	B-X
Probiotics	B-X
in	B-X
the	B-X
critically	B-X
ill	B-X
:	B-X
an	B-X
updated	B-X
systematic	B-X
review	B-X
and	B-X
meta-analysis	B-X
P.	B-X
Langlois	B-X
,	B-X
M.	B-X
Lemieux	B-X
,	B-X
I.	B-X
Aramendi	B-X
,	B-X
D.	B-X
Heyland	B-X
,	B-X
W.	B-X
Manzanares	B-X
P296	B-X
-	B-X
Diabetes	B-X
with	B-X
hyperglycemic	B-X
crisis	B-X
episodes	B-X
may	B-X
be	B-X
associated	B-X
with	B-X
higher	B-X
risk	B-X
of	B-X
pancreatic	B-X
cancer	B-X
:	B-X
a	B-X
population-based	B-X
cohort	B-X
study	B-X
Y.	B-X
Su	B-X
P297	B-X
-	B-X
Incidence	B-X
of	B-X
hypoglycemia	B-X
in	B-X
an	B-X
intensive	B-X
care	B-X
unit	B-X
depending	B-X
on	B-X
insulin	B-X
protocol	B-X
R.	B-X
Marinho	B-X
,	B-X
N.	B-X
Babo	B-X
,	B-X
A.	B-X
Marinho	B-X
P298	B-X
-	B-X
Severity	B-X
of	B-X
the	B-X
diseases	B-X
is	B-X
two-dimensionally	B-X
correlated	B-X
to	B-X
blood	B-X
glucose	B-X
,	B-X
including	B-X
blood	B-X
glucose	B-X
variability	B-X
,	B-X
especially	B-X
in	B-X
moderately	B-X
to	B-X
severely	B-X
ill	B-X
patients	B-X
with	B-X
glucose	B-X
intolerance	B-X
.	B-X
M.	B-X
Hoshino	B-X
,	B-X
Y.	B-X
Haraguchi	B-X
,	B-X
S.	B-X
Kajiwara	B-X
,	B-X
T.	B-X
Mitsuhashi	B-X
,	B-X
T.	B-X
Tsubata	B-X
,	B-X
M.	B-X
Aida	B-X
P299	B-X
-	B-X
A	B-X
study	B-X
of	B-X
glycemic	B-X
control	B-X
by	B-X
subcutaneous	B-X
glargine	B-X
injection	B-X
transition	B-X
from	B-X
continuous	B-X
regular	B-X
insulin	B-X
infusion	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
T.	B-X
Rattanapraphat	B-X
,	B-X
R.	B-X
Bhurayanontachai	B-X
,	B-X
C.	B-X
Kongkamol	B-X
,	B-X
B.	B-X
Khwannimit	B-X
P300	B-X
-	B-X
Glycemic	B-X
control	B-X
in	B-X
Portuguese	B-X
intensive	B-X
care	B-X
unit	B-X
R.	B-X
Marinho	B-X
,	B-X
M.	B-X
Santos	B-X
,	B-X
H.	B-X
Castro	B-X
,	B-X
E.	B-X
Lafuente	B-X
,	B-X
A.	B-X
Salgueiro	B-X
,	B-X
S.	B-X
Cabral	B-X
,	B-X
P.	B-X
Martins	B-X
,	B-X
J.	B-X
Moura	B-X
,	B-X
B.	B-X
Oliveira	B-X
,	B-X
M.	B-X
Melo	B-X
,	B-X
B.	B-X
Xavier	B-X
,	B-X
J.	B-X
Valente	B-X
,	B-X
C.	B-X
Magalhaes	B-X
,	B-X
P.	B-X
Casteloes	B-X
,	B-X
A.	B-X
Marinho	B-X
P301	B-X
-	B-X
Impact	B-X
of	B-X
hyperglycemia	B-X
duration	B-X
on	B-X
the	B-X
day	B-X
of	B-X
operation	B-X
on	B-X
short-term	B-X
outcome	B-X
of	B-X
cardiac	B-X
surgery	B-X
patients	B-X
D.	B-X
Moisidou	B-X
,	B-X
F.	B-X
Ampatzidou	B-X
,	B-X
C.	B-X
Koutsogiannidis	B-X
,	B-X
M.	B-X
Moschopoulou	B-X
,	B-X
G.	B-X
Drossos	B-X
P302	B-X
-	B-X
Lactate	B-X
levels	B-X
in	B-X
diabetic	B-X
ketoacidosis	B-X
patients	B-X
at	B-X
ICU	B-X
admissions	B-X
G.	B-X
Taskin	B-X
,	B-X
M.	B-X
Çakir	B-X
,	B-X
AK	B-X
Güler	B-X
,	B-X
A.	B-X
Taskin	B-X
,	B-X
N.	B-X
Öcal	B-X
,	B-X
S.	B-X
Özer	B-X
,	B-X
L.	B-X
Yamanel	B-X
P303	B-X
-	B-X
Intensive	B-X
care	B-X
implications	B-X
of	B-X
merging	B-X
heart	B-X
attack	B-X
centre	B-X
units	B-X
in	B-X
London	B-X
J.	B-X
M.	B-X
Wong	B-X
,	B-X
C.	B-X
Fitton	B-X
,	B-X
S.	B-X
Anwar	B-X
,	B-X
S.	B-X
Stacey	B-X
P304	B-X
-	B-X
Special	B-X
characteristics	B-X
of	B-X
in-hospital	B-X
cardiac	B-X
arrests	B-X
M.	B-X
Aggou	B-X
,	B-X
B.	B-X
Fyntanidou	B-X
,	B-X
S.	B-X
Patsatzakis	B-X
,	B-X
E.	B-X
Oloktsidou	B-X
,	B-X
K.	B-X
Lolakos	B-X
,	B-X
E.	B-X
Papapostolou	B-X
,	B-X
V.	B-X
Grosomanidis	B-X
P305	B-X
-	B-X
Clinical	B-X
evaluation	B-X
of	B-X
ICU-admitted	B-X
patients	B-X
who	B-X
were	B-X
resuscitated	B-X
in	B-X
the	B-X
general	B-X
medicine	B-X
ward	B-X
S.	B-X
Suda	B-X
,	B-X
T.	B-X
Ikeda	B-X
,	B-X
S.	B-X
Ono	B-X
,	B-X
T.	B-X
Ueno	B-X
,	B-X
Y.	B-X
Izutani	B-X
P306	B-X
-	B-X
Serious	B-X
game	B-X
evaluation	B-X
of	B-X
a	B-X
one-hour	B-X
training	B-X
basic	B-X
life	B-X
support	B-X
session	B-X
for	B-X
secondary	B-X
school	B-X
students	B-X
:	B-X
new	B-X
tools	B-X
for	B-X
future	B-X
bystanders	B-X
S.	B-X
Gaudry	B-X
,	B-X
V.	B-X
Desailly	B-X
,	B-X
P.	B-X
Pasquier	B-X
,	B-X
PB	B-X
Brun	B-X
,	B-X
AT	B-X
Tesnieres	B-X
,	B-X
JD	B-X
Ricard	B-X
,	B-X
D.	B-X
Dreyfuss	B-X
,	B-X
A.	B-X
Mignon	B-X
P307	B-X
-	B-X
Public	B-X
and	B-X
clinical	B-X
staff	B-X
perceptions	B-X
and	B-X
knowledge	B-X
of	B-X
CPR	B-X
compared	B-X
to	B-X
local	B-X
and	B-X
national	B-X
data	B-X
J	B-X
.	B-X
Dean	B-X
,	B-X
A.	B-X
Stilwell	B-X
,	B-X
G.	B-X
Friedlaender	B-X
P308	B-X
Dispatcher-assisted	B-X
telephone	B-X
cardiopulmonary	B-X
resuscitation	B-X
using	B-X
a	B-X
French-language	B-X
compression-ventilation	B-X
pediatric	B-X
protocol	B-X
M.	B-X
Peters	B-X
,	B-X
S.	B-X
Stipulante	B-X
,	B-X
A.	B-X
Delfosse	B-X
,	B-X
AF	B-X
Donneau	B-X
,	B-X
A.	B-X
Ghuysen	B-X
P309	B-X
Dantrolene	B-X
versus	B-X
amiodarone	B-X
for	B-X
resuscitation	B-X
–	B-X
an	B-X
experimental	B-X
study	B-X
C.	B-X
Feldmann	B-X
,	B-X
D.	B-X
Freitag	B-X
,	B-X
W.	B-X
Dersch	B-X
,	B-X
M.	B-X
Irqsusi	B-X
,	B-X
D.	B-X
Eschbach	B-X
,	B-X
T.	B-X
Steinfeldt	B-X
,	B-X
H.	B-X
Wulf	B-X
,	B-X
T.	B-X
Wiesmann	B-X
P310	B-X
Long	B-X
term	B-X
survival	B-X
and	B-X
functional	B-X
neurological	B-X
outcome	B-X
in	B-X
comatose	B-X
survivors	B-X
undergoing	B-X
therapeutic	B-X
hypothermia	B-X
N.	B-X
Kongpolprom	B-X
,	B-X
J.	B-X
Cholkraisuwat	B-X
P311	B-X
Impact	B-X
of	B-X
kidney	B-X
disease	B-X
on	B-X
mortality	B-X
and	B-X
neurological	B-X
outcome	B-X
in	B-X
out-of-hospital	B-X
cardiac	B-X
arrest	B-X
:	B-X
a	B-X
prospective	B-X
observational	B-X
study	B-X
S.	B-X
Beitland	B-X
,	B-X
E.	B-X
Nakstad	B-X
,	B-X
H.	B-X
Stær-Jensen	B-X
,	B-X
T.	B-X
Drægni	B-X
,	B-X
G.	B-X
Andersen	B-X
,	B-X
D.	B-X
Jacobsen	B-X
,	B-X
C.	B-X
Brunborg	B-X
,	B-X
B.	B-X
Waldum-Grevbo	B-X
,	B-X
K.	B-X
Sunde	B-X
P312	B-X
ICU	B-X
dependency	B-X
of	B-X
patients	B-X
admitted	B-X
after	B-X
primary	B-X
percutaneous	B-X
coronary	B-X
intervention	B-X
(	B-X
PPCI	B-X
)	B-X
following	B-X
out	B-X
of	B-X
the	B-X
hospital	B-X
cardiac	B-X
arrest	B-X
K.	B-X
Hoyland	B-X
,	B-X
D.	B-X
Pandit	B-X
P313	B-X
Prognostic	B-X
indicators	B-X
and	B-X
outcome	B-X
prediction	B-X
model	B-X
for	B-X
patients	B-X
with	B-X
return	B-X
of	B-X
spontaneous	B-X
circulation	B-X
from	B-X
cardiopulmonary	B-X
arrest	B-X
:	B-X
comprehensive	B-X
registry	B-X
of	B-X
in-hospital	B-X
intensive	B-X
care	B-X
on	B-X
OHCA	B-X
survival	B-X
(	B-X
critical	B-X
)	B-X
study	B-X
in	B-X
Osaka	B-X
,	B-X
Japan	B-X
K.	B-X
Hayakawa	B-X
P314	B-X
Cerebral	B-X
oxygen	B-X
saturation	B-X
during	B-X
resuscitation	B-X
in	B-X
a	B-X
porcine	B-X
model	B-X
of	B-X
cardiac	B-X
arrest	B-X
E.	B-X
Oloktsidou	B-X
,	B-X
K.	B-X
Kotzampassi	B-X
,	B-X
B.	B-X
Fyntanidou	B-X
,	B-X
S.	B-X
Patsatzakis	B-X
,	B-X
L.	B-X
Loukipoudi	B-X
,	B-X
E.	B-X
Doumaki	B-X
,	B-X
V.	B-X
Grosomanidis	B-X
P315	B-X
Presumption	B-X
of	B-X
cardiopulmonary	B-X
resuscitation	B-X
for	B-X
sustaining	B-X
cerebral	B-X
oxidation	B-X
using	B-X
regional	B-X
cerebral	B-X
saturation	B-X
of	B-X
oxygen	B-X
:	B-X
observational	B-X
cohort	B-X
study	B-X
(	B-X
press	B-X
study	B-X
)	B-X
H.	B-X
Yasuda	B-X
P316	B-X
EEG	B-X
reactivity	B-X
in	B-X
patients	B-X
after	B-X
cardiac	B-X
arrest	B-X
:	B-X
a	B-X
close	B-X
look	B-X
at	B-X
stimuli	B-X
MM	B-X
Admiraal	B-X
,	B-X
M.	B-X
Van	B-X
Assen	B-X
,	B-X
MJ	B-X
Van	B-X
Putten	B-X
,	B-X
M.	B-X
Tjepkema-Cloostermans	B-X
,	B-X
AF	B-X
Van	B-X
Rootselaar	B-X
,	B-X
J.	B-X
Horn	B-X
P317	B-X
Prognostic	B-X
value	B-X
of	B-X
neuron-specific	B-X
enolase	B-X
after	B-X
cardiac	B-X
arrest	B-X
F.	B-X
Ragusa	B-X
,	B-X
A.	B-X
Marudi	B-X
,	B-X
S.	B-X
Baroni	B-X
,	B-X
A.	B-X
Gaspari	B-X
,	B-X
E.	B-X
Bertellini	B-X
P318	B-X
Correlation	B-X
between	B-X
electroencephalographic	B-X
findings	B-X
and	B-X
serum	B-X
neuron	B-X
specific	B-X
enolase	B-X
with	B-X
outcome	B-X
of	B-X
post	B-X
cardiac	B-X
arrest	B-X
patients	B-X
A.	B-X
Taha	B-X
,	B-X
T.	B-X
Abdullah	B-X
,	B-X
S.	B-X
Abdel	B-X
Monem	B-X
P319	B-X
Introduction	B-X
of	B-X
a	B-X
targeted	B-X
temperature	B-X
management	B-X
strategy	B-X
following	B-X
cardiac	B-X
arrest	B-X
in	B-X
a	B-X
district	B-X
general	B-X
hospital	B-X
intensive	B-X
care	B-X
unit	B-X
.	B-X
A.	B-X
Patarchi	B-X
,	B-X
T.	B-X
Spina	B-X
P324	B-X
Factors	B-X
associated	B-X
with	B-X
ventilator	B-X
weaning	B-X
after	B-X
targeted	B-X
temperature	B-X
management	B-X
for	B-X
cardiac	B-X
arrest	B-X
patients	B-X
in	B-X
japan	B-X
H.	B-X
Tanaka	B-X
,	B-X
N.	B-X
Otani	B-X
,	B-X
S.	B-X
Ode	B-X
,	B-X
S.	B-X
Ishimatsu	B-X
P325	B-X
Differential	B-X
activation	B-X
of	B-X
c-fos	B-X
in	B-X
paraventricular	B-X
nuclei	B-X
of	B-X
the	B-X
hypothalamus	B-X
and	B-X
thalamus	B-X
of	B-X
the	B-X
rat	B-X
following	B-X
myocardial	B-X
infarction	B-X
J.	B-X
Cho	B-X
,	B-X
J	B-X
.	B-X
A	B-X
Marudi	B-X
,	B-X
S	B-X
Baroni	B-X
,	B-X
A	B-X
Gaspari	B-X
,	B-X
E	B-X
Bertellini	B-X
P330	B-X
Brain	B-X
magnetic	B-X
resonance	B-X
imaging	B-X
findings	B-X
in	B-X
patients	B-X
with	B-X
septic	B-X
shock	B-X
G.	B-X
Orhun	B-X
,	B-X
E.	B-X
Senturk	B-X
,	B-X
P.	B-X
E.	B-X
Ozcan	B-X
,	B-X
S.	B-X
Sencer	B-X
,	B-X
C.	B-X
Ulusoy	B-X
,	B-X
E.	B-X
Tuzun	B-X
,	B-X
F	B-X
.	B-X
Esen	B-X
P331	B-X
Benefits	B-X
of	B-X
L-carnitine	B-X
in	B-X
valproic	B-X
acid	B-X
induced	B-X
encephalopathy	B-X
R.	B-X
Tincu	B-X
,	B-X
C.	B-X
Cobilinschi	B-X
,	B-X
D.	B-X
Tomescu	B-X
,	B-X
Z.	B-X
Ghiorghiu	B-X
,	B-X
R.	B-X
Macovei	B-X
P332Automatic	B-X
analysis	B-X
of	B-X
EEG	B-X
reactivity	B-X
in	B-X
comatose	B-X
patients	B-X
M.	B-X
Van	B-X
Assen	B-X
,	B-X
M.	B-X
M.	B-X
Admiraal	B-X
,	B-X
M.	B-X
J	B-X
.	B-X
Real	B-X
,	B-X
M.	B-X
Abu-Habsa	B-X
,	B-X
R.	B-X
M.	B-X
Lyon	B-X
,	B-X
N.	B-X
P.	B-X
Oveland	B-X
P357	B-X
-	B-X
Ez-io®	B-X
intraosseous	B-X
access	B-X
teaching	B-X
in	B-X
the	B-X
workplace	B-X
using	B-X
a	B-X
mobile	B-X
‘	B-X
tea	B-X
trolley	B-X
’	B-X
training	B-X
method	B-X
J.	B-X
Penketh	B-X
,	B-X
M.	B-X
Mcdonald	B-X
,	B-X
F.	B-X
Kelly	B-X
P358	B-X
-	B-X
Black	B-X
widow	B-X
envenomation	B-X
in	B-X
Saudi	B-X
Arabia	B-X
:	B-X
a	B-X
prospective	B-X
observational	B-X
case	B-X
series	B-X
M.	B-X
Alfafi	B-X
,	B-X
S.	B-X
Alsolamy	B-X
,	B-X
W.	B-X
Almutairi	B-X
,	B-X
B.	B-X
Alotaibi	B-X
P359	B-X
-	B-X
Mechanical	B-X
ventilation	B-X
in	B-X
patients	B-X
with	B-X
overdose	B-X
not	B-X
yet	B-X
intubated	B-X
on	B-X
icu	B-X
admission	B-X
A.	B-X
E.	B-X
Van	B-X
den	B-X
Berg	B-X
,	B-X
Y.	B-X
Schriel	B-X
,	B-X
L.	B-X
Dawson	B-X
,	B-X
I.	B-X
P.	B-X
Killeen	B-X
,	B-X
M.	B-X
McPhail	B-X
,	B-X
W.	B-X
Bernal	B-X
,	B-X
J.	B-X
Maggs	B-X
,	B-X
J.	B-X
Wendon	B-X
,	B-X
T.	B-X
Hughes	B-X
P382	B-X
-	B-X
Systemic	B-X
inflammatory	B-X
response	B-X
syndrome	B-X
criteria	B-X
and	B-X
hospital	B-X
mortality	B-X
prediction	B-X
in	B-X
a	B-X
brazilian	B-X
cohort	B-X
of	B-X
critically	B-X
ill	B-X
patients	B-X
L.	B-X
U.	B-X
Taniguchi	B-X
,	B-X
E.	B-X
M.	B-X
Siqueira	B-X
,	B-X
J.	B-X
M.	B-X
Vieira	B-X
Jr	B-X
,	B-X
L.	B-X
C.	B-X
Azevedo	B-X
P383	B-X
-	B-X
Evaluating	B-X
the	B-X
efficacy	B-X
of	B-X
a	B-X
risk	B-X
predictor	B-X
panel	B-X
in	B-X
identifying	B-X
patients	B-X
at	B-X
elevated	B-X
risk	B-X
of	B-X
morbidity	B-X
following	B-X
emergency	B-X
admission	B-X
A.	B-X
N.	B-X
Ahmad	B-X
,	B-X
M.	B-X
Abu-Habsa	B-X
,	B-X
R.	B-X
Bahl	B-X
,	B-X
E.	B-X
Helme	B-X
,	B-X
S.	B-X
Hadfield	B-X
,	B-X
R.	B-X
Loveridge	B-X
P384	B-X
-	B-X
A	B-X
retrospective	B-X
comparison	B-X
of	B-X
outcomes	B-X
for	B-X
elective	B-X
surgical	B-X
patients	B-X
admitted	B-X
post-operatively	B-X
to	B-X
the	B-X
critical	B-X
care	B-X
unit	B-X
or	B-X
general	B-X
ward	B-X
J.	B-X
Shak	B-X
,	B-X
C.	B-X
Senver	B-X
,	B-X
R.	B-X
Howard-Griffin	B-X
P385	B-X
-	B-X
Effect	B-X
of	B-X
obesity	B-X
on	B-X
mortality	B-X
in	B-X
surgical	B-X
critically	B-X
ill	B-X
patients	B-X
.	B-X
P.	B-X
Wacharasint	B-X
,	B-X
P.	B-X
Fuengfoo	B-X
,	B-X
N.	B-X
Sukcharoen	B-X
,	B-X
R.	B-X
Rangsin	B-X
P386	B-X
-	B-X
The	B-X
national	B-X
early	B-X
warning	B-X
score	B-X
(	B-X
news	B-X
)	B-X
reliably	B-X
improves	B-X
adverse	B-X
clinical	B-X
outcome	B-X
prediction	B-X
in	B-X
community-acquired	B-X
pneumonia	B-X
-	B-X
results	B-X
from	B-X
a	B-X
6	B-X
year	B-X
follow-up	B-X
D.	B-X
Sbiti-Rohr	B-X
,	B-X
P.	B-X
Schuetz	B-X
P387	B-X
-	B-X
Clinical	B-X
usefulness	B-X
of	B-X
the	B-X
charlson¡¯s	B-X
weighted	B-X
index	B-X
of	B-X
comorbidities	B-X
_as	B-X
prognostic	B-X
factor	B-X
in	B-X
patients	B-X
with	B-X
prolonged	B-X
acute	B-X
mechanical	B-X
ventilation	B-X
H.	B-X
Na	B-X
,	B-X
S.	B-X
Song	B-X
,	B-X
S.	B-X
Lee	B-X
,	B-X
E.	B-X
Jeong	B-X
,	B-X
K.	B-X
Lee	B-X
P388	B-X
-	B-X
Comparison	B-X
of	B-X
mortality	B-X
prediction	B-X
scoring	B-X
systems	B-X
in	B-X
patients	B-X
with	B-X
cirrhosis	B-X
admitted	B-X
to	B-X
general	B-X
intensive	B-X
care	B-X
unit	B-X
M.	B-X
Cooper	B-X
,	B-X
K.	B-X
Milinis	B-X
,	B-X
G.	B-X
Williams	B-X
,	B-X
E.	B-X
McCarron	B-X
,	B-X
S.	B-X
Simants	B-X
,	B-X
I.	B-X
Patanwala	B-X
,	B-X
I.	B-X
D.	B-X
Welters	B-X
P389	B-X
-	B-X
Impact	B-X
of	B-X
admission	B-X
source	B-X
and	B-X
time	B-X
of	B-X
admission	B-X
on	B-X
outcome	B-X
of	B-X
pediatric	B-X
intensive	B-X
care	B-X
patients	B-X
:	B-X
retrospective	B-X
15	B-X
years	B-X
study	B-X
E.	B-X
Zoumpelouli	B-X
,	B-X
EA	B-X
Volakli	B-X
,	B-X
V.	B-X
Chrysohoidou	B-X
,	B-X
S.	B-X
Georgiou	B-X
,	B-X
K.	B-X
Charisopoulou	B-X
,	B-X
E.	B-X
Kotzapanagiotou	B-X
,	B-X
V.	B-X
Panagiotidou	B-X
,	B-X
K.	B-X
Manavidou	B-X
,	B-X
Z.	B-X
Stathi	B-X
,	B-X
M.	B-X
Sdougka	B-X
P390	B-X
-	B-X
Heart	B-X
rate	B-X
variability	B-X
and	B-X
outcomes	B-X
prediction	B-X
in	B-X
critical	B-X
illness	B-X
N.	B-X
Salahuddin	B-X
,	B-X
B.	B-X
AlGhamdi	B-X
,	B-X
Q.	B-X
Marashly	B-X
,	B-X
K.	B-X
Zaza	B-X
,	B-X
M.	B-X
Sharshir	B-X
,	B-X
M.	B-X
Khurshid	B-X
,	B-X
Z.	B-X
Ali	B-X
,	B-X
M.	B-X
Malgapo	B-X
,	B-X
M.	B-X
Jamil	B-X
,	B-X
A.	B-X
Shafquat	B-X
,	B-X
M.	B-X
Shoukri	B-X
,	B-X
M.	B-X
Hijazi	B-X
P391	B-X
-	B-X
The	B-X
incidence	B-X
and	B-X
outcome	B-X
of	B-X
hyperlactatemia	B-X
in	B-X
the	B-X
post	B-X
anaesthesia	B-X
care	B-X
unit	B-X
T.	B-X
Abe	B-X
,	B-X
S.	B-X
Uchino	B-X
,	B-X
M.	B-X
Takinami	B-X
P392	B-X
-	B-X
Correlation	B-X
between	B-X
arterial	B-X
blood	B-X
gas	B-X
disturbances	B-X
and	B-X
arterial	B-X
lactate	B-X
levels	B-X
during	B-X
hospitalization	B-X
and	B-X
outcome	B-X
in	B-X
critically	B-X
septic	B-X
patients	B-X
N.	B-X
R.	B-X
Rangel	B-X
Neto	B-X
,	B-X
S.	B-X
Oliveira	B-X
,	B-X
F.	B-X
Q.	B-X
Reis	B-X
,	B-X
F.	B-X
A.	B-X
Rocha	B-X
P393	B-X
-	B-X
External	B-X
validation	B-X
of	B-X
saps	B-X
3	B-X
and	B-X
mpm	B-X
iii	B-X
scores	B-X
in	B-X
48,816	B-X
patients	B-X
from	B-X
72	B-X
brazilian	B-X
icus	B-X
G.	B-X
Moralez	B-X
,	B-X
K.	B-X
Ebecken	B-X
,	B-X
L.	B-X
S.	B-X
Rabello	B-X
,	B-X
M.	B-X
F.	B-X
Lima	B-X
,	B-X
R.	B-X
Hatum	B-X
,	B-X
F.	B-X
V.	B-X
De	B-X
Marco	B-X
,	B-X
A.	B-X
Alves	B-X
,	B-X
J.	B-X
E.	B-X
Pinto	B-X
,	B-X
M.	B-X
Godoy	B-X
,	B-X
P.	B-X
E.	B-X
Brasil	B-X
,	B-X
F.	B-X
A.	B-X
Bozza	B-X
,	B-X
J.	B-X
I.	B-X
Salluh	B-X
,	B-X
M.	B-X
Soares	B-X
P394	B-X
-	B-X
The	B-X
frailty	B-X
penalty	B-X
:	B-X
pre-admission	B-X
functional	B-X
status	B-X
confounds	B-X
mortality	B-X
prediction	B-X
models	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
J.	B-X
Krinsley	B-X
,	B-X
G.	B-X
Kang	B-X
P395	B-X
-	B-X
‘	B-X
sooner	B-X
rather	B-X
than	B-X
later	B-X
”	B-X
:	B-X
how	B-X
delayed	B-X
discharge	B-X
from	B-X
critical	B-X
care	B-X
leads	B-X
to	B-X
increased	B-X
out	B-X
of	B-X
hours	B-X
discharges	B-X
and	B-X
subsequent	B-X
increase	B-X
in	B-X
in-hospital	B-X
mortality	B-X
.	B-X
R.	B-X
Knafelj	B-X
,	B-X
M.	B-X
Fister	B-X
P411	B-X
-	B-X
The	B-X
very	B-X
elderly	B-X
admitted	B-X
to	B-X
intensive	B-X
care	B-X
unit	B-X
:	B-X
outcomes	B-X
and	B-X
economic	B-X
evaluation	B-X
N.	B-X
Chin-Yee	B-X
,	B-X
G.	B-X
D	B-X
’	B-X
Egidio	B-X
,	B-X
K.	B-X
Thavorn	B-X
,	B-X
D.	B-X
Heyland	B-X
,	B-X
K.	B-X
Kyeremanteng	B-X
P412	B-X
-	B-X
The	B-X
very	B-X
elderly	B-X
in	B-X
intensive	B-X
care	B-X
:	B-X
relationship	B-X
between	B-X
acuity	B-X
of	B-X
illness	B-X
and	B-X
long-term	B-X
mortality	B-X
A.	B-X
G.	B-X
Murchison	B-X
,	B-X
K.	B-X
Swalwell	B-X
,	B-X
J.	B-X
Mandeville	B-X
,	B-X
D.	B-X
Stott	B-X
P413	B-X
-	B-X
Acquired	B-X
weakness	B-X
in	B-X
an	B-X
oncological	B-X
intensive	B-X
care	B-X
unit	B-X
I.	B-X
Guerreiro	B-X
P414	B-X
-	B-X
Musculoskeletal	B-X
problems	B-X
in	B-X
intensive	B-X
care	B-X
unit	B-X
(	B-X
ICU	B-X
)	B-X
patients	B-X
post-discharge	B-X
H.	B-X
Devine	B-X
,	B-X
P.	B-X
MacTavish	B-X
,	B-X
J.	B-X
McPeake	B-X
,	B-X
T.	B-X
Quasim	B-X
,	B-X
J.	B-X
Kinsella	B-X
,	B-X
M.	B-X
Daniel	B-X
P415	B-X
-	B-X
Premorbid	B-X
obesity	B-X
,	B-X
but	B-X
not	B-X
nutrition	B-X
,	B-X
prevents	B-X
critical	B-X
illness-induced	B-X
muscle	B-X
wasting	B-X
and	B-X
weakness	B-X
C.	B-X
Goossens	B-X
M.	B-X
B.	B-X
Marques	B-X
,	B-X
S.	B-X
Derde	B-X
,	B-X
S.	B-X
Vander	B-X
Perre	B-X
,	B-X
T.	B-X
Dufour	B-X
,	B-X
S.	B-X
E.	B-X
Thiessen	B-X
,	B-X
F.	B-X
Güiza	B-X
,	B-X
T.	B-X
Janssens	B-X
,	B-X
G.	B-X
Hermans	B-X
,	B-X
I.	B-X
Vanhorebeek	B-X
,	B-X
K.	B-X
De	B-X
Bock	B-X
,	B-X
G.	B-X
Van	B-X
den	B-X
Berghe	B-X
,	B-X
L.	B-X
Langouche	B-X
P416	B-X
-	B-X
Physical	B-X
outcome	B-X
measures	B-X
for	B-X
critical	B-X
care	B-X
patients	B-X
following	B-X
intensive	B-X
care	B-X
unit	B-X
(	B-X
icu	B-X
)	B-X
discharge	B-X
H.	B-X
Devine	B-X
,	B-X
P.	B-X
MacTavish	B-X
,	B-X
T.	B-X
Quasim	B-X
,	B-X
J.	B-X
Kinsella	B-X
,	B-X
M.	B-X
Daniel	B-X
,	B-X
J.	B-X
McPeake	B-X
P417	B-X
-	B-X
Improving	B-X
active	B-X
mobilisation	B-X
in	B-X
a	B-X
general	B-X
intensive	B-X
care	B-X
unit	B-X
B.	B-X
P.	B-X
Morelli	B-X
,	B-X
M.	B-X
Degiovanangelo	B-X
,	B-X
F.	B-X
Lemos	B-X
,	B-X
V.	B-X
MArtinez	B-X
,	B-X
F.	B-X
Verga	B-X
,	B-X
J.	B-X
Cabrera	B-X
,	B-X
G.	B-X
Burghi	B-X
P460	B-X
-	B-X
Guidance	B-X
of	B-X
visiting	B-X
children	B-X
at	B-X
an	B-X
adult	B-X
intensive	B-X
care	B-X
unit	B-X
(	B-X
icu	B-X
)	B-X
A.	B-X
Rutten	B-X
,	B-X
S.	B-X
Van	B-X
Ieperen	B-X
,	B-X
S.	B-X
De	B-X
Geer	B-X
,	B-X
M.	B-X
Van	B-X
Vugt	B-X
,	B-X
E.	B-X
Der	B-X
Kinderen	B-X
P461	B-X
-	B-X
Visiting	B-X
policies	B-X
in	B-X
Italian	B-X
pediatric	B-X
ICUs	B-X
:	B-X
an	B-X
update	B-X
A.	B-X
Giannini	B-X
,	B-X
G	B-X
Miccinesi	B-X
,	B-X
T	B-X
Marchesi	B-X
,	B-X
E	B-X
Prandi	B-X

Tether	O
assays	O
with	O
DeltayhjH	O
DeltacheZ	O
double	O
mutants	O
showed	O
flagellar	O
rotation	O
indistinguishable	O
from	O
cheZ	O
single	O
mutants	O
(	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
null	O
mutations	O
in	O
cheZ	O
are	O
epistatic	O
to	O
null	O
mutations	O
in	O
yhjH	O
.	O

Together	O
,	O
these	O
results	O
indicate	O
that	O
the	O
yhjH	O
gene	O
product	O
is	O
involved	O
with	O
the	O
frequency	O
of	O
flagellar	O
motor	O
switching	O
,	O
a	O
process	O
that	O
is	O
among	O
the	O
remaining	O
puzzles	O
in	O
bacterial	O
chemotaxis	O
[	O
45	O
]	O
.	O

Genome	O
-	O
Wide	O
Identification	O
of	O
Genetic	O
Interactions	O
<EOS>	B-X
Genome	B-X
data	B-X
have	B-X
accumulated	B-X
rapidly	B-X
in	B-X
recent	B-X
years	B-X
,	B-X
doubling	B-X
roughly	B-X
after	B-X
every	B-X
6	B-X
months	B-X
due	B-X
to	B-X
the	B-X
influx	B-X
of	B-X
next-generation	B-X
sequencing	B-X
technologies	B-X
.	B-X
Genome-wide	B-X
association	B-X
studies	B-X
(	B-X
GWAS	B-X
)	B-X
have	B-X
enabled	B-X
the	B-X
discovery	B-X
of	B-X
candidate	B-X
markers	B-X
that	B-X
play	B-X
significant	B-X
roles	B-X
in	B-X
various	B-X
complex	B-X
traits	B-X
in	B-X
plants	B-X
.	B-X
Genetics	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
late-onset	B-X
Alzheimer	B-X
's	B-X
Disease	B-X
(	B-X
AD	B-X
)	B-X
etiology	B-X
and	B-X
dozens	B-X
of	B-X
genetic	B-X
variants	B-X
have	B-X
been	B-X
implicated	B-X
in	B-X
AD	B-X
risk	B-X
through	B-X
large-scale	B-X
GWAS	B-X
meta-analyses	B-X
.	B-X
Identification	B-X
of	B-X
causal	B-X
drivers	B-X
behind	B-X
regulatory	B-X
gene	B-X
networks	B-X
is	B-X
crucial	B-X
in	B-X
understanding	B-X
gene	B-X
function	B-X
.	B-X

The	O
identification	O
of	O
novel	O
genes	O
that	O
influence	O
the	O
expression	O
of	O
a	O
phenotype	O
is	O
only	O
the	O
first	O
step	O
towards	O
understanding	O
its	O
genetic	O
basis	O
.	O

Gene	O
products	O
function	O
within	O
the	O
context	O
of	O
highly	O
interconnected	O
structural	O
and	O
regulatory	O
networks	O
.	O

We	O
can	O
dissect	O
the	O
genetic	O
network	O
context	O
in	O
which	O
newly	O
identified	O
genes	O
function	O
by	O
making	O
libraries	O
of	O
double	O
mutants	O
in	O
which	O
a	O
transposon	O
library	O
is	O
constructed	O
in	O
the	O
background	O
of	O
a	O
mutation	O
of	O
interest	O
.	O

The	O
phenotypic	O
characterization	O
of	O
this	O
library	O
by	O
a	O
screen	O
or	O
selection	O
can	O
identify	O
genetic	O
interactions	O
between	O
the	O
query	O
mutation	O
and	O
all	O
possible	O
insertional	O
mutations	O
in	O
the	O
genome	O
,	O
thereby	O
revealing	O
the	O
local	O
genetic	O
context	O
in	O
which	O
the	O
query	O
locus	O
functions	O
to	O
influence	O
the	O
phenotype	O
.	O
<EOS>	B-X
Forward	B-X
genetic	B-X
screens	B-X
are	B-X
powerful	B-X
tools	B-X
for	B-X
the	B-X
unbiased	B-X
discovery	B-X
and	B-X
functional	B-X
characterization	B-X
of	B-X
specific	B-X
genetic	B-X
elements	B-X
associated	B-X
with	B-X
a	B-X
phenotype	B-X
of	B-X
interest	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
RNA-guided	B-X
endonuclease	B-X
Cas9	B-X
from	B-X
the	B-X
microbial	B-X
CRISPR	B-X
(	B-X
clustered	B-X
regularly	B-X
interspaced	B-X
short	B-X
palindromic	B-X
repeats	B-X
)	B-X
immune	B-X
system	B-X
has	B-X
been	B-X
adapted	B-X
for	B-X
genome-scale	B-X
screening	B-X
by	B-X
combining	B-X
Cas9	B-X
with	B-X
pooled	B-X
guide	B-X
RNA	B-X
libraries	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
a	B-X
protocol	B-X
for	B-X
genome-scale	B-X
knockout	B-X
and	B-X
transcriptional	B-X
activation	B-X
screening	B-X
using	B-X
the	B-X
CRISPR-Cas9	B-X
system	B-X
.	B-X
Custom-	B-X
or	B-X
ready-made	B-X
guide	B-X
RNA	B-X
libraries	B-X
are	B-X
constructed	B-X
and	B-X
packaged	B-X
into	B-X
lentiviral	B-X
vectors	B-X
for	B-X
delivery	B-X
into	B-X
cells	B-X
for	B-X
screening	B-X
.	B-X
As	B-X
each	B-X
screen	B-X
is	B-X
unique	B-X
,	B-X
we	B-X
provide	B-X
guidelines	B-X
for	B-X
determining	B-X
screening	B-X
parameters	B-X
and	B-X
maintaining	B-X
sufficient	B-X
coverage	B-X
.	B-X
To	B-X
validate	B-X
candidate	B-X
genes	B-X
identified	B-X
by	B-X
the	B-X
screen	B-X
,	B-X
we	B-X
further	B-X
describe	B-X
strategies	B-X
for	B-X
confirming	B-X
the	B-X
screening	B-X
phenotype	B-X
,	B-X
as	B-X
well	B-X
as	B-X
genetic	B-X
perturbation	B-X
,	B-X
through	B-X
analysis	B-X
of	B-X
indel	B-X
rate	B-X
and	B-X
transcriptional	B-X
activation	B-X
.	B-X
Beginning	B-X
with	B-X
library	B-X
design	B-X
,	B-X
a	B-X
genome-scale	B-X
screen	B-X
can	B-X
be	B-X
completed	B-X
in	B-X
9-15	B-X
weeks	B-X
,	B-X
followed	B-X
by	B-X
4-5	B-X
weeks	B-X
of	B-X
validation	B-X
.	B-X

Systematic	O
analyses	O
of	O
such	O
interactions	O
in	O
yeast	B-Organism
[	O
46	O
,	O
47	O
]	O
are	O
providing	O
a	O
wealth	O
of	O
knowledge	O
about	O
gene	O
function	O
and	O
pathway	O
organization	O
.	O

An	O
important	O
class	O
of	O
such	O
interactions	O
is	O
suppressor	O
mutations	O
that	O
either	O
partially	O
or	O
fully	O
restore	O
the	O
phenotype	O
deficits	O
of	O
a	O
query	O
mutation	O
.	O
<EOS>	B-X
CD8	B-X
(	B-X
+	B-X
)	B-X
cytotoxic	B-X
T	B-X
lymphocytes	B-X
(	B-X
CTL	B-X
)	B-X
are	B-X
important	B-X
for	B-X
the	B-X
immunological	B-X
control	B-X
of	B-X
infections	B-X
and	B-X
tumours	B-X
.	B-X
Engagement	B-X
of	B-X
the	B-X
T-cell	B-X
receptor	B-X
(	B-X
TCR	B-X
)	B-X
with	B-X
major	B-X
histocompatibility	B-X
complex	B-X
(	B-X
MHC	B-X
)	B-X
class	B-X
I/peptide	B-X
complexes	B-X
on	B-X
antigen-presenting	B-X
cells	B-X
(	B-X
APC	B-X
)	B-X
is	B-X
the	B-X
key	B-X
interaction	B-X
,	B-X
which	B-X
initiates	B-X
the	B-X
process	B-X
of	B-X
T-cell	B-X
activation	B-X
.	B-X
Molecular	B-X
alterations	B-X
in	B-X
the	B-X
peptide	B-X
bound	B-X
to	B-X
the	B-X
MHC	B-X
class	B-X
I	B-X
can	B-X
lead	B-X
to	B-X
a	B-X
lower	B-X
affinity	B-X
of	B-X
the	B-X
MHC	B-X
:	B-X
TCR	B-X
interaction	B-X
resulting	B-X
in	B-X
incomplete	B-X
or	B-X
qualitatively	B-X
different	B-X
T-cell	B-X
responses	B-X
.	B-X
Emerging	B-X
evidence	B-X
suggests	B-X
long	B-X
noncoding	B-X
RNA	B-X
(	B-X
lncRNA	B-X
)	B-X
as	B-X
an	B-X
important	B-X
class	B-X
of	B-X
regulatory	B-X
molecules	B-X
that	B-X
control	B-X
the	B-X
p53	B-X
signaling	B-X
.	B-X
Functionally	B-X
,	B-X
EMS	B-X
is	B-X
able	B-X
to	B-X
exert	B-X
its	B-X
oncogenic	B-X
activities	B-X
,	B-X
at	B-X
least	B-X
partially	B-X
,	B-X
via	B-X
the	B-X
CPEB2-p53	B-X
axis	B-X
.	B-X

In	O
a	O
genome	O
-	O
wide	O
effort	O
to	O
identify	O
suppressors	O
of	O
swimming	O
defects	O
,	O
additional	O
libraries	O
of	O
transposon	O
insertional	O
mutants	O
were	O
created	O
in	O
genetic	O
backgrounds	O
containing	O
gene	O
deletions	O
of	O
interest	O
.	O

Secondary	O
insertional	O
mutations	O
were	O
observed	O
to	O
suppress	O
motility	O
defects	O
in	O
Deltahns	O
and	O
DeltayhjH	O
genetic	O
backgrounds	O
(	O
Figures	O
6C	O
and	O
S8A	O
)	O
.	O

These	O
suppressor	O
mutations	O
were	O
identified	O
by	O
inoculating	O
soft	O
-	O
agar	O
plates	O
with	O
approximately108	O
double	O
mutants	O
and	O
extracting	O
cells	O
from	O
the	O
motile	O
front	O
after	O
approximately20	O
h	O
of	O
incubation	O
at	O
30	O
degreesC	O
.	O

A	O
sample	O
of	O
suppressor	O
mutants	O
extracted	O
from	O
the	O
extreme	O
edge	O
of	O
the	O
motile	O
front	O
was	O
used	O
for	O
both	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
,	O
and	O
for	O
isolation	O
of	O
individual	O
mutants	O
for	O
subsequent	O
characterization	O
.	O

Transposon	O
insertion	O
sites	O
were	O
identified	O
in	O
individual	O
clones	O
by	O
applying	O
the	O
genetic	O
footprinting	O
procedure	O
outlined	O
in	O
Figure	O
S1	O
.	O

Among	O
the	O
18	O
suppressor	O
mutants	O
sampled	O
at	O
random	O
from	O
the	O
DeltayhjH	O
background	O
,	O
half	O
had	O
insertions	O
in	O
different	O
regions	O
of	O
ycgR	O
,	O
a	O
gene	O
encoding	O
a	O
protein	O
of	O
unknown	O
function	O
(	O
Figure	O
6D	O
)	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
a	O
recent	O
report	O
in	O
which	O
the	O
inactivation	O
of	O
ycgR	O
was	O
observed	O
to	O
improve	O
motility	O
of	O
yhjH	O
mutants	O
[	O
48	O
]	O
.	O

The	O
other	O
half	O
of	O
DeltayhjH	O
suppressor	O
mutations	O
were	O
found	O
to	O
contain	O
insertions	O
within	O
the	O
intergenic	O
region	O
between	O
the	O
divergently	O
transcribed	O
genes	O
yfgF	O
and	O
yfgG	O
,	O
which	O
encode	O
gene	O
products	O
of	O
unknown	O
function	O
.	O

P1	O
transduction	O
of	O
this	O
insertion	O
to	O
the	O
DeltayhjH	O
isogenic	O
background	O
confirmed	O
the	O
ability	O
of	O
the	O
insertion	O
to	O
suppress	O
the	O
motility	O
defect	O
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
deletions	O
of	O
either	O
yfgF	O
or	O
yfgG	O
produced	O
no	O
measurable	O
difference	O
in	O
motility	O
in	O
the	O
DeltayhjH	O
background	O
(	O
Figure	O
S9	O
)	O
.	O

Conversely	O
,	O
overexpression	O
of	O
yfgF	O
(	O
but	O
not	O
yfgG	O
)	O
was	O
found	O
to	O
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	O
mutants	O
(	O
Figure	O
6E	O
)	O
.	O

Microarray	O
-	O
based	O
genetic	O
footprinting	O
of	O
the	O
entire	O
pool	O
of	O
mutants	O
extracted	O
from	O
the	O
motile	O
front	O
guided	O
the	O
identification	O
of	O
five	O
additional	O
suppressor	O
mutations	O
(	O
Figure	O
6F	O
;	O
Dataset	O
S11	O
)	O
.	O

Among	O
the	O
loci	O
that	O
partially	O
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	O
are	O
fliZ	O
(	O
a	O
gene	O
predicted	O
to	O
be	O
a	O
regulator	O
of	O
the	O
flagellum	O
-	O
specific	O
sigma	O
factor	O
sigma28	O
)	O
,	O
yfiR	O
(	O
a	O
gene	O
identified	O
in	O
the	O
selection	O
for	O
swarming	O
motility	O
defective	O
mutants	O
)	O
,	O
and	O
three	O
additional	O
genes	O
of	O
unknown	O
function	O
:	O
yjdA	O
,	O
yjcZ	O
,	O
and	O
yegE	O
.	O

We	O
hypothesize	O
that	O
mutations	O
partially	O
suppressing	O
the	O
chemotaxis	O
defect	O
of	O
DeltayhjH	O
mutants	O
do	O
so	O
by	O
correcting	O
the	O
severe	O
CCW	O
flagellar	O
rotation	O
bias	O
.	O

When	O
combined	O
in	O
the	O
same	O
background	O
,	O
these	O
mutations	O
may	O
bring	O
the	O
motor	O
bias	O
closer	O
to	O
the	O
optimal	O
operating	O
point	O
for	O
chemotaxis	O
,	O
either	O
by	O
having	O
an	O
opposing	O
effect	O
on	O
the	O
intracellular	O
concentration	O
of	O
signaling	O
molecules	O
known	O
to	O
affect	O
motility	O
(	O
discussed	O
in	O
the	O
next	O
section	O
)	O
or	O
by	O
an	O
unknown	O
mechanism	O
that	O
overrides	O
the	O
CCW	O
bias	O
.	O

Further	O
studies	O
are	O
underway	O
to	O
explore	O
the	O
functional	O
relationship	O
between	O
yhjH	O
and	O
these	O
suppressor	O
mutations	O
.	O

The	O
mechanisms	O
by	O
which	O
deletion	O
of	O
yegE	O
and	O
overexpression	O
of	O
yfgF	O
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	O
mutants	O
are	O
discussed	O
in	O
the	O
next	O
section	O
.	O

Suppressor	O
mutations	O
identified	O
in	O
the	O
Deltahns	O
background	O
are	O
shown	O
and	O
discussed	O
in	O
Figure	O
S8	O
,	O
and	O
the	O
microarray	O
results	O
can	O
be	O
found	O
in	O
Dataset	O
S12	O
.	O

The	O
Role	O
of	O
the	O
C	O
-	O
di	O
-	O
GMP	O
Second	O
-	O
Messenger	O
System	O
in	O
Swimming	O
and	O
Swarming	O
Motility	O

Based	O
on	O
sequence	O
homology	O
,	O
YhjH	O
,	O
YfgF	O
,	O
and	O
YegE	O
belong	O
to	O
the	O
newly	O
identified	O
and	O
highly	O
prevalent	O
family	O
of	O
proteins	O
that	O
function	O
in	O
the	O
turnover	O
of	O
bis	O
-	O
(	O
3	O
'	O
-	O
5	O
'	O
)	O
-	O
cyclic	O
dimeric	O
guanosine	O
monophosphate	O
(	O
c	O
-	O
di	O
-	O
GMP	O
)	O
,	O
which	O
is	O
a	O
second	O
messenger	O
involved	O
in	O
the	O
regulation	O
of	O
a	O
wide	O
variety	O
of	O
bacterial	O
behaviors	O
[	O
49	O
]	O
.	O

Synthesis	O
of	O
c	O
-	O
di	O
-	O
GMP	O
is	O
catalyzed	O
by	O
diguanylate	O
cyclases	O
(	O
DGC	O
)	O
and	O
its	O
degradation	O
is	O
regulated	O
by	O
phosphodiesterases	O
(	O
PDE	O
)	O
.	O
<EOS>	B-X
The	B-X
ubiquitous	B-X
bacterial	B-X
second	B-X
messenger	B-X
c-di-GMP	B-X
is	B-X
intensively	B-X
studied	B-X
in	B-X
pathogens	B-X
but	B-X
less	B-X
so	B-X
in	B-X
mutualistic	B-X
bacteria	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
a	B-X
genome-wide	B-X
investigation	B-X
of	B-X
functional	B-X
diguanylate	B-X
cyclases	B-X
(	B-X
DGCs	B-X
)	B-X
synthesizing	B-X
c-di-GMP	B-X
from	B-X
two	B-X
molecules	B-X
of	B-X
GTP	B-X
in	B-X
Sinorhizobium	B-X
fredii	B-X
CCBAU45436	B-X
,	B-X
a	B-X
facultative	B-X
microsymbiont	B-X
fixing	B-X
nitrogen	B-X
in	B-X
nodules	B-X
of	B-X
diverse	B-X
legumes	B-X
,	B-X
including	B-X
soybean	B-X
.	B-X
Among	B-X
25	B-X
proteins	B-X
harboring	B-X
a	B-X
putative	B-X
GGDEF	B-X
domain	B-X
catalyzing	B-X
the	B-X
biosynthesis	B-X
of	B-X
c-di-GMP	B-X
,	B-X
eight	B-X
functional	B-X
DGCs	B-X
were	B-X
identified	B-X
by	B-X
heterogenous	B-X
expression	B-X
in	B-X
Escherichia	B-X
coli	B-X
in	B-X
a	B-X
Congo	B-X
red	B-X
binding	B-X
assay	B-X
.	B-X
This	B-X
screening	B-X
result	B-X
was	B-X
further	B-X
verified	B-X
by	B-X

The	O
cyclase	O
and	O
phosphodiesterase	O
activities	O
have	O
been	O
attributed	O
to	O
GGDEF	O
and	O
EAL	O
protein	O
domains	O
,	O
respectively	O
[	O
50	O
,	O
51	O
]	O
,	O
and	O
the	O
activity	O
of	O
these	O
domains	O
is	O
known	O
to	O
have	O
opposite	O
effects	O
on	O
motility	O
[	O
52	O
]	O
.	O

YhjH	O
contains	O
an	O
EAL	O
domain	O
,	O
and	O
expression	O
of	O
this	O
protein	O
leads	O
to	O
the	O
degradation	O
of	O
c	O
-	O
di	O
-	O
GMP	O
and	O
enhanced	O
motility	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
[	O
52	O
]	O
.	O

Based	O
on	O
this	O
observation	O
and	O
because	O
EAL	O
domain	O
proteins	O
function	O
in	O
the	O
degradation	O
of	O
c	O
-	O
di	O
-	O
GMP	O
,	O
we	O
hypothesized	O
that	O
the	O
motility	O
defect	O
of	O
DeltayhjH	O
(	O
Figure	O
1C	O
)	O
is	O
a	O
result	O
of	O
increased	O
intracellular	O
levels	O
of	O
c	O
-	O
di	O
-	O
GMP	O
.	O

YegE	O
and	O
YfgF	O
both	O
contain	O
an	O
EAL	O
domain	O
C	O
-	O
terminal	O
to	O
a	O
GGDEF	O
domain	O
(	O
Figure	O
6G	O
)	O
.	O

The	O
presence	O
of	O
domains	O
of	O
opposing	O
activities	O
in	O
a	O
single	O
protein	O
complicates	O
functional	O
inferences	O
.	O

However	O
,	O
a	O
single	O
GGDEF	O
/	O
EAL	O
composite	O
protein	O
exhibiting	O
concomitant	O
DGC	O
and	O
PDE	O
activities	O
has	O
not	O
been	O
reported	O
.	O

In	O
addition	O
,	O
several	O
GGDEF	O
/	O
EAL	O
composite	O
proteins	O
were	O
found	O
to	O
exhibit	O
either	O
DGC	O
or	O
PDE	O
activity	O
[	O
53	O
,	O
54	O
]	O
.	O
<EOS>	B-X
(	B-X
1	B-X
)	B-X
A	B-X
theoretical	B-X
analysis	B-X
of	B-X
the	B-X
activation	B-X
steps	B-X
of	B-X
the	B-X
cGMP	B-X
cascade	B-X
shows	B-X
that	B-X
after	B-X
a	B-X
brief	B-X
flash	B-X
of	B-X
phi	B-X
photoisomerizations	B-X
the	B-X
number	B-X
of	B-X
activated	B-X
PDE	B-X
molecules	B-X
should	B-X
rise	B-X
as	B-X
a	B-X
delayed	B-X
ramp	B-X
with	B-X
slope	B-X
proportional	B-X
to	B-X
phi	B-X
,	B-X
and	B-X
that	B-X
,	B-X
as	B-X
a	B-X
consequence	B-X
,	B-X
the	B-X
cGMP-activated	B-X
current	B-X
should	B-X
decay	B-X
as	B-X
a	B-X
delayed	B-X
Gaussian	B-X
function	B-X
of	B-X
time	B-X
(	B-X
Eqn	B-X
.	B-X
(	B-X
ii	B-X
)	B-X
The	B-X
delayed	B-X
ramp	B-X
behavior	B-X
of	B-X
PDE	B-X
activation	B-X
and	B-X
the	B-X
consequent	B-X
decline	B-X
of	B-X
current	B-X
in	B-X
the	B-X
form	B-X
of	B-X
the	B-X
delayed	B-X
Gaussian	B-X
are	B-X
confirmed	B-X
by	B-X
experiments	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
photoreceptors	B-X
;	B-X
the	B-X
analysis	B-X
thus	B-X
yields	B-X
estimates	B-X
of	B-X
the	B-X
amplification	B-X
constant	B-X
from	B-X
these	B-X
diverse	B-X
photoreceptors	B-X
.	B-X
20	B-X
further	B-X
predicts	B-X
that	B-X
the	B-X
response-intensity	B-X
relation	B-X
at	B-X
any	B-X
fixed	B-X
time	B-X
should	B-X
saturate	B-X
exponentially	B-X
,	B-X
as	B-X
has	B-X
been	B-X
found	B-X
experimentally	B-X
.	B-X
9	B-X
and	B-X
21	B-X
)	B-X
,	B-X
where	B-X
(	B-X
i	B-X
)	B-X
nu	B-X
RG	B-X
is	B-X
the	B-X
rate	B-X
of	B-X
G	B-X
*	B-X
production	B-X
per	B-X
Rh	B-X
*	B-X
;	B-X
(	B-X
ii	B-X
)	B-X
cGP	B-X
is	B-X
the	B-X
efficiency	B-X
of	B-X
the	B-X
coupling	B-X
between	B-X
G	B-X
*	B-X
production	B-X
and	B-X
PDE	B-X
*	B-X
production	B-X
;	B-X
(	B-X
iii	B-X
)	B-X
beta	B-X
sub	B-X
is	B-X
the	B-X
increment	B-X
in	B-X
hydrolytic	B-X
rate	B-X
constant	B-X
produced	B-X
by	B-X
one	B-X
PDE	B-X
*	B-X
,	B-X
i.e.	B-X
,	B-X
a	B-X
single	B-X
activated	B-X
catalytic	B-X
subunit	B-X
of	B-X
PDE	B-X
;	B-X
and	B-X
(	B-X
iv	B-X
)	B-X
n	B-X
is	B-X
the	B-X
Hill	B-X
coefficient	B-X
of	B-X
opening	B-X
of	B-X
the	B-X
cGMP-activated	B-X
channels	B-X
.	B-X
(	B-X
3	B-X
)	B-X
The	B-X
amplification	B-X
factor	B-X
beta	B-X
sub	B-X
includes	B-X
the	B-X
ratio	B-X
kcat/Km	B-X
,	B-X
which	B-X
characterizes	B-X
the	B-X
hydrolytic	B-X
activity	B-X
of	B-X
the	B-X
PDE	B-X
in	B-X
vivo	B-X
where	B-X
cG	B-X
<	B-X
<	B-X
Km	B-X
.	B-X

Based	O
on	O
the	O
known	O
antagonistic	O
effects	O
of	O
c	O
-	O
di	O
-	O
GMP	O
on	O
motility	O
[	O
52	O
]	O
and	O
by	O
following	O
several	O
lines	O
of	O
reasoning	O
,	O
we	O
hypothesized	O
the	O
dominant	O
enzymatic	O
activities	O
of	O
the	O
GGDEF	O
and	O
EAL	O
domains	O
in	O
YfgF	O
and	O
YegE	O
.	O

We	O
argue	O
that	O
YfgF	O
has	O
an	O
active	O
EAL	O
domain	O
and	O
functions	O
as	O
a	O
PDE	O
based	O
on	O
three	O
observations	O
:	O
(	O
1	O
)	O
expression	O
of	O
this	O
gene	O
enhances	O
motility	O
of	O
the	O
DeltayhjH	O
strain	O
(	O
Figure	O
6E	O
)	O
;	O
(	O
2	O
)	O
the	O
amino	O
acid	O
sequence	O
of	O
YfgF	O
shows	O
similarity	O
to	O
enzymatically	O
active	O
EAL	O
domains	O
(	O
Figure	O
S10	O
)	O
;	O
and	O
(	O
3	O
)	O
the	O
amino	O
acid	O
sequence	O
lacks	O
a	O
complete	O
GGDEF	O
motif	O
needed	O
for	O
DGC	O
activity	O
(	O
data	O
not	O
shown	O
)	O
.	O

Likewise	O
,	O
three	O
observations	O
suggest	O
that	O
the	O
EAL	O
domain	O
in	O
YegE	O
is	O
inactive	O
and	O
that	O
this	O
protein	O
functions	O
primarily	O
as	O
a	O
DGC	O
:	O
(	O
1	O
)	O
deletion	O
of	O
YegE	O
enhances	O
motility	O
of	O
the	O
DeltayhjH	O
strain	O
(	O
Figure	O
6F	O
)	O
;	O
(	O
2	O
)	O
the	O
amino	O
acid	O
sequence	O
of	O
the	O
EAL	O
domain	O
in	O
YegE	O
is	O
not	O
consistent	O
with	O
an	O
enzymatically	O
active	O
form	O
(	O
Figure	O
S10	O
)	O
;	O
and	O
(	O
3	O
)	O
YegE	O
contains	O
an	O
intact	O
GGDEF	O
motif	O
(	O
data	O
not	O
shown	O
)	O
.	O

Based	O
on	O
these	O
observations	O
,	O
we	O
propose	O
that	O
deleting	O
yegE	O
and	O
over	O
-	O
expressing	O
yfgF	O
suppress	O
the	O
motility	O
defect	O
of	O
the	O
DeltayhjH	O
strain	O
by	O
reducing	O
the	O
intracellular	O
levels	O
of	O
c	O
-	O
di	O
-	O
GMP	O
(	O
Figure	O
7	O
)	O
.	O

Deletion	O
of	O
yegE	O
and	O
over	O
-	O
expression	O
of	O
yfgF	O
did	O
not	O
have	O
significant	O
effects	O
on	O
the	O
motility	O
of	O
the	O
wild	O
-	O
type	O
strain	O
(	O
unpublished	O
data	O
)	O
.	O

E	B-Organism
.	I-Organism
coli	I-Organism
has	O
19	O
genes	O
encoding	O
proteins	O
with	O
GGDEF	O
domains	O
[	O
55	O
]	O
.	O

If	O
c	O
-	O
di	O
-	O
GMP	O
levels	O
act	O
globally	O
and	O
can	O
influence	O
motility	O
,	O
then	O
insertions	O
in	O
many	O
of	O
the	O
genes	O
containing	O
active	O
GGDEF	O
domains	O
should	O
rescue	O
motility	O
in	O
the	O
DeltayhjH	O
double	O
mutant	O
library	O
.	O

However	O
,	O
the	O
results	O
of	O
the	O
genome	O
-	O
wide	O
screen	O
for	O
suppressors	O
of	O
the	O
DeltayhjH	O
motility	O
defect	O
reveals	O
that	O
this	O
is	O
not	O
the	O
case	O
(	O
Table	O
S2	O
)	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
expression	O
and	O
/	O
or	O
enzymatic	O
activities	O
of	O
these	O
GGDEF	O
-	O
containing	O
proteins	O
may	O
be	O
under	O
precise	O
context	O
-	O
dependent	O
control	O
.	O
<EOS>	B-X
Dystrophin	B-X
protein	B-X
71	B-X
(	B-X
Dp71	B-X
)	B-X
is	B-X
the	B-X
major	B-X
DMD	B-X
gene	B-X
product	B-X
expressed	B-X
in	B-X
the	B-X
brain	B-X
and	B-X
mutations	B-X
affecting	B-X
its	B-X
expression	B-X
are	B-X
associated	B-X
with	B-X
the	B-X
DMD	B-X
neuropsychiatric	B-X
syndrome	B-X
.	B-X
We	B-X
then	B-X
review	B-X
the	B-X
gene	B-X
expression	B-X
,	B-X
RNA	B-X
processing	B-X
and	B-X
functions	B-X
of	B-X
Dp71	B-X
.	B-X
The	B-X
literature	B-X
suggests	B-X
changes	B-X
observed	B-X
in	B-X
the	B-X
DMD	B-X
brain	B-X
are	B-X
neurodevelopmental	B-X
in	B-X
origin	B-X
and	B-X
that	B-X
their	B-X
risk	B-X
and	B-X
severity	B-X
is	B-X
associated	B-X
with	B-X
a	B-X
cumulative	B-X
loss	B-X
of	B-X
distal	B-X
DMD	B-X
gene	B-X
products	B-X
such	B-X
as	B-X
Dp71	B-X
.	B-X
The	B-X
term	B-X
epigenetics	B-X
was	B-X
coined	B-X
in	B-X
the	B-X
context	B-X
of	B-X
developmental	B-X
studies	B-X
,	B-X
but	B-X
the	B-X
meaning	B-X
of	B-X
the	B-X
term	B-X
has	B-X
evolved	B-X
over	B-X
time	B-X
.	B-X
Epigenetic	B-X
modulators	B-X
of	B-X
gene	B-X
expression	B-X
are	B-X
now	B-X
known	B-X
to	B-X
include	B-X
DNA	B-X
methylation	B-X
,	B-X
chromatin	B-X
modifications	B-X
and	B-X
noncoding	B-X
RNAs	B-X
.	B-X
Heavy	B-X
metals	B-X
constitute	B-X
an	B-X
important	B-X
class	B-X
of	B-X
environmental	B-X
contaminants	B-X
that	B-X
have	B-X
been	B-X
known	B-X
to	B-X
influence	B-X
gene	B-X
expression	B-X
directly	B-X
by	B-X
binding	B-X
various	B-X
metal	B-X
response	B-X
elements	B-X
in	B-X
the	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Recent	B-X
research	B-X
suggests	B-X
that	B-X
metals	B-X
can	B-X
also	B-X
influence	B-X
gene	B-X
expression	B-X
through	B-X
epigenetic	B-X
mechanisms	B-X
;	B-X
this	B-X
adds	B-X
a	B-X
new	B-X
twist	B-X
to	B-X
the	B-X
complexity	B-X
of	B-X
metal-mediated	B-X
gene	B-X
expression	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
recent	B-X
studies	B-X
that	B-X
investigate	B-X
the	B-X
epigenetic	B-X
,	B-X
gene	B-X
expression	B-X
,	B-X
and	B-X
biological	B-X
effects	B-X
of	B-X
various	B-X
inorganic	B-X
and	B-X
organic	B-X
forms	B-X
of	B-X
heavy	B-X
metals	B-X
,	B-X
such	B-X
as	B-X
cadmium	B-X
,	B-X
arsenic	B-X
,	B-X
nickel	B-X
,	B-X
chromium	B-X
,	B-X
methylmercury	B-X
,	B-X
lead	B-X
,	B-X
copper	B-X
and	B-X
organotin	B-X
compounds	B-X
.	B-X

Alternatively	O
,	O
specificity	O
in	O
c	O
-	O
di	O
-	O
GMP	O
signaling	O
may	O
be	O
due	O
to	O
a	O
number	O
of	O
mechanisms	O
including	O
spatial	O
and	O
temporal	O
sequestration	O
,	O
microcompartmentalization	O
,	O
restricted	O
production	O
/	O
degradation	O
,	O
or	O
target	O
modification	O
[	O
56	O
]	O
.	O
<EOS>	B-X
Specific	B-X
chemical	B-X
modifications	B-X
of	B-X
biological	B-X
molecules	B-X
are	B-X
an	B-X
efficient	B-X
way	B-X
of	B-X
regulating	B-X
molecular	B-X
function	B-X
,	B-X
and	B-X
a	B-X
plethora	B-X
of	B-X
downstream	B-X
signalling	B-X
pathways	B-X
are	B-X
influenced	B-X
by	B-X
the	B-X
modification	B-X
of	B-X
DNA	B-X
and	B-X
proteins	B-X
.	B-X
Many	B-X
of	B-X
the	B-X
enzymes	B-X
responsible	B-X
for	B-X
regulating	B-X
protein	B-X
and	B-X
DNA	B-X
modifications	B-X
are	B-X
targets	B-X
of	B-X
current	B-X
cancer	B-X
therapies	B-X
.	B-X
RNA	B-X
epitranscriptomics	B-X
,	B-X
the	B-X
study	B-X
of	B-X
RNA	B-X
modifications	B-X
,	B-X
is	B-X
the	B-X
new	B-X
frontier	B-X
of	B-X
this	B-X
arena	B-X
.	B-X
Despite	B-X
being	B-X
known	B-X
since	B-X
the	B-X
1970s	B-X
,	B-X
eukaryotic	B-X
RNA	B-X
modifications	B-X
were	B-X
mostly	B-X
identified	B-X
on	B-X
transfer	B-X
RNA	B-X
and	B-X
ribosomal	B-X
RNA	B-X
until	B-X
the	B-X
last	B-X
decade	B-X
,	B-X
when	B-X
they	B-X
have	B-X
been	B-X
identified	B-X
and	B-X
characterized	B-X
on	B-X
mRNA	B-X
and	B-X
various	B-X
non-coding	B-X
RNAs	B-X
.	B-X
Increasing	B-X
evidence	B-X
suggests	B-X
that	B-X
RNA	B-X
modification	B-X
pathways	B-X
are	B-X
also	B-X
misregulated	B-X
in	B-X
human	B-X
cancers	B-X
and	B-X
may	B-X
be	B-X
ideal	B-X
targets	B-X
of	B-X
cancer	B-X
therapy	B-X
.	B-X
In	B-X
this	B-X
Review	B-X
we	B-X
highlight	B-X
the	B-X
RNA	B-X
epitranscriptomic	B-X
pathways	B-X
implicated	B-X
in	B-X
cancer	B-X
,	B-X
describing	B-X
their	B-X
biological	B-X
functions	B-X
and	B-X
their	B-X
connections	B-X
to	B-X
the	B-X
disease	B-X
.	B-X

The	O
manner	O
in	O
which	O
c	O
-	O
di	O
-	O
GMP	O
alters	O
motility	O
at	O
the	O
molecular	O
level	O
is	O
currently	O
unknown	O
.	O

However	O
,	O
it	O
has	O
been	O
reported	O
that	O
c	O
-	O
di	O
-	O
GMP	O
binds	O
to	O
the	O
PilZ	O
domain	O
of	O
the	O
aforementioned	O
YcgR	O
protein	O
[	O
48	O
]	O
.	O

It	O
is	O
hypothesized	O
that	O
YcgR	O
undergoes	O
a	O
conformational	O
change	O
upon	O
binding	O
to	O
c	O
-	O
di	O
-	O
GMP	O
,	O
and	O
that	O
the	O
YcgR	O
-	O
c	O
-	O
di	O
-	O
GMP	O
complex	O
impairs	O
motility	O
through	O
a	O
protein	O
-	O
protein	O
interaction	O
with	O
the	O
flagellar	O
motor	O
[	O
57	O
]	O
.	O

Such	O
an	O
interaction	O
may	O
explain	O
the	O
observed	O
rotational	O
bias	O
of	O
flagella	O
in	O
DeltayhjH	O
mutants	O
(	O
Figure	O
6B	O
)	O
and	O
is	O
in	O
agreement	O
with	O
our	O
finding	O
that	O
mutations	O
in	O
ycgR	O
strongly	O
suppress	O
the	O
motility	O
defects	O
of	O
DeltayhjH	O
mutants	O
(	O
Figure	O
6F	O
)	O
.	O

In	O
addition	O
to	O
its	O
effects	O
on	O
swimming	O
,	O
we	O
found	O
evidence	O
that	O
c	O
-	O
di	O
-	O
GMP	O
signaling	O
also	O
plays	O
a	O
role	O
in	O
swarming	O
motility	O
.	O

As	O
stated	O
previously	O
,	O
mutations	O
in	O
yfiR	O
strongly	O
abolish	O
swarming	O
motility	O
.	O

The	O
yfiR	O
gene	O
is	O
the	O
first	O
in	O
an	O
operon	O
that	O
also	O
contains	O
yfiN	O
and	O
yfiB	O
(	O
inset	O
of	O
Figure	O
7	O
)	O
.	O

The	O
arrangement	O
of	O
these	O
genes	O
in	O
an	O
operon	O
suggests	O
that	O
they	O
may	O
function	O
together	O
.	O

YfiR	O
is	O
predicted	O
to	O
be	O
a	O
periplasmic	O
protein	O
,	O
YfiB	O
shows	O
sequence	O
similarity	O
to	O
outer	O
-	O
membrane	O
porin	O
proteins	O
,	O
and	O
YfiN	O
is	O
a	O
predicted	O
inner	O
-	O
membrane	O
protein	O
with	O
GGDEF	O
and	O
HAMP	O
domains	O
.	O

We	O
found	O
that	O
deletion	O
of	O
yfiN	O
strongly	O
suppresses	O
the	O
swarming	O
defect	O
of	O
the	O
DeltayfiR	O
strain	O
,	O
indicating	O
that	O
yfiR	O
is	O
genetically	O
upstream	O
of	O
yfiN	O
,	O
and	O
that	O
YfiR	O
may	O
regulate	O
the	O
DGC	O
activity	O
of	O
YfiN	O
'	O
s	O
GGDEF	O
output	O
domain	O
by	O
interacting	O
with	O
the	O
HAMP	O
sensory	O
input	O
domain	O
(	O
Figure	O
7	O
)	O
.	O

Mutations	O
in	O
ycgR	O
were	O
also	O
found	O
to	O
suppress	O
the	O
swarming	O
defect	O
of	O
the	O
DeltayfiR	O
strain	O
(	O
unpublished	O
data	O
)	O
,	O
suggesting	O
that	O
YcgR	O
binds	O
c	O
-	O
di	O
-	O
GMP	O
to	O
affect	O
both	O
swimming	O
and	O
swarming	O
motility	O
.	O

The	O
observations	O
that	O
the	O
DeltayhjH	O
mutant	O
is	O
impaired	O
in	O
swimming	O
but	O
indistinguishable	O
from	O
the	O
wild	O
-	O
type	O
strain	O
in	O
swarming	O
,	O
while	O
in	O
contrast	O
the	O
DeltayfiR	O
strain	O
cannot	O
swarm	O
and	O
is	O
only	O
mildly	O
impaired	O
in	O
swimming	O
,	O
support	O
the	O
notion	O
that	O
c	O
-	O
di	O
-	O
GMP	O
signaling	O
pathways	O
are	O
temporally	O
and	O
/	O
or	O
spatially	O
separated	O
,	O
as	O
recently	O
suggested	O
by	O
others	O
[	O
58	O
,	O
59	O
]	O
.	O
<EOS>	B-X
Brain	B-X
tumors	B-X
are	B-X
particularly	B-X
challenging	B-X
malignancies	B-X
,	B-X
due	B-X
to	B-X
their	B-X
location	B-X
in	B-X
a	B-X
structurally	B-X
and	B-X
functionally	B-X
distinct	B-X
part	B-X
of	B-X
the	B-X
human	B-X
body	B-X
-	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
(	B-X
CNS	B-X
)	B-X
.	B-X
The	B-X
CNS	B-X
is	B-X
separated	B-X
and	B-X
protected	B-X
by	B-X
a	B-X
unique	B-X
system	B-X
of	B-X
brain	B-X
and	B-X
blood	B-X
vessel	B-X
cells	B-X
which	B-X
together	B-X
prevent	B-X
most	B-X
bloodborne	B-X
therapeutics	B-X
from	B-X
entering	B-X
the	B-X
brain	B-X
tumor	B-X
microenvironment	B-X
(	B-X
TME	B-X
)	B-X
.	B-X
Recently	B-X
,	B-X
great	B-X
strides	B-X
have	B-X
been	B-X
made	B-X
through	B-X
microbubble	B-X
(	B-X
MB	B-X
)	B-X
ultrasound	B-X
contrast	B-X
agents	B-X
in	B-X
conjunction	B-X
with	B-X
ultrasound	B-X
energy	B-X
to	B-X
locally	B-X
increase	B-X
the	B-X
permeability	B-X
of	B-X
brain	B-X
vessels	B-X
and	B-X
modulate	B-X
the	B-X
brain	B-X
TME	B-X
.	B-X
As	B-X
we	B-X
elaborate	B-X
in	B-X
this	B-X
review	B-X
,	B-X
this	B-X
physical	B-X
method	B-X
can	B-X
effectively	B-X
deliver	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
anticancer	B-X
agents	B-X
,	B-X
including	B-X
chemotherapeutics	B-X
,	B-X
antibodies	B-X
,	B-X
and	B-X
nanoparticle	B-X
drug	B-X
conjugates	B-X
across	B-X
a	B-X
range	B-X
of	B-X
preclinical	B-X
brain	B-X
tumors	B-X
,	B-X
including	B-X
high	B-X
grade	B-X
glioma	B-X
(	B-X
glioblastoma	B-X
)	B-X
,	B-X
diffuse	B-X
intrinsic	B-X
pontine	B-X
gliomas	B-X
,	B-X
and	B-X
brain	B-X
metastasis	B-X
.	B-X
Moreover	B-X
,	B-X
recent	B-X
evidence	B-X
suggests	B-X
that	B-X
this	B-X
technology	B-X
can	B-X
promote	B-X
the	B-X
effective	B-X
delivery	B-X
of	B-X
novel	B-X
immunotherapeutic	B-X
agents	B-X
,	B-X
including	B-X
immune	B-X
check-point	B-X
inhibitors	B-X
and	B-X
chimeric	B-X
antigen	B-X
receptor	B-X
T	B-X
cells	B-X
,	B-X
among	B-X
others	B-X
.	B-X
With	B-X
early	B-X
clinical	B-X
studies	B-X
demonstrating	B-X
safety	B-X
,	B-X
and	B-X
several	B-X
Phase	B-X
I/II	B-X
trials	B-X
testing	B-X
the	B-X
preclinical	B-X
findings	B-X
underway	B-X
,	B-X
this	B-X
technology	B-X
is	B-X
making	B-X
firm	B-X
steps	B-X
towards	B-X
shaping	B-X
the	B-X
future	B-X
treatments	B-X
of	B-X
primary	B-X
and	B-X
metastatic	B-X
brain	B-X
cancer	B-X
.	B-X
By	B-X
elaborating	B-X
on	B-X
its	B-X
key	B-X
components	B-X
,	B-X
including	B-X
ultrasound	B-X
systems	B-X
and	B-X
MB	B-X
technology	B-X
,	B-X
along	B-X
with	B-X
methods	B-X
for	B-X
closed-loop	B-X
spatial	B-X
and	B-X
temporal	B-X
control	B-X
of	B-X
MB	B-X
activity	B-X
,	B-X
we	B-X
highlight	B-X
how	B-X
this	B-X
technology	B-X
can	B-X
be	B-X
tuned	B-X
to	B-X
enable	B-X
new	B-X
,	B-X
personalized	B-X
treatment	B-X
strategies	B-X
for	B-X
primary	B-X
brain	B-X
malignancies	B-X
and	B-X
brain	B-X
metastases	B-X
.	B-X

Involvement	O
of	O
Type	O
1	O
Fimbriae	O
in	O
Swimming	O
Motility	O
<EOS>	B-X
Motility	B-X
is	B-X
a	B-X
common	B-X
behaviour	B-X
in	B-X
prokaryotes	B-X
.	B-X
Escherichia	B-X
coli	B-X
K-12	B-X
has	B-X
the	B-X
ability	B-X
to	B-X
migrate	B-X
on	B-X
semisolid	B-X
media	B-X
by	B-X
means	B-X
of	B-X
swarming	B-X
motility	B-X
.	B-X
A	B-X
systematic	B-X
and	B-X
comprehensive	B-X
collection	B-X
of	B-X
gene-disrupted	B-X
E.	B-X
coli	B-X
K-12	B-X
mutants	B-X
(	B-X
the	B-X
Keio	B-X
collection	B-X
)	B-X
was	B-X
used	B-X
to	B-X
identify	B-X
the	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
swarming	B-X
motility	B-X
of	B-X
this	B-X
bacterium	B-X
.	B-X
Further	B-X
,	B-X
216	B-X
of	B-X
the	B-X
294	B-X
mutants	B-X
displayed	B-X
no	B-X
significant	B-X
defects	B-X
in	B-X
swimming	B-X
motility	B-X
;	B-X
therefore	B-X
,	B-X
the	B-X
216	B-X
genes	B-X
were	B-X
considered	B-X
to	B-X
be	B-X
specifically	B-X
associated	B-X
with	B-X
the	B-X
swarming	B-X
phenotype	B-X
.	B-X
These	B-X
genes	B-X
include	B-X
genes	B-X
for	B-X
tricarboxylic	B-X
acid	B-X
cycle	B-X
and	B-X
glucose	B-X
metabolism	B-X
,	B-X
iron	B-X
acquisition	B-X
,	B-X
chaperones	B-X
and	B-X
protein-folding	B-X
catalysts	B-X
,	B-X
signal	B-X
transduction	B-X
,	B-X
and	B-X
biosynthesis	B-X
of	B-X
cell	B-X
surface	B-X
components	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
,	B-X
the	B-X
enterobacterial	B-X
common	B-X
antigen	B-X
,	B-X
and	B-X
type	B-X
1	B-X
fimbriae	B-X
.	B-X
Lipopolysaccharide	B-X
and	B-X
the	B-X
enterobacterial	B-X
common	B-X
antigen	B-X
may	B-X
be	B-X
important	B-X
surface-acting	B-X
components	B-X
that	B-X
contribute	B-X
to	B-X
the	B-X
reduction	B-X
of	B-X
surface	B-X
tension	B-X
,	B-X
thereby	B-X
facilitating	B-X
the	B-X
swarm	B-X
migration	B-X
in	B-X
the	B-X
E.	B-X
coli	B-X
K-12	B-X
strain	B-X
.	B-X

The	O
abundance	O
of	O
fimE	O
and	O
fimB	O
mutants	O
in	O
the	O
enrichment	O
for	O
nonmotile	O
mutants	O
suggested	O
a	O
role	O
for	O
type	O
1	O
fimbriae	O
in	O
swimming	O
motility	O
.	O

These	O
genes	O
encode	O
site	O
-	O
specific	O
recombinases	O
that	O
catalyze	O
the	O
inversion	O
of	O
a	O
DNA	O
element	O
known	O
as	O
the	O
fim	O
switch	O
or	O
fimS	O
,	O
whose	O
orientation	O
controls	O
the	O
expression	O
of	O
fimbrial	O
structural	O
genes	O
[	O
60	O
]	O
.	O

Inversion	O
of	O
fimS	O
by	O
site	O
-	O
specific	O
recombinases	O
alternately	O
connects	O
and	O
disconnects	O
the	O
fimbrial	O
structural	O
genes	O
from	O
their	O
promoter	O
,	O
resulting	O
in	O
a	O
process	O
of	O
phase	O
variation	O
that	O
gives	O
rise	O
to	O
bacteria	O
in	O
either	O
the	O
fimbriate	O
(	O
phase	O
ON	O
)	O
or	O
afimbriate	O
(	O
phase	O
OFF	O
)	O
state	O
[	O
61	O
]	O
.	O
<EOS>	B-X
The	B-X
expression	B-X
of	B-X
type	B-X
1	B-X
fimbriae	B-X
in	B-X
Escherichia	B-X
coli	B-X
is	B-X
phase	B-X
variable	B-X
,	B-X
with	B-X
cells	B-X
switching	B-X
between	B-X
fimbriate	B-X
(	B-X
ON	B-X
)	B-X
and	B-X
afimbriate	B-X
(	B-X
OFF	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
phase	B-X
variation	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
orientation	B-X
of	B-X
a	B-X
314	B-X
bp	B-X
DNA	B-X
element	B-X
(	B-X
the	B-X
switch	B-X
)	B-X
that	B-X
undergoes	B-X
DNA	B-X
inversion	B-X
.	B-X
DNA	B-X
inversion	B-X
requires	B-X
either	B-X
fimB	B-X
or	B-X
fimE	B-X
,	B-X
site-specific	B-X
recombinases	B-X
that	B-X
differ	B-X
in	B-X
both	B-X
specificity	B-X
and	B-X
activity	B-X
.	B-X
In	B-X
wild-type	B-X
cells	B-X
,	B-X
fimE	B-X
activity	B-X
predominates	B-X
and	B-X
,	B-X
hence	B-X
,	B-X
most	B-X
bacteria	B-X
are	B-X
afimbriate	B-X
.	B-X
Here	B-X
,	B-X
it	B-X
is	B-X
shown	B-X
that	B-X
fimE	B-X
specificity	B-X
is	B-X
caused	B-X
by	B-X
two	B-X
different	B-X
,	B-X
but	B-X
complementary	B-X
,	B-X
mechanisms	B-X
.	B-X
Differences	B-X
in	B-X
the	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
recombinase	B-X
binding	B-X
sites	B-X
is	B-X
a	B-X
key	B-X
factor	B-X
in	B-X
determining	B-X
FimE	B-X
specificity	B-X
,	B-X
although	B-X
one	B-X
or	B-X
more	B-X
additional	B-X
cis-active	B-X
sites	B-X
that	B-X
flank	B-X
the	B-X
fim	B-X
switch	B-X
also	B-X
appear	B-X
to	B-X
be	B-X
involved	B-X
.	B-X

By	O
randomly	O
sampling	O
mutants	O
impaired	O
for	O
motility	O
and	O
sequencing	O
the	O
region	O
of	O
DNA	O
adjacent	O
to	O
the	O
transposon	O
,	O
we	O
identified	O
a	O
mutant	O
with	O
a	O
reduced	O
ability	O
to	O
swim	O
with	O
an	O
insertion	O
within	O
fimS	O
.	O

To	O
determine	O
the	O
nature	O
of	O
the	O
motility	O
defect	O
,	O
we	O
analyzed	O
the	O
fimS	O
mutant	O
by	O
transmission	O
electron	O
microscopy	O
.	O

The	O
fimS	O
mutant	O
exhibited	O
a	O
level	O
of	O
fimbriation	O
similar	O
to	O
fimB	O
-	O
fimE	O
-	O
double	O
mutants	O
locked	O
in	O
phase	O
ON	O
(	O
Figure	O
S11A	O
)	O
,	O
indicating	O
that	O
a	O
high	O
level	O
of	O
fimbriation	O
reduces	O
motility	O
in	O
semi	O
-	O
solid	O
agar	O
.	O

This	O
observation	O
is	O
confirmed	O
by	O
comparing	O
the	O
motility	O
of	O
the	O
fimS	O
mutant	O
to	O
phase	O
ON	O
fimB	O
-	O
fimE	O
-	O
double	O
mutants	O
(	O
Figure	O
S11B	O
)	O
.	O

We	O
found	O
that	O
swarming	O
was	O
not	O
impaired	O
in	O
either	O
the	O
fimS	O
mutant	O
or	O
the	O
mutants	O
with	O
fimbria	O
locked	O
in	O
phase	O
ON	O
,	O
indicating	O
that	O
fimbria	O
expression	O
does	O
not	O
interfere	O
with	O
swarming	O
motility	O
(	O
Figure	O
S11C	O
)	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
provide	B-X
evidence	B-X
of	B-X
swarming	B-X
and	B-X
chemotaxis	B-X
in	B-X
differentiated	B-X
HL-60	B-X
neutrophil-like	B-X
cells	B-X
(	B-X
dHL-60	B-X
)	B-X
using	B-X
precise	B-X
microfluidic	B-X
assays	B-X
.	B-X
We	B-X
found	B-X
that	B-X
dimethyl	B-X
sulfoxide	B-X
differentiated	B-X
HL-60	B-X
cells	B-X
(	B-X
DdHL-60	B-X
)	B-X
have	B-X
a	B-X
larger	B-X
size	B-X
,	B-X
increased	B-X
length	B-X
,	B-X
and	B-X
lower	B-X
ability	B-X
to	B-X
squeeze	B-X
through	B-X
narrow	B-X
channels	B-X
compared	B-X
to	B-X
primary	B-X
neutrophils	B-X
.	B-X
We	B-X
found	B-X
that	B-X
dHL-60	B-X
can	B-X
swarm	B-X
toward	B-X
zymosan	B-X
particle	B-X
clusters	B-X
,	B-X
though	B-X
they	B-X
display	B-X
disorganized	B-X
migratory	B-X
patterns	B-X
and	B-X
produce	B-X
swarms	B-X
of	B-X
smaller	B-X
size	B-X
compared	B-X
to	B-X
primary	B-X
neutrophils	B-X
.	B-X
In	B-X
the	B-X
first	B-X
phase	B-X
of	B-X
LCSO	B-X
,	B-X
the	B-X
swarm	B-X
is	B-X
divided	B-X
into	B-X
sub-swarms	B-X
,	B-X
each	B-X
of	B-X
which	B-X
can	B-X
work	B-X
in	B-X
parallel	B-X
.	B-X
In	B-X
the	B-X
second	B-X
phase	B-X
,	B-X
information	B-X
is	B-X
exchanged	B-X
between	B-X
sub-swarms	B-X
.	B-X

The	O
basis	O
for	O
motility	O
suppression	O
by	O
constitutive	O
fimbriae	O
expression	O
remains	O
unclear	O
;	O
however	O
,	O
we	O
observed	O
that	O
hyper	O
-	O
fimbriated	O
cells	O
tend	O
to	O
have	O
,	O
on	O
average	O
,	O
fewer	O
flagella	O
compared	O
to	O
their	O
afimbriated	O
counterparts	O
(	O
Figure	O
S11D	O
)	O
.	O

This	O
may	O
reflect	O
competing	O
demands	O
for	O
resources	O
and	O
/	O
or	O
surface	O
area	O
for	O
synthesis	O
and	O
assembly	O
of	O
these	O
extracellular	O
appendages	O
.	O
<EOS>	B-X
:	B-X
Compassion	B-X
fatigue	B-X
is	B-X
the	B-X
result	B-X
of	B-X
the	B-X
unique	B-X
stressors	B-X
inherent	B-X
in	B-X
caregiving	B-X
work	B-X
,	B-X
leading	B-X
to	B-X
a	B-X
loss	B-X
of	B-X
compassion	B-X
in	B-X
clinical	B-X
practice	B-X
that	B-X
may	B-X
result	B-X
in	B-X
negative	B-X
outcomes	B-X
for	B-X
mental	B-X
healthcare	B-X
consumers	B-X
.	B-X
Competency-based	B-X
education	B-X
,	B-X
strong	B-X
mental	B-X
health	B-X
nurse	B-X
leadership	B-X
,	B-X
positive	B-X
organizational	B-X
cultures	B-X
,	B-X
clinical	B-X
supervision	B-X
and	B-X
reflection	B-X
alongside	B-X
individual	B-X
self-care	B-X
strategies	B-X
may	B-X
mitigate	B-X
compassion	B-X
fatigue	B-X
.	B-X
Interventions	B-X
addressing	B-X
the	B-X
physical	B-X
,	B-X
cognitive	B-X
and	B-X
emotional	B-X
demands	B-X
of	B-X
care	B-X
work	B-X
are	B-X
needed	B-X
to	B-X
ensure	B-X
mental	B-X
health	B-X
nurses	B-X
have	B-X
the	B-X
capability	B-X
to	B-X
provide	B-X
sustainable	B-X
compassionate	B-X
care	B-X
to	B-X
consumers	B-X
.	B-X
Data	B-X
were	B-X
extracted	B-X
from	B-X
articles	B-X
meeting	B-X
inclusion	B-X
criteria	B-X
and	B-X
integrated	B-X
using	B-X
narrative	B-X
synthesis	B-X
.	B-X
Variables	B-X
were	B-X
identified	B-X
that	B-X
may	B-X
mitigate	B-X
the	B-X
risk	B-X
of	B-X
compassion	B-X
fatigue	B-X
.	B-X
Strong	B-X
leadership	B-X
and	B-X
positive	B-X
workplace	B-X
cultures	B-X
,	B-X
clinical	B-X
supervision	B-X
,	B-X
reflection	B-X
,	B-X
self-care	B-X
and	B-X
personal	B-X
well-being	B-X
may	B-X
protect	B-X
mental	B-X
health	B-X
nurses	B-X
against	B-X
compassion	B-X
fatigue	B-X
.	B-X

The	O
Genetic	O
Basis	O
of	O
Environmentally	O
Induced	O
Repression	O
of	O
Motility	O

Chemotaxis	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
is	O
strongly	O
inhibited	O
by	O
environmental	O
conditions	O
such	O
as	O
high	O
temperature	O
,	O
low	O
pH	O
,	O
and	O
high	O
osmolarity	O
[	O
62	O
-	O
64	O
]	O
.	O

Some	O
of	O
these	O
environmental	O
influences	O
may	O
be	O
due	O
to	O
direct	O
physicochemical	O
perturbations	O
to	O
chemotaxis	O
or	O
flagellar	O
function	O
.	O
<EOS>	B-X
Mitochondria	B-X
are	B-X
central	B-X
to	B-X
cellular	B-X
energy	B-X
production	B-X
but	B-X
they	B-X
also	B-X
have	B-X
various	B-X
other	B-X
functions	B-X
.	B-X
Although	B-X
mitochondria	B-X
are	B-X
recognized	B-X
as	B-X
essential	B-X
to	B-X
spermatozoa	B-X
,	B-X
their	B-X
exact	B-X
pathophysiological	B-X
role	B-X
and	B-X
their	B-X
functioning	B-X
are	B-X
complex	B-X
.	B-X
Furthermore	B-X
,	B-X
mitochondria	B-X
are	B-X
only	B-X
indirectly	B-X
involved	B-X
in	B-X
cytoplasmic	B-X
heredity	B-X
as	B-X
their	B-X
DNA	B-X
,	B-X
the	B-X
paternal	B-X
mitochondrial	B-X
DNA	B-X
,	B-X
is	B-X
not	B-X
transmitted	B-X
to	B-X
descendants	B-X
.	B-X
Though	B-X
a	B-X
small	B-X
cell	B-X
,	B-X
its	B-X
every	B-X
part	B-X
has	B-X
complex	B-X
structure	B-X
and	B-X
different	B-X
function	B-X
to	B-X
play	B-X
in	B-X
carrying	B-X
life	B-X
.	B-X
Sperm	B-X
tail	B-X
is	B-X
most	B-X
complicated	B-X
structure	B-X
with	B-X
more	B-X
than	B-X
1000	B-X
proteins	B-X
involved	B-X
in	B-X
its	B-X
functioning	B-X
.	B-X
A	B-X
number	B-X
of	B-X
genetic	B-X
mutations	B-X
have	B-X
been	B-X
linked	B-X
with	B-X
abnormal	B-X
sperm	B-X
flagellar	B-X
development	B-X
leading	B-X
to	B-X
motility	B-X
defects	B-X
and	B-X
male	B-X
infertility	B-X
.	B-X
Hence	B-X
,	B-X
an	B-X
understanding	B-X
of	B-X
sperm	B-X
tail	B-X
development	B-X
and	B-X
genes	B-X
associated	B-X
with	B-X
its	B-X
normal	B-X
functioning	B-X
can	B-X
help	B-X
in	B-X
better	B-X
diagnosis	B-X
of	B-X
male	B-X
infertility	B-X
and	B-X
its	B-X
management	B-X
.	B-X

Alternatively	O
,	O
these	O
signals	O
may	O
provide	O
crucial	O
information	O
about	O
the	O
cell	O
'	O
s	O
local	O
environment	O
,	O
influencing	O
chemotactic	O
behavior	O
through	O
upstream	O
regulatory	O
pathways	O
.	O

Consistent	O
with	O
this	O
picture	O
,	O
the	O
promoter	O
of	O
the	O
flhDC	O
operon	O
,	O
the	O
master	O
regulator	O
of	O
flagellar	O
gene	O
expression	O
,	O
is	O
one	O
of	O
the	O
most	O
highly	O
regulated	O
loci	O
in	O
the	O
genome	O
and	O
contains	O
many	O
transcription	O
-	O
factor	O
binding	O
sites	O
[	O
65	O
]	O
.	O

We	O
devised	O
a	O
simple	O
selection	O
strategy	O
to	O
identify	O
the	O
genetic	O
loci	O
that	O
contribute	O
to	O
environmentally	O
induced	O
variation	O
in	O
chemotactic	O
behavior	O
.	O

We	O
focused	O
on	O
inhibition	O
of	O
motility	O
by	O
high	O
osmolarity	O
(	O
0	O
.	O
5	O
M	O
NaCl	O
)	O
,	O
since	O
previous	O
evidence	O
suggested	O
that	O
this	O
environmental	O
condition	O
signals	O
to	O
the	O
flhDC	O
regulatory	O
region	O
[	O
66	O
]	O
.	O

We	O
reasoned	O
that	O
null	O
mutations	O
in	O
components	O
of	O
such	O
upstream	O
signaling	O
pathways	O
would	O
alleviate	O
repression	O
of	O
chemotaxis	O
under	O
high	O
[	O
NaCl	O
]	O
conditions	O
.	O

According	O
to	O
this	O
model	O
,	O
the	O
transposon	O
insertion	O
library	O
should	O
harbor	O
mutants	O
that	O
perform	O
chemotaxis	O
in	O
high	O
[	O
NaCl	O
]	O
as	O
well	O
as	O
wild	O
-	O
type	O
cells	O
do	O
under	O
low	O
[	O
NaCl	O
]	O
conditions	O
.	O

As	O
can	O
be	O
seen	O
in	O
Figure	O
S12A	O
,	O
this	O
is	O
in	O
fact	O
what	O
we	O
observe	O
since	O
,	O
during	O
the	O
same	O
time	O
interval	O
,	O
some	O
members	O
from	O
the	O
transposon	O
mutant	O
library	O
travel	O
significantly	O
further	O
away	O
from	O
the	O
site	O
of	O
inoculation	O
than	O
do	O
the	O
homogeneous	O
population	O
of	O
wild	O
-	O
type	O
cells	O
.	O

In	O
order	O
to	O
identify	O
the	O
mutations	O
associated	O
with	O
the	O
observed	O
alleviation	O
in	O
suppression	O
of	O
motility	O
under	O
high	O
[	O
NaCl	O
]	O
,	O
we	O
extracted	O
the	O
population	O
of	O
mutants	O
that	O
traveled	O
to	O
the	O
extreme	O
edge	O
of	O
the	O
chemotaxis	O
front	O
.	O

Microarray	O
-	O
based	O
genetic	O
footprinting	O
of	O
these	O
mutants	O
provided	O
quantitative	O
genome	O
-	O
wide	O
readout	O
of	O
the	O
population	O
(	O
Dataset	O
S13	O
)	O
.	O

The	O
selection	O
results	O
revealed	O
that	O
mutants	O
harboring	O
insertions	O
in	O
five	O
genes	O
(	O
ompR	O
,	O
envZ	O
,	O
znuA	O
,	O
znuC	O
,	O
and	O
yfiM	O
)	O
were	O
the	O
most	O
abundant	O
.	O

The	O
microarray	O
results	O
were	O
confirmed	O
by	O
showing	O
that	O
individual	O
strains	O
with	O
mutations	O
in	O
these	O
genes	O
showed	O
increased	O
motility	O
in	O
high	O
[	O
NaCl	O
]	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
(	O
Figure	O
S12B	O
)	O
.	O

OmpR	O
and	O
EnvZ	O
are	O
well	O
-	O
characterized	O
members	O
of	O
the	O
two	O
-	O
component	O
osmoregulatory	O
system	O
(	O
Figure	O
S12C	O
)	O
.	O

EnvZ	O
is	O
the	O
sensor	O
kinase	O
that	O
phosphorylates	O
OmpR	O
,	O
a	O
DNA	O
-	O
binding	O
regulatory	O
protein	O
,	O
under	O
conditions	O
of	O
high	O
osmolarity	O
[	O
67	O
]	O
.	O

Our	O
finding	O
that	O
the	O
EnvZ	O
/	O
OmpR	O
signaling	O
pathway	O
mediates	O
motility	O
suppression	O
in	O
high	O
[	O
NaCl	O
]	O
is	O
consistent	O
with	O
previous	O
work	O
that	O
found	O
phosphorylated	O
OmpR	O
to	O
negatively	O
regulate	O
the	O
expression	O
of	O
flagella	O
by	O
interacting	O
with	O
the	O
promoter	O
region	O
of	O
flhDC	O
[	O
66	O
]	O
.	O

ZnuA	O
and	O
ZnuC	O
are	O
part	O
of	O
a	O
high	O
-	O
affinity	O
zinc	O
uptake	O
system	O
.	O

The	O
role	O
of	O
yfiM	O
,	O
a	O
novel	O
uncharacterized	O
gene	O
that	O
shows	O
sequence	O
similarity	O
to	O
a	O
lipoprotein	O
,	O
is	O
not	O
clear	O
at	O
this	O
point	O
.	O

Ongoing	O
work	O
will	O
determine	O
how	O
the	O
gene	O
products	O
of	O
yfiM	O
,	O
znuA	O
,	O
and	O
znuC	O
contribute	O
to	O
this	O
signaling	O
pathway	O
,	O
either	O
through	O
Envz	O
/	O
OmpR	O
or	O
through	O
a	O
parallel	O
pathway	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
these	B-X
parallels	B-X
extend	B-X
to	B-X
the	B-X
immune	B-X
response	B-X
of	B-X
Drosophila	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
the	B-X
intracellular	B-X
components	B-X
of	B-X
the	B-X
dorsoventral	B-X
signaling	B-X
pathway	B-X
(	B-X
except	B-X
for	B-X
dorsal	B-X
)	B-X
and	B-X
the	B-X
extracellular	B-X
Toll	B-X
ligand	B-X
,	B-X
spätzle	B-X
,	B-X
control	B-X
expression	B-X
of	B-X
the	B-X
antifungal	B-X
peptide	B-X
gene	B-X
drosomycin	B-X
in	B-X
adults	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
mutations	B-X
in	B-X
the	B-X
Toll	B-X
signaling	B-X
pathway	B-X
dramatically	B-X
reduce	B-X
survival	B-X
after	B-X
fungal	B-X
infection	B-X
.	B-X
Antibacterial	B-X
genes	B-X
are	B-X
induced	B-X
either	B-X
by	B-X
a	B-X
distinct	B-X
pathway	B-X
involving	B-X
the	B-X
immune	B-X
deficiency	B-X
gene	B-X
(	B-X
imd	B-X
)	B-X
or	B-X
by	B-X
combined	B-X
activation	B-X
of	B-X
both	B-X
imd	B-X
and	B-X
dorsoventral	B-X
pathways	B-X
.	B-X

We	O
have	O
shown	O
that	O
the	O
limits	O
on	O
swimming	O
motility	O
under	O
nominally	O
extreme	O
conditions	O
can	O
be	O
regulated	O
by	O
"	O
interpretation	O
"	O
of	O
environmental	O
signals	O
rather	O
than	O
by	O
hard	O
physicochemical	O
constraints	O
on	O
energy	O
generation	O
or	O
mechanics	O
.	O
<EOS>	B-X
The	B-X
last	B-X
step	B-X
toward	B-X
this	B-X
goal	B-X
is	B-X
to	B-X
reconcile	B-X
general	B-X
relativity	B-X
with	B-X
the	B-X
principles	B-X
of	B-X
quantum	B-X
mechanics	B-X
,	B-X
a	B-X
quest	B-X
that	B-X
has	B-X
thus	B-X
far	B-X
eluded	B-X
physicists	B-X
.	B-X
Quantum	B-X
mechanics	B-X
,	B-X
the	B-X
physical	B-X
theory	B-X
describing	B-X
the	B-X
microworld	B-X
,	B-X
is	B-X
one	B-X
of	B-X
science	B-X
's	B-X
greatest	B-X
triumphs	B-X
.	B-X
Remarkably	B-X
,	B-X
however	B-X
,	B-X
after	B-X
more	B-X
than	B-X
100	B-X
years	B-X
it	B-X
is	B-X
still	B-X
unclear	B-X
what	B-X
quantum	B-X
mechanics	B-X
means	B-X
in	B-X
terms	B-X
of	B-X
basic	B-X
philosophical	B-X
questions	B-X
about	B-X
the	B-X
nature	B-X
of	B-X
reality	B-X
.	B-X
While	B-X
there	B-X
are	B-X
many	B-X
interpretations	B-X
of	B-X
the	B-X
mathematical	B-X
machinery	B-X
of	B-X
quantum	B-X
physics	B-X
,	B-X
there	B-X
remain	B-X
no	B-X
experimental	B-X
means	B-X
to	B-X
distinguish	B-X
between	B-X
most	B-X
of	B-X
them	B-X
.	B-X
In	B-X
this	B-X
contribution	B-X
,	B-X
I	B-X
wish	B-X
to	B-X
consider	B-X
the	B-X
ways	B-X
in	B-X
which	B-X
the	B-X
enduring	B-X
lack	B-X
of	B-X
an	B-X
agreed-upon	B-X
interpretation	B-X
of	B-X
quantum	B-X
physics	B-X
influences	B-X
a	B-X
number	B-X
of	B-X
critical	B-X
philosophical	B-X
debates	B-X
about	B-X
physics	B-X
and	B-X
reality	B-X
.	B-X
I	B-X
briefly	B-X
review	B-X
two	B-X
problems	B-X
affected	B-X
by	B-X
quantum	B-X
interpretations	B-X
:	B-X
the	B-X
meaning	B-X
of	B-X
the	B-X
term	B-X
universe	B-X
and	B-X
the	B-X
nature	B-X
of	B-X
consciousness	B-X
.	B-X

This	O
argues	O
for	O
a	O
more	O
nuanced	O
perspective	O
on	O
the	O
functional	O
constraints	O
influencing	O
bacterial	O
behavior	O
in	O
general	O
-	O
including	O
the	O
strong	O
coupling	O
between	O
behavior	O
and	O
environment	O
-	O
and	O
an	O
appreciation	O
of	O
the	O
rich	O
ecological	O
context	O
that	O
has	O
shaped	O
bacterial	O
behavior	O
on	O
geological	O
time	O
scales	O
.	O

Conclusions	O
and	O
Summary	O
<EOS>	B-X
Summary	B-X
formats	B-X
are	B-X
typically	B-X
used	B-X
to	B-X
communicate	B-X
the	B-X
results	B-X
of	B-X
evidence	B-X
syntheses	B-X
;	B-X
however	B-X
,	B-X
there	B-X
is	B-X
little	B-X
consensus	B-X
on	B-X
which	B-X
formats	B-X
are	B-X
most	B-X
effective	B-X
and	B-X
acceptable	B-X
for	B-X
different	B-X
stakeholders	B-X
.	B-X
Summary	B-X
meta-analysis	B-X
showed	B-X
an	B-X
overall	B-X
50	B-X
%	B-X
reduction	B-X
(	B-X
OR	B-X
=	B-X
0.5	B-X
[	B-X
0.41-0.59	B-X
]	B-X
;	B-X
I	B-X
A	B-X
quality	B-X
review	B-X
process	B-X
was	B-X
implemented	B-X
to	B-X
determine	B-X
compliance	B-X
with	B-X
the	B-X
requirement	B-X
from	B-X
the	B-X
Commission	B-X
on	B-X
Cancer	B-X
to	B-X
use	B-X
the	B-X
American	B-X
Society	B-X
of	B-X
Clinical	B-X
Oncology	B-X
(	B-X
ASCO	B-X
)	B-X
template	B-X
as	B-X
the	B-X
minimum	B-X
data	B-X
set	B-X
for	B-X
Treatment	B-X
Summary	B-X
and	B-X
Survivorship	B-X
Care	B-X
Plans	B-X
(	B-X
TS/SCP	B-X
)	B-X
provided	B-X
to	B-X
cancer	B-X
survivors	B-X
.	B-X

Microbes	O
account	O
for	O
half	O
the	O
world	O
'	O
s	O
biomass	O
and	O
are	O
the	O
most	O
widely	O
distributed	O
organisms	O
on	O
the	O
planet	O
.	O

Yet	O
most	O
of	O
our	O
genetic	O
understanding	O
of	O
bacterial	O
behavior	O
comes	O
from	O
the	O
tiny	O
fraction	O
of	O
microbes	O
studied	O
in	O
the	O
laboratory	O
.	O

With	O
the	O
recent	O
advances	O
in	O
bacterial	O
whole	O
-	O
genome	O
sequencing	O
[	O
68	O
,	O
69	O
]	O
,	O
the	O
scientific	O
community	O
is	O
poised	O
to	O
take	O
systems	O
-	O
level	O
experimental	O
approaches	O
to	O
rapidly	O
reveal	O
novel	O
and	O
fundamental	O
insights	O
into	O
the	O
microbial	O
world	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
established	O
a	O
powerful	O
framework	O
for	O
the	O
efficient	O
and	O
comprehensive	O
identification	O
of	O
the	O
genetic	O
basis	O
of	O
complex	O
bacterial	O
behaviors	O
.	O

The	O
power	O
of	O
this	O
approach	O
lies	O
in	O
the	O
rapid	O
and	O
parallel	O
manner	O
in	O
which	O
positive	O
and	O
negative	O
genetic	O
contributions	O
can	O
be	O
mapped	O
to	O
any	O
phenotype	O
after	O
competitive	O
selection	O
.	O

We	O
demonstrated	O
this	O
approach	O
in	O
four	O
distinct	O
but	O
complementary	O
selections	O
to	O
reveal	O
the	O
genetic	O
basis	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
motility	O
.	O

Using	O
this	O
framework	O
,	O
we	O
identified	O
greater	O
than	O
95	O
%	O
of	O
previously	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
,	O
and	O
we	O
found	O
three	O
dozen	O
novel	O
contributors	O
to	O
motility	O
consisting	O
of	O
both	O
characterized	O
and	O
uncharacterized	O
genes	O
.	O

Although	O
similar	O
approaches	O
have	O
been	O
successfully	O
applied	O
to	O
the	O
study	O
of	O
pathogenicity	O
[	O
70	O
-	O
74	O
]	O
,	O
the	O
large	O
number	O
of	O
genes	O
reported	O
and	O
the	O
limited	O
analyses	O
of	O
individual	O
mutants	O
made	O
it	O
difficult	O
to	O
determine	O
whether	O
the	O
methods	O
employed	O
in	O
these	O
studies	O
could	O
detect	O
the	O
subtle	O
quantitative	O
differences	O
necessary	O
to	O
map	O
genetic	O
loci	O
with	O
high	O
sensitivity	O
and	O
specificity	O
.	O

In	O
this	O
study	O
,	O
we	O
confirmed	O
our	O
findings	O
by	O
functional	O
analyses	O
of	O
individual	O
mutants	O
,	O
which	O
revealed	O
high	O
levels	O
of	O
sensitivity	O
and	O
low	O
rates	O
of	O
false	O
positives	O
.	O

In	O
addition	O
,	O
we	O
have	O
shown	O
that	O
the	O
same	O
method	O
can	O
be	O
used	O
to	O
quickly	O
and	O
thoroughly	O
explore	O
the	O
genetic	O
interactions	O
between	O
a	O
single	O
locus	O
and	O
all	O
other	O
genetic	O
loci	O
in	O
the	O
genome	O
.	O

These	O
interactions	O
correspond	O
to	O
important	O
network	O
-	O
level	O
concepts	O
;	O
for	O
example	O
,	O
the	O
flow	O
of	O
information	O
within	O
signal	O
transduction	O
pathways	O
and	O
second	O
-	O
messenger	O
systems	O
such	O
as	O
c	O
-	O
di	O
-	O
GMP	O
.	O
<EOS>	B-X
The	B-X
formulation	B-X
of	B-X
network	B-X
models	B-X
from	B-X
global	B-X
protein	B-X
studies	B-X
is	B-X
essential	B-X
to	B-X
understand	B-X
the	B-X
functioning	B-X
of	B-X
organisms	B-X
.	B-X
Network	B-X
models	B-X
of	B-X
the	B-X
proteome	B-X
enable	B-X
the	B-X
application	B-X
of	B-X
Complex	B-X
Network	B-X
Analysis	B-X
,	B-X
a	B-X
quantitative	B-X
framework	B-X
to	B-X
investigate	B-X
large	B-X
complex	B-X
networks	B-X
using	B-X
techniques	B-X
from	B-X
graph	B-X
theory	B-X
,	B-X
statistical	B-X
physics	B-X
,	B-X
dynamical	B-X
systems	B-X
and	B-X
other	B-X
fields	B-X
.	B-X
This	B-X
approach	B-X
has	B-X
provided	B-X
many	B-X
insights	B-X
into	B-X
the	B-X
functional	B-X
organization	B-X
of	B-X
the	B-X
proteome	B-X
so	B-X
far	B-X
and	B-X
will	B-X
likely	B-X
continue	B-X
to	B-X
do	B-X
so	B-X
.	B-X
Currently	B-X
,	B-X
several	B-X
network	B-X
concepts	B-X
have	B-X
emerged	B-X
in	B-X
the	B-X
field	B-X
of	B-X
proteomics	B-X
.	B-X
It	B-X
is	B-X
important	B-X
to	B-X
highlight	B-X
the	B-X
differences	B-X
between	B-X
these	B-X
concepts	B-X
,	B-X
since	B-X
different	B-X
representations	B-X
allow	B-X
different	B-X
insights	B-X
into	B-X
functional	B-X
organization	B-X
.	B-X
One	B-X
such	B-X
concept	B-X
is	B-X
the	B-X
protein	B-X
interaction	B-X
network	B-X
,	B-X
which	B-X
contains	B-X
proteins	B-X
as	B-X
nodes	B-X
and	B-X
undirected	B-X
edges	B-X
representing	B-X
the	B-X
occurrence	B-X
of	B-X
binding	B-X
in	B-X
large-scale	B-X
protein-protein	B-X
interaction	B-X
studies	B-X
.	B-X
A	B-X
second	B-X
concept	B-X
is	B-X
the	B-X
protein-signaling	B-X
network	B-X
,	B-X
in	B-X
which	B-X
the	B-X
nodes	B-X
correspond	B-X
to	B-X
levels	B-X
of	B-X
post-translationally	B-X
modified	B-X
forms	B-X
of	B-X
proteins	B-X
and	B-X
directed	B-X
edges	B-X
to	B-X
causal	B-X
effects	B-X
through	B-X
post-translational	B-X
modification	B-X
,	B-X
such	B-X
as	B-X
phosphorylation	B-X
.	B-X
Several	B-X
other	B-X
network	B-X
concepts	B-X
were	B-X
introduced	B-X
for	B-X
proteomics	B-X
.	B-X
Although	B-X
all	B-X
formulated	B-X
as	B-X
networks	B-X
,	B-X
the	B-X
concepts	B-X
represent	B-X
widely	B-X
different	B-X
physical	B-X
systems	B-X
.	B-X
Therefore	B-X
caution	B-X
should	B-X
be	B-X
taken	B-X
when	B-X
applying	B-X
relevant	B-X
topological	B-X
analysis	B-X
.	B-X
We	B-X
review	B-X
recent	B-X
literature	B-X
formulating	B-X
and	B-X
analyzing	B-X
such	B-X
networks	B-X
.	B-X

In	O
addition	O
to	O
identifying	O
gene	O
-	O
by	O
-	O
gene	O
interactions	O
,	O
we	O
have	O
shown	O
that	O
the	O
same	O
framework	O
can	O
be	O
used	O
to	O
reveal	O
gene	O
-	O
by	O
-	O
environment	O
interactions	O
that	O
are	O
crucial	O
for	O
understanding	O
function	O
within	O
the	O
rich	O
ecological	O
context	O
in	O
which	O
genetic	O
networks	O
have	O
evolved	O
.	O

Large	O
scale	O
variation	O
in	O
Enterococcus	B-Organism
faecalis	I-Organism
illustrated	O
by	O
the	O
genome	O
analysis	O
of	O
strain	O
OG1RF	B-Organism
<EOS>	B-X
Enterococcus	B-X
faecalis	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
major	B-X
hospital	B-X
pathogen	B-X
.	B-X
To	B-X
explore	B-X
its	B-X
diversity	B-X
,	B-X
we	B-X
sequenced	B-X
E.	B-X
faecalis	B-X
strain	B-X
OG1RF	B-X
,	B-X
which	B-X
is	B-X
commonly	B-X
used	B-X
for	B-X
molecular	B-X
manipulation	B-X
and	B-X
virulence	B-X
studies	B-X
.	B-X

A	O
comparison	O
of	O
two	O
strains	O
of	O
the	O
hospital	O
pathogen	O
Enterococcus	B-Organism
faecalis	I-Organism
suggests	O
that	O
mediators	O
of	O
virulence	O
differ	O
between	O
strains	O
and	O
that	O
virulence	O
does	O
not	O
depend	O
on	O
mobile	O
gene	O
elements	O

Background	O
<EOS>	B-X
Background	B-X
matching	B-X
is	B-X
the	B-X
most	B-X
familiar	B-X
and	B-X
widespread	B-X
camouflage	B-X
strategy	B-X
:	B-X
avoiding	B-X
detection	B-X
by	B-X
having	B-X
a	B-X
similar	B-X
colour	B-X
and	B-X
pattern	B-X
to	B-X
the	B-X
background	B-X
.	B-X
Background	B-X
is	B-X
thus	B-X
a	B-X
relatively	B-X
modest	B-X
correction	B-X
for	B-X
all	B-X
Z	B-X
opacity	B-X
data	B-X
published	B-X
to	B-X
date	B-X
.	B-X
Background	B-X
estimation	B-X
and	B-X
foreground	B-X
segmentation	B-X
are	B-X
important	B-X
steps	B-X
in	B-X
many	B-X
high-level	B-X
vision	B-X
tasks	B-X
.	B-X
Patient	B-X
Preference	B-X
for	B-X
Telehealth	B-X
Background	B-X
Shapes	B-X
Impressions	B-X
of	B-X
Physicians	B-X
and	B-X
Information	B-X
Recall	B-X
:	B-X
A	B-X
Randomized	B-X
Experiment	B-X
.	B-X

Enterococci	B-Organism
have	O
emerged	O
over	O
the	O
past	O
few	O
decades	O
as	O
the	O
second	O
to	O
third	O
most	O
common	O
cause	O
of	O
nosocomial	O
infections	O
,	O
including	O
urinary	O
tract	O
and	O
soft	O
tissue	O
infections	O
,	O
bacteremia	O
,	O
and	O
endocarditis	O
[	O
1	O
-	O
3	O
]	O
.	O

They	O
are	O
well	O
equipped	O
to	O
thrive	O
in	O
environments	O
with	O
heavy	O
antibiotic	O
usage	O
due	O
to	O
both	O
their	O
intrinsic	O
resistance	O
to	O
antibiotics	O
and	O
their	O
talent	O
for	O
swapping	O
genetic	O
information	O
,	O
which	O
allows	O
them	O
to	O
gain	O
and	O
share	O
resistance	O
determinants	O
.	O

Entecococcal	O
infections	O
are	O
predominantly	O
caused	O
by	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
and	O
E	B-Organism
.	I-Organism
faecium	I-Organism
.	O

However	O
,	O
many	O
,	O
if	O
not	O
most	O
,	O
strains	O
of	O
these	O
species	O
are	O
harmless	O
commensals	O
,	O
with	O
some	O
enterococci	B-Organism
being	O
marketed	O
in	O
Europe	O
to	O
alleviate	O
symptoms	O
of	O
irritable	O
bowel	O
syndrome	O
and	O
recurrent	O
chronic	O
sinusitis	O
or	O
bronchitis	O
(	O
Cylactin	B-Organism
(	O
R	O
)	O
and	O
Fargo688	B-Organism
(	O
R	O
)	O
(	O
E	B-Organism
.	I-Organism
faecium	I-Organism
)	O
and	O
Symbioflor	B-Organism
1	I-Organism
(	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
)	O
)	O
.	O

To	O
differentiate	O
the	O
two	O
faces	O
of	O
this	O
organism	O
,	O
genome	O
-	O
wide	O
comparisons	O
are	O
necessary	O
.	O

Although	O
hundreds	O
of	O
microbial	O
genomes	O
have	O
been	O
sequenced	O
,	O
only	O
two	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
genomes	O
have	O
been	O
reported	O
(	O
V583	B-Organism
as	O
a	O
clinical	O
isolate	O
[	O
4	O
]	O
and	O
Symbioflor	B-Organism
1	I-Organism
as	O
a	O
commensal	O
isolate	O
[	O
5	O
]	O
)	O
,	O
but	O
only	O
the	O
V583	B-Organism
genome	O
has	O
been	O
made	O
publicly	O
available	O
.	O

In	O
this	O
strain	O
,	O
more	O
than	O
one	O
-	O
quarter	O
of	O
the	O
genome	O
is	O
mobile	O
DNA	O
,	O
more	O
than	O
any	O
other	O
sequenced	O
bacterial	O
genome	O
[	O
4	O
]	O
.	O

The	O
occurrence	O
of	O
multiple	O
antibiotic	O
resistance	O
determinants	O
in	O
V583	B-Organism
[	O
6	O
]	O
makes	O
it	O
difficult	O
to	O
manipulate	O
genetically	O
.	O

Moreover	O
,	O
the	O
vancomycin	O
resistance	O
phenotype	O
makes	O
this	O
strain	O
more	O
of	O
a	O
risk	O
to	O
handle	O
in	O
the	O
laboratory	O
.	O

To	O
avoid	O
these	O
issues	O
,	O
most	O
laboratories	O
use	O
strain	O
OG1	B-Organism
or	O
its	O
close	O
derivatives	O
.	O
<EOS>	B-X
Nuclear	B-X
Overhauser	B-X
effects	B-X
(	B-X
NOEs	B-X
)	B-X
are	B-X
influenced	B-X
by	B-X
motion	B-X
.	B-X
The	B-X
model	B-X
includes	B-X
steric	B-X
repulsion	B-X
and	B-X
yields	B-X
closed-form	B-X
expressions	B-X
for	B-X
the	B-X
expected	B-X
value	B-X
of	B-X
general	B-X
invertible	B-X
functions	B-X
of	B-X
the	B-X
distance	B-X
between	B-X
two	B-X
atoms	B-X
,	B-X
with	B-X
the	B-X
special	B-X
case	B-X
r	B-X
How	B-X
close	B-X
they	B-X
were	B-X
to	B-X
success	B-X
.	B-X
Sulbutiamine	B-X
(	B-X
isobutyryl	B-X
thiamine	B-X
disulfide	B-X
)	B-X
is	B-X
a	B-X
lipophilic	B-X
derivative	B-X
of	B-X
thiamine	B-X
used	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
asthenia	B-X
and	B-X
other	B-X
related	B-X
pathological	B-X
conditions	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
sulbutiamine	B-X
in	B-X
urinary	B-X
doping	B-X
control	B-X
samples	B-X
was	B-X
monitored	B-X
to	B-X
evaluate	B-X
the	B-X
relevance	B-X
of	B-X
its	B-X
use	B-X
in	B-X
sports	B-X
.	B-X
As	B-X
one	B-X
of	B-X
the	B-X
sulbutiamine	B-X
metabolites	B-X
has	B-X
very	B-X
close	B-X
retention	B-X
time	B-X
and	B-X
the	B-X
same	B-X
characteristic	B-X
ion	B-X
(	B-X
m/z	B-X
194	B-X
)	B-X
as	B-X
the	B-X
main	B-X
boldenone	B-X
metabolite	B-X
,	B-X
the	B-X
raw	B-X
data	B-X
files	B-X
generated	B-X
from	B-X
the	B-X
screening	B-X
for	B-X
anabolic	B-X
steroids	B-X
were	B-X
automatically	B-X
reprocessed	B-X
to	B-X
identify	B-X
the	B-X
samples	B-X
containing	B-X
sulbutiamine	B-X
.	B-X

OG1	B-Organism
is	O
a	O
human	B-Organism
isolate	O
subsequently	O
shown	O
to	O
cause	O
dental	O
caries	O
in	O
rats	B-Organism
[	O
7	O
]	O
.	O

OG1RF	B-Organism
is	O
a	O
rifampicin	O
and	O
fusidic	O
acid	O
resistant	O
derivative	O
of	O
OG1	B-Organism
[	O
8	O
,	O
9	O
]	O
.	O

By	O
pulsed	O
-	O
field	O
gel	O
electrophoresis	O
,	O
Murray	O
et	O
al	O
.	O

[	O
10	O
]	O
estimated	O
the	O
size	O
of	O
the	O
OG1RF	B-Organism
genome	O
as	O
2	O
,	O
825	O
kb	O
and	O
created	O
a	O
restriction	O
map	O
of	O
the	O
chromosome	O
.	O

Multilocus	O
sequence	O
typing	O
(	O
MLST	O
)	O
showed	O
that	O
OG1RF	B-Organism
is	O
clonally	O
distinct	O
from	O
V583	B-Organism
(	O
differs	O
in	O
six	O
out	O
of	O
seven	O
alleles	O
of	O
housekeeping	O
genes	O
)	O
[	O
11	O
]	O
and	O
characterization	O
of	O
regions	O
flanking	O
transposon	O
insertions	O
in	O
OG1RF	B-Organism
suggested	O
that	O
approximately	O
10	O
%	O
of	O
their	O
sequences	O
differed	O
[	O
12	O
]	O
.	O

OG1	B-Organism
and	O
its	O
derivatives	O
have	O
been	O
successfully	O
used	O
over	O
the	O
past	O
20	O
years	O
in	O
various	O
animal	O
models	O
,	O
starting	O
with	O
the	O
demonstration	O
that	O
it	O
can	O
cause	O
caries	O
in	O
germ	O
-	O
free	O
rats	B-Organism
[	O
7	O
]	O
,	O
and	O
later	O
to	O
characterize	O
factors	O
important	O
for	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
virulence	O
in	O
a	O
mouse	B-Organism
model	O
of	O
peritonitis	O
[	O
13	O
]	O
,	O
a	O
rabbit	B-Organism
model	O
of	O
endophthalmitis	O
[	O
14	O
]	O
,	O
a	O
rat	B-Organism
model	O
of	O
endocarditis	O
[	O
15	O
]	O
and	O
in	O
a	O
mouse	B-Organism
urinary	O
tract	O
infection	O
model	O
[	O
16	O
]	O
.	O

OG1RF	B-Organism
was	O
also	O
shown	O
to	O
be	O
as	O
virulent	O
as	O
V583	B-Organism
in	O
the	O
model	O
host	O
Caenorhabditis	B-Organism
elegans	I-Organism
[	O
17	O
]	O
.	O

In	O
addition	O
to	O
its	O
virulence	O
,	O
the	O
main	O
reasons	O
for	O
the	O
extensive	O
use	O
of	O
OG1RF	B-Organism
as	O
a	O
laboratory	O
strain	O
are	O
that	O
it	O
does	O
not	O
carry	O
plasmids	O
,	O
is	O
readily	O
transformable	O
by	O
electroporation	O
,	O
and	O
is	O
not	O
resistant	O
to	O
commonly	O
used	O
antibiotics	O
,	O
other	O
than	O
rifampicin	O
and	O
fusidic	O
acid	O
.	O

These	O
resistances	O
were	O
serially	O
selected	O
in	O
OG1	B-Organism
to	O
provide	O
strain	O
markers	O
[	O
9	O
]	O
.	O

The	O
lack	O
of	O
resistance	O
to	O
common	O
antibiotics	O
facilitates	O
the	O
selection	O
of	O
plasmids	O
,	O
transposons	O
,	O
and	O
allelic	O
replacement	O
markers	O
introduced	O
into	O
the	O
strain	O
.	O

Numerous	O
factors	O
important	O
for	O
virulence	O
have	O
been	O
characterized	O
in	O
OG1RF	B-Organism
.	O
<EOS>	B-X
The	B-X
FsrABC	B-X
system	B-X
of	B-X
Enterococcus	B-X
faecalis	B-X
controls	B-X
the	B-X
expression	B-X
of	B-X
gelatinase	B-X
and	B-X
a	B-X
serine	B-X
protease	B-X
via	B-X
a	B-X
quorum-sensing	B-X
mechanism	B-X
,	B-X
and	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
the	B-X
Fsr	B-X
system	B-X
may	B-X
also	B-X
regulate	B-X
other	B-X
genes	B-X
important	B-X
for	B-X
virulence	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
possibility	B-X
that	B-X
Fsr	B-X
influences	B-X
the	B-X
expression	B-X
of	B-X
additional	B-X
genes	B-X
,	B-X
we	B-X
used	B-X
transcriptional	B-X
profiling	B-X
,	B-X
with	B-X
microarrays	B-X
based	B-X
on	B-X
the	B-X
E.	B-X
faecalis	B-X
strain	B-X
V583	B-X
sequence	B-X
,	B-X
to	B-X
compare	B-X
the	B-X
E.	B-X
faecalis	B-X
strain	B-X
OG1RF	B-X
with	B-X
its	B-X
isogenic	B-X
mutant	B-X
,	B-X
TX5266	B-X
,	B-X
an	B-X
fsrB	B-X
deletion	B-X
mutant	B-X
.	B-X
While	B-X
expression	B-X
of	B-X
some	B-X
genes	B-X
(	B-X
i.e.	B-X
,	B-X
ef1097	B-X
and	B-X
ef0750	B-X
to	B-X
-757	B-X
,	B-X
encoding	B-X
hypothetical	B-X
proteins	B-X
)	B-X
was	B-X
activated	B-X
in	B-X
late	B-X
log	B-X
phase	B-X
in	B-X
OG1RF	B-X
versus	B-X
the	B-X
fsrB	B-X
deletion	B-X
mutant	B-X
,	B-X
expression	B-X
of	B-X
ef1617	B-X
to	B-X
-1634	B-X
(	B-X
eut-pdu	B-X
orthologues	B-X
)	B-X
was	B-X
highly	B-X
repressed	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
intact	B-X
Fsr	B-X
at	B-X
entry	B-X
into	B-X
stationary	B-X
phase	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
time	B-X
that	B-X
Fsr	B-X
has	B-X
been	B-X
characterized	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
.	B-X
The	B-X
newly	B-X
recognized	B-X
Fsr-regulated	B-X
targets	B-X
include	B-X
other	B-X
factors	B-X
,	B-X
besides	B-X
gelatinase	B-X
,	B-X
described	B-X
as	B-X
important	B-X
for	B-X
biofilms	B-X
(	B-X
BopD	B-X
)	B-X
,	B-X
and	B-X
genes	B-X
predicted	B-X
to	B-X
encode	B-X
the	B-X
surface	B-X
proteins	B-X
EF0750	B-X
to	B-X
-0757	B-X
and	B-X
EF1097	B-X
,	B-X
along	B-X
with	B-X
proteins	B-X
implicated	B-X
in	B-X
several	B-X
metabolic	B-X
pathways	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
FsrABC	B-X
system	B-X
may	B-X
be	B-X
an	B-X
important	B-X
regulator	B-X
in	B-X
strain	B-X
OG1RF	B-X
,	B-X
with	B-X
both	B-X
positive	B-X
and	B-X
negative	B-X
effects	B-X
.	B-X

A	O
recently	O
described	O
example	O
are	O
the	O
Ebp	O
pili	O
,	O
whose	O
subunits	O
are	O
encoded	O
by	O
the	O
ebp	O
operon	O
[	O
18	O
]	O
and	O
whose	O
genes	O
are	O
regulated	O
by	O
EbpR	O
[	O
19	O
]	O
.	O

A	O
non	O
-	O
piliated	O
mutant	O
produces	O
less	O
biofilm	O
than	O
the	O
parent	O
strain	O
and	O
is	O
attenuated	O
in	O
a	O
rat	B-Organism
model	O
of	O
endocarditis	O
[	O
18	O
]	O
and	O
in	O
a	O
murine	B-Organism
urinary	O
tract	O
infection	O
model	O
[	O
16	O
]	O
.	O

Also	O
present	O
is	O
Ace	O
,	O
a	O
member	O
of	O
the	O
MSCRAMM	O
(	O
microbial	O
surface	O
component	O
recognizing	O
adhesive	O
matrix	O
molecules	O
)	O
family	O
.	O

The	O
ace	O
gene	O
,	O
like	O
the	O
ebp	O
locus	O
,	O
is	O
ubiquitous	O
in	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
and	O
it	O
occurs	O
in	O
at	O
least	O
four	O
different	O
forms	O
that	O
vary	O
in	O
the	O
number	O
of	O
repeats	O
of	O
the	O
B	O
domain	O
[	O
20	O
]	O
.	O

Ace	O
mediates	O
conditional	O
(	O
that	O
is	O
,	O
after	O
growth	O
at	O
46degreesC	O
or	O
in	O
the	O
presence	O
of	O
serum	O
or	O
collagen	O
)	O
adherence	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
to	O
collagen	O
type	O
IV	O
and	O
to	O
laminin	O
[	O
21	O
]	O
and	O
,	O
in	O
unpublished	O
data	O
,	O
influences	O
the	O
ability	O
of	O
OG1RF	B-Organism
to	O
cause	O
experimental	O
endocarditis	O
(	O
KV	O
Singh	O
and	O
BE	O
Murray	O
,	O
unpublished	O
observation	O
)	O
.	O

Finally	O
,	O
the	O
Fsr	O
system	O
,	O
a	O
major	O
positive	O
and	O
negative	O
transcriptional	O
regulator	O
in	O
OG1RF	B-Organism
[	O
22	O
]	O
,	O
affects	O
expression	O
of	O
several	O
virulence	O
factor	O
genes	O
,	O
including	O
gelE	O
,	O
which	O
encodes	O
gelatinase	O
[	O
23	O
]	O
,	O
and	O
contributes	O
to	O
infection	O
in	O
various	O
animal	O
models	O
[	O
15	O
,	O
24	O
]	O
.	O

The	O
distinct	O
MLST	O
profile	O
and	O
the	O
wide	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
analyses	O
of	O
OG1RF	B-Organism
,	O
including	O
many	O
molecular	O
genetic	O
studies	O
and	O
experiments	O
in	O
various	O
animal	O
models	O
,	O
suggested	O
that	O
genomic	O
analysis	O
of	O
this	O
strain	O
would	O
prove	O
insightful	O
and	O
would	O
be	O
useful	O
to	O
future	O
studies	O
.	O

Thus	O
,	O
we	O
analyzed	O
the	O
sequence	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
OG1RF	I-Organism
.	O
<EOS>	B-X
The	B-X
disease-producing	B-X
capacity	B-X
of	B-X
the	B-X
opportunistic	B-X
pathogen	B-X
Enterococcus	B-X
faecalis	B-X
is	B-X
enhanced	B-X
by	B-X
the	B-X
ability	B-X
of	B-X
the	B-X
bacterium	B-X
to	B-X
evade	B-X
killing	B-X
by	B-X
antimicrobial	B-X
agents	B-X
.	B-X
Survival	B-X
of	B-X
E.	B-X
faecalis	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
human	B-X
antimicrobial	B-X
enzyme	B-X
lysozyme	B-X
is	B-X
mediated	B-X
in	B-X
part	B-X
by	B-X
the	B-X
site	B-X
2	B-X
metalloprotease	B-X
Eep	B-X
;	B-X
however	B-X
,	B-X
a	B-X
complete	B-X
model	B-X
of	B-X
enterococcal	B-X
lysozyme	B-X
resistance	B-X
has	B-X
not	B-X
been	B-X
elucidated	B-X
.	B-X
To	B-X
better	B-X
understand	B-X
the	B-X
molecular	B-X
basis	B-X
for	B-X
lysozyme	B-X
resistance	B-X
in	B-X
E.	B-X
faecalis	B-X
,	B-X
we	B-X
analyzed	B-X
Δ	B-X
The	B-X
opportunistic	B-X
pathogen	B-X
Enterococcus	B-X
faecalis	B-X
utilizes	B-X
a	B-X
TCS	B-X
comprised	B-X
of	B-X
the	B-X
histidine	B-X
kinase	B-X
CroS	B-X
and	B-X
the	B-X
response	B-X
regulator	B-X
CroR	B-X
to	B-X
mediate	B-X
resistance	B-X
to	B-X
cell	B-X
wall	B-X
stresses	B-X
such	B-X
as	B-X
cephalosporin	B-X
antibiotics	B-X
,	B-X
but	B-X
the	B-X
molecular	B-X
details	B-X
by	B-X
which	B-X
CroRS	B-X
promotes	B-X
cephalosporin	B-X
resistance	B-X
have	B-X
not	B-X
been	B-X
elucidated	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
analyzed	B-X
mutants	B-X
of	B-X
E.	B-X
faecalis	B-X
carrying	B-X
substitutions	B-X
in	B-X
CroR	B-X
and	B-X
CroS	B-X
to	B-X
demonstrate	B-X
that	B-X
phosphorylated	B-X
CroR	B-X
drives	B-X
resistance	B-X
to	B-X
cephalosporins	B-X
,	B-X
and	B-X
that	B-X
CroS	B-X
exhibits	B-X
kinase	B-X
and	B-X
phosphatase	B-X
activities	B-X
to	B-X
control	B-X
the	B-X
level	B-X
of	B-X
CroR	B-X
phosphorylation	B-X
in	B-X
vivo	B-X
.	B-X
Deletion	B-X
of	B-X
croS	B-X
in	B-X
various	B-X
lineages	B-X
of	B-X
E.	B-X
faecalis	B-X
revealed	B-X
a	B-X
CroS-independent	B-X
mechanism	B-X
for	B-X
CroR	B-X
phosphorylation	B-X
and	B-X
led	B-X
to	B-X
the	B-X
identification	B-X
of	B-X
a	B-X
noncognate	B-X
histidine	B-X
kinase	B-X
capable	B-X
of	B-X
influencing	B-X
CroR	B-X
(	B-X
encoded	B-X
by	B-X
OG1RF_12162	B-X
;	B-X
here	B-X
called	B-X
cisS	B-X
)	B-X
.	B-X

This	O
revealed	O
approximately	O
232	O
kb	O
encoding	O
227	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
that	O
are	O
unique	O
to	O
this	O
important	O
strain	O
compared	O
to	O
V583	B-Organism
.	O

The	O
unique	O
regions	O
were	O
then	O
characterized	O
further	O
.	O
<EOS>	B-X
Furthermore	B-X
,	B-X
the	B-X
unique	B-X
breathing	B-X
pattern	B-X
,	B-X
characterised	B-X
by	B-X
a	B-X
lack	B-X
of	B-X
tachypnoeic	B-X
shift	B-X
,	B-X
found	B-X
in	B-X
professional	B-X
cyclists	B-X
may	B-X
enhance	B-X
the	B-X
efficiency	B-X
and	B-X
metabolic	B-X
cost	B-X
of	B-X
breathing	B-X
.	B-X
The	B-X
genetic	B-X
background	B-X
of	B-X
the	B-X
Brazilian	B-X
population	B-X
is	B-X
quite	B-X
heterogeneous	B-X
,	B-X
resulting	B-X
from	B-X
5	B-X
centuries	B-X
of	B-X
admixture	B-X
among	B-X
Native	B-X
Americans	B-X
,	B-X
Europeans	B-X
and	B-X
Africans	B-X
,	B-X
making	B-X
the	B-X
Brazilian	B-X
population	B-X
unique	B-X
in	B-X
terms	B-X
of	B-X
genetic	B-X
ancestry	B-X
.	B-X
The	B-X
unique	B-X
characteristics	B-X
of	B-X
populations	B-X
in	B-X
different	B-X
Brazilian	B-X
regions	B-X
make	B-X
them	B-X
an	B-X
exciting	B-X
focus	B-X
for	B-X
genetic	B-X
diversity	B-X
studies	B-X
.	B-X
Tick-borne	B-X
viruses	B-X
(	B-X
TBVs	B-X
)	B-X
belong	B-X
to	B-X
the	B-X
largest	B-X
biological	B-X
group	B-X
known	B-X
as	B-X
arboviruses	B-X
with	B-X
unique	B-X
mode	B-X
of	B-X
transmission	B-X
by	B-X
blood-feeding	B-X
arthropods	B-X
(	B-X
ticks	B-X
,	B-X
mosquitoes	B-X
,	B-X
sand	B-X
flies	B-X
,	B-X
biting	B-X
midges	B-X
,	B-X
etc	B-X
.	B-X
)	B-X

Results	O
and	O
discussion	O
<EOS>	B-X
However	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
evaluated	B-X
the	B-X
perspectives	B-X
of	B-X
oncologists	B-X
on	B-X
the	B-X
current	B-X
state	B-X
of	B-X
this	B-X
discussion	B-X
.	B-X
Advance	B-X
care	B-X
planning	B-X
(	B-X
ACP	B-X
)	B-X
and	B-X
goals	B-X
of	B-X
care	B-X
discussions	B-X
are	B-X
important	B-X
instruments	B-X
that	B-X
enable	B-X
respect	B-X
for	B-X
patient	B-X
autonomy	B-X
,	B-X
especially	B-X
in	B-X
patients	B-X
with	B-X
a	B-X
life-threatening	B-X
disease	B-X
,	B-X
such	B-X
as	B-X
cancer	B-X
.	B-X
Despite	B-X
their	B-X
well-established	B-X
benefits	B-X
,	B-X
ACP	B-X
and	B-X
goals	B-X
of	B-X
care	B-X
discussions	B-X
are	B-X
still	B-X
not	B-X
frequently	B-X
performed	B-X
in	B-X
clinical	B-X
oncology	B-X
practice	B-X
.	B-X
Each	B-X
group	B-X
had	B-X
two	B-X
discussion	B-X
leaders	B-X
.	B-X
All	B-X
discussions	B-X
were	B-X
digitally	B-X
recorded	B-X
for	B-X
accuracy	B-X
.	B-X
After	B-X
discussion	B-X
all	B-X
groups	B-X
reconvened	B-X
and	B-X
reported	B-X
summaries	B-X
of	B-X
discussions	B-X
and	B-X
recommendations	B-X
to	B-X
ensure	B-X
group	B-X
agreement	B-X
.	B-X

General	O
genome	O
features	O
The	O
complete	O
circular	O
chromosome	O
of	O
OG1RF	B-Organism
was	O
found	O
to	O
be	O
2	O
,	O
739	O
,	O
625	O
bp	O
with	O
an	O
average	O
G	O
+	O
C	O
content	O
of	O
37	O
.	O
8	O
%	O
.	O

The	O
complete	O
OG1RF	B-Organism
sequence	O
was	O
obtained	O
using	O
three	O
independent	O
techniques	O
(	O
Solexa	O
,	O
the	O
454	O
,	O
and	O
Sanger	O
sequencing	O
technique	O
)	O
with	O
a	O
higher	O
than	O
classic	O
coverage	O
(	O
more	O
than	O
100	O
times	O
)	O
,	O
diminishing	O
the	O
likelihood	O
of	O
sequencing	O
-	O
related	O
frameshifts	O
,	O
base	O
errors	O
and	O
/	O
or	O
misassembly	O
.	O
<EOS>	B-X
The	B-X
sequence	B-X
assembly	B-X
algorithms	B-X
have	B-X
rapidly	B-X
evolved	B-X
with	B-X
the	B-X
vigorous	B-X
growth	B-X
of	B-X
genome	B-X
sequencing	B-X
technology	B-X
over	B-X
the	B-X
past	B-X
two	B-X
decades	B-X
.	B-X
Assembly	B-X
mainly	B-X
uses	B-X
the	B-X
iterative	B-X
expansion	B-X
of	B-X
overlap	B-X
relationships	B-X
between	B-X
sequences	B-X
to	B-X
construct	B-X
the	B-X
target	B-X
genome	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
due	B-X
to	B-X
the	B-X
rapid	B-X
development	B-X
of	B-X
third-generation	B-X
sequencing	B-X
(	B-X
TGS	B-X
)	B-X
technology	B-X
,	B-X
some	B-X
prevalent	B-X
assembly	B-X
algorithms	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
generate	B-X
high-quality	B-X
chromosome-level	B-X
assemblies	B-X
.	B-X
Therefore	B-X
,	B-X
several	B-X
read-based	B-X
and	B-X
reference-based	B-X
methods	B-X
for	B-X
misassembly	B-X
identification	B-X
have	B-X
been	B-X
developed	B-X
to	B-X
improve	B-X
assembly	B-X
quality	B-X
.	B-X
This	B-X
work	B-X
primarily	B-X
reviewed	B-X
the	B-X
development	B-X
of	B-X
DNA	B-X
sequencing	B-X
technologies	B-X
and	B-X
summarized	B-X
sequencing	B-X
data	B-X
simulation	B-X
methods	B-X
,	B-X
sequencing	B-X
error	B-X
correction	B-X
methods	B-X
,	B-X
various	B-X
mainstream	B-X
sequence	B-X
assembly	B-X
algorithms	B-X
,	B-X
and	B-X
misassembly	B-X
identification	B-X
methods	B-X
.	B-X
A	B-X
large	B-X
amount	B-X
of	B-X
computation	B-X
makes	B-X
the	B-X
sequence	B-X
assembly	B-X
problem	B-X
more	B-X
challenging	B-X
,	B-X
and	B-X
therefore	B-X
,	B-X
it	B-X
is	B-X
necessary	B-X
to	B-X
develop	B-X
more	B-X
efficient	B-X
and	B-X
accurate	B-X
assembly	B-X
algorithms	B-X
and	B-X
alternative	B-X
algorithms	B-X
.	B-X

A	O
comparison	O
of	O
our	O
assembly	O
of	O
the	O
closed	O
OG1RF	B-Organism
genome	O
with	O
the	O
restriction	O
map	O
of	O
OG1RF	B-Organism
published	O
by	O
Murray	O
et	O
al	O
.	O

[	O
10	O
]	O
showed	O
only	O
minor	O
variations	O
(	O
primarily	O
an	O
overestimation	O
of	O
30	O
kb	O
for	O
the	O
Sfi	O
I	O
fragment	O
E	O
,	O
540	O
kb	O
versus	O
509	O
kb	O
predicted	O
from	O
the	O
sequence	O
;	O
Figure	O
1	O
)	O
.	O

We	O
found	O
232	O
kb	O
of	O
OG1RF	B-Organism
unique	O
sequences	O
distributed	O
in	O
48	O
regions	O
ranging	O
from	O
101	O
bp	O
to	O
approximately	O
49	O
kb	O
in	O
length	O
(	O
Figure	O
1	O
;	O
Additional	O
data	O
file	O
1	O
)	O
.	O

Using	O
the	O
published	O
DNA	O
sequence	O
of	O
V583	B-Organism
as	O
reference	O
(	O
NC	O
_	O
004668	O
)	O
,	O
OG1RF	B-Organism
shares	O
2	O
,	O
474	O
ORFs	O
as	O
well	O
as	O
the	O
12	O
rRNA	O
genes	O
and	O
58	O
of	O
68	O
tRNA	O
genes	O
(	O
Table	O
1	O
)	O
.	O

The	O
10	O
missing	O
tRNA	O
are	O
localized	O
in	O
a	O
region	O
in	O
V583	B-Organism
that	O
has	O
been	O
replaced	O
in	O
OG1RF	B-Organism
by	O
a	O
49	O
kb	O
region	O
(	O
see	O
below	O
)	O
.	O

Surprisingly	O
,	O
the	O
genomes	O
align	O
syntenically	O
,	O
as	O
shown	O
in	O
Figure	O
2	O
,	O
despite	O
the	O
fact	O
that	O
25	O
%	O
of	O
the	O
V583	B-Organism
genome	O
is	O
composed	O
of	O
mobile	O
elements	O
.	O

Similarly	O
,	O
the	O
presence	O
of	O
OG1RF	B-Organism
-	O
unique	O
sequences	O
has	O
not	O
affected	O
the	O
overall	O
chromosomal	O
arrangement	O
.	O

Some	O
of	O
the	O
major	O
insertions	O
/	O
deletions	O
in	O
the	O
two	O
genomes	O
are	O
shown	O
in	O
Figure	O
2	O
,	O
such	O
as	O
the	O
absence	O
of	O
the	O
pathogenicity	O
island	O
(	O
PAI	O
)	O
in	O
OG1RF	B-Organism
and	O
the	O
presence	O
of	O
an	O
approximately	O
49	O
kb	O
fragment	O
unique	O
to	O
OG1RF	B-Organism
.	O

However	O
,	O
most	O
of	O
the	O
differences	O
are	O
small	O
and	O
cannot	O
be	O
visualized	O
in	O
this	O
figure	O
.	O
<EOS>	B-X
For	B-X
that	B-X
reason	B-X
,	B-X
the	B-X
published	B-X
comparative	B-X
survival	B-X
analyses	B-X
after	B-X
various	B-X
therapies	B-X
have	B-X
within	B-X
this	B-X
period	B-X
failed	B-X
to	B-X
show	B-X
statistically	B-X
significant	B-X
death	B-X
rates	B-X
differences	B-X
.	B-X
Observed	B-X
mitotic	B-X
figures	B-X
4-6	B-X
years	B-X
after	B-X
irradiation	B-X
indicate	B-X
retained	B-X
reproductive	B-X
integrity	B-X
.	B-X
Retained	B-X
,	B-X
generally	B-X
poor	B-X
,	B-X
visual	B-X
acuity	B-X
in	B-X
a	B-X
small	B-X
percentage	B-X
of	B-X
patients	B-X
can	B-X
not	B-X
balance	B-X
the	B-X
incremental	B-X
risk/benefit	B-X
ratio	B-X
of	B-X
irradiation	B-X
.	B-X
However	B-X
,	B-X
this	B-X
difference	B-X
is	B-X
not	B-X
restrictive	B-X
and	B-X
by	B-X
no	B-X
means	B-X
can	B-X
it	B-X
be	B-X
stated	B-X
that	B-X
colposcopy	B-X
is	B-X
systematically	B-X
being	B-X
used	B-X
by	B-X
all	B-X
European	B-X
or	B-X
Latin	B-X
American	B-X
gynecologists	B-X
for	B-X
reasons	B-X
related	B-X
to	B-X
training	B-X
in	B-X
the	B-X
colposcopic	B-X
technique	B-X
.	B-X
With	B-X
regard	B-X
to	B-X
specificity	B-X
,	B-X
the	B-X
figures	B-X
range	B-X
between	B-X
48	B-X
%	B-X
and	B-X
10	B-X
%	B-X
with	B-X
96	B-X
%	B-X
for	B-X
sensitivity	B-X
.	B-X
Inter-	B-X
and	B-X
intra-observer	B-X
differences	B-X
(	B-X
when	B-X
the	B-X
same	B-X
pathologist	B-X
is	B-X
reviewing	B-X
the	B-X
diagnosis	B-X
after	B-X
a	B-X
certain	B-X
time	B-X
lapse	B-X
)	B-X
may	B-X
be	B-X
present	B-X
.	B-X
It	B-X
is	B-X
likely	B-X
that	B-X
this	B-X
situation	B-X
may	B-X
occur	B-X
when	B-X
colposcopy-guided	B-X
biopsy	B-X
is	B-X
performed	B-X
by	B-X
inexperienced	B-X
hands	B-X
or	B-X
when	B-X
biopsy	B-X
is	B-X
limited	B-X
to	B-X
small	B-X
and	B-X
insufficient	B-X
sampling	B-X
.	B-X

Overall	O
,	O
we	O
found	O
64	O
areas	O
of	O
divergence	O
between	O
the	O
genomes	O
that	O
can	O
be	O
divided	O
into	O
3	O
classes	O
:	O
an	O
additional	O
sequence	O
present	O
in	O
OG1RF	B-Organism
when	O
compared	O
with	O
V583	B-Organism
;	O
a	O
sequence	O
replacement	O
where	O
a	O
sequence	O
in	O
OG1RF	B-Organism
differs	O
from	O
the	O
sequence	O
in	O
V583	B-Organism
;	O
and	O
the	O
absence	O
of	O
a	O
sequence	O
from	O
OG1RF	B-Organism
when	O
compared	O
with	O
V583	B-Organism
.	O

CRISPR	O
loci	O
<EOS>	B-X
Clustered	B-X
regularly	B-X
interspaced	B-X
short	B-X
palindromic	B-X
repeats	B-X
(	B-X
CRISPR	B-X
)	B-X
-CRISPR-associated	B-X
protein	B-X
(	B-X
Cas	B-X
)	B-X
9-mediated	B-X
genome	B-X
modification	B-X
enables	B-X
us	B-X
to	B-X
edit	B-X
the	B-X
genomes	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
organisms	B-X
rapidly	B-X
and	B-X
efficiently	B-X
.	B-X
The	B-X
advantages	B-X
of	B-X
the	B-X
CRISPR-Cas9	B-X
system	B-X
have	B-X
made	B-X
it	B-X
an	B-X
increasingly	B-X
popular	B-X
genetic	B-X
engineering	B-X
tool	B-X
for	B-X
biological	B-X
and	B-X
therapeutic	B-X
applications	B-X
.	B-X
Moreover	B-X
,	B-X
CRISPR-Cas9	B-X
has	B-X
been	B-X
employed	B-X
to	B-X
recruit	B-X
functional	B-X
domains	B-X
that	B-X
repress/activate	B-X
gene	B-X
expression	B-X
or	B-X
label	B-X
specific	B-X
genomic	B-X
loci	B-X
in	B-X
living	B-X
cells	B-X
or	B-X
organisms	B-X
,	B-X
in	B-X
order	B-X
to	B-X
explore	B-X
developmental	B-X
mechanisms	B-X
,	B-X
gene	B-X
expression	B-X
regulation	B-X
,	B-X
and	B-X
animal	B-X
behavior	B-X
.	B-X
One	B-X
major	B-X
concern	B-X
about	B-X
this	B-X
system	B-X
is	B-X
its	B-X
specificity	B-X
;	B-X
although	B-X
CRISPR-Cas9-mediated	B-X
off-target	B-X
mutation	B-X
has	B-X
been	B-X
broadly	B-X
studied	B-X
,	B-X
more	B-X
efforts	B-X
are	B-X
required	B-X
to	B-X
further	B-X
improve	B-X
the	B-X
specificity	B-X
of	B-X
CRISPR-Cas9	B-X
.	B-X
We	B-X
will	B-X
also	B-X
discuss	B-X
the	B-X
potential	B-X
applications	B-X
of	B-X
CRISPR-Cas9	B-X
.	B-X

The	O
CRISPR	O
(	O
comprised	O
of	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
)	O
loci	O
encoded	O
by	O
some	O
bacterial	O
strains	O
is	O
a	O
recently	O
described	O
system	O
that	O
protects	O
cells	O
from	O
infection	O
with	O
bacteriophage	O
[	O
25	O
-	O
27	O
]	O
.	O

The	O
specificity	O
of	O
the	O
phage	O
resistance	O
conferred	O
by	O
the	O
CRISPR	O
elements	O
and	O
CRISPR	O
-	O
associated	O
genes	O
(	O
cas	O
genes	O
)	O
is	O
determined	O
by	O
spacer	O
-	O
phage	O
sequence	O
similarity	O
.	O

OG1RF	B-Organism
carries	O
two	O
CRISPR	O
elements	O
:	O
CRISPR1	O
(	O
between	O
the	O
OG1RF	B-Organism
homologue	O
of	O
EF0672	O
and	O
EF0673	O
)	O
and	O
CRISPR2	O
(	O
between	O
the	O
OG1RF	B-Organism
homologue	O
of	O
EF2062	O
and	O
EF2063	O
)	O
;	O
CRISPR1	O
is	O
linked	O
to	O
cas	O
-	O
like	O
genes	O
while	O
CRISPR2	O
is	O
not	O
(	O
Figure	O
3	O
)	O
.	O

Both	O
OG1RF	B-Organism
CRISPR	O
elements	O
are	O
composed	O
of	O
7	O
repeats	O
of	O
a	O
37	O
bp	O
palindromic	O
sequence	O
with	O
a	O
29	O
bp	O
spacer	O
.	O

None	O
of	O
the	O
29	O
bp	O
spacers	O
(	O
14	O
total	O
)	O
have	O
homology	O
to	O
any	O
sequences	O
in	O
GenBank	O
.	O

The	O
CRISPR1	O
-	O
associated	O
proteins	O
belong	O
to	O
the	O
Nmeni	O
subtype	O
[	O
28	O
]	O
.	O

Species	O
bearing	O
this	O
CRISPR	O
/	O
cas	O
subtype	O
have	O
so	O
far	O
been	O
found	O
exclusively	O
in	O
bacteria	O
that	O
are	O
vertebrate	O
pathogens	O
or	O
commensals	O
.	O
<EOS>	B-X
Escherichia	B-X
coli	B-X
is	B-X
a	B-X
paradigm	B-X
for	B-X
a	B-X
versatile	B-X
bacterial	B-X
species	B-X
which	B-X
comprises	B-X
harmless	B-X
commensal	B-X
as	B-X
well	B-X
as	B-X
different	B-X
pathogenic	B-X
variants	B-X
with	B-X
the	B-X
ability	B-X
to	B-X
either	B-X
cause	B-X
intestinal	B-X
or	B-X
extraintestinal	B-X
diseases	B-X
in	B-X
humans	B-X
and	B-X
many	B-X
animal	B-X
hosts	B-X
.	B-X
Because	B-X
of	B-X
this	B-X
broad	B-X
spectrum	B-X
of	B-X
lifestyles	B-X
and	B-X
phenotypes	B-X
,	B-X
E.	B-X
coli	B-X
is	B-X
a	B-X
well-suited	B-X
model	B-X
organism	B-X
to	B-X
study	B-X
bacterial	B-X
evolution	B-X
and	B-X
adaptation	B-X
to	B-X
different	B-X
growth	B-X
conditions	B-X
and	B-X
niches	B-X
.	B-X
Intestinal	B-X
pathogenic	B-X
E.	B-X
coli	B-X
strains	B-X
can	B-X
be	B-X
reliably	B-X
discriminated	B-X
from	B-X
non-pathogenic	B-X
,	B-X
commensal	B-X
,	B-X
or	B-X
from	B-X
extraintestinal	B-X
E.	B-X
coli	B-X
pathogens	B-X
based	B-X
on	B-X
genome	B-X
content	B-X
and	B-X
phenotypic	B-X
traits	B-X
.	B-X
An	B-X
unambiguous	B-X
distinction	B-X
of	B-X
extraintestinal	B-X
pathogenic	B-X
E.	B-X
coli	B-X
and	B-X
commensals	B-X
is	B-X
,	B-X
nevertheless	B-X
,	B-X
not	B-X
so	B-X
easy	B-X
,	B-X
as	B-X
strains	B-X
with	B-X
the	B-X
ability	B-X
to	B-X
cause	B-X
extraintestinal	B-X
infection	B-X
are	B-X
facultative	B-X
pathogens	B-X
and	B-X
belong	B-X
to	B-X
the	B-X
normal	B-X
flora	B-X
of	B-X
many	B-X
healthy	B-X
individuals	B-X
.	B-X

The	O
Nmeni	O
subtype	O
is	O
characterized	O
by	O
the	O
presence	O
of	O
four	O
specific	O
cas	O
genes	O
and	O
a	O
single	O
copy	O
of	O
the	O
repeat	O
that	O
is	O
upstream	O
of	O
the	O
first	O
gene	O
in	O
the	O
locus	O
.	O

The	O
four	O
cas	O
genes	O
encode	O
Cas	O
_	O
csn1	O
(	O
possible	O
endonuclease	O
)	O
,	O
Cas1	O
(	O
novel	O
nuclease	O
)	O
,	O
Cas2	O
(	O
conserved	O
hypothetical	O
protein	O
)	O
,	O
and	O
Cas	O
_	O
csn2	O
(	O
conserved	O
hypothetical	O
protein	O
)	O
.	O

The	O
repeat	O
upstream	O
of	O
cas	O
_	O
csn1	O
appears	O
to	O
have	O
degenerated	O
since	O
it	O
shares	O
only	O
23	O
bp	O
with	O
the	O
37	O
bp	O
repeat	O
cluster	O
downstream	O
of	O
the	O
last	O
gene	O
.	O

A	O
unique	O
feature	O
of	O
the	O
OG1RF	B-Organism
CRISPR1	O
locus	O
is	O
the	O
presence	O
of	O
a	O
gene	O
downstream	O
of	O
the	O
element	O
,	O
which	O
encodes	O
a	O
hypothetical	O
119	O
amino	O
acid	O
transmembrane	O
protein	O
.	O

The	O
presence	O
of	O
the	O
CRISPR	O
loci	O
among	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
strains	O
may	O
be	O
a	O
powerful	O
tool	O
to	O
avoid	O
the	O
load	O
of	O
prophage	O
replication	O
.	O

To	O
determine	O
the	O
distribution	O
of	O
the	O
CRISPR1	O
locus	O
in	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
strains	O
,	O
16	O
isolates	O
of	O
various	O
MLST	O
types	O
were	O
tested	O
for	O
the	O
presence	O
(	O
PCR	O
with	O
primers	O
specific	O
for	O
csn1	O
and	O
cas1	O
)	O
or	O
absence	O
(	O
PCR	O
with	O
primers	O
overlapping	O
the	O
junction	O
between	O
EF0672	O
and	O
EF0673	O
)	O
of	O
the	O
CRISPR1	O
locus	O
(	O
Table	O
2	O
)	O
.	O

Seven	O
strains	O
were	O
cas	O
positive	O
,	O
but	O
negative	O
for	O
the	O
junction	O
and	O
the	O
remaining	O
nine	O
were	O
positive	O
only	O
for	O
the	O
junction	O
.	O

This	O
indicates	O
that	O
the	O
location	O
of	O
the	O
CRISPR1	O
locus	O
appears	O
to	O
be	O
conserved	O
(	O
between	O
EF0672	O
and	O
EF0673	O
when	O
compared	O
with	O
the	O
V583	B-Organism
genome	O
)	O
.	O

Interestingly	O
,	O
the	O
two	O
vancomycin	O
resistant	O
strains	O
tested	O
were	O
both	O
cas	O
negative	O
.	O

It	O
is	O
appealing	O
to	O
postulate	O
that	O
the	O
presence	O
of	O
the	O
CRISPR	O
locus	O
in	O
OG1RF	B-Organism
may	O
be	O
the	O
reason	O
for	O
the	O
absence	O
of	O
prophage	O
in	O
this	O
strain	O
.	O

A	O
14	O
.	O
8	O
kb	O
region	O
inserted	O
in	O
the	O
23	O
.	O
9	O
kb	O
region	O
containing	O
fsrA	O
and	O
fsrB	O

Nakayama	O
et	O
al	O
.	O
<EOS>	B-X
The	B-X
EMPA-KIDNEY	B-X
trial	B-X
was	B-X
designed	B-X
to	B-X
assess	B-X
the	B-X
effects	B-X
of	B-X
treatment	B-X
with	B-X
empagliflozin	B-X
in	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
such	B-X
patients	B-X
.	B-X
The	B-X
ubiquitin-proteasome	B-X
system	B-X
(	B-X
UPS	B-X
)	B-X
is	B-X
involved	B-X
in	B-X
multiple	B-X
aspects	B-X
of	B-X
cellular	B-X
processes	B-X
,	B-X
such	B-X
as	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
cellular	B-X
differentiation	B-X
,	B-X
and	B-X
survival	B-X
(	B-X
Davis	B-X
RJ	B-X
et	B-X
al.	B-X
,	B-X
Cancer	B-X
Cell	B-X
26:455-64	B-X
,	B-X
2014	B-X
;	B-X
Skaar	B-X
JR	B-X
et	B-X
al.	B-X
,	B-X
Nat	B-X
Rev	B-X
Drug	B-X
Discov	B-X
13:889-903	B-X
,	B-X
2014	B-X
;	B-X
Nakayama	B-X
KI	B-X
and	B-X
Nakayama	B-X
K	B-X
,	B-X
Nat	B-X
Rev	B-X
Cancer	B-X
6:369-81	B-X
,	B-X
2006	B-X
)	B-X
.	B-X
F-box	B-X
and	B-X
WD	B-X
repeat	B-X
domain	B-X
containing	B-X
7	B-X
(	B-X
FBXW7	B-X
)	B-X
,	B-X
also	B-X
known	B-X
as	B-X
Sel10	B-X
,	B-X
hCDC4	B-X
or	B-X
hAgo	B-X
,	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
F-box	B-X
protein	B-X
family	B-X
,	B-X
which	B-X
functions	B-X
as	B-X
the	B-X
substrate	B-X
recognition	B-X
component	B-X
of	B-X
the	B-X
SCF	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
FBXW7	B-X
is	B-X
a	B-X
critical	B-X
tumor	B-X
suppressor	B-X
and	B-X
one	B-X
of	B-X
the	B-X
most	B-X
commonly	B-X
deregulated	B-X
ubiquitin-proteasome	B-X
system	B-X
proteins	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
Consistent	B-X
with	B-X
the	B-X
tumor	B-X
suppressor	B-X
role	B-X
of	B-X
FBXW7	B-X
,	B-X
it	B-X
is	B-X
located	B-X
at	B-X
chromosome	B-X
4q32	B-X
,	B-X
a	B-X
genomic	B-X
region	B-X
deleted	B-X
in	B-X
more	B-X
than	B-X
30	B-X
%	B-X
of	B-X
all	B-X
human	B-X
cancers	B-X
(	B-X
Spruck	B-X
CH	B-X
et	B-X
al.	B-X
,	B-X
Cancer	B-X
Res	B-X
62:4535-9	B-X
,	B-X
2002	B-X
)	B-X
.	B-X
Genetic	B-X
profiles	B-X
of	B-X
human	B-X
cancers	B-X
based	B-X
on	B-X
high-throughput	B-X
sequencing	B-X
have	B-X
revealed	B-X
that	B-X
FBXW7	B-X
is	B-X
frequently	B-X
mutated	B-X
in	B-X
human	B-X
cancers	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
genetic	B-X
mutations	B-X
,	B-X
other	B-X
mechanisms	B-X
involving	B-X
microRNA	B-X
,	B-X
long	B-X
non-coding	B-X
RNA	B-X
,	B-X
and	B-X
specific	B-X
oncogenic	B-X
signaling	B-X
pathways	B-X
can	B-X
inactivate	B-X
FBXW7	B-X
functions	B-X
in	B-X
cancer	B-X
cells	B-X
.	B-X
In	B-X
the	B-X
following	B-X
sections	B-X
,	B-X
we	B-X
will	B-X
discuss	B-X
the	B-X
regulation	B-X
of	B-X
FBXW7	B-X
,	B-X
its	B-X
role	B-X
in	B-X
oncogenesis	B-X
,	B-X
and	B-X
the	B-X
clinical	B-X
implications	B-X
and	B-X
prognostic	B-X
value	B-X
of	B-X
loss	B-X
of	B-X
function	B-X
of	B-X
FBXW7	B-X
in	B-X
human	B-X
cancers	B-X
.	B-X

[	O
29	O
]	O
described	O
a	O
conserved	O
23	O
.	O
9	O
kb	O
chromosomal	O
deletion	O
when	O
comparing	O
fsrA	O
-	O
lacking	O
/	O
fsrC	O
+	O
/	O
gelE	O
+	O
strains	O
(	O
by	O
PCR	O
)	O
from	O
various	O
origins	O
with	O
V583	B-Organism
;	O
the	O
deleted	O
sequences	O
start	O
in	O
the	O
middle	O
of	O
EF1841	O
,	O
include	O
the	O
fsrAB	O
genes	O
and	O
end	O
in	O
the	O
middle	O
of	O
the	O
fsrC	O
gene	O
(	O
EF1820	O
)	O
.	O

Loss	O
of	O
the	O
fsr	O
regulatory	O
components	O
results	O
in	O
a	O
gelatinase	O
-	O
negative	O
phenotype	O
under	O
routine	O
test	O
conditions	O
despite	O
the	O
fact	O
that	O
these	O
strains	O
still	O
carry	O
the	O
gelE	O
gene	O
[	O
23	O
,	O
29	O
]	O
.	O

The	O
absence	O
/	O
presence	O
of	O
the	O
23	O
.	O
9	O
kb	O
region	O
,	O
from	O
EF1820	O
/	O
fsrC	O
to	O
EF1841	O
,	O
did	O
not	O
appear	O
to	O
correlate	O
with	O
the	O
clinical	O
origin	O
of	O
the	O
isolates	O
[	O
30	O
]	O
.	O

In	O
a	O
more	O
recent	O
analysis	O
of	O
relationships	O
between	O
various	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
strains	O
,	O
the	O
23	O
.	O
9	O
kb	O
region	O
was	O
not	O
detected	O
in	O
86	O
%	O
of	O
the	O
strains	O
of	O
the	O
clonal	O
complex	O
(	O
CC	O
)	O
2	O
,	O
58	O
%	O
of	O
the	O
CC9	B-Organism
strains	O
,	O
nor	O
in	O
any	O
of	O
the	O
CC8	B-Organism
strains	O
[	O
31	O
]	O
.	O

The	O
Symbioflor	B-Organism
1	I-Organism
strain	O
,	O
used	O
as	O
a	O
probiotic	O
,	O
is	O
one	O
representative	O
of	O
the	O
7	O
.	O
4	O
%	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
isolates	O
that	O
are	O
missing	O
the	O
gelE	O
gene	O
in	O
addition	O
to	O
the	O
23	O
.	O
9	O
kb	O
region	O
[	O
5	O
,	O
30	O
]	O
.	O

Our	O
analysis	O
of	O
this	O
area	O
in	O
OG1RF	B-Organism
revealed	O
the	O
presence	O
of	O
an	O
additional	O
14	O
.	O
8	O
kb	O
fragment	O
inserted	O
between	O
the	O
corresponding	O
EF1826	O
and	O
EF1827	O
of	O
OG1RF	B-Organism
(	O
confirmed	O
by	O
PCR	O
;	O
results	O
not	O
shown	O
)	O
.	O

In	O
OG1RF	B-Organism
,	O
this	O
14	O
.	O
8	O
kb	O
region	O
contains	O
two	O
loci	O
,	O
a	O
WxL	O
locus	O
(	O
described	O
below	O
)	O
and	O
a	O
seven	O
-	O
gene	O
locus	O
that	O
may	O
encode	O
a	O
possible	O
ABC	O
transporter	O
with	O
similarity	O
to	O
one	O
annotated	O
in	O
Pediococcus	B-Organism
pentosaceus	I-Organism
.	O

Components	O
of	O
the	O
cell	O
surface	O
<EOS>	B-X
The	B-X
cell	B-X
wall	B-X
is	B-X
a	B-X
dynamic	B-X
organelle	B-X
which	B-X
is	B-X
tightly	B-X
controlled	B-X
for	B-X
cell	B-X
morphology	B-X
,	B-X
viability	B-X
,	B-X
and	B-X
pathogenesis	B-X
.	B-X
It	B-X
was	B-X
previously	B-X
shown	B-X
that	B-X
exocytosis	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
secretion	B-X
of	B-X
some	B-X
components	B-X
and	B-X
enzymes	B-X
of	B-X
the	B-X
cell	B-X
wall	B-X
.	B-X
However	B-X
,	B-X
how	B-X
the	B-X
secretory	B-X
pathway	B-X
affects	B-X
the	B-X
cell	B-X
wall	B-X
integrity	B-X
and	B-X
assembly	B-X
remains	B-X
unclear	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
secretory	B-X
pathway	B-X
mutant	B-X
(	B-X
sec	B-X
)	B-X
cells	B-X
were	B-X
sensitive	B-X
to	B-X
cell	B-X
wall	B-X
antagonists	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
and	B-X
they	B-X
were	B-X
lysed	B-X
at	B-X
restrictive	B-X
conditions	B-X
but	B-X
can	B-X
be	B-X
rescued	B-X
by	B-X
osmotic	B-X
stabilizers	B-X
,	B-X
indicating	B-X
their	B-X
cell	B-X
walls	B-X
were	B-X
disrupted	B-X
.	B-X
Although	B-X
glucans	B-X
were	B-X
reduced	B-X
at	B-X
the	B-X
cell	B-X
surface	B-X
in	B-X
sec	B-X
mutants	B-X
as	B-X
speculated	B-X
,	B-X
the	B-X
other	B-X
two	B-X
main	B-X
cell	B-X
wall	B-X
components	B-X
,	B-X
chitins	B-X
,	B-X
and	B-X
mannoproteins	B-X
,	B-X
were	B-X
accumulated	B-X
at	B-X
the	B-X
cell	B-X
surface	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
exocytic	B-X
pathway	B-X
has	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
cell	B-X
wall	B-X
assembly	B-X
.	B-X
Our	B-X
study	B-X
will	B-X
help	B-X
to	B-X
understand	B-X
the	B-X
mechanism	B-X
of	B-X
cell	B-X
wall	B-X
formation	B-X
.	B-X

It	O
has	O
been	O
shown	O
in	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
that	O
at	O
least	O
one	O
cell	O
surface	O
protein	O
(	O
Ace	O
)	O
is	O
subject	O
to	O
domain	O
variation	O
[	O
20	O
]	O
and	O
it	O
has	O
been	O
postulated	O
that	O
domain	O
variation	O
may	O
help	O
bacteria	O
escape	O
the	O
immune	O
system	O
.	O

We	O
found	O
more	O
polymorphisms	O
in	O
two	O
families	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
proteins	O
present	O
on	O
the	O
cell	O
surface	O
:	O
the	O
MSCRAMMs	O
and	O
the	O
WxL	O
domain	O
surface	O
proteins	O
.	O

The	O
MSCRAMMs	O
are	O
composed	O
of	O
two	O
large	O
regions	O
,	O
namely	O
,	O
the	O
non	O
-	O
repeat	O
A	O
region	O
(	O
which	O
is	O
usually	O
the	O
ligand	O
binding	O
region	O
for	O
extracellular	O
matrix	O
molecules	O
such	O
as	O
collagen	O
or	O
fibrinogen	O
)	O
and	O
the	O
B	O
region	O
(	O
which	O
typically	O
contains	O
repeated	O
sub	O
-	O
domains	O
)	O
.	O

The	O
B	O
region	O
of	O
Ace	O
contains	O
five	O
repeats	O
in	O
OG1RF	B-Organism
,	O
while	O
it	O
contains	O
only	O
four	O
in	O
V583	B-Organism
[	O
20	O
]	O
.	O

We	O
found	O
two	O
other	O
MSCRAMM	O
proteins	O
that	O
show	O
polymorphisms	O
in	O
the	O
number	O
of	O
their	O
B	O
repeats	O
.	O

OG1RF	O
_	O
0186	O
(	O
corresponding	O
to	O
EF2505	O
of	O
V583	B-Organism
)	O
has	O
four	O
repeats	O
compared	O
to	O
seven	O
in	O
V583	B-Organism
,	O
and	O
OG1RF	O
_	O
0165	O
(	O
corresponding	O
to	O
EF2224	O
of	O
V583	B-Organism
)	O
has	O
eight	O
repeats	O
compared	O
to	O
five	O
in	O
V583	B-Organism
.	O

It	O
has	O
been	O
proposed	O
that	O
the	O
repeats	O
are	O
used	O
as	O
a	O
stalk	O
that	O
projects	O
the	O
A	O
region	O
across	O
the	O
peptidoglycan	O
and	O
away	O
from	O
the	O
cell	O
surface	O
[	O
32	O
]	O
.	O

A	O
hypothesis	O
that	O
the	O
number	O
of	O
repeats	O
may	O
be	O
proportional	O
to	O
the	O
depth	O
of	O
the	O
peptidoglycan	O
has	O
been	O
proposed	O
[	O
32	O
]	O
.	O

However	O
,	O
OG1RF	O
_	O
0186	O
carries	O
fewer	O
repeats	O
than	O
EF2505	O
while	O
Ace	O
and	O
OG1RF	O
_	O
0165	O
carry	O
more	O
repeats	O
than	O
their	O
counterparts	O
in	O
V583	B-Organism
,	O
suggesting	O
that	O
our	O
observation	O
does	O
not	O
fit	O
this	O
hypothesis	O
or	O
that	O
the	O
peptidoglycan	O
depth	O
is	O
not	O
uniform	O
.	O
<EOS>	B-X
NOD1/2	B-X
ligands	B-X
are	B-X
known	B-X
to	B-X
derive	B-X
from	B-X
peptidoglycan	B-X
,	B-X
and	B-X
the	B-X
latest	B-X
research	B-X
has	B-X
resolved	B-X
the	B-X
paradox	B-X
of	B-X
whether	B-X
chlamydial	B-X
species	B-X
possess	B-X
this	B-X
bacterial	B-X
cell	B-X
wall	B-X
component	B-X
;	B-X
this	B-X
finding	B-X
is	B-X
likely	B-X
to	B-X
promote	B-X
in-depth	B-X
investigations	B-X
into	B-X
the	B-X
interaction	B-X
between	B-X
the	B-X
NOD	B-X
proteins	B-X
and	B-X
chlamydial	B-X
pathogens	B-X
.	B-X
However	B-X
,	B-X
fungal	B-X
cell	B-X
walls	B-X
are	B-X
structurally	B-X
different	B-X
from	B-X
the	B-X
bacterial	B-X
peptidoglycan	B-X
target	B-X
of	B-X
β-lactams	B-X
.	B-X
They	B-X
inhibit	B-X
the	B-X
synthesis	B-X
of	B-X
the	B-X
peptidoglycan	B-X
layer	B-X
in	B-X
the	B-X
bacterial	B-X
cell	B-X
wall	B-X
by	B-X
mimicking	B-X
the	B-X
D-Ala-D-Ala	B-X
in	B-X
the	B-X
pentapeptide	B-X
crosslinking	B-X
neighboring	B-X
glycan	B-X
chains	B-X
.	B-X
The	B-X
structural	B-X
insight	B-X
into	B-X
various	B-X
β-lactams	B-X
will	B-X
provide	B-X
an	B-X
in-depth	B-X
understanding	B-X
of	B-X
the	B-X
antibacterial	B-X
efficacy	B-X
and	B-X
susceptibility	B-X
to	B-X
drug	B-X
resistance	B-X
in	B-X
multidrug-resistant	B-X
bacteria	B-X
and	B-X
help	B-X
to	B-X
develop	B-X
better	B-X
β-lactam	B-X
antibiotics	B-X
and	B-X
inhibitors	B-X
.	B-X

Apart	O
from	O
these	O
three	O
MSCRAMMs	O
with	O
B	O
-	O
repeat	O
polymorphisms	O
,	O
we	O
identified	O
two	O
unique	O
MSCRAMM	O
proteins	O
in	O
OG1RF	B-Organism
:	O
a	O
homologue	O
of	O
EF0089	O
(	O
OG1RF	O
_	O
0063	O
,	O
which	O
shares	O
48	O
%	O
similarity	O
)	O
and	O
a	O
homologue	O
of	O
EF1896	O
(	O
OG1RF	O
_	O
0039	O
,	O
which	O
shares	O
75	O
%	O
similarity	O
)	O
;	O
both	O
are	O
located	O
in	O
the	O
approximately	O
49	O
kb	O
region	O
unique	O
to	O
OG1RF	B-Organism
described	O
below	O
(	O
Figure	O
1	O
;	O
Additional	O
data	O
file	O
1	O
)	O
.	O

Another	O
family	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
surface	O
proteins	O
includes	O
the	O
newly	O
described	O
WxL	O
domain	O
surface	O
proteins	O
.	O

Siezen	O
et	O
al	O
.	O
<EOS>	B-X
In	B-X
the	B-X
bovine	B-X
lens	B-X
the	B-X
gamma	B-X
IV-crystallin	B-X
fraction	B-X
is	B-X
a	B-X
principal	B-X
determinant	B-X
of	B-X
the	B-X
phase	B-X
separation	B-X
and	B-X
opacification	B-X
temperature	B-X
,	B-X
Tc	B-X
(	B-X
Siezen	B-X
et	B-X
al	B-X
,	B-X
Proc	B-X
.	B-X
We	B-X
have	B-X
now	B-X
measured	B-X
the	B-X
effect	B-X
on	B-X
Tc	B-X
of	B-X
purified	B-X
gamma	B-X
IV-crystallin	B-X
solutions	B-X
produced	B-X
by	B-X
a	B-X
variety	B-X
of	B-X
reagents	B-X
which	B-X
affect	B-X
protein-protein	B-X
,	B-X
protein-water	B-X
and	B-X
water-water	B-X
interactions	B-X
.	B-X
Ionic	B-X
strengths	B-X
less	B-X
than	B-X
physiological	B-X
increase	B-X
Tc	B-X
dramatically	B-X
,	B-X
while	B-X
higher	B-X
ionic	B-X
strength	B-X
has	B-X
very	B-X
little	B-X
effect	B-X
.	B-X
Calcium	B-X
ion	B-X
concentrations	B-X
up	B-X
to	B-X
8	B-X
mM	B-X
produce	B-X
no	B-X
change	B-X
in	B-X
Tc	B-X
.	B-X
Glycerol	B-X
and	B-X
acrylamide	B-X
both	B-X
depress	B-X
Tc	B-X
linearly	B-X
with	B-X
reagent	B-X
concentrations	B-X
;	B-X
Tc	B-X
depression	B-X
of	B-X
gamma	B-X
IV-crystallin	B-X
by	B-X
these	B-X
compounds	B-X
is	B-X
quantitatively	B-X
the	B-X
same	B-X
as	B-X
for	B-X
whole	B-X
lens	B-X
.	B-X
Changes	B-X
in	B-X
opacification	B-X
temperature	B-X
of	B-X
gamma	B-X
IV-crystallin	B-X
produced	B-X
by	B-X
oxidizing	B-X
and	B-X
reducing	B-X
agents	B-X
are	B-X
time-dependent	B-X
and	B-X
highly	B-X
non-linear	B-X
with	B-X
reagent	B-X
concentration	B-X
.	B-X
Our	B-X
results	B-X
clearly	B-X
show	B-X
that	B-X
bovine	B-X
gamma	B-X
IV-crystallin	B-X
is	B-X
an	B-X
important	B-X
target	B-X
protein	B-X
for	B-X
various	B-X
reagents	B-X
which	B-X
are	B-X
known	B-X
perturbants	B-X
of	B-X
the	B-X
opacification	B-X
temperature	B-X
of	B-X
whole	B-X
lens	B-X
.	B-X
The	B-X
relevance	B-X
of	B-X
these	B-X
findings	B-X
to	B-X
human	B-X
diabetic	B-X
and	B-X
senile	B-X
cataract	B-X
formation	B-X
is	B-X
discussed	B-X
.	B-X

[	O
33	O
]	O
reported	O
a	O
novel	O
gene	O
cluster	O
encoding	O
exclusively	O
cell	O
-	O
surface	O
proteins	O
that	O
is	O
conserved	O
in	O
a	O
subgroup	O
of	O
Gram	O
-	O
positive	O
bacteria	O
.	O

Each	O
gene	O
cluster	O
has	O
at	O
least	O
one	O
member	O
of	O
three	O
gene	O
families	O
:	O
a	O
gene	O
encoding	O
a	O
small	O
LPxTG	O
protein	O
(	O
approximately	O
120	O
amino	O
acids	O
)	O
;	O
a	O
gene	O
encoding	O
a	O
member	O
of	O
the	O
DUF916	O
transmembrane	O
protein	O
family	O
;	O
and	O
a	O
gene	O
encoding	O
a	O
WxL	O
domain	O
surface	O
protein	O
.	O

In	O
addition	O
,	O
members	O
of	O
these	O
gene	O
families	O
were	O
found	O
as	O
singletons	O
or	O
associated	O
with	O
genes	O
encoding	O
other	O
proteins	O
(	O
Additional	O
data	O
file	O
2	O
)	O
.	O
<EOS>	B-X
Risk	B-X
for	B-X
late-onset	B-X
Alzheimer	B-X
's	B-X
disease	B-X
(	B-X
LOAD	B-X
)	B-X
,	B-X
the	B-X
most	B-X
prevalent	B-X
dementia	B-X
,	B-X
is	B-X
partially	B-X
driven	B-X
by	B-X
genetics	B-X
.	B-X
We	B-X
confirm	B-X
20	B-X
previous	B-X
LOAD	B-X
risk	B-X
loci	B-X
and	B-X
identify	B-X
five	B-X
new	B-X
genome-wide	B-X
loci	B-X
(	B-X
IQCK	B-X
,	B-X
ACE	B-X
,	B-X
ADAM10	B-X
,	B-X
ADAMTS1	B-X
,	B-X
and	B-X
WWOX	B-X
)	B-X
,	B-X
two	B-X
of	B-X
which	B-X
(	B-X
ADAM10	B-X
,	B-X
ACE	B-X
)	B-X
were	B-X
identified	B-X
in	B-X
a	B-X
recent	B-X
genome-wide	B-X
association	B-X
(	B-X
GWAS	B-X
)	B-X
-by-familial-proxy	B-X
of	B-X
Alzheimer	B-X
's	B-X
or	B-X
dementia	B-X
.	B-X
Pathway	B-X
analysis	B-X
implicates	B-X
immunity	B-X
,	B-X
lipid	B-X
metabolism	B-X
,	B-X
tau	B-X
binding	B-X
proteins	B-X
,	B-X
and	B-X
amyloid	B-X
precursor	B-X
protein	B-X
(	B-X
APP	B-X
)	B-X
metabolism	B-X
,	B-X
showing	B-X
that	B-X
genetic	B-X
variants	B-X
affecting	B-X
APP	B-X
and	B-X
Aβ	B-X
processing	B-X
are	B-X
associated	B-X
not	B-X
only	B-X
with	B-X
early-onset	B-X
autosomal	B-X
dominant	B-X
Alzheimer	B-X
's	B-X
disease	B-X
but	B-X
also	B-X
with	B-X
LOAD	B-X
.	B-X
Analyses	B-X
of	B-X
risk	B-X
genes	B-X
and	B-X
pathways	B-X
show	B-X
enrichment	B-X
for	B-X
rare	B-X
variants	B-X
(	B-X
P	B-X
=	B-X
1.32	B-X
×	B-X
10	B-X

Recently	O
,	O
it	O
was	O
shown	O
that	O
the	O
WxL	O
domain	O
attaches	O
to	O
the	O
peptidoglycan	O
on	O
the	O
cell	O
surface	O
[	O
34	O
]	O
and	O
one	O
member	O
of	O
this	O
WxL	O
domain	O
family	O
,	O
the	O
homologue	O
of	O
EF2686	O
in	O
OG1RF	B-Organism
(	O
a	O
probable	O
internalin	O
protein	O
)	O
,	O
was	O
shown	O
to	O
be	O
important	O
for	O
virulence	O
in	O
a	O
mouse	B-Organism
peritonitis	O
model	O
and	O
is	O
required	O
for	O
dissemination	O
to	O
the	O
spleen	O
and	O
liver	O
[	O
35	O
]	O
.	O

OG1RF	B-Organism
shares	O
five	O
complete	O
WxL	O
loci	O
with	O
V583	B-Organism
(	O
EF0750	O
-	O
7	O
,	O
EF2682	O
-	O
6	O
,	O
EF2970	O
-	O
68	O
,	O
EF3181	O
-	O
8	O
,	O
and	O
EF3248	O
-	O
53	O
)	O
.	O

OG1RF	B-Organism
does	O
not	O
contain	O
homologues	O
of	O
EF2248	O
-	O
54	O
(	O
carrying	O
instead	O
the	O
iol	O
operon	O
)	O
,	O
though	O
it	O
has	O
a	O
novel	O
WxL	O
locus	O
within	O
the	O
14	O
.	O
8	O
kb	O
unique	O
region	O
upstream	O
of	O
the	O
fsr	O
locus	O
(	O
Additional	O
data	O
file	O
2	O
)	O
.	O

In	O
addition	O
to	O
the	O
variation	O
in	O
the	O
number	O
of	O
WxL	O
loci	O
,	O
we	O
also	O
observed	O
polymorphisms	O
in	O
six	O
of	O
the	O
WxL	O
domain	O
surface	O
proteins	O
.	O

For	O
example	O
,	O
OG1RF	O
_	O
0213	O
shares	O
88	O
%	O
similarity	O
with	O
EF3188	B-Organism
,	O
while	O
OG1RF	O
_	O
0224	O
,	O
OG1RF	O
_	O
0225	O
,	O
and	O
OG1RF	O
_	O
0227	O
share	O
64	O
-	O
68	O
%	O
similarity	O
with	O
their	O
V583	B-Organism
counterparts	O
,	O
EF3248	O
,	O
EF3250	O
,	O
and	O
EF3252	O
,	O
respectively	O
.	O

Also	O
,	O
in	O
place	O
of	O
EF3153	O
,	O
EF3154	O
,	O
and	O
EF3155	O
(	O
which	O
share	O
70	O
%	O
similarity	O
among	O
themselves	O
)	O
,	O
were	O
found	O
non	O
-	O
distantly	O
related	O
homologues	O
,	O
OG1RF	O
_	O
0209	O
and	O
OG1RF	O
_	O
0210	O
,	O
which	O
share	O
60	O
-	O
80	O
%	O
similarity	O
with	O
EF3153	O
,	O
EF3154	O
,	O
and	O
EF3155	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
while	O
several	O
of	O
these	O
WxL	O
loci	O
,	O
including	O
the	O
EF0750	O
and	O
EF3184	O
loci	O
,	O
were	O
present	O
by	O
hybridization	O
in	O
all	O
the	O
strains	O
(	O
clinical	O
or	O
food	O
isolates	O
)	O
tested	O
by	O
Lepage	O
et	O
al	O
.	O

[	O
36	O
]	O
,	O
other	O
loci	O
,	O
including	O
the	O
EF3153	O
and	O
EF3248	O
loci	O
,	O
were	O
not	O
detected	O
in	O
the	O
majority	O
of	O
these	O
strains	O
.	O
<EOS>	B-X
We	B-X
aimed	B-X
to	B-X
use	B-X
the	B-X
largest	B-X
aggregate	B-X
of	B-X
GWAS	B-X
data	B-X
to	B-X
identify	B-X
novel	B-X
risk	B-X
loci	B-X
and	B-X
gain	B-X
further	B-X
insight	B-X
into	B-X
the	B-X
causes	B-X
of	B-X
Parkinson	B-X
's	B-X
disease	B-X
.	B-X
We	B-X
performed	B-X
a	B-X
genome-wide	B-X
association	B-X
study	B-X
(	B-X
GWAS	B-X
)	B-X
involving	B-X
1,873	B-X
patients	B-X
diagnosed	B-X
with	B-X
acetylcholine	B-X
receptor	B-X
antibody-positive	B-X
myasthenia	B-X
gravis	B-X
and	B-X
36,370	B-X
healthy	B-X
individuals	B-X
to	B-X
identify	B-X
disease-associated	B-X
genetic	B-X
risk	B-X
loci	B-X
.	B-X
Replication	B-X
of	B-X
the	B-X
discovered	B-X
loci	B-X
was	B-X
attempted	B-X
in	B-X
an	B-X
independent	B-X
cohort	B-X
from	B-X
the	B-X
UK	B-X
Biobank	B-X
.	B-X
Given	B-X
the	B-X
central	B-X
role	B-X
of	B-X
HLA	B-X
molecules	B-X
in	B-X
immunity	B-X
,	B-X
variation	B-X
at	B-X
the	B-X
HLA	B-X
loci	B-X
could	B-X
differentially	B-X
affect	B-X
the	B-X
response	B-X
to	B-X
ICIs	B-X
.	B-X

In	O
addition	O
,	O
it	O
appears	O
that	O
the	O
EF3248	O
locus	O
diverges	O
in	O
the	O
Symbioflor	B-Organism
1	I-Organism
strain	O
.	O

When	O
compared	O
to	O
V583	B-Organism
,	O
the	O
sequence	O
identity	O
in	O
this	O
area	O
between	O
the	O
two	O
strains	O
appears	O
to	O
be	O
as	O
low	O
as	O
75	O
%	O
(	O
depicted	O
in	O
Figure	O
2	O
from	O
reference	O
[	O
5	O
]	O
)	O
.	O

However	O
,	O
because	O
the	O
Symbioflor	B-Organism
1	I-Organism
genome	O
sequence	O
is	O
not	O
currently	O
available	O
,	O
it	O
was	O
not	O
possible	O
to	O
compare	O
their	O
respective	O
sequences	O
in	O
more	O
detail	O
.	O
<EOS>	B-X
The	B-X
probiotic	B-X
Symbioflor	B-X
1	B-X
is	B-X
a	B-X
historical	B-X
concoction	B-X
of	B-X
10	B-X
isolates	B-X
of	B-X
Enterococcus	B-X
faecalis	B-X
Pulsed-field	B-X
gel	B-X
electrophoresis	B-X
revealed	B-X
two	B-X
groups	B-X
:	B-X
one	B-X
comprising	B-X
eight	B-X
identical	B-X
clones	B-X
(	B-X
DSM16430	B-X
,	B-X
DSM16432	B-X
,	B-X
DSM16433	B-X
,	B-X
DSM16435	B-X
to	B-X
DSM16439	B-X
)	B-X
and	B-X
a	B-X
further	B-X
two	B-X
isolates	B-X
(	B-X
DSM16431	B-X
,	B-X
DSM16434	B-X
)	B-X
with	B-X
marginally	B-X
different	B-X
profiles	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
a	B-X
comparative	B-X
analysis	B-X
of	B-X
the	B-X
draft	B-X
genome	B-X
sequences	B-X
of	B-X
representative	B-X
isolates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
the	B-X
complete	B-X
and	B-X
annotated	B-X
genome	B-X
sequence	B-X
of	B-X
the	B-X
probiotic	B-X
Enterococcus	B-X
faecalis	B-X
Symbioflor	B-X
1	B-X
clone	B-X
DSM	B-X
16431	B-X
,	B-X
included	B-X
in	B-X
a	B-X
commercial	B-X
probiotic	B-X
product	B-X
used	B-X
for	B-X
more	B-X
than	B-X
50	B-X
years	B-X
without	B-X
any	B-X
reports	B-X
of	B-X
infection	B-X
.	B-X
This	B-X
sequence	B-X
will	B-X
provide	B-X
new	B-X
insights	B-X
into	B-X
the	B-X
biology	B-X
of	B-X
this	B-X
nonpathogenic	B-X
and	B-X
probiotic	B-X
microorganism	B-X
.	B-X

Since	O
these	O
proteins	O
are	O
located	O
at	O
the	O
surface	O
of	O
the	O
cell	O
,	O
the	O
low	O
level	O
of	O
homology	O
shared	O
between	O
them	O
may	O
be	O
the	O
result	O
of	O
antigenic	O
variation	O
.	O

More	O
analyses	O
are	O
required	O
for	O
a	O
better	O
understanding	O
of	O
the	O
number	O
,	O
frequency	O
and	O
function	O
of	O
these	O
WxL	O
domain	O
proteins	O
and	O
their	O
possible	O
relationship	O
with	O
the	O
diversity	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
.	O

Finally	O
,	O
as	O
previously	O
found	O
using	O
PCR	O
,	O
the	O
cpsCDEFGHIJK	O
operon	O
capsule	O
polysaccharide	O
genes	O
[	O
37	O
]	O
were	O
confirmed	O
here	O
as	O
missing	O
,	O
although	O
OG1RF	B-Organism
carries	O
the	O
cpsA	O
and	O
cpsB	O
genes	O
,	O
which	O
were	O
proposed	O
to	O
be	O
essential	O
for	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
since	O
all	O
strains	O
tested	O
by	O
Hufnagel	O
et	O
al	O
.	O

[	O
37	O
]	O
carry	O
these	O
two	O
genes	O
.	O
<EOS>	B-X
About	B-X
5-10	B-X
%	B-X
of	B-X
incidences	B-X
of	B-X
breast	B-X
cancers	B-X
have	B-X
been	B-X
reported	B-X
as	B-X
a	B-X
result	B-X
of	B-X
germline	B-X
mutations	B-X
of	B-X
BRCA	B-X
genes	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mutational	B-X
spectrum	B-X
of	B-X
BRCA1	B-X
and	B-X
BRCA2	B-X
genes	B-X
among	B-X
breast	B-X
cancer	B-X
Saudi	B-X
women	B-X
patients	B-X
is	B-X
inadequate	B-X
at	B-X
present	B-X
.	B-X
The	B-X
predicted	B-X
iap	B-X
product	B-X
contained	B-X
345	B-X
amino	B-X
acids	B-X
with	B-X
an	B-X
estimated	B-X
molecular	B-X
weight	B-X
of	B-X
37,919	B-X
.	B-X
Neither	B-X
the	B-X
isozyme-converting	B-X
activity	B-X
nor	B-X
labeled	B-X
Iap	B-X
proteins	B-X
were	B-X
detected	B-X
in	B-X
the	B-X
osmotic-shock	B-X
fluid	B-X
of	B-X
cells	B-X
carrying	B-X
a	B-X
multicopy	B-X
iap	B-X
plasmid	B-X
.	B-X

In	O
OG1RF	B-Organism
,	O
the	O
region	O
that	O
would	O
encode	O
the	O
cps	O
operon	O
is	O
only	O
59	O
bp	O
in	O
length	O
and	O
has	O
no	O
homology	O
with	O
V583	B-Organism
.	O

Thus	O
,	O
while	O
V583	B-Organism
and	O
OG1RF	B-Organism
share	O
much	O
similarity	O
between	O
their	O
surface	O
components	O
,	O
there	O
are	O
unique	O
differences	O
that	O
could	O
potentially	O
be	O
important	O
in	O
affecting	O
the	O
behavior	O
of	O
the	O
strains	O
and	O
might	O
be	O
useful	O
for	O
strain	O
typing	O
.	O

Two	O
-	O
component	O
regulatory	O
systems	O
<EOS>	B-X
Two-component	B-X
regulatory	B-X
systems	B-X
(	B-X
TCSs	B-X
)	B-X
are	B-X
a	B-X
major	B-X
mechanism	B-X
by	B-X
which	B-X
bacteria	B-X
sense	B-X
and	B-X
respond	B-X
to	B-X
changes	B-X
in	B-X
their	B-X
environment	B-X
.	B-X
The	B-X
resulting	B-X
regulatory	B-X
action	B-X
often	B-X
involves	B-X
activation	B-X
of	B-X
antibiotic	B-X
defenses	B-X
and	B-X
changes	B-X
to	B-X
cell	B-X
physiology	B-X
that	B-X
increase	B-X
antibiotic	B-X
resistance	B-X
.	B-X
Most	B-X
prokaryotic	B-X
signal-transduction	B-X
systems	B-X
and	B-X
a	B-X
few	B-X
eukaryotic	B-X
pathways	B-X
use	B-X
phosphotransfer	B-X
schemes	B-X
involving	B-X
two	B-X
conserved	B-X
components	B-X
,	B-X
a	B-X
histidine	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
response	B-X
regulator	B-X
protein	B-X
.	B-X
Phosphorylation	B-X
induces	B-X
a	B-X
conformational	B-X
change	B-X
in	B-X
the	B-X
regulatory	B-X
domain	B-X
that	B-X
results	B-X
in	B-X
activation	B-X
of	B-X
an	B-X
associated	B-X
domain	B-X
that	B-X
effects	B-X
the	B-X
response	B-X
.	B-X
The	B-X
basic	B-X
scheme	B-X
is	B-X
highly	B-X
adaptable	B-X
,	B-X
and	B-X
numerous	B-X
variations	B-X
have	B-X
provided	B-X
optimization	B-X
within	B-X
specific	B-X
signaling	B-X
systems	B-X
.	B-X
The	B-X
domains	B-X
of	B-X
two-component	B-X
proteins	B-X
are	B-X
modular	B-X
and	B-X
can	B-X
be	B-X
integrated	B-X
into	B-X
proteins	B-X
and	B-X
pathways	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
ways	B-X
,	B-X
but	B-X
the	B-X
core	B-X
structures	B-X
and	B-X
activities	B-X
are	B-X
maintained	B-X
.	B-X

OG1RF	B-Organism
lacks	O
four	O
two	O
-	O
component	O
systems	O
found	O
in	O
V583	B-Organism
.	O

These	O
are	O
histidine	O
kinase	O
-	O
response	O
regulator	O
(	O
HK	O
-	O
RR	O
)	O
08	O
,	O
HK	O
-	O
RR12	O
located	O
in	O
the	O
PAI	O
,	O
HK	O
-	O
RR16	O
and	O
the	O
vanB	O
regulatory	O
system	O
HK	O
-	O
RR11	O
[	O
38	O
]	O
.	O

However	O
,	O
an	O
OG1RF	B-Organism
-	O
unique	O
two	O
-	O
component	O
system	O
with	O
high	O
homology	O
with	O
the	O
vanG	O
locus	O
was	O
found	O
at	O
the	O
location	O
corresponding	O
to	O
the	O
region	O
between	O
EF2860	O
and	O
EF2861	O
in	O
V583	B-Organism
(	O
Table	O
3	O
)	O
.	O

OG1RF	O
_	O
0193	O
shares	O
82	O
%	O
similarity	O
with	O
VanRG	O
and	O
81	O
%	O
similarity	O
with	O
VanRG2	O
.	O

Similarly	O
,	O
OG1RF	O
_	O
0192	O
shares	O
68	O
%	O
similarity	O
with	O
VanSG	O
and	O
VanSG2	O
.	O

A	O
gene	O
(	O
OG1RF	O
_	O
0191	O
)	O
encoding	O
an	O
M15	O
family	O
muramoyl	O
pentapeptide	O
carboxypeptidase	O
is	O
located	O
downstream	O
of	O
these	O
two	O
-	O
component	O
regulatory	O
genes	O
(	O
Figure	O
4a	O
)	O
.	O

The	O
predicted	O
carboxypeptidase	O
(	O
OG1RF	O
_	O
0191	O
)	O
shares	O
69	O
%	O
similarity	O
over	O
179	O
amino	O
acids	O
with	O
EF2297	O
,	O
a	O
membrane	O
-	O
associated	O
D	O
,	O
D	O
-	O
carboxypeptidase	O
encoded	O
by	O
the	O
vanB	O
operon	O
in	O
V583	B-Organism
.	O

However	O
,	O
OG1RF	O
_	O
0191	O
lacks	O
an	O
identifiable	O
transmembrane	O
domain	O
that	O
is	O
important	O
to	O
the	O
VanY	O
function	O
and	O
it	O
is	O
likely	O
,	O
therefore	O
,	O
that	O
this	O
protein	O
may	O
be	O
a	O
soluble	O
D	O
,	O
D	O
-	O
carboxypeptidase	O
/	O
transpeptidase	O
as	O
seen	O
in	O
Streptomyces	B-Organism
[	O
39	O
]	O
and	O
Actinomadura	B-Organism
[	O
40	O
]	O
,	O
and	O
thus	O
may	O
not	O
be	O
involved	O
in	O
peptidoglycan	O
metabolism	O
.	O

Consequently	O
,	O
it	O
seems	O
unlikely	O
that	O
this	O
operon	O
is	O
a	O
remnant	O
of	O
a	O
vancomycin	O
resistance	O
operon	O
in	O
OG1RF	B-Organism
,	O
but	O
rather	O
part	O
of	O
a	O
still	O
unknown	O
regulatory	O
pathway	O
.	O

The	O
iol	O
operon	O
<EOS>	B-X
Previous	B-X
determination	B-X
of	B-X
the	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
iol	B-X
region	B-X
of	B-X
the	B-X
Bacillus	B-X
subtilis	B-X
genome	B-X
allowed	B-X
us	B-X
to	B-X
predict	B-X
the	B-X
structure	B-X
of	B-X
the	B-X
iol	B-X
operon	B-X
for	B-X
myo-inositol	B-X
catabolism	B-X
,	B-X
consisting	B-X
of	B-X
10	B-X
iol	B-X
genes	B-X
(	B-X
iolA	B-X
to	B-X
iouJ	B-X
)	B-X
;	B-X
iolG	B-X
corresponds	B-X
to	B-X
idh	B-X
,	B-X
encoding	B-X
myo-inositol	B-X
2-dehydrogenase	B-X
(	B-X
Idh	B-X
)	B-X
.	B-X
Primer	B-X
extension	B-X
analysis	B-X
suggested	B-X
that	B-X
an	B-X
inositol-inducible	B-X
promoter	B-X
for	B-X
the	B-X
iol	B-X
operon	B-X
(	B-X
iol	B-X
promoter	B-X
)	B-X
might	B-X
be	B-X
a	B-X
promoter-like	B-X
sequence	B-X
in	B-X
the	B-X
5	B-X
'	B-X
region	B-X
of	B-X
iolA	B-X
,	B-X
which	B-X
is	B-X
probably	B-X
recognized	B-X
by	B-X
sigmaA	B-X
.	B-X
S1	B-X
nuclease	B-X
analysis	B-X
implied	B-X
that	B-X
a	B-X
rho-independent	B-X
terminator-like	B-X
structure	B-X
in	B-X
the	B-X
3	B-X
'	B-X
region	B-X
of	B-X
iolJ	B-X
might	B-X
be	B-X
a	B-X
terminator	B-X
for	B-X
iol	B-X
transcription	B-X
.	B-X
Disruption	B-X
of	B-X
the	B-X
iol	B-X
promoter	B-X
prevented	B-X
synthesis	B-X
of	B-X
the	B-X
iol	B-X
transcript	B-X
as	B-X
well	B-X
as	B-X
that	B-X
of	B-X
Idh	B-X
,	B-X
implying	B-X
that	B-X
the	B-X
iol	B-X
operon	B-X
is	B-X
most	B-X
probably	B-X
transcribed	B-X
as	B-X
an	B-X
11.5-kb	B-X
mRNA	B-X
containing	B-X
the	B-X
10	B-X
iol	B-X
genes	B-X
.	B-X
Immediately	B-X
upstream	B-X
of	B-X
the	B-X
iol	B-X
operon	B-X
,	B-X
two	B-X
genes	B-X
(	B-X
iolR	B-X
and	B-X
iolS	B-X
)	B-X
with	B-X
divergent	B-X
orientations	B-X
to	B-X
the	B-X
iol	B-X
operon	B-X
were	B-X
found	B-X
.	B-X
Disruption	B-X
of	B-X
iolR	B-X
(	B-X
but	B-X
not	B-X
iolS	B-X
)	B-X
caused	B-X
constitutive	B-X
synthesis	B-X
of	B-X
the	B-X
iol	B-X
transcript	B-X
and	B-X
Idh	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
iolR	B-X
gene	B-X
encodes	B-X
a	B-X
transcription-negative	B-X
regulator	B-X
(	B-X
presumably	B-X
a	B-X
repressor	B-X
)	B-X
for	B-X
the	B-X
iol	B-X
operon	B-X
.	B-X
Northern	B-X
and	B-X
S1	B-X
nuclease	B-X
analyses	B-X
revealed	B-X
that	B-X
the	B-X
iolRS	B-X
genes	B-X
were	B-X
cotranscribed	B-X
from	B-X
another	B-X
inositol-inducible	B-X
promoter	B-X
,	B-X
which	B-X
is	B-X
probably	B-X
recognized	B-X
by	B-X
sigmaA	B-X
.	B-X
The	B-X
promoter	B-X
assignments	B-X
of	B-X
the	B-X
iol	B-X
and	B-X
iolRS	B-X
operons	B-X
were	B-X
confirmed	B-X
in	B-X
vivo	B-X
with	B-X
a	B-X
lacZ	B-X
fusion	B-X
integrated	B-X
into	B-X
the	B-X
amyE	B-X
locus	B-X
.	B-X

OG1RF	B-Organism
carries	O
an	O
iol	O
operon	O
while	O
V583	B-Organism
does	O
not	O
.	O
<EOS>	B-X
To	B-X
explore	B-X
its	B-X
diversity	B-X
,	B-X
we	B-X
sequenced	B-X
E.	B-X
faecalis	B-X
strain	B-X
OG1RF	B-X
,	B-X
which	B-X
is	B-X
commonly	B-X
used	B-X
for	B-X
molecular	B-X
manipulation	B-X
and	B-X
virulence	B-X
studies	B-X
.	B-X

This	O
operon	O
encodes	O
the	O
factors	O
necessary	O
for	O
the	O
degradation	O
of	O
myo	O
-	O
inositol	O
into	O
glyceraldehyde	O
-	O
3P	O
.	O

Many	O
soil	O
and	O
plant	O
micro	O
-	O
organisms	O
,	O
including	O
Bacillus	B-Organism
subtilis	I-Organism
[	O
41	O
]	O
(	O
first	O
iol	O
operon	O
identified	O
)	O
,	O
Klebsiella	B-Organism
spp	O
.	O

[	O
42	O
]	O
,	O
and	O
cryptococci	O
[	O
43	O
]	O
,	O
have	O
been	O
reported	O
to	O
use	O
myo	O
-	O
inositol	O
as	O
a	O
sole	O
carbon	O
source	O
.	O

Myo	O
-	O
inositol	O
,	O
one	O
of	O
the	O
nine	O
isomers	O
of	O
the	O
inositol	O
group	O
,	O
belongs	O
to	O
the	O
cyclitol	O
group	O
and	O
is	O
abundant	O
in	O
nature	O
,	O
particularly	O
in	O
the	O
soil	O
.	O

The	O
OG1RF	B-Organism
iol	O
operon	O
appears	O
to	O
be	O
closely	O
related	O
to	O
ones	O
described	O
in	O
Clostridium	B-Organism
perfringens	I-Organism
[	O
44	O
]	O
and	O
Lactobacillus	B-Organism
casei	I-Organism
[	O
45	O
]	O
.	O

In	O
L	B-Organism
.	I-Organism
casei	I-Organism
,	O
the	O
myo	O
-	O
inositol	O
operon	O
consists	O
of	O
ten	O
genes	O
with	O
an	O
upstream	O
divergent	O
regulator	O
gene	O
,	O
iolR	O
.	O

In	O
OG1RF	B-Organism
,	O
the	O
operon	O
appears	O
to	O
include	O
ten	O
genes	O
,	O
beginning	O
with	O
a	O
probable	O
transcriptional	O
regulator	O
(	O
helix	O
-	O
turn	O
-	O
helix	O
domain	O
protein	O
)	O
.	O

Also	O
,	O
the	O
OG1RF	B-Organism
operon	O
carries	O
two	O
copies	O
of	O
an	O
iolG	O
-	O
like	O
gene	O
,	O
which	O
encodes	O
inositol	O
2	O
-	O
dehydrogenase	O
,	O
the	O
first	O
enzyme	O
of	O
the	O
myo	O
-	O
inositol	O
degradation	O
pathway	O
(	O
Figure	O
5	O
)	O
.	O

However	O
,	O
the	O
order	O
of	O
the	O
genes	O
is	O
not	O
the	O
same	O
between	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
and	O
L	B-Organism
.	I-Organism
casei	I-Organism
.	O

In	O
addition	O
,	O
iolH	O
,	O
iolJ	O
and	O
iolK	O
,	O
present	O
in	O
L	B-Organism
.	I-Organism
casei	I-Organism
,	O
are	O
not	O
present	O
in	O
OG1RF	B-Organism
,	O
nor	O
are	O
iolH	O
and	O
iolK	O
present	O
in	O
the	O
C	B-Organism
.	I-Organism
perfringens	I-Organism
iol	O
operon	O
.	O

Yebra	O
et	O
al	O
.	O
reported	O
that	O
L	B-Organism
.	I-Organism
casei	I-Organism
was	O
the	O
sole	O
member	O
of	O
the	O
Lactobacillales	B-Organism
to	O
carry	O
a	O
functional	O
iol	O
operon	O
[	O
45	O
]	O
.	O

To	O
survey	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
,	O
also	O
a	O
member	O
of	O
this	O
order	O
,	O
for	O
the	O
presence	O
of	O
the	O
iol	O
operon	O
,	O
48	O
isolates	O
with	O
different	O
MLST	O
and	O
/	O
or	O
from	O
various	O
origins	O
(	O
including	O
OG1RF	B-Organism
and	O
V583	B-Organism
)	O
were	O
tested	O
for	O
myo	O
-	O
inositol	O
fermentation	O
;	O
23	O
of	O
48	O
isolates	O
were	O
positive	O
.	O

In	O
addition	O
,	O
PCR	O
verified	O
the	O
presence	O
of	O
iolE	O
and	O
iolR	O
in	O
these	O
strains	O
and	O
in	O
one	O
negative	O
for	O
myo	O
-	O
inositol	O
fermentation	O
,	O
indicating	O
that	O
the	O
iol	O
operon	O
is	O
not	O
unique	O
to	O
OG1RF	B-Organism
.	O

To	O
verify	O
that	O
the	O
iol	O
genes	O
are	O
responsible	O
for	O
the	O
fermentation	O
of	O
myo	O
-	O
inositol	O
in	O
OG1RF	B-Organism
,	O
transposon	O
insertion	O
mutants	O
[	O
9	O
]	O
in	O
the	O
iolB	O
and	O
iolG2	O
genes	O
of	O
OG1RF	B-Organism
were	O
tested	O
.	O

Both	O
mutants	O
failed	O
to	O
ferment	O
myo	O
-	O
inositol	O
(	O
data	O
not	O
shown	O
)	O
,	O
demonstrating	O
that	O
these	O
genes	O
are	O
essential	O
for	O
myo	O
-	O
inositol	O
fermentation	O
.	O

To	O
investigate	O
whether	O
the	O
iol	O
operon	O
was	O
'	O
inserted	O
into	O
'	O
or	O
'	O
removed	O
from	O
'	O
a	O
putative	O
ancestral	O
strain	O
,	O
the	O
sequences	O
surrounding	O
the	O
iol	O
genes	O
were	O
examined	O
.	O

In	O
OG1RF	B-Organism
,	O
the	O
iol	O
operon	O
is	O
located	O
between	O
the	O
equivalent	O
of	O
EF2239	O
and	O
EF2352	O
when	O
compared	O
with	O
V583	B-Organism
.	O

In	O
V583	B-Organism
,	O
this	O
region	O
encodes	O
probable	O
prophage	O
proteins	O
and	O
carries	O
the	O
vanB	O
transposon	O
,	O
which	O
confers	O
vancomycin	O
resistance	O
.	O

Since	O
we	O
did	O
not	O
identify	O
any	O
remnants	O
of	O
the	O
iol	O
operon	O
in	O
V583	B-Organism
,	O
it	O
would	O
appear	O
that	O
at	O
least	O
two	O
independent	O
events	O
at	O
the	O
same	O
location	O
differentiate	O
OG1RF	B-Organism
and	O
V583	B-Organism
,	O
suggesting	O
that	O
it	O
is	O
a	O
hot	O
region	O
for	O
rearrangement	O
.	O

This	O
region	O
between	O
EF2239	O
and	O
EF2352	O
(	O
111	O
Kb	O
)	O
is	O
also	O
missing	O
in	O
the	O
Symbioflor	B-Organism
1	I-Organism
strain	O
(	O
referred	O
to	O
as	O
gap	O
2	O
)	O
[	O
5	O
]	O
.	O

The	O
possible	O
junction	O
and	O
presence	O
of	O
unique	O
sequence	O
in	O
this	O
region	O
,	O
if	O
investigated	O
,	O
was	O
not	O
mentioned	O
in	O
the	O
publication	O
.	O

Nonetheless	O
,	O
preliminary	O
analysis	O
of	O
other	O
strains	O
'	O
genotypes	O
in	O
this	O
area	O
seemed	O
to	O
confirm	O
the	O
hypothesis	O
of	O
a	O
hot	O
region	O
for	O
rearrangement	O
(	O
data	O
not	O
shown	O
)	O
.	O

A	O
homologue	O
of	O
Tn916	O
in	O
OG1RF	B-Organism

An	O
analysis	O
of	O
the	O
G	O
+	O
C	O
content	O
of	O
OG1RF	B-Organism
unique	O
regions	O
revealed	O
several	O
loci	O
with	O
a	O
lower	O
G	O
+	O
C	O
content	O
than	O
the	O
37	O
.	O
8	O
%	O
average	O
content	O
of	O
OG1RF	B-Organism
.	O

One	O
of	O
these	O
is	O
an	O
approximately	O
49	O
kb	O
fragment	O
with	O
a	O
G	O
+	O
C	O
content	O
of	O
32	O
.	O
1	O
%	O
located	O
between	O
an	O
rRNA	O
operon	O
and	O
the	O
homologue	O
in	O
OG1RF	B-Organism
of	O
EF1053	O
,	O
replacing	O
10	O
tRNA	O
genes	O
present	O
in	O
V583	B-Organism
(	O
Figure	O
1	O
)	O
.	O

This	O
fragment	O
appears	O
to	O
be	O
a	O
patchwork	O
composed	O
of	O
hypothetical	O
genes	O
,	O
homologues	O
of	O
Tn916	O
-	O
associated	O
genes	O
and	O
homologues	O
of	O
genes	O
from	O
other	O
Gram	O
-	O
positive	O
organisms	O
,	O
including	O
Listeria	O
,	O
E	B-Organism
.	I-Organism
faecium	I-Organism
,	O
staphylococci	B-Organism
,	O
or	O
lactococci	B-Organism
(	O
Additional	O
data	O
file	O
1	O
)	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
this	O
region	O
contains	O
:	O
a	O
putative	O
adhesin	O
protein	O
gene	O
(	O
OG1RF	O
_	O
0039	O
)	O
at	O
one	O
end	O
of	O
the	O
fragment	O
;	O
homologues	O
of	O
14	O
Tn916	O
-	O
associated	O
genes	O
(	O
Tn916	O
_	O
2	O
to	O
Tn916	O
_	O
12	O
,	O
Tn916	O
_	O
18	O
and	O
Tn916	O
_	O
19	O
,	O
with	O
an	O
average	O
of	O
70	O
%	O
similarity	O
)	O
;	O
and	O
a	O
gene	O
encoding	O
a	O
putative	O
integrase	O
(	O
OG1RF	O
_	O
0088	O
)	O
at	O
the	O
other	O
end	O
-	O
these	O
three	O
features	O
are	O
also	O
present	O
in	O
Tn5386	O
in	O
E	B-Organism
.	I-Organism
faecium	I-Organism
D344R	I-Organism
[	O
46	O
]	O
.	O

However	O
,	O
the	O
approximately	O
49	O
kb	O
fragment	O
lacks	O
an	O
excisase	O
gene	O
and	O
the	O
probable	O
lantibiotic	O
ABC	O
transporter	O
genes	O
present	O
in	O
Tn5386	O
.	O

An	O
uninterrupted	O
competence	O
operon	O
in	O
OG1RF	B-Organism

OG1RF	B-Organism
contains	O
what	O
appears	O
to	O
be	O
an	O
intact	O
competence	O
operon	O
while	O
that	O
of	O
V583	B-Organism
appears	O
to	O
be	O
non	O
-	O
functional	O
.	O

This	O
operon	O
in	O
OG1RF	B-Organism
is	O
similar	O
to	O
a	O
nine	O
-	O
gene	O
operon	O
described	O
in	O
Streptococcus	B-Organism
mutans	I-Organism
[	O
47	O
]	O
,	O
as	O
shown	O
in	O
Figure	O
6	O
.	O

For	O
example	O
,	O
the	O
homologue	O
in	O
OG1RF	B-Organism
of	O
EF2046	O
shares	O
61	O
%	O
similarity	O
with	O
ComYA	O
and	O
the	O
OG1RF	B-Organism
homologue	O
of	O
EF2045	O
is	O
55	O
%	O
similar	O
to	O
ComYB	O
.	O

In	O
S	B-Organism
.	I-Organism
mutans	I-Organism
,	O
only	O
the	O
first	O
seven	O
genes	O
of	O
the	O
operon	O
are	O
essential	O
for	O
competence	O
[	O
47	O
]	O
.	O

In	O
V583	B-Organism
,	O
the	O
fourth	O
gene	O
of	O
this	O
operon	O
(	O
corresponding	O
to	O
OG1RF	O
_	O
0148	O
)	O
is	O
interrupted	O
by	O
phage	O
4	O
(	O
EF1896	O
-	O
EF2043	O
)	O
;	O
in	O
addition	O
,	O
EF1984	O
contains	O
a	O
premature	O
stop	O
codon	O
not	O
found	O
in	O
the	O
corresponding	O
gene	O
in	O
OG1RF	B-Organism
(	O
OG1RF	O
_	O
0228	O
)	O
.	O

Natural	O
competence	O
has	O
not	O
been	O
reported	O
for	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
.	O
<EOS>	B-X
Its	B-X
popularity	B-X
has	B-X
spawned	B-X
several	B-X
alternatives	B-X
(	B-X
i.e.	B-X
,	B-X
cultural	B-X
competence	B-X
,	B-X
cultural	B-X
safety	B-X
,	B-X
cultural	B-X
humility	B-X
,	B-X
cultural	B-X
intelligence	B-X
)	B-X
and	B-X
overlapping	B-X
derivatives	B-X
(	B-X
diversity	B-X
training	B-X
,	B-X
anti-racism	B-X
training	B-X
,	B-X
micro-aggression	B-X
training	B-X
)	B-X
.	B-X
Yet	B-X
few	B-X
studies	B-X
have	B-X
explored	B-X
how	B-X
professionals	B-X
perceive	B-X
cross-cultural	B-X
educational	B-X
models	B-X
(	B-X
e.g.	B-X
,	B-X
cultural	B-X
awareness	B-X
,	B-X
cultural	B-X
competence	B-X
)	B-X
and	B-X
the	B-X
extent	B-X
to	B-X
which	B-X
they	B-X
(	B-X
and	B-X
their	B-X
organizations	B-X
)	B-X
execute	B-X
the	B-X
principles	B-X
in	B-X
practice	B-X
.	B-X
In	B-X
response	B-X
,	B-X
this	B-X
study	B-X
aimed	B-X
to	B-X
explore	B-X
the	B-X
general	B-X
perspectives	B-X
of	B-X
health	B-X
care	B-X
professionals	B-X
on	B-X
culturally	B-X
competent	B-X
care	B-X
,	B-X
their	B-X
experiences	B-X
working	B-X
with	B-X
multi-cultural	B-X
patients	B-X
,	B-X
their	B-X
own	B-X
levels	B-X
of	B-X
cultural	B-X
competence	B-X
and	B-X
the	B-X
extent	B-X
to	B-X
which	B-X
they	B-X
believe	B-X
their	B-X
workplaces	B-X
address	B-X
cross-cultural	B-X
challenges	B-X
.	B-X
Original	B-X
quantitative	B-X
studies	B-X
were	B-X
identified	B-X
in	B-X
four	B-X
databases	B-X
(	B-X
PubMed	B-X
,	B-X
PsycInfo	B-X
,	B-X
Scopus	B-X
,	B-X
Embase	B-X
)	B-X
,	B-X
resulting	B-X
in	B-X
186	B-X
eligible	B-X
studies	B-X
.	B-X
A	B-X
third	B-X
of	B-X
included	B-X
studies	B-X
were	B-X
undertaken	B-X
in	B-X
Europe	B-X
and	B-X
almost	B-X
as	B-X
many	B-X
in	B-X
the	B-X
United	B-X
States	B-X
.	B-X

To	O
assess	O
the	O
functionality	O
of	O
this	O
operon	O
in	O
OG1RF	B-Organism
,	O
we	O
evaluated	O
the	O
competence	O
of	O
cells	O
in	O
different	O
phases	O
of	O
growth	O
(	O
early	O
log	O
growth	O
to	O
stationary	O
phase	O
)	O
using	O
pAM401	O
[	O
48	O
]	O
and	O
pMSP3535VA	O
[	O
49	O
]	O
.	O

We	O
were	O
not	O
able	O
to	O
show	O
natural	O
competence	O
under	O
the	O
conditions	O
tested	O
.	O

We	O
have	O
also	O
noted	O
that	O
V583	B-Organism
is	O
less	O
transformable	O
by	O
electroporation	O
than	O
OG1RF	B-Organism
.	O

To	O
investigate	O
the	O
possibility	O
that	O
directly	O
or	O
indirectly	O
the	O
com	O
operon	O
might	O
be	O
responsible	O
for	O
this	O
phenotype	O
,	O
we	O
also	O
evaluated	O
transformability	O
by	O
electroporation	O
.	O
<EOS>	B-X
In	B-X
particular	B-X
,	B-X
PREPs	B-X
offer	B-X
the	B-X
possibility	B-X
of	B-X
an	B-X
objective	B-X
assessment	B-X
of	B-X
nociceptive	B-X
pathways	B-X
.	B-X
These	B-X
three	B-X
techniques	B-X
investigate	B-X
both	B-X
small-diameter	B-X
peripheral	B-X
nociceptive	B-X
afferents	B-X
(	B-X
mainly	B-X
Aδ	B-X
nerve	B-X
fibers	B-X
)	B-X
and	B-X
spinothalamic	B-X
tracts	B-X
without	B-X
theoretically	B-X
being	B-X
able	B-X
to	B-X
differentiate	B-X
the	B-X
level	B-X
of	B-X
lesion	B-X
in	B-X
the	B-X
case	B-X
of	B-X
abnormal	B-X
results	B-X
.	B-X
Other	B-X
methods	B-X
,	B-X
such	B-X
as	B-X
nerve	B-X
fiber	B-X
excitability	B-X
studies	B-X
using	B-X
microneurography	B-X
,	B-X
more	B-X
directly	B-X
reflect	B-X
the	B-X
activities	B-X
of	B-X
nociceptive	B-X
axons	B-X
in	B-X
response	B-X
to	B-X
provoked	B-X
pain	B-X
,	B-X
but	B-X
without	B-X
detecting	B-X
or	B-X
quantifying	B-X
the	B-X
presence	B-X
of	B-X
spontaneous	B-X
pain	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
should	B-X
be	B-X
kept	B-X
in	B-X
mind	B-X
that	B-X
most	B-X
of	B-X
the	B-X
results	B-X
of	B-X
neurophysiologic	B-X
investigation	B-X
performed	B-X
in	B-X
clinical	B-X
practice	B-X
assess	B-X
small	B-X
fiber	B-X
or	B-X
spinothalamic	B-X
tract	B-X
lesions	B-X
rather	B-X
than	B-X
the	B-X
neuronal	B-X
mechanisms	B-X
directly	B-X
at	B-X
the	B-X
origin	B-X
of	B-X
pain	B-X
and	B-X
they	B-X
do	B-X
not	B-X
provide	B-X
objective	B-X
quantification	B-X
of	B-X
pain	B-X
.	B-X

When	O
compared	O
with	O
OG1RF	B-Organism
,	O
transposon	O
mutants	O
[	O
12	O
]	O
in	O
the	O
OG1RF	B-Organism
equivalent	O
of	O
EF2045	O
(	O
encoding	O
the	O
comGB	O
homologue	O
)	O
and	O
in	O
the	O
OG1RF	B-Organism
equivalent	O
of	O
EF1986	O
(	O
encoding	O
the	O
comGF	O
homologue	O
)	O
showed	O
similar	O
levels	O
of	O
transformability	O
by	O
electroporation	O
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
that	O
the	O
difference	O
in	O
electroporation	O
efficiency	O
observed	O
between	O
OG1RF	B-Organism
and	O
V583	B-Organism
is	O
not	O
related	O
to	O
this	O
locus	O
.	O

In	O
Streptococcus	B-Organism
pneumoniae	I-Organism
[	O
50	O
]	O
,	O
the	O
competence	O
operon	O
is	O
tightly	O
regulated	O
by	O
a	O
quorum	O
sensing	O
two	O
-	O
component	O
system	O
(	O
ComDE	O
)	O
and	O
a	O
competence	O
-	O
stimulating	O
peptide	O
(	O
CSP	O
;	O
encoded	O
by	O
comC	O
)	O
.	O

We	O
did	O
not	O
find	O
any	O
homologues	O
of	O
CSP	O
in	O
OG1RF	B-Organism
.	O

Two	O
homologous	O
ComDE	O
sensor	O
histidine	O
kinase	O
/	O
response	O
regulators	O
were	O
found	O
in	O
OG1RF	B-Organism
,	O
one	O
of	O
which	O
is	O
FsrC	O
/	O
FsrA	O
.	O

Based	O
on	O
our	O
previous	O
microarray	O
data	O
,	O
the	O
Fsr	O
system	O
does	O
not	O
regulate	O
the	O
comY	O
operon	O
,	O
at	O
least	O
under	O
our	O
previously	O
used	O
conditions	O
(	O
mid	O
-	O
log	O
phase	O
growth	O
to	O
early	O
stationary	O
phase	O
in	O
brain	O
heart	O
infusion	O
(	O
BHI	O
)	O
)	O
[	O
22	O
]	O
.	O

The	O
other	O
ComDE	O
homology	O
is	O
that	O
with	O
a	O
two	O
-	O
component	O
system	O
unique	O
to	O
OG1RF	B-Organism
(	O
OG1RF	O
_	O
0199	O
and	O
OG1RF	O
_	O
0198	O
,	O
respectively	O
)	O
that	O
lies	O
on	O
a	O
4	O
,	O
706	O
bp	O
unique	O
fragment	O
that	O
maps	O
between	O
EF3114	O
and	O
EF3115	O
in	O
V583	B-Organism
.	O

This	O
fragment	O
also	O
carries	O
two	O
genes	O
(	O
OG1RF	O
_	O
0200	O
and	O
OG1RF	O
_	O
0201	O
)	O
encoding	O
homologues	O
of	O
the	O
YhaQ	O
and	O
YhaP	O
sodium	O
efflux	O
ATP	O
-	O
binding	O
cassette	O
efflux	O
/	O
transporter	O
proteins	O
(	O
Figure	O
4b	O
)	O
.	O

Although	O
they	O
are	O
potential	O
elements	O
of	O
a	O
secretion	O
apparatus	O
,	O
these	O
two	O
proteins	O
do	O
not	O
share	O
any	O
homology	O
at	O
the	O
protein	O
level	O
with	O
the	O
competence	O
secretion	O
apparatus	O
ComAB	O
of	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
[	O
51	O
]	O
nor	O
CslAB	O
from	O
S	B-Organism
.	I-Organism
mutans	I-Organism
[	O
52	O
]	O
.	O
<EOS>	B-X
These	B-X
methods	B-X
are	B-X
sometimes	B-X
called	B-X
``	B-X
optogenetic	B-X
''	B-X
because	B-X
they	B-X
use	B-X
light-responsive	B-X
proteins	B-X
(	B-X
``	B-X
opto-	B-X
''	B-X
)	B-X
encoded	B-X
in	B-X
DNA	B-X
(	B-X
``	B-X
-genetic	B-X
''	B-X
)	B-X
.	B-X
This	B-X
role	B-X
is	B-X
supported	B-X
by	B-X
recent	B-X
proteomic	B-X
data	B-X
showing	B-X
that	B-X
TPCs	B-X
interact	B-X
with	B-X
proteins	B-X
controlling	B-X
membrane	B-X
organization	B-X
and	B-X
dynamics	B-X
,	B-X
including	B-X
Rab	B-X
GTPases	B-X
and	B-X
components	B-X
of	B-X
the	B-X
fusion	B-X
apparatus	B-X
.	B-X
Regulation	B-X
of	B-X
TPCs	B-X
by	B-X
PtdIns	B-X
(	B-X
3,5	B-X
)	B-X
P2	B-X
and/or	B-X
NAADP	B-X
(	B-X
nicotinic	B-X
acid	B-X
adenine	B-X
dinucleotide	B-X
phosphate	B-X
)	B-X
together	B-X
with	B-X
their	B-X
functional	B-X
and	B-X
physical	B-X
association	B-X
with	B-X
Rab	B-X
proteins	B-X
provides	B-X
a	B-X
mechanism	B-X
for	B-X
coupling	B-X
phosphoinositide	B-X
and	B-X
trafficking	B-X
protein	B-X
cues	B-X
to	B-X
local	B-X
ion	B-X
fluxes	B-X
.	B-X
Therefore	B-X
,	B-X
TPCs	B-X
work	B-X
at	B-X
the	B-X
regulatory	B-X
cross-roads	B-X
of	B-X
(	B-X
patho	B-X
)	B-X
physiological	B-X
cues	B-X
to	B-X
co-ordinate	B-X
and	B-X
potentially	B-X
deregulate	B-X
traffic	B-X
flow	B-X
through	B-X
the	B-X
endolysosomal	B-X
network	B-X
.	B-X

Searching	O
for	O
a	O
possible	O
CSP	O
in	O
the	O
vicinity	O
of	O
these	O
genes	O
,	O
we	O
identified	O
a	O
small	O
ORF	O
encoding	O
50	O
amino	O
acids	O
between	O
yhaP	O
and	O
OG1RF199	O
and	O
another	O
encoding	O
20	O
amino	O
acids	O
downstream	O
of	O
OG1RF198	O
.	O

More	O
analysis	O
will	O
be	O
required	O
to	O
determine	O
if	O
there	O
are	O
conditions	O
in	O
which	O
the	O
OG1RF	B-Organism
com	O
operon	O
is	O
expressed	O
and	O
to	O
determine	O
whether	O
or	O
not	O
this	O
two	O
-	O
component	O
system	O
is	O
involved	O
in	O
competence	O
.	O
<EOS>	B-X
Two-component	B-X
regulatory	B-X
systems	B-X
(	B-X
TCSs	B-X
)	B-X
are	B-X
a	B-X
major	B-X
mechanism	B-X
by	B-X
which	B-X
bacteria	B-X
sense	B-X
and	B-X
respond	B-X
to	B-X
changes	B-X
in	B-X
their	B-X
environment	B-X
.	B-X
TCSs	B-X
typically	B-X
consist	B-X
of	B-X
two	B-X
proteins	B-X
that	B-X
bring	B-X
about	B-X
major	B-X
regulation	B-X
of	B-X
the	B-X
cell	B-X
genome	B-X
through	B-X
coordinated	B-X
action	B-X
mediated	B-X
by	B-X
phosphorylation	B-X
.	B-X
Environmental	B-X
conditions	B-X
that	B-X
activate	B-X
TCSs	B-X
are	B-X
numerous	B-X
and	B-X
diverse	B-X
and	B-X
include	B-X
exposure	B-X
to	B-X
antibiotics	B-X
as	B-X
well	B-X
as	B-X
conditions	B-X
inside	B-X
a	B-X
host	B-X
.	B-X
Arf-family	B-X
small	B-X
GTPases	B-X
are	B-X
essential	B-X
protein	B-X
components	B-X
for	B-X
membrane	B-X
trafficking	B-X
in	B-X
all	B-X
eukaryotic	B-X
endomembrane	B-X
systems	B-X
,	B-X
particularly	B-X
during	B-X
the	B-X
formation	B-X
of	B-X
membrane-bound	B-X
,	B-X
coat	B-X
protein	B-X
complex-coated	B-X
transport	B-X
carriers	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
their	B-X
roles	B-X
in	B-X
the	B-X
transport	B-X
carrier	B-X
formation	B-X
,	B-X
a	B-X
number	B-X
of	B-X
Arf-family	B-X
GTPases	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
physically	B-X
associate	B-X
with	B-X
coiled-coil	B-X
tethering	B-X
proteins	B-X
and	B-X
multisubunit	B-X
tethering	B-X
complexes	B-X
,	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
membrane	B-X
tethering	B-X
,	B-X
a	B-X
process	B-X
of	B-X
the	B-X
initial	B-X
contact	B-X
between	B-X
transport	B-X
carriers	B-X
and	B-X
their	B-X
target	B-X
subcellular	B-X
compartments	B-X
.	B-X
Nevertheless	B-X
,	B-X
whether	B-X
and	B-X
how	B-X
indeed	B-X
Arf	B-X
GTPases	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
tethering	B-X
process	B-X
remain	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
using	B-X
a	B-X
chemically-defined	B-X
reconstitution	B-X
approach	B-X
with	B-X
purified	B-X
proteins	B-X
of	B-X
two	B-X
representative	B-X
Arf	B-X
isoforms	B-X
in	B-X
humans	B-X
(	B-X
Arf1	B-X
,	B-X
Arf6	B-X
)	B-X
and	B-X
synthetic	B-X
liposomes	B-X
for	B-X
model	B-X
membranes	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
Arf6	B-X
can	B-X
function	B-X
as	B-X
a	B-X
bona	B-X
fide	B-X
membrane	B-X
tether	B-X
,	B-X
directly	B-X
and	B-X
physically	B-X
linking	B-X
two	B-X
distinct	B-X
lipid	B-X
bilayers	B-X
even	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
any	B-X
other	B-X
tethering	B-X
factors	B-X
,	B-X
whereas	B-X
Arf1	B-X
retained	B-X
little	B-X
potency	B-X
to	B-X
trigger	B-X
membrane	B-X
tethering	B-X
under	B-X
the	B-X
current	B-X
experimental	B-X
conditions	B-X
.	B-X

Limited	O
presence	O
of	O
mobile	O
elements	O
<EOS>	B-X
While	B-X
Gram-negative	B-X
organisms	B-X
have	B-X
developed	B-X
several	B-X
mechanisms	B-X
to	B-X
avert	B-X
the	B-X
bactericidal	B-X
effects	B-X
of	B-X
commonly	B-X
prescribed	B-X
antibiotic	B-X
agents	B-X
,	B-X
the	B-X
increasing	B-X
prevalence	B-X
of	B-X
carbapenemase-producing	B-X
organisms	B-X
(	B-X
CPO	B-X
)	B-X
is	B-X
particularly	B-X
concerning	B-X
given	B-X
the	B-X
rapid	B-X
spread	B-X
of	B-X
mobile	B-X
genetic	B-X
elements	B-X
containing	B-X
carbapenemase	B-X
genes	B-X
,	B-X
the	B-X
limited	B-X
treatment	B-X
options	B-X
for	B-X
infections	B-X
caused	B-X
by	B-X
these	B-X
organisms	B-X
,	B-X
and	B-X
the	B-X
high	B-X
mortality	B-X
rates	B-X
associated	B-X
with	B-X
CPO	B-X
infections	B-X
.	B-X
Phenotypic	B-X
assays	B-X
currently	B-X
used	B-X
in	B-X
clinical	B-X
practice	B-X
to	B-X
detect	B-X
CPO	B-X
consist	B-X
of	B-X
the	B-X
following	B-X
:	B-X
(	B-X
i	B-X
)	B-X
growth-based	B-X
assays	B-X
which	B-X
measure	B-X
carbapenem	B-X
resistance	B-X
based	B-X
on	B-X
organism	B-X
growth	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
carbapenem	B-X
antibiotic	B-X
(	B-X
e.g.	B-X
,	B-X
modified	B-X
Hodge	B-X
test	B-X
and	B-X
modified	B-X
carbapenem	B-X
inactivation	B-X
method	B-X
)	B-X
,	B-X
(	B-X
ii	B-X
)	B-X
hydrolysis	B-X
methods	B-X
which	B-X
detect	B-X
carbapenem	B-X
degradation	B-X
products	B-X
(	B-X
e.g.	B-X
,	B-X
Carba	B-X
NP	B-X
test	B-X
and	B-X
matrix-assisted	B-X
laser	B-X
desorption-ionization	B-X
time	B-X
of	B-X
flight	B-X
mass	B-X
spectrometry	B-X
)	B-X
,	B-X
and	B-X
(	B-X
iii	B-X
)	B-X
lateral	B-X
flow	B-X
immunoassays	B-X
which	B-X
detect	B-X
carbapenemase	B-X
enzymes	B-X
through	B-X
the	B-X
use	B-X
of	B-X
specific	B-X
antibodies	B-X
.	B-X
The	B-X
cause	B-X
of	B-X
resistance	B-X
to	B-X
methicillin	B-X
and	B-X
all	B-X
other	B-X
beta-lactam	B-X
antibiotics	B-X
is	B-X
the	B-X
mecA	B-X
gene	B-X
,	B-X
which	B-X
is	B-X
situated	B-X
on	B-X
a	B-X
mobile	B-X
genetic	B-X
element	B-X
,	B-X
the	B-X
staphylococcal	B-X
cassette	B-X
chromosome	B-X
mec	B-X
(	B-X
SCCmec	B-X
)	B-X
.	B-X
CA-MRSA	B-X
harbors	B-X
SCCmec	B-X
type	B-X
IV	B-X
,	B-X
V	B-X
or	B-X
VII	B-X
,	B-X
the	B-X
majority	B-X
belong	B-X
to	B-X
other	B-X
S.	B-X
aureus	B-X
lineages	B-X
compared	B-X
to	B-X
HA-MRSA	B-X
,	B-X
and	B-X
CA-MRSA	B-X
is	B-X
often	B-X
associated	B-X
with	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
toxin	B-X
Panton-Valentine	B-X
leukocidin	B-X
(	B-X
PVL	B-X
)	B-X
.	B-X

By	O
probing	O
a	O
microarray	O
of	O
the	O
V583	O
genome	O
and	O
plasmids	O
with	O
OG1RF	B-Organism
genomic	O
DNA	O
,	O
we	O
previously	O
estimated	O
that	O
only	O
75	O
%	O
of	O
V583	B-Organism
ORFs	O
were	O
also	O
present	O
in	O
OG1RF	B-Organism
[	O
22	O
]	O
.	O

Later	O
,	O
Aakra	O
et	O
al	O
.	O

[	O
53	O
]	O
compared	O
nine	O
strains	O
,	O
including	O
OG1RF	B-Organism
to	O
V583	B-Organism
,	O
using	O
comparative	O
genomic	O
hybridization	O
.	O

In	O
these	O
results	O
,	O
OG1RF	B-Organism
appears	O
to	O
carry	O
a	O
few	O
genes	O
included	O
in	O
the	O
PAI	O
,	O
and	O
a	O
few	O
prophage	O
genes	O
.	O

Using	O
the	O
complete	O
genome	O
sequence	O
,	O
we	O
have	O
now	O
found	O
that	O
OG1RF	B-Organism
lacks	O
639	O
genes	O
and	O
the	O
three	O
pTET	O
plasmids	O
described	O
in	O
V583	B-Organism
.	O

All	O
but	O
45	O
of	O
the	O
missing	O
genes	O
are	O
associated	O
with	O
putative	O
mobile	O
elements	O
,	O
such	O
as	O
the	O
entire	O
PAI	O
,	O
the	O
recently	O
described	O
phages	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
and	O
7	O
[	O
31	O
]	O
,	O
and	O
the	O
approximately	O
111	O
kb	O
area	O
between	O
genes	O
EF2240	O
and	O
EF2351	O
(	O
including	O
the	O
vanB	O
transposon	O
)	O
present	O
in	O
V583	B-Organism
.	O

The	O
absence	O
of	O
these	O
elements	O
appears	O
also	O
to	O
be	O
a	O
characteristic	O
of	O
the	O
commensal	O
strain	O
Symbioflor	B-Organism
1	I-Organism
,	O
although	O
because	O
the	O
genome	O
was	O
not	O
completely	O
finished	O
,	O
the	O
possibility	O
remains	O
that	O
some	O
of	O
these	O
regions	O
were	O
not	O
sequenced	O
.	O

In	O
conclusion	O
,	O
other	O
than	O
the	O
approximately	O
49	O
kb	O
fragment	O
containing	O
a	O
Tn916	O
homologue	O
,	O
it	O
appears	O
that	O
OG1RF	B-Organism
has	O
only	O
one	O
additional	O
possible	O
mobile	O
element	O
derivative	O
,	O
namely	O
the	O
phage	O
2	O
proposed	O
to	O
be	O
part	O
of	O
the	O
core	O
genome	O
[	O
31	O
]	O
.	O

Fusidic	O
acid	O
and	O
rifampicin	O
resistance	O
<EOS>	B-X
Nosocomial	B-X
strains	B-X
of	B-X
MRSA	B-X
are	B-X
typically	B-X
multi-resistant	B-X
(	B-X
mrMRSA	B-X
)	B-X
,	B-X
and	B-X
mrMRSA	B-X
strains	B-X
must	B-X
always	B-X
be	B-X
treated	B-X
with	B-X
a	B-X
combination	B-X
of	B-X
two	B-X
oral	B-X
antimicrobials	B-X
,	B-X
typically	B-X
rifampicin	B-X
and	B-X
fusidic	B-X
acid	B-X
,	B-X
because	B-X
resistance	B-X
develops	B-X
rapidly	B-X
if	B-X
they	B-X
are	B-X
used	B-X
as	B-X
single	B-X
agents	B-X
.	B-X
Methicillin	B-X
resistance	B-X
among	B-X
staphylococci	B-X
isolated	B-X
from	B-X
patients	B-X
in	B-X
northern	B-X
Egypt	B-X
has	B-X
escalated	B-X
alarmingly	B-X
in	B-X
the	B-X
past	B-X
decade	B-X
.	B-X
Data	B-X
about	B-X
the	B-X
prevalence	B-X
of	B-X
fusidic	B-X
acid	B-X
(	B-X
FA	B-X
)	B-X
resistance	B-X
in	B-X
Egyptian	B-X
clinical	B-X
isolates	B-X
are	B-X
limited	B-X
.	B-X
This	B-X
work	B-X
investigates	B-X
the	B-X
prevalence	B-X
and	B-X
mechanism	B-X
of	B-X
FA	B-X
resistance	B-X
among	B-X
81	B-X
methicillin-resistant	B-X
staphylococcal	B-X
isolates	B-X
from	B-X
major	B-X
hospitals	B-X
of	B-X
Alexandria	B-X
,	B-X
Egypt	B-X
.	B-X
Twenty-six	B-X
isolates	B-X
(	B-X
32.1	B-X
%	B-X
)	B-X
were	B-X
FA	B-X
resistant	B-X
(	B-X
minimum	B-X
inhibitory	B-X
concentrations	B-X
[	B-X
MICs	B-X
]	B-X
=	B-X
2-1,024	B-X
μg/ml	B-X
)	B-X
,	B-X
and	B-X
fusB	B-X
and	B-X
fusC	B-X
genes	B-X
coding	B-X
for	B-X
FA	B-X
resistance	B-X
were	B-X
detected	B-X
in	B-X
30.77	B-X
%	B-X
and	B-X
34.62	B-X
%	B-X
of	B-X
the	B-X
FA-resistant	B-X
strains	B-X
,	B-X
respectively	B-X
.	B-X
Conjugation	B-X
caused	B-X
acquisition	B-X
of	B-X
FA	B-X
resistance	B-X
among	B-X
susceptible	B-X
isolates	B-X
.	B-X
A	B-X
relatively	B-X
moderate	B-X
rate	B-X
of	B-X
FA	B-X
resistance	B-X
was	B-X
detected	B-X
in	B-X
Alexandria	B-X
hospitals	B-X
.	B-X

OG1RF	B-Organism
was	O
sequentially	O
selected	O
from	O
OG1	B-Organism
for	O
resistance	O
to	O
fusidic	O
acid	O
and	O
rifampicin	O
[	O
9	O
]	O
.	O

The	O
mutation	O
leading	O
to	O
rifampicin	O
resistance	O
was	O
identified	O
in	O
the	O
rpoB	O
gene	O
by	O
Ozawa	O
et	O
al	O
.	O

[	O
54	O
]	O
and	O
is	O
caused	O
by	O
the	O
A1467G	O
mutation	O
,	O
which	O
results	O
in	O
substitution	O
of	O
arginine	O
for	O
histidine	O
at	O
amino	O
acid	O
489	O
.	O

The	O
mutation	O
also	O
affected	O
the	O
clumping	O
phenotype	O
of	O
traA	O
mutants	O
and	O
this	O
effect	O
appears	O
to	O
be	O
specific	O
for	O
the	O
pAM373	O
system	O
[	O
54	O
]	O
.	O

All	O
of	O
the	O
other	O
22	O
differences	O
in	O
rpoB	O
between	O
OG1RF	B-Organism
and	O
V583	B-Organism
are	O
synonymous	O
.	O

Fusidic	O
acid	O
resistance	O
is	O
associated	O
with	O
mutation	O
(	O
s	O
)	O
in	O
the	O
fusA	O
gene	O
,	O
which	O
encodes	O
elongation	O
factor	O
G	O
.	O
<EOS>	B-X
Fusidic	B-X
acid	B-X
has	B-X
activity	B-X
against	B-X
a	B-X
range	B-X
of	B-X
pathogens	B-X
but	B-X
has	B-X
mainly	B-X
been	B-X
used	B-X
to	B-X
treat	B-X
staphylococcal	B-X
infections	B-X
.	B-X
Fusidic	B-X
acid	B-X
monotherapy	B-X
,	B-X
especially	B-X
topical	B-X
preparations	B-X
,	B-X
has	B-X
been	B-X
strongly	B-X
associated	B-X
with	B-X
the	B-X
emergence	B-X
of	B-X
fusidic	B-X
acid	B-X
resistance	B-X
among	B-X
both	B-X
methicillin-resistant	B-X
Staphylococcus	B-X
aureus	B-X
(	B-X
MRSA	B-X
)	B-X
and	B-X
methicillin-susceptible	B-X
S.	B-X
aureus	B-X
.	B-X
Key	B-X
resistance	B-X
determinants	B-X
include	B-X
mutations	B-X
in	B-X
the	B-X
fusA	B-X
gene	B-X
,	B-X
which	B-X
encodes	B-X
elongation	B-X
factor	B-X
G	B-X
,	B-X
and	B-X
plasmid-mediated	B-X
resistance	B-X
(	B-X
i.e.	B-X
,	B-X
acquisition	B-X
of	B-X
resistance	B-X
gene	B-X
fusB	B-X
)	B-X
.	B-X
Clonal	B-X
outbreaks	B-X
of	B-X
fusidic	B-X
acid-resistant	B-X
S.	B-X
aureus	B-X
have	B-X
been	B-X
noted	B-X
throughout	B-X
the	B-X
United	B-X
Kingdom	B-X
and	B-X
Europe	B-X
,	B-X
such	B-X
that	B-X
the	B-X
efficacy	B-X
of	B-X
fusidic	B-X
acid	B-X
is	B-X
threatened	B-X
.	B-X
Fusidic	B-X
acid	B-X
in	B-X
combination	B-X
with	B-X
other	B-X
agents	B-X
,	B-X
such	B-X
as	B-X
rifampicin	B-X
,	B-X
has	B-X
proven	B-X
effective	B-X
for	B-X
difficult-to-treat	B-X
MRSA	B-X
infections	B-X
and	B-X
provides	B-X
a	B-X
convenient	B-X
oral	B-X
alternative	B-X
to	B-X
oxazolidinones	B-X
.	B-X
Ensuring	B-X
that	B-X
systemic	B-X
fusidic	B-X
acid	B-X
is	B-X
always	B-X
used	B-X
in	B-X
combination	B-X
and	B-X
that	B-X
the	B-X
use	B-X
of	B-X
topical	B-X
fusidic	B-X
acid	B-X
is	B-X
either	B-X
abolished	B-X
or	B-X
restricted	B-X
will	B-X
be	B-X
vital	B-X
if	B-X
we	B-X
are	B-X
to	B-X
prevent	B-X
the	B-X
loss	B-X
of	B-X
this	B-X
potentially	B-X
useful	B-X
agent	B-X
.	B-X

We	O
compared	O
fusA	O
from	O
OG1RF	B-Organism
with	O
that	O
in	O
V583	B-Organism
and	O
identified	O
two	O
differences	O
(	O
C1368A	O
and	O
T1992C	O
)	O
.	O

The	O
mutation	O
T1992C	O
is	O
synonymous	O
,	O
while	O
the	O
mutation	O
C1368A	O
leads	O
to	O
the	O
presence	O
of	O
glutamine	O
(	O
histidine	O
in	O
V583	B-Organism
)	O
at	O
position	O
404	O
in	O
OG1RF	B-Organism
.	O

Mutations	O
in	O
this	O
region	O
have	O
been	O
associated	O
with	O
fusidic	O
acid	O
resistance	O
in	O
Staphylococcus	B-Organism
aureus	I-Organism
[	O
55	O
,	O
56	O
]	O
,	O
and	O
thus	O
the	O
C1368A	O
mutation	O
is	O
likely	O
the	O
cause	O
of	O
the	O
fusidic	O
acid	O
resistance	O
phenotype	O
in	O
OG1RF	B-Organism
.	O

Virulence	O
and	O
biofilm	O
comparisons	O
of	O
OG1RF	B-Organism
with	O
V583	B-Organism
<EOS>	B-X
To	B-X
investigate	B-X
the	B-X
possibility	B-X
that	B-X
Fsr	B-X
influences	B-X
the	B-X
expression	B-X
of	B-X
additional	B-X
genes	B-X
,	B-X
we	B-X
used	B-X
transcriptional	B-X
profiling	B-X
,	B-X
with	B-X
microarrays	B-X
based	B-X
on	B-X
the	B-X
E.	B-X
faecalis	B-X
strain	B-X
V583	B-X
sequence	B-X
,	B-X
to	B-X
compare	B-X
the	B-X
E.	B-X
faecalis	B-X
strain	B-X
OG1RF	B-X
with	B-X
its	B-X
isogenic	B-X
mutant	B-X
,	B-X
TX5266	B-X
,	B-X
an	B-X
fsrB	B-X
deletion	B-X
mutant	B-X
.	B-X
While	B-X
expression	B-X
of	B-X
some	B-X
genes	B-X
(	B-X
i.e.	B-X
,	B-X
ef1097	B-X
and	B-X
ef0750	B-X
to	B-X
-757	B-X
,	B-X
encoding	B-X
hypothetical	B-X
proteins	B-X
)	B-X
was	B-X
activated	B-X
in	B-X
late	B-X
log	B-X
phase	B-X
in	B-X
OG1RF	B-X
versus	B-X
the	B-X
fsrB	B-X
deletion	B-X
mutant	B-X
,	B-X
expression	B-X
of	B-X
ef1617	B-X
to	B-X
-1634	B-X
(	B-X
eut-pdu	B-X
orthologues	B-X
)	B-X
was	B-X
highly	B-X
repressed	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
intact	B-X
Fsr	B-X
at	B-X
entry	B-X
into	B-X
stationary	B-X
phase	B-X
.	B-X
The	B-X
newly	B-X
recognized	B-X
Fsr-regulated	B-X
targets	B-X
include	B-X
other	B-X
factors	B-X
,	B-X
besides	B-X
gelatinase	B-X
,	B-X
described	B-X
as	B-X
important	B-X
for	B-X
biofilms	B-X
(	B-X
BopD	B-X
)	B-X
,	B-X
and	B-X
genes	B-X
predicted	B-X
to	B-X
encode	B-X
the	B-X
surface	B-X
proteins	B-X
EF0750	B-X
to	B-X
-0757	B-X
and	B-X
EF1097	B-X
,	B-X
along	B-X
with	B-X
proteins	B-X
implicated	B-X
in	B-X
several	B-X
metabolic	B-X
pathways	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
FsrABC	B-X
system	B-X
may	B-X
be	B-X
an	B-X
important	B-X
regulator	B-X
in	B-X
strain	B-X
OG1RF	B-X
,	B-X
with	B-X
both	B-X
positive	B-X
and	B-X
negative	B-X
effects	B-X
.	B-X

When	O
compared	O
in	O
the	O
mouse	B-Organism
peritonitis	O
model	O
,	O
the	O
LD50	O
values	O
of	O
V583	B-Organism
in	O
different	O
determinations	O
were	O
lower	O
(	O
4	O
.	O
8	O
x	O
107	O
to	O
1	O
.	O
1	O
x	O
108	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
ml	O
)	O
than	O
the	O
LD50	O
values	O
of	O
OG1RF	B-Organism
(	O
1	O
.	O
2	O
x	O
108	O
to	O
4	O
.	O
8	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
.	O

However	O
,	O
at	O
comparable	O
inoculum	O
,	O
OG1RF	B-Organism
(	O
4	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
showed	O
more	O
rapid	O
mortality	O
versus	O
V583	B-Organism
(	O
5	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
in	O
the	O
first	O
48	O
hours	O
(	O
P	O
=	O
0	O
.	O
0034	O
;	O
Additional	O
data	O
file	O
3	O
)	O
.	O

In	O
a	O
urinary	O
tract	O
infection	O
model	O
administering	O
mixed	O
equal	O
inocula	O
of	O
V583	B-Organism
and	O
OG1RF	B-Organism
,	O
OG1RF	B-Organism
significantly	O
outnumbered	O
V583	B-Organism
in	O
kidney	O
with	O
geometric	O
means	O
of	O
1	O
.	O
3	O
x	O
104	O
CFU	O
/	O
gm	O
for	O
OG1RF	B-Organism
versus	O
1	O
.	O
9	O
x	O
102	O
CFU	O
/	O
gm	O
for	O
V583	B-Organism
(	O
P	O
=	O
0	O
.	O
0005	O
)	O
;	O
in	O
urinary	O
bladder	O
homogenates	O
,	O
the	O
geometric	O
mean	O
CFU	O
/	O
gm	O
was	O
1	O
.	O
7	O
x	O
103	O
for	O
OG1RF	B-Organism
versus	O
6	O
.	O
6	O
x	O
101	O
for	O
V583	B-Organism
(	O
P	O
=	O
0	O
.	O
003	O
;	O
Figure	O
7a	O
)	O
.	O

Similarly	O
,	O
in	O
mono	O
-	O
infection	O
,	O
the	O
geometric	O
mean	O
CFU	O
/	O
gm	O
of	O
OG1RF	B-Organism
in	O
kidneys	O
was	O
9	O
.	O
4	O
x	O
103	O
versus	O
4	O
x	O
101	O
for	O
V583	B-Organism
(	O
P	O
=	O
0	O
.	O
0035	O
;	O
Figure	O
7b	O
)	O
.	O

We	O
also	O
found	O
that	O
OG1RF	B-Organism
produced	O
20	O
%	O
more	O
biofilm	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
than	O
V583	B-Organism
at	O
24	O
hours	O
(	O
results	O
not	O
shown	O
)	O
.	O

These	O
results	O
,	O
together	O
with	O
the	O
previous	O
results	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
[	O
17	O
]	O
,	O
demonstrate	O
that	O
OG1RF	B-Organism
,	O
although	O
lacking	O
what	O
was	O
thought	O
to	O
be	O
important	O
for	O
virulence	O
(	O
PAI	O
,	O
plasmids	O
,	O
prophages	O
)	O
,	O
is	O
as	O
pathogenic	O
as	O
V583	B-Organism
in	O
at	O
least	O
three	O
assays	O
.	O

Conclusion	O
<EOS>	B-X
Conclusion	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X

E	B-Organism
.	I-Organism
faecalis	I-Organism
OG1RF	I-Organism
carries	O
a	O
number	O
of	O
unique	O
loci	O
compared	O
to	O
V583	B-Organism
.	O
<EOS>	B-X
Enterococcus	B-X
faecalis	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
major	B-X
hospital	B-X
pathogen	B-X
.	B-X
To	B-X
explore	B-X
its	B-X
diversity	B-X
,	B-X
we	B-X
sequenced	B-X
E.	B-X
faecalis	B-X
strain	B-X
OG1RF	B-X
,	B-X
which	B-X
is	B-X
commonly	B-X
used	B-X
for	B-X
molecular	B-X
manipulation	B-X
and	B-X
virulence	B-X
studies	B-X
.	B-X

Those	O
of	O
particular	O
interest	O
include	O
new	O
surface	O
proteins	O
(	O
MSCRAMMs	O
and	O
WxL	O
domain	O
proteins	O
)	O
,	O
an	O
operon	O
encoding	O
myo	O
-	O
inositol	O
utilization	O
,	O
an	O
intact	O
competence	O
operon	O
,	O
and	O
two	O
CRISPR	O
elements	O
.	O

The	O
CRISPR	O
elements	O
may	O
be	O
of	O
particular	O
significance	O
when	O
one	O
considers	O
that	O
most	O
of	O
what	O
is	O
missing	O
from	O
OG1RF	B-Organism
compared	O
to	O
V583	B-Organism
consists	O
of	O
mobile	O
genetic	O
elements	O
(	O
MGEs	O
)	O
,	O
including	O
6	O
phages	O
or	O
remnants	O
thereof	O
.	O
<EOS>	B-X
Surgery	B-X
,	B-X
stereotactic	B-X
radiosurgery	B-X
,	B-X
radiotherapy	B-X
,	B-X
and	B-X
chemotherapy	B-X
including	B-X
novel	B-X
targeted	B-X
therapy	B-X
strategies	B-X
and	B-X
any	B-X
combination	B-X
thereof	B-X
as	B-X
well	B-X
as	B-X
supportive	B-X
care	B-X
are	B-X
the	B-X
key	B-X
elements	B-X
for	B-X
treatment	B-X
of	B-X
brain	B-X
metastases	B-X
.	B-X
Goals	B-X
of	B-X
microsurgery	B-X
are	B-X
to	B-X
obtain	B-X
tissue	B-X
samples	B-X
for	B-X
histologic	B-X
diagnosis	B-X
(	B-X
particularly	B-X
in	B-X
case	B-X
of	B-X
uncertainty	B-X
about	B-X
the	B-X
unknown	B-X
primary	B-X
tumor	B-X
but	B-X
also	B-X
in	B-X
the	B-X
context	B-X
of	B-X
future	B-X
targeted	B-X
therapies	B-X
)	B-X
,	B-X
to	B-X
relieve	B-X
burden	B-X
from	B-X
space-occupying	B-X
effects	B-X
,	B-X
to	B-X
improve	B-X
local	B-X
tumor	B-X
control	B-X
,	B-X
and	B-X
to	B-X
prolong	B-X
overall	B-X
survival	B-X
.	B-X
Complete	B-X
surgical	B-X
resection	B-X
improves	B-X
local	B-X
tumor	B-X
control	B-X
and	B-X
may	B-X
even	B-X
affect	B-X
overall	B-X
survival	B-X
.	B-X
Particularly	B-X
in	B-X
cases	B-X
of	B-X
incomplete	B-X
resections	B-X
,	B-X
focal	B-X
irradiation	B-X
or	B-X
radiosurgery	B-X
of	B-X
the	B-X
resection	B-X
cavity	B-X
or	B-X
tumor	B-X
remnant	B-X
rather	B-X
than	B-X
WBRT	B-X
may	B-X
be	B-X
attempted	B-X
.	B-X

The	O
presence	O
of	O
the	O
CRISPR	O
elements	O
in	O
OG1RF	B-Organism
provides	O
a	O
tantalizing	O
,	O
but	O
as	O
yet	O
unproven	O
,	O
explanation	O
for	O
the	O
discordance	O
in	O
the	O
number	O
of	O
mobile	O
elements	O
between	O
these	O
two	O
strains	O
.	O

The	O
acquisition	O
of	O
MGE	O
is	O
believed	O
to	O
be	O
an	O
important	O
mechanism	O
by	O
which	O
the	O
species	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
had	O
been	O
able	O
to	O
generate	O
genetic	O
diversity	O
and	O
,	O
thereby	O
,	O
highly	O
variable	O
phenotypes	O
[	O
4	O
]	O
.	O

It	O
has	O
been	O
proposed	O
that	O
the	O
ability	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
to	O
cause	O
healthcare	O
related	O
infections	O
is	O
associated	O
with	O
these	O
MGEs	O
[	O
4	O
,	O
5	O
]	O
.	O

This	O
hypothesis	O
was	O
supported	O
by	O
several	O
studies	O
that	O
have	O
highlighted	O
the	O
importance	O
of	O
virulence	O
determinants	O
carried	O
by	O
these	O
mobile	O
elements	O
,	O
such	O
as	O
cytolysin	O
[	O
57	O
]	O
by	O
the	O
PAI	O
.	O

However	O
,	O
more	O
recent	O
results	O
from	O
Aakra	O
et	O
al	O
.	O

[	O
53	O
]	O
and	O
Lepage	O
et	O
al	O
.	O
<EOS>	B-X
There	B-X
is	B-X
no	B-X
standard	B-X
second-line	B-X
treatment	B-X
after	B-X
platinum-etoposide	B-X
chemotherapy	B-X
for	B-X
gastroenteropancreatic	B-X
neuroendocrine	B-X
carcinoma	B-X
.	B-X
We	B-X
aimed	B-X
to	B-X
evaluate	B-X
the	B-X
efficacy	B-X
of	B-X
FOLFIRI	B-X
plus	B-X
bevacizumab	B-X
,	B-X
and	B-X
FOLFIRI	B-X
alone	B-X
,	B-X
in	B-X
this	B-X
setting	B-X
.	B-X

[	O
36	O
]	O
demonstrate	O
that	O
these	O
factors	O
may	O
be	O
present	O
in	O
harmless	O
strains	O
while	O
absent	O
in	O
clinical	O
isolates	O
,	O
indicating	O
that	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
virulence	O
is	O
not	O
dependent	O
on	O
any	O
single	O
virulence	O
factor	O
.	O

Indeed	O
,	O
few	O
studies	O
have	O
compared	O
the	O
virulence	O
pattern	O
of	O
strains	O
from	O
various	O
origins	O
.	O

The	O
increased	O
ability	O
of	O
OG1RF	B-Organism
to	O
infect	O
kidneys	O
and	O
to	O
produce	O
biofilm	O
,	O
despite	O
the	O
absence	O
of	O
MGEs	O
and	O
their	O
associated	O
virulence	O
factors	O
,	O
was	O
surprising	O
.	O

Different	O
possibilities	O
can	O
be	O
proposed	O
relating	O
to	O
the	O
factors	O
important	O
for	O
these	O
differences	O
in	O
enterococcal	O
infections	O
.	O

One	O
of	O
these	O
is	O
that	O
virulence	O
in	O
the	O
assays	O
used	O
may	O
be	O
linked	O
to	O
the	O
shared	O
core	O
genome	O
of	O
these	O
two	O
strains	O
,	O
with	O
the	O
differences	O
arising	O
from	O
the	O
unique	O
genes	O
.	O

On	O
the	O
other	O
hand	O
,	O
virulence	O
could	O
be	O
associated	O
primarily	O
with	O
the	O
genes	O
unique	O
to	O
each	O
strain	O
,	O
but	O
with	O
each	O
set	O
being	O
able	O
to	O
complement	O
the	O
absence	O
of	O
the	O
other	O
.	O

It	O
seems	O
most	O
likely	O
that	O
virulence	O
,	O
and	O
/	O
or	O
some	O
combination	O
of	O
virulence	O
and	O
fitness	O
,	O
is	O
caused	O
by	O
the	O
expression	O
of	O
a	O
mixture	O
of	O
both	O
the	O
core	O
and	O
unique	O
genes	O
.	O
<EOS>	B-X
T	B-X
cell	B-X
memory	B-X
encompasses	B-X
broad	B-X
recognition	B-X
of	B-X
viral	B-X
proteins	B-X
,	B-X
estimated	B-X
at	B-X
around	B-X
30	B-X
epitopes	B-X
within	B-X
each	B-X
individual	B-X
,	B-X
and	B-X
seems	B-X
to	B-X
be	B-X
well	B-X
sustained	B-X
so	B-X
far	B-X
.	B-X
This	B-X
breadth	B-X
of	B-X
recognition	B-X
can	B-X
limit	B-X
the	B-X
impact	B-X
of	B-X
individual	B-X
viral	B-X
mutations	B-X
and	B-X
is	B-X
likely	B-X
to	B-X
underpin	B-X
protection	B-X
against	B-X
severe	B-X
disease	B-X
from	B-X
viral	B-X
variants	B-X
,	B-X
including	B-X
Omicron	B-X
.	B-X
Current	B-X
COVID-19	B-X
vaccines	B-X
elicit	B-X
robust	B-X
T	B-X
cell	B-X
responses	B-X
that	B-X
likely	B-X
contribute	B-X
to	B-X
remarkable	B-X
protection	B-X
against	B-X
hospitalization	B-X
or	B-X
death	B-X
,	B-X
and	B-X
novel	B-X
or	B-X
heterologous	B-X
regimens	B-X
offer	B-X
the	B-X
potential	B-X
to	B-X
further	B-X
enhance	B-X
cellular	B-X
responses	B-X
.	B-X
Antimicrobial	B-X
Resistance	B-X
in	B-X

It	O
is	O
also	O
important	O
to	O
remember	O
that	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
is	O
a	O
well	O
adapted	O
commensal	O
,	O
carrying	O
the	O
genes	O
necessary	O
to	O
survive	O
and	O
to	O
colonize	O
the	O
gut	O
,	O
and	O
that	O
a	O
subset	O
,	O
particularly	O
MLST	O
CC2	B-Organism
and	O
CC9	B-Organism
[	O
58	O
]	O
,	O
predominates	O
among	O
hospital	O
acquired	O
infections	O
.	O

It	O
may	O
be	O
that	O
these	O
clonal	O
complexes	O
are	O
not	O
more	O
virulent	O
per	O
se	O
,	O
as	O
defined	O
in	O
the	O
assays	O
described	O
here	O
,	O
but	O
rather	O
are	O
better	O
able	O
to	O
survive	O
and	O
/	O
or	O
colonize	O
hospitalized	O
patients	B-Organism
,	O
taking	O
advantage	O
of	O
factors	O
that	O
predispose	O
to	O
nosocomial	O
infections	O
such	O
as	O
urinary	O
or	O
venous	O
catheters	O
,	O
or	O
mucositis	O
,	O
among	O
others	O
.	O
<EOS>	B-X
The	B-X
use	B-X
of	B-X
ultrasound	B-X
(	B-X
US	B-X
)	B-X
has	B-X
been	B-X
proposed	B-X
to	B-X
reduce	B-X
the	B-X
number	B-X
of	B-X
complications	B-X
and	B-X
to	B-X
increase	B-X
the	B-X
safety	B-X
and	B-X
quality	B-X
of	B-X
central	B-X
venous	B-X
catheter	B-X
(	B-X
CVC	B-X
)	B-X
placement	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
rationale	B-X
for	B-X
the	B-X
use	B-X
of	B-X
US	B-X
during	B-X
CVC	B-X
placement	B-X
,	B-X
the	B-X
basic	B-X
principles	B-X
of	B-X
this	B-X
technique	B-X
,	B-X
and	B-X
the	B-X
current	B-X
evidence	B-X
and	B-X
existing	B-X
guidelines	B-X
for	B-X
its	B-X
use	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
recommend	B-X
a	B-X
structured	B-X
approach	B-X
for	B-X
US-guided	B-X
central	B-X
venous	B-X
access	B-X
for	B-X
clinical	B-X
practice	B-X
.	B-X
Static	B-X
and	B-X
real-time	B-X
US	B-X
can	B-X
be	B-X
used	B-X
to	B-X
visualize	B-X
the	B-X
anatomy	B-X
and	B-X
patency	B-X
of	B-X
the	B-X
target	B-X
vein	B-X
in	B-X
a	B-X
short-axis	B-X
and	B-X
a	B-X
long-axis	B-X
view	B-X
.	B-X
US-guided	B-X
needle	B-X
advancement	B-X
can	B-X
be	B-X
performed	B-X
in	B-X
an	B-X
``	B-X
out-of-plane	B-X
''	B-X
and	B-X
an	B-X
``	B-X
in-plane	B-X
''	B-X
technique	B-X
.	B-X
Based	B-X
on	B-X
the	B-X
available	B-X
evidence	B-X
from	B-X
clinical	B-X
studies	B-X
,	B-X
several	B-X
guidelines	B-X
from	B-X
medical	B-X
societies	B-X
strongly	B-X
recommend	B-X
the	B-X
use	B-X
of	B-X
US	B-X
for	B-X
CVC	B-X
placement	B-X
in	B-X
the	B-X
internal	B-X
jugular	B-X
vein	B-X
.	B-X
Data	B-X
from	B-X
survey	B-X
studies	B-X
show	B-X
that	B-X
there	B-X
is	B-X
still	B-X
a	B-X
gap	B-X
between	B-X
the	B-X
existing	B-X
evidence	B-X
and	B-X
guidelines	B-X
and	B-X
the	B-X
use	B-X
of	B-X
US	B-X
in	B-X
clinical	B-X
practice	B-X
.	B-X
For	B-X
clinical	B-X
practice	B-X
,	B-X
we	B-X
recommend	B-X
a	B-X
six-step	B-X
systematic	B-X
approach	B-X
for	B-X
US-guided	B-X
central	B-X
venous	B-X
access	B-X
that	B-X
includes	B-X
assessing	B-X
the	B-X
target	B-X
vein	B-X
(	B-X
anatomy	B-X
and	B-X
vessel	B-X
localization	B-X
,	B-X
vessel	B-X
patency	B-X
)	B-X
,	B-X
using	B-X
real-time	B-X
US	B-X
guidance	B-X
for	B-X
puncture	B-X
of	B-X
the	B-X
vein	B-X
,	B-X
and	B-X
confirming	B-X
the	B-X
correct	B-X
needle	B-X
,	B-X
wire	B-X
,	B-X
and	B-X
catheter	B-X
position	B-X
in	B-X
the	B-X
vein	B-X
.	B-X

Sequencing	O
of	O
more	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
strains	O
may	O
facilitate	O
our	O
understanding	O
of	O
the	O
path	O
from	O
commensalism	O
to	O
pathogenicity	O
,	O
a	O
crucial	O
prerequisite	O
for	O
designing	O
therapeutic	O
interventions	O
directed	O
to	O
control	O
an	O
organism	O
that	O
is	O
already	O
resistant	O
to	O
a	O
large	O
spectrum	O
of	O
antibiotics	O
.	O

A	O
Naturally	O
Occurring	O
Mutation	O
in	O
ropB	O
Suppresses	O
SpeB	O
Expression	O
and	O
Reduces	O
M1T1	B-Organism
Group	O
A	O
Streptococcal	O
Systemic	O
Virulence	O

Epidemiological	O
studies	O
of	O
group	B-Organism
A	I-Organism
streptococcus	I-Organism
(	O
GAS	B-Organism
)	O
have	O
noted	O
an	O
inverse	O
relationship	O
between	O
SpeB	O
expression	O
and	O
invasive	O
disease	O
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
Microarray	B-X
analysis	B-X
found	B-X
genes	B-X
of	B-X
the	B-X
SpeB	B-X
operon	B-X
to	B-X
be	B-X
the	B-X
primary	B-X
target	B-X
of	B-X
RopB	B-X
regulation	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

However	O
,	O
the	O
role	O
of	O
SpeB	O
in	O
the	O
course	O
of	O
infection	O
is	O
still	O
unclear	O
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
Microarray	B-X
analysis	B-X
found	B-X
genes	B-X
of	B-X
the	B-X
SpeB	B-X
operon	B-X
to	B-X
be	B-X
the	B-X
primary	B-X
target	B-X
of	B-X
RopB	B-X
regulation	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

In	O
this	O
study	O
we	O
utilize	O
a	O
SpeB	O
-	O
negative	O
M1T1	O
clinical	O
isolate	O
,	O
5628	B-Organism
,	O
with	O
a	O
naturally	O
occurring	O
mutation	O
in	O
the	O
gene	O
encoding	O
the	O
regulator	O
RopB	O
,	O
to	O
elucidate	O
the	O
role	O
of	O
RopB	O
and	O
SpeB	O
in	O
systemic	O
virulence	O
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
Microarray	B-X
analysis	B-X
found	B-X
genes	B-X
of	B-X
the	B-X
SpeB	B-X
operon	B-X
to	B-X
be	B-X
the	B-X
primary	B-X
target	B-X
of	B-X
RopB	B-X
regulation	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

Allelic	O
exchange	O
mutagenesis	O
was	O
used	O
to	O
replace	O
the	O
mutated	O
ropB	O
allele	O
in	O
5628	B-Organism
with	O
the	O
intact	O
allele	O
from	O
the	O
well	O
characterized	O
isolate	O
5448	B-Organism
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

The	O
inverse	O
allelic	O
exchange	O
was	O
also	O
performed	O
to	O
replace	O
the	O
intact	O
ropB	O
in	O
5448	B-Organism
with	O
the	O
mutated	O
allele	O
from	O
5628	B-Organism
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

An	O
intact	O
ropB	O
was	O
found	O
to	O
be	O
essential	O
for	O
SpeB	O
expression	O
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
Microarray	B-X
analysis	B-X
found	B-X
genes	B-X
of	B-X
the	B-X
SpeB	B-X
operon	B-X
to	B-X
be	B-X
the	B-X
primary	B-X
target	B-X
of	B-X
RopB	B-X
regulation	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

While	O
the	O
ropB	O
mutation	O
was	O
shown	O
to	O
have	O
no	O
effect	O
on	O
hemolysis	O
of	O
RBC	O
'	O
s	O
,	O
extracellular	O
DNase	O
activity	O
or	O
survival	O
in	O
the	O
presence	O
of	O
neutrophils	O
,	O
strains	O
with	O
the	O
mutated	O
ropB	O
allele	O
were	O
less	O
virulent	O
in	O
murine	B-Organism
systemic	O
models	O
of	O
infection	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

An	O
isogenic	O
SpeB	O
knockout	O
strain	O
containing	O
an	O
intact	O
RopB	O
showed	O
similarly	O
reduced	O
virulence	O
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
Microarray	B-X
analysis	B-X
found	B-X
genes	B-X
of	B-X
the	B-X
SpeB	B-X
operon	B-X
to	B-X
be	B-X
the	B-X
primary	B-X
target	B-X
of	B-X
RopB	B-X
regulation	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

Microarray	O
analysis	O
found	O
genes	O
of	O
the	O
SpeB	O
operon	O
to	O
be	O
the	O
primary	O
target	O
of	O
RopB	O
regulation	O
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
Microarray	B-X
analysis	B-X
found	B-X
genes	B-X
of	B-X
the	B-X
SpeB	B-X
operon	B-X
to	B-X
be	B-X
the	B-X
primary	B-X
target	B-X
of	B-X
RopB	B-X
regulation	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

These	O
data	O
show	O
that	O
an	O
intact	O
RopB	O
and	O
efficient	O
SpeB	O
production	O
are	O
necessary	O
for	O
systemic	O
infection	O
with	O
GAS	B-Organism
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
Microarray	B-X
analysis	B-X
found	B-X
genes	B-X
of	B-X
the	B-X
SpeB	B-X
operon	B-X
to	B-X
be	B-X
the	B-X
primary	B-X
target	B-X
of	B-X
RopB	B-X
regulation	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

Introduction	O

Streptococcus	B-Organism
pyogenes	I-Organism
(	O
group	B-Organism
A	I-Organism
streptococcus	I-Organism
;	O
GAS	B-Organism
)	O
is	O
a	O
Gram	O
-	O
positive	O
,	O
human	B-Organism
-	O
specific	O
pathogen	O
responsible	O
for	O
over	O
500	O
,	O
000	O
deaths	O
each	O
year	O
[	O
1	O
]	O
.	O
<EOS>	B-X
Streptococcus	B-X
pyogenes	B-X
.	B-X
Group	B-X
A	B-X
Streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
is	B-X
a	B-X
leading	B-X
human	B-X
bacterial	B-X
pathogen	B-X
with	B-X
diverse	B-X
clinical	B-X
manifestations	B-X
.	B-X
Macrophages	B-X
constitute	B-X
a	B-X
critical	B-X
first	B-X
line	B-X
of	B-X
host	B-X
defense	B-X
against	B-X
GAS	B-X
infection	B-X
,	B-X
using	B-X
numerous	B-X
surface	B-X
and	B-X
intracellular	B-X
receptors	B-X
such	B-X
as	B-X
Toll-like	B-X
receptors	B-X
and	B-X
inflammasomes	B-X
for	B-X
pathogen	B-X
recognition	B-X
and	B-X
activation	B-X
of	B-X
inflammatory	B-X
signaling	B-X
pathways	B-X
.	B-X
Depending	B-X
on	B-X
the	B-X
intensity	B-X
of	B-X
the	B-X
GAS	B-X
infection	B-X
,	B-X
activation	B-X
of	B-X
these	B-X
signaling	B-X
cascades	B-X
may	B-X
provide	B-X
a	B-X
beneficial	B-X
early	B-X
alarm	B-X
for	B-X
effective	B-X
immune	B-X
clearance	B-X
,	B-X
or	B-X
conversely	B-X
,	B-X
may	B-X
cause	B-X
hyperinflammation	B-X
and	B-X
tissue	B-X
injury	B-X
during	B-X
severe	B-X
invasive	B-X
infection	B-X
.	B-X
Although	B-X
traditionally	B-X
considered	B-X
an	B-X
extracellular	B-X
pathogen	B-X
,	B-X
GAS	B-X
can	B-X
invade	B-X
and	B-X
replicate	B-X
within	B-X
macrophages	B-X
using	B-X
specific	B-X
molecular	B-X
mechanisms	B-X
to	B-X
resist	B-X
phagolysosomal	B-X
and	B-X
xenophagic	B-X
killing	B-X
.	B-X
Unraveling	B-X
GAS-macrophage	B-X
encounters	B-X
may	B-X
reveal	B-X
new	B-X
treatment	B-X
options	B-X
for	B-X
this	B-X
leading	B-X
agent	B-X
of	B-X
infection-associated	B-X
mortality	B-X
.	B-X

Severe	O
invasive	O
GAS	B-Organism
infections	O
such	O
as	O
necrotizing	O
fasciitis	O
account	O
for	O
approximately	O
30	O
%	O
of	O
these	O
deaths	O
,	O
and	O
the	O
incidence	O
of	O
such	O
acute	O
conditions	O
has	O
been	O
on	O
the	O
rise	O
since	O
the	O
mid	O
1980	O
'	O
s	O
[	O
2	O
]	O
.	O

This	O
resurgence	O
has	O
been	O
paralleled	O
by	O
the	O
emergence	O
of	O
a	O
globally	O
disseminated	O
GAS	B-Organism
cone	O
belonging	O
to	O
serotype	O
M1T1	B-Organism
[	O
3	O
]	O
-	O
[	O
5	O
]	O
.	O

While	O
the	O
M1T1	B-Organism
GAS	I-Organism
has	O
become	O
the	O
most	O
common	O
cause	O
of	O
streptococcal	O
pharyngitis	O
,	O
this	O
clone	O
is	O
also	O
overrepresented	O
in	O
cases	O
of	O
severe	O
invasive	O
disease	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Studies	O
of	O
M1T1	B-Organism
clinical	O
isolates	O
from	O
invasive	O
disease	O
cases	O
have	O
revealed	O
an	O
inverse	O
relationship	O
between	O
expression	O
of	O
the	O
extracellular	O
cysteine	O
protease	O
SpeB	O
and	O
clinical	O
severity	O
[	O
8	O
]	O
.	O

The	O
existence	O
of	O
a	O
SpeB	O
-	O
negative	O
invasive	O
phenotype	O
has	O
been	O
hypothesized	O
that	O
results	O
from	O
mutations	O
in	O
the	O
regulator	O
covR	O
/	O
S	O
[	O
9	O
]	O
.	O

SpeB	O
is	O
a	O
secreted	O
cysteine	O
protease	O
initially	O
expressed	O
as	O
40	O
kDa	O
zymogen	O
which	O
is	O
then	O
converted	O
to	O
the	O
28	O
kDa	O
active	O
form	O
by	O
autocatalytic	O
processing	O
[	O
10	O
]	O
.	O

SpeB	O
is	O
known	O
to	O
cleave	O
numerous	O
host	O
proteins	O
including	O
components	O
of	O
the	O
extracellular	O
matrix	O
,	O
cytokine	O
precursors	O
,	O
immunoglobulins	O
and	O
antimicrobial	O
peptides	O
[	O
11	O
]	O
-	O
[	O
13	O
]	O
,	O
which	O
could	O
interfere	O
with	O
host	O
immune	O
functions	O
.	O

However	O
,	O
SpeB	O
has	O
also	O
been	O
shown	O
to	O
cleave	O
a	O
range	O
of	O
GAS	B-Organism
proteins	O
such	O
as	O
the	O
fibrinogen	O
-	O
binding	O
M1	O
protein	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
,	O
various	O
superantigens	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
,	O
the	O
secreted	O
plasminogen	O
activator	O
streptokinase	O
[	O
18	O
]	O
as	O
well	O
as	O
the	O
DNase	O
Sda1	O
[	O
17	O
]	O
,	O
and	O
thus	O
possibly	O
interfere	O
with	O
the	O
proven	O
virulence	O
functions	O
of	O
these	O
bacterial	O
factors	O
.	O

The	O
precise	O
role	O
(	O
s	O
)	O
of	O
SpeB	O
throughout	O
the	O
course	O
of	O
infection	O
are	O
undoubtedly	O
complex	O
,	O
and	O
not	O
surprisingly	O
,	O
different	O
studies	O
using	O
different	O
in	O
vivo	O
animal	O
models	O
have	O
produced	O
seemingly	O
contradictory	O
results	O
[	O
19	O
]	O
-	O
[	O
21	O
]	O
.	O

In	O
this	O
study	O
we	O
examined	O
the	O
effect	O
of	O
a	O
natural	O
mutation	O
in	O
the	O
gene	O
encoding	O
the	O
regulator	O
RopB	O
(	O
also	O
known	O
as	O
Rgg	O
[	O
22	O
]	O
)	O
identified	O
in	O
a	O
SpeB	O
-	O
negative	O
GAS	O
clinical	O
isolate	O
.	O

RopB	O
is	O
a	O
GAS	B-Organism
transcriptional	O
regulator	O
that	O
has	O
been	O
shown	O
to	O
be	O
essential	O
for	O
expression	O
of	O
SpeB	O
and	O
binds	O
directly	O
to	O
the	O
promoter	O
region	O
of	O
speB	O
[	O
23	O
]	O
,	O
[	O
24	O
]	O
.	O

In	O
studies	O
performed	O
in	O
different	O
GAS	B-Organism
serotype	O
strains	O
,	O
RopB	O
has	O
variably	O
been	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
other	O
GAS	B-Organism
genes	O
including	O
those	O
associated	O
with	O
metabolism	O
of	O
non	O
-	O
glucose	O
carbohydrates	O
and	O
amino	O
acids	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
,	O
response	O
to	O
thermal	O
and	O
oxidative	O
stress	O
[	O
25	O
]	O
,	O
[	O
27	O
]	O
and	O
the	O
expression	O
of	O
virulence	O
factors	O
including	O
DNases	O
(	O
MF	O
-	O
1	O
and	O
MF	O
-	O
3	O
)	O
and	O
hemolysins	O
(	O
streptolysin	O
S	O
and	O
streptolysin	O
O	O
)	O
[	O
26	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
.	O

Subsequent	O
investigations	O
into	O
the	O
effect	O
of	O
RopB	O
on	O
virulence	O
have	O
yielded	O
differing	O
results	O
.	O

A	O
study	O
utilizing	O
a	O
zebrafish	B-Organism
intramuscular	O
infection	O
model	O
with	O
serotype	O
M5	B-Organism
GAS	I-Organism
showed	O
that	O
inactivation	O
of	O
RopB	O
resulted	O
in	O
decreased	O
virulence	O
[	O
30	O
]	O
,	O
whereas	O
a	O
study	O
utilizing	O
a	O
murine	B-Organism
intraperitoneal	O
infection	O
model	O
with	O
serotype	O
M49	B-Organism
GAS	I-Organism
showed	O
that	O
inactivation	O
of	O
RopB	O
resulted	O
in	O
increased	O
virulence	O
[	O
27	O
]	O
.	O

While	O
such	O
global	O
differences	O
in	O
virulence	O
effects	O
could	O
in	O
part	O
result	O
from	O
the	O
differing	O
animal	O
models	O
used	O
,	O
it	O
may	O
also	O
reflect	O
strain	O
-	O
specific	O
variation	O
in	O
the	O
RopB	O
regulon	O
.	O

For	O
example	O
,	O
separate	O
studies	O
have	O
shown	O
ropB	O
mutation	O
to	O
have	O
either	O
no	O
effect	O
on	O
hemolysis	O
and	O
DNase	O
activity	O
or	O
,	O
alternatively	O
,	O
to	O
increase	O
expression	O
of	O
hemolysin	O
and	O
DNase	O
-	O
encoding	O
genes	O
and	O
the	O
associated	O
phenotypic	O
activities	O
[	O
23	O
]	O
,	O
[	O
26	O
]	O
.	O

This	O
strain	O
-	O
specific	O
variation	O
is	O
highlighted	O
in	O
a	O
recent	O
work	O
by	O
Dmitriev	O
et	O
al	O
.	O

[	O
29	O
]	O
that	O
shows	O
inter	O
-	O
and	O
intra	O
-	O
serotypic	O
variation	O
in	O
the	O
transcriptome	O
of	O
ropB	O
mutant	O
GAS	O
,	O
with	O
only	O
members	O
of	O
the	O
SpeB	O
operon	O
being	O
commonly	O
regulated	O
in	O
all	O
strains	O
tested	O
.	O

It	O
is	O
in	O
the	O
light	O
of	O
the	O
current	O
uncertainty	O
surrounding	O
RopB	O
and	O
its	O
role	O
in	O
virulence	O
that	O
we	O
sought	O
to	O
investigate	O
the	O
role	O
of	O
this	O
transcriptional	O
regulator	O
in	O
the	O
serotype	O
M1T1	B-Organism
GAS	I-Organism
background	O
that	O
is	O
the	O
leading	O
agent	O
of	O
severe	O
human	B-Organism
infection	O
.	O

This	O
analysis	O
begins	O
with	O
a	O
naturally	O
-	O
occuring	O
mutation	O
in	O
ropB	O
identified	O
in	O
one	O
such	O
strain	O
.	O

Results	O

Sequence	O
analysis	O
of	O
clinical	O
isolate	O
5628	B-Organism
reveals	O
intact	O
speB	O
and	O
covR	O
/	O
S	O
but	O
mutation	O
in	O
ropB	O
M1T1	B-Organism
GAS	I-Organism
clinical	O
isolate	O
5628	B-Organism
was	O
found	O
on	O
screening	O
to	O
lack	O
SpeB	O
activity	O
by	O
azocasein	O
assay	O
.	O

DNA	O
sequencing	O
was	O
performed	O
using	O
primers	O
listed	O
in	O
Table	O
1	O
.	O

No	O
mutations	O
were	O
found	O
in	O
the	O
strain	O
5628	B-Organism
in	O
the	O
speB	O
gene	O
nor	O
in	O
the	O
covR	O
/	O
S	O
locus	O
,	O
which	O
has	O
been	O
previously	O
linked	O
to	O
loss	O
of	O
SpeB	O
expression	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
.	O

Further	O
sequencing	O
was	O
performed	O
on	O
the	O
previously	O
described	O
regulators	O
luxS	O
,	O
rofA	O
,	O
ropA	O
and	O
ropB	O
[	O
24	O
]	O
,	O
[	O
39	O
]	O
-	O
[	O
41	O
]	O
.	O

This	O
analysis	O
revealed	O
a	O
point	O
mutation	O
in	O
ropB	O
,	O
leading	O
to	O
truncation	O
of	O
RopB	O
at	O
amino	O
acid	O
170	O
of	O
the	O
280	O
amino	O
acid	O
protein	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

The	O
truncation	O
of	O
RopB	O
suggested	O
that	O
this	O
may	O
be	O
the	O
cause	O
of	O
lack	O
of	O
SpeB	O
expression	O
in	O
this	O
strain	O
.	O

Repair	O
of	O
the	O
5628	B-Organism
ropB	O
allele	O
restores	O
SpeB	O
expression	O
and	O
activity	O

Western	O
blot	O
detected	O
SpeB	O
in	O
overnight	O
culture	O
supernatants	O
of	O
5628R	B-Organism
+	I-Organism
,	O
containing	O
the	O
intact	O
ropB	O
allele	O
,	O
but	O
not	O
in	O
the	O
clinical	O
isolate	O
5628	B-Organism
nor	O
the	O
isogenic	O
mutant	O
5628RDeltaSpeB	O
,	O
containing	O
the	O
intact	O
ropB	O
allele	O
but	O
lacking	O
speB	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

This	O
expression	O
correlated	O
with	O
a	O
restoration	O
of	O
extracellular	O
protease	O
activity	O
as	O
detected	O
by	O
azocasein	O
degradation	O
assay	O
(	O
Fig	O
.	O
1C	O
)	O
.	O

Protease	O
activity	O
was	O
abrogated	O
by	O
the	O
addition	O
of	O
the	O
cysteine	O
protease	O
inhibitor	O
E64	O
.	O
<EOS>	B-X
The	B-X
addition	B-X
of	B-X
80	B-X
μg	B-X
of	B-X
either	B-X
component/ml	B-X
decreased	B-X
the	B-X
neuron	B-X
number	B-X
by	B-X
30	B-X
%	B-X
,	B-X
whereas	B-X
the	B-X
axon	B-X
number	B-X
was	B-X
decreased	B-X
by	B-X
50	B-X
%	B-X
.	B-X
Cytotoxicity	B-X
was	B-X
specific	B-X
to	B-X
the	B-X
neuronal	B-X
population	B-X
,	B-X
since	B-X
the	B-X
glial	B-X
and	B-X
smooth	B-X
muscle	B-X
cell	B-X
number	B-X
remained	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
control	B-X
,	B-X
and	B-X
was	B-X
completely	B-X
abrogated	B-X
by	B-X
prior	B-X
heat	B-X
denaturation	B-X
.	B-X
Neuronal	B-X
damage	B-X
was	B-X
partially	B-X
prevented	B-X
by	B-X
the	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
E-64	B-X
,	B-X
showing	B-X
that	B-X
a	B-X
heat-labile	B-X
protease	B-X
was	B-X
involved	B-X
.	B-X
E.	B-X
histolytica	B-X
lysates	B-X
derived	B-X
from	B-X
amebas	B-X
deficient	B-X
in	B-X
the	B-X
major	B-X
secreted	B-X
protease	B-X
EhCP5	B-X
caused	B-X
a	B-X
neurotoxicity	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
wild-type	B-X
amebas	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
E.	B-X
histolytica	B-X
infection	B-X
and	B-X
ameba	B-X
protease	B-X
activity	B-X
can	B-X
cause	B-X
selective	B-X
damage	B-X
to	B-X
enteric	B-X
neurons	B-X
.	B-X

These	O
data	O
demonstrated	O
that	O
the	O
ropB	O
point	O
mutation	O
was	O
indeed	O
responsible	O
for	O
the	O
lack	O
of	O
SpeB	O
expression	O
in	O
the	O
clinical	O
isolate	O
5628	B-Organism
.	O

RopB	O
mutation	O
does	O
not	O
affect	O
bacterial	O
growth	O
,	O
hemolysis	O
,	O
DNase	O
activity	O
or	O
resistance	O
to	O
neutrophil	O
killing	O
<EOS>	B-X
In	B-X
cancer	B-X
,	B-X
tumour-associated	B-X
neutrophils	B-X
(	B-X
TANs	B-X
)	B-X
have	B-X
emerged	B-X
as	B-X
an	B-X
important	B-X
component	B-X
of	B-X
the	B-X
tumour	B-X
microenvironment	B-X
.	B-X
Conversely	B-X
,	B-X
neutrophils	B-X
can	B-X
also	B-X
mediate	B-X
antitumour	B-X
responses	B-X
by	B-X
direct	B-X
killing	B-X
of	B-X
tumour	B-X
cells	B-X
and	B-X
by	B-X
participating	B-X
in	B-X
cellular	B-X
networks	B-X
that	B-X
mediate	B-X
antitumour	B-X
resistance	B-X
.	B-X
Myeloid	B-X
checkpoints	B-X
as	B-X
well	B-X
as	B-X
the	B-X
tumour	B-X
and	B-X
tissue	B-X
contexture	B-X
shape	B-X
neutrophil	B-X
function	B-X
in	B-X
response	B-X
to	B-X
conventional	B-X
therapies	B-X
and	B-X
immunotherapy	B-X
.	B-X
We	B-X
surmise	B-X
that	B-X
neutrophils	B-X
can	B-X
provide	B-X
tools	B-X
to	B-X
tailor	B-X
current	B-X
immunotherapy	B-X
strategies	B-X
and	B-X
pave	B-X
the	B-X
way	B-X
to	B-X
myeloid	B-X
cell-centred	B-X
therapeutic	B-X
strategies	B-X
,	B-X
which	B-X
would	B-X
be	B-X
complementary	B-X
to	B-X
current	B-X
approaches	B-X
.	B-X

GAS	B-Organism
strain	I-Organism
5628	I-Organism
and	O
its	O
isogenic	O
mutants	O
5628R	B-Organism
+	I-Organism
and	O
5628RDeltaSpeB	O
were	O
grown	O
in	O
THB	O
,	O
and	O
the	O
OD600	O
was	O
measured	O
over	O
time	O
.	O

No	O
significant	O
difference	O
was	O
found	O
among	O
the	O
growth	O
rates	O
of	O
the	O
three	O
bacterial	O
strains	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Hemolysis	O
assays	O
were	O
performed	O
to	O
determine	O
the	O
effect	O
of	O
ropB	O
mutation	O
on	O
the	O
cytolytic	O
ability	O
of	O
GAS	B-Organism
.	O

No	O
significant	O
difference	O
was	O
seen	O
in	O
hemolytic	O
activity	O
among	O
strains	O
containing	O
the	O
WT	O
or	O
mutated	O
ropB	O
allele	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Extracellular	O
DNase	O
activity	O
of	O
mid	O
-	O
log	O
phase	O
bacteria	O
and	O
GAS	B-Organism
resistance	O
to	O
neutrophil	O
killing	O
were	O
also	O
unaffected	O
by	O
mutation	O
in	O
ropB	O
(	O
Fig	O
.	O
2C	O
and	O
2D	O
)	O
.	O

SpeB	O
-	O
positive	O
bacteria	O
revert	O
to	O
a	O
SpeB	O
-	O
negative	O
phenotype	O
on	O
subcutaneous	O
infection	O

C57BL6	B-Organism
/	I-Organism
J	I-Organism
mice	I-Organism
were	O
subcutaneously	O
infected	O
with	O
the	O
SpeB	O
-	O
positive	O
strain	O
5628R	B-Organism
+	I-Organism
.	O

Three	O
days	O
post	O
-	O
infection	O
,	O
bacteria	O
were	O
recovered	O
from	O
the	O
lesion	O
and	O
screened	O
for	O
SpeB	O
status	O
using	O
the	O
skim	O
-	O
milk	O
agar	O
method	O
.	O

While	O
the	O
inoculum	O
was	O
100	O
%	O
SpeB	O
-	O
positive	O
,	O
bacterial	O
populations	O
recovered	O
from	O
the	O
lesions	O
of	O
individual	O
mice	B-Organism
were	O
found	O
to	O
be	O
2	O
%	O
,	O
4	O
%	O
,	O
6	O
%	O
,	O
8	O
%	O
,	O
and	O
24	O
%	O
SpeB	O
-	O
negative	O
.	O

Five	O
representative	O
colonies	O
were	O
picked	O
,	O
and	O
the	O
covR	O
/	O
S	O
locus	O
was	O
sequenced	O
in	O
each	O
of	O
them	O
.	O

All	O
colonies	O
sequenced	O
were	O
found	O
to	O
have	O
substitution	O
mutations	O
in	O
covR	O
/	O
S	O
resulting	O
in	O
truncation	O
of	O
CovS	O
.	O

This	O
finding	O
reveals	O
that	O
when	O
SpeB	O
-	O
negative	O
colonies	O
are	O
selected	O
for	O
in	O
vivo	O
,	O
this	O
selection	O
is	O
predominantly	O
a	O
phenomenon	O
associated	O
with	O
CovR	O
/	O
S	O
inactivation	O
.	O

The	O
ropB	O
mutation	O
of	O
strain	O
5628	B-Organism
was	O
not	O
recapitulated	O
on	O
passage	O
in	O
the	O
mouse	B-Organism
subcutaneous	O
infection	O
model	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

SpeB	O
is	O
the	O
principal	O
target	O
of	O
RopB	O
regulation	O
in	O
vivo	O

Microarray	O
analysis	O
was	O
performed	O
on	O
in	O
vivo	O
-	O
derived	O
RNA	O
from	O
the	O
well	O
characterized	O
GAS	B-Organism
strain	I-Organism
5448	I-Organism
and	O
its	O
derivative	O
5448R	B-Organism
-	I-Organism
,	O
containing	O
the	O
mutated	O
ropB	O
allele	O
from	O
5628	B-Organism
.	O

Fourty	O
-	O
seven	O
genes	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
and	O
52	O
genes	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
5448R	O
-	O
greater	O
than	O
2	O
-	O
fold	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
most	O
strongly	O
down	O
-	O
regulated	O
genes	O
in	O
5448R	B-Organism
-	I-Organism
are	O
members	O
of	O
the	O
SpeB	O
operon	O
,	O
as	O
would	O
be	O
expected	O
from	O
the	O
lack	O
of	O
SpeB	O
expression	O
and	O
activity	O
in	O
5628	B-Organism
(	O
Fig	O
.	O
3	O
)	O
.	O

In	O
addition	O
to	O
the	O
SpeB	O
operon	O
,	O
genes	O
of	O
the	O
streptolysin	O
S	O
operon	O
were	O
also	O
found	O
to	O
be	O
strongly	O
down	O
-	O
regulated	O
in	O
the	O
ropB	O
mutant	O
strain	O
.	O

Apart	O
from	O
the	O
gene	O
encoding	O
the	O
superantigen	O
SmeZ	O
,	O
there	O
was	O
an	O
absence	O
of	O
virulence	O
-	O
related	O
genes	O
found	O
to	O
be	O
strongly	O
up	O
-	O
regulated	O
in	O
the	O
strain	O
5448R	B-Organism
-	I-Organism
,	O
which	O
expressed	O
the	O
truncated	O
RopB	O
.	O

RopB	O
is	O
required	O
for	O
virulence	O
in	O
systemic	O
infection	O

To	O
determine	O
the	O
effect	O
of	O
ropB	O
mutation	O
on	O
virulence	O
,	O
C57BL6	B-Organism
/	I-Organism
J	I-Organism
mice	I-Organism
were	O
subjected	O
to	O
intraperitoneal	O
infection	O
with	O
mid	O
-	O
logarithmic	O
phase	O
bacteria	O
.	O

GAS	B-Organism
strain	I-Organism
5628R	I-Organism
+	I-Organism
expressing	O
a	O
full	O
length	O
RopB	O
showed	O
increased	O
virulence	O
compared	O
to	O
the	O
strain	O
5628	B-Organism
with	O
a	O
truncated	O
RopB	O
(	O
Figure	O
4A	O
)	O
.	O

Strain	O
5628RDeltaSpeB	O
containing	O
a	O
full	O
-	O
length	O
RopB	O
but	O
lacking	O
SpeB	O
also	O
showed	O
reduced	O
virulence	O
,	O
suggesting	O
that	O
the	O
reduced	O
virulence	O
of	O
5628	B-Organism
may	O
primarily	O
result	O
from	O
the	O
lack	O
of	O
SpeB	O
expression	O
in	O
this	O
strain	O
.	O

Virulence	O
was	O
also	O
examined	O
in	O
an	O
intravenous	O
model	O
of	O
systemic	O
infection	O
.	O

The	O
well	O
characterized	O
strain	O
5448	B-Organism
and	O
its	O
isogenic	O
mutant	O
5448R	B-Organism
-	I-Organism
,	O
containing	O
the	O
ropB	O
allele	O
from	O
5628	B-Organism
,	O
were	O
further	O
included	O
to	O
examine	O
the	O
effect	O
of	O
this	O
allelic	O
variation	O
in	O
a	O
well	O
-	O
characterized	O
virulent	O
strain	O
of	O
GAS	B-Organism
.	O

The	O
two	O
strains	O
containing	O
a	O
truncated	O
RopB	O
(	O
5628	B-Organism
and	O
5448R	B-Organism
-	I-Organism
)	O
demonstrated	O
similarly	O
reduced	O
virulence	O
compared	O
to	O
the	O
two	O
strains	O
containing	O
a	O
full	O
-	O
length	O
RopB	O
(	O
5628R	B-Organism
+	I-Organism
and	O
5448	B-Organism
)	O
(	O
Fig	O
.	O
4B	O
)	O
,	O
confirming	O
that	O
inactivation	O
of	O
RopB	O
results	O
in	O
decreased	O
virulence	O
in	O
systemic	O
infection	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

The	O
cumulative	O
contribution	O
of	O
the	O
secreted	O
cysteine	O
protease	O
SpeB	O
to	O
the	O
pathogenesis	O
of	O
invasive	O
GAS	B-Organism
infection	O
is	O
at	O
present	O
unclear	O
,	O
and	O
studies	O
in	O
various	O
GAS	B-Organism
serotypes	O
and	O
animal	O
models	O
have	O
produced	O
varying	O
results	O
[	O
19	O
]	O
-	O
[	O
21	O
]	O
.	O

In	O
the	O
globally	O
-	O
disseminated	O
clonal	O
M1T1	B-Organism
serotype	O
associated	O
with	O
epidemic	O
invasive	O
GAS	B-Organism
infection	O
,	O
an	O
inverse	O
relationship	O
has	O
been	O
found	O
between	O
SpeB	O
activity	O
and	O
clinical	O
disease	O
severity	O
[	O
8	O
]	O
.	O

Recently	O
,	O
we	O
and	O
others	O
have	O
found	O
a	O
connection	O
between	O
inactivation	O
of	O
SpeB	O
through	O
mutation	O
in	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
covR	O
/	O
S	O
and	O
development	O
of	O
invasive	O
disease	O
in	O
the	O
murine	B-Organism
model	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
investigated	O
a	O
second	O
mechanism	O
of	O
inactivation	O
of	O
SpeB	O
,	O
namely	O
through	O
truncation	O
of	O
the	O
regulator	O
RopB	O
.	O

We	O
have	O
shown	O
that	O
in	O
M1T1	B-Organism
GAS	I-Organism
,	O
when	O
the	O
covR	O
/	O
S	O
locus	O
is	O
intact	O
and	O
DNase	O
Sda1	O
activity	O
is	O
unaffected	O
,	O
ropB	O
point	O
mutation	O
results	O
in	O
reduced	O
virulence	O
in	O
vivo	O
,	O
despite	O
inactivation	O
of	O
SpeB	O
activity	O
.	O

The	O
SpeB	O
-	O
negative	O
,	O
serotype	O
M1T1	O
clinical	O
isolate	O
5628	O
was	O
used	O
to	O
investigate	O
the	O
role	O
of	O
RopB	O
in	O
virulence	O
.	O

RopB	O
has	O
previously	O
been	O
shown	O
to	O
be	O
necessary	O
for	O
SpeB	O
production	O
[	O
23	O
]	O
,	O
[	O
24	O
]	O
as	O
well	O
as	O
regulation	O
of	O
other	O
GAS	B-Organism
virulence	O
factors	O
[	O
25	O
]	O
-	O
[	O
29	O
]	O
.	O

The	O
M1T1	B-Organism
strain	I-Organism
5628	I-Organism
contains	O
a	O
point	O
mutation	O
in	O
the	O
ropB	O
gene	O
that	O
results	O
in	O
a	O
truncation	O
of	O
the	O
last	O
110	O
amino	O
acids	O
of	O
the	O
280	O
amino	O
acid	O
protein	O
.	O

Restoration	O
of	O
full	O
-	O
length	O
RopB	O
in	O
5628R	B-Organism
+	I-Organism
resulted	O
in	O
gaining	O
SpeB	O
expression	O
,	O
but	O
did	O
not	O
result	O
in	O
changes	O
in	O
hemolysis	O
,	O
DNase	O
activity	O
or	O
resistance	O
to	O
killing	O
by	O
neutrophils	O
.	O
<EOS>	B-X
In	B-X
cancer	B-X
,	B-X
tumour-associated	B-X
neutrophils	B-X
(	B-X
TANs	B-X
)	B-X
have	B-X
emerged	B-X
as	B-X
an	B-X
important	B-X
component	B-X
of	B-X
the	B-X
tumour	B-X
microenvironment	B-X
.	B-X
Conversely	B-X
,	B-X
neutrophils	B-X
can	B-X
also	B-X
mediate	B-X
antitumour	B-X
responses	B-X
by	B-X
direct	B-X
killing	B-X
of	B-X
tumour	B-X
cells	B-X
and	B-X
by	B-X
participating	B-X
in	B-X
cellular	B-X
networks	B-X
that	B-X
mediate	B-X
antitumour	B-X
resistance	B-X
.	B-X
We	B-X
surmise	B-X
that	B-X
neutrophils	B-X
can	B-X
provide	B-X
tools	B-X
to	B-X
tailor	B-X
current	B-X
immunotherapy	B-X
strategies	B-X
and	B-X
pave	B-X
the	B-X
way	B-X
to	B-X
myeloid	B-X
cell-centred	B-X
therapeutic	B-X
strategies	B-X
,	B-X
which	B-X
would	B-X
be	B-X
complementary	B-X
to	B-X
current	B-X
approaches	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
human	B-X
,	B-X
but	B-X
not	B-X
murine	B-X
,	B-X
neutrophils	B-X
release	B-X
catalytically	B-X
active	B-X
neutrophil	B-X
elastase	B-X
(	B-X
ELANE	B-X
)	B-X
to	B-X
kill	B-X
many	B-X
cancer	B-X
cell	B-X
types	B-X
while	B-X
sparing	B-X
non-cancer	B-X
cells	B-X
.	B-X

RopB	O
mutation	O
in	O
this	O
particular	O
strain	O
does	O
not	O
result	O
in	O
the	O
kind	O
of	O
global	O
phenotypic	O
change	O
found	O
with	O
covR	O
/	O
S	O
mutation	O
where	O
differential	O
expression	O
was	O
observed	O
of	O
multiple	O
genes	O
encoding	O
virulence	O
determinants	O
,	O
including	O
sic	O
,	O
ska	O
,	O
slo	O
,	O
speA	O
,	O
speJ	O
,	O
scpC	O
and	O
the	O
hyaluronic	O
acid	O
synthesis	O
operon	O
[	O
37	O
]	O
which	O
were	O
all	O
unaffected	O
in	O
the	O
ropB	O
mutant	O
examined	O
in	O
this	O
work	O
.	O

Recently	O
,	O
we	O
have	O
demonstrated	O
that	O
WT	O
,	O
SpeB	O
-	O
positive	O
bacteria	O
undergo	O
a	O
phase	O
-	O
shift	O
to	O
a	O
SpeB	O
-	O
negative	O
phenotype	O
after	O
subcutaneous	O
infection	O
of	O
mice	B-Organism
[	O
17	O
]	O
.	O

This	O
phase	O
switch	O
was	O
observed	O
to	O
be	O
the	O
result	O
of	O
mutations	O
in	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
covR	O
/	O
S	O
[	O
38	O
]	O
.	O

CovR	O
/	O
S	O
is	O
a	O
global	O
regulator	O
,	O
whose	O
inactivation	O
is	O
linked	O
to	O
an	O
invasive	O
phenotype	O
and	O
involves	O
up	O
-	O
regulation	O
of	O
many	O
genes	O
encoding	O
virulence	O
factors	O
such	O
as	O
streptodornase	O
,	O
streptokinase	O
,	O
streptolysin	O
O	O
,	O
streptococcal	O
inhibitor	O
of	O
complement	O
and	O
the	O
hyaluronic	O
acid	O
capsule	O
synthesis	O
operon	O
[	O
37	O
]	O
.	O

Of	O
the	O
down	O
-	O
regulated	O
genes	O
in	O
CovR	O
/	O
S	O
mutant	O
strains	O
,	O
SpeB	O
would	O
appear	O
to	O
be	O
one	O
of	O
the	O
most	O
important	O
due	O
to	O
its	O
ability	O
to	O
degrade	O
many	O
host	O
and	O
self	O
-	O
proteins	O
.	O

It	O
is	O
the	O
loss	O
of	O
SpeB	O
expression	O
in	O
these	O
mutant	O
bacteria	O
that	O
is	O
hypothesized	O
to	O
allow	O
the	O
invasive	O
spread	O
of	O
GAS	B-Organism
by	O
sparing	O
from	O
SpeB	O
degradation	O
self	O
-	O
proteins	O
involved	O
in	O
plasminogen	O
accumulation	O
and	O
activation	O
[	O
42	O
]	O
.	O

In	O
this	O
study	O
we	O
found	O
that	O
SpeB	O
-	O
positive	O
bacteria	O
with	O
a	O
restored	O
RopB	O
reverted	O
to	O
a	O
SpeB	O
-	O
negative	O
phenotype	O
on	O
subcutaneous	O
infection	O
.	O

Furthermore	O
,	O
the	O
switch	O
to	O
a	O
SpeB	O
-	O
negative	O
phenotype	O
appeared	O
to	O
occur	O
exclusively	O
through	O
mutations	O
in	O
covR	O
/	O
S	O
.	O

This	O
result	O
suggests	O
that	O
covR	O
/	O
S	O
mutations	O
are	O
the	O
predominant	O
method	O
of	O
phenotypic	O
switching	O
in	O
GAS	B-Organism
and	O
that	O
ropB	O
mutation	O
is	O
not	O
readily	O
selected	O
for	O
in	O
vivo	O
.	O

This	O
leads	O
to	O
the	O
conclusion	O
that	O
ropB	O
mutation	O
in	O
5628	B-Organism
does	O
not	O
represent	O
a	O
similar	O
mechanism	O
to	O
covR	O
/	O
S	O
mutation	O
and	O
may	O
(	O
a	O
)	O
be	O
an	O
incidental	O
occurrence	O
or	O
(	O
b	O
)	O
arise	O
secondary	O
to	O
different	O
selection	O
pressures	O
than	O
those	O
associated	O
with	O
the	O
shift	O
to	O
invasive	O
infection	O
.	O

Microarray	O
analysis	O
was	O
conducted	O
using	O
in	O
vivo	O
-	O
derived	O
RNA	O
,	O
since	O
the	O
transcriptome	O
of	O
bacteria	O
grown	O
in	O
vitro	O
may	O
differ	O
greatly	O
from	O
the	O
transcriptome	O
found	O
during	O
the	O
course	O
of	O
infection	O
.	O

Implantation	O
of	O
tissue	O
cages	O
allows	O
for	O
bacteria	O
to	O
be	O
grown	O
in	O
an	O
in	O
vivo	O
environment	O
for	O
24	O
hours	O
prior	O
to	O
recovery	O
and	O
RNA	O
extraction	O
.	O

The	O
microarray	O
data	O
showed	O
members	O
of	O
the	O
SpeB	O
operon	O
to	O
be	O
the	O
most	O
strongly	O
down	O
-	O
regulated	O
genes	O
following	O
inactivation	O
of	O
RopB	O
.	O

This	O
finding	O
supported	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
that	O
suggested	O
SpeB	O
is	O
the	O
main	O
target	O
of	O
RopB	O
regulation	O
in	O
this	O
strain	O
.	O

Virulence	O
studies	O
utilizing	O
systemic	O
models	O
of	O
infection	O
showed	O
that	O
a	O
full	O
-	O
length	O
RopB	O
was	O
required	O
for	O
virulence	O
.	O

The	O
clinical	O
isolate	O
5628	B-Organism
expressing	O
a	O
truncated	O
RopB	O
,	O
as	O
well	O
as	O
the	O
allelic	O
exchange	O
mutant	O
5448R	B-Organism
-	I-Organism
also	O
expressing	O
the	O
truncated	O
RopB	O
from	O
5628	B-Organism
,	O
showed	O
reduced	O
virulence	O
compared	O
to	O
strains	O
containing	O
a	O
full	O
-	O
length	O
RopB	O
.	O

These	O
data	O
illustrate	O
the	O
necessity	O
for	O
an	O
intact	O
RopB	O
for	O
full	O
virulence	O
in	O
vivo	O
.	O

In	O
addition	O
,	O
the	O
strain	O
5628RDeltaSpeB	O
expressing	O
an	O
intact	O
RopB	O
but	O
lacking	O
SpeB	O
showed	O
similarly	O
reduced	O
virulence	O
to	O
the	O
strain	O
with	O
a	O
truncated	O
RopB	O
.	O

While	O
the	O
down	O
-	O
regulation	O
of	O
the	O
streptolysin	O
S	O
operon	O
may	O
contribute	O
to	O
the	O
reduced	O
virulence	O
,	O
this	O
finding	O
implies	O
that	O
the	O
loss	O
of	O
SpeB	O
in	O
this	O
strain	O
is	O
the	O
main	O
cause	O
of	O
the	O
lack	O
of	O
virulence	O
exhibited	O
.	O

This	O
finding	O
leads	O
to	O
the	O
conclusion	O
that	O
inactivation	O
of	O
SpeB	O
alone	O
is	O
not	O
sufficient	O
to	O
initiate	O
invasive	O
disease	O
.	O

Moreover	O
,	O
these	O
data	O
suggest	O
that	O
SpeB	O
loss	O
,	O
only	O
in	O
the	O
context	O
of	O
mutation	O
of	O
the	O
covR	O
/	O
S	O
regulatory	O
circuit	O
,	O
promotes	O
invasion	O
.	O

Of	O
note	O
,	O
the	O
additional	O
virulence	O
factors	O
streptokinase	O
and	O
M1	O
protein	O
,	O
are	O
both	O
up	O
-	O
regulated	O
in	O
covR	O
/	O
S	O
mutant	O
M1T1	O
strains	O
[	O
37	O
]	O
,	O
but	O
not	O
in	O
the	O
ropB	O
mutant	O
under	O
investigation	O
in	O
this	O
study	O
.	O

Streptokinase	O
and	O
M1	O
protein	O
are	O
believed	O
to	O
play	O
a	O
role	O
in	O
the	O
accumulation	O
of	O
host	O
plasmin	O
at	O
the	O
GAS	B-Organism
cell	O
surface	O
,	O
a	O
process	O
which	O
is	O
thought	O
to	O
accentuate	O
invasive	O
disease	O
[	O
5	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

Together	O
these	O
data	O
provide	O
evidence	O
of	O
RopB	O
'	O
s	O
role	O
in	O
virulence	O
.	O

In	O
M1T1	B-Organism
GAS	I-Organism
,	O
an	O
intact	O
RopB	O
and	O
efficient	O
SpeB	O
production	O
are	O
necessary	O
for	O
systemic	O
infection	O
.	O
<EOS>	B-X
Epidemiological	B-X
studies	B-X
of	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
)	B-X
have	B-X
noted	B-X
an	B-X
inverse	B-X
relationship	B-X
between	B-X
SpeB	B-X
expression	B-X
and	B-X
invasive	B-X
disease	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
SpeB	B-X
in	B-X
the	B-X
course	B-X
of	B-X
infection	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
utilize	B-X
a	B-X
SpeB-negative	B-X
M1T1	B-X
clinical	B-X
isolate	B-X
,	B-X
5628	B-X
,	B-X
with	B-X
a	B-X
naturally	B-X
occurring	B-X
mutation	B-X
in	B-X
the	B-X
gene	B-X
encoding	B-X
the	B-X
regulator	B-X
RopB	B-X
,	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
RopB	B-X
and	B-X
SpeB	B-X
in	B-X
systemic	B-X
virulence	B-X
.	B-X
Allelic	B-X
exchange	B-X
mutagenesis	B-X
was	B-X
used	B-X
to	B-X
replace	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
in	B-X
5628	B-X
with	B-X
the	B-X
intact	B-X
allele	B-X
from	B-X
the	B-X
well	B-X
characterized	B-X
isolate	B-X
5448	B-X
.	B-X
The	B-X
inverse	B-X
allelic	B-X
exchange	B-X
was	B-X
also	B-X
performed	B-X
to	B-X
replace	B-X
the	B-X
intact	B-X
ropB	B-X
in	B-X
5448	B-X
with	B-X
the	B-X
mutated	B-X
allele	B-X
from	B-X
5628	B-X
.	B-X
An	B-X
intact	B-X
ropB	B-X
was	B-X
found	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
SpeB	B-X
expression	B-X
.	B-X
While	B-X
the	B-X
ropB	B-X
mutation	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
no	B-X
effect	B-X
on	B-X
hemolysis	B-X
of	B-X
RBC	B-X
's	B-X
,	B-X
extracellular	B-X
DNase	B-X
activity	B-X
or	B-X
survival	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
neutrophils	B-X
,	B-X
strains	B-X
with	B-X
the	B-X
mutated	B-X
ropB	B-X
allele	B-X
were	B-X
less	B-X
virulent	B-X
in	B-X
murine	B-X
systemic	B-X
models	B-X
of	B-X
infection	B-X
.	B-X
An	B-X
isogenic	B-X
SpeB	B-X
knockout	B-X
strain	B-X
containing	B-X
an	B-X
intact	B-X
RopB	B-X
showed	B-X
similarly	B-X
reduced	B-X
virulence	B-X
.	B-X
Microarray	B-X
analysis	B-X
found	B-X
genes	B-X
of	B-X
the	B-X
SpeB	B-X
operon	B-X
to	B-X
be	B-X
the	B-X
primary	B-X
target	B-X
of	B-X
RopB	B-X
regulation	B-X
.	B-X
These	B-X
data	B-X
show	B-X
that	B-X
an	B-X
intact	B-X
RopB	B-X
and	B-X
efficient	B-X
SpeB	B-X
production	B-X
are	B-X
necessary	B-X
for	B-X
systemic	B-X
infection	B-X
with	B-X
GAS	B-X
.	B-X

Global	O
Systems	O
-	O
Level	O
Analysis	O
of	O
Hfq	O
and	O
SmpB	O
Deletion	O
Mutants	O
in	O
Salmonella	B-Organism
:	O
Implications	O
for	O
Virulence	O
and	O
Global	O
Protein	O
Translation	O
<EOS>	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
A	B-X
mutation	B-X
in	B-X
any	B-X
one	B-X
of	B-X
these	B-X
three	B-X
genes	B-X
,	B-X
csrA	B-X
,	B-X
hfq	B-X
,	B-X
and	B-X
smpB	B-X
,	B-X
in	B-X
Salmonella	B-X
is	B-X
attenuated	B-X
for	B-X
mouse	B-X
virulence	B-X
and	B-X
unable	B-X
to	B-X
survive	B-X
in	B-X
macrophages	B-X
.	B-X
However	B-X
,	B-X
the	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
and	B-X
SmpB	B-X
are	B-X
not	B-X
as	B-X
clearly	B-X
defined	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

Using	O
sample	O
-	O
matched	O
transcriptomics	O
and	O
proteomics	O
measurements	O
it	O
is	O
now	O
possible	O
to	O
begin	O
to	O
understand	O
the	O
impact	O
of	O
post	O
-	O
transcriptional	O
regulatory	O
programs	O
in	O
Enterobacteria	B-Organism
.	O
<EOS>	B-X
Using	B-X
sample-matched	B-X
transcriptomics	B-X
and	B-X
proteomics	B-X
measurements	B-X
it	B-X
is	B-X
now	B-X
possible	B-X
to	B-X
begin	B-X
to	B-X
understand	B-X
the	B-X
impact	B-X
of	B-X
post-transcriptional	B-X
regulatory	B-X
programs	B-X
in	B-X
Enterobacteria	B-X
.	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
From	B-X
these	B-X
same	B-X
samples	B-X
we	B-X
also	B-X
prepared	B-X
RNA	B-X
for	B-X
microarray	B-X
analysis	B-X
to	B-X
determine	B-X
if	B-X
alteration	B-X
of	B-X
protein	B-X
expression	B-X
was	B-X
mediated	B-X
post-transcriptionally	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

In	O
bacteria	O
post	O
-	O
transcriptional	O
regulation	O
is	O
mediated	O
by	O
relatively	O
few	O
identified	O
RNA	O
-	O
binding	O
protein	O
factors	O
including	O
CsrA	O
,	O
Hfq	O
and	O
SmpB	O
.	O
<EOS>	B-X
Using	B-X
sample-matched	B-X
transcriptomics	B-X
and	B-X
proteomics	B-X
measurements	B-X
it	B-X
is	B-X
now	B-X
possible	B-X
to	B-X
begin	B-X
to	B-X
understand	B-X
the	B-X
impact	B-X
of	B-X
post-transcriptional	B-X
regulatory	B-X
programs	B-X
in	B-X
Enterobacteria	B-X
.	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
CsrA	B-X
has	B-X
a	B-X
clearly	B-X
defined	B-X
specificity	B-X
based	B-X
on	B-X
binding	B-X
to	B-X
a	B-X
specific	B-X
mRNA	B-X
sequence	B-X
to	B-X
inhibit	B-X
translation	B-X
.	B-X
However	B-X
,	B-X
the	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
and	B-X
SmpB	B-X
are	B-X
not	B-X
as	B-X
clearly	B-X
defined	B-X
.	B-X
Previous	B-X
work	B-X
identified	B-X
proteins	B-X
regulated	B-X
by	B-X
hfq	B-X
using	B-X
purification	B-X
of	B-X
the	B-X
RNA-protein	B-X
complex	B-X
with	B-X
direct	B-X
sequencing	B-X
of	B-X
the	B-X
bound	B-X
RNAs	B-X
and	B-X
found	B-X
binding	B-X
to	B-X
a	B-X
surprisingly	B-X
large	B-X
number	B-X
of	B-X
transcripts	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
From	B-X
these	B-X
same	B-X
samples	B-X
we	B-X
also	B-X
prepared	B-X
RNA	B-X
for	B-X
microarray	B-X
analysis	B-X
to	B-X
determine	B-X
if	B-X
alteration	B-X
of	B-X
protein	B-X
expression	B-X
was	B-X
mediated	B-X
post-transcriptionally	B-X
.	B-X
Samples	B-X
were	B-X
analyzed	B-X
from	B-X
bacteria	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
conditions	B-X
;	B-X
two	B-X
laboratory	B-X
conditions	B-X
and	B-X
two	B-X
that	B-X
are	B-X
thought	B-X
to	B-X
mimic	B-X
the	B-X
intracellular	B-X
environment	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

A	O
mutation	O
in	O
any	O
one	O
of	O
these	O
three	O
genes	O
,	O
csrA	O
,	O
hfq	O
,	O
and	O
smpB	O
,	O
in	O
Salmonella	B-Organism
is	O
attenuated	O
for	O
mouse	B-Organism
virulence	O
and	O
unable	O
to	O
survive	O
in	O
macrophages	O
.	O
<EOS>	B-X
A	B-X
mutation	B-X
in	B-X
any	B-X
one	B-X
of	B-X
these	B-X
three	B-X
genes	B-X
,	B-X
csrA	B-X
,	B-X
hfq	B-X
,	B-X
and	B-X
smpB	B-X
,	B-X
in	B-X
Salmonella	B-X
is	B-X
attenuated	B-X
for	B-X
mouse	B-X
virulence	B-X
and	B-X
unable	B-X
to	B-X
survive	B-X
in	B-X
macrophages	B-X
.	B-X
Previous	B-X
work	B-X
identified	B-X
proteins	B-X
regulated	B-X
by	B-X
hfq	B-X
using	B-X
purification	B-X
of	B-X
the	B-X
RNA-protein	B-X
complex	B-X
with	B-X
direct	B-X
sequencing	B-X
of	B-X
the	B-X
bound	B-X
RNAs	B-X
and	B-X
found	B-X
binding	B-X
to	B-X
a	B-X
surprisingly	B-X
large	B-X
number	B-X
of	B-X
transcripts	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

CsrA	O
has	O
a	O
clearly	O
defined	O
specificity	O
based	O
on	O
binding	O
to	O
a	O
specific	O
mRNA	O
sequence	O
to	O
inhibit	O
translation	O
.	O

However	O
,	O
the	O
proteins	O
regulated	O
by	O
Hfq	O
and	O
SmpB	O
are	O
not	O
as	O
clearly	O
defined	O
.	O
<EOS>	B-X
In	B-X
bacterial	B-X
cells	B-X
we	B-X
find	B-X
a	B-X
variety	B-X
of	B-X
interacting	B-X
macromolecules	B-X
,	B-X
among	B-X
them	B-X
RNAs	B-X
and	B-X
proteins	B-X
.	B-X
Not	B-X
only	B-X
small	B-X
regulatory	B-X
RNAs	B-X
(	B-X
sRNAs	B-X
)	B-X
,	B-X
but	B-X
also	B-X
small	B-X
proteins	B-X
have	B-X
been	B-X
increasingly	B-X
recognized	B-X
as	B-X
regulators	B-X
of	B-X
bacterial	B-X
gene	B-X
expression	B-X
.	B-X
An	B-X
average	B-X
bacterial	B-X
genome	B-X
encodes	B-X
between	B-X
200	B-X
and	B-X
300	B-X
sRNAs	B-X
,	B-X
but	B-X
an	B-X
unknown	B-X
number	B-X
of	B-X
small	B-X
proteins	B-X
.	B-X

Previous	O
work	O
identified	O
proteins	O
regulated	O
by	O
hfq	O
using	O
purification	O
of	O
the	O
RNA	O
-	O
protein	O
complex	O
with	O
direct	O
sequencing	O
of	O
the	O
bound	O
RNAs	O
and	O
found	O
binding	O
to	O
a	O
surprisingly	O
large	O
number	O
of	O
transcripts	O
.	O
<EOS>	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
A	B-X
mutation	B-X
in	B-X
any	B-X
one	B-X
of	B-X
these	B-X
three	B-X
genes	B-X
,	B-X
csrA	B-X
,	B-X
hfq	B-X
,	B-X
and	B-X
smpB	B-X
,	B-X
in	B-X
Salmonella	B-X
is	B-X
attenuated	B-X
for	B-X
mouse	B-X
virulence	B-X
and	B-X
unable	B-X
to	B-X
survive	B-X
in	B-X
macrophages	B-X
.	B-X
CsrA	B-X
has	B-X
a	B-X
clearly	B-X
defined	B-X
specificity	B-X
based	B-X
on	B-X
binding	B-X
to	B-X
a	B-X
specific	B-X
mRNA	B-X
sequence	B-X
to	B-X
inhibit	B-X
translation	B-X
.	B-X
However	B-X
,	B-X
the	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
and	B-X
SmpB	B-X
are	B-X
not	B-X
as	B-X
clearly	B-X
defined	B-X
.	B-X
Previous	B-X
work	B-X
identified	B-X
proteins	B-X
regulated	B-X
by	B-X
hfq	B-X
using	B-X
purification	B-X
of	B-X
the	B-X
RNA-protein	B-X
complex	B-X
with	B-X
direct	B-X
sequencing	B-X
of	B-X
the	B-X
bound	B-X
RNAs	B-X
and	B-X
found	B-X
binding	B-X
to	B-X
a	B-X
surprisingly	B-X
large	B-X
number	B-X
of	B-X
transcripts	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
From	B-X
these	B-X
same	B-X
samples	B-X
we	B-X
also	B-X
prepared	B-X
RNA	B-X
for	B-X
microarray	B-X
analysis	B-X
to	B-X
determine	B-X
if	B-X
alteration	B-X
of	B-X
protein	B-X
expression	B-X
was	B-X
mediated	B-X
post-transcriptionally	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X

In	O
this	O
report	O
we	O
have	O
used	O
global	O
proteomics	O
to	O
directly	O
identify	O
proteins	O
regulated	O
by	O
Hfq	O
or	O
SmpB	O
by	O
comparing	O
protein	O
abundance	O
in	O
the	O
parent	O
and	O
isogenic	O
hfq	O
or	O
smpB	O
mutant	O
.	O
<EOS>	B-X
SmpB	B-X
(	B-X
small	B-X
protein	B-X
B	B-X
)	B-X
and	B-X
SsrA	B-X
(	B-X
small	B-X
stable	B-X
RNA	B-X
A	B-X
)	B-X
are	B-X
components	B-X
of	B-X
a	B-X
unique	B-X
bacterial	B-X
translational	B-X
control	B-X
system	B-X
that	B-X
help	B-X
maintain	B-X
the	B-X
bacterial	B-X
translational	B-X
machinery	B-X
in	B-X
a	B-X
fully	B-X
operational	B-X
state	B-X
.	B-X
We	B-X
have	B-X
found	B-X
that	B-X
loss	B-X
of	B-X
the	B-X
SmpB-SsrA	B-X
function	B-X
causes	B-X
acute	B-X
defects	B-X
in	B-X
the	B-X
ability	B-X
of	B-X
Yersinia	B-X
pseudotuberculosis	B-X
to	B-X
survive	B-X
in	B-X
hostile	B-X
environments	B-X
.	B-X
Most	B-X
significantly	B-X
,	B-X
we	B-X
show	B-X
that	B-X
mutations	B-X
in	B-X
smpB-ssrA	B-X
genes	B-X
render	B-X
the	B-X
bacterium	B-X
avirulent	B-X
and	B-X
unable	B-X
to	B-X
cause	B-X
mortality	B-X
in	B-X
mice	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
observations	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
mutant	B-X
strain	B-X
is	B-X
unable	B-X
to	B-X
proliferate	B-X
in	B-X
macrophages	B-X
and	B-X
exhibits	B-X
delayed	B-X
Yop-mediated	B-X
host	B-X
cell	B-X
cytotoxicity	B-X
.	B-X
Correspondingly	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
smpB-ssrA	B-X
mutant	B-X
suffers	B-X
severe	B-X
deficiencies	B-X
in	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
Yersinia	B-X
virulence	B-X
effector	B-X
proteins	B-X
,	B-X
and	B-X
that	B-X
this	B-X
defect	B-X
is	B-X
at	B-X
the	B-X
level	B-X
of	B-X
transcription	B-X
.	B-X
Of	B-X
further	B-X
interest	B-X
is	B-X
the	B-X
finding	B-X
that	B-X
the	B-X
SmpB-SsrA	B-X
system	B-X
might	B-X
play	B-X
a	B-X
similar	B-X
role	B-X
in	B-X
the	B-X
related	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
that	B-X
governs	B-X
flagella	B-X
assembly	B-X
and	B-X
bacterial	B-X
motility	B-X
.	B-X
These	B-X
findings	B-X
highlight	B-X
the	B-X
significance	B-X
of	B-X
the	B-X
SmpB-SsrA	B-X
system	B-X
in	B-X
bacterial	B-X
pathogenesis	B-X
,	B-X
survival	B-X
under	B-X
adverse	B-X
environmental	B-X
conditions	B-X
,	B-X
and	B-X
motility	B-X
.	B-X

From	O
these	O
same	O
samples	O
we	O
also	O
prepared	O
RNA	O
for	O
microarray	O
analysis	O
to	O
determine	O
if	O
alteration	O
of	O
protein	O
expression	O
was	O
mediated	O
post	O
-	O
transcriptionally	O
.	O
<EOS>	B-X
Using	B-X
sample-matched	B-X
transcriptomics	B-X
and	B-X
proteomics	B-X
measurements	B-X
it	B-X
is	B-X
now	B-X
possible	B-X
to	B-X
begin	B-X
to	B-X
understand	B-X
the	B-X
impact	B-X
of	B-X
post-transcriptional	B-X
regulatory	B-X
programs	B-X
in	B-X
Enterobacteria	B-X
.	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
CsrA	B-X
has	B-X
a	B-X
clearly	B-X
defined	B-X
specificity	B-X
based	B-X
on	B-X
binding	B-X
to	B-X
a	B-X
specific	B-X
mRNA	B-X
sequence	B-X
to	B-X
inhibit	B-X
translation	B-X
.	B-X
However	B-X
,	B-X
the	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
and	B-X
SmpB	B-X
are	B-X
not	B-X
as	B-X
clearly	B-X
defined	B-X
.	B-X
Previous	B-X
work	B-X
identified	B-X
proteins	B-X
regulated	B-X
by	B-X
hfq	B-X
using	B-X
purification	B-X
of	B-X
the	B-X
RNA-protein	B-X
complex	B-X
with	B-X
direct	B-X
sequencing	B-X
of	B-X
the	B-X
bound	B-X
RNAs	B-X
and	B-X
found	B-X
binding	B-X
to	B-X
a	B-X
surprisingly	B-X
large	B-X
number	B-X
of	B-X
transcripts	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
From	B-X
these	B-X
same	B-X
samples	B-X
we	B-X
also	B-X
prepared	B-X
RNA	B-X
for	B-X
microarray	B-X
analysis	B-X
to	B-X
determine	B-X
if	B-X
alteration	B-X
of	B-X
protein	B-X
expression	B-X
was	B-X
mediated	B-X
post-transcriptionally	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

Samples	O
were	O
analyzed	O
from	O
bacteria	O
grown	O
under	O
four	O
different	O
conditions	O
;	O
two	O
laboratory	O
conditions	O
and	O
two	O
that	O
are	O
thought	O
to	O
mimic	O
the	O
intracellular	O
environment	O
.	O
<EOS>	B-X
For	B-X
this	B-X
purpose	B-X
,	B-X
the	B-X
three	B-X
grass	B-X
species	B-X
Lolium	B-X
perenne	B-X
,	B-X
Festulolium	B-X
pabulare	B-X
and	B-X
Festulolium	B-X
braunii	B-X
were	B-X
cultivated	B-X
and	B-X
sampled	B-X
during	B-X
four	B-X
months	B-X
,	B-X
from	B-X
June	B-X
to	B-X
September	B-X
.	B-X
The	B-X
same	B-X
species	B-X
were	B-X
also	B-X
grown	B-X
under	B-X
controlled	B-X
conditions	B-X
.	B-X
Data	B-X
were	B-X
statistically	B-X
processed	B-X
and	B-X
analyzed	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
fungicide	B-X
treatments	B-X
applied	B-X
under	B-X
field	B-X
conditions	B-X
on	B-X
the	B-X
content	B-X
of	B-X
the	B-X
evaluated	B-X
thiols	B-X
was	B-X
shown	B-X
to	B-X
be	B-X
insignificant	B-X
.	B-X
F.	B-X
pabulare	B-X
,	B-X
an	B-X
intergeneric	B-X
hybrid	B-X
of	B-X
drought-	B-X
and	B-X
fungi-resistant	B-X
Festuca	B-X
arundinacea	B-X
,	B-X
was	B-X
comparable	B-X
in	B-X
PC3	B-X
content	B-X
with	B-X
L.	B-X
perenne	B-X
and	B-X
F.	B-X
braunii	B-X
under	B-X
field	B-X
conditions	B-X
.	B-X
Under	B-X
controlled	B-X
conditions	B-X
,	B-X
however	B-X
,	B-X
F.	B-X
pabulare	B-X
had	B-X
higher	B-X
(	B-X
p	B-X
<	B-X
0.05	B-X
)	B-X
PC3	B-X
content	B-X
than	B-X
did	B-X
L.	B-X
perenne	B-X
and	B-X
F.	B-X
braunii	B-X
.	B-X
Under	B-X
field	B-X
conditions	B-X
,	B-X
differences	B-X
between	B-X
the	B-X
evaluated	B-X
species	B-X
were	B-X
recorded	B-X
only	B-X
in	B-X
GSSG	B-X
content	B-X
,	B-X
but	B-X
only	B-X
sampling	B-X
in	B-X
June	B-X
was	B-X
significant	B-X
.	B-X

We	O
show	O
that	O
mutants	O
of	O
hfq	O
and	O
smpB	O
directly	O
or	O
indirectly	O
modulate	O
at	O
least	O
20	O
%	O
and	O
4	O
%	O
of	O
all	O
possible	O
Salmonella	B-Organism
proteins	O
,	O
respectively	O
,	O
with	O
limited	O
correlation	O
between	O
transcription	O
and	O
protein	O
expression	O
.	O
<EOS>	B-X
Using	B-X
sample-matched	B-X
transcriptomics	B-X
and	B-X
proteomics	B-X
measurements	B-X
it	B-X
is	B-X
now	B-X
possible	B-X
to	B-X
begin	B-X
to	B-X
understand	B-X
the	B-X
impact	B-X
of	B-X
post-transcriptional	B-X
regulatory	B-X
programs	B-X
in	B-X
Enterobacteria	B-X
.	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
A	B-X
mutation	B-X
in	B-X
any	B-X
one	B-X
of	B-X
these	B-X
three	B-X
genes	B-X
,	B-X
csrA	B-X
,	B-X
hfq	B-X
,	B-X
and	B-X
smpB	B-X
,	B-X
in	B-X
Salmonella	B-X
is	B-X
attenuated	B-X
for	B-X
mouse	B-X
virulence	B-X
and	B-X
unable	B-X
to	B-X
survive	B-X
in	B-X
macrophages	B-X
.	B-X
However	B-X
,	B-X
the	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
and	B-X
SmpB	B-X
are	B-X
not	B-X
as	B-X
clearly	B-X
defined	B-X
.	B-X
Previous	B-X
work	B-X
identified	B-X
proteins	B-X
regulated	B-X
by	B-X
hfq	B-X
using	B-X
purification	B-X
of	B-X
the	B-X
RNA-protein	B-X
complex	B-X
with	B-X
direct	B-X
sequencing	B-X
of	B-X
the	B-X
bound	B-X
RNAs	B-X
and	B-X
found	B-X
binding	B-X
to	B-X
a	B-X
surprisingly	B-X
large	B-X
number	B-X
of	B-X
transcripts	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
From	B-X
these	B-X
same	B-X
samples	B-X
we	B-X
also	B-X
prepared	B-X
RNA	B-X
for	B-X
microarray	B-X
analysis	B-X
to	B-X
determine	B-X
if	B-X
alteration	B-X
of	B-X
protein	B-X
expression	B-X
was	B-X
mediated	B-X
post-transcriptionally	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

These	O
proteins	O
represent	O
a	O
broad	O
spectrum	O
of	O
Salmonella	B-Organism
proteins	O
required	O
for	O
many	O
biological	O
processes	O
including	O
host	O
cell	O
invasion	O
,	O
motility	O
,	O
central	O
metabolism	O
,	O
LPS	O
biosynthesis	O
,	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
and	O
fatty	O
acid	O
metabolism	O
.	O
<EOS>	B-X
Using	B-X
sample-matched	B-X
transcriptomics	B-X
and	B-X
proteomics	B-X
measurements	B-X
it	B-X
is	B-X
now	B-X
possible	B-X
to	B-X
begin	B-X
to	B-X
understand	B-X
the	B-X
impact	B-X
of	B-X
post-transcriptional	B-X
regulatory	B-X
programs	B-X
in	B-X
Enterobacteria	B-X
.	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
A	B-X
mutation	B-X
in	B-X
any	B-X
one	B-X
of	B-X
these	B-X
three	B-X
genes	B-X
,	B-X
csrA	B-X
,	B-X
hfq	B-X
,	B-X
and	B-X
smpB	B-X
,	B-X
in	B-X
Salmonella	B-X
is	B-X
attenuated	B-X
for	B-X
mouse	B-X
virulence	B-X
and	B-X
unable	B-X
to	B-X
survive	B-X
in	B-X
macrophages	B-X
.	B-X
However	B-X
,	B-X
the	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
and	B-X
SmpB	B-X
are	B-X
not	B-X
as	B-X
clearly	B-X
defined	B-X
.	B-X
Previous	B-X
work	B-X
identified	B-X
proteins	B-X
regulated	B-X
by	B-X
hfq	B-X
using	B-X
purification	B-X
of	B-X
the	B-X
RNA-protein	B-X
complex	B-X
with	B-X
direct	B-X
sequencing	B-X
of	B-X
the	B-X
bound	B-X
RNAs	B-X
and	B-X
found	B-X
binding	B-X
to	B-X
a	B-X
surprisingly	B-X
large	B-X
number	B-X
of	B-X
transcripts	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
Samples	B-X
were	B-X
analyzed	B-X
from	B-X
bacteria	B-X
grown	B-X
under	B-X
four	B-X
different	B-X
conditions	B-X
;	B-X
two	B-X
laboratory	B-X
conditions	B-X
and	B-X
two	B-X
that	B-X
are	B-X
thought	B-X
to	B-X
mimic	B-X
the	B-X
intracellular	B-X
environment	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

Our	O
results	O
represent	O
one	O
of	O
the	O
first	O
global	O
analyses	O
of	O
post	O
-	O
transcriptional	O
regulons	O
in	O
any	O
organism	O
and	O
suggest	O
that	O
regulation	O
at	O
the	O
translational	O
level	O
is	O
widespread	O
and	O
plays	O
an	O
important	O
role	O
in	O
virulence	O
regulation	O
and	O
environmental	O
adaptation	O
for	O
Salmonella	B-Organism
.	O
<EOS>	B-X
Using	B-X
sample-matched	B-X
transcriptomics	B-X
and	B-X
proteomics	B-X
measurements	B-X
it	B-X
is	B-X
now	B-X
possible	B-X
to	B-X
begin	B-X
to	B-X
understand	B-X
the	B-X
impact	B-X
of	B-X
post-transcriptional	B-X
regulatory	B-X
programs	B-X
in	B-X
Enterobacteria	B-X
.	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
A	B-X
mutation	B-X
in	B-X
any	B-X
one	B-X
of	B-X
these	B-X
three	B-X
genes	B-X
,	B-X
csrA	B-X
,	B-X
hfq	B-X
,	B-X
and	B-X
smpB	B-X
,	B-X
in	B-X
Salmonella	B-X
is	B-X
attenuated	B-X
for	B-X
mouse	B-X
virulence	B-X
and	B-X
unable	B-X
to	B-X
survive	B-X
in	B-X
macrophages	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
From	B-X
these	B-X
same	B-X
samples	B-X
we	B-X
also	B-X
prepared	B-X
RNA	B-X
for	B-X
microarray	B-X
analysis	B-X
to	B-X
determine	B-X
if	B-X
alteration	B-X
of	B-X
protein	B-X
expression	B-X
was	B-X
mediated	B-X
post-transcriptionally	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

Introduction	O

Post	O
-	O
transcriptional	O
regulation	O
of	O
gene	O
expression	O
by	O
small	O
noncoding	O
RNAs	O
(	O
sRNAs	O
)	O
is	O
widespread	O
in	O
both	O
prokaryotes	O
and	O
eukaryotes	O
and	O
has	O
only	O
recently	O
been	O
recognized	O
as	O
playing	O
a	O
prominent	O
role	O
in	O
the	O
regulation	O
of	O
cellular	O
processes	O
.	O

In	O
bacteria	O
,	O
regulatory	O
sRNAs	O
act	O
via	O
base	O
-	O
pairing	O
interactions	O
with	O
their	O
target	O
mRNAs	O
to	O
modulate	O
their	O
translation	O
and	O
/	O
or	O
decay	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
in	O
a	O
reaction	O
typically	O
dependent	O
on	O
the	O
RNA	O
-	O
binding	O
protein	O
Hfq	O
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

While	O
the	O
role	O
of	O
DNA	O
-	O
binding	O
proteins	O
,	O
particularly	O
transcription	O
factors	O
,	O
in	O
regulating	O
gene	O
expression	O
at	O
the	O
level	O
of	O
transcription	O
has	O
received	O
much	O
attention	O
,	O
how	O
RNA	O
-	O
binding	O
proteins	O
control	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
remains	O
unclear	O
.	O

The	O
RNA	O
-	O
binding	O
protein	O
Hfq	O
was	O
initially	O
shown	O
to	O
be	O
the	O
host	O
factor	O
required	O
for	O
replication	O
of	O
Qbeta	B-Organism
RNA	O
bacteriophage	O
[	O
5	O
]	O
and	O
is	O
a	O
member	O
of	O
the	O
Sm	O
protein	O
family	O
of	O
RNA	O
binding	O
proteins	O
that	O
also	O
include	O
eukaryotic	O
proteins	O
required	O
for	O
mRNA	O
splicing	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Hfq	O
is	O
a	O
highly	O
conserved	O
protein	O
encoded	O
within	O
many	O
bacterial	O
genomes	O
and	O
at	O
least	O
one	O
archaeon	O
genome	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
.	O

In	O
bacteria	O
,	O
Hfq	O
functions	O
as	O
a	O
post	O
-	O
transcriptional	O
regulator	O
that	O
modulates	O
the	O
stability	O
and	O
translation	O
of	O
mRNAs	O
chiefly	O
by	O
facilitating	O
sRNA	O
-	O
mRNA	O
interactions	O
[	O
1	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
9	O
]	O
.	O

Its	O
broad	O
role	O
in	O
regulation	O
at	O
the	O
translational	O
level	O
has	O
recently	O
been	O
hinted	O
at	O
by	O
Sittka	O
and	O
co	O
-	O
workers	O
[	O
10	O
]	O
.	O

The	O
RNA	O
-	O
binding	O
protein	O
SmpB	O
specifically	O
interacts	O
with	O
the	O
sRNA	O
tmRNA	O
(	O
also	O
known	O
as	O
ssrA	O
and	O
10Sa	O
)	O
and	O
is	O
required	O
for	O
all	O
known	O
functions	O
of	O
tmRNA	O
[	O
11	O
]	O
.	O

Indeed	O
SmpB	O
deletion	O
mutants	O
have	O
been	O
observed	O
to	O
have	O
the	O
same	O
phenotype	O
as	O
tmRNA	O
deletion	O
mutants	O
[	O
11	O
]	O
.	O

tmRNA	O
is	O
found	O
in	O
a	O
wide	O
range	O
of	O
bacteria	O
and	O
in	O
the	O
mitochondria	O
of	O
some	O
eukaryotes	O
and	O
uniquely	O
exhibits	O
properties	O
of	O
both	O
tRNA	O
and	O
mRNA	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

tmRNA	O
functions	O
as	O
a	O
part	O
of	O
the	O
translational	O
quality	O
control	O
process	O
,	O
recognizing	O
and	O
binding	O
to	O
ribosomes	O
that	O
become	O
stalled	O
.	O

Once	O
bound	O
,	O
tmRNA	O
adds	O
a	O
peptide	O
tag	O
to	O
the	O
nascent	O
partially	O
synthesized	O
protein	O
chain	O
which	O
targets	O
it	O
for	O
degradation	O
by	O
C	O
-	O
terminal	O
-	O
specific	O
cellular	O
proteases	O
[	O
15	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
,	O
[	O
18	O
]	O
.	O

Usually	O
classified	O
as	O
a	O
housekeeping	O
or	O
repair	O
system	O
,	O
a	O
role	O
for	O
tmRNA	O
as	O
a	O
regulatory	O
sRNA	O
has	O
been	O
recently	O
suggested	O
.	O
<EOS>	B-X
Most	B-X
frequently	B-X
,	B-X
these	B-X
are	B-X
housekeeping	B-X
genes	B-X
and	B-X
they	B-X
must	B-X
meet	B-X
several	B-X
criteria	B-X
so	B-X
that	B-X
they	B-X
can	B-X
lay	B-X
claim	B-X
to	B-X
the	B-X
name	B-X
.	B-X
According	B-X
to	B-X
the	B-X
extent	B-X
of	B-X
hexacoordination	B-X
,	B-X
nsHbs	B-X
are	B-X
classified	B-X
as	B-X
belonging	B-X
to	B-X
class-1	B-X
(	B-X
nsHbs1	B-X
)	B-X
or	B-X
class-2	B-X
(	B-X
nsHbs2	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
nsHbs2	B-X
exhibit	B-X
strong	B-X
hexacoordination	B-X
,	B-X
low	B-X
rates	B-X
of	B-X
O	B-X
(	B-X
2	B-X
)	B-X
-binding	B-X
and	B-X
moderately	B-X
low	B-X
O	B-X
(	B-X
2	B-X
)	B-X
dissociation	B-X
and	B-X
affinity	B-X
,	B-X
suggesting	B-X
a	B-X
sensing	B-X
role	B-X
for	B-X
sustained	B-X
low	B-X
(	B-X
μM	B-X
)	B-X
levels	B-X
of	B-X
O	B-X
(	B-X
2	B-X
)	B-X
.	B-X
The	B-X
existence	B-X
of	B-X
spatial	B-X
and	B-X
specific	B-X
expression	B-X
of	B-X
nsHbs1	B-X
suggests	B-X
that	B-X
nsHbs	B-X
play	B-X
tissue-specific	B-X
rather	B-X
than	B-X
housekeeping	B-X
functions	B-X
.	B-X
This	B-X
review	B-X
considers	B-X
the	B-X
current	B-X
status	B-X
of	B-X
our	B-X
knowledge	B-X
of	B-X
seed	B-X
nsHbs	B-X
and	B-X
considers	B-X
key	B-X
issues	B-X
of	B-X
further	B-X
work	B-X
to	B-X
better	B-X
understand	B-X
their	B-X
role	B-X
in	B-X
seed	B-X
physiology	B-X
.	B-X

Ranquet	O
and	O
Gottesman	O
[	O
19	O
]	O
report	O
that	O
the	O
sRNA	O
tmRNA	O
plays	O
a	O
regulatory	O
role	O
in	O
gene	O
expression	O
and	O
is	O
required	O
for	O
the	O
correct	O
high	O
-	O
level	O
translation	O
of	O
RpoS	O
.	O

Recent	O
reports	O
suggest	O
that	O
both	O
Hfq	O
and	O
SmpB	O
play	O
essential	O
roles	O
in	O
bacterial	O
pathogenesis	O
.	O

For	O
example	O
an	O
Deltahfq	O
mutant	O
derivative	O
in	O
the	O
pathogen	O
Salmonella	B-Organism
enterica	I-Organism
serovars	I-Organism
Typhimurium	I-Organism
(	O
Salmonella	B-Organism
Typhimurium	I-Organism
)	O
was	O
found	O
to	O
attenuate	O
virulence	O
in	O
mice	B-Organism
and	O
was	O
impaired	O
in	O
the	O
invasion	O
of	O
non	O
-	O
phagocytic	O
cells	O
[	O
20	O
]	O
.	O

Hfq	O
was	O
also	O
reported	O
to	O
be	O
essential	O
for	O
Vibrio	B-Organism
cholerae	I-Organism
virulence	O
,	O
with	O
sRNAs	O
in	O
conjunction	O
with	O
Hfq	O
suggested	O
as	O
likely	O
critical	O
regulators	O
of	O
Vibrio	B-Organism
cholerae	I-Organism
pathogenicity	O
[	O
21	O
]	O
.	O

Robertson	O
and	O
Roop	O
demonstrated	O
that	O
a	O
Brucella	O
abortus	O
Deltahfq	O
mutant	O
failed	O
to	O
replicate	O
in	O
cultured	O
murine	B-Organism
macrophages	O
,	O
and	O
displayed	O
attenuated	O
virulence	O
in	O
a	O
mouse	B-Organism
model	O
[	O
22	O
]	O
.	O

In	O
another	O
study	O
,	O
a	O
smpB	O
mutant	O
of	O
Salmonella	B-Organism
Typhimurium	I-Organism
exhibited	O
defects	O
in	O
intra	O
-	O
macrophage	O
survival	O
,	O
a	O
model	O
of	O
Salmonella	B-Organism
pathogenesis	O
[	O
23	O
]	O
.	O

More	O
recently	O
mutation	O
of	O
tmRNA	O
was	O
shown	O
to	O
be	O
responsible	O
for	O
a	O
marked	O
reduction	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
virulence	O
in	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	I-Organism
[	O
24	O
]	O
.	O

In	O
Yersinia	B-Organism
pseudotuberculosis	I-Organism
mutations	O
of	O
smpB	O
and	O
tmRNA	O
generated	O
a	O
bacterium	O
that	O
exhibited	O
defects	O
in	O
survival	O
and	O
replication	O
in	O
macrophages	O
and	O
was	O
avirulent	O
in	O
mice	B-Organism
[	O
25	O
]	O
.	O

Collectively	O
,	O
these	O
results	O
demonstrate	O
that	O
Hfq	O
and	O
SmpB	O
are	O
essential	O
for	O
regulating	O
virulence	O
by	O
controlling	O
translation	O
of	O
key	O
components	O
.	O

Identifying	O
what	O
proteins	O
are	O
actually	O
regulated	O
by	O
Hfq	O
and	O
SmpB	O
is	O
an	O
important	O
step	O
in	O
understanding	O
the	O
impact	O
of	O
post	O
-	O
transcriptional	O
gene	O
regulation	O
in	O
Enterobacteria	B-Organism
and	O
more	O
specifically	O
how	O
Hfq	O
and	O
SmpB	O
control	O
Salmonella	B-Organism
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
/	O
translational	O
level	O
and	O
the	O
role	O
that	O
this	O
may	O
play	O
in	O
Salmonella	B-Organism
pathogenesis	O
.	O

Towards	O
the	O
global	O
identification	O
of	O
Hfq	O
targets	O
,	O
previous	O
efforts	O
have	O
employed	O
a	O
combination	O
of	O
co	O
-	O
immunoprecipiatation	O
(	O
co	O
-	O
IP	O
)	O
and	O
or	O
microarray	O
analysis	O
.	O
<EOS>	B-X
In	B-X
the	B-X
last	B-X
decade	B-X
,	B-X
the	B-X
ability	B-X
to	B-X
detect	B-X
antigens	B-X
(	B-X
Ags	B-X
)	B-X
in	B-X
tissue	B-X
sections	B-X
has	B-X
improved	B-X
dramatically	B-X
,	B-X
mainly	B-X
by	B-X
countering	B-X
the	B-X
deleterious	B-X
effects	B-X
of	B-X
formaldehyde	B-X
with	B-X
antigen	B-X
retrieval	B-X
(	B-X
AR	B-X
)	B-X
and	B-X
increasing	B-X
sensitivity	B-X
of	B-X
the	B-X
detection	B-X
systems	B-X
.	B-X
Gene	B-X
expression	B-X
profiling	B-X
refers	B-X
to	B-X
the	B-X
simultaneous	B-X
measurement	B-X
of	B-X
the	B-X
expression	B-X
levels	B-X
of	B-X
a	B-X
large	B-X
number	B-X
of	B-X
genes	B-X
(	B-X
often	B-X
all	B-X
genes	B-X
in	B-X
a	B-X
genome	B-X
)	B-X
,	B-X
typically	B-X
in	B-X
multiple	B-X
experiments	B-X
spanning	B-X
a	B-X
variety	B-X
of	B-X
cell	B-X
types	B-X
,	B-X
treatments	B-X
,	B-X
or	B-X
environmental	B-X
conditions	B-X
.	B-X
Expression	B-X
profiling	B-X
is	B-X
accomplished	B-X
by	B-X
assaying	B-X
mRNA	B-X
levels	B-X
with	B-X
microarrays	B-X
or	B-X
next-generation	B-X
sequencing	B-X
technologies	B-X
(	B-X
RNA-seq	B-X
)	B-X
.	B-X
This	B-X
introduction	B-X
describes	B-X
normalization	B-X
and	B-X
analysis	B-X
of	B-X
data	B-X
generated	B-X
from	B-X
microarray	B-X
or	B-X
RNA-seq	B-X
experiments	B-X
.	B-X

Zhang	O
et	O
al	O
.	O

[	O
26	O
]	O
used	O
high	O
-	O
density	O
microarrays	O
to	O
detect	O
potential	O
targets	O
of	O
Hfq	O
co	O
-	O
immunoprecipitated	O
with	O
Hfq	O
-	O
specific	O
antibodies	O
.	O

In	O
a	O
recent	O
study	O
Sittka	O
et	O
al	O
.	O

[	O
10	O
]	O
used	O
high	O
-	O
throughput	O
pyrosequencing	O
(	O
HTPS	O
)	O
to	O
detect	O
potential	O
targets	O
of	O
an	O
epitope	O
tagged	O
-	O
Hfq	O
protein	O
co	O
-	O
immunoprecipitated	O
with	O
commercially	O
available	O
antibodies	O
,	O
overcoming	O
the	O
limitations	O
of	O
the	O
previous	O
strategy	O
;	O
the	O
need	O
for	O
custom	O
microarrays	O
and	O
specialized	O
antibodies	O
.	O

In	O
another	O
study	O
[	O
27	O
]	O
microarray	O
analysis	O
was	O
used	O
to	O
identify	O
changes	O
in	O
gene	O
expression	O
resulting	O
from	O
lack	O
of	O
Hfq	O
,	O
thus	O
providing	O
potential	O
new	O
target	O
genes	O
for	O
sRNA	O
regulation	O
.	O

While	O
co	O
-	O
immunoprecipiatation	O
has	O
proven	O
valuable	O
in	O
identifying	O
targets	O
of	O
Hfq	O
,	O
and	O
thus	O
targets	O
of	O
translational	O
regulation	O
,	O
one	O
possible	O
criticism	O
of	O
this	O
approach	O
is	O
that	O
the	O
RNA	O
co	O
-	O
immunoprecipitated	O
with	O
Hfq	O
may	O
be	O
brought	O
down	O
simply	O
because	O
Hfq	O
strongly	O
binds	O
to	O
RNA	O
molecules	O
and	O
that	O
the	O
binding	O
is	O
somewhat	O
non	O
-	O
specific	O
.	O

In	O
addition	O
,	O
it	O
is	O
clear	O
that	O
a	O
transcriptional	O
analysis	O
solely	O
can	O
not	O
distinguish	O
between	O
transcriptional	O
and	O
translational	O
/	O
post	O
-	O
transcriptional	O
regulatory	O
effects	O
.	O
<EOS>	B-X
In	B-X
the	B-X
case	B-X
of	B-X
mood	B-X
disorders	B-X
,	B-X
such	B-X
as	B-X
major	B-X
depressive	B-X
disorder	B-X
(	B-X
MDD	B-X
)	B-X
and	B-X
bipolar	B-X
disorder	B-X
(	B-X
BPD	B-X
)	B-X
,	B-X
where	B-X
diagnoses	B-X
are	B-X
based	B-X
solely	B-X
on	B-X
nosology	B-X
rather	B-X
than	B-X
pathophysiology	B-X
,	B-X
there	B-X
exists	B-X
a	B-X
clear	B-X
unmet	B-X
medical	B-X
need	B-X
to	B-X
advance	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
underlying	B-X
molecular	B-X
mechanisms	B-X
and	B-X
to	B-X
develop	B-X
fundamentally	B-X
new	B-X
mechanism	B-X
experimental	B-X
medicines	B-X
with	B-X
improved	B-X
efficacy	B-X
.	B-X
We	B-X
discuss	B-X
evidence	B-X
for	B-X
the	B-X
direct	B-X
and	B-X
indirect	B-X
effects	B-X
of	B-X
mood	B-X
stabilizers	B-X
,	B-X
antidepressants	B-X
,	B-X
and	B-X
antipsychotics	B-X
,	B-X
among	B-X
their	B-X
many	B-X
other	B-X
effects	B-X
,	B-X
on	B-X
chromatin-modifying	B-X
enzymes	B-X
and	B-X
on	B-X
the	B-X
epigenetic	B-X
state	B-X
of	B-X
defined	B-X
genomic	B-X
loci	B-X
,	B-X
in	B-X
defined	B-X
cell	B-X
types	B-X
and	B-X
in	B-X
specific	B-X
regions	B-X
of	B-X
the	B-X
brain	B-X
.	B-X
Looking	B-X
beyond	B-X
current	B-X
knowledge	B-X
,	B-X
we	B-X
discuss	B-X
how	B-X
high-resolution	B-X
,	B-X
whole-genome	B-X
methodologies	B-X
,	B-X
such	B-X
as	B-X
RNA-sequencing	B-X
(	B-X
RNA-Seq	B-X
)	B-X
for	B-X
transcriptome	B-X
analysis	B-X
and	B-X
chromatin	B-X
immunoprecipitation-sequencing	B-X
(	B-X
ChIP-Seq	B-X
)	B-X
for	B-X
analyzing	B-X
genome-wide	B-X
occupancy	B-X
of	B-X
chromatin-associated	B-X
factors	B-X
,	B-X
are	B-X
beginning	B-X
to	B-X
provide	B-X
an	B-X
unprecedented	B-X
view	B-X
of	B-X
both	B-X
specific	B-X
genomic	B-X
loci	B-X
as	B-X
well	B-X
as	B-X
global	B-X
properties	B-X
of	B-X
chromatin	B-X
in	B-X
the	B-X
nervous	B-X
system	B-X
.	B-X
These	B-X
methodologies	B-X
when	B-X
applied	B-X
to	B-X
the	B-X
characterization	B-X
of	B-X
model	B-X
systems	B-X
,	B-X
including	B-X
those	B-X
of	B-X
patient-derived	B-X
induced	B-X
pluripotent	B-X
cell	B-X
(	B-X
iPSC	B-X
)	B-X
and	B-X
induced	B-X
neurons	B-X
(	B-X
iNs	B-X
)	B-X
,	B-X
will	B-X
greatly	B-X
shape	B-X
our	B-X
understanding	B-X
of	B-X
epigenetic	B-X
mechanisms	B-X
and	B-X
the	B-X
impact	B-X
of	B-X
genetic	B-X
variation	B-X
on	B-X
the	B-X
regulatory	B-X
regions	B-X
of	B-X
the	B-X
human	B-X
genome	B-X
that	B-X
can	B-X
affect	B-X
neuroplasticity	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
point	B-X
out	B-X
critical	B-X
unanswered	B-X
questions	B-X
and	B-X
areas	B-X
where	B-X
additional	B-X
data	B-X
are	B-X
needed	B-X
in	B-X
order	B-X
to	B-X
better	B-X
understand	B-X
the	B-X
potential	B-X
to	B-X
target	B-X
mechanisms	B-X
of	B-X
chromatin-mediated	B-X
neuroplasticity	B-X
for	B-X
novel	B-X
treatments	B-X
of	B-X
mood	B-X
and	B-X
other	B-X
psychiatric	B-X
disorders	B-X
.	B-X

Using	O
sample	O
-	O
matched	O
transcriptomics	O
and	O
proteomics	O
measurements	O
it	O
is	O
possible	O
to	O
accurately	O
characterize	O
on	O
a	O
global	O
scale	O
control	O
of	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
.	O

Here	O
,	O
we	O
performed	O
sample	O
-	O
matched	O
global	O
proteomics	O
and	O
transcriptional	O
analyses	O
together	O
with	O
cellular	O
assays	O
and	O
animal	O
studies	O
to	O
begin	O
to	O
understand	O
how	O
Hfq	O
and	O
SmpB	O
control	O
Salmonella	B-Organism
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
and	O
the	O
role	O
that	O
this	O
may	O
play	O
in	O
Salmonella	B-Organism
pathogenesis	O
.	O

Our	O
global	O
analyses	O
revealed	O
that	O
a	O
relatively	O
high	O
percentage	O
of	O
all	O
the	O
annotated	O
Salmonella	B-Organism
genes	O
(	O
>	O
20	O
%	O
)	O
are	O
regulated	O
post	O
-	O
transcriptionally	O
either	O
directly	O
or	O
indirectly	O
.	O
<EOS>	B-X
The	B-X
evidence	B-X
suggests	B-X
that	B-X
Reuss	B-X
did	B-X
indeed	B-X
discover	B-X
electro-osmosis	B-X
,	B-X
which	B-X
takes	B-X
its	B-X
name	B-X
(	B-X
indirectly	B-X
)	B-X
from	B-X
the	B-X
work	B-X
of	B-X
Porrett	B-X
.	B-X
The	B-X
underlying	B-X
mechanisms	B-X
and	B-X
associated	B-X
phenomenological	B-X
lipid	B-X
membrane	B-X
transports	B-X
are	B-X
linked	B-X
directly	B-X
or	B-X
indirectly	B-X
to	B-X
the	B-X
cell	B-X
health	B-X
condition	B-X
.	B-X
A	B-X
large	B-X
number	B-X
of	B-X
ion	B-X
channels	B-X
active	B-X
across	B-X
MOM	B-X
and	B-X
MIM	B-X
are	B-X
known	B-X
to	B-X
belong	B-X
to	B-X
vital	B-X
cell-based	B-X
structures	B-X
found	B-X
to	B-X
be	B-X
linked	B-X
directly	B-X
to	B-X
cellular	B-X
signaling	B-X
.	B-X
This	B-X
article	B-X
aims	B-X
to	B-X
pinpoint	B-X
ion	B-X
channels	B-X
that	B-X
are	B-X
directly	B-X
or	B-X
indirectly	B-X
linked	B-X
to	B-X
especially	B-X
aging	B-X
and	B-X
related	B-X
abnormalities	B-X
in	B-X
health	B-X
conditions	B-X
.	B-X
The	B-X
malfunction	B-X
of	B-X
ion	B-X
channel	B-X
subunits	B-X
,	B-X
especially	B-X
various	B-X
proteins	B-X
,	B-X
involved	B-X
directly	B-X
in	B-X
channel	B-X
formation	B-X
and/or	B-X
indirectly	B-X
in	B-X
channel	B-X
stabilization	B-X
leads	B-X
to	B-X
the	B-X
rise	B-X
of	B-X
various	B-X
channel-specific	B-X
diseases	B-X
,	B-X
which	B-X
are	B-X
known	B-X
as	B-X
channelopathies	B-X
.	B-X

The	O
extent	O
of	O
global	O
regulation	O
of	O
translation	O
is	O
much	O
greater	O
than	O
previously	O
thought	O
[	O
10	O
]	O
,	O
with	O
profound	O
effects	O
in	O
all	O
stages	O
of	O
Salmonella	B-Organism
'	O
s	O
life	O
cycle	O
including	O
a	O
variety	O
of	O
house	O
keeping	O
pathways	O
and	O
known	O
and	O
novel	O
virulence	O
factors	O
,	O
in	O
part	O
explaining	O
the	O
requirement	O
of	O
both	O
translational	O
regulators	O
for	O
virulence	O
in	O
Salmonella	B-Organism
.	O

This	O
study	O
represents	O
one	O
of	O
the	O
first	O
comparative	O
global	O
analyses	O
of	O
post	O
-	O
transcriptional	O
regulation	O
in	O
any	O
organism	O
;	O
the	O
data	O
suggest	O
post	O
-	O
transcriptional	O
regulation	O
is	O
widespread	O
and	O
plays	O
an	O
important	O
role	O
in	O
virulence	O
regulation	O
and	O
environmental	O
adaptation	O
for	O
Salmonella	B-Organism
.	O
<EOS>	B-X
Using	B-X
sample-matched	B-X
transcriptomics	B-X
and	B-X
proteomics	B-X
measurements	B-X
it	B-X
is	B-X
now	B-X
possible	B-X
to	B-X
begin	B-X
to	B-X
understand	B-X
the	B-X
impact	B-X
of	B-X
post-transcriptional	B-X
regulatory	B-X
programs	B-X
in	B-X
Enterobacteria	B-X
.	B-X
In	B-X
bacteria	B-X
post-transcriptional	B-X
regulation	B-X
is	B-X
mediated	B-X
by	B-X
relatively	B-X
few	B-X
identified	B-X
RNA-binding	B-X
protein	B-X
factors	B-X
including	B-X
CsrA	B-X
,	B-X
Hfq	B-X
and	B-X
SmpB	B-X
.	B-X
A	B-X
mutation	B-X
in	B-X
any	B-X
one	B-X
of	B-X
these	B-X
three	B-X
genes	B-X
,	B-X
csrA	B-X
,	B-X
hfq	B-X
,	B-X
and	B-X
smpB	B-X
,	B-X
in	B-X
Salmonella	B-X
is	B-X
attenuated	B-X
for	B-X
mouse	B-X
virulence	B-X
and	B-X
unable	B-X
to	B-X
survive	B-X
in	B-X
macrophages	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
have	B-X
used	B-X
global	B-X
proteomics	B-X
to	B-X
directly	B-X
identify	B-X
proteins	B-X
regulated	B-X
by	B-X
Hfq	B-X
or	B-X
SmpB	B-X
by	B-X
comparing	B-X
protein	B-X
abundance	B-X
in	B-X
the	B-X
parent	B-X
and	B-X
isogenic	B-X
hfq	B-X
or	B-X
smpB	B-X
mutant	B-X
.	B-X
From	B-X
these	B-X
same	B-X
samples	B-X
we	B-X
also	B-X
prepared	B-X
RNA	B-X
for	B-X
microarray	B-X
analysis	B-X
to	B-X
determine	B-X
if	B-X
alteration	B-X
of	B-X
protein	B-X
expression	B-X
was	B-X
mediated	B-X
post-transcriptionally	B-X
.	B-X
We	B-X
show	B-X
that	B-X
mutants	B-X
of	B-X
hfq	B-X
and	B-X
smpB	B-X
directly	B-X
or	B-X
indirectly	B-X
modulate	B-X
at	B-X
least	B-X
20	B-X
%	B-X
and	B-X
4	B-X
%	B-X
of	B-X
all	B-X
possible	B-X
Salmonella	B-X
proteins	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
limited	B-X
correlation	B-X
between	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
.	B-X
These	B-X
proteins	B-X
represent	B-X
a	B-X
broad	B-X
spectrum	B-X
of	B-X
Salmonella	B-X
proteins	B-X
required	B-X
for	B-X
many	B-X
biological	B-X
processes	B-X
including	B-X
host	B-X
cell	B-X
invasion	B-X
,	B-X
motility	B-X
,	B-X
central	B-X
metabolism	B-X
,	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
two-component	B-X
regulatory	B-X
systems	B-X
,	B-X
and	B-X
fatty	B-X
acid	B-X
metabolism	B-X
.	B-X
Our	B-X
results	B-X
represent	B-X
one	B-X
of	B-X
the	B-X
first	B-X
global	B-X
analyses	B-X
of	B-X
post-transcriptional	B-X
regulons	B-X
in	B-X
any	B-X
organism	B-X
and	B-X
suggest	B-X
that	B-X
regulation	B-X
at	B-X
the	B-X
translational	B-X
level	B-X
is	B-X
widespread	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
virulence	B-X
regulation	B-X
and	B-X
environmental	B-X
adaptation	B-X
for	B-X
Salmonella	B-X
.	B-X

Results	O
and	O
Discussion	O
<EOS>	B-X
Discussion	B-X
of	B-X
religion	B-X
and/or	B-X
spirituality	B-X
in	B-X
the	B-X
medical	B-X
consultation	B-X
is	B-X
desired	B-X
by	B-X
patients	B-X
and	B-X
known	B-X
to	B-X
be	B-X
beneficial	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Construction	O
and	O
growth	O
characteristics	O
of	O
mutant	O
and	O
wildtype	O
Salmonella	B-Organism
Typhimurium	I-Organism
strains	O
Hfq	O
and	O
SmpB	O
are	O
essential	O
for	O
virulence	O
in	O
a	O
variety	O
of	O
pathogenic	O
bacteria	O
including	O
Salmonella	B-Organism
Typhimurium	I-Organism
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
,	O
[	O
25	O
]	O
.	O

To	O
address	O
the	O
role	O
of	O
Hfq	O
and	O
SmpB	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
pathogenesis	O
and	O
protein	O
synthesis	O
we	O
first	O
constructed	O
non	O
-	O
polar	O
deletion	O
mutations	O
of	O
the	O
hfq	O
and	O
smpB	O
genes	O
using	O
a	O
modified	O
pKD13	O
derivative	O
as	O
the	O
template	O
.	O

In	O
this	O
method	O
[	O
28	O
]	O
,	O
the	O
coding	O
region	O
between	O
the	O
initiation	O
methionine	O
and	O
the	O
last	O
seven	O
amino	O
acids	O
of	O
the	O
gene	O
was	O
replaced	O
with	O
an	O
inframe	O
"	O
scar	O
"	O
sequence	O
that	O
does	O
not	O
contain	O
any	O
stop	O
codons	O
.	O

Functional	O
disruption	O
of	O
the	O
hfq	O
and	O
smpB	O
mutant	O
derivatives	O
was	O
first	O
confirmed	O
by	O
PCR	O
analysis	O
after	O
which	O
the	O
mutants	O
were	O
P22	O
transduced	O
to	O
a	O
new	O
genetic	O
background	O
to	O
avoid	O
the	O
possibility	O
of	O
secondary	O
mutations	O
.	O

Mutants	O
that	O
lacked	O
either	O
of	O
these	O
proteins	O
showed	O
impaired	O
growth	O
phenotype	O
in	O
acidic	O
minimal	O
media	O
(	O
AMM	O
)	O
.	O

The	O
hfq	O
-	O
deficient	O
strain	O
also	O
exhibited	O
decreased	O
growth	O
rate	O
in	O
Luria	O
-	O
Bertani	O
(	O
LB	O
)	O
broth	O
(	O
Figure	O
S1	O
)	O
.	O

These	O
results	O
suggest	O
SmpB	O
and	O
Hfq	O
are	O
involved	O
in	O
broad	O
cellular	O
functions	O
,	O
including	O
growth	O
rate	O
regulation	O
.	O

Deltahfq	O
and	O
DeltasmpB	O
Salmonella	O
Typhimurium	O
mutant	O
strains	O
are	O
avirulent	O

To	O
directly	O
assess	O
the	O
role	O
of	O
Hfq	O
and	O
SmpB	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
pathogenesis	O
,	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	I-Organism
were	O
infected	O
intraperitoneally	O
with	O
200	O
cfu	O
of	O
either	O
Deltahfq	O
mutant	O
strain	O
,	O
DeltasmpB	O
mutant	O
strain	O
or	O
wildtype	O
strain	O
and	O
monitored	O
for	O
21	O
days	O
(	O
Figure	O
1	O
)	O
.	O

The	O
absence	O
of	O
smpB	O
and	O
hfq	O
attenuated	O
Salmonella	B-Organism
virulence	O
;	O
mice	B-Organism
infected	O
with	O
the	O
DeltasmpB	O
mutant	O
strain	O
died	O
at	O
10	O
days	O
post	O
-	O
infection	O
while	O
mice	B-Organism
infected	O
with	O
the	O
Deltahfq	O
mutant	O
strain	O
were	O
fully	O
resistant	O
to	O
the	O
infection	O
.	O

Mice	B-Organism
infected	O
with	O
wildtype	O
strain	O
exhibited	O
typical	O
symptoms	O
of	O
infection	O
and	O
died	O
at	O
around	O
six	O
days	O
.	O

These	O
results	O
are	O
similar	O
to	O
those	O
in	O
previous	O
reports	O
[	O
20	O
]	O
,	O
[	O
23	O
]	O
.	O
<EOS>	B-X
What	B-X
are	B-X
the	B-X
data	B-X
on	B-X
ART	B-X
and	B-X
IUI	B-X
cycles	B-X
,	B-X
and	B-X
fertility	B-X
preservation	B-X
(	B-X
FP	B-X
)	B-X
interventions	B-X
reported	B-X
in	B-X
2017	B-X
as	B-X
compared	B-X
to	B-X
previous	B-X
years	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
main	B-X
trends	B-X
over	B-X
the	B-X
years	B-X
?	B-X
What	B-X
are	B-X
the	B-X
data	B-X
and	B-X
trends	B-X
on	B-X
ART	B-X
and	B-X
IUI	B-X
cycle	B-X
numbers	B-X
and	B-X
their	B-X
outcomes	B-X
,	B-X
and	B-X
on	B-X
fertility	B-X
preservation	B-X
(	B-X
FP	B-X
)	B-X
interventions	B-X
,	B-X
reported	B-X
in	B-X
2018	B-X
as	B-X
compared	B-X
to	B-X
previous	B-X
years	B-X
?	B-X
This	B-X
meta-analysis	B-X
aims	B-X
to	B-X
provide	B-X
updated	B-X
evidence	B-X
on	B-X
the	B-X
success	B-X
rate	B-X
,	B-X
return	B-X
to	B-X
play	B-X
(	B-X
RTP	B-X
)	B-X
rate	B-X
,	B-X
time	B-X
to	B-X
RTP	B-X
,	B-X
and	B-X
complications	B-X
of	B-X
operatively	B-X
and	B-X
conservatively	B-X
managed	B-X
navicular	B-X
stress	B-X
fractures	B-X
(	B-X
NSFs	B-X
)	B-X
as	B-X
well	B-X
as	B-X
delays	B-X
in	B-X
diagnosis	B-X
while	B-X
avoiding	B-X
limitations	B-X
of	B-X
previous	B-X
similar	B-X
studies	B-X
.	B-X
Ustekinumab	B-X
is	B-X
a	B-X
human	B-X
monoclonal	B-X
antibody	B-X
approved	B-X
for	B-X
psoriasis	B-X
,	B-X
that	B-X
targets	B-X
the	B-X
interleukin	B-X
(	B-X
IL	B-X
)	B-X
-12	B-X
and	B-X
IL-23	B-X
,	B-X
and	B-X
it	B-X
may	B-X
also	B-X
play	B-X
a	B-X
role	B-X
in	B-X
AD	B-X
.	B-X
Administration	B-X
of	B-X
ustekinumab	B-X
in	B-X
AD	B-X
is	B-X
presented	B-X
in	B-X
anecdotal	B-X
reports	B-X
with	B-X
conflicting	B-X
results	B-X
.	B-X

Deltahfq	O
and	O
DeltasmpB	O
Salmonella	O
Typhimurium	O
mutant	O
strains	O
show	O
defects	O
in	O
intra	O
-	O
macrophage	O
proliferation	O

As	O
Salmonella	B-Organism
'	O
s	O
ability	O
to	O
replicate	O
within	O
macrophages	O
is	O
essential	O
for	O
its	O
virulence	O
[	O
29	O
]	O
,	O
we	O
examined	O
intracellular	O
replication	O
of	O
Deltahfq	O
and	O
DeltasmpB	O
Salmonella	O
Typhimurium	O
mutant	O
strains	O
within	O
the	O
macrophage	O
-	O
like	O
cell	O
line	O
RAW264	O
.	O
7	O
.	O

These	O
cells	O
were	O
infected	O
at	O
a	O
multiplicity	O
of	O
infection	O
(	O
m	O
.	O
o	O
.	O
i	O
.	O
)	O
of	O
about	O
1	O
bacteria	O
per	O
cell	O
with	O
stationary	O
phase	O
bacteria	O
grown	O
overnight	O
in	O
LB	O
broth	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

Extracellular	O
bacteria	O
were	O
removed	O
by	O
washing	O
and	O
treatment	O
with	O
gentamicin	O
.	O
<EOS>	B-X
H.	B-X
Hawa	B-X
,	B-X
M.	B-X
Sharshir	B-X
,	B-X
M.	B-X
Aburageila	B-X
,	B-X
N.	B-X
Salahuddin	B-X
P013	B-X
-	B-X
The	B-X
predictive	B-X
role	B-X
of	B-X
C-reactive	B-X
protein	B-X
and	B-X
procalcitonin	B-X
biomarkers	B-X
in	B-X
central	B-X
nervous	B-X
system	B-X
infections	B-X
with	B-X
extensively	B-X
drug	B-X
resistant	B-X
bacteria	B-X
V.	B-X
Chantziara	B-X
,	B-X
S.	B-X
Georgiou	B-X
,	B-X
A.	B-X
Tsimogianni	B-X
,	B-X
P.	B-X
Alexandropoulos	B-X
,	B-X
A.	B-X
Vassi	B-X
,	B-X
F.	B-X
Lagiou	B-X
,	B-X
M.	B-X
Valta	B-X
,	B-X
G.	B-X
Micha	B-X
,	B-X
E.	B-X
Chinou	B-X
,	B-X
G.	B-X
Michaloudis	B-X
P014	B-X
-	B-X
Changes	B-X
in	B-X
endotoxin	B-X
activity	B-X
assay	B-X
and	B-X
procalcitonin	B-X
levels	B-X
after	B-X
direct	B-X
hemoperfusion	B-X
with	B-X
polymyxin-b	B-X
immobilized	B-X
fiber	B-X
A.	B-X
Kodaira	B-X
,	B-X
T.	B-X
Ikeda	B-X
,	B-X
S.	B-X
Ono	B-X
,	B-X
T.	B-X
Ueno	B-X
,	B-X
S.	B-X
Suda	B-X
,	B-X
Y.	B-X
Izutani	B-X
,	B-X
H.	B-X
Imaizumi	B-X
P015	B-X
-	B-X
Diagnostic	B-X
usefullness	B-X
of	B-X
combination	B-X
biomarkers	B-X
on	B-X
ICU	B-X
admission	B-X
M.	B-X
V.	B-X
De	B-X
la	B-X
Torre-Prados	B-X
,	B-X
A.	B-X
Garcia-De	B-X
la	B-X
Torre	B-X
,	B-X
A.	B-X
Enguix-Armada	B-X
,	B-X
A.	B-X
Puerto-Morlan	B-X
,	B-X
V.	B-X
Perez-Valero	B-X
,	B-X
A.	B-X
Garcia-Alcantara	B-X
P016	B-X
-	B-X
Platelet	B-X
function	B-X
analysis	B-X
utilising	B-X
the	B-X
PFA-100	B-X
does	B-X
not	B-X
predict	B-X
infection	B-X
,	B-X
bacteraemia	B-X
,	B-X
sepsis	B-X
or	B-X
outcome	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
N.	B-X
Bolton	B-X
,	B-X
J.	B-X
Dudziak	B-X
,	B-X
S.	B-X
Bonney	B-X
,	B-X
A.	B-X
Tridente	B-X
,	B-X
P.	B-X
Nee	B-X
P017	B-X
-	B-X
Extracellular	B-X
histone	B-X
H3	B-X
levels	B-X
are	B-X
inversely	B-X
correlated	B-X
with	B-X
antithrombin	B-X
levels	B-X
and	B-X
platelet	B-X
counts	B-X
and	B-X
are	B-X
associated	B-X
with	B-X
mortality	B-X
in	B-X
sepsis	B-X
patients	B-X
G.	B-X
Nicolaes	B-X
,	B-X
M.	B-X
Wiewel	B-X
,	B-X
M.	B-X
Schultz	B-X
,	B-X
K.	B-X
Wildhagen	B-X
,	B-X
J.	B-X
Horn	B-X
,	B-X
R.	B-X
Schrijver	B-X
,	B-X
T.	B-X
Van	B-X
der	B-X
Poll	B-X
,	B-X
C.	B-X
Reutelingsperger	B-X
P018	B-X
-	B-X
Il-8	B-X
:	B-X
is	B-X
this	B-X
a	B-X
more	B-X
reliable	B-X
biomarker	B-X
for	B-X
sepsis	B-X
severity	B-X
than	B-X
CRP	B-X
,	B-X
Procalcitonin	B-X
,	B-X
E-selectin	B-X
,	B-X
IL-6	B-X
and	B-X
TNF-	B-X
[	B-X
alpha	B-X
]	B-X
S.	B-X
Pillai	B-X
,	B-X
G.	B-X
Davies	B-X
,	B-X
G.	B-X
Mills	B-X
,	B-X
R.	B-X
Aubrey	B-X
,	B-X
K.	B-X
Morris	B-X
,	B-X
P.	B-X
Williams	B-X
,	B-X
P.	B-X
Evans	B-X
P019	B-X
-	B-X
Relation	B-X
between	B-X
adrenomedullin	B-X
and	B-X
short-term	B-X
outcome	B-X
in	B-X
ICU	B-X
patients	B-X
:	B-X
Results	B-X
from	B-X
the	B-X
frog	B-X
ICU	B-X
study	B-X
E.	B-X
G.	B-X
Gayat	B-X
,	B-X
J	B-X
.	B-X
A	B-X
pilot	B-X
study	B-X
M.	B-X
Popescu	B-X
,	B-X
D.	B-X
Tomescu	B-X
P022	B-X
-	B-X
Comparison	B-X
of	B-X
CD64	B-X
levels	B-X
performed	B-X
by	B-X
the	B-X
facs	B-X
and	B-X
accellix	B-X
systems	B-X
C.	B-X
L.	B-X
Sprung	B-X
,	B-X
R.	B-X
Calderon	B-X
Morales	B-X
,	B-X
G.	B-X
Munteanu	B-X
,	B-X
E.	B-X
Orenbuch-Harroch	B-X
,	B-X
P.	B-X
Levin	B-X
,	B-X
H.	B-X
Kasdan	B-X
,	B-X
A.	B-X
Reiter	B-X
,	B-X
T.	B-X
Volker	B-X
,	B-X
Y.	B-X
Himmel	B-X
,	B-X
Y.	B-X
Cohen	B-X
,	B-X
J.	B-X
Meissonnier	B-X
P023	B-X
-	B-X
Diagnosing	B-X
sepsis	B-X
in	B-X
5	B-X
minutes	B-X
:	B-X
Nanofluidic	B-X
technology	B-X
study	B-X
with	B-X
pancreatic-stone	B-X
protein	B-X
(	B-X
PSP/	B-X
reg	B-X
)	B-X
L.	B-X
Girard	B-X
,	B-X
F.	B-X
Rebeaud	B-X
P024	B-X
-	B-X
How	B-X
nanotechnology-based	B-X
approaches	B-X
could	B-X
contribute	B-X
to	B-X
sepsis	B-X
prevention	B-X
,	B-X
diagnosis	B-X
and	B-X
treatment	B-X
I.	B-X
Herrmann	B-X
P025	B-X
-	B-X
Il7r	B-X
transcriptional	B-X
expression	B-X
analysis	B-X
during	B-X
septic	B-X
shock	B-X
B.	B-X
Delwarde	B-X
,	B-X
E.	B-X
Peronnet	B-X
,	B-X
E.	B-X
Cerrato	B-X
,	B-X
F.	B-X
Venet	B-X
,	B-X
A.	B-X
Lepape	B-X
,	B-X
T.	B-X
Rimmelé	B-X
,	B-X
G.	B-X
Monneret	B-X
,	B-X
J.	B-X
Textoris	B-X
P026	B-X
-	B-X
Disbalance	B-X
of	B-X
microbial	B-X
metabolites	B-X
of	B-X
aromatic	B-X
acids	B-X
affects	B-X
the	B-X
severity	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
N.	B-X
Beloborodova	B-X
,	B-X
V.	B-X
Moroz	B-X
,	B-X
A.	B-X
Osipov	B-X
,	B-X
A.	B-X
Bedova	B-X
,	B-X
Y.	B-X
Sarshor	B-X
,	B-X
A.	B-X
Pautova	B-X
,	B-X
A.	B-X
Sergeev	B-X
,	B-X
E.	B-X
Chernevskaya	B-X
P027	B-X
-	B-X
Copeptin	B-X
predicts	B-X
10-year	B-X
all-cause	B-X
mortality	B-X
in	B-X
community	B-X
patients	B-X
J.	B-X
Odermatt	B-X
,	B-X
R.	B-X
Bolliger	B-X
,	B-X
L.	B-X
Hersberger	B-X
,	B-X
M.	B-X
Ottiger	B-X
,	B-X
M.	B-X
Christ-Crain	B-X
,	B-X
B.	B-X
Mueller	B-X
,	B-X
P.	B-X
Schuetz	B-X
P028	B-X
-	B-X
Identification	B-X
of	B-X
differential	B-X
proteomic	B-X
response	B-X
in	B-X
septic	B-X
patients	B-X
secondary	B-X
to	B-X
community	B-X
and	B-X
hospital	B-X
acquired	B-X
pneumonia	B-X
N.	B-X
K.	B-X
Sharma	B-X
,	B-X
A.	B-X
K.	B-X
Tashima	B-X
,	B-X
M.	B-X
K.	B-X
Brunialti	B-X
,	B-X
F.	B-X
R.	B-X
Machado	B-X
,	B-X
M.	B-X
Assuncao	B-X
,	B-X
O.	B-X
Rigato	B-X
,	B-X
R.	B-X
Salomao	B-X
P029	B-X
-	B-X
Monocyte	B-X
HLA-DR	B-X
expression	B-X
in	B-X
community-acquired	B-X
bacteremic	B-X
sepsis	B-X
-	B-X
dynamics	B-X
associated	B-X
to	B-X
aetiology	B-X
and	B-X
prediction	B-X
of	B-X
secondary	B-X
sepsis	B-X
S.	B-X
C.	B-X
Cajander	B-X
,	B-X
G.	B-X
Rasmussen	B-X
,	B-X
E.	B-X
Tina	B-X
,	B-X
B.	B-X
Söderquist	B-X
,	B-X
J.	B-X
Källman	B-X
,	B-X
K.	B-X
Strålin	B-X
P030	B-X
-	B-X
Soluble	B-X
B-	B-X
and	B-X
T-lymphocyte	B-X
attenuator	B-X
:	B-X
A	B-X
possible	B-X
prognostic	B-X
marker	B-X
in	B-X
sepsis	B-X
A.	B-X
L.	B-X
Lange	B-X
,	B-X
J.	B-X
S.	B-X
Sundén-Cullberg	B-X
,	B-X
A.	B-X
M.	B-X
Magnuson	B-X
,	B-X
O.	B-X
H.	B-X
Hultgren	B-X
P031	B-X
-	B-X
Fractal	B-X
dimension	B-X
:	B-X
A	B-X
new	B-X
biomarker	B-X
for	B-X
quantifying	B-X
clot	B-X
microstructure	B-X
in	B-X
patients	B-X
across	B-X
the	B-X
sepsis	B-X
spectrum	B-X
G.	B-X
Davies	B-X
,	B-X
S.	B-X
Pillai	B-X
,	B-X
G.	B-X
Mills	B-X
,	B-X
R.	B-X
Aubrey	B-X
,	B-X
K.	B-X
Morris	B-X
,	B-X
P.	B-X
Williams	B-X
,	B-X
P.	B-X
Evans	B-X
P032	B-X
-	B-X
Comparison	B-X
between	B-X
the	B-X
new	B-X
biomarker	B-X
for	B-X
coagulation	B-X
,	B-X
clot	B-X
microstructure	B-X
(	B-X
Df	B-X
)	B-X
with	B-X
rotational	B-X
thromboelastometry	B-X
(	B-X
ROTEM	B-X
)	B-X
in	B-X
patients	B-X
across	B-X
the	B-X
sepsis	B-X
spectrum	B-X
S.	B-X
Pillai	B-X
,	B-X
G.	B-X
Davies	B-X
,	B-X
G.	B-X
Mills	B-X
,	B-X
R.	B-X
Aubrey	B-X
,	B-X
K.	B-X
Morris	B-X
,	B-X
P.	B-X
Williams	B-X
,	B-X
P.	B-X
Evans	B-X
P033	B-X
-	B-X
Changes	B-X
in	B-X
fibrinolysis	B-X
across	B-X
the	B-X
sepsis	B-X
spectrum	B-X
:	B-X
The	B-X
use	B-X
of	B-X
rotational	B-X
thromboelastometry	B-X
(	B-X
ROTEM	B-X
)	B-X
lysis	B-X
index	B-X
(	B-X
LI60	B-X
)	B-X
and	B-X
D-Dimer	B-X
concentration	B-X
S.	B-X
Pillai	B-X
,	B-X
G.	B-X
Davies	B-X
,	B-X
G.	B-X
Mills	B-X
,	B-X
R.	B-X
Aubrey	B-X
,	B-X
K.	B-X
Morris	B-X
,	B-X
P.	B-X
Williams	B-X
,	B-X
P.	B-X
Evans	B-X
P034	B-X
-	B-X
The	B-X
intensive	B-X
care	B-X
infection	B-X
score	B-X
–	B-X
a	B-X
promising	B-X
marker	B-X
for	B-X
the	B-X
prediction	B-X
of	B-X
infection	B-X
and	B-X
its	B-X
severity	B-X
.	B-X
Bond	B-X
,	B-X
A.	B-X
Molokhia	B-X
P037	B-X
-	B-X
Advancing	B-X
quality	B-X
(	B-X
AQ	B-X
)	B-X
sepsis	B-X
programme	B-X
:	B-X
Improving	B-X
early	B-X
identification	B-X
&	B-X
treatment	B-X
of	B-X
sepsis	B-X
in	B-X
North	B-X
West	B-X
England	B-X
.	B-X
C.	B-X
Mcgrath	B-X
,	B-X
E.	B-X
Nsutebu	B-X
P038	B-X
-	B-X
Prehospital	B-X
transport	B-X
of	B-X
acute	B-X
septic	B-X
patients	B-X
P.	B-X
Bank	B-X
Pedersen	B-X
,	B-X
D.	B-X
Pilsgaard	B-X
Henriksen	B-X
,	B-X
S.	B-X
Mikkelsen	B-X
,	B-X
A.	B-X
Touborg	B-X
Lassen	B-X
P039	B-X
-	B-X
Vasodilatory	B-X
plant	B-X
extracts	B-X
gel	B-X
as	B-X
an	B-X
alternative	B-X
treatment	B-X
for	B-X
fever	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
R.	B-X
Tincu	B-X
,	B-X
C.	B-X
Cobilinschi	B-X
,	B-X
D.	B-X
Tomescu	B-X
,	B-X
Z.	B-X
Ghiorghiu	B-X
,	B-X
R.	B-X
Macovei	B-X
P040	B-X
-	B-X
Host	B-X
response	B-X
and	B-X
outcome	B-X
of	B-X
hypothermic	B-X
sepsis	B-X
M.	B-X
A.	B-X
Wiewel	B-X
,	B-X
M.	B-X
B.	B-X
Harmon	B-X
,	B-X
L.	B-X
A	B-X
.	B-X
Van	B-X
Vught	B-X
,	B-X
B.	B-X
P.	B-X
Scicluna	B-X
,	B-X
A.	B-X
J.	B-X
Hoogendijk	B-X
,	B-X
J.	B-X
Horn	B-X
,	B-X
A.	B-X
H.	B-X
Zwinderman	B-X
,	B-X
O.	B-X
L.	B-X
Cremer	B-X
,	B-X
M.	B-X
J.	B-X
Bonten	B-X
,	B-X
M.	B-X
J.	B-X
Schultz	B-X
,	B-X
T.	B-X
Van	B-X
der	B-X
Poll	B-X
,	B-X
N.	B-X
P.	B-X
Juffermans	B-X
,	B-X
W.	B-X
J.	B-X
Wiersinga	B-X
P041	B-X
-	B-X
Septic	B-X
shock	B-X
alert	B-X
over	B-X
SIRS	B-X
criteria	B-X
has	B-X
an	B-X
impact	B-X
on	B-X
outcome	B-X
but	B-X
needs	B-X
to	B-X
be	B-X
revised	B-X
G.	B-X
Eren	B-X
,	B-X
Y	B-X
Tekdos	B-X
,	B-X
M.	B-X
Dogan	B-X
,	B-X
O.	B-X
Acicbe	B-X
,	B-X
E.	B-X
Kaya	B-X
,	B-X
O.	B-X
Hergunsel	B-X
P042	B-X
-	B-X
Association	B-X
between	B-X
previous	B-X
prescription	B-X
of	B-X
βblockers	B-X
and	B-X
mortality	B-X
rate	B-X
among	B-X
septic	B-X
patients	B-X
:	B-X
A	B-X
retrospective	B-X
observational	B-X
study	B-X
S.	B-X
Alsolamy	B-X
,	B-X
G.	B-X
Ghamdi	B-X
,	B-X
L.	B-X
Alswaidan	B-X
,	B-X
S.	B-X
Alharbi	B-X
,	B-X
F.	B-X
Alenezi	B-X
,	B-X
Y.	B-X
Arabi	B-X
P043	B-X
-	B-X
Recognition	B-X
and	B-X
treatment	B-X
of	B-X
sepsis	B-X
on	B-X
labour	B-X
ward–	B-X
teaching	B-X
&	B-X
information	B-X
resources	B-X
can	B-X
improve	B-X
knowledge	B-X
J.	B-X
Heaton	B-X
,	B-X
A.	B-X
Boyce	B-X
,	B-X
L.	B-X
Nolan	B-X
,	B-X
J.	B-X
Johnston	B-X
,	B-X
A.	B-X
Dukoff-Gordon	B-X
,	B-X
A.	B-X
T.	B-X
Mann	B-X
Ben	B-X
Yehudah	B-X
P045	B-X
-	B-X
Organ	B-X
dysfunction	B-X
in	B-X
severe	B-X
sepsis	B-X
patients	B-X
identified	B-X
in	B-X
administrative	B-X
data	B-X
in	B-X
Germany	B-X
,	B-X
2007-2013	B-X
C.	B-X
Fleischmann	B-X
,	B-X
D.	B-X
Thomas-Rueddel	B-X
,	B-X
C.	B-X
Haas	B-X
,	B-X
U.	B-X
Dennler	B-X
,	B-X
K.	B-X
Reinhart	B-X
P046	B-X
-	B-X
A	B-X
comparison	B-X
of	B-X
residents	B-X
’	B-X
knowledge	B-X
regarding	B-X
;	B-X
the	B-X
Surviving	B-X
Sepsis	B-X
Campaign	B-X
2012	B-X
guideline	B-X
O.	B-X
Suntornlohanakul	B-X
,	B-X
B.	B-X
Khwannimit	B-X
P047	B-X
-	B-X
Effectiveness	B-X
of	B-X
a	B-X
septic	B-X
shock	B-X
bundle	B-X
to	B-X
improve	B-X
outcomes	B-X
in	B-X
the	B-X
ICU	B-X
F.	B-X
Breckenridge	B-X
,	B-X
A.	B-X
Puxty	B-X
P048	B-X
-	B-X
Dose	B-X
of	B-X
norepinephrine	B-X
in	B-X
the	B-X
first	B-X
24	B-X
hours	B-X
as	B-X
a	B-X
parameter	B-X
evaluating	B-X
the	B-X
effectiveness	B-X
of	B-X
treatment	B-X
in	B-X
patients	B-X
with	B-X
severe	B-X
sepsis	B-X
and	B-X
septic	B-X
shock	B-X
P.	B-X
Szturz	B-X
,	B-X
P.	B-X
Folwarzcny	B-X
,	B-X
J.	B-X
Svancara	B-X
,	B-X
R.	B-X
Kula	B-X
,	B-X
P.	B-X
Sevcik	B-X
P049	B-X
-	B-X
Norepinephrine	B-X
or	B-X
vasopressin	B-X
+	B-X
norepinephrine	B-X
in	B-X
septic	B-X
shock	B-X
.	B-X
A	B-X
retrospective	B-X
series	B-X
of	B-X
39	B-X
patients	B-X
L.	B-X
Caneva	B-X
,	B-X
A.	B-X
Casazza	B-X
,	B-X
E.	B-X
Bellazzi	B-X
,	B-X
S.	B-X
Marra	B-X
,	B-X
L.	B-X
Pagani	B-X
,	B-X
M.	B-X
Vetere	B-X
,	B-X
R.	B-X
Vanzino	B-X
,	B-X
D.	B-X
Ciprandi	B-X
,	B-X
R.	B-X
Preda	B-X
,	B-X
R.	B-X
Boschi	B-X
,	B-X
L.	B-X
Carnevale	B-X
P050	B-X
-	B-X
Methylene	B-X
blue	B-X
effectiveness	B-X
as	B-X
contributory	B-X
treatment	B-X
in	B-X
patients	B-X
with	B-X
septic	B-X
shock	B-X
V.	B-X
Lopez	B-X
,	B-X
M.	B-X
Aguilar	B-X
Arzapalo	B-X
,	B-X
L.	B-X
Barradas	B-X
,	B-X
A.	B-X
Escalante	B-X
,	B-X
J.	B-X
Gongora	B-X
,	B-X
M.	B-X
Cetina	B-X
P051	B-X
-	B-X
Coagulation	B-X
disorders	B-X
in	B-X
patients	B-X
with	B-X
severe	B-X
sepsis	B-X
and	B-X
DIC	B-X
evaluated	B-X
with	B-X
thromboelastometry	B-X
.	B-X
A	B-X
case-control	B-X
pilot	B-X
study	B-X
E.	B-X
Scarlatescu	B-X
,	B-X
D.	B-X
Tomescu	B-X
,	B-X
G.	B-X
Droc	B-X
,	B-X
S.	B-X
Arama	B-X
P054	B-X
-	B-X
Thromboelastometry	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
with	B-X
disseminated	B-X
intravascular	B-X
coagulation	B-X
M.	B-X
Müller	B-X
,	B-X
M.	B-X
Straat	B-X
,	B-X
S.	B-X
S.	B-X
Zeerleder	B-X
,	B-X
N.	B-X
P.	B-X
Juffermans	B-X
P055	B-X
-	B-X
Cessation	B-X
of	B-X
a	B-X
preexisting	B-X
chronic	B-X
antiplatelet	B-X
therapy	B-X
is	B-X
associated	B-X
with	B-X
increased	B-X
mortality	B-X
rates	B-X
in	B-X
severe	B-X
sepsis	B-X
and	B-X
septic	B-X
shock	B-X
C.	B-X
F.	B-X
Fuchs	B-X
,	B-X
C.	B-X
S.	B-X
Scheer	B-X
,	B-X
S.	B-X
W.	B-X
Wauschkuhn	B-X
,	B-X
M.	B-X
V.	B-X
Vollmer	B-X
,	B-X
K.	B-X
M.	B-X
Meissner	B-X
,	B-X
S.	B-X
K.	B-X
Kuhn	B-X
,	B-X
K.	B-X
H.	B-X
Hahnenkamp	B-X
,	B-X
S.	B-X
R.	B-X
Rehberg	B-X
,	B-X
M.	B-X
G.	B-X
Gründling	B-X
P056	B-X
-	B-X
Neutrophil	B-X
Extracellular	B-X
Traps	B-X
(	B-X
NETs	B-X
)	B-X
production	B-X
under	B-X
hypoxic	B-X
condition	B-X
N.	B-X
Yamamoto	B-X
,	B-X
M.	B-X
Ojima	B-X
,	B-X
S.	B-X
Hamaguchi	B-X
,	B-X
T.	B-X
Hirose	B-X
,	B-X
Y.	B-X
Akeda	B-X
,	B-X
R.	B-X
Takegawa	B-X
,	B-X
O.	B-X
Tasaki	B-X
,	B-X
T.	B-X
Shimazu	B-X
,	B-X
K.	B-X
Tomono	B-X
P057	B-X
-	B-X
Impact	B-X
of	B-X
ultraviolet	B-X
air	B-X
sterilizer	B-X
in	B-X
intensive	B-X
care	B-X
unit	B-X
room	B-X
,	B-X
and	B-X
clinical	B-X
outcomes	B-X
of	B-X
patients	B-X
E.	B-X
Gómez-Sánchez	B-X
,	B-X
M.	B-X
Heredia-Rodríguez	B-X
,	B-X
E.	B-X
Álvarez-Fuente	B-X
,	B-X
M.	B-X
Lorenzo-López	B-X
,	B-X
E.	B-X
Gómez-Pesquera	B-X
,	B-X
M.	B-X
Aragón-Camino	B-X
,	B-X
P.	B-X
Liu-Zhu	B-X
,	B-X
A.	B-X
Sánchez-López	B-X
,	B-X
A.	B-X
Hernández-Lozano	B-X
,	B-X
M.	B-X
T.	B-X
Peláez-Jareño	B-X
,	B-X
E.	B-X
Tamayo	B-X
P058	B-X
-	B-X
Focus	B-X
of	B-X
infection	B-X
in	B-X
severe	B-X
sepsis	B-X
-	B-X
comparison	B-X
of	B-X
administrative	B-X
data	B-X
and	B-X
prospective	B-X
cohorts	B-X
from	B-X
Germany	B-X
D.	B-X
O.	B-X
Thomas-Rüddel	B-X
,	B-X
C.	B-X
Fleischmann	B-X
,	B-X
C.	B-X
Haas	B-X
,	B-X
U.	B-X
Dennler	B-X
,	B-X
K.	B-X
Reinhart	B-X
P059	B-X
-	B-X
“	B-X
Zero	B-X
CLABSI	B-X
”	B-X
–	B-X
can	B-X
we	B-X
get	B-X
there	B-X
?	B-X
monobacteremia	B-X
in	B-X
surgical	B-X
and	B-X
medical	B-X
intensive	B-X
care	B-X
units	B-X
at	B-X
university	B-X
hospital	B-X
in	B-X
Lithuania	B-X
D.	B-X
Adukauskiene	B-X
,	B-X
D.	B-X
Valanciene	B-X
P067	B-X
-	B-X
Group	B-X
A	B-X
and	B-X
group	B-X
B	B-X
streptococcal	B-X
infections	B-X
in	B-X
intensive	B-X
care	B-X
unit	B-X
–	B-X
our	B-X
experience	B-X
in	B-X
a	B-X
tertiary	B-X
centre	B-X
G.	B-X
Bose	B-X
,	B-X
V.	B-X
Lostarakos	B-X
,	B-X
B.	B-X
Carr	B-X
P068	B-X
-	B-X
Improved	B-X
detection	B-X
of	B-X
spontaneous	B-X
bacterial	B-X
peritonitis	B-X
by	B-X
uritop	B-X
+	B-X
tm	B-X
strip	B-X
test	B-X
and	B-X
inoculation	B-X
of	B-X
blood	B-X
culture	B-X
bottles	B-X
with	B-X
ascitic	B-X
fluid	B-X
S.	B-X
Khedher	B-X
,	B-X
A.	B-X
Maaoui	B-X
,	B-X
A.	B-X
Ezzamouri	B-X
,	B-X
M.	B-X
Salem	B-X
P069	B-X
-	B-X
Increased	B-X
risk	B-X
of	B-X
cellulitis	B-X
in	B-X
patients	B-X
with	B-X
congestive	B-X
heart	B-X
failure	B-X
:	B-X
a	B-X
population	B-X
based	B-X
cohort	B-X
study	B-X
J.	B-X
Chen	B-X
P070	B-X
-	B-X
Outcomes	B-X
of	B-X
severe	B-X
cellulitis	B-X
and	B-X
necrotizing	B-X
fasciitis	B-X
in	B-X
the	B-X
critically	B-X
ill	B-X
D.	B-X
R.	B-X
Cranendonk	B-X
,	B-X
L.	B-X
A.	B-X
M.	B-X
Day	B-X
,	B-X
G.	B-X
Penrice	B-X
,	B-X
K.	B-X
Roy	B-X
,	B-X
P.	B-X
Robertson	B-X
,	B-X
G.	B-X
Godbole	B-X
,	B-X
B.	B-X
Jones	B-X
,	B-X
M.	B-X
Booth	B-X
,	B-X
L.	B-X
Donaldson	B-X
P072	B-X
-	B-X
Surveillance	B-X
of	B-X
ESBL-producing	B-X
enterobacteriaceae	B-X
fecal	B-X
carriers	B-X
in	B-X
the	B-X
ICU	B-X
Y.	B-X
Kawano	B-X
,	B-X
H.	B-X
Ishikura	B-X
P073	B-X
-	B-X
Prevalence	B-X
of	B-X
ESBL	B-X
and	B-X
carbapenemase	B-X
producing	B-X
uropathogens	B-X
in	B-X
a	B-X
newly	B-X
opened	B-X
hospital	B-X
in	B-X
south	B-X
India	B-X
S.	B-X
Sreevidya	B-X
,	B-X
N.	B-X
Brahmananda	B-X
Reddy	B-X
,	B-X
P.	B-X
Muraray	B-X
Govind	B-X
,	B-X
R.	B-X
Pratheema	B-X
,	B-X
J.	B-X
Devachandran	B-X
Apollo	B-X
Speciality	B-X
Hospital	B-X
-	B-X
OMR	B-X
,	B-X
Chennai	B-X
,	B-X
India	B-X
P074	B-X
-	B-X
Prevalence	B-X
,	B-X
risk	B-X
factors	B-X
and	B-X
outcomes	B-X
of	B-X
methicillin-resistant	B-X
staphylococcus	B-X
aureus	B-X
nasal	B-X
colonization	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
H.	B-X
Al-Dorzi	B-X
,	B-X
M.	B-X
Almutairi	B-X
,	B-X
B.	B-X
Alhamadi	B-X
,	B-X
A.	B-X
Crizaldo	B-X
Toledo	B-X
,	B-X
R.	B-X
Khan	B-X
,	B-X
B.	B-X
Al	B-X
Raiy	B-X
,	B-X
Y.	B-X
Arabi	B-X
P075	B-X
-	B-X
Multidrug-resistant	B-X
Acinetobacter	B-X
baumannii	B-X
infection	B-X
in	B-X
intensive	B-X
care	B-X
unit	B-X
patients	B-X
in	B-X
a	B-X
hospital	B-X
with	B-X
building	B-X
construction	B-X
:	B-X
Is	B-X
there	B-X
an	B-X
association	B-X
?	B-X
A.	B-X
Vakalos	B-X
,	B-X
V.	B-X
Avramidis	B-X
P093	B-X
-	B-X
A	B-X
comparison	B-X
of	B-X
two	B-X
ventilator	B-X
associated	B-X
pneumonia	B-X
surveillance	B-X
techniques	B-X
T.	B-X
H.	B-X
Craven	B-X
,	B-X
G.	B-X
Wojcik	B-X
,	B-X
K.	B-X
Kefala	B-X
,	B-X
J.	B-X
McCoubrey	B-X
,	B-X
J.	B-X
Reilly	B-X
,	B-X
R.	B-X
Paterson	B-X
,	B-X
D.	B-X
Inverarity	B-X
,	B-X
I.	B-X
Laurenson	B-X
,	B-X
T.	B-X
S.	B-X
Walsh	B-X
P094	B-X
-	B-X
Lung	B-X
ultrasound	B-X
before	B-X
and	B-X
after	B-X
fiberbronchoscopy	B-X
-	B-X
modifications	B-X
may	B-X
improve	B-X
ventilator-associated	B-X
pneumonia	B-X
diagnosis	B-X
S.	B-X
Mongodi	B-X
,	B-X
B.	B-X
Bouhemad	B-X
,	B-X
A.	B-X
Orlando	B-X
,	B-X
A.	B-X
Stella	B-X
,	B-X
G.	B-X
Via	B-X
,	B-X
G.	B-X
Iotti	B-X
,	B-X
A.	B-X
Braschi	B-X
,	B-X
F.	B-X
Mojoli	B-X
P095	B-X
-	B-X
Comparing	B-X
the	B-X
accuracy	B-X
of	B-X
predictors	B-X
of	B-X
mortality	B-X
in	B-X
ventilator-associated	B-X
pneumonia	B-X
M.	B-X
Haliloglu	B-X
,	B-X
B.	B-X
Bilgili	B-X
,	B-X
U.	B-X
Kasapoglu	B-X
,	B-X
I.	B-X
Sayan	B-X
,	B-X
M.	B-X
Süzer	B-X
Aslan	B-X
,	B-X
A.	B-X
Yalcın	B-X
,	B-X
I.	B-X
Cinel	B-X
P096	B-X
-	B-X
Impact	B-X
of	B-X
pRBCs	B-X
transfusion	B-X
on	B-X
percentage	B-X
of	B-X
ventilated	B-X
patients	B-X
developed	B-X
VAP	B-X
in	B-X
ICU	B-X
patients	B-X
A.	B-X
Vakalos	B-X
,	B-X
V.	B-X
Avramidis	B-X
P097	B-X
-	B-X
The	B-X
impact	B-X
of	B-X
a	B-X
series	B-X
of	B-X
interventions	B-X
on	B-X
the	B-X
rate	B-X
of	B-X
ventilator	B-X
associated	B-X
pneumonia	B-X
in	B-X
a	B-X
large	B-X
teaching	B-X
hospital	B-X
H.	B-X
E.	B-X
Ellis	B-X
,	B-X
K.	B-X
Bauchmuller	B-X
,	B-X
D.	B-X
Miller	B-X
,	B-X
A	B-X
Temple	B-X
P098	B-X
-	B-X
The	B-X
EVADE	B-X
study	B-X
:	B-X
Prevention	B-X
of	B-X
Nosocomial	B-X
Pneumonia	B-X
(	B-X
NP	B-X
)	B-X
caused	B-X
by	B-X
P	B-X
aeruginosa	B-X
with	B-X
MEDI3902	B-X
,	B-X
a	B-X
Novel	B-X
Bispecific	B-X
Monoclonal	B-X
Antibody	B-X
,	B-X
against	B-X
P	B-X
aeruginosa	B-X
virulence	B-X
factors	B-X
J.	B-X
Chastre	B-X
,	B-X
B.	B-X
François	B-X
,	B-X
A.	B-X
Torres	B-X
,	B-X
C.	B-X
E.	B-X
Luyt	B-X
,	B-X
M.	B-X
Sánchez	B-X
,	B-X
M.	B-X
Singer	B-X
,	B-X
H.	B-X
S.	B-X
Jafri	B-X
P099	B-X
-	B-X
Short-term	B-X
inhaled	B-X
colistin	B-X
adjunctive	B-X
therapy	B-X
for	B-X
ventilator-associated	B-X
pneumonia	B-X
Y.	B-X
Nassar	B-X
,	B-X
M.	B-X
S.	B-X
Ayad	B-X
P100	B-X
-	B-X
Effect	B-X
of	B-X
aerosolised	B-X
colistin	B-X
on	B-X
weaning	B-X
from	B-X
mechanical	B-X
ventilation	B-X
A.	B-X
Trifi	B-X
,	B-X
S.	B-X
Abdellatif	B-X
,	B-X
F.	B-X
Daly	B-X
,	B-X
R.	B-X
Nasri	B-X
,	B-X
S.	B-X
Ben	B-X
Lakhal	B-X
P101	B-X
-	B-X
Septic	B-X
shock	B-X
is	B-X
an	B-X
independent	B-X
risk	B-X
factor	B-X
for	B-X
colistin-induced	B-X
severe	B-X
acute	B-X
kidney	B-X
injury	B-X
:	B-X
a	B-X
retrospective	B-X
cohort	B-X
study	B-X
B.	B-X
Bilgili	B-X
,	B-X
M.	B-X
Haliloglu	B-X
,	B-X
F.	B-X
Gul	B-X
,	B-X
I.	B-X
Cinel	B-X
P102	B-X
-	B-X
Nosocomial	B-X
pneumonia	B-X
-	B-X
emphasis	B-X
on	B-X
inhaled	B-X
tobramycin	B-X
A.	B-X
Kuzovlev	B-X
,	B-X
A.	B-X
Shabanov	B-X
,	B-X
S.	B-X
Polovnikov	B-X
,	B-X
V.	B-X
Moroz	B-X
P103	B-X
-	B-X
In	B-X
vitro	B-X
evaluation	B-X
of	B-X
amikacin	B-X
inhale	B-X
and	B-X
commercial	B-X
nebulizers	B-X
in	B-X
a	B-X
mechanical	B-X
ventilator	B-X
N.	B-X
Kadrichu	B-X
,	B-X
T.	B-X
Dang	B-X
,	B-X
K.	B-X
Corkery	B-X
,	B-X
P.	B-X
Challoner	B-X
P104	B-X
-	B-X
The	B-X
effects	B-X
of	B-X
nebulized	B-X
amikacin/fosfomycin	B-X
and	B-X
systemic	B-X
meropenem	B-X
on	B-X
severe	B-X
amikacin-resistant	B-X
meropenem-susceptible	B-X
P.aeruginosa	B-X
pneumonia	B-X
G.	B-X
Li	B-X
Bassi	B-X
,	B-X
E.	B-X
Aguilera	B-X
,	B-X
C.	B-X
Chiurazzi	B-X
,	B-X
C.	B-X
Travierso	B-X
,	B-X
A.	B-X
Motos	B-X
,	B-X
L.	B-X
Fernandez	B-X
,	B-X
R.	B-X
Amaro	B-X
,	B-X
T.	B-X
Senussi	B-X
,	B-X
F.	B-X
Idone	B-X
,	B-X
J.	B-X
Bobi	B-X
,	B-X
M.	B-X
Rigol	B-X
,	B-X
A.	B-X
Torres	B-X
P105	B-X
-	B-X
Optimization	B-X
of	B-X
gentamicin	B-X
peak	B-X
concentrations	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
C.	B-X
J.	B-X
Hodiamont	B-X
,	B-X
N.	B-X
P.	B-X
Juffermans	B-X
,	B-X
J.	B-X
M.	B-X
Janssen	B-X
,	B-X
C.	B-X
S.	B-X
Bouman	B-X
,	B-X
R.	B-X
A.	B-X
Mathôt	B-X
,	B-X
M.	B-X
D.	B-X
De	B-X
Jong	B-X
,	B-X
R.	B-X
M.	B-X
Van	B-X
Hest	B-X
P106	B-X
-	B-X
Systematic	B-X
review	B-X
of	B-X
cefepime	B-X
induced	B-X
neurotoxicity	B-X
L.	B-X
Payne	B-X
,	B-X
G.	B-X
L.	B-X
Fraser	B-X
P107	B-X
-	B-X
Unasyn®	B-X
causes	B-X
QT	B-X
prolongation	B-X
during	B-X
treatment	B-X
of	B-X
intensive	B-X
care	B-X
patients	B-X
B.	B-X
Tudor	B-X
,	B-X
M.	B-X
Lahner	B-X
,	B-X
G.	B-X
Roth	B-X
,	B-X
C.	B-X
Krenn	B-X
P108	B-X
-	B-X
Comparative	B-X
study	B-X
between	B-X
teicoplanin	B-X
and	B-X
vancomycin	B-X
in	B-X
methicillin-resistant	B-X
staphylococcus	B-X
aureus	B-X
(	B-X
mrsa	B-X
)	B-X
infectious	B-X
of	B-X
toxicological	B-X
intensive	B-X
care	B-X
unit	B-X
(	B-X
ticu	B-X
)	B-X
patients	B-X
–	B-X
Tehran	B-X
,	B-X
Iran	B-X
H.	B-X
Talaie	B-X
P109	B-X
-	B-X
Phage	B-X
therapy	B-X
against	B-X
antimicrobial	B-X
resistance	B-X
,	B-X
design	B-X
of	B-X
the	B-X
first	B-X
clinical	B-X
study	B-X
phagoburn	B-X
P.	B-X
Jault	B-X
,	B-X
J.	B-X
Gabard	B-X
,	B-X
T.	B-X
Leclerc	B-X
,	B-X
S.	B-X
Jennes	B-X
,	B-X
Y.	B-X
Que	B-X
,	B-X
A.	B-X
Rousseau	B-X
,	B-X
F.	B-X
Ravat	B-X
P110	B-X
-	B-X
Antibiotic	B-X
dosing	B-X
errors	B-X
in	B-X
critically	B-X
ill	B-X
patients	B-X
with	B-X
severe	B-X
sepsis	B-X
or	B-X
septic	B-X
shock	B-X
H.	B-X
Al-Dorzi	B-X
,	B-X
A.	B-X
Eissa	B-X
,	B-X
S.	B-X
Al-Harbi	B-X
,	B-X
T.	B-X
Aldabbagh	B-X
,	B-X
R.	B-X
Khan	B-X
,	B-X
Y.	B-X
Arabi	B-X
P111	B-X
-	B-X
Does	B-X
empiric	B-X
antifungal	B-X
therapy	B-X
improve	B-X
survival	B-X
in	B-X
septic	B-X
critically	B-X
ill	B-X
patients	B-X
?	B-X
B.	B-X
C.	B-X
Civanto	B-X
,	B-X
J.	B-X
L.	B-X
Lopez	B-X
,	B-X
A.	B-X
Robles	B-X
,	B-X
J.	B-X
Figueira	B-X
,	B-X
S.	B-X
Yus	B-X
,	B-X
A.	B-X
Garcia	B-X
P230	B-X
-	B-X
The	B-X
application	B-X
of	B-X
tracheostomy	B-X
in	B-X
children	B-X
in	B-X
ICU	B-X
A.	B-X
Oglinda	B-X
,	B-X
G.	B-X
Ciobanu	B-X
,	B-X
C.	B-X
Oglinda	B-X
,	B-X
L.	B-X
Schirca	B-X
,	B-X
T.	B-X
Sertinean	B-X
,	B-X
V.	B-X
Lupu	B-X
P231	B-X
-	B-X
The	B-X
impact	B-X
of	B-X
passive	B-X
humidifiers	B-X
on	B-X
aerosol	B-X
drug	B-X
delivery	B-X
during	B-X
mechanical	B-X
ventilation	B-X
P.	B-X
Kelly	B-X
,	B-X
A.	B-X
O	B-X
’	B-X
Sullivan	B-X
,	B-X
L.	B-X
Sweeney	B-X
,	B-X
R.	B-X
MacLoughlin	B-X
P232	B-X
-	B-X
Evaluation	B-X
of	B-X
vibrating	B-X
mesh	B-X
and	B-X
jet	B-X
nebuliser	B-X
performance	B-X
at	B-X
two	B-X
different	B-X
attachment	B-X
setups	B-X
in	B-X
line	B-X
with	B-X
a	B-X
humidifier	B-X
nebuliser	B-X
system	B-X
A.	B-X
O	B-X
’	B-X
Sullivan	B-X
,	B-X
P.	B-X
Kelly	B-X
,	B-X
L.	B-X
Sweeney	B-X
,	B-X
E.	B-X
Mukeria	B-X
,	B-X
M.	B-X
Wolny	B-X
,	B-X
R.	B-X
MacLoughlin	B-X
P233	B-X
-	B-X
Psv-niv	B-X
versus	B-X
cpap	B-X
in	B-X
the	B-X
treatment	B-X
of	B-X
acute	B-X
cardiogenic	B-X
pulmonary	B-X
edema	B-X
A.	B-X
Pagano	B-X
,	B-X
F.	B-X
Numis	B-X
,	B-X
G.	B-X
Vison	B-X
,	B-X
L.	B-X
Saldamarco	B-X
,	B-X
T.	B-X
Russo	B-X
,	B-X
G.	B-X
Porta	B-X
,	B-X
F.	B-X
Paladino	B-X
P234	B-X
-	B-X
Noninvasive	B-X
ventilation	B-X
in	B-X
patients	B-X
with	B-X
haematologic	B-X
malignancy	B-X
:	B-X
a	B-X
retrospective	B-X
review	B-X
C.	B-X
Bell	B-X
,	B-X
J.	B-X
Liu	B-X
,	B-X
J.	B-X
Debacker	B-X
,	B-X
C.	B-X
Lee	B-X
,	B-X
E.	B-X
Tamberg	B-X
,	B-X
V.	B-X
Campbell	B-X
,	B-X
S.	B-X
Mehta	B-X
P235	B-X
-	B-X
Use	B-X
of	B-X
non-invasive	B-X
ventilation	B-X
in	B-X
infectious	B-X
diseases	B-X
besides	B-X
classical	B-X
indications	B-X
A.	B-X
Silva-Pinto	B-X
,	B-X
A.	B-X
Sarmento	B-X
,	B-X
L.	B-X
Santos	B-X
P236	B-X
-	B-X
The	B-X
impact	B-X
of	B-X
fragility	B-X
on	B-X
noninvasive	B-X
mechanical	B-X
ventilation	B-X
application	B-X
and	B-X
results	B-X
in	B-X
the	B-X
ICU	B-X
Ý.	B-X
Kara	B-X
,	B-X
F.	B-X
Yýldýrým	B-X
,	B-X
A.	B-X
Zerman	B-X
,	B-X
Z.	B-X
Güllü	B-X
,	B-X
N.	B-X
Boyacý	B-X
,	B-X
B.	B-X
Basarýk	B-X
Aydogan	B-X
,	B-X
Ü.	B-X
Gaygýsýz	B-X
,	B-X
K.	B-X
Gönderen	B-X
,	B-X
G.	B-X
Arýk	B-X
,	B-X
M.	B-X
Turkoglu	B-X
,	B-X
M.	B-X
Aydogdu	B-X
,	B-X
G.	B-X
Aygencel	B-X
,	B-X
Z.	B-X
Ülger	B-X
,	B-X
G.	B-X
Gursel	B-X
P237	B-X
-	B-X
Effects	B-X
of	B-X
metabolic	B-X
alkalosis	B-X
on	B-X
noninvasive	B-X
ventilation	B-X
success	B-X
and	B-X
ICU	B-X
outcome	B-X
in	B-X
patients	B-X
with	B-X
hypercapnic	B-X
respiratory	B-X
failure	B-X
N.	B-X
Boyacý	B-X
,	B-X
Z.	B-X
Isýkdogan	B-X
,	B-X
Ö.	B-X
Özdedeoglu	B-X
,	B-X
Z.	B-X
Güllü	B-X
,	B-X
M.	B-X
Badoglu	B-X
,	B-X
U.	B-X
Gaygýsýz	B-X
,	B-X
M.	B-X
Aydogdu	B-X
,	B-X
G.	B-X
Gursel	B-X
P238	B-X
-	B-X
Asynchrony	B-X
index	B-X
and	B-X
breathing	B-X
patterns	B-X
of	B-X
acute	B-X
exacerbation	B-X
copd	B-X
patients	B-X
assisted	B-X
with	B-X
noninvasive	B-X
pressure	B-X
support	B-X
ventilation	B-X
and	B-X
neurally	B-X
adjusted	B-X
ventilatory	B-X
assist	B-X
N.	B-X
Kongpolprom	B-X
,	B-X
C.	B-X
Sittipunt	B-X
P239	B-X
-	B-X
High	B-X
frequency	B-X
jet	B-X
ventilation	B-X
for	B-X
severe	B-X
acute	B-X
hypoxemia	B-X
A.	B-X
Eden	B-X
,	B-X
Y.	B-X
Kokhanovsky	B-X
,	B-X
S.	B-X
Bursztein	B-X
–	B-X
De	B-X
Myttenaere	B-X
,	B-X
R.	B-X
Pizov	B-X
P240	B-X
-	B-X
HFOV	B-X
revisited	B-X
:	B-X
a	B-X
7	B-X
year	B-X
retrospective	B-X
analysis	B-X
of	B-X
patients	B-X
receiving	B-X
HFOV	B-X
who	B-X
met	B-X
oscillate	B-X
trial	B-X
entry	B-X
criteria	B-X
L.	B-X
Neilans	B-X
,	B-X
N.	B-X
MacIntyre	B-X
P241	B-X
-	B-X
Implementation	B-X
of	B-X
a	B-X
goal-directed	B-X
mechanical	B-X
ventilation	B-X
order	B-X
set	B-X
driven	B-X
by	B-X
respiratory	B-X
therapists	B-X
can	B-X
improve	B-X
compliance	B-X
with	B-X
best	B-X
practices	B-X
for	B-X
mechanical	B-X
ventilation	B-X
M.	B-X
Radosevich	B-X
,	B-X
B.	B-X
Wanta	B-X
,	B-X
V.	B-X
Weber	B-X
,	B-X
T.	B-X
Meyer	B-X
,	B-X
N.	B-X
Smischney	B-X
,	B-X
D.	B-X
Brown	B-X
,	B-X
D.	B-X
Diedrich	B-X
P242	B-X
-	B-X
A	B-X
reduction	B-X
in	B-X
tidal	B-X
volumes	B-X
for	B-X
ventilated	B-X
patients	B-X
on	B-X
ICU	B-X
calculated	B-X
from	B-X
IBW	B-X
.	B-X
Van	B-X
Assche	B-X
,	B-X
L.	B-X
Jamaer	B-X
,	B-X
J.	B-X
Dubois	B-X
P287	B-X
-	B-X
Nutrition	B-X
may	B-X
be	B-X
another	B-X
treatment	B-X
in	B-X
the	B-X
intensive	B-X
care	B-X
unit	B-X
where	B-X
less	B-X
is	B-X
more	B-X
?	B-X
Van	B-X
Putten	B-X
,	B-X
M.	B-X
Tjepkema-Cloostermans	B-X
,	B-X
A.	B-X
F.	B-X
Van	B-X
Rootselaar	B-X
,	B-X
J.	B-X
Horn	B-X
P333	B-X
Usefulness	B-X
of	B-X
common	B-X
ICU	B-X
severity	B-X
scoring	B-X
systems	B-X
in	B-X
predicting	B-X
outcome	B-X
after	B-X
spontaneous	B-X
intracerebral	B-X
hemorrhage	B-X
M.	B-X
Fallenius	B-X
,	B-X
M.	B-X
B.	B-X
Skrifvars	B-X
,	B-X
M.	B-X
Reinikainen	B-X
,	B-X
S.	B-X
Bendel	B-X
,	B-X
R.	B-X
Raj	B-X
P334	B-X
Evalution	B-X
of	B-X
patients	B-X
with	B-X
suspected	B-X
subarachnoid	B-X
haemorrhage	B-X
and	B-X
negative	B-X
ct	B-X
imaging	B-X
M.	B-X
Abu-Habsa	B-X
,	B-X
C.	B-X
Hymers	B-X
,	B-X
A.	B-X
Borowska	B-X
,	B-X
H.	B-X
Sivadhas	B-X
,	B-X
S.	B-X
Sahiba	B-X
,	B-X
S.	B-X
Perkins	B-X
P335	B-X
Timing	B-X
of	B-X
endovascular	B-X
and	B-X
surgical	B-X
treatment	B-X
for	B-X
aneurysmal	B-X
subarachnoid	B-X
haemorrhage	B-X
:	B-X
early	B-X
but	B-X
not	B-X
so	B-X
fast	B-X
.	B-X
O.	B-X
Howarth	B-X
,	B-X
K.	B-X
Davenport	B-X
,	B-X
P.	B-X
Jeanrenaud	B-X
,	B-X
S.	B-X
Raftery	B-X
P365	B-X
-	B-X
Clasification	B-X
of	B-X
pain	B-X
and	B-X
its	B-X
treatment	B-X
and	B-X
an	B-X
intensive	B-X
care	B-X
rehabiliation	B-X
clinic	B-X
P.	B-X
MacTavish	B-X
,	B-X
H.	B-X
Devine	B-X
,	B-X
J.	B-X
McPeake	B-X
,	B-X
M.	B-X
Daniel	B-X
,	B-X
J.	B-X
Kinsella	B-X
,	B-X
T.	B-X
Quasim	B-X
P366	B-X
-	B-X
Pain	B-X
management	B-X
adequacy	B-X
in	B-X
critical	B-X
care	B-X
areas	B-X
,	B-X
the	B-X
process	B-X
and	B-X
the	B-X
barriers	B-X
perceived	B-X
by	B-X
critical	B-X
care	B-X
nurses	B-X
S.	B-X
Alrabiee	B-X
,	B-X
A.	B-X
Alrashid	B-X
,	B-X
S.	B-X
Alsolamy	B-X
P367	B-X
-	B-X
Pain	B-X
assessment	B-X
in	B-X
critically	B-X
ill	B-X
adult	B-X
patients	B-X
:	B-X
validation	B-X
of	B-X
the	B-X
Turkish	B-X
version	B-X
of	B-X
the	B-X
critical-care	B-X
pain	B-X
observation	B-X
tool	B-X
O.	B-X
Gundogan	B-X
,	B-X
C.	B-X
Bor	B-X
,	B-X
E.	B-X
Akýn	B-X
Korhan	B-X
,	B-X
K.	B-X
Demirag	B-X
,	B-X
M.	B-X
Uyar	B-X
P368	B-X
-	B-X
An	B-X
audit	B-X
of	B-X
pain	B-X
and	B-X
sedation	B-X
assessments	B-X
in	B-X
the	B-X
intensive	B-X
care	B-X
unit	B-X
:	B-X
recommendations	B-X
for	B-X
clinical	B-X
practice	B-X
F.	B-X
Frame	B-X
,	B-X
C.	B-X
Ashton	B-X
,	B-X
L.	B-X
Bergstrom	B-X
Niska	B-X
P369	B-X
-	B-X
Impact	B-X
of	B-X
pharmaceutical	B-X
care	B-X
on	B-X
treatment	B-X
of	B-X
pain	B-X
and	B-X
agitation	B-X
in	B-X
medical	B-X
intensive	B-X
care	B-X
unit	B-X
P.	B-X
Dilokpattanamongkol	B-X
,	B-X
T.	B-X
Suansanae	B-X
,	B-X
C.	B-X
Suthisisang	B-X
,	B-X
S.	B-X
Morakul	B-X
,	B-X
C.	B-X
Karnjanarachata	B-X
,	B-X
V.	B-X
Tangsujaritvijit	B-X
P370	B-X
-	B-X
Agitation	B-X
in	B-X
trauma	B-X
ICU	B-X
,	B-X
prevention	B-X
and	B-X
outcome	B-X
S.	B-X
Mahmood	B-X
,	B-X
H.	B-X
Al	B-X
Thani	B-X
,	B-X
A.	B-X
Almenyar	B-X
P371	B-X
Correlation	B-X
between	B-X
percentages	B-X
of	B-X
ventilated	B-X
patients	B-X
developed	B-X
vap	B-X
and	B-X
use	B-X
of	B-X
sedative	B-X
agents	B-X
in	B-X
icu	B-X
patients	B-X
.	B-X
Van	B-X
Assche	B-X
,	B-X
L.	B-X
Jamaer	B-X
,	B-X
J.	B-X
Dubois	B-X
P441	B-X
-	B-X
Accidental	B-X
removal	B-X
of	B-X
invasive	B-X
devices	B-X
in	B-X
the	B-X
critical	B-X
patient	B-X
into	B-X
the	B-X
bed-washing	B-X
.	B-X

After	O
infection	O
the	O
cells	O
were	O
lysed	O
at	O
various	O
times	O
by	O
rapid	O
resuspension	O
in	O
PBS	O
containing	O
1	O
%	O
Triton	O
X	O
-	O
100	O
.	O

Intracellular	O
survival	O
/	O
replication	O
results	O
(	O
Figure	O
2	O
)	O
are	O
consistent	O
with	O
earlier	O
reports	O
that	O
suggest	O
Deltahfq	O
and	O
DeltasmpB	O
Salmonella	O
Typhimurium	O
mutant	O
strains	O
are	O
essential	O
for	O
intra	O
-	O
macrophage	O
proliferation	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
,	O
[	O
25	O
]	O
.	O

Global	O
effects	O
of	O
Hfq	O
and	O
SmpB	O
mutation	O
on	O
Salmonella	B-Organism
Typhimurium	I-Organism
chromosome	O

LC	O
-	O
MS	O
-	O
based	O
proteomics	O
was	O
used	O
to	O
obtain	O
a	O
general	O
overview	O
of	O
the	O
effects	O
of	O
Hfq	O
and	O
SmpB	O
on	O
global	O
protein	O
translation	O
in	O
Salmonella	B-Organism
.	O

The	O
differences	O
in	O
protein	O
expression	O
between	O
parent	O
and	O
isogenic	O
mutant	O
was	O
assessed	O
via	O
hypothesis	O
testing	O
,	O
specifically	O
a	O
comprehensive	O
ANOVA	O
scheme	O
included	O
in	O
the	O
computer	O
program	O
DAnTE	O
[	O
30	O
]	O
.	O

Relative	O
changes	O
in	O
protein	O
abundance	O
between	O
DeltasmpB	O
or	O
Deltahfq	O
mutant	O
strains	O
and	O
a	O
wild	O
-	O
type	O
strain	O
were	O
evaluated	O
across	O
four	O
differing	O
growth	O
conditions	O
.	O

These	O
included	O
logarithmic	O
(	O
log	O
)	O
and	O
stationary	O
(	O
stat	O
)	O
phase	O
cultures	O
and	O
growth	O
in	O
two	O
variations	O
of	O
an	O
acidic	O
,	O
low	O
magnesium	O
[	O
Mg2	O
+	O
]	O
minimal	O
media	O
(	O
AMM	O
)	O
,	O
to	O
approximate	O
conditions	O
encountered	O
in	O
the	O
hosts	O
'	O
s	O
phagocytes	O
(	O
Materials	O
and	O
Methods	O
)	O
.	O

Across	O
all	O
experimental	O
datasets	O
we	O
observed	O
a	O
total	O
of	O
1621	O
Salmonella	B-Organism
Typhimurium	I-Organism
proteins	O
(	O
Table	O
S1	O
)	O
,	O
corresponding	O
to	O
approximately36	O
%	O
coverage	O
of	O
predicted	O
protein	O
coding	O
regions	O
.	O

These	O
proteins	O
represent	O
a	O
broad	O
spectrum	O
of	O
gene	O
products	O
from	O
the	O
genetic	O
translation	O
(	O
Table	O
1	O
)	O
,	O
with	O
proteins	O
of	O
unknown	O
or	O
unclassified	O
function	O
representing	O
the	O
largest	O
functional	O
category	O
as	O
might	O
be	O
expected	O
.	O

Across	O
each	O
of	O
the	O
four	O
growth	O
conditions	O
examined	O
our	O
analysis	O
revealed	O
that	O
Hfq	O
had	O
a	O
far	O
more	O
significant	O
effect	O
on	O
the	O
Salmonella	B-Organism
Typhimurium	I-Organism
proteome	O
than	O
SmpB	O
.	O

Overall	O
,	O
in	O
comparison	O
to	O
expression	O
in	O
the	O
parent	O
strain	O
,	O
Hfq	O
and	O
SmpB	O
altered	O
,	O
approximately50	O
%	O
(	O
781proteins	O
)	O
and	O
approximately12	O
%	O
(	O
189	O
proteins	O
)	O
of	O
the	O
observed	O
proteome	O
(	O
1621	O
proteins	O
)	O
respectively	O
,	O
as	O
determined	O
by	O
an	O
ANOVA	O
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
using	O
the	O
computer	O
program	O
DAnTE	O
[	O
30	O
]	O
(	O
Table	O
S1	O
)	O
.	O

When	O
compared	O
to	O
the	O
entire	O
Salmonella	B-Organism
proteome	O
of	O
4450	O
annotated	O
open	O
reading	O
frames	O
(	O
orf	O
;	O
[	O
31	O
]	O
)	O
,	O
781	O
proteins	O
represents	O
approximately20	O
%	O
of	O
the	O
entire	O
Salmonella	B-Organism
genome	O
.	O

This	O
is	O
in	O
agreement	O
with	O
a	O
recent	O
study	O
that	O
found	O
that	O
Hfq	O
affects	O
18	O
%	O
of	O
the	O
Salmonella	B-Organism
genome	O
[	O
10	O
]	O
.	O

Considering	O
the	O
reported	O
pleitropic	O
nature	O
of	O
deletion	O
of	O
hfq	O
on	O
the	O
biology	O
of	O
Salmonella	B-Organism
Typhimurium	I-Organism
it	O
is	O
likely	O
that	O
a	O
proportion	O
of	O
the	O
changes	O
in	O
protein	O
abundances	O
maybe	O
a	O
non	O
-	O
specific	O
and	O
/	O
or	O
secondary	O
consequence	O
of	O
hfq	O
deletion	O
.	O

That	O
is	O
,	O
not	O
every	O
deregulated	O
protein	O
in	O
the	O
hfq	O
mutant	O
strain	O
is	O
necessarily	O
directly	O
regulated	O
by	O
Hfq	O
.	O

Indeed	O
analysis	O
of	O
the	O
correlation	O
between	O
Hfq	O
-	O
dependent	O
proteins	O
identified	O
in	O
this	O
study	O
and	O
Hfq	O
-	O
associated	O
mRNAs	O
identified	O
by	O
Sittka	O
et	O
al	O
.	O

[	O
10	O
]	O
showed	O
an	O
approximately	O
25	O
%	O
overlap	O
(	O
Table	O
S2	O
)	O
,	O
similar	O
to	O
the	O
approximately30	O
%	O
overlap	O
observed	O
between	O
data	O
from	O
a	O
transcriptional	O
analysis	O
of	O
an	O
Deltahfq	O
mutant	O
strain	O
and	O
data	O
from	O
a	O
co	O
-	O
IP	O
analysis	O
of	O
Hfq	O
-	O
associated	O
mRNAs	O
[	O
10	O
]	O
.	O

We	O
report	O
that	O
Hfq	O
directly	O
or	O
indirectly	O
modulates	O
approximately20	O
%	O
of	O
the	O
Salmonella	B-Organism
genome	O
.	O
<EOS>	B-X
RNA	B-X
chaperone	B-X
protein	B-X
Hfq	B-X
is	B-X
an	B-X
important	B-X
post-transcriptional	B-X
regulator	B-X
in	B-X
bacteria	B-X
,	B-X
while	B-X
c-di-GMP	B-X
is	B-X
a	B-X
second	B-X
messenger	B-X
signaling	B-X
molecule	B-X
widely	B-X
distributed	B-X
in	B-X
bacteria	B-X
.	B-X
Therefore	B-X
,	B-X
there	B-X
may	B-X
be	B-X
regulatory	B-X
relationship	B-X
between	B-X
Hfq	B-X
and	B-X
c-di-GMP	B-X
.	B-X
For	B-X
example	B-X
,	B-X
Hfq	B-X
can	B-X
directly	B-X
regulate	B-X
the	B-X
activity	B-X
of	B-X
c-di-GMP	B-X
metabolic	B-X
enzymes	B-X
or	B-X
alter	B-X
the	B-X
c-di-GMP	B-X
level	B-X
through	B-X
other	B-X
systems	B-X
,	B-X
while	B-X
c-di-GMP	B-X
can	B-X
indirectly	B-X
enhance	B-X
or	B-X
inhibit	B-X
the	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
mutation	B-X
in	B-X
the	B-X
polynucleotide	B-X
phosphorylase	B-X
(	B-X
PNPase	B-X
)	B-X
coding	B-X
gene	B-X
pnp	B-X
increases	B-X
the	B-X
levels	B-X
of	B-X
RsmY/Z	B-X
.	B-X
In	B-X
vitro	B-X
translation	B-X
experiments	B-X
demonstrated	B-X
that	B-X
P27	B-X
directly	B-X
represses	B-X
the	B-X
translation	B-X
of	B-X
the	B-X
rhlI	B-X
mRNA	B-X
through	B-X
its	B-X
5'UTR	B-X
in	B-X
an	B-X
Hfq-dependent	B-X
manner	B-X
.	B-X

However	O
this	O
most	O
likely	O
is	O
an	O
underestimate	O
of	O
the	O
true	O
number	O
of	O
proteins	O
that	O
are	O
regulated	O
by	O
Hfq	O
,	O
if	O
accurate	O
protein	O
identifications	O
could	O
be	O
made	O
for	O
the	O
remaining	O
2829	O
orfs	O
of	O
the	O
entire	O
Salmonella	B-Organism
proteome	O
(	O
4450	O
orfs	O
)	O
that	O
are	O
either	O
expressed	O
at	O
levels	O
too	O
low	O
to	O
be	O
detected	O
or	O
not	O
expressed	O
under	O
the	O
four	O
growth	O
conditions	O
employed	O
in	O
this	O
study	O
.	O
<EOS>	B-X
For	B-X
tea	B-X
plants	B-X
,	B-X
nitrogen	B-X
(	B-X
N	B-X
)	B-X
is	B-X
a	B-X
foundational	B-X
element	B-X
and	B-X
large	B-X
quantities	B-X
of	B-X
N	B-X
are	B-X
required	B-X
during	B-X
periods	B-X
of	B-X
roundly	B-X
vigorous	B-X
growth	B-X
.	B-X
However	B-X
,	B-X
the	B-X
fluctuation	B-X
of	B-X
N	B-X
in	B-X
the	B-X
tea	B-X
garden	B-X
could	B-X
not	B-X
always	B-X
meet	B-X
the	B-X
dynamic	B-X
demand	B-X
of	B-X
the	B-X
tea	B-X
plants	B-X
.	B-X
Autophagy	B-X
,	B-X
an	B-X
intracellular	B-X
degradation	B-X
process	B-X
for	B-X
materials	B-X
recycling	B-X
in	B-X
eukaryotes	B-X
,	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
nutrient	B-X
remobilization	B-X
upon	B-X
stressful	B-X
conditions	B-X
and	B-X
leaf	B-X
senescence	B-X
.	B-X
Much	B-X
headway	B-X
has	B-X
been	B-X
made	B-X
in	B-X
understanding	B-X
the	B-X
numerous	B-X
strategies	B-X
that	B-X
enable	B-X
microorganisms	B-X
to	B-X
counteract	B-X
various	B-X
types	B-X
of	B-X
environmental	B-X
stress	B-X
,	B-X
but	B-X
little	B-X
is	B-X
known	B-X
about	B-X
how	B-X
microbial	B-X
populations	B-X
recover	B-X
after	B-X
a	B-X
massive	B-X
death	B-X
caused	B-X
by	B-X
exposure	B-X
to	B-X
extreme	B-X
conditions	B-X
.	B-X

Considering	O
that	O
we	O
observe	O
36	O
%	O
(	O
1621	O
orfs	O
)	O
of	O
the	O
entire	O
Salmonella	B-Organism
proteome	O
(	O
4450	O
orfs	O
)	O
and	O
that	O
50	O
%	O
(	O
781	O
orfs	O
)	O
of	O
this	O
observed	O
proteome	O
(	O
1621	O
orfs	O
)	O
is	O
modulated	O
by	O
Hfq	O
,	O
it	O
would	O
be	O
expected	O
that	O
a	O
significant	O
portion	O
of	O
the	O
unobserved	O
Salmonella	B-Organism
proteome	O
(	O
2829	O
orfs	O
)	O
would	O
also	O
be	O
regulated	O
by	O
Hfq	O
,	O
thus	O
our	O
assertion	O
that	O
the	O
approximately20	O
%	O
value	O
may	O
very	O
well	O
represent	O
an	O
underestimation	O
.	O

Similarly	O
189	O
proteins	O
represents	O
approximately4	O
%	O
when	O
compared	O
to	O
all	O
annotated	O
orfs	O
but	O
again	O
this	O
is	O
likely	O
an	O
underestimate	O
of	O
proteins	O
regulated	O
by	O
SmpB	O
if	O
accurate	O
protein	O
identifications	O
could	O
be	O
made	O
for	O
the	O
remaining	O
2829	O
orfs	O
that	O
are	O
either	O
expressed	O
at	O
levels	O
too	O
low	O
to	O
be	O
detected	O
or	O
not	O
expressed	O
under	O
the	O
four	O
growth	O
conditions	O
employed	O
in	O
this	O
study	O
.	O
<EOS>	B-X
For	B-X
tea	B-X
plants	B-X
,	B-X
nitrogen	B-X
(	B-X
N	B-X
)	B-X
is	B-X
a	B-X
foundational	B-X
element	B-X
and	B-X
large	B-X
quantities	B-X
of	B-X
N	B-X
are	B-X
required	B-X
during	B-X
periods	B-X
of	B-X
roundly	B-X
vigorous	B-X
growth	B-X
.	B-X
However	B-X
,	B-X
the	B-X
fluctuation	B-X
of	B-X
N	B-X
in	B-X
the	B-X
tea	B-X
garden	B-X
could	B-X
not	B-X
always	B-X
meet	B-X
the	B-X
dynamic	B-X
demand	B-X
of	B-X
the	B-X
tea	B-X
plants	B-X
.	B-X
Autophagy	B-X
,	B-X
an	B-X
intracellular	B-X
degradation	B-X
process	B-X
for	B-X
materials	B-X
recycling	B-X
in	B-X
eukaryotes	B-X
,	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
nutrient	B-X
remobilization	B-X
upon	B-X
stressful	B-X
conditions	B-X
and	B-X
leaf	B-X
senescence	B-X
.	B-X
Much	B-X
headway	B-X
has	B-X
been	B-X
made	B-X
in	B-X
understanding	B-X
the	B-X
numerous	B-X
strategies	B-X
that	B-X
enable	B-X
microorganisms	B-X
to	B-X
counteract	B-X
various	B-X
types	B-X
of	B-X
environmental	B-X
stress	B-X
,	B-X
but	B-X
little	B-X
is	B-X
known	B-X
about	B-X
how	B-X
microbial	B-X
populations	B-X
recover	B-X
after	B-X
a	B-X
massive	B-X
death	B-X
caused	B-X
by	B-X
exposure	B-X
to	B-X
extreme	B-X
conditions	B-X
.	B-X

Classification	O
of	O
the	O
Salmonella	B-Organism
proteins	O
deregulated	O
by	O
either	O
Hfq	O
or	O
SmpB	O
by	O
the	O
J	O
.	O

Craig	O
Venter	O
Institute	O
(	O
JCVI	O
)	O
functional	O
categories	O
[	O
32	O
]	O
showed	O
that	O
Hfq	O
modulated	O
the	O
expression	O
of	O
>	O
/	O
=	O
40	O
%	O
of	O
the	O
observed	O
proteins	O
in	O
15	O
of	O
the	O
19	O
functional	O
categories	O
annotated	O
for	O
Salmonella	B-Organism
(	O
Table	O
1	O
)	O
.	O

The	O
"	O
Cellular	O
Processes	O
"	O
functional	O
category	O
represented	O
the	O
category	O
with	O
most	O
genes	O
impacted	O
by	O
Hfq	O
(	O
approximately63	O
%	O
)	O
.	O

This	O
category	O
encompasses	O
sub	O
-	O
categories	O
including	O
adaptations	O
to	O
atypical	O
conditions	O
,	O
cell	O
adhesion	O
,	O
pathogenesis	O
,	O
chemotaxis	O
and	O
motility	O
,	O
detoxification	O
,	O
toxin	O
production	O
and	O
resistance	O
,	O
DNA	O
transformation	O
and	O
cell	O
division	O
.	O

Translational	O
regulation	O
of	O
these	O
genes	O
permits	O
more	O
rapid	O
adaptation	O
than	O
would	O
be	O
required	O
if	O
the	O
genes	O
had	O
to	O
be	O
first	O
transcribed	O
.	O

This	O
observation	O
may	O
explain	O
the	O
acute	O
attenuation	O
in	O
virulence	O
observed	O
for	O
the	O
Deltahfq	O
mutant	O
as	O
well	O
as	O
the	O
previously	O
observed	O
invasion	O
and	O
motility	O
phenotypes	O
of	O
an	O
Deltahfq	O
mutant	O
[	O
10	O
]	O
,	O
[	O
20	O
]	O
.	O

We	O
validated	O
a	O
representative	O
set	O
of	O
proteins	O
by	O
comparing	O
our	O
results	O
with	O
published	O
results	O
.	O
<EOS>	B-X
In	B-X
order	B-X
to	B-X
define	B-X
an	B-X
in	B-X
vitro	B-X
integrated	B-X
testing	B-X
strategy	B-X
(	B-X
ITS	B-X
)	B-X
for	B-X
estrogenicity	B-X
,	B-X
a	B-X
set	B-X
of	B-X
23	B-X
reference	B-X
compounds	B-X
representing	B-X
diverse	B-X
chemical	B-X
classes	B-X
were	B-X
tested	B-X
in	B-X
a	B-X
series	B-X
of	B-X
in	B-X
vitro	B-X
assays	B-X
including	B-X
proliferation	B-X
and	B-X
reporter	B-X
gene	B-X
assays	B-X
.	B-X
Outcomes	B-X
of	B-X
these	B-X
assays	B-X
were	B-X
combined	B-X
with	B-X
published	B-X
results	B-X
for	B-X
estrogen	B-X
receptor	B-X
(	B-X
ER	B-X
)	B-X
binding	B-X
assays	B-X
and	B-X
the	B-X
OECD	B-X
validated	B-X
BG1Luc	B-X
ER	B-X
transcriptional	B-X
activation	B-X
(	B-X
TA	B-X
)	B-X
assay	B-X
and	B-X
compared	B-X
with	B-X
the	B-X
outcomes	B-X
of	B-X
the	B-X
in	B-X
vivo	B-X
uterotrophic	B-X
assay	B-X
to	B-X
investigate	B-X
which	B-X
assays	B-X
most	B-X
accurately	B-X
predict	B-X
the	B-X
in	B-X
vivo	B-X
uterotrophic	B-X
effect	B-X
and	B-X
to	B-X
identify	B-X
discrepancies	B-X
between	B-X
the	B-X
in	B-X
vitro	B-X
assays	B-X
and	B-X
the	B-X
in	B-X
vivo	B-X
uterotrophic	B-X
assay	B-X
.	B-X
With	B-X
the	B-X
development	B-X
of	B-X
next-generation	B-X
sequencing	B-X
technologies	B-X
,	B-X
it	B-X
is	B-X
now	B-X
possible	B-X
to	B-X
sequence	B-X
representative	B-X
subpopulations	B-X
of	B-X
the	B-X
viral	B-X
quasispecies	B-X
.	B-X
The	B-X
selection	B-X
of	B-X
an	B-X
optimal	B-X
set	B-X
of	B-X
features	B-X
characterising	B-X
the	B-X
protein	B-X
interface	B-X
and	B-X
the	B-X
development	B-X
of	B-X
an	B-X
effective	B-X
method	B-X
to	B-X
represent	B-X
and	B-X
capture	B-X
the	B-X
complex	B-X
protein	B-X
recognition	B-X
patterns	B-X
are	B-X
of	B-X
paramount	B-X
importance	B-X
for	B-X
this	B-X
task	B-X
.	B-X

Sittka	O
et	O
al	O
.	O
<EOS>	B-X
Bacterial	B-X
non-coding	B-X
small	B-X
RNAs	B-X
(	B-X
sRNAs	B-X
)	B-X
have	B-X
attracted	B-X
considerable	B-X
attention	B-X
due	B-X
to	B-X
their	B-X
ubiquitous	B-X
nature	B-X
and	B-X
contribution	B-X
to	B-X
numerous	B-X
cellular	B-X
processes	B-X
including	B-X
survival	B-X
,	B-X
adaptation	B-X
and	B-X
pathogenesis	B-X
.	B-X
Existing	B-X
computational	B-X
approaches	B-X
for	B-X
identifying	B-X
bacterial	B-X
sRNAs	B-X
demonstrate	B-X
varying	B-X
levels	B-X
of	B-X
success	B-X
and	B-X
there	B-X
remains	B-X
considerable	B-X
room	B-X
for	B-X
improvement	B-X
.	B-X
Recently	B-X
,	B-X
Queck	B-X
et	B-X
al	B-X
.	B-X

[	O
20	O
]	O
investigated	O
the	O
proteome	O
of	O
an	O
Deltahfq	O
mutant	O
strain	O
using	O
2D	O
gel	O
analysis	O
,	O
and	O
found	O
approximately70	O
differentially	O
expressed	O
proteins	O
in	O
early	O
stationary	O
phase	O
.	O

Across	O
all	O
growth	O
conditions	O
we	O
identified	O
67	O
of	O
the	O
approximately70	O
differentially	O
expressed	O
proteins	O
identified	O
in	O
that	O
study	O
.	O

Furthermore	O
51	O
of	O
the	O
approximately70	O
Hfq	O
-	O
dependent	O
proteins	O
identified	O
by	O
Sittka	O
et	O
al	O
.	O
were	O
also	O
found	O
to	O
be	O
differentially	O
expressed	O
in	O
the	O
present	O
study	O
.	O

The	O
direction	O
of	O
regulation	O
of	O
many	O
of	O
these	O
proteins	O
was	O
in	O
general	O
agreement	O
with	O
the	O
literature	O
including	O
OmpF	O
,	O
DppA	O
,	O
FliC	O
,	O
SurA	O
,	O
and	O
LuxS	O
as	O
shown	O
in	O
Table	O
S3	O
.	O

As	O
best	O
as	O
we	O
can	O
approximate	O
our	O
LB	O
Stat	O
growth	O
condition	O
would	O
most	O
closely	O
match	O
the	O
early	O
stationary	O
phase	O
growth	O
condition	O
described	O
by	O
Sittka	O
et	O
al	O
.	O

[	O
20	O
]	O
and	O
hence	O
one	O
would	O
expect	O
minimal	O
variability	O
in	O
a	O
cross	O
-	O
comparison	O
between	O
both	O
studies	O
under	O
these	O
two	O
growth	O
conditions	O
.	O

Indeed	O
the	O
direction	O
of	O
regulation	O
of	O
21	O
out	O
of	O
22	O
differentially	O
expressed	O
proteins	O
in	O
LB	O
Stat	O
growth	O
is	O
in	O
agreement	O
with	O
the	O
literature	O
providing	O
validation	O
.	O

The	O
exception	O
was	O
the	O
SPI	O
-	O
1	O
protein	O
SipA	O
under	O
LB	O
Stat	O
growth	O
conditions	O
.	O

However	O
under	O
SPI	O
-	O
1	O
inducing	O
conditions	O
(	O
LB	O
Log	O
)	O
regulation	O
of	O
SPI	O
-	O
1	O
proteins	O
by	O
Hfq	O
was	O
generally	O
consistent	O
with	O
the	O
literature	O
.	O

To	O
extend	O
our	O
validation	O
of	O
the	O
proteomics	O
results	O
we	O
also	O
directly	O
analyzed	O
protein	O
levels	O
by	O
Western	O
blot	O
analysis	O
of	O
selected	O
proteins	O
based	O
on	O
our	O
proteomics	O
results	O
.	O

Our	O
proteomics	O
results	O
showed	O
that	O
HtrA	O
protein	O
levels	O
were	O
strongly	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	O
mutant	O
relative	O
to	O
wildtype	O
in	O
LB	O
Log	O
,	O
while	O
OsmY	O
and	O
STM1513	O
were	O
strongly	O
down	O
-	O
regulated	O
in	O
the	O
Deltahfq	O
mutant	O
relative	O
to	O
wildtype	O
in	O
AMM	O
-	O
1	O
and	O
LB	O
Stat	O
respectively	O
.	O

Deletion	O
of	O
SmpB	O
resulted	O
in	O
a	O
significant	O
decrease	O
in	O
protein	O
expression	O
levels	O
of	O
FliC	O
under	O
LB	O
Log	O
and	O
a	O
significant	O
increase	O
in	O
the	O
protein	O
levels	O
of	O
YciF	O
in	O
AMM	O
-	O
2	O
.	O

Western	O
blot	O
analysis	O
of	O
the	O
relative	O
protein	O
levels	O
of	O
each	O
of	O
HtrA	O
,	O
OsmY	O
,	O
STM1513	O
,	O
FliC	O
,	O
and	O
YciF	O
(	O
Figure	O
S2	O
)	O
served	O
to	O
further	O
verify	O
our	O
global	O
proteomics	O
measurements	O
.	O

As	O
transcript	O
levels	O
are	O
often	O
equated	O
to	O
protein	O
expression	O
levels	O
,	O
it	O
was	O
of	O
particular	O
interest	O
to	O
determine	O
whether	O
genes	O
that	O
showed	O
significant	O
changes	O
in	O
protein	O
expression	O
also	O
exhibited	O
significant	O
changes	O
in	O
transcript	O
levels	O
.	O

Examination	O
of	O
transcript	O
levels	O
using	O
microarray	O
analysis	O
(	O
>	O
/	O
=	O
2	O
-	O
fold	O
change	O
)	O
revealed	O
a	O
more	O
modest	O
effect	O
on	O
Salmonella	B-Organism
transcription	O
,	O
with	O
approximately11	O
%	O
(	O
492	O
genes	O
)	O
and	O
approximately8	O
%	O
(	O
370	O
genes	O
)	O
of	O
the	O
Salmonella	B-Organism
Typhimurium	I-Organism
genome	O
(	O
4550	O
genes	O
;	O
[	O
31	O
]	O
)	O
under	O
control	O
of	O
Hfq	O
and	O
SmpB	O
,	O
respectively	O
(	O
Table	O
S4	O
)	O
.	O

The	O
result	O
for	O
hfq	O
transcriptional	O
analysis	O
is	O
in	O
general	O
agreement	O
with	O
previous	O
studies	O
for	O
Salmonella	B-Organism
[	O
10	O
]	O
and	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
[	O
33	O
]	O
where	O
approximately20	O
%	O
and	O
approximately15	O
%	O
of	O
all	O
genes	O
,	O
respectively	O
,	O
were	O
regulated	O
by	O
Hfq	O
,	O
but	O
slightly	O
higher	O
than	O
the	O
number	O
of	O
Hfq	O
-	O
dependent	O
genes	O
reported	O
for	O
E	B-Organism
.	I-Organism
coli	I-Organism
[	O
27	O
]	O
and	O
Vibrio	B-Organism
cholerae	I-Organism
[	O
21	O
]	O
,	O
approximately6	O
%	O
each	O
.	O

In	O
light	O
of	O
the	O
fact	O
that	O
these	O
studies	O
employed	O
varying	O
growth	O
conditions	O
it	O
is	O
not	O
possible	O
to	O
perform	O
a	O
rigorous	O
direct	O
comparison	O
across	O
these	O
diverse	O
datasets	O
.	O

However	O
it	O
is	O
worth	O
noting	O
that	O
our	O
observation	O
that	O
Hfq	O
strongly	O
regulates	O
flagellar	O
genes	O
and	O
SPI	O
-	O
1	O
TTSS	O
genes	O
,	O
discussed	O
below	O
,	O
is	O
consistent	O
with	O
previous	O
results	O
in	O
Salmonella	B-Organism
[	O
10	O
]	O
,	O
[	O
20	O
]	O
.	O

Overall	O
,	O
the	O
transcription	O
data	O
showed	O
fewer	O
discernable	O
patterns	O
of	O
regulation	O
by	O
Hfq	O
or	O
SmpB	O
relative	O
to	O
the	O
proteome	O
analysis	O
,	O
and	O
comparison	O
across	O
all	O
growth	O
conditions	O
revealed	O
little	O
overlap	O
in	O
proteins	O
and	O
transcripts	O
regulated	O
by	O
either	O
Hfq	O
or	O
SmpB	O
(	O
Figure	O
3	O
)	O
.	O

Of	O
the	O
781	O
proteins	O
and	O
492	O
transcripts	O
regulated	O
by	O
Hfq	O
,	O
113	O
genes	O
overlapped	O
both	O
sets	O
.	O

For	O
SmpB	O
-	O
regulated	O
proteins	O
(	O
189	O
)	O
and	O
transcripts	O
(	O
370	O
)	O
there	O
was	O
an	O
overlap	O
of	O
20	O
genes	O
.	O

Given	O
the	O
fact	O
that	O
the	O
present	O
study	O
specifically	O
examines	O
the	O
effects	O
of	O
two	O
translational	O
regulators	O
,	O
which	O
decouple	O
transcription	O
and	O
translation	O
,	O
a	O
lack	O
of	O
correlation	O
between	O
transcriptomics	O
and	O
proteomics	O
might	O
be	O
expected	O
.	O

Overall	O
Hfq	O
has	O
a	O
much	O
stronger	O
global	O
effect	O
on	O
Salmonella	B-Organism
protein	O
translation	O
than	O
SmpB	O
which	O
is	O
in	O
agreement	O
with	O
the	O
large	O
number	O
of	O
regulatory	O
sRNAs	O
that	O
serve	O
as	O
guides	O
for	O
Hfq	O
translational	O
modulation	O
as	O
opposed	O
to	O
the	O
single	O
regulatory	O
sRNA	O
(	O
i	O
.	O
e	O
.	O
tmRNA	O
)	O
that	O
requires	O
SmpB	O
for	O
activity	O
.	O

Hfq	O
control	O
of	O
biological	O
processes	O
<EOS>	B-X
The	B-X
formation	B-X
and	B-X
composition	B-X
of	B-X
photosynthetic	B-X
complexes	B-X
has	B-X
to	B-X
be	B-X
tightly	B-X
controlled	B-X
in	B-X
response	B-X
to	B-X
environmental	B-X
conditions	B-X
,	B-X
as	B-X
exposure	B-X
to	B-X
sunlight	B-X
can	B-X
be	B-X
harmful	B-X
due	B-X
to	B-X
the	B-X
generation	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
and	B-X
the	B-X
damaging	B-X
effects	B-X
of	B-X
UV	B-X
irradiation	B-X
.	B-X
The	B-X
trans-acting	B-X
small	B-X
non-coding	B-X
RNAs	B-X
(	B-X
sRNAs	B-X
)	B-X
,	B-X
PcrZ	B-X
and	B-X
PsrR1	B-X
,	B-X
control	B-X
pigment	B-X
and	B-X
photosystem	B-X
biogenesis	B-X
in	B-X
Rhodobacter	B-X
sphaeroides	B-X
and	B-X
cyanobacteria	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
creation	B-X
,	B-X
destruction	B-X
and	B-X
activity	B-X
of	B-X
RNA	B-X
must	B-X
be	B-X
well	B-X
controlled	B-X
and	B-X
tightly	B-X
synchronized	B-X
with	B-X
numerous	B-X
cellular	B-X
processes	B-X
.	B-X
We	B-X
discuss	B-X
here	B-X
the	B-X
pathways	B-X
and	B-X
mechanism	B-X
of	B-X
bacterial	B-X
RNA	B-X
turnover	B-X
,	B-X
and	B-X
describe	B-X
how	B-X
RNA	B-X
itself	B-X
modulates	B-X
these	B-X
processes	B-X
as	B-X
part	B-X
of	B-X
decision-making	B-X
networks	B-X
.	B-X
The	B-X
central	B-X
roles	B-X
of	B-X
RNA	B-X
decay	B-X
and	B-X
other	B-X
aspects	B-X
of	B-X
RNA	B-X
metabolism	B-X
in	B-X
cellular	B-X
control	B-X
are	B-X
also	B-X
suggested	B-X
by	B-X
their	B-X
vulnerability	B-X
to	B-X
sabotage	B-X
by	B-X
phages	B-X
;	B-X
nonetheless	B-X
,	B-X
RNA	B-X
can	B-X
be	B-X
used	B-X
in	B-X
defense	B-X
against	B-X
phage	B-X
infection	B-X
,	B-X
and	B-X
these	B-X
processes	B-X
are	B-X
described	B-X
here	B-X
.	B-X

While	O
the	O
role	O
of	O
Hfq	O
as	O
a	O
global	O
regulator	O
has	O
become	O
increasingly	O
appreciated	O
over	O
the	O
past	O
few	O
years	O
,	O
the	O
actual	O
extent	O
of	O
Hfq	O
regulation	O
of	O
translation	O
remains	O
unknown	O
.	O

We	O
observed	O
changes	O
in	O
expression	O
for	O
approximately50	O
%	O
of	O
the	O
observed	O
Salmonella	B-Organism
Typhimurium	I-Organism
proteome	O
based	O
on	O
an	O
ANOVA	O
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
(	O
Table	O
S1	O
)	O
.	O

The	O
proteins	O
affected	O
represent	O
a	O
broad	O
spectrum	O
of	O
Salmonella	B-Organism
proteins	O
required	O
for	O
many	O
biological	O
processes	O
including	O
general	O
metabolism	O
,	O
the	O
translational	O
machinery	O
,	O
stress	O
response	O
,	O
and	O
virulence	O
-	O
assocaited	O
processes	O
as	O
described	O
next	O
.	O

General	O
metabolism	O
Proteome	O
profiling	O
data	O
suggested	O
Hfq	O
regulates	O
nucleoside	O
(	O
DeoABC	O
)	O
and	O
nucleotide	O
metabolism	O
(	O
CarAB	O
,	O
PurUBCMHAD	O
,	O
Ndk	O
)	O
under	O
AMM	O
conditions	O
,	O
as	O
well	O
as	O
regulates	O
ribose	O
metabolism	O
and	O
transport	O
(	O
RbsABK	O
)	O
under	O
AMM	O
-	O
2	O
.	O

Hfq	O
also	O
appears	O
to	O
play	O
a	O
significant	O
role	O
in	O
central	O
metabolism	O
based	O
on	O
observed	O
differential	O
regulation	O
of	O
numerous	O
proteins	O
involved	O
in	O
glycolysis	O
/	O
gluconeogenesis	O
,	O
the	O
TCA	O
pathway	O
,	O
pyruvate	O
decarboxylation	O
and	O
the	O
pentose	O
phosphate	O
shunt	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Other	O
metabolic	O
processes	O
regulated	O
by	O
Hfq	O
include	O
Fatty	O
acid	O
metabolism	O
(	O
FadA	O
,	O
FadB	O
,	O
FabA	O
,	O
FabZ	O
,	O
fbab	O
,	O
AccB	O
,	O
Acs	O
,	O
FabG	O
,	O
FabF	O
,	O
FabI	O
,	O
FabB	O
)	O
;	O
Arginine	O
catabolism	O
(	O
AstABCD	O
)	O
;	O
and	O
Propanoite	O
catabolism	O
(	O
PrpBCDE	O
)	O
.	O

Examination	O
of	O
the	O
transcript	O
levels	O
of	O
the	O
corresponding	O
genes	O
showed	O
no	O
significant	O
change	O
in	O
mRNA	O
expression	O
levels	O
relative	O
to	O
wildtype	O
,	O
suggesting	O
that	O
Hfq	O
provides	O
most	O
of	O
the	O
control	O
of	O
these	O
pathways	O
for	O
the	O
growth	O
conditions	O
monitored	O
.	O

Translation	O
<EOS>	B-X
Translation	B-X
memory	B-X
technology	B-X
can	B-X
solve	B-X
many	B-X
practical	B-X
problems	B-X
,	B-X
especially	B-X
in	B-X
the	B-X
machinery	B-X
manufacturing	B-X
industry	B-X
,	B-X
processing	B-X
some	B-X
sentences	B-X
in	B-X
documents	B-X
,	B-X
which	B-X
can	B-X
reduce	B-X
repetitive	B-X
labor	B-X
,	B-X
unify	B-X
vocabulary	B-X
,	B-X
and	B-X
make	B-X
translation	B-X
styles	B-X
more	B-X
coordinated	B-X
.	B-X

Hfq	O
also	O
appears	O
to	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
the	O
translational	O
machinery	O
itself	O
presumably	O
as	O
a	O
feedback	O
mechanism	O
to	O
maintain	O
tight	O
control	O
over	O
the	O
amount	O
of	O
ribosomal	O
synthesis	O
.	O

Several	O
ribosomal	O
proteins	O
including	O
RpsM	O
,	O
RpsG	O
,	O
RpmD	O
,	O
and	O
RplN	O
exhibited	O
a	O
marked	O
reduction	O
in	O
both	O
protein	O
and	O
mRNA	O
levels	O
in	O
the	O
Deltahfq	O
mutant	O
strain	O
compared	O
to	O
the	O
wildtype	O
under	O
LB	O
Stat	O
growth	O
condition	O
.	O

One	O
hallmark	O
of	O
growth	O
under	O
nutrient	O
poor	O
conditions	O
is	O
lower	O
expression	O
of	O
the	O
machinery	O
necessary	O
to	O
synthesize	O
proteins	O
,	O
including	O
tRNA	O
synthetases	O
and	O
other	O
factors	O
.	O

In	O
fact	O
all	O
of	O
the	O
aminoacyl	O
-	O
tRNA	O
synthetases	O
(	O
IleS	O
,	O
ProS	O
,	O
CysS	O
,	O
GlnS	O
,	O
AspS	O
,	O
ArgS	O
,	O
GltX	O
,	O
AlaS	O
,	O
TrpS	O
,	O
GlyS	O
,	O
GlyQ	O
)	O
observed	O
were	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	O
mutant	O
relative	O
to	O
the	O
wild	O
type	O
without	O
a	O
concurrent	O
change	O
in	O
transcription	O
.	O

This	O
suggests	O
that	O
Hfq	O
normally	O
represses	O
translation	O
of	O
these	O
genes	O
under	O
conditions	O
that	O
mimics	O
the	O
intracellular	O
environment	O
(	O
AMM	O
)	O
.	O

Stress	O
response	O
<EOS>	B-X
This	B-X
review	B-X
aims	B-X
to	B-X
comprehensively	B-X
describe	B-X
individual	B-X
stress	B-X
responses	B-X
in	B-X
Rhodococcus	B-X
strains	B-X
,	B-X
the	B-X
interconnection	B-X
of	B-X
different	B-X
types	B-X
of	B-X
stresses	B-X
and	B-X
their	B-X
consequences	B-X
for	B-X
cell	B-X
physiology	B-X
.	B-X
We	B-X
examine	B-X
here	B-X
the	B-X
responses	B-X
to	B-X
(	B-X
1	B-X
)	B-X
environmental	B-X
stresses	B-X
(	B-X
desiccation	B-X
,	B-X
heat	B-X
,	B-X
cold	B-X
,	B-X
osmotic	B-X
and	B-X
pH	B-X
stress	B-X
)	B-X
,	B-X
(	B-X
2	B-X
)	B-X
the	B-X
presence	B-X
of	B-X
stress-inducing	B-X
compounds	B-X
(	B-X
metals	B-X
,	B-X
organic	B-X
compounds	B-X
and	B-X
antibiotics	B-X
)	B-X
in	B-X
the	B-X
environment	B-X
(	B-X
3	B-X
)	B-X
starvation	B-X
and	B-X
(	B-X
4	B-X
)	B-X
stresses	B-X
encountered	B-X
during	B-X
biotechnological	B-X
applications	B-X
.	B-X
The	B-X
roles	B-X
of	B-X
sigma	B-X
factors	B-X
of	B-X
RNA	B-X
polymerase	B-X
in	B-X
the	B-X
global	B-X
regulation	B-X
of	B-X
stress	B-X
responses	B-X
in	B-X
rhodococci	B-X
are	B-X
described	B-X
as	B-X
well	B-X
.	B-X
Although	B-X
the	B-X
review	B-X
covers	B-X
a	B-X
large	B-X
number	B-X
of	B-X
stressful	B-X
conditions	B-X
,	B-X
our	B-X
intention	B-X
was	B-X
to	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
the	B-X
selected	B-X
stress	B-X
responses	B-X
and	B-X
their	B-X
possible	B-X
connection	B-X
to	B-X
biotechnological	B-X
processes	B-X
,	B-X
not	B-X
an	B-X
exhaustive	B-X
survey	B-X
of	B-X
the	B-X
scientific	B-X
literature	B-X
.	B-X
The	B-X
findings	B-X
on	B-X
stress	B-X
responses	B-X
summarized	B-X
in	B-X
this	B-X
review	B-X
and	B-X
the	B-X
demonstration	B-X
of	B-X
gaps	B-X
in	B-X
current	B-X
knowledge	B-X
may	B-X
motivate	B-X
researchers	B-X
working	B-X
to	B-X
fill	B-X
these	B-X
gaps	B-X
.	B-X

Hfq	O
was	O
observed	O
to	O
modulate	O
numerous	O
proteins	O
involved	O
in	O
envelope	O
stress	O
under	O
AMM	O
-	O
2	O
conditions	O
,	O
including	O
FkpA	O
,	O
SurA	O
,	O
HtrA	O
,	O
NlpB	O
,	O
NmpC	O
,	O
ClpA	O
,	O
SlyD	O
,	O
RseA	O
,	O
RseB	O
,	O
RpoE	O
,	O
OmpF	O
,	O
and	O
HtpG	O
,	O
which	O
were	O
all	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	O
mutant	O
strain	O
.	O

These	O
observations	O
are	O
in	O
agreement	O
with	O
the	O
recently	O
suggested	O
role	O
of	O
Hfq	O
in	O
envelope	O
stress	O
based	O
on	O
lacZ	O
translational	O
fusions	O
[	O
34	O
]	O
as	O
well	O
as	O
the	O
observation	O
that	O
rpoE	O
is	O
translationally	O
regulated	O
by	O
Hfq	O
[	O
10	O
]	O
.	O

Proteins	O
involved	O
in	O
oxidative	O
stress	O
(	O
NarY	O
,	O
Qor	O
,	O
Dps	O
,	O
WraB	O
,	O
OxyR	O
,	O
GrxA	O
,	O
Gor	O
,	O
GrxB	O
,	O
KatG	O
,	O
KatE	O
,	O
SodC	O
,	O
SodB	O
,	O
AhpF	O
)	O
;	O
acid	O
stress	O
(	O
CadA	O
)	O
;	O
and	O
starvation	O
(	O
SspA	O
,	O
SspB	O
)	O
were	O
all	O
also	O
differentially	O
regulated	O
by	O
Hfq	O
(	O
Table	O
S1	O
)	O
.	O

Collectively	O
,	O
these	O
results	O
point	O
to	O
a	O
central	O
role	O
for	O
Hfq	O
in	O
regulating	O
stress	O
response	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
.	O

Many	O
of	O
these	O
genes	O
are	O
required	O
for	O
virulence	O
as	O
discussed	O
in	O
more	O
detail	O
below	O
.	O

For	O
example	O
rpoE	O
has	O
been	O
shown	O
to	O
be	O
required	O
for	O
the	O
virulence	O
of	O
Salmonella	B-Organism
Typhimurium	I-Organism
[	O
35	O
]	O
.	O

Two	O
RpoE	O
-	O
regulated	O
genes	O
,	O
htrA	O
and	O
surA	O
,	O
have	O
also	O
been	O
shown	O
to	O
be	O
involved	O
in	O
Salmonella	B-Organism
virulence	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

The	O
OxyR	O
-	O
regulated	O
gene	O
dps	O
was	O
demonstrated	O
to	O
contribute	O
to	O
Salmonella	B-Organism
oxidative	O
stress	O
resistance	O
,	O
survival	O
in	O
macrophages	O
,	O
and	O
virulence	O
in	O
mice	B-Organism
[	O
38	O
]	O
.	O

Recent	O
studies	O
have	O
shown	O
the	O
periplasmic	O
Cu	O
,	O
Zn	O
-	O
superoxide	O
dismutase	O
sodC	O
to	O
contribute	O
to	O
Salmonella	B-Organism
virulence	O
in	O
mice	B-Organism
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

Virulence	O
-	O
associated	O
<EOS>	B-X
Virulence	B-X
factor	B-X
production	B-X
by	B-X
pathogenic	B-X
bacteria	B-X
is	B-X
one	B-X
of	B-X
the	B-X
important	B-X
traits	B-X
that	B-X
is	B-X
under	B-X
the	B-X
control	B-X
of	B-X
QS	B-X
.	B-X
A	B-X
growing	B-X
body	B-X
of	B-X
evidence	B-X
has	B-X
indicated	B-X
the	B-X
role	B-X
of	B-X
the	B-X
nutritional	B-X
environment	B-X
notably	B-X
by	B-X
carbohydrates	B-X
in	B-X
dictating	B-X
the	B-X
QS-associated	B-X
virulence	B-X
gene	B-X
regulation	B-X
.	B-X
The	B-X
dissemination	B-X
of	B-X
resistance	B-X
is	B-X
associated	B-X
with	B-X
genetic	B-X
mobile	B-X
elements	B-X
,	B-X
such	B-X
as	B-X
plasmids	B-X
,	B-X
that	B-X
may	B-X
also	B-X
carry	B-X
virulence	B-X
determinants	B-X
.	B-X
This	B-X
paradoxical	B-X
evolution	B-X
,	B-X
which	B-X
is	B-X
not	B-X
unique	B-X
to	B-X
members	B-X
of	B-X
the	B-X
genus	B-X
Rickettsia	B-X
but	B-X
has	B-X
been	B-X
identified	B-X
as	B-X
a	B-X
convergent	B-X
evolution	B-X
of	B-X
several	B-X
major	B-X
human	B-X
pathogenic	B-X
bacteria	B-X
,	B-X
parallels	B-X
a	B-X
selected	B-X
loss	B-X
of	B-X
genes	B-X
associated	B-X
with	B-X
transcriptional	B-X
regulators	B-X
,	B-X
but	B-X
with	B-X
a	B-X
high	B-X
preservation	B-X
of	B-X
toxin-antitoxin	B-X
(	B-X
TA	B-X
)	B-X
modules	B-X
and	B-X
recombination	B-X
and	B-X
DNA	B-X
repair	B-X
proteins	B-X
.	B-X

LPS	O
(	O
lipopolysaccharide	O
)	O
has	O
long	O
been	O
known	O
as	O
an	O
essential	O
component	O
of	O
virulence	O
of	O
Gram	O
negative	O
pathogens	O
and	O
,	O
more	O
recently	O
,	O
the	O
agonist	O
for	O
toll	O
like	O
receptor	O
4	O
.	O

Hfq	O
differentially	O
regulated	O
the	O
expression	O
of	O
several	O
proteins	O
involved	O
in	O
lipopolysaccharides	O
(	O
LPS	O
)	O
biosynthesis	O
in	O
acidic	O
minimal	O
media	O
.	O

LpxA	O
and	O
LpxD	O
involved	O
in	O
Lipid	O
A	O
synthesis	O
,	O
TolC	O
involved	O
in	O
LPS	O
Core	O
completion	O
,	O
as	O
well	O
as	O
proteins	O
involved	O
in	O
O	O
-	O
antigen	O
synthesis	O
(	O
RfbACKMGJU	O
)	O
,	O
appeared	O
as	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	O
mutant	O
strain	O
suggesting	O
that	O
Hfq	O
may	O
normally	O
down	O
regulate	O
expression	O
within	O
the	O
host	O
.	O

Complementary	O
transcriptional	O
analysis	O
revealed	O
no	O
change	O
in	O
the	O
corresponding	O
mRNA	O
levels	O
relative	O
to	O
the	O
wildtype	O
.	O

Reduced	O
expression	O
of	O
LPS	O
and	O
alterations	O
in	O
LPS	O
modification	O
has	O
been	O
reported	O
for	O
intracellular	O
Salmonella	B-Organism
[	O
41	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

Our	O
results	O
suggest	O
Hfq	O
plays	O
a	O
role	O
in	O
the	O
post	O
-	O
transcriptional	O
regulation	O
of	O
several	O
two	O
component	O
systems	O
including	O
three	O
that	O
have	O
been	O
shown	O
to	O
be	O
essential	O
for	O
virulence	O
in	O
a	O
variety	O
of	O
animal	O
models	O
;	O
SsrA	O
/	O
B	O
,	O
PhoP	O
/	O
Q	O
,	O
and	O
OmpR	O
/	O
EnvZ	O
.	O

Two	O
component	O
systems	O
are	O
widespread	O
methods	O
of	O
sensing	O
external	O
conditions	O
and	O
responding	O
by	O
altering	O
gene	O
expression	O
in	O
prokaryotes	O
,	O
eukaryotes	O
and	O
archaea	O
.	O

Well	O
known	O
two	O
component	O
regulators	O
respond	O
to	O
osmolarity	O
,	O
nitrogen	O
and	O
oxygen	O
limitation	O
[	O
44	O
]	O
,	O
[	O
45	O
]	O
.	O

As	O
such	O
,	O
they	O
are	O
critical	O
to	O
the	O
ability	O
of	O
pathogenic	O
bacteria	O
to	O
adapt	O
and	O
survive	O
following	O
environmental	O
changes	O
.	O

In	O
addition	O
to	O
the	O
three	O
mentioned	O
above	O
Hfq	O
negatively	O
modulates	O
PhoB	O
involved	O
in	O
the	O
phosphate	O
starvation	O
response	O
,	O
RstA	O
,	O
NarP	O
,	O
RcsB	O
,	O
BasR	O
,	O
and	O
CpxR	O
.	O

Microarray	O
analysis	O
showed	O
no	O
effect	O
on	O
transcription	O
of	O
these	O
genes	O
.	O
<EOS>	B-X
It	B-X
is	B-X
likely	B-X
that	B-X
HPV	B-X
gene	B-X
products	B-X
also	B-X
alter	B-X
expression	B-X
of	B-X
cellular	B-X
genes	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
used	B-X
microarray	B-X
analysis	B-X
to	B-X
examine	B-X
the	B-X
global	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
induced	B-X
by	B-X
high-risk	B-X
HPV	B-X
type	B-X
31	B-X
(	B-X
HPV31	B-X
)	B-X
.	B-X
Among	B-X
7,075	B-X
known	B-X
genes	B-X
and	B-X
ESTs	B-X
(	B-X
expressed	B-X
sequence	B-X
tags	B-X
)	B-X
tested	B-X
,	B-X
we	B-X
found	B-X
that	B-X
178	B-X
were	B-X
upregulated	B-X
and	B-X
150	B-X
were	B-X
downregulated	B-X
twofold	B-X
or	B-X
more	B-X
in	B-X
HPV31	B-X
cells	B-X
compared	B-X
to	B-X
normal	B-X
human	B-X
keratinocytes	B-X
.	B-X
While	B-X
no	B-X
specific	B-X
pattern	B-X
could	B-X
be	B-X
deduced	B-X
from	B-X
the	B-X
list	B-X
of	B-X
genes	B-X
that	B-X
were	B-X
upregulated	B-X
,	B-X
downregulated	B-X
genes	B-X
could	B-X
be	B-X
classified	B-X
to	B-X
three	B-X
groups	B-X
:	B-X
genes	B-X
that	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cell	B-X
growth	B-X
,	B-X
genes	B-X
that	B-X
are	B-X
specifically	B-X
expressed	B-X
in	B-X
keratinocytes	B-X
,	B-X
and	B-X
genes	B-X
whose	B-X
expression	B-X
is	B-X
increased	B-X
in	B-X
response	B-X
to	B-X
interferon	B-X
stimulation	B-X
.	B-X
The	B-X
basal	B-X
level	B-X
of	B-X
expression	B-X
of	B-X
several	B-X
interferon-responsive	B-X
genes	B-X
was	B-X
found	B-X
to	B-X
be	B-X
downregulated	B-X
in	B-X
HPV31	B-X
cells	B-X
by	B-X
both	B-X
microarray	B-X
analysis	B-X
and	B-X
Northern	B-X
blot	B-X
analysis	B-X
in	B-X
different	B-X
HPV31	B-X
cell	B-X
lines	B-X
.	B-X
When	B-X
cells	B-X
were	B-X
treated	B-X
with	B-X
alpha	B-X
or	B-X
gamma	B-X
interferon	B-X
,	B-X
expression	B-X
of	B-X
interferon-inducible	B-X
genes	B-X
was	B-X
impaired	B-X
.	B-X
At	B-X
high	B-X
doses	B-X
of	B-X
interferon	B-X
,	B-X
the	B-X
effects	B-X
were	B-X
less	B-X
pronounced	B-X
.	B-X
Among	B-X
the	B-X
genes	B-X
repressed	B-X
by	B-X
HPV31	B-X
was	B-X
the	B-X
signal	B-X
transducer	B-X
and	B-X
activator	B-X
of	B-X
transcription	B-X
(	B-X
Stat-1	B-X
)	B-X
,	B-X
which	B-X
plays	B-X
a	B-X
major	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
interferon	B-X
response	B-X
.	B-X

Salmonella	B-Organism
motility	O
enhances	O
cell	O
contact	O
thereby	O
increasing	O
host	O
cell	O
invasion	O
.	O

A	O
recent	O
study	O
showed	O
that	O
an	O
Deltahfq	O
mutant	O
that	O
was	O
non	O
-	O
motile	O
exhibited	O
an	O
invasion	O
defect	O
[	O
20	O
]	O
.	O

Analysis	O
of	O
protein	O
expression	O
in	O
the	O
Deltahfq	O
strain	O
showed	O
reduced	O
expression	O
of	O
SPI	O
-	O
1	O
TTSS	O
components	O
and	O
the	O
flagellar	O
subunit	O
protein	O
FliC	O
compared	O
to	O
the	O
wildtype	O
Salmonella	B-Organism
strain	O
.	O

Consistent	O
with	O
this	O
previous	O
study	O
,	O
we	O
observed	O
reduced	O
expression	O
of	O
SPI	O
-	O
1	O
invasion	O
proteins	O
and	O
numerous	O
motility	O
proteins	O
in	O
the	O
Deltahfq	O
mutant	O
strain	O
primarily	O
in	O
the	O
log	O
phase	O
growth	O
condition	O
compared	O
to	O
the	O
wildtype	O
strain	O
.	O

Among	O
the	O
SPI	O
-	O
1	O
invasion	O
proteins	O
were	O
PrgI	O
,	O
SptP	O
,	O
SipD	O
,	O
SicA	O
,	O
InvC	O
and	O
InvG	O
,	O
and	O
the	O
motility	O
proteins	O
FliC	O
,	O
FliT	O
,	O
FliB	O
,	O
CheZ	O
,	O
CheY	O
,	O
and	O
CheW	O
.	O

Microarray	O
results	O
revealed	O
a	O
reduction	O
in	O
mRNA	O
expression	O
of	O
the	O
SPI	O
-	O
1	O
TTSS	O
and	O
several	O
flagellar	O
proteins	O
,	O
including	O
FliC	O
,	O
FliO	O
,	O
and	O
FliN	O
grown	O
under	O
LB	O
Log	O
growth	O
conditions	O
.	O

This	O
reduction	O
in	O
mRNA	O
expression	O
suggests	O
that	O
Hfq	O
regulates	O
motility	O
and	O
invasion	O
at	O
the	O
transcription	O
level	O
,	O
presumably	O
by	O
modulating	O
one	O
of	O
the	O
upstream	O
regulators	O
.	O

Regulatory	O
elements	O
are	O
generally	O
not	O
made	O
at	O
high	O
levels	O
and	O
thus	O
difficult	O
to	O
identify	O
and	O
quantify	O
.	O
<EOS>	B-X
[	B-X
1	B-X
]	B-X
previously	B-X
analyzed	B-X
the	B-X
pharmacokinetics	B-X
of	B-X
aluminum	B-X
for	B-X
infant	B-X
dietary	B-X
and	B-X
vaccine	B-X
exposures	B-X
and	B-X
compared	B-X
the	B-X
resulting	B-X
body	B-X
burdens	B-X
to	B-X
those	B-X
based	B-X
on	B-X
the	B-X
minimal	B-X
risk	B-X
levels	B-X
(	B-X
MRLs	B-X
)	B-X
established	B-X
by	B-X
the	B-X
Agency	B-X
for	B-X
Toxic	B-X
Substances	B-X
and	B-X
Disease	B-X
Registry	B-X
.	B-X
[	B-X
1	B-X
]	B-X
with	B-X
a	B-X
current	B-X
pediatric	B-X
vaccination	B-X
schedule	B-X
[	B-X
2	B-X
]	B-X
;	B-X
baseline	B-X
aluminum	B-X
levels	B-X
at	B-X
birth	B-X
;	B-X
an	B-X
aluminum	B-X
retention	B-X
function	B-X
that	B-X
reflects	B-X
changing	B-X
glomerular	B-X
filtration	B-X
rates	B-X
in	B-X
infants	B-X
;	B-X
an	B-X
adjustment	B-X
for	B-X
the	B-X
kinetics	B-X
of	B-X
aluminum	B-X
efflux	B-X
at	B-X
the	B-X
site	B-X
of	B-X
injection	B-X
;	B-X
contemporaneous	B-X
MRLs	B-X
;	B-X
and	B-X
the	B-X
most	B-X
recent	B-X
infant	B-X
body	B-X
weight	B-X
data	B-X
for	B-X
children	B-X
0-60	B-X
months	B-X
of	B-X
age	B-X
[	B-X
3	B-X
]	B-X
.	B-X
Interspecific	B-X
gene	B-X
flow	B-X
is	B-X
thus	B-X
increasingly	B-X
thought	B-X
to	B-X
lead	B-X
to	B-X
evolutionary	B-X
innovation	B-X
and	B-X
diversification	B-X
,	B-X
via	B-X
adaptive	B-X
introgression	B-X
,	B-X
homoploid	B-X
hybrid	B-X
speciation	B-X
and	B-X
allopolyploid	B-X
speciation	B-X
.	B-X
We	B-X
highlight	B-X
both	B-X
these	B-X
novel	B-X
combinatorial	B-X
possibilities	B-X
and	B-X
the	B-X
range	B-X
of	B-X
temporal	B-X
scales	B-X
over	B-X
which	B-X
such	B-X
complexity	B-X
might	B-X
be	B-X
generated	B-X
,	B-X
and	B-X
thus	B-X
exposed	B-X
to	B-X
natural	B-X
selection	B-X
and	B-X
drift	B-X
.	B-X

Analysis	O
of	O
our	O
data	O
however	O
demonstrated	O
the	O
upstream	O
regulator	O
for	O
motility	O
flgM	O
[	O
46	O
]	O
was	O
poorly	O
expressed	O
in	O
an	O
Deltahfq	O
mutant	O
.	O

Propanediol	O
utilization	O
operon	O
<EOS>	B-X
The	B-X
propanediol	B-X
utilization	B-X
(	B-X
pdu	B-X
)	B-X
operon	B-X
of	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
LT2	B-X
contains	B-X
genes	B-X
needed	B-X
for	B-X
the	B-X
coenzyme	B-X
B	B-X
(	B-X
12	B-X
)	B-X
-dependent	B-X
catabolism	B-X
of	B-X
1,2-propanediol	B-X
.	B-X
Here	B-X
the	B-X
completed	B-X
DNA	B-X
sequence	B-X
of	B-X
the	B-X
pdu	B-X
operon	B-X
is	B-X
presented	B-X
.	B-X
Analyses	B-X
of	B-X
previously	B-X
unpublished	B-X
pdu	B-X
DNA	B-X
sequence	B-X
substantiated	B-X
previous	B-X
studies	B-X
indicating	B-X
that	B-X
the	B-X
pdu	B-X
operon	B-X
was	B-X
acquired	B-X
by	B-X
horizontal	B-X
gene	B-X
transfer	B-X
and	B-X
allowed	B-X
the	B-X
identification	B-X
of	B-X
16	B-X
hypothetical	B-X
genes	B-X
.	B-X
This	B-X
brings	B-X
the	B-X
total	B-X
number	B-X
of	B-X
genes	B-X
in	B-X
the	B-X
pdu	B-X
operon	B-X
to	B-X
21	B-X
and	B-X
the	B-X
total	B-X
number	B-X
of	B-X
genes	B-X
at	B-X
the	B-X
pdu	B-X
locus	B-X
to	B-X
23	B-X
.	B-X
Genetic	B-X
tests	B-X
demonstrate	B-X
that	B-X
genes	B-X
of	B-X
the	B-X
pdu	B-X
operon	B-X
are	B-X
required	B-X
for	B-X
polyhedral	B-X
body	B-X
formation	B-X
,	B-X
and	B-X
immunoelectron	B-X
microscopy	B-X
shows	B-X
that	B-X
AdoCbl-dependent	B-X
diol	B-X
dehydratase	B-X
is	B-X
associated	B-X
with	B-X
these	B-X
polyhedra	B-X
.	B-X

The	O
cob	O
operon	O
is	O
required	O
for	O
the	O
de	O
novo	O
biosynthesis	O
of	O
vitamin	O
B12	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
.	O

Propanediol	O
,	O
derived	O
from	O
rhamnose	O
and	O
fucose	O
catabolism	O
,	O
is	O
degraded	O
by	O
products	O
of	O
the	O
propanediol	O
utilization	O
(	O
pdu	O
)	O
operon	O
(	O
immediately	O
adjacent	O
to	O
the	O
cob	O
operon	O
)	O
in	O
a	O
vitamin	O
B12	O
dependent	O
manner	O
.	O

This	O
allows	O
Salmonella	B-Organism
Typhimurium	I-Organism
to	O
grow	O
using	O
propanediol	O
as	O
a	O
sole	O
carbon	O
source	O
and	O
because	O
it	O
is	O
required	O
for	O
growth	O
in	O
macrophages	O
this	O
may	O
be	O
the	O
preferred	O
intracellular	O
metabolite	O
[	O
47	O
]	O
.	O

Results	O
from	O
our	O
proteomics	O
analysis	O
revealed	O
that	O
Hfq	O
regulates	O
the	O
cob	O
-	O
pdu	O
operon	O
in	O
AMM	O
-	O
2	O
(	O
Figure	O
4A	O
)	O
and	O
stationary	O
phase	O
(	O
Figure	O
4D	O
)	O
growth	O
conditions	O
,	O
with	O
several	O
products	O
of	O
the	O
cob	O
-	O
pdu	O
operon	O
exhibiting	O
increased	O
expression	O
compared	O
to	O
wild	O
type	O
.	O

Among	O
these	O
were	O
PduA	O
,	O
PduB	O
,	O
PduG	O
,	O
PduL	O
,	O
PduM	O
and	O
PduT	O
as	O
well	O
as	O
CobT	O
,	O
CbiH	O
,	O
CbiF	O
,	O
CbiC	O
,	O
and	O
CbiL	O
.	O

This	O
was	O
not	O
apparent	O
in	O
the	O
DeltasmpB	O
mutant	O
strain	O
in	O
which	O
cob	O
-	O
pdu	O
protein	O
levels	O
are	O
the	O
same	O
as	O
the	O
parent	O
(	O
Figure	O
4A	O
and	O
4D	O
)	O
.	O

Western	O
blot	O
analysis	O
of	O
PduA	O
and	O
PduE	O
relative	O
protein	O
levels	O
validated	O
results	O
from	O
the	O
proteomics	O
analysis	O
(	O
Figures	O
4B	O
,	O
4C	O
and	O
4E	O
,	O
4F	O
)	O
.	O

The	O
strong	O
regulation	O
of	O
Pdu	O
protein	O
expression	O
by	O
Hfq	O
suggests	O
the	O
pdu	O
operon	O
to	O
be	O
a	O
potential	O
target	O
of	O
sRNA	O
regulation	O
and	O
that	O
correct	O
coordinate	O
expression	O
may	O
be	O
essential	O
for	O
activity	O
.	O

Both	O
microarray	O
analysis	O
and	O
confirmative	O
qRT	O
-	O
PCR	O
assays	O
showed	O
that	O
RNA	O
levels	O
were	O
unchanged	O
for	O
pduA	O
and	O
pduE	O
genes	O
in	O
the	O
Deltahfq	O
mutant	O
strain	O
compared	O
to	O
the	O
wildtype	O
strain	O
(	O
Figure	O
5	O
)	O
,	O
thus	O
showing	O
that	O
Hfq	O
represses	O
translation	O
in	O
these	O
two	O
environmental	O
conditions	O
.	O

The	O
data	O
presented	O
here	O
suggests	O
Hfq	O
likely	O
plays	O
a	O
substantial	O
role	O
in	O
the	O
regulation	O
of	O
the	O
protein	O
expression	O
of	O
the	O
cob	O
-	O
pdu	O
operon	O
,	O
required	O
for	O
intra	O
-	O
macrophage	O
replication	O
[	O
47	O
]	O
,	O
via	O
post	O
-	O
transcriptional	O
regulatory	O
mechanisms	O
.	O

SmpB	O
control	O
of	O
biological	O
processes	O
<EOS>	B-X
The	B-X
trans-translation	B-X
mechanism	B-X
is	B-X
a	B-X
key	B-X
component	B-X
of	B-X
multiple	B-X
quality	B-X
control	B-X
pathways	B-X
in	B-X
bacteria	B-X
that	B-X
ensure	B-X
proteins	B-X
are	B-X
synthesized	B-X
with	B-X
high	B-X
fidelity	B-X
in	B-X
spite	B-X
of	B-X
challenges	B-X
such	B-X
as	B-X
transcription	B-X
errors	B-X
,	B-X
mRNA	B-X
damage	B-X
,	B-X
and	B-X
translational	B-X
frameshifting	B-X
.	B-X
trans-Translation	B-X
is	B-X
performed	B-X
by	B-X
a	B-X
ribonucleoprotein	B-X
complex	B-X
composed	B-X
of	B-X
tmRNA	B-X
,	B-X
a	B-X
specialized	B-X
RNA	B-X
with	B-X
properties	B-X
of	B-X
both	B-X
a	B-X
tRNA	B-X
and	B-X
an	B-X
mRNA	B-X
,	B-X
and	B-X
the	B-X
small	B-X
protein	B-X
SmpB	B-X
.	B-X
tmRNA-SmpB	B-X
interacts	B-X
with	B-X
translational	B-X
complexes	B-X
stalled	B-X
at	B-X
the	B-X
3	B-X
'	B-X
end	B-X
of	B-X
an	B-X
mRNA	B-X
to	B-X
release	B-X
the	B-X
stalled	B-X
ribosomes	B-X
and	B-X
target	B-X
the	B-X
nascent	B-X
polypeptides	B-X
and	B-X
mRNAs	B-X
for	B-X
degradation	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
quality	B-X
control	B-X
pathways	B-X
,	B-X
some	B-X
genetic	B-X
regulatory	B-X
circuits	B-X
use	B-X
trans-translation	B-X
to	B-X
control	B-X
gene	B-X
expression	B-X
.	B-X

SmpB	O
is	O
thought	O
to	O
be	O
limited	O
to	O
trans	O
-	O
translation	O
but	O
has	O
been	O
shown	O
to	O
increase	O
the	O
translation	O
of	O
a	O
single	O
protein	O
-	O
the	O
stationary	O
phase	O
sigma	O
factor	O
RpoS	O
[	O
19	O
]	O
.	O

The	O
normal	O
function	O
of	O
SmpB	O
is	O
in	O
quality	O
control	O
to	O
free	O
ribosomes	O
stalled	O
on	O
defective	O
mRNAs	O
[	O
11	O
]	O
,	O
[	O
16	O
]	O
.	O

However	O
,	O
results	O
from	O
our	O
global	O
proteomics	O
analysis	O
indicate	O
that	O
SmpB	O
directly	O
or	O
indirectly	O
modulates	O
the	O
expression	O
of	O
at	O
least	O
4	O
%	O
of	O
the	O
entire	O
Salmonella	B-Organism
Typhimurium	I-Organism
proteome	O
determined	O
from	O
ANOVA	O
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
(	O
Table	O
S1	O
)	O
.	O

The	O
majority	O
of	O
genes	O
encoding	O
these	O
proteins	O
showed	O
no	O
changes	O
in	O
mRNA	O
level	O
thus	O
it	O
is	O
interesting	O
to	O
speculate	O
an	O
additional	O
role	O
for	O
SmpB	O
as	O
a	O
general	O
post	O
-	O
transcriptional	O
/	O
translational	O
regulator	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
.	O

Few	O
of	O
the	O
genes	O
identified	O
are	O
regulated	O
by	O
RpoS	O
again	O
suggesting	O
that	O
this	O
is	O
a	O
direct	O
translational	O
effect	O
and	O
not	O
indirect	O
transcriptional	O
.	O

The	O
RpoS	O
regulon	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
has	O
been	O
initially	O
characterized	O
,	O
identifying	O
13	O
conserved	O
RpoS	O
-	O
regulated	O
genes	O
[	O
48	O
]	O
.	O

From	O
our	O
global	O
proteomics	O
analysis	O
we	O
were	O
able	O
to	O
observe	O
gene	O
products	O
for	O
8	O
of	O
the	O
13	O
conserved	O
RpoS	O
-	O
regulated	O
genes	O
,	O
of	O
which	O
only	O
a	O
single	O
protein	O
,	O
YciF	O
,	O
was	O
regulated	O
by	O
SmpB	O
.	O

We	O
note	O
however	O
that	O
a	O
more	O
detailed	O
and	O
rigorous	O
analysis	O
is	O
required	O
to	O
confirm	O
the	O
speculated	O
global	O
regulatory	O
role	O
of	O
SmpB	O
.	O

Examination	O
of	O
proteins	O
modulated	O
by	O
SmpB	O
revealed	O
a	O
number	O
of	O
SmpB	O
regulated	O
cellular	O
processes	O
.	O

SmpB	O
regulates	O
histidine	O
biosynthesis	O
in	O
AMM	O
-	O
1	O
,	O
affecting	O
HisDGCBHAF	O
.	O

Proteins	O
involved	O
in	O
motility	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
also	O
showed	O
down	O
-	O
regulation	O
during	O
growth	O
in	O
LB	O
media	O
.	O

This	O
set	O
of	O
proteins	O
included	O
the	O
chemotaxis	O
proteins	O
CheZ	O
,	O
CheY	O
,	O
CheW	O
,	O
CheA	O
and	O
Tsr	O
as	O
well	O
as	O
the	O
flagellar	O
proteins	O
FliC	O
,	O
FliD	O
,	O
FliG	O
and	O
FljB	O
.	O

This	O
suggests	O
that	O
a	O
more	O
thorough	O
examination	O
of	O
the	O
role	O
of	O
SmpB	O
in	O
the	O
regulation	O
of	O
cell	O
motility	O
and	O
histidine	O
biosynthesis	O
is	O
warranted	O
.	O

Western	O
blot	O
analysis	O
of	O
FliC	O
relative	O
protein	O
levels	O
validated	O
results	O
from	O
the	O
proteomics	O
analysis	O
(	O
Figure	O
S2B	O
)	O
.	O

Proteins	O
co	O
-	O
regulated	O
by	O
Hfq	O
and	O
SmpB	O

We	O
were	O
interested	O
in	O
determining	O
whether	O
there	O
was	O
overlap	O
in	O
translational	O
regulation	O
between	O
Hfq	O
and	O
SmpB	O
i	O
.	O
e	O
.	O
,	O
the	O
extent	O
of	O
cross	O
-	O
talk	O
or	O
level	O
of	O
co	O
-	O
ordination	O
if	O
any	O
between	O
these	O
two	O
translational	O
regulators	O
(	O
Table	O
S1	O
)	O
.	O

For	O
example	O
it	O
was	O
possible	O
that	O
Hfq	O
directly	O
modulates	O
translation	O
of	O
smpB	O
and	O
therefore	O
all	O
of	O
the	O
effects	O
observed	O
for	O
smpB	O
could	O
be	O
related	O
to	O
Hfq	O
.	O

For	O
logarithmic	O
phase	O
growth	O
conditions	O
,	O
the	O
expression	O
pattern	O
of	O
242	O
proteins	O
appeared	O
to	O
exhibit	O
a	O
dependence	O
on	O
Hfq	O
,	O
while	O
37	O
proteins	O
exhibited	O
a	O
dependency	O
on	O
SmpB	O
.	O

Twenty	O
proteins	O
overlapped	O
both	O
sets	O
,	O
including	O
the	O
motility	O
proteins	O
FliC	O
,	O
CheA	O
,	O
CheZ	O
and	O
Tsr	O
.	O

Under	O
stationary	O
phase	O
growth	O
conditions	O
270	O
proteins	O
appeared	O
to	O
be	O
under	O
control	O
of	O
Hfq	O
and	O
27	O
proteins	O
under	O
control	O
of	O
SmpB	O
.	O

Nine	O
proteins	O
,	O
including	O
the	O
NADPH	O
-	O
dependent	O
quinine	O
oxidoreductase	O
Qor	O
,	O
TolC	O
involved	O
in	O
LPS	O
biosynthesis	O
,	O
and	O
a	O
putative	O
hydrolase	O
YbeM	O
,	O
overlapped	O
.	O

Of	O
the	O
390	O
proteins	O
regulated	O
by	O
Hfq	O
and	O
50	O
proteins	O
regulated	O
by	O
SmpB	O
in	O
growth	O
in	O
AMM	O
-	O
2	O
,	O
15	O
proteins	O
were	O
co	O
-	O
regulated	O
by	O
both	O
Hfq	O
and	O
SmpB	O
,	O
including	O
the	O
invasion	O
protein	O
PrgI	O
,	O
MdoH	O
involved	O
in	O
the	O
synthesis	O
of	O
membrane	O
-	O
derived	O
oligosaccharide	O
,	O
and	O
a	O
putative	O
periplasmic	O
protein	O
CreA	O
.	O

Under	O
growth	O
in	O
AMM	O
-	O
1	O
267	O
proteins	O
appeared	O
regulated	O
by	O
Hfq	O
and	O
the	O
expression	O
pattern	O
of	O
86	O
proteins	O
exhibited	O
a	O
dependence	O
on	O
SmpB	O
.	O

Twenty	O
four	O
of	O
these	O
proteins	O
were	O
co	O
-	O
regulated	O
by	O
both	O
Hfq	O
and	O
SmpB	O
.	O

This	O
subset	O
included	O
a	O
putative	O
serine	O
/	O
threonine	O
protein	O
kinase	O
,	O
a	O
putative	O
intracellular	O
proteinase	O
YhbO	O
,	O
SrfJ	O
,	O
a	O
known	O
Salmonella	B-Organism
Typhimurium	I-Organism
virulence	O
protein	O
,	O
and	O
the	O
stress	O
protein	O
HtpG	O
.	O

These	O
results	O
also	O
confirm	O
that	O
there	O
is	O
no	O
direct	O
translational	O
control	O
of	O
smpB	O
by	O
Hfq	O
.	O

Summary	O
<EOS>	B-X
Improving	B-X
Patient	B-X
Discharge	B-X
Summary	B-X
Communication	B-X
.	B-X
The	B-X
International	B-X
Patient	B-X
Summary	B-X
(	B-X
IPS	B-X
)	B-X
standard	B-X
is	B-X
a	B-X
step	B-X
towards	B-X
communicating	B-X
safe	B-X
,	B-X
relevant	B-X
patient	B-X
summaries	B-X
for	B-X
use	B-X
throughout	B-X
the	B-X
world	B-X
.	B-X
This	B-X
Is	B-X
the	B-X
Story	B-X
of	B-X
a	B-X
Discharge	B-X
Summary	B-X
.	B-X
The	B-X
discharge	B-X
summary	B-X
as	B-X
a	B-X
medium	B-X
for	B-X
teaching	B-X
and	B-X
learning	B-X
.	B-X

Post	O
-	O
transcriptional	O
regulation	O
has	O
not	O
been	O
directly	O
examined	O
on	O
a	O
global	O
scale	O
by	O
proteomic	O
methods	O
.	O
<EOS>	B-X
Work	B-X
from	B-X
the	B-X
past	B-X
decade	B-X
has	B-X
altered	B-X
our	B-X
perception	B-X
of	B-X
ncRNAs	B-X
from	B-X
'junk	B-X
'	B-X
transcriptional	B-X
products	B-X
to	B-X
functional	B-X
regulatory	B-X
molecules	B-X
that	B-X
mediate	B-X
cellular	B-X
processes	B-X
including	B-X
chromatin	B-X
remodelling	B-X
,	B-X
transcription	B-X
,	B-X
post-transcriptional	B-X
modifications	B-X
and	B-X
signal	B-X
transduction	B-X
.	B-X
At	B-X
the	B-X
transcriptional	B-X
level	B-X
,	B-X
a	B-X
model	B-X
is	B-X
emerging	B-X
whereby	B-X
lncRNA	B-X
bridges	B-X
DNA	B-X
and	B-X
protein	B-X
by	B-X
binding	B-X
to	B-X
chromatin	B-X
and	B-X
serving	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
modifying	B-X
protein	B-X
complexes	B-X
.	B-X
These	B-X
transcripts	B-X
and	B-X
proteins	B-X
are	B-X
encoded	B-X
by	B-X
less	B-X
than	B-X
20,000	B-X
genes	B-X
,	B-X
suggesting	B-X
extensive	B-X
regulation	B-X
at	B-X
the	B-X
transcriptional	B-X
,	B-X
post-transcriptional	B-X
,	B-X
and	B-X
translational	B-X
level	B-X
.	B-X
We	B-X
discuss	B-X
their	B-X
transcriptome-wide	B-X
distribution	B-X
,	B-X
their	B-X
impact	B-X
on	B-X
protein	B-X
expression	B-X
,	B-X
their	B-X
biological	B-X
relevance	B-X
,	B-X
and	B-X
the	B-X
possible	B-X
molecular	B-X
mechanisms	B-X
leading	B-X
to	B-X
their	B-X
alternative	B-X
regulation	B-X
.	B-X

This	O
work	O
has	O
focused	O
on	O
two	O
translational	O
regulators	O
in	O
Salmonella	B-Organism
(	O
Hfq	O
and	O
SmpB	O
)	O
that	O
are	O
required	O
for	O
virulence	O
.	O

In	O
order	O
to	O
accurately	O
characterize	O
global	O
control	O
of	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
it	O
is	O
essential	O
to	O
measure	O
global	O
changes	O
in	O
both	O
transcript	O
and	O
protein	O
levels	O
.	O

We	O
performed	O
a	O
sample	O
-	O
matched	O
global	O
proteomics	O
and	O
transcriptional	O
analysis	O
to	O
examine	O
the	O
broad	O
impacts	O
of	O
deletion	O
mutants	O
of	O
hfq	O
and	O
smpB	O
on	O
global	O
protein	O
and	O
transcript	O
abundance	O
levels	O
to	O
begin	O
to	O
understand	O
how	O
Hfq	O
and	O
SmpB	O
mediate	O
the	O
control	O
of	O
global	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
.	O

Using	O
a	O
sample	O
-	O
matched	O
procedure	O
our	O
strategy	O
simultaneously	O
measures	O
changes	O
in	O
global	O
transcript	O
and	O
protein	O
abundance	O
levels	O
allowing	O
for	O
a	O
clear	O
distinction	O
between	O
the	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
effects	O
of	O
Hfq	O
or	O
SmpB	O
.	O
<EOS>	B-X
What	B-X
follows	B-X
is	B-X
a	B-X
summary	B-X
of	B-X
those	B-X
data	B-X
together	B-X
with	B-X
our	B-X
personal	B-X
view	B-X
of	B-X
the	B-X
dynamics	B-X
of	B-X
trans-translation	B-X
,	B-X
with	B-X
emphasis	B-X
to	B-X
the	B-X
pivotal	B-X
and	B-X
leading	B-X
roles	B-X
that	B-X
the	B-X
SmpB	B-X
protein	B-X
has	B-X
,	B-X
being	B-X
the	B-X
essential	B-X
conductor	B-X
during	B-X
the	B-X
whole	B-X
process	B-X
.	B-X
Genes	B-X
for	B-X
the	B-X
RNA	B-X
tmRNA	B-X
and	B-X
protein	B-X
SmpB	B-X
,	B-X
partners	B-X
in	B-X
the	B-X
trans-translation	B-X
process	B-X
that	B-X
rescues	B-X
stalled	B-X
ribosomes	B-X
,	B-X
have	B-X
previously	B-X
been	B-X
found	B-X
in	B-X
all	B-X
bacteria	B-X
and	B-X
some	B-X
organelles	B-X
.	B-X
During	B-X
a	B-X
major	B-X
update	B-X
of	B-X
The	B-X
tmRNA	B-X
Website	B-X
(	B-X
relocated	B-X
to	B-X
http	B-X
:	B-X
//bioinformatics.sandia.gov/tmrna	B-X
)	B-X
,	B-X
including	B-X
addition	B-X
of	B-X
an	B-X
SmpB	B-X
sequence	B-X
database	B-X
,	B-X
we	B-X
found	B-X
some	B-X
bacteria	B-X
that	B-X
lack	B-X
functionally	B-X
significant	B-X
regions	B-X
of	B-X
SmpB	B-X
.	B-X
Three	B-X
groups	B-X
with	B-X
reduced	B-X
genomes	B-X
have	B-X
lost	B-X
the	B-X
central	B-X
loop	B-X
of	B-X
SmpB	B-X
,	B-X
which	B-X
is	B-X
thought	B-X
to	B-X
improve	B-X
alanylation	B-X
and	B-X
EF-Tu	B-X
activation	B-X
:	B-X
Carsonella	B-X
,	B-X
Hodgkinia	B-X
,	B-X
and	B-X
the	B-X
hemoplasmas	B-X
(	B-X
hemotropic	B-X
Mycoplasma	B-X
)	B-X
.	B-X
Carsonella	B-X
has	B-X
also	B-X
lost	B-X
the	B-X
SmpB	B-X
C-terminal	B-X
tail	B-X
,	B-X
thought	B-X
to	B-X
stimulate	B-X
the	B-X
decoding	B-X
center	B-X
of	B-X
the	B-X
ribosome	B-X
.	B-X
We	B-X
validate	B-X
recent	B-X
identification	B-X
of	B-X
tmRNA	B-X
homologs	B-X
in	B-X
oomycete	B-X
mitochondria	B-X
by	B-X
finding	B-X
partner	B-X
genes	B-X
from	B-X
oomycete	B-X
nuclei	B-X
that	B-X
target	B-X
SmpB	B-X
to	B-X
the	B-X
mitochondrion	B-X
.	B-X
We	B-X
have	B-X
moreover	B-X
identified	B-X
through	B-X
exhaustive	B-X
search	B-X
a	B-X
small	B-X
number	B-X
of	B-X
complete	B-X
,	B-X
but	B-X
often	B-X
highly	B-X
derived	B-X
,	B-X
bacterial	B-X
genomes	B-X
that	B-X
appear	B-X
to	B-X
lack	B-X
a	B-X
functional	B-X
copy	B-X
of	B-X
either	B-X
the	B-X
tmRNA	B-X
or	B-X
SmpB	B-X
gene	B-X
(	B-X
but	B-X
not	B-X
both	B-X
)	B-X
.	B-X
After	B-X
loss	B-X
of	B-X
the	B-X
SmpB	B-X
central	B-X
loop	B-X
in	B-X
the	B-X
hemoplasmas	B-X
,	B-X
one	B-X
subclade	B-X
apparently	B-X
lost	B-X
tmRNA	B-X
.	B-X
At	B-X
least	B-X
some	B-X
of	B-X
the	B-X
tmRNA/SmpB-deficient	B-X
strains	B-X
appear	B-X
to	B-X
further	B-X
lack	B-X
the	B-X
ArfA	B-X
and	B-X
ArfB	B-X
backup	B-X
systems	B-X
for	B-X
ribosome	B-X
rescue	B-X
.	B-X
The	B-X
most	B-X
frequent	B-X
neighbors	B-X
of	B-X
smpB	B-X
are	B-X
the	B-X
tmRNA	B-X
gene	B-X
,	B-X
a	B-X
ratA/rnfH	B-X
unit	B-X
,	B-X
and	B-X
the	B-X
gene	B-X
for	B-X
RNaseR	B-X
,	B-X
a	B-X
known	B-X
physical	B-X
and	B-X
functional	B-X
partner	B-X
of	B-X
tmRNA-SmpB	B-X
.	B-X

Furthermore	O
,	O
our	O
strategy	O
requires	O
no	O
tagging	O
and	O
or	O
isolation	O
of	O
Hfq	O
or	O
SmpB	O
precluding	O
the	O
possibility	O
of	O
spurious	O
results	O
introduced	O
by	O
tagging	O
and	O
or	O
co	O
-	O
immunoprecipitation	O
processes	O
.	O
<EOS>	B-X
Growing	B-X
evidence	B-X
shows	B-X
that	B-X
protein-protein	B-X
interactions	B-X
are	B-X
crucial	B-X
in	B-X
many	B-X
biological	B-X
processes	B-X
in	B-X
living	B-X
cells	B-X
.	B-X
Genetic	B-X
(	B-X
such	B-X
as	B-X
yeast	B-X
two-hybrid	B-X
,	B-X
Y2H	B-X
)	B-X
and	B-X
biochemical	B-X
(	B-X
such	B-X
as	B-X
co-immunoprecipitation	B-X
,	B-X
co-IP	B-X
)	B-X
methods	B-X
are	B-X
the	B-X
methods	B-X
commonly	B-X
used	B-X
at	B-X
the	B-X
beginning	B-X
of	B-X
a	B-X
study	B-X
to	B-X
identify	B-X
the	B-X
interacting	B-X
proteins	B-X
.	B-X
Immunoprecipitation	B-X
(	B-X
IP	B-X
)	B-X
,	B-X
a	B-X
method	B-X
using	B-X
a	B-X
target	B-X
protein-specific	B-X
antibody	B-X
in	B-X
conjunction	B-X
with	B-X
Protein	B-X
A/G	B-X
affinity	B-X
beads	B-X
,	B-X
is	B-X
a	B-X
powerful	B-X
tool	B-X
to	B-X
identify	B-X
molecules	B-X
that	B-X
interact	B-X
with	B-X
specific	B-X
proteins	B-X
.	B-X
Therefore	B-X
,	B-X
co-IP	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
one	B-X
of	B-X
the	B-X
standard	B-X
methods	B-X
of	B-X
identifying	B-X
or	B-X
confirming	B-X
the	B-X
occurrence	B-X
of	B-X
protein-protein	B-X
interaction	B-X
events	B-X
in	B-X
vivo	B-X
.	B-X
Co-IP	B-X
experiments	B-X
can	B-X
identify	B-X
proteins	B-X
via	B-X
direct	B-X
or	B-X
indirect	B-X
interactions	B-X
or	B-X
in	B-X
a	B-X
protein	B-X
complex	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
use	B-X
Agrobacterium	B-X
type	B-X
VI	B-X
secretion	B-X
system	B-X
(	B-X
T6SS	B-X
)	B-X
sheath	B-X
components	B-X
TssB-TssC	B-X

Previous	O
attempts	O
to	O
identify	O
processes	O
/	O
targets	O
regulated	O
by	O
Hfq	O
,	O
and	O
thus	O
targets	O
of	O
sRNA	O
regulation	O
,	O
have	O
relied	O
on	O
transcript	O
-	O
centric	O
approaches	O
.	O

In	O
one	O
study	O
microarray	O
analysis	O
was	O
used	O
to	O
identify	O
changes	O
in	O
gene	O
expression	O
resulting	O
from	O
lack	O
of	O
Hfq	O
,	O
thus	O
providing	O
potential	O
new	O
target	O
genes	O
for	O
sRNA	O
regulation	O
[	O
27	O
]	O
.	O

High	O
-	O
density	O
oligonucleotide	O
microarrays	O
were	O
used	O
to	O
detect	O
sRNA	O
and	O
other	O
targets	O
of	O
Hfq	O
co	O
-	O
immunoprecipitated	O
with	O
Hfq	O
-	O
specific	O
antibodies	O
[	O
26	O
]	O
.	O

Most	O
recently	O
high	O
-	O
throughput	O
pyrosequencing	O
(	O
HTPS	O
)	O
was	O
used	O
to	O
detect	O
message	O
and	O
sRNA	O
bound	O
to	O
Hfq	O
following	O
immunoprecipitation	O
[	O
10	O
]	O
.	O

The	O
result	O
of	O
this	O
work	O
was	O
very	O
surprising	O
namely	O
that	O
Hfq	O
bound	O
to	O
20	O
%	O
of	O
all	O
Salmonella	B-Organism
mRNA	O
transcripts	O
and	O
at	O
least	O
64	O
small	O
RNA	O
molecules	O
.	O

One	O
possible	O
criticism	O
of	O
this	O
work	O
is	O
that	O
the	O
RNA	O
co	O
-	O
immunoprecipitated	O
with	O
Hfq	O
may	O
be	O
brought	O
down	O
simply	O
because	O
Hfq	O
strongly	O
binds	O
to	O
RNA	O
molecules	O
and	O
that	O
the	O
binding	O
is	O
somewhat	O
non	O
-	O
specific	O
.	O

Our	O
efforts	O
presented	O
here	O
support	O
the	O
conclusions	O
of	O
that	O
study	O
and	O
suggest	O
that	O
an	O
even	O
larger	O
number	O
of	O
Salmonella	B-Organism
proteins	O
are	O
translationally	O
regulated	O
than	O
the	O
20	O
%	O
suggested	O
by	O
these	O
authors	O
,	O
when	O
accessed	O
across	O
a	O
larger	O
number	O
of	O
growth	O
conditions	O
.	O

We	O
have	O
compared	O
wildtype	O
and	O
isogenic	O
hfq	O
and	O
smpB	O
derivatives	O
with	O
matched	O
samples	O
to	O
examine	O
both	O
transcription	O
and	O
translation	O
by	O
global	O
proteomics	O
.	O

There	O
were	O
some	O
cases	O
in	O
which	O
a	O
change	O
in	O
protein	O
level	O
could	O
be	O
related	O
to	O
a	O
change	O
in	O
transcription	O
but	O
this	O
was	O
the	O
exception	O
.	O
<EOS>	B-X
Asthma	B-X
is	B-X
a	B-X
chronic	B-X
respiratory	B-X
disease	B-X
related	B-X
to	B-X
hyper‑responsiveness	B-X
.	B-X
The	B-X
majority	B-X
of	B-X
patients	B-X
suffer	B-X
mild	B-X
symptoms	B-X
,	B-X
however	B-X
,	B-X
some	B-X
cases	B-X
,	B-X
especially	B-X
in	B-X
the	B-X
young	B-X
and	B-X
the	B-X
elderly	B-X
,	B-X
can	B-X
lead	B-X
to	B-X
death	B-X
by	B-X
apnea	B-X
.	B-X
M.	B-X
atichisonii	B-X
dose‑dependently	B-X
suppressed	B-X
the	B-X
levels	B-X
of	B-X
white	B-X
blood	B-X
cells	B-X
,	B-X
eosinophils	B-X
and	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
E	B-X
in	B-X
BALB/c	B-X
mice	B-X
,	B-X
resulting	B-X
from	B-X
ovalbumin‑induced	B-X
asthma	B-X
.	B-X
M.	B-X
atichisonii	B-X
recovered	B-X
the	B-X
typical	B-X
asthmatic	B-X
morphological	B-X
changes	B-X
in	B-X
lungs	B-X
,	B-X
such	B-X
as	B-X
mucous	B-X
hyper‑secretion	B-X
,	B-X
epithelial	B-X
layer	B-X
hyperplasia	B-X
,	B-X
eosinophil	B-X
infiltration	B-X
and	B-X
various	B-X
cell	B-X
surface	B-X
molecules	B-X
,	B-X
such	B-X
as	B-X
CD3	B-X
,	B-X
CD4	B-X
,	B-X
CD8	B-X
,	B-X
CD19	B-X
and	B-X
major	B-X
histocompatibility	B-X
complex	B-X
class	B-X
II	B-X
.	B-X
With	B-X
the	B-X
exception	B-X
of	B-X
CD19+	B-X
cells	B-X
and	B-X
IL‑12p40	B-X
,	B-X
M.	B-X
atichisonii	B-X
affected	B-X
almost	B-X
all	B-X
factors	B-X
related	B-X
to	B-X
asthma	B-X
induction	B-X
including	B-X
the	B-X
T	B-X
helper	B-X
(	B-X
Th	B-X
)	B-X
1/Th2	B-X
transcription	B-X
factors	B-X
,	B-X
T‑bet	B-X
and	B-X
GATA‑3	B-X
,	B-X
Th1‑related	B-X
cytokines	B-X
,	B-X
Th2‑related	B-X
cytokines	B-X
and	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X

These	O
results	O
suggest	O
that	O
while	O
feedback	O
mechanisms	O
between	O
protein	O
abundance	O
and	O
transcript	O
levels	O
exist	O
,	O
the	O
majority	O
of	O
the	O
effects	O
observed	O
here	O
for	O
both	O
hfq	O
and	O
smpB	O
are	O
a	O
result	O
of	O
direct	O
modulation	O
of	O
post	O
-	O
transcriptional	O
events	O
.	O

These	O
results	O
have	O
been	O
validated	O
by	O
Western	O
blotting	O
to	O
a	O
number	O
of	O
proteins	O
.	O
<EOS>	B-X
The	B-X
landscape	B-X
of	B-X
cancer-associated	B-X
fibroblasts	B-X
in	B-X
colorectal	B-X
cancer	B-X
liver	B-X
metastases	B-X
.	B-X
Recent	B-X
advances	B-X
in	B-X
intracellular	B-X
staining	B-X
techniques	B-X
,	B-X
cytometer	B-X
technology	B-X
,	B-X
fluorescent	B-X
reagents	B-X
,	B-X
and	B-X
antibody	B-X
production	B-X
have	B-X
expanded	B-X
the	B-X
number	B-X
of	B-X
intracellular	B-X
antigens	B-X
that	B-X
can	B-X
be	B-X
analyzed	B-X
by	B-X
flow	B-X
cytometry	B-X
.	B-X
BRCA1	B-X
Antibodies	B-X
Matter	B-X
.	B-X
Fibulin-3	B-X
(	B-X
F3	B-X
)	B-X
is	B-X
an	B-X
important	B-X
,	B-X
disulfide-rich	B-X
,	B-X
extracellular	B-X
matrix	B-X
glycoprotein	B-X
that	B-X
has	B-X
been	B-X
associated	B-X
with	B-X
a	B-X
number	B-X
of	B-X
diseases	B-X
ranging	B-X
from	B-X
cancer	B-X
to	B-X
retinal	B-X
degeneration	B-X
.	B-X
After	B-X
immunoprecipitation	B-X
,	B-X
interacting	B-X
proteins	B-X
were	B-X
identified	B-X
by	B-X
multidimensional	B-X
protein	B-X
identification	B-X
technology	B-X
(	B-X
MudPIT	B-X
)	B-X
.	B-X
Eight	B-X
of	B-X
these	B-X
interactions	B-X
(	B-X
ANXA5	B-X
,	B-X
ERdj5	B-X
,	B-X
PDIA4	B-X
,	B-X
P4HB	B-X
,	B-X
PDIA6	B-X
,	B-X
RCN1	B-X
,	B-X
SDF2L1	B-X
,	B-X
and	B-X
TXNDC5	B-X
)	B-X
were	B-X
verified	B-X
at	B-X
the	B-X
western	B-X
blotting	B-X
level	B-X
.	B-X
These	B-X
F3	B-X
interactome	B-X
results	B-X
can	B-X
serve	B-X
as	B-X
the	B-X
basis	B-X
for	B-X
pursuing	B-X
targeted	B-X
genetic	B-X
or	B-X
pharmacologic	B-X
approaches	B-X
in	B-X
an	B-X
effort	B-X
to	B-X
alter	B-X
the	B-X
fate	B-X
of	B-X
either	B-X
WT	B-X
or	B-X
mutant	B-X
F3	B-X
.	B-X

The	O
amount	O
of	O
translational	O
regulation	O
varied	O
with	O
growth	O
conditions	O
.	O
<EOS>	B-X
Their	B-X
products	B-X
are	B-X
generally	B-X
essential	B-X
for	B-X
ribosome	B-X
synthesis	B-X
,	B-X
which	B-X
is	B-X
the	B-X
cornerstone	B-X
for	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
.	B-X
Ribosomal	B-X
protein	B-X
genes	B-X
have	B-X
classically	B-X
been	B-X
viewed	B-X
as	B-X
a	B-X
uniform	B-X
interconnected	B-X
regulon	B-X
regulated	B-X
in	B-X
eukaryotic	B-X
cells	B-X
by	B-X
target	B-X
of	B-X
rapamycin	B-X
and	B-X
protein	B-X
kinase	B-X
A	B-X
pathway	B-X
in	B-X
response	B-X
to	B-X
changes	B-X
in	B-X
growth	B-X
conditions	B-X
and/or	B-X
cellular	B-X
status	B-X
.	B-X
However	B-X
,	B-X
recent	B-X
literature	B-X
depicts	B-X
a	B-X
more	B-X
complex	B-X
picture	B-X
in	B-X
which	B-X
the	B-X
amount	B-X
of	B-X
ribosomal	B-X
proteins	B-X
produced	B-X
varies	B-X
between	B-X
genes	B-X
in	B-X
response	B-X
to	B-X
two	B-X
overlapping	B-X
regulatory	B-X
circuits	B-X
.	B-X
The	B-X
first	B-X
includes	B-X
the	B-X
classical	B-X
general	B-X
ribosome-producing	B-X
program	B-X
and	B-X
the	B-X
second	B-X
is	B-X
a	B-X
gene-specific	B-X
feature	B-X
responsible	B-X
for	B-X
fine-tuning	B-X
the	B-X
amount	B-X
of	B-X
ribosomal	B-X
proteins	B-X
produced	B-X
from	B-X
each	B-X
individual	B-X
ribosomal	B-X
gene	B-X
.	B-X
Unlike	B-X
the	B-X
general	B-X
pathway	B-X
that	B-X
is	B-X
mainly	B-X
controlled	B-X
at	B-X
the	B-X
level	B-X
of	B-X
transcription	B-X
and	B-X
translation	B-X
,	B-X
this	B-X
specific	B-X
regulation	B-X
of	B-X
ribosomal	B-X
protein	B-X
genes	B-X
is	B-X
largely	B-X
achieved	B-X
through	B-X
changes	B-X
in	B-X
pre-mRNA	B-X
splicing	B-X
efficiency	B-X
and	B-X
mRNA	B-X
stability	B-X
.	B-X
By	B-X
combining	B-X
general	B-X
and	B-X
specific	B-X
regulation	B-X
,	B-X
the	B-X
cell	B-X
can	B-X
coordinate	B-X
ribosome	B-X
production	B-X
,	B-X
while	B-X
allowing	B-X
functional	B-X
specialization	B-X
and	B-X
diversity	B-X
.	B-X

During	O
growth	O
in	O
rich	O
media	O
approximately	O
14	O
%	O
of	O
all	O
proteins	O
observed	O
showed	O
differences	O
in	O
abundance	O
where	O
as	O
in	O
acidic	O
minimal	O
media	O
the	O
result	O
was	O
approximately21	O
%	O
.	O

Taking	O
into	O
account	O
all	O
growth	O
conditions	O
about	O
approximately50	O
%	O
of	O
all	O
observed	O
proteins	O
are	O
regulated	O
by	O
Hfq	O
an	O
astonishingly	O
high	O
number	O
.	O

These	O
results	O
may	O
explain	O
the	O
very	O
high	O
LD50	O
of	O
the	O
hfq	O
mutant	O
strain	O
(	O
>	O
109	O
i	O
.	O
p	O
.	O
)	O
and	O
its	O
growth	O
defect	O
even	O
in	O
rich	O
media	O
.	O

It	O
has	O
recently	O
been	O
shown	O
that	O
half	O
of	O
all	O
the	O
known	O
sRNAs	O
in	O
Salmonella	B-Organism
associate	O
with	O
Hfq	O
[	O
10	O
]	O
.	O
<EOS>	B-X
We	B-X
used	B-X
HTPS	B-X
to	B-X
discover	B-X
the	B-X
Salmonella	B-X
RNAs	B-X
that	B-X
are	B-X
targeted	B-X
by	B-X
the	B-X
common	B-X
bacterial	B-X
Sm-like	B-X
protein	B-X
,	B-X
Hfq	B-X
.	B-X
Initial	B-X
transcriptomic	B-X
analysis	B-X
revealed	B-X
that	B-X
Hfq	B-X
controls	B-X
the	B-X
expression	B-X
of	B-X
almost	B-X
a	B-X
fifth	B-X
of	B-X
all	B-X
Salmonella	B-X
genes	B-X
,	B-X
including	B-X
several	B-X
horizontally	B-X
acquired	B-X
pathogenicity	B-X
islands	B-X
(	B-X
SPI-1	B-X
,	B-X
-2	B-X
,	B-X
-4	B-X
,	B-X
-5	B-X
)	B-X
,	B-X
two	B-X
sigma	B-X
factor	B-X
regulons	B-X
,	B-X
and	B-X
the	B-X
flagellar	B-X
gene	B-X
cascade	B-X
.	B-X
Subsequent	B-X
HTPS	B-X
analysis	B-X
of	B-X
350,000	B-X
cDNAs	B-X
,	B-X
derived	B-X
from	B-X
RNA	B-X
co-immunoprecipitation	B-X
(	B-X
coIP	B-X
)	B-X
with	B-X
epitope-tagged	B-X
Hfq	B-X
or	B-X
control	B-X
coIP	B-X
,	B-X
identified	B-X
727	B-X
mRNAs	B-X
that	B-X
are	B-X
Hfq-bound	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
cDNA	B-X
analysis	B-X
discovered	B-X
new	B-X
,	B-X
small	B-X
noncoding	B-X
RNAs	B-X
(	B-X
sRNAs	B-X
)	B-X
and	B-X
more	B-X
than	B-X
doubled	B-X
the	B-X
number	B-X
of	B-X
sRNAs	B-X
known	B-X
to	B-X
be	B-X
expressed	B-X
in	B-X
Salmonella	B-X
to	B-X
64	B-X
;	B-X
about	B-X
half	B-X
of	B-X
these	B-X
are	B-X
associated	B-X
with	B-X
Hfq	B-X
.	B-X
Our	B-X
analysis	B-X
explained	B-X
aspects	B-X
of	B-X
the	B-X
pleiotropic	B-X
effects	B-X
of	B-X
Hfq	B-X
loss-of-function	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
mRNAs	B-X
of	B-X
hilD	B-X
(	B-X
master	B-X
regulator	B-X
of	B-X
the	B-X
SPI-1	B-X
invasion	B-X
genes	B-X
)	B-X
and	B-X
flhDC	B-X
(	B-X
flagellar	B-X
master	B-X
regulator	B-X
)	B-X
were	B-X
bound	B-X
by	B-X
Hfq	B-X
.	B-X
The	B-X
combination	B-X
of	B-X
epitope-tagging	B-X
and	B-X
HTPS	B-X
of	B-X
immunoprecipitated	B-X
RNA	B-X
detected	B-X
the	B-X
expression	B-X
of	B-X
many	B-X
intergenic	B-X
chromosomal	B-X
regions	B-X
of	B-X
Salmonella	B-X
.	B-X

It	O
is	O
interesting	O
to	O
note	O
that	O
in	O
adaptive	O
evolution	O
experiments	O
using	O
a	O
chemostat	O
to	O
continuously	O
alter	O
grow	O
conditions	O
often	O
results	O
in	O
changes	O
in	O
Hfq	O
(	O
Bernard	O
Palsson	O
,	O
UCSD	O
,	O
personal	O
communication	O
)	O
.	O

It	O
has	O
long	O
been	O
known	O
that	O
many	O
proteins	O
are	O
transcriptionally	O
regulated	O
.	O
<EOS>	B-X
Among	B-X
the	B-X
gene	B-X
expression	B-X
networks	B-X
known	B-X
to	B-X
influence	B-X
the	B-X
process	B-X
of	B-X
oncogenic	B-X
transformation	B-X
,	B-X
the	B-X
one	B-X
controlled	B-X
by	B-X
the	B-X
proto-oncogene	B-X
Clinically	B-X
indistinguishable	B-X
forms	B-X
of	B-X
ALS	B-X
occur	B-X
as	B-X
sporadic	B-X
disease	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
known	B-X
mutation	B-X
,	B-X
or	B-X
can	B-X
be	B-X
initiated	B-X
by	B-X
genetic	B-X
mutations	B-X
.	B-X
MiRNAs	B-X
are	B-X
conserved	B-X
,	B-X
endogenous	B-X
,	B-X
non-coding	B-X
RNAs	B-X
that	B-X
post-transcriptionally	B-X
regulate	B-X
protein	B-X
expression	B-X
.	B-X
Produced	B-X
as	B-X
long	B-X
primary	B-X
transcripts	B-X
,	B-X
they	B-X
are	B-X
exported	B-X
to	B-X
the	B-X
cytoplasm	B-X
and	B-X
further	B-X
modified	B-X
to	B-X
obtain	B-X
the	B-X
mature	B-X
miRNAs	B-X
,	B-X
with	B-X
each	B-X
step	B-X
of	B-X
their	B-X
biogenesis	B-X
being	B-X
a	B-X
potential	B-X
step	B-X
of	B-X
regulation	B-X
.	B-X
There	B-X
are	B-X
more	B-X
than	B-X
1000	B-X
different	B-X
known	B-X
human	B-X
miRNA	B-X
sequences	B-X
,	B-X
and	B-X
more	B-X
than	B-X
20-30	B-X
%	B-X
of	B-X
all	B-X
human	B-X
protein-coding	B-X
genes	B-X
are	B-X
likely	B-X
controlled	B-X
by	B-X
miRNAs	B-X
.	B-X
The	B-X
discovery	B-X
of	B-X
the	B-X
involvement	B-X
of	B-X
ALS	B-X
mutated	B-X
proteins	B-X
TDP43	B-X
and	B-X
FUS/TLS	B-X
in	B-X
miRNAs	B-X
biogenesis	B-X
strongly	B-X
suggests	B-X
a	B-X
role	B-X
of	B-X
miRNA	B-X
dysregulation	B-X
also	B-X
in	B-X
ALS	B-X
and	B-X
many	B-X
efforts	B-X
are	B-X
thus	B-X
directed	B-X
toward	B-X
understanding	B-X
the	B-X
role	B-X
of	B-X
these	B-X
small	B-X
RNA	B-X
molecules	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
ALS	B-X
.	B-X

These	O
results	O
and	O
the	O
results	O
recently	O
described	O
by	O
Sittka	O
et	O
al	O
.	O

[	O
10	O
]	O
demonstrate	O
that	O
post	O
-	O
transcriptional	O
/	O
translational	O
regulation	O
plays	O
as	O
large	O
a	O
role	O
in	O
controlling	O
the	O
myriad	O
of	O
bacterial	O
processes	O
as	O
does	O
transcriptional	O
regulation	O
.	O

It	O
is	O
the	O
precisely	O
this	O
ability	O
to	O
rapidly	O
adjust	O
to	O
changing	O
conditions	O
in	O
less	O
time	O
than	O
it	O
takes	O
to	O
make	O
an	O
RNA	O
molecule	O
that	O
makes	O
this	O
a	O
pivotal	O
regulatory	O
process	O
.	O

Comparative	O
in	O
vivo	O
gene	O
expression	O
of	O
the	O
closely	O
related	O
bacteria	O
Photorhabdus	B-Organism
temperata	I-Organism
and	O
Xenorhabdus	B-Organism
koppenhoeferi	I-Organism
upon	O
infection	O
of	O
the	O
same	O
insect	O
host	O
,	O
Rhizotrogus	B-Organism
majalis	I-Organism
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
mutualistic	B-X
bacteria	B-X
living	B-X
in	B-X
the	B-X
intestines	B-X
of	B-X
the	B-X
nematode	B-X
infective	B-X
juveniles	B-X
are	B-X
pathogenic	B-X
to	B-X
the	B-X
insect	B-X
upon	B-X
release	B-X
by	B-X
the	B-X
nematodes	B-X
into	B-X
the	B-X
insect	B-X
hemolymph	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X
We	B-X
studied	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
in	B-X
Photorhabdus	B-X
temperata	B-X
and	B-X
Xenorhabdus	B-X
koppenhoeferi	B-X
upon	B-X
infection	B-X
of	B-X
the	B-X
white	B-X
grub	B-X
Rhizotrogus	B-X
majalis	B-X
using	B-X
selective	B-X
capture	B-X
of	B-X
transcribed	B-X
sequences	B-X
technique	B-X
.	B-X

Background	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
are	O
Gram	O
-	O
negative	O
,	O
phylogenetically	O
related	O
,	O
enterobacteria	B-Organism
,	O
forming	O
mutualism	O
with	O
the	O
entomopathogenic	O
nematodes	O
Heterorhabditis	B-Organism
and	O
Steinernema	B-Organism
,	O
respectively	O
.	O
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
mutualistic	B-X
bacteria	B-X
living	B-X
in	B-X
the	B-X
intestines	B-X
of	B-X
the	B-X
nematode	B-X
infective	B-X
juveniles	B-X
are	B-X
pathogenic	B-X
to	B-X
the	B-X
insect	B-X
upon	B-X
release	B-X
by	B-X
the	B-X
nematodes	B-X
into	B-X
the	B-X
insect	B-X
hemolymph	B-X
.	B-X
We	B-X
studied	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
in	B-X
Photorhabdus	B-X
temperata	B-X
and	B-X
Xenorhabdus	B-X
koppenhoeferi	B-X
upon	B-X
infection	B-X
of	B-X
the	B-X
white	B-X
grub	B-X
Rhizotrogus	B-X
majalis	B-X
using	B-X
selective	B-X
capture	B-X
of	B-X
transcribed	B-X
sequences	B-X
technique	B-X
.	B-X

The	O
mutualistic	O
bacteria	O
living	O
in	O
the	O
intestines	O
of	O
the	O
nematode	O
infective	O
juveniles	O
are	O
pathogenic	O
to	O
the	O
insect	O
upon	O
release	O
by	O
the	O
nematodes	O
into	O
the	O
insect	O
hemolymph	O
.	O

Such	O
a	O
switch	O
needs	O
activation	O
of	O
genes	O
that	O
promote	O
bacterial	O
virulence	O
.	O
<EOS>	B-X
Cell	B-X
density-dependent	B-X
regulation	B-X
of	B-X
gene	B-X
expression	B-X
in	B-X
Xylella	B-X
fastidiosa	B-X
that	B-X
is	B-X
crucial	B-X
to	B-X
its	B-X
switching	B-X
between	B-X
plant	B-X
hosts	B-X
and	B-X
insect	B-X
vectors	B-X
is	B-X
dependent	B-X
on	B-X
RpfF	B-X
and	B-X
its	B-X
production	B-X
of	B-X
2-enoic	B-X
acids	B-X
known	B-X
as	B-X
diffusible	B-X
signal	B-X
factor	B-X
(	B-X
DSF	B-X
)	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X

We	O
studied	O
in	O
vivo	O
gene	O
expression	O
in	O
Photorhabdus	B-Organism
temperata	I-Organism
and	O
Xenorhabdus	B-Organism
koppenhoeferi	I-Organism
upon	O
infection	O
of	O
the	O
white	O
grub	O
Rhizotrogus	B-Organism
majalis	I-Organism
using	O
selective	O
capture	O
of	O
transcribed	O
sequences	O
technique	O
.	O
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
mutualistic	B-X
bacteria	B-X
living	B-X
in	B-X
the	B-X
intestines	B-X
of	B-X
the	B-X
nematode	B-X
infective	B-X
juveniles	B-X
are	B-X
pathogenic	B-X
to	B-X
the	B-X
insect	B-X
upon	B-X
release	B-X
by	B-X
the	B-X
nematodes	B-X
into	B-X
the	B-X
insect	B-X
hemolymph	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X
We	B-X
studied	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
in	B-X
Photorhabdus	B-X
temperata	B-X
and	B-X
Xenorhabdus	B-X
koppenhoeferi	B-X
upon	B-X
infection	B-X
of	B-X
the	B-X
white	B-X
grub	B-X
Rhizotrogus	B-X
majalis	B-X
using	B-X
selective	B-X
capture	B-X
of	B-X
transcribed	B-X
sequences	B-X
technique	B-X
.	B-X

Results	O
A	O
total	O
of	O
40	O
genes	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
39	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
were	O
found	O
to	O
be	O
upregulated	O
in	O
R	B-Organism
.	I-Organism
majalis	I-Organism
hemolymph	O
at	O
24	O
h	O
post	O
infection	O
.	O

Genomic	O
presence	O
or	O
upregulation	O
of	O
these	O
genes	O
specific	O
in	O
either	O
one	O
of	O
the	O
bacterium	O
was	O
confirmed	O
by	O
the	O
assay	O
of	O
comparative	O
hybridization	O
,	O
and	O
the	O
changes	O
of	O
randomly	O
selected	O
genes	O
were	O
further	O
validated	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O
<EOS>	B-X
We	B-X
present	B-X
a	B-X
tomato	B-X
pan-genome	B-X
constructed	B-X
using	B-X
genome	B-X
sequences	B-X
of	B-X
725	B-X
phylogenetically	B-X
and	B-X
geographically	B-X
representative	B-X
accessions	B-X
,	B-X
revealing	B-X
4,873	B-X
genes	B-X
absent	B-X
from	B-X
the	B-X
reference	B-X
genome	B-X
.	B-X
Presence/absence	B-X
variation	B-X
analyses	B-X
reveal	B-X
substantial	B-X
gene	B-X
loss	B-X
and	B-X
intense	B-X
negative	B-X
selection	B-X
of	B-X
genes	B-X
and	B-X
promoters	B-X
during	B-X
tomato	B-X
domestication	B-X
and	B-X
improvement	B-X
.	B-X
Lost	B-X
or	B-X
negatively	B-X
selected	B-X
genes	B-X
are	B-X
enriched	B-X
for	B-X
important	B-X
traits	B-X
,	B-X
especially	B-X
disease	B-X
resistance	B-X
.	B-X
We	B-X
identify	B-X
a	B-X
rare	B-X
allele	B-X
in	B-X
the	B-X
TomLoxC	B-X
promoter	B-X
selected	B-X
against	B-X
during	B-X
domestication	B-X
.	B-X
In	B-X
orange-stage	B-X
fruit	B-X
,	B-X
accessions	B-X
harboring	B-X
both	B-X
the	B-X
rare	B-X
and	B-X
common	B-X
TomLoxC	B-X
alleles	B-X
(	B-X
heterozygotes	B-X
)	B-X
have	B-X
higher	B-X
TomLoxC	B-X
expression	B-X
than	B-X
those	B-X
homozygous	B-X
for	B-X
either	B-X
and	B-X
are	B-X
resurgent	B-X
in	B-X
modern	B-X
tomatoes	B-X
.	B-X

The	O
identified	O
genes	O
could	O
be	O
broadly	O
divided	O
into	O
seven	O
functional	O
groups	O
including	O
cell	O
surface	O
structure	O
,	O
regulation	O
,	O
virulence	O
and	O
secretion	O
,	O
stress	O
response	O
,	O
intracellular	O
metabolism	O
,	O
nutrient	O
scavenging	O
,	O
and	O
unknown	O
.	O
<EOS>	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X

The	O
two	O
bacteria	O
shared	O
more	O
genes	O
in	O
stress	O
response	O
category	O
than	O
any	O
other	O
functional	O
group	O
.	O
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
mutualistic	B-X
bacteria	B-X
living	B-X
in	B-X
the	B-X
intestines	B-X
of	B-X
the	B-X
nematode	B-X
infective	B-X
juveniles	B-X
are	B-X
pathogenic	B-X
to	B-X
the	B-X
insect	B-X
upon	B-X
release	B-X
by	B-X
the	B-X
nematodes	B-X
into	B-X
the	B-X
insect	B-X
hemolymph	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X

More	O
than	O
60	O
%	O
of	O
the	O
identified	O
genes	O
were	O
uniquely	O
induced	O
in	O
either	O
bacterium	O
suggesting	O
vastly	O
different	O
molecular	O
mechanisms	O
of	O
pathogenicity	O
to	O
the	O
same	O
insect	O
host	O
.	O

In	O
P	B-Organism
.	I-Organism
temperata	I-Organism
lysR	O
gene	O
encoding	O
transcriptional	O
activator	O
was	O
induced	O
,	O
while	O
genes	O
yijC	O
and	O
rseA	O
encoding	O
transcriptional	O
repressors	O
were	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Lipopolysaccharide	O
synthesis	O
gene	O
lpsE	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
but	O
not	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
.	O

Except	O
tcaC	O
and	O
hemolysin	O
related	O
genes	O
,	O
other	O
virulence	O
genes	O
were	O
different	O
between	O
the	O
two	O
bacteria	O
.	O
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
mutualistic	B-X
bacteria	B-X
living	B-X
in	B-X
the	B-X
intestines	B-X
of	B-X
the	B-X
nematode	B-X
infective	B-X
juveniles	B-X
are	B-X
pathogenic	B-X
to	B-X
the	B-X
insect	B-X
upon	B-X
release	B-X
by	B-X
the	B-X
nematodes	B-X
into	B-X
the	B-X
insect	B-X
hemolymph	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X

Genes	O
involved	O
in	O
TCA	O
cycle	O
were	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
whereas	O
those	O
involved	O
in	O
glyoxylate	O
pathway	O
were	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
suggesting	O
differences	O
in	O
metabolism	O
between	O
the	O
two	O
bacteria	O
in	O
the	O
same	O
insect	O
host	O
.	O

Upregulation	O
of	O
genes	O
encoding	O
different	O
types	O
of	O
nutrient	O
uptake	O
systems	O
further	O
emphasized	O
the	O
differences	O
in	O
nutritional	O
requirements	O
of	O
the	O
two	O
bacteria	O
in	O
the	O
same	O
insect	O
host	O
.	O
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
mutualistic	B-X
bacteria	B-X
living	B-X
in	B-X
the	B-X
intestines	B-X
of	B-X
the	B-X
nematode	B-X
infective	B-X
juveniles	B-X
are	B-X
pathogenic	B-X
to	B-X
the	B-X
insect	B-X
upon	B-X
release	B-X
by	B-X
the	B-X
nematodes	B-X
into	B-X
the	B-X
insect	B-X
hemolymph	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X

Photorhabdus	B-Organism
temperata	I-Organism
displayed	O
upregulation	O
of	O
genes	O
encoding	O
siderophore	O
-	O
dependent	O
iron	O
uptake	O
system	O
,	O
but	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
upregulated	O
genes	O
encoding	O
siderophore	O
-	O
independent	O
ion	O
uptake	O
system	O
.	O
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X
We	B-X
studied	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
in	B-X
Photorhabdus	B-X
temperata	B-X
and	B-X
Xenorhabdus	B-X
koppenhoeferi	B-X
upon	B-X
infection	B-X
of	B-X
the	B-X
white	B-X
grub	B-X
Rhizotrogus	B-X
majalis	B-X
using	B-X
selective	B-X
capture	B-X
of	B-X
transcribed	B-X
sequences	B-X
technique	B-X
.	B-X

Photorhabdus	B-Organism
temperata	I-Organism
induced	O
genes	O
for	O
amino	O
acid	O
acquisition	O
but	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
upregulated	O
malF	O
gene	O
,	O
encoding	O
a	O
maltose	O
uptake	O
system	O
.	O
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X
We	B-X
studied	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
in	B-X
Photorhabdus	B-X
temperata	B-X
and	B-X
Xenorhabdus	B-X
koppenhoeferi	B-X
upon	B-X
infection	B-X
of	B-X
the	B-X
white	B-X
grub	B-X
Rhizotrogus	B-X
majalis	B-X
using	B-X
selective	B-X
capture	B-X
of	B-X
transcribed	B-X
sequences	B-X
technique	B-X
.	B-X

Further	O
analyses	O
identified	O
possible	O
mechanistic	O
associations	O
between	O
the	O
identified	O
gene	O
products	O
in	O
metabolic	O
pathways	O
,	O
providing	O
an	O
interactive	O
model	O
of	O
pathogenesis	O
for	O
each	O
bacterium	O
species	O
.	O
<EOS>	B-X
Photorhabdus	B-X
and	B-X
Xenorhabdus	B-X
are	B-X
Gram-negative	B-X
,	B-X
phylogenetically	B-X
related	B-X
,	B-X
enterobacteria	B-X
,	B-X
forming	B-X
mutualism	B-X
with	B-X
the	B-X
entomopathogenic	B-X
nematodes	B-X
Heterorhabditis	B-X
and	B-X
Steinernema	B-X
,	B-X
respectively	B-X
.	B-X
Such	B-X
a	B-X
switch	B-X
needs	B-X
activation	B-X
of	B-X
genes	B-X
that	B-X
promote	B-X
bacterial	B-X
virulence	B-X
.	B-X
We	B-X
studied	B-X
in	B-X
vivo	B-X
gene	B-X
expression	B-X
in	B-X
Photorhabdus	B-X
temperata	B-X
and	B-X
Xenorhabdus	B-X
koppenhoeferi	B-X
upon	B-X
infection	B-X
of	B-X
the	B-X
white	B-X
grub	B-X
Rhizotrogus	B-X
majalis	B-X
using	B-X
selective	B-X
capture	B-X
of	B-X
transcribed	B-X
sequences	B-X
technique	B-X
.	B-X

Conclusion	O
This	O
study	O
identifies	O
set	O
of	O
genes	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
upon	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
,	O
and	O
highlights	O
differences	O
in	O
molecular	O
features	O
used	O
by	O
these	O
two	O
closely	O
related	O
bacteria	O
to	O
promote	O
their	O
pathogenicity	O
in	O
the	O
same	O
insect	O
host	O
.	O

Background	O
<EOS>	B-X
Background	B-X
matching	B-X
is	B-X
the	B-X
most	B-X
familiar	B-X
and	B-X
widespread	B-X
camouflage	B-X
strategy	B-X
:	B-X
avoiding	B-X
detection	B-X
by	B-X
having	B-X
a	B-X
similar	B-X
colour	B-X
and	B-X
pattern	B-X
to	B-X
the	B-X
background	B-X
.	B-X
Background	B-X
is	B-X
thus	B-X
a	B-X
relatively	B-X
modest	B-X
correction	B-X
for	B-X
all	B-X
Z	B-X
opacity	B-X
data	B-X
published	B-X
to	B-X
date	B-X
.	B-X
Background	B-X
estimation	B-X
and	B-X
foreground	B-X
segmentation	B-X
are	B-X
important	B-X
steps	B-X
in	B-X
many	B-X
high-level	B-X
vision	B-X
tasks	B-X
.	B-X
Patient	B-X
Preference	B-X
for	B-X
Telehealth	B-X
Background	B-X
Shapes	B-X
Impressions	B-X
of	B-X
Physicians	B-X
and	B-X
Information	B-X
Recall	B-X
:	B-X
A	B-X
Randomized	B-X
Experiment	B-X
.	B-X

Entomopathogenic	O
Gram	O
-	O
negative	O
enterobacteria	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
form	O
symbioses	O
with	O
the	O
entomopathogenic	O
nematodes	O
Heterorhabditis	B-Organism
and	O
Steinernema	B-Organism
,	O
respectively	O
[	O
1	O
]	O
.	O

These	O
bacteria	O
not	O
only	O
have	O
similar	O
biology	O
but	O
are	O
also	O
phylogenetically	O
related	O
based	O
on	O
16s	O
rDNA	O
sequence	O
identities	O
[	O
2	O
]	O
.	O
<EOS>	B-X
One	B-X
of	B-X
the	B-X
current	B-X
priorities	B-X
of	B-X
the	B-X
World	B-X
Health	B-X
Organization	B-X
is	B-X
multidrug-resistant	B-X
bacteria	B-X
,	B-X
because	B-X
they	B-X
are	B-X
a	B-X
global	B-X
problem	B-X
due	B-X
to	B-X
their	B-X
rapid	B-X
spread	B-X
and	B-X
the	B-X
difficulty	B-X
of	B-X
their	B-X
treatment	B-X
.	B-X
There	B-X
are	B-X
multidrug-resistant	B-X
bacteria	B-X
,	B-X
both	B-X
Gram-positive	B-X
and	B-X
Gram-negative	B-X
,	B-X
including	B-X
Pseudomonas	B-X
aeruginosa	B-X
and	B-X
Acinetobacter	B-X
baumannii	B-X
resistant	B-X
to	B-X
carbapenems	B-X
,	B-X
enterobacteria	B-X
producing	B-X
carbapenemases	B-X
,	B-X
Staphylococcus	B-X
aureus	B-X
resistant	B-X
to	B-X
methicillin	B-X
and/or	B-X
with	B-X
intermediate	B-X
sensitivity	B-X
to	B-X
vancomycin	B-X
,	B-X
and	B-X
Enterococcus	B-X
faecium	B-X
(	B-X
and	B-X
less	B-X
frequently	B-X
Enterococcus	B-X
faecalis	B-X
)	B-X
resistant	B-X
to	B-X
vancomycin	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
an	B-X
abnormal	B-X
amount	B-X
of	B-X
single-stranded	B-X
DNA	B-X
in	B-X
the	B-X
bacterial	B-X
cell	B-X
constitutes	B-X
a	B-X
genotoxic	B-X
alarm	B-X
signal	B-X
that	B-X
induces	B-X
the	B-X
SOS	B-X
response	B-X
,	B-X
a	B-X
broad	B-X
regulatory	B-X
network	B-X
found	B-X
in	B-X
most	B-X
bacterial	B-X
species	B-X
to	B-X
address	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
aim	B-X
of	B-X
this	B-X
review	B-X
was	B-X
to	B-X
point	B-X
out	B-X
that	B-X
beyond	B-X
being	B-X
a	B-X
repair	B-X
process	B-X
,	B-X
SOS	B-X
induction	B-X
leads	B-X
to	B-X
a	B-X
very	B-X
strong	B-X
but	B-X
transient	B-X
response	B-X
to	B-X
genotoxic	B-X
stress	B-X
,	B-X
during	B-X
which	B-X
bacteria	B-X
can	B-X
rearrange	B-X
and	B-X
mutate	B-X
their	B-X
genome	B-X
,	B-X
induce	B-X
several	B-X
phenotypic	B-X
changes	B-X
through	B-X
differential	B-X
regulation	B-X
of	B-X
genes	B-X
,	B-X
and	B-X
sometimes	B-X
acquire	B-X
characteristics	B-X
that	B-X
potentiate	B-X
bacterial	B-X
survival	B-X
and	B-X
adaptation	B-X
to	B-X
changing	B-X
environments	B-X
.	B-X
We	B-X
review	B-X
here	B-X
the	B-X
causes	B-X
and	B-X
consequences	B-X
of	B-X
SOS	B-X
induction	B-X
,	B-X
but	B-X
also	B-X
how	B-X
this	B-X
response	B-X
can	B-X
be	B-X
modulated	B-X
under	B-X
various	B-X
circumstances	B-X
and	B-X
how	B-X
it	B-X
is	B-X
connected	B-X
to	B-X
the	B-X
network	B-X
of	B-X
other	B-X
important	B-X
stress	B-X
responses	B-X
.	B-X
The	B-X
second	B-X
section	B-X
discusses	B-X
consequences	B-X
of	B-X
this	B-X
induction	B-X
in	B-X
terms	B-X
of	B-X
DNA	B-X
repair	B-X
,	B-X
changes	B-X
in	B-X
the	B-X
genome	B-X
and	B-X
gene	B-X
expression	B-X
,	B-X
and	B-X
sharing	B-X
of	B-X
genomic	B-X
information	B-X
,	B-X
with	B-X
their	B-X
effects	B-X
on	B-X
the	B-X
bacteria	B-X
's	B-X
life	B-X
and	B-X
evolution	B-X
.	B-X
The	B-X
third	B-X
section	B-X
is	B-X
about	B-X
the	B-X
fine	B-X
tuning	B-X
of	B-X
this	B-X
response	B-X
to	B-X
fit	B-X
with	B-X
the	B-X
bacteria	B-X
's	B-X
'needs	B-X
'	B-X
.	B-X
Under	B-X
these	B-X
perspectives	B-X
,	B-X
SOS	B-X
can	B-X
be	B-X
perceived	B-X
as	B-X
a	B-X
powerful	B-X
bacterial	B-X
strategy	B-X
against	B-X
aggressions	B-X
.	B-X

They	O
naturally	O
colonize	O
intestines	O
of	O
the	O
nematode	O
infective	O
juveniles	O
which	O
invade	O
susceptible	O
insects	O
to	O
release	O
the	O
bacteria	O
into	O
the	O
hemolymph	O
.	O

The	O
bacteria	O
multiply	O
in	O
the	O
hemolymph	O
,	O
killing	O
the	O
insect	O
host	O
within	O
24	O
-	O
48	O
h	O
and	O
converting	O
the	O
cadaver	O
into	O
a	O
food	O
source	O
suitable	O
for	O
nematode	O
growth	O
and	O
reproduction	O
.	O

After	O
1	O
-	O
3	O
rounds	O
of	O
nematode	O
reproduction	O
,	O
the	O
bacteria	O
recolonize	O
the	O
emerging	O
infective	O
juveniles	O
ensuring	O
their	O
transmission	O
to	O
a	O
new	O
host	O
[	O
1	O
]	O
.	O

Available	O
evidence	O
suggests	O
that	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
encode	O
specific	O
factors	O
to	O
engage	O
in	O
a	O
pathogenic	O
relationship	O
with	O
the	O
insect	O
host	O
[	O
3	O
]	O
.	O

The	O
published	O
genome	O
sequence	O
of	O
Photorhabdus	B-Organism
luminescens	I-Organism
TT01	I-Organism
strain	O
indicates	O
that	O
virulence	O
genes	O
are	O
encoded	O
within	O
a	O
number	O
of	O
pathogenicity	O
islands	O
located	O
on	O
the	O
bacterial	O
chromosome	O
[	O
4	O
,	O
5	O
]	O
.	O

Besides	O
producing	O
toxins	O
to	O
cause	O
insect	O
death	O
,	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
have	O
to	O
first	O
evade	O
the	O
insect	O
'	O
s	O
immune	O
response	O
to	O
establish	O
a	O
successful	O
infection	O
.	O

The	O
two	O
bacteria	O
differ	O
in	O
mechanisms	O
by	O
which	O
they	O
evade	O
host	O
immune	O
responses	O
.	O
<EOS>	B-X
OM	B-X
is	B-X
generally	B-X
classified	B-X
into	B-X
two	B-X
main	B-X
types	B-X
:	B-X
acute	B-X
and	B-X
chronic	B-X
OM	B-X
(	B-X
AOM	B-X
and	B-X
COM	B-X
)	B-X
.	B-X
Innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
provide	B-X
protection	B-X
against	B-X
OM	B-X
.	B-X
However	B-X
,	B-X
pathogens	B-X
employ	B-X
a	B-X
wide	B-X
arsenal	B-X
of	B-X
weapons	B-X
to	B-X
evade	B-X
potent	B-X
immune	B-X
responses	B-X
and	B-X
these	B-X
mechanisms	B-X
likely	B-X
contribute	B-X
to	B-X
AOM	B-X
and	B-X
COM	B-X
.	B-X
Immunologic	B-X
evasion	B-X
is	B-X
multifactorial	B-X
,	B-X
and	B-X
involves	B-X
damage	B-X
to	B-X
host	B-X
mucociliary	B-X
tract	B-X
,	B-X
genetic	B-X
polymorphisms	B-X
within	B-X
otopathogens	B-X
,	B-X
the	B-X
number	B-X
and	B-X
variety	B-X
of	B-X
different	B-X
otopathogens	B-X
in	B-X
the	B-X
nasopharynx	B-X
as	B-X
well	B-X
as	B-X
the	B-X
interaction	B-X
between	B-X
the	B-X
host	B-X
's	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
Otopathogens	B-X
utilize	B-X
host	B-X
mucin	B-X
production	B-X
,	B-X
phase	B-X
variation	B-X
,	B-X
biofilm	B-X
production	B-X
,	B-X
glycans	B-X
,	B-X
as	B-X
well	B-X
as	B-X
neutrophil	B-X
and	B-X
eosinophilic	B-X
extracellular	B-X
traps	B-X
to	B-X
induce	B-X
OM	B-X
.	B-X
The	B-X
objective	B-X
of	B-X
this	B-X
review	B-X
article	B-X
is	B-X
to	B-X
discuss	B-X
our	B-X
current	B-X
understanding	B-X
about	B-X
the	B-X
mechanisms	B-X
through	B-X
which	B-X
otopathogens	B-X
escape	B-X
host	B-X
immunity	B-X
to	B-X
induce	B-X
OM	B-X
.	B-X
A	B-X
better	B-X
knowledge	B-X
about	B-X
the	B-X
molecular	B-X
mechanisms	B-X
leading	B-X
to	B-X
subversion	B-X
of	B-X
host	B-X
immune	B-X
responses	B-X
will	B-X
provide	B-X
novel	B-X
clues	B-X
to	B-X
develop	B-X
effective	B-X
treatment	B-X
modalities	B-X
for	B-X
OM	B-X
.	B-X

For	O
example	O
,	O
in	O
Photorhabdus	B-Organism
,	O
mutational	O
inactivation	O
of	O
phoP	O
gene	O
results	O
in	O
increased	O
sensitivity	O
to	O
insect	O
immune	O
response	O
and	O
decreased	O
virulence	O
towards	O
insects	O
[	O
6	O
,	O
7	O
]	O
,	O
while	O
in	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
,	O
phoPQ	O
mutants	O
are	O
more	O
susceptible	O
to	O
immune	O
response	O
but	O
are	O
fully	O
virulent	O
[	O
3	O
]	O
.	O

P	B-Organism
.	I-Organism
luminescens	I-Organism
produces	O
a	O
signaling	O
molecule	O
AI	O
-	O
2	O
to	O
resist	O
reactive	O
oxygen	O
species	O
[	O
8	O
]	O
and	O
phenylpropanoid	O
chemical	O
ST	O
to	O
inhibit	O
the	O
activity	O
of	O
antimicrobial	O
enzyme	O
PO	O
and	O
formation	O
of	O
melanotic	O
nodules	O
[	O
9	O
]	O
,	O
but	O
the	O
strategy	O
used	O
by	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
appears	O
to	O
be	O
that	O
of	O
suppression	O
of	O
transcripts	O
involved	O
in	O
the	O
insect	O
immune	O
response	O
[	O
10	O
-	O
12	O
]	O
.	O

In	O
addition	O
,	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
encodes	O
a	O
type	O
III	O
secretion	O
system	O
and	O
one	O
of	O
the	O
effectors	O
,	O
LopT	O
,	O
suppresses	O
phagocytosis	O
and	O
reduces	O
nodulation	O
by	O
haemocytes	O
[	O
13	O
,	O
14	O
]	O
.	O

However	O
,	O
the	O
genomes	O
of	O
Xenorhabdus	B-Organism
bovienii	I-Organism
and	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
do	O
not	O
show	O
homologues	O
of	O
LopT	O
or	O
a	O
dedicated	O
type	O
III	O
secretion	O
system	O
[	O
3	O
]	O
,	O
and	O
Xenorhabdus	B-Organism
likely	O
uses	O
flagellar	O
regulatory	O
cascade	O
to	O
control	O
cellular	O
immunity	O
[	O
15	O
]	O
.	O

Despite	O
the	O
identification	O
of	O
the	O
above	O
regulatory	O
and	O
virulence	O
factors	O
from	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
,	O
the	O
full	O
profiles	O
of	O
genes	O
expressed	O
during	O
insect	O
infection	O
by	O
these	O
two	O
closely	O
related	O
bacteria	O
are	O
unknown	O
.	O

Munch	O
et	O
al	O
.	O
<EOS>	B-X
Glaucoma	B-X
is	B-X
a	B-X
neurodegenerative	B-X
disease	B-X
that	B-X
features	B-X
the	B-X
death	B-X
of	B-X
retinal	B-X
ganglion	B-X
cells	B-X
(	B-X
RGCs	B-X
)	B-X
in	B-X
the	B-X
retina	B-X
,	B-X
often	B-X
as	B-X
a	B-X
result	B-X
of	B-X
prolonged	B-X
increases	B-X
in	B-X
intraocular	B-X
pressure	B-X
.	B-X
We	B-X
show	B-X
that	B-X
preventing	B-X
the	B-X
formation	B-X
of	B-X
neuroinflammatory	B-X
reactive	B-X
astrocytes	B-X
prevents	B-X
the	B-X
death	B-X
of	B-X
RGCs	B-X
normally	B-X
seen	B-X
in	B-X
a	B-X
mouse	B-X
model	B-X
of	B-X
glaucoma	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
these	B-X
spared	B-X
RGCs	B-X
are	B-X
electrophysiologically	B-X
functional	B-X
and	B-X
thus	B-X
still	B-X
have	B-X
potential	B-X
value	B-X
for	B-X
the	B-X
function	B-X
and	B-X
regeneration	B-X
of	B-X
the	B-X
retina	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
death	B-X
of	B-X
RGCs	B-X
depends	B-X
on	B-X
a	B-X
combination	B-X
of	B-X
both	B-X
an	B-X
injury	B-X
to	B-X
the	B-X
neurons	B-X
and	B-X
the	B-X
presence	B-X
of	B-X
reactive	B-X
astrocytes	B-X
,	B-X
suggesting	B-X
a	B-X
model	B-X
that	B-X
may	B-X
explain	B-X
why	B-X
reactive	B-X
astrocytes	B-X
are	B-X
toxic	B-X
only	B-X
in	B-X
some	B-X
circumstances	B-X
.	B-X
Altogether	B-X
,	B-X
these	B-X
findings	B-X
highlight	B-X
reactive	B-X
astrocytes	B-X
as	B-X
drivers	B-X
of	B-X
RGC	B-X
death	B-X
in	B-X
a	B-X
chronic	B-X
neurodegenerative	B-X
disease	B-X
of	B-X
the	B-X
eye	B-X
.	B-X

[	O
16	O
]	O
identified	O
29	O
promoters	O
induced	O
by	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
in	O
the	O
presence	O
of	O
isolated	O
Galleria	B-Organism
mellonella	I-Organism
homogenate	O
using	O
a	O
differential	O
fluorescence	O
induction	O
approach	O
.	O

However	O
,	O
treatment	O
with	O
insect	O
homogenate	O
might	O
neglect	O
physicochemical	O
parameters	O
as	O
inducers	O
which	O
could	O
result	O
in	O
different	O
sets	O
of	O
genes	O
being	O
upregulated	O
during	O
natural	O
infection	O
of	O
live	O
insects	O
.	O

We	O
used	O
selective	O
capture	O
of	O
transcribed	O
sequences	O
(	O
SCOTS	O
)	O
technique	O
to	O
study	O
in	O
vivo	O
gene	O
expression	O
in	O
Photorhabdus	B-Organism
temperata	I-Organism
(	O
associated	O
with	O
the	O
nematode	O
Heterorhabditis	B-Organism
bacteriophora	I-Organism
GPS11	I-Organism
)	O
and	O
Xenorhabdus	B-Organism
koppenhoeferi	I-Organism
(	O
associated	O
with	O
the	O
nematode	O
Steinernema	B-Organism
scarabaei	I-Organism
AMK001	I-Organism
)	O
during	O
infection	O
of	O
the	O
same	O
insect	O
host	O
Rhizotrogus	B-Organism
majalis	I-Organism
.	O

They	O
were	O
selected	O
according	O
to	O
their	O
distinct	O
pathogenicity	O
in	O
insects	O
of	O
the	O
family	O
of	O
Scarabaeidae	O
-	O
S	B-Organism
.	I-Organism
scarabaei	I-Organism
is	O
more	O
virulent	O
to	O
R	B-Organism
.	I-Organism
majalis	I-Organism
than	O
H	B-Organism
.	I-Organism
bacteriophora	I-Organism
.	O

However	O
,	O
unlike	O
their	O
nematode	O
partners	O
,	O
both	O
bacterial	O
species	O
are	O
highly	O
virulent	O
to	O
Rhizotrogus	B-Organism
majalis	I-Organism
.	O

In	O
addition	O
,	O
although	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
grows	O
slower	O
than	O
P	B-Organism
.	I-Organism
temperata	I-Organism
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
the	O
LD50	O
and	O
LT50	O
value	O
do	O
not	O
differ	O
between	O
these	O
two	O
bacteria	O
[	O
17	O
]	O
.	O

We	O
hypothesize	O
that	O
the	O
two	O
bacteria	O
species	O
will	O
use	O
both	O
common	O
and	O
distinct	O
molecular	O
mechanisms	O
during	O
infection	O
of	O
the	O
same	O
insect	O
host	O
.	O

Results	O

Isolation	O
of	O
bacterial	O
transcripts	O
induced	O
in	O
Rhizotrogus	B-Organism
majalis	I-Organism
To	O
isolate	O
bacterial	O
genes	O
induced	O
upon	O
infection	O
,	O
total	O
RNA	O
was	O
isolated	O
from	O
live	O
grubs	O
at	O
24	O
h	O
post	O
injection	O
with	O
P	B-Organism
.	I-Organism
temperata	I-Organism
or	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
as	O
well	O
as	O
from	O
48	O
h	O
log	O
-	O
phase	O
bacterial	O
cultures	O
grown	O
in	O
Brain	O
Heart	O
Infusion	O
(	O
BHI	O
)	O
broth	O
that	O
were	O
used	O
to	O
inject	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Random	O
-	O
primed	O
bacterial	O
cDNAs	O
were	O
normalized	O
by	O
hybridization	O
to	O
biotinylated	O
bacterial	O
genomic	O
DNA	O
that	O
had	O
been	O
blocked	O
beforehand	O
using	O
bacterial	O
ribosomal	O
RNA	O
operon	O
,	O
resulting	O
in	O
sampling	O
of	O
bacterial	O
mRNA	O
transcripts	O
apart	O
from	O
its	O
ribosomal	O
and	O
insect	O
transcripts	O
.	O

The	O
normalized	O
bacterial	O
cDNAs	O
representing	O
total	O
mRNA	O
transcripts	O
produced	O
by	O
bacteria	O
grown	O
in	O
vitro	O
or	O
within	O
the	O
infected	O
insects	O
were	O
named	O
as	O
normalized	O
in	O
vitro	O
and	O
in	O
vivo	O
cDNA	O
libraries	O
,	O
respectively	O
.	O

To	O
isolate	O
bacterial	O
mRNA	O
transcripts	O
preferentially	O
induced	O
during	O
infection	O
of	O
the	O
insect	O
compared	O
to	O
the	O
culture	O
,	O
normalized	O
in	O
vivo	O
cDNAs	O
were	O
enriched	O
by	O
hybridization	O
to	O
biotinylated	O
bacterial	O
genomic	O
DNA	O
that	O
had	O
been	O
pre	O
-	O
hybridized	O
with	O
rRNA	O
operon	O
and	O
in	O
vitro	O
normalized	O
cDNAs	O
.	O

The	O
enriched	O
cDNAs	O
representing	O
in	O
vivo	O
-	O
induced	O
genes	O
,	O
which	O
were	O
either	O
lower	O
in	O
abundance	O
or	O
absent	O
in	O
48	O
h	O
in	O
vitro	O
bacterial	O
cultures	O
were	O
then	O
cloned	O
into	O
a	O
TA	O
cloning	O
vector	O
to	O
construct	O
in	O
vivo	O
enriched	O
cDNA	O
libraries	O
.	O
<EOS>	B-X
To	B-X
identify	B-X
changes	B-X
in	B-X
gene	B-X
expression	B-X
with	B-X
transformation	B-X
and	B-X
metastasis	B-X
,	B-X
we	B-X
investigated	B-X
differential	B-X
gene	B-X
expression	B-X
in	B-X
a	B-X
squamous	B-X
carcinoma	B-X
model	B-X
established	B-X
in	B-X
syngeneic	B-X
mice	B-X
.	B-X
We	B-X
used	B-X
mRNA	B-X
differential	B-X
display	B-X
(	B-X
DD	B-X
)	B-X
to	B-X
detect	B-X
global	B-X
differences	B-X
and	B-X
cDNA	B-X
arrays	B-X
enriched	B-X
for	B-X
cancer-associated	B-X
genes	B-X
using	B-X
mRNA	B-X
from	B-X
primary	B-X
keratinocytes	B-X
,	B-X
transformed	B-X
Pam	B-X
212	B-X
squamous	B-X
carcinoma	B-X
cells	B-X
,	B-X
and	B-X
metastases	B-X
of	B-X
Pam	B-X
212	B-X
.	B-X
After	B-X
DD	B-X
,	B-X
72	B-X
candidate	B-X
cDNAs	B-X
expressed	B-X
primarily	B-X
in	B-X
transformed	B-X
and	B-X
metastatic	B-X
cells	B-X
were	B-X
selected	B-X
and	B-X
cloned	B-X
.	B-X
Fifty-seven	B-X
were	B-X
detected	B-X
,	B-X
and	B-X
32	B-X
were	B-X
confirmed	B-X
to	B-X
be	B-X
differentially	B-X
expressed	B-X
by	B-X
Northern	B-X
blot	B-X
analysis	B-X
.	B-X
mRNA	B-X
expression	B-X
profiles	B-X
were	B-X
also	B-X
generated	B-X
using	B-X
a	B-X
mouse	B-X
cDNA	B-X
array	B-X
composed	B-X
of	B-X
4000	B-X
elements	B-X
representing	B-X
known	B-X
genes	B-X
and	B-X
expressed	B-X
sequence	B-X
tags	B-X
plus	B-X
the	B-X
57	B-X
DD	B-X
candidate	B-X
cDNAs	B-X
detected	B-X
by	B-X
Northern	B-X
analysis	B-X
to	B-X
facilitate	B-X
data	B-X
validation	B-X
.	B-X
cDNA	B-X
array	B-X
detected	B-X
76.9	B-X
%	B-X
of	B-X
the	B-X
differentially	B-X
expressed	B-X
mRNAs	B-X
selected	B-X
from	B-X
DD	B-X
and	B-X
confirmed	B-X
by	B-X
Northern	B-X
blot	B-X
,	B-X
whereas	B-X
low-abundance	B-X
mRNAs	B-X
did	B-X
not	B-X
reach	B-X
the	B-X
threshold	B-X
for	B-X
detection	B-X
by	B-X
the	B-X
lower-sensitivity	B-X
array	B-X
method	B-X
.	B-X
Clustering	B-X
analysis	B-X
of	B-X
DD	B-X
and	B-X
array	B-X
results	B-X
from	B-X
transformed	B-X
and	B-X
metastatic	B-X
cells	B-X
identified	B-X
genes	B-X
that	B-X
exhibited	B-X
decreased	B-X
or	B-X
increased	B-X
expression	B-X
with	B-X
transformation	B-X
and	B-X
metastasis	B-X
.	B-X
Alterations	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
genes	B-X
detected	B-X
during	B-X
tumor	B-X
progression	B-X
were	B-X
consistent	B-X
with	B-X
their	B-X
functional	B-X
activities	B-X
involving	B-X
growth	B-X
(	B-X
p21	B-X
,	B-X
p27	B-X
,	B-X
and	B-X
cyclin	B-X
D1	B-X
)	B-X
,	B-X
resistance	B-X
and	B-X
apoptosis	B-X
(	B-X
glutathione-S-transferase	B-X
,	B-X
cIAP-1	B-X
,	B-X
PEA-15	B-X
,	B-X
and	B-X
Fas	B-X
ligand	B-X
)	B-X
,	B-X
inflammation	B-X
and	B-X
angiogenesis	B-X
[	B-X
chemokine	B-X
growth-regulated	B-X
oncogene	B-X
1	B-X
(	B-X
also	B-X
called	B-X
KC	B-X
)	B-X
]	B-X
,	B-X
and	B-X
signal	B-X
transduction	B-X
(	B-X
c-Met	B-X
,	B-X
yes-associated	B-X
protein	B-X
,	B-X
and	B-X
syk	B-X
)	B-X
.	B-X
Strikingly	B-X
,	B-X
10	B-X
of	B-X
22	B-X
genes	B-X
in	B-X
the	B-X
cluster	B-X
expressed	B-X
in	B-X
metastases	B-X
have	B-X
been	B-X
associated	B-X
with	B-X
activation	B-X
of	B-X
the	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
signal	B-X
pathway	B-X
.	B-X
The	B-X
NF-kappaB-inducible	B-X
cytokine	B-X
Gro-1	B-X
was	B-X
recently	B-X
shown	B-X
to	B-X
promote	B-X
tumor	B-X
growth	B-X
,	B-X
metastasis	B-X
,	B-X
and	B-X
angiogenesis	B-X
of	B-X
squamous	B-X
cell	B-X
carcinomas	B-X
in	B-X
vivo	B-X
(	B-X
Loukinova	B-X
et	B-X
al.	B-X
,	B-X
Oncogene	B-X
,	B-X
19	B-X
:	B-X
3477-3486	B-X
,	B-X
2000	B-X
)	B-X
.	B-X
The	B-X
results	B-X
demonstrate	B-X
that	B-X
early	B-X
response	B-X
genes	B-X
related	B-X
to	B-X
NF-kappaB	B-X
contribute	B-X
to	B-X
metastatic	B-X
tumor	B-X
progression	B-X
.	B-X
Comparison	B-X
of	B-X
cell	B-X
lines	B-X
and	B-X
tumor	B-X
tissue	B-X
revealed	B-X
a	B-X
concordance	B-X
of	B-X
approximately	B-X
50	B-X
%	B-X
by	B-X
array	B-X
,	B-X
and	B-X
70	B-X
%	B-X
for	B-X
Northern-confirmed	B-X
,	B-X
metastasis-related	B-X
genes	B-X
.	B-X
Functional	B-X
genomic	B-X
approaches	B-X
comparing	B-X
expression	B-X
among	B-X
cell	B-X
lines	B-X
and	B-X
tumor	B-X
tissue	B-X
may	B-X
promote	B-X
a	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
genes	B-X
expressed	B-X
by	B-X
malignant	B-X
and	B-X
host	B-X
cells	B-X
during	B-X
tumor	B-X
progression	B-X
and	B-X
metastasis	B-X
.	B-X

A	O
total	O
of	O
384	O
clones	O
(	O
192	O
for	O
each	O
bacterium	O
)	O
derived	O
from	O
enriched	O
cDNA	O
libraries	O
were	O
randomly	O
picked	O
for	O
screening	O
.	O

Out	O
of	O
these	O
,	O
the	O
clones	O
(	O
150	O
for	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
140	O
for	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
)	O
that	O
showed	O
stronger	O
signal	O
upon	O
hybridization	O
with	O
in	O
vivo	O
-	O
derived	O
cDNAs	O
compared	O
to	O
in	O
vitro	O
-	O
derived	O
cDNAs	O
(	O
Fig	O
.	O
1	O
)	O
were	O
sequenced	O
and	O
analyzed	O
using	O
the	O
non	O
-	O
redundant	O
algorithms	O
of	O
BLAST	O
in	O
NCBI	O
and	O
database	O
of	O
Xenorhabdus	B-Organism
Genomes	I-Organism
.	O

These	O
sequenced	O
clones	O
were	O
therefore	O
considered	O
to	O
represent	O
reliable	O
transcripts	O
specifically	O
expressed	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
or	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
after	O
24	O
h	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Analysis	O
of	O
bacterial	O
genes	O
induced	O
in	O
Rhizotrogus	B-Organism
majalis	I-Organism

Most	O
identified	O
transcripts	O
were	O
either	O
similar	O
to	O
sequences	O
from	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
or	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
,	O
suggesting	O
that	O
bacterial	O
transcripts	O
were	O
successfully	O
enriched	O
from	O
the	O
infected	O
insects	O
.	O

For	O
both	O
bacteria	O
,	O
each	O
isolated	O
transcript	O
was	O
identified	O
at	O
least	O
twice	O
from	O
the	O
sequenced	O
clones	O
.	O
<EOS>	B-X
In	B-X
natural	B-X
environments	B-X
,	B-X
bacteria	B-X
survive	B-X
conditions	B-X
of	B-X
starvation	B-X
and	B-X
stress	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
genomes	B-X
of	B-X
1,117	B-X
clones	B-X
isolated	B-X
from	B-X
a	B-X
single	B-X
long-term	B-X
batch	B-X
culture	B-X
incubated	B-X
for	B-X
1,200	B-X
days	B-X
.	B-X
At	B-X
least	B-X
twice	B-X
,	B-X
a	B-X
previously	B-X
fixed	B-X
mutation	B-X
reverted	B-X
back	B-X
to	B-X
the	B-X
wild-type	B-X
allele	B-X
,	B-X
suggesting	B-X
beneficial	B-X
mutations	B-X
may	B-X
later	B-X
become	B-X
maladaptive	B-X
due	B-X
to	B-X
the	B-X
dynamic	B-X
environment	B-X
and	B-X
changing	B-X
selective	B-X
pressures	B-X
.	B-X
Most	B-X
of	B-X
the	B-X
mutated	B-X
genes	B-X
encode	B-X
proteins	B-X
involved	B-X
in	B-X
metabolism	B-X
,	B-X
transport	B-X
,	B-X
or	B-X
transcriptional	B-X
regulation	B-X
.	B-X

The	O
coverage	O
of	O
in	O
vivo	O
enriched	O
libraries	O
was	O
then	O
evaluated	O
using	O
Analytic	O
Rarefaction	O
according	O
to	O
the	O
redundancy	O
of	O
each	O
identical	O
transcript	O
in	O
the	O
sequenced	O
clones	O
.	O

As	O
indicated	O
by	O
the	O
rarefaction	O
curves	O
(	O
Fig	O
.	O
2	O
)	O
,	O
saturation	O
was	O
achieved	O
for	O
the	O
sequenced	O
clones	O
,	O
indicating	O
that	O
most	O
of	O
representative	O
genes	O
in	O
the	O
in	O
vivo	O
enriched	O
cDNA	O
libraries	O
were	O
identified	O
.	O

Totally	O
,	O
we	O
isolated	O
40	O
different	O
sequences	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
(	O
Table	O
1	O
)	O
and	O
39	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
(	O
Table	O
2	O
)	O
.	O

Based	O
on	O
homology	O
searches	O
,	O
the	O
genes	O
corresponding	O
to	O
distinct	O
sequences	O
could	O
be	O
divided	O
into	O
seven	O
functional	O
groups	O
:	O
cell	O
surface	O
structure	O
(	O
Class	O
I	O
)	O
,	O
intracellular	O
metabolism	O
(	O
Class	O
II	O
)	O
,	O
nutrient	O
scavenging	O
(	O
Class	O
III	O
)	O
,	O
regulation	O
(	O
Class	O
IV	O
)	O
,	O
stress	O
response	O
(	O
Class	O
V	O
)	O
,	O
virulence	O
(	O
Class	O
VI	O
)	O
and	O
uncharacterized	O
genes	O
(	O
Class	O
VII	O
)	O
.	O

Genes	O
involved	O
in	O
metabolism	O
constitute	O
about	O
25	O
%	O
to	O
33	O
%	O
of	O
the	O
total	O
number	O
of	O
in	O
vivo	O
-	O
induced	O
genes	O
(	O
Fig	O
.	O
3	O
)	O
,	O
showing	O
large	O
numbers	O
of	O
metabolic	O
changes	O
during	O
insect	O
infection	O
.	O

Semi	O
-	O
quantitative	O
reverse	O
transcriptase	O
PCR	O
performed	O
on	O
10	O
randomly	O
selected	O
identified	O
genes	O
(	O
five	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
:	O
cysK	O
,	O
fliA	O
,	O
lysR	O
,	O
pchC	O
and	O
pmt1	O
and	O
five	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
:	O
aceE	O
,	O
dacC	O
,	O
cobJ	O
,	O
malF	O
,	O
and	O
yijC	O
)	O
showed	O
that	O
these	O
genes	O
were	O
detectable	O
from	O
the	O
in	O
vivo	O
-	O
derived	O
cDNA	O
but	O
not	O
from	O
in	O
vitro	O
-	O
derived	O
cDNA	O
.	O

In	O
addition	O
,	O
18S	O
rRNA	O
gene	O
,	O
a	O
eukaryotic	O
housekeeping	O
gene	O
,	O
was	O
detected	O
in	O
the	O
in	O
vivo	O
cDNA	O
population	O
before	O
normalization	O
,	O
but	O
not	O
after	O
normalization	O
,	O
suggesting	O
that	O
bacterial	O
cDNAs	O
were	O
successfully	O
purified	O
from	O
the	O
insect	O
cDNAs	O
after	O
SCOTS	O
normalization	O
.	O

Also	O
gyrase	O
A	O
gene	O
,	O
a	O
prokaryotic	O
housekeeping	O
gene	O
,	O
was	O
not	O
detected	O
from	O
the	O
enriched	O
in	O
vivo	O
cDNAs	O
,	O
but	O
was	O
detected	O
in	O
all	O
other	O
cDNA	O
populations	O
including	O
in	O
vitro	O
and	O
in	O
vivo	O
cDNAs	O
before	O
and	O
after	O
normalization	O
,	O
indicating	O
that	O
only	O
differentially	O
expressed	O
genes	O
were	O
captured	O
after	O
enrichment	O
.	O
<EOS>	B-X
It	B-X
rapidly	B-X
blocks	B-X
bacterial	B-X
deoxyribonucleic	B-X
acid	B-X
(	B-X
DNA	B-X
)	B-X
replication	B-X
by	B-X
inhibiting	B-X
DNA	B-X
gyrase	B-X
,	B-X
an	B-X
essential	B-X
prokaryotic	B-X
enzyme	B-X
that	B-X
catalyzes	B-X
chromosomal	B-X
DNA	B-X
supercoiling	B-X
.	B-X
Molecular	B-X
genetic	B-X
approaches	B-X
have	B-X
been	B-X
used	B-X
to	B-X
study	B-X
the	B-X
interaction	B-X
of	B-X
4-quinolones	B-X
with	B-X
DNA	B-X
gyrase	B-X
from	B-X
quinolone-sensitive	B-X
strains	B-X
and	B-X
from	B-X
uropathogenic	B-X
quinolone-resistant	B-X
clinical	B-X
isolates	B-X
of	B-X
Escherichia	B-X
coli	B-X
.	B-X
An	B-X
important	B-X
mutational	B-X
locus	B-X
in	B-X
the	B-X
gyrase	B-X
A	B-X
gene	B-X
that	B-X
confers	B-X
resistance	B-X
to	B-X
ciprofloxacin	B-X
and	B-X
other	B-X
quinolones	B-X
has	B-X
been	B-X
identified	B-X
,	B-X
and	B-X
a	B-X
new	B-X
,	B-X
rapid	B-X
method	B-X
to	B-X
examine	B-X
clinical	B-X
isolates	B-X
for	B-X
the	B-X
presence	B-X
of	B-X
mutations	B-X
at	B-X
this	B-X
position	B-X
has	B-X
been	B-X
devised	B-X
.	B-X
A	B-X
quinolone	B-X
resistant	B-X
gyrA	B-X
gene	B-X
has	B-X
been	B-X
previously	B-X
cloned	B-X
and	B-X
sequenced	B-X
from	B-X
an	B-X
E.	B-X
coli	B-X
clinical	B-X
isolate	B-X
.	B-X
Genetic	B-X
analysis	B-X
indicated	B-X
that	B-X
resistance	B-X
resulted	B-X
from	B-X
a	B-X
Ser-83	B-X
--	B-X
--	B-X
Trp	B-X
change	B-X
in	B-X
the	B-X
875	B-X
residue	B-X
gyrase	B-X
A	B-X
protein	B-X
:	B-X
two	B-X
other	B-X
changes	B-X
observed	B-X
in	B-X
the	B-X
protein	B-X
,	B-X
Asp-678	B-X
--	B-X
--	B-X
Glu	B-X
and	B-X
Ala-828	B-X
--	B-X
--	B-X
Ser	B-X
,	B-X
were	B-X
neutral	B-X
.	B-X
GyrA	B-X
genes	B-X
carrying	B-X
these	B-X
mutations	B-X
have	B-X
now	B-X
been	B-X
expressed	B-X
,	B-X
corresponding	B-X
mutant	B-X
gyrase	B-X
A	B-X
proteins	B-X
purified	B-X
,	B-X
and	B-X
their	B-X
quinolone	B-X
resistance	B-X
properties	B-X
tested	B-X
by	B-X
complementing	B-X
with	B-X
gyrase	B-X
B	B-X
protein	B-X
and	B-X
studying	B-X
the	B-X
resulting	B-X
gyrase	B-X
activity	B-X
in	B-X
an	B-X
adenosine	B-X
triphosphate-dependent	B-X
DNA	B-X
supercoiling	B-X
assay	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
DNA	B-X
supercoiling	B-X
activity	B-X
of	B-X
the	B-X
A	B-X
(	B-X
Ser-83	B-X
--	B-X
--	B-X
Trp	B-X
)	B-X
mutant	B-X
subunit	B-X
complemented	B-X
with	B-X
wild-type	B-X
gyrase	B-X
B	B-X
subunit	B-X
was	B-X
highly	B-X
resistant	B-X
to	B-X
ciprofloxacin	B-X
and	B-X
other	B-X
4-quinolones	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
A	B-X
subunit	B-X
carrying	B-X
codon	B-X
678	B-X
and	B-X
828	B-X
changes	B-X
reconstituted	B-X
a	B-X
quinolone-sensitive	B-X
gyrase	B-X
activity	B-X
.	B-X
Thus	B-X
,	B-X
quinolone-resistant	B-X
gyrase	B-X
A	B-X
proteins	B-X
may	B-X
be	B-X
readily	B-X
obtained	B-X
for	B-X
study	B-X
by	B-X
using	B-X
high-copy	B-X
gyrA	B-X
plasmids	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
other	B-X
quinolone-resistant	B-X
strains	B-X
of	B-X
E.	B-X
coli	B-X
have	B-X
been	B-X
examined	B-X
for	B-X
the	B-X
presence	B-X
of	B-X
mutations	B-X
at	B-X
gyrase	B-X
A	B-X
codons	B-X
82	B-X
and	B-X
83	B-X
using	B-X
a	B-X
new	B-X
analytical	B-X
method	B-X
based	B-X
on	B-X
a	B-X
restriction	B-X
fragment	B-X
length	B-X
polymorphism	B-X
(	B-X
RFLP	B-X
)	B-X
.	B-X
Thus	B-X
,	B-X
mutations	B-X
at	B-X
codon	B-X
83	B-X
(	B-X
and	B-X
possibly	B-X
82	B-X
)	B-X
in	B-X
the	B-X
gyrA	B-X
gene	B-X
frequently	B-X
confer	B-X
resistance	B-X
to	B-X
4-quinolones	B-X
,	B-X
including	B-X
ciprofloxacin	B-X
.	B-X
These	B-X
results	B-X
are	B-X
discussed	B-X
with	B-X
regard	B-X
to	B-X
the	B-X
mode	B-X
of	B-X
interaction	B-X
of	B-X
the	B-X
4-quinolones	B-X
with	B-X
gyrase	B-X
.	B-X

Identification	O
of	O
Photorhabdus	B-Organism
temperata	I-Organism
or	O
Xenorhabdus	B-Organism
koppenhoeferi	I-Organism
specific	O
genes	O
<EOS>	B-X
Photorhabdus	B-X
temperata	B-X
is	B-X
an	B-X
entomopathogenic	B-X
enterobacterium	B-X
;	B-X
it	B-X
is	B-X
a	B-X
nematode	B-X
symbiont	B-X
that	B-X
possesses	B-X
pathogenicity	B-X
islands	B-X
involved	B-X
in	B-X
insect	B-X
virulence	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
constructed	B-X
a	B-X
P.	B-X
temperata	B-X
M1021	B-X
cosmid	B-X
library	B-X
in	B-X
Escherichia	B-X
coli	B-X
XL1-Blue	B-X
MRF	B-X
`	B-X
and	B-X
obtained	B-X
7.14	B-X
×	B-X
105	B-X
clones	B-X
.	B-X
The	B-X
sequence	B-X
alignment	B-X
against	B-X
the	B-X
available	B-X
sequences	B-X
in	B-X
Swiss-Prot	B-X
and	B-X
NCBI	B-X
databases	B-X
,	B-X
confirmed	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
mcf	B-X
gene	B-X
homolog	B-X
in	B-X
the	B-X
genome	B-X
of	B-X
P.	B-X
temperata	B-X
M1021	B-X
showing	B-X
85	B-X
%	B-X
homology	B-X
and	B-X
98	B-X
%	B-X
query	B-X
coverage	B-X
with	B-X
the	B-X
P.	B-X
luminescens	B-X
counterpart	B-X
.	B-X
Photorhabdus	B-X
temperata	B-X
is	B-X
a	B-X
symbiont	B-X
of	B-X
the	B-X
entomopathogenic	B-X
nematode	B-X
Heterorhabditis	B-X
bacteriophora	B-X
and	B-X
an	B-X
insect	B-X
pathogen	B-X
.	B-X
A	B-X
genetic	B-X
approach	B-X
was	B-X
used	B-X
to	B-X
identify	B-X
mutants	B-X
with	B-X
altered	B-X
hemolytic	B-X
activity	B-X
by	B-X
screening	B-X
a	B-X
library	B-X
of	B-X
10	B-X
000	B-X
P.	B-X
temperata	B-X
transposon	B-X
mutants	B-X
.	B-X
The	B-X
transposon	B-X
insertion	B-X
sites	B-X
for	B-X
these	B-X
mutants	B-X
were	B-X
identified	B-X
and	B-X
used	B-X
to	B-X
investigate	B-X
other	B-X
physiological	B-X
properties	B-X
,	B-X
including	B-X
insect	B-X
pathogenesis	B-X
and	B-X
motility	B-X
.	B-X
The	B-X
hemolysin-defective	B-X
mutants	B-X
,	B-X
P10A-C11	B-X
,	B-X
P10A-H12	B-X
,	B-X
and	B-X
P79-B5	B-X
,	B-X
had	B-X
inserts	B-X
in	B-X
genes	B-X
involved	B-X
in	B-X
RNA	B-X
turnover	B-X
(	B-X
RNase	B-X
II	B-X
and	B-X
5'-pentaphospho-5'-adenosine	B-X
pyrophosphohydrolase	B-X
)	B-X
and	B-X
showed	B-X
reduced	B-X
virulence	B-X
and	B-X
production	B-X
of	B-X
extracellular	B-X
factors	B-X
.	B-X
These	B-X
data	B-X
support	B-X
the	B-X
role	B-X
of	B-X
RNA	B-X
turnover	B-X
in	B-X
insect	B-X
pathogenesis	B-X
and	B-X
other	B-X
physiological	B-X
functions	B-X
.	B-X

To	O
identify	O
genes	O
that	O
were	O
distinctive	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
or	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
genome	O
or	O
exclusively	O
induced	O
in	O
one	O
or	O
the	O
other	O
bacterium	O
,	O
comparative	O
hybridization	O
was	O
performed	O
based	O
upon	O
the	O
identified	O
genes	O
.	O
<EOS>	B-X
Free	B-X
radicals	B-X
are	B-X
chemical	B-X
species	B-X
(	B-X
atoms	B-X
,	B-X
molecules	B-X
,	B-X
or	B-X
ions	B-X
)	B-X
containing	B-X
one	B-X
or	B-X
more	B-X
unpaired	B-X
electrons	B-X
in	B-X
their	B-X
external	B-X
orbitals	B-X
and	B-X
generally	B-X
display	B-X
a	B-X
remarkable	B-X
reactivity	B-X
.	B-X
For	B-X
several	B-X
decades	B-X
,	B-X
free	B-X
radicals	B-X
were	B-X
thought	B-X
to	B-X
cause	B-X
exclusively	B-X
damaging	B-X
effects	B-X
.	B-X
Their	B-X
use	B-X
is	B-X
usually	B-X
regarded	B-X
as	B-X
helpful	B-X
to	B-X
counteract	B-X
the	B-X
damaging	B-X
effects	B-X
of	B-X
free	B-X
radicals	B-X
but	B-X
sometimes	B-X
is	B-X
harmful	B-X
as	B-X
it	B-X
can	B-X
block	B-X
adaptive	B-X
responses	B-X
induced	B-X
by	B-X
low	B-X
levels	B-X
of	B-X
radicals	B-X
.	B-X
Tau	B-X
aggregates	B-X
have	B-X
the	B-X
ability	B-X
to	B-X
transfer	B-X
from	B-X
one	B-X
cell	B-X
to	B-X
another	B-X
and	B-X
to	B-X
induce	B-X
templated	B-X
misfolding	B-X
and	B-X
aggregation	B-X
of	B-X
healthy	B-X
tau	B-X
molecules	B-X
in	B-X
previously	B-X
healthy	B-X
cells	B-X
,	B-X
thereby	B-X
propagating	B-X
tau	B-X
pathology	B-X
across	B-X
different	B-X
brain	B-X
areas	B-X
in	B-X
a	B-X
prion-like	B-X
manner	B-X
.	B-X

Twenty	O
nine	O
of	O
the	O
40	O
distinct	O
P	B-Organism
.	I-Organism
temperata	I-Organism
transcripts	O
have	O
similar	O
sequences	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
genome	O
,	O
thus	O
11	O
were	O
P	B-Organism
.	I-Organism
temperata	I-Organism
specific	O
;	O
30	O
of	O
the	O
39	O
distinct	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
transcripts	O
share	O
sequence	O
similarity	O
with	O
P	B-Organism
.	I-Organism
temperata	I-Organism
genome	O
,	O
thus	O
9	O
were	O
specific	O
to	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

Although	O
these	O
59	O
transcripts	O
(	O
29	O
+	O
30	O
)	O
corresponding	O
to	O
genes	O
present	O
in	O
the	O
genome	O
of	O
both	O
bacteria	O
,	O
21	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
22	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
were	O
identified	O
to	O
be	O
exclusively	O
induced	O
in	O
each	O
of	O
them	O
.	O

Only	O
a	O
small	O
number	O
of	O
transcripts	O
were	O
induced	O
in	O
both	O
bacteria	O
,	O
and	O
most	O
of	O
them	O
corresponded	O
to	O
genes	O
required	O
for	O
stress	O
response	O
.	O

Further	O
,	O
the	O
level	O
of	O
changes	O
in	O
the	O
transcripts	O
exclusively	O
induced	O
in	O
one	O
or	O
the	O
other	O
bacterium	O
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
was	O
determined	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
on	O
following	O
representative	O
genes	O
:	O
cysK	O
,	O
def	O
,	O
dnaB	O
,	O
lysR	O
,	O
pchC	O
,	O
pckA	O
,	O
phoP	O
,	O
ptst1	O
,	O
sctL	O
,	O
selD	O
,	O
tolB	O
and	O
virB	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
and	O
aceK	O
,	O
clpP	O
,	O
cobJ	O
,	O
dacC	O
,	O
dld	O
,	O
malF	O
,	O
res	O
,	O
rtxC	O
,	O
tilS	O
,	O
virH	O
,	O
xhlA	O
,	O
and	O
xkst4	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O
<EOS>	B-X
The	B-X
resulting	B-X
decrease	B-X
in	B-X
muscle	B-X
strength	B-X
and	B-X
motility	B-X
irreversibly	B-X
impacts	B-X
quality	B-X
of	B-X
life	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
directly	B-X
affecting	B-X
skeletal	B-X
muscle	B-X
,	B-X
pathogenesis	B-X
can	B-X
also	B-X
arise	B-X
from	B-X
dysfunctional	B-X
crosstalk	B-X
between	B-X
nerves	B-X
and	B-X
muscles	B-X
,	B-X
and	B-X
may	B-X
include	B-X
cardiac	B-X
impairment	B-X
.	B-X
Muscular	B-X
weakness	B-X
is	B-X
often	B-X
progressive	B-X
and	B-X
paralleled	B-X
by	B-X
continuous	B-X
decline	B-X
in	B-X
the	B-X
ability	B-X
of	B-X
skeletal	B-X
muscle	B-X
to	B-X
functionally	B-X
adapt	B-X
and	B-X
regenerate	B-X
.	B-X
Normally	B-X
,	B-X
the	B-X
skeletal	B-X
muscle	B-X
resident	B-X
stem	B-X
cells	B-X
,	B-X
named	B-X
satellite	B-X
cells	B-X
,	B-X
ensure	B-X
tissue	B-X
homeostasis	B-X
by	B-X
providing	B-X
myoblasts	B-X
for	B-X
growth	B-X
,	B-X
maintenance	B-X
,	B-X
repair	B-X
and	B-X
regeneration	B-X
.	B-X
We	B-X
recently	B-X
defined	B-X
'Satellite	B-X
Cell-opathies	B-X
'	B-X
as	B-X
those	B-X
inherited	B-X
neuromuscular	B-X
conditions	B-X
presenting	B-X
satellite	B-X
cell	B-X
dysfunction	B-X
in	B-X
muscular	B-X
dystrophies	B-X
and	B-X
myopathies	B-X
(	B-X
doi:10.1016/j.yexcr.2021.112906	B-X
)	B-X
.	B-X
We	B-X
explore	B-X
the	B-X
expression	B-X
dynamics	B-X
of	B-X
myopathogenes	B-X
,	B-X
genes	B-X
whose	B-X
mutation	B-X
leads	B-X
to	B-X
skeletal	B-X
muscle	B-X
pathogenesis	B-X
,	B-X
using	B-X
transcriptomic	B-X
analysis	B-X
.	B-X
This	B-X
revealed	B-X
that	B-X
45	B-X
%	B-X
of	B-X
myopathogenes	B-X
are	B-X
differentially	B-X
expressed	B-X
during	B-X
early	B-X
satellite	B-X
cell	B-X
activation	B-X
(	B-X
0	B-X
-	B-X
5	B-X
hours	B-X
)	B-X
.	B-X
Of	B-X
these	B-X
271	B-X
myopathogenes	B-X
,	B-X
83	B-X
respond	B-X
to	B-X
Pax7	B-X
,	B-X
a	B-X
master	B-X
regulator	B-X
of	B-X
satellite	B-X
cells	B-X
.	B-X

qRT	O
-	O
PCR	O
results	O
displayed	O
consistence	O
with	O
the	O
SCOTS	O
assay	O
.	O

Most	O
tested	O
genes	O
displayed	O
6	O
-	O
16	O
fold	O
induction	O
in	O
qRT	O
-	O
PCR	O
assays	O
,	O
and	O
a	O
few	O
genes	O
including	O
sctL	O
,	O
phoP	O
,	O
rtxC	O
and	O
clpP	O
exhibited	O
about	O
3	O
-	O
fold	O
induction	O
(	O
Fig	O
.	O
4	O
)	O
.	O

Analysis	O
of	O
biological	O
associations	O
of	O
in	O
vivo	O
-	O
induced	O
genes	O
<EOS>	B-X
The	B-X
objective	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
determine	B-X
whether	B-X
EMT	B-X
and	B-X
stemness	B-X
characteristics	B-X
induced	B-X
by	B-X
TGF-β	B-X
might	B-X
be	B-X
associated	B-X
with	B-X
epigenetic	B-X
regulation	B-X
in	B-X
lung	B-X
cancer	B-X
.	B-X
Wound	B-X
healing	B-X
and	B-X
Matrigel	B-X
invasion	B-X
assay	B-X
,	B-X
sphere	B-X
formation	B-X
assay	B-X
,	B-X
and	B-X
in	B-X
vivo	B-X
mice	B-X
tumor	B-X
model	B-X
were	B-X
performed	B-X
to	B-X
evaluate	B-X
functional	B-X
characteristics	B-X
of	B-X
EMT	B-X
and	B-X
stemness	B-X
acquisition	B-X
.	B-X
Expression	B-X
of	B-X
slug	B-X
and	B-X
CD87	B-X
genes	B-X
was	B-X
activated	B-X
following	B-X
treatment	B-X
with	B-X
AZA	B-X
and	B-X
TGF-β	B-X
.	B-X
MSP	B-X
and	B-X
bisulfite	B-X
sequencing	B-X
indicated	B-X
DNA	B-X
demethylation	B-X
of	B-X
slug	B-X
and	B-X
CD87	B-X
genes	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
TGF-β	B-X
induced	B-X
EMT	B-X
and	B-X
cancer	B-X
stemness	B-X
acquisition	B-X
could	B-X
be	B-X
associated	B-X
with	B-X
activation	B-X
of	B-X
slug	B-X
and	B-X
CD87	B-X
gene	B-X
by	B-X
their	B-X
promoter	B-X
demethylation	B-X
.	B-X

To	O
understand	O
the	O
function	O
and	O
interactions	O
of	O
the	O
identified	O
gene	O
products	O
,	O
interactive	O
networks	O
were	O
built	O
to	O
provide	O
an	O
overview	O
of	O
how	O
gene	O
products	O
relate	O
to	O
each	O
other	O
by	O
leveraging	O
databases	O
of	O
published	O
literature	O
.	O

Using	O
PathwayStudio	O
(	O
Ariadne	O
,	O
Rockville	O
,	O
MD	O
,	O
USA	O
)	O
program	O
,	O
we	O
were	O
able	O
to	O
distill	O
all	O
published	O
information	O
about	O
biological	O
relationships	O
of	O
bacterial	O
homologs	O
of	O
the	O
identified	O
genes	O
.	O

Molecular	O
interactions	O
linking	O
each	O
identified	O
gene	O
product	O
in	O
terms	O
of	O
binding	O
,	O
direct	O
molecular	O
regulation	O
,	O
effects	O
on	O
expression	O
,	O
transportation	O
,	O
and	O
molecule	O
synthesis	O
were	O
elucidated	O
in	O
PathwayStudio	O
.	O

Based	O
on	O
this	O
analysis	O
,	O
the	O
biological	O
significance	O
of	O
each	O
gene	O
was	O
inferred	O
.	O
<EOS>	B-X
En	B-X
masse	B-X
population-based	B-X
phenotypic	B-X
analysis	B-X
under	B-X
insulin	B-X
insensitive	B-X
conditions	B-X
predicted	B-X
key	B-X
non-alcoholic	B-X
steatohepatitis	B-X
(	B-X
NASH	B-X
)	B-X
-genetic	B-X
factors	B-X
including	B-X
the	B-X
glucokinase	B-X
regulatory	B-X
protein	B-X
(	B-X
GCKR	B-X
)	B-X
-rs1260326	B-X
:	B-X
C	B-X
>	B-X
T	B-X
.	B-X
Thus	B-X
,	B-X
``	B-X
in-a-dish	B-X
''	B-X
genotype-phenotype	B-X
association	B-X
strategies	B-X
disentangle	B-X
the	B-X
opposing	B-X
roles	B-X
of	B-X
metabolic-associated	B-X
gene	B-X
variant	B-X
functions	B-X
and	B-X
offer	B-X
a	B-X
rich	B-X
mechanistic	B-X
,	B-X
diagnostic	B-X
,	B-X
and	B-X
therapeutic	B-X
inference	B-X
toolbox	B-X
toward	B-X
precision	B-X
hepatology	B-X
.	B-X
So	B-X
we	B-X
aimed	B-X
to	B-X
identify	B-X
potential	B-X
differentially	B-X
expressed	B-X
proteins	B-X
and	B-X
genes	B-X
in	B-X
TBI	B-X
for	B-X
clinical	B-X
diagnosis	B-X
and	B-X
therapeutic	B-X
purposes	B-X
.	B-X
Networks	B-X
are	B-X
often	B-X
used	B-X
to	B-X
represent	B-X
the	B-X
interactions	B-X
among	B-X
genes	B-X
and	B-X
proteins	B-X
.	B-X
These	B-X
interactions	B-X
are	B-X
known	B-X
to	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
vital	B-X
cell	B-X
functions	B-X
and	B-X
should	B-X
be	B-X
included	B-X
in	B-X
the	B-X
analysis	B-X
of	B-X
genes	B-X
that	B-X
are	B-X
differentially	B-X
expressed	B-X
.	B-X
Methods	B-X
of	B-X
gene	B-X
set	B-X
analysis	B-X
take	B-X
advantage	B-X
of	B-X
external	B-X
biological	B-X
information	B-X
and	B-X
analyze	B-X
a	B-X
priori	B-X
defined	B-X
sets	B-X
of	B-X
genes	B-X
.	B-X
These	B-X
methods	B-X
can	B-X
potentially	B-X
preserve	B-X
the	B-X
correlation	B-X
among	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
they	B-X
do	B-X
not	B-X
directly	B-X
incorporate	B-X
the	B-X
information	B-X
about	B-X
the	B-X
gene	B-X
network	B-X
.	B-X
We	B-X
then	B-X
use	B-X
the	B-X
theory	B-X
of	B-X
mixed	B-X
linear	B-X
models	B-X
to	B-X
present	B-X
a	B-X
general	B-X
inference	B-X
framework	B-X
for	B-X
the	B-X
problem	B-X
of	B-X
testing	B-X
the	B-X
significance	B-X
of	B-X
subnetworks	B-X
.	B-X
Several	B-X
possible	B-X
test	B-X
procedures	B-X
are	B-X
introduced	B-X
and	B-X
a	B-X
network	B-X
based	B-X
method	B-X
for	B-X
testing	B-X
the	B-X
changes	B-X
in	B-X
expression	B-X
levels	B-X
of	B-X
genes	B-X
as	B-X
well	B-X
as	B-X
the	B-X
structure	B-X
of	B-X
the	B-X
network	B-X
is	B-X
presented	B-X
.	B-X
The	B-X
performance	B-X
of	B-X
the	B-X
proposed	B-X
method	B-X
is	B-X
compared	B-X
with	B-X
methods	B-X
of	B-X
gene	B-X
set	B-X
analysis	B-X
using	B-X
both	B-X
simulation	B-X
studies	B-X
,	B-X
as	B-X
well	B-X
as	B-X
real	B-X
data	B-X
on	B-X
genes	B-X
related	B-X
to	B-X
the	B-X
galactose	B-X
utilization	B-X
pathway	B-X
in	B-X
yeast	B-X
.	B-X

Linkage	O
between	O
proteins	O
shows	O
how	O
upregulated	O
genes	O
may	O
influence	O
other	O
genes	O
or	O
gene	O
products	O
.	O
<EOS>	B-X
Recombinant	B-X
adeno-associated	B-X
viruses	B-X
(	B-X
rAAVs	B-X
)	B-X
are	B-X
one	B-X
of	B-X
the	B-X
most	B-X
commonly	B-X
used	B-X
vectors	B-X
for	B-X
a	B-X
variety	B-X
of	B-X
gene	B-X
therapy	B-X
applications	B-X
.	B-X
Vectors	B-X
derived	B-X
from	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
(	B-X
HIV	B-X
)	B-X
are	B-X
highly	B-X
efficient	B-X
vehicles	B-X
for	B-X
in	B-X
vivo	B-X
gene	B-X
delivery	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
structural	B-X
genes	B-X
,	B-X
HIV	B-X
contains	B-X
two	B-X
regulatory	B-X
genes	B-X
,	B-X
tat	B-X
and	B-X
rev	B-X
,	B-X
that	B-X
are	B-X
essential	B-X
for	B-X
HIV	B-X
replication	B-X
,	B-X
and	B-X
four	B-X
accessory	B-X
genes	B-X
that	B-X
encode	B-X
critical	B-X
virulence	B-X
factors	B-X
.	B-X
We	B-X
previously	B-X
reported	B-X
that	B-X
the	B-X
HIV	B-X
type	B-X
1	B-X
accessory	B-X
open	B-X
reading	B-X
frames	B-X
are	B-X
dispensable	B-X
for	B-X
efficient	B-X
gene	B-X
transduction	B-X
by	B-X
a	B-X
lentivirus	B-X
vector	B-X
.	B-X
We	B-X
now	B-X
demonstrate	B-X
that	B-X
the	B-X
requirement	B-X
for	B-X
the	B-X
tat	B-X
gene	B-X
can	B-X
be	B-X
offset	B-X
by	B-X
placing	B-X
constitutive	B-X
promoters	B-X
upstream	B-X
of	B-X
the	B-X
vector	B-X
transcript	B-X
.	B-X
Vectors	B-X
generated	B-X
from	B-X
constructs	B-X
containing	B-X
such	B-X
a	B-X
chimeric	B-X
long	B-X
terminal	B-X
repeat	B-X
(	B-X
LTR	B-X
)	B-X
transduced	B-X
neurons	B-X
in	B-X
vivo	B-X
at	B-X
very	B-X
high	B-X
efficiency	B-X
,	B-X
whether	B-X
or	B-X
not	B-X
they	B-X
were	B-X
produced	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
Tat	B-X
.	B-X
When	B-X
the	B-X
rev	B-X
gene	B-X
was	B-X
also	B-X
deleted	B-X
from	B-X
the	B-X
packaging	B-X
construct	B-X
,	B-X
expression	B-X
of	B-X
gag	B-X
and	B-X
pol	B-X
was	B-X
strictly	B-X
dependent	B-X
on	B-X
Rev	B-X
complementation	B-X
in	B-X
trans	B-X
.	B-X
This	B-X
third-generation	B-X
lentivirus	B-X
vector	B-X
uses	B-X
only	B-X
a	B-X
fractional	B-X
set	B-X
of	B-X
HIV	B-X
genes	B-X
:	B-X
gag	B-X
,	B-X
pol	B-X
,	B-X
and	B-X
rev	B-X
.	B-X
This	B-X
split-genome	B-X
,	B-X
conditional	B-X
packaging	B-X
system	B-X
is	B-X
based	B-X
on	B-X
existing	B-X
viral	B-X
sequences	B-X
and	B-X
acts	B-X
as	B-X
a	B-X
built-in	B-X
device	B-X
against	B-X
the	B-X
generation	B-X
of	B-X
productive	B-X
recombinants	B-X
.	B-X

For	O
example	O
,	O
gene	O
rpoB	O
,	O
induced	O
in	O
both	O
bacteria	O
,	O
interacts	O
with	O
many	O
gene	O
products	O
,	O
suggesting	O
its	O
overall	O
importance	O
during	O
insect	O
infection	O
(	O
see	O
Additional	O
files	O
1	O
and	O
2	O
)	O
.	O

Other	O
identified	O
genes	O
with	O
multiple	O
connections	O
to	O
different	O
gene	O
products	O
were	O
different	O
between	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
indicating	O
distinct	O
biological	O
processes	O
used	O
by	O
the	O
two	O
bacteria	O
for	O
insect	O
infection	O
.	O

Moreover	O
,	O
linkages	O
with	O
small	O
molecules	O
indicate	O
how	O
normal	O
functions	O
in	O
gene	O
regulation	O
networks	O
are	O
influenced	O
by	O
small	O
molecules	O
that	O
may	O
be	O
available	O
in	O
the	O
insect	O
body	O
.	O

For	O
example	O
,	O
regulation	O
of	O
genes	O
yncB	O
and	O
purH	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
are	O
influenced	O
by	O
aromatic	O
compounds	O
and	O
formate	O
,	O
respectively	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

In	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
gene	O
trxB	O
is	O
influenced	O
by	O
arabinose	O
and	O
selenium	O
,	O
and	O
gene	O
znuA	O
is	O
influenced	O
by	O
etoposide	O
(	O
see	O
Additional	O
file	O
2	O
)	O
.	O

Compared	O
to	O
the	O
biological	O
interactions	O
(	O
see	O
Additional	O
files	O
1	O
and	O
2	O
)	O
,	O
molecular	O
pathways	O
or	O
networks	O
in	O
which	O
identified	O
genes	O
link	O
to	O
each	O
other	O
were	O
further	O
illustrated	O
(	O
see	O
Additional	O
file	O
3	O
)	O
.	O

In	O
total	O
,	O
20	O
genes	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
18	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
(	O
see	O
Additional	O
file	O
3	O
)	O
were	O
found	O
to	O
be	O
part	O
of	O
the	O
dense	O
protein	O
interaction	O
networks	O
,	O
indicating	O
that	O
these	O
genes	O
may	O
act	O
in	O
concert	O
to	O
achieve	O
successful	O
infection	O
.	O

Some	O
products	O
encoded	O
by	O
induced	O
genes	O
were	O
found	O
to	O
interact	O
with	O
as	O
many	O
as	O
eight	O
other	O
gene	O
products	O
in	O
the	O
network	O
.	O

For	O
example	O
,	O
P	B-Organism
.	I-Organism
temperata	I-Organism
pckA	O
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
aceE	O
both	O
influence	O
8	O
other	O
genes	O
in	O
the	O
network	O
(	O
see	O
Additional	O
file	O
3	O
)	O
.	O

As	O
a	O
whole	O
,	O
the	O
protein	O
networks	O
of	O
the	O
identified	O
genes	O
were	O
different	O
for	O
the	O
two	O
bacteria	O
except	O
that	O
NAD	O
synthetase	O
gene	O
nadE	O
was	O
found	O
to	O
be	O
common	O
to	O
both	O
bacteria	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Our	O
gene	O
expression	O
data	O
reveal	O
similarities	O
and	O
differences	O
in	O
molecular	O
mechanisms	O
of	O
pathogenicity	O
by	O
the	O
two	O
bacteria	O
with	O
apparently	O
similar	O
biology	O
.	O

As	O
depicted	O
in	O
the	O
conceptual	O
molecular	O
model	O
(	O
Fig	O
.	O
5	O
)	O
,	O
apart	O
from	O
a	O
relatively	O
small	O
number	O
of	O
common	O
strategies	O
used	O
by	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
to	O
cause	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
,	O
most	O
upregulated	O
genes	O
were	O
different	O
between	O
the	O
two	O
bacteria	O
,	O
suggesting	O
vastly	O
different	O
pathways	O
to	O
bring	O
about	O
infection	O
of	O
the	O
same	O
insect	O
host	O
.	O

Genes	O
involved	O
in	O
cell	O
structure	O
modification	O
As	O
the	O
physical	O
contact	O
between	O
bacteria	O
and	O
their	O
host	O
is	O
accomplished	O
by	O
the	O
outer	O
surface	O
,	O
the	O
bacterial	O
cell	O
envelope	O
is	O
crucial	O
for	O
communication	O
and	O
interaction	O
with	O
host	O
cells	O
during	O
infection	O
.	O

Genes	O
involved	O
in	O
the	O
synthesis	O
of	O
outer	O
membrane	O
proteins	O
(	O
skp	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
ompF	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
)	O
and	O
flagella	O
(	O
fliA	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
fliM	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
)	O
were	O
induced	O
in	O
both	O
bacteria	O
,	O
indicating	O
the	O
importance	O
of	O
surface	O
proteins	O
in	O
this	O
bacteria	O
-	O
insect	O
interface	O
.	O

Outer	O
membrane	O
proteins	O
may	O
contribute	O
to	O
the	O
modulation	O
of	O
bacterial	O
cell	O
surface	O
properties	O
during	O
interaction	O
with	O
the	O
host	O
,	O
thus	O
playing	O
a	O
role	O
in	O
evading	O
host	O
immune	O
response	O
[	O
18	O
]	O
.	O

Flagellum	O
-	O
mediated	O
motility	O
may	O
provide	O
an	O
advantage	O
for	O
infection	O
by	O
attachment	O
to	O
the	O
host	O
surface	O
[	O
19	O
,	O
20	O
]	O
,	O
whereas	O
it	O
has	O
been	O
reported	O
in	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
that	O
the	O
expression	O
of	O
virulence	O
factors	O
is	O
not	O
controlled	O
by	O
the	O
regulation	O
of	O
flagella	O
motility	O
[	O
21	O
]	O
.	O

Gene	O
dacC	O
encoding	O
a	O
peptidoglycan	O
synthesis	O
enzyme	O
D	O
-	O
alanyl	O
-	O
D	O
-	O
alanine	O
carboxypeptidase	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
but	O
not	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
implying	O
that	O
peptidoglycan	O
undergoes	O
structural	O
alterations	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
that	O
probably	O
add	O
to	O
its	O
fitness	O
when	O
residing	O
in	O
the	O
host	O
.	O

As	O
a	O
well	O
-	O
defined	O
virulence	O
factor	O
playing	O
a	O
major	O
role	O
in	O
the	O
development	O
of	O
septicemia	O
[	O
22	O
]	O
,	O
lipopolysaccharide	O
biosynthesis	O
gene	O
lpsE	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
but	O
not	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
which	O
may	O
explain	O
in	O
part	O
why	O
relatively	O
slower	O
growing	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
did	O
not	O
differ	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
in	O
virulence	O
to	O
R	B-Organism
.	I-Organism
majalis	I-Organism
in	O
our	O
previous	O
studies	O
[	O
17	O
]	O
.	O

Genes	O
involved	O
in	O
regulatory	O
networks	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
the	B-X
genes	B-X
required	B-X
for	B-X
M.	B-X
tuberculosis	B-X
persistence	B-X
and	B-X
propose	B-X
a	B-X
regulatory	B-X
network	B-X
for	B-X
the	B-X
action	B-X
of	B-X
these	B-X
genes	B-X
using	B-X
text	B-X
mining	B-X
.	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
Calvin-Benson-Bassham	B-X
(	B-X
CBB	B-X
)	B-X
cycle	B-X
revealed	B-X
706	B-X
motifs	B-X
and	B-X
326	B-X
potentially	B-X
interacting	B-X
TFs	B-X
.	B-X
A	B-X
backward	B-X
elimination	B-X
random	B-X
forest	B-X
(	B-X
BWERF	B-X
)	B-X
algorithm	B-X
reduced	B-X
the	B-X
number	B-X
of	B-X
TFs	B-X
to	B-X
40	B-X
,	B-X
involved	B-X
in	B-X
a	B-X
three-layer	B-X
gene	B-X
regulatory	B-X
network	B-X
(	B-X
GRN	B-X
)	B-X
including	B-X
46	B-X
photosynthesis	B-X
genes	B-X
(	B-X
bottom	B-X
layer	B-X
)	B-X
,	B-X
25	B-X
TFs	B-X
(	B-X
second	B-X
layer	B-X
)	B-X
and	B-X
15	B-X
TFs	B-X
(	B-X
top	B-X
layer	B-X
)	B-X
.	B-X
Of	B-X
the	B-X
regulatory	B-X
pairs	B-X
identified	B-X
by	B-X
the	B-X
BWERF	B-X
(	B-X
202	B-X
pairs	B-X
)	B-X
,	B-X
77	B-X
TF-target	B-X
combinations	B-X
harbored	B-X
SNPs	B-X
associated	B-X
with	B-X
the	B-X
same	B-X
trait	B-X
,	B-X
supporting	B-X
similar	B-X
mechanisms	B-X
of	B-X
phenotype	B-X
modulation	B-X
.	B-X
We	B-X
used	B-X
expression	B-X
quantitative	B-X
trait	B-X
nucleotide	B-X
(	B-X
eQTN	B-X
)	B-X
analysis	B-X
to	B-X
identify	B-X
causal	B-X
SNPs	B-X
affecting	B-X
gene	B-X
expression	B-X
,	B-X
identifying	B-X
1851	B-X
eQTN	B-X
signals	B-X
for	B-X
50	B-X
eGenes	B-X
(	B-X
genes	B-X
whose	B-X
expressions	B-X
are	B-X
regulated	B-X
by	B-X
eQTNs	B-X
)	B-X
.	B-X

Facing	O
stimuli	O
,	O
different	O
regulatory	O
genes	O
were	O
upregulated	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
reflecting	O
their	O
unique	O
ability	O
to	O
respond	O
to	O
environmental	O
challenges	O
.	O

phoP	O
and	O
cpxR	O
genes	O
identified	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
encode	O
response	O
regulators	O
in	O
two	O
-	O
component	O
regulatory	O
systems	O
PhoPQ	O
and	O
CpxRA	O
,	O
respectively	O
[	O
23	O
,	O
24	O
]	O
.	O

PhoP	O
and	O
CpxR	O
are	O
dual	O
transcriptional	O
regulators	O
that	O
are	O
activated	O
in	O
response	O
to	O
environmental	O
stimuli	O
and	O
then	O
act	O
to	O
modulate	O
activity	O
of	O
other	O
genes	O
[	O
23	O
,	O
24	O
]	O
.	O

Responding	O
to	O
low	O
Mg2	O
+	O
levels	O
,	O
phoP	O
expression	O
is	O
auto	O
-	O
regulated	O
by	O
PhoP	O
and	O
PhoQ	O
proteins	O
and	O
phoQ	O
is	O
constitutive	O
[	O
25	O
]	O
.	O

Auto	O
-	O
regulation	O
of	O
phoP	O
likely	O
regulates	O
expression	O
of	O
other	O
genes	O
that	O
mediate	O
various	O
cellular	O
functions	O
such	O
as	O
LPS	O
modification	O
,	O
cell	O
structure	O
[	O
26	O
]	O
,	O
and	O
type	O
III	O
secretion	O
systems	O
[	O
27	O
]	O
.	O

phoP	O
has	O
been	O
previously	O
identified	O
to	O
be	O
involved	O
in	O
virulence	O
as	O
mutational	O
inactivation	O
of	O
this	O
gene	O
rendered	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
avirulent	O
to	O
Spodoptera	B-Organism
littoralis	I-Organism
larvae	O
[	O
6	O
]	O
.	O

Similarly	O
,	O
the	O
regulatory	O
protein	O
CpxR	O
can	O
be	O
activated	O
in	O
response	O
to	O
signals	O
associated	O
with	O
growth	O
and	O
metabolic	O
pathways	O
[	O
28	O
]	O
.	O

By	O
sensing	O
cell	O
envelope	O
stress	O
CpxR	O
appears	O
to	O
control	O
expression	O
of	O
other	O
genes	O
involved	O
in	O
envelope	O
stress	O
response	O
,	O
secretion	O
,	O
motility	O
and	O
multidrug	O
resistance	O
[	O
29	O
]	O
.	O

Sometimes	O
,	O
CpxR	O
acts	O
to	O
modulate	O
other	O
transcriptional	O
factors	O
[	O
30	O
]	O
.	O

Although	O
there	O
is	O
no	O
evidence	O
showing	O
links	O
between	O
phoP	O
/	O
cpxR	O
and	O
other	O
isolated	O
genes	O
,	O
overexpression	O
of	O
these	O
two	O
response	O
regulator	O
genes	O
may	O
possibly	O
relate	O
to	O
genes	O
involved	O
in	O
stress	O
responses	O
(	O
gshB	O
,	O
gor	O
,	O
msrA	O
and	O
surA	O
)	O
,	O
cell	O
structure	O
(	O
skp	O
,	O
dacC	O
and	O
ompF	O
)	O
and	O
type	O
III	O
secretion	O
systems	O
(	O
sctL	O
)	O
identified	O
in	O
this	O
study	O
.	O

Further	O
,	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
lysR	O
gene	O
encoding	O
a	O
transcriptional	O
activator	O
protein	O
was	O
found	O
to	O
be	O
upregulated	O
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
,	O
while	O
two	O
genes	O
yijC	O
and	O
rseA	O
encoding	O
transcriptional	O
repressors	O
were	O
identified	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

The	O
pathway	O
network	O
analysis	O
indicates	O
that	O
the	O
product	O
of	O
yijC	O
may	O
function	O
as	O
a	O
repressor	O
to	O
potentially	O
control	O
the	O
expression	O
of	O
the	O
fabB	O
gene	O
,	O
which	O
in	O
turn	O
,	O
modulates	O
the	O
physical	O
properties	O
of	O
the	O
membrane	O
by	O
altering	O
the	O
level	O
of	O
unsaturated	O
fatty	O
acid	O
production	O
.	O

Besides	O
transcriptional	O
regulatory	O
genes	O
,	O
gene	O
tilS	O
,	O
encoding	O
a	O
putative	O
cell	O
cycle	O
protein	O
[	O
4	O
]	O
,	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Upregulation	O
of	O
distinct	O
regulatory	O
genes	O
in	O
these	O
two	O
bacteria	O
indicates	O
the	O
different	O
stress	O
response	O
mechanisms	O
between	O
the	O
bacterial	O
species	O
in	O
the	O
same	O
host	O
.	O

However	O
,	O
none	O
of	O
these	O
regulatory	O
factors	O
were	O
identified	O
in	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
exposed	O
to	O
G	B-Organism
.	I-Organism
mellonella	I-Organism
homogenate	O
in	O
a	O
previous	O
study	O
[	O
16	O
]	O
,	O
suggesting	O
that	O
regulation	O
of	O
these	O
factors	O
either	O
depends	O
on	O
host	O
(	O
R	B-Organism
.	I-Organism
majalis	I-Organism
not	O
G	B-Organism
.	I-Organism
mellonella	I-Organism
)	O
or	O
bacteria	O
themselves	O
.	O
<EOS>	B-X
Gut	B-X
commensal	B-X
bacteria	B-X
with	B-X
the	B-X
ability	B-X
to	B-X
translocate	B-X
across	B-X
the	B-X
intestinal	B-X
barrier	B-X
can	B-X
drive	B-X
the	B-X
development	B-X
of	B-X
diverse	B-X
immune-mediated	B-X
diseases	B-X
They	B-X
are	B-X
catalase	B-X
,	B-X
oxidase	B-X
and	B-X
urea	B-X
positive	B-X
bacteria	B-X
.	B-X
Identification	B-X
in	B-X
species	B-X
level	B-X
can	B-X
be	B-X
done	B-X
by	B-X
agglutination	B-X
with	B-X
monospecific	B-X
serum	B-X
,	B-X
cultivating	B-X
the	B-X
strains	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
dyes	B-X
and/or	B-X
with	B-X
PCR	B-X
methods	B-X
.	B-X
Thanks	B-X
to	B-X
various	B-X
virulence	B-X
factors	B-X
that	B-X
act	B-X
as	B-X
metabolic	B-X
regulators	B-X
,	B-X
Brucella	B-X
strains	B-X
can	B-X
protect	B-X
themselves	B-X
from	B-X
immune	B-X
system	B-X
of	B-X
the	B-X
host	B-X
,	B-X
adapt	B-X
easily	B-X
to	B-X
different	B-X
environmental	B-X
conditions	B-X
,	B-X
and	B-X
multiply	B-X
intracellular	B-X
.	B-X
Classification	B-X
,	B-X
epidemiological	B-X
features	B-X
,	B-X
isolation	B-X
and	B-X
identification	B-X
,	B-X
antigenic	B-X
structure	B-X
and	B-X
virulence	B-X
factors	B-X
of	B-X
Brucella	B-X
species	B-X
along	B-X
with	B-X
the	B-X
discussion	B-X
of	B-X
very	B-X
few	B-X
patents	B-X
associated	B-X
with	B-X
Brucellosis	B-X
have	B-X
been	B-X
reviewed	B-X
in	B-X
this	B-X
paper	B-X
.	B-X

Genes	O
involved	O
in	O
virulence	O
and	O
secretion	O
<EOS>	B-X
RNA	B-X
modifications	B-X
are	B-X
involved	B-X
in	B-X
numerous	B-X
biological	B-X
processes	B-X
and	B-X
are	B-X
present	B-X
in	B-X
all	B-X
RNA	B-X
classes	B-X
.	B-X
They	B-X
show	B-X
how	B-X
RNA	B-X
modifications	B-X
can	B-X
regulate	B-X
immune	B-X
responses	B-X
,	B-X
antibiotic	B-X
resistance	B-X
,	B-X
expression	B-X
of	B-X
virulence	B-X
genes	B-X
,	B-X
and	B-X
bacterial	B-X
persistence	B-X
.	B-X
Expression	B-X
of	B-X
hrp	B-X
(	B-X
hypersensitive	B-X
reaction	B-X
and	B-X
pathogenicity	B-X
)	B-X
genes	B-X
inside	B-X
the	B-X
host	B-X
is	B-X
crucial	B-X
for	B-X
virulence	B-X
of	B-X
phytopathogenic	B-X
bacteria	B-X
.	B-X
The	B-X
hrp	B-X
genes	B-X
encode	B-X
components	B-X
of	B-X
type3	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
,	B-X
HR	B-X
elicitors	B-X
and	B-X
several	B-X
regulators	B-X
,	B-X
which	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
co-ordinated	B-X
expression	B-X
of	B-X
hrp	B-X
genes	B-X
in	B-X
the	B-X
host	B-X
environment	B-X
and	B-X
in	B-X
hrp	B-X
inducing	B-X
chemically	B-X
defined	B-X
medium	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
iron-limiting	B-X
condition	B-X
elicits	B-X
induced	B-X
expression	B-X
of	B-X
hrp	B-X
genes	B-X
,	B-X
including	B-X
type3	B-X
secretion	B-X
system	B-X
(	B-X
T3SS	B-X
)	B-X
and	B-X
effectors	B-X
(	B-X
T3E	B-X
)	B-X
.	B-X

Identification	O
of	O
genes	O
encoding	O
hemolysin	O
related	O
proteins	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
(	O
fhaC	O
)	O
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
(	O
xhlA	O
)	O
may	O
suggest	O
their	O
role	O
in	O
dealing	O
with	O
the	O
insect	O
cellular	O
immune	O
response	O
and	O
iron	O
scavenge	O
[	O
31	O
,	O
32	O
]	O
.	O

Subsequently	O
,	O
bacterial	O
virulence	O
factors	O
actively	O
contribute	O
to	O
a	O
successful	O
infection	O
by	O
colonization	O
of	O
and	O
toxicity	O
towards	O
the	O
insect	O
host	O
.	O

Among	O
the	O
virulence	O
genes	O
identified	O
in	O
this	O
study	O
,	O
tcaC	O
was	O
identified	O
to	O
be	O
induced	O
in	O
both	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

The	O
tca	O
gene	O
family	O
encodes	O
four	O
toxin	O
complexes	O
TcaA	O
,	O
TcaB	O
,	O
TcaC	O
and	O
TcaD	O
[	O
33	O
]	O
,	O
and	O
has	O
been	O
found	O
in	O
several	O
bacterial	O
pathogens	O
including	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
,	O
Yersinia	B-Organism
and	O
Xenorhabdus	B-Organism
[	O
34	O
]	O
.	O

Interestingly	O
,	O
Tca	O
toxin	O
encoding	O
genes	O
were	O
also	O
found	O
to	O
be	O
induced	O
in	O
a	O
related	O
species	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
treated	O
with	O
the	O
homogenate	O
of	O
G	B-Organism
.	I-Organism
mellonella	I-Organism
[	O
16	O
]	O
.	O

This	O
leads	O
us	O
to	O
speculate	O
that	O
TcaC	O
serves	O
as	O
either	O
an	O
activator	O
or	O
a	O
chaperone	O
in	O
secretion	O
of	O
toxin	O
complex	O
from	O
the	O
cell	O
as	O
proposed	O
by	O
ffrench	O
-	O
Constant	O
et	O
al	O
.	O

[	O
35	O
]	O
and	O
Waterfield	O
et	O
al	O
.	O
<EOS>	B-X
Derivatives	B-X
of	B-X
Sabin	B-X
3	B-X
shed	B-X
from	B-X
recipients	B-X
of	B-X
oral	B-X
poliovirus	B-X
vaccine	B-X
in	B-X
the	B-X
United	B-X
States	B-X
(	B-X
U.S.	B-X
)	B-X
were	B-X
examined	B-X
for	B-X
genetic	B-X
changes	B-X
identified	B-X
in	B-X
strains	B-X
excreted	B-X
by	B-X
vaccinees	B-X
in	B-X
the	B-X
United	B-X
Kingdom	B-X
[	B-X
U.K.	B-X
;	B-X
Evans	B-X
et	B-X
al.	B-X
,	B-X
1985	B-X
;	B-X
Cammack	B-X
et	B-X
al.	B-X
,	B-X
1988	B-X
,	B-X
Macadam	B-X
et	B-X
al.	B-X
,	B-X
1989	B-X
]	B-X
.	B-X
Among	B-X
the	B-X
eight	B-X
primary	B-X
vaccinees	B-X
studied	B-X
,	B-X
the	B-X
duration	B-X
of	B-X
excretion	B-X
and	B-X
molecular	B-X
evolution	B-X
of	B-X
type	B-X
3	B-X
strains	B-X
varied	B-X
greatly	B-X
.	B-X
The	B-X
period	B-X
of	B-X
virus	B-X
excretion	B-X
after	B-X
vaccination	B-X
ranged	B-X
from	B-X
as	B-X
few	B-X
as	B-X
2	B-X
days	B-X
to	B-X
as	B-X
many	B-X
as	B-X
36	B-X
days	B-X
.	B-X
Nucleotide	B-X
sequence	B-X
analysis	B-X
of	B-X
viral	B-X
RNAs	B-X
extracted	B-X
from	B-X
shed	B-X
virus	B-X
indicated	B-X
that	B-X
only	B-X
fifty	B-X
percent	B-X
of	B-X
the	B-X
vaccinees	B-X
exclusively	B-X
excreted	B-X
strains	B-X
in	B-X
which	B-X
the	B-X
attenuating	B-X
mutation	B-X
at	B-X
nucleotide	B-X
472	B-X
in	B-X
the	B-X
5	B-X
'	B-X
noncoding	B-X
region	B-X
of	B-X
the	B-X
genome	B-X
had	B-X
reverted	B-X
from	B-X
uracil	B-X
(	B-X
U	B-X
)	B-X
to	B-X
cytosine	B-X
(	B-X
C	B-X
)	B-X
,	B-X
the	B-X
nucleotide	B-X
found	B-X
in	B-X
neurovirulent	B-X
strains	B-X
.	B-X
Compared	B-X
to	B-X
the	B-X
wild-type	B-X
Leon	B-X
strain	B-X
,	B-X
the	B-X
low	B-X
activity	B-X
of	B-X
stool	B-X
isolate	B-X
KW4	B-X
in	B-X
a	B-X
complete	B-X
monkey	B-X
neurovirulence	B-X
test	B-X
demonstrated	B-X
that	B-X
presence	B-X
of	B-X
C	B-X
at	B-X
472	B-X
does	B-X
not	B-X
render	B-X
a	B-X
type	B-X
3	B-X
strain	B-X
pathogenic	B-X
.	B-X
Oligonucleotide	B-X
fingerprinting	B-X
and	B-X
sequence	B-X
analysis	B-X
of	B-X
viral	B-X
RNAs	B-X
from	B-X
stool	B-X
isolates	B-X
indicated	B-X
that	B-X
one	B-X
vaccinee	B-X
(	B-X
KW	B-X
)	B-X
eventually	B-X
excreted	B-X
intertypic	B-X
recombinant	B-X
strains	B-X
consistent	B-X
with	B-X
those	B-X
reported	B-X
in	B-X
the	B-X
U.K.	B-X
studies	B-X
.	B-X
Unique	B-X
to	B-X
this	B-X
study	B-X
,	B-X
one	B-X
vaccinee	B-X
(	B-X
KS	B-X
)	B-X
excreted	B-X
nonrecombinant	B-X
virus	B-X
possessing	B-X
U	B-X
at	B-X
472	B-X
for	B-X
up	B-X
to	B-X
21	B-X
days	B-X
.	B-X

[	O
36	O
]	O
.	O

Induction	O
of	O
gene	O
pplA	O
,	O
encoding	O
a	O
phospholipase	O
,	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
is	O
expected	O
to	O
contribute	O
to	O
its	O
faster	O
growth	O
rate	O
[	O
37	O
]	O
compared	O
to	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
in	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Further	O
,	O
genes	O
encoding	O
components	O
of	O
different	O
types	O
of	O
secretion	O
machineries	O
were	O
isolated	O
in	O
this	O
study	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
method	B-X
of	B-X
studying	B-X
synaptic	B-X
transmission	B-X
in	B-X
neurons	B-X
cultured	B-X
at	B-X
high-density	B-X
from	B-X
different	B-X
brain	B-X
regions	B-X
such	B-X
as	B-X
the	B-X
cortex	B-X
,	B-X
striatum	B-X
and	B-X
spinal	B-X
cord	B-X
.	B-X
Pharmacologically	B-X
isolated	B-X
excitatory	B-X
or	B-X
inhibitory	B-X
postsynaptic	B-X
currents	B-X
can	B-X
be	B-X
reliably	B-X
induced	B-X
,	B-X
with	B-X
amplitudes	B-X
,	B-X
synaptic	B-X
charge	B-X
transfers	B-X
,	B-X
and	B-X
short-term	B-X
plasticity	B-X
properties	B-X
that	B-X
are	B-X
reproducible	B-X
from	B-X
culture	B-X
to	B-X
culture	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
size	B-X
and	B-X
kinetics	B-X
of	B-X
pharmacologically	B-X
isolated	B-X
inhibitory	B-X
postsynaptic	B-X
currents	B-X
triggered	B-X
by	B-X
single	B-X
action	B-X
potentials	B-X
or	B-X
stimulus	B-X
trains	B-X
depend	B-X
on	B-X
the	B-X
Ca2+	B-X
concentration	B-X
,	B-X
temperature	B-X
and	B-X
stimulation	B-X
frequency	B-X
.	B-X
This	B-X
method	B-X
can	B-X
be	B-X
applied	B-X
to	B-X
study	B-X
synaptic	B-X
transmission	B-X
in	B-X
wildtype	B-X
neurons	B-X
infected	B-X
with	B-X
lentiviruses	B-X
encoding	B-X
various	B-X
components	B-X
of	B-X
presynaptic	B-X
release	B-X
machinery	B-X
,	B-X
or	B-X
in	B-X
neurons	B-X
from	B-X
genetically	B-X
modified	B-X
mice	B-X
,	B-X
for	B-X
example	B-X
neurons	B-X
carrying	B-X
floxed	B-X
genes	B-X
in	B-X
which	B-X
gene	B-X
expression	B-X
can	B-X
be	B-X
acutely	B-X
ablated	B-X
by	B-X
expression	B-X
of	B-X
Cre	B-X
recombinase	B-X
.	B-X
The	B-X
preparation	B-X
described	B-X
in	B-X
this	B-X
paper	B-X
should	B-X
be	B-X
useful	B-X
for	B-X
analysis	B-X
of	B-X
synaptic	B-X
transmission	B-X
in	B-X
inter-neuronal	B-X
synapses	B-X
formed	B-X
by	B-X
different	B-X
types	B-X
of	B-X
neurons	B-X
.	B-X

Upregulation	O
of	O
gene	O
sctL	O
,	O
encoding	O
components	O
of	O
type	O
III	O
secretion	O
machinery	O
,	O
possibly	O
coordinates	O
protein	O
secretion	O
system	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
for	O
translocating	O
effector	O
molecules	O
across	O
the	O
bacterial	O
cell	O
envelope	O
into	O
host	O
cells	O
[	O
38	O
-	O
40	O
]	O
.	O

Unlike	O
Photorhabdus	B-Organism
,	O
the	O
genomes	O
of	O
Xenorhabdus	B-Organism
bovienii	I-Organism
and	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
do	O
not	O
encode	O
homologues	O
of	O
a	O
dedicated	O
type	O
III	O
secretion	O
system	O
[	O
3	O
]	O
,	O
indicating	O
that	O
Xenorhabdus	B-Organism
likely	O
uses	O
different	O
effectors	O
or	O
secretion	O
systems	O
.	O
<EOS>	B-X
The	B-X
gastrointestinal	B-X
(	B-X
GI	B-X
)	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
digestion	B-X
and	B-X
absorption	B-X
of	B-X
ingested	B-X
food	B-X
and	B-X
liquids	B-X
.	B-X
The	B-X
HPA	B-X
axis	B-X
is	B-X
an	B-X
example	B-X
of	B-X
such	B-X
a	B-X
homeostatic	B-X
system	B-X
.	B-X
Recent	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
circadian	B-X
rhythmicity	B-X
of	B-X
the	B-X
major	B-X
output	B-X
of	B-X
this	B-X
system-the	B-X
adrenal	B-X
glucocorticoid	B-X
hormones	B-X
corticosterone	B-X
in	B-X
rodent	B-X
and	B-X
predominately	B-X
cortisol	B-X
in	B-X
man-comprises	B-X
varying	B-X
amplitude	B-X
pulses	B-X
that	B-X
exist	B-X
due	B-X
to	B-X
a	B-X
subhypothalamic	B-X
pulse	B-X
generator	B-X
.	B-X
Oscillating	B-X
endogenous	B-X
glucocorticoid	B-X
signals	B-X
interact	B-X
with	B-X
regulatory	B-X
systems	B-X
within	B-X
individual	B-X
parts	B-X
of	B-X
the	B-X
axis	B-X
including	B-X
the	B-X
adrenal	B-X
gland	B-X
itself	B-X
,	B-X
where	B-X
a	B-X
regulatory	B-X
network	B-X
can	B-X
further	B-X
modify	B-X
the	B-X
pulsatile	B-X
release	B-X
of	B-X
hormone	B-X
.	B-X
If	B-X
the	B-X
pulsatile	B-X
signal	B-X
is	B-X
abolished	B-X
by	B-X
the	B-X
administration	B-X
of	B-X
a	B-X
long-acting	B-X
synthetic	B-X
glucocorticoid	B-X
,	B-X
the	B-X
resulting	B-X
disruption	B-X
in	B-X
physiological	B-X
regulation	B-X
has	B-X
the	B-X
potential	B-X
to	B-X
negatively	B-X
impact	B-X
many	B-X
glucocorticoid-dependent	B-X
bodily	B-X
systems	B-X
.	B-X
Even	B-X
subtle	B-X
alterations	B-X
to	B-X
the	B-X
dynamics	B-X
of	B-X
the	B-X
system	B-X
,	B-X
during	B-X
chronic	B-X
stress	B-X
or	B-X
certain	B-X
disease	B-X
states	B-X
,	B-X
can	B-X
potentially	B-X
result	B-X
in	B-X
changes	B-X
in	B-X
functional	B-X
output	B-X
of	B-X
multiple	B-X
cells	B-X
and	B-X
tissues	B-X
throughout	B-X
the	B-X
body	B-X
,	B-X
altering	B-X
metabolic	B-X
processes	B-X
,	B-X
behavior	B-X
,	B-X
affective	B-X
state	B-X
,	B-X
and	B-X
cognitive	B-X
function	B-X
in	B-X
susceptible	B-X
individuals	B-X
.	B-X

Notably	O
,	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
virH	O
with	O
sequence	O
similarity	O
to	O
a	O
gene	O
encoding	O
putative	O
toxin	O
secretion	O
transporter	O
in	O
Vibrio	B-Organism
cholera	I-Organism
,	O
was	O
upregulated	O
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

In	O
addition	O
,	O
several	O
other	O
genes	O
encoding	O
proteins	O
with	O
putative	O
virulence	O
functions	O
identified	O
in	O
this	O
study	O
may	O
represent	O
novel	O
toxin	O
candidates	O
involved	O
in	O
insect	O
infection	O
.	O

These	O
include	O
pmt1	O
,	O
toxC	O
and	O
virB	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
and	O
virH	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Differences	O
in	O
expression	O
of	O
virulence	O
and	O
secretion	O
related	O
genes	O
imply	O
the	O
differential	O
virulence	O
mechanisms	O
employed	O
by	O
the	O
two	O
bacteria	O
.	O

Genes	O
involved	O
in	O
adaptation	O
to	O
host	O
-	O
induced	O
stresses	O
<EOS>	B-X
When	B-X
in	B-X
association	B-X
with	B-X
plants	B-X
,	B-X
this	B-X
genus	B-X
colonizes	B-X
the	B-X
host	B-X
plant	B-X
epiphytically	B-X
and/or	B-X
endophytically	B-X
.	B-X
We	B-X
focused	B-X
on	B-X
the	B-X
identification	B-X
of	B-X
the	B-X
key	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
initial	B-X
step	B-X
of	B-X
soybean	B-X
colonization	B-X
by	B-X
methylotrophic	B-X
bacteria	B-X
,	B-X
which	B-X
includes	B-X
the	B-X
plant	B-X
exudate	B-X
recognition	B-X
and	B-X
adaptation	B-X
by	B-X
planktonic	B-X
bacteria	B-X
.	B-X
Visualization	B-X
by	B-X
scanning	B-X
electron	B-X
microscopy	B-X
revealed	B-X
that	B-X
M.	B-X
mesophilicum	B-X
SR1.6/6	B-X
colonizes	B-X
soybean	B-X
roots	B-X
surface	B-X
effectively	B-X
at	B-X
48	B-X
h	B-X
after	B-X
inoculation	B-X
,	B-X
suggesting	B-X
a	B-X
mechanism	B-X
for	B-X
root	B-X
recognition	B-X
and	B-X
adaptation	B-X
before	B-X
this	B-X
period	B-X
.	B-X
Transcriptomic	B-X
analysis	B-X
of	B-X
the	B-X
planktonic	B-X
bacteria	B-X
(	B-X
with	B-X
plant	B-X
)	B-X
revealed	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
genes	B-X
involved	B-X
in	B-X
membrane	B-X
transport	B-X
,	B-X
thus	B-X
confirming	B-X
an	B-X
initial	B-X
metabolic	B-X
activation	B-X
of	B-X
bacterial	B-X
responses	B-X
when	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
plant	B-X
root	B-X
exudates	B-X
.	B-X
These	B-X
findings	B-X
support	B-X
that	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
is	B-X
potentially	B-X
a	B-X
key	B-X
molecule	B-X
involved	B-X
in	B-X
cellular	B-X
detoxification	B-X
during	B-X
plant	B-X
root	B-X
colonization	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
methylotrophic	B-X
metabolism	B-X
,	B-X
antioxidant	B-X
genes	B-X
,	B-X
mainly	B-X
glutathione-related	B-X
genes	B-X
,	B-X
play	B-X
a	B-X
key	B-X
role	B-X
during	B-X
soybean	B-X
exudate	B-X
recognition	B-X
and	B-X
adaptation	B-X
,	B-X
the	B-X
first	B-X
step	B-X
in	B-X
bacterial	B-X
colonization	B-X
.	B-X

Compared	O
to	O
all	O
other	O
functional	O
classes	O
,	O
more	O
stress	O
response	O
genes	O
were	O
identified	O
to	O
be	O
shared	O
by	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
suggesting	O
common	O
themes	O
in	O
adaptation	O
to	O
host	O
-	O
imposed	O
stresses	O
.	O

Upregulation	O
of	O
both	O
surA	O
and	O
uspB	O
in	O
both	O
bacteria	O
indicates	O
their	O
importance	O
in	O
bacterial	O
adaptation	O
to	O
global	O
stress	O
during	O
insect	O
infection	O
.	O

Gene	O
surA	O
is	O
important	O
for	O
bacterial	O
survival	O
during	O
infection	O
[	O
41	O
,	O
42	O
]	O
to	O
avoid	O
accumulation	O
of	O
non	O
-	O
native	O
protein	O
conformations	O
[	O
42	O
-	O
44	O
]	O
,	O
and	O
uspB	O
gene	O
product	O
is	O
usually	O
accumulated	O
in	O
the	O
stationary	O
phase	O
and	O
probably	O
important	O
for	O
ethanol	O
stress	O
[	O
45	O
]	O
.	O

Similarly	O
,	O
induction	O
of	O
a	O
chaperone	O
protein	O
encoding	O
gene	O
dnaK	O
in	O
both	O
bacteria	O
may	O
picture	O
common	O
stress	O
responses	O
between	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
in	O
a	O
number	O
of	O
cellular	O
processes	O
including	O
rescue	O
of	O
misfolded	O
proteins	O
and	O
control	O
of	O
the	O
activity	O
of	O
folded	O
regulatory	O
proteins	O
[	O
46	O
]	O
.	O

The	O
glutathione	O
synthetase	O
gene	O
gshB	O
which	O
mediates	O
condensation	O
of	O
gamma	O
-	O
glutamylcysteine	O
and	O
glycine	O
to	O
form	O
glutathione	O
[	O
47	O
,	O
48	O
]	O
was	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
but	O
glutathione	O
reductase	O
gene	O
gor	O
which	O
reduces	O
glutathione	O
disulfide	O
to	O
the	O
sulfhydryl	O
form	O
of	O
glutathione	O
[	O
47	O
,	O
48	O
]	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Glutathione	O
plays	O
a	O
major	O
role	O
in	O
protection	O
against	O
oxidative	O
stress	O
and	O
in	O
detoxification	O
of	O
hazardous	O
chemicals	O
or	O
heavy	O
metals	O
[	O
49	O
]	O
.	O
<EOS>	B-X
As	B-X
technology	B-X
continues	B-X
to	B-X
advance	B-X
,	B-X
heavy	B-X
metals	B-X
in	B-X
drinking	B-X
water	B-X
have	B-X
exceeded	B-X
recommended	B-X
limits	B-X
from	B-X
regulators	B-X
around	B-X
the	B-X
world	B-X
.	B-X
The	B-X
main	B-X
source	B-X
of	B-X
human	B-X
exposure	B-X
to	B-X
heavy	B-X
metals	B-X
is	B-X
from	B-X
contaminated	B-X
drinking	B-X
water	B-X
.	B-X
The	B-X
effects	B-X
of	B-X
drinking	B-X
water	B-X
contaminated	B-X
with	B-X
heavy	B-X
metals	B-X
,	B-X
such	B-X
as	B-X
arsenic	B-X
,	B-X
lead	B-X
,	B-X
nickel	B-X
,	B-X
cadmium	B-X
and	B-X
mercury	B-X
,	B-X
have	B-X
gradually	B-X
caught	B-X
the	B-X
attention	B-X
of	B-X
the	B-X
relevant	B-X
departments	B-X
and	B-X
personnel	B-X
.	B-X
It	B-X
is	B-X
well	B-X
known	B-X
that	B-X
occupational	B-X
exposure	B-X
to	B-X
heavy	B-X
metals	B-X
occurs	B-X
as	B-X
a	B-X
result	B-X
of	B-X
using	B-X
these	B-X
metals	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
industrial	B-X
processes	B-X
in	B-X
and/or	B-X
a	B-X
variety	B-X
of	B-X
materials	B-X
,	B-X
including	B-X
color	B-X
pigments	B-X
and	B-X
alloys	B-X
.	B-X
A	B-X
series	B-X
of	B-X
adverse	B-X
effects	B-X
on	B-X
human	B-X
metabolism	B-X
has	B-X
resulted	B-X
from	B-X
exposure	B-X
to	B-X
heavy	B-X
metal-contaminated	B-X
drinking	B-X
water	B-X
,	B-X
which	B-X
has	B-X
been	B-X
recorded	B-X
from	B-X
around	B-X
the	B-X
world	B-X
.	B-X
The	B-X
general	B-X
mechanism	B-X
of	B-X
heavy	B-X
metal	B-X
toxicity	B-X
is	B-X
through	B-X
the	B-X
production	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
,	B-X
the	B-X
appearance	B-X
of	B-X
oxidative	B-X
damage	B-X
,	B-X
and	B-X
subsequent	B-X
adverse	B-X
effects	B-X
on	B-X
health	B-X
.	B-X
Therefore	B-X
,	B-X
water	B-X
contaminated	B-X
with	B-X
heavy	B-X
metals	B-X
causes	B-X
high	B-X
morbidity	B-X
and	B-X
mortality	B-X
worldwide	B-X
.	B-X
In	B-X
order	B-X
to	B-X
address	B-X
concern	B-X
regarding	B-X
the	B-X
health	B-X
effects	B-X
of	B-X
different	B-X
heavy	B-X
metals	B-X
,	B-X
this	B-X
paper	B-X
reviews	B-X
its	B-X
sources	B-X
,	B-X
distribution	B-X
and	B-X
effects	B-X
of	B-X
heavy	B-X
metal	B-X
on	B-X
human	B-X
metabolism.HIGHLIGHTSThe	B-X
accumulation	B-X
of	B-X
heavy	B-X
metals	B-X
such	B-X
as	B-X
lead	B-X
,	B-X
arsenic	B-X
,	B-X
mercury	B-X
,	B-X
cadmium	B-X
and	B-X
nickel	B-X
will	B-X
destroy	B-X
the	B-X
main	B-X
metabolic	B-X
process	B-X
of	B-X
human	B-X
body.Redox	B-X
reactions	B-X
in	B-X
biological	B-X
systems	B-X
are	B-X
caused	B-X
by	B-X
carcinogenic	B-X
metal	B-X
ions	B-X
such	B-X
as	B-X
nickel	B-X
and	B-X
arsenic	B-X
.	B-X
The	B-X
free	B-X
radicals	B-X
produced	B-X
by	B-X
these	B-X
reactions	B-X
cause	B-X
oxidative	B-X
damage	B-X
to	B-X
proteins	B-X
and	B-X
DNA.The	B-X
accumulation	B-X
of	B-X
heavy	B-X
metals	B-X
eventually	B-X
produces	B-X
reactive	B-X
oxygen	B-X
species	B-X
that	B-X
can	B-X
cause	B-X
oxidative	B-X
stress	B-X
,	B-X
which	B-X
may	B-X
lead	B-X
to	B-X
the	B-X
production	B-X
of	B-X
various	B-X
diseases	B-X
.	B-X

Thus	O
,	O
although	O
gshB	O
and	O
gor	O
corresponding	O
products	O
are	O
involved	O
in	O
different	O
glutathione	O
biosynthesis	O
pathways	O
,	O
expression	O
of	O
these	O
two	O
genes	O
may	O
suggests	O
possible	O
role	O
of	O
detoxification	O
mechanism	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Further	O
,	O
as	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
bacteria	O
can	O
switch	O
their	O
phenotypes	O
upon	O
insect	O
infection	O
,	O
we	O
speculate	O
that	O
upregulation	O
of	O
transposase	O
genes	O
in	O
both	O
bacteria	O
may	O
contribute	O
to	O
genetic	O
variability	O
for	O
better	O
adaptation	O
and	O
survival	O
in	O
a	O
particular	O
niche	O
[	O
50	O
]	O
.	O

Apart	O
from	O
the	O
common	O
mechanisms	O
handling	O
stresses	O
,	O
gene	O
msrA	O
encoding	O
a	O
peptide	O
methionine	O
sulfoxide	O
reductase	O
was	O
unique	O
to	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

As	O
an	O
important	O
antioxidant	O
enzyme	O
,	O
peptide	O
methionine	O
sulfoxide	O
reductase	O
mediates	O
the	O
repair	O
of	O
proteins	O
damaged	O
by	O
sulfoxidation	O
of	O
methionine	O
residues	O
[	O
51	O
,	O
52	O
]	O
.	O
<EOS>	B-X
M.	B-X
genitalium	B-X
colonizes	B-X
host	B-X
cells	B-X
primarily	B-X
through	B-X
adherence	B-X
mechanisms	B-X
mediated	B-X
by	B-X
a	B-X
network	B-X
of	B-X
surface-associated	B-X
membrane	B-X
proteins	B-X
,	B-X
including	B-X
adhesins	B-X
and	B-X
cytadherence-related	B-X
proteins	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
,	B-X
we	B-X
show	B-X
that	B-X
cytadherence	B-X
in	B-X
M.	B-X
genitalium	B-X
is	B-X
affected	B-X
by	B-X
an	B-X
unrelated	B-X
protein	B-X
known	B-X
as	B-X
peptide	B-X
methionine	B-X
sulfoxide	B-X
reductase	B-X
(	B-X
MsrA	B-X
)	B-X
,	B-X
an	B-X
antioxidant	B-X
repair	B-X
enzyme	B-X
that	B-X
catalyzes	B-X
the	B-X
reduction	B-X
of	B-X
methionine	B-X
sulfoxide	B-X
[	B-X
Met	B-X
(	B-X
O	B-X
)	B-X
]	B-X
residues	B-X
in	B-X
proteins	B-X
to	B-X
methionine	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
MsrA	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
M.	B-X
genitalium	B-X
pathogenicity	B-X
,	B-X
possibly	B-X
by	B-X
protecting	B-X
mycoplasma	B-X
protein	B-X
structures	B-X
from	B-X
oxidative	B-X
damage	B-X
or	B-X
through	B-X
alternate	B-X
virulence-related	B-X
pathways	B-X
.	B-X
Inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
(	B-X
iNOS	B-X
)	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
host	B-X
defense	B-X
.	B-X
Macrophages	B-X
expressing	B-X
iNOS	B-X
release	B-X
the	B-X
reactive	B-X
nitrogen	B-X
intermediates	B-X
(	B-X
RNI	B-X
)	B-X
nitrite	B-X
and	B-X
S-nitrosoglutathione	B-X
(	B-X
GSNO	B-X
)	B-X
,	B-X
which	B-X
are	B-X
bactericidal	B-X
in	B-X
vitro	B-X
at	B-X
a	B-X
pH	B-X
characteristic	B-X
of	B-X
the	B-X
phagosome	B-X
of	B-X
activated	B-X
macrophages	B-X
.	B-X
Peptide	B-X
methionine	B-X
sulfoxide	B-X
reductase	B-X
(	B-X
MsrA	B-X
;	B-X
EC	B-X
)	B-X
catalyzes	B-X
the	B-X
reduction	B-X
of	B-X
methionine	B-X
sulfoxide	B-X
(	B-X
Met-O	B-X
)	B-X
in	B-X
proteins	B-X
to	B-X
methionine	B-X
(	B-X
Met	B-X
)	B-X
.	B-X
It	B-X
seemed	B-X
paradoxical	B-X
that	B-X
nitrite	B-X
and	B-X
GSNO	B-X
kill	B-X
bacteria	B-X
by	B-X
oxidizing	B-X
Met	B-X
residues	B-X
when	B-X
these	B-X
RNI	B-X
can	B-X
not	B-X
themselves	B-X
oxidize	B-X
Met	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
findings	B-X
are	B-X
consistent	B-X
with	B-X
the	B-X
hypotheses	B-X
that	B-X
nitrite	B-X
and	B-X
GSNO	B-X
kill	B-X
E.	B-X
coli	B-X
by	B-X
intracellular	B-X
conversion	B-X
to	B-X
peroxynitrite	B-X
,	B-X
that	B-X
intracellular	B-X
Met	B-X
residues	B-X
in	B-X
proteins	B-X
constitute	B-X
a	B-X
critical	B-X
target	B-X
for	B-X
peroxynitrite	B-X
,	B-X
and	B-X
that	B-X
MsrA	B-X
can	B-X
be	B-X
essential	B-X
for	B-X
the	B-X
repair	B-X
of	B-X
peroxynitrite-mediated	B-X
intracellular	B-X
damage	B-X
.	B-X

Products	O
of	O
msrA	O
are	O
found	O
to	O
interact	O
with	O
several	O
other	O
gene	O
products	O
(	O
see	O
Additional	O
file	O
2	O
)	O
,	O
also	O
suggesting	O
its	O
importance	O
during	O
insect	O
infection	O
.	O

Genes	O
involved	O
in	O
intracellular	O
metabolism	O
<EOS>	B-X
Peroxisome	B-X
is	B-X
an	B-X
organelle	B-X
conserved	B-X
in	B-X
almost	B-X
all	B-X
eukaryotic	B-X
cells	B-X
with	B-X
a	B-X
variety	B-X
of	B-X
functions	B-X
in	B-X
cellular	B-X
metabolism	B-X
,	B-X
including	B-X
fatty	B-X
acid	B-X
β-oxidation	B-X
,	B-X
synthesis	B-X
of	B-X
ether	B-X
glycerolipid	B-X
plasmalogens	B-X
,	B-X
and	B-X
redox	B-X
homeostasis	B-X
.	B-X
Peroxisome	B-X
plays	B-X
pivotal	B-X
roles	B-X
in	B-X
the	B-X
cellular	B-X
redox	B-X
homeostasis	B-X
and	B-X
the	B-X
response	B-X
to	B-X
oxidative	B-X
stresses	B-X
,	B-X
depending	B-X
on	B-X
intracellular	B-X
localization	B-X
of	B-X
catalase	B-X
.	B-X
The	B-X
plant	B-X
hormone	B-X
auxin	B-X
,	B-X
which	B-X
is	B-X
predominantly	B-X
represented	B-X
by	B-X
indole-3-acetic	B-X
acid	B-X
(	B-X
IAA	B-X
)	B-X
,	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
plant	B-X
growth	B-X
and	B-X
development	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
the	B-X
genes	B-X
now	B-X
known	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
auxin	B-X
biosynthesis	B-X
are	B-X
summarized	B-X
and	B-X
the	B-X
major	B-X
IAA	B-X
biosynthetic	B-X
pathway	B-X
distributed	B-X
widely	B-X
in	B-X
the	B-X
plant	B-X
kingdom	B-X
is	B-X
discussed	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
biochemical	B-X
and	B-X
molecular	B-X
biological	B-X
findings	B-X
and	B-X
bioinformatics	B-X
studies	B-X
.	B-X

Induction	O
of	O
different	O
metabolism	O
genes	O
in	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
during	O
insect	O
infection	O
highlights	O
the	O
differences	O
in	O
metabolic	O
changes	O
between	O
the	O
two	O
bacteria	O
.	O

Three	O
genes	O
,	O
aceE	O
,	O
aceK	O
and	O
dld	O
,	O
whose	O
products	O
catalyze	O
subsequent	O
steps	O
of	O
the	O
glyoxylate	O
pathway	O
[	O
53	O
]	O
,	O
were	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

In	O
contrast	O
,	O
two	O
genes	O
kdgK	O
and	O
pckA	O
involved	O
in	O
energy	O
metabolism	O
in	O
the	O
TCA	O
cycle	O
were	O
upregulated	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
[	O
54	O
,	O
55	O
]	O
.	O

Genes	O
related	O
to	O
the	O
TCA	O
cycle	O
have	O
been	O
also	O
found	O
to	O
be	O
induced	O
in	O
other	O
bacteria	O
upon	O
host	O
infection	O
,	O
for	O
example	O
in	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
in	O
the	O
presence	O
of	O
G	B-Organism
.	I-Organism
mellonella	I-Organism
homogenate	O
[	O
16	O
]	O
and	O
in	O
Vibrio	B-Organism
cholerae	I-Organism
upon	O
infection	O
of	O
infant	O
mice	B-Organism
[	O
56	O
,	O
57	O
]	O
.	O

Further	O
,	O
as	O
a	O
cofactor	O
in	O
the	O
metabolism	O
of	O
fatty	O
acids	O
and	O
leucine	O
,	O
biotin	O
plays	O
a	O
role	O
in	O
TCA	O
cycle	O
by	O
assisting	O
in	O
metabolic	O
reactions	O
and	O
helping	O
to	O
transfer	O
carbon	O
dioxide	O
[	O
58	O
]	O
.	O

Therefore	O
,	O
upregulation	O
of	O
bioB	O
encoding	O
a	O
biontin	O
synthetase	O
protein	O
further	O
suggests	O
that	O
TCA	O
cycle	O
is	O
involved	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
.	O

Induction	O
of	O
different	O
amino	O
acid	O
biosynthetic	O
genes	O
may	O
suggest	O
the	O
differences	O
in	O
amino	O
acid	O
requirements	O
in	O
the	O
two	O
bacteria	O
during	O
infection	O
.	O
<EOS>	B-X
The	B-X
few	B-X
differences	B-X
between	B-X
R.	B-X
prowazekii	B-X
and	B-X
R.	B-X
typhi	B-X
include	B-X
a	B-X
12-kb	B-X
insertion	B-X
in	B-X
R.	B-X
prowazekii	B-X
,	B-X
a	B-X
large	B-X
inversion	B-X
close	B-X
to	B-X
the	B-X
origin	B-X
of	B-X
replication	B-X
in	B-X
R.	B-X
typhi	B-X
,	B-X
and	B-X
loss	B-X
of	B-X
the	B-X
complete	B-X
cytochrome	B-X
c	B-X
oxidase	B-X
system	B-X
by	B-X
R.	B-X
typhi	B-X
.	B-X
R.	B-X
prowazekii	B-X
,	B-X
R.	B-X
typhi	B-X
,	B-X
and	B-X
R.	B-X
conorii	B-X
have	B-X
13	B-X
,	B-X
24	B-X
,	B-X
and	B-X
560	B-X
unique	B-X
genes	B-X
,	B-X
respectively	B-X
,	B-X
and	B-X
share	B-X
775	B-X
genes	B-X
,	B-X
most	B-X
likely	B-X
their	B-X
essential	B-X
genes	B-X
.	B-X
The	B-X
small	B-X
genomes	B-X
contain	B-X
many	B-X
pseudogenes	B-X
and	B-X
much	B-X
noncoding	B-X
DNA	B-X
,	B-X
reflecting	B-X
the	B-X
process	B-X
of	B-X
genome	B-X
decay	B-X
.	B-X
R.	B-X
typhi	B-X
contains	B-X
the	B-X
largest	B-X
number	B-X
of	B-X
pseudogenes	B-X
(	B-X
41	B-X
)	B-X
,	B-X
and	B-X
R.	B-X
conorii	B-X
the	B-X
fewest	B-X
,	B-X
in	B-X
accordance	B-X
with	B-X
its	B-X
larger	B-X
number	B-X
of	B-X
genes	B-X
and	B-X
smaller	B-X
proportion	B-X
of	B-X
noncoding	B-X
DNA	B-X
.	B-X
These	B-X
genomes	B-X
portray	B-X
the	B-X
key	B-X
themes	B-X
of	B-X
rickettsial	B-X
intracellular	B-X
survival	B-X
:	B-X
lack	B-X
of	B-X
enzymes	B-X
for	B-X
sugar	B-X
metabolism	B-X
,	B-X
lipid	B-X
biosynthesis	B-X
,	B-X
nucleotide	B-X
synthesis	B-X
,	B-X
and	B-X
amino	B-X
acid	B-X
metabolism	B-X
,	B-X
suggesting	B-X
that	B-X
rickettsiae	B-X
depend	B-X
on	B-X
the	B-X
host	B-X
for	B-X
nutrition	B-X
and	B-X
building	B-X
blocks	B-X
;	B-X
enzymes	B-X
for	B-X
the	B-X
complete	B-X
TCA	B-X
cycle	B-X
and	B-X
several	B-X
copies	B-X
of	B-X
ATP/ADP	B-X
translocase	B-X
genes	B-X
,	B-X
suggesting	B-X
independent	B-X
synthesis	B-X
of	B-X
ATP	B-X
and	B-X
acquisition	B-X
of	B-X
host	B-X
ATP	B-X
;	B-X
and	B-X
type	B-X
IV	B-X
secretion	B-X
system	B-X
.	B-X
All	B-X
rickettsiae	B-X
share	B-X
two	B-X
outer	B-X
membrane	B-X
proteins	B-X
(	B-X
OmpB	B-X
and	B-X
Sca	B-X
4	B-X
)	B-X
and	B-X
LPS	B-X
biosynthesis	B-X
machinery	B-X
.	B-X
The	B-X
genome	B-X
of	B-X
R.	B-X
typhi	B-X
contains	B-X
four	B-X
potentially	B-X
membranolytic	B-X
genes	B-X
(	B-X
tlyA	B-X
,	B-X
tlyC	B-X
,	B-X
pldA	B-X
,	B-X
and	B-X
pat-1	B-X
)	B-X
and	B-X
five	B-X
autotransporter	B-X
genes	B-X
,	B-X
sca	B-X
1	B-X
,	B-X
sca	B-X
2	B-X
,	B-X
sca	B-X
3	B-X
,	B-X
ompA	B-X
,	B-X
and	B-X
ompB	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
six	B-X
50-amino	B-X
acid	B-X
repeat	B-X
units	B-X
in	B-X
Sca	B-X
2	B-X
suggests	B-X
function	B-X
as	B-X
an	B-X
adhesin	B-X
.	B-X
The	B-X
high	B-X
laboratory	B-X
passage	B-X
of	B-X
the	B-X
sequenced	B-X
strains	B-X
raises	B-X
the	B-X
issue	B-X
of	B-X
the	B-X
occurrence	B-X
of	B-X
laboratory	B-X
mutations	B-X
in	B-X
genes	B-X
not	B-X
required	B-X
for	B-X
growth	B-X
in	B-X
cell	B-X
culture	B-X
or	B-X
eggs	B-X
.	B-X
Resequencing	B-X
revealed	B-X
that	B-X
eight	B-X
annotated	B-X
pseudogenes	B-X
of	B-X
E	B-X
strain	B-X
are	B-X
actually	B-X
intact	B-X
genes	B-X
.	B-X
Comparative	B-X
genomics	B-X
of	B-X
virulent	B-X
and	B-X
avirulent	B-X
strains	B-X
of	B-X
rickettsial	B-X
species	B-X
may	B-X
reveal	B-X
their	B-X
virulence	B-X
factors	B-X
.	B-X

Induction	O
of	O
cysK	O
gene	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
suggests	O
that	O
cysteine	O
may	O
be	O
required	O
when	O
growing	O
in	O
the	O
insect	O
,	O
but	O
lysine	O
may	O
be	O
needed	O
for	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
as	O
lysC	O
gene	O
was	O
induced	O
.	O

Isolation	O
of	O
P	B-Organism
.	I-Organism
temperata	I-Organism
def	O
,	O
encoding	O
an	O
amino	O
acid	O
tRNA	O
synthesis	O
enzyme	O
N	O
-	O
formylmethionylaminoacyl	O
-	O
tRNA	O
deformylase	O
,	O
may	O
reflect	O
the	O
importance	O
of	O
specific	O
amino	O
acids	O
involved	O
in	O
the	O
translation	O
process	O
during	O
growth	O
in	O
the	O
insect	O
host	O
.	O

Indeed	O
,	O
the	O
pathway	O
analysis	O
reveals	O
that	O
def	O
gene	O
product	O
interacts	O
with	O
CysS	O
,	O
a	O
cysteinyl	O
-	O
tRNA	O
synthetase	O
(	O
see	O
Additional	O
file	O
1	O
)	O
,	O
also	O
suggesting	O
the	O
requirement	O
for	O
cysteine	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
during	O
infection	O
.	O

Genes	O
involved	O
in	O
protein	O
synthesis	O
and	O
degradation	O
can	O
also	O
be	O
distinguished	O
between	O
the	O
two	O
bacteria	O
.	O
<EOS>	B-X
Interferons	B-X
induce	B-X
the	B-X
synthesis	B-X
of	B-X
cell	B-X
proteins	B-X
with	B-X
antiviral	B-X
activity	B-X
,	B-X
and	B-X
also	B-X
shape	B-X
the	B-X
adaptive	B-X
immune	B-X
response	B-X
by	B-X
priming	B-X
T	B-X
cells	B-X
.	B-X
Two	B-X
families	B-X
of	B-X
pattern	B-X
recognition	B-X
receptors	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
distinguish	B-X
unique	B-X
molecules	B-X
present	B-X
in	B-X
pathogens	B-X
,	B-X
such	B-X
as	B-X
bacterial	B-X
and	B-X
fungal	B-X
cell	B-X
wall	B-X
components	B-X
,	B-X
viral	B-X
RNA	B-X
and	B-X
DNA	B-X
,	B-X
and	B-X
lipoproteins	B-X
.	B-X
Studies	B-X
of	B-X
the	B-X
signaling	B-X
pathways	B-X
that	B-X
lead	B-X
from	B-X
pattern	B-X
recognition	B-X
to	B-X
cytokine	B-X
induction	B-X
have	B-X
revealed	B-X
extensive	B-X
and	B-X
overlapping	B-X
cascades	B-X
that	B-X
involve	B-X
protein-protein	B-X
interactions	B-X
and	B-X
phosphorylation	B-X
,	B-X
and	B-X
culminate	B-X
in	B-X
activation	B-X
of	B-X
transcription	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
genes	B-X
encoding	B-X
interferons	B-X
and	B-X
other	B-X
cytokines	B-X
.	B-X
In	B-X
this	B-X
review	B-X
we	B-X
summarize	B-X
the	B-X
discovery	B-X
of	B-X
these	B-X
cytoplasmic	B-X
sensors	B-X
,	B-X
how	B-X
they	B-X
recognize	B-X
nucleic	B-X
acids	B-X
,	B-X
the	B-X
signaling	B-X
pathways	B-X
leading	B-X
to	B-X
cytokine	B-X
synthesis	B-X
,	B-X
and	B-X
viral	B-X
countermeasures	B-X
that	B-X
have	B-X
evolved	B-X
to	B-X
antagonize	B-X
the	B-X
functions	B-X
of	B-X
these	B-X
proteins	B-X
.	B-X
We	B-X
also	B-X
consider	B-X
the	B-X
function	B-X
of	B-X
these	B-X
cytoplasmic	B-X
sensors	B-X
in	B-X
apoptosis	B-X
,	B-X
development	B-X
and	B-X
differentiation	B-X
,	B-X
and	B-X
diabetes	B-X
.	B-X

A	O
protease	O
gene	O
,	O
clpP	O
,	O
involved	O
in	O
protein	O
degradation	O
,	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
upon	O
infection	O
.	O

In	O
fact	O
proteases	O
have	O
been	O
identified	O
as	O
virulence	O
factors	O
in	O
some	O
other	O
bacterial	O
pathogens	O
[	O
59	O
]	O
.	O
<EOS>	B-X
Functional	B-X
analysis	B-X
and	B-X
cryo-electron	B-X
microscopy	B-X
of	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
benzamidine-type	B-X
compounds	B-X
can	B-X
inhibit	B-X
the	B-X
activity	B-X
of	B-X
arginine-specific	B-X
cysteine	B-X
proteinases	B-X
(	B-X
gingipains	B-X
HRgpA	B-X
and	B-X
RgpB	B-X
)	B-X
;	B-X
well-known	B-X
virulence	B-X
factors	B-X
of	B-X
Porphyromonas	B-X
gingivalis	B-X
.	B-X
Apparently	B-X
growth	B-X
arrest	B-X
is	B-X
not	B-X
associated	B-X
with	B-X
their	B-X
ability	B-X
to	B-X
inhibit	B-X
these	B-X
proteases	B-X
,	B-X
because	B-X
pentamidine	B-X
,	B-X
which	B-X
is	B-X
a	B-X
20-fold	B-X
less	B-X
efficient	B-X
inhibitor	B-X
of	B-X
gingipain	B-X
than	B-X
2,6-bis-	B-X
(	B-X
4-amidinobenzyl	B-X
)	B-X
-cyclohexanone	B-X
(	B-X
ACH	B-X
)	B-X
,	B-X
blocked	B-X
P.	B-X
gingivalis	B-X
growth	B-X
far	B-X
more	B-X
effectively	B-X
.	B-X
Interestingly	B-X
,	B-X
despite	B-X
the	B-X
fact	B-X
that	B-X
gingipains	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
the	B-X
main	B-X
virulence	B-X
factors	B-X
in	B-X
a	B-X
fertilized	B-X
egg	B-X
model	B-X
of	B-X
infection	B-X
,	B-X
mortality	B-X
rates	B-X
were	B-X
strongly	B-X
reduced	B-X
,	B-X
not	B-X
only	B-X
by	B-X
ACH	B-X
,	B-X
but	B-X
also	B-X
by	B-X
pentamidine	B-X
,	B-X
a	B-X
relatively	B-X
weak	B-X
gingipain	B-X
inhibitor	B-X
.	B-X

The	O
signal	O
peptidase	O
II	O
encoded	O
by	O
lspA	O
gene	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
belongs	O
to	O
a	O
class	O
of	O
aspartyl	O
proteases	O
.	O

Since	O
the	O
product	O
of	O
lspA	O
has	O
been	O
suggested	O
as	O
an	O
important	O
virulence	O
factor	O
operating	O
via	O
maturation	O
of	O
several	O
lipoproteins	O
[	O
60	O
]	O
,	O
we	O
postulate	O
that	O
the	O
product	O
of	O
lspA	O
may	O
play	O
a	O
pathological	O
role	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
by	O
cleaving	O
some	O
core	O
proteins	O
and	O
thus	O
influencing	O
bacterial	O
life	O
cycle	O
in	O
the	O
insect	O
host	O
.	O

Genes	O
involved	O
in	O
nutrient	O
scavenging	O
<EOS>	B-X
The	B-X
radical-scavenging	B-X
and	B-X
anti-inflammatory	B-X
activity	B-X
of	B-X
coffee	B-X
constituents	B-X
is	B-X
too	B-X
weak	B-X
to	B-X
account	B-X
for	B-X
such	B-X
effects	B-X
.	B-X
Recent	B-X
studies	B-X
have	B-X
identified	B-X
a	B-X
health	B-X
promoting	B-X
mechanism	B-X
common	B-X
to	B-X
coffee	B-X
,	B-X
vegetables	B-X
and	B-X
fruits	B-X
,	B-X
i.e.	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
an	B-X
adaptive	B-X
cellular	B-X
response	B-X
characterized	B-X
by	B-X
the	B-X
upregulation	B-X
of	B-X
proteins	B-X
involved	B-X
in	B-X
cell	B-X
protection	B-X
,	B-X
notably	B-X
antioxidant	B-X
,	B-X
detoxifying	B-X
and	B-X
repair	B-X
enzymes	B-X
.	B-X
Leafy	B-X
green	B-X
vegetables	B-X
,	B-X
in	B-X
particular	B-X
,	B-X
are	B-X
recognized	B-X
as	B-X
having	B-X
substantial	B-X
health-promoting	B-X
activities	B-X
that	B-X
are	B-X
attributed	B-X
to	B-X
the	B-X
functional	B-X
properties	B-X
of	B-X
their	B-X
nutrients	B-X
and	B-X
non-essential	B-X
chemical	B-X
compounds	B-X
.	B-X
Spinach-derived	B-X
phytochemicals	B-X
and	B-X
bioactives	B-X
are	B-X
able	B-X
to	B-X
(	B-X
i	B-X
)	B-X
scavenge	B-X
reactive	B-X
oxygen	B-X
species	B-X
and	B-X
prevent	B-X
macromolecular	B-X
oxidative	B-X
damage	B-X
,	B-X
(	B-X
ii	B-X
)	B-X
modulate	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
metabolism	B-X
,	B-X
proliferation	B-X
,	B-X
inflammation	B-X
,	B-X
and	B-X
antioxidant	B-X
defence	B-X
,	B-X
and	B-X
(	B-X
iii	B-X
)	B-X
curb	B-X
food	B-X
intake	B-X
by	B-X
inducing	B-X
secretion	B-X
of	B-X
satiety	B-X
hormones	B-X
.	B-X

Induction	O
of	O
different	O
types	O
of	O
nutrient	O
uptake	O
systems	O
in	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
further	O
emphasized	O
the	O
possible	O
differences	O
in	O
nutritional	O
requirements	O
of	O
the	O
two	O
bacteria	O
in	O
the	O
insect	O
host	O
.	O

Ion	O
scavenging	O
systems	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
are	O
completely	O
different	O
.	O

In	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
pchC	O
,	O
a	O
gene	O
involved	O
in	O
the	O
biogenesis	O
of	O
pyochelin	O
type	O
of	O
siderophore	O
[	O
61	O
]	O
,	O
was	O
upregulated	O
indicating	O
the	O
importance	O
of	O
iron	O
,	O
whereas	O
a	O
siderophore	O
-	O
independent	O
zinc	O
ion	O
transport	O
system	O
encoded	O
by	O
gene	O
znuA	O
[	O
62	O
]	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
indicating	O
the	O
importance	O
of	O
zinc	O
.	O

Also	O
supported	O
by	O
the	O
pathway	O
analysis	O
,	O
product	O
of	O
glnD	O
identified	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
likely	O
controls	O
the	O
production	O
of	O
siderophore	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

In	O
addition	O
to	O
ion	O
scavenging	O
systems	O
,	O
artM	O
,	O
encoding	O
a	O
putative	O
ABC	O
amino	O
acid	O
transport	O
system	O
[	O
63	O
]	O
was	O
identified	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
but	O
not	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Besides	O
transporting	O
L	O
-	O
arginine	O
across	O
the	O
inner	O
membrane	O
[	O
63	O
]	O
,	O
the	O
pathway	O
network	O
reveals	O
that	O
the	O
product	O
of	O
artM	O
participates	O
in	O
cystine	O
transport	O
(	O
see	O
Additional	O
file	O
1	O
)	O
,	O
suggesting	O
that	O
this	O
gene	O
may	O
also	O
mediate	O
cystine	O
amino	O
acid	O
acquisition	O
.	O

Upregulation	O
of	O
artM	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
also	O
suggests	O
that	O
amino	O
acids	O
may	O
be	O
available	O
for	O
uptake	O
in	O
the	O
insect	O
.	O

Similarly	O
,	O
it	O
has	O
been	O
discussed	O
previously	O
that	O
histidine	O
and	O
phosphatidylethanolamine	O
,	O
the	O
possible	O
components	O
presented	O
in	O
the	O
insect	O
host	O
hemolymph	O
,	O
may	O
be	O
important	O
food	O
sources	O
used	O
by	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
for	O
growth	O
within	O
the	O
insect	O
host	O
[	O
64	O
]	O
.	O

As	O
cysteine	O
synthesis	O
gene	O
cysK	O
was	O
also	O
identified	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
as	O
discussed	O
above	O
,	O
it	O
may	O
indicate	O
that	O
the	O
level	O
of	O
cysteine	O
either	O
synthesized	O
by	O
P	B-Organism
.	I-Organism
temperata	I-Organism
or	O
acquired	O
from	O
the	O
insect	O
host	O
is	O
not	O
sufficient	O
during	O
infection	O
.	O
<EOS>	B-X
Plants	B-X
protect	B-X
themselves	B-X
with	B-X
a	B-X
vast	B-X
array	B-X
of	B-X
toxic	B-X
secondary	B-X
metabolites	B-X
,	B-X
yet	B-X
most	B-X
plants	B-X
serve	B-X
as	B-X
food	B-X
for	B-X
insects	B-X
.	B-X
The	B-X
evolutionary	B-X
processes	B-X
that	B-X
allow	B-X
herbivorous	B-X
insects	B-X
to	B-X
resist	B-X
plant	B-X
defenses	B-X
remain	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
,	B-X
through	B-X
an	B-X
exceptional	B-X
horizontal	B-X
gene	B-X
transfer	B-X
event	B-X
,	B-X
the	B-X
whitefly	B-X
has	B-X
acquired	B-X
the	B-X
plant-derived	B-X
phenolic	B-X
glucoside	B-X
malonyltransferase	B-X
gene	B-X
BtPMaT1	B-X
.	B-X
This	B-X
gene	B-X
enables	B-X
whiteflies	B-X
to	B-X
neutralize	B-X
phenolic	B-X
glucosides	B-X
.	B-X
This	B-X
was	B-X
confirmed	B-X
by	B-X
genetically	B-X
transforming	B-X
tomato	B-X
plants	B-X
to	B-X
produce	B-X
small	B-X
interfering	B-X
RNAs	B-X
that	B-X
silence	B-X
BtPMaT1	B-X
,	B-X
thus	B-X
impairing	B-X
the	B-X
whiteflies	B-X
'	B-X
detoxification	B-X
ability	B-X
.	B-X
These	B-X
findings	B-X
reveal	B-X
an	B-X
evolutionary	B-X
scenario	B-X
whereby	B-X
herbivores	B-X
harness	B-X
the	B-X
genetic	B-X
toolkit	B-X
of	B-X
their	B-X
host	B-X
plants	B-X
to	B-X
develop	B-X
resistance	B-X
to	B-X
plant	B-X
defenses	B-X
and	B-X
how	B-X
this	B-X
can	B-X
be	B-X
exploited	B-X
for	B-X
crop	B-X
protection	B-X
.	B-X

Interestingly	O
,	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
seems	O
to	O
require	O
sugar	O
as	O
malF	O
gene	O
which	O
is	O
involved	O
in	O
uptake	O
for	O
maltose	O
and	O
lactose	O
was	O
upregulated	O
.	O

Further	O
,	O
P	B-Organism
.	I-Organism
temperata	I-Organism
but	O
not	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
induced	O
tolB	O
gene	O
that	O
encodes	O
a	O
Tol	O
protein	O
upon	O
insect	O
infection	O
.	O
<EOS>	B-X
The	B-X
entomopathogenic	B-X
nematode	B-X
Heterorhabditis	B-X
downesi	B-X
associates	B-X
with	B-X
two	B-X
bacterial	B-X
symbionts	B-X
,	B-X
Photorhabdus	B-X
temperata	B-X
subsp	B-X
.	B-X
temperata	B-X
and	B-X
P.	B-X
temperata	B-X
subsp	B-X
.	B-X
At	B-X
one	B-X
intensively	B-X
studied	B-X
coastal	B-X
dune	B-X
site	B-X
,	B-X
P.	B-X
temperata	B-X
subsp	B-X
.	B-X
cinerea	B-X
is	B-X
consistently	B-X
more	B-X
frequently	B-X
isolated	B-X
than	B-X
P.	B-X
temperata	B-X
subsp	B-X
.	B-X
temperata	B-X
in	B-X
H.	B-X
downesi	B-X
recovered	B-X
from	B-X
under	B-X
the	B-X
bare	B-X
sand/Ammophila	B-X
arrenaria	B-X
of	B-X
the	B-X
front	B-X
dunes	B-X
(	B-X
where	B-X
harsh	B-X
conditions	B-X
,	B-X
including	B-X
drought	B-X
,	B-X
prevail	B-X
)	B-X
.	B-X
No	B-X
differences	B-X
were	B-X
detected	B-X
in	B-X
ITS1	B-X
(	B-X
internal	B-X
transcribed	B-X
spacer	B-X
)	B-X
sequence	B-X
between	B-X
nematode	B-X
lines	B-X
carrying	B-X
either	B-X
of	B-X
the	B-X
two	B-X
symbiont	B-X
subspecies	B-X
,	B-X
nor	B-X
did	B-X
they	B-X
differ	B-X
in	B-X
their	B-X
ability	B-X
to	B-X
utilise	B-X
insects	B-X
from	B-X
three	B-X
orders	B-X
.	B-X
In	B-X
laboratory	B-X
experiments	B-X
,	B-X
we	B-X
tested	B-X
whether	B-X
the	B-X
symbionts	B-X
differentially	B-X
affected	B-X
nematode	B-X
survival	B-X
in	B-X
insect	B-X
cadavers	B-X
that	B-X
were	B-X
allowed	B-X
to	B-X
dry	B-X
.	B-X
We	B-X
assessed	B-X
numbers	B-X
of	B-X
nematode	B-X
infective	B-X
juveniles	B-X
emerging	B-X
from	B-X
insects	B-X
that	B-X
had	B-X
been	B-X
infected	B-X
with	B-X
H.	B-X
downesi	B-X
carrying	B-X
either	B-X
symbiont	B-X
subspecies	B-X
and	B-X
then	B-X
allowed	B-X
to	B-X
desiccate	B-X
for	B-X
up	B-X
to	B-X
62	B-X
days	B-X
.	B-X
In	B-X
moist	B-X
conditions	B-X
,	B-X
cadavers	B-X
produced	B-X
similar	B-X
numbers	B-X
of	B-X
nematodes	B-X
,	B-X
irrespective	B-X
of	B-X
the	B-X
symbiont	B-X
subspecies	B-X
present	B-X
,	B-X
while	B-X
under	B-X
desiccating	B-X
conditions	B-X
,	B-X
P.	B-X
temperata	B-X
subsp	B-X
.	B-X
cinerea	B-X
cadavers	B-X
yielded	B-X
more	B-X
nematode	B-X
progeny	B-X
than	B-X
P.	B-X
temperata	B-X
subsp	B-X
.	B-X
temperata	B-X
cadavers	B-X
.	B-X
Moreover	B-X
,	B-X
cadavers	B-X
harbouring	B-X
P.	B-X
temperata	B-X
subsp	B-X
.	B-X
cinerea	B-X
had	B-X
a	B-X
reduced	B-X
rate	B-X
of	B-X
drying	B-X
relative	B-X
to	B-X
cadavers	B-X
harbouring	B-X
P.	B-X
temperata	B-X
subsp	B-X
.	B-X
temperata	B-X
.	B-X
Our	B-X
experiments	B-X
support	B-X
the	B-X
hypothesis	B-X
that	B-X
H.	B-X
downesi	B-X
can	B-X
extend	B-X
its	B-X
niche	B-X
into	B-X
harsher	B-X
conditions	B-X
by	B-X
associating	B-X
with	B-X
P.	B-X
temperata	B-X
subsp	B-X
.	B-X

As	O
a	O
periplasmic	O
protein	O
,	O
TolB	O
is	O
an	O
extra	O
member	O
in	O
the	O
Tol	O
system	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
Tol	O
system	O
stabilizes	O
the	O
outer	O
membrane	O
structure	O
and	O
mutations	O
in	O
Tol	O
encoding	O
genes	O
result	O
in	O
hypersensitivity	O
to	O
deleterious	O
agents	O
[	O
65	O
]	O
.	O

Despite	O
unknown	O
mechanistic	O
details	O
of	O
Tol	O
system	O
,	O
upregulation	O
of	O
P	B-Organism
.	I-Organism
temperata	I-Organism
tolB	O
gene	O
suggests	O
that	O
it	O
may	O
be	O
involved	O
in	O
importing	O
biomolecules	O
by	O
somehow	O
supplying	O
energy	O
or	O
transport	O
as	O
noted	O
by	O
Nikaido	O
[	O
66	O
]	O
in	O
other	O
bacteria	O
.	O

Genes	O
with	O
unknown	O
function	O
<EOS>	B-X
Unexpectedly	B-X
,	B-X
it	B-X
also	B-X
contains	B-X
149	B-X
genes	B-X
with	B-X
unknown	B-X
biological	B-X
functions	B-X
.	B-X
JCVI-syn3.0	B-X
is	B-X
a	B-X
versatile	B-X
platform	B-X
for	B-X
investigating	B-X
the	B-X
core	B-X
functions	B-X
of	B-X
life	B-X
and	B-X
for	B-X
exploring	B-X
whole-genome	B-X
design	B-X
.	B-X
Gene	B-X
co-expression	B-X
networks	B-X
can	B-X
be	B-X
used	B-X
to	B-X
associate	B-X
genes	B-X
of	B-X
unknown	B-X
function	B-X
with	B-X
biological	B-X
processes	B-X
,	B-X
to	B-X
prioritize	B-X
candidate	B-X
disease	B-X
genes	B-X
or	B-X
to	B-X
discern	B-X
transcriptional	B-X
regulatory	B-X
programmes	B-X
.	B-X
With	B-X
recent	B-X
advances	B-X
in	B-X
transcriptomics	B-X
and	B-X
next-generation	B-X
sequencing	B-X
,	B-X
co-expression	B-X
networks	B-X
constructed	B-X
from	B-X
RNA	B-X
sequencing	B-X
data	B-X
also	B-X
enable	B-X
the	B-X
inference	B-X
of	B-X
functions	B-X
and	B-X
disease	B-X
associations	B-X
for	B-X
non-coding	B-X
genes	B-X
and	B-X
splice	B-X
variants	B-X
.	B-X

Ten	O
genes	O
encoding	O
products	O
with	O
unknown	O
functions	O
were	O
identified	O
to	O
be	O
upregulated	O
in	O
both	O
bacteria	O
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

These	O
include	O
two	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
three	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
genes	O
which	O
show	O
sequence	O
similarity	O
to	O
genes	O
encoding	O
hypothetical	O
proteins	O
with	O
unknown	O
functions	O
,	O
and	O
two	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
three	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
sequences	O
that	O
exhibit	O
no	O
similarity	O
to	O
any	O
gene	O
or	O
gene	O
product	O
in	O
current	O
databases	O
.	O
<EOS>	B-X
KEGG	B-X
(	B-X
http	B-X
:	B-X
//www.kegg.jp/	B-X
or	B-X
http	B-X
:	B-X
//www.genome.jp/kegg/	B-X
)	B-X
is	B-X
an	B-X
integrated	B-X
database	B-X
resource	B-X
for	B-X
biological	B-X
interpretation	B-X
of	B-X
genome	B-X
sequences	B-X
and	B-X
other	B-X
high-throughput	B-X
data	B-X
.	B-X
Molecular	B-X
functions	B-X
of	B-X
genes	B-X
and	B-X
proteins	B-X
are	B-X
associated	B-X
with	B-X
ortholog	B-X
groups	B-X
and	B-X
stored	B-X
in	B-X
the	B-X
KEGG	B-X
Orthology	B-X
(	B-X
KO	B-X
)	B-X
database	B-X
.	B-X
The	B-X
KEGG	B-X
pathway	B-X
maps	B-X
,	B-X
BRITE	B-X
hierarchies	B-X
and	B-X
KEGG	B-X
modules	B-X
are	B-X
developed	B-X
as	B-X
networks	B-X
of	B-X
KO	B-X
nodes	B-X
,	B-X
representing	B-X
high-level	B-X
functions	B-X
of	B-X
the	B-X
cell	B-X
and	B-X
the	B-X
organism	B-X
.	B-X
Currently	B-X
,	B-X
more	B-X
than	B-X
4000	B-X
complete	B-X
genomes	B-X
are	B-X
annotated	B-X
with	B-X
KOs	B-X
in	B-X
the	B-X
KEGG	B-X
GENES	B-X
database	B-X
,	B-X
which	B-X
can	B-X
be	B-X
used	B-X
as	B-X
a	B-X
reference	B-X
data	B-X
set	B-X
for	B-X
KO	B-X
assignment	B-X
and	B-X
subsequent	B-X
reconstruction	B-X
of	B-X
KEGG	B-X
pathways	B-X
and	B-X
other	B-X
molecular	B-X
networks	B-X
.	B-X
First	B-X
,	B-X
each	B-X
KO	B-X
record	B-X
is	B-X
re-examined	B-X
and	B-X
associated	B-X
with	B-X
protein	B-X
sequence	B-X
data	B-X
used	B-X
in	B-X
experiments	B-X
of	B-X
functional	B-X
characterization	B-X
.	B-X
Second	B-X
,	B-X
the	B-X
GENES	B-X
database	B-X
now	B-X
includes	B-X
viruses	B-X
,	B-X
plasmids	B-X
,	B-X
and	B-X
the	B-X
addendum	B-X
category	B-X
for	B-X
functionally	B-X
characterized	B-X
proteins	B-X
that	B-X
are	B-X
not	B-X
represented	B-X
in	B-X
complete	B-X
genomes	B-X
.	B-X
Third	B-X
,	B-X
new	B-X
automatic	B-X
annotation	B-X
servers	B-X
,	B-X
BlastKOALA	B-X
and	B-X
GhostKOALA	B-X
,	B-X
are	B-X
made	B-X
available	B-X
utilizing	B-X
the	B-X
non-redundant	B-X
pangenome	B-X
data	B-X
set	B-X
generated	B-X
from	B-X
the	B-X
GENES	B-X
database	B-X
.	B-X
As	B-X
a	B-X
resource	B-X
for	B-X
translational	B-X
bioinformatics	B-X
,	B-X
various	B-X
data	B-X
sets	B-X
are	B-X
created	B-X
for	B-X
antimicrobial	B-X
resistance	B-X
and	B-X
drug	B-X
interaction	B-X
networks	B-X
.	B-X

These	O
unknown	O
genes	O
may	O
represent	O
novel	O
pathogenicity	O
factors	O
used	O
by	O
bacteria	O
during	O
insect	O
infection	O
and	O
thus	O
require	O
further	O
investigation	O
.	O

Conclusion	O
<EOS>	B-X
Conclusion	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X
[	B-X
Conclusion	B-X
]	B-X
.	B-X

This	O
research	O
indicates	O
that	O
selective	O
capture	O
of	O
transcribed	O
sequences	O
(	O
SCOTS	O
)	O
is	O
a	O
powerful	O
technique	O
to	O
study	O
in	O
vivo	O
gene	O
expression	O
in	O
bacterial	O
pathogens	O
of	O
insects	O
.	O

Results	O
reveal	O
that	O
phylogenetically	O
related	O
bacteria	O
with	O
similar	O
biology	O
differ	O
dramatically	O
in	O
molecular	O
mechanisms	O
of	O
pathogenicity	O
in	O
the	O
same	O
host	O
.	O

Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
bacteria	O
appear	O
to	O
share	O
more	O
genes	O
in	O
host	O
-	O
induced	O
stress	O
protection	O
category	O
,	O
including	O
tolerance	O
against	O
universal	O
stresses	O
,	O
glutathione	O
-	O
mediated	O
protection	O
against	O
oxidative	O
stress	O
,	O
and	O
protection	O
against	O
nucleic	O
acid	O
damage	O
,	O
compared	O
to	O
genes	O
in	O
all	O
other	O
categories	O
.	O

While	O
genes	O
encoding	O
TcaC	O
toxin	O
and	O
hemolysin	O
related	O
proteins	O
were	O
identified	O
to	O
be	O
induced	O
in	O
both	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
the	O
two	O
bacteria	O
seem	O
to	O
use	O
different	O
regulatory	O
genes	O
,	O
secretion	O
systems	O
and	O
virulence	O
factors	O
to	O
achieve	O
infection	O
of	O
the	O
same	O
insect	O
host	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Further	O
,	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
displayed	O
different	O
metabolic	O
adaptations	O
in	O
the	O
same	O
insect	O
host	O
as	O
reflected	O
by	O
the	O
high	O
proportion	O
of	O
identified	O
genes	O
involved	O
in	O
metabolism	O
.	O

Overall	O
,	O
this	O
study	O
provides	O
a	O
better	O
understanding	O
of	O
the	O
evolution	O
of	O
bacterial	O
pathogenesis	O
and	O
provides	O
molecular	O
targets	O
for	O
genetic	O
manipulation	O
of	O
these	O
economically	O
important	O
nematode	O
symbiotic	O
insect	O
pathogens	O
.	O

Transcriptional	O
profiling	O
of	O
Actinobacillus	B-Organism
pleuropneumoniae	I-Organism
during	O
the	O
acute	O
phase	O
of	O
a	O
natural	O
infection	O
in	O
pigs	B-Organism
<EOS>	B-X
Actinobacillus	B-X
pleuropneumoniae	B-X
is	B-X
the	B-X
etiological	B-X
agent	B-X
of	B-X
porcine	B-X
pleuropneumonia	B-X
,	B-X
a	B-X
respiratory	B-X
disease	B-X
which	B-X
causes	B-X
great	B-X
economic	B-X
losses	B-X
worldwide	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X
Gene	B-X
expression	B-X
profiles	B-X
of	B-X
bacteria	B-X
in	B-X
their	B-X
natural	B-X
hosts	B-X
can	B-X
provide	B-X
novel	B-X
insight	B-X
into	B-X
the	B-X
host-pathogen	B-X
interactions	B-X
and	B-X
molecular	B-X
determinants	B-X
of	B-X
bacterial	B-X
infections	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
the	B-X
transcriptional	B-X
profile	B-X
of	B-X
the	B-X
porcine	B-X
lung	B-X
pathogen	B-X
Actinobacillus	B-X
pleuropneumoniae	B-X
was	B-X
monitored	B-X
during	B-X
the	B-X
acute	B-X
phase	B-X
of	B-X
infection	B-X
in	B-X
its	B-X
natural	B-X
host	B-X
.	B-X

Background	O
Actinobacillus	B-Organism
pleuropneumoniae	I-Organism
is	O
the	O
etiological	O
agent	O
of	O
porcine	O
pleuropneumonia	O
,	O
a	O
respiratory	O
disease	O
which	O
causes	O
great	O
economic	O
losses	O
worldwide	O
.	O
<EOS>	B-X
Actinobacillus	B-X
pleuropneumoniae	B-X
is	B-X
the	B-X
etiological	B-X
agent	B-X
of	B-X
porcine	B-X
pleuropneumonia	B-X
,	B-X
a	B-X
respiratory	B-X
disease	B-X
which	B-X
causes	B-X
great	B-X
economic	B-X
losses	B-X
worldwide	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X
AppChip2	B-X
contains	B-X
2033	B-X
PCR	B-X
amplicons	B-X
based	B-X
on	B-X
the	B-X
genomic	B-X
sequence	B-X
of	B-X
App	B-X
serotype	B-X
5b	B-X
strain	B-X
L20	B-X
,	B-X
representing	B-X
more	B-X
than	B-X
95	B-X
%	B-X
of	B-X
ORFs	B-X
greater	B-X
than	B-X
160	B-X
bp	B-X
in	B-X
length	B-X
.	B-X
The	B-X
Gram-negative	B-X
bacterium	B-X
Actinobacillus	B-X
pleuropneumoniae	B-X
is	B-X
the	B-X
etiologic	B-X
agent	B-X
of	B-X
porcine	B-X
contagious	B-X
pleuropneumoniae	B-X
,	B-X
a	B-X
lethal	B-X
respiratory	B-X
infectious	B-X
disease	B-X
causing	B-X
great	B-X
economic	B-X
losses	B-X
in	B-X
the	B-X
swine	B-X
industry	B-X
worldwide	B-X
.	B-X
In	B-X
order	B-X
to	B-X
better	B-X
interpret	B-X
the	B-X
genetic	B-X
background	B-X
of	B-X
serotypic	B-X
diversity	B-X
,	B-X
nine	B-X
genomes	B-X
of	B-X
A.	B-X
pleuropneumoniae	B-X
reference	B-X
strains	B-X
of	B-X
serovars	B-X
1	B-X
,	B-X
2	B-X
,	B-X
4	B-X
,	B-X
6	B-X
,	B-X
9	B-X
,	B-X
10	B-X
,	B-X
11	B-X
,	B-X
12	B-X
,	B-X
and	B-X
13	B-X
were	B-X
sequenced	B-X
by	B-X
using	B-X
rapid	B-X
high-throughput	B-X
approach	B-X
.	B-X
Clustering	B-X
of	B-X
26,012	B-X
predicted	B-X
protein-coding	B-X
genes	B-X
showed	B-X
that	B-X
the	B-X
pan	B-X
genome	B-X
of	B-X
A.	B-X
pleuropneumoniae	B-X
consists	B-X
of	B-X
3,303	B-X
gene	B-X
clusters	B-X
,	B-X
which	B-X
contain	B-X
1,709	B-X
core	B-X
genome	B-X
genes	B-X
,	B-X
822	B-X
distributed	B-X
genes	B-X
,	B-X
and	B-X
772	B-X
strain-specific	B-X
genes	B-X
.	B-X
Our	B-X
findings	B-X
shed	B-X
more	B-X
light	B-X
on	B-X
genomic	B-X
features	B-X
associated	B-X
with	B-X
serovar	B-X
diversity	B-X
of	B-X
A.	B-X
pleuropneumoniae	B-X
and	B-X
provide	B-X
broader	B-X
insight	B-X
into	B-X
both	B-X
pathogenesis	B-X
research	B-X
and	B-X
clinical/epidemiological	B-X
application	B-X
against	B-X
the	B-X
severe	B-X
disease	B-X
caused	B-X
by	B-X
this	B-X
swine	B-X
pathogen	B-X
.	B-X

Many	O
virulence	O
factors	O
are	O
involved	O
in	O
the	O
pathogenesis	O
,	O
namely	O
capsular	O
polysaccharides	O
,	O
RTX	O
toxins	O
,	O
LPS	O
and	O
many	O
iron	O
acquisition	O
systems	O
.	O
<EOS>	B-X
Many	B-X
virulence	B-X
factors	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
,	B-X
namely	B-X
capsular	B-X
polysaccharides	B-X
,	B-X
RTX	B-X
toxins	B-X
,	B-X
LPS	B-X
and	B-X
many	B-X
iron	B-X
acquisition	B-X
systems	B-X
.	B-X

In	O
order	O
to	O
identify	O
genes	O
that	O
are	O
expressed	O
in	O
vivo	O
during	O
a	O
natural	O
infection	O
,	O
we	O
undertook	O
transcript	O
profiling	O
experiments	O
with	O
an	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
DNA	O
microarray	O
,	O
after	O
recovery	O
of	O
bacterial	O
mRNAs	O
from	O
serotype	B-Organism
5b	I-Organism
-	O
infected	O
porcine	O
lungs	O
.	O
<EOS>	B-X
Actinobacillus	B-X
pleuropneumoniae	B-X
is	B-X
the	B-X
etiological	B-X
agent	B-X
of	B-X
porcine	B-X
pleuropneumonia	B-X
,	B-X
a	B-X
respiratory	B-X
disease	B-X
which	B-X
causes	B-X
great	B-X
economic	B-X
losses	B-X
worldwide	B-X
.	B-X
Many	B-X
virulence	B-X
factors	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
,	B-X
namely	B-X
capsular	B-X
polysaccharides	B-X
,	B-X
RTX	B-X
toxins	B-X
,	B-X
LPS	B-X
and	B-X
many	B-X
iron	B-X
acquisition	B-X
systems	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X
AppChip2	B-X
contains	B-X
2033	B-X
PCR	B-X
amplicons	B-X
based	B-X
on	B-X
the	B-X
genomic	B-X
sequence	B-X
of	B-X
App	B-X
serotype	B-X
5b	B-X
strain	B-X
L20	B-X
,	B-X
representing	B-X
more	B-X
than	B-X
95	B-X
%	B-X
of	B-X
ORFs	B-X
greater	B-X
than	B-X
160	B-X
bp	B-X
in	B-X
length	B-X
.	B-X

AppChip2	B-Organism
contains	O
2033	O
PCR	O
amplicons	O
based	O
on	O
the	O
genomic	O
sequence	O
of	O
App	B-Organism
serotype	I-Organism
5b	I-Organism
strain	I-Organism
L20	I-Organism
,	O
representing	O
more	O
than	O
95	O
%	O
of	O
ORFs	O
greater	O
than	O
160	O
bp	O
in	O
length	O
.	O
<EOS>	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X
AppChip2	B-X
contains	B-X
2033	B-X
PCR	B-X
amplicons	B-X
based	B-X
on	B-X
the	B-X
genomic	B-X
sequence	B-X
of	B-X
App	B-X
serotype	B-X
5b	B-X
strain	B-X
L20	B-X
,	B-X
representing	B-X
more	B-X
than	B-X
95	B-X
%	B-X
of	B-X
ORFs	B-X
greater	B-X
than	B-X
160	B-X
bp	B-X
in	B-X
length	B-X
.	B-X

Results	O
Transcriptional	O
profiling	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
recovered	O
from	O
the	O
lung	O
of	O
a	O
pig	B-Organism
suffering	O
from	O
a	O
natural	O
infection	O
or	O
following	O
growth	O
of	O
the	O
bacterial	O
isolate	O
in	O
BHI	O
medium	O
was	O
performed	O
.	O
<EOS>	B-X
Actinobacillus	B-X
pleuropneumoniae	B-X
is	B-X
the	B-X
etiological	B-X
agent	B-X
of	B-X
porcine	B-X
pleuropneumonia	B-X
,	B-X
a	B-X
respiratory	B-X
disease	B-X
which	B-X
causes	B-X
great	B-X
economic	B-X
losses	B-X
worldwide	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X

An	O
RNA	O
extraction	O
protocol	O
combining	O
beadbeating	O
and	O
hot	O
-	O
acid	O
-	O
phenol	O
was	O
developed	O
in	O
order	O
to	O
maximize	O
bacterial	O
mRNA	O
yields	O
and	O
quality	O
following	O
total	O
RNA	O
extraction	O
from	O
lung	O
lesions	O
.	O
<EOS>	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X

Nearly	O
all	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
transcripts	O
could	O
be	O
detected	O
on	O
our	O
microarrays	O
,	O
and	O
150	O
genes	O
were	O
deemed	O
differentially	O
expressed	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
infection	O
.	O
<EOS>	B-X
Actinobacillus	B-X
pleuropneumoniae	B-X
is	B-X
the	B-X
etiological	B-X
agent	B-X
of	B-X
porcine	B-X
pleuropneumonia	B-X
,	B-X
a	B-X
respiratory	B-X
disease	B-X
which	B-X
causes	B-X
great	B-X
economic	B-X
losses	B-X
worldwide	B-X
.	B-X
Many	B-X
virulence	B-X
factors	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
,	B-X
namely	B-X
capsular	B-X
polysaccharides	B-X
,	B-X
RTX	B-X
toxins	B-X
,	B-X
LPS	B-X
and	B-X
many	B-X
iron	B-X
acquisition	B-X
systems	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X

Our	O
results	O
indicate	O
that	O
,	O
for	O
example	O
,	O
gene	O
apxIVA	O
from	O
an	O
operon	O
coding	O
for	O
RTX	O
toxin	O
ApxIV	O
is	O
highly	O
up	O
-	O
regulated	O
in	O
vivo	O
,	O
and	O
that	O
two	O
genes	O
from	O
the	O
operon	O
coding	O
for	O
type	O
IV	O
fimbriae	O
(	O
APL	O
_	O
0878	O
and	O
APL	O
_	O
0879	O
)	O
were	O
also	O
up	O
-	O
regulated	O
.	O
<EOS>	B-X
Many	B-X
virulence	B-X
factors	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
,	B-X
namely	B-X
capsular	B-X
polysaccharides	B-X
,	B-X
RTX	B-X
toxins	B-X
,	B-X
LPS	B-X
and	B-X
many	B-X
iron	B-X
acquisition	B-X
systems	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X
AppChip2	B-X
contains	B-X
2033	B-X
PCR	B-X
amplicons	B-X
based	B-X
on	B-X
the	B-X
genomic	B-X
sequence	B-X
of	B-X
App	B-X
serotype	B-X
5b	B-X
strain	B-X
L20	B-X
,	B-X
representing	B-X
more	B-X
than	B-X
95	B-X
%	B-X
of	B-X
ORFs	B-X
greater	B-X
than	B-X
160	B-X
bp	B-X
in	B-X
length	B-X
.	B-X

These	O
transcriptional	O
profiling	O
data	O
,	O
combined	O
with	O
previous	O
comparative	O
genomic	O
hybridizations	O
performed	O
by	O
our	O
group	O
,	O
revealed	O
that	O
66	O
out	O
of	O
the	O
72	O
up	O
-	O
regulated	O
genes	O
are	O
conserved	O
amongst	O
all	O
serotypes	O
and	O
that	O
3	O
of	O
them	O
code	O
for	O
products	O
that	O
are	O
predicted	O
outer	O
membrane	O
proteins	O
(	O
genes	O
irp	O
and	O
APL	O
_	O
0959	O
,	O
predicted	O
to	O
code	O
for	O
a	O
TonB	O
-	O
dependent	O
receptor	O
and	O
a	O
filamentous	O
hemagglutinin	O
/	O
adhesin	O
respectively	O
)	O
or	O
lipoproteins	O
(	O
gene	O
APL	O
_	O
0920	O
)	O
.	O
<EOS>	B-X
Many	B-X
virulence	B-X
factors	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
,	B-X
namely	B-X
capsular	B-X
polysaccharides	B-X
,	B-X
RTX	B-X
toxins	B-X
,	B-X
LPS	B-X
and	B-X
many	B-X
iron	B-X
acquisition	B-X
systems	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X
AppChip2	B-X
contains	B-X
2033	B-X
PCR	B-X
amplicons	B-X
based	B-X
on	B-X
the	B-X
genomic	B-X
sequence	B-X
of	B-X
App	B-X
serotype	B-X
5b	B-X
strain	B-X
L20	B-X
,	B-X
representing	B-X
more	B-X
than	B-X
95	B-X
%	B-X
of	B-X
ORFs	B-X
greater	B-X
than	B-X
160	B-X
bp	B-X
in	B-X
length	B-X
.	B-X

Only	O
4	O
of	O
72	O
up	O
-	O
regulated	O
genes	O
had	O
previously	O
been	O
identified	O
in	O
controled	O
experimental	O
infections	O
.	O
<EOS>	B-X
Many	B-X
virulence	B-X
factors	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
,	B-X
namely	B-X
capsular	B-X
polysaccharides	B-X
,	B-X
RTX	B-X
toxins	B-X
,	B-X
LPS	B-X
and	B-X
many	B-X
iron	B-X
acquisition	B-X
systems	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X

Conclusions	O
These	O
genes	O
that	O
we	O
have	O
identified	O
as	O
up	O
-	O
regulated	O
in	O
vivo	O
,	O
conserved	O
across	O
serotypes	O
and	O
coding	O
for	O
potential	O
outer	O
membrane	O
proteins	O
represent	O
potential	O
candidates	O
for	O
the	O
development	O
of	O
a	O
cross	O
-	O
protective	O
vaccine	O
against	O
porcine	O
pleuropneumonia	O
.	O
<EOS>	B-X
Actinobacillus	B-X
pleuropneumoniae	B-X
is	B-X
the	B-X
etiological	B-X
agent	B-X
of	B-X
porcine	B-X
pleuropneumonia	B-X
,	B-X
a	B-X
respiratory	B-X
disease	B-X
which	B-X
causes	B-X
great	B-X
economic	B-X
losses	B-X
worldwide	B-X
.	B-X
Many	B-X
virulence	B-X
factors	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
pathogenesis	B-X
,	B-X
namely	B-X
capsular	B-X
polysaccharides	B-X
,	B-X
RTX	B-X
toxins	B-X
,	B-X
LPS	B-X
and	B-X
many	B-X
iron	B-X
acquisition	B-X
systems	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
genes	B-X
that	B-X
are	B-X
expressed	B-X
in	B-X
vivo	B-X
during	B-X
a	B-X
natural	B-X
infection	B-X
,	B-X
we	B-X
undertook	B-X
transcript	B-X
profiling	B-X
experiments	B-X
with	B-X
an	B-X
A.	B-X
pleuropneumoniae	B-X
DNA	B-X
microarray	B-X
,	B-X
after	B-X
recovery	B-X
of	B-X
bacterial	B-X
mRNAs	B-X
from	B-X
serotype	B-X
5b-infected	B-X
porcine	B-X
lungs	B-X
.	B-X
AppChip2	B-X
contains	B-X
2033	B-X
PCR	B-X
amplicons	B-X
based	B-X
on	B-X
the	B-X
genomic	B-X
sequence	B-X
of	B-X
App	B-X
serotype	B-X
5b	B-X
strain	B-X
L20	B-X
,	B-X
representing	B-X
more	B-X
than	B-X
95	B-X
%	B-X
of	B-X
ORFs	B-X
greater	B-X
than	B-X
160	B-X
bp	B-X
in	B-X
length	B-X
.	B-X

Background	O
<EOS>	B-X
Background	B-X
matching	B-X
is	B-X
the	B-X
most	B-X
familiar	B-X
and	B-X
widespread	B-X
camouflage	B-X
strategy	B-X
:	B-X
avoiding	B-X
detection	B-X
by	B-X
having	B-X
a	B-X
similar	B-X
colour	B-X
and	B-X
pattern	B-X
to	B-X
the	B-X
background	B-X
.	B-X
Background	B-X
is	B-X
thus	B-X
a	B-X
relatively	B-X
modest	B-X
correction	B-X
for	B-X
all	B-X
Z	B-X
opacity	B-X
data	B-X
published	B-X
to	B-X
date	B-X
.	B-X
Background	B-X
estimation	B-X
and	B-X
foreground	B-X
segmentation	B-X
are	B-X
important	B-X
steps	B-X
in	B-X
many	B-X
high-level	B-X
vision	B-X
tasks	B-X
.	B-X
Patient	B-X
Preference	B-X
for	B-X
Telehealth	B-X
Background	B-X
Shapes	B-X
Impressions	B-X
of	B-X
Physicians	B-X
and	B-X
Information	B-X
Recall	B-X
:	B-X
A	B-X
Randomized	B-X
Experiment	B-X
.	B-X

Actinobacillus	B-Organism
pleuropneumoniae	I-Organism
is	O
the	O
causative	O
agent	O
of	O
porcine	O
pleuropneumonia	O
,	O
a	O
highly	O
contagious	O
respiratory	O
disease	O
that	O
causes	O
great	O
economic	O
losses	O
worldwide	O
[	O
1	O
]	O
.	O

Transmission	O
occurs	O
through	O
aerosol	O
or	O
close	O
contact	O
with	O
infected	O
animals	O
or	O
asymptomatic	O
carriers	O
,	O
and	O
can	O
affect	O
pigs	B-Organism
of	O
all	O
ages	O
[	O
2	O
]	O
.	O
<EOS>	B-X
Monkeypox	B-X
is	B-X
caused	B-X
by	B-X
a	B-X
pox	B-X
virus	B-X
closely	B-X
related	B-X
to	B-X
smallpox	B-X
virus	B-X
and	B-X
spreads	B-X
from	B-X
animals	B-X
to	B-X
humans	B-X
,	B-X
and	B-X
humans	B-X
to	B-X
humans	B-X
following	B-X
close	B-X
contact	B-X
.	B-X
Recovery	B-X
occurs	B-X
in	B-X
most	B-X
patients	B-X
within	B-X
2-4	B-X
wk	B-X
.	B-X
Vaccination	B-X
with	B-X
the	B-X
currently	B-X
available	B-X
smallpox	B-X
vaccines	B-X
is	B-X
recommended	B-X
for	B-X
high-risk	B-X
groups	B-X
,	B-X
health	B-X
care	B-X
workers	B-X
,	B-X
and	B-X
close	B-X
contacts	B-X
.	B-X
Control	B-X
of	B-X
the	B-X
monkeypox	B-X
outbreak	B-X
needs	B-X
a	B-X
multipronged	B-X
effort	B-X
comprising	B-X
enhanced	B-X
surveillance	B-X
,	B-X
quick	B-X
diagnosis	B-X
,	B-X
isolation	B-X
of	B-X
affected	B-X
people	B-X
,	B-X
ring	B-X
immunization	B-X
,	B-X
and	B-X
adoption	B-X
of	B-X
``	B-X
one	B-X
health	B-X
''	B-X
approach	B-X
.	B-X

In	O
the	O
acute	O
phase	O
,	O
the	O
disease	O
is	O
often	O
lethal	O
in	O
24	O
to	O
48	O
h	O
,	O
and	O
leads	O
to	O
the	O
formation	O
of	O
extensive	O
fibrinohemorrhagic	O
lung	O
lesions	O
.	O

Animals	O
that	O
survive	O
the	O
infection	O
often	O
become	O
healthy	O
carriers	O
,	O
and	O
develop	O
localized	O
necrotizing	O
lesions	O
associated	O
with	O
pleuritis	O
[	O
3	O
]	O
.	O

Fifteen	O
different	O
serotypes	O
can	O
be	O
identified	O
based	O
on	O
differences	O
in	O
capsular	O
polysaccharides	O
.	O
<EOS>	B-X
A	B-X
simple	B-X
and	B-X
rapid	B-X
method	B-X
of	B-X
simultaneously	B-X
determining	B-X
15	B-X
Streptococcus	B-X
pneumoniae	B-X
serotypes	B-X
was	B-X
developed	B-X
.	B-X
Fifteen	B-X
latex	B-X
beads	B-X
of	B-X
different	B-X
sizes	B-X
and	B-X
different	B-X
red	B-X
fluorescence	B-X
levels	B-X
were	B-X
coated	B-X
with	B-X
1	B-X
of	B-X
15	B-X
serotypes	B-X
(	B-X
1	B-X
,	B-X
3	B-X
,	B-X
4	B-X
,	B-X
5	B-X
,	B-X
6A	B-X
,	B-X
6B	B-X
,	B-X
7F	B-X
,	B-X
9N	B-X
,	B-X
9V	B-X
,	B-X
14	B-X
,	B-X
18C	B-X
,	B-X
19A	B-X
,	B-X
19F	B-X
,	B-X
22F	B-X
,	B-X
and	B-X
23F	B-X
)	B-X
of	B-X
pneumococcal	B-X
capsular	B-X
polysaccharide	B-X
(	B-X
PS	B-X
)	B-X
.	B-X
The	B-X
bead	B-X
mixture	B-X
was	B-X
incubated	B-X
with	B-X
individual	B-X
pneumococcal	B-X
lysate	B-X
,	B-X
a	B-X
pool	B-X
of	B-X
rabbit	B-X
antisera	B-X
capable	B-X
of	B-X
binding	B-X
the	B-X
15	B-X
serotypes	B-X
,	B-X
and	B-X
fluorescein	B-X
(	B-X
green	B-X
fluorescence	B-X
)	B-X
-conjugated	B-X
anti-rabbit	B-X
antibody	B-X
.	B-X
This	B-X
method	B-X
distinguished	B-X
cross-reactive	B-X
serotypes	B-X
and	B-X
correctly	B-X
identified	B-X
the	B-X
serotypes	B-X
in	B-X
100	B-X
%	B-X
of	B-X
86	B-X
pneumococcal	B-X
isolates	B-X
tested	B-X
.	B-X

While	O
serotypes	O
1	O
to	O
12	O
and	O
15	O
usually	O
belong	O
to	O
biotype	O
1	O
,	O
which	O
contains	O
strains	O
that	O
are	O
NAD	O
-	O
dependent	O
,	O
serotypes	O
13	O
and	O
14	O
are	O
usually	O
NAD	O
-	O
independent	O
and	O
belong	O
to	O
biotype	O
2	O
[	O
4	O
]	O
.	O

However	O
,	O
biotype	O
2	O
variants	O
of	O
serotypes	O
2	O
,	O
4	O
,	O
7	O
and	O
9	O
have	O
been	O
reported	O
[	O
5	O
-	O
7	O
]	O
.	O

Despite	O
years	O
of	O
research	O
,	O
mechanisms	O
involved	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
pathogenicity	O
are	O
still	O
not	O
fully	O
understood	O
.	O

While	O
many	O
virulence	O
factors	O
have	O
been	O
identified	O
,	O
such	O
as	O
lipopolysaccharides	O
,	O
capsular	O
polysaccharides	O
,	O
Apx	O
toxins	O
and	O
iron	O
acquisition	O
systems	O
[	O
4	O
]	O
,	O
or	O
suggested	O
,	O
like	O
biofilm	O
formation	O
[	O
8	O
]	O
,	O
autotransporter	O
adhesin	O
[	O
9	O
]	O
and	O
autotransporter	O
protease	O
synthesis	O
[	O
10	O
]	O
,	O
very	O
little	O
is	O
known	O
about	O
the	O
overall	O
contribution	O
of	O
each	O
component	O
to	O
the	O
infection	O
process	O
.	O

In	O
order	O
to	O
gain	O
new	O
insight	O
into	O
the	O
disease	O
,	O
researchers	O
have	O
relied	O
on	O
techniques	O
that	O
allow	O
for	O
the	O
identification	O
of	O
genes	O
expressed	O
in	O
bacteria	O
during	O
infection	O
of	O
the	O
host	O
[	O
11	O
]	O
,	O
namely	O
In	O
Vivo	O
Expression	O
Technology	O
(	O
IVET	O
)	O
,	O
Signature	O
Tagged	O
Mutagenesis	O
(	O
STM	O
)	O
and	O
Selective	O
Capture	O
of	O
Transcribed	O
Sequences	O
(	O
SCOTS	O
)	O
.	O

First	O
,	O
an	O
IVET	O
experiment	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
led	O
to	O
the	O
identification	O
of	O
10	O
loci	O
(	O
termed	O
ivi	O
)	O
transcribed	O
in	O
vivo	O
[	O
12	O
]	O
and	O
highlighted	O
the	O
importance	O
of	O
genes	O
involved	O
in	O
branched	O
-	O
chain	O
amino	O
acid	O
(	O
BCAA	O
)	O
synthesis	O
[	O
13	O
,	O
14	O
]	O
.	O

Later	O
,	O
over	O
the	O
course	O
of	O
two	O
STM	O
experiments	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
nearly	O
3000	O
mutants	O
were	O
screened	O
in	O
vivo	O
[	O
15	O
,	O
16	O
]	O
.	O

Both	O
experiments	O
showed	O
that	O
iron	O
acquisition	O
was	O
highly	O
important	O
for	O
the	O
virulence	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
with	O
the	O
identification	O
of	O
mutants	O
impaired	O
for	O
the	O
ExbB	O
-	O
ExbD	O
-	O
TonB	O
energy	O
-	O
transducing	O
system	O
.	O

The	O
study	O
by	O
Sheehan	O
et	O
al	O
[	O
16	O
]	O
,	O
lead	O
to	O
the	O
identification	O
of	O
a	O
second	O
set	O
of	O
exbB	O
-	O
exbD	O
-	O
tonB	O
genes	O
,	O
and	O
it	O
was	O
determined	O
that	O
inactivation	O
of	O
tonB2	O
and	O
not	O
tonB1	O
lead	O
to	O
attenuation	O
in	O
vivo	O
[	O
17	O
]	O
.	O

More	O
recently	O
,	O
SCOTS	O
experiments	O
were	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
at	O
two	O
different	O
stages	O
of	O
infection	O
:	O
at	O
the	O
end	O
of	O
the	O
acute	O
stage	O
,	O
in	O
necrotic	O
lung	O
tissues	O
(	O
7	O
days	O
post	O
-	O
infection	O
)	O
[	O
18	O
]	O
,	O
and	O
in	O
the	O
chronic	O
stage	O
(	O
21	O
days	O
post	O
-	O
infection	O
)	O
[	O
10	O
]	O
.	O

These	O
studies	O
demonstrated	O
the	O
importance	O
of	O
anaerobic	O
metabolism	O
and	O
HlyX	O
-	O
regulated	O
mechanisms	O
during	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
infection	O
in	O
the	O
lungs	O
,	O
and	O
led	O
to	O
the	O
identification	O
and	O
characterisation	O
of	O
a	O
maturation	O
autotransporter	O
protease	O
,	O
AasP	O
,	O
responsible	O
for	O
cleavage	O
and	O
release	O
of	O
fragments	O
of	O
OmlA	O
from	O
the	O
cell	O
surface	O
[	O
19	O
]	O
.	O

The	O
HlyX	O
regulon	O
was	O
characterized	O
recently	O
,	O
and	O
iron	O
-	O
regulated	O
protein	O
B	O
(	O
FrpB	O
)	O
was	O
identified	O
as	O
a	O
potentially	O
important	O
virulence	O
factor	O
up	O
-	O
regulated	O
when	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
is	O
grown	O
in	O
oxygen	O
-	O
deprived	O
environments	O
[	O
20	O
]	O
.	O

Although	O
these	O
in	O
vivo	O
studies	O
have	O
been	O
very	O
valuable	O
in	O
gaining	O
a	O
better	O
understanding	O
of	O
the	O
mechanisms	O
involved	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
pathogenesis	O
,	O
limitations	O
associated	O
with	O
the	O
techniques	O
used	O
lead	O
only	O
to	O
a	O
partial	O
overview	O
of	O
the	O
transcriptional	O
events	O
taking	O
place	O
in	O
vivo	O
.	O

DNA	O
microarrays	O
have	O
been	O
used	O
to	O
determine	O
the	O
complete	O
transcriptomic	O
profile	O
of	O
microorganisms	O
in	O
vitro	O
,	O
but	O
technical	O
drawbacks	O
that	O
are	O
associated	O
with	O
the	O
use	O
of	O
this	O
technique	O
in	O
vivo	O
,	O
such	O
as	O
the	O
qualitative	O
and	O
quantitative	O
recovery	O
of	O
bacterial	O
RNA	O
from	O
host	O
tissues	O
,	O
explain	O
why	O
the	O
use	O
of	O
this	O
technique	O
to	O
monitor	O
bacterial	O
infections	O
has	O
been	O
limited	O
[	O
21	O
]	O
.	O

While	O
various	O
cell	O
culture	O
,	O
ex	O
-	O
vivo	O
or	O
mouse	B-Organism
infection	O
models	O
have	O
been	O
used	O
,	O
in	O
vivo	O
experiments	O
can	O
provide	O
more	O
accurate	O
information	O
on	O
bacterial	O
adaptation	O
and	O
virulence	O
when	O
the	O
natural	O
host	O
is	O
studied	O
.	O
<EOS>	B-X
Adipocytes	B-X
are	B-X
specialized	B-X
cells	B-X
with	B-X
pleiotropic	B-X
roles	B-X
in	B-X
physiology	B-X
and	B-X
pathology	B-X
.	B-X
Several	B-X
types	B-X
of	B-X
fat	B-X
cells	B-X
with	B-X
distinct	B-X
metabolic	B-X
properties	B-X
coexist	B-X
in	B-X
various	B-X
anatomically	B-X
defined	B-X
fat	B-X
depots	B-X
in	B-X
mammals	B-X
.	B-X
The	B-X
intrinsic	B-X
properties	B-X
of	B-X
adipocytes	B-X
pose	B-X
specific	B-X
challenges	B-X
in	B-X
culture	B-X
.	B-X
Mature	B-X
adipocytes	B-X
float	B-X
in	B-X
suspension	B-X
culture	B-X
due	B-X
to	B-X
high	B-X
triacylglycerol	B-X
content	B-X
and	B-X
are	B-X
fragile	B-X
.	B-X
Moreover	B-X
,	B-X
a	B-X
fully	B-X
differentiated	B-X
state	B-X
,	B-X
notably	B-X
acquirement	B-X
of	B-X
the	B-X
unilocular	B-X
lipid	B-X
droplet	B-X
of	B-X
white	B-X
adipocyte	B-X
,	B-X
has	B-X
so	B-X
far	B-X
not	B-X
been	B-X
reached	B-X
in	B-X
two-dimensional	B-X
culture	B-X
.	B-X
Cultures	B-X
of	B-X
mouse	B-X
and	B-X
human-differentiated	B-X
preadipocyte	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
have	B-X
been	B-X
established	B-X
to	B-X
mimic	B-X
white	B-X
,	B-X
beige	B-X
,	B-X
and	B-X
brown	B-X
adipocytes	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
survey	B-X
various	B-X
models	B-X
of	B-X
differentiated	B-X
preadipocyte	B-X
cells	B-X
and	B-X
primary	B-X
mature	B-X
adipocyte	B-X
survival	B-X
describing	B-X
main	B-X
characteristics	B-X
,	B-X
culture	B-X
conditions	B-X
,	B-X
advantages	B-X
,	B-X
and	B-X
limitations	B-X
.	B-X
An	B-X
important	B-X
development	B-X
is	B-X
the	B-X
advent	B-X
of	B-X
three-dimensional	B-X
culture	B-X
,	B-X
notably	B-X
of	B-X
adipose	B-X
spheroids	B-X
that	B-X
recapitulate	B-X
in	B-X
vivo	B-X
adipocyte	B-X
function	B-X
and	B-X
morphology	B-X
in	B-X
fat	B-X
depots	B-X
.	B-X
Challenges	B-X
for	B-X
the	B-X
future	B-X
include	B-X
isolation	B-X
and	B-X
culture	B-X
of	B-X
adipose-derived	B-X
stem	B-X
cells	B-X
from	B-X
different	B-X
anatomic	B-X
location	B-X
in	B-X
animal	B-X
models	B-X
and	B-X
humans	B-X
differing	B-X
in	B-X
sex	B-X
,	B-X
age	B-X
,	B-X
fat	B-X
mass	B-X
,	B-X
and	B-X
pathophysiological	B-X
conditions	B-X
.	B-X
Further	B-X
understanding	B-X
of	B-X
fat	B-X
cell	B-X
physiology	B-X
and	B-X
dysfunction	B-X
will	B-X
be	B-X
achieved	B-X
through	B-X
genetic	B-X
manipulation	B-X
,	B-X
notably	B-X
CRISPR-mediated	B-X
gene	B-X
editing	B-X
.	B-X
Capturing	B-X
adipocyte	B-X
heterogeneity	B-X
at	B-X
the	B-X
single-cell	B-X
level	B-X
within	B-X
a	B-X
single	B-X
fat	B-X
depot	B-X
will	B-X
be	B-X
key	B-X
to	B-X
understanding	B-X
diversities	B-X
in	B-X
cardiometabolic	B-X
parameters	B-X
among	B-X
lean	B-X
and	B-X
obese	B-X
individuals	B-X
.	B-X

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
only	O
two	O
genome	O
-	O
wide	O
transcriptional	O
profiling	O
experiments	O
using	O
DNA	O
microarrays	O
have	O
been	O
conducted	O
with	O
bacterial	O
pathogens	O
in	O
their	O
natural	O
host	O
,	O
during	O
a	O
natural	O
infection	O
.	O

LaRocque	O
et	O
al	O
.	O
have	O
evaluated	O
the	O
transcriptome	O
of	O
Vibrio	B-Organism
cholerae	I-Organism
in	O
the	O
early	O
and	O
late	O
stages	O
of	O
the	O
disease	O
by	O
collecting	O
stools	O
of	O
naturally	O
infected	O
patients	B-Organism
[	O
22	O
]	O
.	O

Son	O
et	O
al	O
.	O
used	O
fresh	O
sputum	O
samples	O
from	O
a	O
patient	B-Organism
with	O
cystic	O
fibrosis	O
to	O
study	O
the	O
in	O
vivo	O
transcriptome	O
of	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
[	O
23	O
]	O
.	O

Additionally	O
,	O
Agarwal	O
et	O
al	O
.	O
used	O
a	O
custom	O
-	O
made	O
Fur	O
and	O
iron	O
regulon	O
microarray	O
to	O
investigate	O
the	O
expression	O
of	O
these	O
genes	O
during	O
gonococcal	O
infection	O
in	O
women	B-Organism
[	O
24	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
conducted	O
in	O
vivo	O
transcript	O
profiling	O
with	O
DNA	O
microarrays	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
during	O
the	O
acute	O
phase	O
of	O
a	O
natural	O
infection	O
in	O
pigs	B-Organism
.	O

Our	O
results	O
indicate	O
that	O
150	O
genes	O
are	O
differentially	O
expressed	O
during	O
the	O
acute	O
phase	O
of	O
infection	O
in	O
the	O
host	O
.	O

Of	O
these	O
,	O
72	O
were	O
up	O
-	O
regulated	O
,	O
and	O
three	O
of	O
these	O
encode	O
lipoproteins	O
or	O
OMPs	O
that	O
are	O
well	O
-	O
conserved	O
among	O
strains	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

Results	O
and	O
discussion	O
<EOS>	B-X
However	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
evaluated	B-X
the	B-X
perspectives	B-X
of	B-X
oncologists	B-X
on	B-X
the	B-X
current	B-X
state	B-X
of	B-X
this	B-X
discussion	B-X
.	B-X
Advance	B-X
care	B-X
planning	B-X
(	B-X
ACP	B-X
)	B-X
and	B-X
goals	B-X
of	B-X
care	B-X
discussions	B-X
are	B-X
important	B-X
instruments	B-X
that	B-X
enable	B-X
respect	B-X
for	B-X
patient	B-X
autonomy	B-X
,	B-X
especially	B-X
in	B-X
patients	B-X
with	B-X
a	B-X
life-threatening	B-X
disease	B-X
,	B-X
such	B-X
as	B-X
cancer	B-X
.	B-X
Despite	B-X
their	B-X
well-established	B-X
benefits	B-X
,	B-X
ACP	B-X
and	B-X
goals	B-X
of	B-X
care	B-X
discussions	B-X
are	B-X
still	B-X
not	B-X
frequently	B-X
performed	B-X
in	B-X
clinical	B-X
oncology	B-X
practice	B-X
.	B-X
Each	B-X
group	B-X
had	B-X
two	B-X
discussion	B-X
leaders	B-X
.	B-X
All	B-X
discussions	B-X
were	B-X
digitally	B-X
recorded	B-X
for	B-X
accuracy	B-X
.	B-X
After	B-X
discussion	B-X
all	B-X
groups	B-X
reconvened	B-X
and	B-X
reported	B-X
summaries	B-X
of	B-X
discussions	B-X
and	B-X
recommendations	B-X
to	B-X
ensure	B-X
group	B-X
agreement	B-X
.	B-X

Animal	O
samples	O
While	O
working	O
with	O
samples	O
from	O
commercial	O
herds	O
means	O
that	O
we	O
are	O
working	O
with	O
disease	O
cases	O
that	O
are	O
representative	O
of	O
what	O
is	O
really	O
happening	O
in	O
the	O
field	O
,	O
it	O
also	O
means	O
that	O
limited	O
amounts	O
of	O
material	O
is	O
available	O
.	O

During	O
the	O
course	O
of	O
our	O
experiments	O
,	O
we	O
were	O
able	O
to	O
collect	O
samples	O
from	O
three	O
different	O
animals	O
from	O
the	O
same	O
herd	O
,	O
before	O
antibiotherapy	O
was	O
undertaken	O
to	O
eradicate	O
the	O
infection	O
.	O

All	O
the	O
animals	O
that	O
were	O
sampled	O
had	O
presented	O
symptoms	O
of	O
the	O
disease	O
for	O
less	O
than	O
24	O
h	O
.	O
<EOS>	B-X
Particulate	B-X
matter	B-X
with	B-X
10	B-X
μm	B-X
or	B-X
less	B-X
in	B-X
diameter	B-X
(	B-X
PM	B-X
A	B-X
sensitive	B-X
bioassay	B-X
for	B-X
the	B-X
measurement	B-X
of	B-X
plasma	B-X
ACTH	B-X
is	B-X
presented	B-X
.	B-X
The	B-X
use	B-X
of	B-X
silicic	B-X
acid	B-X
adsorption	B-X
of	B-X
plasma	B-X
,	B-X
with	B-X
a	B-X
subsequent	B-X
acid	B-X
wash	B-X
and	B-X
aqueous	B-X
acetone	B-X
desorption	B-X
,	B-X
was	B-X
successful	B-X
in	B-X
removing	B-X
those	B-X
substances	B-X
which	B-X
had	B-X
interfered	B-X
with	B-X
the	B-X
steroidogenic	B-X
response	B-X
of	B-X
dispersed	B-X
adrenal	B-X
cells	B-X
when	B-X
unextracted	B-X
plasma	B-X
was	B-X
employed	B-X
.	B-X
This	B-X
extraction	B-X
procedure	B-X
extracted	B-X
72-76	B-X
%	B-X
of	B-X
ACTH	B-X
present	B-X
in	B-X
plasma	B-X
.	B-X
Alpha-hACTH1-39	B-X
and	B-X
alpha-pACTH1-39	B-X
exhibited	B-X
equal	B-X
potencies	B-X
.	B-X
One	B-X
x	B-X
10	B-X
(	B-X
8	B-X
)	B-X
pg	B-X
of	B-X
ACTH1-10	B-X
,	B-X
ACTH4-10	B-X
,	B-X
or	B-X
alpha-MSH	B-X
had	B-X
a	B-X
steroidogenic	B-X
effect	B-X
equivalent	B-X
to	B-X
that	B-X
of	B-X
40	B-X
pg	B-X
ACTH1-39	B-X
.	B-X
ACTH	B-X
17-39	B-X
and	B-X
ACTH	B-X
11-24	B-X
were	B-X
incapable	B-X
of	B-X
stimulating	B-X
steroid	B-X
production	B-X
at	B-X
doses	B-X
of	B-X
1	B-X
x	B-X
10	B-X
(	B-X
8	B-X
)	B-X
pg	B-X
.	B-X
Excesses	B-X
of	B-X
the	B-X
latter	B-X
,	B-X
but	B-X
not	B-X
of	B-X
the	B-X
former	B-X
appeared	B-X
to	B-X
be	B-X
able	B-X
to	B-X
antagonize	B-X
the	B-X
steroidogenic	B-X
effect	B-X
of	B-X
ACTH1-39	B-X
.	B-X
Plasma	B-X
from	B-X
normal	B-X
subjects	B-X
,	B-X
bioassayed	B-X
by	B-X
this	B-X
extraction	B-X
procedure	B-X
,	B-X
contained	B-X
12-186	B-X
pg/ml	B-X
ACTH	B-X
at	B-X
0400-0800	B-X
:	B-X
14-93	B-X
pg/ml	B-X
ACTH	B-X
at	B-X
1000-1300	B-X
,	B-X
and	B-X
less	B-X
than	B-X
10-34	B-X
pg/ml	B-X
ACTH	B-X
at	B-X
1600-2200	B-X
.	B-X
Plasma	B-X
ACTH	B-X
concentrations	B-X
in	B-X
untreated	B-X
patients	B-X
with	B-X
Cushing	B-X
's	B-X
disease	B-X
(	B-X
sampled	B-X
over	B-X
the	B-X
period	B-X
0900-1300	B-X
)	B-X
ranged	B-X
from	B-X
65-220	B-X
pg/ml	B-X
.	B-X
Three	B-X
patients	B-X
with	B-X
Addison	B-X
's	B-X
disease	B-X
(	B-X
untreated	B-X
or	B-X
12	B-X
h	B-X
following	B-X
replacement	B-X
steroid	B-X
withdrawal	B-X
)	B-X
had	B-X
ACTH	B-X
concentrations	B-X
of	B-X
223	B-X
,	B-X
370	B-X
and	B-X
1226	B-X
pg/ml	B-X
.	B-X
Markedly	B-X
elevated	B-X
ACTH	B-X
concentrations	B-X
were	B-X
observed	B-X
in	B-X
a	B-X
patient	B-X
with	B-X
Nelson	B-X
's	B-X
syndrome	B-X
(	B-X
391	B-X
and	B-X
835	B-X
pg/ml	B-X
)	B-X
.	B-X
Bioassayable	B-X
ACTH	B-X
was	B-X
not	B-X
detected	B-X
in	B-X
2	B-X
patients	B-X
with	B-X
panhypopituitarism	B-X
.	B-X

Two	O
animals	O
died	O
as	O
a	O
result	O
of	O
the	O
infection	O
,	O
and	O
were	O
sampled	O
a	O
few	O
hours	O
after	O
death	O
.	O

Those	O
samples	O
were	O
not	O
used	O
for	O
the	O
microarray	O
experiments	O
since	O
significant	O
transcriptomic	O
changes	O
might	O
have	O
occurred	O
between	O
the	O
time	O
of	O
death	O
and	O
the	O
time	O
of	O
sampling	O
.	O
<EOS>	B-X
The	B-X
aim	B-X
of	B-X
post-mortem	B-X
toxicology	B-X
is	B-X
to	B-X
help	B-X
establish	B-X
the	B-X
role	B-X
that	B-X
drugs	B-X
or	B-X
other	B-X
poisons	B-X
played	B-X
in	B-X
a	B-X
death	B-X
,	B-X
or	B-X
in	B-X
events	B-X
immediately	B-X
before	B-X
death	B-X
.	B-X
If	B-X
the	B-X
cause	B-X
of	B-X
death	B-X
is	B-X
not	B-X
immediately	B-X
obvious	B-X
,	B-X
however	B-X
,	B-X
then	B-X
suspicion	B-X
of	B-X
possible	B-X
poisoning	B-X
is	B-X
of	B-X
course	B-X
crucial	B-X
.	B-X
Blood	B-X
sampling	B-X
(	B-X
needle	B-X
aspiration	B-X
,	B-X
peripheral	B-X
vein	B-X
,	B-X
e.g	B-X
.	B-X
The	B-X
site	B-X
of	B-X
blood	B-X
sampling	B-X
should	B-X
always	B-X
be	B-X
recorded	B-X
.	B-X
The	B-X
availability	B-X
of	B-X
ante-mortem	B-X
specimens	B-X
should	B-X
not	B-X
preclude	B-X
post-mortem	B-X
sampling	B-X
.	B-X
Interpretation	B-X
of	B-X
post-mortem	B-X
toxicology	B-X
must	B-X
take	B-X
into	B-X
account	B-X
what	B-X
is	B-X
known	B-X
of	B-X
the	B-X
clinical	B-X
pharmacology	B-X
,	B-X
including	B-X
pharmacokinetics	B-X
,	B-X
and	B-X
toxicology	B-X
of	B-X
the	B-X
agent	B-X
(	B-X
s	B-X
)	B-X
in	B-X
question	B-X
,	B-X
the	B-X
circumstances	B-X
under	B-X
which	B-X
death	B-X
occurred	B-X
including	B-X
the	B-X
possible	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
of	B-X
exposure	B-X
,	B-X
and	B-X
other	B-X
factors	B-X
such	B-X
as	B-X
the	B-X
sample	B-X
(	B-X
s	B-X
)	B-X
analysed	B-X
and	B-X
the	B-X
analytical	B-X
methods	B-X
used	B-X
.	B-X
However	B-X
,	B-X
we	B-X
now	B-X
know	B-X
that	B-X
changes	B-X
may	B-X
occur	B-X
in	B-X
the	B-X
composition	B-X
of	B-X
body	B-X
fluids	B-X
,	B-X
even	B-X
peripheral	B-X
blood	B-X
,	B-X
after	B-X
death	B-X
.	B-X
Such	B-X
changes	B-X
are	B-X
likely	B-X
to	B-X
be	B-X
greater	B-X
with	B-X
centrally-acting	B-X
drugs	B-X
such	B-X
as	B-X
clozapine	B-X
with	B-X
large	B-X
volumes	B-X
of	B-X
distribution	B-X
,	B-X
and	B-X
may	B-X
perhaps	B-X
be	B-X
minimised	B-X
by	B-X
prompt	B-X
refrigeration	B-X
of	B-X
the	B-X
body	B-X
and	B-X
performing	B-X
the	B-X
autopsy	B-X
quickly	B-X
.	B-X

However	O
,	O
preliminary	O
microscopic	O
observations	O
were	O
made	O
and	O
our	O
RNA	O
extraction	O
protocol	O
was	O
tested	O
with	O
those	O
samples	O
.	O

The	O
last	O
animal	O
was	O
euthanized	O
on	O
site	O
by	O
a	O
veterinarian	O
,	O
and	O
sampled	O
less	O
than	O
5	O
minutes	O
after	O
death	O
.	O

The	O
infectious	O
field	O
strain	O
was	O
isolated	O
from	O
this	O
animal	O
.	O
<EOS>	B-X
In	B-X
recent	B-X
years	B-X
,	B-X
acute	B-X
severe	B-X
outbreaks	B-X
of	B-X
infectious	B-X
bursal	B-X
disease	B-X
(	B-X
IBD	B-X
)	B-X
are	B-X
frequently	B-X
observed	B-X
in	B-X
commercial	B-X
chicken	B-X
populations	B-X
of	B-X
the	B-X
North	B-X
East	B-X
Region	B-X
(	B-X
NER	B-X
)	B-X
of	B-X
India	B-X
,	B-X
resulting	B-X
in	B-X
huge	B-X
economic	B-X
loses	B-X
to	B-X
poultry	B-X
farmers	B-X
.	B-X
Nucleotide	B-X
sequences	B-X
,	B-X
deduced	B-X
amino	B-X
acid	B-X
sequences	B-X
,	B-X
and	B-X
phylogenetic	B-X
analysis	B-X
of	B-X
both	B-X
VP2	B-X
and	B-X
VP1	B-X
genes	B-X
revealed	B-X
two	B-X
genetically	B-X
diverse	B-X
strains	B-X
of	B-X
very	B-X
virulent	B-X
IBDV	B-X
(	B-X
vvIBDV	B-X
)	B-X
and	B-X
one	B-X
intermediate	B-X
strain	B-X
circulating	B-X
in	B-X
the	B-X
NER	B-X
.	B-X
Interestingly	B-X
,	B-X
one	B-X
of	B-X
the	B-X
isolates	B-X
showed	B-X
99	B-X
%	B-X
sequence	B-X
homology	B-X
with	B-X
attenuated	B-X
vaccine	B-X
strains	B-X
in	B-X
the	B-X
VP2	B-X
gene	B-X
and	B-X
clustered	B-X
together	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
the	B-X
diversity	B-X
of	B-X
IBDVs	B-X
in	B-X
India	B-X
and	B-X
document	B-X
for	B-X
the	B-X
first	B-X
time	B-X
the	B-X
possible	B-X
involvement	B-X
of	B-X
attenuated	B-X
vaccine	B-X
strains	B-X
in	B-X
the	B-X
epidemiology	B-X
of	B-X
IBD	B-X
in	B-X
India	B-X
.	B-X

While	O
it	O
can	O
be	O
argued	O
that	O
different	O
animals	O
might	O
react	O
differently	O
to	O
an	O
infection	O
by	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
and	O
therefore	O
elicit	O
different	O
transcriptional	O
changes	O
in	O
the	O
pathogen	O
,	O
we	O
are	O
confident	O
that	O
the	O
results	O
that	O
were	O
obtained	O
reflect	O
accurately	O
the	O
conditions	O
encountered	O
by	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
in	O
its	O
natural	O
host	O
following	O
acute	O
infection	O
.	O

Macroscopic	O
and	O
microscopic	O
observations	O
<EOS>	B-X
This	B-X
study	B-X
provides	B-X
macroscopic	B-X
and	B-X
microscopic	B-X
observations	B-X
of	B-X
needle-gel	B-X
interactions	B-X
.	B-X
The	B-X
needle	B-X
tip	B-X
and	B-X
gel	B-X
interactions	B-X
are	B-X
observed	B-X
using	B-X
confocal	B-X
microscopic	B-X
images	B-X
.	B-X
These	B-X
variations	B-X
are	B-X
due	B-X
to	B-X
the	B-X
coupling	B-X
between	B-X
gel	B-X
rupture	B-X
and	B-X
tip	B-X
compression	B-X
interactions	B-X
,	B-X
which	B-X
are	B-X
observed	B-X
during	B-X
microscopic	B-X
studies	B-X
.	B-X
Because	B-X
of	B-X
the	B-X
advantages	B-X
in	B-X
specificity	B-X
,	B-X
sensitivity	B-X
,	B-X
high	B-X
throughput	B-X
,	B-X
and	B-X
cost-effectiveness	B-X
,	B-X
optical	B-X
imaging	B-X
(	B-X
OI	B-X
)	B-X
approaches	B-X
,	B-X
including	B-X
optical	B-X
microscopic	B-X
imaging	B-X
and	B-X
macroscopic	B-X
imaging	B-X
techniques	B-X
have	B-X
also	B-X
been	B-X
applied	B-X
in	B-X
the	B-X
studies	B-X
of	B-X
NPs	B-X
.	B-X
Optical	B-X
microscopic	B-X
imaging	B-X
can	B-X
observe	B-X
NPs	B-X
as	B-X
cancer	B-X
therapeutics	B-X
at	B-X
the	B-X
cellular	B-X
level	B-X
and	B-X
analyze	B-X
its	B-X
cytotoxicity	B-X
and	B-X
mechanism	B-X
of	B-X
action	B-X
.	B-X

Clinical	O
signs	O
and	O
macroscopic	O
and	O
microscopic	O
examinations	O
were	O
consistent	O
with	O
acute	O
porcine	O
pleuropneumonia	O
.	O

Clinical	O
signs	O
ranged	O
from	O
depression	O
to	O
respiratory	O
distress	O
,	O
while	O
macroscopic	O
observation	O
of	O
deceased	O
pigs	B-Organism
revealed	O
lobar	O
fibrinohemorrhagic	O
pleuropneumonia	O
,	O
along	O
with	O
necrotic	O
lesions	O
and	O
the	O
accumulation	O
of	O
bloody	O
fluid	O
in	O
the	O
thorax	O
.	O

On	O
microscopic	O
examination	O
,	O
multiple	O
pulmonary	O
necrotic	O
areas	O
surrounded	O
by	O
or	O
containing	O
oat	B-Organism
cells	O
were	O
present	O
,	O
as	O
well	O
as	O
fibrin	O
accumulation	O
in	O
the	O
alveolar	O
lumen	O
,	O
interlobular	O
septa	O
and	O
pleura	O
(	O
Figure	O
1	O
)	O
.	O
<EOS>	B-X
We	B-X
reported	B-X
a	B-X
case	B-X
of	B-X
cervico-mediastinal	B-X
tuberculous	B-X
lymphadenitis	B-X
followed	B-X
by	B-X
the	B-X
development	B-X
of	B-X
pulmonary	B-X
lesions	B-X
and	B-X
recurrent	B-X
laryngeal	B-X
nerve	B-X
palsy	B-X
.	B-X
Chest	B-X
computed	B-X
tomography	B-X
showed	B-X
multiple	B-X
swollen	B-X
mediastinal	B-X
lymph	B-X
nodes	B-X
,	B-X
including	B-X
multiple	B-X
low-density	B-X
areas	B-X
and	B-X
contrast	B-X
medium-enhanced	B-X
septa	B-X
and	B-X
margins	B-X
.	B-X
Microscopic	B-X
examination	B-X
of	B-X
the	B-X
biopsy	B-X
specimen	B-X
revealed	B-X
acid-fast	B-X
bacilli	B-X
and	B-X
granuloma	B-X
with	B-X
central	B-X
caseous	B-X
necrosis	B-X
surrounded	B-X
by	B-X
Langhans	B-X
'	B-X
giant	B-X
cells	B-X
and	B-X
epithelioid	B-X
cells	B-X
.	B-X
Because	B-X
the	B-X
incidence	B-X
of	B-X
tuberculosis	B-X
in	B-X
Japan	B-X
is	B-X
gradually	B-X
increasing	B-X
among	B-X
young	B-X
people	B-X
as	B-X
well	B-X
as	B-X
the	B-X
elderly	B-X
,	B-X
the	B-X
differential	B-X
diagnosis	B-X
of	B-X
this	B-X
disease	B-X
will	B-X
become	B-X
more	B-X
necessary	B-X
.	B-X

The	O
infectious	O
field	O
strain	O
that	O
was	O
isolated	O
from	O
the	O
lung	O
tissues	O
was	O
named	O
896	O
-	O
07	O
,	O
and	O
serotyping	O
analysis	O
showed	O
that	O
it	O
belongs	O
to	O
serotype	B-Organism
5b	I-Organism
,	O
one	O
of	O
the	O
most	O
prevalent	O
in	O
North	O
America	O
[	O
4	O
]	O
.	O

Comparative	O
genomic	O
hybridizations	O
<EOS>	B-X
In	B-X
2004	B-X
,	B-X
the	B-X
implementation	B-X
of	B-X
array	B-X
comparative	B-X
genomic	B-X
hybridization	B-X
(	B-X
array	B-X
comparative	B-X
genome	B-X
hybridization	B-X
[	B-X
CGH	B-X
]	B-X
)	B-X
into	B-X
clinical	B-X
practice	B-X
marked	B-X
a	B-X
new	B-X
milestone	B-X
for	B-X
genetic	B-X
diagnosis	B-X
.	B-X
In	B-X
the	B-X
past	B-X
two	B-X
decades	B-X
,	B-X
comparative	B-X
genomic	B-X
hybridization	B-X
(	B-X
CGH	B-X
)	B-X
and	B-X
array	B-X
CGH	B-X
have	B-X
become	B-X
indispensable	B-X
tools	B-X
in	B-X
clinical	B-X
diagnostics	B-X
and	B-X
toxicological	B-X
risk	B-X
assessment	B-X
.	B-X
Initially	B-X
developed	B-X
for	B-X
the	B-X
genome-wide	B-X
screening	B-X
of	B-X
chromosomal	B-X
imbalances	B-X
,	B-X
that	B-X
is	B-X
,	B-X
copy-number	B-X
variations	B-X
in	B-X
tumor	B-X
cells	B-X
,	B-X
both	B-X
CGH	B-X
and	B-X
array	B-X
CGH	B-X
have	B-X
been	B-X
employed	B-X
in	B-X
genotoxicology	B-X
and	B-X
most	B-X
recently	B-X
in	B-X
toxicogenomics	B-X
.	B-X
As	B-X
toxicogenomics	B-X
is	B-X
an	B-X
emerging	B-X
sub-discipline	B-X
of	B-X
toxicology	B-X
research	B-X
,	B-X
effectively	B-X
evaluating	B-X
toxicogenomic	B-X
microarray	B-X
data	B-X
can	B-X
be	B-X
hugely	B-X
advantageous	B-X
for	B-X
human	B-X
risk	B-X
assessment	B-X
,	B-X
even	B-X
though	B-X
international	B-X
regulatory	B-X
guidelines	B-X
on	B-X
toxicogenomics	B-X
have	B-X
yet	B-X
to	B-X
be	B-X
fully	B-X
agreed	B-X
and	B-X
implemented	B-X
.	B-X

CGH	O
experiments	O
conducted	O
previously	O
in	O
our	O
laboratory	O
have	O
shown	O
that	O
the	O
majority	O
of	O
genes	O
in	O
the	O
reference	O
5b	B-Organism
L20	I-Organism
strain	O
were	O
conserved	O
in	O
reference	O
strains	O
and	O
fresh	O
field	O
isolates	O
.	O

Conversely	O
,	O
205	O
genes	O
were	O
identified	O
as	O
divergent	O
in	O
at	O
least	O
one	O
strain	O
,	O
including	O
39	O
that	O
are	O
either	O
phage	O
or	O
transposon	O
related	O
out	O
of	O
the	O
2033	O
ORFs	O
represented	O
on	O
the	O
microarray	O
,	O
which	O
represents	O
10	O
.	O
1	O
%	O
of	O
divergent	O
genes	O
[	O
25	O
]	O
.	O

As	O
anticipated	O
,	O
clusters	O
of	O
genes	O
associated	O
with	O
LPS	O
/	O
capsule	O
biosynthesis	O
and	O
toxin	O
production	O
showed	O
variations	O
.	O

AppChip2	B-Organism
was	O
designed	O
using	O
the	O
complete	O
genome	O
sequence	O
from	O
the	O
serotype	B-Organism
5b	I-Organism
reference	I-Organism
strain	I-Organism
L20	I-Organism
.	O

In	O
order	O
to	O
validate	O
its	O
use	O
to	O
assess	O
transcriptomic	O
events	O
taking	O
place	O
with	O
our	O
infectious	O
field	O
strain	O
during	O
the	O
infection	O
,	O
we	O
first	O
used	O
it	O
to	O
analyze	O
the	O
gene	O
content	O
of	O
the	O
896	B-Organism
-	I-Organism
07	I-Organism
field	O
strain	O
.	O

The	O
CGH	O
data	O
obtained	O
with	O
strain	O
896	B-Organism
-	I-Organism
07	I-Organism
was	O
added	O
to	O
that	O
obtained	O
with	O
other	O
field	O
and	O
reference	O
strains	O
[	O
25	O
]	O
in	O
order	O
to	O
generate	O
a	O
strain	O
dendogram	O
(	O
Figure	O
2	O
)	O
.	O

Serotyping	O
data	O
correlates	O
well	O
with	O
genetic	O
data	O
since	O
strain	O
896	B-Organism
-	I-Organism
07	I-Organism
forms	O
a	O
cluster	O
with	O
the	O
serotype	B-Organism
5b	I-Organism
reference	I-Organism
strain	I-Organism
L20	I-Organism
.	O

The	O
same	O
clusters	O
as	O
those	O
observed	O
previously	O
could	O
be	O
found	O
in	O
our	O
dendrogram	O
[	O
25	O
]	O
.	O
<EOS>	B-X
Previously	B-X
,	B-X
the	B-X
resulting	B-X
patterns	B-X
were	B-X
analyzed	B-X
using	B-X
the	B-X
Hopkins	B-X
statistic	B-X
,	B-X
which	B-X
distinguishes	B-X
nonclustered	B-X
from	B-X
modestly	B-X
and	B-X
highly	B-X
clustered	B-X
distributions	B-X
,	B-X
but	B-X
is	B-X
not	B-X
designed	B-X
to	B-X
quantify	B-X
the	B-X
number	B-X
or	B-X
sizes	B-X
of	B-X
the	B-X
clusters	B-X
.	B-X
An	B-X
intrinsic	B-X
distance	B-X
is	B-X
computed	B-X
,	B-X
which	B-X
is	B-X
the	B-X
distance	B-X
that	B-X
produces	B-X
the	B-X
maximum	B-X
number	B-X
of	B-X
clusters	B-X
in	B-X
the	B-X
biological	B-X
data	B-X
,	B-X
eliminating	B-X
the	B-X
need	B-X
to	B-X
choose	B-X
a	B-X
distance	B-X
.	B-X
Replacing	B-X
the	B-X
chosen	B-X
cluster	B-X
distance	B-X
by	B-X
the	B-X
intrinsic	B-X
clustering	B-X
distance	B-X
emphasizes	B-X
densely	B-X
packed	B-X
clusters	B-X
that	B-X
are	B-X
likely	B-X
more	B-X
important	B-X
to	B-X
downstream	B-X
signaling	B-X
events.We	B-X
test	B-X
our	B-X
new	B-X
clustering	B-X
analysis	B-X
approach	B-X
against	B-X
electron	B-X
microscopy	B-X
images	B-X
from	B-X
an	B-X
experiment	B-X
in	B-X
which	B-X
mast	B-X
cells	B-X
were	B-X
exposed	B-X
for	B-X
1	B-X
or	B-X
2	B-X
minutes	B-X
to	B-X
increasing	B-X
concentrations	B-X
of	B-X
antigen	B-X
that	B-X
crosslink	B-X
IgE	B-X
bound	B-X
to	B-X
its	B-X
high	B-X
affinity	B-X
receptor	B-X
,	B-X
FcϵRI	B-X
,	B-X
then	B-X
fixed	B-X
and	B-X
the	B-X
FcϵRI	B-X
β	B-X
subunit	B-X
labeled	B-X
with	B-X
5	B-X
nm	B-X
gold	B-X
particles	B-X
.	B-X
However	B-X
,	B-X
microsatellites	B-X
are	B-X
not	B-X
always	B-X
available	B-X
for	B-X
the	B-X
species	B-X
to	B-X
be	B-X
studied	B-X
and	B-X
their	B-X
isolation	B-X
could	B-X
be	B-X
time-	B-X
and	B-X
cost-consuming	B-X
.	B-X
To	B-X
investigate	B-X
transferability	B-X
in	B-X
cross-species	B-X
applications	B-X
,	B-X
102	B-X
primer	B-X
pairs	B-X
previously	B-X
developed	B-X
in	B-X
ryegrass	B-X
and	B-X
tall	B-X
fescue	B-X
were	B-X
amplified	B-X
across	B-X
three	B-X
allogamous	B-X
ryegrass	B-X
species	B-X
including	B-X
Lolium	B-X
rigidum	B-X
,	B-X
Lolium	B-X
perenne	B-X
and	B-X
Lolium	B-X
multiflorum	B-X
.	B-X
The	B-X
mean	B-X
polymorphism	B-X
information	B-X
content	B-X
(	B-X
PIC	B-X
)	B-X
and	B-X
observed	B-X
heterozygosity	B-X
(	B-X
Ho	B-X
)	B-X
values	B-X
at	B-X
genus	B-X
was	B-X
0.5532	B-X
and	B-X
0.5423	B-X
,	B-X
respectively	B-X
.	B-X
Also	B-X
,	B-X
the	B-X
unweighted	B-X
pair	B-X
group	B-X
method	B-X
with	B-X
arithmetic	B-X
averaging	B-X
dendrogram	B-X
(	B-X
UPGMA	B-X
)	B-X
,	B-X
Bayesian	B-X
model-based	B-X
STRUCTURE	B-X
analysis	B-X
and	B-X
the	B-X
principal	B-X
coordinate	B-X
analysis	B-X
(	B-X
PCoA	B-X
)	B-X
showed	B-X
that	B-X
accessions	B-X
within	B-X
species	B-X
always	B-X
tended	B-X
to	B-X
the	B-X
same	B-X
cluster	B-X
firstly	B-X
and	B-X
then	B-X
to	B-X
related	B-X
species	B-X
.	B-X

Only	O
28	O
genes	O
were	O
identified	O
as	O
divergent	O
/	O
absent	O
in	O
our	O
field	O
strain	O
,	O
when	O
compared	O
to	O
the	O
reference	O
serotype	O
5b	B-Organism
L20	I-Organism
strain	O
(	O
Table	O
1	O
)	O
.	O

This	O
represents	O
only	O
1	O
.	O
43	O
%	O
of	O
all	O
the	O
genes	O
(	O
1954	O
)	O
that	O
are	O
represented	O
on	O
AppChip2	B-Organism
[	O
25	O
]	O
.	O

Out	O
of	O
these	O
28	O
genes	O
,	O
20	O
can	O
be	O
found	O
in	O
two	O
major	O
regions	O
of	O
the	O
genome	O
:	O
14	O
putative	O
ORFs	O
code	O
for	O
phage	O
structures	O
,	O
while	O
6	O
are	O
located	O
in	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
tight	O
adherence	O
(	O
tad	O
)	O
locus	O
.	O

In	O
Aggregatibacter	B-Organism
actinomycetemcomitans	I-Organism
,	O
a	O
close	O
relative	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
the	O
tad	O
locus	O
is	O
involved	O
in	O
adherence	O
to	O
biological	O
and	O
abiological	O
surfaces	O
[	O
26	O
]	O
.	O

In	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
genes	O
from	O
this	O
locus	O
were	O
shown	O
to	O
be	O
up	O
-	O
regulated	O
during	O
adhesion	O
to	O
lung	O
epithelial	O
cells	O
in	O
vitro	O
[	O
9	O
]	O
.	O

The	O
other	O
important	O
locus	O
for	O
gene	O
divergence	O
/	O
absence	O
was	O
composed	O
of	O
phage	O
-	O
related	O
features	O
,	O
and	O
these	O
were	O
shown	O
to	O
be	O
divergent	O
during	O
inter	O
and	O
intra	O
-	O
serotype	O
comparisons	O
in	O
previous	O
experiments	O
[	O
25	O
]	O
.	O

Some	O
genes	O
might	O
also	O
be	O
present	O
in	O
the	O
genome	O
of	O
strain	O
896	B-Organism
-	I-Organism
07	I-Organism
and	O
absent	O
in	O
reference	O
strain	O
L20	B-Organism
,	O
and	O
therefore	O
absent	O
on	O
AppChip2	B-Organism
.	O

RNA	O
extraction	O
<EOS>	B-X
Extraction	B-X
of	B-X
DNA	B-X
,	B-X
RNA	B-X
,	B-X
and	B-X
protein	B-X
is	B-X
the	B-X
basic	B-X
method	B-X
used	B-X
in	B-X
molecular	B-X
biology	B-X
.	B-X
In	B-X
the	B-X
past	B-X
,	B-X
the	B-X
process	B-X
of	B-X
extraction	B-X
and	B-X
purification	B-X
of	B-X
nucleic	B-X
acids	B-X
used	B-X
to	B-X
be	B-X
complicated	B-X
,	B-X
time-consuming	B-X
,	B-X
labor-intensive	B-X
,	B-X
and	B-X
limited	B-X
in	B-X
terms	B-X
of	B-X
overall	B-X
throughput	B-X
.	B-X
Current	B-X
extraction	B-X
methods	B-X
often	B-X
extract	B-X
DNA	B-X
and	B-X
RNA	B-X
separately	B-X
,	B-X
and	B-X
few	B-X
methods	B-X
are	B-X
capable	B-X
of	B-X
co-extracting	B-X
DNA	B-X
and	B-X
RNA	B-X
from	B-X
sputum	B-X
.	B-X
We	B-X
established	B-X
a	B-X
nucleic	B-X
acid	B-X
co-extraction	B-X
method	B-X
from	B-X
sputum	B-X
based	B-X
on	B-X
magnetic	B-X
beads	B-X
and	B-X
optimized	B-X
the	B-X
method	B-X
by	B-X
evaluating	B-X
influencing	B-X
factors	B-X
,	B-X
such	B-X
as	B-X
the	B-X
guanidinium	B-X
thiocyanate	B-X
(	B-X
GTC	B-X
)	B-X
and	B-X
dithiothreitol	B-X
(	B-X
DTT	B-X
)	B-X
concentrations	B-X
,	B-X
magnetic	B-X
bead	B-X
amount	B-X
,	B-X
incubation	B-X
temperature	B-X
,	B-X
lysis	B-X
buffer	B-X
pH	B-X
and	B-X
RNA	B-X
carrier	B-X
type	B-X
.	B-X
The	B-X
feasibility	B-X
of	B-X
the	B-X
simultaneous	B-X
nucleic	B-X
acid	B-X
co-extraction	B-X
method	B-X
was	B-X
evaluated	B-X
by	B-X
amplifying	B-X
DNA	B-X
and	B-X
RNA	B-X
viruses	B-X
from	B-X
a	B-X
single	B-X
clinical	B-X
specimen	B-X
with	B-X
a	B-X
multiplex	B-X
RT-qPCR	B-X
method	B-X
.	B-X
Both	B-X
DNA	B-X
and	B-X
RNA	B-X
were	B-X
most	B-X
efficiently	B-X
extracted	B-X
when	B-X
the	B-X
GTC	B-X
and	B-X
DTT	B-X
concentrations	B-X
were	B-X
2.0	B-X
M	B-X
and	B-X
80	B-X
mM	B-X
,	B-X
respectively	B-X
,	B-X
20	B-X
μl	B-X
magnetic	B-X
beads	B-X
were	B-X
added	B-X
,	B-X
the	B-X
incubation	B-X
temperature	B-X
was	B-X
80	B-X
°C	B-X
,	B-X
the	B-X
pH	B-X
was	B-X
8	B-X
or	B-X
9	B-X
,	B-X
and	B-X
RNA	B-X
carrier	B-X
A	B-X
was	B-X
used	B-X
.	B-X
This	B-X
magnetic	B-X
beads-based	B-X
co-extraction	B-X
method	B-X
for	B-X
sputum	B-X
followed	B-X
by	B-X
a	B-X
multiplex	B-X
RT-qPCR	B-X
can	B-X
rapidly	B-X
and	B-X
precisely	B-X
detect	B-X
DNA	B-X
and	B-X
RNA	B-X
viruses	B-X
from	B-X
a	B-X
single	B-X
clinical	B-X
specimen	B-X
and	B-X
has	B-X
many	B-X
advantages	B-X
,	B-X
such	B-X
as	B-X
decreased	B-X
time	B-X
,	B-X
low	B-X
cost	B-X
,	B-X
and	B-X
a	B-X
lack	B-X
of	B-X
harmful	B-X
chemicals	B-X
.	B-X

Tissue	O
samples	O
were	O
taken	O
where	O
lung	O
lesions	O
were	O
present	O
to	O
ensure	O
that	O
bacterial	O
yields	O
would	O
be	O
optimal	O
.	O

A	O
beadbeating	O
step	O
was	O
performed	O
prior	O
to	O
a	O
standard	O
hot	O
acid	O
-	O
phenol	O
-	O
chloroform	O
RNA	O
extraction	O
protocol	O
to	O
extract	O
bacterial	O
RNA	O
from	O
infected	O
lung	O
tissues	O
.	O

Tissues	O
were	O
homogenized	O
with	O
1	O
.	O
0	O
mm	O
zirconia	O
/	O
silica	O
beads	O
to	O
release	O
but	O
not	O
lyse	O
bacterial	O
cells	O
from	O
the	O
tissue	O
.	O

This	O
size	O
of	O
beads	O
is	O
too	O
large	O
to	O
lyse	O
bacterial	O
cells	O
(	O
Biospec	O
,	O
personal	O
communication	O
)	O
.	O

Following	O
homogenization	O
,	O
serial	O
dilutions	O
of	O
the	O
resulting	O
supernatant	O
were	O
plated	O
in	O
order	O
to	O
determine	O
an	O
approximate	O
number	O
of	O
CFU	O
per	O
gram	O
of	O
tissue	O
.	O

Our	O
results	O
indicated	O
that	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
could	O
easily	O
be	O
isolated	O
in	O
pure	O
culture	O
from	O
lung	O
tissues	O
of	O
all	O
animals	O
,	O
and	O
that	O
the	O
number	O
of	O
CFU	O
varied	O
from	O
1	O
x	O
106	O
to	O
1	O
x	O
107	O
per	O
gram	O
of	O
infected	O
tissue	O
.	O

Centrifugation	O
of	O
homogenized	O
samples	O
enabled	O
the	O
removal	O
of	O
most	O
cellular	O
debris	O
and	O
the	O
recovery	O
of	O
bacteria	O
.	O

Approximately	O
20	O
to	O
45	O
mug	O
of	O
total	O
RNA	O
could	O
routinely	O
be	O
extracted	O
from	O
approximately	O
2	O
g	O
of	O
necrotic	O
lung	O
tissue	O
,	O
with	O
no	O
apparent	O
contamination	O
by	O
eukaryotic	O
RNA	O
,	O
as	O
observed	O
on	O
agarose	O
gel	O
when	O
using	O
bacterial	O
RNA	O
extracted	O
from	O
BHI	O
broth	O
and	O
eukaryotic	O
RNA	O
recovered	O
from	O
porcine	O
lung	O
epithelial	O
cells	O
(	O
SJPL	O
cell	O
line	O
)	O
[	O
27	O
]	O
as	O
on	O
-	O
gel	O
controls	O
(	O
data	O
not	O
shown	O
)	O
.	O

Nevertheless	O
,	O
the	O
MicrobENRICH	O
kit	O
was	O
still	O
used	O
to	O
remove	O
any	O
possible	O
trace	O
of	O
remaining	O
eukaryotic	O
RNA	O
,	O
and	O
treatments	O
with	O
TurboDNase	O
removed	O
traces	O
of	O
contaminating	O
DNA	O
.	O

No	O
trace	O
of	O
bacterial	O
or	O
host	O
DNA	O
could	O
be	O
detected	O
following	O
PCR	O
amplification	O
with	O
primers	O
for	O
gene	O
ompW	O
and	O
for	O
pig	B-Organism
mitochondrial	O
DNA	O
.	O
<EOS>	B-X
A	B-X
very	B-X
simple	B-X
and	B-X
rapid	B-X
method	B-X
for	B-X
extracting	B-X
genomic	B-X
DNA	B-X
from	B-X
Gram-negative	B-X
bacteria	B-X
,	B-X
Gram-positive	B-X
bacteria	B-X
and	B-X
yeasts	B-X
is	B-X
presented	B-X
.	B-X
In	B-X
this	B-X
method	B-X
,	B-X
bacteria	B-X
or	B-X
yeasts	B-X
are	B-X
lysed	B-X
directly	B-X
by	B-X
phenol	B-X
and	B-X
the	B-X
supernatant	B-X
is	B-X
extracted	B-X
with	B-X
chloroform	B-X
to	B-X
remove	B-X
traces	B-X
of	B-X
phenol	B-X
.	B-X
The	B-X
supernatant	B-X
contains	B-X
DNA	B-X
that	B-X
is	B-X
suitable	B-X
for	B-X
molecular	B-X
analyses	B-X
,	B-X
such	B-X
as	B-X
PCR	B-X
,	B-X
restriction	B-X
enzyme	B-X
digestion	B-X
and	B-X
genomic	B-X
library	B-X
construction	B-X
.	B-X
This	B-X
method	B-X
is	B-X
reproducible	B-X
and	B-X
simple	B-X
for	B-X
the	B-X
routine	B-X
DNA	B-X
extraction	B-X
from	B-X
bacteria	B-X
and	B-X
yeasts	B-X
.	B-X

We	O
propose	O
that	O
this	O
combination	O
of	O
techniques	O
could	O
prove	O
useful	O
in	O
isolating	O
pathogens	O
from	O
other	O
tissues	O
as	O
well	O
.	O

In	O
vivo	O
transcript	O
profiling	O
<EOS>	B-X
A	B-X
set	B-X
of	B-X
alternatively	B-X
processed	B-X
antisense	B-X
non-coding	B-X
transcripts	B-X
,	B-X
which	B-X
are	B-X
collectively	B-X
called	B-X
COOLAIR	B-X
,	B-X
are	B-X
generated	B-X
at	B-X
the	B-X
Arabidopsis	B-X
floral-repressor	B-X
locus	B-X
FLOWERING	B-X
LOCUS	B-X
C	B-X
(	B-X
FLC	B-X
)	B-X
The	B-X
dynamics	B-X
of	B-X
transcription	B-X
can	B-X
be	B-X
studied	B-X
genome	B-X
wide	B-X
by	B-X
high-throughput	B-X
sequencing	B-X
of	B-X
nascent	B-X
and	B-X
newly	B-X
synthesized	B-X
RNA	B-X
.	B-X
4-thiouridine	B-X
(	B-X
4SU	B-X
)	B-X
labeling	B-X
in	B-X
vivo	B-X
enables	B-X
the	B-X
specific	B-X
capture	B-X
of	B-X
such	B-X
new	B-X
transcripts	B-X
,	B-X
with	B-X
4SU	B-X
residues	B-X
being	B-X
tagged	B-X
by	B-X
biotin	B-X
linkers	B-X
and	B-X
captured	B-X
using	B-X
streptavidin	B-X
beads	B-X
before	B-X
library	B-X
production	B-X
and	B-X
high-throughput	B-X
sequencing	B-X
.	B-X
To	B-X
achieve	B-X
high-resolution	B-X
profiles	B-X
of	B-X
transcribed	B-X
regions	B-X
,	B-X
an	B-X
RNA	B-X
fragmentation	B-X
step	B-X
before	B-X
biotin	B-X
tagging	B-X
was	B-X
introduced	B-X
,	B-X
in	B-X
an	B-X
approach	B-X
known	B-X
as	B-X
transient	B-X
transcriptome	B-X
sequencing	B-X
(	B-X
TT-seq	B-X
)	B-X
.	B-X

Before	O
investigating	O
the	O
in	O
vivo	O
transcript	O
profile	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
we	O
used	O
self	O
-	O
self	O
hybridizations	O
in	O
order	O
to	O
quantifiy	O
the	O
dye	O
bias	O
effect	O
after	O
hybridization	O
on	O
AppChip2	B-Organism
.	O

Duplicate	O
experiments	O
showed	O
a	O
R2	O
correlation	O
factor	O
of	O
0	O
.	O
996	O
between	O
the	O
intensity	O
detected	O
for	O
the	O
Cy3	O
labelled	O
and	O
Cy5	O
labelled	O
probes	O
,	O
and	O
only	O
two	O
genes	O
seemed	O
to	O
qualify	O
as	O
obvious	O
outliers	O
(	O
data	O
not	O
shown	O
)	O
.	O

Both	O
genes	O
,	O
APL	O
_	O
1141	O
and	O
APL	O
_	O
0484	O
,	O
were	O
not	O
identified	O
as	O
differentially	O
expressed	O
during	O
the	O
course	O
of	O
a	O
natural	O
infection	O
.	O

While	O
designing	O
the	O
microarray	O
experiments	O
,	O
growth	O
in	O
BHI	O
medium	O
to	O
an	O
optical	O
density	O
of	O
0	O
.	O
3	O
at	O
a	O
600	O
nm	O
wavelenght	O
was	O
chosen	O
as	O
our	O
reference	O
condition	O
.	O

This	O
condition	O
was	O
not	O
only	O
chosen	O
for	O
practical	O
reasons	O
,	O
but	O
also	O
to	O
fulfill	O
two	O
precise	O
objectives	O
:	O
first	O
,	O
to	O
allow	O
for	O
the	O
identification	O
of	O
genes	O
that	O
,	O
while	O
important	O
to	O
the	O
infection	O
process	O
,	O
have	O
not	O
been	O
identified	O
previously	O
in	O
vitro	O
in	O
rich	O
medium	O
,	O
and	O
second	O
,	O
to	O
allow	O
comparison	O
of	O
the	O
results	O
obtained	O
in	O
vivo	O
to	O
those	O
obtained	O
in	O
our	O
laboratory	O
in	O
other	O
growth	O
conditions	O
by	O
keeping	O
the	O
same	O
reference	O
[	O
28	O
-	O
30	O
]	O
.	O
<EOS>	B-X
Anemia	B-X
is	B-X
quite	B-X
frequently	B-X
diagnosed	B-X
in	B-X
older	B-X
individuals	B-X
and	B-X
is	B-X
a	B-X
key	B-X
indicator	B-X
of	B-X
various	B-X
reactive	B-X
and	B-X
clonal	B-X
conditions	B-X
.	B-X
The	B-X
etiology	B-X
of	B-X
anemia	B-X
at	B-X
older	B-X
age	B-X
is	B-X
complex	B-X
and	B-X
ranges	B-X
from	B-X
bone	B-X
marrow	B-X
failure	B-X
syndromes	B-X
to	B-X
chronic	B-X
kidney	B-X
disease	B-X
,	B-X
and	B-X
from	B-X
nutritional	B-X
deficiencies	B-X
to	B-X
inflammatory	B-X
processes	B-X
including	B-X
inflammaging	B-X
in	B-X
immunosenescence	B-X
.	B-X
In	B-X
a	B-X
smaller	B-X
number	B-X
of	B-X
cases	B-X
,	B-X
no	B-X
clear-cut	B-X
etiology	B-X
is	B-X
identified	B-X
.	B-X
In	B-X
others	B-X
,	B-X
somatic	B-X
mutations	B-X
in	B-X
leukocytes	B-X
are	B-X
found	B-X
,	B-X
but	B-X
diagnostic	B-X
criteria	B-X
for	B-X
MDS	B-X
or	B-X
other	B-X
hematologic	B-X
diseases	B-X
are	B-X
not	B-X
fulfilled	B-X
,	B-X
a	B-X
condition	B-X
termed	B-X
clonal	B-X
cytopenia	B-X
of	B-X
undetermined	B-X
significance	B-X
.	B-X
Management	B-X
of	B-X
anemias	B-X
at	B-X
older	B-X
age	B-X
depends	B-X
on	B-X
(	B-X
1	B-X
)	B-X
the	B-X
severity	B-X
of	B-X
the	B-X
anemia	B-X
,	B-X
(	B-X
2	B-X
)	B-X
underlying	B-X
condition	B-X
(	B-X
s	B-X
)	B-X
,	B-X
and	B-X
(	B-X
3	B-X
)	B-X
patient-related	B-X
factors	B-X
,	B-X
including	B-X
comorbidities	B-X
.	B-X

Working	O
with	O
a	O
limited	O
amount	O
of	O
biological	O
material	O
meant	O
that	O
only	O
one	O
time	O
-	O
point	O
in	O
the	O
infection	O
could	O
be	O
investigated	O
.	O

In	O
the	O
acute	O
stage	O
of	O
porcine	O
pleuropneumonia	O
,	O
bacteria	O
are	O
likely	O
in	O
the	O
exponential	O
phase	O
of	O
growth	O
.	O

This	O
is	O
also	O
the	O
case	O
in	O
the	O
control	O
condition	O
.	O
<EOS>	B-X
Treatment	B-X
concepts	B-X
for	B-X
peri-implantitis	B-X
were	B-X
briefly	B-X
reviewed	B-X
,	B-X
and	B-X
prevention	B-X
of	B-X
the	B-X
condition	B-X
was	B-X
brought	B-X
to	B-X
attention	B-X
as	B-X
a	B-X
priority	B-X
in	B-X
implant	B-X
dentistry	B-X
.	B-X
The	B-X
overview	B-X
also	B-X
highlighted	B-X
the	B-X
2017	B-X
World	B-X
Workshop	B-X
on	B-X
Classification	B-X
of	B-X
Periodontal	B-X
and	B-X
Peri-implant	B-X
diseases	B-X
and	B-X
Conditions	B-X
,	B-X
in	B-X
which	B-X
new	B-X
disease	B-X
definitions	B-X
and	B-X
case	B-X
definitions	B-X
were	B-X
presented	B-X
for	B-X
peri-implant	B-X
health	B-X
,	B-X
peri-implant	B-X
mucositis	B-X
,	B-X
and	B-X
peri-implantitis	B-X
.	B-X
Case-control	B-X
studies	B-X
are	B-X
commonly	B-X
used	B-X
to	B-X
evaluate	B-X
effectiveness	B-X
of	B-X
licensed	B-X
vaccines	B-X
after	B-X
deployment	B-X
in	B-X
public	B-X
health	B-X
programs	B-X
.	B-X
Such	B-X
studies	B-X
can	B-X
provide	B-X
policy-relevant	B-X
data	B-X
on	B-X
vaccine	B-X
performance	B-X
under	B-X
'real	B-X
world	B-X
'	B-X
conditions	B-X
,	B-X
contributing	B-X
to	B-X
the	B-X
evidence	B-X
base	B-X
to	B-X
support	B-X
and	B-X
sustain	B-X
introduction	B-X
of	B-X
new	B-X
vaccines	B-X
.	B-X
However	B-X
,	B-X
case-control	B-X
studies	B-X
do	B-X
not	B-X
measure	B-X
the	B-X
impact	B-X
of	B-X
vaccine	B-X
introduction	B-X
on	B-X
disease	B-X
at	B-X
a	B-X
population	B-X
level	B-X
,	B-X
and	B-X
are	B-X
subject	B-X
to	B-X
bias	B-X
and	B-X
confounding	B-X
,	B-X
which	B-X
may	B-X
lead	B-X
to	B-X
inaccurate	B-X
results	B-X
that	B-X
can	B-X
misinform	B-X
policy	B-X
decisions	B-X
.	B-X
In	B-X
2012	B-X
,	B-X
a	B-X
group	B-X
of	B-X
experts	B-X
met	B-X
to	B-X
review	B-X
recent	B-X
experience	B-X
with	B-X
case-control	B-X
studies	B-X
evaluating	B-X
the	B-X
effectiveness	B-X
of	B-X
several	B-X
vaccines	B-X
;	B-X
here	B-X
we	B-X
summarize	B-X
the	B-X
recommendations	B-X
of	B-X
that	B-X
group	B-X
regarding	B-X
best	B-X
practices	B-X
for	B-X
planning	B-X
,	B-X
design	B-X
and	B-X
enrollment	B-X
of	B-X
cases	B-X
and	B-X
controls	B-X
.	B-X
Case-control	B-X
vaccine	B-X
effectiveness	B-X
studies	B-X
are	B-X
best	B-X
carried	B-X
out	B-X
soon	B-X
after	B-X
vaccine	B-X
introduction	B-X
because	B-X
high	B-X
coverage	B-X
creates	B-X
strong	B-X
potential	B-X
for	B-X
confounding	B-X
.	B-X
Controls	B-X
should	B-X
be	B-X
representative	B-X
of	B-X
the	B-X
source	B-X
population	B-X
from	B-X
which	B-X
cases	B-X
arise	B-X
,	B-X
and	B-X
are	B-X
generally	B-X
recruited	B-X
from	B-X
the	B-X
community	B-X
or	B-X
health	B-X
facilities	B-X
where	B-X
cases	B-X
are	B-X
enrolled	B-X
.	B-X
Matching	B-X
of	B-X
controls	B-X
to	B-X
cases	B-X
for	B-X
potential	B-X
confounding	B-X
factors	B-X
is	B-X
commonly	B-X
used	B-X
,	B-X
although	B-X
should	B-X
be	B-X
reserved	B-X
for	B-X
a	B-X
limited	B-X
number	B-X
of	B-X
key	B-X
variables	B-X
believed	B-X
to	B-X
be	B-X
linked	B-X
to	B-X
both	B-X
vaccination	B-X
and	B-X
disease	B-X
.	B-X
Case-control	B-X
vaccine	B-X
effectiveness	B-X
studies	B-X
can	B-X
provide	B-X
information	B-X
useful	B-X
to	B-X
guide	B-X
policy	B-X
decisions	B-X
and	B-X
vaccine	B-X
development	B-X
,	B-X
however	B-X
rigorous	B-X
preparation	B-X
and	B-X
design	B-X
is	B-X
essential	B-X
.	B-X

The	O
transcriptome	O
of	O
A	B-Organism
.	I-Organism
pleuropneumonia	I-Organism
is	O
certainly	O
very	O
different	O
when	O
the	O
infection	O
is	O
in	O
the	O
chronic	O
stage	O
.	O

Therefore	O
,	O
while	O
our	O
results	O
are	O
an	O
accurate	O
representation	O
of	O
the	O
transcriptomic	O
events	O
that	O
occur	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
infection	O
process	O
as	O
compared	O
to	O
those	O
occuring	O
in	O
vitro	O
in	O
a	O
rich	O
culture	O
medium	O
,	O
events	O
occuring	O
earlier	O
of	O
later	O
in	O
the	O
infection	O
process	O
cannot	O
be	O
inferred	O
.	O

In	O
vivo	O
transcript	O
profiling	O
experiments	O
were	O
performed	O
on	O
samples	O
from	O
three	O
different	O
lesion	O
sites	O
on	O
the	O
euthanized	O
pig	B-Organism
.	O

Since	O
this	O
pig	B-Organism
was	O
euthanized	O
on	O
site	O
by	O
a	O
veterinarian	O
,	O
the	O
time	O
laps	O
between	O
the	O
death	O
of	O
the	O
animal	O
and	O
tissue	O
sampling	O
was	O
kept	O
to	O
a	O
minimum	O
.	O

Following	O
microarray	O
hybridization	O
and	O
analysis	O
,	O
86	O
.	O
7	O
%	O
of	O
all	O
coding	O
sequences	O
included	O
on	O
AppChip2	B-Organism
could	O
be	O
detected	O
during	O
our	O
experiments	O
,	O
and	O
150	O
genes	O
were	O
significantly	O
differentially	O
expressed	O
in	O
vivo	O
when	O
their	O
level	O
of	O
expression	O
was	O
compared	O
to	O
that	O
seen	O
in	O
vitro	O
,	O
with	O
a	O
FDR	O
of	O
4	O
.	O
25	O
%	O
over	O
the	O
course	O
of	O
three	O
hybridizations	O
:	O
72	O
of	O
these	O
were	O
up	O
-	O
regulated	O
,	O
while	O
78	O
were	O
down	O
-	O
regulated	O
.	O

Functional	O
classification	O
of	O
these	O
genes	O
revealed	O
that	O
up	O
-	O
regulated	O
genes	O
mostly	O
belonged	O
to	O
the	O
"	O
Transport	O
and	O
Binding	O
Proteins	O
"	O
and	O
"	O
Energy	O
Metabolism	O
"	O
classes	O
,	O
with	O
respectively	O
17	O
and	O
14	O
genes	O
(	O
see	O
Additional	O
file	O
1	O
and	O
Figure	O
3	O
)	O
.	O

Repressed	O
genes	O
mostly	O
belonged	O
to	O
the	O
"	O
Protein	O
Synthesis	O
"	O
,	O
"	O
Energy	O
Metabolism	O
"	O
and	O
"	O
Cell	O
Envelope	O
"	O
functional	O
classes	O
.	O

A	O
large	O
number	O
of	O
genes	O
encoding	O
"	O
Hypothetical	O
/	O
Unknown	O
/	O
Unclassified	O
"	O
products	O
were	O
differentially	O
expressed	O
.	O

Only	O
ten	O
out	O
of	O
the	O
150	O
differentially	O
expressed	O
genes	O
(	O
8	O
.	O
2	O
%	O
)	O
could	O
be	O
found	O
in	O
the	O
list	O
of	O
divergent	O
or	O
highly	O
divergent	O
/	O
absent	O
genes	O
in	O
at	O
least	O
one	O
reference	O
strain	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
as	O
established	O
by	O
Goure	O
et	O
al	O
.	O

[	O
25	O
]	O
.	O

Three	O
of	O
these	O
are	O
involved	O
in	O
surface	O
structures	O
,	O
namely	O
LPS	O
and	O
capsule	O
,	O
biosynthesis	O
(	O
genes	O
kpsF	O
,	O
cps5b	O
and	O
cpxC	O
)	O
,	O
and	O
two	O
others	O
are	O
found	O
in	O
phage	O
-	O
associated	O
regions	O
(	O
APL	O
_	O
0512	O
and	O
APL	O
_	O
0524	O
)	O
.	O

Of	O
the	O
last	O
five	O
genes	O
,	O
four	O
are	O
divergent	O
in	O
only	O
one	O
strain	O
(	O
hktE	O
,	O
fur	O
,	O
phoR	O
and	O
hisH	O
,	O
respectively	O
in	O
reference	O
strains	O
from	O
serotypes	B-Organism
8	I-Organism
,	O
2	B-Organism
,	O
15	B-Organism
and	O
7	B-Organism
)	O
,	O
and	O
the	O
APL	O
_	O
0999	O
gene	O
codes	O
for	O
a	O
hypothetical	O
protein	O
that	O
is	O
divergent	O
in	O
serotype	B-Organism
2	I-Organism
,	O
7	B-Organism
-	O
11	B-Organism
and	O
14	B-Organism
reference	O
strains	O
.	O

a	O
)	O
Validation	O
of	O
microarray	O
results	O
by	O
qRT	O
-	O
PCR	O
In	O
order	O
to	O
confirm	O
results	O
obtained	O
using	O
the	O
AppChip2	B-Organism
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
microarray	O
,	O
eleven	O
genes	O
were	O
selected	O
for	O
qRT	O
-	O
PCR	O
analysis	O
.	O

Five	O
of	O
these	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
(	O
sohB	O
,	O
hbpA	O
,	O
kpsF	O
,	O
apxIVA	O
,	O
phoR	O
)	O
and	O
six	O
were	O
down	O
-	O
regulated	O
(	O
nlpI	O
,	O
visC	O
,	O
proQ	O
,	O
APL	O
_	O
1456	O
,	O
APL	O
_	O
1135	O
and	O
nusG	O
)	O
.	O

These	O
genes	O
represented	O
a	O
large	O
range	O
of	O
log2	O
ratio	O
values	O
.	O
<EOS>	B-X
NBS	B-X
sample	B-X
storage	B-X
period	B-X
ranged	B-X
from	B-X
3	B-X
to	B-X
16years	B-X
at	B-X
ambient	B-X
temperature	B-X
.	B-X
We	B-X
found	B-X
persistently	B-X
low	B-X
RNA	B-X
integrity	B-X
numbers	B-X
(	B-X
RIN=2.3±0.71	B-X
)	B-X
and	B-X
28S/18S	B-X
rRNA	B-X
ratios	B-X
(	B-X
~0	B-X
)	B-X
across	B-X
NBS	B-X
samples	B-X
for	B-X
all	B-X
storage	B-X
periods	B-X
.	B-X
In	B-X
both	B-X
qRT-PCR	B-X
and	B-X
microarray	B-X
data	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
three	B-X
common	B-X
housekeeping	B-X
genes-beta	B-X
cytoskeletal	B-X
actin	B-X
(	B-X
ACTB	B-X
)	B-X
,	B-X
glyceraldehyde	B-X
3-phosphate	B-X
dehydrogenase	B-X
(	B-X
GAPDH	B-X
)	B-X
,	B-X
and	B-X
peptidylprolyl	B-X
isomerase	B-X
A	B-X
(	B-X
PPIA	B-X
)	B-X
-decreased	B-X
with	B-X
increased	B-X
storage	B-X
time	B-X
.	B-X
Median	B-X
values	B-X
of	B-X
each	B-X
microarray	B-X
probe	B-X
intensity	B-X
at	B-X
log	B-X

In	O
all	O
cases	O
,	O
microarray	O
results	O
were	O
supported	O
by	O
those	O
obtained	O
by	O
qRT	O
-	O
PCR	O
:	O
all	O
genes	O
that	O
were	O
identified	O
as	O
up	O
-	O
regulated	O
using	O
the	O
AppChip2	B-Organism
also	O
showed	O
up	O
-	O
regulation	O
following	O
qRT	O
-	O
PCR	O
analysis	O
,	O
and	O
the	O
same	O
was	O
true	O
for	O
selected	O
down	O
-	O
regulated	O
genes	O
(	O
Figure	O
4	O
)	O
.	O

b	O
)	O
Comparison	O
with	O
other	O
in	O
vivo	O
studies	O
<EOS>	B-X
Increasing	B-X
concern	B-X
over	B-X
bisphenol	B-X
A	B-X
(	B-X
BPA	B-X
)	B-X
as	B-X
an	B-X
endocrine-disrupting	B-X
chemical	B-X
and	B-X
its	B-X
possible	B-X
effects	B-X
on	B-X
human	B-X
health	B-X
have	B-X
prompted	B-X
the	B-X
removal	B-X
of	B-X
BPA	B-X
from	B-X
consumer	B-X
products	B-X
,	B-X
often	B-X
labeled	B-X
``	B-X
BPA-free	B-X
.	B-X
''	B-X
Some	B-X
of	B-X
the	B-X
chemical	B-X
replacements	B-X
,	B-X
however	B-X
,	B-X
are	B-X
also	B-X
bisphenols	B-X
and	B-X
may	B-X
have	B-X
similar	B-X
physiological	B-X
effects	B-X
in	B-X
organisms	B-X
.	B-X
Bisphenol	B-X
S	B-X
(	B-X
BPS	B-X
)	B-X
and	B-X
bisphenol	B-X
F	B-X
(	B-X
BPF	B-X
)	B-X
are	B-X
two	B-X
such	B-X
BPA	B-X
substitutes	B-X
.	B-X
Nikkomycin	B-X
Z	B-X
was	B-X
tested	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
for	B-X
efficacy	B-X
against	B-X
Histoplasma	B-X
capsulatum	B-X
.	B-X
Twenty	B-X
clinical	B-X
isolates	B-X
were	B-X
tested	B-X
for	B-X
susceptibility	B-X
to	B-X
nikkomycin	B-X
Z	B-X
in	B-X
comparison	B-X
to	B-X
amphotericin	B-X
B	B-X
and	B-X
itraconazole	B-X
.	B-X
Primary	B-X
studies	B-X
were	B-X
carried	B-X
out	B-X
by	B-X
using	B-X
a	B-X
clinical	B-X
isolate	B-X
of	B-X
H.	B-X
capsulatum	B-X
for	B-X
which	B-X
the	B-X
MIC	B-X
of	B-X
nikkomycin	B-X
Z	B-X
was	B-X
greater	B-X
than	B-X
or	B-X
equal	B-X
to	B-X
64	B-X
microg/ml	B-X
.	B-X
All	B-X
vehicle	B-X
control	B-X
mice	B-X
died	B-X
by	B-X
day	B-X
12	B-X
.	B-X
Fungal	B-X
burden	B-X
was	B-X
assessed	B-X
on	B-X
survivors	B-X
.	B-X
Fungal	B-X
burden	B-X
assessed	B-X
on	B-X
survivors	B-X
showed	B-X
similar	B-X
levels	B-X
of	B-X
Histoplasma	B-X
antigen	B-X
in	B-X
lung	B-X
and	B-X
spleen	B-X
homogenates	B-X
of	B-X
mice	B-X
treated	B-X
with	B-X
amphotericin	B-X
B	B-X
at	B-X
2.0	B-X
mg/kg/dose	B-X
QOD	B-X
;	B-X
itraconazole	B-X
at	B-X
75	B-X
mg/kg/dose	B-X
BID	B-X
;	B-X
and	B-X
nikkomycin	B-X
Z	B-X
at	B-X
100	B-X
,	B-X
20	B-X
,	B-X
and	B-X
5	B-X
mg/kg/dose	B-X
BID	B-X
.	B-X
The	B-X
efficacy	B-X
of	B-X
nikkomycin	B-X
Z	B-X
at	B-X
preventing	B-X
mortality	B-X
and	B-X
reducing	B-X
fungal	B-X
burden	B-X
correlates	B-X
with	B-X
in	B-X
vitro	B-X
susceptibility	B-X
.	B-X

Among	O
previous	O
in	O
vivo	O
experiments	O
that	O
were	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
the	O
one	O
that	O
was	O
closest	O
to	O
ours	O
in	O
terms	O
of	O
experimental	O
conditions	O
and	O
results	O
was	O
by	O
Baltes	O
et	O
al	O
[	O
18	O
]	O
.	O

In	O
their	O
experiment	O
,	O
Selective	O
Capture	O
of	O
Transcribed	O
Sequences	O
(	O
SCOTS	O
)	O
was	O
performed	O
on	O
lung	O
tissues	O
after	O
a	O
7	O
day	O
infection	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
(	O
end	O
of	O
acute	O
phase	O
)	O
,	O
and	O
46	O
genes	O
were	O
identified	O
[	O
18	O
]	O
.	O

Of	O
the	O
150	O
differentially	O
expressed	O
genes	O
that	O
we	O
have	O
identified	O
(	O
see	O
Additional	O
file	O
1	O
)	O
,	O
15	O
were	O
also	O
identified	O
in	O
other	O
in	O
vivo	O
studies	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
(	O
Table	O
2	O
)	O
:	O
only	O
4	O
of	O
these	O
were	O
up	O
-	O
regulated	O
following	O
transcript	O
profiling	O
in	O
vivo	O
.	O

These	O
include	O
3	O
genes	O
already	O
identified	O
by	O
Baltes	O
et	O
al	O
.	O
using	O
SCOTS	O
at	O
the	O
end	O
of	O
the	O
acute	O
stage	O
of	O
the	O
disease	O
[	O
18	O
]	O
:	O
fucI	O
,	O
encoding	O
the	O
L	O
-	O
fucose	O
isomerase	O
,	O
nrdD	O
,	O
encoding	O
an	O
anaerobic	O
ribonucleoside	O
triphosphate	O
reductase	O
,	O
and	O
apxIVA	O
,	O
encoding	O
the	O
ApxIVA	O
toxin	O
structural	O
protein	O
.	O

The	O
latter	O
,	O
the	O
gene	O
encoding	O
the	O
recently	O
discovered	O
fourth	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
Apx	O
toxin	O
[	O
31	O
]	O
,	O
had	O
only	O
been	O
detected	O
in	O
vivo	O
[	O
32	O
-	O
34	O
]	O
until	O
it	O
was	O
discovered	O
recently	O
that	O
it	O
is	O
also	O
up	O
-	O
regulated	O
after	O
contact	O
with	O
broncho	O
-	O
alveolar	O
lavage	O
fluids	O
[	O
30	O
]	O
.	O

It	O
is	O
also	O
the	O
only	O
apx	O
gene	O
that	O
was	O
up	O
-	O
regulated	O
in	O
our	O
experiment	O
,	O
but	O
it	O
is	O
worth	O
noting	O
that	O
the	O
apxIBCD	O
and	O
apxIIAB	O
genes	O
,	O
although	O
not	O
differentially	O
expressed	O
,	O
were	O
all	O
actively	O
transcribed	O
in	O
vivo	O
.	O

Finally	O
,	O
the	O
last	O
gene	O
that	O
was	O
up	O
-	O
regulated	O
in	O
our	O
study	O
and	O
identified	O
in	O
another	O
in	O
vivo	O
study	O
is	O
nanE	O
,	O
which	O
codes	O
for	O
a	O
putative	O
N	O
-	O
acetylmannosamine	O
-	O
6	O
-	O
phosphate	O
2	O
-	O
epimerase	O
,	O
an	O
enzyme	O
involved	O
in	O
the	O
use	O
of	O
N	O
-	O
acetylneuraminate	O
and	O
N	O
-	O
acetylmannosamine	O
as	O
carbon	O
sources	O
[	O
35	O
]	O
.	O

The	O
differences	O
between	O
our	O
results	O
and	O
those	O
obtained	O
in	O
other	O
in	O
vivo	O
studies	O
can	O
be	O
easily	O
explained	O
:	O
while	O
the	O
second	O
SCOTS	O
experiment	O
was	O
conducted	O
with	O
animals	O
suffering	O
from	O
chronic	O
infections	O
[	O
10	O
]	O
,	O
a	O
condition	O
which	O
differs	O
greatly	O
from	O
our	O
field	O
case	O
,	O
the	O
STM	O
and	O
IVET	O
techniques	O
do	O
not	O
provide	O
a	O
"	O
snap	O
-	O
shot	O
"	O
of	O
the	O
transcriptome	O
at	O
a	O
precise	O
time	O
point	O
during	O
the	O
infection	O
process	O
.	O

While	O
STM	O
and	O
IVET	O
can	O
theoretically	O
provide	O
a	O
global	O
overview	O
of	O
transcriptomic	O
events	O
,	O
the	O
experiments	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
are	O
not	O
likely	O
to	O
have	O
achieved	O
this	O
goal	O
.	O

Only	O
800	O
mutants	O
were	O
screened	O
by	O
Fuller	O
et	O
al	O
.	O
with	O
IVET	O
[	O
12	O
]	O
,	O
well	O
short	O
of	O
the	O
approximately	O
2000	O
genes	O
of	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
genome	O
,	O
and	O
although	O
Sheehan	O
et	O
al	O
.	O
screened	O
2064	O
mutants	O
using	O
STM	O
[	O
16	O
]	O
,	O
the	O
authors	O
noted	O
that	O
both	O
their	O
STM	O
screen	O
and	O
the	O
previous	O
STM	O
experiment	O
by	O
Fuller	O
et	O
al	O
.	O

[	O
15	O
]	O
were	O
likely	O
not	O
saturating	O
.	O
<EOS>	B-X
(	B-X
2	B-X
)	B-X
Methods	B-X
:	B-X
The	B-X
study	B-X
applied	B-X
the	B-X
Finnish	B-X
nationally	B-X
representative	B-X
HBSC	B-X
data	B-X
(	B-X
persons	B-X
aged	B-X
11	B-X
,	B-X
13	B-X
,	B-X
and	B-X
15	B-X
,	B-X
n	B-X
=	B-X
3408	B-X
)	B-X
,	B-X
descriptive	B-X
observation	B-X
,	B-X
latent	B-X
class	B-X
analysis	B-X
,	B-X
and	B-X
multinomial	B-X
logistic	B-X
regression	B-X
analysis	B-X
.	B-X
Adolescents	B-X
in	B-X
the	B-X
interest-driven	B-X
user	B-X
group	B-X
were	B-X
more	B-X
likely	B-X
to	B-X
be	B-X
boys	B-X
and	B-X
participants	B-X
with	B-X
low	B-X
academic	B-X
achievement	B-X
,	B-X
high	B-X
parental	B-X
monitoring	B-X
,	B-X
and	B-X
high	B-X
problematic	B-X
social	B-X
media	B-X
use	B-X
.	B-X
Adolescents	B-X
in	B-X
the	B-X
friendship-driven	B-X
user	B-X
group	B-X
were	B-X
more	B-X
likely	B-X
to	B-X
be	B-X
girls	B-X
and	B-X
participants	B-X
aged	B-X
13	B-X
or	B-X
15	B-X
,	B-X
with	B-X
high	B-X
peer	B-X
and	B-X
family	B-X
support	B-X
.	B-X
Adolescents	B-X
in	B-X
the	B-X
abstinent	B-X
and	B-X
irregular	B-X
user	B-X
groups	B-X
were	B-X
likely	B-X
to	B-X
be	B-X
boys	B-X
and	B-X
participants	B-X
aged	B-X
11	B-X
with	B-X
high	B-X
family	B-X
support	B-X
.	B-X
Adolescents	B-X
in	B-X
the	B-X
excessive	B-X
user	B-X
group	B-X
were	B-X
more	B-X
likely	B-X
to	B-X
be	B-X
participants	B-X
with	B-X
high	B-X
problematic	B-X
social	B-X
media	B-X
use	B-X
and	B-X
were	B-X
most	B-X
likely	B-X
to	B-X
feel	B-X
low	B-X
and	B-X
tired	B-X
on	B-X
school	B-X
mornings	B-X
.	B-X

STM	O
relies	O
on	O
transposon	O
mutagenesis	O
,	O
and	O
there	O
are	O
some	O
insertional	O
hot	O
spots	O
in	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
genome	O
[	O
16	O
]	O
.	O

We	O
also	O
compared	O
our	O
results	O
to	O
the	O
transcriptional	O
profile	O
of	O
a	O
virulent	O
strain	O
of	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
,	O
another	O
lung	O
pathogen	O
,	O
isolated	O
from	O
a	O
chronically	O
infected	O
cystic	O
fibrosis	O
patient	B-Organism
[	O
23	O
]	O
.	O

There	O
were	O
no	O
striking	O
similarities	O
when	O
comparing	O
the	O
functions	O
of	O
differentially	O
expressed	O
genes	O
in	O
both	O
studies	O
.	O
<EOS>	B-X
This	B-X
striking	B-X
phenotype	B-X
represents	B-X
a	B-X
classic	B-X
example	B-X
of	B-X
modulation	B-X
of	B-X
plant	B-X
architecture	B-X
and	B-X
developmental	B-X
plasticity	B-X
.	B-X
Recent	B-X
studies	B-X
show	B-X
that	B-X
polycomb	B-X
group	B-X
proteins	B-X
control	B-X
microRNA156	B-X
,	B-X
phytohormone	B-X
metabolism/transport/signaling	B-X
and	B-X
key	B-X
tuberization	B-X
genes	B-X
through	B-X
histone	B-X
modifications	B-X
to	B-X
govern	B-X
tuber	B-X
development	B-X
.	B-X
Our	B-X
comparative	B-X
analysis	B-X
of	B-X
differentially	B-X
expressed	B-X
genes	B-X
between	B-X
the	B-X
overexpression	B-X
lines	B-X
of	B-X
StMSI1	B-X
,	B-X
StBEL5	B-X
(	B-X
BEL1-LIKE	B-X
transcription	B-X
factor	B-X
[	B-X
TF	B-X
]	B-X
)	B-X
,	B-X
and	B-X
POTATO	B-X
HOMEOBOX	B-X
15	B-X
TF	B-X
revealed	B-X
more	B-X
than	B-X
1,000	B-X
common	B-X
genes	B-X
,	B-X
indicative	B-X
of	B-X
a	B-X
mutual	B-X
gene	B-X
regulatory	B-X
network	B-X
potentially	B-X
involved	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
aerial	B-X
and	B-X
belowground	B-X
tubers	B-X
.	B-X
Feline	B-X
immunodeficiency	B-X
virus	B-X
(	B-X
FIV	B-X
)	B-X
is	B-X
a	B-X
naturally	B-X
occurring	B-X
T-cell	B-X
tropic	B-X
lentiviral	B-X
disease	B-X
of	B-X
felids	B-X
with	B-X
many	B-X
similarities	B-X
to	B-X
HIV/AIDS	B-X
in	B-X
humans	B-X
.	B-X
We	B-X
thus	B-X
examined	B-X
expression	B-X
of	B-X
the	B-X
feline	B-X
A3	B-X
genes	B-X
A3Z2	B-X
,	B-X
A3Z3	B-X
and	B-X
A3Z2-Z3	B-X
during	B-X
experimental	B-X
infection	B-X
of	B-X
domestic	B-X
cats	B-X
with	B-X
host-adapted	B-X
domestic	B-X
cat	B-X
FIV	B-X
(	B-X
referred	B-X
to	B-X
as	B-X
FIV	B-X
)	B-X
and	B-X
non-adapted	B-X

Since	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
is	O
well	O
-	O
known	O
for	O
the	O
versatility	O
of	O
nutrients	O
it	O
can	O
use	O
for	O
growth	O
,	O
and	O
since	O
both	O
conditions	O
(	O
chronic	O
infection	O
vs	O
acute	O
infection	O
)	O
were	O
highly	O
different	O
,	O
this	O
was	O
to	O
be	O
expected	O
.	O

However	O
,	O
one	O
interesting	O
aspect	O
of	O
both	O
cases	O
was	O
the	O
list	O
of	O
genes	O
that	O
weren	O
'	O
t	O
up	O
-	O
regulated	O
as	O
predicted	O
.	O

As	O
with	O
Son	O
et	O
al	O
.	O
,	O
we	O
noticed	O
that	O
few	O
of	O
the	O
landmark	O
virulence	O
genes	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
were	O
up	O
-	O
regulated	O
in	O
vivo	O
.	O

Out	O
of	O
the	O
three	O
Apx	O
toxins	O
present	O
in	O
serotype	B-Organism
5b	I-Organism
,	O
only	O
the	O
gene	O
encoding	O
the	O
ApxIV	O
toxin	O
was	O
up	O
-	O
regulated	O
.	O

The	O
Hsf	O
autotransporter	O
homolog	O
,	O
thought	O
to	O
be	O
important	O
in	O
adhesion	O
processes	O
,	O
as	O
well	O
as	O
pga	O
genes	O
necessary	O
for	O
biofilm	O
formation	O
,	O
were	O
not	O
identified	O
either	O
.	O

Well	O
-	O
characterized	O
iron	O
acquisition	O
genes	O
such	O
as	O
those	O
coding	O
for	O
the	O
hemoglobin	O
receptor	O
HgbA	O
(	O
despite	O
the	O
important	O
hemorrhage	O
noticed	O
in	O
the	O
infected	O
lungs	O
)	O
and	O
the	O
genes	O
coding	O
for	O
transferrin	O
binding	O
proteins	O
TbpA	O
and	O
TbpB	O
did	O
no	O
show	O
differential	O
expression	O
,	O
nor	O
did	O
genes	O
involved	O
in	O
anaerobic	O
respiration	O
.	O

While	O
in	O
the	O
latter	O
case	O
it	O
can	O
be	O
argued	O
that	O
the	O
environmental	O
conditions	O
encountered	O
during	O
the	O
acute	O
infection	O
might	O
explain	O
why	O
differential	O
expression	O
of	O
these	O
gene	O
transcripts	O
was	O
not	O
observed	O
,	O
it	O
could	O
also	O
be	O
hypothesized	O
that	O
years	O
of	O
evolution	O
of	O
the	O
field	O
strain	O
in	O
nature	O
might	O
have	O
led	O
to	O
the	O
loss	O
of	O
some	O
regulatory	O
mechanisms	O
that	O
could	O
still	O
be	O
present	O
in	O
well	O
-	O
characterized	O
laboratory	O
strains	O
,	O
thereby	O
leading	O
to	O
the	O
constitutive	O
expression	O
of	O
some	O
important	O
virulence	O
genes	O
.	O

In	O
the	O
case	O
of	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
clinical	O
isolate	O
,	O
it	O
was	O
shown	O
that	O
more	O
than	O
300	O
genes	O
had	O
higher	O
levels	O
of	O
constitutive	O
expression	O
in	O
the	O
clinical	O
isolate	O
than	O
in	O
a	O
well	O
-	O
characterised	O
reference	O
strain	O
,	O
therefore	O
showing	O
the	O
deregulation	O
of	O
several	O
pathways	O
[	O
23	O
]	O
.	O

Whether	O
this	O
is	O
also	O
the	O
case	O
for	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
will	O
have	O
to	O
be	O
assessed	O
.	O

c	O
)	O
Down	O
-	O
regulated	O
genes	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
expression	B-X
profile	B-X
of	B-X
c-myc	B-X
in	B-X
the	B-X
mammary	B-X
gland	B-X
.	B-X
During	B-X
pregnancy	B-X
when	B-X
the	B-X
gland	B-X
is	B-X
actively	B-X
growing	B-X
c-myc	B-X
mRNA	B-X
was	B-X
present	B-X
,	B-X
while	B-X
in	B-X
the	B-X
differentiated	B-X
lactating	B-X
gland	B-X
no	B-X
c-myc	B-X
mRNA	B-X
was	B-X
detected	B-X
.	B-X
This	B-X
correspondence	B-X
between	B-X
the	B-X
differentiation	B-X
state	B-X
and	B-X
c-myc	B-X
mRNA	B-X
levels	B-X
in	B-X
the	B-X
mouse	B-X
mammary	B-X
gland	B-X
in	B-X
vivo	B-X
was	B-X
paralleled	B-X
by	B-X
HC11	B-X
mouse	B-X
mammary	B-X
epithelial	B-X
cells	B-X
in	B-X
vitro	B-X
.	B-X
Firstly	B-X
,	B-X
the	B-X
endogenous	B-X
c-myc	B-X
gene	B-X
was	B-X
suppressed	B-X
in	B-X
confluent	B-X
compared	B-X
to	B-X
growing	B-X
HC11	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
treating	B-X
the	B-X
cells	B-X
with	B-X
lactogenic	B-X
hormones	B-X
did	B-X
not	B-X
induce	B-X
c-myc	B-X
expression	B-X
.	B-X
Secondly	B-X
,	B-X
a	B-X
stably	B-X
transfected	B-X
c-myc-CAT	B-X
reporter	B-X
construct	B-X
was	B-X
similarly	B-X
down-regulated	B-X
.	B-X
Furthermore	B-X
,	B-X
using	B-X
this	B-X
transfection	B-X
model	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
mechanism	B-X
(	B-X
s	B-X
)	B-X
involved	B-X
in	B-X
regulating	B-X
c-myc	B-X
expression	B-X
must	B-X
act	B-X
through	B-X
the	B-X
P1	B-X
and	B-X
P2	B-X
core	B-X
promoter	B-X
and	B-X
exon	B-X
1	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
suppression	B-X
of	B-X
c-myc	B-X
expression	B-X
occurs	B-X
when	B-X
HC11	B-X
cells	B-X
growth-arrest	B-X
as	B-X
they	B-X
become	B-X
confluent	B-X
.	B-X

Interestingly	O
,	O
genes	O
involved	O
in	O
protein	O
synthesis	O
were	O
down	O
-	O
regulated	O
in	O
vivo	O
towards	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
.	O

A	O
total	O
of	O
8	O
different	O
30S	O
or	O
50S	O
ribosomal	O
genes	O
showed	O
levels	O
of	O
down	O
-	O
regulation	O
ranging	O
from	O
-	O
1	O
.	O
59	O
to	O
-	O
3	O
.	O
97	O
fold	O
.	O
<EOS>	B-X
Therefore	B-X
,	B-X
it	B-X
's	B-X
vital	B-X
to	B-X
investigate	B-X
the	B-X
effect	B-X
of	B-X
PRT	B-X
on	B-X
muscle	B-X
strength	B-X
and	B-X
functional	B-X
capacity	B-X
early	B-X
postoperative	B-X
total	B-X
hip	B-X
arthroplasty	B-X
(	B-X
THA	B-X
)	B-X
or	B-X
total	B-X
knee	B-X
arthroplasty	B-X
(	B-X
TKA	B-X
)	B-X
.	B-X
Relevant	B-X
studies	B-X
were	B-X
identified	B-X
via	B-X
a	B-X
search	B-X
of	B-X
Medline	B-X
,	B-X
Web	B-X
of	B-X
science	B-X
and	B-X
Cochrane	B-X
Library	B-X
from	B-X
2002	B-X
to	B-X
12	B-X
May	B-X
2020	B-X
.	B-X
Fifteen	B-X
of	B-X
704	B-X
studies	B-X
which	B-X
comprised	B-X
6	B-X
THAs	B-X
and	B-X
8	B-X
TKAs	B-X
,	B-X
involving	B-X
1021	B-X
adult	B-X
patients	B-X
were	B-X
eligible	B-X
for	B-X
inclusion	B-X
in	B-X
the	B-X
meta-analysis	B-X
.	B-X
There	B-X
were	B-X
no	B-X
significant	B-X
differences	B-X
between	B-X
the	B-X
two	B-X
groups	B-X
after	B-X
TKA	B-X
in	B-X
the	B-X
6-min	B-X
walk	B-X
test	B-X
(	B-X
6-WMT	B-X
)	B-X
within	B-X
1	B-X
month	B-X
(	B-X
95	B-X
%	B-X
CI	B-X
=	B-X
-0.41	B-X
,	B-X
1.53	B-X
)	B-X
,	B-X
within	B-X
3	B-X
months	B-X
(	B-X
95	B-X
%	B-X
CI	B-X
=	B-X
-0.27	B-X
,	B-X
0.76	B-X
)	B-X
,	B-X
within	B-X
12	B-X
months	B-X
(	B-X
95	B-X
%	B-X
CI	B-X
=	B-X
-0.29	B-X
,	B-X
0.66	B-X
)	B-X
;	B-X
climb	B-X
performance	B-X
in	B-X
seconds	B-X
(	B-X
s	B-X
)	B-X
(	B-X
SCP	B-X
)	B-X
,	B-X
leg	B-X
extension	B-X
power	B-X
,	B-X
timed	B-X
up	B-X
and	B-X
go	B-X
test	B-X
in	B-X
seconds	B-X
(	B-X
s	B-X
)	B-X
(	B-X
TUG	B-X
)	B-X
within	B-X
1	B-X
month	B-X
(	B-X
95	B-X
%	B-X
CI	B-X
=	B-X
-1.75	B-X
,	B-X
0.77	B-X
)	B-X
,	B-X
within	B-X
3	B-X
months	B-X
(	B-X
95	B-X
%	B-X
CI	B-X
=	B-X
-0.48	B-X
,	B-X
0.33	B-X
)	B-X
,	B-X
within	B-X
12	B-X
months	B-X
(	B-X
95	B-X
%	B-X
CI	B-X
=	B-X
-0.44	B-X
,	B-X
0.35	B-X
)	B-X
,	B-X
sit	B-X
to	B-X
stand	B-X
,	B-X
number	B-X
of	B-X
repetitions	B-X
in	B-X
30s	B-X
(	B-X
ST	B-X
)	B-X
.	B-X
There	B-X
was	B-X
no	B-X
difference	B-X
in	B-X
the	B-X
incidence	B-X
of	B-X
adverse	B-X
events	B-X
(	B-X
95	B-X
%	B-X
CI	B-X
=	B-X
-0.01	B-X
,	B-X
0.10	B-X
)	B-X
.	B-X

These	O
genes	O
are	O
scattered	O
in	O
the	O
L20	B-Organism
genome	O
,	O
but	O
all	O
their	O
respective	O
operonic	O
structures	O
are	O
well	O
conserved	O
when	O
compared	O
to	O
those	O
observed	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
[	O
36	O
]	O
.	O

Not	O
much	O
is	O
known	O
,	O
however	O
,	O
about	O
the	O
regulation	O
of	O
these	O
transcriptional	O
units	O
.	O
<EOS>	B-X
Despite	B-X
the	B-X
importance	B-X
of	B-X
ASFV	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
mechanisms	B-X
and	B-X
regulation	B-X
of	B-X
ASFV	B-X
transcription	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
ASFV	B-X
utilizes	B-X
alternative	B-X
transcription	B-X
start	B-X
sites	B-X
between	B-X
early	B-X
and	B-X
late	B-X
stages	B-X
of	B-X
infection	B-X
and	B-X
that	B-X
ASFV	B-X
RNA	B-X
polymerase	B-X
(	B-X
RNAP	B-X
)	B-X
undergoes	B-X
promoter-proximal	B-X
transcript	B-X
slippage	B-X
at	B-X
5	B-X
'	B-X
ends	B-X
of	B-X
transcription	B-X
units	B-X
,	B-X
adding	B-X
quasitemplated	B-X
AU-	B-X
and	B-X
AUAU-5	B-X
'	B-X
extensions	B-X
to	B-X
mRNAs	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
present	B-X
the	B-X
first	B-X
much-needed	B-X
genome-wide	B-X
transcriptome	B-X
study	B-X
that	B-X
provides	B-X
unique	B-X
insight	B-X
into	B-X
ASFV	B-X
transcription	B-X
and	B-X
serves	B-X
as	B-X
a	B-X
resource	B-X
to	B-X
aid	B-X
future	B-X
functional	B-X
analyses	B-X
of	B-X
ASFV	B-X
genes	B-X
which	B-X
are	B-X
essential	B-X
to	B-X
combat	B-X
this	B-X
devastating	B-X
disease	B-X
.	B-X
The	B-X
construction	B-X
of	B-X
organisms	B-X
from	B-X
units	B-X
that	B-X
develop	B-X
under	B-X
semi-autonomous	B-X
genetic	B-X
control	B-X
(	B-X
modules	B-X
)	B-X
has	B-X
been	B-X
proposed	B-X
to	B-X
be	B-X
an	B-X
important	B-X
component	B-X
of	B-X
their	B-X
ability	B-X
to	B-X
undergo	B-X
adaptive	B-X
phenotypic	B-X
evolution	B-X
.	B-X
The	B-X
organization	B-X
of	B-X
the	B-X
vertebrate	B-X
dentition	B-X
as	B-X
a	B-X
system	B-X
of	B-X
repeated	B-X
parts	B-X
provides	B-X
an	B-X
opportunity	B-X
to	B-X
study	B-X
the	B-X
extent	B-X
to	B-X
which	B-X
phenotypic	B-X
modules	B-X
,	B-X
identified	B-X
by	B-X
their	B-X
evolutionary	B-X
independence	B-X
from	B-X
other	B-X
such	B-X
units	B-X
,	B-X
are	B-X
related	B-X
to	B-X
modularity	B-X
in	B-X
the	B-X
genetic	B-X
control	B-X
of	B-X
development	B-X
.	B-X
Ectopic	B-X
expression	B-X
of	B-X
tooth	B-X
initiation	B-X
signals	B-X
provides	B-X
a	B-X
potential	B-X
mechanism	B-X
for	B-X
the	B-X
novel	B-X
deployment	B-X
or	B-X
reacquisition	B-X
of	B-X
teeth	B-X
;	B-X
a	B-X
single	B-X
instance	B-X
is	B-X
known	B-X
of	B-X
a	B-X
gene	B-X
whose	B-X
ectopic	B-X
expression	B-X
in	B-X
transgenic	B-X
mice	B-X
can	B-X
lead	B-X
to	B-X
ectopic	B-X
teeth	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
teleost	B-X
fishes	B-X
may	B-X
have	B-X
a	B-X
much	B-X
more	B-X
extensive	B-X
dentition	B-X
.	B-X

While	O
some	O
experimental	O
evidence	O
seems	O
to	O
indicate	O
that	O
rpsJ	O
could	O
be	O
activated	O
by	O
FNR	O
[	O
37	O
]	O
and	O
repressed	O
by	O
ArcA	O
[	O
38	O
]	O
,	O
rpsT	O
seems	O
to	O
be	O
repressed	O
by	O
FNR	O
[	O
37	O
]	O
.	O

Both	O
rpsK	O
and	O
rpsU	O
are	O
transcribed	O
from	O
sigma	O
70	O
promoters	O
,	O
which	O
is	O
the	O
main	O
sigma	O
factor	O
during	O
the	O
exponential	O
growth	O
phase	O
[	O
39	O
]	O
.	O

This	O
would	O
probably	O
indicate	O
that	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
has	O
a	O
slower	O
metabolism	O
and	O
replication	O
rate	O
in	O
vivo	O
than	O
when	O
it	O
is	O
growing	O
in	O
a	O
rich	O
culture	O
medium	O
.	O

Further	O
strengthening	O
this	O
hypothesis	O
is	O
the	O
fact	O
that	O
two	O
subunits	O
from	O
DNA	O
polymerase	O
III	O
(	O
dnaN	O
,	O
dnaX	O
)	O
,	O
which	O
is	O
the	O
primary	O
enzyme	O
for	O
replicative	O
DNA	O
functions	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
are	O
down	O
-	O
regulated	O
,	O
as	O
well	O
the	O
genes	O
coding	O
for	O
the	O
DNA	O
primase	O
(	O
dnaG	O
)	O
and	O
the	O
cell	O
division	O
protein	O
FtsX	O
.	O

With	O
regards	O
to	O
their	O
possible	O
involvement	O
in	O
virulence	O
processes	O
,	O
some	O
genes	O
that	O
were	O
down	O
-	O
regulated	O
were	O
of	O
particular	O
interest	O
.	O

The	O
Fur	O
transcriptional	O
regulator	O
,	O
which	O
represses	O
transcription	O
of	O
genes	O
associated	O
with	O
iron	O
acquisition	O
[	O
40	O
]	O
,	O
showed	O
a	O
2	O
.	O
6	O
fold	O
down	O
-	O
regulation	O
in	O
transcription	O
.	O

In	O
bacteria	O
,	O
Fur	O
down	O
-	O
regulates	O
the	O
transcription	O
of	O
genes	O
involved	O
in	O
iron	O
-	O
acquisition	O
and	O
iron	O
homeostasis	O
in	O
bacterial	O
cells	O
,	O
and	O
its	O
action	O
is	O
directly	O
linked	O
to	O
the	O
amount	O
of	O
available	O
iron	O
,	O
as	O
it	O
requires	O
Fe2	O
+	O
as	O
a	O
cofactor	O
[	O
41	O
]	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
Fur	O
also	O
regulates	O
its	O
own	O
level	O
of	O
expression	O
.	O

Iron	O
restriction	O
if	O
often	O
thought	O
to	O
be	O
an	O
important	O
signal	O
for	O
bacteria	O
,	O
and	O
has	O
often	O
been	O
linked	O
with	O
the	O
expression	O
of	O
virulence	O
factors	O
such	O
as	O
toxins	O
[	O
42	O
]	O
.	O

Therefore	O
,	O
it	O
would	O
seem	O
that	O
the	O
in	O
vivo	O
environment	O
towards	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
pleuropneumonia	O
is	O
not	O
iron	O
-	O
restricted	O
for	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

This	O
is	O
not	O
surprising	O
considering	O
that	O
there	O
is	O
extensive	O
hemorrhage	O
and	O
tissue	O
destruction	O
,	O
caused	O
most	O
probably	O
by	O
the	O
secretion	O
of	O
Apx	O
toxins	O
.	O

However	O
,	O
a	O
few	O
genes	O
involved	O
in	O
iron	O
acquisition	O
,	O
namely	O
APL	O
_	O
0096	O
,	O
APL	O
_	O
0668	O
,	O
hbpA	O
and	O
irp	O
,	O
were	O
up	O
-	O
regulated	O
.	O

Since	O
these	O
genes	O
were	O
not	O
identified	O
in	O
a	O
previous	O
transcript	O
profiling	O
experiment	O
under	O
iron	O
-	O
restricted	O
conditions	O
[	O
28	O
]	O
,	O
this	O
might	O
imply	O
that	O
they	O
are	O
not	O
regulated	O
by	O
Fur	O
.	O
<EOS>	B-X
Noncoding	B-X
events	B-X
near	B-X
tissue-specific	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
Enhancers	B-X
are	B-X
cis-regulatory	B-X
elements	B-X
that	B-X
can	B-X
activate	B-X
transcription	B-X
remotely	B-X
to	B-X
regulate	B-X
a	B-X
specific	B-X
pattern	B-X
of	B-X
a	B-X
gene	B-X
's	B-X
expression	B-X
.	B-X
Genes	B-X
typically	B-X
have	B-X
many	B-X
enhancers	B-X
that	B-X
are	B-X
often	B-X
intermingled	B-X
in	B-X
the	B-X
loci	B-X
of	B-X
other	B-X
genes	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
highly	B-X
expressed	B-X
genes	B-X
in	B-X
certain	B-X
functional	B-X
categories	B-X
are	B-X
enriched	B-X
with	B-X
optimal	B-X
codons	B-X
,	B-X
which	B-X
are	B-X
decoded	B-X
by	B-X
the	B-X
abundant	B-X
tRNAs	B-X
,	B-X
thus	B-X
enhancing	B-X
the	B-X
speed	B-X
and	B-X
accuracy	B-X
of	B-X
the	B-X
translating	B-X
ribosome	B-X
.	B-X
The	B-X
set	B-X
of	B-X
genes	B-X
exhibiting	B-X
codon	B-X
adaptation	B-X
differs	B-X
between	B-X
genomes	B-X
,	B-X
and	B-X
these	B-X
differences	B-X
show	B-X
robust	B-X
associations	B-X
to	B-X
organismal	B-X
phenotypes	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
selection	B-X
for	B-X
translation	B-X
efficiency	B-X
,	B-X
other	B-X
distinct	B-X
codon	B-X
bias	B-X
patterns	B-X
have	B-X
been	B-X
found	B-X
in	B-X
:	B-X
amino	B-X
acid	B-X
starvation	B-X
genes	B-X
,	B-X
cyclically	B-X
expressed	B-X
genes	B-X
,	B-X
tissue-specific	B-X
genes	B-X
in	B-X
animals	B-X
and	B-X
plants	B-X
,	B-X
oxidative	B-X
stress	B-X
response	B-X
genes	B-X
,	B-X
cellular	B-X
differentiation	B-X
genes	B-X
,	B-X
and	B-X
oncogenes	B-X
.	B-X
The	B-X
evolutionary	B-X
trace	B-X
of	B-X
codon	B-X
bias	B-X
patterns	B-X
across	B-X
orthologous	B-X
genes	B-X
may	B-X
be	B-X
examined	B-X
to	B-X
learn	B-X
about	B-X
a	B-X
gene	B-X
's	B-X
relevance	B-X
to	B-X
various	B-X
phenotypes	B-X
,	B-X
or	B-X
,	B-X
more	B-X
generally	B-X
,	B-X
its	B-X
function	B-X
in	B-X
the	B-X
cell	B-X
.	B-X

The	O
hfq	O
gene	O
,	O
which	O
codes	O
for	O
a	O
protein	O
involved	O
in	O
RNA	O
molecule	O
stability	O
and	O
RNA	O
-	O
RNA	O
interactions	O
[	O
43	O
]	O
and	O
that	O
therefore	O
has	O
an	O
important	O
regulatory	O
function	O
,	O
was	O
also	O
down	O
-	O
regulated	O
.	O

Hfq	O
is	O
an	O
RNA	O
chaperone	O
that	O
acts	O
as	O
a	O
post	O
-	O
transcriptional	O
riboregulator	O
[	O
44	O
]	O
.	O

The	O
role	O
of	O
Hfq	O
,	O
a	O
Sm	O
-	O
like	O
protein	O
,	O
has	O
been	O
investigated	O
with	O
greater	O
interest	O
over	O
the	O
last	O
decade	O
since	O
it	O
was	O
shown	O
that	O
it	O
is	O
involved	O
in	O
the	O
function	O
of	O
small	O
RNAs	O
(	O
sRNAs	O
)	O
[	O
45	O
]	O
.	O

It	O
is	O
believed	O
to	O
form	O
a	O
complex	O
with	O
sRNAs	O
and	O
RNAse	O
E	O
,	O
thereby	O
targeting	O
mRNAs	O
that	O
are	O
recognized	O
by	O
sRNAs	O
for	O
degradation	O
.	O

The	O
fact	O
that	O
the	O
hfq	O
gene	O
is	O
down	O
-	O
regulated	O
in	O
vivo	O
at	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
could	O
lead	O
to	O
a	O
decline	O
of	O
the	O
activity	O
of	O
sRNAs	O
that	O
require	O
Hfq	O
to	O
function	O
properly	O
.	O

No	O
sRNAs	O
have	O
been	O
identified	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
yet	O
,	O
but	O
they	O
have	O
been	O
found	O
in	O
numerous	O
bacterial	O
pathogens	O
[	O
46	O
]	O
.	O

Also	O
of	O
interest	O
was	O
the	O
down	O
-	O
regulation	O
of	O
the	O
cps5b	O
(	O
-	O
2	O
.	O
21	O
fold	O
)	O
and	O
cpxC	O
(	O
-	O
1	O
.	O
82	O
fold	O
)	O
genes	O
,	O
involved	O
respectively	O
in	O
the	O
biosynthesis	O
of	O
capsular	O
polysaccharide	O
and	O
in	O
the	O
export	O
of	O
these	O
polysaccharides	O
.	O

Down	O
-	O
regulation	O
of	O
cpxABC	O
,	O
involved	O
in	O
capsule	O
biosynthesis	O
,	O
has	O
also	O
been	O
observed	O
during	O
planktonic	O
life	O
in	O
liquid	O
medium	O
in	O
contact	O
with	O
porcine	O
lung	O
epithelial	O
cells	O
[	O
9	O
]	O
.	O

The	O
down	O
-	O
regulation	O
of	O
genes	O
involved	O
in	O
capsule	O
synthesis	O
could	O
potentially	O
lead	O
to	O
the	O
production	O
of	O
a	O
thinner	O
capsule	O
on	O
the	O
surface	O
of	O
bacteria	O
,	O
thereby	O
unmasking	O
potential	O
adhesins	O
.	O

Indeed	O
,	O
an	O
acapsular	O
mutant	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
that	O
was	O
generated	O
in	O
our	O
laboratory	O
was	O
shown	O
to	O
adhere	O
more	O
strongly	O
to	O
frozen	O
porcine	O
tracheal	O
sections	O
than	O
the	O
capsulated	O
wild	O
-	O
type	O
strain	O
[	O
47	O
]	O
.	O

d	O
)	O
Up	O
-	O
regulated	O
genes	O
<EOS>	B-X
During	B-X
embryogenesis	B-X
,	B-X
the	B-X
genome	B-X
shifts	B-X
from	B-X
transcriptionally	B-X
quiescent	B-X
to	B-X
extensively	B-X
active	B-X
in	B-X
a	B-X
process	B-X
known	B-X
as	B-X
Zygotic	B-X
Genome	B-X
Activation	B-X
(	B-X
ZGA	B-X
)	B-X
.	B-X
In	B-X
Drosophila	B-X
,	B-X
the	B-X
pioneer	B-X
factor	B-X
Zelda	B-X
is	B-X
known	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
the	B-X
progression	B-X
of	B-X
development	B-X
;	B-X
still	B-X
,	B-X
it	B-X
regulates	B-X
the	B-X
activation	B-X
of	B-X
only	B-X
a	B-X
small	B-X
subset	B-X
of	B-X
genes	B-X
at	B-X
ZGA	B-X
.	B-X
However	B-X
,	B-X
thousands	B-X
of	B-X
genes	B-X
do	B-X
not	B-X
require	B-X
Zelda	B-X
,	B-X
suggesting	B-X
that	B-X
other	B-X
mechanisms	B-X
exist	B-X
.	B-X
By	B-X
conducting	B-X
GRO-seq	B-X
,	B-X
HiC	B-X
and	B-X
ChIP-seq	B-X
in	B-X
Drosophila	B-X
embryos	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
up	B-X
to	B-X
65	B-X
%	B-X
of	B-X
zygotically	B-X
activated	B-X
genes	B-X
are	B-X
enriched	B-X
for	B-X
the	B-X
histone	B-X
variant	B-X
H2A.Z	B-X
.	B-X
In	B-X
vivo	B-X
knockdown	B-X
of	B-X
maternally	B-X
contributed	B-X
Domino	B-X
,	B-X
a	B-X
histone	B-X
chaperone	B-X
and	B-X
ATPase	B-X
,	B-X
reduces	B-X
H2A.Z	B-X
deposition	B-X
at	B-X
transcription	B-X
start	B-X
sites	B-X
,	B-X
causes	B-X
global	B-X
downregulation	B-X
of	B-X
housekeeping	B-X
genes	B-X
at	B-X
ZGA	B-X
,	B-X
and	B-X
compromises	B-X
the	B-X
establishment	B-X
of	B-X
the	B-X
3D	B-X
chromatin	B-X
structure	B-X
.	B-X

Numerous	O
genes	O
that	O
could	O
be	O
involved	O
in	O
the	O
progression	O
of	O
the	O
disease	O
were	O
identified	O
as	O
up	O
-	O
regulated	O
.	O
<EOS>	B-X
Parkinson	B-X
's	B-X
disease	B-X
(	B-X
PD	B-X
)	B-X
is	B-X
a	B-X
progressive	B-X
neurodegenerative	B-X
condition	B-X
characterized	B-X
by	B-X
a	B-X
gradual	B-X
loss	B-X
of	B-X
a	B-X
specific	B-X
group	B-X
of	B-X
dopaminergic	B-X
neurons	B-X
in	B-X
the	B-X
substantia	B-X
nigra	B-X
.	B-X
Concomitantly	B-X
,	B-X
the	B-X
function	B-X
of	B-X
genes	B-X
that	B-X
cause	B-X
inherited	B-X
forms	B-X
of	B-X
PD	B-X
point	B-X
to	B-X
mitochondrial	B-X
dysfunction	B-X
as	B-X
a	B-X
major	B-X
contributor	B-X
in	B-X
the	B-X
etiology	B-X
of	B-X
PD	B-X
.	B-X
One	B-X
such	B-X
mechanism	B-X
is	B-X
mitophagy	B-X
,	B-X
a	B-X
process	B-X
which	B-X
involves	B-X
PTEN-induced	B-X
putative	B-X
kinase	B-X
1	B-X
(	B-X
PINK1	B-X
)	B-X
,	B-X
a	B-X
mitochondrial	B-X
Ser/Thr	B-X
kinase	B-X
and	B-X
Parkin	B-X
,	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
,	B-X
each	B-X
encoded	B-X
by	B-X
genes	B-X
responsible	B-X
for	B-X
early-onset	B-X
autosomal	B-X
recessive	B-X
familial	B-X
PD	B-X
.	B-X
Numerous	B-X
hypotheses	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
endometriosis	B-X
can	B-X
be	B-X
found	B-X
in	B-X
the	B-X
literature	B-X
,	B-X
but	B-X
there	B-X
is	B-X
growing	B-X
evidence	B-X
of	B-X
serious	B-X
genetic	B-X
contributions	B-X
to	B-X
endometriosis	B-X
susceptibility	B-X
.	B-X
The	B-X
involvement	B-X
of	B-X
genes	B-X
,	B-X
steroid	B-X
hormone	B-X
metabolism	B-X
,	B-X
immunological	B-X
reactions	B-X
,	B-X
receptor	B-X
formation	B-X
,	B-X
inflammation	B-X
,	B-X
proliferation	B-X
,	B-X
apoptosis	B-X
,	B-X
intercellular	B-X
adhesion	B-X
,	B-X
cell	B-X
invasion	B-X
and	B-X
angiogenesis	B-X
as	B-X
well	B-X
as	B-X
genes	B-X
regulating	B-X
the	B-X
activity	B-X
of	B-X
aforementioned	B-X
enzymes	B-X
have	B-X
been	B-X
suggested	B-X
.	B-X
Some	B-X
more	B-X
recently	B-X
suggested	B-X
candidate	B-X
genes	B-X
picked	B-X
up	B-X
in	B-X
genome-wide	B-X
association	B-X
studies	B-X
are	B-X
involved	B-X
in	B-X
oncogenesis	B-X
,	B-X
metaplasia	B-X
of	B-X
endometrium	B-X
cells	B-X
and	B-X
pathways	B-X
of	B-X
embryonic	B-X
development	B-X
of	B-X
the	B-X
female	B-X
reproductive	B-X
system	B-X
.	B-X
However	B-X
,	B-X
gene	B-X
mutations	B-X
proven	B-X
to	B-X
be	B-X
causative	B-X
for	B-X
endometriosis	B-X
have	B-X
not	B-X
been	B-X
identified	B-X
so	B-X
far	B-X
,	B-X
even	B-X
though	B-X
the	B-X
abnormal	B-X
expression	B-X
of	B-X
candidate	B-X
genes	B-X
for	B-X
endometriosis	B-X
could	B-X
be	B-X
provoked	B-X
by	B-X
different	B-X
epigenetic	B-X
modifications	B-X
including	B-X
DNA	B-X
methylation	B-X
,	B-X
heterochromatization	B-X
or	B-X
introduction	B-X
of	B-X
regulatory	B-X
miRNA	B-X
.	B-X
Two	B-X
stages	B-X
in	B-X
the	B-X
endometriosis	B-X
pathway	B-X
are	B-X
suggested	B-X
:	B-X
(	B-X
1	B-X
)	B-X
induction	B-X
of	B-X
primary	B-X
endometrial	B-X
cells	B-X
toward	B-X
endometriosis	B-X
,	B-X
and	B-X
(	B-X
2	B-X
)	B-X
implantation	B-X
and	B-X
progression	B-X
of	B-X
these	B-X
cells	B-X
into	B-X
endometriosis	B-X
lesions	B-X
.	B-X
The	B-X
model	B-X
favors	B-X
endometriosis	B-X
as	B-X
an	B-X
outgrowth	B-X
of	B-X
primary	B-X
cells	B-X
different	B-X
in	B-X
their	B-X
origin	B-X
,	B-X
canalization	B-X
of	B-X
pathological	B-X
processes	B-X
,	B-X
manifestation	B-X
diversity	B-X
provoked	B-X
by	B-X
unique	B-X
genetic	B-X
background	B-X
and	B-X
epigenetic	B-X
influences	B-X
,	B-X
which	B-X
result	B-X
in	B-X
many	B-X
different	B-X
clinical	B-X
forms	B-X
of	B-X
the	B-X
disease	B-X
.	B-X

Gene	O
sohB	O
has	O
the	O
highest	O
observed	O
fold	O
change	O
(	O
5	O
.	O
39x	O
)	O
and	O
codes	O
for	O
a	O
putative	O
secreted	O
serine	O
protease	O
that	O
seems	O
to	O
be	O
well	O
conserved	O
in	O
other	O
pathogenic	O
bacteria	O
,	O
such	O
as	O
Haemophilus	B-Organism
parasuis	I-Organism
,	O
Neisseria	B-Organism
meningitidis	I-Organism
and	O
N	B-Organism
.	I-Organism
gonorrhoeae	I-Organism
.	O

In	O
the	O
lungs	O
,	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
causes	O
extensive	O
tissue	O
damage	O
that	O
could	O
result	O
from	O
the	O
combined	O
action	O
of	O
Apx	O
toxins	O
and	O
secreted	O
proteases	O
[	O
48	O
]	O
.	O

Adhesion	O
processes	O
are	O
essential	O
for	O
the	O
establishment	O
of	O
bacterial	O
infections	O
.	O
<EOS>	B-X
First	B-X
described	B-X
by	B-X
Paul	B-X
Ehrlich	B-X
in	B-X
1879	B-X
,	B-X
who	B-X
noted	B-X
its	B-X
characteristic	B-X
staining	B-X
by	B-X
acidophilic	B-X
dyes	B-X
,	B-X
for	B-X
many	B-X
years	B-X
,	B-X
the	B-X
eosinophil	B-X
was	B-X
considered	B-X
to	B-X
be	B-X
an	B-X
end-effector	B-X
cell	B-X
associated	B-X
with	B-X
helminth	B-X
infections	B-X
and	B-X
a	B-X
cause	B-X
of	B-X
tissue	B-X
damage	B-X
.	B-X
Eosinophils	B-X
can	B-X
function	B-X
as	B-X
antigen	B-X
presenting	B-X
cells	B-X
and	B-X
can	B-X
regulate	B-X
processes	B-X
associated	B-X
with	B-X
both	B-X
T1	B-X
and	B-X
T2	B-X
immunity	B-X
.	B-X
In	B-X
this	B-X
paper	B-X
,	B-X
we	B-X
review	B-X
the	B-X
eosinophil	B-X
's	B-X
unique	B-X
biology	B-X
and	B-X
structure	B-X
,	B-X
including	B-X
its	B-X
characteristic	B-X
granules	B-X
and	B-X
the	B-X
effects	B-X
of	B-X
its	B-X
proteins	B-X
,	B-X
our	B-X
developing	B-X
understanding	B-X
of	B-X
its	B-X
role	B-X
in	B-X
innate	B-X
and	B-X
adaptive	B-X
immunity	B-X
and	B-X
importance	B-X
in	B-X
immunomodulation	B-X
,	B-X
and	B-X
the	B-X
part	B-X
it	B-X
plays	B-X
in	B-X
defense	B-X
against	B-X
parasitic	B-X
,	B-X
viral	B-X
,	B-X
fungal	B-X
and	B-X
bacterial	B-X
infections	B-X
.	B-X
Rather	B-X
than	B-X
our	B-X
worst	B-X
enemy	B-X
,	B-X
the	B-X
eosinophil	B-X
may	B-X
,	B-X
in	B-X
fact	B-X
,	B-X
be	B-X
one	B-X
of	B-X
the	B-X
most	B-X
essential	B-X
components	B-X
in	B-X
host	B-X
defense	B-X
and	B-X
immunity	B-X
.	B-X

The	O
apf	O
promoter	O
was	O
shown	O
to	O
be	O
active	O
in	O
vitro	O
during	O
adhesion	O
experiments	O
to	O
primary	O
epithelial	O
cells	O
,	O
and	O
in	O
vivo	O
early	O
in	O
the	O
infection	O
process	O
[	O
49	O
]	O
.	O

Here	O
,	O
we	O
report	O
that	O
genes	O
apfB	O
and	O
apfC	O
,	O
coding	O
for	O
the	O
type	O
IV	O
pilin	O
biogenesis	O
proteins	O
ApfB	O
and	O
ApfC	O
,	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
during	O
natural	O
infection	O
by	O
an	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
isolate	O
.	O

Type	O
IV	O
fimbriae	O
,	O
although	O
primarily	O
involved	O
in	O
promoting	O
the	O
attachment	O
to	O
biotic	O
or	O
abiotic	O
surfaces	O
,	O
are	O
also	O
involved	O
in	O
many	O
other	O
processes	O
,	O
including	O
DNA	O
uptake	O
,	O
biofilm	O
formation	O
and	O
twitching	O
mobility	O
[	O
50	O
]	O
.	O

Interestingly	O
,	O
another	O
gene	O
that	O
could	O
share	O
similar	O
functions	O
was	O
also	O
up	O
-	O
regulated	O
.	O
<EOS>	B-X
We	B-X
identify	B-X
a	B-X
53	B-X
%	B-X
overlap	B-X
between	B-X
Ism1	B-X
and	B-X
insulin	B-X
signaling	B-X
and	B-X
Ism1-mediated	B-X
phosphoproteome-wide	B-X
alterations	B-X
in	B-X
~450	B-X
proteins	B-X
that	B-X
are	B-X
not	B-X
shared	B-X
with	B-X
insulin	B-X
.	B-X
Interestingly	B-X
,	B-X
we	B-X
find	B-X
several	B-X
unknown	B-X
phosphorylation	B-X
sites	B-X
on	B-X
proteins	B-X
related	B-X
to	B-X
protein	B-X
translation	B-X
,	B-X
mTOR	B-X
pathway	B-X
,	B-X
and	B-X
,	B-X
unexpectedly	B-X
,	B-X
muscle	B-X
function	B-X
in	B-X
the	B-X
Ism1	B-X
signaling	B-X
network	B-X
.	B-X
Product	B-X
of	B-X
the	B-X
Itga2b	B-X
gene	B-X
,	B-X
CD41	B-X
contributes	B-X
to	B-X
hematopoietic	B-X
stem	B-X
cell	B-X
(	B-X
HSC	B-X
)	B-X
and	B-X
megakaryocyte/platelet	B-X
functions	B-X
.	B-X
Key	B-X
to	B-X
platelet	B-X
aggregation	B-X
,	B-X
CD41	B-X
expression	B-X
also	B-X
characterises	B-X
their	B-X
precursor	B-X
,	B-X
the	B-X
megakaryocyte	B-X
,	B-X
and	B-X
is	B-X
specifically	B-X
up	B-X
regulated	B-X
during	B-X
megakaryopoiesis	B-X
.	B-X
Though	B-X
phenotypically	B-X
unique	B-X
,	B-X
megakaryocytes	B-X
and	B-X
HSC	B-X
share	B-X
numerous	B-X
features	B-X
,	B-X
including	B-X
key	B-X
transcription	B-X
factors	B-X
,	B-X
which	B-X
could	B-X
indicate	B-X
common	B-X
sub-regulatory	B-X
networks	B-X
.	B-X
A	B-X
developmental	B-X
process	B-X
connects	B-X
epigenetic	B-X
regulation	B-X
and	B-X
promoter	B-X
switching	B-X
leading	B-X
to	B-X
CD41	B-X
expression	B-X
in	B-X
HSC	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
similar	B-X
process	B-X
can	B-X
be	B-X
observed	B-X
at	B-X
the	B-X
Mpl	B-X
locus	B-X
,	B-X
which	B-X
codes	B-X
for	B-X
another	B-X
receptor	B-X
that	B-X
defines	B-X
both	B-X
HSC	B-X
and	B-X
megakaryocyte	B-X
identities	B-X
.	B-X

APL	O
_	O
0220	O
codes	O
for	O
a	O
member	O
of	O
the	O
CscG	O
superfamily	O
of	O
proteins	O
involved	O
in	O
the	O
assembly	O
of	O
curli	O
fibers	O
.	O

Curli	O
fibers	O
are	O
important	O
for	O
biofilm	O
formation	O
in	O
numerous	O
pathogens	O
,	O
including	O
E	B-Organism
.	I-Organism
coli	I-Organism
and	O
Salmonella	B-Organism
enteritidis	I-Organism
,	O
and	O
are	O
involved	O
in	O
the	O
first	O
steps	O
of	O
attachment	O
.	O

Curli	O
-	O
deficient	O
strains	O
tend	O
to	O
form	O
flat	O
biofilms	O
[	O
51	O
]	O
.	O

CscG	O
is	O
the	O
outer	O
membrane	O
protein	O
that	O
is	O
responsible	O
for	O
the	O
secretion	O
of	O
the	O
curli	O
structural	O
subunits	O
,	O
and	O
the	O
cscG	O
gene	O
is	O
generally	O
found	O
within	O
an	O
operon	O
composed	O
of	O
the	O
genes	O
cscDEFG	O
.	O

In	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
L20	I-Organism
,	O
this	O
organization	O
is	O
not	O
respected	O
:	O
APL	O
_	O
0220	O
seems	O
to	O
form	O
an	O
operon	O
with	O
the	O
genes	O
APL	O
_	O
0221	O
and	O
APL	O
_	O
0222	O
.	O

Neither	O
of	O
these	O
two	O
other	O
genes	O
shares	O
homology	O
with	O
known	O
csc	O
genes	O
.	O

Finally	O
,	O
the	O
kpsF	O
gene	O
,	O
coding	O
for	O
an	O
arabinose	O
-	O
5	O
-	O
phosphate	O
isomerase	O
,	O
should	O
also	O
be	O
mentioned	O
since	O
it	O
is	O
involved	O
in	O
the	O
pathway	O
responsible	O
for	O
the	O
synthesis	O
of	O
2	O
-	O
keto	O
-	O
3deozyoctulosonic	O
acid	O
(	O
Kdo	O
)	O
,	O
which	O
is	O
present	O
in	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
LPS	O
core	O
oligosaccharide	O
[	O
52	O
]	O
and	O
capsule	O
of	O
serotype	B-Organism
5	I-Organism
[	O
53	O
]	O
.	O

Studies	O
in	O
our	O
laboratory	O
have	O
shown	O
that	O
it	O
is	O
the	O
core	O
oligosaccharide	O
that	O
is	O
responsible	O
for	O
the	O
previously	O
observed	O
LPS	O
-	O
associated	O
adhesion	O
mechanism	O
[	O
54	O
,	O
55	O
]	O
.	O

Two	O
operon	O
structures	O
that	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
could	O
give	O
some	O
insight	O
into	O
the	O
environment	O
the	O
bacteria	O
encounters	O
in	O
the	O
host	O
,	O
and	O
are	O
the	O
main	O
reason	O
why	O
the	O
"	O
Transport	O
and	O
Binding	O
Protein	O
"	O
functional	O
class	O
is	O
so	O
prominently	O
represented	O
in	O
our	O
list	O
of	O
up	O
-	O
regulated	O
genes	O
.	O

Genes	O
from	O
the	O
maltose	O
operon	O
,	O
involved	O
in	O
the	O
uptake	O
and	O
catabolism	O
of	O
maltose	O
[	O
56	O
]	O
,	O
were	O
up	O
-	O
regulated	O
:	O
the	O
genes	O
malP	O
,	O
malK	O
,	O
malF	O
,	O
malG	O
,	O
malQ	O
and	O
a	O
malM	O
homolog	O
(	O
APL	O
_	O
1234	O
)	O
were	O
actively	O
transcribed	O
in	O
the	O
host	O
(	O
average	O
fold	O
increase	O
of	O
3	O
.	O
1	O
)	O
,	O
and	O
gene	O
lamB1	O
,	O
which	O
codes	O
for	O
a	O
maltoporin	O
,	O
showed	O
a	O
5	O
.	O
14	O
fold	O
change	O
in	O
the	O
only	O
hybridization	O
in	O
which	O
the	O
reporter	O
wasn	O
'	O
t	O
manually	O
flagged	O
because	O
of	O
signal	O
saturation	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
the	O
mal	O
genes	O
are	O
essential	O
for	O
the	O
transport	O
and	O
utilization	O
of	O
maltose	O
and	O
maltodextrin	O
[	O
56	O
]	O
.	O

Although	O
it	O
is	O
not	O
known	O
whether	O
maltose	O
or	O
maltodextrin	O
are	O
readily	O
available	O
as	O
carbohydrate	O
sources	O
in	O
mammalian	O
lungs	O
,	O
it	O
was	O
previously	O
shown	O
that	O
maltodextrin	O
utilization	O
is	O
important	O
for	O
the	O
colonization	O
of	O
the	O
oro	O
-	O
pharynx	O
in	O
Group	B-Organism
A	I-Organism
Streptococcus	I-Organism
[	O
57	O
,	O
58	O
]	O
.	O

It	O
was	O
also	O
recently	O
shown	O
that	O
catabolism	O
of	O
maltose	O
provides	O
a	O
competitive	O
advantage	O
to	O
pathogenic	O
and	O
commensal	O
E	B-Organism
.	I-Organism
coli	I-Organism
strains	O
in	O
the	O
gut	O
[	O
59	O
]	O
.	O

Meanwhile	O
,	O
genes	O
from	O
the	O
ula	O
operon	O
(	O
ulaDCAG	O
)	O
,	O
coding	O
for	O
a	O
PTS	O
transport	O
system	O
for	O
ascorbate	O
,	O
showed	O
an	O
average	O
fold	O
change	O
of	O
2	O
.	O
76	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
these	O
genes	O
are	O
responsible	O
for	O
the	O
transport	O
and	O
utilization	O
of	O
ascorbate	O
in	O
anaerobic	O
conditions	O
[	O
60	O
]	O
.	O

While	O
ascorbate	O
use	O
has	O
not	O
been	O
linked	O
to	O
bacterial	O
virulence	O
before	O
,	O
it	O
has	O
been	O
shown	O
on	O
multiple	O
occasions	O
that	O
genes	O
involved	O
in	O
anaerobic	O
metabolism	O
are	O
important	O
for	O
the	O
virulence	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
[	O
10	O
,	O
61	O
-	O
63	O
]	O
.	O
<EOS>	B-X
Ascorbate	B-X
acts	B-X
as	B-X
an	B-X
electron-donor	B-X
keeping	B-X
iron	B-X
in	B-X
the	B-X
ferrous	B-X
state	B-X
thereby	B-X
maintaining	B-X
the	B-X
full	B-X
activity	B-X
of	B-X
collagen	B-X
hydroxylases	B-X
;	B-X
parallel	B-X
reactions	B-X
with	B-X
a	B-X
variety	B-X
of	B-X
dioxygenases	B-X
affect	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
wide	B-X
array	B-X
of	B-X
genes	B-X
,	B-X
for	B-X
example	B-X
via	B-X
the	B-X
HIF	B-X
system	B-X
,	B-X
as	B-X
well	B-X
as	B-X
via	B-X
the	B-X
epigenetic	B-X
landscape	B-X
of	B-X
cells	B-X
and	B-X
tissues	B-X
.	B-X
In	B-X
fact	B-X
,	B-X
all	B-X
known	B-X
physiological	B-X
and	B-X
biochemical	B-X
functions	B-X
of	B-X
ascorbate	B-X
are	B-X
due	B-X
to	B-X
its	B-X
action	B-X
as	B-X
an	B-X
electron	B-X
donor	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
chemical	B-X
and	B-X
biochemical	B-X
nature	B-X
of	B-X
ascorbate	B-X
contribute	B-X
to	B-X
its	B-X
antioxidant	B-X
as	B-X
well	B-X
as	B-X
its	B-X
prooxidant	B-X
properties	B-X
.	B-X
administration	B-X
of	B-X
ascorbate	B-X
bypasses	B-X
the	B-X
tight	B-X
control	B-X
of	B-X
the	B-X
gut	B-X
producing	B-X
highly	B-X
elevated	B-X
plasma	B-X
levels	B-X
;	B-X
ascorbate	B-X
at	B-X
very	B-X
high	B-X
levels	B-X
can	B-X
act	B-X
as	B-X
prodrug	B-X
to	B-X
deliver	B-X
a	B-X
significant	B-X
flux	B-X
of	B-X
H	B-X
(	B-X
2	B-X
)	B-X
O	B-X
(	B-X
2	B-X
)	B-X
to	B-X
tumors	B-X
.	B-X
This	B-X
new	B-X
knowledge	B-X
has	B-X
rekindled	B-X
interest	B-X
and	B-X
spurred	B-X
new	B-X
research	B-X
into	B-X
the	B-X
clinical	B-X
potential	B-X
of	B-X
pharmacological	B-X
ascorbate	B-X
.	B-X
Knowledge	B-X
and	B-X
understanding	B-X
of	B-X
the	B-X
mechanisms	B-X
of	B-X
action	B-X
of	B-X
pharmacological	B-X
ascorbate	B-X
bring	B-X
a	B-X
rationale	B-X
to	B-X
its	B-X
use	B-X
to	B-X
treat	B-X
disease	B-X
especially	B-X
the	B-X
use	B-X
of	B-X
i.v	B-X
.	B-X
delivery	B-X
of	B-X
pharmacological	B-X
ascorbate	B-X
as	B-X
an	B-X
adjuvant	B-X
in	B-X
the	B-X
treatment	B-X
of	B-X
cancer	B-X
.	B-X

In	O
pigs	B-Organism
lungs	O
,	O
following	O
extensive	O
infection	O
and	O
tissue	O
destruction	O
,	O
the	O
bacteria	O
are	O
likely	O
to	O
face	O
oxygen	O
deprivation	O
.	O

A	O
few	O
other	O
genes	O
that	O
are	O
involved	O
in	O
anaerobic	O
metabolism	O
were	O
up	O
-	O
regulated	O
.	O
<EOS>	B-X
Of	B-X
the	B-X
2545	B-X
genes	B-X
expressed	B-X
in	B-X
both	B-X
isolates	B-X
that	B-X
were	B-X
cultivated	B-X
aerobically	B-X
,	B-X
256	B-X
genes	B-X
were	B-X
up-	B-X
and	B-X
161	B-X
were	B-X
down-regulated	B-X
with	B-X
a	B-X
minimum	B-X
2-fold	B-X
change	B-X
(	B-X
2f	B-X
)	B-X
.	B-X
Focusing	B-X
on	B-X
25	B-X
highly	B-X
(	B-X
≥8f	B-X
)	B-X
up-	B-X
(	B-X
n=9	B-X
)	B-X
or	B-X
down-	B-X
(	B-X
n=16	B-X
)	B-X
regulated	B-X
genes	B-X
,	B-X
we	B-X
identified	B-X
several	B-X
genes	B-X
encoding	B-X
for	B-X
virulence	B-X
factors	B-X
involved	B-X
in	B-X
immune	B-X
evasion	B-X
,	B-X
bacterial	B-X
spread	B-X
or	B-X
secretion	B-X
(	B-X
e.g	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
genes	B-X
displayed	B-X
similar	B-X
expression	B-X
trends	B-X
under	B-X
aerobic	B-X
,	B-X
microaerophilic	B-X
and	B-X
anaerobic	B-X
conditions	B-X
.	B-X
Further	B-X
qRT-PCR-experiments	B-X
of	B-X
highly	B-X
up-	B-X
or	B-X
down-regulated	B-X
genes	B-X
within	B-X
intermediate	B-X
S.	B-X
aureus	B-X
isolates	B-X
resulted	B-X
in	B-X
different	B-X
gene	B-X
expression	B-X
patterns	B-X
over	B-X
the	B-X
years	B-X
.	B-X
Using	B-X
sequencing	B-X
analysis	B-X
of	B-X
the	B-X
differently	B-X
expressed	B-X
genes	B-X
and	B-X
their	B-X
upstream	B-X
regions	B-X
in	B-X
the	B-X
late	B-X
S.	B-X
aureus	B-X
isolate	B-X
resulted	B-X
in	B-X
only	B-X
few	B-X
genomic	B-X
alterations	B-X
.	B-X
Comparative	B-X
transcriptomic	B-X
analysis	B-X
revealed	B-X
adaptive	B-X
changes	B-X
affecting	B-X
mainly	B-X
genes	B-X
involved	B-X
in	B-X
host-pathogen	B-X
interaction	B-X
.	B-X

The	O
hybB	O
gene	O
codes	O
for	O
hydrogenase	O
2	O
,	O
a	O
nickel	O
-	O
containing	O
enzyme	O
thought	O
to	O
be	O
responsible	O
for	O
H2	O
-	O
dependent	O
reduction	O
of	O
quinone	O
under	O
anaerobic	O
conditions	O
[	O
64	O
]	O
.	O

The	O
phosphoenolpyruvate	O
carboxylase	O
and	O
fumarate	O
reductase	O
subunit	O
C	O
,	O
respectively	O
encoded	O
by	O
genes	O
pepC	O
and	O
frdC	O
,	O
are	O
also	O
required	O
during	O
anaerobic	O
growth	O
.	O

However	O
,	O
other	O
genes	O
related	O
to	O
anaerobic	O
metabolism	O
and	O
that	O
were	O
previously	O
shown	O
to	O
be	O
important	O
in	O
vivo	O
[	O
61	O
-	O
63	O
]	O
,	O
namely	O
dmsA	O
,	O
aspA	O
and	O
hlyX	O
,	O
were	O
not	O
found	O
in	O
our	O
list	O
of	O
differentially	O
expressed	O
genes	O
.	O

The	O
dmsA	O
gene	O
did	O
show	O
a	O
mean	O
fold	O
change	O
of	O
1	O
.	O
60	O
over	O
two	O
successful	O
hybridizations	O
,	O
but	O
hlyX	O
had	O
a	O
mean	O
fold	O
change	O
of	O
-	O
1	O
.	O
66	O
over	O
three	O
successful	O
hybridizations	O
.	O

However	O
,	O
neither	O
of	O
these	O
changes	O
were	O
deemed	O
statistically	O
significant	O
.	O
<EOS>	B-X
A	B-X
systematic	B-X
review	B-X
commissioned	B-X
by	B-X
the	B-X
United	B-X
Kingdom	B-X
's	B-X
(	B-X
UK	B-X
)	B-X
Department	B-X
of	B-X
Health	B-X
reviewed	B-X
a	B-X
large	B-X
number	B-X
of	B-X
international	B-X
healthy	B-X
workplace	B-X
interventions	B-X
and	B-X
recommended	B-X
five	B-X
whole-system	B-X
changes	B-X
to	B-X
improve	B-X
healthcare	B-X
staff	B-X
health	B-X
and	B-X
wellbeing	B-X
:	B-X
identification	B-X
and	B-X
response	B-X
to	B-X
local	B-X
need	B-X
,	B-X
engagement	B-X
of	B-X
staff	B-X
at	B-X
all	B-X
levels	B-X
,	B-X
and	B-X
the	B-X
involvement	B-X
,	B-X
visible	B-X
leadership	B-X
from	B-X
,	B-X
and	B-X
up-skilling	B-X
of	B-X
,	B-X
management	B-X
and	B-X
board-level	B-X
staff	B-X
.	B-X
Studies	B-X
were	B-X
deemed	B-X
eligible	B-X
for	B-X
inclusion	B-X
if	B-X
they	B-X
met	B-X
the	B-X
following	B-X
criteria	B-X
:	B-X
(	B-X
a	B-X
)	B-X
were	B-X
an	B-X
experimental	B-X
trial	B-X
published	B-X
in	B-X
an	B-X
English-language	B-X
refereed	B-X
journal	B-X
;	B-X
(	B-X
b	B-X
)	B-X
directly	B-X
compared	B-X
concentric	B-X
and	B-X
eccentric	B-X
actions	B-X
without	B-X
the	B-X
use	B-X
of	B-X
external	B-X
implements	B-X
(	B-X
i.e.	B-X
,	B-X
blood	B-X
pressure	B-X
cuffs	B-X
)	B-X
and	B-X
all	B-X
other	B-X
RT	B-X
variables	B-X
equivalent	B-X
;	B-X
(	B-X
c	B-X
)	B-X
measured	B-X
morphologic	B-X
changes	B-X
using	B-X
biopsy	B-X
,	B-X
imaging	B-X
(	B-X
magnetic	B-X
resonance	B-X
imaging	B-X
,	B-X
computerized	B-X
tomography	B-X
,	B-X
or	B-X
ultrasound	B-X
)	B-X
,	B-X
bioelectrical	B-X
impedance	B-X
,	B-X
and/or	B-X
densitometry	B-X
;	B-X
(	B-X
d	B-X
)	B-X
had	B-X
a	B-X
minimum	B-X
duration	B-X
of	B-X
6	B-X
weeks	B-X
;	B-X
and	B-X
(	B-X
e	B-X
)	B-X
used	B-X
human	B-X
participants	B-X
without	B-X
musculoskeletal	B-X
injury	B-X
or	B-X
any	B-X
health	B-X
condition	B-X
that	B-X
could	B-X
directly	B-X
,	B-X
or	B-X
through	B-X
the	B-X
medications	B-X
associated	B-X
with	B-X
the	B-X
management	B-X
of	B-X
said	B-X
condition	B-X
,	B-X
be	B-X
expected	B-X
to	B-X
impact	B-X
the	B-X
hypertrophic	B-X
response	B-X
to	B-X
resistance	B-X
exercise	B-X
.	B-X
The	B-X
minimal	B-X
clinically	B-X
important	B-X
difference	B-X
(	B-X
MCID	B-X
)	B-X
of	B-X
a	B-X
patient-reported	B-X
outcome	B-X
measure	B-X
(	B-X
PROM	B-X
)	B-X
represents	B-X
a	B-X
threshold	B-X
value	B-X
of	B-X
change	B-X
in	B-X
PROM	B-X
score	B-X
deemed	B-X
to	B-X
have	B-X
an	B-X
implication	B-X
in	B-X
clinical	B-X
management	B-X
.	B-X
However	B-X
,	B-X
an	B-X
understanding	B-X
of	B-X
the	B-X
many	B-X
caveats	B-X
of	B-X
the	B-X
MCID	B-X
,	B-X
as	B-X
well	B-X
as	B-X
its	B-X
strengths	B-X
and	B-X
limitations	B-X
,	B-X
is	B-X
necessary	B-X
.	B-X

This	O
suggests	O
that	O
HlyX	O
is	O
probably	O
not	O
highly	O
expressed	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
caused	O
by	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

Accordingly	O
,	O
of	O
17	O
genes	O
in	O
our	O
list	O
that	O
were	O
previously	O
shown	O
to	O
be	O
up	O
-	O
regulated	O
directly	O
or	O
indirectly	O
by	O
HlyX	O
under	O
anaerobiosis	O
,	O
12	O
(	O
dnaX	O
,	O
visC	O
,	O
dsbC	O
,	O
mazG	O
,	O
amiB	O
,	O
cpxC	O
,	O
dacA	O
,	O
rpoZ	O
,	O
APL	O
_	O
0086	O
,	O
APL	O
_	O
1597	O
,	O
APL	O
_	O
1802	O
and	O
APL	O
_	O
2043	O
)	O
were	O
down	O
-	O
regulated	O
in	O
vivo	O
,	O
while	O
only	O
5	O
(	O
sohB	O
,	O
mglB	O
,	O
hybB	O
,	O
APL	O
_	O
0096	O
and	O
APL	O
_	O
0920	O
)	O
were	O
up	O
-	O
regulated	O
.	O

Two	O
genes	O
coding	O
for	O
proteins	O
with	O
regulatory	O
functions	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
.	O
<EOS>	B-X
Heritable	B-X
factors	B-X
account	B-X
for	B-X
60-80	B-X
%	B-X
of	B-X
optimal	B-X
bone	B-X
mineralization	B-X
;	B-X
however	B-X
,	B-X
the	B-X
finer	B-X
details	B-X
of	B-X
pathogenesis	B-X
remain	B-X
to	B-X
be	B-X
elucidated	B-X
.	B-X
Micro	B-X
RNA	B-X
(	B-X
miRNA	B-X
)	B-X
and	B-X
long-non-coding	B-X
RNA	B-X
(	B-X
lncRNA	B-X
)	B-X
are	B-X
two	B-X
targets	B-X
that	B-X
have	B-X
recently	B-X
come	B-X
into	B-X
the	B-X
spotlight	B-X
due	B-X
to	B-X
their	B-X
ability	B-X
to	B-X
control	B-X
gene	B-X
expression	B-X
at	B-X
the	B-X
post-transcriptional	B-X
level	B-X
and	B-X
provide	B-X
epigenetic	B-X
modification	B-X
.	B-X
miRNAs	B-X
are	B-X
a	B-X
class	B-X
of	B-X
non-coding	B-X
RNAs	B-X
that	B-X
are	B-X
approximately	B-X
18-25	B-X
nucleotides	B-X
long	B-X
.	B-X
It	B-X
is	B-X
thought	B-X
that	B-X
up	B-X
to	B-X
60	B-X
%	B-X
of	B-X
human	B-X
protein-coding	B-X
genes	B-X
may	B-X
be	B-X
regulated	B-X
by	B-X
miRNAs	B-X
.	B-X
They	B-X
have	B-X
been	B-X
found	B-X
to	B-X
regulate	B-X
gene	B-X
expression	B-X
that	B-X
controls	B-X
osteoblast-dependent	B-X
bone	B-X
formation	B-X
and	B-X
osteoclast-related	B-X
bone	B-X
remodeling	B-X
.	B-X
lncRNAs	B-X
are	B-X
highly	B-X
structured	B-X
RNA	B-X
transcripts	B-X
longer	B-X
than	B-X
200	B-X
nucleotides	B-X
that	B-X
do	B-X
not	B-X
translate	B-X
into	B-X
proteins	B-X
.	B-X
Further	B-X
research	B-X
into	B-X
the	B-X
epigenetic	B-X
modification	B-X
and	B-X
the	B-X
regulatory	B-X
roles	B-X
of	B-X
these	B-X
molecules	B-X
will	B-X
bring	B-X
us	B-X
closer	B-X
to	B-X
potential	B-X
disease-modifying	B-X
treatment	B-X
for	B-X
osteoporosis	B-X
.	B-X

The	O
phoR	O
gene	O
codes	O
for	O
the	O
phosphate	O
regulon	O
PhoR	O
sensing	O
protein	O
,	O
located	O
in	O
the	O
inner	O
membrane	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
this	O
protein	O
is	O
part	O
of	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
that	O
responds	O
to	O
periplasmic	O
orthophosphate	O
concentration	O
variations	O
[	O
65	O
]	O
.	O

The	O
phosphate	O
regulon	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
controls	O
the	O
expression	O
of	O
at	O
least	O
47	O
genes	O
,	O
and	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
virulence	O
.	O

Numerous	O
phoR	O
,	O
phoB	O
(	O
the	O
other	O
component	O
of	O
the	O
two	O
-	O
component	O
system	O
)	O
and	O
pts	O
(	O
the	O
phosphate	O
transport	O
genes	O
genetically	O
and	O
functionally	O
linked	O
to	O
phoBR	O
)	O
mutants	O
were	O
found	O
to	O
be	O
less	O
virulent	O
or	O
avirulent	O
when	O
compared	O
to	O
wild	O
-	O
type	O
strains	O
,	O
with	O
phenotypes	O
such	O
as	O
increased	O
sensitivity	O
to	O
serum	O
,	O
acidity	O
and	O
cationic	O
antimicrobial	O
peptides	O
[	O
66	O
]	O
and	O
reduced	O
colonization	O
[	O
67	O
]	O
.	O

A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
strain	I-Organism
L20	I-Organism
harbours	O
an	O
operon	O
composed	O
of	O
the	O
genes	O
ptsSCAB	O
-	O
phoBR	O
.	O

Although	O
only	O
phoR	O
was	O
deemed	O
significantly	O
up	O
-	O
regulated	O
,	O
all	O
other	O
genes	O
showed	O
levels	O
of	O
variations	O
ranging	O
from	O
a	O
1	O
.	O
5	O
-	O
to	O
2	O
-	O
fold	O
increase	O
.	O

Since	O
it	O
seems	O
unlikely	O
that	O
porcine	O
lungs	O
are	O
devoid	O
of	O
phosphate	O
,	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
PhoBR	O
system	O
might	O
be	O
important	O
in	O
order	O
to	O
adapt	O
correctly	O
to	O
changing	O
conditions	O
inside	O
the	O
host	O
.	O

Another	O
gene	O
coding	O
for	O
a	O
member	O
of	O
a	O
two	O
-	O
component	O
system	O
was	O
up	O
-	O
regulated	O
:	O
gene	O
APL	O
_	O
0628	O
codes	O
for	O
a	O
cpxA	O
homolog	O
.	O

In	O
different	O
EPEC	B-Organism
and	O
UPEC	B-Organism
strains	O
,	O
the	O
CpxAR	O
system	O
was	O
found	O
to	O
important	O
for	O
the	O
correct	O
folding	O
and	O
assembly	O
of	O
pili	O
subunits	O
[	O
68	O
-	O
70	O
]	O
.	O

However	O
,	O
the	O
L20	B-Organism
cpxA	O
homolog	O
seems	O
to	O
either	O
be	O
truncated	O
,	O
or	O
found	O
on	O
two	O
separate	O
gene	O
loci	O
.	O
<EOS>	B-X
On	B-X
average	B-X
a	B-X
pair	B-X
of	B-X
loci	B-X
separated	B-X
by	B-X
a	B-X
given	B-X
genomic	B-X
distance	B-X
contact	B-X
each	B-X
other	B-X
2-3	B-X
times	B-X
more	B-X
frequently	B-X
when	B-X
they	B-X
are	B-X
in	B-X
the	B-X
same	B-X
TAD	B-X
as	B-X
compared	B-X
to	B-X
a	B-X
pair	B-X
of	B-X
loci	B-X
located	B-X
in	B-X
two	B-X
neighbouring	B-X
TADs	B-X
.	B-X
Even	B-X
though	B-X
fungi	B-X
do	B-X
not	B-X
have	B-X
separate	B-X
sexes	B-X
,	B-X
most	B-X
filamentous	B-X
fungi	B-X
mate	B-X
in	B-X
a	B-X
hermaphroditic	B-X
fashion	B-X
,	B-X
with	B-X
distinct	B-X
sex	B-X
roles	B-X
,	B-X
that	B-X
is	B-X
,	B-X
investment	B-X
in	B-X
large	B-X
gametes	B-X
(	B-X
female	B-X
role	B-X
)	B-X
and	B-X
fertilization	B-X
by	B-X
other	B-X
small	B-X
gametes	B-X
(	B-X
male	B-X
role	B-X
)	B-X
.	B-X
Mating	B-X
types	B-X
,	B-X
which	B-X
determine	B-X
genetic	B-X
compatibility	B-X
among	B-X
fungal	B-X
gametes	B-X
,	B-X
are	B-X
important	B-X
for	B-X
sexual	B-X
selection	B-X
in	B-X
two	B-X
respects	B-X
.	B-X
First	B-X
,	B-X
genes	B-X
at	B-X
the	B-X
mating-type	B-X
loci	B-X
regulate	B-X
different	B-X
aspects	B-X
of	B-X
mating	B-X
and	B-X
thus	B-X
can	B-X
be	B-X
subject	B-X
to	B-X
sexual	B-X
selection	B-X
.	B-X
Second	B-X
,	B-X
for	B-X
sexual	B-X
selection	B-X
,	B-X
not	B-X
only	B-X
the	B-X
two	B-X
sexes	B-X
(	B-X
or	B-X
sex	B-X
roles	B-X
)	B-X
but	B-X
also	B-X
the	B-X
mating	B-X
types	B-X
can	B-X
form	B-X
the	B-X
classes	B-X
,	B-X
the	B-X
members	B-X
of	B-X
which	B-X
compete	B-X
for	B-X
access	B-X
to	B-X
members	B-X
of	B-X
the	B-X
other	B-X
class	B-X
.	B-X
This	B-X
is	B-X
significant	B-X
if	B-X
mating-type	B-X
gene	B-X
products	B-X
are	B-X
costly	B-X
,	B-X
thus	B-X
signalling	B-X
genetic	B-X
quality	B-X
according	B-X
to	B-X
Zahavi	B-X
's	B-X
handicap	B-X
principle	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
argue	B-X
that	B-X
fungi	B-X
are	B-X
good	B-X
model	B-X
systems	B-X
to	B-X
experimentally	B-X
study	B-X
fundamental	B-X
aspects	B-X
of	B-X
sexual	B-X
selection	B-X
,	B-X
due	B-X
to	B-X
their	B-X
fast	B-X
generation	B-X
times	B-X
and	B-X
high	B-X
diversity	B-X
of	B-X
life	B-X
cycles	B-X
and	B-X
mating	B-X
systems	B-X
.	B-X

This	O
seems	O
to	O
be	O
the	O
case	O
since	O
cpxA	O
is	O
found	O
down	O
-	O
stream	O
of	O
cpxR	O
(	O
APL	O
_	O
0629	O
)	O
,	O
and	O
gene	O
APL	O
_	O
0627	O
is	O
a	O
hypothetical	O
two	O
-	O
component	O
sensor	O
protein	O
with	O
a	O
histidine	O
-	O
kinase	O
domain	O
.	O

e	O
)	O
Up	O
-	O
regulated	O
genes	O
which	O
are	O
conserved	O
and	O
predicted	O
to	O
code	O
for	O
OMPs	O
or	O
lipoproteins	O
<EOS>	B-X
Plasma	B-X
lipoprotein	B-X
metabolism	B-X
is	B-X
regulated	B-X
and	B-X
controlled	B-X
by	B-X
the	B-X
specific	B-X
apolipoprotein	B-X
(	B-X
apo-	B-X
)	B-X
constituents	B-X
of	B-X
the	B-X
various	B-X
lipoprotein	B-X
classes	B-X
.	B-X
The	B-X
major	B-X
apolipoproteins	B-X
include	B-X
apoE	B-X
,	B-X
apoB	B-X
,	B-X
apoA-I	B-X
,	B-X
apoA-II	B-X
,	B-X
apoA-IV	B-X
,	B-X
apoC-I	B-X
,	B-X
apoC-II	B-X
,	B-X
and	B-X
apoC-III	B-X
.	B-X
Specific	B-X
apolipoproteins	B-X
function	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
lipoprotein	B-X
metabolism	B-X
through	B-X
their	B-X
involvement	B-X
in	B-X
the	B-X
transport	B-X
and	B-X
redistribution	B-X
of	B-X
lipids	B-X
among	B-X
various	B-X
cells	B-X
and	B-X
tissues	B-X
,	B-X
through	B-X
their	B-X
role	B-X
as	B-X
cofactors	B-X
for	B-X
enzymes	B-X
of	B-X
lipid	B-X
metabolism	B-X
,	B-X
or	B-X
through	B-X
their	B-X
maintenance	B-X
of	B-X
the	B-X
structure	B-X
of	B-X
the	B-X
lipoprotein	B-X
particles	B-X
.	B-X
The	B-X
primary	B-X
structures	B-X
of	B-X
most	B-X
of	B-X
the	B-X
apolipoproteins	B-X
are	B-X
now	B-X
known	B-X
,	B-X
and	B-X
various	B-X
functional	B-X
domains	B-X
of	B-X
these	B-X
proteins	B-X
are	B-X
being	B-X
mapped	B-X
using	B-X
selective	B-X
chemical	B-X
modification	B-X
,	B-X
synthetic	B-X
peptides	B-X
,	B-X
and	B-X
monoclonal	B-X
antibodies	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
establishment	B-X
of	B-X
structure-function	B-X
relationships	B-X
has	B-X
been	B-X
greatly	B-X
advanced	B-X
by	B-X
the	B-X
identification	B-X
of	B-X
genetically	B-X
determined	B-X
variants	B-X
of	B-X
specific	B-X
apolipoproteins	B-X
that	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
disorder	B-X
of	B-X
lipoprotein	B-X
metabolism	B-X
.	B-X
Future	B-X
studies	B-X
will	B-X
rely	B-X
heavily	B-X
on	B-X
the	B-X
use	B-X
of	B-X
recombinant	B-X
DNA	B-X
technology	B-X
and	B-X
site-specific	B-X
mutagenesis	B-X
to	B-X
elucidate	B-X
further	B-X
the	B-X
correlations	B-X
between	B-X
structure	B-X
and	B-X
function	B-X
and	B-X
the	B-X
role	B-X
of	B-X
specific	B-X
apolipoproteins	B-X
in	B-X
lipoprotein	B-X
metabolism	B-X
.	B-X

The	O
main	O
goal	O
of	O
our	O
experiment	O
was	O
to	O
identify	O
genes	O
that	O
were	O
expressed	O
in	O
vivo	O
during	O
infection	O
of	O
the	O
natural	O
host	O
.	O

We	O
were	O
also	O
interested	O
by	O
genes	O
showing	O
high	O
-	O
level	O
of	O
sequence	O
conservation	O
among	O
different	O
field	O
and	O
reference	O
strains	O
[	O
25	O
]	O
,	O
and	O
coding	O
for	O
proteins	O
predicted	O
to	O
localize	O
to	O
the	O
outer	O
membrane	O
[	O
71	O
]	O
.	O

Three	O
genes	O
satisfied	O
those	O
criteria	O
:	O
two	O
that	O
are	O
coding	O
for	O
outer	O
membrane	O
proteins	O
(	O
APL	O
_	O
0959	O
and	O
irp	O
)	O
,	O
and	O
one	O
coding	O
for	O
a	O
lipoprotein	O
(	O
APL	O
_	O
0920	O
)	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

The	O
irp	O
(	O
iron	O
responsive	O
protein	O
)	O
gene	O
codes	O
for	O
a	O
predicted	O
TonB	O
-	O
dependant	O
receptor	O
,	O
possibly	O
involved	O
in	O
hemin	O
transport	O
.	O

However	O
,	O
since	O
this	O
was	O
deduced	O
from	O
sequence	O
homologies	O
,	O
the	O
real	O
function	O
of	O
irp	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
cannot	O
be	O
reliably	O
inferred	O
,	O
but	O
it	O
is	O
conserved	O
in	O
various	O
bacterial	O
pathogens	O
.	O

Interestingly	O
,	O
the	O
irp	O
gene	O
is	O
located	O
directly	O
next	O
to	O
APL	O
_	O
0920	O
,	O
a	O
conserved	O
lipoprotein	O
in	O
the	O
L20	B-Organism
genome	O
although	O
they	O
are	O
transcribed	O
in	O
opposite	O
directions	O
.	O

The	O
protein	O
sequence	O
deduced	O
from	O
the	O
APL	O
_	O
0920	O
gene	O
sequence	O
is	O
present	O
in	O
all	O
sequenced	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
strains	O
and	O
in	O
Mannheimia	B-Organism
haemolytica	I-Organism
PHL213	I-Organism
,	O
but	O
no	O
other	O
strong	O
homologies	O
can	O
be	O
found	O
in	O
other	O
bacterial	O
species	O
.	O

The	O
APL	O
_	O
0959	O
gene	O
codes	O
for	O
a	O
hypothetical	O
hemagglutinin	O
/	O
hemolysin	O
-	O
like	O
outer	O
membrane	O
protein	O
.	O

The	O
protein	O
sequence	O
deduced	O
from	O
the	O
gene	O
sequence	O
shares	O
approximately	O
30	O
%	O
identity	O
with	O
different	O
large	O
sections	O
of	O
the	O
filamentous	O
hemagglitinin	O
/	O
adhesin	O
(	O
FhaB	O
)	O
from	O
bacteria	O
of	O
the	O
Bordetella	B-Organism
genus	O
,	O
which	O
also	O
colonize	O
the	O
respiratory	O
tract	O
of	O
various	O
mammalian	O
hosts	O
.	O

While	O
it	O
was	O
first	O
identified	O
for	O
its	O
hemagglutination	O
properties	O
[	O
72	O
]	O
,	O
FHA	O
can	O
bind	O
carbohydrates	O
,	O
heparan	O
sulphate	O
and	O
integrin	O
[	O
73	O
]	O
.	O

It	O
is	O
the	O
most	O
important	O
adhesin	O
in	O
B	B-Organism
.	I-Organism
pertussis	I-Organism
,	O
and	O
deletion	O
of	O
FHA	O
in	O
B	B-Organism
.	I-Organism
bronchiseptica	I-Organism
,	O
another	O
important	O
swine	B-Organism
respiratory	O
pathogen	O
,	O
caused	O
lower	O
colonization	O
than	O
the	O
wild	O
-	O
type	O
strain	O
at	O
all	O
respiratory	O
tract	O
sites	O
tested	O
with	O
was	O
unable	O
to	O
cause	O
disease	O
[	O
74	O
]	O
.	O

The	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
FHA	O
homolog	O
is	O
conserved	O
amongst	O
all	O
field	O
and	O
reference	O
strains	O
previously	O
tested	O
[	O
25	O
]	O
,	O
and	O
was	O
predicted	O
to	O
locate	O
to	O
the	O
outer	O
membrane	O
[	O
71	O
]	O
.	O

In	O
B	B-Organism
.	I-Organism
bronchiseptica	I-Organism
,	O
FhaB	O
is	O
believed	O
to	O
be	O
important	O
early	O
in	O
the	O
infection	O
process	O
in	O
order	O
to	O
allow	O
colonization	O
of	O
the	O
ciliated	O
epithelial	O
cells	O
of	O
the	O
upper	O
respiratory	O
tract	O
.	O

In	O
Histophilus	B-Organism
somni	I-Organism
,	O
the	O
FhaB	O
homolog	O
is	O
thought	O
to	O
also	O
have	O
an	O
important	O
role	O
in	O
biofilm	O
formation	O
in	O
cases	O
of	O
myocarditis	O
caused	O
by	O
this	O
micro	O
-	O
organism	O
[	O
75	O
]	O
.	O

Up	O
-	O
regulation	O
of	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
fhaB	O
homolog	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
hints	O
at	O
a	O
similar	O
role	O
for	O
this	O
adhesin	O
in	O
the	O
establishment	O
of	O
pleuropneumonia	O
.	O

Surprisingly	O
,	O
this	O
gene	O
was	O
not	O
identified	O
as	O
up	O
-	O
regulated	O
in	O
previous	O
adhesion	O
experiments	O
performed	O
in	O
our	O
lab	O
[	O
9	O
]	O
,	O
and	O
it	O
even	O
showed	O
a	O
slight	O
,	O
although	O
not	O
significant	O
,	O
down	O
-	O
regulation	O
when	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
adhered	O
to	O
immortalized	O
lung	O
epithelial	O
cells	O
.	O
<EOS>	B-X
Transient	B-X
and	B-X
stable	B-X
vector	B-X
transfections	B-X
have	B-X
played	B-X
important	B-X
roles	B-X
in	B-X
illustrating	B-X
the	B-X
function	B-X
of	B-X
specific	B-X
genes/proteins	B-X
.	B-X
The	B-X
general	B-X
assumption	B-X
is	B-X
that	B-X
such	B-X
a	B-X
platform	B-X
could	B-X
effectively	B-X
link	B-X
a	B-X
given	B-X
gene/protein	B-X
to	B-X
gained	B-X
phenotypes	B-X
,	B-X
revealing	B-X
the	B-X
mechanism	B-X
of	B-X
how	B-X
a	B-X
gene	B-X
works	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
an	B-X
assumption	B-X
that	B-X
empty	B-X
vector-transfected	B-X
cells	B-X
preserve	B-X
the	B-X
cytogenetic	B-X
and	B-X
phenotypic	B-X
characteristics	B-X
,	B-X
and	B-X
represent	B-X
the	B-X
adequate	B-X
control	B-X
in	B-X
transfection	B-X
experiments	B-X
is	B-X
not	B-X
universally	B-X
valid	B-X
.	B-X
A	B-X
DNA	B-X
vector	B-X
,	B-X
a	B-X
transfection	B-X
reagent	B-X
,	B-X
expression	B-X
of	B-X
an	B-X
antibiotic	B-X
resistance	B-X
(	B-X
trans	B-X
)	B-X
gene	B-X
,	B-X
expression	B-X
of	B-X
a	B-X
reporter	B-X
(	B-X
trans	B-X
)	B-X
gene	B-X
,	B-X
and	B-X
selection	B-X
by	B-X
acute/chronic	B-X
antibiotic	B-X
treatment	B-X
may	B-X
evoke	B-X
cellular	B-X
responses	B-X
that	B-X
affect	B-X
the	B-X
biochemical	B-X
processes	B-X
under	B-X
investigation	B-X
.	B-X
We	B-X
exemplify	B-X
a	B-X
number	B-X
of	B-X
studies	B-X
,	B-X
which	B-X
reported	B-X
obvious	B-X
genomic	B-X
,	B-X
transcriptomic	B-X
and	B-X
phenotypic	B-X
changes	B-X
of	B-X
tumor	B-X
cells	B-X
after	B-X
transient/stable	B-X
transfection	B-X
of	B-X
an	B-X
empty	B-X
vector	B-X
.	B-X
To	B-X
further	B-X
address	B-X
the	B-X
common	B-X
mechanisms	B-X
of	B-X
these	B-X
unexpected	B-X
findings	B-X
,	B-X
we	B-X
will	B-X
apply	B-X
the	B-X
genome	B-X
theory	B-X
of	B-X
somatic	B-X
evolution	B-X
to	B-X
explain	B-X
stress-mediated	B-X
system	B-X
dynamics	B-X
and	B-X
the	B-X
limitations	B-X
of	B-X
predicting	B-X
the	B-X
system	B-X
behavior	B-X
solely	B-X
based	B-X
on	B-X
targeted	B-X
genes	B-X
.	B-X
We	B-X
conceptualize	B-X
that	B-X
the	B-X
diverse	B-X
experimental	B-X
manipulations	B-X
(	B-X
e.g.	B-X
,	B-X
transgene	B-X
overexpression	B-X
,	B-X
gene	B-X
knock	B-X
out/down	B-X
,	B-X
chemical	B-X
treatments	B-X
,	B-X
acute	B-X
changes	B-X
in	B-X
culture	B-X
conditions	B-X
,	B-X
etc	B-X
.	B-X
)	B-X
may	B-X
act	B-X
as	B-X
a	B-X
system	B-X
stress	B-X
,	B-X
promoting	B-X
intensive	B-X
genome-level	B-X
alterations	B-X
(	B-X
chromosomal	B-X
instability	B-X
,	B-X
CIN	B-X
)	B-X
,	B-X
epigenetic	B-X
and	B-X
phenotypic	B-X
alterations	B-X
,	B-X
which	B-X
are	B-X
beyond	B-X
the	B-X
function	B-X
of	B-X
manipulated	B-X
genes	B-X
.	B-X
Such	B-X
analysis	B-X
calls	B-X
for	B-X
more	B-X
attention	B-X
on	B-X
the	B-X
reduced	B-X
specificities	B-X
of	B-X
gene-focused	B-X
methodologies	B-X
.	B-X

This	O
can	O
either	O
reflect	O
differences	O
in	O
regulatory	O
events	O
between	O
a	O
freshly	O
isolated	O
field	O
strain	O
and	O
a	O
well	O
-	O
conserved	O
and	O
characterized	O
laboratory	O
strain	O
,	O
or	O
simply	O
that	O
in	O
vitro	O
experiments	O
,	O
however	O
carefully	O
designed	O
they	O
may	O
be	O
,	O
can	O
never	O
really	O
completely	O
reproduce	O
complex	O
in	O
vivo	O
environments	O
.	O

Despite	O
years	O
of	O
research	O
,	O
an	O
efficient	O
cross	O
-	O
serotype	O
vaccine	O
that	O
can	O
prevent	O
porcine	O
pleuropneumonia	O
has	O
yet	O
to	O
be	O
successfully	O
produced	O
.	O

To	O
generate	O
a	O
vaccine	O
that	O
provides	O
good	O
cross	O
-	O
serotype	O
protection	O
against	O
porcine	O
pleuropneumonia	O
,	O
one	O
would	O
most	O
probably	O
have	O
to	O
include	O
antigens	O
that	O
are	O
conserved	O
amongst	O
all	O
serotypes	O
that	O
the	O
host	O
could	O
encounter	O
and	O
be	O
surface	O
-	O
exposed	O
.	O

The	O
three	O
proteins	O
that	O
are	O
encoded	O
by	O
genes	O
fhaB	O
,	O
irp	O
and	O
APL	O
_	O
0920	O
have	O
all	O
these	O
features	O
,	O
and	O
might	O
therefore	O
represent	O
good	O
candidates	O
to	O
include	O
in	O
future	O
cross	O
-	O
serotype	O
vaccines	O
against	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

FHA	O
of	O
B	B-Organism
.	I-Organism
pertussis	I-Organism
is	O
present	O
in	O
various	O
combined	O
diphteria	O
-	O
tetanus	O
-	O
pertussis	O
(	O
dTpa	O
)	O
acellular	O
vaccines	O
.	O

These	O
vaccines	O
have	O
been	O
successfully	O
used	O
to	O
prevent	O
whopping	O
cough	O
and	O
have	O
contributed	O
to	O
a	O
considerable	O
decrease	O
in	O
the	O
number	O
of	O
cases	O
registered	O
per	O
year	O
[	O
76	O
]	O
.	O

Thus	O
the	O
A	B-Organism
.	I-Organism
pleuropneumonie	I-Organism
FhaB	O
homolog	O
represents	O
an	O
excellent	O
candidate	O
to	O
include	O
in	O
a	O
future	O
pleuropneumonia	O
vaccine	O
that	O
could	O
actually	O
lead	O
to	O
efficient	O
protection	O
against	O
this	O
important	O
swine	B-Organism
pathogen	O
.	O

Conclusions	O
<EOS>	B-X
[	B-X
Conclusions	B-X
of	B-X
the	B-X
First	B-X
Workshop	B-X
of	B-X
the	B-X
oncology	B-X
societies	B-X
AIOM	B-X
,	B-X
AIRO	B-X
and	B-X
SICO	B-X
about	B-X
pancreatic	B-X
cancer	B-X
]	B-X
.	B-X

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
study	O
represents	O
the	O
first	O
and	O
only	O
genome	O
-	O
wide	O
in	O
vivo	O
gene	O
expression	O
experiment	O
to	O
be	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
in	O
its	O
natural	O
host	O
,	O
the	O
pig	B-Organism
,	O
following	O
a	O
natural	O
infection	O
.	O

Of	O
the	O
150	O
genes	O
that	O
we	O
could	O
identify	O
as	O
differentially	O
expressed	O
,	O
72	O
showed	O
greater	O
levels	O
of	O
expression	O
in	O
vivo	O
at	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
than	O
in	O
a	O
rich	O
culture	O
medium	O
,	O
while	O
78	O
were	O
repressed	O
.	O

By	O
comparing	O
our	O
results	O
to	O
those	O
obtained	O
following	O
comparative	O
genomics	O
and	O
proteomics	O
experiments	O
,	O
we	O
were	O
able	O
to	O
identify	O
three	O
genes	O
that	O
were	O
conserved	O
in	O
tested	O
reference	O
strains	O
and	O
in	O
fresh	O
field	O
isolates	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
and	O
these	O
were	O
also	O
predicted	O
to	O
code	O
for	O
outer	O
membrane	O
proteins	O
or	O
lipoproteins	O
.	O
<EOS>	B-X
The	B-X
major	B-X
apolipoproteins	B-X
include	B-X
apoE	B-X
,	B-X
apoB	B-X
,	B-X
apoA-I	B-X
,	B-X
apoA-II	B-X
,	B-X
apoA-IV	B-X
,	B-X
apoC-I	B-X
,	B-X
apoC-II	B-X
,	B-X
and	B-X
apoC-III	B-X
.	B-X
Specific	B-X
apolipoproteins	B-X
function	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
lipoprotein	B-X
metabolism	B-X
through	B-X
their	B-X
involvement	B-X
in	B-X
the	B-X
transport	B-X
and	B-X
redistribution	B-X
of	B-X
lipids	B-X
among	B-X
various	B-X
cells	B-X
and	B-X
tissues	B-X
,	B-X
through	B-X
their	B-X
role	B-X
as	B-X
cofactors	B-X
for	B-X
enzymes	B-X
of	B-X
lipid	B-X
metabolism	B-X
,	B-X
or	B-X
through	B-X
their	B-X
maintenance	B-X
of	B-X
the	B-X
structure	B-X
of	B-X
the	B-X
lipoprotein	B-X
particles	B-X
.	B-X
The	B-X
primary	B-X
structures	B-X
of	B-X
most	B-X
of	B-X
the	B-X
apolipoproteins	B-X
are	B-X
now	B-X
known	B-X
,	B-X
and	B-X
various	B-X
functional	B-X
domains	B-X
of	B-X
these	B-X
proteins	B-X
are	B-X
being	B-X
mapped	B-X
using	B-X
selective	B-X
chemical	B-X
modification	B-X
,	B-X
synthetic	B-X
peptides	B-X
,	B-X
and	B-X
monoclonal	B-X
antibodies	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
establishment	B-X
of	B-X
structure-function	B-X
relationships	B-X
has	B-X
been	B-X
greatly	B-X
advanced	B-X
by	B-X
the	B-X
identification	B-X
of	B-X
genetically	B-X
determined	B-X
variants	B-X
of	B-X
specific	B-X
apolipoproteins	B-X
that	B-X
are	B-X
associated	B-X
with	B-X
a	B-X
disorder	B-X
of	B-X
lipoprotein	B-X
metabolism	B-X
.	B-X
Future	B-X
studies	B-X
will	B-X
rely	B-X
heavily	B-X
on	B-X
the	B-X
use	B-X
of	B-X
recombinant	B-X
DNA	B-X
technology	B-X
and	B-X
site-specific	B-X
mutagenesis	B-X
to	B-X
elucidate	B-X
further	B-X
the	B-X
correlations	B-X
between	B-X
structure	B-X
and	B-X
function	B-X
and	B-X
the	B-X
role	B-X
of	B-X
specific	B-X
apolipoproteins	B-X
in	B-X
lipoprotein	B-X
metabolism	B-X
.	B-X

These	O
three	O
genes	O
,	O
namely	O
fhaB	O
(	O
APL	O
_	O
0959	O
)	O
,	O
irp	O
(	O
APL	O
_	O
0919	O
)	O
and	O
APL	O
_	O
0920	O
,	O
could	O
all	O
represent	O
excellent	O
candidates	O
for	O
the	O
development	O
of	O
a	O
protective	O
cross	O
-	O
serotype	O
subunit	O
vaccine	O
against	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

While	O
our	O
results	O
can	O
help	O
decipher	O
some	O
of	O
the	O
adaptations	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
has	O
to	O
make	O
once	O
it	O
infects	O
the	O
host	O
,	O
much	O
more	O
research	O
is	O
necessary	O
in	O
order	O
to	O
understand	O
the	O
whole	O
picture	O
of	O
the	O
disease	O
.	O

The	O
acute	O
stage	O
and	O
the	O
chronic	O
stage	O
of	O
the	O
disease	O
are	O
probably	O
highly	O
different	O
conditions	O
,	O
and	O
it	O
would	O
be	O
interesting	O
in	O
future	O
works	O
to	O
compare	O
our	O
present	O
data	O
with	O
the	O
transcriptomic	O
profile	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
during	O
a	O
chronic	O
infection	O
.	O

Identification	O
of	O
the	O
Regulatory	O
Logic	O
Controlling	O
Salmonella	B-Organism
Pathoadaptation	O
by	O
the	O
SsrA	O
-	O
SsrB	O
Two	O
-	O
Component	O
System	O
<EOS>	B-X
Regulatory	B-X
evolution	B-X
,	B-X
in	B-X
which	B-X
non-coding	B-X
DNA	B-X
is	B-X
mutated	B-X
to	B-X
create	B-X
new	B-X
regulatory	B-X
nodes	B-X
,	B-X
also	B-X
contributes	B-X
to	B-X
this	B-X
diversity	B-X
to	B-X
allow	B-X
niche	B-X
adaptation	B-X
and	B-X
the	B-X
evolution	B-X
of	B-X
pathogenesis	B-X
.	B-X
To	B-X
survive	B-X
in	B-X
the	B-X
host	B-X
environment	B-X
,	B-X
Salmonella	B-X
enterica	B-X
uses	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
and	B-X
effector	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
activated	B-X
by	B-X
the	B-X
SsrA-SsrB	B-X
two-component	B-X
system	B-X
in	B-X
response	B-X
to	B-X
the	B-X
host	B-X
environment	B-X
.	B-X
To	B-X
better	B-X
understand	B-X
the	B-X
phenomenon	B-X
of	B-X
regulatory	B-X
evolution	B-X
in	B-X
S.	B-X
enterica	B-X
,	B-X
we	B-X
defined	B-X
the	B-X
SsrB	B-X
regulon	B-X
and	B-X
asked	B-X
how	B-X
this	B-X
transcription	B-X
factor	B-X
interacts	B-X
with	B-X
the	B-X
cis-regulatory	B-X
region	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
Using	B-X
ChIP-on-chip	B-X
,	B-X
cDNA	B-X
hybridization	B-X
,	B-X
and	B-X
comparative	B-X
genomics	B-X
analyses	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
SsrB-dependent	B-X
regulon	B-X
of	B-X
ancestral	B-X
and	B-X
horizontally	B-X
acquired	B-X
genes	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
used	B-X
a	B-X
genetic	B-X
screen	B-X
and	B-X
computational	B-X
analyses	B-X
integrating	B-X
experimental	B-X
data	B-X
from	B-X
S.	B-X
enterica	B-X
and	B-X
sequence	B-X
data	B-X
from	B-X
an	B-X
orthologous	B-X
regulatory	B-X
system	B-X
in	B-X
the	B-X
insect	B-X
endosymbiont	B-X
,	B-X
Sodalis	B-X
glossinidius	B-X
,	B-X
to	B-X
identify	B-X
the	B-X
conserved	B-X
yet	B-X
flexible	B-X
palindrome	B-X
sequence	B-X
that	B-X
defines	B-X
DNA	B-X
recognition	B-X
by	B-X
SsrB	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
a	B-X
representative	B-X
promoter	B-X
validated	B-X
this	B-X
palindrome	B-X
as	B-X
the	B-X
minimal	B-X
architecture	B-X
needed	B-X
for	B-X
regulatory	B-X
input	B-X
by	B-X
SsrB	B-X
.	B-X

Sequence	O
data	O
from	O
the	O
past	O
decade	O
has	O
laid	O
bare	O
the	O
significance	O
of	O
horizontal	O
gene	O
transfer	O
in	O
creating	O
genetic	O
diversity	O
in	O
the	O
bacterial	O
world	O
.	O
<EOS>	B-X
Sequence	B-X
data	B-X
from	B-X
the	B-X
past	B-X
decade	B-X
has	B-X
laid	B-X
bare	B-X
the	B-X
significance	B-X
of	B-X
horizontal	B-X
gene	B-X
transfer	B-X
in	B-X
creating	B-X
genetic	B-X
diversity	B-X
in	B-X
the	B-X
bacterial	B-X
world	B-X
.	B-X
Regulatory	B-X
evolution	B-X
,	B-X
in	B-X
which	B-X
non-coding	B-X
DNA	B-X
is	B-X
mutated	B-X
to	B-X
create	B-X
new	B-X
regulatory	B-X
nodes	B-X
,	B-X
also	B-X
contributes	B-X
to	B-X
this	B-X
diversity	B-X
to	B-X
allow	B-X
niche	B-X
adaptation	B-X
and	B-X
the	B-X
evolution	B-X
of	B-X
pathogenesis	B-X
.	B-X
To	B-X
better	B-X
understand	B-X
the	B-X
phenomenon	B-X
of	B-X
regulatory	B-X
evolution	B-X
in	B-X
S.	B-X
enterica	B-X
,	B-X
we	B-X
defined	B-X
the	B-X
SsrB	B-X
regulon	B-X
and	B-X
asked	B-X
how	B-X
this	B-X
transcription	B-X
factor	B-X
interacts	B-X
with	B-X
the	B-X
cis-regulatory	B-X
region	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
Using	B-X
ChIP-on-chip	B-X
,	B-X
cDNA	B-X
hybridization	B-X
,	B-X
and	B-X
comparative	B-X
genomics	B-X
analyses	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
SsrB-dependent	B-X
regulon	B-X
of	B-X
ancestral	B-X
and	B-X
horizontally	B-X
acquired	B-X
genes	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
used	B-X
a	B-X
genetic	B-X
screen	B-X
and	B-X
computational	B-X
analyses	B-X
integrating	B-X
experimental	B-X
data	B-X
from	B-X
S.	B-X
enterica	B-X
and	B-X
sequence	B-X
data	B-X
from	B-X
an	B-X
orthologous	B-X
regulatory	B-X
system	B-X
in	B-X
the	B-X
insect	B-X
endosymbiont	B-X
,	B-X
Sodalis	B-X
glossinidius	B-X
,	B-X
to	B-X
identify	B-X
the	B-X
conserved	B-X
yet	B-X
flexible	B-X
palindrome	B-X
sequence	B-X
that	B-X
defines	B-X
DNA	B-X
recognition	B-X
by	B-X
SsrB	B-X
.	B-X
These	B-X
data	B-X
provide	B-X
a	B-X
high-resolution	B-X
map	B-X
of	B-X
a	B-X
regulatory	B-X
network	B-X
and	B-X
the	B-X
underlying	B-X
logic	B-X
enabling	B-X
pathogen	B-X
adaptation	B-X
to	B-X
a	B-X
host	B-X
.	B-X

Regulatory	O
evolution	O
,	O
in	O
which	O
non	O
-	O
coding	O
DNA	O
is	O
mutated	O
to	O
create	O
new	O
regulatory	O
nodes	O
,	O
also	O
contributes	O
to	O
this	O
diversity	O
to	O
allow	O
niche	O
adaptation	O
and	O
the	O
evolution	O
of	O
pathogenesis	O
.	O
<EOS>	B-X
Sequence	B-X
data	B-X
from	B-X
the	B-X
past	B-X
decade	B-X
has	B-X
laid	B-X
bare	B-X
the	B-X
significance	B-X
of	B-X
horizontal	B-X
gene	B-X
transfer	B-X
in	B-X
creating	B-X
genetic	B-X
diversity	B-X
in	B-X
the	B-X
bacterial	B-X
world	B-X
.	B-X
Regulatory	B-X
evolution	B-X
,	B-X
in	B-X
which	B-X
non-coding	B-X
DNA	B-X
is	B-X
mutated	B-X
to	B-X
create	B-X
new	B-X
regulatory	B-X
nodes	B-X
,	B-X
also	B-X
contributes	B-X
to	B-X
this	B-X
diversity	B-X
to	B-X
allow	B-X
niche	B-X
adaptation	B-X
and	B-X
the	B-X
evolution	B-X
of	B-X
pathogenesis	B-X
.	B-X
To	B-X
better	B-X
understand	B-X
the	B-X
phenomenon	B-X
of	B-X
regulatory	B-X
evolution	B-X
in	B-X
S.	B-X
enterica	B-X
,	B-X
we	B-X
defined	B-X
the	B-X
SsrB	B-X
regulon	B-X
and	B-X
asked	B-X
how	B-X
this	B-X
transcription	B-X
factor	B-X
interacts	B-X
with	B-X
the	B-X
cis-regulatory	B-X
region	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
Using	B-X
ChIP-on-chip	B-X
,	B-X
cDNA	B-X
hybridization	B-X
,	B-X
and	B-X
comparative	B-X
genomics	B-X
analyses	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
SsrB-dependent	B-X
regulon	B-X
of	B-X
ancestral	B-X
and	B-X
horizontally	B-X
acquired	B-X
genes	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
used	B-X
a	B-X
genetic	B-X
screen	B-X
and	B-X
computational	B-X
analyses	B-X
integrating	B-X
experimental	B-X
data	B-X
from	B-X
S.	B-X
enterica	B-X
and	B-X
sequence	B-X
data	B-X
from	B-X
an	B-X
orthologous	B-X
regulatory	B-X
system	B-X
in	B-X
the	B-X
insect	B-X
endosymbiont	B-X
,	B-X
Sodalis	B-X
glossinidius	B-X
,	B-X
to	B-X
identify	B-X
the	B-X
conserved	B-X
yet	B-X
flexible	B-X
palindrome	B-X
sequence	B-X
that	B-X
defines	B-X
DNA	B-X
recognition	B-X
by	B-X
SsrB	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
a	B-X
representative	B-X
promoter	B-X
validated	B-X
this	B-X
palindrome	B-X
as	B-X
the	B-X
minimal	B-X
architecture	B-X
needed	B-X
for	B-X
regulatory	B-X
input	B-X
by	B-X
SsrB	B-X
.	B-X
These	B-X
data	B-X
provide	B-X
a	B-X
high-resolution	B-X
map	B-X
of	B-X
a	B-X
regulatory	B-X
network	B-X
and	B-X
the	B-X
underlying	B-X
logic	B-X
enabling	B-X
pathogen	B-X
adaptation	B-X
to	B-X
a	B-X
host	B-X
.	B-X

To	O
survive	O
in	O
the	O
host	O
environment	O
,	O
Salmonella	B-Organism
enterica	I-Organism
uses	O
a	O
type	O
III	O
secretion	O
system	O
and	O
effector	O
proteins	O
,	O
which	O
are	O
activated	O
by	O
the	O
SsrA	O
-	O
SsrB	O
two	O
-	O
component	O
system	O
in	O
response	O
to	O
the	O
host	O
environment	O
.	O

To	O
better	O
understand	O
the	O
phenomenon	O
of	O
regulatory	O
evolution	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
,	O
we	O
defined	O
the	O
SsrB	O
regulon	O
and	O
asked	O
how	O
this	O
transcription	O
factor	O
interacts	O
with	O
the	O
cis	O
-	O
regulatory	O
region	O
of	O
target	O
genes	O
.	O

Using	O
ChIP	O
-	O
on	O
-	O
chip	O
,	O
cDNA	O
hybridization	O
,	O
and	O
comparative	O
genomics	O
analyses	O
,	O
we	O
describe	O
the	O
SsrB	O
-	O
dependent	O
regulon	O
of	O
ancestral	O
and	O
horizontally	O
acquired	O
genes	O
.	O
<EOS>	B-X
Regulatory	B-X
evolution	B-X
,	B-X
in	B-X
which	B-X
non-coding	B-X
DNA	B-X
is	B-X
mutated	B-X
to	B-X
create	B-X
new	B-X
regulatory	B-X
nodes	B-X
,	B-X
also	B-X
contributes	B-X
to	B-X
this	B-X
diversity	B-X
to	B-X
allow	B-X
niche	B-X
adaptation	B-X
and	B-X
the	B-X
evolution	B-X
of	B-X
pathogenesis	B-X
.	B-X
To	B-X
survive	B-X
in	B-X
the	B-X
host	B-X
environment	B-X
,	B-X
Salmonella	B-X
enterica	B-X
uses	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
and	B-X
effector	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
activated	B-X
by	B-X
the	B-X
SsrA-SsrB	B-X
two-component	B-X
system	B-X
in	B-X
response	B-X
to	B-X
the	B-X
host	B-X
environment	B-X
.	B-X
To	B-X
better	B-X
understand	B-X
the	B-X
phenomenon	B-X
of	B-X
regulatory	B-X
evolution	B-X
in	B-X
S.	B-X
enterica	B-X
,	B-X
we	B-X
defined	B-X
the	B-X
SsrB	B-X
regulon	B-X
and	B-X
asked	B-X
how	B-X
this	B-X
transcription	B-X
factor	B-X
interacts	B-X
with	B-X
the	B-X
cis-regulatory	B-X
region	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
Using	B-X
ChIP-on-chip	B-X
,	B-X
cDNA	B-X
hybridization	B-X
,	B-X
and	B-X
comparative	B-X
genomics	B-X
analyses	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
SsrB-dependent	B-X
regulon	B-X
of	B-X
ancestral	B-X
and	B-X
horizontally	B-X
acquired	B-X
genes	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
used	B-X
a	B-X
genetic	B-X
screen	B-X
and	B-X
computational	B-X
analyses	B-X
integrating	B-X
experimental	B-X
data	B-X
from	B-X
S.	B-X
enterica	B-X
and	B-X
sequence	B-X
data	B-X
from	B-X
an	B-X
orthologous	B-X
regulatory	B-X
system	B-X
in	B-X
the	B-X
insect	B-X
endosymbiont	B-X
,	B-X
Sodalis	B-X
glossinidius	B-X
,	B-X
to	B-X
identify	B-X
the	B-X
conserved	B-X
yet	B-X
flexible	B-X
palindrome	B-X
sequence	B-X
that	B-X
defines	B-X
DNA	B-X
recognition	B-X
by	B-X
SsrB	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
a	B-X
representative	B-X
promoter	B-X
validated	B-X
this	B-X
palindrome	B-X
as	B-X
the	B-X
minimal	B-X
architecture	B-X
needed	B-X
for	B-X
regulatory	B-X
input	B-X
by	B-X
SsrB	B-X
.	B-X

Further	O
,	O
we	O
used	O
a	O
genetic	O
screen	O
and	O
computational	O
analyses	O
integrating	O
experimental	O
data	O
from	O
S	B-Organism
.	I-Organism
enterica	I-Organism
and	O
sequence	O
data	O
from	O
an	O
orthologous	O
regulatory	O
system	O
in	O
the	O
insect	O
endosymbiont	O
,	O
Sodalis	B-Organism
glossinidius	I-Organism
,	O
to	O
identify	O
the	O
conserved	O
yet	O
flexible	O
palindrome	O
sequence	O
that	O
defines	O
DNA	O
recognition	O
by	O
SsrB	O
.	O

Mutational	O
analysis	O
of	O
a	O
representative	O
promoter	O
validated	O
this	O
palindrome	O
as	O
the	O
minimal	O
architecture	O
needed	O
for	O
regulatory	O
input	O
by	O
SsrB	O
.	O
<EOS>	B-X
Regulatory	B-X
evolution	B-X
,	B-X
in	B-X
which	B-X
non-coding	B-X
DNA	B-X
is	B-X
mutated	B-X
to	B-X
create	B-X
new	B-X
regulatory	B-X
nodes	B-X
,	B-X
also	B-X
contributes	B-X
to	B-X
this	B-X
diversity	B-X
to	B-X
allow	B-X
niche	B-X
adaptation	B-X
and	B-X
the	B-X
evolution	B-X
of	B-X
pathogenesis	B-X
.	B-X
To	B-X
survive	B-X
in	B-X
the	B-X
host	B-X
environment	B-X
,	B-X
Salmonella	B-X
enterica	B-X
uses	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
and	B-X
effector	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
activated	B-X
by	B-X
the	B-X
SsrA-SsrB	B-X
two-component	B-X
system	B-X
in	B-X
response	B-X
to	B-X
the	B-X
host	B-X
environment	B-X
.	B-X
To	B-X
better	B-X
understand	B-X
the	B-X
phenomenon	B-X
of	B-X
regulatory	B-X
evolution	B-X
in	B-X
S.	B-X
enterica	B-X
,	B-X
we	B-X
defined	B-X
the	B-X
SsrB	B-X
regulon	B-X
and	B-X
asked	B-X
how	B-X
this	B-X
transcription	B-X
factor	B-X
interacts	B-X
with	B-X
the	B-X
cis-regulatory	B-X
region	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
Using	B-X
ChIP-on-chip	B-X
,	B-X
cDNA	B-X
hybridization	B-X
,	B-X
and	B-X
comparative	B-X
genomics	B-X
analyses	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
SsrB-dependent	B-X
regulon	B-X
of	B-X
ancestral	B-X
and	B-X
horizontally	B-X
acquired	B-X
genes	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
used	B-X
a	B-X
genetic	B-X
screen	B-X
and	B-X
computational	B-X
analyses	B-X
integrating	B-X
experimental	B-X
data	B-X
from	B-X
S.	B-X
enterica	B-X
and	B-X
sequence	B-X
data	B-X
from	B-X
an	B-X
orthologous	B-X
regulatory	B-X
system	B-X
in	B-X
the	B-X
insect	B-X
endosymbiont	B-X
,	B-X
Sodalis	B-X
glossinidius	B-X
,	B-X
to	B-X
identify	B-X
the	B-X
conserved	B-X
yet	B-X
flexible	B-X
palindrome	B-X
sequence	B-X
that	B-X
defines	B-X
DNA	B-X
recognition	B-X
by	B-X
SsrB	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
a	B-X
representative	B-X
promoter	B-X
validated	B-X
this	B-X
palindrome	B-X
as	B-X
the	B-X
minimal	B-X
architecture	B-X
needed	B-X
for	B-X
regulatory	B-X
input	B-X
by	B-X
SsrB	B-X
.	B-X
These	B-X
data	B-X
provide	B-X
a	B-X
high-resolution	B-X
map	B-X
of	B-X
a	B-X
regulatory	B-X
network	B-X
and	B-X
the	B-X
underlying	B-X
logic	B-X
enabling	B-X
pathogen	B-X
adaptation	B-X
to	B-X
a	B-X
host	B-X
.	B-X

These	O
data	O
provide	O
a	O
high	O
-	O
resolution	O
map	O
of	O
a	O
regulatory	O
network	O
and	O
the	O
underlying	O
logic	O
enabling	O
pathogen	O
adaptation	O
to	O
a	O
host	O
.	O
<EOS>	B-X
Sequence	B-X
data	B-X
from	B-X
the	B-X
past	B-X
decade	B-X
has	B-X
laid	B-X
bare	B-X
the	B-X
significance	B-X
of	B-X
horizontal	B-X
gene	B-X
transfer	B-X
in	B-X
creating	B-X
genetic	B-X
diversity	B-X
in	B-X
the	B-X
bacterial	B-X
world	B-X
.	B-X
Regulatory	B-X
evolution	B-X
,	B-X
in	B-X
which	B-X
non-coding	B-X
DNA	B-X
is	B-X
mutated	B-X
to	B-X
create	B-X
new	B-X
regulatory	B-X
nodes	B-X
,	B-X
also	B-X
contributes	B-X
to	B-X
this	B-X
diversity	B-X
to	B-X
allow	B-X
niche	B-X
adaptation	B-X
and	B-X
the	B-X
evolution	B-X
of	B-X
pathogenesis	B-X
.	B-X
To	B-X
survive	B-X
in	B-X
the	B-X
host	B-X
environment	B-X
,	B-X
Salmonella	B-X
enterica	B-X
uses	B-X
a	B-X
type	B-X
III	B-X
secretion	B-X
system	B-X
and	B-X
effector	B-X
proteins	B-X
,	B-X
which	B-X
are	B-X
activated	B-X
by	B-X
the	B-X
SsrA-SsrB	B-X
two-component	B-X
system	B-X
in	B-X
response	B-X
to	B-X
the	B-X
host	B-X
environment	B-X
.	B-X
To	B-X
better	B-X
understand	B-X
the	B-X
phenomenon	B-X
of	B-X
regulatory	B-X
evolution	B-X
in	B-X
S.	B-X
enterica	B-X
,	B-X
we	B-X
defined	B-X
the	B-X
SsrB	B-X
regulon	B-X
and	B-X
asked	B-X
how	B-X
this	B-X
transcription	B-X
factor	B-X
interacts	B-X
with	B-X
the	B-X
cis-regulatory	B-X
region	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
used	B-X
a	B-X
genetic	B-X
screen	B-X
and	B-X
computational	B-X
analyses	B-X
integrating	B-X
experimental	B-X
data	B-X
from	B-X
S.	B-X
enterica	B-X
and	B-X
sequence	B-X
data	B-X
from	B-X
an	B-X
orthologous	B-X
regulatory	B-X
system	B-X
in	B-X
the	B-X
insect	B-X
endosymbiont	B-X
,	B-X
Sodalis	B-X
glossinidius	B-X
,	B-X
to	B-X
identify	B-X
the	B-X
conserved	B-X
yet	B-X
flexible	B-X
palindrome	B-X
sequence	B-X
that	B-X
defines	B-X
DNA	B-X
recognition	B-X
by	B-X
SsrB	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
a	B-X
representative	B-X
promoter	B-X
validated	B-X
this	B-X
palindrome	B-X
as	B-X
the	B-X
minimal	B-X
architecture	B-X
needed	B-X
for	B-X
regulatory	B-X
input	B-X
by	B-X
SsrB	B-X
.	B-X
These	B-X
data	B-X
provide	B-X
a	B-X
high-resolution	B-X
map	B-X
of	B-X
a	B-X
regulatory	B-X
network	B-X
and	B-X
the	B-X
underlying	B-X
logic	B-X
enabling	B-X
pathogen	B-X
adaptation	B-X
to	B-X
a	B-X
host	B-X
.	B-X

Introduction	O

Precise	O
gene	O
regulation	O
is	O
crucial	O
to	O
the	O
successful	O
activation	O
and	O
execution	O
of	O
virulence	O
programs	O
for	O
all	O
pathogenic	O
organisms	O
.	O

The	O
acquisition	O
of	O
genes	O
through	O
horizontal	O
gene	O
transfer	O
,	O
a	O
widespread	O
means	O
of	O
bacterial	O
evolution	O
[	O
1	O
]	O
,	O
requires	O
a	O
process	O
to	O
integrate	O
new	O
coding	O
sequence	O
into	O
pre	O
-	O
existing	O
regulatory	O
circuitry	O
.	O

Silencing	O
of	O
horizontally	O
-	O
acquired	O
genes	O
by	O
DNA	O
binding	O
proteins	O
like	O
H	O
-	O
NS	O
is	O
one	O
way	O
some	O
incoming	O
genes	O
are	O
initially	O
controlled	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
,	O
which	O
can	O
then	O
be	O
subject	O
to	O
regulatory	O
evolution	O
by	O
mutating	O
cis	O
-	O
regulatory	O
operator	O
regions	O
to	O
select	O
for	O
optional	O
gene	O
expression	O
.	O

The	O
eventual	O
promoter	O
architecture	O
selected	O
to	O
deploy	O
virulence	O
genes	O
is	O
often	O
modular	O
and	O
should	O
reflect	O
a	O
design	O
that	O
maximizes	O
organismal	O
fitness	O
while	O
limiting	O
fitness	O
trade	O
-	O
offs	O
and	O
antagonistic	O
pleiotropy	O
[	O
4	O
]	O
.	O

Both	O
simulated	O
[	O
5	O
]	O
and	O
functional	O
experiments	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
show	O
that	O
mutation	O
of	O
cis	O
-	O
regulatory	O
sequences	O
can	O
be	O
rapid	O
,	O
and	O
that	O
plasticity	O
-	O
the	O
degree	O
to	O
which	O
regulatory	O
mutation	O
can	O
perturb	O
the	O
larger	O
gene	O
network	O
-	O
can	O
be	O
well	O
tolerated	O
in	O
bacterial	O
systems	O
.	O

Promoter	O
architectures	O
that	O
control	O
quantitative	O
traits	O
such	O
as	O
bacterial	O
virulence	O
are	O
,	O
in	O
fact	O
,	O
modular	O
and	O
evolvable	O
[	O
8	O
]	O
.	O

For	O
instance	O
,	O
Salmonella	B-Organism
enterica	I-Organism
has	O
a	O
multi	O
-	O
faceted	O
pathogenic	O
strategy	O
fine	O
-	O
tuned	O
by	O
several	O
transcriptional	O
regulators	O
.	O

Intracellular	O
survival	O
and	O
persistence	O
of	O
Salmonella	B-Organism
requires	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
encoded	O
in	O
a	O
horizontally	O
-	O
acquired	O
genomic	O
island	O
called	O
Salmonella	B-Organism
Pathogenicity	O
Island	O
-	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

T3SS	O
are	O
complex	O
secretion	O
machines	O
that	O
deliver	O
bacterial	O
effector	O
proteins	O
directly	O
into	O
host	O
cells	O
through	O
an	O
injectisome	O
during	O
infection	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
.	O

Several	O
ancestral	O
regulators	O
control	O
the	O
genes	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
including	O
the	O
two	O
-	O
component	O
systems	O
EnvZ	O
-	O
OmpR	O
and	O
PhoQ	O
-	O
PhoP	O
,	O
and	O
the	O
regulatory	O
protein	O
SlyA	O
[	O
13	O
]	O
.	O

SsrA	O
-	O
SsrB	O
is	O
another	O
two	O
-	O
component	O
regulatory	O
system	O
co	O
-	O
inherited	O
by	O
genetic	O
linkage	O
with	O
the	O
SPI	O
-	O
2	O
locus	O
that	O
is	O
essential	O
for	O
gene	O
expression	O
in	O
SPI	O
-	O
2	O
[	O
14	O
]	O
-	O
[	O
16	O
]	O
.	O

SsrA	O
is	O
a	O
sensor	O
kinase	O
activated	O
in	O
the	O
host	O
environment	O
that	O
phosphorylates	O
the	O
SsrB	O
response	O
regulator	O
to	O
create	O
an	O
active	O
transcription	O
factor	O
needed	O
for	O
spatiotemporal	O
control	O
of	O
virulence	O
genes	O
[	O
13	O
]	O
,	O
[	O
17	O
]	O
.	O

In	O
the	O
Salmonella	B-Organism
genus	O
,	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
is	O
found	O
only	O
in	O
pathogenic	O
serotypes	O
of	O
Salmonella	B-Organism
enterica	I-Organism
that	O
infect	O
warm	O
-	O
blooded	O
animals	O
and	O
is	O
absent	O
from	O
Salmonella	B-Organism
bongori	I-Organism
,	O
which	O
colonizes	O
cold	O
-	O
blooded	O
animals	O
[	O
18	O
]	O
.	O

It	O
is	O
generally	O
accepted	O
that	O
SPI	O
-	O
2	O
was	O
acquired	O
by	O
Salmonella	B-Organism
enterica	I-Organism
after	O
divergence	O
from	O
S	B-Organism
.	I-Organism
bongori	I-Organism
,	O
providing	O
a	O
useful	O
pedigree	O
to	O
study	O
regulatory	O
evolution	O
influenced	O
by	O
SsrB	O
.	O

We	O
recently	O
demonstrated	O
the	O
evolutionary	O
significance	O
of	O
cis	O
-	O
regulatory	O
mutations	O
for	O
pathoadaptation	O
of	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
(	O
S	B-Organism
.	I-Organism
Typhimurium	I-Organism
)	O
to	O
an	O
animal	O
host	O
[	O
19	O
]	O
.	O

Our	O
focus	O
was	O
on	O
SsrB	O
because	O
of	O
its	O
broad	O
conservation	O
among	O
the	O
pathogenic	O
Salmonellae	B-Organism
and	O
its	O
essentiality	O
for	O
animal	O
infection	O
,	O
suggesting	O
it	O
coordinates	O
fundamental	O
aspects	O
of	O
Salmonella	B-Organism
pathogenesis	O
beyond	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
.	O

In	O
this	O
study	O
we	O
investigated	O
how	O
regulatory	O
evolution	O
assimilates	O
horizontally	O
acquired	O
and	O
ancestral	O
genes	O
into	O
the	O
SsrB	O
regulon	O
on	O
a	O
genome	O
-	O
wide	O
scale	O
using	O
an	O
integrated	O
set	O
of	O
experimental	O
methods	O
.	O

Combining	O
our	O
data	O
with	O
previous	O
biochemical	O
work	O
,	O
along	O
with	O
comparative	O
genomic	O
analyses	O
with	O
an	O
orthologous	O
T3SS	O
-	O
encoding	O
genomic	O
island	O
in	O
the	O
tsetse	O
fly	O
endosymbiont	O
,	O
Sodalis	B-Organism
glossinidius	I-Organism
,	O
we	O
reveal	O
the	O
flexible	O
DNA	O
palindrome	O
that	O
distributes	O
SsrB	O
in	O
the	O
genome	O
to	O
influence	O
transcriptional	O
activation	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
and	O
almost	O
all	O
of	O
its	O
accessory	O
effector	O
proteins	O
.	O

Our	O
data	O
uncovers	O
the	O
principal	O
SsrB	O
circuitry	O
that	O
appears	O
to	O
have	O
been	O
conserved	O
to	O
support	O
multiple	O
bacterial	O
lifestyles	O
,	O
including	O
parasitic	O
and	O
mutualist	O
symbioses	O
.	O

Results	O

Transcriptional	O
profiling	O
of	O
an	O
ssrB	O
mutant	O
To	O
begin	O
to	O
understand	O
regulatory	O
evolution	O
and	O
network	O
expansion	O
of	O
the	O
SsrB	O
response	O
regulator	O
,	O
we	O
profiled	O
the	O
transcriptome	O
of	O
an	O
ssrB	O
mutant	O
and	O
compared	O
it	O
to	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
wild	O
-	O
type	O
cells	O
grown	O
in	O
an	O
acidic	O
minimal	O
medium	O
that	O
activates	O
the	O
SsrA	O
-	O
SsrB	O
two	O
-	O
component	O
regulatory	O
system	O
[	O
20	O
]	O
.	O

We	O
identified	O
133	O
genes	O
that	O
were	O
significantly	O
down	O
-	O
regulated	O
in	O
the	O
ssrB	O
mutant	O
[	O
z	O
<	O
-	O
1	O
.	O
96	O
]	O
[	O
21	O
]	O
(	O
Table	O
1	O
)	O
.	O

This	O
included	O
almost	O
all	O
genes	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
as	O
well	O
as	O
effector	O
genes	O
encoded	O
throughout	O
the	O
genome	O
(	O
Dataset	O
S1	O
)	O
.	O

Next	O
,	O
we	O
performed	O
a	O
Clusters	O
of	O
Orthologous	O
Groups	O
(	O
COG	O
)	O
analysis	O
[	O
22	O
]	O
on	O
the	O
118	O
genes	O
that	O
had	O
an	O
ortholog	O
in	O
the	O
annotated	O
genome	O
of	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
strain	I-Organism
LT2	I-Organism
[	O
23	O
]	O
.	O
<EOS>	B-X
Salmonella	B-X
enterica	B-X
subspecies	B-X
I	B-X
,	B-X
serovar	B-X
Typhimurium	B-X
(	B-X
S.	B-X
typhimurium	B-X
)	B-X
,	B-X
is	B-X
a	B-X
leading	B-X
cause	B-X
of	B-X
human	B-X
gastroenteritis	B-X
,	B-X
and	B-X
is	B-X
used	B-X
as	B-X
a	B-X
mouse	B-X
model	B-X
of	B-X
human	B-X
typhoid	B-X
fever	B-X
.	B-X
Here	B-X
we	B-X
sequenced	B-X
the	B-X
4,857-kilobase	B-X
(	B-X
kb	B-X
)	B-X
chromosome	B-X
and	B-X
94-kb	B-X
virulence	B-X
plasmid	B-X
of	B-X
S.	B-X
typhimurium	B-X
strain	B-X
LT2	B-X
.	B-X
The	B-X
distribution	B-X
of	B-X
close	B-X
homologues	B-X
of	B-X
S.	B-X
typhimurium	B-X
LT2	B-X
genes	B-X
in	B-X
eight	B-X
related	B-X
enterobacteria	B-X
was	B-X
determined	B-X
using	B-X
previously	B-X
completed	B-X
genomes	B-X
of	B-X
three	B-X
related	B-X
bacteria	B-X
,	B-X
sample	B-X
sequencing	B-X
of	B-X
both	B-X
S.	B-X
enterica	B-X
serovar	B-X
Paratyphi	B-X
A	B-X
(	B-X
S.	B-X
paratyphi	B-X
A	B-X
)	B-X
and	B-X
Klebsiella	B-X
pneumoniae	B-X
,	B-X
and	B-X
hybridization	B-X
of	B-X
three	B-X
unsequenced	B-X
genomes	B-X
to	B-X
a	B-X
microarray	B-X
of	B-X
S.	B-X
typhimurium	B-X
LT2	B-X
genes	B-X
.	B-X
Lateral	B-X
transfer	B-X
of	B-X
genes	B-X
is	B-X
frequent	B-X
,	B-X
with	B-X
11	B-X
%	B-X
of	B-X
the	B-X
S.	B-X
typhimurium	B-X
LT2	B-X
genes	B-X
missing	B-X
from	B-X
S.	B-X
enterica	B-X
serovar	B-X
Typhi	B-X
(	B-X
S.	B-X
typhi	B-X
)	B-X
,	B-X
and	B-X
29	B-X
%	B-X
missing	B-X
from	B-X
Escherichia	B-X
coli	B-X
K12	B-X
.	B-X
The	B-X
352	B-X
gene	B-X
homologues	B-X
of	B-X
S.	B-X
typhimurium	B-X
LT2	B-X
confined	B-X
to	B-X
subspecies	B-X
I	B-X
of	B-X
S.	B-X
enterica-containing	B-X
most	B-X
mammalian	B-X
and	B-X
bird	B-X
pathogens-are	B-X
useful	B-X
for	B-X
studies	B-X
of	B-X
epidemiology	B-X
,	B-X
host	B-X
specificity	B-X
and	B-X
pathogenesis	B-X
.	B-X

Among	O
these	O
,	O
45	O
genes	O
lacked	O
a	O
functional	O
COG	O
assignment	O
and	O
the	O
73	O
remaining	O
genes	O
were	O
distributed	O
among	O
86	O
COGs	O
(	O
Figure	O
1	O
)	O
.	O

The	O
majority	O
of	O
functions	O
in	O
the	O
latter	O
groups	O
are	O
in	O
transport	O
,	O
secretion	O
,	O
and	O
trafficking	O
of	O
cellular	O
components	O
in	O
addition	O
to	O
protein	O
and	O
membrane	O
modification	O
.	O

The	O
SsrA	O
-	O
SsrB	O
system	O
was	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
into	O
the	O
S	B-Organism
.	I-Organism
enterica	I-Organism
species	O
after	O
divergence	O
from	O
what	O
is	O
now	O
extant	O
S	B-Organism
.	I-Organism
bongori	I-Organism
.	O

As	O
such	O
,	O
S	B-Organism
.	I-Organism
bongori	I-Organism
has	O
evolved	O
in	O
the	O
absence	O
of	O
SsrA	O
-	O
SsrB	O
and	O
its	O
regulatory	O
architecture	O
has	O
not	O
been	O
influenced	O
by	O
it	O
.	O

Orthologous	O
genes	O
ancestral	O
to	O
both	O
species	O
but	O
regulated	O
by	O
SsrB	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
provide	O
evidence	O
for	O
network	O
expansion	O
and	O
regulatory	O
evolution	O
that	O
we	O
previously	O
showed	O
can	O
be	O
mapped	O
to	O
a	O
single	O
cis	O
-	O
input	O
location	O
by	O
using	O
functional	O
and	O
comparative	O
genomics	O
[	O
19	O
]	O
.	O

To	O
expand	O
on	O
this	O
,	O
we	O
used	O
a	O
reciprocal	O
BLAST	O
-	O
based	O
analysis	O
and	O
identified	O
47	O
orthologs	O
in	O
S	B-Organism
.	I-Organism
bongori	I-Organism
among	O
the	O
133	O
genes	O
whose	O
transcription	O
was	O
down	O
-	O
regulated	O
in	O
an	O
ssrB	O
mutant	O
(	O
Table	O
1	O
)	O
.	O

In	O
DeltassrB	O
cells	O
,	O
the	O
mean	O
fold	O
-	O
change	O
of	O
the	O
orthologous	O
genes	O
(	O
-	O
6	O
.	O
1	O
-	O
fold	O
)	O
was	O
subtler	O
than	O
for	O
the	O
S	B-Organism
.	I-Organism
enterica	I-Organism
-	O
specific	O
gene	O
set	O
(	O
mean	O
-	O
21	O
.	O
2	O
-	O
fold	O
)	O
,	O
which	O
included	O
the	O
T3SS	O
and	O
associated	O
effector	O
genes	O
(	O
Dataset	O
S1	O
)	O
.	O

We	O
also	O
determined	O
the	O
distribution	O
of	O
down	O
-	O
regulated	O
genes	O
among	O
genomic	O
islands	O
[	O
24	O
]	O
,	O
including	O
prophages	O
,	O
pathogenicity	O
islands	O
(	O
SPI	O
-	O
islands	O
)	O
and	O
additional	O
regions	O
of	O
difference	O
(	O
ROD	O
)	O
between	O
S	B-Organism
.	I-Organism
enterica	I-Organism
and	O
S	B-Organism
.	I-Organism
bongori	I-Organism
(	O
Dataset	O
S2	O
)	O
.	O

For	O
this	O
we	O
used	O
a	O
BLAST	O
-	O
based	O
comparison	O
of	O
genome	O
-	O
wide	O
synteny	O
between	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
and	O
S	B-Organism
.	I-Organism
bongori	I-Organism
and	O
identified	O
50	O
ROD	O
that	O
included	O
17	O
previously	O
reported	O
SPI	O
-	O
islands	O
and	O
prophages	O
.	O

Of	O
the	O
133	O
down	O
-	O
regulated	O
genes	O
identified	O
,	O
56	O
were	O
present	O
within	O
genomic	O
islands	O
(	O
Table	O
1	O
)	O
,	O
with	O
a	O
mean	O
change	O
in	O
gene	O
expression	O
of	O
-	O
25	O
.	O
3	O
-	O
fold	O
in	O
DeltassrB	O
cells	O
.	O

Genome	O
-	O
wide	O
SsrB	O
interactions	O

To	O
examine	O
SsrB	O
allocation	O
on	O
the	O
chromosome	O
in	O
vivo	O
,	O
we	O
isolated	O
functional	O
SsrB	O
-	O
DNA	O
interactions	O
using	O
chromatin	O
immunoprecipitation	O
and	O
examined	O
the	O
bound	O
DNA	O
by	O
chip	O
analysis	O
(	O
ChIP	O
-	O
on	O
-	O
chip	O
)	O
using	O
an	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
SL1344	I-Organism
array	O
containing	O
44	O
,	O
021	O
probes	O
.	O

With	O
this	O
method	O
,	O
we	O
identified	O
256	O
significant	O
interaction	O
peaks	O
distributed	O
throughout	O
the	O
genome	O
that	O
were	O
enriched	O
under	O
SsrB	O
-	O
activating	O
conditions	O
and	O
with	O
interaction	O
scores	O
three	O
standard	O
deviations	O
greater	O
than	O
the	O
mean	O
probe	O
score	O
(	O
Figure	O
2A	O
and	O
Table	O
1	O
)	O
.	O

Of	O
these	O
256	O
peaks	O
,	O
126	O
(	O
49	O
%	O
)	O
occurred	O
within	O
coding	O
regions	O
of	O
genes	O
(	O
CDS	O
)	O
and	O
130	O
(	O
51	O
%	O
)	O
were	O
in	O
intergenic	O
regions	O
(	O
IGR	O
)	O
.	O

Given	O
the	O
strong	O
influence	O
of	O
SsrB	O
on	O
horizontally	O
acquired	O
genes	O
(	O
Table	O
1	O
)	O
,	O
we	O
plotted	O
the	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
against	O
all	O
genomic	O
islands	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
SL1344	I-Organism
.	O
<EOS>	B-X
With	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
hosts	B-X
,	B-X
Salmonella	B-X
enterica	B-X
serovar	B-X
Typhimurium	B-X
(	B-X
S.	B-X
Typhimurium	B-X
)	B-X
is	B-X
the	B-X
major	B-X
cause	B-X
of	B-X
gastroenteritis	B-X
in	B-X
human	B-X
beings	B-X
and	B-X
systemic	B-X
disease	B-X
in	B-X
susceptible	B-X
mice	B-X
strains	B-X
.	B-X
However	B-X
,	B-X
different	B-X
S.	B-X
Typhimurium	B-X
strains	B-X
differ	B-X
in	B-X
regard	B-X
to	B-X
virulence	B-X
and	B-X
host	B-X
adaptation	B-X
.	B-X
Here	B-X
,	B-X
C57BL/6	B-X
mice	B-X
were	B-X
infected	B-X
,	B-X
respectively	B-X
,	B-X
with	B-X
different	B-X
S.	B-X
Typhimurium	B-X
strains	B-X
SL1344	B-X
(	B-X
calf	B-X
)	B-X
,	B-X
CVCC541	B-X
(	B-X
chicken	B-X
)	B-X
and	B-X
CMCC50115	B-X
(	B-X
mutton	B-X
)	B-X
to	B-X
determine	B-X
their	B-X
virulence	B-X
and	B-X
host	B-X
immune	B-X
responses	B-X
.	B-X
It	B-X
was	B-X
found	B-X
that	B-X
mice	B-X
were	B-X
less	B-X
susceptible	B-X
to	B-X
infection	B-X
by	B-X
S.	B-X
Typhimurium	B-X
CVCC541	B-X
and	B-X
CMCC50115	B-X
strains	B-X
,	B-X
with	B-X
lower	B-X
lethality	B-X
and	B-X
decreased	B-X
bacterial	B-X
burden	B-X
in	B-X
liver	B-X
and	B-X
spleen	B-X
.	B-X
Besides	B-X
,	B-X
S.	B-X
Typhimurium	B-X
strains	B-X
CVCC541	B-X
and	B-X
CMCC50115	B-X
enhanced	B-X
host	B-X
innate	B-X
immune	B-X
responses	B-X
by	B-X
increased	B-X
frequencies	B-X
of	B-X
macrophages	B-X
and	B-X
neutrophils	B-X
3	B-X
days	B-X
after	B-X
infection	B-X
.	B-X
But	B-X
SL1344	B-X
strain	B-X
evaded	B-X
immune	B-X
response	B-X
by	B-X
inducing	B-X
apoptosis	B-X
of	B-X
macrophages	B-X
.	B-X

From	O
this	O
analysis	O
,	O
62	O
of	O
256	O
SsrB	O
binding	O
peaks	O
(	O
24	O
.	O
3	O
%	O
)	O
occurred	O
within	O
genomic	O
islands	O
(	O
Figure	O
2B	O
)	O
.	O

SsrB	O
ChIP	O
peaks	O
were	O
observed	O
upstream	O
of	O
previously	O
identified	O
SsrB	O
regulated	O
genes	O
indicating	O
that	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
captured	O
functional	O
interactions	O
(	O
Dataset	O
S3	O
)	O
.	O

To	O
generate	O
a	O
consensus	O
set	O
of	O
SsrB	O
regulated	O
genes	O
,	O
we	O
performed	O
an	O
analysis	O
to	O
identify	O
operons	O
in	O
the	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
SL1344	I-Organism
genome	O
that	O
encoded	O
at	O
least	O
one	O
gene	O
down	O
-	O
regulated	O
in	O
DeltassrB	O
cells	O
and	O
that	O
possessed	O
an	O
SsrB	O
binding	O
peak	O
in	O
the	O
upstream	O
regulatory	O
region	O
as	O
defined	O
by	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
analysis	O
.	O

From	O
this	O
,	O
the	O
133	O
down	O
-	O
regulated	O
genes	O
mapped	O
to	O
86	O
operons	O
,	O
49	O
of	O
which	O
had	O
an	O
SsrB	O
interaction	O
upstream	O
or	O
within	O
the	O
first	O
gene	O
of	O
the	O
operon	O
(	O
Table	O
2	O
)	O
.	O
<EOS>	B-X
We	B-X
have	B-X
combined	B-X
the	B-X
use	B-X
of	B-X
adult	B-X
and	B-X
perinatal	B-X
molecular	B-X
markers	B-X
of	B-X
compartmentation-zebrin	B-X
II	B-X
,	B-X
calbindin	B-X
,	B-X
and	B-X
an	B-X
L7/pcp-2-lacZ	B-X
transgene-to	B-X
resolve	B-X
some	B-X
of	B-X
these	B-X
issues	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
the	B-X
transverse	B-X
zones	B-X
of	B-X
the	B-X
vermis	B-X
form	B-X
first	B-X
during	B-X
development	B-X
and	B-X
that	B-X
parasagittal	B-X
compartmentation	B-X
develops	B-X
independently	B-X
in	B-X
each	B-X
transverse	B-X
zone	B-X
.	B-X
The	B-X
first	B-X
was	B-X
mutational	B-X
spectra	B-X
(	B-X
MS	B-X
)	B-X
for	B-X
697	B-X
GC	B-X
to	B-X
AT	B-X
transitions	B-X
produced	B-X
with	B-X
eight	B-X
alkylating	B-X
agents	B-X
(	B-X
AAs	B-X
)	B-X
in	B-X
the	B-X
lacI	B-X
gene	B-X
of	B-X
Escherichia	B-X
coli	B-X
.	B-X
The	B-X
second	B-X
was	B-X
a	B-X
recently	B-X
summarized	B-X
data	B-X
on	B-X
the	B-X
distributions	B-X
of	B-X
11562	B-X
spontaneous	B-X
,	B-X
radiation-	B-X
and	B-X
chemical-induced	B-X
forward	B-X
mutations	B-X
in	B-X
the	B-X
ad-3	B-X
region	B-X
of	B-X
heterokaryon	B-X
12	B-X
of	B-X
Neurospora	B-X
crassa	B-X
.	B-X
To	B-X
measure	B-X
similarity	B-X
(	B-X
homogeneity	B-X
)	B-X
between	B-X
any	B-X
pair	B-X
of	B-X
profiles	B-X
,	B-X
the	B-X
relevant	B-X
sufficient	B-X
statistics	B-X
,	B-X
Kastenbaum-Hirotsu	B-X
squared	B-X
distance	B-X
(	B-X
KHi	B-X
(	B-X
2	B-X
)	B-X
)	B-X
,	B-X
was	B-X
used	B-X
.	B-X
Collapsing	B-X
the	B-X
similar	B-X
profiles	B-X
into	B-X
distinct	B-X
internally	B-X
homogeneous	B-X
clusters	B-X
named	B-X
'collapsets	B-X
'	B-X
revealed	B-X
their	B-X
similarity	B-X
pattern	B-X
.	B-X
In	B-X
the	B-X
ad-3	B-X
data	B-X
set	B-X
,	B-X
five	B-X
collapsets	B-X
were	B-X
revealed	B-X
among	B-X
origin	B-X
profiles	B-X
(	B-X
OPs	B-X
)	B-X
:	B-X
(	B-X
I	B-X
)	B-X
ENU	B-X
=	B-X
4NQO	B-X
=	B-X
4HAQO	B-X
=	B-X
FANFT	B-X
=	B-X
SQ18506	B-X
;	B-X
(	B-X
II	B-X
)	B-X
AF-2	B-X
=	B-X
EI	B-X
=	B-X
MMS	B-X
=	B-X
DEP	B-X
;	B-X
(	B-X
III	B-X
)	B-X
ETO	B-X
=	B-X
UV	B-X
;	B-X
(	B-X
IV	B-X
)	B-X
AHA	B-X
=	B-X
PROCARB	B-X
;	B-X
and	B-X
(	B-X
V	B-X
)	B-X
He	B-X
ions	B-X
=	B-X
protons	B-X
.	B-X

This	O
analysis	O
captured	O
all	O
five	O
reported	O
operons	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
in	O
addition	O
to	O
ten	O
operons	O
outside	O
of	O
this	O
island	O
that	O
encode	O
SPI	O
-	O
2	O
translocated	O
effectors	O
.	O

SsrB	O
binds	O
to	O
six	O
promoters	O
within	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O

In	O
order	O
to	O
rigorously	O
evaluate	O
our	O
genome	O
-	O
wide	O
functional	O
genomics	O
data	O
,	O
we	O
compared	O
it	O
against	O
traditional	O
biochemical	O
experiments	O
describing	O
SsrB	O
-	O
DNA	O
interactions	O
at	O
the	O
SPI	O
-	O
2	O
locus	O
.	O

Previous	O
data	O
reported	O
SsrB	O
footprints	O
upstream	O
of	O
6	O
genes	O
in	O
SPI	O
-	O
2	O
:	O
ssrA	O
,	O
ssrB	O
,	O
ssaB	O
,	O
sseA	O
,	O
ssaG	O
,	O
and	O
ssaM	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

Our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
showed	O
discrete	O
SsrB	O
binding	O
at	O
all	O
of	O
these	O
promoters	O
except	O
for	O
the	O
promoter	O
reported	O
to	O
be	O
between	O
ssrA	O
and	O
ssrB	O
[	O
25	O
]	O
(	O
Figure	O
3	O
)	O
.	O

We	O
attempted	O
to	O
verify	O
functional	O
activity	O
at	O
this	O
site	O
,	O
but	O
could	O
not	O
using	O
transcriptional	O
fusions	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
Amylin	B-X
(	B-X
1-8	B-X
)	B-X
,	B-X
a	B-X
cyclic	B-X
peptide	B-X
consisting	B-X
of	B-X
the	B-X
eight	B-X
N-terminal	B-X
amino	B-X
acids	B-X
of	B-X
the	B-X
37-amino	B-X
acid	B-X
peptide	B-X
amylin	B-X
,	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
induce	B-X
proliferation	B-X
of	B-X
primary	B-X
osteoblasts	B-X
and	B-X
to	B-X
induce	B-X
bone	B-X
formation	B-X
in	B-X
healthy	B-X
male	B-X
mice	B-X
,	B-X
whereas	B-X
no	B-X
data	B-X
on	B-X
efficacy	B-X
in	B-X
bone	B-X
disease-related	B-X
models	B-X
have	B-X
been	B-X
reported	B-X
.	B-X
In	B-X
an	B-X
attempt	B-X
to	B-X
verify	B-X
any	B-X
potential	B-X
biological	B-X
effects	B-X
of	B-X
amylin	B-X
(	B-X
1-8	B-X
)	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
efficacy	B-X
of	B-X
this	B-X
peptide	B-X
in	B-X
various	B-X
in	B-X
vitro	B-X
assays	B-X
.	B-X
Amylin	B-X
(	B-X
1-8	B-X
)	B-X
was	B-X
able	B-X
to	B-X
partially	B-X
displace	B-X
(	B-X
125	B-X
)	B-X
I-rat	B-X
amylin	B-X
(	B-X
1-37	B-X
)	B-X
from	B-X
amylin	B-X
receptors	B-X
composed	B-X
of	B-X
the	B-X
calcitonin	B-X
receptor	B-X
and	B-X
RAMP1	B-X
,	B-X
indicating	B-X
specific	B-X
interaction	B-X
of	B-X
the	B-X
peptide	B-X
with	B-X
the	B-X
amylin	B-X
binding	B-X
site	B-X
.	B-X
However	B-X
,	B-X
in	B-X
vitro	B-X
efficacy	B-X
assays	B-X
with	B-X
amylin	B-X
(	B-X
1-8	B-X
)	B-X
in	B-X
calcitonin	B-X
receptor-RAMP-positive	B-X
HEK293T	B-X
and	B-X
MCF7	B-X
cells	B-X
failed	B-X
to	B-X
reveal	B-X
any	B-X
agonist	B-X
activity	B-X
of	B-X
amylin	B-X
(	B-X
1-8	B-X
)	B-X
,	B-X
whereas	B-X
amylin	B-X
(	B-X
1-37	B-X
)	B-X
showed	B-X
the	B-X
expected	B-X
agonist	B-X
activity	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
amylin	B-X
(	B-X
1-8	B-X
)	B-X
does	B-X
not	B-X
show	B-X
agonist	B-X
activity	B-X
on	B-X
amylin	B-X
receptors	B-X
,	B-X
does	B-X
not	B-X
affect	B-X
osteoblast	B-X
proliferation	B-X
,	B-X
and	B-X
is	B-X
devoid	B-X
of	B-X
anabolic	B-X
activity	B-X
in	B-X
bone	B-X
.	B-X

Our	O
data	O
also	O
identified	O
three	O
additional	O
SsrB	O
binding	O
peaks	O
upstream	O
of	O
sseA	O
,	O
within	O
the	O
CDS	O
of	O
ssaJ	O
,	O
and	O
in	O
the	O
IGR	O
upstream	O
of	O
ssaR	O
(	O
Figure	O
3	O
)	O
.	O

Functional	O
interactions	O
were	O
confirmed	O
for	O
sseA	O
and	O
ssaR	O
in	O
subsequent	O
reporter	O
experiments	O
described	O
below	O
.	O

Identification	O
of	O
a	O
functional	O
DNA	O
element	O
for	O
SsrB	O
binding	O
<EOS>	B-X
As	B-X
an	B-X
example	B-X
for	B-X
such	B-X
a	B-X
mechanism	B-X
,	B-X
we	B-X
show	B-X
here	B-X
that	B-X
the	B-X
ancestral	B-X
PhoPQ	B-X
system	B-X
of	B-X
Salmonella	B-X
enterica	B-X
is	B-X
able	B-X
to	B-X
regulate	B-X
directly	B-X
the	B-X
SPI-2	B-X
effector	B-X
gene	B-X
sseL	B-X
(	B-X
encoding	B-X
a	B-X
secreted	B-X
deubiquitinase	B-X
)	B-X
in	B-X
an	B-X
SsrB-independent	B-X
manner	B-X
and	B-X
that	B-X
PhoP	B-X
plays	B-X
a	B-X
part	B-X
in	B-X
a	B-X
feed-forward	B-X
regulatory	B-X
loop	B-X
,	B-X
which	B-X
fine-tunes	B-X
the	B-X
cellular	B-X
level	B-X
of	B-X
SseL	B-X
.	B-X
Additionally	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
presence	B-X
of	B-X
conserved	B-X
cis	B-X
regulatory	B-X
elements	B-X
in	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
sseL	B-X
and	B-X
show	B-X
direct	B-X
binding	B-X
of	B-X
purified	B-X
PhoP	B-X
to	B-X
this	B-X
region	B-X
.	B-X
These	B-X
findings	B-X
have	B-X
led	B-X
to	B-X
the	B-X
identification	B-X
of	B-X
a	B-X
previously	B-X
uncharacterized	B-X
residue	B-X
in	B-X
the	B-X
DNA-binding	B-X
domain	B-X
of	B-X
PhoP	B-X
,	B-X
which	B-X
is	B-X
required	B-X
for	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
PhoP	B-X
regulated	B-X
genes	B-X
in	B-X
Salmonella	B-X
spp	B-X
.	B-X
Collectively	B-X
our	B-X
data	B-X
demonstrate	B-X
an	B-X
interesting	B-X
interface	B-X
between	B-X
the	B-X
acquired	B-X
SsrB	B-X
regulon	B-X
and	B-X
the	B-X
ancestral	B-X
PhoPQ	B-X
regulatory	B-X
circuit	B-X
,	B-X
provide	B-X
novel	B-X
insights	B-X
into	B-X
the	B-X
function	B-X
of	B-X
PhoP	B-X
,	B-X
and	B-X
highlight	B-X
a	B-X
mechanism	B-X
of	B-X
regulatory	B-X
integration	B-X
of	B-X
horizontally	B-X
acquired	B-X
genes	B-X
into	B-X
the	B-X
virulence	B-X
network	B-X
of	B-X
Salmonella	B-X
enterica	B-X
.	B-X

Previous	O
attempts	O
by	O
others	O
to	O
identify	O
a	O
conserved	O
SsrB	O
DNA	O
recognition	O
motif	O
have	O
been	O
unsuccessful	O
.	O

To	O
overcome	O
this	O
,	O
we	O
employed	O
a	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
originally	O
developed	O
to	O
define	O
binding	O
site	O
preferences	O
for	O
eukaryotic	O
transcription	O
factors	O
[	O
27	O
]	O
.	O

We	O
fused	O
the	O
DNA	O
binding	O
domain	O
of	O
SsrB	O
(	O
SsrBc	O
)	O
to	O
the	O
alpha	O
-	O
subunit	O
of	O
RNA	O
polymerase	O
and	O
screened	O
a	O
prey	O
library	O
of	O
approximately108	O
DNA	O
molecules	O
previously	O
counter	O
-	O
selected	O
against	O
self	O
-	O
activation	O
(	O
Figure	O
4A	O
)	O
.	O

We	O
used	O
the	O
PhoP	O
response	O
regulator	O
from	O
E	B-Organism
.	I-Organism
coli	I-Organism
as	O
a	O
control	O
because	O
a	O
DNA	O
recognition	O
sequence	O
for	O
it	O
was	O
known	O
[	O
28	O
]	O
.	O

Bait	O
-	O
prey	O
combinations	O
surviving	O
selection	O
on	O
medium	O
lacking	O
histidine	O
were	O
purified	O
,	O
and	O
preys	O
were	O
sequenced	O
and	O
analyzed	O
using	O
the	O
motif	O
-	O
finding	O
program	O
MEME	O
[	O
29	O
]	O
.	O

From	O
189	O
unique	O
sequences	O
isolated	O
for	O
SsrBc	O
,	O
over	O
80	O
%	O
contained	O
a	O
degenerate	O
consensus	O
motif	O
,	O
mCCyTA	O
(	O
Figure	O
4B	O
)	O
.	O

In	O
control	O
screens	O
with	O
the	O
PhoP	O
-	O
alphaNTD	O
fusion	O
,	O
the	O
PhoP	O
box	O
sequence	O
(	O
G	O
/	O
T	O
)	O
GTTTA	O
was	O
identified	O
in	O
11	O
%	O
of	O
sequenced	O
preys	O
(	O
12	O
/	O
109	O
,	O
data	O
not	O
shown	O
)	O
but	O
this	O
sequence	O
was	O
never	O
captured	O
by	O
SsrB	O
-	O
alphaNTD	O
and	O
vice	O
versa	O
,	O
demonstrating	O
specificity	O
of	O
the	O
bacterial	O
one	O
-	O
hybrid	O
system	O
for	O
prokaryotic	O
regulatory	O
proteins	O
.	O

Next	O
,	O
we	O
examined	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
for	O
the	O
presence	O
of	O
a	O
conserved	O
regulatory	O
motif	O
.	O

We	O
extracted	O
sequence	O
data	O
from	O
the	O
local	O
maxima	O
of	O
the	O
256	O
binding	O
peaks	O
and	O
analyzed	O
the	O
sequences	O
with	O
the	O
computational	O
program	O
MDscan	O
[	O
30	O
]	O
.	O

Using	O
the	O
highest	O
-	O
ranking	O
probes	O
to	O
generate	O
an	O
initial	O
prediction	O
followed	O
by	O
lower	O
-	O
ranking	O
probes	O
for	O
refinement	O
,	O
this	O
analysis	O
identified	O
motifs	O
that	O
represented	O
either	O
the	O
forward	O
or	O
the	O
reverse	O
complement	O
of	O
the	O
consensus	O
sequence	O
ACmTTA	O
,	O
which	O
shares	O
consensus	O
with	O
the	O
motif	O
identified	O
in	O
the	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
(	O
Figure	O
4B	O
)	O
.	O

We	O
identified	O
variations	O
of	O
this	O
motif	O
within	O
footprinted	O
regions	O
of	O
SsrB	O
-	O
regulated	O
promoters	O
[	O
25	O
]	O
,	O
,	O
however	O
sequence	O
degeneracy	O
made	O
it	O
difficult	O
to	O
precisely	O
map	O
the	O
input	O
functions	O
.	O

Identification	O
of	O
a	O
functional	O
DNA	O
palindrome	O
conserved	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
SPI	O
-	O
2	O
and	O
the	O
Sodalis	B-Organism
glossinidius	I-Organism
SSR	O
-	O
3	O
region	O

The	O
analysis	O
of	O
regulatory	O
evolution	O
is	O
particularly	O
challenging	O
because	O
it	O
is	O
difficult	O
to	O
distinguish	O
neutral	O
stochastic	O
change	O
from	O
functional	O
divergence	O
.	O

To	O
solve	O
this	O
problem	O
in	O
the	O
context	O
of	O
mapping	O
the	O
SsrB	O
binding	O
element	O
,	O
we	O
used	O
comparative	O
genomics	O
to	O
search	O
for	O
conserved	O
promoter	O
architecture	O
in	O
another	O
organism	O
with	O
a	O
similar	O
genomic	O
island	O
to	O
Salmonella	B-Organism
SPI	O
-	O
2	O
.	O

The	O
tsetse	O
fly	O
endosymbiont	O
Sodalis	B-Organism
glossinidius	I-Organism
contains	O
the	O
Sodalis	B-Organism
Symbiosis	O
Region	O
-	O
3	O
(	O
SSR	O
-	O
3	O
)	O
that	O
is	O
similar	O
in	O
content	O
and	O
synteny	O
with	O
the	O
S	B-Organism
.	I-Organism
enterica	I-Organism
SPI	O
-	O
2	O
locus	O
[	O
31	O
]	O
.	O

Gene	O
conservation	O
includes	O
the	O
entire	O
T3SS	O
structural	O
module	O
extending	O
to	O
the	O
regulatory	O
genes	O
ssrA	O
-	O
ssrB	O
and	O
all	O
other	O
genes	O
except	O
the	O
effectors	O
sseF	O
and	O
sseG	O
,	O
which	O
are	O
not	O
present	O
in	O
Sodalis	B-Organism
SSR	O
-	O
3	O
.	O

We	O
aligned	O
the	O
sequences	O
of	O
the	O
five	O
mapped	O
promoters	O
in	O
SPI	O
-	O
2	O
with	O
the	O
orthologous	O
SSR	O
-	O
3	O
regions	O
to	O
identify	O
local	O
conservation	O
.	O

Highly	O
conserved	O
sites	O
within	O
the	O
promoters	O
were	O
restricted	O
to	O
regions	O
previously	O
footprinted	O
by	O
SsrB	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
,	O
whereas	O
adjacent	O
sequence	O
showed	O
substantial	O
drift	O
(	O
Figure	O
4C	O
)	O
.	O

Within	O
the	O
conserved	O
sites	O
we	O
identified	O
a	O
heptameric	O
sequence	O
in	O
7	O
-	O
4	O
-	O
7	O
tail	O
-	O
to	O
-	O
tail	O
architecture	O
that	O
created	O
an	O
18	O
-	O
bp	O
degenerate	O
palindrome	O
.	O

This	O
palindrome	O
was	O
found	O
in	O
all	O
SPI	O
-	O
2	O
and	O
SSR	O
-	O
3	O
T3SS	O
promoters	O
with	O
the	O
exception	O
of	O
the	O
sseA	O
promoter	O
that	O
had	O
only	O
one	O
reasonably	O
well	O
-	O
conserved	O
heptamer	O
in	O
the	O
footprinted	O
region	O
(	O
Figure	O
4C	O
and	O
Figure	O
S1	O
)	O
.	O

Interestingly	O
,	O
two	O
copies	O
of	O
the	O
palindrome	O
occur	O
upstream	O
of	O
the	O
ssrA	O
-	O
ssrB	O
operon	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
within	O
the	O
same	O
footprint	O
,	O
and	O
the	O
conservation	O
of	O
either	O
site	O
in	O
Sodalis	B-Organism
was	O
weak	O
.	O

Evaluation	O
of	O
the	O
heptamer	O
motif	O
in	O
the	O
palindrome	O
showed	O
high	O
similarity	O
to	O
the	O
motifs	O
identified	O
by	O
the	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
and	O
the	O
ChIP	O
-	O
on	O
-	O
chip	O
experiments	O
(	O
Figure	O
4B	O
and	O
4D	O
)	O
,	O
giving	O
us	O
confidence	O
that	O
we	O
had	O
identified	O
the	O
major	O
recognition	O
module	O
for	O
transcriptional	O
input	O
by	O
SsrB	O
.	O

In	O
accord	O
with	O
a	O
previous	O
observation	O
[	O
26	O
]	O
,	O
there	O
was	O
not	O
a	O
strict	O
requirement	O
in	O
the	O
spacing	O
between	O
the	O
SsrB	O
binding	O
site	O
and	O
the	O
downstream	O
transcriptional	O
start	O
site	O
.	O
<EOS>	B-X
This	B-X
common	B-X
complication	B-X
of	B-X
pregnancy	B-X
has	B-X
long	B-X
been	B-X
viewed	B-X
as	B-X
a	B-X
disorder	B-X
linked	B-X
primarily	B-X
to	B-X
placental	B-X
dysfunction	B-X
,	B-X
which	B-X
is	B-X
caused	B-X
by	B-X
abnormal	B-X
trophoblast	B-X
invasion	B-X
,	B-X
however	B-X
,	B-X
evidence	B-X
from	B-X
the	B-X
previous	B-X
two	B-X
decades	B-X
has	B-X
triggered	B-X
and	B-X
supported	B-X
a	B-X
major	B-X
shift	B-X
in	B-X
viewing	B-X
preeclampsia	B-X
as	B-X
a	B-X
condition	B-X
that	B-X
is	B-X
caused	B-X
by	B-X
inherent	B-X
maternal	B-X
cardiovascular	B-X
dysfunction	B-X
,	B-X
perhaps	B-X
entirely	B-X
independent	B-X
of	B-X
the	B-X
placenta	B-X
.	B-X
More	B-X
recent	B-X
evidence	B-X
identified	B-X
that	B-X
the	B-X
underlying	B-X
cardiovascular	B-X
dysfunction	B-X
in	B-X
these	B-X
phenotypes	B-X
can	B-X
be	B-X
categorized	B-X
according	B-X
to	B-X
the	B-X
presence	B-X
of	B-X
coexisting	B-X
fetal	B-X
growth	B-X
restriction	B-X
instead	B-X
of	B-X
according	B-X
to	B-X
the	B-X
gestational	B-X
period	B-X
at	B-X
onset	B-X
,	B-X
the	B-X
former	B-X
being	B-X
far	B-X
more	B-X
common	B-X
at	B-X
early	B-X
gestational	B-X
ages	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
review	B-X
is	B-X
to	B-X
summarize	B-X
the	B-X
hemodynamic	B-X
research	B-X
observations	B-X
for	B-X
the	B-X
two	B-X
phenotypes	B-X
of	B-X
preeclampsia	B-X
.	B-X
This	B-X
review	B-X
is	B-X
an	B-X
update	B-X
of	B-X
an	B-X
review	B-X
originally	B-X
published	B-X
in	B-X
2005	B-X
and	B-X
previously	B-X
updated	B-X
in	B-X
2012	B-X
and	B-X
2016	B-X
.	B-X

SsrB	O
directs	O
transcriptional	O
input	O
using	O
a	O
flexible	O
palindrome	O
architecture	O

The	O
presence	O
of	O
a	O
conserved	O
palindrome	O
sequence	O
in	O
SPI	O
-	O
2	O
promoters	O
and	O
in	O
related	O
sequences	O
from	O
the	O
endosymbiont	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
suggested	O
that	O
regulatory	O
input	O
by	O
SsrB	O
was	O
through	O
a	O
palindrome	O
sequence	O
architecture	O
.	O

However	O
,	O
other	O
lines	O
of	O
evidence	O
suggested	O
that	O
the	O
recognition	O
site	O
architecture	O
was	O
flexible	O
in	O
nature	O
:	O
(	O
i	O
)	O
our	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
isolated	O
functional	O
single	O
hexamer	O
sequences	O
,	O
(	O
ii	O
)	O
the	O
SsrB	O
footprint	O
at	O
the	O
naturally	O
evolved	O
sseA	O
promoter	O
within	O
SPI	O
-	O
2	O
[	O
26	O
]	O
contained	O
only	O
one	O
reasonably	O
well	O
-	O
conserved	O
heptamer	O
,	O
and	O
(	O
iii	O
)	O
degenerate	O
or	O
non	O
-	O
ideal	O
palindromes	O
exist	O
in	O
the	O
genome	O
.	O

In	O
order	O
to	O
deconstruct	O
this	O
architecture	O
,	O
we	O
designed	O
a	O
set	O
of	O
experiments	O
to	O
test	O
the	O
palindrome	O
'	O
s	O
tolerance	O
to	O
mutation	O
.	O

We	O
chose	O
the	O
ssaG	O
promoter	O
for	O
these	O
experiments	O
because	O
16	O
of	O
18	O
bases	O
were	O
identical	O
between	O
SPI	O
-	O
2	O
and	O
SSR	O
-	O
3	O
from	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
,	O
differing	O
only	O
in	O
the	O
4	O
-	O
bp	O
spacer	O
between	O
heptamers	O
(	O
Figure	O
4C	O
)	O
.	O

We	O
mutated	O
the	O
palindrome	O
in	O
a	O
series	O
of	O
transcriptional	O
reporters	O
that	O
were	O
otherwise	O
identical	O
to	O
the	O
evolved	O
ssaG	O
promoter	O
(	O
Figure	O
5A	O
)	O
and	O
promoter	O
activity	O
was	O
compared	O
to	O
that	O
of	O
a	O
wild	O
-	O
type	O
palindrome	O
sequence	O
.	O

Variants	O
in	O
which	O
the	O
first	O
half	O
-	O
site	O
(	O
7	O
'	O
)	O
or	O
second	O
half	O
-	O
site	O
(	O
7	O
'	O
'	O
)	O
was	O
deleted	O
produced	O
similar	O
transcriptional	O
activity	O
to	O
the	O
wild	O
-	O
type	O
palindrome	O
,	O
verifying	O
that	O
a	O
single	O
well	O
-	O
conserved	O
heptamer	O
is	O
sufficient	O
for	O
transcriptional	O
input	O
under	O
these	O
experimental	O
conditions	O
(	O
Figure	O
5B	O
)	O
.	O

Deletion	O
of	O
the	O
4	O
-	O
bp	O
spacer	O
sequence	O
between	O
the	O
heptamers	O
-	O
the	O
most	O
degenerate	O
element	O
of	O
the	O
palindrome	O
-	O
also	O
generated	O
wild	O
-	O
type	O
promoter	O
activity	O
.	O

However	O
,	O
the	O
orientation	O
of	O
individual	O
heptamers	O
was	O
essential	O
for	O
transcriptional	O
input	O
since	O
rewiring	O
the	O
palindrome	O
in	O
any	O
head	O
-	O
to	O
-	O
head	O
orientation	O
produced	O
negligible	O
promoter	O
activity	O
.	O

However	O
,	O
if	O
the	O
two	O
half	O
sites	O
were	O
swapped	O
front	O
-	O
to	O
-	O
back	O
so	O
that	O
they	O
maintained	O
tail	O
-	O
to	O
-	O
tail	O
orientation	O
(	O
construct	O
labelled	O
"	O
Reverse	O
"	O
in	O
Figure	O
5	O
)	O
,	O
wild	O
-	O
type	O
promoter	O
activity	O
was	O
restored	O
.	O

Precise	O
deletion	O
of	O
the	O
entire	O
18	O
-	O
bp	O
palindrome	O
lead	O
to	O
approximately10	O
%	O
residual	O
activity	O
in	O
wild	O
-	O
type	O
cells	O
,	O
which	O
was	O
reduced	O
to	O
less	O
than	O
1	O
%	O
in	O
an	O
ssrB	O
mutant	O
(	O
Figure	O
5C	O
)	O
.	O

To	O
determine	O
whether	O
the	O
remaining	O
10	O
%	O
transcriptional	O
activity	O
was	O
a	O
result	O
of	O
an	O
SsrB	O
-	O
dependent	O
feed	O
-	O
forward	O
mechanism	O
or	O
transcriptional	O
read	O
-	O
through	O
of	O
our	O
chromosomally	O
integrated	O
reporter	O
,	O
we	O
constructed	O
an	O
ectopic	O
deletion	O
reporter	O
.	O

Assessment	O
of	O
reporter	O
activity	O
for	O
this	O
construct	O
in	O
addition	O
to	O
wild	O
-	O
type	O
constructs	O
in	O
wild	O
-	O
type	O
and	O
ssrB	O
mutant	O
backgrounds	O
showed	O
a	O
similar	O
level	O
of	O
activity	O
to	O
the	O
ssrB	O
mutant	O
(	O
Figure	O
5D	O
)	O
.	O

The	O
results	O
for	O
the	O
half	O
-	O
site	O
deletion	O
constructs	O
,	O
which	O
retained	O
activity	O
similar	O
to	O
wild	O
type	O
,	O
were	O
unexpected	O
.	O

Therefore	O
,	O
we	O
compared	O
the	O
sequences	O
generated	O
upon	O
mutation	O
against	O
a	O
consensus	O
palindrome	O
matrix	O
generated	O
from	O
all	O
SPI	O
-	O
2	O
and	O
other	O
identified	O
putative	O
elements	O
.	O

The	O
7	O
'	O
-	O
4	O
-	O
X	O
,	O
X	O
-	O
4	O
-	O
7	O
'	O
'	O
and	O
7	O
'	O
-	O
X	O
-	O
7	O
'	O
'	O
mutations	O
introduced	O
a	O
number	O
of	O
base	O
transitions	O
and	O
transversions	O
never	O
occurring	O
in	O
the	O
matrix	O
,	O
however	O
the	O
modified	O
7	O
base	O
pair	O
heptamer	O
retained	O
4	O
-	O
5	O
naturally	O
-	O
occurring	O
bases	O
along	O
with	O
the	O
unchanged	O
wild	O
-	O
type	O
sequence	O
in	O
the	O
other	O
heptamer	O
(	O
Figure	O
S2	O
)	O
.	O

The	O
possibility	O
existed	O
that	O
this	O
modified	O
heptamer	O
,	O
although	O
now	O
weaker	O
in	O
consensus	O
,	O
could	O
still	O
be	O
sufficient	O
for	O
recruitment	O
of	O
a	O
functional	O
form	O
of	O
SsrB	O
when	O
paired	O
with	O
the	O
other	O
wild	O
-	O
type	O
heptamer	O
.	O

To	O
test	O
this	O
,	O
we	O
created	O
an	O
additional	O
ectopic	O
transcriptional	O
fusion	O
construct	O
in	O
which	O
the	O
left	O
half	O
(	O
7	O
'	O
)	O
of	O
the	O
palindrome	O
was	O
mutated	O
to	O
bases	O
never	O
occurring	O
in	O
the	O
consensus	O
matrix	O
.	O

When	O
tested	O
in	O
promoter	O
activity	O
experiments	O
,	O
this	O
reporter	O
was	O
unable	O
to	O
activate	O
transcription	O
and	O
was	O
identical	O
to	O
the	O
X	O
-	O
X	O
-	O
X	O
mutant	O
construct	O
(	O
Figure	O
5D	O
)	O
.	O

Salmonella	O
SsrB	O
and	O
the	O
Sodalis	B-Organism
ortholog	O
(	O
SG1279	O
)	O
are	O
69	O
%	O
identical	O
and	O
81	O
%	O
similar	O
at	O
the	O
amino	O
acid	O
level	O
.	O

All	O
of	O
the	O
critical	O
residues	O
in	O
the	O
dimerization	O
helix	O
and	O
HTH	O
motif	O
required	O
for	O
specific	O
transcriptional	O
activity	O
by	O
SsrB	O
[	O
32	O
]	O
are	O
conserved	O
in	O
the	O
Sodalis	B-Organism
ortholog	O
(	O
Figure	O
S3	O
)	O
.	O

To	O
demonstrate	O
a	O
functional	O
role	O
for	O
the	O
palindrome	O
identified	O
in	O
Sodalis	B-Organism
,	O
we	O
engineered	O
luciferase	O
transcriptional	O
reporters	O
that	O
either	O
contained	O
(	O
7	O
'	O
-	O
4	O
-	O
7	O
'	O
'	O
)	O
or	O
lacked	O
(	O
X	O
-	O
X	O
-	O
X	O
)	O
the	O
identified	O
palindrome	O
from	O
the	O
Sodalis	B-Organism
SG1292	O
promoter	O
(	O
ssaG	O
ortholog	O
)	O
and	O
transformed	O
them	O
into	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
and	O
an	O
ssrB	O
mutant	O
.	O

The	O
transcriptional	O
activity	O
from	O
a	O
wild	O
-	O
type	O
Sodalis	B-Organism
palindrome	O
sequence	O
was	O
high	O
,	O
but	O
was	O
completely	O
abolished	O
in	O
an	O
ssrB	O
mutant	O
and	O
in	O
experiments	O
where	O
only	O
the	O
palindrome	O
sequence	O
was	O
precisely	O
deleted	O
(	O
Figure	O
5D	O
)	O
.	O

These	O
experiments	O
demonstrated	O
a	O
functional	O
role	O
for	O
the	O
conserved	O
palindrome	O
in	O
Sodalis	B-Organism
and	O
the	O
requirement	O
for	O
SsrB	O
for	O
transcriptional	O
activation	O
.	O

Regulatory	O
evolution	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
effector	O
repertoire	O

The	O
above	O
results	O
identified	O
the	O
conserved	O
,	O
yet	O
flexible	O
,	O
palindrome	O
sequence	O
defining	O
DNA	O
recognition	O
by	O
SsrB	O
.	O

To	O
examine	O
the	O
extent	O
to	O
which	O
regulatory	O
evolution	O
has	O
been	O
selective	O
for	O
this	O
genetic	O
architecture	O
,	O
we	O
created	O
a	O
position	O
weight	O
matrix	O
(	O
PWM	O
)	O
for	O
the	O
five	O
strongest	O
palindrome	O
sites	O
in	O
SPI	O
-	O
2	O
and	O
the	O
orthologous	O
sites	O
in	O
Sodalis	B-Organism
SSR	O
-	O
3	O
.	O

We	O
then	O
searched	O
for	O
representative	O
candidates	O
of	O
this	O
motif	O
in	O
the	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
genome	O
using	O
the	O
simple	O
scoring	O
algorithm	O
MotifLocator	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

This	O
analysis	O
recovered	O
the	O
motifs	O
upstream	O
of	O
ssaB	O
,	O
ssaG	O
,	O
ssaM	O
,	O
and	O
ssaR	O
that	O
were	O
used	O
to	O
generate	O
the	O
PWM	O
.	O

The	O
palindrome	O
in	O
the	O
ssrA	O
promoter	O
was	O
not	O
used	O
to	O
create	O
the	O
PWM	O
due	O
to	O
its	O
weaker	O
consensus	O
in	O
the	O
left	O
heptamer	O
,	O
however	O
,	O
it	O
was	O
recovered	O
in	O
the	O
computational	O
analysis	O
in	O
a	O
second	O
group	O
of	O
lower	O
-	O
scoring	O
motifs	O
(	O
Figure	O
6A	O
)	O
.	O
<EOS>	B-X
Regulatory	B-X
evolution	B-X
,	B-X
in	B-X
which	B-X
non-coding	B-X
DNA	B-X
is	B-X
mutated	B-X
to	B-X
create	B-X
new	B-X
regulatory	B-X
nodes	B-X
,	B-X
also	B-X
contributes	B-X
to	B-X
this	B-X
diversity	B-X
to	B-X
allow	B-X
niche	B-X
adaptation	B-X
and	B-X
the	B-X
evolution	B-X
of	B-X
pathogenesis	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
used	B-X
a	B-X
genetic	B-X
screen	B-X
and	B-X
computational	B-X
analyses	B-X
integrating	B-X
experimental	B-X
data	B-X
from	B-X
S.	B-X
enterica	B-X
and	B-X
sequence	B-X
data	B-X
from	B-X
an	B-X
orthologous	B-X
regulatory	B-X
system	B-X
in	B-X
the	B-X
insect	B-X
endosymbiont	B-X
,	B-X
Sodalis	B-X
glossinidius	B-X
,	B-X
to	B-X
identify	B-X
the	B-X
conserved	B-X
yet	B-X
flexible	B-X
palindrome	B-X
sequence	B-X
that	B-X
defines	B-X
DNA	B-X
recognition	B-X
by	B-X
SsrB	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
a	B-X
representative	B-X
promoter	B-X
validated	B-X
this	B-X
palindrome	B-X
as	B-X
the	B-X
minimal	B-X
architecture	B-X
needed	B-X
for	B-X
regulatory	B-X
input	B-X
by	B-X
SsrB	B-X
.	B-X
Temperate	B-X
bacteriophages	B-X
express	B-X
transcription	B-X
repressors	B-X
that	B-X
maintain	B-X
lysogeny	B-X
by	B-X
down-regulating	B-X
lytic	B-X
promoters	B-X
and	B-X
confer	B-X
superinfection	B-X
immunity	B-X
.	B-X
Mycobacteriophage	B-X
BPs	B-X
and	B-X
its	B-X
relatives	B-X
use	B-X
an	B-X
unusual	B-X
integration-dependent	B-X
immunity	B-X
system	B-X
in	B-X
which	B-X
the	B-X
phage	B-X
attachment	B-X
site	B-X
(	B-X
attP	B-X
)	B-X
is	B-X
located	B-X
within	B-X
the	B-X
repressor	B-X
gene	B-X
(	B-X
33	B-X
)	B-X
such	B-X
that	B-X
site-specific	B-X
integration	B-X
leads	B-X
to	B-X
synthesis	B-X
of	B-X
a	B-X
prophage-encoded	B-X
product	B-X
(	B-X
gp33103	B-X
)	B-X
that	B-X
is	B-X
33	B-X
residues	B-X
shorter	B-X
at	B-X
its	B-X
C-terminus	B-X
than	B-X
the	B-X
virally-encoded	B-X
protein	B-X
(	B-X
gp33136	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
shorter	B-X
form	B-X
of	B-X
the	B-X
repressor	B-X
(	B-X
gp33103	B-X
)	B-X
is	B-X
stable	B-X
and	B-X
active	B-X
in	B-X
repression	B-X
of	B-X
the	B-X
early	B-X
lytic	B-X
promoter	B-X
PR	B-X
,	B-X
whereas	B-X
the	B-X
longer	B-X
virally-encoded	B-X
form	B-X
(	B-X
gp33136	B-X
)	B-X
is	B-X
inactive	B-X
due	B-X
to	B-X
targeted	B-X
degradation	B-X
via	B-X
a	B-X
C-terminal	B-X
ssrA-like	B-X
tag	B-X
.	B-X
The	B-X
BPs	B-X
gp33103	B-X
repressor	B-X
binds	B-X
to	B-X
five	B-X
regulatory	B-X
regions	B-X
spanning	B-X
the	B-X
BPs	B-X
genome	B-X
,	B-X
and	B-X
regulates	B-X
four	B-X
promoters	B-X
including	B-X
the	B-X
early	B-X
lytic	B-X
promoter	B-X
,	B-X
PR	B-X
.	B-X
The	B-X
operator	B-X
site	B-X
structure	B-X
is	B-X
unusual	B-X
in	B-X
that	B-X
one	B-X
half	B-X
site	B-X
corresponds	B-X
to	B-X
a	B-X
12	B-X
bp	B-X
palindrome	B-X
identified	B-X
previously	B-X
,	B-X
but	B-X
the	B-X
other	B-X
half	B-X
site	B-X
is	B-X
a	B-X
highly	B-X
variable	B-X
variant	B-X
of	B-X
the	B-X
palindrome	B-X
.	B-X

We	O
identified	O
24	O
palindromes	O
co	O
-	O
occurring	O
with	O
ChIP	O
-	O
on	O
-	O
chip	O
peaks	O
upstream	O
of	O
24	O
different	O
SsrB	O
-	O
regulated	O
genes	O
or	O
operons	O
.	O
<EOS>	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
simple	B-X
and	B-X
highly	B-X
efficient	B-X
method	B-X
to	B-X
disrupt	B-X
chromosomal	B-X
genes	B-X
in	B-X
Escherichia	B-X
coli	B-X
in	B-X
which	B-X
PCR	B-X
primers	B-X
provide	B-X
the	B-X
homology	B-X
to	B-X
the	B-X
targeted	B-X
gene	B-X
(	B-X
s	B-X
)	B-X
.	B-X
In	B-X
this	B-X
procedure	B-X
,	B-X
recombination	B-X
requires	B-X
the	B-X
phage	B-X
lambda	B-X
Red	B-X
recombinase	B-X
,	B-X
which	B-X
is	B-X
synthesized	B-X
under	B-X
the	B-X
control	B-X
of	B-X
an	B-X
inducible	B-X
promoter	B-X
on	B-X
an	B-X
easily	B-X
curable	B-X
,	B-X
low	B-X
copy	B-X
number	B-X
plasmid	B-X
.	B-X
To	B-X
demonstrate	B-X
the	B-X
utility	B-X
of	B-X
this	B-X
approach	B-X
,	B-X
we	B-X
generated	B-X
PCR	B-X
products	B-X
by	B-X
using	B-X
primers	B-X
with	B-X
36-	B-X
to	B-X
50-nt	B-X
extensions	B-X
that	B-X
are	B-X
homologous	B-X
to	B-X
regions	B-X
adjacent	B-X
to	B-X
the	B-X
gene	B-X
to	B-X
be	B-X
inactivated	B-X
and	B-X
template	B-X
plasmids	B-X
carrying	B-X
antibiotic	B-X
resistance	B-X
genes	B-X
that	B-X
are	B-X
flanked	B-X
by	B-X
FRT	B-X
(	B-X
FLP	B-X
recognition	B-X
target	B-X
)	B-X
sites	B-X
.	B-X
By	B-X
using	B-X
the	B-X
respective	B-X
PCR	B-X
products	B-X
,	B-X
we	B-X
made	B-X
13	B-X
different	B-X
disruptions	B-X
of	B-X
chromosomal	B-X
genes	B-X
.	B-X
Mutants	B-X
of	B-X
the	B-X
arcB	B-X
,	B-X
cyaA	B-X
,	B-X
lacZYA	B-X
,	B-X
ompR-envZ	B-X
,	B-X
phnR	B-X
,	B-X
pstB	B-X
,	B-X
pstCA	B-X
,	B-X
pstS	B-X
,	B-X
pstSCAB-phoU	B-X
,	B-X
recA	B-X
,	B-X
and	B-X
torSTRCAD	B-X
genes	B-X
or	B-X
operons	B-X
were	B-X
isolated	B-X
as	B-X
antibiotic-resistant	B-X
colonies	B-X
after	B-X
the	B-X
introduction	B-X
into	B-X
bacteria	B-X
carrying	B-X
a	B-X
Red	B-X
expression	B-X
plasmid	B-X
of	B-X
synthetic	B-X
(	B-X
PCR-generated	B-X
)	B-X
DNA	B-X
.	B-X
The	B-X
resistance	B-X
genes	B-X
were	B-X
then	B-X
eliminated	B-X
by	B-X
using	B-X
a	B-X
helper	B-X
plasmid	B-X
encoding	B-X
the	B-X
FLP	B-X
recombinase	B-X
which	B-X
is	B-X
also	B-X
easily	B-X
curable	B-X
.	B-X
This	B-X
procedure	B-X
should	B-X
be	B-X
widely	B-X
useful	B-X
,	B-X
especially	B-X
in	B-X
genome	B-X
analysis	B-X
of	B-X
E.	B-X
coli	B-X
and	B-X
other	B-X
bacteria	B-X
because	B-X
the	B-X
procedure	B-X
can	B-X
be	B-X
done	B-X
in	B-X
wild-type	B-X
cells	B-X
.	B-X

Applying	O
a	O
stringent	O
threshold	O
to	O
the	O
output	O
allowed	O
us	O
to	O
identify	O
two	O
groups	O
-	O
genes	O
with	O
high	O
-	O
scoring	O
upstream	O
palindromes	O
(	O
ssaB	O
,	O
ssaG	O
,	O
ssaM	O
,	O
ssaR	O
,	O
sopD2	O
,	O
sifA	O
,	O
sifB	O
,	O
sseK2	O
,	O
sseK3	O
,	O
sseL	O
,	O
sseA	O
'	O
,	O
steC	O
,	O
and	O
srcA	O
)	O
and	O
those	O
with	O
medium	O
-	O
scoring	O
palindromes	O
(	O
0	O
.	O
7	O
-	O
0	O
.	O
8	O
threshold	O
;	O
ssrA	O
,	O
STM1633	O
,	O
sseI	O
,	O
slrP	O
sspH2	O
,	O
pipB	O
,	O
sseJ	O
,	O
pipB2	O
,	O
srfN	O
,	O
sseA	O
and	O
steB	O
)	O
(	O
Figure	O
6A	O
and	O
Dataset	O
S4	O
)	O
(	O
sseA	O
'	O
denotes	O
the	O
SsrB	O
palindrome	O
sequence	O
upstream	O
of	O
sseA	O
that	O
falls	O
within	O
the	O
ssaE	O
CDS	O
,	O
while	O
sseA	O
refers	O
to	O
the	O
SsrB	O
-	O
footprinted	O
IGR	O
site	O
with	O
only	O
one	O
conserved	O
heptamer	O
defined	O
in	O
Figure	O
4C	O
)	O
.	O

Remarkably	O
,	O
this	O
accounted	O
for	O
17	O
of	O
22	O
SL1344	O
genome	O
-	O
encoded	O
effectors	O
translocated	O
by	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
(	O
exceptions	O
are	O
chromosomal	O
steA	O
,	O
gogB	O
,	O
and	O
sseK	O
,	O
and	O
plasmid	O
-	O
encoded	O
spvB	O
and	O
spvC	O
)	O
.	O

These	O
genes	O
either	O
lacked	O
an	O
upstream	O
ChIP	O
peak	O
above	O
our	O
3	O
-	O
standard	O
deviation	O
cut	O
-	O
off	O
(	O
sseK	O
)	O
or	O
had	O
such	O
a	O
peak	O
but	O
did	O
not	O
reach	O
statistical	O
significance	O
in	O
our	O
transcriptional	O
profiling	O
experiments	O
(	O
steA	O
,	O
gogB	O
)	O
.	O

Our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
revealed	O
three	O
additional	O
strong	O
SsrB	O
binding	O
peaks	O
within	O
SPI	O
-	O
2	O
:	O
one	O
in	O
the	O
IGR	O
directly	O
upstream	O
of	O
ssaR	O
,	O
a	O
second	O
within	O
the	O
CDS	O
for	O
ssaJ	O
,	O
and	O
a	O
third	O
within	O
the	O
CDS	O
for	O
ssaE	O
that	O
would	O
be	O
predicted	O
to	O
influence	O
transcription	O
of	O
the	O
downstream	O
effector	O
/	O
chaperone	O
operon	O
beginning	O
with	O
sseA	O
.	O

The	O
analysis	O
described	O
above	O
recovered	O
SsrB	O
palindrome	O
sequences	O
at	O
the	O
sseA	O
'	O
and	O
ssaR	O
locations	O
prompting	O
further	O
validation	O
of	O
these	O
sites	O
.	O

No	O
palindrome	O
was	O
identified	O
for	O
the	O
ssaJ	O
interaction	O
peak	O
and	O
so	O
further	O
characterization	O
was	O
not	O
pursued	O
.	O

For	O
the	O
IGR	O
palindrome	O
upstream	O
of	O
ssaR	O
,	O
we	O
tested	O
both	O
a	O
chromosome	O
-	O
integrated	O
transcriptional	O
fusion	O
and	O
an	O
autonomous	O
episomal	O
reporter	O
.	O

In	O
wild	O
-	O
type	O
cells	O
these	O
reporters	O
were	O
as	O
active	O
as	O
other	O
SPI	O
-	O
2	O
promoters	O
,	O
whereas	O
promoter	O
activity	O
was	O
abrogated	O
in	O
DeltassrB	O
cells	O
,	O
implicating	O
this	O
IGR	O
as	O
a	O
functional	O
promoter	O
for	O
ssaR	O
(	O
Figure	O
6B	O
and	O
Figure	O
S4	O
)	O
.	O

We	O
next	O
tested	O
the	O
function	O
of	O
the	O
intragenic	O
palindrome	O
within	O
ssaE	O
(	O
sseA	O
'	O
)	O
.	O

For	O
this	O
,	O
we	O
constructed	O
a	O
single	O
-	O
copy	O
transcriptional	O
reporter	O
that	O
either	O
contained	O
(	O
WT	O
PsseA	O
)	O
or	O
lacked	O
(	O
PsseA	O
del	O
)	O
the	O
single	O
heptamer	O
site	O
in	O
the	O
sseA	O
IGR	O
and	O
integrated	O
this	O
reporter	O
into	O
wild	O
-	O
type	O
cells	O
and	O
mutants	O
lacking	O
either	O
ssrB	O
or	O
the	O
ssaE	O
coding	O
sequence	O
that	O
removed	O
the	O
high	O
-	O
scoring	O
intragenic	O
palindrome	O
sseA	O
'	O
.	O

These	O
experiments	O
showed	O
that	O
the	O
sseA	O
'	O
sequence	O
contributes	O
approximately	O
75	O
%	O
of	O
transcriptional	O
output	O
at	O
the	O
sseA	O
promoter	O
(	O
Figure	O
6C	O
)	O
,	O
since	O
deleting	O
the	O
single	O
heptamer	O
in	O
the	O
sseA	O
IGR	O
had	O
little	O
effect	O
on	O
transcriptional	O
output	O
in	O
any	O
of	O
the	O
strain	O
backgrounds	O
.	O

These	O
reporter	O
data	O
are	O
in	O
line	O
with	O
the	O
respective	O
binding	O
scores	O
for	O
the	O
ChIP	O
-	O
on	O
-	O
chip	O
interaction	O
peaks	O
(	O
Figure	O
3	O
)	O
and	O
the	O
sequence	O
similarity	O
for	O
these	O
elements	O
with	O
respect	O
to	O
the	O
consensus	O
palindrome	O
(	O
Figure	O
6A	O
and	O
Figure	O
4D	O
)	O
.	O

Together	O
,	O
these	O
data	O
provide	O
compelling	O
evidence	O
for	O
the	O
identity	O
of	O
the	O
DNA	O
recognition	O
element	O
that	O
has	O
been	O
selected	O
through	O
evolution	O
to	O
co	O
-	O
regulate	O
an	O
SsrB	O
-	O
dependent	O
gene	O
program	O
involved	O
in	O
adaptation	O
to	O
a	O
host	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Horizontal	O
gene	O
transfer	O
is	O
a	O
well	O
-	O
recognized	O
mechanism	O
of	O
bacterial	O
evolution	O
that	O
gives	O
rise	O
to	O
new	O
phenotypes	O
due	O
to	O
the	O
coordinated	O
expression	O
of	O
novel	O
genetic	O
components	O
[	O
1	O
]	O
.	O

A	O
good	O
example	O
of	O
this	O
is	O
acquisition	O
of	O
type	O
III	O
secretion	O
by	O
mutualists	O
and	O
pathogenic	O
bacteria	O
enabling	O
new	O
colonization	O
strategies	O
within	O
a	O
host	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

Evolved	O
changes	O
to	O
regulatory	O
circuitry	O
can	O
also	O
give	O
rise	O
to	O
phenotypic	O
diversity	O
at	O
the	O
species	O
level	O
[	O
19	O
]	O
.	O

In	O
both	O
cases	O
,	O
regulatory	O
evolution	O
is	O
required	O
to	O
correctly	O
deploy	O
gene	O
products	O
during	O
infection	O
,	O
yet	O
the	O
extent	O
to	O
which	O
regulatory	O
evolution	O
contributes	O
to	O
pathogenic	O
adaptation	O
is	O
only	O
beginning	O
to	O
be	O
realized	O
[	O
8	O
]	O
.	O

The	O
SsrA	O
-	O
SsrB	O
two	O
-	O
component	O
regulatory	O
system	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
has	O
been	O
the	O
focus	O
of	O
our	O
efforts	O
to	O
understand	O
the	O
significance	O
of	O
regulatory	O
evolution	O
for	O
pathogenic	O
adaptation	O
.	O

This	O
regulatory	O
system	O
was	O
co	O
-	O
acquired	O
with	O
a	O
T3SS	O
encoded	O
in	O
the	O
SPI	O
-	O
2	O
pathogenicity	O
island	O
and	O
likely	O
contributed	O
to	O
immediate	O
and	O
gradual	O
phenotypic	O
diversity	O
as	O
new	O
regulatory	O
nodes	O
were	O
explored	O
and	O
acted	O
upon	O
by	O
natural	O
selection	O
.	O

Extensive	O
work	O
has	O
been	O
reported	O
on	O
the	O
characterization	O
of	O
SsrB	O
dependent	O
genes	O
,	O
including	O
functional	O
evaluation	O
of	O
genes	O
encoded	O
within	O
SPI	O
-	O
2	O
in	O
addition	O
to	O
genome	O
-	O
wide	O
transcriptional	O
studies	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O

In	O
this	O
study	O
we	O
identified	O
genes	O
co	O
-	O
expressed	O
under	O
SsrB	O
-	O
inducing	O
conditions	O
and	O
found	O
those	O
with	O
strong	O
levels	O
of	O
expression	O
localized	O
predominantly	O
to	O
mobile	O
genetic	O
elements	O
,	O
recently	O
acquired	O
genomic	O
islands	O
or	O
other	O
annotated	O
islands	O
.	O
<EOS>	B-X
Many	B-X
mutations	B-X
that	B-X
contribute	B-X
to	B-X
the	B-X
pathogenesis	B-X
of	B-X
acute	B-X
myeloid	B-X
leukemia	B-X
(	B-X
AML	B-X
)	B-X
are	B-X
undefined	B-X
.	B-X
The	B-X
relationships	B-X
between	B-X
patterns	B-X
of	B-X
mutations	B-X
and	B-X
epigenetic	B-X
phenotypes	B-X
are	B-X
not	B-X
yet	B-X
clear	B-X
.	B-X
A	B-X
major	B-X
challenge	B-X
in	B-X
human	B-X
genetics	B-X
is	B-X
to	B-X
devise	B-X
a	B-X
systematic	B-X
strategy	B-X
to	B-X
integrate	B-X
disease-associated	B-X
variants	B-X
with	B-X
diverse	B-X
genomic	B-X
and	B-X
biological	B-X
data	B-X
sets	B-X
to	B-X
provide	B-X
insight	B-X
into	B-X
disease	B-X
pathogenesis	B-X
and	B-X
guide	B-X
drug	B-X
discovery	B-X
for	B-X
complex	B-X
traits	B-X
such	B-X
as	B-X
rheumatoid	B-X
arthritis	B-X
(	B-X
RA	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
performed	B-X
a	B-X
genome-wide	B-X
association	B-X
study	B-X
meta-analysis	B-X
in	B-X
a	B-X
total	B-X
of	B-X
>	B-X
100,000	B-X
subjects	B-X
of	B-X
European	B-X
and	B-X
Asian	B-X
ancestries	B-X
(	B-X
29,880	B-X
RA	B-X
cases	B-X
and	B-X
73,758	B-X
controls	B-X
)	B-X
,	B-X
by	B-X
evaluating	B-X
∼10	B-X
million	B-X
single-nucleotide	B-X
polymorphisms	B-X
.	B-X
We	B-X
discovered	B-X
42	B-X
novel	B-X
RA	B-X
risk	B-X
loci	B-X
at	B-X
a	B-X
genome-wide	B-X
level	B-X
of	B-X
significance	B-X
,	B-X
bringing	B-X
the	B-X
total	B-X
to	B-X
101	B-X
(	B-X
refs	B-X
2	B-X
-	B-X
4	B-X
)	B-X
.	B-X
We	B-X
devised	B-X
an	B-X
in	B-X
silico	B-X
pipeline	B-X
using	B-X
established	B-X
bioinformatics	B-X
methods	B-X
based	B-X
on	B-X
functional	B-X
annotation	B-X
,	B-X
cis-acting	B-X
expression	B-X
quantitative	B-X
trait	B-X
loci	B-X
and	B-X
pathway	B-X
analyses	B-X
--	B-X
as	B-X
well	B-X
as	B-X
novel	B-X
methods	B-X
based	B-X
on	B-X
genetic	B-X
overlap	B-X
with	B-X
human	B-X
primary	B-X
immunodeficiency	B-X
,	B-X
haematological	B-X
cancer	B-X
somatic	B-X
mutations	B-X
and	B-X
knockout	B-X
mouse	B-X
phenotypes	B-X
--	B-X
to	B-X
identify	B-X
98	B-X
biological	B-X
candidate	B-X
genes	B-X
at	B-X
these	B-X
101	B-X
risk	B-X
loci	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
these	B-X
genes	B-X
are	B-X
the	B-X
targets	B-X
of	B-X
approved	B-X
therapies	B-X
for	B-X
RA	B-X
,	B-X
and	B-X
further	B-X
suggest	B-X
that	B-X
drugs	B-X
approved	B-X
for	B-X
other	B-X
indications	B-X
may	B-X
be	B-X
repurposed	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
RA	B-X
.	B-X
Together	B-X
,	B-X
this	B-X
comprehensive	B-X
genetic	B-X
study	B-X
sheds	B-X
light	B-X
on	B-X
fundamental	B-X
genes	B-X
,	B-X
pathways	B-X
and	B-X
cell	B-X
types	B-X
that	B-X
contribute	B-X
to	B-X
RA	B-X
pathogenesis	B-X
,	B-X
and	B-X
provides	B-X
empirical	B-X
evidence	B-X
that	B-X
the	B-X
genetics	B-X
of	B-X
RA	B-X
can	B-X
provide	B-X
important	B-X
information	B-X
for	B-X
drug	B-X
discovery	B-X
.	B-X

We	O
also	O
identified	O
many	O
weakly	O
co	O
-	O
expressed	O
genes	O
,	O
some	O
of	O
which	O
may	O
represent	O
ancestral	O
Salmonella	B-Organism
genes	O
recruited	O
into	O
the	O
SsrB	O
regulon	O
like	O
the	O
previously	O
reported	O
srfN	O
[	O
18	O
]	O
.	O

Some	O
of	O
these	O
genes	O
may	O
not	O
be	O
directly	O
regulated	O
by	O
SsrB	O
and	O
will	O
require	O
further	O
experimental	O
investigation	O
.	O
<EOS>	B-X
Noncoding	B-X
events	B-X
near	B-X
tissue-specific	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
Genes	B-X
typically	B-X
have	B-X
many	B-X
enhancers	B-X
that	B-X
are	B-X
often	B-X
intermingled	B-X
in	B-X
the	B-X
loci	B-X
of	B-X
other	B-X
genes	B-X
.	B-X
To	B-X
regulate	B-X
expression	B-X
,	B-X
enhancers	B-X
must	B-X
therefore	B-X
activate	B-X
their	B-X
correct	B-X
promoter	B-X
while	B-X
ignoring	B-X
others	B-X
that	B-X
may	B-X
be	B-X
in	B-X
closer	B-X
linear	B-X
proximity	B-X
.	B-X
In	B-X
the	B-X
recent	B-X
years	B-X
,	B-X
genome-wide	B-X
analyses	B-X
have	B-X
identified	B-X
signatures	B-X
and	B-X
mapped	B-X
novel	B-X
enhancers	B-X
;	B-X
however	B-X
,	B-X
being	B-X
able	B-X
to	B-X
precisely	B-X
identify	B-X
their	B-X
target	B-X
gene	B-X
(	B-X
s	B-X
)	B-X
requires	B-X
massive	B-X
biological	B-X
and	B-X
bioinformatics	B-X
efforts	B-X
.	B-X

Direct	O
profiling	O
of	O
SsrB	O
-	O
DNA	O
interactions	O
using	O
ChIP	O
-	O
on	O
-	O
chip	O
was	O
used	O
to	O
identify	O
SsrB	O
binding	O
sites	O
in	O
the	O
genome	O
.	O

This	O
analysis	O
identified	O
many	O
interactions	O
which	O
have	O
not	O
been	O
previously	O
described	O
and	O
interaction	O
sites	O
within	O
coding	O
regions	O
of	O
genes	O
which	O
may	O
represent	O
non	O
-	O
canonical	O
functions	O
for	O
SsrB	O
.	O
<EOS>	B-X
Growing	B-X
evidence	B-X
shows	B-X
that	B-X
protein-protein	B-X
interactions	B-X
are	B-X
crucial	B-X
in	B-X
many	B-X
biological	B-X
processes	B-X
in	B-X
living	B-X
cells	B-X
.	B-X
Therefore	B-X
,	B-X
co-IP	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
one	B-X
of	B-X
the	B-X
standard	B-X
methods	B-X
of	B-X
identifying	B-X
or	B-X
confirming	B-X
the	B-X
occurrence	B-X
of	B-X
protein-protein	B-X
interaction	B-X
events	B-X
in	B-X
vivo	B-X
.	B-X
Co-IP	B-X
experiments	B-X
can	B-X
identify	B-X
proteins	B-X
via	B-X
direct	B-X
or	B-X
indirect	B-X
interactions	B-X
or	B-X
in	B-X
a	B-X
protein	B-X
complex	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
identify	B-X
6703	B-X
and	B-X
1536	B-X
protein-protein	B-X
interactions	B-X
for	B-X
109	B-X
different	B-X
human	B-X
TFs	B-X
through	B-X
proximity-dependent	B-X
biotinylation	B-X
(	B-X
BioID	B-X
)	B-X
and	B-X
affinity	B-X
purification	B-X
mass	B-X
spectrometry	B-X
(	B-X
AP-MS	B-X
)	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
BioID	B-X
analysis	B-X
identifies	B-X
more	B-X
high-confidence	B-X
interactions	B-X
,	B-X
highlighting	B-X
the	B-X
transient	B-X
and	B-X
dynamic	B-X
nature	B-X
of	B-X
many	B-X
of	B-X
the	B-X
TF	B-X
interactions	B-X
.	B-X
By	B-X
performing	B-X
clustering	B-X
and	B-X
correlation	B-X
analyses	B-X
,	B-X
we	B-X
identify	B-X
subgroups	B-X
of	B-X
TFs	B-X
associated	B-X
with	B-X
specific	B-X
biological	B-X
functions	B-X
,	B-X
such	B-X
as	B-X
RNA	B-X
splicing	B-X
or	B-X
chromatin	B-X
remodeling	B-X
.	B-X
We	B-X
also	B-X
observe	B-X
202	B-X
TF-TF	B-X
interactions	B-X
,	B-X
of	B-X
which	B-X
118	B-X
are	B-X
interactions	B-X
with	B-X
nuclear	B-X
factor	B-X
1	B-X
(	B-X
NFI	B-X
)	B-X
family	B-X
members	B-X
,	B-X
indicating	B-X
uncharacterized	B-X
cross-talk	B-X
between	B-X
NFI	B-X
signaling	B-X
and	B-X
other	B-X
TF	B-X
signaling	B-X
pathways	B-X
.	B-X
Moreover	B-X
,	B-X
TF	B-X
interactions	B-X
with	B-X
basal	B-X
transcription	B-X
machinery	B-X
are	B-X
mainly	B-X
observed	B-X
through	B-X
TFIID	B-X
and	B-X
SAGA	B-X
complexes	B-X
.	B-X
This	B-X
study	B-X
provides	B-X
a	B-X
rich	B-X
resource	B-X
of	B-X
human	B-X
TF	B-X
interactions	B-X
and	B-X
also	B-X
act	B-X
as	B-X
a	B-X
starting	B-X
point	B-X
for	B-X
future	B-X
studies	B-X
aimed	B-X
at	B-X
understanding	B-X
TF-mediated	B-X
transcription	B-X
.	B-X

Other	O
groups	O
have	O
reported	O
the	O
existence	O
of	O
similar	O
numbers	O
of	O
ChIP	O
-	O
on	O
-	O
chip	O
interactions	O
within	O
intragenic	O
regions	O
for	O
other	O
transcription	O
factors	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
suggesting	O
that	O
this	O
phenomenon	O
is	O
not	O
restricted	O
to	O
SsrB	O
.	O

In	O
light	O
of	O
the	O
disparate	O
number	O
of	O
microarray	O
genes	O
in	O
comparison	O
to	O
ChIP	O
-	O
on	O
-	O
chip	O
peaks	O
we	O
attempted	O
to	O
generate	O
a	O
more	O
comprehensive	O
picture	O
of	O
the	O
SsrB	O
regulon	O
by	O
combining	O
these	O
data	O
sets	O
at	O
the	O
operon	O
level	O
.	O

In	O
doing	O
so	O
we	O
believe	O
that	O
the	O
nineteen	O
operons	O
containing	O
differentially	O
expressed	O
genes	O
determined	O
by	O
microarray	O
and	O
containing	O
a	O
ChIP	O
-	O
on	O
-	O
chip	O
peak	O
three	O
standard	O
deviations	O
above	O
the	O
mean	O
captured	O
by	O
this	O
analysis	O
represent	O
the	O
genes	O
directly	O
activated	O
by	O
SsrB	O
(	O
Table	O
2	O
)	O
.	O

Those	O
operons	O
having	O
a	O
ChIP	O
-	O
on	O
-	O
chip	O
peak	O
directly	O
upstream	O
in	O
the	O
IGR	O
region	O
encompass	O
the	O
majority	O
of	O
known	O
SsrB	O
regulated	O
genes	O
while	O
those	O
possessing	O
a	O
ChIP	O
peak	O
within	O
the	O
CDS	O
of	O
the	O
first	O
gene	O
may	O
represent	O
non	O
-	O
functional	O
interactions	O
that	O
deserve	O
follow	O
-	O
up	O
experimental	O
investigation	O
.	O

The	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
not	O
only	O
provided	O
information	O
on	O
the	O
identities	O
of	O
SsrB	O
-	O
regulated	O
genes	O
but	O
also	O
gave	O
insight	O
as	O
to	O
the	O
identity	O
of	O
the	O
SsrB	O
recognition	O
element	O
specified	O
by	O
the	O
interaction	O
site	O
sequences	O
.	O
<EOS>	B-X
The	B-X
ATAC-seq	B-X
workflow	B-X
has	B-X
five	B-X
main	B-X
steps	B-X
:	B-X
sample	B-X
preparation	B-X
,	B-X
transposition	B-X
,	B-X
library	B-X
preparation	B-X
,	B-X
sequencing	B-X
and	B-X
data	B-X
analysis	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
followed	B-X
by	B-X
sequencing	B-X
(	B-X
ChIP-seq	B-X
)	B-X
is	B-X
a	B-X
central	B-X
method	B-X
in	B-X
epigenomic	B-X
research	B-X
.	B-X
Genome-wide	B-X
analysis	B-X
of	B-X
histone	B-X
modifications	B-X
,	B-X
such	B-X
as	B-X
enhancer	B-X
analysis	B-X
and	B-X
genome-wide	B-X
chromatin	B-X
state	B-X
annotation	B-X
,	B-X
enables	B-X
systematic	B-X
analysis	B-X
of	B-X
how	B-X
the	B-X
epigenomic	B-X
landscape	B-X
contributes	B-X
to	B-X
cell	B-X
identity	B-X
,	B-X
development	B-X
,	B-X
lineage	B-X
specification	B-X
,	B-X
and	B-X
disease	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
first	B-X
present	B-X
a	B-X
typical	B-X
ChIP-seq	B-X
analysis	B-X
workflow	B-X
,	B-X
from	B-X
quality	B-X
assessment	B-X
to	B-X
chromatin-state	B-X
annotation	B-X
.	B-X
Next	B-X
,	B-X
we	B-X
outline	B-X
various	B-X
advanced	B-X
ChIP-seq	B-X
applications	B-X
and	B-X
introduce	B-X
several	B-X
state-of-the-art	B-X
methods	B-X
,	B-X
including	B-X
prediction	B-X
of	B-X
gene	B-X
expression	B-X
level	B-X
and	B-X
chromatin	B-X
loops	B-X
from	B-X
epigenome	B-X
data	B-X
and	B-X
data	B-X
imputation	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
discuss	B-X
recently	B-X
developed	B-X
single-cell	B-X
ChIP-seq	B-X
analysis	B-X
methodologies	B-X
that	B-X
elucidate	B-X
the	B-X
cellular	B-X
diversity	B-X
within	B-X
complex	B-X
tissues	B-X
and	B-X
cancers	B-X
.	B-X

The	O
regulatory	O
architecture	O
governing	O
SsrB	O
input	O
has	O
been	O
elusive	O
despite	O
several	O
SsrB	O
footprints	O
being	O
defined	O
biochemically	O
[	O
19	O
]	O
,	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

Our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
further	O
suggested	O
that	O
SsrB	O
binding	O
within	O
SPI	O
-	O
2	O
was	O
specific	O
,	O
with	O
binding	O
peaks	O
overlapping	O
precisely	O
with	O
regions	O
of	O
the	O
DNA	O
footprinted	O
by	O
SsrB	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

By	O
using	O
a	O
genetic	O
screening	O
strategy	O
together	O
with	O
functional	O
and	O
comparative	O
genomics	O
,	O
we	O
were	O
able	O
to	O
define	O
the	O
essential	O
SsrB	O
regulatory	O
element	O
as	O
being	O
an	O
18	O
-	O
bp	O
palindrome	O
with	O
a	O
conserved	O
7	O
-	O
4	O
-	O
7	O
internal	O
organization	O
.	O

In	O
support	O
of	O
the	O
palindrome	O
as	O
the	O
functional	O
entity	O
we	O
showed	O
the	O
loss	O
of	O
SsrB	O
dependence	O
as	O
a	O
result	O
of	O
deletion	O
of	O
this	O
element	O
for	O
the	O
ssaG	O
promoter	O
.	O

Evaluation	O
of	O
the	O
7	O
-	O
4	O
-	O
7	O
palindrome	O
in	O
the	O
ssaG	O
promoter	O
revealed	O
the	O
minimal	O
architecture	O
and	O
sequence	O
orientation	O
required	O
for	O
transcriptional	O
input	O
.	O

Deletion	O
of	O
the	O
entire	O
palindrome	O
resulted	O
in	O
less	O
than	O
1	O
%	O
activity	O
in	O
wild	O
-	O
type	O
cells	O
,	O
an	O
equivalent	O
level	O
of	O
activity	O
to	O
those	O
lacking	O
ssrB	O
entirely	O
.	O

A	O
search	O
of	O
the	O
S	B-Organism
.	I-Organism
enterica	I-Organism
genome	O
for	O
this	O
palindromic	O
motif	O
revealed	O
candidates	O
upstream	O
of	O
the	O
previously	O
noted	O
SsrB	O
dependent	O
genes	O
,	O
including	O
two	O
additional	O
SPI	O
-	O
2	O
sites	O
;	O
one	O
IGR	O
site	O
upstream	O
of	O
ssaR	O
that	O
until	O
now	O
had	O
been	O
cryptic	O
,	O
and	O
one	O
intragenic	O
palindrome	O
upstream	O
of	O
sseA	O
in	O
the	O
ssaE	O
CDS	O
.	O

In	O
both	O
cases	O
these	O
input	O
sites	O
were	O
found	O
to	O
be	O
functional	O
.	O
<EOS>	B-X
Although	B-X
chronological	B-X
age	B-X
correlates	B-X
with	B-X
various	B-X
age-related	B-X
diseases	B-X
and	B-X
conditions	B-X
,	B-X
it	B-X
does	B-X
not	B-X
adequately	B-X
reflect	B-X
an	B-X
individual	B-X
's	B-X
functional	B-X
capacity	B-X
,	B-X
well-being	B-X
,	B-X
or	B-X
mortality	B-X
risk	B-X
.	B-X
Estimates	B-X
of	B-X
biological	B-X
age	B-X
are	B-X
thought	B-X
to	B-X
be	B-X
provided	B-X
by	B-X
aging	B-X
clocks	B-X
,	B-X
which	B-X
are	B-X
computational	B-X
models	B-X
(	B-X
e.g.	B-X
,	B-X
elastic	B-X
net	B-X
)	B-X
that	B-X
use	B-X
a	B-X
set	B-X
of	B-X
inputs	B-X
(	B-X
e.g.	B-X
,	B-X
DNA	B-X
methylation	B-X
sites	B-X
)	B-X
to	B-X
make	B-X
a	B-X
prediction	B-X
.	B-X
Sun	B-X
,	B-X
S.	B-X
Elsea	B-X
O10	B-X
A	B-X
novel	B-X
causal	B-X
methylation	B-X
network	B-X
approach	B-X
to	B-X
Alzheimer	B-X
’	B-X
s	B-X
disease	B-X
Z.	B-X
Hu	B-X
,	B-X
P.	B-X
Wang	B-X
,	B-X
Y.	B-X
Zhu	B-X
,	B-X
J.	B-X
Zhao	B-X
,	B-X
M.	B-X
Xiong	B-X
,	B-X
David	B-X
A	B-X
Bennett	B-X
O11	B-X
A	B-X
microRNA	B-X
signature	B-X
identifies	B-X
subtypes	B-X
of	B-X
triple-negative	B-X
breast	B-X
cancer	B-X
and	B-X
reveals	B-X
MIR-342-3P	B-X
as	B-X
regulator	B-X
of	B-X
a	B-X
lactate	B-X
metabolic	B-X
pathway	B-X
A.	B-X
Hidalgo-Miranda	B-X
,	B-X
S.	B-X
Romero-Cordoba	B-X
,	B-X
S.	B-X
Rodriguez-Cuevas	B-X
,	B-X
R.	B-X
Rebollar-Vega	B-X
,	B-X
E.	B-X
Tagliabue	B-X
,	B-X
M.	B-X
Iorio	B-X
,	B-X
E.	B-X
D	B-X
’	B-X
Ippolito	B-X
,	B-X
S.	B-X
Baroni	B-X
O12	B-X
Transcriptome	B-X
analysis	B-X
identifies	B-X
genes	B-X
,	B-X
enhancer	B-X
RNAs	B-X
and	B-X
repetitive	B-X
elements	B-X
that	B-X
are	B-X
recurrently	B-X
deregulated	B-X
across	B-X
multiple	B-X
cancer	B-X
types	B-X
B.	B-X
Kaczkowski	B-X
,	B-X
Y.	B-X
Tanaka	B-X
,	B-X
H.	B-X
Kawaji	B-X
,	B-X
A.	B-X
Sandelin	B-X
,	B-X
R.	B-X
Andersson	B-X
,	B-X
M.	B-X
Itoh	B-X
,	B-X
T.	B-X
Lassmann	B-X
,	B-X
the	B-X
FANTOM5	B-X
consortium	B-X
,	B-X
Y.	B-X
Hayashizaki	B-X
,	B-X
P.	B-X
Carninci	B-X
,	B-X
A.	B-X
R.	B-X
R.	B-X
Forrest	B-X
O13	B-X
Elevated	B-X
mutation	B-X
and	B-X
widespread	B-X
loss	B-X
of	B-X
constraint	B-X
at	B-X
regulatory	B-X
and	B-X
architectural	B-X
binding	B-X
sites	B-X
across	B-X
11	B-X
tumour	B-X
types	B-X
C.	B-X
A.	B-X
Semple	B-X
O14	B-X
Exome	B-X
sequencing	B-X
provides	B-X
evidence	B-X
of	B-X
pathogenicity	B-X
for	B-X
genes	B-X
implicated	B-X
in	B-X
colorectal	B-X
cancer	B-X
E.	B-X
A.	B-X
Rosenthal	B-X
,	B-X
B	B-X
.	B-X
King	B-X
,	B-X
E.	B-X
Berman	B-X
Rosenzweig	B-X
,	B-X
U.	B-X
Krishnan	B-X
,	B-X
J.	B-X
G.	B-X
Reid	B-X
,	B-X
J.	B-X
D.	B-X
Overton	B-X
,	B-X
F.	B-X
Dewey	B-X
,	B-X
W.	B-X
K.	B-X
Chung	B-X
O28	B-X
NORTH	B-X
CAROLINA	B-X
macular	B-X
dystrophy	B-X
(	B-X
MCDR1	B-X
)	B-X
:	B-X
mutations	B-X
found	B-X
affecting	B-X
PRDM13	B-X
K.	B-X
Small	B-X
,	B-X
A.	B-X
DeLuca	B-X
,	B-X
F.	B-X
Cremers	B-X
,	B-X
R.	B-X
A.	B-X
Lewis	B-X
,	B-X
V.	B-X
Puech	B-X
,	B-X
B.	B-X
Bakall	B-X
,	B-X
R.	B-X
Silva-Garcia	B-X
,	B-X
K.	B-X
Rohrschneider	B-X
,	B-X
M.	B-X
Leys	B-X
,	B-X
F.	B-X
S.	B-X
Shaya	B-X
,	B-X
E.	B-X
Stone	B-X
O29	B-X
PhenoDB	B-X
and	B-X
genematcher	B-X
,	B-X
solving	B-X
unsolved	B-X
whole	B-X
exome	B-X
sequencing	B-X
data	B-X
N.	B-X
L.	B-X
Sobreira	B-X
,	B-X
F.	B-X
Schiettecatte	B-X
,	B-X
H.	B-X
Ling	B-X
,	B-X
E.	B-X
Pugh	B-X
,	B-X
D.	B-X
Witmer	B-X
,	B-X
K.	B-X
Hetrick	B-X
,	B-X
P.	B-X
Zhang	B-X
,	B-X
K.	B-X
Doheny	B-X
,	B-X
D.	B-X
Valle	B-X
,	B-X
A.	B-X
Hamosh	B-X
O30	B-X
Baylor-Johns	B-X
Hopkins	B-X
Center	B-X
for	B-X
Mendelian	B-X
genomics	B-X
:	B-X
a	B-X
four	B-X
year	B-X
review	B-X
S.	B-X
N.	B-X
Jhangiani	B-X
,	B-X
Z.	B-X
Coban	B-X
Akdemir	B-X
,	B-X
M.	B-X
N.	B-X
Bainbridge	B-X
,	B-X
W.	B-X
Charng	B-X
,	B-X
W.	B-X
Wiszniewski	B-X
,	B-X
T.	B-X
Gambin	B-X
,	B-X
E.	B-X
Karaca	B-X
,	B-X
Y.	B-X
Bayram	B-X
,	B-X
M.	B-X
K.	B-X
Eldomery	B-X
,	B-X
J.	B-X
Posey	B-X
,	B-X
H.	B-X
Doddapaneni	B-X
,	B-X
J.	B-X
Hu	B-X
,	B-X
V.	B-X
R.	B-X
Sutton	B-X
,	B-X
D.	B-X
M.	B-X
Muzny	B-X
,	B-X
E.	B-X
A.	B-X
Boerwinkle	B-X
,	B-X
D.	B-X
Valle	B-X
,	B-X
J.	B-X
R.	B-X
Lupski	B-X
,	B-X
R.	B-X
A.	B-X
Gibbs	B-X
O31	B-X
Using	B-X
read	B-X
overlap	B-X
assembly	B-X
to	B-X
accurately	B-X
identify	B-X
structural	B-X
genetic	B-X
differences	B-X
in	B-X
an	B-X
ashkenazi	B-X
jewish	B-X
trio	B-X
S.	B-X
Shekar	B-X
,	B-X
W.	B-X
Salerno	B-X
,	B-X
A.	B-X
English	B-X
,	B-X
A.	B-X
Mangubat	B-X
,	B-X
J.	B-X
Bruestle	B-X
O32	B-X
Legal	B-X
interoperability	B-X
:	B-X
a	B-X
sine	B-X
qua	B-X
non	B-X
for	B-X
international	B-X
data	B-X
sharing	B-X
A.	B-X
Thorogood	B-X
,	B-X
B.	B-X
M.	B-X
Knoppers	B-X
,	B-X
Global	B-X
Alliance	B-X
for	B-X
Genomics	B-X
and	B-X
Health	B-X
-	B-X
Regulatory	B-X
and	B-X
Ethics	B-X
Working	B-X
Group	B-X
O33	B-X
High	B-X
throughput	B-X
screening	B-X
platform	B-X
of	B-X
competent	B-X
sineups	B-X
:	B-X
that	B-X
can	B-X
enhance	B-X
translation	B-X
activities	B-X
of	B-X
therapeutic	B-X
target	B-X
H.	B-X
Takahashi	B-X
,	B-X
K.	B-X
R.	B-X
Nitta	B-X
,	B-X
A.	B-X
Kozhuharova	B-X
,	B-X
A.	B-X
M.	B-X
Suzuki	B-X
,	B-X
H.	B-X
Sharma	B-X
,	B-X
D.	B-X
Cotella	B-X
,	B-X
C.	B-X
Santoro	B-X
,	B-X
S.	B-X
Zucchelli	B-X
,	B-X
S.	B-X
Gustincich	B-X
,	B-X
P.	B-X
Carninci	B-X
O34	B-X
The	B-X
undiagnosed	B-X
diseases	B-X
network	B-X
international	B-X
(	B-X
UDNI	B-X
)	B-X
:	B-X
clinical	B-X
and	B-X
laboratory	B-X
research	B-X
to	B-X
meet	B-X
patient	B-X
needs	B-X
J.	B-X
J.	B-X
Mulvihill	B-X
,	B-X
G.	B-X
Baynam	B-X
,	B-X
W.	B-X
Gahl	B-X
,	B-X
S.	B-X
C.	B-X
Groft	B-X
,	B-X
K.	B-X
Kosaki	B-X
,	B-X
P.	B-X
Lasko	B-X
,	B-X
B.	B-X
Melegh	B-X
,	B-X
D.	B-X
Taruscio	B-X
O36	B-X
Performance	B-X
of	B-X
computational	B-X
algorithms	B-X
in	B-X
pathogenicity	B-X
predictions	B-X
for	B-X
activating	B-X
variants	B-X
in	B-X
oncogenes	B-X
versus	B-X
loss	B-X
of	B-X
function	B-X
mutations	B-X
in	B-X
tumor	B-X
suppressor	B-X
genes	B-X
R.	B-X
Ghosh	B-X
,	B-X
S.	B-X
Plon	B-X
O37	B-X
Identification	B-X
and	B-X
electronic	B-X
health	B-X
record	B-X
incorporation	B-X
of	B-X
clinically	B-X
actionable	B-X
pharmacogenomic	B-X
variants	B-X
using	B-X
prospective	B-X
targeted	B-X
sequencing	B-X
S.	B-X
Scherer	B-X
,	B-X
X.	B-X
Qin	B-X
,	B-X
R.	B-X
Sanghvi	B-X
,	B-X
K.	B-X
Walker	B-X
,	B-X
T.	B-X
Chiang	B-X
,	B-X
D.	B-X
Muzny	B-X
,	B-X
L.	B-X
Wang	B-X
,	B-X
J	B-X
.	B-X
Song	B-X
,	B-X
A.	B-X
Lazar	B-X
,	B-X
J.	B-X
Gershenwald	B-X
,	B-X
M.	B-X
Davies	B-X
,	B-X
C.	B-X
Bernatchez	B-X
,	B-X
J.	B-X
Zhang	B-X
,	B-X
A.	B-X
Futreal	B-X
,	B-X
S.	B-X
Woodman	B-X
O39	B-X
Data-driven	B-X
refinement	B-X
of	B-X
complex	B-X
disease	B-X
classification	B-X
from	B-X
integration	B-X
of	B-X
heterogeneous	B-X
functional	B-X
genomics	B-X
data	B-X
in	B-X
GeneWeaver	B-X
E.	B-X
J.	B-X
Chesler	B-X
,	B-X
T.	B-X
Reynolds	B-X
,	B-X
J	B-X
.	B-X
Young	B-X
,	B-X
P.	B-X
James	B-X
,	B-X
Lifepool	B-X
O53	B-X
Comprehensive	B-X
coverage	B-X
from	B-X
low	B-X
DNA	B-X
input	B-X
using	B-X
novel	B-X
NGS	B-X
library	B-X
preparation	B-X
methods	B-X
for	B-X
WGS	B-X
and	B-X
WGBS	B-X
C.	B-X
Schumacher	B-X
,	B-X
S.	B-X
Sandhu	B-X
,	B-X
T.	B-X
Harkins	B-X
,	B-X
V.	B-X
Makarov	B-X
O54	B-X
Methods	B-X
for	B-X
large	B-X
scale	B-X
construction	B-X
of	B-X
robust	B-X
PCR-free	B-X
libraries	B-X
for	B-X
sequencing	B-X
on	B-X
Illumina	B-X
HiSeqX	B-X
platform	B-X
H.	B-X
DoddapaneniR	B-X
.	B-X
Below	B-X
,	B-X
D.	B-X
Muzny	B-X
,	B-X
R.	B-X
Gibbs	B-X
,	B-X
F.	B-X
Yu	B-X
,	B-X
J.	B-X
Rogers	B-X
O59	B-X
Assessing	B-X
RNA	B-X
structure	B-X
disruption	B-X
induced	B-X
by	B-X
single-nucleotide	B-X
variation	B-X
J.	B-X
Lin	B-X
,	B-X
Y.	B-X
Zhang	B-X
,	B-X
Z.	B-X
Ouyang	B-X
P1	B-X
A	B-X
meta-analysis	B-X
of	B-X
genome-wide	B-X
association	B-X
studies	B-X
of	B-X
mitochondrial	B-X
dna	B-X
copy	B-X
number	B-X
A.	B-X
Moore	B-X
,	B-X
Z.	B-X
Wang	B-X
,	B-X
J.	B-X
Hofmann	B-X
,	B-X
M.	B-X
Purdue	B-X
,	B-X
R.	B-X
Stolzenberg-Solomon	B-X
,	B-X
S.	B-X
Weinstein	B-X
,	B-X
D.	B-X
Albanes	B-X
,	B-X
C.-S.	B-X
Liu	B-X
,	B-X
W.-L.	B-X
Cheng	B-X
,	B-X
T.-T.	B-X
Lin	B-X
,	B-X
Q.	B-X
Lan	B-X
,	B-X
N.	B-X
Rothman	B-X
,	B-X
S.	B-X
Berndt	B-X
P2	B-X
Missense	B-X
polymorphic	B-X
genetic	B-X
combinations	B-X
underlying	B-X
down	B-X
syndrome	B-X
susceptibility	B-X
E.	B-X
S.	B-X
Chen	B-X
P4	B-X
The	B-X
evaluation	B-X
of	B-X
alteration	B-X
of	B-X
ELAM-1	B-X
expression	B-X
in	B-X
the	B-X
endometriosis	B-X
patients	B-X
H.	B-X
Bahrami	B-X
,	B-X
A.	B-X
Khoshzaban	B-X
,	B-X
S.	B-X
Heidari	B-X
Keshal	B-X
P5	B-X
Obesity	B-X
and	B-X
the	B-X
incidence	B-X
of	B-X
apolipoprotein	B-X
E	B-X
polymorphisms	B-X
in	B-X
an	B-X
assorted	B-X
population	B-X
from	B-X
Saudi	B-X
Arabia	B-X
population	B-X
K.	B-X
K.	B-X
R.	B-X
Alharbi	B-X
P6	B-X
Genome-associated	B-X
personalized	B-X
antithrombotical	B-X
therapy	B-X
for	B-X
patients	B-X
with	B-X
high	B-X
risk	B-X
of	B-X
thrombosis	B-X
and	B-X
bleeding	B-X
M.	B-X
Zhalbinova	B-X
,	B-X
A.	B-X
Akilzhanova	B-X
,	B-X
S.	B-X
Rakhimova	B-X
,	B-X
M.	B-X
Bekbosynova	B-X
,	B-X
S.	B-X
Myrzakhmetova	B-X
P7	B-X
Frequency	B-X
of	B-X
Xmn1	B-X
polymorphism	B-X
among	B-X
sickle	B-X
cell	B-X
carrier	B-X
cases	B-X
in	B-X
UAE	B-X
population	B-X
M.	B-X
Matar	B-X
P8	B-X
Differentiating	B-X
inflammatory	B-X
bowel	B-X
diseases	B-X
by	B-X
using	B-X
genomic	B-X
data	B-X
:	B-X
dimension	B-X
of	B-X
the	B-X
problem	B-X
and	B-X
network	B-X
organization	B-X
N.	B-X
Mili	B-X
,	B-X
R.	B-X
Molinari	B-X
,	B-X
Y.	B-X
Ma	B-X
,	B-X
S.	B-X
Guerrier	B-X
P9	B-X
Vulnerability	B-X
of	B-X
genetic	B-X
variants	B-X
to	B-X
the	B-X
risk	B-X
of	B-X
autism	B-X
among	B-X
Saudi	B-X
children	B-X
N.	B-X
Elhawary	B-X
,	B-X
M.	B-X
Tayeb	B-X
,	B-X
N.	B-X
Bogari	B-X
,	B-X
N.	B-X
Qotb	B-X
P10	B-X
Chromatin	B-X
profiles	B-X
from	B-X
ex	B-X
vivo	B-X
purified	B-X
dopaminergic	B-X
neurons	B-X
establish	B-X
a	B-X
promising	B-X
model	B-X
to	B-X
support	B-X
studies	B-X
of	B-X
neurological	B-X
function	B-X
and	B-X
dysfunction	B-X
S.	B-X
A.	B-X
McClymont	B-X
,	B-X
P.	B-X
W.	B-X
Hook	B-X
,	B-X
L.	B-X
A.	B-X
Goff	B-X
,	B-X
A.	B-X
McCallion	B-X
P11	B-X
Utilization	B-X
of	B-X
a	B-X
sensitized	B-X
chemical	B-X
mutagenesis	B-X
screen	B-X
to	B-X
identify	B-X
genetic	B-X
modifiers	B-X
of	B-X
retinal	B-X
dysplasia	B-X
in	B-X
homozygous	B-X
Nr2e3	B-X

Although	O
palindrome	O
architecture	O
was	O
conserved	O
upstream	O
of	O
SsrB	O
-	O
regulated	O
genes	O
,	O
degenerate	O
palindromes	O
in	O
which	O
one	O
half	O
-	O
site	O
was	O
more	O
conserved	O
were	O
also	O
functional	O
.	O

As	O
a	O
result	O
of	O
our	O
mutational	O
analyses	O
we	O
conclude	O
that	O
so	O
long	O
as	O
the	O
orientation	O
of	O
a	O
single	O
heptamer	O
of	O
the	O
palindrome	O
is	O
conserved	O
with	O
respect	O
to	O
the	O
downstream	O
gene	O
,	O
SsrB	O
is	O
tolerant	O
of	O
degeneracy	O
in	O
the	O
adjacent	O
spacer	O
and	O
heptamer	O
sequences	O
.	O

While	O
we	O
were	O
able	O
to	O
identify	O
a	O
number	O
of	O
limited	O
palindrome	O
-	O
like	O
sequences	O
from	O
our	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
,	O
this	O
tolerance	O
in	O
addition	O
to	O
the	O
library	O
size	O
required	O
to	O
pull	O
out	O
an	O
18	O
-	O
bp	O
palindrome	O
in	O
large	O
numbers	O
may	O
explain	O
why	O
we	O
isolated	O
functional	O
single	O
heptamer	O
sequences	O
and	O
why	O
degenerate	O
palindromes	O
naturally	O
exist	O
in	O
the	O
genome	O
.	O

A	O
recent	O
report	O
by	O
Carroll	O
et	O
al	O
,	O
postulated	O
that	O
SsrB	O
first	O
interacts	O
with	O
DNA	O
as	O
a	O
monomer	O
,	O
followed	O
by	O
dimerization	O
[	O
32	O
]	O
.	O

Our	O
findings	O
also	O
suggest	O
that	O
dimerization	O
is	O
likely	O
required	O
for	O
transcriptional	O
activation	O
however	O
strong	O
recognition	O
by	O
one	O
monomer	O
may	O
stabilize	O
interaction	O
of	O
a	O
second	O
monomer	O
with	O
a	O
less	O
than	O
ideal	O
sequence	O
.	O

The	O
finding	O
that	O
a	O
flexible	O
palindromic	O
sequence	O
can	O
be	O
selective	O
for	O
SsrB	O
input	O
raises	O
many	O
interesting	O
questions	O
around	O
the	O
nature	O
of	O
regulatory	O
evolution	O
.	O

The	O
ability	O
to	O
use	O
a	O
short	O
functional	O
half	O
-	O
site	O
adjacent	O
to	O
an	O
uncharacterized	O
threshold	O
level	O
of	O
tolerated	O
bases	O
would	O
reduce	O
the	O
period	O
of	O
neutral	O
evolution	O
required	O
to	O
generate	O
an	O
inverted	O
repeat	O
sequence	O
twice	O
the	O
length	O
[	O
37	O
]	O
,	O
and	O
would	O
limit	O
the	O
loss	O
of	O
intermediate	O
variations	O
to	O
drift	O
while	O
a	O
more	O
desirable	O
palindrome	O
is	O
created	O
by	O
regulatory	O
evolution	O
.	O

For	O
bacteria	O
that	O
make	O
use	O
of	O
horizontal	O
gene	O
transfer	O
,	O
this	O
could	O
increase	O
the	O
tempo	O
with	O
which	O
new	O
DNA	O
is	O
integrated	O
into	O
the	O
regulatory	O
circuitry	O
of	O
the	O
cell	O
.	O

We	O
showed	O
that	O
the	O
SsrB	O
regulatory	O
palindrome	O
is	O
also	O
present	O
in	O
the	O
orthologous	O
SSR	O
-	O
3	O
island	O
of	O
the	O
endosymbiont	O
Sodalis	B-Organism
glossinidius	I-Organism
and	O
that	O
the	O
palindrome	O
evolved	O
in	O
Sodalis	B-Organism
can	O
act	O
as	O
a	O
cis	O
regulatory	O
input	O
function	O
in	O
Salmonella	B-Organism
.	O

Thus	O
,	O
in	O
addition	O
to	O
supporting	O
a	O
pathogenic	O
lifestyle	O
within	O
a	O
host	O
in	O
Salmonella	B-Organism
,	O
it	O
seems	O
probable	O
that	O
this	O
common	O
promoter	O
architecture	O
may	O
direct	O
the	O
activation	O
of	O
the	O
SSR	O
-	O
3	O
T3SS	O
of	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
in	O
its	O
endosymbiotic	O
relationship	O
with	O
the	O
tsetse	B-Organism
fly	I-Organism
host	O
,	O
although	O
we	O
acknowledge	O
this	O
requires	O
experimental	O
validation	O
.	O

The	O
SSR	O
-	O
3	O
region	O
in	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
is	O
fully	O
conserved	O
in	O
gene	O
synteny	O
and	O
content	O
with	O
that	O
of	O
SPI	O
-	O
2	O
[	O
31	O
]	O
,	O
with	O
the	O
exception	O
of	O
two	O
effector	O
genes	O
missing	O
in	O
SSR	O
-	O
3	O
(	O
sseF	O
and	O
sseG	O
)	O
that	O
are	O
required	O
to	O
localize	O
vacuolar	O
Salmonella	B-Organism
to	O
the	O
perinuclear	O
Golgi	O
in	O
host	O
cells	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
.	O

The	O
SsrB	O
ortholog	O
in	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
is	O
approximately30	O
%	O
divergent	O
with	O
SsrB	O
at	O
the	O
protein	O
level	O
,	O
initially	O
leading	O
us	O
to	O
think	O
that	O
they	O
might	O
have	O
different	O
binding	O
site	O
preferences	O
.	O

To	O
the	O
contrary	O
,	O
high	O
local	O
conservation	O
in	O
the	O
promoters	O
evolved	O
in	O
Salmonella	B-Organism
and	O
Sodalis	B-Organism
was	O
the	O
crux	O
in	O
defining	O
the	O
functional	O
SsrB	O
input	O
among	O
stochastic	O
noise	O
.	O

This	O
analysis	O
revealed	O
strong	O
palindrome	O
sequence	O
conservation	O
in	O
five	O
promoters	O
identified	O
in	O
SPI	O
-	O
2	O
and	O
in	O
the	O
orthologous	O
sequences	O
in	O
Sodalis	B-Organism
SSR	O
-	O
3	O
.	O

Among	O
palindrome	O
-	O
containing	O
promoters	O
,	O
the	O
ssrA	O
promoter	O
is	O
exceptional	O
for	O
two	O
reasons	O
:	O
a	O
lack	O
of	O
conservation	O
between	O
Salmonella	B-Organism
and	O
Sodalis	B-Organism
,	O
and	O
the	O
evolution	O
of	O
tandem	O
palindromes	O
in	O
Salmonella	B-Organism
.	O

One	O
possible	O
interpretation	O
of	O
this	O
divergent	O
regulatory	O
architecture	O
in	O
front	O
of	O
ssrA	O
might	O
relate	O
to	O
bacterial	O
lifestyle	O
.	O

Salmonella	B-Organism
may	O
have	O
retained	O
or	O
evolved	O
SsrB	O
input	O
here	O
to	O
create	O
a	O
positive	O
feedback	O
loop	O
on	O
the	O
regulatory	O
system	O
to	O
rapidly	O
adapt	O
to	O
the	O
host	O
environment	O
during	O
infection	O
,	O
similar	O
to	O
transcriptional	O
surge	O
described	O
for	O
the	O
PhoP	O
response	O
regulator	O
[	O
40	O
]	O
.	O
<EOS>	B-X
Tolerance	B-X
and	B-X
persistence	B-X
are	B-X
superficially	B-X
similar	B-X
phenomena	B-X
by	B-X
which	B-X
bacteria	B-X
survive	B-X
bactericidal	B-X
antibiotics	B-X
.	B-X
However	B-X
,	B-X
by	B-X
comparing	B-X
tolerance	B-X
and	B-X
persistence	B-X
during	B-X
Salmonella	B-X
Typhimurium	B-X
infection	B-X
,	B-X
we	B-X
reveal	B-X
that	B-X
these	B-X
two	B-X
phenomena	B-X
are	B-X
underpinned	B-X
by	B-X
different	B-X
bacterial	B-X
physiologies	B-X
.	B-X
Multidrug-tolerant	B-X
mutant	B-X
Salmonella	B-X
enter	B-X
a	B-X
near-dormant	B-X
state	B-X
protected	B-X
from	B-X
immune-mediated	B-X
genotoxic	B-X
damages	B-X
.	B-X
However	B-X
,	B-X
the	B-X
numerous	B-X
tolerant	B-X
cells	B-X
,	B-X
optimized	B-X
for	B-X
survival	B-X
,	B-X
lack	B-X
the	B-X
capabilities	B-X
necessary	B-X
to	B-X
initiate	B-X
infection	B-X
relapse	B-X
following	B-X
antibiotic	B-X
withdrawal	B-X
.	B-X
This	B-X
leaves	B-X
them	B-X
vulnerable	B-X
to	B-X
accumulation	B-X
of	B-X
macrophage-induced	B-X
dsDNA	B-X
breaks	B-X
but	B-X
concurrently	B-X
confers	B-X
the	B-X
versatility	B-X
to	B-X
initiate	B-X
infection	B-X
relapse	B-X
if	B-X
protected	B-X
by	B-X
RecA-mediated	B-X
DNA	B-X
repair	B-X
.	B-X
Accordingly	B-X
,	B-X
recurrent	B-X
,	B-X
invasive	B-X
,	B-X
non-typhoidal	B-X
Salmonella	B-X
clinical	B-X
isolates	B-X
display	B-X
hallmarks	B-X
of	B-X
persistence	B-X
rather	B-X
than	B-X
tolerance	B-X
during	B-X
antibiotic	B-X
treatment	B-X
.	B-X
Our	B-X
study	B-X
highlights	B-X
the	B-X
complex	B-X
trade-off	B-X
that	B-X
antibiotic-recalcitrant	B-X
Salmonella	B-X
balance	B-X
to	B-X
act	B-X
as	B-X
a	B-X
reservoir	B-X
for	B-X
infection	B-X
relapse	B-X
.	B-X

The	O
endosymbiotic	O
relationship	O
of	O
Sodalis	O
with	O
the	O
tsetse	B-Organism
fly	I-Organism
-	O
where	O
long	O
-	O
term	O
vertical	O
transmission	O
has	O
ostensibly	O
been	O
formative	O
in	O
shaping	O
regulatory	O
circuitry	O
at	O
certain	O
promoters	O
-	O
may	O
obviate	O
the	O
need	O
for	O
rapid	O
transcriptional	O
surge	O
,	O
leading	O
to	O
regulatory	O
drift	O
or	O
selection	O
against	O
positive	O
feedback	O
.	O
<EOS>	B-X
Identification	B-X
of	B-X
a	B-X
novel	B-X
cancer	B-X
stem	B-X
cell	B-X
subpopulation	B-X
that	B-X
promotes	B-X
progression	B-X
of	B-X
human	B-X
fatal	B-X
renal	B-X
cell	B-X
carcinoma	B-X
by	B-X
single-cell	B-X
RNA-seq	B-X
analysis	B-X
.	B-X
Colorectal	B-X
cancer	B-X
(	B-X
CRC	B-X
)	B-X
presenting	B-X
as	B-X
colorectal	B-X
adenocarcinoma	B-X
(	B-X
COAD	B-X
)	B-X
is	B-X
the	B-X
second	B-X
leading	B-X
cause	B-X
of	B-X
cancer	B-X
deaths	B-X
worldwide	B-X
.	B-X
Multimodality	B-X
treatment	B-X
includes	B-X
surgery	B-X
,	B-X
chemotherapy	B-X
,	B-X
and	B-X
targeted	B-X
therapies	B-X
with	B-X
selective	B-X
utilization	B-X
of	B-X
immunotherapy	B-X
and	B-X
radiation	B-X
therapy	B-X
.	B-X
Despite	B-X
the	B-X
early	B-X
success	B-X
of	B-X
anti-epidermal	B-X
growth	B-X
factor	B-X
receptor	B-X
(	B-X
anti-EGFR	B-X
)	B-X
therapy	B-X
,	B-X
treatment	B-X
resistance	B-X
is	B-X
common	B-X
and	B-X
often	B-X
driven	B-X
by	B-X
mutations	B-X
in	B-X
APC	B-X
,	B-X
KRAS	B-X
,	B-X
RAF	B-X
,	B-X
and	B-X
PI3K/mTOR	B-X
and	B-X
positive	B-X
feedback	B-X
between	B-X
activated	B-X
KRAS	B-X
and	B-X
WNT	B-X
effectors	B-X
.	B-X
Based	B-X
on	B-X
the	B-X
data-driven	B-X
approach	B-X
using	B-X
available	B-X
patient	B-X
datasets	B-X
(	B-X
The	B-X
Cancer	B-X
Genome	B-X
Atlas	B-X
(	B-X
TCGA	B-X
)	B-X
)	B-X
,	B-X
we	B-X
constructed	B-X
transcriptomic	B-X
correlations	B-X
between	B-X
gene	B-X
DDR1	B-X
,	B-X
with	B-X
an	B-X
expression	B-X
of	B-X
genes	B-X
for	B-X
EGFR	B-X
,	B-X
ERBB2-4	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
pathway	B-X
intermediates	B-X
,	B-X
BCR	B-X
,	B-X
and	B-X
ABL	B-X
and	B-X
genes	B-X
for	B-X
cancer	B-X
stem	B-X
cell	B-X
reactivation	B-X
,	B-X
cell	B-X
polarity	B-X
,	B-X
and	B-X
adhesion	B-X
;	B-X
we	B-X
identified	B-X
a	B-X
positive	B-X
association	B-X
of	B-X
DDR1	B-X
with	B-X
EGFR	B-X
,	B-X
ERBB2	B-X
,	B-X
BRAF	B-X
,	B-X
SOX9	B-X
,	B-X
and	B-X
VANGL2	B-X
in	B-X
Pan-Cancer	B-X
.	B-X

With	O
the	O
structure	O
of	O
SsrB	O
available	O
[	O
32	O
]	O
and	O
its	O
recognized	O
sequence	O
now	O
identified	O
,	O
future	O
studies	O
will	O
be	O
able	O
to	O
build	O
a	O
picture	O
of	O
how	O
SsrB	O
interacts	O
with	O
both	O
its	O
target	O
DNA	O
,	O
RNA	O
polymerase	O
and	O
potentially	O
other	O
transcription	O
factors	O
including	O
nucleoid	O
associated	O
proteins	O
in	O
order	O
to	O
direct	O
transcription	O
of	O
its	O
regulon	O
.	O

In	O
summary	O
,	O
this	O
work	O
highlights	O
the	O
evolutionary	O
significance	O
of	O
cis	O
-	O
regulatory	O
mutation	O
for	O
the	O
adaptation	O
of	O
Salmonella	O
to	O
a	O
host	O
animal	O
.	O

The	O
DNA	O
module	O
that	O
choreographs	O
SsrB	O
-	O
mediated	O
pathogenic	O
behaviour	O
in	O
Salmonella	B-Organism
appears	O
to	O
have	O
been	O
conserved	O
for	O
mutualism	O
as	O
well	O
,	O
thereby	O
shedding	O
new	O
light	O
on	O
the	O
significance	O
of	O
cis	O
-	O
regulatory	O
mutations	O
for	O
bacteria	O
evolving	O
in	O
different	O
ecological	O
settings	O
.	O

Microevolution	O
of	O
Group	B-Organism
A	I-Organism
Streptococci	I-Organism
In	O
Vivo	O
:	O
Capturing	O
Regulatory	O
Networks	O
Engaged	O
in	O
Sociomicrobiology	O
,	O
Niche	O
Adaptation	O
,	O
and	O
Hypervirulence	O

The	O
onset	O
of	O
infection	O
and	O
the	O
switch	O
from	O
primary	O
to	O
secondary	O
niches	O
are	O
dramatic	O
environmental	O
changes	O
that	O
not	O
only	O
alter	O
bacterial	O
transcriptional	O
programs	O
,	O
but	O
also	O
perturb	O
their	O
sociomicrobiology	O
,	O
often	O
driving	O
minor	O
subpopulations	O
with	O
mutant	O
phenotypes	O
to	O
prevail	O
in	O
specific	O
niches	O
.	O

Having	O
previously	O
reported	O
that	O
M1T1	B-Organism
Streptococcus	I-Organism
pyogenes	I-Organism
become	O
hypervirulent	O
in	O
mice	B-Organism
due	O
to	O
selection	O
of	O
mutants	O
in	O
the	O
covRS	O
regulatory	O
genes	O
,	O
we	O
set	O
out	O
to	O
dissect	O
the	O
impact	O
of	O
these	O
mutations	O
in	O
vitro	O
and	O
in	O
vivo	O
from	O
the	O
impact	O
of	O
other	O
adaptive	O
events	O
.	O
<EOS>	B-X
The	B-X
onset	B-X
of	B-X
infection	B-X
and	B-X
the	B-X
switch	B-X
from	B-X
primary	B-X
to	B-X
secondary	B-X
niches	B-X
are	B-X
dramatic	B-X
environmental	B-X
changes	B-X
that	B-X
not	B-X
only	B-X
alter	B-X
bacterial	B-X
transcriptional	B-X
programs	B-X
,	B-X
but	B-X
also	B-X
perturb	B-X
their	B-X
sociomicrobiology	B-X
,	B-X
often	B-X
driving	B-X
minor	B-X
subpopulations	B-X
with	B-X
mutant	B-X
phenotypes	B-X
to	B-X
prevail	B-X
in	B-X
specific	B-X
niches	B-X
.	B-X
Having	B-X
previously	B-X
reported	B-X
that	B-X
M1T1	B-X
Streptococcus	B-X
pyogenes	B-X
become	B-X
hypervirulent	B-X
in	B-X
mice	B-X
due	B-X
to	B-X
selection	B-X
of	B-X
mutants	B-X
in	B-X
the	B-X
covRS	B-X
regulatory	B-X
genes	B-X
,	B-X
we	B-X
set	B-X
out	B-X
to	B-X
dissect	B-X
the	B-X
impact	B-X
of	B-X
these	B-X
mutations	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
from	B-X
the	B-X
impact	B-X
of	B-X
other	B-X
adaptive	B-X
events	B-X
.	B-X
Using	B-X
a	B-X
murine	B-X
subcutaneous	B-X
chamber	B-X
model	B-X
to	B-X
sample	B-X
the	B-X
bacteria	B-X
prior	B-X
to	B-X
selection	B-X
or	B-X
expansion	B-X
of	B-X
mutants	B-X
,	B-X
we	B-X
compared	B-X
gene	B-X
expression	B-X
dynamics	B-X
of	B-X
wild	B-X
type	B-X
(	B-X
WT	B-X
)	B-X
and	B-X
previously	B-X
isolated	B-X
animal-passaged	B-X
(	B-X
AP	B-X
)	B-X
covS	B-X
mutant	B-X
bacteria	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
we	B-X
found	B-X
extensive	B-X
transcriptional	B-X
alterations	B-X
of	B-X
pathoadaptive	B-X
and	B-X
metabolic	B-X
gene	B-X
sets	B-X
associated	B-X
with	B-X
invasion	B-X
,	B-X
immune	B-X
evasion	B-X
,	B-X
tissue-dissemination	B-X
,	B-X
and	B-X
metabolic	B-X
reprogramming	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
the	B-X
virulence-associated	B-X
differences	B-X
between	B-X
WT	B-X
and	B-X
AP	B-X
bacteria	B-X
,	B-X
Phenotype	B-X
Microarray	B-X
analysis	B-X
showed	B-X
minor	B-X
in	B-X
vitro	B-X
phenotypic	B-X
differences	B-X
between	B-X
the	B-X
two	B-X
isogenic	B-X
variants	B-X
.	B-X
Additionally	B-X
,	B-X
our	B-X
results	B-X
reflect	B-X
that	B-X
WT	B-X
bacteria	B-X
's	B-X
rapid	B-X
host-adaptive	B-X
transcriptional	B-X
reprogramming	B-X
was	B-X
not	B-X
sufficient	B-X
for	B-X
their	B-X
survival	B-X
,	B-X
and	B-X
they	B-X
were	B-X
outnumbered	B-X
by	B-X
hypervirulent	B-X
covS	B-X
mutants	B-X
with	B-X
SpeB	B-X
(	B-X
-	B-X
)	B-X
/Sda	B-X
(	B-X
high	B-X
)	B-X
phenotype	B-X
,	B-X
which	B-X
survived	B-X
up	B-X
to	B-X
14	B-X
days	B-X
in	B-X
mice	B-X
chambers	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
the	B-X
engagement	B-X
of	B-X
unique	B-X
regulatory	B-X
modules	B-X
in	B-X
niche	B-X
adaptation	B-X
,	B-X
implicate	B-X
a	B-X
critical	B-X
role	B-X
for	B-X
bacterial	B-X
genetic	B-X
heterogeneity	B-X
that	B-X
surpasses	B-X
transcriptional	B-X
in	B-X
vivo	B-X
adaptation	B-X
,	B-X
and	B-X
portray	B-X
the	B-X
dynamics	B-X
underlying	B-X
the	B-X
selection	B-X
of	B-X
hypervirulent	B-X
covS	B-X
mutants	B-X
over	B-X
their	B-X
parental	B-X
WT	B-X
cells	B-X
.	B-X

Using	O
a	O
murine	B-Organism
subcutaneous	O
chamber	O
model	O
to	O
sample	O
the	O
bacteria	O
prior	O
to	O
selection	O
or	O
expansion	O
of	O
mutants	O
,	O
we	O
compared	O
gene	O
expression	O
dynamics	O
of	O
wild	O
type	O
(	O
WT	O
)	O
and	O
previously	O
isolated	O
animal	O
-	O
passaged	O
(	O
AP	O
)	O
covS	O
mutant	O
bacteria	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
we	O
found	O
extensive	O
transcriptional	O
alterations	O
of	O
pathoadaptive	O
and	O
metabolic	O
gene	O
sets	O
associated	O
with	O
invasion	O
,	O
immune	O
evasion	O
,	O
tissue	O
-	O
dissemination	O
,	O
and	O
metabolic	O
reprogramming	O
.	O
<EOS>	B-X
The	B-X
onset	B-X
of	B-X
infection	B-X
and	B-X
the	B-X
switch	B-X
from	B-X
primary	B-X
to	B-X
secondary	B-X
niches	B-X
are	B-X
dramatic	B-X
environmental	B-X
changes	B-X
that	B-X
not	B-X
only	B-X
alter	B-X
bacterial	B-X
transcriptional	B-X
programs	B-X
,	B-X
but	B-X
also	B-X
perturb	B-X
their	B-X
sociomicrobiology	B-X
,	B-X
often	B-X
driving	B-X
minor	B-X
subpopulations	B-X
with	B-X
mutant	B-X
phenotypes	B-X
to	B-X
prevail	B-X
in	B-X
specific	B-X
niches	B-X
.	B-X
Having	B-X
previously	B-X
reported	B-X
that	B-X
M1T1	B-X
Streptococcus	B-X
pyogenes	B-X
become	B-X
hypervirulent	B-X
in	B-X
mice	B-X
due	B-X
to	B-X
selection	B-X
of	B-X
mutants	B-X
in	B-X
the	B-X
covRS	B-X
regulatory	B-X
genes	B-X
,	B-X
we	B-X
set	B-X
out	B-X
to	B-X
dissect	B-X
the	B-X
impact	B-X
of	B-X
these	B-X
mutations	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
from	B-X
the	B-X
impact	B-X
of	B-X
other	B-X
adaptive	B-X
events	B-X
.	B-X
Using	B-X
a	B-X
murine	B-X
subcutaneous	B-X
chamber	B-X
model	B-X
to	B-X
sample	B-X
the	B-X
bacteria	B-X
prior	B-X
to	B-X
selection	B-X
or	B-X
expansion	B-X
of	B-X
mutants	B-X
,	B-X
we	B-X
compared	B-X
gene	B-X
expression	B-X
dynamics	B-X
of	B-X
wild	B-X
type	B-X
(	B-X
WT	B-X
)	B-X
and	B-X
previously	B-X
isolated	B-X
animal-passaged	B-X
(	B-X
AP	B-X
)	B-X
covS	B-X
mutant	B-X
bacteria	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
we	B-X
found	B-X
extensive	B-X
transcriptional	B-X
alterations	B-X
of	B-X
pathoadaptive	B-X
and	B-X
metabolic	B-X
gene	B-X
sets	B-X
associated	B-X
with	B-X
invasion	B-X
,	B-X
immune	B-X
evasion	B-X
,	B-X
tissue-dissemination	B-X
,	B-X
and	B-X
metabolic	B-X
reprogramming	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
the	B-X
virulence-associated	B-X
differences	B-X
between	B-X
WT	B-X
and	B-X
AP	B-X
bacteria	B-X
,	B-X
Phenotype	B-X
Microarray	B-X
analysis	B-X
showed	B-X
minor	B-X
in	B-X
vitro	B-X
phenotypic	B-X
differences	B-X
between	B-X
the	B-X
two	B-X
isogenic	B-X
variants	B-X
.	B-X
Additionally	B-X
,	B-X
our	B-X
results	B-X
reflect	B-X
that	B-X
WT	B-X
bacteria	B-X
's	B-X
rapid	B-X
host-adaptive	B-X
transcriptional	B-X
reprogramming	B-X
was	B-X
not	B-X
sufficient	B-X
for	B-X
their	B-X
survival	B-X
,	B-X
and	B-X
they	B-X
were	B-X
outnumbered	B-X
by	B-X
hypervirulent	B-X
covS	B-X
mutants	B-X
with	B-X
SpeB	B-X
(	B-X
-	B-X
)	B-X
/Sda	B-X
(	B-X
high	B-X
)	B-X
phenotype	B-X
,	B-X
which	B-X
survived	B-X
up	B-X
to	B-X
14	B-X
days	B-X
in	B-X
mice	B-X
chambers	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
the	B-X
engagement	B-X
of	B-X
unique	B-X
regulatory	B-X
modules	B-X
in	B-X
niche	B-X
adaptation	B-X
,	B-X
implicate	B-X
a	B-X
critical	B-X
role	B-X
for	B-X
bacterial	B-X
genetic	B-X
heterogeneity	B-X
that	B-X
surpasses	B-X
transcriptional	B-X
in	B-X
vivo	B-X
adaptation	B-X
,	B-X
and	B-X
portray	B-X
the	B-X
dynamics	B-X
underlying	B-X
the	B-X
selection	B-X
of	B-X
hypervirulent	B-X
covS	B-X
mutants	B-X
over	B-X
their	B-X
parental	B-X
WT	B-X
cells	B-X
.	B-X

In	O
contrast	O
to	O
the	O
virulence	O
-	O
associated	O
differences	O
between	O
WT	O
and	O
AP	B-Organism
bacteria	O
,	O
Phenotype	O
Microarray	O
analysis	O
showed	O
minor	O
in	O
vitro	O
phenotypic	O
differences	O
between	O
the	O
two	O
isogenic	O
variants	O
.	O

Additionally	O
,	O
our	O
results	O
reflect	O
that	O
WT	O
bacteria	O
'	O
s	O
rapid	O
host	O
-	O
adaptive	O
transcriptional	O
reprogramming	O
was	O
not	O
sufficient	O
for	O
their	O
survival	O
,	O
and	O
they	O
were	O
outnumbered	O
by	O
hypervirulent	O
covS	O
mutants	O
with	O
SpeB	O
-	O
/	O
Sdahigh	O
phenotype	O
,	O
which	O
survived	O
up	O
to	O
14	O
days	O
in	O
mice	B-Organism
chambers	O
.	O

Our	O
findings	O
demonstrate	O
the	O
engagement	O
of	O
unique	O
regulatory	O
modules	O
in	O
niche	O
adaptation	O
,	O
implicate	O
a	O
critical	O
role	O
for	O
bacterial	O
genetic	O
heterogeneity	O
that	O
surpasses	O
transcriptional	O
in	O
vivo	O
adaptation	O
,	O
and	O
portray	O
the	O
dynamics	O
underlying	O
the	O
selection	O
of	O
hypervirulent	O
covS	O
mutants	O
over	O
their	O
parental	O
WT	O
cells	O
.	O
<EOS>	B-X
The	B-X
onset	B-X
of	B-X
infection	B-X
and	B-X
the	B-X
switch	B-X
from	B-X
primary	B-X
to	B-X
secondary	B-X
niches	B-X
are	B-X
dramatic	B-X
environmental	B-X
changes	B-X
that	B-X
not	B-X
only	B-X
alter	B-X
bacterial	B-X
transcriptional	B-X
programs	B-X
,	B-X
but	B-X
also	B-X
perturb	B-X
their	B-X
sociomicrobiology	B-X
,	B-X
often	B-X
driving	B-X
minor	B-X
subpopulations	B-X
with	B-X
mutant	B-X
phenotypes	B-X
to	B-X
prevail	B-X
in	B-X
specific	B-X
niches	B-X
.	B-X
Having	B-X
previously	B-X
reported	B-X
that	B-X
M1T1	B-X
Streptococcus	B-X
pyogenes	B-X
become	B-X
hypervirulent	B-X
in	B-X
mice	B-X
due	B-X
to	B-X
selection	B-X
of	B-X
mutants	B-X
in	B-X
the	B-X
covRS	B-X
regulatory	B-X
genes	B-X
,	B-X
we	B-X
set	B-X
out	B-X
to	B-X
dissect	B-X
the	B-X
impact	B-X
of	B-X
these	B-X
mutations	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
from	B-X
the	B-X
impact	B-X
of	B-X
other	B-X
adaptive	B-X
events	B-X
.	B-X
Using	B-X
a	B-X
murine	B-X
subcutaneous	B-X
chamber	B-X
model	B-X
to	B-X
sample	B-X
the	B-X
bacteria	B-X
prior	B-X
to	B-X
selection	B-X
or	B-X
expansion	B-X
of	B-X
mutants	B-X
,	B-X
we	B-X
compared	B-X
gene	B-X
expression	B-X
dynamics	B-X
of	B-X
wild	B-X
type	B-X
(	B-X
WT	B-X
)	B-X
and	B-X
previously	B-X
isolated	B-X
animal-passaged	B-X
(	B-X
AP	B-X
)	B-X
covS	B-X
mutant	B-X
bacteria	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
we	B-X
found	B-X
extensive	B-X
transcriptional	B-X
alterations	B-X
of	B-X
pathoadaptive	B-X
and	B-X
metabolic	B-X
gene	B-X
sets	B-X
associated	B-X
with	B-X
invasion	B-X
,	B-X
immune	B-X
evasion	B-X
,	B-X
tissue-dissemination	B-X
,	B-X
and	B-X
metabolic	B-X
reprogramming	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
the	B-X
virulence-associated	B-X
differences	B-X
between	B-X
WT	B-X
and	B-X
AP	B-X
bacteria	B-X
,	B-X
Phenotype	B-X
Microarray	B-X
analysis	B-X
showed	B-X
minor	B-X
in	B-X
vitro	B-X
phenotypic	B-X
differences	B-X
between	B-X
the	B-X
two	B-X
isogenic	B-X
variants	B-X
.	B-X
Additionally	B-X
,	B-X
our	B-X
results	B-X
reflect	B-X
that	B-X
WT	B-X
bacteria	B-X
's	B-X
rapid	B-X
host-adaptive	B-X
transcriptional	B-X
reprogramming	B-X
was	B-X
not	B-X
sufficient	B-X
for	B-X
their	B-X
survival	B-X
,	B-X
and	B-X
they	B-X
were	B-X
outnumbered	B-X
by	B-X
hypervirulent	B-X
covS	B-X
mutants	B-X
with	B-X
SpeB	B-X
(	B-X
-	B-X
)	B-X
/Sda	B-X
(	B-X
high	B-X
)	B-X
phenotype	B-X
,	B-X
which	B-X
survived	B-X
up	B-X
to	B-X
14	B-X
days	B-X
in	B-X
mice	B-X
chambers	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
the	B-X
engagement	B-X
of	B-X
unique	B-X
regulatory	B-X
modules	B-X
in	B-X
niche	B-X
adaptation	B-X
,	B-X
implicate	B-X
a	B-X
critical	B-X
role	B-X
for	B-X
bacterial	B-X
genetic	B-X
heterogeneity	B-X
that	B-X
surpasses	B-X
transcriptional	B-X
in	B-X
vivo	B-X
adaptation	B-X
,	B-X
and	B-X
portray	B-X
the	B-X
dynamics	B-X
underlying	B-X
the	B-X
selection	B-X
of	B-X
hypervirulent	B-X
covS	B-X
mutants	B-X
over	B-X
their	B-X
parental	B-X
WT	B-X
cells	B-X
.	B-X

Introduction	O

Group	B-Organism
A	I-Organism
streptococci	I-Organism
(	O
GAS	B-Organism
)	O
are	O
human	B-Organism
pathogens	O
that	O
infect	O
over	O
700	O
million	O
children	O
and	O
adults	O
each	O
year	O
[	O
1	O
]	O
.	O

Whereas	O
the	O
overall	O
mortality	O
rate	O
of	O
GAS	B-Organism
infections	O
is	O
less	O
than	O
0	O
.	O
1	O
%	O
,	O
the	O
mortality	O
rate	O
of	O
invasive	O
GAS	B-Organism
infections	O
,	O
which	O
have	O
resurged	O
in	O
the	O
past	O
30	O
years	O
,	O
mounts	O
to	O
25	O
%	O
(	O
out	O
of	O
>	O
650	O
,	O
000	O
new	O
cases	O
per	O
year	O
)	O
[	O
1	O
]	O
.	O

Among	O
the	O
various	O
GAS	B-Organism
serotypes	O
,	O
the	O
globally	O
disseminated	O
M1T1	B-Organism
clonal	O
strain	O
remains	O
the	O
most	O
frequently	O
isolated	O
from	O
cases	O
of	O
invasive	O
and	O
non	O
-	O
invasive	O
infections	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
,	O
and	O
although	O
disease	O
severity	O
partially	O
depends	O
on	O
host	O
genetic	O
factors	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
,	O
M1T1	B-Organism
GAS	I-Organism
possesses	O
unique	O
genomic	O
features	O
that	O
contribute	O
to	O
its	O
evolutionary	O
fitness	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Among	O
these	O
features	O
is	O
the	O
ability	O
of	O
M1T1	B-Organism
bacteria	O
to	O
switch	O
to	O
a	O
hypervirulent	O
phenotype	O
associated	O
with	O
invasive	O
diseases	O
in	O
vivo	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
a	O
phenomenon	O
that	O
is	O
not	O
fully	O
understood	O
and	O
whose	O
specificity	O
to	O
the	O
M1	B-Organism
serotype	O
remains	O
to	O
be	O
established	O
[	O
15	O
]	O
.	O

We	O
previously	O
reported	O
that	O
virulent	O
representatives	O
of	O
M1T1	B-Organism
GAS	I-Organism
,	O
with	O
the	O
phenotype	O
SpeBhi	O
/	O
SpeA	O
-	O
/	O
Sda1low	O
,	O
irreversibly	O
switch	O
to	O
the	O
hypervirulent	O
SpeB	O
-	O
/	O
SpeA	O
+	O
/	O
Sda1high	O
phenotype	O
after	O
>	O
/	O
=	O
3	O
days	O
in	O
vivo	O
[	O
12	O
]	O
,	O
[	O
16	O
]	O
and	O
that	O
the	O
parent	O
phenotype	O
vanishes	O
by	O
day	O
7	O
post	O
-	O
infection	O
[	O
16	O
]	O
.	O

Subsequent	O
studies	O
uncovered	O
that	O
this	O
genetic	O
switch	O
is	O
driven	O
by	O
host	O
innate	O
immune	O
pressure	O
that	O
selects	O
for	O
bacteria	O
with	O
pathoadaptive	O
mutations	O
in	O
the	O
covRS	O
genetic	O
locus	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

CovRS	O
is	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
in	O
which	O
CovS	O
transduces	O
external	O
signals	O
[	O
17	O
]	O
,	O
[	O
18	O
]	O
to	O
CovR	O
,	O
which	O
in	O
turn	O
represses	O
the	O
transcription	O
of	O
several	O
group	B-Organism
A	I-Organism
streptococcal	I-Organism
(	O
GAS	B-Organism
)	O
virulence	O
gene	O
sets	O
,	O
including	O
the	O
capsule	O
synthesis	O
operon	O
(	O
hasABC	O
)	O
,	O
the	O
streptolysin	O
S	O
operon	O
(	O
SLS	O
or	O
sagA	O
-	O
H	O
)	O
,	O
and	O
the	O
streptokinase	O
gene	O
(	O
ska	O
)	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
.	O

CovR	O
regulatory	O
activity	O
is	O
thought	O
to	O
be	O
triggered	O
when	O
the	O
protein	O
is	O
phosphorylated	O
at	O
D53	O
[	O
21	O
]	O
,	O
possibly	O
by	O
acetyl	O
phosphate	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

On	O
the	O
other	O
hand	O
,	O
under	O
stress	O
conditions	O
,	O
CovS	O
dephosphorylates	O
CovR	O
and	O
reverses	O
virulence	O
gene	O
repression	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
.	O

Mutations	O
in	O
covS	O
are	O
thus	O
expected	O
to	O
affect	O
CovR	O
phosphorylation	O
status	O
differentially	O
in	O
vitro	O
and	O
in	O
vivo	O
(	O
under	O
stress	O
conditions	O
)	O
,	O
and	O
to	O
consequently	O
modulate	O
CovRS	O
signaling	O
-	O
regulation	O
circuits	O
in	O
a	O
complex	O
manner	O
that	O
remains	O
largely	O
unexplored	O
.	O

This	O
complexity	O
is	O
further	O
magnified	O
by	O
the	O
reported	O
strain	O
-	O
specific	O
differences	O
in	O
the	O
impact	O
of	O
CovS	O
on	O
pathogenesis	O
[	O
24	O
]	O
,	O
by	O
the	O
finding	O
that	O
phosphorylated	O
CovR	O
has	O
different	O
affinities	O
to	O
different	O
streptococcal	O
promoters	O
[	O
21	O
]	O
,	O
and	O
by	O
the	O
possibility	O
that	O
CovR	O
promoter	O
binding	O
may	O
be	O
modulated	O
by	O
kinases	O
or	O
phosphatases	O
other	O
than	O
CovS	O
[	O
25	O
]	O
.	O
<EOS>	B-X
GAS	B-X
can	B-X
cause	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
diseases	B-X
because	B-X
it	B-X
elaborates	B-X
virulence	B-X
factors	B-X
that	B-X
enable	B-X
it	B-X
to	B-X
spread	B-X
and	B-X
survive	B-X
in	B-X
different	B-X
environmental	B-X
niches	B-X
within	B-X
the	B-X
human	B-X
host	B-X
.	B-X
The	B-X
production	B-X
of	B-X
many	B-X
of	B-X
these	B-X
virulence	B-X
factors	B-X
is	B-X
directly	B-X
controlled	B-X
by	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
CovR/S	B-X
two-component	B-X
regulatory	B-X
system	B-X
.	B-X
CovS	B-X
acts	B-X
in	B-X
one	B-X
direction	B-X
as	B-X
a	B-X
kinase	B-X
primarily	B-X
to	B-X
activate	B-X
the	B-X
response	B-X
regulator	B-X
CovR	B-X
and	B-X
repress	B-X
the	B-X
expression	B-X
of	B-X
major	B-X
virulence	B-X
factors	B-X
and	B-X
in	B-X
the	B-X
other	B-X
direction	B-X
as	B-X
a	B-X
phosphatase	B-X
to	B-X
permit	B-X
gene	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
environmental	B-X
changes	B-X
that	B-X
mimic	B-X
conditions	B-X
found	B-X
during	B-X
human	B-X
infection	B-X
.	B-X
This	B-X
Janus-like	B-X
behaviour	B-X
of	B-X
the	B-X
CovR/S	B-X
system	B-X
is	B-X
recapitulated	B-X
in	B-X
the	B-X
binding	B-X
of	B-X
CovR	B-X
to	B-X
the	B-X
promoters	B-X
that	B-X
it	B-X
directly	B-X
regulates	B-X
.	B-X
Interactions	B-X
between	B-X
different	B-X
faces	B-X
of	B-X
the	B-X
CovR	B-X
DNA	B-X
binding	B-X
domain	B-X
appear	B-X
to	B-X
depend	B-X
upon	B-X
DNA	B-X
sequence	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
potential	B-X
for	B-X
differential	B-X
regulation	B-X
of	B-X
virulence	B-X
gene	B-X
expression	B-X
.	B-X

In	O
fact	O
,	O
CovR	O
retains	O
some	O
of	O
its	O
functions	O
in	O
the	O
absence	O
of	O
wild	O
type	O
CovS	O
[	O
26	O
]	O
,	O
and	O
different	O
covS	O
mutations	O
,	O
albeit	O
clustered	O
in	O
its	O
histidine	O
kinase	O
domain	O
,	O
might	O
have	O
different	O
effects	O
on	O
expression	O
of	O
CovR	O
-	O
regulated	O
genes	O
[	O
27	O
]	O
.	O

In	O
accordance	O
with	O
these	O
biochemical	O
findings	O
,	O
we	O
and	O
others	O
have	O
reported	O
that	O
some	O
covS	O
mutations	O
generate	O
hypervirulent	O
isolates	O
associated	O
with	O
invasive	O
forms	O
of	O
streptococcal	O
infection	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
28	O
]	O
.	O

One	O
of	O
the	O
most	O
striking	O
outcomes	O
of	O
these	O
mutations	O
is	O
the	O
constitutive	O
repression	O
of	O
a	O
gene	O
encoding	O
the	O
key	O
GAS	B-Organism
cysteine	O
protease	O
,	O
SpeB	O
,	O
which	O
remodels	O
the	O
host	O
-	O
pathogen	O
interface	O
[	O
29	O
]	O
by	O
differentially	O
degrading	O
bacterial	O
surface	O
and	O
secreted	O
proteins	O
[	O
12	O
]	O
,	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
as	O
well	O
as	O
host	O
proteins	O
[	O
32	O
]	O
,	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

Consequently	O
,	O
absence	O
of	O
a	O
proteolytically	O
active	O
SpeB	O
preserves	O
several	O
virulence	O
factors	O
that	O
it	O
normally	O
degrades	O
[	O
12	O
]	O
,	O
[	O
35	O
]	O
.	O

One	O
of	O
these	O
preserved	O
factors	O
is	O
the	O
highly	O
potent	O
DNase	O
,	O
Sda1	O
,	O
which	O
destroys	O
neutrophil	O
extracellular	O
traps	O
,	O
NETs	O
[	O
36	O
]	O
,	O
protecting	O
the	O
bacteria	O
from	O
neutrophil	O
killing	O
,	O
promoting	O
bacterial	O
invasion	O
,	O
and	O
facilitating	O
human	B-Organism
plasminogen	O
-	O
mediated	O
bacterial	O
dissemination	O
into	O
normally	O
sterile	O
sites	O
,	O
which	O
results	O
in	O
invasive	O
infections	O
[	O
14	O
]	O
.	O

Despite	O
the	O
association	O
between	O
covS	O
mutations	O
and	O
the	O
emergence	O
of	O
the	O
hypervirulent	O
phenotype	O
of	O
M1T1	B-Organism
strains	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
increased	O
virulence	O
can	O
be	O
entirely	O
attributed	O
to	O
the	O
modulation	O
of	O
the	O
CovR	O
regulon	O
or	O
if	O
other	O
networks	O
are	O
also	O
perturbed	O
in	O
vivo	O
directly	O
,	O
indirectly	O
,	O
or	O
independently	O
of	O
the	O
CovRS	O
system	O
.	O
<EOS>	B-X
In	B-X
the	B-X
group	B-X
A	B-X
streptococcus	B-X
(	B-X
GAS	B-X
;	B-X
Streptococcus	B-X
pyogenes	B-X
)	B-X
,	B-X
a	B-X
two-component	B-X
system	B-X
known	B-X
as	B-X
CovRS	B-X
(	B-X
or	B-X
CsrRS	B-X
)	B-X
regulates	B-X
about	B-X
15	B-X
%	B-X
of	B-X
the	B-X
genes	B-X
,	B-X
including	B-X
several	B-X
important	B-X
virulence	B-X
factors	B-X
like	B-X
the	B-X
hyaluronic	B-X
acid	B-X
capsule	B-X
.	B-X
Most	B-X
of	B-X
these	B-X
genes	B-X
,	B-X
including	B-X
covR	B-X
itself	B-X
,	B-X
are	B-X
negatively	B-X
regulated	B-X
by	B-X
CovR	B-X
.	B-X
We	B-X
have	B-X
isolated	B-X
two	B-X
independent	B-X
ISS1	B-X
insertions	B-X
in	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
(	B-X
ORF	B-X
)	B-X
that	B-X
increases	B-X
CovR	B-X
expression	B-X
as	B-X
measured	B-X
by	B-X
a	B-X
Pcov-gusA	B-X
reporter	B-X
fusion	B-X
in	B-X
single	B-X
copy	B-X
in	B-X
the	B-X
GAS	B-X
chromosome	B-X
.	B-X
As	B-X
expected	B-X
,	B-X
a	B-X
rocA	B-X
mutant	B-X
is	B-X
mucoid	B-X
and	B-X
produces	B-X
more	B-X
transcript	B-X
from	B-X
the	B-X
has	B-X
promoter	B-X
since	B-X
this	B-X
promoter	B-X
is	B-X
repressed	B-X
by	B-X
CovR	B-X
.	B-X
All	B-X
the	B-X
phenotypes	B-X
of	B-X
the	B-X
rocA	B-X
mutant	B-X
were	B-X
complemented	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
rocA	B-X
gene	B-X
on	B-X
a	B-X
plasmid	B-X
.	B-X
The	B-X
rocA	B-X
gene	B-X
is	B-X
present	B-X
in	B-X
strains	B-X
of	B-X
all	B-X
nine	B-X
M	B-X
serotypes	B-X
of	B-X
GAS	B-X
tested	B-X
and	B-X
is	B-X
absent	B-X
from	B-X
strains	B-X
representing	B-X
11	B-X
other	B-X
groups	B-X
of	B-X
streptococci	B-X
and	B-X
related	B-X
bacteria	B-X
,	B-X
including	B-X
strains	B-X
of	B-X
the	B-X
closely	B-X
related	B-X
group	B-X
C	B-X
and	B-X
G	B-X
streptococci	B-X
.	B-X
It	B-X
seems	B-X
likely	B-X
that	B-X
rocA	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
GAS	B-X
since	B-X
it	B-X
affects	B-X
expression	B-X
of	B-X
the	B-X
global	B-X
regulator	B-X
CovR	B-X
.	B-X

Additionally	O
,	O
the	O
effects	O
of	O
covS	O
mutations	O
on	O
bacterial	O
niche	O
adaptability	O
are	O
still	O
undetermined	O
because	O
the	O
in	O
vivo	O
transcriptomes	O
of	O
the	O
wild	O
type	O
(	O
WT	O
)	O
and	O
animal	O
-	O
passaged	O
(	O
AP	B-Organism
)	O
bacteria	O
have	O
not	O
been	O
compared	O
under	O
the	O
same	O
experimental	O
conditions	O
.	O

To	O
address	O
these	O
issues	O
and	O
improve	O
our	O
understanding	O
of	O
the	O
gene	O
regulatory	O
impact	O
of	O
mutational	O
and	O
adaptive	O
events	O
contributing	O
to	O
the	O
hypervirulent	O
phenotype	O
of	O
M1T1	B-Organism
strains	O
,	O
we	O
analyzed	O
differences	O
in	O
growth	O
requirements	O
,	O
transcriptome	O
profiles	O
,	O
and	O
regulatory	O
circuits	O
of	O
the	O
virulent	O
(	O
WT	O
)	O
and	O
hypervirulent	O
(	O
AP	B-Organism
)	O
phenotypes	O
of	O
the	O
M1T1	B-Organism
strain	O
both	O
in	O
vitro	O
and	O
during	O
initial	O
in	O
vivo	O
infection	O
.	O

Such	O
comprehensive	O
analyses	O
highlighted	O
the	O
behavior	O
of	O
genomic	O
subsystems	O
that	O
may	O
be	O
involved	O
directly	O
or	O
indirectly	O
in	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
niche	O
adaptation	O
and	O
pathogenesis	O
.	O

In	O
addition	O
,	O
this	O
approach	O
offered	O
a	O
rare	O
transcriptional	O
snapshot	O
of	O
the	O
SpeBhi	O
/	O
SpeA	O
-	O
/	O
Sda1low	O
population	O
prior	O
to	O
its	O
extinction	O
in	O
vivo	O
.	O

Results	O

Phenotype	O
Microarrays	O
show	O
no	O
major	O
nutritional	O
or	O
metabolic	O
differences	O
between	O
wild	O
type	O
and	O
animal	O
-	O
passaged	O
,	O
hypervirulent	O
M1T1	B-Organism
GAS	I-Organism
We	O
used	O
Biolog	O
(	O
R	O
)	O
Phenotype	O
Microarrays	O
(	O
PM	O
)	O
to	O
screen	O
1900	O
different	O
growth	O
conditions	O
,	O
including	O
a	O
large	O
set	O
of	O
different	O
carbon	O
and	O
nitrogen	O
sources	O
,	O
pH	O
values	O
and	O
salt	O
concentrations	O
,	O
as	O
well	O
as	O
different	O
concentrations	O
of	O
various	O
antimicrobial	O
agents	O
(	O
Fig	O
.	O
S1	O
)	O
,	O
and	O
found	O
that	O
both	O
WT	O
and	O
AP	B-Organism
GAS	I-Organism
have	O
similar	O
growth	O
requirements	O
in	O
vitro	O
with	O
minor	O
differences	O
.	O

For	O
example	O
,	O
AP	B-Organism
bacteria	O
grew	O
better	O
than	O
WT	O
bacteria	O
in	O
the	O
presence	O
of	O
N	O
-	O
acetyl	O
-	O
neuraminic	O
acid	O
,	O
and	O
were	O
more	O
sensitive	O
to	O
four	O
antimicrobials	O
(	O
out	O
of	O
373	O
screened	O
in	O
PM	O
)	O
,	O
including	O
the	O
calcium	O
-	O
specific	O
metal	O
chelator	O
EGTA	O
,	O
the	O
lipophilic	O
chelator	O
5	O
-	O
chloro	O
-	O
7	O
-	O
iodo	O
-	O
8	O
-	O
hydroxyquinoline	O
,	O
and	O
the	O
antibiotics	O
tobramycin	O
and	O
cefotaxime	O
(	O
Table	O
1	O
)	O
.	O

However	O
,	O
when	O
both	O
bacterial	O
variants	O
were	O
grown	O
at	O
37degreesC	O
in	O
the	O
enriched	O
Todd	O
Hewitt	O
broth	O
medium	O
,	O
their	O
growth	O
rates	O
were	O
indistinguishable	O
,	O
and	O
the	O
only	O
detectable	O
difference	O
was	O
that	O
AP	B-Organism
bacteria	O
were	O
more	O
buoyant	O
in	O
liquid	O
culture	O
compared	O
to	O
WT	O
.	O

This	O
difference	O
in	O
buoyancy	O
can	O
be	O
attributed	O
to	O
differences	O
in	O
proteolytic	O
activity	O
(	O
WT	O
>	O
>	O
AP	B-Organism
)	O
that	O
may	O
degrade	O
many	O
surface	O
proteins	O
,	O
including	O
pilin	O
,	O
or	O
induce	O
changes	O
in	O
the	O
surface	O
charge	O
making	O
bacterial	O
aggregates	O
more	O
compact	O
.	O

The	O
difference	O
in	O
buoyancy	O
can	O
also	O
be	O
attributed	O
to	O
differences	O
in	O
the	O
expression	O
of	O
hyaluronic	O
acid	O
capsule	O
(	O
AP	B-Organism
>	O
WT	O
)	O
.	O

Although	O
the	O
PM	O
results	O
confirm	O
previous	O
experiments	O
[	O
16	O
]	O
showing	O
a	O
few	O
minor	O
differences	O
between	O
WT	O
and	O
AP	B-Organism
bacteria	O
in	O
vitro	O
,	O
this	O
technology	O
is	O
limited	O
because	O
it	O
uses	O
minimal	O
media	O
and	O
measures	O
microbial	O
respiration	O
as	O
a	O
growth	O
indicator	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
biolog	O
.	O
com	O
)	O
.	O

Minimal	O
media	O
are	O
not	O
optimal	O
for	O
the	O
expression	O
of	O
GAS	B-Organism
proteins	O
,	O
which	O
may	O
explain	O
why	O
GAS	B-Organism
failed	O
to	O
grow	O
at	O
many	O
of	O
the	O
PM	O
conditions	O
(	O
Fig	O
.	O
S1	O
)	O
and	O
why	O
fewer	O
phenotypic	O
differences	O
were	O
observed	O
between	O
WT	O
and	O
AP	B-Organism
bacteria	O
than	O
transcriptomic	O
differences	O
(	O
see	O
below	O
)	O
.	O

In	O
vivo	O
murine	B-Organism
chamber	O
infection	O
model	O
allows	O
the	O
dissection	O
of	O
regulatory	O
vs	O
.	O
mutation	O
-	O
selection	O
events	O

Several	O
studies	O
,	O
including	O
ours	O
,	O
have	O
examined	O
phenotypic	O
,	O
proteomic	O
,	O
and	O
transcriptional	O
differences	O
between	O
WT	O
and	O
animal	O
-	O
passaged	O
M1T1	B-Organism
GAS	I-Organism
strains	O
[	O
For	O
example	O
,	O
11	O
,	O
12	O
,	O
13	O
,	O
16	O
,	O
26	O
,	O
27	O
,	O
37	O
]	O
,	O
but	O
none	O
attempted	O
to	O
capture	O
the	O
dynamic	O
changes	O
in	O
the	O
bacterial	O
population	O
in	O
vivo	O
.	O

Because	O
bacteria	O
recovered	O
from	O
animals	O
and	O
cultured	O
in	O
the	O
laboratory	O
are	O
likely	O
to	O
have	O
reprogrammed	O
many	O
regulatory	O
networks	O
to	O
re	O
-	O
adapt	O
to	O
the	O
in	O
vitro	O
growth	O
conditions	O
,	O
transcriptome	O
profiling	O
of	O
these	O
bacteria	O
may	O
not	O
reflect	O
their	O
actual	O
in	O
vivo	O
gene	O
expression	O
and	O
regulation	O
.	O

In	O
this	O
study	O
,	O
we	O
designed	O
and	O
performed	O
in	O
vivo	O
passage	O
experiments	O
in	O
which	O
equal	O
loads	O
of	O
in	O
vitro	O
-	O
grown	O
WT	O
and	O
AP	B-Organism
bacteria	O
were	O
separately	O
inoculated	O
into	O
murine	B-Organism
subcutaneous	O
chambers	O
[	O
16	O
]	O
and	O
collected	O
by	O
needle	O
aspiration	O
after	O
24	O
h	O
,	O
a	O
time	O
sufficient	O
for	O
the	O
bacteria	O
to	O
sense	O
the	O
host	O
environment	O
and	O
transcriptionally	O
respond	O
to	O
it	O
,	O
but	O
not	O
long	O
enough	O
to	O
allow	O
detectable	O
restructuring	O
of	O
the	O
bacterial	O
community	O
and	O
selection	O
of	O
mutants	O
.	O

The	O
concentrations	O
of	O
viable	O
WT	O
and	O
AP	B-Organism
bacteria	O
at	O
24	O
h	O
post	O
-	O
inoculation	O
remained	O
essentially	O
the	O
same	O
:	O
1	O
-	O
5x109	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
ml	O
vs	O
.	O
approximately2x109	O
CFU	O
/	O
ml	O
inoculum	O
.	O

We	O
extracted	O
RNA	O
from	O
these	O
bacteria	O
immediately	O
after	O
their	O
recovery	O
from	O
mouse	B-Organism
chambers	O
with	O
no	O
additional	O
culturing	O
and	O
used	O
the	O
extracted	O
RNA	O
for	O
transcriptome	O
profiling	O
as	O
detailed	O
in	O
Materials	O
and	O
Methods	O
.	O

For	O
transcriptional	O
profiling	O
,	O
we	O
followed	O
a	O
cyclic	O
,	O
two	O
-	O
color	O
design	O
and	O
performed	O
28	O
oligonucleotide	O
microarray	O
hybridization	O
experiments	O
representing	O
technical	O
and	O
biological	O
replicates	O
of	O
the	O
four	O
cell	O
states	O
under	O
investigation	O
:	O
WT	O
grown	O
in	O
vitro	O
(	O
WT	O
-	O
vitro	O
)	O
,	O
WT	O
grown	O
in	O
vivo	O
(	O
WT	O
-	O
vivo	O
)	O
,	O
AP	B-Organism
grown	O
in	O
vitro	O
(	O
AP	B-Organism
-	O
vitro	O
)	O
,	O
and	O
AP	B-Organism
grown	O
in	O
vivo	O
(	O
AP	B-Organism
-	O
vivo	O
)	O
,	O
Fig	O
.	O

1	O
.	O
<EOS>	B-X
Formate	B-X
assay	B-X
in	B-X
body	B-X
fluids	B-X
:	B-X
application	B-X
in	B-X
methanol	B-X
poisoning	B-X
.	B-X

Multiple	O
approaches	O
to	O
microarray	O
analysis	O
show	O
statistically	O
significant	O
and	O
biologically	O
relevant	O
differences	O
between	O
the	O
WT	O
and	O
AP	B-Organism
populations	O
in	O
vitro	O
and	O
in	O
vivo	O

To	O
gain	O
biologically	O
relevant	O
knowledge	O
from	O
the	O
transcriptome	O
studies	O
without	O
compromising	O
statistical	O
significance	O
,	O
we	O
interrogated	O
the	O
data	O
using	O
multiple	O
strategies	O
that	O
had	O
been	O
developed	O
for	O
microarray	O
analysis	O
and	O
visualization	O
,	O
taking	O
into	O
consideration	O
the	O
strengths	O
and	O
limitations	O
of	O
each	O
strategy	O
.	O

By	O
clustering	O
normalized	O
expression	O
values	O
from	O
different	O
biological	O
replicates	O
in	O
all	O
data	O
sets	O
,	O
we	O
generated	O
an	O
overall	O
"	O
pathovivogram	O
"	O
that	O
includes	O
276	O
genes	O
in	O
ten	O
coexpression	O
clusters	O
,	O
CCs	O
(	O
Fig	O
.	O
2	O
,	O
Fig	O
.	O
S2	O
,	O
and	O
Table	O
S1	O
)	O
.	O

This	O
pathovivogram	O
highlights	O
the	O
transcriptional	O
patterns	O
that	O
distinguish	O
WT	O
from	O
AP	B-Organism
bacteria	O
regardless	O
of	O
their	O
growth	O
habitat	O
(	O
pathogram	O
,	O
Fig	O
2	O
.	O
CC4	O
-	O
CC6	O
and	O
CC8	O
-	O
CC10	O
)	O
,	O
and	O
the	O
transcriptional	O
patterns	O
that	O
are	O
shared	O
by	O
WT	O
-	O
vitro	O
and	O
AP	B-Organism
-	O
vitro	O
bacteria	O
but	O
that	O
differentiate	O
them	O
from	O
their	O
corresponding	O
in	O
vivo	O
samples	O
(	O
vivogram	O
,	O
Fig	O
.	O
2	O
,	O
CC1	O
-	O
CC3	O
)	O
.	O

Moreover	O
,	O
we	O
identified	O
a	O
unique	O
cluster	O
,	O
CC7	O
,	O
that	O
includes	O
genes	O
upregulated	O
both	O
in	O
vivo	O
and	O
as	O
a	O
consequence	O
of	O
the	O
covS	O
mutation	O
(	O
e	O
.	O
g	O
.	O
,	O
those	O
encoding	O
M	O
protein	O
,	O
streptolysin	O
O	O
,	O
and	O
nicotinamide	O
adenine	O
dinucleotide	O
glycohydrolase	O
(	O
NADGH	O
)	O
,	O
Fig	O
.	O
2	O
,	O
CC7	O
)	O
.	O

The	O
patterns	O
in	O
clusters	O
CC1	O
-	O
CC3	O
describe	O
those	O
gene	O
sets	O
whose	O
transcription	O
was	O
turned	O
on	O
(	O
CC1	O
-	O
CC2	O
)	O
or	O
off	O
(	O
CC3	O
)	O
to	O
drive	O
the	O
bacterial	O
adaptation	O
to	O
the	O
host	O
environment	O
,	O
but	O
are	O
not	O
primarily	O
related	O
to	O
bacterial	O
pathogenesis	O
.	O

Many	O
of	O
these	O
genes	O
encode	O
metabolic	O
enzymes	O
(	O
e	O
.	O
g	O
.	O
,	O
carbohydrate	O
metabolism	O
,	O
arginine	O
degradation	O
,	O
and	O
pyrimidine	O
biosynthesis	O
)	O
,	O
ribosomal	O
proteins	O
(	O
mostly	O
downregulated	O
)	O
,	O
and	O
sugar	O
or	O
peptide	O
transport	O
systems	O
,	O
reflecting	O
the	O
transition	O
from	O
a	O
carbohydrate	O
-	O
rich	O
laboratory	O
medium	O
to	O
a	O
protein	O
-	O
rich	O
,	O
oxygen	O
-	O
poor	O
subcutaneous	O
tissue	O
.	O

Such	O
transition	O
is	O
bound	O
to	O
have	O
major	O
downstream	O
effects	O
on	O
the	O
bacterial	O
virulence	O
gene	O
expression	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

While	O
the	O
expression	O
patterns	O
in	O
clusters	O
CC4	O
,	O
CC5	O
,	O
CC8	O
,	O
and	O
CC9	O
match	O
the	O
previously	O
described	O
in	O
vitro	O
differences	O
between	O
WT	O
and	O
AP	B-Organism
strains	O
[	O
10	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
(	O
e	O
.	O
g	O
.	O
,	O
downregulation	O
of	O
SpeB	O
,	O
CAMP	O
,	O
and	O
EndoS	O
genes	O
;	O
upregulation	O
of	O
SpeA	O
,	O
SIC	O
,	O
and	O
capsule	O
genes	O
)	O
,	O
the	O
combined	O
comparative	O
analysis	O
of	O
in	O
vitro	O
and	O
in	O
vivo	O
samples	O
revealed	O
novel	O
expression	O
patterns	O
exemplified	O
by	O
CC6	O
and	O
CC10	O
.	O

These	O
two	O
clusters	O
include	O
genes	O
whose	O
expression	O
has	O
been	O
repressed	O
(	O
CC6	O
)	O
or	O
induced	O
(	O
CC10	O
)	O
by	O
the	O
AP	B-Organism
mutation	O
,	O
but	O
the	O
repression	O
or	O
induction	O
becomes	O
observable	O
only	O
in	O
vivo	O
.	O
<EOS>	B-X
Experiments	B-X
using	B-X
organ	B-X
homogenates	B-X
or	B-X
hepatic	B-X
microsome	B-X
fractions	B-X
were	B-X
used	B-X
for	B-X
simulating	B-X
the	B-X
biotransformation	B-X
of	B-X
the	B-X
drug	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
classical	B-X
approaches	B-X
,	B-X
such	B-X
as	B-X
correlation	B-X
analysis	B-X
,	B-X
specifically	B-X
the	B-X
inhibitory	B-X
effect	B-X
,	B-X
or	B-X
induction	B-X
of	B-X
chemicals	B-X
,	B-X
and	B-X
immunoinhibition	B-X
,	B-X
may	B-X
be	B-X
combined	B-X
with	B-X
the	B-X
use	B-X
of	B-X
recombinant	B-X
enzymes	B-X
for	B-X
identifying	B-X
the	B-X
enzymes	B-X
involved	B-X
in	B-X
the	B-X
drug	B-X
metabolism	B-X
.	B-X
The	B-X
pre-treatment	B-X
with	B-X
chemicals	B-X
,	B-X
which	B-X
influences	B-X
the	B-X
change	B-X
(	B-X
inhibition	B-X
or	B-X
induction	B-X
)	B-X
in	B-X
the	B-X
drug	B-X
disposition	B-X
,	B-X
may	B-X
provide	B-X
insights	B-X
into	B-X
the	B-X
enzymes	B-X
involved	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
clinical	B-X
use	B-X
of	B-X
the	B-X
antiarrhythmics	B-X
becomes	B-X
complex	B-X
,	B-X
when	B-X
the	B-X
drug	B-X
metabolism	B-X
is	B-X
genetically/phenotypically	B-X
dependent	B-X
and	B-X
active	B-X
metabolites	B-X
are	B-X
formed	B-X
.	B-X

For	O
example	O
,	O
the	O
expression	O
of	O
genes	O
in	O
the	O
SLS	O
and	O
Trx	O
operons	O
is	O
induced	O
in	O
vivo	O
only	O
in	O
WT	O
bacteria	O
,	O
but	O
is	O
mostly	O
repressed	O
in	O
AP	B-Organism
bacteria	O
(	O
Fig	O
.	O
2	O
,	O
CC6	O
)	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Likewise	O
,	O
some	O
genes	O
are	O
only	O
induced	O
in	O
AP	B-Organism
-	O
vivo	O
,	O
including	O
those	O
encoding	O
the	O
toxin	O
/	O
enzyme	O
streptokinase	O
and	O
a	O
RofA	O
/	O
Nra	O
-	O
like	O
transcriptional	O
regulator	O
(	O
Fig	O
.	O
2	O
,	O
CC10	O
)	O
.	O

Subsequent	O
to	O
the	O
coexpression	O
analysis	O
,	O
we	O
calculated	O
differential	O
expression	O
ratios	O
between	O
each	O
pair	O
of	O
conditions	O
(	O
Table	O
S2	O
)	O
at	O
different	O
statistical	O
significance	O
cutoffs	O
,	O
starting	O
by	O
the	O
commonly	O
used	O
significance	O
threshold	O
of	O
twofold	O
ratio	O
and	O
P	O
value	O
<	O
0	O
.	O
05	O
,	O
and	O
moving	O
to	O
thresholds	O
that	O
are	O
more	O
conservative	O
.	O

At	O
all	O
significance	O
cutoffs	O
,	O
the	O
fewest	O
observed	O
transcriptional	O
changes	O
were	O
those	O
differentiating	O
WT	O
and	O
AP	B-Organism
bacteria	O
in	O
vitro	O
compared	O
to	O
other	O
pairs	O
of	O
conditions	O
.	O

By	O
contrast	O
,	O
the	O
most	O
dramatic	O
transcriptional	O
reprogramming	O
was	O
that	O
exhibited	O
by	O
the	O
WT	O
bacteria	O
in	O
their	O
attempt	O
to	O
adapt	O
to	O
the	O
in	O
vivo	O
environment	O
(	O
Table	O
2	O
)	O
.	O

Overall	O
,	O
at	O
the	O
least	O
conservative	O
statistical	O
threshold	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
the	O
transcription	O
of	O
557	O
(	O
23	O
.	O
9	O
%	O
)	O
out	O
of	O
2	O
,	O
329	O
genes	O
probed	O
in	O
the	O
microarrays	O
was	O
significantly	O
perturbed	O
(	O
up	O
or	O
down	O
,	O
at	O
one	O
or	O
more	O
conditions	O
,	O
Fig	O
.	O
S3	O
)	O
and	O
the	O
only	O
set	O
of	O
contiguous	O
genes	O
that	O
underwent	O
transcriptional	O
changes	O
at	O
all	O
tested	O
conditions	O
is	O
the	O
SpeB	O
operon	O
gene	O
set	O
(	O
CC4	O
in	O
Fig	O
.	O
2	O
)	O
.	O

However	O
,	O
the	O
fold	O
-	O
change	O
in	O
SpeB	O
operon	O
transcription	O
level	O
largely	O
varied	O
across	O
the	O
four	O
experimental	O
conditions	O
,	O
ranging	O
from	O
a	O
2	O
.	O
2	O
-	O
fold	O
to	O
a	O
30	O
-	O
fold	O
downregulation	O
(	O
Table	O
3	O
)	O
.	O

Inspired	O
by	O
the	O
recently	O
described	O
neighbor	O
clustering	O
method	O
for	O
microarray	O
analysis	O
[	O
41	O
]	O
,	O
we	O
also	O
mapped	O
the	O
significant	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
differential	O
expression	O
ratios	O
of	O
different	O
genes	O
to	O
their	O
chromosomal	O
loci	O
(	O
Fig	O
.	O
3	O
and	O
Fig	O
.	O
S4	O
)	O
to	O
allow	O
the	O
visualization	O
of	O
coexpressed	O
contiguous	O
genes	O
,	O
including	O
operons	O
.	O

This	O
mapping	O
highlighted	O
genes	O
that	O
might	O
otherwise	O
have	O
been	O
overlooked	O
by	O
the	O
CC	O
or	O
expression	O
ratio	O
methods	O
.	O
<EOS>	B-X
Importantly	B-X
,	B-X
the	B-X
large	B-X
majority	B-X
of	B-X
GWAS-associated	B-X
loci	B-X
involve	B-X
noncoding	B-X
variation	B-X
,	B-X
many	B-X
of	B-X
which	B-X
modulate	B-X
levels	B-X
of	B-X
gene	B-X
expression	B-X
.	B-X
Recent	B-X
expression	B-X
quantitative	B-X
trait	B-X
loci	B-X
(	B-X
eQTL	B-X
)	B-X
studies	B-X
have	B-X
established	B-X
that	B-X
the	B-X
expression	B-X
of	B-X
most	B-X
human	B-X
genes	B-X
is	B-X
regulated	B-X
by	B-X
noncoding	B-X
genetic	B-X
variations	B-X
.	B-X
Common	B-X
variation	B-X
accounts	B-X
for	B-X
only	B-X
a	B-X
modest	B-X
fraction	B-X
of	B-X
the	B-X
predicted	B-X
heritability	B-X
and	B-X
the	B-X
role	B-X
of	B-X
rare	B-X
genetic	B-X
variation	B-X
of	B-X
higher	B-X
effects	B-X
(	B-X
ie	B-X
,	B-X
odds	B-X
ratios	B-X
markedly	B-X
deviating	B-X
from	B-X
1	B-X
)	B-X
is	B-X
increasingly	B-X
being	B-X
identified	B-X
through	B-X
sequencing	B-X
efforts	B-X
.	B-X
RNA-seq	B-X
reads	B-X
yield	B-X
insights	B-X
into	B-X
the	B-X
regulation	B-X
of	B-X
alternative	B-X
splicing	B-X
by	B-X
revealing	B-X
the	B-X
usage	B-X
of	B-X
known	B-X
or	B-X
unknown	B-X
splice	B-X
sites	B-X
as	B-X
well	B-X
as	B-X
the	B-X
expression	B-X
level	B-X
of	B-X
exons	B-X
.	B-X
The	B-X
ratio	B-X
between	B-X
reads	B-X
including	B-X
or	B-X
excluding	B-X
exons	B-X
,	B-X
also	B-X
known	B-X
as	B-X
percent	B-X
spliced	B-X
in	B-X
index	B-X
(	B-X
PSI	B-X
)	B-X
,	B-X
indicates	B-X
how	B-X
efficiently	B-X
sequences	B-X
of	B-X
interest	B-X
are	B-X
spliced	B-X
into	B-X
transcripts	B-X
.	B-X

Examples	O
of	O
neighbor	O
clusters	O
(	O
NCs	O
)	O
enriched	O
in	O
differentially	O
expressed	O
genes	O
are	O
a	O
locus	O
involved	O
in	O
L	O
-	O
ascorbate	O
utilization	O
(	O
SPy0175	O
-	O
SPy0179	O
)	O
;	O
the	O
citrate	O
lyase	O
locus	O
(	O
SPy1186	O
-	O
SPy1191	O
)	O
;	O
the	O
Trx	O
chromosomal	O
locus	O
(	O
SPy1582	O
-	O
SPy1596	O
)	O
that	O
includes	O
the	O
recently	O
described	O
,	O
CovR	O
-	O
repressed	O
two	O
-	O
component	O
response	O
regulator	O
TrxR	O
[	O
42	O
]	O
;	O
and	O
the	O
well	O
-	O
studied	O
Mga	O
(	O
SPy2010	O
-	O
SPy2025	O
)	O
,	O
SpeB	O
(	O
SPy2037	O
-	O
SPy2042	O
)	O
,	O
and	O
capsule	O
synthesis	O
(	O
SPy2200	O
-	O
SPy2202	O
)	O
loci	O
(	O
Fig	O
.	O
3	O
and	O
Fig	O
.	O
S4	O
)	O
.	O

NC	O
analysis	O
also	O
allowed	O
us	O
to	O
visualize	O
genomic	O
clusters	O
that	O
are	O
similarly	O
regulated	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
those	O
that	O
are	O
reciprocally	O
regulated	O
.	O

For	O
example	O
,	O
in	O
both	O
the	O
SLS	O
operon	O
and	O
the	O
Trx	O
locus	O
,	O
we	O
observed	O
a	O
striking	O
difference	O
between	O
the	O
effects	O
of	O
the	O
covS	O
mutation	O
and	O
the	O
in	O
vivo	O
adaptation	O
(	O
Fig	O
.	O
4	O
,	O
CC6	O
)	O
.	O

Genes	O
of	O
these	O
two	O
chromosomal	O
clusters	O
are	O
significantly	O
downregulated	O
in	O
AP	B-Organism
compared	O
to	O
WT	O
bacteria	O
,	O
but	O
significantly	O
upregulated	O
in	O
WT	O
-	O
vivo	O
relative	O
to	O
WT	O
-	O
vitro	O
conditions	O
(	O
Fig	O
.	O
4	O
,	O
CC6	O
)	O
.	O

As	O
a	O
final	O
step	O
of	O
our	O
multifaceted	O
data	O
analysis	O
approach	O
,	O
we	O
tabulated	O
significant	O
transcriptional	O
changes	O
of	O
individual	O
genes	O
that	O
encode	O
known	O
regulators	O
and	O
well	O
-	O
studied	O
virulence	O
factors	O
(	O
Table	O
3	O
)	O
.	O

Focusing	O
on	O
those	O
genes	O
highlights	O
the	O
pathogenesis	O
-	O
related	O
changes	O
and	O
allows	O
easy	O
comparison	O
of	O
our	O
data	O
with	O
those	O
in	O
the	O
literature	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
37	O
]	O
.	O

Data	O
integration	O
reveals	O
genomic	O
subsystems	O
influenced	O
by	O
the	O
covS	O
mutation	O
in	O
vitro	O
and	O
in	O
vivo	O

By	O
combining	O
different	O
strategies	O
for	O
microarray	O
data	O
analysis	O
,	O
we	O
took	O
advantage	O
of	O
the	O
strengths	O
of	O
each	O
strategy	O
to	O
generate	O
biologically	O
relevant	O
gene	O
sets	O
rather	O
than	O
gene	O
lists	O
ordered	O
solely	O
according	O
to	O
statistical	O
parameters	O
.	O

The	O
next	O
stage	O
in	O
our	O
analysis	O
was	O
to	O
integrate	O
microarray	O
data	O
,	O
moving	O
from	O
the	O
gene	O
/	O
cluster	O
level	O
to	O
the	O
level	O
of	O
biological	O
subsystems	O
.	O

A	O
subsystem	O
is	O
a	O
part	O
of	O
a	O
genome	O
that	O
represents	O
a	O
functional	O
module	O
,	O
e	O
.	O
g	O
.	O
,	O
an	O
operon	O
,	O
a	O
cellular	O
pathway	O
,	O
a	O
regulon	O
,	O
or	O
a	O
complex	O
regulatory	O
network	O
[	O
43	O
]	O
.	O
<EOS>	B-X
Given	B-X
the	B-X
functional	B-X
interdependencies	B-X
between	B-X
the	B-X
molecular	B-X
components	B-X
in	B-X
a	B-X
human	B-X
cell	B-X
,	B-X
a	B-X
disease	B-X
is	B-X
rarely	B-X
a	B-X
consequence	B-X
of	B-X
an	B-X
abnormality	B-X
in	B-X
a	B-X
single	B-X
gene	B-X
,	B-X
but	B-X
reflects	B-X
the	B-X
perturbations	B-X
of	B-X
the	B-X
complex	B-X
intracellular	B-X
and	B-X
intercellular	B-X
network	B-X
that	B-X
links	B-X
tissue	B-X
and	B-X
organ	B-X
systems	B-X
.	B-X
The	B-X
emerging	B-X
tools	B-X
of	B-X
network	B-X
medicine	B-X
offer	B-X
a	B-X
platform	B-X
to	B-X
explore	B-X
systematically	B-X
not	B-X
only	B-X
the	B-X
molecular	B-X
complexity	B-X
of	B-X
a	B-X
particular	B-X
disease	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
identification	B-X
of	B-X
disease	B-X
modules	B-X
and	B-X
pathways	B-X
,	B-X
but	B-X
also	B-X
the	B-X
molecular	B-X
relationships	B-X
among	B-X
apparently	B-X
distinct	B-X
(	B-X
patho	B-X
)	B-X
phenotypes	B-X
.	B-X
Advances	B-X
in	B-X
this	B-X
direction	B-X
are	B-X
essential	B-X
for	B-X
identifying	B-X
new	B-X
disease	B-X
genes	B-X
,	B-X
for	B-X
uncovering	B-X
the	B-X
biological	B-X
significance	B-X
of	B-X
disease-associated	B-X
mutations	B-X
identified	B-X
by	B-X
genome-wide	B-X
association	B-X
studies	B-X
and	B-X
full-genome	B-X
sequencing	B-X
,	B-X
and	B-X
for	B-X
identifying	B-X
drug	B-X
targets	B-X
and	B-X
biomarkers	B-X
for	B-X
complex	B-X
diseases	B-X
.	B-X
Modern	B-X
network	B-X
science	B-X
is	B-X
a	B-X
new	B-X
and	B-X
exciting	B-X
research	B-X
field	B-X
that	B-X
has	B-X
transformed	B-X
the	B-X
study	B-X
of	B-X
complex	B-X
systems	B-X
over	B-X
the	B-X
last	B-X
2	B-X
decades	B-X
.	B-X
Of	B-X
particular	B-X
interest	B-X
is	B-X
the	B-X
identification	B-X
of	B-X
small	B-X
``	B-X
network	B-X
motifs	B-X
''	B-X
that	B-X
might	B-X
be	B-X
embedded	B-X
in	B-X
a	B-X
larger	B-X
network	B-X
and	B-X
that	B-X
indicate	B-X
the	B-X
presence	B-X
of	B-X
evolutionary	B-X
design	B-X
principles	B-X
or	B-X
have	B-X
an	B-X
overly	B-X
influential	B-X
role	B-X
on	B-X
system-wide	B-X
dynamics	B-X
.	B-X
Motifs	B-X
are	B-X
patterns	B-X
of	B-X
interconnections	B-X
,	B-X
or	B-X
subgraphs	B-X
,	B-X
that	B-X
appear	B-X
in	B-X
an	B-X
observed	B-X
network	B-X
significantly	B-X
more	B-X
often	B-X
than	B-X
in	B-X
compatible	B-X
randomized	B-X
networks	B-X
.	B-X
The	B-X
concept	B-X
of	B-X
network	B-X
motifs	B-X
was	B-X
introduced	B-X
into	B-X
Systems	B-X
Biology	B-X
by	B-X
Milo	B-X
,	B-X
Alon	B-X
and	B-X
colleagues	B-X
in	B-X
2002	B-X
,	B-X
quickly	B-X
revolutionized	B-X
the	B-X
field	B-X
,	B-X
and	B-X
it	B-X
has	B-X
had	B-X
a	B-X
huge	B-X
impact	B-X
in	B-X
wider	B-X
scientific	B-X
domains	B-X
ever	B-X
since	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
argue	B-X
that	B-X
the	B-X
same	B-X
concept	B-X
and	B-X
tools	B-X
for	B-X
the	B-X
detection	B-X
of	B-X
motifs	B-X
were	B-X
well	B-X
known	B-X
in	B-X
the	B-X
ecological	B-X
literature	B-X
decades	B-X
into	B-X
the	B-X
last	B-X
century	B-X
,	B-X
a	B-X
fact	B-X
that	B-X
is	B-X
generally	B-X
not	B-X
recognized	B-X
.	B-X
We	B-X
review	B-X
the	B-X
early	B-X
history	B-X
of	B-X
network	B-X
motifs	B-X
,	B-X
their	B-X
evolution	B-X
in	B-X
the	B-X
mathematics	B-X
literature	B-X
,	B-X
and	B-X
their	B-X
recent	B-X
rediscoveries	B-X
.	B-X

The	O
genes	O
perturbed	O
by	O
the	O
different	O
experimental	O
conditions	O
of	O
this	O
study	O
correspond	O
to	O
multiple	O
subsystems	O
(	O
Fig	O
.	O
5	O
)	O
.	O

Of	O
interest	O
,	O
among	O
the	O
genes	O
of	O
known	O
function	O
,	O
25	O
%	O
of	O
those	O
whose	O
transcription	O
was	O
modulated	O
as	O
a	O
consequence	O
of	O
the	O
covS	O
mutation	O
are	O
virulence	O
-	O
related	O
and	O
another	O
25	O
%	O
are	O
related	O
to	O
carbohydrate	O
metabolism	O
pathways	O
,	O
which	O
are	O
connected	O
to	O
virulence	O
in	O
streptococci	B-Organism
[	O
44	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

When	O
we	O
attempted	O
to	O
correlate	O
the	O
array	O
results	O
with	O
known	O
GAS	B-Organism
regulons	O
,	O
some	O
differentially	O
expressed	O
gene	O
sets	O
could	O
be	O
fitted	O
into	O
previously	O
described	O
regulatory	O
networks	O
while	O
others	O
did	O
not	O
belong	O
to	O
any	O
such	O
networks	O
.	O

For	O
example	O
,	O
the	O
upregulation	O
of	O
Ska	O
,	O
SLO	O
/	O
Nga	O
,	O
and	O
the	O
Has	O
operon	O
is	O
a	O
pattern	O
that	O
reflects	O
the	O
inhibition	O
of	O
CovR	O
repression	O
,	O
whereas	O
the	O
downregulation	O
of	O
both	O
SpeB	O
and	O
SLS	O
operons	O
is	O
a	O
pattern	O
associated	O
with	O
the	O
transcriptional	O
regulator	O
RopB	O
/	O
Rgg	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
but	O
that	O
may	O
also	O
reflect	O
augmented	O
CovR	O
repression	O
[	O
20	O
]	O
.	O

Although	O
CovS	O
is	O
expected	O
to	O
modulate	O
many	O
known	O
CovR	O
-	O
repressed	O
subsystems	O
,	O
certain	O
operons	O
may	O
be	O
differentially	O
modulated	O
or	O
may	O
be	O
influenced	O
by	O
other	O
regulator	O
(	O
s	O
)	O
.	O
<EOS>	B-X
We	B-X
sought	B-X
to	B-X
quantify	B-X
,	B-X
by	B-X
year	B-X
,	B-X
how	B-X
many	B-X
approvals	B-X
incorporated	B-X
RWE	B-X
in	B-X
any	B-X
form	B-X
,	B-X
and	B-X
the	B-X
intended	B-X
use	B-X
of	B-X
RWE	B-X
in	B-X
those	B-X
applications	B-X
.	B-X
Among	B-X
these	B-X
88	B-X
approvals	B-X
,	B-X
65	B-X
of	B-X
the	B-X
studies	B-X
influenced	B-X
FDA	B-X
's	B-X
final	B-X
decision	B-X
and	B-X
38	B-X
were	B-X
included	B-X
in	B-X
product	B-X
labels	B-X
.	B-X
Passing	B-X
time	B-X
has	B-X
seen	B-X
the	B-X
duty	B-X
of	B-X
disclosure	B-X
evolve	B-X
to	B-X
include	B-X
non-medical	B-X
aspects	B-X
that	B-X
may	B-X
influence	B-X
the	B-X
delivery	B-X
of	B-X
care	B-X
.	B-X
The	B-X
uptake	B-X
of	B-X
the	B-X
expanded	B-X
duty	B-X
of	B-X
disclosure	B-X
has	B-X
been	B-X
slow	B-X
and	B-X
incomplete	B-X
by	B-X
practitioners	B-X
and	B-X
regulators	B-X
.	B-X
The	B-X
expanded	B-X
duty	B-X
of	B-X
disclosure	B-X
has	B-X
implications	B-X
,	B-X
both	B-X
educative	B-X
and	B-X
punitive	B-X
for	B-X
regulators	B-X
,	B-X
chiropractic	B-X
educators	B-X
and	B-X
professional	B-X
associations	B-X
.	B-X
We	B-X
discuss	B-X
how	B-X
practitioners	B-X
and	B-X
regulators	B-X
can	B-X
be	B-X
informed	B-X
by	B-X
other	B-X
sources	B-X
such	B-X
as	B-X
consumer	B-X
law	B-X
.	B-X
For	B-X
regulators	B-X
,	B-X
reviewing	B-X
and	B-X
updating	B-X
informed	B-X
consent	B-X
requirements	B-X
is	B-X
required	B-X
.	B-X
For	B-X
practitioners	B-X
it	B-X
may	B-X
necessitate	B-X
disclosure	B-X
of	B-X
health	B-X
status	B-X
,	B-X
conflict	B-X
of	B-X
interest	B-X
when	B-X
recommending	B-X
``	B-X
inhouse	B-X
''	B-X
products	B-X
,	B-X
recency	B-X
of	B-X
training	B-X
after	B-X
attending	B-X
continuing	B-X
professional	B-X
development	B-X
,	B-X
practice	B-X
patterns	B-X
,	B-X
personal	B-X
interests	B-X
and	B-X
disciplinary	B-X
findings	B-X
.	B-X

Alternatively	O
,	O
the	O
mutation	O
in	O
covS	O
may	O
have	O
different	O
effects	O
on	O
CovR	O
-	O
mediated	O
regulation	O
of	O
different	O
genes	O
[	O
26	O
]	O
.	O

In	O
fact	O
,	O
our	O
in	O
vivo	O
data	O
show	O
that	O
covR	O
itself	O
is	O
downregulated	O
in	O
vivo	O
in	O
both	O
WT	O
and	O
AP	B-Organism
strains	O
(	O
Fig	O
.	O
2	O
,	O
CC2	O
and	O
Table	O
S1	O
)	O
;	O
however	O
,	O
the	O
SLS	O
operon	O
is	O
upregulated	O
in	O
vivo	O
in	O
WT	O
bacteria	O
,	O
suggesting	O
that	O
its	O
regulation	O
is	O
not	O
solely	O
modulated	O
by	O
CovRS	O
.	O

It	O
is	O
possible	O
that	O
SLS	O
is	O
regulated	O
by	O
the	O
catabolite	O
control	O
protein	O
(	O
CcpA	O
)	O
,	O
which	O
was	O
recently	O
shown	O
to	O
be	O
another	O
key	O
transcriptional	O
regulator	O
of	O
the	O
SLS	O
operon	O
[	O
46	O
]	O
and	O
which	O
may	O
override	O
CovR	O
-	O
mediated	O
repression	O
of	O
SLS	O
.	O

Another	O
complex	O
regulatory	O
pattern	O
is	O
exhibited	O
by	O
the	O
genes	O
of	O
the	O
Trx	O
locus	O
,	O
which	O
include	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
TrxRS	O
.	O

The	O
TrxRS	O
system	O
reportedly	O
responds	O
to	O
a	O
yet	O
-	O
to	O
-	O
be	O
-	O
identified	O
extracellular	O
signal	O
while	O
TrxR	O
itself	O
is	O
directly	O
regulated	O
by	O
CovR	O
[	O
42	O
]	O
.	O

Most	O
genes	O
within	O
the	O
Trx	O
locus	O
are	O
downregulated	O
in	O
AP	B-Organism
GAS	I-Organism
relative	O
to	O
WT	O
,	O
but	O
upregulated	O
in	O
the	O
WT	O
bacteria	O
in	O
vivo	O
(	O
Fig	O
.	O
2	O
,	O
CC6	O
and	O
Fig	O
.	O
3	O
)	O
suggesting	O
the	O
possibility	O
of	O
CovS	O
-	O
dependent	O
in	O
vivo	O
signaling	O
.	O

One	O
last	O
factor	O
that	O
adds	O
to	O
the	O
complexity	O
of	O
data	O
integration	O
analysis	O
and	O
that	O
may	O
explain	O
unexpected	O
transcriptional	O
patterns	O
is	O
that	O
regulators	O
are	O
often	O
controlled	O
by	O
sensitive	O
feedback	O
mechanisms	O
.	O

Inactivation	O
or	O
downregulation	O
of	O
one	O
regulator	O
may	O
eventually	O
perturb	O
the	O
entire	O
system	O
,	O
and	O
several	O
other	O
regulators	O
are	O
likely	O
to	O
become	O
engaged	O
in	O
compensatory	O
mechanisms	O
to	O
maintain	O
cellular	O
homeostasis	O
.	O
<EOS>	B-X
Nonetheless	B-X
,	B-X
ritonavir	B-X
is	B-X
clearly	B-X
a	B-X
potent	B-X
mechanism-based	B-X
inactivator	B-X
,	B-X
which	B-X
irreversibly	B-X
blocks	B-X
CYP3A4	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
discuss	B-X
four	B-X
fundamentally	B-X
different	B-X
mechanisms	B-X
proposed	B-X
for	B-X
this	B-X
irreversible	B-X
inactivation/inhibition	B-X
,	B-X
namely	B-X
the	B-X
(	B-X
I	B-X
)	B-X
formation	B-X
of	B-X
a	B-X
metabolic-intermediate	B-X
complex	B-X
(	B-X
MIC	B-X
)	B-X
,	B-X
tightly	B-X
coordinating	B-X
to	B-X
the	B-X
heme	B-X
group	B-X
;	B-X
(	B-X
II	B-X
)	B-X
strong	B-X
ligation	B-X
of	B-X
unmodified	B-X
ritonavir	B-X
to	B-X
the	B-X
heme	B-X
iron	B-X
;	B-X
(	B-X
III	B-X
)	B-X
heme	B-X
destruction	B-X
;	B-X
and	B-X
(	B-X
IV	B-X
)	B-X
covalent	B-X
attachment	B-X
of	B-X
a	B-X
reactive	B-X
ritonavir	B-X
intermediate	B-X
to	B-X
the	B-X
CYP3A4	B-X
apoprotein	B-X
.	B-X
Although	B-X
it	B-X
is	B-X
currently	B-X
not	B-X
possible	B-X
to	B-X
conclude	B-X
what	B-X
the	B-X
primary	B-X
mechanism	B-X
of	B-X
action	B-X
in	B-X
vivo	B-X
is	B-X
,	B-X
it	B-X
is	B-X
unlikely	B-X
that	B-X
any	B-X
of	B-X
the	B-X
proposed	B-X
mechanisms	B-X
are	B-X
fundamentally	B-X
wrong	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
ritonavir	B-X
markedly	B-X
inactivates	B-X
CYP3A	B-X
through	B-X
a	B-X
mixed	B-X
set	B-X
of	B-X
mechanisms	B-X
.	B-X
This	B-X
functional	B-X
redundancy	B-X
may	B-X
well	B-X
contribute	B-X
to	B-X
its	B-X
overall	B-X
inhibitory	B-X
efficacy	B-X
.	B-X

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Group	O
A	O
streptococcal	O
sociomicrobiology	O
It	O
is	O
now	O
well	O
established	O
that	O
bacterial	O
populations	O
often	O
consist	O
of	O
heterogeneous	O
communities	O
rather	O
than	O
genetically	O
identical	O
cells	O
with	O
synchronized	O
gene	O
expression	O
profiles	O
[	O
49	O
]	O
,	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
how	O
gross	O
changes	O
in	O
the	O
bacterial	O
environment	O
,	O
such	O
as	O
the	O
onset	O
of	O
infection	O
,	O
can	O
profoundly	O
perturb	O
the	O
sociomicrobiological	O
structure	O
of	O
the	O
bacterial	O
population	O
,	O
driving	O
a	O
minor	O
subpopulation	O
with	O
a	O
mutant	O
hypervirulent	O
phenotype	O
to	O
thrive	O
,	O
prevail	O
,	O
and	O
cause	O
severe	O
disease	O
.	O

Although	O
a	O
number	O
of	O
informative	O
studies	O
have	O
compared	O
gene	O
and	O
protein	O
expression	O
in	O
virulent	O
and	O
hypervirulent	O
GAS	B-Organism
isolates	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
37	O
]	O
,	O
none	O
have	O
captured	O
the	O
transitional	O
state	O
that	O
reflects	O
the	O
dynamics	O
of	O
the	O
bacterial	O
struggle	O
to	O
survive	O
in	O
a	O
new	O
host	O
environment	O
.	O

Normally	O
,	O
capturing	O
such	O
evolutionary	O
events	O
in	O
real	O
time	O
is	O
difficult	O
,	O
both	O
because	O
multiple	O
sampling	O
of	O
the	O
bacteria	O
in	O
vivo	O
is	O
often	O
unfeasible	O
due	O
to	O
their	O
dissemination	O
,	O
and	O
because	O
the	O
fittest	O
members	O
of	O
the	O
community	O
usually	O
overtake	O
the	O
rest	O
of	O
the	O
population	O
rather	O
rapidly	O
,	O
thereby	O
hampering	O
the	O
ability	O
to	O
capture	O
dynamic	O
changes	O
associated	O
with	O
the	O
restructuring	O
of	O
the	O
bacterial	O
community	O
at	O
different	O
host	O
niches	O
.	O

Our	O
subcutaneous	O
chamber	O
model	O
of	O
infection	O
allowed	O
us	O
to	O
sample	O
the	O
inoculated	O
WT	O
and	O
AP	B-Organism
bacteria	O
at	O
specific	O
times	O
post	O
-	O
infection	O
,	O
during	O
their	O
adaptation	O
to	O
their	O
new	O
environment	O
,	O
to	O
determine	O
how	O
their	O
interaction	O
with	O
the	O
host	O
affects	O
their	O
community	O
structure	O
and	O
their	O
transcriptional	O
reprogramming	O
.	O

In	O
doing	O
so	O
,	O
we	O
were	O
able	O
to	O
dissect	O
changes	O
in	O
gene	O
expression	O
associated	O
with	O
niche	O
adaptation	O
from	O
those	O
resulting	O
from	O
restructuring	O
of	O
the	O
bacterial	O
community	O
,	O
where	O
undetected	O
minority	O
members	O
in	O
vitro	O
became	O
the	O
new	O
majority	O
in	O
vivo	O
,	O
armed	O
with	O
the	O
necessary	O
tools	O
to	O
survive	O
in	O
their	O
new	O
niche	O
.	O

These	O
in	O
vivo	O
-	O
selected	O
bacteria	O
with	O
the	O
AP	B-Organism
phenotype	O
could	O
be	O
differentiated	O
from	O
the	O
WT	O
bacteria	O
by	O
mutations	O
that	O
are	O
clustered	O
in	O
the	O
sensor	O
kinase	O
-	O
encoding	O
covS	O
gene	O
in	O
AP	B-Organism
bacteria	O
[	O
14	O
]	O
,	O
[	O
27	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
captured	O
dynamic	O
events	O
underlying	O
the	O
phenotypic	O
switch	O
resulting	O
from	O
this	O
population	O
restructuring	O
.	O

Environmental	O
adaptation	O
vs	O
.	O
covS	O
mutation	O

In	O
vitro	O
,	O
the	O
growth	O
of	O
these	O
two	O
variants	O
of	O
the	O
M1T1	B-Organism
bacteria	O
was	O
comparable	O
and	O
,	O
although	O
137	O
(	O
5	O
.	O
9	O
%	O
)	O
of	O
their	O
genes	O
were	O
differentially	O
expressed	O
(	O
Table	O
2	O
)	O
,	O
in	O
vitro	O
phenotypic	O
screening	O
revealed	O
negligible	O
differences	O
(	O
Table	O
1	O
)	O
.	O

This	O
suggests	O
that	O
the	O
majority	O
of	O
in	O
vitro	O
vs	O
.	O
in	O
vivo	O
differentially	O
expressed	O
genes	O
between	O
the	O
WT	O
and	O
AP	B-Organism
variants	O
may	O
be	O
involved	O
in	O
niche	O
adaptation	O
.	O

This	O
finding	O
is	O
in	O
agreement	O
with	O
studies	O
showing	O
that	O
the	O
CovRS	O
system	O
is	O
mainly	O
linked	O
to	O
the	O
regulation	O
of	O
virulence	O
factors	O
and	O
virulence	O
-	O
associated	O
pathways	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
,	O
[	O
24	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
52	O
]	O
,	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

Indeed	O
,	O
several	O
virulence	O
genes	O
were	O
among	O
the	O
137	O
in	O
vitro	O
differentially	O
expressed	O
genes	O
between	O
these	O
two	O
M1T1	B-Organism
variants	O
.	O

Upregulated	O
gene	O
sets	O
in	O
AP	B-Organism
vs	O
.	O
WT	O
bacteria	O
in	O
vitro	O
included	O
Mga	O
locus	O
genes	O
(	O
e	O
.	O
g	O
.	O
,	O
sic	O
,	O
emm	O
,	O
scp	O
)	O
;	O
hyaluronic	O
acid	O
capsule	O
-	O
encoding	O
genes	O
(	O
hasABC	O
)	O
;	O
and	O
genes	O
encoding	O
the	O
toxins	O
SpeA	O
,	O
SclA	O
,	O
SLO	O
,	O
and	O
the	O
streptodornase	O
Sda1	O
(	O
Fig	O
.	O
2	O
,	O
Fig	O
.	O
S2	O
,	O
and	O
Table	O
3	O
)	O
.	O

Other	O
well	O
-	O
studied	O
gene	O
sets	O
were	O
downregulated	O
in	O
AP	O
bacteria	O
grown	O
in	O
vitro	O
.	O

Besides	O
metabolic	O
gene	O
sets	O
involved	O
in	O
trehalose	O
and	O
ascorbate	O
utilization	O
,	O
several	O
known	O
virulence	O
factors	O
were	O
downregulated	O
in	O
AP	B-Organism
bacteria	O
,	O
and	O
these	O
included	O
the	O
SpeB	O
operon	O
,	O
GRAB	O
,	O
EndoS	O
,	O
and	O
CAMP	O
factor	O
.	O

SpeB	O
is	O
a	O
major	O
virulence	O
factor	O
in	O
GAS	B-Organism
pathogenesis	O
and	O
its	O
expression	O
is	O
regulated	O
by	O
different	O
systems	O
[	O
40	O
]	O
,	O
[	O
56	O
]	O
,	O
[	O
57	O
]	O
,	O
[	O
58	O
]	O
,	O
including	O
the	O
CovRS	O
system	O
[	O
20	O
]	O
,	O
[	O
53	O
]	O
.	O

Whereas	O
SpeB	O
expression	O
may	O
be	O
important	O
in	O
the	O
initial	O
stages	O
of	O
skin	O
infections	O
[	O
29	O
]	O
,	O
[	O
35	O
]	O
,	O
its	O
downregulation	O
has	O
been	O
associated	O
with	O
an	O
invasive	O
and	O
hypervirulent	O
phenotype	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
[	O
59	O
]	O
.	O

The	O
downregulation	O
of	O
GRAB	O
makes	O
biological	O
sense	O
because	O
this	O
protein	O
binds	O
alpha	O
-	O
2	O
-	O
macroglobulin	O
in	O
blood	O
[	O
60	O
]	O
to	O
protect	O
the	O
bacteria	O
against	O
its	O
own	O
protease	O
,	O
SpeB	O
,	O
and	O
thus	O
the	O
bacteria	O
no	O
longer	O
need	O
to	O
express	O
high	O
levels	O
of	O
GRAB	O
when	O
SpeB	O
is	O
not	O
expressed	O
.	O

Similarly	O
,	O
EndoS	O
,	O
an	O
IgG	O
protease	O
,	O
and	O
CAMP	O
,	O
a	O
hemolysin	O
,	O
are	O
likely	O
needed	O
in	O
blood	O
but	O
with	O
no	O
defined	O
function	O
in	O
subcutaneous	O
or	O
deep	O
tissue	O
.	O
<EOS>	B-X
Histologically	B-X
,	B-X
skin	B-X
has	B-X
two	B-X
main	B-X
layers-the	B-X
epidermis	B-X
and	B-X
the	B-X
dermis-with	B-X
a	B-X
subcutaneous	B-X
fascia	B-X
called	B-X
the	B-X
hypodermis	B-X
,	B-X
which	B-X
lies	B-X
deep	B-X
in	B-X
the	B-X
dermis	B-X
.	B-X
The	B-X
hypodermis	B-X
is	B-X
a	B-X
looser	B-X
connective	B-X
tissue	B-X
that	B-X
is	B-X
located	B-X
beneath	B-X
the	B-X
dermis	B-X
.	B-X
The	B-X
relationship	B-X
of	B-X
the	B-X
skin	B-X
,	B-X
the	B-X
superficial	B-X
and	B-X
deep	B-X
fat	B-X
compartments	B-X
,	B-X
and	B-X
the	B-X
ligaments	B-X
that	B-X
connect	B-X
these	B-X
structures	B-X
is	B-X
key	B-X
to	B-X
performing	B-X
any	B-X
rhytidectomy	B-X
.	B-X
In	B-X
order	B-X
to	B-X
successfully	B-X
mobilize	B-X
,	B-X
elevate	B-X
,	B-X
and	B-X
reposition	B-X
the	B-X
facial	B-X
soft	B-X
tissues	B-X
,	B-X
a	B-X
detailed	B-X
understanding	B-X
of	B-X
facial	B-X
anatomy	B-X
is	B-X
required	B-X
.	B-X

Their	O
downregulation	O
in	O
AP	B-Organism
is	O
thus	O
consistent	O
with	O
the	O
hypothesis	O
that	O
this	O
hypervirulent	O
variant	O
is	O
adapted	O
for	O
deep	O
infection	O
.	O

In	O
addition	O
,	O
the	O
downregulation	O
of	O
SpeB	O
,	O
EndoS	O
,	O
and	O
CAMP	O
is	O
in	O
agreement	O
with	O
our	O
previous	O
proteomic	O
results	O
[	O
12	O
]	O
as	O
well	O
as	O
other	O
published	O
transcriptional	O
analyses	O
[	O
13	O
]	O
,	O
[	O
27	O
]	O
.	O

As	O
both	O
bacterial	O
variants	O
were	O
subjected	O
to	O
the	O
host	O
environment	O
,	O
they	O
underwent	O
additional	O
changes	O
in	O
gene	O
expression	O
.	O

In	O
vivo	O
,	O
both	O
WT	O
and	O
AP	B-Organism
bacteria	O
downregulated	O
a	O
substantial	O
number	O
of	O
their	O
genes	O
(	O
127	O
genes	O
in	O
CC1	O
and	O
CC2	O
,	O
Fig	O
.	O
2	O
and	O
Table	O
S1	O
)	O
,	O
and	O
upregulated	O
many	O
fewer	O
(	O
24	O
genes	O
in	O
CC3	O
,	O
Fig	O
.	O
2	O
and	O
Table	O
S1	O
)	O
.	O

By	O
parsing	O
these	O
differentially	O
expressed	O
genes	O
into	O
operons	O
,	O
subsystems	O
,	O
and	O
functional	O
pathways	O
,	O
we	O
found	O
that	O
many	O
reflect	O
the	O
engagement	O
of	O
several	O
regulatory	O
networks	O
involved	O
in	O
metabolic	O
adaptation	O
and	O
immune	O
camouflage	O
or	O
evasion	O
of	O
host	O
defenses	O
.	O
<EOS>	B-X
The	B-X
major	B-X
innate	B-X
immune	B-X
cell	B-X
types	B-X
involved	B-X
in	B-X
tuberculosis	B-X
(	B-X
TB	B-X
)	B-X
infection	B-X
are	B-X
macrophages	B-X
,	B-X
dendritic	B-X
cells	B-X
(	B-X
DCs	B-X
)	B-X
,	B-X
neutrophils	B-X
and	B-X
natural	B-X
killer	B-X
(	B-X
NK	B-X
)	B-X
cells	B-X
.	B-X
These	B-X
immune	B-X
cells	B-X
recognize	B-X
the	B-X
TB-causing	B-X
pathogen	B-X
Mycobacterium	B-X
tuberculosis	B-X
(	B-X
Mtb	B-X
)	B-X
through	B-X
various	B-X
pattern	B-X
recognition	B-X
receptors	B-X
(	B-X
PRRs	B-X
)	B-X
,	B-X
including	B-X
but	B-X
not	B-X
limited	B-X
to	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
,	B-X
Nod-like	B-X
receptors	B-X
(	B-X
NLRs	B-X
)	B-X
and	B-X
C-type	B-X
lectin	B-X
receptors	B-X
(	B-X
CLRs	B-X
)	B-X
.	B-X
Upon	B-X
infection	B-X
by	B-X
Mtb	B-X
,	B-X
the	B-X
host	B-X
orchestrates	B-X
multiple	B-X
signaling	B-X
cascades	B-X
via	B-X
the	B-X
PRRs	B-X
to	B-X
launch	B-X
a	B-X
variety	B-X
of	B-X
innate	B-X
immune	B-X
defense	B-X
functions	B-X
such	B-X
as	B-X
phagocytosis	B-X
,	B-X
autophagy	B-X
,	B-X
apoptosis	B-X
and	B-X
inflammasome	B-X
activation	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Mtb	B-X
utilizes	B-X
numerous	B-X
exquisite	B-X
strategies	B-X
to	B-X
evade	B-X
or	B-X
circumvent	B-X
host	B-X
innate	B-X
immunity	B-X
.	B-X
Here	B-X
we	B-X
discuss	B-X
recent	B-X
research	B-X
on	B-X
major	B-X
host	B-X
innate	B-X
immune	B-X
cells	B-X
,	B-X
PRR	B-X
signaling	B-X
,	B-X
and	B-X
the	B-X
cellular	B-X
functions	B-X
involved	B-X
in	B-X
Mtb	B-X
infection	B-X
,	B-X
with	B-X
a	B-X
specific	B-X
focus	B-X
on	B-X
the	B-X
host	B-X
's	B-X
innate	B-X
immune	B-X
defense	B-X
and	B-X
Mtb	B-X
immune	B-X
evasion	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
host-pathogen	B-X
interactions	B-X
could	B-X
provide	B-X
a	B-X
rational	B-X
basis	B-X
for	B-X
the	B-X
development	B-X
of	B-X
effective	B-X
anti-TB	B-X
therapeutics	B-X
.	B-X

Many	O
of	O
the	O
in	O
vivo	O
changes	O
that	O
both	O
the	O
WT	O
and	O
AP	B-Organism
bacteria	O
underwent	O
are	O
suggestive	O
of	O
major	O
metabolic	O
reprogramming	O
associated	O
with	O
the	O
transition	O
from	O
a	O
saprophytic	O
lifestyle	O
in	O
the	O
carbohydrate	O
-	O
rich	O
laboratory	O
culture	O
medium	O
to	O
a	O
parasitic	O
lifestyle	O
in	O
the	O
vascularized	O
and	O
the	O
anaerobic	O
subcutaneous	O
environments	O
rich	O
in	O
peptides	O
,	O
amino	O
acids	O
,	O
nucleotides	O
,	O
and	O
different	O
types	O
of	O
complex	O
carbohydrates	O
.	O

For	O
example	O
,	O
among	O
the	O
downregulated	O
gene	O
sets	O
are	O
those	O
involved	O
in	O
citrate	O
metabolism	O
,	O
arginine	O
degradation	O
,	O
and	O
de	O
novo	O
pyrimidine	O
synthesis	O
;	O
many	O
of	O
those	O
gene	O
sets	O
were	O
previously	O
reported	O
to	O
be	O
perturbed	O
upon	O
blood	O
inoculation	O
and	O
to	O
be	O
controlled	O
by	O
CovR	O
[	O
61	O
]	O
and	O
RopB	O
/	O
Rgg	O
[	O
38	O
]	O
.	O

We	O
also	O
found	O
that	O
many	O
ribosomal	O
and	O
cell	O
-	O
division	O
proteins	O
were	O
downregulated	O
in	O
vivo	O
,	O
which	O
suggests	O
that	O
the	O
cells	O
may	O
be	O
slowing	O
down	O
protein	O
synthesis	O
to	O
preserve	O
energy	O
,	O
or	O
redirect	O
this	O
energy	O
to	O
colonizing	O
the	O
host	O
and	O
evading	O
its	O
immune	O
system	O
.	O

The	O
downregulation	O
of	O
arginine	O
deiminase	O
,	O
a	O
streptococcal	O
immunogen	O
and	O
a	O
potential	O
vaccine	O
target	O
(	O
Henningham	O
et	O
al	O
.	O
,	O
submitted	O
)	O
,	O
is	O
also	O
suggestive	O
of	O
immune	O
evasion	O
.	O

Among	O
the	O
upregulated	O
genes	O
are	O
dipepetide	O
and	O
sucrose	O
-	O
specific	O
transporters	O
,	O
whose	O
upregulation	O
supports	O
the	O
hypothesis	O
that	O
the	O
bacteria	O
are	O
switching	O
diets	O
[	O
39	O
]	O
and	O
attempting	O
to	O
scavenge	O
nutrients	O
available	O
in	O
their	O
new	O
host	O
environment	O
.	O

Several	O
phage	O
genes	O
are	O
split	O
between	O
the	O
upregulated	O
and	O
downregulated	O
gene	O
clusters	O
;	O
this	O
may	O
indicate	O
a	O
stress	O
-	O
dependent	O
reprogramming	O
of	O
prophage	O
induction	O
and	O
gene	O
expression	O
that	O
needs	O
to	O
be	O
explored	O
in	O
future	O
studies	O
.	O

Interestingly	O
,	O
what	O
this	O
study	O
revealed	O
is	O
that	O
some	O
of	O
the	O
downstream	O
regulatory	O
effects	O
of	O
the	O
covS	O
mutation	O
in	O
AP	B-Organism
bacteria	O
are	O
only	O
manifested	O
in	O
vivo	O
.	O

For	O
example	O
,	O
several	O
gene	O
sets	O
(	O
e	O
.	O
g	O
.	O
,	O
SLS	O
genes	O
,	O
Trx	O
-	O
locus	O
genes	O
,	O
L	O
-	O
ascorbate	O
utilization	O
genes	O
)	O
were	O
upregulated	O
in	O
WT	O
bacteria	O
in	O
vivo	O
,	O
but	O
were	O
mostly	O
silenced	O
in	O
AP	B-Organism
bacteria	O
in	O
vivo	O
(	O
Fig	O
.	O
2	O
,	O
CC6	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
genes	O
encoding	O
the	O
fibrinolytic	O
enzyme	O
streptokinase	O
,	O
Ska	O
,	O
a	O
RofA	O
-	O
like	O
transcriptional	O
regulator	O
,	O
several	O
cell	O
division	O
proteins	O
,	O
and	O
some	O
phage	O
proteins	O
were	O
only	O
upregulated	O
when	O
the	O
AP	B-Organism
bacteria	O
sensed	O
the	O
in	O
vivo	O
environment	O
(	O
AP	B-Organism
-	O
vivo	O
,	O
Fig	O
.	O
2	O
,	O
CC10	O
)	O
.	O

Both	O
these	O
expression	O
patterns	O
suggest	O
CovS	O
-	O
dependent	O
in	O
vivo	O
signaling	O
via	O
different	O
downstream	O
pathways	O
.	O

Finally	O
,	O
genes	O
encoding	O
the	O
antiphagocytic	O
M	O
protein	O
,	O
and	O
the	O
toxins	O
streptolysin	O
O	O
and	O
NADGH	O
were	O
among	O
few	O
genes	O
that	O
were	O
upregulated	O
in	O
all	O
conditions	O
except	O
WT	O
-	O
vitro	O
(	O
Fig	O
.	O
2	O
,	O
CC7	O
)	O
,	O
which	O
suggests	O
that	O
their	O
transcription	O
is	O
dependent	O
on	O
multiple	O
signals	O
,	O
including	O
signals	O
from	O
the	O
host	O
as	O
well	O
as	O
covS	O
-	O
dependent	O
cues	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
how	O
the	O
murine	B-Organism
model	O
has	O
allowed	O
us	O
to	O
finely	O
dissect	O
two	O
classes	O
of	O
events	O
affecting	O
GAS	B-Organism
sociomicrobiology	O
:	O
those	O
related	O
to	O
reversible	O
transcriptional	O
adaptation	O
and	O
those	O
irreversibly	O
caused	O
by	O
the	O
covS	O
mutation	O
in	O
AP	B-Organism
bacteria	O
.	O

Microarray	O
validation	O
and	O
analysis	O
<EOS>	B-X
The	B-X
expression	B-X
of	B-X
BCL11A	B-X
,	B-X
PRP4B	B-X
,	B-X
TCP1	B-X
,	B-X
and	B-X
TPI1	B-X
genes	B-X
was	B-X
significantly	B-X
(	B-X
P	B-X
≤	B-X
0.05	B-X
)	B-X
DR	B-X
in	B-X
parthenotes	B-X
in	B-X
the	B-X
micro-array	B-X
study	B-X
,	B-X
while	B-X
the	B-X
TCP1	B-X
gene	B-X
was	B-X
up-regulated	B-X
,	B-X
and	B-X
there	B-X
was	B-X
no	B-X
variation	B-X
in	B-X
TPI1	B-X
gene	B-X
expression	B-X
in	B-X
the	B-X
PCR	B-X
validation	B-X
study	B-X
.	B-X
Concomitant	B-X
with	B-X
the	B-X
rise	B-X
in	B-X
technology	B-X
,	B-X
the	B-X
possibility	B-X
of	B-X
screening	B-X
for	B-X
other	B-X
genetic	B-X
conditions	B-X
by	B-X
analysis	B-X
of	B-X
cfDNA	B-X
,	B-X
such	B-X
as	B-X
sex	B-X
chromosome	B-X
anomalies	B-X
(	B-X
SCAs	B-X
)	B-X
,	B-X
rare	B-X
autosomal	B-X
anomalies	B-X
(	B-X
RATs	B-X
)	B-X
and	B-X
microdeletions	B-X
and	B-X
duplications	B-X
,	B-X
is	B-X
offered	B-X
by	B-X
different	B-X
providers	B-X
to	B-X
an	B-X
often	B-X
not	B-X
preselected	B-X
population	B-X
of	B-X
pregnant	B-X
women	B-X
.	B-X
Microarrays	B-X
and	B-X
related	B-X
technologies	B-X
have	B-X
allowed	B-X
investigators	B-X
to	B-X
ask	B-X
biological	B-X
questions	B-X
in	B-X
far	B-X
greater	B-X
detail	B-X
than	B-X
has	B-X
previously	B-X
been	B-X
possible	B-X
.	B-X
Microarrays	B-X
had	B-X
a	B-X
troubled	B-X
beginning	B-X
,	B-X
but	B-X
most	B-X
of	B-X
these	B-X
problems	B-X
resulted	B-X
from	B-X
the	B-X
growing	B-X
pains	B-X
of	B-X
this	B-X
technology	B-X
,	B-X
which	B-X
,	B-X
like	B-X
many	B-X
new	B-X
things	B-X
,	B-X
was	B-X
initially	B-X
more	B-X
promise	B-X
than	B-X
delivery	B-X
.	B-X
These	B-X
steps	B-X
include	B-X
a	B-X
clearly	B-X
stated	B-X
biological	B-X
question	B-X
,	B-X
experimental	B-X
design	B-X
,	B-X
careful	B-X
experimental	B-X
conduct	B-X
,	B-X
complete	B-X
statistical	B-X
analysis	B-X
,	B-X
validation/verification	B-X
of	B-X
results	B-X
,	B-X
and	B-X
dissemination	B-X
of	B-X
the	B-X
data	B-X
.	B-X

Although	O
our	O
microarray	O
studies	O
were	O
extensive	O
(	O
28	O
arrays	O
for	O
4	O
conditions	O
)	O
,	O
we	O
ran	O
qPCR	O
to	O
validate	O
the	O
microarray	O
findings	O
,	O
focusing	O
on	O
virulence	O
genes	O
that	O
are	O
biomarkers	O
of	O
the	O
bacterial	O
switch	O
to	O
a	O
hypervirulent	O
phenotype	O
.	O

These	O
include	O
SpeA	O
,	O
SpeB	O
,	O
Sda1	O
,	O
M	O
protein	O
,	O
and	O
SIC	O
[	O
data	O
published	O
in	O
14	O
]	O
.	O

Comparing	O
the	O
microarray	O
data	O
in	O
this	O
study	O
with	O
previously	O
published	O
work	O
provides	O
further	O
validation	O
of	O
these	O
results	O
.	O
<EOS>	B-X
Analysis	B-X
of	B-X
gene	B-X
expression	B-X
data	B-X
using	B-X
genome-wide	B-X
microarrays	B-X
is	B-X
a	B-X
technique	B-X
often	B-X
used	B-X
in	B-X
genomic	B-X
studies	B-X
to	B-X
find	B-X
coexpression	B-X
patterns	B-X
and	B-X
locate	B-X
groups	B-X
of	B-X
co-transcribed	B-X
genes	B-X
.	B-X
However	B-X
,	B-X
most	B-X
studies	B-X
done	B-X
at	B-X
global	B-X
``	B-X
omic	B-X
''	B-X
scale	B-X
are	B-X
not	B-X
focused	B-X
on	B-X
human	B-X
samples	B-X
and	B-X
when	B-X
they	B-X
correspond	B-X
to	B-X
human	B-X
very	B-X
often	B-X
include	B-X
heterogeneous	B-X
datasets	B-X
,	B-X
mixing	B-X
normal	B-X
with	B-X
disease-altered	B-X
samples	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
technical	B-X
noise	B-X
present	B-X
in	B-X
genome-wide	B-X
expression	B-X
microarrays	B-X
is	B-X
another	B-X
well	B-X
reported	B-X
problem	B-X
that	B-X
many	B-X
times	B-X
is	B-X
not	B-X
addressed	B-X
with	B-X
robust	B-X
statistical	B-X
methods	B-X
,	B-X
and	B-X
the	B-X
estimation	B-X
of	B-X
errors	B-X
in	B-X
the	B-X
data	B-X
is	B-X
not	B-X
provided	B-X
.	B-X

For	O
example	O
,	O
the	O
in	O
vitro	O
microarray	O
results	O
are	O
consistent	O
with	O
our	O
previous	O
proteomic	O
studies	O
of	O
the	O
WT	O
and	O
AP	B-Organism
secreted	O
bacterial	O
proteomes	O
[	O
12	O
]	O
as	O
well	O
as	O
with	O
other	O
recently	O
published	O
studies	O
of	O
the	O
in	O
vitro	O
transcriptome	O
of	O
closely	O
related	O
strains	O
[	O
13	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

Importantly	O
,	O
we	O
did	O
not	O
base	O
our	O
analysis	O
on	O
single	O
measurements	O
of	O
gene	O
expression	O
,	O
nor	O
did	O
we	O
focus	O
on	O
individual	O
genes	O
;	O
rather	O
,	O
we	O
used	O
gene	O
expression	O
data	O
from	O
biological	O
replicates	O
to	O
rule	O
out	O
biological	O
variability	O
(	O
especially	O
between	O
bacteria	O
recovered	O
from	O
different	O
mice	B-Organism
)	O
and	O
to	O
look	O
for	O
changes	O
in	O
gene	O
clusters	O
,	O
operons	O
,	O
and	O
pathways	O
.	O
<EOS>	B-X
Syringomyelia	B-X
is	B-X
listed	B-X
as	B-X
a	B-X
degenerative	B-X
disorder	B-X
with	B-X
no	B-X
satisfactory	B-X
treatment	B-X
.	B-X
The	B-X
authors	B-X
will	B-X
discuss	B-X
the	B-X
evolution	B-X
in	B-X
understanding	B-X
of	B-X
the	B-X
Chiari	B-X
malformation	B-X
and	B-X
,	B-X
importantly	B-X
,	B-X
distinguish	B-X
between	B-X
symptomatic	B-X
CIM	B-X
and	B-X
asymptomatic	B-X
tonsillar	B-X
ectopia	B-X
,	B-X
based	B-X
on	B-X
imaging	B-X
and	B-X
presenting	B-X
symptomatology	B-X
.	B-X
Proper	B-X
patient	B-X
selection	B-X
for	B-X
surgery	B-X
based	B-X
on	B-X
appropriate	B-X
symptomatology	B-X
is	B-X
tantamount	B-X
to	B-X
achieving	B-X
good	B-X
surgical	B-X
outcomes	B-X
in	B-X
this	B-X
population	B-X
,	B-X
separating	B-X
those	B-X
who	B-X
can	B-X
be	B-X
helped	B-X
by	B-X
surgery	B-X
from	B-X
those	B-X
who	B-X
are	B-X
unlikely	B-X
to	B-X
improve	B-X
.	B-X
Importantly	B-X
,	B-X
CSCs	B-X
can	B-X
survive	B-X
current	B-X
standard	B-X
therapies	B-X
,	B-X
resulting	B-X
in	B-X
metastatic	B-X
disease	B-X
and	B-X
tumor	B-X
recurrence	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
the	B-X
alterations	B-X
of	B-X
iron	B-X
homeostasis	B-X
occurring	B-X
in	B-X
CSCs	B-X
,	B-X
which	B-X
in	B-X
general	B-X
are	B-X
characterized	B-X
by	B-X
high	B-X
intracellular	B-X
iron	B-X
content	B-X
.	B-X
Importantly	B-X
,	B-X
abnormalities	B-X
of	B-X
iron	B-X
metabolism	B-X
correlate	B-X
with	B-X
faster	B-X
tumor	B-X
growth	B-X
and	B-X
adverse	B-X
prognosis	B-X
in	B-X
cancer	B-X
patients	B-X
.	B-X
In	B-X
line	B-X
with	B-X
the	B-X
dependence	B-X
of	B-X
cancer	B-X
on	B-X
iron	B-X
,	B-X
we	B-X
also	B-X
discuss	B-X
iron-dependent	B-X
mechanisms	B-X
as	B-X
druggable	B-X
pathways	B-X
,	B-X
as	B-X
iron	B-X
chelators	B-X
have	B-X
been	B-X
considered	B-X
for	B-X
tumor	B-X
therapy	B-X
and	B-X
new	B-X
molecules	B-X
currently	B-X
proposed	B-X
and	B-X
studied	B-X
as	B-X
antineoplastic	B-X
drugs	B-X
may	B-X
impinge	B-X
on	B-X
iron	B-X
and	B-X
its	B-X
capacity	B-X
to	B-X
promote	B-X
oxidative	B-X
stress	B-X
to	B-X
have	B-X
therapeutic	B-X
value	B-X
in	B-X
cancer	B-X
.	B-X

In	O
doing	O
so	O
,	O
we	O
were	O
able	O
to	O
assess	O
trends	O
across	O
experiments	O
rather	O
than	O
absolute	O
numerical	O
values	O
that	O
could	O
vary	O
due	O
to	O
technical	O
rather	O
than	O
biological	O
factors	O
.	O

We	O
believe	O
that	O
this	O
approach	O
provided	O
more	O
confidence	O
in	O
the	O
final	O
assessment	O
of	O
which	O
genes	O
/	O
pathways	O
were	O
expressed	O
similarly	O
or	O
differentially	O
in	O
both	O
WT	O
and	O
AP	B-Organism
bacteria	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

It	O
also	O
allowed	O
us	O
to	O
dissect	O
changes	O
related	O
to	O
niche	O
adaptation	O
from	O
those	O
reflecting	O
the	O
selection	O
of	O
the	O
fittest	O
members	O
of	O
the	O
bacterial	O
community	O
when	O
faced	O
with	O
different	O
environments	O
and	O
conditions	O
.	O

The	O
use	O
of	O
multiple	O
microarray	O
analysis	O
strategies	O
and	O
the	O
integration	O
of	O
their	O
results	O
strengthened	O
this	O
study	O
since	O
each	O
strategy	O
has	O
advantages	O
and	O
disadvantages	O
.	O

For	O
example	O
,	O
coexpression	O
clustering	O
-	O
one	O
of	O
the	O
earliest	O
developed	O
microarray	O
analysis	O
tools	O
[	O
62	O
]	O
,	O
[	O
63	O
]	O
-	O
provides	O
an	O
overall	O
view	O
of	O
expression	O
patterns	O
of	O
different	O
genes	O
,	O
and	O
greatly	O
helps	O
dissect	O
and	O
demonstrate	O
the	O
effect	O
of	O
each	O
condition	O
on	O
the	O
overall	O
transcriptome	O
.	O

However	O
,	O
coexpression	O
analysis	O
alone	O
can	O
miss	O
some	O
biologically	O
relevant	O
genes	O
that	O
could	O
fail	O
the	O
statistical	O
tests	O
for	O
non	O
-	O
biological	O
reasons	O
(	O
e	O
.	O
g	O
.	O
,	O
poorly	O
hybridizing	O
probes	O
,	O
low	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
,	O
or	O
high	O
variance	O
)	O
and	O
may	O
instead	O
include	O
some	O
irrelevant	O
genes	O
in	O
isolation	O
of	O
their	O
biological	O
networks	O
[	O
41	O
]	O
.	O

In	O
bacteria	O
,	O
biochemical	O
pathways	O
,	O
virulence	O
systems	O
,	O
and	O
multimeric	O
proteins	O
are	O
often	O
encoded	O
next	O
to	O
each	O
other	O
by	O
chromosomally	O
contiguous	O
or	O
clustered	O
genes	O
[	O
64	O
]	O
,	O
[	O
65	O
]	O
.	O
<EOS>	B-X
Fusion	B-X
genes	B-X
are	B-X
potent	B-X
driver	B-X
mutations	B-X
in	B-X
cancer	B-X
.	B-X
Using	B-X
RNA	B-X
sequencing	B-X
,	B-X
we	B-X
find	B-X
in-frame	B-X
fusion	B-X
genes	B-X
in	B-X
127	B-X
(	B-X
65	B-X
%	B-X
)	B-X
cases	B-X
,	B-X
including	B-X
27	B-X
novel	B-X
fusions	B-X
.	B-X
Thus	B-X
,	B-X
this	B-X
study	B-X
provides	B-X
a	B-X
detailed	B-X
overview	B-X
of	B-X
fusion	B-X
genes	B-X
in	B-X
paediatric	B-X
BCP	B-X
ALL	B-X
and	B-X
adds	B-X
new	B-X
pathogenetic	B-X
insights	B-X
,	B-X
which	B-X
may	B-X
improve	B-X
risk	B-X
stratification	B-X
and	B-X
provide	B-X
therapeutic	B-X
options	B-X
for	B-X
this	B-X
disease	B-X
.	B-X
MicroRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
their	B-X
target	B-X
genes	B-X
post-transcriptionally	B-X
;	B-X
thus	B-X
,	B-X
they	B-X
are	B-X
deeply	B-X
involved	B-X
in	B-X
fundamental	B-X
biological	B-X
processes	B-X
.	B-X
miRNA	B-X
clusters	B-X
contain	B-X
two	B-X
or	B-X
more	B-X
miRNA-encoding	B-X
genes	B-X
,	B-X
and	B-X
these	B-X
miRNAs	B-X
are	B-X
usually	B-X
coexpressed	B-X
due	B-X
to	B-X
common	B-X
expression	B-X
mechanisms	B-X
.	B-X
Therefore	B-X
,	B-X
miRNA	B-X
clusters	B-X
are	B-X
effective	B-X
modulators	B-X
of	B-X
biological	B-X
pathways	B-X
by	B-X
the	B-X
members	B-X
coordinately	B-X
regulating	B-X
their	B-X
multiple	B-X
target	B-X
genes	B-X
,	B-X
and	B-X
an	B-X
miRNA	B-X
cluster	B-X
located	B-X
on	B-X
the	B-X
X	B-X
chromosome	B-X
q27.3	B-X
region	B-X
has	B-X
received	B-X
much	B-X
attention	B-X
in	B-X
cancer	B-X
research	B-X
recently	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
discuss	B-X
the	B-X
novel	B-X
findings	B-X
of	B-X
the	B-X
chrXq27.3	B-X
miRNA	B-X
cluster	B-X
in	B-X
various	B-X
types	B-X
of	B-X
cancer.The	B-X
chrXq27.3	B-X
miRNA	B-X
cluster	B-X
contains	B-X
30	B-X
mature	B-X
miRNAs	B-X
synthesized	B-X
from	B-X
22	B-X
miRNA-encoding	B-X
genes	B-X
in	B-X
an	B-X
~	B-X
1.3-Mb	B-X
region	B-X
.	B-X
The	B-X
miRNA-encoding	B-X
genes	B-X
are	B-X
not	B-X
uniformly	B-X
distributed	B-X
in	B-X
the	B-X
region	B-X
,	B-X
and	B-X
they	B-X
are	B-X
further	B-X
divided	B-X
into	B-X
two	B-X
groups	B-X
(	B-X
the	B-X
miR-506-514	B-X
and	B-X
miR-888-892	B-X
groups	B-X
)	B-X
according	B-X
to	B-X
their	B-X
location	B-X
on	B-X
the	B-X
genome	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
functions	B-X
of	B-X
the	B-X
miR-888-892	B-X
group	B-X
are	B-X
considered	B-X
to	B-X
be	B-X
cell	B-X
type-	B-X
or	B-X
tissue-specific.In	B-X
conclusion	B-X
,	B-X
the	B-X
chrXq27.3	B-X
miRNA	B-X
cluster	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cancer	B-X
progression	B-X
,	B-X
and	B-X
the	B-X
miRNAs	B-X
themselves	B-X
,	B-X
their	B-X
regulatory	B-X
mechanisms	B-X
,	B-X
and	B-X
their	B-X
target	B-X
genes	B-X
might	B-X
be	B-X
promising	B-X
therapeutic	B-X
targets	B-X
.	B-X

Analyzing	O
coexpressed	O
genes	O
in	O
the	O
context	O
of	O
chromosomal	O
clusters	O
is	O
thus	O
most	O
informative	O
.	O

Indeed	O
,	O
neighbor	O
clustering	O
[	O
41	O
]	O
has	O
allowed	O
the	O
enrichment	O
for	O
contiguous	O
gene	O
sets	O
and	O
the	O
prediction	O
of	O
more	O
context	O
-	O
related	O
expression	O
patterns	O
.	O

Genes	O
in	O
neighbor	O
clusters	O
could	O
have	O
been	O
otherwise	O
overlooked	O
either	O
because	O
they	O
were	O
misannotated	O
but	O
their	O
co	O
-	O
occurrence	O
in	O
known	O
clusters	O
revealed	O
their	O
importance	O
,	O
or	O
because	O
they	O
did	O
not	O
pass	O
the	O
statistical	O
tests	O
but	O
,	O
since	O
many	O
bacterial	O
transcripts	O
are	O
polycistronic	O
,	O
the	O
expression	O
of	O
two	O
or	O
more	O
members	O
of	O
a	O
polycistron	O
strongly	O
suggests	O
that	O
the	O
whole	O
operon	O
is	O
expressed	O
.	O

Besides	O
these	O
two	O
clustering	O
methods	O
,	O
expression	O
ratios	O
provided	O
pairwise	O
comparison	O
,	O
thereby	O
allowing	O
the	O
quantification	O
of	O
the	O
impact	O
of	O
each	O
individual	O
change	O
of	O
condition	O
on	O
overall	O
gene	O
expression	O
(	O
Table	O
2	O
)	O
as	O
well	O
as	O
on	O
specific	O
genes	O
of	O
interest	O
(	O
Table	O
3	O
)	O
.	O

However	O
,	O
the	O
use	O
of	O
ratios	O
alone	O
may	O
be	O
misleading	O
,	O
especially	O
when	O
they	O
are	O
calculated	O
between	O
two	O
transcripts	O
with	O
low	O
expression	O
levels	O
,	O
resulting	O
in	O
spurious	O
ratios	O
of	O
low	O
biological	O
significance	O
.	O

Similarly	O
,	O
the	O
common	O
use	O
of	O
statistical	O
constraints	O
with	O
ratio	O
calculation	O
(	O
e	O
.	O
g	O
.	O
,	O
two	O
-	O
fold	O
ratios	O
and	O
P	O
values	O
<	O
0	O
.	O
05	O
)	O
filters	O
out	O
many	O
biologically	O
relevant	O
genes	O
that	O
are	O
true	O
positives	O
.	O

Finally	O
,	O
the	O
use	O
of	O
operons	O
,	O
subsystems	O
,	O
and	O
pathways	O
to	O
describe	O
the	O
array	O
results	O
avoids	O
inappropriately	O
building	O
conclusions	O
on	O
the	O
transcriptional	O
changes	O
of	O
individual	O
genes	O
and	O
thus	O
better	O
reflects	O
biologically	O
relevant	O
perturbations	O
in	O
specific	O
pathways	O
.	O

The	O
bigger	O
picture	O
:	O
niche	O
adaptation	O
and	O
the	O
evolution	O
of	O
hypervirulence	O
in	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism

Having	O
used	O
multiple	O
strategies	O
and	O
integrated	O
the	O
PM	O
data	O
with	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
microarray	O
data	O
,	O
we	O
propose	O
the	O
following	O
hypotheses	O
about	O
streptococcal	O
niche	O
adaptation	O
and	O
switch	O
to	O
hypervirulence	O
:	O
(	O
1	O
)	O
Exposure	O
to	O
the	O
in	O
vivo	O
environment	O
perturbs	O
a	O
substantial	O
number	O
of	O
GAS	B-Organism
genes	O
and	O
regulatory	O
networks	O
.	O

This	O
has	O
been	O
demonstrated	O
by	O
the	O
larger	O
number	O
of	O
genes	O
affected	O
during	O
in	O
vivo	O
adaptation	O
of	O
both	O
M1T1	B-Organism
variants	O
compared	O
to	O
those	O
affected	O
by	O
the	O
covS	O
mutation	O
(	O
Table	O
2	O
)	O
.	O

However	O
,	O
many	O
of	O
the	O
genes	O
modulated	O
in	O
vivo	O
seem	O
to	O
be	O
involved	O
in	O
metabolic	O
reprogramming	O
and	O
stress	O
responses	O
rather	O
than	O
pathoadaptation	O
and	O
virulence	O
.	O

This	O
is	O
why	O
we	O
believe	O
that	O
transcriptional	O
reprogramming	O
by	O
environmental	O
adaptation	O
alone	O
was	O
insufficient	O
to	O
provide	O
WT	O
bacteria	O
with	O
an	O
in	O
vivo	O
survival	O
advantage	O
.	O

In	O
fact	O
,	O
WT	O
bacteria	O
underwent	O
the	O
most	O
dramatic	O
in	O
vivo	O
transcriptional	O
reprogramming	O
(	O
Table	O
2	O
)	O
;	O
yet	O
,	O
they	O
failed	O
to	O
survive	O
since	O
after	O
five	O
to	O
seven	O
days	O
post	O
-	O
infection	O
,	O
they	O
became	O
extinct	O
,	O
and	O
only	O
AP	O
bacteria	O
could	O
be	O
isolated	O
from	O
the	O
mice	B-Organism
chambers	O
[	O
16	O
]	O
.	O

(	O
2	O
)	O
The	O
covS	O
mutation	O
in	O
AP	B-Organism
bacteria	O
seems	O
to	O
be	O
preferentially	O
modulating	O
virulence	O
mechanisms	O
,	O
as	O
about	O
25	O
%	O
of	O
the	O
known	O
genes	O
perturbed	O
by	O
the	O
mutation	O
belong	O
to	O
virulence	O
subsystems	O
(	O
Fig	O
.	O
5	O
)	O
and	O
many	O
of	O
the	O
other	O
perturbed	O
genes	O
are	O
indirectly	O
associated	O
with	O
virulence	O
(	O
e	O
.	O
g	O
.	O
,	O
carbohydrate	O
metabolism	O
[	O
66	O
]	O
and	O
arginine	O
utilization	O
proteins	O
[	O
38	O
]	O
)	O
.	O

In	O
addition	O
,	O
the	O
pathoadaptive	O
clusters	O
(	O
CC4	O
-	O
CC10	O
in	O
Fig	O
.	O
2	O
)	O
are	O
more	O
enriched	O
in	O
virulence	O
-	O
related	O
genes	O
than	O
the	O
clusters	O
involved	O
in	O
in	O
vivo	O
adaption	O
(	O
CC1	O
-	O
CC3	O
in	O
Fig	O
.	O
2	O
)	O
.	O

This	O
finding	O
suggests	O
that	O
AP	B-Organism
bacteria	O
are	O
somehow	O
"	O
pre	O
-	O
adapted	O
"	O
to	O
invasiveness	O
and	O
,	O
consequently	O
,	O
when	O
injected	O
into	O
mice	B-Organism
,	O
they	O
do	O
not	O
undergo	O
much	O
virulence	O
-	O
related	O
changes	O
as	O
they	O
already	O
possess	O
a	O
thicker	O
capsule	O
,	O
lack	O
a	O
functional	O
SpeB	O
,	O
are	O
equipped	O
with	O
surface	O
virulence	O
proteins	O
,	O
and	O
secrete	O
ready	O
-	O
to	O
-	O
use	O
toxins	O
,	O
including	O
the	O
potent	O
DNase	O
,	O
Sda1	O
.	O

However	O
,	O
the	O
degree	O
of	O
AP	B-Organism
invasiveness	O
might	O
vary	O
depending	O
on	O
the	O
route	O
of	O
infection	O
and	O
animal	O
model	O
[	O
15	O
]	O
.	O

It	O
is	O
noteworthy	O
that	O
SpeB	O
expression	O
has	O
a	O
dominant	O
effect	O
,	O
since	O
even	O
if	O
secreted	O
in	O
low	O
amounts	O
by	O
a	O
minor	O
subpopulation	O
,	O
this	O
broad	O
-	O
spectrum	O
protease	O
would	O
still	O
be	O
able	O
to	O
degrade	O
,	O
fully	O
or	O
partially	O
,	O
many	O
GAS	B-Organism
virulence	O
proteins	O
,	O
including	O
Sda1	O
,	O
thereby	O
rendering	O
the	O
bacteria	O
vulnerable	O
to	O
different	O
effector	O
mechanisms	O
of	O
the	O
host	O
'	O
s	O
innate	O
immune	O
system	O
including	O
neutrophil	O
killing	O
[	O
14	O
]	O
,	O
[	O
67	O
]	O
,	O
[	O
68	O
]	O
.	O

Thus	O
,	O
a	O
complete	O
shutdown	O
of	O
proteolytically	O
active	O
SpeB	O
is	O
essential	O
to	O
preserve	O
effective	O
extracellular	O
virulence	O
factors	O
[	O
15	O
]	O
.	O

This	O
dominant	O
SpeB	O
effect	O
may	O
explain	O
why	O
WT	O
bacteria	O
parish	O
in	O
vivo	O
even	O
though	O
they	O
partially	O
downregulate	O
SpeB	O
transcription	O
(	O
Table	O
3	O
)	O
.	O

(	O
3	O
)	O
The	O
GAS	B-Organism
genome	O
has	O
at	O
least	O
13	O
two	O
-	O
component	O
regulatory	O
systems	O
[	O
69	O
]	O
in	O
addition	O
to	O
several	O
stand	O
-	O
alone	O
transcriptional	O
regulators	O
[	O
47	O
]	O
,	O
[	O
70	O
]	O
.	O

However	O
,	O
the	O
CovRS	O
system	O
is	O
a	O
major	O
player	O
,	O
among	O
these	O
regulators	O
,	O
in	O
driving	O
the	O
bacterial	O
adaptation	O
to	O
the	O
host	O
'	O
s	O
environment	O
and	O
regulating	O
virulence	O
directly	O
or	O
through	O
other	O
downstream	O
regulators	O
[	O
20	O
]	O
,	O
[	O
54	O
]	O
.	O
<EOS>	B-X
Unfortunately	B-X
,	B-X
these	B-X
proteins	B-X
are	B-X
difficult	B-X
to	B-X
directly	B-X
target	B-X
using	B-X
traditional	B-X
pharmacological	B-X
strategies	B-X
,	B-X
in	B-X
part	B-X
due	B-X
to	B-X
their	B-X
lack	B-X
of	B-X
obvious	B-X
binding	B-X
pockets	B-X
or	B-X
allosteric	B-X
sites	B-X
.	B-X
This	B-X
obstacle	B-X
has	B-X
driven	B-X
a	B-X
considerable	B-X
amount	B-X
of	B-X
research	B-X
into	B-X
pursuing	B-X
alternative	B-X
ways	B-X
to	B-X
effectively	B-X
inhibit	B-X
Ras	B-X
,	B-X
examples	B-X
of	B-X
which	B-X
include	B-X
inducing	B-X
mislocalization	B-X
to	B-X
prevent	B-X
Ras	B-X
maturation	B-X
and	B-X
inactivating	B-X
downstream	B-X
proteins	B-X
in	B-X
Ras-driven	B-X
signaling	B-X
pathways	B-X
.	B-X
Here	B-X
we	B-X
review	B-X
the	B-X
role	B-X
activated	B-X
Rap1	B-X
in	B-X
ERK	B-X
signaling	B-X
and	B-X
other	B-X
downstream	B-X
pathways	B-X
to	B-X
promote	B-X
invasion	B-X
and	B-X
cell	B-X
migration	B-X
and	B-X
metastasis	B-X
in	B-X
various	B-X
cancer	B-X
types	B-X
.	B-X
The	B-X
majority	B-X
of	B-X
prior	B-X
research	B-X
has	B-X
applied	B-X
that	B-X
some	B-X
cations	B-X
such	B-X
as	B-X
magnesium	B-X
(	B-X
Mg	B-X

It	O
is	O
thus	O
counterintuitive	O
that	O
bacteria	O
lacking	O
the	O
important	O
environmental	O
sensor	O
,	O
CovS	O
,	O
would	O
prevail	O
in	O
one	O
of	O
the	O
most	O
stressful	O
environments	O
.	O

However	O
,	O
losing	O
this	O
sensor	O
might	O
be	O
the	O
last	O
resort	O
for	O
these	O
bacteria	O
stranded	O
away	O
from	O
their	O
primary	O
niche	O
and	O
surrounded	O
by	O
hostile	O
immune	O
cells	O
and	O
proteins	O
.	O

From	O
an	O
evolutionary	O
point	O
of	O
view	O
,	O
it	O
is	O
possible	O
to	O
speculate	O
that	O
the	O
bacteria	O
lose	O
their	O
danger	O
sensor	O
to	O
keep	O
their	O
"	O
weapons	O
"	O
constitutively	O
expressed	O
and	O
fight	O
to	O
survive	O
when	O
escape	O
is	O
not	O
an	O
option	O
.	O

Such	O
mutation	O
is	O
likely	O
detrimental	O
to	O
the	O
bacterial	O
long	O
-	O
term	O
survival	O
and	O
dissemination	O
via	O
colonization	O
of	O
new	O
hosts	O
[	O
71	O
]	O
,	O
as	O
they	O
need	O
a	O
WT	O
sensor	O
for	O
better	O
adaptability	O
[	O
72	O
]	O
(	O
e	O
.	O
g	O
.	O
,	O
in	O
less	O
hostile	O
niches	O
like	O
throat	O
or	O
saliva	O
[	O
26	O
]	O
)	O
.	O

An	O
intact	O
CovRS	O
system	O
would	O
offer	O
the	O
bacteria	O
enough	O
versatility	O
to	O
turn	O
on	O
and	O
off	O
many	O
regulatory	O
networks	O
through	O
CovS	O
signaling	O
.	O

This	O
flexible	O
mechanism	O
allows	O
the	O
bacteria	O
to	O
initially	O
hide	O
from	O
the	O
immune	O
system	O
through	O
SpeB	O
-	O
driven	O
camouflaging	O
,	O
i	O
.	O
e	O
.	O
degradation	O
of	O
most	O
of	O
their	O
immunogenic	O
virulence	O
factors	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

(	O
4	O
)	O
We	O
also	O
show	O
that	O
the	O
impact	O
of	O
the	O
covS	O
mutation	O
goes	O
beyond	O
the	O
defined	O
CovR	O
regulon	O
.	O

This	O
finding	O
is	O
in	O
accordance	O
with	O
previous	O
observations	O
that	O
CovR	O
and	O
CovS	O
are	O
not	O
committed	O
to	O
each	O
other	O
,	O
as	O
CovR	O
could	O
be	O
phosphorylated	O
in	O
the	O
absence	O
of	O
a	O
functional	O
CovS	O
[	O
22	O
]	O
and	O
as	O
different	O
covS	O
mutations	O
,	O
albeit	O
clustered	O
in	O
the	O
histidine	O
kinase	O
domain	O
,	O
might	O
have	O
different	O
transcriptional	O
effects	O
[	O
27	O
]	O
,	O
including	O
opposite	O
effects	O
on	O
different	O
members	O
of	O
the	O
CovR	O
regulon	O
[	O
26	O
]	O
.	O

Concluding	O
remarks	O
<EOS>	B-X
Concluding	B-X
Remarks	B-X
.	B-X
Concluding	B-X
remarks	B-X
.	B-X
Concluding	B-X
remarks	B-X
.	B-X
Concluding	B-X
remarks	B-X
.	B-X

In	O
conclusion	O
,	O
we	O
have	O
established	O
a	O
model	O
that	O
allowed	O
us	O
to	O
resolve	O
two	O
sets	O
of	O
complex	O
transcriptional	O
events	O
:	O
(	O
i	O
)	O
those	O
occurring	O
in	O
response	O
to	O
the	O
host	O
environment	O
and	O
(	O
ii	O
)	O
those	O
caused	O
by	O
a	O
mutation	O
in	O
covS	O
sensor	O
kinase	O
.	O

We	O
believe	O
that	O
our	O
results	O
offer	O
a	O
proof	O
of	O
principle	O
that	O
in	O
vivo	O
-	O
extracted	O
RNA	O
can	O
provide	O
transcriptional	O
profiles	O
that	O
better	O
reflect	O
the	O
complexity	O
of	O
heterogeneous	O
bacterial	O
communities	O
,	O
and	O
,	O
as	O
shown	O
in	O
this	O
study	O
,	O
can	O
provide	O
a	O
transcriptional	O
snapshot	O
of	O
a	O
bacterial	O
population	O
right	O
before	O
its	O
extinction	O
.	O

The	O
use	O
of	O
in	O
vivo	O
-	O
driven	O
RNA	O
in	O
understanding	O
virulence	O
has	O
been	O
appreciated	O
in	O
streptococcal	O
research	O
[	O
73	O
]	O
,	O
but	O
the	O
technique	O
has	O
not	O
previously	O
been	O
used	O
to	O
explain	O
the	O
switch	O
to	O
hypervirulent	O
,	O
invasive	O
phenotypes	O
or	O
to	O
dissect	O
heterogeneous	O
microbial	O
subpopulations	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
used	B-X
video	B-X
microscopy	B-X
to	B-X
dissect	B-X
with	B-X
unprecedented	B-X
resolution	B-X
the	B-X
chemotactic	B-X
accumulation	B-X
of	B-X
marine	B-X
bacteria	B-X
around	B-X
individual	B-X
Chaetoceros	B-X
affinis	B-X
diatoms	B-X
undergoing	B-X
lysis	B-X
.	B-X
The	B-X
observed	B-X
spatiotemporal	B-X
distribution	B-X
of	B-X
bacteria	B-X
was	B-X
used	B-X
in	B-X
a	B-X
resource	B-X
utilization	B-X
model	B-X
to	B-X
map	B-X
the	B-X
conditions	B-X
under	B-X
which	B-X
competition	B-X
between	B-X
different	B-X
bacterial	B-X
groups	B-X
favors	B-X
chemotaxis	B-X
.	B-X
By	B-X
informing	B-X
a	B-X
DOM	B-X
utilization	B-X
model	B-X
with	B-X
highly	B-X
resolved	B-X
behavioral	B-X
data	B-X
,	B-X
the	B-X
hybrid	B-X
approach	B-X
used	B-X
here	B-X
represents	B-X
a	B-X
new	B-X
path	B-X
toward	B-X
the	B-X
elusive	B-X
goal	B-X
of	B-X
predicting	B-X
the	B-X
consequences	B-X
of	B-X
microscale	B-X
interactions	B-X
in	B-X
the	B-X
ocean	B-X
.	B-X
We	B-X
have	B-X
used	B-X
the	B-X
Mycobacterium	B-X
marinum	B-X
infection	B-X
model	B-X
in	B-X
the	B-X
adult	B-X
zebrafish	B-X
and	B-X
taken	B-X
advantage	B-X
of	B-X
heterogeneity	B-X
of	B-X
zebrafish	B-X
population	B-X
to	B-X
dissect	B-X
the	B-X
characteristics	B-X
of	B-X
adaptive	B-X
immune	B-X
responses	B-X
,	B-X
some	B-X
of	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
well-controlled	B-X
latency	B-X
or	B-X
bacterial	B-X
clearance	B-X
while	B-X
others	B-X
with	B-X
progressive	B-X
infection	B-X
.	B-X
Differences	B-X
in	B-X
T	B-X
cell	B-X
responses	B-X
between	B-X
subpopulations	B-X
were	B-X
measured	B-X
at	B-X
the	B-X
transcriptional	B-X
level	B-X
.	B-X

This	O
study	O
is	O
a	O
first	O
step	O
towards	O
exploring	O
the	O
sociomicrobiology	O
of	O
invasive	O
GAS	B-Organism
in	O
vivo	O
.	O

Having	O
captured	O
snapshots	O
of	O
different	O
transcriptional	O
programs	O
within	O
the	O
same	O
bacterial	O
community	O
,	O
we	O
plan	O
to	O
follow	O
with	O
single	O
cell	O
studies	O
[	O
74	O
]	O
,	O
[	O
75	O
]	O
of	O
bacteria	O
associated	O
with	O
immune	O
cells	O
to	O
further	O
dissect	O
the	O
different	O
roles	O
played	O
by	O
members	O
of	O
the	O
same	O
bacterial	O
community	O
.	O

Inactivation	O
of	O
DNA	O
-	O
Binding	O
Response	O
Regulator	O
Sak189	O
Abrogates	O
beta	O
-	O
Antigen	O
Expression	O
and	O
Affects	O
Virulence	O
of	O
Streptococcus	B-Organism
agalactiae	I-Organism
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

Background	O
Streptococcus	B-Organism
agalactiae	I-Organism
is	O
able	O
to	O
colonize	O
numerous	O
tissues	O
employing	O
different	O
mechanisms	O
of	O
gene	O
regulation	O
,	O
particularly	O
via	O
two	O
-	O
component	O
regulatory	O
systems	O
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
These	B-X
systems	B-X
sense	B-X
the	B-X
environmental	B-X
stimuli	B-X
and	B-X
regulate	B-X
expression	B-X
of	B-X
the	B-X
genes	B-X
including	B-X
virulence	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

These	O
systems	O
sense	O
the	O
environmental	O
stimuli	O
and	O
regulate	O
expression	O
of	O
the	O
genes	O
including	O
virulence	O
genes	O
.	O
<EOS>	B-X
Two-component	B-X
signal	B-X
transduction	B-X
systems	B-X
(	B-X
TCSs	B-X
)	B-X
are	B-X
widespread	B-X
types	B-X
of	B-X
protein	B-X
machinery	B-X
,	B-X
typically	B-X
consisting	B-X
of	B-X
a	B-X
histidine	B-X
kinase	B-X
membrane	B-X
sensor	B-X
and	B-X
a	B-X
cytoplasmic	B-X
transcriptional	B-X
regulator	B-X
that	B-X
can	B-X
sense	B-X
and	B-X
respond	B-X
to	B-X
environmental	B-X
signals	B-X
.	B-X
TCSs	B-X
are	B-X
responsible	B-X
for	B-X
modulating	B-X
genes	B-X
involved	B-X
in	B-X
a	B-X
multitude	B-X
of	B-X
bacterial	B-X
functions	B-X
,	B-X
including	B-X
cell	B-X
division	B-X
,	B-X
motility	B-X
,	B-X
differentiation	B-X
,	B-X
biofilm	B-X
formation	B-X
,	B-X
antibiotic	B-X
resistance	B-X
,	B-X
and	B-X
virulence	B-X
.	B-X
Pathogenic	B-X
bacteria	B-X
exploit	B-X
the	B-X
capabilities	B-X
of	B-X
TCSs	B-X
to	B-X
reprogram	B-X
gene	B-X
expression	B-X
according	B-X
to	B-X
the	B-X
different	B-X
niches	B-X
they	B-X
encounter	B-X
during	B-X
host	B-X
infection	B-X
.	B-X
This	B-X
review	B-X
focuses	B-X
on	B-X
the	B-X
role	B-X
of	B-X
TCSs	B-X
in	B-X
regulating	B-X
the	B-X
virulence	B-X
phenotype	B-X
of	B-X

Recently	O
,	O
the	O
novel	O
two	O
-	O
component	O
regulatory	O
system	O
Sak188	O
/	O
Sak189	O
was	O
identified	O
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
These	B-X
systems	B-X
sense	B-X
the	B-X
environmental	B-X
stimuli	B-X
and	B-X
regulate	B-X
expression	B-X
of	B-X
the	B-X
genes	B-X
including	B-X
virulence	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X

In	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
genome	O
,	O
it	O
was	O
adjacent	O
to	O
the	O
bac	O
gene	O
encoding	O
for	O
beta	O
-	O
antigen	O
,	O
an	O
important	O
virulence	O
factor	O
.	O

Methodology	O
/	O
Principal	O
Findings	O
In	O
this	O
study	O
,	O
the	O
sak188	O
and	O
sak189	O
genes	O
were	O
inactivated	O
,	O
and	O
the	O
functional	O
role	O
of	O
Sak188	O
/	O
Sak189	O
two	O
-	O
component	O
system	O
in	O
regulation	O
of	O
the	O
beta	O
-	O
antigen	O
expression	O
was	O
investigated	O
.	O

It	O
was	O
demonstrated	O
that	O
both	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
encoded	O
beta	O
-	O
antigen	O
were	O
controlled	O
by	O
Sak189	O
response	O
regulator	O
,	O
but	O
not	O
Sak188	O
histidine	O
kinase	O
.	O

It	O
was	O
also	O
found	O
that	O
the	O
regulation	O
occurred	O
at	O
transcriptional	O
level	O
.	O
<EOS>	B-X
Transcriptional	B-X
regulation	B-X
in	B-X
metazoans	B-X
occurs	B-X
through	B-X
long-range	B-X
genomic	B-X
contacts	B-X
between	B-X
enhancers	B-X
and	B-X
promoters	B-X
,	B-X
and	B-X
most	B-X
genes	B-X
are	B-X
transcribed	B-X
in	B-X
episodic	B-X
``	B-X
bursts	B-X
''	B-X
of	B-X
RNA	B-X
synthesis	B-X
.	B-X
To	B-X
understand	B-X
the	B-X
relationship	B-X
between	B-X
these	B-X
two	B-X
phenomena	B-X
and	B-X
the	B-X
dynamic	B-X
regulation	B-X
of	B-X
genes	B-X
in	B-X
response	B-X
to	B-X
upstream	B-X
signals	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
use	B-X
of	B-X
live-cell	B-X
RNA	B-X
imaging	B-X
coupled	B-X
with	B-X
Hi-C	B-X
measurements	B-X
and	B-X
dissect	B-X
the	B-X
endogenous	B-X
regulation	B-X
of	B-X
the	B-X
estrogen-responsive	B-X
TFF1	B-X
gene	B-X
.	B-X
The	B-X
heterogeneity	B-X
in	B-X
inactive	B-X
times	B-X
gives	B-X
rise	B-X
to	B-X
the	B-X
widely	B-X
observed	B-X
``	B-X
noise	B-X
''	B-X
in	B-X
human	B-X
gene	B-X
expression	B-X
and	B-X
explains	B-X
the	B-X
distribution	B-X
of	B-X
protein	B-X
levels	B-X
in	B-X
human	B-X
tissue	B-X
.	B-X
We	B-X
derive	B-X
a	B-X
mathematical	B-X
model	B-X
of	B-X
regulation	B-X
that	B-X
relates	B-X
transcription	B-X
,	B-X
chromosome	B-X
structure	B-X
,	B-X
and	B-X
the	B-X
cell	B-X
's	B-X
ability	B-X
to	B-X
sense	B-X
changes	B-X
in	B-X
estrogen	B-X
and	B-X
predicts	B-X
that	B-X
hypervariability	B-X
is	B-X
largely	B-X
dynamic	B-X
and	B-X
does	B-X
not	B-X
reflect	B-X
a	B-X
stable	B-X
biological	B-X
state	B-X
.	B-X

Finally	O
,	O
insertional	O
inactivation	O
of	O
sak189	O
gene	O
,	O
but	O
not	O
sak188	O
gene	O
,	O
significantly	O
affected	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

Conclusions	O
/	O
Significance	O
Sak189	O
response	O
regulator	O
is	O
necessary	O
for	O
activation	O
of	O
bac	O
gene	O
transcription	O
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
These	B-X
systems	B-X
sense	B-X
the	B-X
environmental	B-X
stimuli	B-X
and	B-X
regulate	B-X
expression	B-X
of	B-X
the	B-X
genes	B-X
including	B-X
virulence	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

It	O
also	O
controls	O
the	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
genome	B-X
encodes	B-X
21	B-X
two-component	B-X
systems	B-X
(	B-X
TCS	B-X
)	B-X
and	B-X
a	B-X
variety	B-X
of	B-X
regulatory	B-X
proteins	B-X
in	B-X
order	B-X
to	B-X
control	B-X
gene	B-X
expression	B-X
.	B-X
Inactivation	B-X
of	B-X
bgrR	B-X
abrogated	B-X
bac	B-X
gene	B-X
expression	B-X
and	B-X
increased	B-X
virulence	B-X
properties	B-X
of	B-X
S.	B-X
agalactiae	B-X
.	B-X
The	B-X
complemented	B-X
strain	B-X
A49V/BgrRS	B-X
demonstrated	B-X
attenuated	B-X
virulence	B-X
in	B-X
intraperitoneal	B-X
mice	B-X
model	B-X
of	B-X
S.	B-X
agalactiae	B-X
infection	B-X
compared	B-X
to	B-X
parental	B-X
strain	B-X
A49V	B-X
.	B-X
The	B-X
fact	B-X
that	B-X
BgrRS	B-X
negatively	B-X
controls	B-X
virulent	B-X
properties	B-X
of	B-X
S.	B-X
agalactiae	B-X
gives	B-X
a	B-X
novel	B-X
clue	B-X
for	B-X
understanding	B-X
of	B-X
S.	B-X
agalactiae	B-X
adaptation	B-X
to	B-X
the	B-X
human	B-X
.	B-X

Given	O
that	O
the	O
primary	O
functional	O
role	O
of	O
Sak188	O
/	O
Sak189	O
two	O
-	O
component	O
systems	O
is	O
a	O
control	O
of	O
bac	O
gene	O
transcription	O
,	O
this	O
system	O
can	O
be	O
annotated	O
as	O
BgrR	O
/	O
S	O
(	O
bac	O
gene	O
regulatory	O
system	O
)	O
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
These	B-X
systems	B-X
sense	B-X
the	B-X
environmental	B-X
stimuli	B-X
and	B-X
regulate	B-X
expression	B-X
of	B-X
the	B-X
genes	B-X
including	B-X
virulence	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

Introduction	O

Streptococcus	B-Organism
agalactiae	I-Organism
(	O
group	B-Organism
B	I-Organism
streptococcus	I-Organism
)	O
is	O
an	O
important	O
cause	O
of	O
neonatal	O
invasive	O
infections	O
and	O
variety	O
of	O
diseases	O
in	O
human	B-Organism
and	O
animals	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

This	O
bacterium	O
is	O
able	O
to	O
sense	O
the	O
changing	O
environmental	O
conditions	O
and	O
colonize	O
numerous	O
tissues	O
employing	O
different	O
mechanisms	O
of	O
gene	O
regulation	O
.	O

One	O
mechanism	O
for	O
adaptation	O
to	O
changing	O
environment	O
is	O
transcriptional	O
regulation	O
by	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
TCSs	O
)	O
,	O
a	O
family	O
of	O
systems	O
that	O
are	O
widely	O
distributed	O
among	O
many	O
bacterial	O
genera	O
[	O
3	O
]	O
.	O

These	O
regulatory	O
systems	O
comprise	O
two	O
proteins	O
,	O
sensor	O
histidine	O
kinase	O
,	O
HK	O
,	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
,	O
RR	O
.	O
<EOS>	B-X
In	B-X
bacteria	B-X
,	B-X
adaptive	B-X
responses	B-X
to	B-X
environmental	B-X
stimuli	B-X
are	B-X
often	B-X
initiated	B-X
by	B-X
two-component	B-X
signal	B-X
transduction	B-X
systems	B-X
(	B-X
TCS	B-X
)	B-X
.	B-X
The	B-X
prototypical	B-X
TCS	B-X
comprises	B-X
two	B-X
proteins	B-X
:	B-X
a	B-X
histidine	B-X
kinase	B-X
(	B-X
HK	B-X
,	B-X
hk	B-X
)	B-X
and	B-X
a	B-X
response	B-X
regulator	B-X
(	B-X
RR	B-X
rr	B-X
)	B-X
.	B-X
Recent	B-X
research	B-X
has	B-X
suggested	B-X
that	B-X
compounds	B-X
that	B-X
inhibit	B-X
two-component	B-X
systems	B-X
might	B-X
have	B-X
good	B-X
antibacterial	B-X
activity	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
TCS	B-X
that	B-X
are	B-X
crucial	B-X
for	B-X
growth	B-X
or	B-X
virulence	B-X
of	B-X
Streptococcus	B-X
pneumoniae	B-X
,	B-X
we	B-X
have	B-X
examined	B-X
the	B-X
genomic	B-X
sequence	B-X
of	B-X
a	B-X
virulent	B-X
S.	B-X
pneumoniae	B-X
strain	B-X
for	B-X
genes	B-X
that	B-X
are	B-X
related	B-X
to	B-X
known	B-X
histidine	B-X
kinases	B-X
or	B-X
response	B-X
regulators	B-X
.	B-X
Altogether	B-X
13	B-X
histidine	B-X
kinases	B-X
and	B-X
13	B-X
response	B-X
regulators	B-X
have	B-X
been	B-X
identified	B-X
.	B-X
This	B-X
analysis	B-X
revealed	B-X
that	B-X
two	B-X
of	B-X
the	B-X
13	B-X
pneumococcal	B-X
TCSs	B-X
have	B-X
been	B-X
described	B-X
before	B-X
(	B-X
ciaRH	B-X
and	B-X
comDE	B-X
)	B-X
and	B-X
two	B-X
are	B-X
homologous	B-X
to	B-X
the	B-X
yycFG	B-X
and	B-X
the	B-X
phoRP	B-X
genes	B-X
of	B-X
Bacillus	B-X
subtilis	B-X
.	B-X
All	B-X
the	B-X
pneumococcal	B-X
response	B-X
regulators	B-X
contain	B-X
putative	B-X
DNA	B-X
binding	B-X
motifs	B-X
within	B-X
the	B-X
C-terminal	B-X
output	B-X
domain	B-X
,	B-X
implying	B-X
that	B-X
they	B-X
are	B-X
involved	B-X
in	B-X
transcriptional	B-X
control	B-X
.	B-X
Two	B-X
of	B-X
these	B-X
response	B-X
regulators	B-X
are	B-X
obviously	B-X
the	B-X
first	B-X
representatives	B-X
of	B-X
a	B-X
new	B-X
subfamily	B-X
containing	B-X
an	B-X
AraC-type	B-X
DNA-binding	B-X
effector	B-X
domain	B-X
.	B-X
To	B-X
assess	B-X
the	B-X
regulatory	B-X
role	B-X
of	B-X
these	B-X
transcription	B-X
factors	B-X
,	B-X
we	B-X
disrupted	B-X
each	B-X
of	B-X
the	B-X
13	B-X
response	B-X
regulator	B-X
genes	B-X
by	B-X
insertional	B-X
mutagenesis	B-X
.	B-X
All	B-X
the	B-X
viable	B-X
mutant	B-X
strains	B-X
with	B-X
disrupted	B-X
response	B-X
regulator	B-X
genes	B-X
were	B-X
further	B-X
characterized	B-X
with	B-X
regard	B-X
to	B-X
growth	B-X
in	B-X
vitro	B-X
,	B-X
competence	B-X
,	B-X
and	B-X
experimental	B-X
virulence	B-X
.	B-X
Two	B-X
response	B-X
regulator	B-X
genes	B-X
could	B-X
not	B-X
be	B-X
inactivated	B-X
,	B-X
indicating	B-X
that	B-X
they	B-X
may	B-X
regulate	B-X
essential	B-X
cellular	B-X
functions	B-X
.	B-X
The	B-X
possibility	B-X
of	B-X
using	B-X
these	B-X
systems	B-X
as	B-X
targets	B-X
for	B-X
the	B-X
development	B-X
of	B-X
novel	B-X
antibacterials	B-X
will	B-X
be	B-X
discussed	B-X
.	B-X

HK	O
is	O
a	O
sensor	O
protein	O
,	O
responding	O
to	O
the	O
environmental	O
changes	O
by	O
autophosphorylating	O
a	O
conserved	O
histidine	O
residue	O
.	O

Subsequently	O
,	O
phosphoryl	O
group	O
is	O
transferred	O
to	O
RR	O
protein	O
resulting	O
in	O
conformational	O
changes	O
in	O
RR	O
molecule	O
.	O

Conformationally	O
modified	O
RR	O
molecule	O
functions	O
as	O
transcriptional	O
regulator	O
(	O
activator	O
or	O
repressor	O
)	O
by	O
binding	O
with	O
promoter	O
regions	O
of	O
the	O
genes	O
through	O
helix	O
-	O
turn	O
-	O
helix	O
(	O
HTH	O
)	O
motif	O
.	O

In	O
many	O
cases	O
,	O
two	O
-	O
component	O
systems	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
multiple	O
genes	O
encoding	O
products	O
which	O
are	O
essential	O
for	O
adaptation	O
of	O
bacteria	O
to	O
a	O
particular	O
environment	O
and	O
development	O
of	O
bacterial	O
diseases	O
[	O
3	O
]	O
-	O
[	O
5	O
]	O
.	O

In	O
contrast	O
to	O
other	O
pathogenic	O
gram	O
-	O
positive	O
cocci	O
such	O
as	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
and	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
,	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
has	O
larger	O
number	O
of	O
TCSs	O
.	O

For	O
example	O
,	O
20	O
TCSs	O
have	O
been	O
identified	O
after	O
the	O
complete	O
genome	O
sequencing	O
in	O
the	O
strain	O
NEM316	B-Organism
[	O
6	O
]	O
,	O
and	O
17	O
TCSs	O
-	O
in	O
the	O
strain	B-Organism
2603	I-Organism
V	I-Organism
/	I-Organism
R	I-Organism
[	O
7	O
]	O
.	O

Three	O
of	O
them	O
,	O
CsrRS	O
/	O
CovRS	O
,	O
DltR	O
/	O
DltS	O
,	O
and	O
RgfA	O
/	O
RgfC	O
,	O
have	O
been	O
previously	O
investigated	O
[	O
8	O
]	O
-	O
[	O
12	O
]	O
.	O

S	B-Organism
.	I-Organism
agalactiae	I-Organism
CsrRS	O
/	O
CovRS	O
demonstrated	O
high	O
similarity	O
with	O
CsrRS	O
/	O
CovRS	O
of	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
[	O
8	O
]	O
.	O

Inactivation	O
of	O
covR	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
increased	O
transcription	O
levels	O
of	O
hemolysin	O
cylE	O
gene	O
and	O
C5a	O
peptidase	O
scpB	O
gene	O
,	O
and	O
reduced	O
the	O
level	O
of	O
CAMP	O
factor	O
cfb	O
gene	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

Inactivation	O
of	O
CovRS	O
was	O
also	O
observed	O
at	O
phenotypic	O
level	O
:	O
the	O
mutant	O
strains	O
became	O
less	O
virulent	O
compared	O
to	O
the	O
parental	O
wild	O
-	O
type	O
strain	O
[	O
9	O
]	O
.	O

Transcriptome	O
analysis	O
revealed	O
the	O
CovRS	O
core	O
-	O
regulon	O
which	O
consisted	O
of	O
39	O
genes	O
including	O
genes	O
of	O
the	O
stress	O
response	O
,	O
the	O
genes	O
important	O
for	O
adhesion	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
to	O
the	O
host	O
cells	O
and	O
others	O
[	O
10	O
]	O
.	O

DltR	O
/	O
DltS	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
is	O
important	O
for	O
transcription	O
of	O
dlt	O
operon	O
(	O
dltA	O
,	O
dltB	O
,	O
dltC	O
,	O
and	O
dltD	O
genes	O
)	O
,	O
which	O
is	O
necessary	O
for	O
incorporation	O
of	O
D	O
-	O
alanine	O
residues	O
in	O
lipoteichoic	O
acids	O
.	O

The	O
role	O
of	O
DltR	O
/	O
DltS	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
virulence	O
was	O
shown	O
by	O
the	O
attenuated	O
virulent	O
properties	O
of	O
dltA	O
and	O
dltR	O
mutant	O
strains	O
in	O
vivo	O
[	O
11	O
]	O
.	O

RgfA	O
/	O
RgfC	O
controls	O
adhesion	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
to	O
epithelial	O
cells	O
.	O

In	O
addition	O
,	O
inactivation	O
of	O
histidine	O
kinase	O
gene	O
rgfC	O
resulted	O
in	O
increased	O
transcription	O
of	O
scpB	O
gene	O
[	O
12	O
]	O
.	O

Recently	O
,	O
putative	O
two	O
-	O
component	O
regulatory	O
system	O
genes	O
encoding	O
for	O
sensor	O
histidine	O
kinase	O
(	O
sak188	O
)	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
(	O
sak189	O
)	O
were	O
identified	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strains	I-Organism
98	I-Organism
-	I-Organism
D60C	I-Organism
and	O
A909	B-Organism
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

sak188	O
and	O
sak189	O
genes	O
were	O
located	O
on	O
putative	O
pathogenicity	O
island	O
[	O
13	O
]	O
adjacent	O
to	O
the	O
bac	O
gene	O
encoding	O
for	O
beta	O
-	O
antigen	O
.	O

This	O
surface	O
protein	O
has	O
capacity	O
to	O
bind	O
IgA	O
and	O
factor	O
H	O
of	O
complement	O
,	O
and	O
it	O
is	O
supposed	O
to	O
be	O
an	O
important	O
virulence	O
factor	O
[	O
15	O
]	O
.	O

Sak188	O
and	O
Sak189	O
proteins	O
revealed	O
78	O
%	O
and	O
83	O
%	O
similarity	O
with	O
sensor	O
histidine	O
kinase	O
HK06	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
RR06	O
of	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
strains	O
,	O
respectively	O
[	O
13	O
]	O
,	O
[	O
16	O
]	O
-	O
[	O
19	O
]	O
.	O

In	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
genome	O
,	O
the	O
hk06	O
and	O
rr06	O
genes	O
are	O
adjacent	O
to	O
cbpA	O
gene	O
encoding	O
choline	O
binding	O
protein	O
,	O
CbpA	O
,	O
a	O
surface	O
-	O
exposed	O
protective	O
antigen	O
and	O
virulence	O
factor	O
of	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

Similarly	O
to	O
the	O
beta	O
-	O
antigen	O
,	O
CbpA	O
has	O
capacity	O
to	O
bind	O
factor	O
H	O
of	O
complement	O
.	O

In	O
addition	O
,	O
some	O
regions	O
of	O
CbpA	O
protein	O
has	O
the	O
certain	O
similarity	O
with	O
beta	O
-	O
antigen	O
.	O

Inactivation	O
of	O
RR06	O
in	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
resulted	O
in	O
the	O
loss	O
of	O
CbpA	O
expression	O
[	O
22	O
]	O
-	O
[	O
24	O
]	O
.	O

HK06	O
/	O
RR06	O
was	O
also	O
important	O
for	O
the	O
ability	O
of	O
pneumococci	B-Organism
to	O
adhere	O
to	O
epithelial	O
cells	O
in	O
vitro	O
and	O
to	O
survive	O
and	O
proliferate	O
in	O
an	O
in	O
vivo	O
mouse	B-Organism
model	O
[	O
22	O
]	O
.	O

Given	O
the	O
certain	O
similarity	O
in	O
the	O
sequences	O
,	O
functions	O
and	O
relative	O
locations	O
of	O
Sak188	O
/	O
Sak189	O
and	O
HK06	O
/	O
RR06	O
,	O
and	O
beta	O
-	O
antigen	O
and	O
CbpA	O
,	O
we	O
suggested	O
that	O
Sak188	O
/	O
Sak189	O
TCS	O
affected	O
beta	O
-	O
antigen	O
expression	O
and	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
in	O
the	O
same	O
manner	O
as	O
HK06	O
/	O
RR06	O
affected	O
CbpA	O
in	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
function	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
Sak188	O
/	O
Sak189	O
TCS	O
.	O

Results	O

An	O
occurrence	O
of	O
bac	O
gene	O
,	O
sak188	O
,	O
sak189	O
TCS	O
genes	O
and	O
erythromycin	O
resistance	O
among	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strains	I-Organism
A	O
total	O
of	O
239	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strains	O
isolated	O
from	O
human	B-Organism
and	O
animals	O
were	O
studied	O
.	O

The	O
strains	O
were	O
tested	O
by	O
PCR	O
for	O
the	O
presence	O
of	O
virulence	O
gene	O
bac	O
and	O
sak188	O
and	O
sak189	O
TCS	O
genes	O
,	O
which	O
were	O
previously	O
found	O
to	O
be	O
located	O
on	O
pathogenicity	O
island	O
[	O
13	O
]	O
.	O

As	O
result	O
,	O
53	O
strains	O
isolated	O
from	O
pregnant	O
women	B-Organism
and	O
5	O
strains	O
isolated	O
from	O
the	O
cow	B-Organism
'	O
s	O
milk	O
were	O
found	O
to	O
be	O
bac	O
gene	O
positive	O
.	O

They	O
were	O
selected	O
for	O
further	O
study	O
.	O
<EOS>	B-X
In	B-X
the	B-X
evolution	B-X
of	B-X
cognition	B-X
and	B-X
behavior	B-X
,	B-X
a	B-X
recurrent	B-X
question	B-X
concerns	B-X
the	B-X
degree	B-X
to	B-X
which	B-X
any	B-X
given	B-X
aspect	B-X
of	B-X
the	B-X
phenotype	B-X
has	B-X
been	B-X
``	B-X
selected	B-X
for	B-X
''	B-X
or	B-X
``	B-X
specified	B-X
,	B-X
''	B-X
as	B-X
opposed	B-X
to	B-X
arising	B-X
as	B-X
a	B-X
byproduct	B-X
of	B-X
some	B-X
other	B-X
process	B-X
.	B-X
Here	B-X
I	B-X
explore	B-X
the	B-X
idea	B-X
of	B-X
selected	B-X
emergence	B-X
,	B-X
in	B-X
which	B-X
phenotypic	B-X
outcomes	B-X
do	B-X
emerge	B-X
from	B-X
a	B-X
confluence	B-X
of	B-X
factors	B-X
,	B-X
some	B-X
haphazard	B-X
,	B-X
but	B-X
which	B-X
include	B-X
in	B-X
part	B-X
a	B-X
history	B-X
of	B-X
selection	B-X
,	B-X
genetic	B-X
and	B-X
/	B-X
or	B-X
cultural	B-X
,	B-X
to	B-X
produce	B-X
phenotypic	B-X
outcomes	B-X
of	B-X
that	B-X
type	B-X
.	B-X
I	B-X
discuss	B-X
potential	B-X
case	B-X
studies	B-X
of	B-X
selected	B-X
emergence	B-X
,	B-X
explore	B-X
its	B-X
empirical	B-X
implications	B-X
and	B-X
provide	B-X
suggestions	B-X
for	B-X
future	B-X
research	B-X
on	B-X
the	B-X
evolution	B-X
of	B-X
emergent	B-X
outcomes	B-X
.	B-X
From	B-X
an	B-X
adaptation	B-X
perspective	B-X
,	B-X
unoccupied	B-X
patches	B-X
of	B-X
morphological	B-X
space	B-X
are	B-X
inferred	B-X
to	B-X
be	B-X
empty	B-X
because	B-X
they	B-X
are	B-X
of	B-X
low	B-X
fitness	B-X
and	B-X
selected	B-X
against	B-X
.	B-X
In	B-X
response	B-X
,	B-X
biologists	B-X
increasingly	B-X
study	B-X
ontogeny	B-X
to	B-X
test	B-X
the	B-X
assumption	B-X
that	B-X
unobserved	B-X
phenotypes	B-X
could	B-X
be	B-X
produced	B-X
if	B-X
selection	B-X
were	B-X
to	B-X
favor	B-X
them	B-X
;	B-X
finding	B-X
that	B-X
empty	B-X
space	B-X
morphologies	B-X
can	B-X
be	B-X
readily	B-X
produced	B-X
in	B-X
development	B-X
helps	B-X
reject	B-X
constraint	B-X
and	B-X
lends	B-X
support	B-X
to	B-X
adaptive	B-X
hypotheses	B-X
.	B-X

PCR	O
analysis	O
of	O
the	O
bac	O
gene	O
positive	O
strains	O
revealed	O
that	O
the	O
presence	O
of	O
bac	O
gene	O
correlated	O
with	O
the	O
presence	O
of	O
sensor	O
histidine	O
kinase	O
gene	O
sak188	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
gene	O
sak189	O
(	O
data	O
not	O
shown	O
)	O
.	O

Genomic	O
architecture	O
of	O
DNA	O
fragments	O
containing	O
sak188	O
,	O
sak189	O
and	O
bac	O
genes	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
and	O
rr06	O
,	O
hk06	O
and	O
cbpA	O
genes	O
in	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
[	O
22	O
]	O
is	O
presented	O
in	O
the	O
Fig	O
.	O

1	O
.	O
<EOS>	B-X
Formate	B-X
assay	B-X
in	B-X
body	B-X
fluids	B-X
:	B-X
application	B-X
in	B-X
methanol	B-X
poisoning	B-X
.	B-X

For	O
the	O
purpose	O
of	O
insertional	O
inactivation	O
,	O
the	O
vector	O
pVA891	O
-	O
2	O
that	O
provides	O
erythromycin	O
(	O
Em	O
)	O
resistance	O
was	O
used	O
.	O

Thus	O
,	O
the	O
strains	O
were	O
additionally	O
screened	O
for	O
sensitivity	O
to	O
Em	O
.	O

As	O
result	O
,	O
most	O
of	O
human	B-Organism
bac	O
gene	O
positive	O
strains	O
showed	O
resistance	O
or	O
intermediate	O
resistance	O
to	O
Em	O
in	O
the	O
standard	O
diffusion	O
disk	O
test	O
,	O
that	O
is	O
in	O
agreement	O
with	O
previous	O
observations	O
demonstrating	O
an	O
increase	O
in	O
Em	O
resistance	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
population	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
.	O
<EOS>	B-X
This	B-X
study	B-X
determined	B-X
the	B-X
prevalence	B-X
of	B-X
qac	B-X
and	B-X
smr	B-X
genes	B-X
in	B-X
clinical	B-X
Staphylococcus	B-X
aureus	B-X
isolates	B-X
from	B-X
hospital-acquired	B-X
infections	B-X
and	B-X
their	B-X
susceptibility	B-X
to	B-X
quaternary	B-X
ammonium	B-X
compounds	B-X
(	B-X
QACs	B-X
)	B-X
and	B-X
antibiotics	B-X
,	B-X
and	B-X
correlated	B-X
the	B-X
presence	B-X
of	B-X
antiseptic	B-X
resistance	B-X
genes	B-X
with	B-X
antibiotic	B-X
resistance	B-X
.	B-X
This	B-X
study	B-X
was	B-X
carried	B-X
out	B-X
to	B-X
identify	B-X
antibiotic	B-X
resistance	B-X
and	B-X
virulence	B-X
genes	B-X
associated	B-X
with	B-X
GBS	B-X
isolated	B-X
from	B-X
pregnant	B-X
women	B-X
.	B-X
Listeria	B-X
monocytogenes	B-X
is	B-X
the	B-X
etiological	B-X
agent	B-X
of	B-X
listeriosis	B-X
,	B-X
a	B-X
major	B-X
foodborne	B-X
disease	B-X
and	B-X
an	B-X
important	B-X
public	B-X
health	B-X
concern	B-X
.	B-X
Contamination	B-X
of	B-X
meat	B-X
with	B-X
L.	B-X
monocytogenes	B-X
occurs	B-X
frequently	B-X
at	B-X
the	B-X
slaughterhouse	B-X
.	B-X
Our	B-X
aims	B-X
were	B-X
;	B-X
1	B-X
)	B-X
to	B-X
investigate	B-X
the	B-X
distribution	B-X
of	B-X
L.	B-X
monocytogenes	B-X
in	B-X
the	B-X
processing	B-X
areas	B-X
of	B-X
four	B-X
swine	B-X
slaughterhouses	B-X
;	B-X
2	B-X
)	B-X
to	B-X
describe	B-X
the	B-X
diversity	B-X
of	B-X
L.	B-X
monocytogenes	B-X
strains	B-X
by	B-X
pulsed-field	B-X
gel	B-X
electrophoresis	B-X
;	B-X
3	B-X
)	B-X
to	B-X
identify	B-X
persistent	B-X
L.	B-X
monocytogenes	B-X
strains	B-X
and	B-X
describe	B-X
their	B-X
distribution	B-X
;	B-X
4	B-X
)	B-X
to	B-X
investigate	B-X
the	B-X
associations	B-X
between	B-X
persistence	B-X
of	B-X
strains	B-X
and	B-X
their	B-X
following	B-X
characteristics	B-X
:	B-X
detection	B-X
in	B-X
food	B-X
isolates	B-X
,	B-X
detection	B-X
in	B-X
human	B-X
clinical	B-X
isolates	B-X
,	B-X
and	B-X
the	B-X
presence	B-X
of	B-X
benzalkonium	B-X
chloride	B-X
(	B-X
BAC	B-X
)	B-X
resistance	B-X
genes	B-X
.	B-X
A	B-X
total	B-X
of	B-X
2496	B-X
samples	B-X
were	B-X
analyzed	B-X
,	B-X
and	B-X
L.	B-X
monocytogenes	B-X
was	B-X
successfully	B-X
isolated	B-X
from	B-X
243	B-X
samples	B-X
.	B-X
The	B-X
proportion	B-X
of	B-X
positive	B-X
samples	B-X
ranged	B-X
from	B-X
32	B-X
to	B-X
58	B-X
%	B-X
in	B-X
each	B-X
slaughterhouse	B-X
and	B-X
from	B-X
24	B-X
to	B-X
68	B-X
%	B-X
in	B-X
each	B-X
operation	B-X
area	B-X
.	B-X
The	B-X
persistent	B-X
pulsotypes	B-X
were	B-X
significantly	B-X
more	B-X
likely	B-X
to	B-X
be	B-X
detected	B-X
in	B-X
food	B-X
(	B-X
P	B-X
<	B-X
0.01	B-X
,	B-X
exact	B-X
χ²	B-X
)	B-X
and	B-X
human	B-X
clinical	B-X
cases	B-X
(	B-X
P	B-X
<	B-X
0.01	B-X
,	B-X
exact	B-X
χ²	B-X
)	B-X
,	B-X
respectively	B-X
.	B-X
Among	B-X
pulsotypes	B-X
harboring	B-X
the	B-X
BAC	B-X
bcrABC	B-X
resistance	B-X
cassette	B-X
or	B-X
the	B-X
emrE	B-X
multidrug	B-X
transporter	B-X
gene	B-X
,	B-X
42.8	B-X
%	B-X
were	B-X
persistent	B-X
compared	B-X
to	B-X
4.5	B-X
%	B-X
for	B-X
pulsotypes	B-X
without	B-X
these	B-X
resistance	B-X
genes	B-X
(	B-X
P	B-X
<	B-X
0.01	B-X
,	B-X
exact	B-X
χ²	B-X
)	B-X
.	B-X
Our	B-X
study	B-X
highlights	B-X
the	B-X
importance	B-X
of	B-X
persistent	B-X
L.	B-X
monocytogenes	B-X
strains	B-X
in	B-X
the	B-X
environmental	B-X
contamination	B-X
of	B-X
slaughterhouses	B-X
,	B-X
which	B-X
may	B-X
lead	B-X
to	B-X
repeated	B-X
contamination	B-X
of	B-X
meat	B-X
products	B-X
.	B-X
It	B-X
also	B-X
shows	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
disinfectants	B-X
resistance	B-X
genes	B-X
is	B-X
an	B-X
important	B-X
contributing	B-X
factor	B-X
.	B-X

One	O
of	O
the	O
strains	O
,	O
168	B-Organism
/	I-Organism
00	I-Organism
,	O
which	O
demonstrated	O
the	O
large	O
diameter	O
of	O
growth	O
inhibition	O
zone	O
,	O
was	O
selected	O
for	O
further	O
study	O
.	O

In	O
this	O
strain	O
,	O
the	O
bac	O
gene	O
has	O
unique	O
allele	O
with	O
the	O
closest	O
similarity	O
with	O
676a	O
and	O
676b	O
alleles	O
according	O
to	O
classification	O
of	O
Kong	O
et	O
al	O
.	O

[	O
32	O
]	O
.	O

Construction	O
and	O
characterization	O
of	O
mutant	O
strains	O
<EOS>	B-X
A	B-X
capsule-defective	B-X
mutant	B-X
strain	B-X
PBA129	B-X
of	B-X
Pasteurella	B-X
multocida	B-X
was	B-X
constructed	B-X
by	B-X
electroporation	B-X
of	B-X
phagemid	B-X
containing	B-X
the	B-X
coding	B-X
region	B-X
of	B-X
the	B-X
antisense	B-X
RNA	B-X
of	B-X
the	B-X
ompH	B-X
gene	B-X
into	B-X
the	B-X
wild	B-X
type	B-X
strain	B-X
X-73	B-X
(	B-X
serovar	B-X
A:1	B-X
)	B-X
of	B-X
P.	B-X
multocida	B-X
.	B-X
The	B-X
pathogenicity	B-X
and	B-X
protective	B-X
potency	B-X
of	B-X
the	B-X
mutant	B-X
against	B-X
homologous	B-X
and	B-X
heterologous	B-X
challenge	B-X
in	B-X
mice	B-X
and	B-X
chickens	B-X
were	B-X
characterized	B-X
.	B-X
Greyish	B-X
colonies	B-X
of	B-X
the	B-X
mutant	B-X
,	B-X
indicating	B-X
lower	B-X
capsule	B-X
thickness	B-X
,	B-X
on	B-X
selective	B-X
dextrose	B-X
starch	B-X
agar	B-X
were	B-X
observed	B-X
under	B-X
an	B-X
obliquely	B-X
transmitted	B-X
light	B-X
stereomicroscope	B-X
and	B-X
compared	B-X
to	B-X
iridescent	B-X
colonies	B-X
of	B-X
the	B-X
wild	B-X
type	B-X
strain	B-X
X-73	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
a	B-X
tetH	B-X
knockout	B-X
(	B-X
ΔtetH	B-X
)	B-X
mutant	B-X
and	B-X
a	B-X
tetH	B-X
overexpression	B-X
strain	B-X
were	B-X
constructed	B-X
and	B-X
characterized	B-X
.	B-X
The	B-X
ΔtetH	B-X
mutant	B-X
could	B-X
not	B-X
grow	B-X
on	B-X
tetrathionate	B-X
but	B-X
could	B-X
proliferate	B-X
on	B-X
sulfur	B-X
with	B-X
a	B-X
lower	B-X
cell	B-X
yield	B-X
than	B-X
the	B-X
wild	B-X
type	B-X
's	B-X
,	B-X
which	B-X
indicated	B-X
that	B-X
tetrathionate	B-X
hydrolysis	B-X
is	B-X
mediated	B-X
only	B-X
by	B-X
TetH	B-X
,	B-X
encoded	B-X
by	B-X
tetH	B-X
.	B-X
The	B-X
ΔtetH	B-X
mutant	B-X
could	B-X
survive	B-X
in	B-X
ferrous	B-X
medium	B-X
with	B-X
an	B-X
Fe	B-X
(	B-X
2+	B-X
)	B-X
oxidation	B-X
rate	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
wild	B-X
type	B-X
.	B-X

To	O
investigate	O
a	O
functional	O
role	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
Sak188	O
/	O
Sak189	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
,	O
the	O
sak188	O
and	O
sak189	O
genes	O
were	O
inactivated	O
by	O
insertional	O
mutagenesis	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Briefly	O
,	O
DNA	O
fragments	O
of	O
sak188	O
and	O
sak189	O
genes	O
were	O
PCR	O
amplified	O
using	O
pairs	O
of	O
primers	O
hkFor	O
,	O
hkRev	O
,	O
and	O
rrFor	O
,	O
rrRev	O
(	O
Table	O
1	O
)	O
,	O
respectively	O
.	O

PCR	O
products	O
were	O
cloned	O
into	O
pGEM	O
-	O
T	O
Easy	O
vector	O
(	O
Promega	O
,	O
USA	O
)	O
,	O
and	O
the	O
recombinant	O
plasmids	O
named	O
as	O
pGEM	O
-	O
Tsak188	O
and	O
pGEM	O
-	O
Tsak189	O
were	O
digested	O
with	O
EcoRI	O
.	O

Subsequently	O
,	O
EcoRI	O
fragments	O
were	O
cloned	O
into	O
suicide	O
vector	O
pVA891	O
-	O
2	O
,	O
and	O
the	O
recombinant	O
plasmids	O
named	O
as	O
pHK	O
and	O
pRR	O
,	O
respectively	O
,	O
were	O
used	O
to	O
transform	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strain	O
168	O
/	O
00	O
according	O
to	O
the	O
protocol	O
[	O
33	O
]	O
.	O

The	O
recombinant	O
clones	O
were	O
selected	O
on	O
THB	O
agar	O
plates	O
containing	O
2	O
.	O
5	O
microg	O
/	O
ml	O
of	O
erythromycin	O
.	O

Construction	O
of	O
the	O
strains	O
was	O
confirmed	O
by	O
PCR	O
and	O
nucleotide	O
sequencing	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
The	B-X
PRV	B-X
gE/gI	B-X
gene	B-X
deletion	B-X
vaccine	B-X
strain	B-X
(	B-X
Fa	B-X
ΔgE/gI	B-X
strain	B-X
)	B-X
constructed	B-X
from	B-X
the	B-X
PRV	B-X
Fa	B-X
wild-type	B-X
strain	B-X
was	B-X
shown	B-X
to	B-X
have	B-X
a	B-X
protective	B-X
effect	B-X
against	B-X
infection	B-X
.	B-X
High-throughput	B-X
sequencing	B-X
reads	B-X
were	B-X
aligned	B-X
to	B-X
known	B-X
Sus	B-X
scrofa	B-X
pre-miRNAs	B-X
in	B-X
the	B-X
miRBase	B-X
database	B-X
.	B-X
Target	B-X
genes	B-X
of	B-X
differentially	B-X
expressed	B-X
miRNAs	B-X
were	B-X
predicted	B-X
using	B-X
the	B-X
miRGen	B-X
3.0	B-X
database	B-X
,	B-X
then	B-X
filtered	B-X
miRNA	B-X
target	B-X
genes	B-X
were	B-X
subjected	B-X
to	B-X
Gene	B-X
Ontology	B-X
(	B-X
GO	B-X
)	B-X
analysis	B-X
and	B-X
Search	B-X
Tool	B-X
for	B-X
the	B-X
Retrieval	B-X
of	B-X
Interacting	B-X
Genes/	B-X
Proteins	B-X
(	B-X
STRING	B-X
)	B-X
analysis	B-X
.	B-X
Stem-loop	B-X
quantitative	B-X
real-time	B-X
PCR	B-X
was	B-X
performed	B-X
to	B-X
confirm	B-X
the	B-X
accuracy	B-X
of	B-X
high-throughput	B-X
sequencing	B-X
data	B-X
.	B-X
Our	B-X
findings	B-X
will	B-X
contribute	B-X
to	B-X
the	B-X
prevention	B-X
and	B-X
treatment	B-X
of	B-X
PRV	B-X
mutant	B-X
strains	B-X
.	B-X

Given	O
that	O
insertional	O
inactivation	O
of	O
RR	O
gene	O
results	O
in	O
inactivation	O
of	O
HK	O
gene	O
[	O
22	O
]	O
which	O
are	O
co	O
-	O
transcribed	O
(	O
Fig	O
.	O
1	O
)	O
,	O
the	O
strain	O
with	O
insertionally	O
inactivated	O
sak189	O
gene	O
can	O
be	O
considered	O
as	O
sak189	O
/	O
sak188	O
double	O
mutant	O
strain	O
,	O
while	O
the	O
strain	O
with	O
insertionally	O
inactivated	O
sak188	O
gene	O
-	O
as	O
sak188	O
mutant	O
strain	O
.	O

Comparative	O
analysis	O
of	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
mutant	O
strains	O
revealed	O
no	O
difference	O
in	O
morphological	O
properties	O
.	O

The	O
size	O
,	O
shape	O
and	O
color	O
of	O
the	O
colonies	O
,	O
diameter	O
of	O
zone	O
of	O
hemolysis	O
,	O
morphology	O
of	O
the	O
cells	O
and	O
the	O
chain	O
length	O
were	O
similar	O
in	O
all	O
the	O
strains	O
.	O

At	O
the	O
same	O
time	O
the	O
growth	O
curves	O
of	O
mutant	O
strains	O
in	O
THB	O
slightly	O
differed	O
from	O
the	O
growth	O
curve	O
of	O
the	O
strain	O
168	O
/	O
00	O
(	O
data	O
not	O
shown	O
)	O
.	O

Two	O
time	O
points	O
(	O
2	O
hrs	O
and	O
5	O
hrs	O
)	O
corresponding	O
to	O
the	O
middle	O
-	O
exponential	O
and	O
post	O
-	O
exponential	O
phases	O
of	O
growth	O
,	O
respectively	O
,	O
were	O
selected	O
for	O
further	O
study	O
.	O

Effect	O
of	O
insertional	O
inactivation	O
on	O
expression	O
of	O
beta	O
-	O
antigen	O
<EOS>	B-X
In	B-X
Neisseria	B-X
meningitidis	B-X
,	B-X
the	B-X
reversible	B-X
expression	B-X
of	B-X
surface	B-X
antigens	B-X
,	B-X
i.e	B-X
.	B-X
Overexpression	B-X
of	B-X
dinB	B-X
enhanced	B-X
the	B-X
instability	B-X
of	B-X
the	B-X
homopolymeric	B-X
tract	B-X
associated	B-X
with	B-X
siaD	B-X
.	B-X
IS1548	B-X
impacts	B-X
S.	B-X
agalactiae	B-X
in	B-X
two	B-X
reported	B-X
ways	B-X
:	B-X
i	B-X
)	B-X
inactivation	B-X
of	B-X
virulence	B-X
genes	B-X
by	B-X
insertion	B-X
in	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
(	B-X
e.g	B-X
.	B-X
hylB	B-X
or	B-X
cpsD	B-X
)	B-X
,	B-X
ii	B-X
)	B-X
positive	B-X
modulation	B-X
of	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
downstream	B-X
gene	B-X
by	B-X
insertion	B-X
in	B-X
an	B-X
intergenic	B-X
region	B-X
(	B-X
e.g	B-X
.	B-X
We	B-X
evaluated	B-X
the	B-X
impact	B-X
of	B-X
the	B-X
insertion	B-X
of	B-X
IS1548	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
murB	B-X
by	B-X
locating	B-X
transcriptional	B-X
promoters	B-X
influencing	B-X
its	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
or	B-X
absence	B-X
of	B-X
IS1548	B-X
and	B-X
by	B-X
comparative	B-X
β-galactosidase	B-X
transcriptional	B-X
fusion	B-X
assays	B-X
.	B-X
The	B-X
insertion	B-X
of	B-X
IS1548	B-X
in	B-X
this	B-X
region	B-X
has	B-X
thus	B-X
a	B-X
dual	B-X
and	B-X
divergent	B-X
impact	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
murB	B-X
.	B-X
This	B-X
study	B-X
provides	B-X
new	B-X
insights	B-X
into	B-X
gene	B-X
expression	B-X
effects	B-X
mediated	B-X
by	B-X
IS1548	B-X
in	B-X
S.	B-X
agalactiae	B-X
.	B-X

Several	O
approaches	O
were	O
used	O
to	O
prepare	O
the	O
cell	O
lysates	O
of	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
mutant	O
strains	O
.	O

As	O
result	O
,	O
10	O
min	O
boiling	O
of	O
the	O
cells	O
in	O
2	O
-	O
mercaptoethanol	O
(	O
10	O
%	O
,	O
w	O
/	O
w	O
)	O
was	O
found	O
to	O
be	O
most	O
effective	O
with	O
respect	O
to	O
higher	O
yield	O
and	O
quality	O
of	O
the	O
protein	O
bands	O
observed	O
after	O
SDS	O
-	O
PAGE	O
(	O
data	O
not	O
shown	O
)	O
.	O

Subsequently	O
,	O
bacterial	O
cell	O
lysates	O
and	O
secreted	O
proteins	O
after	O
2	O
hrs	O
and	O
5	O
hrs	O
of	O
growth	O
in	O
THB	O
were	O
analyzed	O
.	O

SDS	O
-	O
PAGE	O
of	O
secreted	O
proteins	O
did	O
not	O
reveal	O
any	O
difference	O
among	O
the	O
wild	O
-	O
type	O
strain	O
and	O
mutant	O
strains	O
(	O
data	O
not	O
shown	O
)	O
.	O
<EOS>	B-X
Peptide	B-X
mass	B-X
fingerprinting	B-X
by	B-X
MALDI-MS	B-X
and	B-X
sequencing	B-X
by	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
have	B-X
evolved	B-X
into	B-X
the	B-X
major	B-X
methods	B-X
for	B-X
identification	B-X
of	B-X
proteins	B-X
following	B-X
separation	B-X
by	B-X
two-dimensional	B-X
gel	B-X
electrophoresis	B-X
,	B-X
SDS-PAGE	B-X
or	B-X
liquid	B-X
chromatography	B-X
.	B-X
One	B-X
main	B-X
technological	B-X
goal	B-X
of	B-X
proteome	B-X
analyses	B-X
beside	B-X
high	B-X
sensitivity	B-X
and	B-X
automation	B-X
was	B-X
the	B-X
comprehensive	B-X
analysis	B-X
of	B-X
proteins	B-X
.	B-X
The	B-X
power	B-X
of	B-X
peptide	B-X
mass	B-X
fingerprinting	B-X
for	B-X
protein	B-X
identification	B-X
was	B-X
described	B-X
here	B-X
,	B-X
as	B-X
exemplified	B-X
by	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
species	B-X
with	B-X
high	B-X
molecular	B-X
masses	B-X
(	B-X
spectrin	B-X
alpha	B-X
and	B-X
beta	B-X
)	B-X
,	B-X
low	B-X
molecular	B-X
masses	B-X
(	B-X
elongation	B-X
factor	B-X
EF-TU	B-X
fragments	B-X
)	B-X
,	B-X
splice	B-X
variants	B-X
(	B-X
alpha	B-X
A	B-X
crystallin	B-X
)	B-X
,	B-X
aggregates	B-X
with	B-X
disulfide	B-X
bridges	B-X
(	B-X
alkylhydroperoxide	B-X
reductase	B-X
)	B-X
,	B-X
and	B-X
phosphorylated	B-X
proteins	B-X
(	B-X
heat	B-X
shock	B-X
protein	B-X
27	B-X
)	B-X
.	B-X
Phos-tag	B-X
SDS-PAGE	B-X
followed	B-X
by	B-X
Western	B-X
blotting	B-X
confirmed	B-X
ERK-dependent	B-X
phosphorylation	B-X
of	B-X
these	B-X
three	B-X
proteins	B-X
in	B-X
cells	B-X
.	B-X
Phos-tag	B-X
SDS-PAGE	B-X
of	B-X
in	B-X
vitro	B-X
kinase	B-X
assay	B-X
samples	B-X
revealed	B-X
high	B-X
degrees	B-X
of	B-X
phosphorylation	B-X
of	B-X
these	B-X
proteins	B-X
by	B-X
active	B-X
ERK	B-X
.	B-X
Furthermore	B-X
,	B-X
in-gel	B-X
digestion	B-X
of	B-X
the	B-X
phosphorylated	B-X
protein	B-X
bands	B-X
from	B-X
Phos-tag	B-X
SDS-PAGE	B-X
followed	B-X
by	B-X
LC-MS/MS	B-X
indicated	B-X
that	B-X
active	B-X
ERK	B-X
directly	B-X
phosphorylates	B-X
the	B-X
same	B-X
sites	B-X
in	B-X
vitro	B-X
as	B-X
those	B-X
observed	B-X
in	B-X
cells	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
the	B-X
usefulness	B-X
of	B-X
Phos-tag	B-X
SDS-PAGE	B-X
for	B-X
validation	B-X
of	B-X
candidate	B-X
substrates	B-X
of	B-X
protein	B-X
kinases	B-X
.	B-X
SIGNIFICANCE	B-X
:	B-X
Label-free	B-X
quantitative	B-X
phosphoproteomics	B-X
identified	B-X
1439	B-X
phosphopeptides	B-X
derived	B-X
from	B-X
840	B-X
proteins	B-X
that	B-X
were	B-X
significantly	B-X
increased	B-X
by	B-X
ERK	B-X
activation	B-X
in	B-X
mouse	B-X
fibroblasts	B-X
.	B-X
Through	B-X
gene	B-X
ontology	B-X
and	B-X
pathway	B-X
analysis	B-X
,	B-X
we	B-X
selected	B-X
three	B-X
proteins	B-X
involved	B-X
in	B-X
transcriptional	B-X
regulation	B-X
and/or	B-X
tumorigenesis	B-X
.	B-X
The	B-X
identified	B-X
phosphorylation	B-X
sites	B-X
of	B-X
these	B-X
proteins	B-X
conform	B-X
to	B-X
the	B-X
ERK	B-X
consensus	B-X
motif	B-X
and	B-X
were	B-X
directly	B-X
phosphorylated	B-X
by	B-X
active	B-X
ERK	B-X
in	B-X
vitro	B-X
.	B-X
Phos-tag	B-X
SDS-PAGE	B-X
was	B-X
useful	B-X
for	B-X
detecting	B-X
ERK-mediated	B-X
phosphorylation	B-X
of	B-X
these	B-X
substrates	B-X
both	B-X
in	B-X
cells	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
Further	B-X
characterization	B-X
of	B-X
these	B-X
new	B-X
ERK	B-X
substrates	B-X
will	B-X
be	B-X
needed	B-X
to	B-X
better	B-X
understand	B-X
the	B-X
ERK	B-X
signaling	B-X
pathway	B-X
,	B-X
and	B-X
our	B-X
phosphoproteomic	B-X
data	B-X
provide	B-X
useful	B-X
information	B-X
for	B-X
studying	B-X
downstream	B-X
substrates	B-X
of	B-X
ERK	B-X
.	B-X

However	O
,	O
SDS	O
-	O
PAGE	O
of	O
the	O
cell	O
lysates	O
revealed	O
that	O
at	O
least	O
one	O
protein	O
band	O
of	O
approximately140	O
kDa	O
was	O
present	O
in	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
sak188	O
mutant	O
strain	O
,	O
and	O
was	O
absent	O
in	O
sak189	O
/	O
sak188	O
double	O
mutant	O
strain	O
.	O

Western	O
-	O
blotting	O
with	O
labeled	O
human	B-Organism
IgA	O
identified	O
this	O
protein	O
as	O
beta	O
-	O
antigen	O
(	O
Fig	O
.	O
3	O
)	O
.	O

Effect	O
of	O
insertional	O
inactivation	O
on	O
transcription	O
of	O
bac	O
gene	O
<EOS>	B-X
Little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
mechanism	B-X
of	B-X
the	B-X
SHRF	B-X
pathogenesis	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
studied	B-X
the	B-X
effect	B-X
of	B-X
mutations	B-X
in	B-X
EXOSC2/RRP4	B-X
in	B-X
patient-derived	B-X
lymphoblasts	B-X
,	B-X
clustered	B-X
regularly	B-X
interspaced	B-X
short	B-X
palindromic	B-X
repeats	B-X
(	B-X
CRISPR	B-X
)	B-X
-generated	B-X
mutant	B-X
fetal	B-X
keratinocytes	B-X
and	B-X
Drosophila	B-X
.	B-X
We	B-X
determined	B-X
that	B-X
human	B-X
EXOSC2	B-X
is	B-X
an	B-X
essential	B-X
gene	B-X
and	B-X
that	B-X
the	B-X
pathogenic	B-X
G198D	B-X
mutation	B-X
prevents	B-X
binding	B-X
to	B-X
other	B-X
RNA	B-X
exosome	B-X
components	B-X
,	B-X
resulting	B-X
in	B-X
protein	B-X
and	B-X
complex	B-X
instability	B-X
and	B-X
altered	B-X
expression	B-X
and/or	B-X
activities	B-X
of	B-X
critical	B-X
genes	B-X
,	B-X
including	B-X
those	B-X
in	B-X
the	B-X
autophagy	B-X
pathway	B-X
.	B-X
In	B-X
parallel	B-X
,	B-X
we	B-X
generated	B-X
multiple	B-X
CRISPR	B-X
knockouts	B-X
of	B-X
the	B-X
fly	B-X
rrp4	B-X
gene	B-X
.	B-X
We	B-X
found	B-X
that	B-X
overexpression	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
MITF	B-X
was	B-X
sufficient	B-X
to	B-X
rescue	B-X
the	B-X
small	B-X
eye	B-X
and	B-X
adult	B-X
lethal	B-X
phenotypes	B-X
caused	B-X
by	B-X
rrp4	B-X
inhibition	B-X
.	B-X
The	B-X
autophagy	B-X
genes	B-X
ATG1	B-X
and	B-X
ATG17	B-X
,	B-X
which	B-X
are	B-X
regulated	B-X
by	B-X
MITF	B-X
,	B-X
had	B-X
similar	B-X
effect	B-X
.	B-X
Pharmacological	B-X
stimulation	B-X
of	B-X
autophagy	B-X
with	B-X
rapamycin	B-X
also	B-X
rescued	B-X
the	B-X
lethality	B-X
caused	B-X
by	B-X
rrp4	B-X
inactivation	B-X
.	B-X
Our	B-X
results	B-X
implicate	B-X
defective	B-X
autophagy	B-X
in	B-X
SHRF	B-X
pathogenesis	B-X
and	B-X
suggest	B-X
therapeutic	B-X
strategies	B-X
.	B-X

In	O
order	O
to	O
analyze	O
if	O
changes	O
in	O
beta	O
-	O
antigen	O
expression	O
are	O
regulated	O
at	O
transcriptional	O
level	O
,	O
the	O
quantitative	O
RT	O
-	O
PCR	O
was	O
performed	O
using	O
RNA	O
samples	O
isolated	O
during	O
the	O
middle	O
-	O
exponential	O
phase	O
corresponding	O
to	O
2	O
hrs	O
of	O
growth	O
.	O

As	O
result	O
,	O
transcription	O
of	O
bac	O
gene	O
in	O
sak189	O
/	O
sak188	O
double	O
mutant	O
strain	O
was	O
17	O
-	O
fold	O
less	O
than	O
in	O
168	O
/	O
00	O
wild	O
-	O
type	O
strain	O
(	O
Fig	O
.	O
3	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
bac	O
gene	O
transcription	O
level	O
in	O
sak188	O
mutant	O
strain	O
was	O
almost	O
similar	O
to	O
that	O
in	O
the	O
wild	O
-	O
type	O
strain	O
that	O
confirmed	O
the	O
results	O
of	O
SDS	O
-	O
PAGE	O
and	O
western	O
-	O
blotting	O
.	O

Thus	O
,	O
these	O
data	O
demonstrate	O
that	O
Sak189	O
protein	O
regulates	O
expression	O
of	O
beta	O
-	O
antigen	O
at	O
transcriptional	O
level	O
.	O

In	O
vivo	O
virulent	O
properties	O
of	O
the	O
wild	O
-	O
type	O
strain	O
and	O
mutant	O
strains	O
<EOS>	B-X
The	B-X
Western	B-X
Reserve	B-X
(	B-X
WR	B-X
)	B-X
strain	B-X
of	B-X
mature	B-X
vaccinia	B-X
virus	B-X
contains	B-X
an	B-X
A26	B-X
envelope	B-X
protein	B-X
that	B-X
mediates	B-X
virus	B-X
binding	B-X
to	B-X
cell	B-X
surface	B-X
laminin	B-X
and	B-X
subsequent	B-X
endocytic	B-X
entry	B-X
into	B-X
HeLa	B-X
cells	B-X
.	B-X
Removal	B-X
of	B-X
the	B-X
A26	B-X
protein	B-X
from	B-X
the	B-X
WR	B-X
strain	B-X
mature	B-X
virus	B-X
generates	B-X
a	B-X
mutant	B-X
,	B-X
WRΔA26	B-X
,	B-X
that	B-X
enters	B-X
HeLa	B-X
cells	B-X
through	B-X
plasma	B-X
membrane	B-X
fusion	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
infected	B-X
murine	B-X
bone	B-X
marrow-derived	B-X
macrophages	B-X
(	B-X
BMDM	B-X
)	B-X
with	B-X
wild-type	B-X
strain	B-X
WR	B-X
and	B-X
the	B-X
WRΔA26	B-X
mutant	B-X
and	B-X
analyzed	B-X
viral	B-X
gene	B-X
expression	B-X
and	B-X
cellular	B-X
innate	B-X
immune	B-X
signaling	B-X
.	B-X
Microarray	B-X
analysis	B-X
of	B-X
the	B-X
cellular	B-X
transcripts	B-X
in	B-X
BMDM	B-X
induced	B-X
by	B-X
virus	B-X
infection	B-X
revealed	B-X
that	B-X
WR	B-X
preferentially	B-X
activated	B-X
type	B-X
1	B-X
interferon	B-X
receptor	B-X
(	B-X
IFNAR	B-X
)	B-X
-dependent	B-X
signaling	B-X
but	B-X
WRΔA26	B-X
did	B-X
not	B-X
.	B-X
Finally	B-X
,	B-X
wild-type	B-X
C57BL/6	B-X
mice	B-X
were	B-X
more	B-X
susceptible	B-X
to	B-X
mortality	B-X
from	B-X
WRΔA26	B-X
infection	B-X
than	B-X
to	B-X
that	B-X
from	B-X
WR	B-X
infection	B-X
,	B-X
whereas	B-X
IFNAR-knockout	B-X
mice	B-X
were	B-X
equally	B-X
susceptible	B-X
to	B-X
WR	B-X
and	B-X
WRΔA26	B-X
infection	B-X
,	B-X
demonstrating	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
WRΔA26	B-X
to	B-X
evade	B-X
IFNAR	B-X
signaling	B-X
has	B-X
an	B-X
important	B-X
influence	B-X
on	B-X
viral	B-X
pathogenesis	B-X

Murine	B-Organism
intraperitoneal	O
model	O
of	O
streptococcal	O
infection	O
was	O
developed	O
to	O
compare	O
the	O
virulent	O
properties	O
of	O
the	O
strains	O
under	O
study	O
.	O

Mice	B-Organism
were	O
injected	O
with	O
0	O
.	O
5	O
ml	O
of	O
PBS	O
containing	O
108	O
CFUs	O
and	O
observed	O
for	O
10	O
days	O
.	O

As	O
seen	O
from	O
the	O
Fig	O
.	O
<EOS>	B-X
Cervical	B-X
spine	B-X
radiography	B-X
was	B-X
performed	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
,	B-X
followed	B-X
by	B-X
MRI	B-X
(	B-X
Fig	B-X
2	B-X
)	B-X
.	B-X
Included	B-X
are	B-X
representative	B-X
radiographs	B-X
of	B-X
the	B-X
pelvis	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
,	B-X
left	B-X
forearm	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
,	B-X
and	B-X
distal	B-X
right	B-X
leg	B-X
with	B-X
ankle	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X
Unenhanced	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
and	B-X
multiphasic	B-X
contrast-enhanced	B-X
CT	B-X
imaging	B-X
was	B-X
performed	B-X
in	B-X
arterial	B-X
(	B-X
Fig	B-X
2A	B-X
)	B-X
,	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
2B	B-X
)	B-X
,	B-X
and	B-X
delayed	B-X
(	B-X
3	B-X
minutes	B-X
after	B-X
injection	B-X
)	B-X
(	B-X
Fig	B-X
2C	B-X
)	B-X
phases	B-X
.	B-X
Axial	B-X
and	B-X
coronal	B-X
maximum	B-X
intensity	B-X
projection	B-X
reconstructed	B-X
CT	B-X
images	B-X
were	B-X
obtained	B-X
in	B-X
the	B-X
arterial	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
and	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
patient	B-X
also	B-X
underwent	B-X
whole-body	B-X
iodine	B-X
131	B-X
scintigraphy	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X

4	O
,	O
the	O
mortality	O
rate	O
caused	O
by	O
sak189	O
/	O
sak188	O
double	O
mutant	O
strain	O
significantly	O
differed	O
in	O
comparison	O
with	O
that	O
caused	O
by	O
the	O
wild	O
-	O
type	O
and	O
sak188	O
mutant	O
strains	O
.	O

Compared	O
to	O
the	O
wild	O
-	O
type	O
strain	O
,	O
the	O
differences	O
in	O
virulent	O
properties	O
were	O
statistically	O
significant	O
in	O
case	O
of	O
sak189	O
/	O
sak188	O
double	O
mutant	O
strain	O
(	O
P	O
-	O
value	O
<	O
0	O
.	O
02	O
)	O
,	O
and	O
not	O
significant	O
in	O
case	O
of	O
sak188	O
mutant	O
strain	O
(	O
P	O
-	O
value	O
=	O
0	O
.	O
73	O
)	O
.	O

Discussion	O
<EOS>	B-X
Discussion	B-X
structures	B-X
are	B-X
argumentation-theoretical	B-X
tools	B-X
that	B-X
can	B-X
be	B-X
employed	B-X
to	B-X
tackle	B-X
three	B-X
barriers	B-X
that	B-X
separate	B-X
lay	B-X
stakeholders	B-X
from	B-X
policy	B-X
debates	B-X
:	B-X
difficulty	B-X
,	B-X
magnitude	B-X
,	B-X
and	B-X
complexity	B-X
.	B-X
Discussions	B-X
about	B-X
preventive	B-X
behaviors	B-X
were	B-X
assessed	B-X
before	B-X
testing	B-X
and	B-X
1	B-X
and	B-X
6	B-X
months	B-X
post-testing	B-X
.	B-X
Discussion	B-X
of	B-X
preventive	B-X
behaviors	B-X
declined	B-X
following	B-X
test	B-X
reporting	B-X
,	B-X
with	B-X
more	B-X
rapid	B-X
decline	B-X
reported	B-X
by	B-X
noncarriers	B-X
.	B-X
Discussions	B-X
are	B-X
an	B-X
important	B-X
part	B-X
of	B-X
medical	B-X
education	B-X
research	B-X
papers	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
guidance	B-X
on	B-X
how	B-X
to	B-X
write	B-X
up	B-X
the	B-X
discussion	B-X
section	B-X
.	B-X

Transcriptional	O
regulation	O
of	O
the	O
genes	O
is	O
important	O
process	O
for	O
successful	O
adaptation	O
of	O
pathogenic	O
bacteria	O
to	O
changing	O
environments	O
,	O
particularly	O
,	O
during	O
the	O
interaction	O
of	O
pathogen	O
with	O
human	B-Organism
host	O
.	O

In	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
,	O
a	O
total	O
of	O
21	O
TCSs	O
are	O
involved	O
in	O
the	O
regulatory	O
network	O
essential	O
for	O
successful	O
colonization	O
,	O
penetration	O
and	O
/	O
or	O
invasion	O
as	O
well	O
as	O
for	O
resistance	O
to	O
human	B-Organism
immune	O
system	O
.	O
<EOS>	B-X
Cancers	B-X
develop	B-X
in	B-X
complex	B-X
tissue	B-X
environments	B-X
,	B-X
which	B-X
they	B-X
depend	B-X
on	B-X
for	B-X
sustained	B-X
growth	B-X
,	B-X
invasion	B-X
and	B-X
metastasis	B-X
.	B-X
Unlike	B-X
tumor	B-X
cells	B-X
,	B-X
stromal	B-X
cell	B-X
types	B-X
within	B-X
the	B-X
tumor	B-X
microenvironment	B-X
(	B-X
TME	B-X
)	B-X
are	B-X
genetically	B-X
stable	B-X
and	B-X
thus	B-X
represent	B-X
an	B-X
attractive	B-X
therapeutic	B-X
target	B-X
with	B-X
reduced	B-X
risk	B-X
of	B-X
resistance	B-X
and	B-X
tumor	B-X
recurrence	B-X
.	B-X
Here	B-X
we	B-X
discuss	B-X
the	B-X
paradoxical	B-X
roles	B-X
of	B-X
the	B-X
TME	B-X
during	B-X
specific	B-X
stages	B-X
of	B-X
cancer	B-X
progression	B-X
and	B-X
metastasis	B-X
,	B-X
as	B-X
well	B-X
as	B-X
recent	B-X
therapeutic	B-X
attempts	B-X
to	B-X
re-educate	B-X
stromal	B-X
cells	B-X
within	B-X
the	B-X
TME	B-X
to	B-X
have	B-X
anti-tumorigenic	B-X
effects	B-X
.	B-X
CC	B-X
chemokines	B-X
(	B-X
or	B-X
β-chemokines	B-X
)	B-X
are	B-X
28	B-X
chemotactic	B-X
cytokines	B-X
with	B-X
an	B-X
N-terminal	B-X
CC	B-X
domain	B-X
that	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
immune	B-X
system	B-X
cells	B-X
,	B-X
such	B-X
as	B-X
CD4	B-X

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
functional	O
role	O
of	O
Sak188	O
/	O
Sak189	O
two	O
-	O
component	O
system	O
in	O
regulation	O
of	O
the	O
expression	O
of	O
beta	O
-	O
antigen	O
,	O
an	O
important	O
virulence	O
factor	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
These	B-X
systems	B-X
sense	B-X
the	B-X
environmental	B-X
stimuli	B-X
and	B-X
regulate	B-X
expression	B-X
of	B-X
the	B-X
genes	B-X
including	B-X
virulence	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

It	O
was	O
demonstrated	O
that	O
both	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
encoded	O
beta	O
-	O
antigen	O
were	O
controlled	O
by	O
the	O
Sak189	O
response	O
regulator	O
,	O
but	O
not	O
Sak188	O
histidine	O
kinase	O
.	O

It	O
was	O
also	O
found	O
that	O
regulation	O
occurred	O
at	O
transcriptional	O
level	O
.	O
<EOS>	B-X
Transcriptional	B-X
regulation	B-X
in	B-X
metazoans	B-X
occurs	B-X
through	B-X
long-range	B-X
genomic	B-X
contacts	B-X
between	B-X
enhancers	B-X
and	B-X
promoters	B-X
,	B-X
and	B-X
most	B-X
genes	B-X
are	B-X
transcribed	B-X
in	B-X
episodic	B-X
``	B-X
bursts	B-X
''	B-X
of	B-X
RNA	B-X
synthesis	B-X
.	B-X
To	B-X
understand	B-X
the	B-X
relationship	B-X
between	B-X
these	B-X
two	B-X
phenomena	B-X
and	B-X
the	B-X
dynamic	B-X
regulation	B-X
of	B-X
genes	B-X
in	B-X
response	B-X
to	B-X
upstream	B-X
signals	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
use	B-X
of	B-X
live-cell	B-X
RNA	B-X
imaging	B-X
coupled	B-X
with	B-X
Hi-C	B-X
measurements	B-X
and	B-X
dissect	B-X
the	B-X
endogenous	B-X
regulation	B-X
of	B-X
the	B-X
estrogen-responsive	B-X
TFF1	B-X
gene	B-X
.	B-X
The	B-X
heterogeneity	B-X
in	B-X
inactive	B-X
times	B-X
gives	B-X
rise	B-X
to	B-X
the	B-X
widely	B-X
observed	B-X
``	B-X
noise	B-X
''	B-X
in	B-X
human	B-X
gene	B-X
expression	B-X
and	B-X
explains	B-X
the	B-X
distribution	B-X
of	B-X
protein	B-X
levels	B-X
in	B-X
human	B-X
tissue	B-X
.	B-X
We	B-X
derive	B-X
a	B-X
mathematical	B-X
model	B-X
of	B-X
regulation	B-X
that	B-X
relates	B-X
transcription	B-X
,	B-X
chromosome	B-X
structure	B-X
,	B-X
and	B-X
the	B-X
cell	B-X
's	B-X
ability	B-X
to	B-X
sense	B-X
changes	B-X
in	B-X
estrogen	B-X
and	B-X
predicts	B-X
that	B-X
hypervariability	B-X
is	B-X
largely	B-X
dynamic	B-X
and	B-X
does	B-X
not	B-X
reflect	B-X
a	B-X
stable	B-X
biological	B-X
state	B-X
.	B-X

Finally	O
,	O
insertional	O
inactivation	O
of	O
sak189	O
gene	O
,	O
but	O
not	O
sak188	O
gene	O
,	O
significantly	O
affects	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

Variety	O
of	O
publications	O
are	O
currently	O
available	O
regarding	O
the	O
occurrence	O
of	O
bac	O
gene	O
among	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strains	O
as	O
well	O
as	O
genetic	O
polymorphism	O
of	O
bac	O
gene	O
and	O
use	O
of	O
encoded	O
beta	O
-	O
antigen	O
as	O
a	O
vaccine	O
component	O
[	O
32	O
]	O
,	O
[	O
34	O
]	O
-	O
[	O
38	O
]	O
.	O

In	O
some	O
strains	O
,	O
the	O
mutations	O
in	O
bac	O
gene	O
resulted	O
in	O
expression	O
of	O
truncated	O
non	O
-	O
functional	O
forms	O
of	O
beta	O
-	O
antigen	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

However	O
,	O
the	O
regulatory	O
mechanism	O
of	O
bac	O
gene	O
expression	O
has	O
not	O
been	O
studied	O
.	O
<EOS>	B-X
Parkinson	B-X
's	B-X
disease	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
common	B-X
movement	B-X
disorders	B-X
and	B-X
is	B-X
characterized	B-X
by	B-X
dopaminergic	B-X
cell	B-X
loss	B-X
and	B-X
the	B-X
accumulation	B-X
of	B-X
pathological	B-X
α-synuclein	B-X
,	B-X
but	B-X
its	B-X
precise	B-X
pathogenetic	B-X
mechanisms	B-X
remain	B-X
elusive	B-X
.	B-X
As	B-X
subjects	B-X
with	B-X
α-synuclein	B-X
gene	B-X
(	B-X
SNCA	B-X
)	B-X
multiplication	B-X
as	B-X
well	B-X
as	B-X
point	B-X
mutations	B-X
develop	B-X
familial	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
a	B-X
genome-wide	B-X
association	B-X
study	B-X
in	B-X
Parkinson	B-X
's	B-X
disease	B-X
has	B-X
identified	B-X
SNCA	B-X
as	B-X
a	B-X
risk	B-X
gene	B-X
for	B-X
Parkinson	B-X
's	B-X
disease	B-X
,	B-X
the	B-X
increased	B-X
expression	B-X
of	B-X
α-synuclein	B-X
is	B-X
closely	B-X
associated	B-X
with	B-X
the	B-X
aetiology	B-X
of	B-X
Parkinson	B-X
's	B-X
disease	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
generated	B-X
bacterial	B-X
artificial	B-X
chromosome	B-X
transgenic	B-X
mice	B-X
harbouring	B-X
SNCA	B-X
and	B-X
its	B-X
gene	B-X
expression	B-X
regulatory	B-X
regions	B-X
in	B-X
order	B-X
to	B-X
maintain	B-X
the	B-X
native	B-X
expression	B-X
pattern	B-X
of	B-X
α-synuclein	B-X
.	B-X
These	B-X
A53T	B-X
SNCA	B-X
bacterial	B-X
artificial	B-X
chromosome	B-X
transgenic	B-X
mice	B-X
showed	B-X
an	B-X
expression	B-X
pattern	B-X
of	B-X
human	B-X
α-synuclein	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
endogenous	B-X
mouse	B-X
α-synuclein	B-X
.	B-X
The	B-X
dopaminergic	B-X
neurons	B-X
in	B-X
the	B-X
substantia	B-X
nigra	B-X
pars	B-X
compacta	B-X
degenerated	B-X
,	B-X
and	B-X
their	B-X
number	B-X
was	B-X
decreased	B-X
in	B-X
an	B-X
age-dependent	B-X
manner	B-X
by	B-X
up	B-X
to	B-X
17.1	B-X
%	B-X
at	B-X
18	B-X
months	B-X
of	B-X
age	B-X
compared	B-X
to	B-X
wild-type	B-X
,	B-X
although	B-X
the	B-X
mice	B-X
did	B-X
not	B-X
show	B-X
any	B-X
related	B-X
locomotor	B-X
dysfunction	B-X
.	B-X

In	O
present	O
study	O
,	O
the	O
sak188	O
and	O
sak189	O
genes	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
were	O
inactivated	O
.	O

Given	O
that	O
insertional	O
inactivation	O
does	O
not	O
delete	O
the	O
entire	O
gene	O
from	O
the	O
chromosome	O
and	O
often	O
results	O
in	O
truncated	O
or	O
modified	O
protein	O
,	O
we	O
analyzed	O
which	O
functional	O
activities	O
of	O
Sak188	O
and	O
Sak189	O
proteins	O
could	O
potentially	O
retain	O
if	O
the	O
modified	O
proteins	O
expressed	O
.	O
<EOS>	B-X
Since	B-X
that	B-X
time	B-X
,	B-X
many	B-X
viruses	B-X
have	B-X
been	B-X
associated	B-X
with	B-X
carcinogenesis	B-X
including	B-X
the	B-X
most	B-X
studied	B-X
,	B-X
human	B-X
papilloma	B-X
virus	B-X
associated	B-X
with	B-X
cervical	B-X
carcinoma	B-X
,	B-X
many	B-X
other	B-X
anogenital	B-X
carcinomas	B-X
,	B-X
and	B-X
oropharyngeal	B-X
carcinoma	B-X
.	B-X
The	B-X
field	B-X
of	B-X
tumor	B-X
virology/viral	B-X
carcinogenesis	B-X
has	B-X
not	B-X
only	B-X
identified	B-X
viruses	B-X
as	B-X
etiologic	B-X
agents	B-X
of	B-X
human	B-X
cancers	B-X
,	B-X
but	B-X
has	B-X
also	B-X
given	B-X
molecular	B-X
insights	B-X
to	B-X
all	B-X
human	B-X
cancers	B-X
including	B-X
the	B-X
oncogene	B-X
activation	B-X
and	B-X
tumor	B-X
suppressor	B-X
gene	B-X
inactivation	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
genes	B-X
is	B-X
altered	B-X
in	B-X
various	B-X
diseases	B-X
and	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
disease	B-X
's	B-X
initiation	B-X
,	B-X
progression	B-X
and	B-X
pathology	B-X
.	B-X
Several	B-X
other	B-X
genes	B-X
,	B-X
predominantly	B-X
inactivated	B-X
,	B-X
may	B-X
become	B-X
activated	B-X
in	B-X
a	B-X
given	B-X
condition	B-X
and	B-X
contribute	B-X
to	B-X
the	B-X
initiation	B-X
and	B-X
progression	B-X
of	B-X
the	B-X
disease	B-X
.	B-X
Similarly	B-X
,	B-X
human	B-X
endogenous	B-X
viruses	B-X
(	B-X
HERVs	B-X
)	B-X
are	B-X
an	B-X
incomplete	B-X
,	B-X
non-productive	B-X
and	B-X
inactive	B-X
viral	B-X
sequence	B-X
present	B-X
in	B-X
the	B-X
heterochromatin	B-X
of	B-X
the	B-X
human	B-X
genome	B-X
,	B-X
and	B-X
are	B-X
often	B-X
referred	B-X
to	B-X
as	B-X
junk	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
their	B-X
expression	B-X
is	B-X
increased	B-X
in	B-X
cancers	B-X
due	B-X
to	B-X
either	B-X
epigenetic	B-X
or	B-X
transcriptional	B-X
dysregulation	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
HERVs	B-X
having	B-X
intact	B-X
open	B-X
reading	B-X
frames	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
express	B-X
virus-like	B-X
particles	B-X
,	B-X
functional	B-X
peptides	B-X
and	B-X
proteins	B-X
involved	B-X
in	B-X
tumorigenesis	B-X
.	B-X

Comparative	O
analysis	O
of	O
Sak188	O
and	O
Sak189	O
amino	O
acid	O
sequences	O
in	O
the	O
wild	O
-	O
type	O
strain	O
168	B-Organism
/	I-Organism
00	I-Organism
and	O
deduced	O
protein	O
sequences	O
in	O
mutant	O
strains	O
predicted	O
the	O
replacement	O
of	O
95	O
amino	O
acids	O
at	O
the	O
C	O
-	O
terminal	O
end	O
of	O
Sak188	O
protein	O
by	O
191	O
amino	O
acids	O
,	O
and	O
replacement	O
of	O
51	O
amino	O
acids	O
at	O
the	O
C	O
-	O
terminal	O
end	O
of	O
Sak189	O
protein	O
by	O
15	O
amino	O
acids	O
(	O
Fig	O
.	O
5	O
)	O
.	O

Importantly	O
,	O
8	O
out	O
of	O
9	O
amino	O
acids	O
,	O
which	O
composed	O
HTH	O
motif	O
presumably	O
involved	O
in	O
DNA	O
-	O
binding	O
according	O
to	O
BLASTp	O
analysis	O
(	O
http	O
:	O
/	O
/	O
blast	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Blast	O
.	O
cgi	O
)	O
,	O
were	O
lost	O
in	O
Sak189	O
protein	O
due	O
to	O
insertional	O
mutagenesis	O
.	O

Similarly	O
,	O
ATP	O
-	O
binding	O
and	O
Mg2	O
+	O
-	O
binding	O
sites	O
located	O
at	O
C	O
-	O
terminal	O
end	O
of	O
Sak188	O
,	O
which	O
are	O
essential	O
for	O
phosphorylation	O
,	O
were	O
lost	O
in	O
Sak188	O
protein	O
due	O
to	O
the	O
mutagenesis	O
.	O

Theoretically	O
,	O
in	O
both	O
sak188	O
mutant	O
strain	O
and	O
sak189	O
/	O
sak188	O
double	O
mutant	O
strain	O
,	O
the	O
Sak188	O
/	O
Sak189	O
TCS	O
can	O
be	O
inactive	O
.	O

In	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
,	O
inactivation	O
of	O
the	O
response	O
regulator	O
RR06	O
(	O
83	O
%	O
similarity	O
with	O
Sak189	O
)	O
,	O
which	O
binds	O
promoter	O
region	O
of	O
cbpA	O
,	O
repressed	O
transcription	O
of	O
the	O
cbpA	O
gene	O
[	O
22	O
]	O
.	O

In	O
this	O
study	O
,	O
western	O
blotting	O
and	O
quantitative	O
RT	O
-	O
PCR	O
revealed	O
that	O
DNA	O
-	O
binding	O
response	O
regulator	O
Sak189	O
is	O
necessary	O
for	O
beta	O
-	O
antigen	O
expression	O
suggesting	O
direct	O
binding	O
of	O
Sak189	O
with	O
bac	O
gene	O
promoter	O
.	O

This	O
is	O
not	O
surprising	O
given	O
the	O
high	O
similarity	O
in	O
the	O
sequences	O
,	O
functions	O
and	O
relative	O
locations	O
of	O
Sak188	O
/	O
Sak189	O
and	O
HK06	O
/	O
RR06	O
,	O
and	O
beta	O
-	O
antigen	O
and	O
CbpA	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Importantly	O
,	O
insertional	O
inactivation	O
can	O
have	O
a	O
polar	O
effect	O
on	O
the	O
genes	O
located	O
downstream	O
.	O

In	O
this	O
study	O
,	O
both	O
sak188	O
and	O
bac	O
genes	O
located	O
downstream	O
the	O
sak189	O
gene	O
(	O
Fig	O
.	O
1	O
)	O
.	O

As	O
seen	O
from	O
the	O
Fig	O
.	O
<EOS>	B-X
Cervical	B-X
spine	B-X
radiography	B-X
was	B-X
performed	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
,	B-X
followed	B-X
by	B-X
MRI	B-X
(	B-X
Fig	B-X
2	B-X
)	B-X
.	B-X
Included	B-X
are	B-X
representative	B-X
radiographs	B-X
of	B-X
the	B-X
pelvis	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
,	B-X
left	B-X
forearm	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
,	B-X
and	B-X
distal	B-X
right	B-X
leg	B-X
with	B-X
ankle	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X
Unenhanced	B-X
(	B-X
Fig	B-X
1	B-X
)	B-X
and	B-X
multiphasic	B-X
contrast-enhanced	B-X
CT	B-X
imaging	B-X
was	B-X
performed	B-X
in	B-X
arterial	B-X
(	B-X
Fig	B-X
2A	B-X
)	B-X
,	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
2B	B-X
)	B-X
,	B-X
and	B-X
delayed	B-X
(	B-X
3	B-X
minutes	B-X
after	B-X
injection	B-X
)	B-X
(	B-X
Fig	B-X
2C	B-X
)	B-X
phases	B-X
.	B-X
Axial	B-X
and	B-X
coronal	B-X
maximum	B-X
intensity	B-X
projection	B-X
reconstructed	B-X
CT	B-X
images	B-X
were	B-X
obtained	B-X
in	B-X
the	B-X
arterial	B-X
(	B-X
Fig	B-X
3	B-X
)	B-X
and	B-X
portal	B-X
venous	B-X
(	B-X
Fig	B-X
4	B-X
)	B-X
phases	B-X
.	B-X
The	B-X
patient	B-X
also	B-X
underwent	B-X
whole-body	B-X
iodine	B-X
131	B-X
scintigraphy	B-X
(	B-X
Fig	B-X
5	B-X
)	B-X
.	B-X

3	O
,	O
insertional	O
inactivation	O
of	O
sak189	O
affected	O
bac	O
gene	O
transcription	O
,	O
while	O
insertional	O
inactivation	O
of	O
the	O
sak188	O
did	O
not	O
affect	O
.	O

Thus	O
,	O
we	O
can	O
conclude	O
that	O
sak188	O
and	O
bac	O
gene	O
are	O
not	O
in	O
the	O
operon	O
,	O
and	O
repression	O
of	O
bac	O
gene	O
transcription	O
in	O
sak189	O
/	O
sak188	O
double	O
mutant	O
strain	O
is	O
not	O
due	O
to	O
the	O
polar	O
effect	O
.	O

Given	O
that	O
insertional	O
inactivation	O
of	O
sak188	O
gene	O
does	O
not	O
affect	O
beta	O
-	O
antigen	O
expression	O
,	O
we	O
suggest	O
that	O
beta	O
-	O
antigen	O
expression	O
can	O
be	O
activated	O
independently	O
of	O
Sak188	O
,	O
perhaps	O
through	O
small	O
-	O
molecular	O
-	O
weight	O
phosphodonors	O
such	O
as	O
acetyl	O
phosphate	O
or	O
other	O
noncognate	O
histidine	O
kinases	O
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
These	B-X
systems	B-X
sense	B-X
the	B-X
environmental	B-X
stimuli	B-X
and	B-X
regulate	B-X
expression	B-X
of	B-X
the	B-X
genes	B-X
including	B-X
virulence	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

Thus	O
,	O
we	O
can	O
not	O
rule	O
out	O
the	O
possibility	O
of	O
a	O
cross	O
-	O
talk	O
between	O
Sak189	O
response	O
regulator	O
and	O
sensor	O
kinase	O
(	O
s	O
)	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
,	O
and	O
Sak189	O
can	O
potentially	O
recruit	O
another	O
histidine	O
kinase	O
for	O
proper	O
functioning	O
.	O

The	O
cross	O
-	O
talk	O
among	O
different	O
TCSs	O
has	O
been	O
described	O
for	O
many	O
bacterial	O
species	O
[	O
3	O
]	O
including	O
pathogenic	O
streptococci	B-Organism
.	O

For	O
example	O
,	O
in	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
inactivation	O
of	O
histidine	O
kinase	O
HK06	O
(	O
78	O
%	O
similarity	O
with	O
Sak188	O
)	O
,	O
in	O
contrast	O
to	O
RR06	O
(	O
83	O
%	O
similarity	O
with	O
Sak189	O
)	O
,	O
did	O
not	O
repress	O
transcription	O
of	O
the	O
adjacent	O
cbpA	O
gene	O
[	O
22	O
]	O
indicating	O
a	O
cross	O
-	O
talk	O
between	O
RR06	O
and	O
noncognate	O
histidine	O
kinase	O
(	O
s	O
)	O
.	O

Intraperitoneal	O
infection	O
of	O
laboratory	O
mice	B-Organism
demonstrated	O
that	O
Sak189	O
DNA	O
-	O
binding	O
response	O
regulatory	O
protein	O
is	O
important	O
for	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

It	O
could	O
be	O
predicted	O
given	O
that	O
inactivation	O
of	O
other	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
TCSs	O
(	O
CovS	O
/	O
CovR	O
,	O
DltR	O
/	O
DltS	O
,	O
RgfA	O
/	O
RgfC	O
)	O
resulted	O
in	O
the	O
changes	O
of	O
virulent	O
properties	O
,	O
however	O
,	O
in	O
all	O
these	O
studies	O
the	O
mutant	O
strains	O
became	O
less	O
virulent	O
compared	O
to	O
the	O
wild	O
-	O
type	O
strains	O
[	O
8	O
]	O
-	O
[	O
12	O
]	O
.	O

In	O
the	O
present	O
study	O
,	O
insertional	O
inactivation	O
of	O
sak189	O
gene	O
abrogated	O
beta	O
-	O
antigen	O
expression	O
but	O
resulted	O
in	O
increased	O
virulence	O
(	O
Fig	O
.	O
4	O
)	O
.	O

Thus	O
,	O
we	O
suggest	O
that	O
beta	O
-	O
antigen	O
located	O
on	O
the	O
bacterial	O
surface	O
can	O
interfere	O
with	O
the	O
disease	O
process	O
and	O
play	O
a	O
role	O
of	O
anti	O
-	O
virulent	O
factor	O
(	O
at	O
least	O
,	O
in	O
mice	B-Organism
)	O
similarly	O
to	O
hyaluronate	O
lyase	O
of	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
[	O
41	O
]	O
.	O

It	O
is	O
also	O
in	O
agreement	O
with	O
results	O
of	O
Kong	O
et	O
al	O
.	O
who	O
demonstrated	O
that	O
presence	O
of	O
shorter	O
variants	O
of	O
beta	O
-	O
antigen	O
is	O
associated	O
with	O
increased	O
virulence	O
[	O
32	O
]	O
.	O

It	O
is	O
also	O
possible	O
that	O
bac	O
gene	O
encoding	O
for	O
beta	O
-	O
antigen	O
is	O
not	O
only	O
target	O
for	O
Sak188	O
/	O
Sak189	O
TCS	O
.	O
<EOS>	B-X
The	B-X
Gram-negative	B-X
bacterium	B-X
All	B-X
of	B-X
the	B-X
strains	B-X
with	B-X
ISSa4	B-X
possessed	B-X
both	B-X
bca	B-X
and	B-X
bac	B-X
virulence	B-X
genes	B-X
coding	B-X
for	B-X
alpha	B-X
and	B-X
beta	B-X
antigens	B-X
,	B-X
respectively	B-X
.	B-X
Multiple	B-X
target	B-X
sites	B-X
for	B-X
insertions	B-X
of	B-X
ISSa4	B-X
were	B-X
identified	B-X
and	B-X
included	B-X
a	B-X
putative	B-X
pathogenicity	B-X
island	B-X
,	B-X
``	B-X
housekeeping	B-X
''	B-X
genes	B-X
,	B-X
and	B-X
intergenic	B-X
regions	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
genes	B-X
for	B-X
hypothetical	B-X
proteins	B-X
.	B-X
No	B-X
significant	B-X
similarity	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
sequences	B-X
of	B-X
the	B-X
target	B-X
genes	B-X
for	B-X
ISSa4	B-X
insertions	B-X
,	B-X
in	B-X
the	B-X
relative	B-X
location	B-X
of	B-X
the	B-X
target	B-X
genes	B-X
on	B-X
the	B-X
chromosome	B-X
,	B-X
or	B-X
the	B-X
biological	B-X
functions	B-X
of	B-X
the	B-X
encoded	B-X
proteins	B-X
.	B-X
The	B-X
possible	B-X
significance	B-X
of	B-X
ISSa4-based	B-X
differentiation	B-X
of	B-X
the	B-X
strains	B-X
and	B-X
the	B-X
presence	B-X
of	B-X
possible	B-X
``	B-X
hot	B-X
spots	B-X
''	B-X
for	B-X
insertions	B-X
of	B-X
ISSa4	B-X
in	B-X
GBS	B-X
genome	B-X
are	B-X
discussed	B-X
.	B-X

The	O
difference	O
among	O
the	O
growth	O
curves	O
of	O
the	O
wild	O
-	O
type	O
and	O
mutant	O
strains	O
(	O
data	O
not	O
shown	O
)	O
indicate	O
that	O
in	O
addition	O
to	O
bac	O
gene	O
,	O
some	O
metabolic	O
genes	O
can	O
be	O
controlled	O
by	O
Sak188	O
/	O
Sak189	O
TCS	O
.	O

This	O
suggestion	O
is	O
confirmed	O
by	O
the	O
numerous	O
studies	O
demonstrating	O
the	O
genome	O
-	O
wide	O
location	O
of	O
the	O
genes	O
affected	O
by	O
TCSs	O
[	O
10	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
,	O
and	O
set	O
of	O
the	O
genes	O
controlled	O
by	O
Sak188	O
/	O
Sak189	O
(	O
TCS	O
regulon	O
)	O
can	O
be	O
identified	O
using	O
microarray	O
technology	O
.	O

As	O
seen	O
from	O
the	O
data	O
of	O
this	O
study	O
,	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
encoded	O
beta	O
-	O
antigen	O
are	O
the	O
primary	O
genotypic	O
/	O
phenotypic	O
properties	O
controlled	O
by	O
Sak188	O
/	O
Sak189	O
TCS	O
.	O

Therefore	O
,	O
it	O
is	O
reasonable	O
to	O
annotate	O
this	O
system	O
as	O
BgrR	O
/	O
S	O
(	O
bac	O
gene	O
regulatory	O
system	O
)	O
,	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
Sak189	O
and	O
sensor	O
histidine	O
kinase	O
Sak188	O
as	O
BgrR	O
and	O
BgrS	O
proteins	O
,	O
respectively	O
.	O

In	O
conclusion	O
,	O
the	O
data	O
presented	O
here	O
characterize	O
the	O
functional	O
role	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
Sak188	O
/	O
Sak189	O
two	O
-	O
component	O
system	O
.	O

Both	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
encoded	O
beta	O
-	O
antigen	O
are	O
controlled	O
by	O
Sak189	O
response	O
regulator	O
,	O
and	O
the	O
regulation	O
occurs	O
at	O
transcriptional	O
level	O
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
These	B-X
systems	B-X
sense	B-X
the	B-X
environmental	B-X
stimuli	B-X
and	B-X
regulate	B-X
expression	B-X
of	B-X
the	B-X
genes	B-X
including	B-X
virulence	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

Inactivation	O
of	O
histidine	O
kinase	O
Sak188	O
does	O
not	O
affect	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
beta	O
-	O
antigen	O
,	O
that	O
suggests	O
the	O
cross	O
-	O
talk	O
between	O
Sak189	O
and	O
other	O
sensor	O
kinase	O
(	O
s	O
)	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
These	B-X
systems	B-X
sense	B-X
the	B-X
environmental	B-X
stimuli	B-X
and	B-X
regulate	B-X
expression	B-X
of	B-X
the	B-X
genes	B-X
including	B-X
virulence	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

Finally	O
,	O
Sak189	O
,	O
but	O
not	O
Sak188	O
,	O
controls	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
in	O
vivo	O
.	O
<EOS>	B-X
Streptococcus	B-X
agalactiae	B-X
is	B-X
able	B-X
to	B-X
colonize	B-X
numerous	B-X
tissues	B-X
employing	B-X
different	B-X
mechanisms	B-X
of	B-X
gene	B-X
regulation	B-X
,	B-X
particularly	B-X
via	B-X
two-component	B-X
regulatory	B-X
systems	B-X
.	B-X
Recently	B-X
,	B-X
the	B-X
novel	B-X
two-component	B-X
regulatory	B-X
system	B-X
Sak188/Sak189	B-X
was	B-X
identified	B-X
.	B-X
In	B-X
S.	B-X
agalactiae	B-X
genome	B-X
,	B-X
it	B-X
was	B-X
adjacent	B-X
to	B-X
the	B-X
bac	B-X
gene	B-X
encoding	B-X
for	B-X
beta-antigen	B-X
,	B-X
an	B-X
important	B-X
virulence	B-X
factor	B-X
.	B-X

